PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dance, A				Dance, Amber			HEALTH IMPACT Breathless	NATURE			English	Editorial Material																			0	69	72	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S2	S2		10.1038/489S2a	http://dx.doi.org/10.1038/489S2a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013713	Bronze			2022-12-28	WOS:000309167100002
J	Binzel, RP				Binzel, Richard P.			A Golden Spike for Planetary Science	SCIENCE			English	Editorial Material							ASTEROID 4 VESTA; PARENT BODY; METEORITES; EARTH		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Binzel, RP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	rpb@mit.edu						Binzel RP, 1997, ICARUS, V128, P95, DOI 10.1006/icar.1997.5734; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; BOBROVNIKOFF NT, 1929, LICK OBS B, V14, P18; CONSOLMAGNO GJ, 1977, GEOCHIM COSMOCHIM AC, V41, P1271, DOI 10.1016/0016-7037(77)90072-2; CRUIKSHANK DP, 1991, ICARUS, V89, P1, DOI 10.1016/0019-1035(91)90083-6; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; Denevi BW, 2012, SCIENCE, V338, P246, DOI 10.1126/science.1225374; Gaffey MJ, 1997, ICARUS, V127, P130, DOI 10.1006/icar.1997.5680; Keil K., 2002, ASTEROIDS 3, P573; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Prettyman TH, 2012, SCIENCE, V338, P242, DOI 10.1126/science.1225354; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Srinivasan G, 1999, SCIENCE, V284, P1348, DOI 10.1126/science.284.5418.1348; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; WETHERILL GW, 1987, PHILOS T R SOC A, V323, P323, DOI 10.1098/rsta.1987.0089; WISDOM J, 1985, NATURE, V315, P731, DOI 10.1038/315731a0	17	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					203	204		10.1126/science.1228328	http://dx.doi.org/10.1126/science.1228328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22997132				2022-12-28	WOS:000309712300027
J	Ebbeling, CB; Feldman, HA; Chomitz, VR; Antonelli, TA; Gortmaker, SL; Osganian, SK; Ludwig, DS				Ebbeling, Cara B.; Feldman, Henry A.; Chomitz, Virginia R.; Antonelli, Tracy A.; Gortmaker, Steven L.; Osganian, Stavroula K.; Ludwig, David S.			A Randomized Trial of Sugar-Sweetened Beverages and Adolescent Body Weight	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-SCHOOL-STUDENTS; NON-HISPANIC WHITES; CHILDHOOD OBESITY; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; UNITED-STATES; CONSUMPTION; CHILDREN; AMERICANS; RESPONSES	Background Consumption of sugar-sweetened beverages may cause excessive weight gain. We aimed to assess the effect on weight gain of an intervention that included the provision of noncaloric beverages at home for overweight and obese adolescents. Methods We randomly assigned 224 overweight and obese adolescents who regularly consumed sugar-sweetened beverages to experimental and control groups. The experimental group received a 1-year intervention designed to decrease consumption of sugar-sweetened beverages, with follow-up for an additional year without intervention. We hypothesized that the experimental group would gain weight at a slower rate than the control group. Results Retention rates were 97% at 1 year and 93% at 2 years. Reported consumption of sugar-sweetened beverages was similar at baseline in the experimental and control groups (1.7 servings per day), declined to nearly 0 in the experimental group at 1 year, and remained lower in the experimental group than in the control group at 2 years. The primary outcome, the change in mean body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) at 2 years, did not differ significantly between the two groups (change in experimental group minus change in control group, -0.3; P = 0.46). At 1 year, however, there were significant between-group differences for changes in BMI (-0.57, P = 0.045) and weight (-1.9 kg, P = 0.04). We found evidence of effect modification according to ethnic group at 1 year (P = 0.04) and 2 years (P = 0.01). In a prespecified analysis according to ethnic group, among Hispanic participants (27 in the experimental group and 19 in the control group), there was a significant between-group difference in the change in BMI at 1 year (-1.79, P = 0.007) and 2 years (-2.35, P = 0.01), but not among non-Hispanic participants (P>0.35 at years 1 and 2). The change in body fat as a percentage of total weight did not differ significantly between groups at 2 years (-0.5%, P = 0.40). There were no adverse events related to study participation. Conclusions Among overweight and obese adolescents, the increase in BMI was smaller in the experimental group than in the control group after a 1-year intervention designed to reduce consumption of sugar-sweetened beverages, but not at the 2-year follow-up (the prespecified primary outcome). (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; ClinicalTrials.gov number, NCT00381160.)	[Ebbeling, Cara B.; Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Feldman, Henry A.; Antonelli, Tracy A.; Osganian, Stavroula K.] Boston Childrens Hosp, Clin Res Ctr, Boston, MA 02115 USA; [Chomitz, Virginia R.] Inst Community Hlth, Cambridge, MA USA; [Gortmaker, Steven L.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Feldman, Henry/M-2302-2013	Ludwig, David/0000-0003-3307-8544	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK073025, K24DK082730]; National Center for Research Resources [M01RR02172]; Harvard Catalyst Clinical and Translational Science Center [UL1RR025758]; New Balance Foundation; National Institute of Child Health and Human Development [HD30780]; Centers for Disease Control and Prevention [1U48DP001946]; Robert Wood Johnson Foundation [66284]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030780] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001946] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730, R01DK073025] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard Catalyst Clinical and Translational Science Center; New Balance Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073025 and K24DK082730, to Dr. Ludwig) and from the National Center for Research Resources to the Boston Children's Hospital General Clinical Research Center (M01RR02172), the Harvard Catalyst Clinical and Translational Science Center (UL1RR025758), and the New Balance Foundation. The observational study was supported by grants from the National Institute of Child Health and Human Development (HD30780), the Centers for Disease Control and Prevention (1U48DP001946), and the Robert Wood Johnson Foundation (66284).	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Allison DB, 2009, JAMA-J AM MED ASSOC, V301, P318, DOI 10.1001/jama.2008.974; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P778; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Bremer Andrew A, 2011, Int J Adolesc Med Health, V23, P279; Cradock AL, 2011, PREV CHRONIC DIS, V8; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Department of Agriculture Department of Health and Human Services, 2010, DIET GUID AM 2010; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Goran MI, 2002, DIABETES CARE, V25, P2184, DOI 10.2337/diacare.25.12.2184; Haffner SM, 1996, DIABETES, V45, P742, DOI 10.2337/diabetes.45.6.742; Haffner SM, 1996, DIABETES CARE, V19, P67, DOI 10.2337/diacare.19.1.67; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Lee JM, 2010, INT J OBESITY, V34, P614, DOI 10.1038/ijo.2009.235; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; McGovern L, 2008, J CLIN ENDOCR METAB, V93, P4600, DOI 10.1210/jc.2006-2409; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; Singh R, 2009, AM J CLIN NUTR, V89, P1744, DOI 10.3945/ajcn.2008.26752; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; Weston AT, 1997, MED SCI SPORT EXER, V29, P138, DOI 10.1097/00005768-199701000-00020	29	472	481	3	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1407	1416		10.1056/NEJMoa1203388	http://dx.doi.org/10.1056/NEJMoa1203388			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	22998339	Green Accepted, Bronze			2022-12-28	WOS:000309652700007
J	Kocabas, A; Shen, CH; Guo, ZCV; Ramanathan, S				Kocabas, Askin; Shen, Ching-Han; Guo, Zengcai V.; Ramanathan, Sharad			Controlling interneuron activity in Caenorhabditis elegans to evoke chemotactic behaviour	NATURE			English	Article							LIM HOMEOBOX GENE; C-ELEGANS; NEURAL ACTIVITY; NERVOUS-SYSTEM; OPTICAL CONTROL; NEURONS; WORM; EXPRESSION; CIRCUITS; PROTEIN	Animals locate and track chemoattractive gradients in the environment to find food. With its small nervous system, Caenorhabditis elegans is a good model system(1,2) in which to understand how the dynamics of neural activity control this search behaviour. Extensive work on the nematode has identified the neurons that are necessary for the different locomotory behaviours underlying chemotaxis through the use of laser ablation(3-7), activity recording in immobilized animals and the study of mutants(4,5). However, we do not know the neural activity patterns in C. elegans that are sufficient to control its complex chemotactic behaviour. To understand how the activity in its interneurons coordinate different motor programs to lead the animal to food, here we used optogenetics and new optical tools to manipulate neural activity directly in freely moving animals to evoke chemotactic behaviour. By deducing the classes of activity patterns triggered during chemotaxis and exciting individual neurons with these patterns, we identified interneurons that control the essential locomotory programs for this behaviour. Notably, we discovered that controlling the dynamics of activity in just one interneuron pair (AIY) was sufficient to force the animal to locate, turn towards and track virtual light gradients. Two distinct activity patterns triggered in AIY as the animal moved through the gradient controlled reversals and gradual turns to drive chemotactic behaviour. Because AIY neurons are post-synaptic to most chemosensory and thermosensory neurons(8), it is probable that these activity patterns in AIY have an important role in controlling and coordinating different taxis behaviours of the animal.	[Kocabas, Askin; Shen, Ching-Han; Ramanathan, Sharad] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Kocabas, Askin; Shen, Ching-Han; Ramanathan, Sharad] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Guo, Zengcai V.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ramanathan, Sharad] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Ramanathan, Sharad] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ramanathan, Sharad] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Allen Institute for Brain Science; Harvard University; Harvard University	Kocabas, A (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	akocabas@cgr.harvard.edu; sharad@post.harvard.edu		Kocabas, Askin/0000-0002-6930-1202	Human Frontier Science Program (HFSP) Postdoctoral Fellowship; National Science Foundation (NSF) Graduate Fellowship; NSF Career Award; Pew Scholar, Klingenstein Fellowship Award; National Institutes of Health (NIH) Pioneer Awards; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099906] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP) Postdoctoral Fellowship(Human Frontier Science Program); National Science Foundation (NSF) Graduate Fellowship(National Science Foundation (NSF)); NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Pew Scholar, Klingenstein Fellowship Award; National Institutes of Health (NIH) Pioneer Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Dowling, S. Lockery, J. Lichtman, K. McCormick, A. Murray, E. O'Shea, A. Schier, B. Stern and members of the Ramanathan laboratory for discussions and comments, the Human Frontier Science Program (HFSP) Postdoctoral Fellowship (A. K.), National Science Foundation (NSF) Graduate Fellowship (C.-H.S.), NSF Career Award, Pew Scholar, Klingenstein Fellowship Award and the National Institutes of Health (NIH) Pioneer Awards (S. R.) for support.	Bendena WG, 2008, P NATL ACAD SCI USA, V105, P1339, DOI 10.1073/pnas.0709492105; BOULIN T, 2006, WORMBOOK; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRENNER S, 1974, GENETICS, V77, P71; BRENNER S, 1973, BRIT MED BULL, V29, P269, DOI 10.1093/oxfordjournals.bmb.a071019; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chou JH, 2001, GENETICS, V157, P211; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Izquierdo EJ, 2010, J NEUROSCI, V30, P12908, DOI 10.1523/JNEUROSCI.2606-10.2010; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kim D, 2011, J EXP BIOL, V214, P1554, DOI 10.1242/jeb.052092; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lockery SR, 2011, CURR OPIN NEUROBIOL, V21, P782, DOI 10.1016/j.conb.2011.06.009; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Okazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035370; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	33	83	86	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					273	+		10.1038/nature11431	http://dx.doi.org/10.1038/nature11431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23000898	Green Accepted, Green Submitted			2022-12-28	WOS:000309733300052
J	Wootton, DM; Alevriadou, BR				Wootton, David M.; Alevriadou, B. Rita			The Shear Stress of Busting Blood Clots	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FLOW		[Wootton, David M.] Cooper Union Adv Sci & Art, Dept Mech Engn, New York, NY 10003 USA; [Wootton, David M.] Cooper Union Adv Sci & Art, Maurice Kanbar Ctr Biomed Engn, New York, NY 10003 USA; [Alevriadou, B. Rita] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Alevriadou, B. Rita] Ohio State Univ, Dept Internal Med Cardiovasc Med, Columbus, OH USA; [Alevriadou, B. Rita] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH USA	Ohio State University; Ohio State University; Ohio State University	Wootton, DM (corresponding author), Cooper Union Adv Sci & Art, Dept Mech Engn, New York, NY 10003 USA.		Alevriadou, Barbara R/E-2628-2011	Alevriadou, Barbara/0000-0003-1897-755X				Korin N, 2012, SCIENCE, V337, P738, DOI 10.1126/science.1217815; Ruggeri ZM, 2009, MICROCIRCULATION, V16, P58, DOI 10.1080/10739680802651477; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; TILLES AW, 1987, MICROVASC RES, V33, P211, DOI 10.1016/0026-2862(87)90018-5; Wootton DM, 2002, BIOTECHNOL BIOENG, V77, P405, DOI 10.1002/bit.10127	5	10	10	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1361	1363		10.1056/NEJMcibr1207994	http://dx.doi.org/10.1056/NEJMcibr1207994			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034026				2022-12-28	WOS:000309406100017
J	Arshad, A; Powell, C; Tighe, MP				Arshad, A.; Powell, C.; Tighe, M. P.			Hirschsprung's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTORS; 1ST STOOL; DIAGNOSIS; ENTEROCOLITIS; CONSTIPATION; BIOPSY; JAPAN		[Arshad, A.; Tighe, M. P.] Poole Hosp NHS Trust, Dept Paediat, Poole BH15 2JB, Dorset, England; [Powell, C.] Upton Surg, Poole BH16 5PW, Dorset, England		Tighe, MP (corresponding author), Poole Hosp NHS Fdn Trust, Poole Hosp, Longfleet Rd, Poole BH21 2HJ, Dorset, England.	mpt195@hotmail.com						Afzal NA, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-28; Aslam A, 1997, J PEDIATR SURG, V32, P1206, DOI 10.1016/S0022-3468(97)90683-7; Beaudet A.R., 2001, METABOLIC MOL BASES, V8th; Blake NS, 2010, HIRSCHSPRUNGS DIS AL, P223; CLARK DA, 1977, PEDIATRICS, V60, P457; de Lorijn F, 2005, J PEDIATR-US, V146, P787, DOI 10.1016/j.jpeds.2005.01.044; Doodnath R, 2010, PEDIATR SURG INT, V26, P1107, DOI 10.1007/s00383-010-2694-2; Ghosh A, 1998, ARCH DIS CHILD, V79, P266, DOI 10.1136/adc.79.3.266; Hackam DJ, 1998, J PEDIATR SURG, V33, P830, DOI 10.1016/S0022-3468(98)90652-2; Haricharan RN, 2008, J PEDIATR SURG, V43, P1115, DOI 10.1016/j.jpedsurg.2008.02.039; IKEDA K, 1984, ANN SURG, V199, P400, DOI 10.1097/00000658-198404000-00005; KLEINHAUS S, 1979, J PEDIATR SURG, V14, P588, DOI 10.1016/S0022-3468(79)80145-1; Liem NT, 2008, ASIAN J SURG, V31, P216, DOI 10.1016/S1015-9584(08)60090-1; National Institute for Health and Clinical Excellence, 2010, DIAGN MAN ID CHILDH; Nofech-Mozes Y, 2004, J PAEDIATR CHILD H, V40, P716, DOI 10.1111/j.1440-1754.2004.00519.x; Pini-Prato A, 2007, PEDIATR SURG INT, V23, P117, DOI 10.1007/s00383-006-1845-y; RESCORLA FJ, 1992, ARCH SURG-CHICAGO, V127, P934; SHERRY SN, 1955, J PEDIATR-US, V46, P158, DOI 10.1016/S0022-3476(55)80205-3; Singh SJ, 2003, PEDIATR SURG INT, V19, P247, DOI 10.1007/s00383-002-0842-z; Suita S, 2005, J PEDIATR SURG, V40, P197, DOI 10.1016/j.jpedsurg.2004.09.052; SWENSON O, 1973, J PEDIATR SURG, V8, P587, DOI 10.1016/0022-3468(73)90395-3; TEITELBAUM DH, 1988, ANN SURG, V207, P240, DOI 10.1097/00000658-198803000-00003; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; Ziad F, 2006, ANN SAUDI MED, V26, P200, DOI 10.5144/0256-4947.2006.200	24	21	23	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2012	345								e5521	10.1136/bmj.e5521	http://dx.doi.org/10.1136/bmj.e5521			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KB	23028095				2022-12-28	WOS:000309657900005
J	Leppik, IE; Walczak, TS; Birnbaum, AK				Leppik, Ilo E.; Walczak, Thaddeus S.; Birnbaum, Angela K.			Challenges of epilepsy in elderly people	LANCET			English	Editorial Material							NURSING-HOME RESIDENTS; ANTIEPILEPTIC DRUG-USE; VARIABILITY; THERAPY		[Leppik, Ilo E.; Birnbaum, Angela K.] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Leppik, Ilo E.; Walczak, Thaddeus S.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Leppik, Ilo E.; Walczak, Thaddeus S.] MINCEP Epilepsy Care, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Leppik, IE (corresponding author), Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	leppi001@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026390] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG026390] Funding Source: Medline; NINDS NIH HHS [P50 NS016308] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn JE, 2008, NEUROLOGY, V71, P38, DOI 10.1212/01.wnl.0000316392.55784.57; Birnbaum A, 2003, NEUROLOGY, V60, P555, DOI 10.1212/01.WNL.0000052997.43492.E0; Birnbaum AK, 2012, EPILEPSY RES, V101, P22, DOI 10.1016/j.eplepsyres.2012.02.014; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; COLD JA, 1990, DICP ANN PHARMAC, V24, P601, DOI 10.1177/106002809002400610; Eberly LE, 2010, NEUROLOGY, V74, pA42; Ensrud KE, 2008, NEUROLOGY, V71, P723, DOI 10.1212/01.wnl.0000324919.86696.a9; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Fisher RS, 2008, EPILEPSIA, V49, P7, DOI 10.1111/j.1528-1167.2008.01921.x; Garrard J, 2000, J GERONTOL A-BIOL, V55, pM384, DOI 10.1093/gerona/55.7.M384; Garrard J, 2007, INT REV NEUROBIOL, V81, P165, DOI 10.1016/S0074-7742(06)81010-X; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Leppik IE, 2006, EPILEPSY RES, V68, pS1; LEPPIK IE, 1979, THER DRUG MONIT, V1, P475, DOI 10.1097/00007691-197910000-00004	14	10	10	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1128	1130		10.1016/S0140-6736(12)61517-7	http://dx.doi.org/10.1016/S0140-6736(12)61517-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021270				2022-12-28	WOS:000309255900007
J	Pla, JJ; Tan, KY; Dehollain, JP; Lim, WH; Morton, JJL; Jamieson, DN; Dzurak, AS; Morello, A				Pla, Jarryd J.; Tan, Kuan Y.; Dehollain, Juan P.; Lim, Wee H.; Morton, John J. L.; Jamieson, David N.; Dzurak, Andrew S.; Morello, Andrea			A single-atom electron spin qubit in silicon	NATURE			English	Article							QUANTUM-DOT; NUCLEAR-SPIN; OSCILLATIONS; TRANSISTOR; COHERENCE; RESONANCE; MEMORY; GATES	A single atom is the prototypical quantum system, and a natural candidate for a quantum bit, or qubit-the elementary unit of a quantum computer. Atoms have been successfully used to store and process quantum information in electromagnetic traps(1), as well as in diamond through the use of the nitrogen-vacancy-centre point defect(2). Solid-state electrical devices possess great potential to scale up such demonstrations from few-qubit control to larger-scale quantum processors. Coherent control of spin qubits has been achieved in lithographically defined double quantum dots in both GaAs (refs 3-5) and Si (ref. 6). However, it is a formidable challenge to combine the electrical measurement capabilities of engineered nanostructures with the benefits inherent in atomic spin qubits. Here we demonstrate the coherent manipulation of an individual electron spin qubit bound to a phosphorus donor atom in natural silicon, measured electrically via single-shot read-out(7-9). We use electron spin resonance to drive Rabi oscillations, and a Hahn echo pulse sequence reveals a spin coherence time exceeding 200 mu s. This time should be even longer in isotopically enriched Si-28 samples(10,11). Combined with a device architecture(12) that is compatible with modern integrated circuit technology, the electron spin of a single phosphorus atom in silicon should be an excellent platform on which to build a scalable quantum computer.	[Pla, Jarryd J.; Tan, Kuan Y.; Dehollain, Juan P.; Lim, Wee H.; Dzurak, Andrew S.; Morello, Andrea] Univ New S Wales, Ctr Quantum Computat & Commun Technol, Sch Elect Engn & Telecommun, Sydney, NSW 2052, Australia; [Morton, John J. L.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Jamieson, David N.] Univ Melbourne, Ctr Quantum Computat & Commun Technol, Sch Phys, Melbourne, Vic 3010, Australia	University of New South Wales Sydney; University of Oxford; University of Melbourne	Pla, JJ (corresponding author), Univ New S Wales, Ctr Quantum Computat & Commun Technol, Sch Elect Engn & Telecommun, Sydney, NSW 2052, Australia.	jarryd@unsw.edu.au; a.morello@unsw.edu.au	Pla, Jarryd J/J-4987-2015; Dehollain, Juan Pablo/G-9915-2012; Morello, Andrea/B-6475-2008; Dzurak, Andrew S/C-5973-2009; Tan, Kuan Yen/G-4475-2010; Morton, John/I-3515-2013; Jamieson, David N/G-3753-2010	Pla, Jarryd J/0000-0002-7152-3453; Dehollain, Juan Pablo/0000-0002-0425-4345; Morello, Andrea/0000-0001-7445-699X; Dzurak, Andrew S/0000-0003-1389-5096; Tan, Kuan Yen/0000-0001-5168-4914; Cador, Olivier/0000-0003-2064-6223; Jamieson, David/0000-0001-7733-6715	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology [CE11E0096]; US Army Research Office [W911NF-08-1-0527]; Australian National Fabrication Facility; Engineering and Physical Sciences Research Council [EP/H025952/1, EP/H025952/2, EP/I035536/1, EP/I035536/2] Funding Source: researchfish; EPSRC [EP/I035536/2, EP/H025952/1, EP/H025952/2, EP/I035536/1] Funding Source: UKRI	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology(Australian Research Council); US Army Research Office; Australian National Fabrication Facility; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank R. P. Starrett, D. Barber, C. Y. Yang and R. Szymanski for technical assistance. We also thank A. Laucht for the Bloch sphere artwork and D. Reilly for comments on the manuscript. This research was funded by the Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology (project number CE11E0096) and the US Army Research Office (W911NF-08-1-0527). We acknowledge support from the Australian National Fabrication Facility.	Ager JW, 2005, J ELECTROCHEM SOC, V152, pG448, DOI 10.1149/1.1901674; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Biercuk MJ, 2009, NATURE, V458, P996, DOI 10.1038/nature07951; Bradbury FR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.176404; CHIBA M, 1972, J PHYS SOC JPN, V33, P730, DOI 10.1143/JPSJ.33.730; Dehollain J. P., 2012, NANOSCALE BROADBAND; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; FEHER G, 1959, PHYS REV, V114, P1245, DOI 10.1103/PhysRev.114.1245; Fuechsle M, 2012, NAT NANOTECHNOL, V7, P242, DOI [10.1038/nnano.2012.21, 10.1038/NNANO.2012.21]; Hollenberg LCL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045311; Jamieson DN, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1925320; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Maune BM, 2012, NATURE, V481, P344, DOI 10.1038/nature10707; Morello A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.081307; Morello A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207206; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Morton JJL, 2011, NATURE, V479, P345, DOI 10.1038/nature10681; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Schenkel T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2182068; Simmons CB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156804; Tyryshkin AM, 2006, J PHYS-CONDENS MAT, V18, pS783, DOI 10.1088/0953-8984/18/21/S06; Tyryshkin A. M., 2010, DYNAMICAL DECOUPLING; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; van der Sar T, 2012, NATURE, V484, P82, DOI 10.1038/nature10900; Witzel WM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035322; Witzel WM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.187602; Xiao M, 2004, NATURE, V430, P435, DOI 10.1038/nature02727	30	566	577	16	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					541	545		10.1038/nature11449	http://dx.doi.org/10.1038/nature11449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22992519	Green Submitted			2022-12-28	WOS:000309167100045
J	Van den Bruel, A; Thompson, M; Buntinx, F; Mant, D				Van den Bruel, Ann; Thompson, Matthew; Buntinx, Frank; Mant, David			Clinicians' gut feeling about serious infections in children: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; YOUNG-CHILDREN; MODEL; RECOGNITION; BACTEREMIA; DIAGNOSIS; SIGNS	Objective To investigate the basis and added value of clinicians' "gut feeling" that infections in children are more serious than suggested by clinical assessment. Design Observational study. Setting Primary care setting, Flanders, Belgium. Participants Consecutive series of 3890 children and young people aged 0-16 years presenting in primary care. Main outcome measures Presenting features, clinical assessment, doctors' intuitive response at first contact with children in primary care, and any subsequent diagnosis of serious infection determined from hospital records. Results Of the 3369 children and young people assessed clinically as having a non-severe illness, six (0.2%) were subsequently admitted to hospital with a serious infection. Intuition that something was wrong despite the clinical assessment of non-severe illness substantially increased the risk of serious illness (likelihood ratio 25.5, 95% confidence interval 7.9 to 82.0) and acting on this gut feeling had the potential to prevent two of the six cases being missed (33%, 95% confidence interval 4.0% to 100%) at a cost of 44 false alarms (1.3%, 95% confidence interval 0.95% to 1.75%). The clinical features most strongly associated with gut feeling were the children's overall response (drowsiness, no laughing), abnormal breathing, weight loss, and convulsions. The strongest contextual factor was the parents' concern that the illness was different from their previous experience (odds ratio 36.3, 95% confidence interval 12.3 to 107). Conclusions A gut feeling about the seriousness of illness in children is an instinctive response by clinicians to the concerns of the parents and the appearance of the children. It should trigger action such as seeking a second opinion or further investigations. The observed association between intuition and clinical markers of serious infection means that by reflecting on the genesis of their gut feeling, clinicians should be able to hone their clinical skills.	[Van den Bruel, Ann; Thompson, Matthew; Mant, David] Radcliffe Observ Quarter, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Buntinx, Frank] Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium	Universite Catholique Louvain	Van den Bruel, A (corresponding author), Radcliffe Observ Quarter, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	ann.vandenbruel@phc.ox.ac.uk	Van den Bruel, Ann/AAC-2442-2020	Van den Bruel, Ann/0000-0001-9012-2009	Research Foundation-Flanders (FWO); Eurogenerics; National Institute for Health Research [RP-PG-0407-10347]; National Institute for Health Research [CL-2009-13-007, NF-SI-0507-10198, CDF-2011-04-052] Funding Source: researchfish	Research Foundation-Flanders (FWO)(FWO); Eurogenerics; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The original study was funded by a grant of the Research Foundation-Flanders (FWO) and an unconditional grant from Eurogenerics. None of the funders had any role in the design or analysis of the original study nor of the current analyses. The present analyses were done as part of the MaDOx programme, which presents independent research commissioned by the National Institute for Health Research under its programme grants for applied research funding scheme (RP-PG-0407-10347). MT is funded by a career development fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almond S, 2009, BRIT J GEN PRACT, V59, P872, DOI 10.3399/bjgp09X472971; Balla JI, 2009, J EVAL CLIN PRACT, V15, P964, DOI 10.1111/j.1365-2753.2009.01243.x; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Bruyninckx R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-55; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Grant CC, 2012, ARCH DIS CHILD, V97, P21, DOI 10.1136/archdischild-2011-300604; Greenhalgh R, 2002, BRIT J GEN PRACT, V52, P395; Haddon RA, 1999, MED J AUSTRALIA, V170, P475, DOI 10.5694/j.1326-5377.1999.tb127847.x; Harnden A, 2007, BRIT MED J, V335, P409, DOI 10.1136/bmj.39295.383843.AD; Lykke K, 2008, FAM PRACT, V25, P146, DOI 10.1093/fampra/cmn021; MCCARTHY PL, 1987, J PEDIATR-US, V110, P26, DOI 10.1016/S0022-3476(87)80282-2; Pearson GA, 2008, CONFIDENTIAL ENQUIRY; Shavit I, 2006, PEDIATRICS, V118, P2402, DOI 10.1542/peds.2006-1108; Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026; Stolper E, 2011, J GEN INTERN MED, V26, P197, DOI 10.1007/s11606-010-1524-5; Stolper E, 2010, EUR J GEN PRACT, V16, P72, DOI 10.3109/13814781003653424; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; WASKERWITZ S, 1981, J PEDIATR-US, V99, P231, DOI 10.1016/S0022-3476(81)80458-1; Wells LC, 2001, ARCH DIS CHILD, V85, P218, DOI 10.1136/adc.85.3.218	26	105	106	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2012	345								e6144	10.1136/bmj.e6144	http://dx.doi.org/10.1136/bmj.e6144			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014ON	23015034	hybrid, Green Published			2022-12-28	WOS:000309385500004
J	Davis, CL; Pollock, NK; Waller, JL; Allison, JD; Dennis, BA; Bassali, R; Melendez, A; Boyle, CA; Gower, BA				Davis, Catherine L.; Pollock, Norman K.; Waller, Jennifer L.; Allison, Jerry D.; Dennis, B. Adam; Bassali, Reda; Melendez, Agustin; Boyle, Colleen A.; Gower, Barbara A.			Exercise Dose and Diabetes Risk in Overweight and Obese Children A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN SENSITIVITY INDEXES; ORAL DISPOSITION INDEX; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; RESISTANCE SYNDROME; VISCERAL ADIPOSITY; YOUTH; INTERVENTION; FITNESS; FAT	Context Pediatric studies have shown that aerobic exercise reduces metabolic risk, but dose-response information is not available. Objectives To test the effect of different doses of aerobic training on insulin resistance, fatness, visceral fat, and fitness in overweight, sedentary children and to test moderation by sex and race. Design, Setting, and Participants Randomized controlled efficacy trial conducted from 2003 through 2007 in which 222 overweight or obese sedentary children (mean age, 9.4 years; 42% male; 58% black) were recruited from 15 public schools in the Augusta, Georgia, area. Intervention Children were randomly assigned to low-dose (20 min/d; n = 71) or high-dose (40 min/d; n = 73) aerobic training (5 d/wk; mean duration, 13 [SD, 1.6] weeks) or a control condition (usual physical activity; n = 78). Main Outcome Measures The prespecified primary outcomes were postintervention type 2 diabetes risk assessed by insulin area under the curve (AUC) from an oral glucose tolerance test, aerobic fitness (peak oxygen consumption [(V) over dotO(2)]), percent body fat via dual-energy x-ray absorptiometry, and visceral fat via magnetic resonance, analyzed by intention to treat. Results The study had 94% retention (n = 209). Most children (85%) were obese. At baseline, mean body mass index was 26 (SD, 4.4). Reductions in insulin AUC were larger in the high-dose group (adjusted mean difference, -3.56 [95% CI, -6.26 to -0.85] x 10(3) mu U/mL; P = .01) and the low-dose group (adjusted mean difference, -2.96 [95% CI, -5.69 to -0.22] x 10(3) mu U/mL; P = .03) than the control group. Dose-response trends were also observed for body fat (adjusted mean difference, -1.4% [95% CI, -2.2% to -0.7%]; P < .001 and -0.8% [95% CI, -1.6% to -0.07%]; P = .03) and visceral fat (adjusted mean difference, -3.9 cm(3) [95% CI, -6.0 to -1.7 cm(3)]; P < .001 and -2.8 cm(3) [95% CI, -4.9 to -0.6 cm(3)]; P = .01) in the high- and low-dose vs control groups, respectively. Effects in the high-and low-dose groups vs control were similar for fitness (adjusted mean difference in peak (V) over dotO(2), 2.4 [95% CI, 0.4-4.5] mL/kg/min; P = .02 and 2.4 [95% CI, 0.3-4.5] mL/kg/min; P = .03, respectively). High-vs low-dose group effects were similar for these outcomes. There was no moderation by sex or race. Conclusion In this trial, after 13 weeks, 20 or 40 min/d of aerobic training improved fitness and demonstrated dose-response benefits for insulin resistance and general and visceral adiposity in sedentary overweight or obese children, regardless of sex or race.	[Davis, Catherine L.] Med Coll Georgia, Dept Pediat, Inst Publ & Prevent Hlth, Georgia Prevent Ctr, Augusta, GA 30912 USA; [Waller, Jennifer L.] Med Coll Georgia, Dept Biostat, Augusta, GA 30912 USA; [Allison, Jerry D.] Med Coll Georgia, Dept Radiol, Augusta, GA 30912 USA; [Dennis, B. Adam] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Melendez, Agustin] Univ Politecn Madrid, Sch Phys Act & Sports Sci, Natl Inst Phys Educ, Madrid, Spain; [Gower, Barbara A.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Universidad Politecnica de Madrid; University of Alabama System; University of Alabama Birmingham	Davis, CL (corresponding author), Med Coll Georgia, Dept Pediat, Inst Publ & Prevent Hlth, Georgia Prevent Ctr, 1120 15th St,Ste 1640, Augusta, GA 30912 USA.	cadavis@georgiahealth.edu	Davis, Catherine L/A-7522-2011	Pollock, Norman/0000-0002-5465-2018; Davis, Catherine Lucy/0000-0002-2942-8233	National Institutes of Health [R01 DK060692, R01 HL087923, P30 DK056336]; Salvador de Madariaga Program of the Spanish Ministry of Education and Science [PR2006-0125]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060692, P30DK056336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salvador de Madariaga Program of the Spanish Ministry of Education and Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants R01 DK060692, R01 HL087923, and P30 DK056336 from the National Institutes of Health and grant PR2006-0125 from the Salvador de Madariaga Program of the Spanish Ministry of Education and Science.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; American College of Sports Medicine, 2000, ACSMS GUID EX TEST P; [Anonymous], AEROBIC EXERCISE TES; Barbeau P, 2007, OBESITY, V15, P2077, DOI 10.1038/oby.2007.247; Brener Nancy D., 2004, Morbidity and Mortality Weekly Report, V53, P1; BRENER ND, 1995, AM J EPIDEMIOL, V141, P575, DOI 10.1093/oxfordjournals.aje.a117473; Committee on Accelerating Progress in Obesity Prevention, 2012, ACCELERATING PROGR O; D'Adamo E, 2010, AM J CLIN NUTR, V92, P500, DOI 10.3945/ajcn.2010.29270; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Davis CL, 2011, HEALTH PSYCHOL, V30, P91, DOI 10.1037/a0021766; Davis CL, 2005, AM J MED SCI, V330, P53, DOI 10.1097/00000441-200508000-00001; Davis CL, 2002, AM J MED SCI, V324, P72, DOI 10.1097/00000441-200208000-00005; Donnelly JE, 2009, PREV MED, V49, P336, DOI 10.1016/j.ypmed.2009.07.022; Ferguson MA, 1999, INT J OBESITY, V23, P889, DOI 10.1038/sj.ijo.0800968; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Gower BA, 1998, AM J CLIN NUTR, V67, P821, DOI 10.1093/ajcn/67.5.821; Gutin B, 2005, AM J CLIN NUTR, V81, P746, DOI 10.1093/ajcn/81.4.746; Gutin B, 2002, AM J CLIN NUTR, V75, P818, DOI 10.1093/ajcn/75.5.818; Gutin B, 1999, OBES RES, V7, P208, DOI 10.1002/j.1550-8528.1999.tb00703.x; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Haskell WL, 1995, PHYS ACTIVITY FITNES, V2, P1; Howe CA, 2010, J PEDIATR-US, V157, P936, DOI 10.1016/j.jpeds.2010.06.041; Institute of Medicine, 2007, AQ EV PHYS ACT GUID; Johnson JL, 2007, AM J CARDIOL, V100, P1759, DOI 10.1016/j.amjcard.2007.07.027; Kesten JM, 2011, OBES REV, V12, P997, DOI 10.1111/j.1467-789X.2011.00919.x; Kibbe DL, 2011, PREV MED, V52, pS43, DOI 10.1016/j.ypmed.2011.01.025; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Mahar MT, 2006, MED SCI SPORT EXER, V38, P2086, DOI 10.1249/01.mss.0000235359.16685.a3; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669; McGill HC, 2000, CIRCULATION, V102, P374; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Owens S, 1999, MED SCI SPORT EXER, V31, P143, DOI 10.1097/00005768-199901000-00022; Owens S, 1998, J PEDIATR-US, V133, P41, DOI 10.1016/S0022-3476(98)70175-1; Pate RR, 2006, CIRCULATION, V114, P1214, DOI 10.1161/CIRCULATIONAHA.106.177052; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Rosenbloom A, 2000, DIABETES CARE, V23, P381; Sallis JF, 1997, AM J PUBLIC HEALTH, V87, P1328, DOI 10.2105/AJPH.87.8.1328; SALLIS JF, 1993, ANN NY ACAD SCI, V699, P127, DOI 10.1111/j.1749-6632.1993.tb18844.x; Sjaarda LG, 2012, J PEDIATR-US, V161, P51, DOI 10.1016/j.jpeds.2011.12.050; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Webber LS, 1996, PREV MED, V25, P432, DOI 10.1006/pmed.1996.0075; White J, 2012, ARCH PEDIAT ADOL MED, V166, P522, DOI 10.1001/archpediatrics.2012.99; Williams CL, 2002, CIRCULATION, V106, P143, DOI 10.1161/01.CIR.0000019555.61092.9E; Yeckel CW, 2004, J CLIN ENDOCR METAB, V89, P1096, DOI 10.1210/jc.2003-031503; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171	53	130	132	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1103	1112		10.1001/2012.jama.10762	http://dx.doi.org/10.1001/2012.jama.10762			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990269	Green Accepted, Bronze			2022-12-28	WOS:000308861000026
J	Augestad, KM; Dehli, T; Thuy, L; Nygren, J				Augestad, Knut Magne; Dehli, Trond; Thuy, Lu; Nygren, Jonas			A Littre bleed	LANCET			English	Editorial Material							MECKEL DIVERTICULUM; HERNIA		[Augestad, Knut Magne] Univ Hosp N Norway, Norwegian Natl Ctr Integrated Care & Telemed, Dept Gastrointestinal Surg, N-9037 Tromso, Norway; [Augestad, Knut Magne] Univ Hosp N Norway, Dept Integrated Care & Telemed, N-9037 Tromso, Norway; [Thuy, Lu] Univ Hosp N Norway, Dept Radiol & Nucl Med, N-9037 Tromso, Norway; [Augestad, Knut Magne] Univ Tromso, Inst Clin Med, Tromso, Norway; [Nygren, Jonas] Ersta Hosp, Dept Surg, Stockholm, Sweden; [Nygren, Jonas] Danderyd Hosp, Dept Clin Sci, Karolinska Inst, Stockholm, Sweden	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; Ersta Sjukhus; Danderyds Hospital; Karolinska Institutet	Augestad, KM (corresponding author), Univ Hosp N Norway, Norwegian Natl Ctr Integrated Care & Telemed, Dept Gastrointestinal Surg, N-9037 Tromso, Norway.	knut.magne.augestad@telemed.no	Nygren, Jonas/AAQ-2775-2021					DUNN TM, 1962, AM J SURG, V103, P144, DOI 10.1016/0002-9610(62)90030-2; Kiratli PO, 2009, ANN NUCL MED, V23, P97, DOI 10.1007/s12149-008-0204-6; Park JJ, 2005, ANN SURG, V241, P529, DOI 10.1097/01.sla.0000154270.14308.5f; Skandalakis PN, 2006, AM SURGEON, V72, P238; ZUNIGA D, 1977, JAMA-J AM MED ASSOC, V237, P1599, DOI 10.1001/jama.237.15.1599	5	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					1030	1030		10.1016/S0140-6736(12)60777-6	http://dx.doi.org/10.1016/S0140-6736(12)60777-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22981115				2022-12-28	WOS:000308746000032
J	Makinodan, M; Rosen, KM; Ito, S; Corfas, G				Makinodan, Manabu; Rosen, Kenneth M.; Ito, Susumu; Corfas, Gabriel			A Critical Period for Social Experience-Dependent Oligodendrocyte Maturation and Myelination	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; EARLY DEPRIVATION; WORKING-MEMORY; IN-VIVO; CHILDREN; SCHIZOPHRENIA; DISORDERS; ALTERS; CELLS; ERBB3	Early social isolation results in adult behavioral and cognitive dysfunction that correlates with white matter alterations. However, how social deprivation influences myelination and the significance of these myelin defects in the adult remained undefined. We show that mice isolated for 2 weeks immediately after weaning have alterations in prefrontal cortex function and myelination that do not recover with reintroduction into a social environment. These alterations, which occur only during this critical period, are phenocopied by loss of oligodendrocyte ErbB3 receptors, and social isolation leads to reduced expression of the ErbB3 ligand neuregulin-1. These findings indicate that social experience regulates prefrontal cortex myelination through neuregulin-1/ErbB3 signaling and that this is essential for normal cognitive function, thus providing a cellular and molecular context to understand the consequences of social isolation.	[Makinodan, Manabu; Rosen, Kenneth M.; Corfas, Gabriel] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Makinodan, Manabu; Corfas, Gabriel] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Rosen, Kenneth M.; Corfas, Gabriel] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA; [Ito, Susumu] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Corfas, G (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@childrens.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	National Institute of Neurological Disorders and Stroke, NIH [R01 NS35884]; Lori and Joel Freedman; NIH Intellectual and Developmental Disabilities Research Center [P30-HD 18655]; Nara Medical University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lori and Joel Freedman; NIH Intellectual and Developmental Disabilities Research Center; Nara Medical University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Schwarz, C. J. Woolf, R. A. Corfas, M. Rao, F. Sher and M. Lozada for critical reading of the manuscript; C. Hart for help with the mouse colony; G. Gorski for help with electron microscopy; C. Arteaga for the generous gift of the ErbB3 floxed mouse line; J. C. Dodart for advice on behavioral tests; M. Fagiolini for allowing us to use behavioral equipment. This research was supported in part by the National Institute of Neurological Disorders and Stroke, NIH, grant R01 NS35884 (to G. C.), by Lori and Joel Freedman (to G. C.), an NIH Intellectual and Developmental Disabilities Research Center grant P30-HD 18655, and Nara Medical University (M.M.).	Bos K, 2011, HARVARD REV PSYCHIAT, V19, P15, DOI 10.3109/10673229.2011.549773; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Egeland B, 1983, Child Abuse Negl, V7, P459, DOI 10.1016/0145-2134(83)90053-4; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; GARIEPY JL, 1995, PHARMACOL BIOCHEM BE, V51, P767, DOI 10.1016/0091-3057(95)00028-U; Hol T, 1999, BEHAV BRAIN RES, V100, P91, DOI 10.1016/S0166-4328(98)00116-8; Kim JY, 2003, J NEUROSCI, V23, P5561; Li CR, 2010, BRAIN RES, V1346, P183, DOI 10.1016/j.brainres.2010.05.064; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Murtie JC, 2007, J NEUROSCI RES, V85, P2080, DOI 10.1002/jnr.21339; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Prevot V, 2003, J NEUROSCI, V23, P230; Qu SM, 2006, GENESIS, V44, P477, DOI 10.1002/dvg.20243; Rico B, 2011, CURR OPIN GENET DEV, V21, P262, DOI 10.1016/j.gde.2010.12.010; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Sanchez MM, 1998, BRAIN RES, V812, P38, DOI 10.1016/S0006-8993(98)00857-9; Schmucker J, 2003, GLIA, V44, P67, DOI 10.1002/glia.10275; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; Winterfeld KT, 1998, J NEUROSCI RES, V52, P201, DOI 10.1002/(SICI)1097-4547(19980415)52:2<201::AID-JNR8>3.0.CO;2-E; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	37	539	545	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1357	1360		10.1126/science.1220845	http://dx.doi.org/10.1126/science.1220845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984073	Green Accepted			2022-12-28	WOS:000308705000046
J	Sherratt, TN; Roberts, G				Sherratt, Thomas N.; Roberts, Gilbert			When Paths to Cooperation Converge	SCIENCE			English	Editorial Material							RECIPROCAL ALTRUISM; EVOLUTION		[Sherratt, Thomas N.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Roberts, Gilbert] Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Carleton University; Newcastle University - UK	Sherratt, TN (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	tom_sherratt@carleton.ca	Roberts, Gilbert/K-5449-2019					Akcay E, 2011, P ROY SOC B-BIOL SCI, V278, P2198, DOI 10.1098/rspb.2010.2105; Andre JB, 2011, EVOLUTION, V65, P1447, DOI 10.1111/j.1558-5646.2011.01232.x; Archetti M, 2012, J THEOR BIOL, V299, P9, DOI 10.1016/j.jtbi.2011.06.018; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Backwell PRY, 2004, NATURE, V430, P417, DOI 10.1038/430417a; BENDOR J, 1995, P NATL ACAD SCI USA, V92, P3596, DOI 10.1073/pnas.92.8.3596; Binmore K., 2007, PLAYING REAL; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001	15	6	6	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1304	1305		10.1126/science.1226328	http://dx.doi.org/10.1126/science.1226328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	004TW	22984060				2022-12-28	WOS:000308705000030
J	State, MW; Sestan, N				State, Matthew W.; Sestan, Nenad			The Emerging Biology of Autism Spectrum Disorders	SCIENCE			English	Editorial Material							DE-NOVO MUTATIONS; BRAIN; CHILDREN		[State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	State, MW (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 333 Cedar St, New Haven, CT 06510 USA.	matthew.state@yale.edu; nenad.sestan@yale.edu	State, Matthew/W-2256-2019	Candy, Cotton/0000-0002-3032-5872; State, Matthew/0000-0003-1624-8302	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, U01MH081896, P50MH081756, RC2MH089956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH081754, RC2MH089956, U01MH081896, U01 MH081896, P50MH081756, P50 MH081756, RC2 MH089956, R01 MH081754] Funding Source: Medline; NINDS NIH HHS [R01 NS054273, R01NS054273] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Rapoport JL, 2008, NEUROPSYCHOPHARMACOL, V33, P181, DOI 10.1038/sj.npp.1301553; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	14	112	120	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1301	1303		10.1126/science.1224989	http://dx.doi.org/10.1126/science.1224989			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984058	Green Accepted			2022-12-28	WOS:000308705000028
J	Sung, JH; Zhang, H; Moseman, EA; Alvarez, D; Iannacone, M; Henrickson, SE; de la Torre, JC; Groom, JR; Luster, AD; von Andrian, UH				Sung, Jung Hwan; Zhang, Han; Moseman, E. Ashley; Alvarez, David; Iannacone, Matteo; Henrickson, Sarah E.; de la Torre, Juan C.; Groom, Joanna R.; Luster, Andrew D.; von Andrian, Ulrich H.			Chemokine Guidance of Central Memory T Cells Is Critical for Antiviral Recall Responses in Lymph Nodes	CELL			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SUBCAPSULAR SINUS MACROPHAGES; HIGH ENDOTHELIAL VENULES; DENDRITIC CELLS; NONLYMPHOID TISSUE; RECEPTOR CXCR3; IN-VIVO; B-CELLS; EFFECTOR; IMMUNITY	A defining feature of vertebrate immunity is the acquisition of immunological memory, which confers enhanced protection against pathogens by mechanisms that are incompletely understood. Here, we compared responses by virus-specific naive T cells (T-N) and central memory T cells (T-CM) to viral antigen challenge in lymph nodes (LNs). In steady-state LNs, both T cell subsets localized in the deep T cell area and interacted similarly with antigen-presenting dendritic cells. However, upon entry of lymph-borne virus, only T-CM relocalized rapidly and efficiently toward the outermost LN regions in the medullary, interfollicular, and subcapsular areas where viral infection was initially confined. This rapid peripheralization was coordinated by a cascade of cytokines and chemokines, particularly ligands for T-CM-expressed CXCR3. Consequently, in vivo recall responses to viral infection by CXCR3-deficient T-CM were markedly compromised, indicating that early antigen detection afforded by intranodal chemokine guidance of T-CM is essential for efficient antiviral memory.	[Sung, Jung Hwan; Zhang, Han; Moseman, E. Ashley; Alvarez, David; Iannacone, Matteo; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [de la Torre, Juan C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Groom, Joanna R.; Luster, Andrew D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; Scripps Research Institute; Harvard University; Massachusetts General Hospital	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	uva@hms.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Iannacone, Matteo/I-8507-2018; Luster, Andrew/ABE-6504-2020	Iannacone, Matteo/0000-0002-9370-2671; Luster, Andrew/0000-0001-9679-7912; Groom, Joanna/0000-0001-5251-7835; Henrickson, Sarah/0000-0001-5569-4132	NIH [AI078897, AI069259, 5T32-HL07623-20, CA069212]; Samsung Scholarship; Armenise-Harvard Foundation; Canadian Institutes of Health Research; Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI069259, P01AI078897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samsung Scholarship(Samsung); Armenise-Harvard Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Flynn and Dr. G. Cheng for technical support, M. Perdue for secretarial assistance, and the members of the von Andrian laboratory for helpful discussion. This work was supported by NIH grants AI078897, AI069259 (to U.H.v.A.), 5T32-HL07623-20 (to E.A.M.), and CA069212 (to A.D.L.); a Samsung Scholarship (to J.H.S.); the Armenise-Harvard Foundation (to M.I.); the Canadian Institutes of Health Research (to D.A.); and an Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia (to J.R.G.).	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; BYRNE JA, 1984, J VIROL, V51, P682, DOI 10.1128/JVI.51.3.682-686.1984; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gil-Cruz C, 2012, P NATL ACAD SCI USA, V109, P1233, DOI 10.1073/pnas.1115154109; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Medoff BD, 2006, J IMMUNOL, V176, P7087, DOI 10.4049/jimmunol.176.11.7087; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Mora JR, 2006, CURR TOP MICROBIOL, V308, P83; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; von Herrath M, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1910s36; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093	54	154	155	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1249	1263		10.1016/j.cell.2012.08.015	http://dx.doi.org/10.1016/j.cell.2012.08.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980984	Green Accepted, Bronze			2022-12-28	WOS:000308928100017
J	Visco, AG; Brubaker, L; Richter, HE; Nygaard, I; Paraiso, MFR; Menefee, SA; Schaffer, J; Lowder, J; Khandwala, S; Sirls, L; Spino, C; Nolen, TL; Wallace, D; Meikle, SF				Visco, Anthony G.; Brubaker, Linda; Richter, Holly E.; Nygaard, Ingrid; Paraiso, Marie Fidela R.; Menefee, Shawn A.; Schaffer, Joseph; Lowder, Jerry; Khandwala, Salil; Sirls, Larry; Spino, Cathie; Nolen, Tracy L.; Wallace, Dennis; Meikle, Susan F.		Pelvic Floor Disorders Network	Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXIN TYPE-A; OVERACTIVE BLADDER; OAB-Q; QUESTIONNAIRES; PERSISTENCE; WOMEN; EFFICACY	Background Anticholinergic medications and onabotulinumtoxinA are used to treat urgency urinary incontinence, but data directly comparing the two types of therapy are needed. Methods We performed a double-blind, double-placebo-controlled, randomized trial involving women with idiopathic urgency urinary incontinence who had five or more episodes of urgency urinary incontinence per 3-day period, as recorded in a diary. For a 6-month period, participants were randomly assigned to daily oral anticholinergic medication (solifenacin, 5 mg initially, with possible escalation to 10 mg and, if necessary, subsequent switch to trospium XR, 60 mg) plus one intradetrusor injection of saline or one intradetrusor injection of 100 U of onabotulinumtoxinA plus daily oral placebo. The primary outcome was the reduction from baseline in mean episodes of urgency urinary incontinence per day over the 6-month period, as recorded in 3-day diaries submitted monthly. Secondary outcomes included complete resolution of urgency urinary incontinence, quality of life, use of catheters, and adverse events. Results Of 249 women who underwent randomization, 247 were treated, and 241 had data available for the primary outcome analyses. The mean reduction in episodes of urgency urinary incontinence per day over the course of 6 months, from a baseline average of 5.0 per day, was 3.4 in the anticholinergic group and 3.3 in the onabotulinumtoxinA group (P = 0.81). Complete resolution of urgency urinary incontinence was reported by 13% and 27% of the women, respectively (P = 0.003). Quality of life improved in both groups, without significant between-group differences. The anticholinergic group had a higher rate of dry mouth (46% vs. 31%, P = 0.02) but lower rates of catheter use at 2 months (0% vs. 5%, P = 0.01) and urinary tract infections (13% vs. 33%, P<0.001). Conclusions Oral anticholinergic therapy and onabotulinumtoxinA by injection were associated with similar reductions in the frequency of daily episodes of urgency urinary incontinence. The group receiving onabotulinumtoxinA was less likely to have dry mouth and more likely to have complete resolution of urgency urinary incontinence but had higher rates of transient urinary retention and urinary tract infections. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health; ClinicalTrials.gov number, NCT01166438.)	[Visco, Anthony G.] Duke Univ, Dept Obstet & Gynecol, Med Ctr, Durham, NC 27707 USA; [Nolen, Tracy L.; Wallace, Dennis] RTI Int, Res Triangle Pk, NC USA; [Brubaker, Linda] Loyola Univ, Stritch Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Brubaker, Linda] Loyola Univ, Stritch Sch Med, Dept Urol, Chicago, IL 60611 USA; [Richter, Holly E.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL USA; [Nygaard, Ingrid] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Paraiso, Marie Fidela R.] Cleveland Clin, Dept Obstet & Gynecol, Cleveland, OH USA; [Menefee, Shawn A.] Kaiser Permanente San Diego, Dept Obstet & Gynecol, San Diego, CA USA; [Schaffer, Joseph] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Lowder, Jerry] Univ Pittsburgh, Pittsburgh, PA USA; [Khandwala, Salil] Oakwood Hosp & Med Ctr, Dearborn, MI USA; [Sirls, Larry] Oakland Univ, William Beaumont Sch Med, Dept Urol, Beaumont Hlth Syst, Royal Oak, MI USA; [Spino, Cathie] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Meikle, Susan F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Contracept & Reprod Hlth Branch, Populat Res Ctr, NIH, Rockville, MD USA	Duke University; Research Triangle Institute; Loyola University Chicago; Loyola University Chicago; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Cleveland Clinic Foundation; Kaiser Permanente; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Beaumont Health; Beaumont Health; Oakland University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Visco, AG (corresponding author), Duke Univ, Dept Obstet & Gynecol, Med Ctr, 5324 McFarland Dr,Suite 310, Durham, NC 27707 USA.	anthony.visco@duke.edu	Wallace, Dennis/AAR-7005-2021; Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589; Nolen, Tracy/0000-0003-2512-343X; Richter, Holly E/0000-0001-7741-5771	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health Office of Research on Women's Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development [2-U10-HD04267-12, U10-HD054136, 2-U10-HD041261-11, U10-HD041250, 2-U10-HD054215-06, 2-U10-HD054214-06, 1-U10-HD069006-01, 2-U10-HD054241-06, U01-HD41249, 1-U01-HD069010-01]; Astellas Pharma; GlaxoSmithKline; Uromedica; IDEO; Pfizer; Xanodyne Pharmaceuticals; Pelvalon; Warner Chilcott; Ethicon; Ferring Pharmaceuticals; Cadence; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD054136, U10HD041267, U10HD069006, U10HD054215, U10HD041250, U10HD069010, UG1HD041267, U10HD054214, U10HD054241, U10HD041261] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041249] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Astellas Pharma(Astellas Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Uromedica; IDEO; Pfizer(Pfizer); Xanodyne Pharmaceuticals; Pelvalon; Warner Chilcott; Ethicon; Ferring Pharmaceuticals(Ferring Pharmaceuticals); Cadence; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health; ClinicalTrials.gov number, NCT01166438.; Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (2-U10-HD04267-12, to Duke University Medical Center; U10-HD054136, to Loyola University; 2-U10-HD041261-11, to the University of Alabama at Birmingham; U10-HD041250, to the University of Utah; 2-U10-HD054215-06, to the Cleveland Clinic; 2-U10-HD054214-06, to the University of California, San Diego; 1-U10-HD069006-01, to the University of Pittsburgh; 2-U10-HD054241-06, to the University of Texas Southwestern Medical Center; U01-HD41249, to the University of Michigan; and 1-U01-HD069010-01, to RTI International) and the National Institutes of Health Office of Research on Women's Health.; Dr. Richter reports receiving consulting fees from Astellas Pharma, GlaxoSmithKline, Uromedica, IDEO, Pfizer, and Xanodyne Pharmaceuticals and grant support on behalf of her institution from Pelvalon, Astellas Pharma, Warner Chilcott, and Pfizer; Dr. Paraiso, receiving consulting fees from Ethicon; and Dr. Shaffer, receiving consulting fees from Astellas Pharma, Ferring Pharmaceuticals, and Cadence, lecture fees from Astellas Pharma and Cadence, and royalties from McGraw-Hill Companies. No other potential conflict of interest relevant to this article was reported.	Barber MD, 2005, AM J OBSTET GYNECOL, V193, P103, DOI 10.1016/j.ajog.2004.12.025; Brubaker L., 2006, J APPL RES, V6, P260; Brubaker L, 2008, J UROLOGY, V180, P217, DOI 10.1016/j.juro.2008.03.028; Chapple CR, 2004, BJU INT, V93, P71, DOI 10.1111/j.1464-410X.2004.04561.x; Coyne KS, 2006, J UROLOGY, V176, P627, DOI 10.1016/j.juro.2006.03.088; Coyne KS, 2007, NEUROUROL URODYNAM, V26, P196, DOI 10.1002/nau.20342; Diokno AC, 2006, FAM PRACT, V23, P568, DOI 10.1093/fampra/cml018; Dmochowski R, 2010, J UROLOGY, V184, P2416, DOI 10.1016/j.juro.2010.08.021; Dyer KY, 2011, NEUROUROL URODYNAM, V30, P1319, DOI 10.1002/nau.21028; Gordon MF, 2006, SOUTH MED J, V99, P853, DOI 10.1097/01.smj.0000220888.88722.ab; Hartmann Katherine E, 2009, Evid Rep Technol Assess (Full Rep), P1; Herschorn Sender, 2004, Can J Urol, V11, P2430; Karsenty G, 2006, UROLOGY, V68, P1193, DOI 10.1016/j.urology.2006.08.1069; Kelleher CJ, 1997, BRIT J OBSTET GYNAEC, V104, P988, DOI 10.1111/j.1471-0528.1997.tb12054.x; Matza LS, 2005, NEUROUROL URODYNAM, V24, P215, DOI 10.1002/nau.20110; Nabi G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003781.pub2; Shaya FT, 2005, AM J MANAG CARE, V11, pS121; Staskin D, 2007, J UROLOGY, V178, P978, DOI 10.1016/j.juro.2007.05.058; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Visco AG, 2012, CONTEMP CLIN TRIALS, V33, P184, DOI 10.1016/j.cct.2011.09.019; Yalcin I, 2003, AM J OBSTET GYNECOL, V189, P98, DOI 10.1067/mob.2003.379; Yu YF, 2005, VALUE HEALTH, V8, P495, DOI 10.1111/j.1524-4733.2005.00041.x	22	146	151	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1803	1813		10.1056/NEJMoa1208872	http://dx.doi.org/10.1056/NEJMoa1208872			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23036134	Green Accepted			2022-12-28	WOS:000310773200007
J	McLaughlin, RN; Poelwijk, FJ; Raman, A; Gosal, WS; Ranganathan, R				McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama			The spatial architecture of protein function and adaptation	NATURE			English	Article							PDZ DOMAIN; ACTIVATION; TRANSCRIPTION; DETERMINANTS; INFORMATION; ROBUSTNESS; MECHANISM; NETWORK; FITNESS; UNITS	Statistical analysis of protein evolution suggests a design for natural proteins in which sparse networks of coevolving amino acids (termed sectors) comprise the essence of three-dimensional structure and function(1-5). However, proteins are also subject to pressures deriving from the dynamics of the evolutionary process itself-the ability to tolerate mutation and to be adaptive to changing selection pressures(6-10). To understand the relationship of the sector architecture to these properties, we developed a high-throughput quantitative method for a comprehensive single-mutation study in which every position is substituted individually to every other amino acid. Using a PDZ domain (PSD95(pdz3)) model system, we show that sector positions are functionally sensitive to mutation, whereas non-sector positions are more tolerant to substitution. In addition, we find that adaptation to a new binding specificity initiates exclusively through variation within sector residues. A combination of just two sector mutations located near and away from the ligand-binding site suffices to switch the binding specificity of PSD95(pdz3) quantitatively towards a class-switching ligand. The localization of functional constraint and adaptive variation within the sector has important implications for understanding and engineering proteins.	[McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	Gosal, Walraj/J-5260-2012	Gosal, Walraj/0000-0003-3396-1505; McLaughlin, Richard/0000-0003-0950-2253; Poelwijk, Frank/0000-0002-5696-4357	University of Texas Southwestern Graduate School and Pharmacology Training Grant; Helen Hay Whitney Fellowship program; National Institutes of Health [R01EY018720-05]; Robert A. Welch Foundation [I-1366]; Green Center for Systems Biology; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	University of Texas Southwestern Graduate School and Pharmacology Training Grant; Helen Hay Whitney Fellowship program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Green Center for Systems Biology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank W. Russ, P. Mishra and other members of the Ranganathan laboratory for contributions to this work, W. Wakeland and C. Liang for assistance with Solexa sequencing, E. Curry and A. Mobley for assistance with flow cytometry, and M. Elowitz for providing the pZ plasmids. We acknowledge support from the University of Texas Southwestern Graduate School and Pharmacology Training Grant (R. N. M.), the Helen Hay Whitney Fellowship program (F.J.P.) and support from the National Institutes of Health (R01EY018720-05, R. R.), The Robert A. Welch Foundation (I-1366, R. R.) and the Green Center for Systems Biology (R.R.).	Adkar BV, 2012, STRUCTURE, V20, P371, DOI 10.1016/j.str.2011.11.021; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BUSHMAN FD, 1989, CELL, V58, P1163, DOI 10.1016/0092-8674(89)90514-X; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tiana G, 2004, P NATL ACAD SCI USA, V101, P2846, DOI 10.1073/pnas.0306638101; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Whipple FW, 1997, J MOL BIOL, V265, P261, DOI 10.1006/jmbi.1996.0735	35	298	299	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					138	U163		10.1038/nature11500	http://dx.doi.org/10.1038/nature11500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23041932	Green Accepted			2022-12-28	WOS:000310434500046
J	Sylwestrak, EL; Ghosh, A				Sylwestrak, Emily L.; Ghosh, Anirvan			Elfn1 Regulates Target-Specific Release Probability at CA1-Interneuron Synapses	SCIENCE			English	Article							DUAL INTRACELLULAR-RECORDINGS; SCHAFFER COLLATERAL SYNAPSES; EXCITATORY SYNAPSES; HIPPOCAMPAL SLICES; PYRAMIDAL CELLS; INTERNEURONS; FACILITATION; EXPRESSION; CIRCUITS; RAT	Although synaptic transmission may be unidirectional, the establishment of synaptic connections with specific properties can involve bidirectional signaling. Pyramidal neurons in the hippocampus form functionally distinct synapses onto two types of interneurons. Excitatory synapses onto oriens-lacunosum moleculare (O-LM) interneurons are facilitating and have a low release probability, whereas synapses onto parvalbumin interneurons are depressing and have a high release probability. Here, we show that the extracellular leucine-rich repeat fibronectin containing 1 (Elfn1) protein is selectively expressed by O-LM interneurons and regulates presynaptic release probability to direct the formation of highly facilitating pyramidal-O-LM synapses. Thus, postsynaptic expression of Elfn1 in O-LM interneurons regulates presynaptic release probability, which confers target-specific synaptic properties to pyramidal cell axons.	[Sylwestrak, Emily L.; Ghosh, Anirvan] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Sylwestrak, Emily L.; Ghosh, Anirvan] F Hoffmann La Roche, CNS Discovery, CH-4070 Basel, Switzerland; [Sylwestrak, Emily L.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of California System; University of California San Diego; Roche Holding; University of Basel	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	anirvan.ghosh@roche.com	Sylwestrak, Emily/GSE-3871-2022	Sylwestrak, Emily/0000-0002-1172-6523	NIH [R01NS067216]; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Scanziani, P. Scheiffele, and members of the Ghosh lab for suggestions and comments on the manuscript; J. de Wit for generating the Elfn1-GFP construct; and M. Macias, C. Sanchez, and E. Kang for help with virus and protein production. This work was supported by NIH grant R01NS067216 and the Gatsby Charitable Foundation.	Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Buchanan KA, 2012, NEURON, V75, P451, DOI 10.1016/j.neuron.2012.06.017; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sun HY, 2009, J NEUROPHYSIOL, V101, P1043, DOI 10.1152/jn.90286.2008; Sun HY, 2006, J NEUROSCI, V26, P10796, DOI 10.1523/JNEUROSCI.2746-06.2006; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	30	91	94	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					536	540		10.1126/science.1222482	http://dx.doi.org/10.1126/science.1222482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23042292	Green Accepted			2022-12-28	WOS:000310195800060
J	Koven, S				Koven, Suzanne			Head and Shoulder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koven, Suzanne] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Koven, Suzanne] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Koven, S (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1284	1285		10.1056/NEJMp1209766	http://dx.doi.org/10.1056/NEJMp1209766			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014WJ	23034019				2022-12-28	WOS:000309406100004
J	Ford, AC; Talley, NJ				Ford, Alexander C.; Talley, Nicholas J.			Laxatives for chronic constipation in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC IDIOPATHIC CONSTIPATION; THERAPIES		[Ford, Alexander C.] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England; [Ford, Alexander C.] Univ Leeds, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England; [Talley, Nicholas J.] Univ Newcastle, Fac Hlth, Callaghan, NSW 2308, Australia	Saint James's University Hospital; University of Leeds; University of Newcastle	Ford, AC (corresponding author), St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England.	alexf12399@yahoo.com	Talley, Nicholas J/D-5399-2013; Ford, Alexander/K-5491-2012	Talley, Nicholas J/0000-0003-2537-3092; Ford, Alexander/0000-0001-6371-4359				Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Chang JY, 2010, AM J GASTROENTEROL, V105, P822, DOI 10.1038/ajg.2010.40; Choung RS, 2012, CLIN GASTROENTEROL H, V10, P494, DOI 10.1016/j.cgh.2011.12.041; Ford AC, 2011, GUT, V60, P209, DOI 10.1136/gut.2010.227132; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Lee-Robichaud, 2010, COCHRANE DB SYST REV, V7; Ramkumar D, 2005, AM J GASTROENTEROL, V100, P936, DOI 10.1111/j.1572-0241.2005.40925.x; Suares NC, 2011, ALIMENT PHARM THER, V33, P895, DOI 10.1111/j.1365-2036.2011.04602.x; Suares NC, 2011, AM J GASTROENTEROL, V106, P1582, DOI 10.1038/ajg.2011.164; Talley NJ, 2008, AM J GASTROENTEROL, V103, P820, DOI 10.1111/j.1572-0241.2008.01832.x; Talley NJ, 2009, CLIN GASTROENTEROL H, V7, P9, DOI 10.1016/j.cgh.2008.07.005; Taylor RR, 2010, ALIMENT PHARM THER, V31, P302, DOI 10.1111/j.1365-2036.2009.04191.x; World Gastroenterology Organisation, 2007, WGO PRACT GUID CONST	13	8	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2012	345								e6168	10.1136/bmj.e6168	http://dx.doi.org/10.1136/bmj.e6168			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KB	23028096				2022-12-28	WOS:000309657900004
J	Della Santina, L; Wong, ROL				Della Santina, Luca; Wong, Rachel O. L.			A Molecular Link Tethering Neuronal Responses with the Past	CELL			English	Editorial Material							SYNAPTIC PLASTICITY; VISUAL-CORTEX; IN-VIVO; METAPLASTICITY	Neurons need to alter their response to a given stimulus over time in order for the animal to modify its behavior within a changing environment. Chen et al. now demonstrate that neuronal structure and function are altered coordinately by the history of the cell's activity through an unexpected molecular pathway.	[Della Santina, Luca; Wong, Rachel O. L.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wong, ROL (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	wongr2@u.washington.edu	Della Santina, Luca/J-9795-2016	Della Santina, Luca/0000-0001-6036-1295	NATIONAL EYE INSTITUTE [R01EY010699, R01EY017101] Funding Source: NIH RePORTER; NEI NIH HHS [EY10699, EY17101] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chen SX, 2012, CELL, V151, P41, DOI 10.1016/j.cell.2012.08.028; Dunfield D, 2009, NEURON, V64, P240, DOI 10.1016/j.neuron.2009.08.034; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Li Z, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-15; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007	10	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					9	11		10.1016/j.cell.2012.09.008	http://dx.doi.org/10.1016/j.cell.2012.09.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021210	Bronze			2022-12-28	WOS:000309544200005
J	Siegel, JM				Siegel, Jerome M.			Suppression of Sleep for Mating	SCIENCE			English	Editorial Material							PERFORMANCE; DEPRIVATION		[Siegel, Jerome M.] Univ Calif Los Angeles, Dept Psychiat, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 91343 USA; [Siegel, Jerome M.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 91343 USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Siegel, JM (corresponding author), Univ Calif Los Angeles, Dept Psychiat, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 91343 USA.	jsiegel@ucla.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001753] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS023724, R01 NS069640] Funding Source: Medline; BLRD VA [I01 BX001753, IK6 BX005245] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BLRD VA		BONNET MH, 1989, NEUROBIOL AGING, V10, P21, DOI 10.1016/S0197-4580(89)80006-5; JACOBS BL, 1971, EXP NEUROL, V30, P212, DOI 10.1016/S0014-4886(71)80002-X; Jones SG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-87; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lesku JA, 2012, SCIENCE, V337, P1654, DOI 10.1126/science.1220939; Lyamin O, 2005, NATURE, V435, P1177, DOI 10.1038/4351177a; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; Ridgway S, 2009, J EXP BIOL, V212, P1519, DOI 10.1242/jeb.027896; Siegel JM, 2008, TRENDS NEUROSCI, V31, P208, DOI 10.1016/j.tins.2008.02.001; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Van Dongen HPA, 2012, ACCIDENT ANAL PREV, V45, P11, DOI 10.1016/j.aap.2011.09.018; WEBB WB, 1988, SLEEP, V11, P488, DOI 10.1093/sleep/11.5.488	14	5	5	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1610	1611		10.1126/science.1228466	http://dx.doi.org/10.1126/science.1228466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019635	Green Accepted			2022-12-28	WOS:000309215400028
J	Fried, TR; Fragoso, CAV; Rabow, MW				Fried, Terri R.; Fragoso, Carlos A. Vaz; Rabow, Michael W.			Caring for the Older Person With Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE CHRONIC CONDITIONS; SERIOUSLY ILL PATIENTS; CHRONIC LUNG-DISEASE; QUALITY-OF-LIFE; PALLIATIVE CARE; REFRACTORY DYSPNEA; COPD PATIENTS; INHALED ANTICHOLINERGICS	Chronic obstructive pulmonary disease (COPD), a common disease in elderly patients, is characterized by high symptom burden, health care utilization, mortality, and unmet needs of patients and caregivers. Respiratory failure and dyspnea maybe exacerbated by heart failure, pulmonary embolism, and anxiety; by medication effects; and by other conditions, including deconditioning and malnutrition. Randomized controlled trials, which provide the strongest evidence for guideline recommendations, may underestimate the risk of adverse effects of interventions for older patients with COPD. The focus of guidelines on disease-modifying therapies may not address the full spectrum of patient and caregiver needs, particularly the high rates of bothersome symptoms, risk of functional and cognitive decline, and need for end-of-life care planning. Meeting the many needs of older patients with COPD and their families requires that clinicians supplement guideline-recommended care with treatment decision making that takes into account older persons' comorbid conditions, recognizes the trade-offs engendered by the increased risk of adverse events, focuses on symptom relief and function, and prepares patients and their loved ones for further declines in the patient's health and their end-of-life care. A case of COPD in an 81-year-old man hospitalized with severe dyspnea and respiratory failure highlights both the challenges in managing COPD in the elderly and the limitations in applying guidelines to geriatric patients. JAMA. 2012;308(12):1254-1263 www.jama.com	[Fried, Terri R.; Fragoso, Carlos A. Vaz] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Fried, Terri R.; Fragoso, Carlos A. Vaz] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, Washington, DC USA; [Rabow, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Yale University; University of California System; University of California San Francisco	Fried, TR (corresponding author), VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr 151B, 950 Campbell Ave, West Haven, CT 06516 USA.	terri.fried@yale.edu		Vaz Fragoso, Carlos/0000-0002-7045-3334	National Institute on Aging [K24AG028443, R03AG037051]; Department of Veterans Affairs; SCAN Foundation; NATIONAL INSTITUTE ON AGING [K24AG028443, R03AG037051, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Fried is the recipient of amid-career development award from the National Institute on Aging (K24AG028443). Dr Vaz Fragoso is a recipient of a Career Development Award from the Department of Veterans Affairs and an R03 award from the National Institute on Aging (R03AG037051). The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Abernethy AP, 2009, WIEN MED WOCHENSCHR, V159, P583, DOI 10.1007/s10354-009-0727-z; Agostini JV, 2004, J AM GERIATR SOC, V52, P1719, DOI 10.1111/j.1532-5415.2004.52467.x; Allen SC, 2003, AGE AGEING, V32, P299, DOI 10.1093/ageing/32.3.299; Allen SC, 1997, AGE AGEING, V26, P83, DOI 10.1093/ageing/26.2.83; Alonso-Coello P, 2012, CHEST, V141, pE669S, DOI 10.1378/chest.11-2307; *AM THOR SOC, STAND DIAGN MAN PAT; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Au DH, 2003, CHEST, V123, P1964, DOI 10.1378/chest.123.6.1964; Back AL, 2006, J CLIN ONCOL, V24, P4209, DOI 10.1200/JCO.2006.06.007; Baltzan Marcel A, 2004, Can Respir J, V11, P407; Bausewein C, 2010, J PALLIAT MED, V13, P1109, DOI 10.1089/jpm.2010.0068; Beauchamp MK, 2009, RESP MED, V103, P1885, DOI 10.1016/j.rmed.2009.06.008; Berger RL, 2010, CHEST, V138, P407, DOI 10.1378/chest.09-1822; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; BORSON S, 1992, PSYCHOSOMATICS, V33, P190, DOI 10.1016/S0033-3182(92)71995-1; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Casaburi R, 2009, NEW ENGL J MED, V360, P1329, DOI 10.1056/NEJMct0804632; Chan ED, 1998, CHEST, V114, P1704, DOI 10.1378/chest.114.6.1704; Chatham K, 2009, PHYS THER, V89, P257, DOI 10.2522/ptj.20080155; Claessens MT, 2000, J AM GERIATR SOC, V48, pS146, DOI 10.1111/j.1532-5415.2000.tb03124.x; Clemens KE, 2012, CURR OPIN SUPPORT PA, V6, P163, DOI 10.1097/SPC.0b013e3283530fee; Clini EM, 2008, EUR RESPIR J, V32, P218, DOI 10.1183/09031936.00134007; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Currow DC, 2011, J PAIN SYMPTOM MANAG, V42, P388, DOI 10.1016/j.jpainsymman.2010.11.021; Curtis JR, 2008, EUR RESPIR J, V32, P796, DOI 10.1183/09031936.00126107; Curtis JR, 1997, AM J RESP CRIT CARE, V156, P1032, DOI 10.1164/ajrccm.156.4.97-02011; Di Meo F, 2008, AGE AGEING, V37, P530, DOI 10.1093/ageing/afn126; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030; Elliott MW, 2011, CLIN MED, V11, P150, DOI 10.7861/clinmedicine.11-2-150; Emery CF, 2008, RESP CARE, V53, P1208; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Fragoso CAV, 2011, J AM GERIATR SOC, V59, P1847, DOI 10.1111/j.1532-5415.2011.03596.x; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Graat-Verboom L, 2009, EUR RESPIR J, V34, P209, DOI 10.1183/09031936.50130408; Harrison RA, 2007, J BONE MINER RES, V22, P447, DOI 10.1359/jbmr.061202; HEATON RK, 1983, ARCH INTERN MED, V143, P1941, DOI 10.1001/archinte.143.10.1941; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Horton Robert, 2010, Curr Opin Support Palliat Care, V4, P56, DOI 10.1097/SPC.0b013e328338c1c6; Howard C, 2010, PSYCHOL HEALTH MED, V15, P371, DOI 10.1080/13548506.2010.482142; Hunt T, 2010, EUR RESPIR REV, V19, P30, DOI 10.1183/09059180.00006009; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Johnson MJ, 2012, J PAIN SYMPTOM MANAG, V43, P614, DOI 10.1016/j.jpainsymman.2011.04.024; Kallet RH, 2007, RESP CARE, V52, P900; Kamal AH, 2012, J PALLIAT MED, V15, P106, DOI 10.1089/jpm.2011.0110; Karapolat H, 2008, CHINESE MED J-PEKING, V121, P592; Katsura H, 2004, RESPIROLOGY, V9, P230, DOI 10.1111/j.1440-1843.2004.00561.x; Kunik ME, 2008, PSYCHOL MED, V38, P385, DOI 10.1017/S0033291707001687; Kunik ME, 2007, PSYCHOSOMATICS, V48, P16, DOI 10.1176/appi.psy.48.1.16; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; Luce JM, 2001, JAMA-J AM MED ASSOC, V285, P1331, DOI 10.1001/jama.285.10.1331; Mahler Donald A, 2011, Curr Opin Support Palliat Care, V5, P71, DOI 10.1097/SPC.0b013e328345bc84; Marciniuk DD, 2011, CAN RESPIR J, V18, P69, DOI 10.1155/2011/745047; Maurer J, 2008, CHEST, V134, p43S, DOI 10.1378/chest.08-0342; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; MORRISON NJ, 1989, CHEST, V95, P90, DOI 10.1378/chest.95.1.90; ODONNELL DE, 1994, CHEST, V106, P904, DOI 10.1378/chest.106.3.904; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pinnock H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d142; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Quill TE, 2011, JAMA-J AM MED ASSOC, V306, P1483, DOI 10.1001/jama.2011.1413; Rafii R, 2011, PULM MED, V2011, DOI 10.1155/2011/257496; REUBEN DB, 1992, AM J MED, V93, P663, DOI 10.1016/0002-9343(92)90200-U; Reuben DB, 2009, HAZZARDS GERIATRIC M; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Rocker G, 2012, CAN MED ASSOC J, V184, pE497, DOI 10.1503/cmaj.111758; Roig M, 2009, RESP MED, V103, P1257, DOI 10.1016/j.rmed.2009.03.022; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; SCHWARTZSTEIN RM, 1987, AM REV RESPIR DIS, V136, P58, DOI 10.1164/ajrccm/136.1.58; Simon ST, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub2; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Singh S, 2011, ARCH INTERN MED, V171, P920, DOI 10.1001/archinternmed.2011.171; Smith TA, 2012, RESPIROLOGY, V17, P300, DOI 10.1111/j.1440-1843.2011.02085.x; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stephenson A, 2011, ARCH INTERN MED, V171, P914, DOI 10.1001/archinternmed.2011.170; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Suzuki M, 2012, ARCH INTERN MED, V172, P878, DOI 10.1001/archinternmed.2012.1233; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thakur Neeta, 2010, Int J Chron Obstruct Pulmon Dis, V5, P263; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Vandenbroucke JP, 2008, JAMA-J AM MED ASSOC, V300, P2417, DOI 10.1001/jama.2008.723; Vandenbroucke JP, 2006, CAN MED ASSOC J, V174, P645, DOI 10.1503/cmaj.051484; Varkey B, 2010, CURR OPIN PULM MED, V16, P150, DOI 10.1097/MCP.0b013e3283364378; Vaz Fragoso CA, 2012, J GERONTOL A-BIOL, V67, P264, DOI 10.1093/gerona/glr198; White P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X578043; WILLIAMS SJ, 1989, SOC SCI MED, V29, P609, DOI 10.1016/0277-9536(89)90180-9; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; ZuWallack R, 2008, AM J MED, V121, pS25, DOI 10.1016/j.amjmed.2008.04.004; Zvezdin B, 2009, CHEST, V136, P376, DOI 10.1378/chest.08-2918	103	42	45	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1254	1263		10.1001/jama.2012.12422	http://dx.doi.org/10.1001/jama.2012.12422			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011715	Green Accepted			2022-12-28	WOS:000309103600029
J	Gruen, RL; Brohi, K; Schreiber, M; Balogh, ZJ; Pitt, V; Narayan, M; Maier, RV				Gruen, Russell L.; Brohi, Karim; Schreiber, Martin; Balogh, Zsolt J.; Pitt, Veronica; Narayan, Mayur; Maier, Ronald V.			Haemorrhage control in severely injured patients	LANCET			English	Article							ACUTE TRAUMATIC COAGULOPATHY; MASSIVE TRANSFUSION; LYOPHILIZED PLASMA; HYPERTONIC RESUSCITATION; DAMAGE CONTROL; FACTOR-VIIA; PROTEIN-C; FIBRINOGEN; BLOOD; COAGULATION	Most surgeons have adopted damage control surgery for severely injured patients, in which the initial operation is abbreviated after control of bleeding and contamination to allow ongoing resuscitation in the intensive-care unit. Developments in early resuscitation that emphasise rapid control of bleeding, restrictive volume replacement, and prevention or early management of coagulopathy are making definitive surgery during the first operation possible for many patients. Improved topical haemostatic agents and interventional radiology are becoming increasingly useful adjuncts to surgical control of bleeding. Better understanding of trauma-induced coagulopathy is paving the way for the replacement of blind, unguided protocols for blood component therapy with systemic treatments targeting specific deficiencies in coagulation. Similarly, treatments targeting dysregulated inflammatory responses to severe injury are under investigation. As point-of-care diagnostics become more suited to emergency environments, timely targeted intervention for haemorrhage control will result in better patient outcomes and reduced demand for blood products. Our Series paper describes how our understanding of the roles of the microcirculation, inflammation, and coagulation has shaped new and emerging treatment strategies.	[Gruen, Russell L.; Pitt, Veronica] Monash Univ, Natl Trauma Res Inst, Alfred Hosp, Melbourne, Vic 3004, Australia; [Brohi, Karim] Royal London Hosp, Barts & London Sch Med & Dent, Trauma Clin Acad Unit, Ctr Neurosci & Trauma, London E1 1BB, England; [Schreiber, Martin] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Balogh, Zsolt J.] Univ Newcastle, John Hunter Hosp, Dept Trauma, Newcastle, NSW 2300, Australia; [Narayan, Mayur] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Ctr Injury Prevent & Policy, Baltimore, MD 21201 USA; [Maier, Ronald V.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA	Florey Institute of Neuroscience & Mental Health; Monash University; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; Oregon Health & Science University; John Hunter Hospital; University of Newcastle; University System of Maryland; University of Maryland Baltimore; Harborview Medical Center; University of Washington; University of Washington Seattle	Gruen, RL (corresponding author), Monash Univ, Natl Trauma Res Inst, Alfred Hosp, 89 Commercial Rd, Melbourne, Vic 3004, Australia.	r.gruen@alfred.org.au	Balogh, Zsolt/A-2002-2010	Balogh, Zsolt/0000-0002-0277-4822	Australian National Health and Medical Research Council Practitioner Fellowship; National Institute for Health Research [RP-PG-0407-10036] Funding Source: researchfish	Australian National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	RLG is supported by an Australian National Health and Medical Research Council Practitioner Fellowship. We thank Loretta Piccenna for the illustration, Ornella Clavisi for leading the searches and selection of studies, and Romy Granek, Manda Kaled, and Loyal Pattuwage for screening search outputs.	Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca; Alam HB, 2012, BRIT J SURG, V99, P29, DOI 10.1002/bjs.7756; [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD001319.PUB3; [Anonymous], COCHRANE DATABASE SY; [Anonymous], COCHRANE DATABASE SY; Armand R, 2003, TRANSFUS MED REV, V17, P223, DOI 10.1016/S0887-7963(03)00022-1; Aubron C, 2011, CRIT CARE RESUSC, V13, P67; Ball CG, 2011, CAN J SURG, V54, pE3; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bunn F, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/146151858.CD002045.PUB2; Burlew CC, 2011, J AM COLL SURGEONS, V212, P628, DOI 10.1016/j.jamcollsurg.2010.12.020; Carless PA, 2003, COCHRANE DB SYST REV, V1; Casstevens EC, 2010, TRANSFUSION, V50, p36A; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Committee on Tactical Combat Casualty Care, TACT COMB CAS CAR GU; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Cotton BA, 2011, NEW ENGL J MED, V365, P2039, DOI 10.1056/NEJMc1111095; Cotton BA, 2010, J TRAUMA, V69, pS33, DOI 10.1097/TA.0b013e3181e42411; Darlington DN, 2011, J TRAUMA, V71, P1271, DOI 10.1097/TA.0b013e318214f522; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Davenport RA, 2009, CURR OPIN ANESTHESIO, V22, P261, DOI 10.1097/ACO.0b013e328325a6d9; Desai KH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001093; Development Concepts and Doctrine Centre, CLIN GUID OP JOINT D; Doran CM, 2012, J TRAUMA ACUTE CARE, V72, P835, DOI 10.1097/TA.0b013e318248347b; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Frevert S, 2008, INJURY, V39, P1290, DOI 10.1016/j.injury.2008.07.004; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Fu CY, 2012, AM J EMERG MED, V30, P207, DOI 10.1016/j.ajem.2010.11.005; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Godier A, 2012, CURR OPIN ANESTHESIO, V25, P242, DOI 10.1097/ACO.0b013e32834fcc3e; Granville-Chapman J, 2011, INJURY, V42, P447, DOI 10.1016/j.injury.2010.09.037; Hamilton GJ, 2011, J TRAUMA, V71, P292, DOI 10.1097/TA.0b013e31821f4234; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Ho AMH, 2012, ANESTHESIOLOGY, V116, P716, DOI 10.1097/ALN.0b013e318245c47b; Hubetamann Bjorn, 2011, J Emerg Trauma Shock, V4, P465, DOI 10.4103/0974-2700.86630; Inaba K, 2010, J AM COLL SURGEONS, V211, P573, DOI 10.1016/j.jamcollsurg.2010.06.392; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; Kautza BC, 2012, J TRAUMA ACUTE CARE, V72, P106, DOI 10.1097/TA.0b013e3182410a3c; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kragh JF, 2008, J TRAUMA, V64, pS38, DOI 10.1097/TA.0b013e31816086b1; Kragh John F Jr, 2011, US Army Med Dep J, P38; Krieg JC, 2005, J TRAUMA, V59, P659, DOI 10.1097/01.ta.000186544.06101.11; Letoublon C, 2011, J TRAUMA, V70, P1032, DOI 10.1097/TA.0b013e31820e7ca1; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Lpaktchi K, 2007, CRIT CARE MED, V35, P2139, DOI 10.1097/01.CCM.0000280568.61217.26; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Martinaud C, 2011, J TRAUMA, V71, P1761, DOI 10.1097/TA.0b013e31822f1285; Martini WZ, 2011, MOL MED, V17, P757, DOI 10.2119/molmed.2010.00093; Martini WZ, 2009, J TRAUMA, V67, P202, DOI 10.1097/TA.0b013e3181a602a7; MAZZONI MC, 1988, AM J PHYSIOL, V255, pH629, DOI 10.1152/ajpheart.1988.255.3.H629; McLaughlin DF, 2008, J TRAUMA, V64, pS57, DOI 10.1097/TA.0b013e318160a566; Meyer MAS, 2011, VOX SANG, V101, P185, DOI 10.1111/j.1423-0410.2011.01478.x; Mitra B, 2012, INJURY, V43, P33, DOI 10.1016/j.injury.2011.10.011; Mitra B, 2011, RESUSCITATION, V82, P1208, DOI 10.1016/j.resuscitation.2011.04.007; Mitra B, 2012, INJURY, V43, P22, DOI 10.1016/j.injury.2010.10.015; Neal MD, 2012, J TRAUMA ACUTE CARE, V72, P892, DOI 10.1097/TA.0b013e31823d84a7; Plurad DS, 2011, J TRAUMA, V71, P565, DOI 10.1097/TA.0b013e3182213d52; Rees K, 2001, COCHRANE DATABASE SY, V1, pCD002138; Requarth JA, 2011, J TRAUMA, V71, P898, DOI 10.1097/TA.0b013e318227ea50; Rizoli SB, 2011, J TRAUMA, V71, pS427, DOI 10.1097/TA.0b013e318232e5ab; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10078; Schreiber MA, 2012, BRIT J SURG, V99, P10, DOI 10.1002/bjs.7773; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sorensen B, 2012, BRIT J SURG, V99, P40, DOI 10.1002/bjs.7770; Sperry JL, 2008, J TRAUMA, V64, P9, DOI 10.1097/TA.0b013e31815dd029; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Szopinski J, 2011, J TRAUMA, V71, P1779, DOI 10.1097/TA.0b013e31823a05b5; US Army Institute of Surgical Research Clinical Practice Guidelines, FRESH WHOL BLOOD FWB; Van PY, 2011, J TRAUMA, V71, P20, DOI 10.1097/TA.0b013e3182214f44; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014; Zuidema MY, 2010, WORLD J CARDIOL, V2, P325, DOI 10.4330/wjc.v2.i10.325	93	150	165	2	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1099	1108		10.1016/S0140-6736(12)61224-0	http://dx.doi.org/10.1016/S0140-6736(12)61224-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007VL	22998719				2022-12-28	WOS:000308916400031
J	Liao, WS; Cheunkar, S; Cao, HH; Bednar, HR; Weiss, PS; Andrews, AM				Liao, Wei-Ssu; Cheunkar, Sarawut; Cao, Huan H.; Bednar, Heidi R.; Weiss, Paul S.; Andrews, Anne M.			Subtractive Patterning via Chemical Lift-Off Lithography	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; FABRICATION; GOLD; PROTEINS; SYSTEM; MOTION; STAMP	Conventional soft-lithography methods involving the transfer of molecular "inks" from polymeric stamps to substrates often encounter micrometer-scale resolution limits due to diffusion of the transferred molecules during printing. We report a "subtractive" stamping process in which silicone rubber stamps, activated by oxygen plasma, selectively remove hydroxyl-terminated alkanethiols from self-assembled monolayers (SAMs) on gold surfaces with high pattern fidelity. The covalent interactions formed at the stamp-substrate interface are sufficiently strong to remove not only alkanethiol molecules but also gold atoms from the substrate. A variety of high-resolution patterned features were fabricated, and stamps were cleaned and reused many times without feature deterioration. The remaining SAM acted as a resist for etching exposed gold features. Monolayer backfilling into the lift-off areas enabled patterned protein capture, and 40-nanometer chemical patterns were achieved.	[Liao, Wei-Ssu; Cheunkar, Sarawut; Cao, Huan H.; Bednar, Heidi R.; Weiss, Paul S.; Andrews, Anne M.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Liao, Wei-Ssu; Cao, Huan H.; Bednar, Heidi R.; Weiss, Paul S.; Andrews, Anne M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cheunkar, Sarawut; Weiss, Paul S.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Weiss, Paul S.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Weiss, Paul S.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Andrews, Anne M.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Andrews, Anne M.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Weiss, PS (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	psw@cnsi.ucla.edu; aandrews@mednet.ucla.edu	Weiss, Paul/P-8016-2019; Weiss, Paul S/A-2575-2011; Andrews, Anne/AAA-8459-2021; LIAO, WEI-SSU/AAF-8952-2021; Liao, Wei-Ssu/G-9219-2012; Andrews, Anne M/B-4442-2011	Weiss, Paul/0000-0001-5527-6248; Weiss, Paul S/0000-0001-5527-6248; Andrews, Anne/0000-0002-1961-4833; LIAO, WEI-SSU/0000-0002-5619-4997; Liao, Wei-Ssu/0000-0002-5619-4997; Andrews, Anne M/0000-0002-1961-4833	U.S. Department of Energy [DOE_FG02_10ER46734]; NSF [CHE-1013042]; Kavli Foundation; government of Thailand; Division Of Chemistry [1013042] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Kavli Foundation; government of Thailand; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by U.S. Department of Energy grant DOE_FG02_10ER46734, NSF grant CHE-1013042, and the Kavli Foundation. S. C. thanks the government of Thailand for a graduate fellowship. We thank D. L. Allara, J. N. Hohman, and S. A. Claridge for helpful discussions; A. Nel for the use of his fluorescent microscope; the California NanoSystems Institute Nano and Pico Characterization Facility; and S. Rujikietgumjorn for help in image processing.	Braunschweig AB, 2009, NAT CHEM, V1, P353, DOI [10.1038/NCHEM.258, 10.1038/nchem.258]; Childs WR, 2002, J AM CHEM SOC, V124, P13583, DOI 10.1021/ja020942z; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; Christman KL, 2006, SOFT MATTER, V2, P928, DOI 10.1039/b611000b; Dameron AA, 2005, NANO LETT, V5, P1834, DOI 10.1021/nl050981j; Donzel C., 2001, CATALYSTS AFFECT GRO, V13, P1164; Duffy DC, 1999, J MICROMECH MICROENG, V9, P211, DOI 10.1088/0960-1317/9/3/301; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Geissler M, 2003, LANGMUIR, V19, P6301, DOI 10.1021/la034464x; Gou HL, 2010, ACS APPL MATER INTER, V2, P1324, DOI 10.1021/am100196z; Han P, 2009, ACS NANO, V3, P3115, DOI 10.1021/nn901030x; Kaufmann T, 2010, POLYM CHEM-UK, V1, P371, DOI 10.1039/b9py00281b; KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628; Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970; Li XM, 2003, NANO LETT, V3, P1449, DOI 10.1021/nl034423l; Liao WS, 2007, NANO LETT, V7, P2452, DOI 10.1021/nl071195c; Liu M, 2008, ANNU REV PHYS CHEM, V59, P367, DOI 10.1146/annurev.physchem.58.032806.104542; Loo YL, 2002, J VAC SCI TECHNOL B, V20, P2853, DOI 10.1116/1.1523405; Loo YL, 2002, J AM CHEM SOC, V124, P7654, DOI 10.1021/ja026355v; Maksymovych P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146103; McLellan JM, 2004, J AM CHEM SOC, V126, P10830, DOI 10.1021/ja0470766; Moore AM, 2007, J AM CHEM SOC, V129, P10352, DOI 10.1021/ja0745153; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; POIRIER GE, 1995, J PHYS CHEM-US, V99, P10966, DOI 10.1021/j100027a042; POIRIER GE, 1994, LANGMUIR, V10, P2853, DOI 10.1021/la00021a001; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Rogers JA, 2005, MATER TODAY, V8, P50, DOI 10.1016/S1369-7021(05)00702-9; Saavedra HM, 2009, J AM CHEM SOC, V131, P2252, DOI 10.1021/ja807648g; Saavedra HM, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/3/036501; Schueller OJA, 1999, SENSOR ACTUAT A-PHYS, V78, P149, DOI 10.1016/S0924-4247(98)00242-8; Shim W, 2011, NATURE, V469, P516, DOI 10.1038/nature09697; Shuster MJ, 2011, CHEM COMMUN, V47, P10641, DOI 10.1039/c1cc13002a; Skulason H, 2000, J AM CHEM SOC, V122, P9750, DOI 10.1021/ja994524e; Srinivasan C, 2007, ACS NANO, V1, P191, DOI 10.1021/nn7000799; Stranick SJ, 1996, NANOTECHNOLOGY, V7, P438, DOI 10.1088/0957-4484/7/4/025; STRANICK SJ, 1994, J PHYS CHEM-US, V98, P11136, DOI 10.1021/j100094a024; STRANICK SJ, 1995, SURF SCI, V338, P41, DOI 10.1016/0039-6028(95)00529-3; TIBERIO RC, 1993, APPL PHYS LETT, V62, P476, DOI 10.1063/1.108938; Vaish A, 2011, SMALL, V7, P1471, DOI 10.1002/smll.201100094; WASSERMAN SR, 1989, J MATER RES, V4, P886, DOI 10.1557/JMR.1989.0886; WILBUR JL, 1994, ADV MATER, V6, P600, DOI 10.1002/adma.19940060719; Willson CG, 2008, ACS NANO, V2, P1323, DOI 10.1021/nn800410c; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Xu S, 1999, LANGMUIR, V15, P7244, DOI 10.1021/la9906727; Xu S, 1998, J AM CHEM SOC, V120, P9356, DOI 10.1021/ja981938j; Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f; Yu M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.166102	47	116	116	2	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1517	1521		10.1126/science.1221774	http://dx.doi.org/10.1126/science.1221774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997333				2022-12-28	WOS:000308912900046
J	Ludwig, J; Duncan, GJ; Gennetian, LA; Katz, LF; Kessler, RC; Kling, JR; Sanbonmatsu, L				Ludwig, Jens; Duncan, Greg J.; Gennetian, Lisa A.; Katz, Lawrence F.; Kessler, Ronald C.; Kling, Jeffrey R.; Sanbonmatsu, Lisa			Neighborhood Effects on the Long-Term Well-Being of Low-Income Adults	SCIENCE			English	Article							INEQUALITY; CHILDREN; SEGREGATION	Nearly 9 million Americans live in extreme-poverty neighborhoods, places that also tend to be racially segregated and dangerous. Yet, the effects on the well-being of residents of moving out of such communities into less distressed areas remain uncertain. Using data from Moving to Opportunity, a unique randomized housing mobility experiment, we found that moving from a high-poverty to lower-poverty neighborhood leads to long-term (10- to 15-year) improvements in adult physical and mental health and subjective well-being, despite not affecting economic self-sufficiency. A 1-standard deviation decline in neighborhood poverty (13 percentage points) increases subjective well-being by an amount equal to the gap in subjective well-being between people whose annual incomes differ by $13,000-a large amount given that the average control group income is $20,000. Subjective well-being is more strongly affected by changes in neighborhood economic disadvantage than racial segregation, which is important because racial segregation has been declining since 1970, but income segregation has been increasing.	[Ludwig, Jens] Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA; [Ludwig, Jens; Katz, Lawrence F.; Kling, Jeffrey R.; Sanbonmatsu, Lisa] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Duncan, Greg J.] Univ Calif Irvine, Sch Educ, Irvine, CA 92697 USA; [Gennetian, Lisa A.] Brookings Inst, Washington, DC 20036 USA; [Katz, Lawrence F.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Kling, Jeffrey R.] Congress Budget Off, Washington, DC 20515 USA	University of Chicago; National Bureau of Economic Research; University of California System; University of California Irvine; Brookings Institution; Harvard University; Harvard University; Harvard Medical School; Congressional Budget Office	Ludwig, J (corresponding author), Univ Chicago, Harris Sch Publ Policy, 1155 E 60th St, Chicago, IL 60637 USA.	jludwig@uchicago.edu			HUD [C-CHI-00808]; National Science Foundation [SES-0527615]; National Institute for Child Health and Human Development [R01-HD040404, R01-HD040444]; Centers for Disease Control [R49-CE000906]; National Institute of Mental Health [R01-MH077026]; National Institute for Aging [P20-AG012180, R56-AG031259, P01-AG005842-22S1]; National Opinion Research Center's Population Research Center (from the National Institute of Child Health and Human Development) [R24-HD051152-04]; University of Chicago's Center for Health Administration Studies; U.S. Department of Education/Institute of Education Sciences [R305U070006]; Bill & Melinda Gates Foundation; John D. and Catherine T. MacArthur Foundation; Russell Sage Foundation; Smith Richardson Foundation; Spencer Foundation; Annie E. Casey Foundation; Robert Wood Johnson Investigator Award in Health Policy Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD051152] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040444, R01HD040404] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG012810, R01AG031259, P01AG005842, R56AG031259] Funding Source: NIH RePORTER	HUD; National Science Foundation(National Science Foundation (NSF)); National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Opinion Research Center's Population Research Center (from the National Institute of Child Health and Human Development); University of Chicago's Center for Health Administration Studies; U.S. Department of Education/Institute of Education Sciences(US Department of Education); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); John D. and Catherine T. MacArthur Foundation; Russell Sage Foundation; Smith Richardson Foundation; Spencer Foundation; Annie E. Casey Foundation; Robert Wood Johnson Investigator Award in Health Policy Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this research was provided by a contract from HUD (C-CHI-00808) and grants from the National Science Foundation (SES-0527615), the National Institute for Child Health and Human Development (R01-HD040404 and R01-HD040444), the Centers for Disease Control (R49-CE000906), the National Institute of Mental Health (R01-MH077026), the National Institute for Aging (P20-AG012180, R56-AG031259, and P01-AG005842-22S1), the National Opinion Research Center's Population Research Center (through R24-HD051152-04 from the National Institute of Child Health and Human Development), University of Chicago's Center for Health Administration Studies, the U.S. Department of Education/Institute of Education Sciences (R305U070006), the Bill & Melinda Gates Foundation, the John D. and Catherine T. MacArthur Foundation, the Russell Sage Foundation, the Smith Richardson Foundation, the Spencer Foundation, and the Annie E. Casey Foundation. This paper was also supported by a visiting scholar award from the Russell Sage Foundation to J.L. and a Robert Wood Johnson Investigator Award in Health Policy Research to J.L. and G.J.D. Outstanding assistance with the data preparation and analysis was provided by J. Amick, R. Gillette, I. Lai, J. Marvakov, N. Potter, M. Sciandra, F. Yang, S. Yusuf, and M. Zabek. The survey data collection effort was led by N. Gebler of the University of Michigan's Survey Research Center under subcontract to our research team. Helpful comments were provided by I. Gould Ellen, A. Krueger, D. Pager, G. Pham-Kanter, T. Richardson, M. Shroder, R. Suzman, J. Wolfers, and seminar participants at Princeton University and the Russell Sage Foundation. MTO data was provided by HUD. The data used in this paper will be made available through the Inter-university Consortium for Political and Social Research (ICPSR) at the University of Michigan and also at www.nber.org/mtopuf. Any errors and all opinions are our own. The views expressed in this work are those of the authors and should not be interpreted as those of the Congressional Budget Office or HUD.	Ben-Shalom Y., 2011, NATL BUREAU EC RES W; DeLuca S, 2010, HOUS POLICY DEBATE, V20, P7, DOI 10.1080/10511481003599829; Dolan P., 2011, MEASURING SUBJECTIVE; Ellickson Robert C., 2009, PROPERTY RIGHTS LAND, p[418, 425]; Glaeser Edward L, 2012, 66 MANH I CIV; Huebner ES, 2004, SOC INDIC RES, V66, P3, DOI 10.1023/B:SOCI.0000007497.57754.e3; Jacob BA, 2004, AM ECON REV, V94, P233, DOI 10.1257/000282804322970788; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Kneebone E., 2011, REEMERGENCE CONCENTR; Ludwig J, 2012, CITYSCAPE, V14, P1; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Macintyre S., 2003, NEIGHBORHOODS HLTH, V20, P42; Massey D., 1993, AM APARTHEID SEGREGA; Myrdal G., 1944, AM DILEMMA NEGRO PRO, V1; National Advisory Commission on Civil Disorders, 1968, KERN REP; Oreopoulos P, 2003, Q J ECON, V118, P1533, DOI 10.1162/003355303322552865; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Reardon S.F., 2011, MORE UNEQUAL MORE SE; Reardon SF, 2011, AM J SOCIOL, V116, P1092, DOI 10.1086/657114; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; SAMPSON RJ, 1997, LOGIC CIRCUITS CARBO, V277, P918; Sampson RJ., 2012, GREAT AMERICAN CITY; Sampson RJ, 2008, AM J SOCIOL, V114, P189, DOI 10.1086/589843; Sampson RJ, 2008, P NATL ACAD SCI USA, V105, P845, DOI 10.1073/pnas.0710189104; SANBONMATSU LISA, 2011, MOVING OPPORTUNITY F; Smith Tom W., 2011, GEN SOCIAL SURVEYS 1; Stevenson B., 2010, SUBJECTIVE OBJECTIVE; U.S. Census Bureau, 2010, TABL F 3 MEAN INC RE; U.S. Census Bureau, 2012, POV THRESH 2011 SIZ; Watson T, 2009, REV INCOME WEALTH, V55, P820, DOI 10.1111/j.1475-4991.2009.00346.x; Wilson R., 1987, TRULY DISADVANTAGED	33	410	416	8	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1505	1510		10.1126/science.1224648	http://dx.doi.org/10.1126/science.1224648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997331	Green Submitted, Green Accepted			2022-12-28	WOS:000308912900043
J	Lutter, CK; Lutter, R				Lutter, Chessa K.; Lutter, Randall			Fetal and Early Childhood Undernutrition, Mortality, and Lifelong Health	SCIENCE			English	Editorial Material							FEEDING PATTERNS; WEIGHT-GAIN; BIRTH; NUTRITION; INFANT; RISK; ORIGINS; COHORTS; BURDEN; IMPACT	Child undernutrition is a major public health challenge, estimated to be responsible for 2.2 million annual deaths. Implementation of available interventions could prevent one-third of these deaths. Emerging evidence suggests that breast-feeding can lead to improvements in intelligence quotient in children and lower risks of noncommunicable diseases in mothers and children decades later. Nonetheless, breast-feeding and complementary feeding practices differ greatly from global recommendations. Although the World Health Organization recommends that infants receive solely breast milk for the first 6 months of life, only about one-third of infants in low-income countries meet this goal, just one-third of children 6 to 24 months old in low-income countries meet the minimum criteria for dietary diversity, and only one in five who are breast-fed receive a minimum acceptable diet. Although the potential effects of improved breast-feeding and complementary feeding appear large, funding for research and greater use of existing effective interventions seems low compared with other life-saving child health interventions.	[Lutter, Chessa K.] PAHO WHO, Washington, DC 20037 USA; [Lutter, Randall] Resources Future Inc, Washington, DC 20036 USA	Resources for the Future	Lutter, CK (corresponding author), PAHO WHO, 525 23rd St NW, Washington, DC 20037 USA.	lutterch@paho.org		Lutter, Chessa/0000-0003-1601-4645				Adair LS, 2012, NUTR METAB CARDIOVAS, V22, P765, DOI 10.1016/j.numecd.2012.03.011; Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Archer C., 2012, IMPACT BREASTFEEDING; Arimond M., 2010, COMBATING MICRONUTRI; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; Bartick M, 2010, PEDIATRICS, V125, pE1048, DOI 10.1542/peds.2009-1616; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2009, LANCET, V373, P1584, DOI 10.1016/S0140-6736(09)60886-2; Bloom DE, 2011, GLOBAL EC BURDEN NON; Brady JP, 2012, ARCH DIS CHILD, V97, P529, DOI 10.1136/archdischild-2011-301299; Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481; Clinton H. Rodham, 2010, 1000 DAYS CHANGE LIF; Edmond K., 2006, OPTIMAL FEEDING LOW; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; Field E, 2009, AM ECON J-APPL ECON, V1, P1, DOI 10.1257/app.1.1.1; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gribble JN, 2009, MATERN CHILD NUTR, V5, P49, DOI 10.1111/j.1740-8709.2008.00158.x; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Horta BL, 2007, EVIDENCE LONG TERM E; Horton S, 1996, HEALTH POLICY PLANN, V11, P156, DOI 10.1093/heapol/11.2.156; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Jelliffe D B, 1972, Nutr Rev, V30, P199; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Leroy JL, 2009, J DEV EFFECT, V1, P103, DOI 10.1080/19439340902924043; LESTER RT, 2010, J GERONTOL B-PSYCHOL, V376, P1838, DOI DOI 10.1016/S0140-6736(10)61997-6; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Lutter CK, 2011, AM J PUBLIC HEALTH, V101, P2130, DOI 10.2105/AJPH.2011.300244; Lutter Chessa K., 1992, Food and Nutrition Bulletin, V14, P36; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Mullany LC, 2008, J NUTR, V138, P599, DOI 10.1093/jn/138.3.599; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Poskitt EME, 2012, NUTR METAB CARDIOVAS, V22, P819, DOI 10.1016/j.numecd.2012.08.005; Rea M. F., 2003, CAUDE SALUD PUB, V19, P119; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; SHORT RV, 1991, LANCET, V337, P715, DOI 10.1016/0140-6736(91)90288-Z; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P787, DOI 10.1016/j.numecd.2012.04.003; Stuebe AM, 2011, AM J EPIDEMIOL, V174, P1147, DOI 10.1093/aje/kwr227; U.S. EPA, 2008, REG IMP AN PROP REV; U. S. EPA (U. S. Environmental Protection Agency), 1997, BEN COSTS CLEAN AIR; [UN UNGA], 2011, PREV CONTR NONC DIS; United States Office of Management and Budget (OMB), 2003, A4 US OMB; WHO and partners, 2010, IND ASS INF YOUNG 3; WHO UNICEF, 2008, AFR HLTH 2010 LEARN; Woo JG, 2012, J PEDIATR GASTR NUTR, V54, P532, DOI 10.1097/MPG.0b013e31823fde04; World Health Organization, 1981, INT COD MARK BREAST	52	27	32	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1495	1499		10.1126/science.1224616	http://dx.doi.org/10.1126/science.1224616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997328	Green Published			2022-12-28	WOS:000308912900040
J	Pradzynski, CC; Forck, RM; Zeuch, T; Slavicek, P; Buck, U				Pradzynski, Christoph C.; Forck, Richard M.; Zeuch, Thomas; Slavicek, Petr; Buck, Udo			A Fully Size-Resolved Perspective on the Crystallization of Water Clusters	SCIENCE			English	Article							INFRARED-SPECTROSCOPY; SOLID WATER; METHANOL CLUSTERS; DOUBLE-RESONANCE; SODIUM-WATER; FRAGMENTATION; ATOMS; NUCLEATION; CHEMISTRY; ELECTRONS	The number of water molecules needed to form the smallest ice crystals has proven challenging to pinpoint experimentally. This information would help to better understand the hydrogen-bonding interactions that account for the macroscopic properties of water. Here, we report infrared (IR) spectra of precisely size-selected (H2O)(n) clusters, with n ranging from 85 to 475; sodium doping and associated IR excitation-modulated photoionization spectroscopy allowed the study of this previously intractable size domain. Spectral features indicating the onset of crystallization are first observed for n = 275 +/- 25; for n = 475 +/- 25, the well-known band of crystalline ice around 3200 cm(-1) dominates the OH-stretching region. The applied method has the potential to push size-resolved IR spectroscopy of neutral clusters more broadly to the 100- to 1000-molecule range, in which many solvents start to manifest condensed phase properties.	[Pradzynski, Christoph C.; Forck, Richard M.; Zeuch, Thomas] Univ Gottingen, Inst Phys Chem, D-37077 Gottingen, Germany; [Slavicek, Petr] Prague Inst Chem Technol, Dept Phys Chem, CR-16628 Prague 6, Czech Republic; [Buck, Udo] Max Planck Inst Dynam & Selbstorg, D-37077 Gottingen, Germany	University of Gottingen; University of Chemistry & Technology, Prague; Max Planck Society	Zeuch, T (corresponding author), Univ Gottingen, Inst Phys Chem, Tammannstr 6, D-37077 Gottingen, Germany.	tzeuch1@gwdg.de; ubuck@gwdg.de	Slavicek, Petr/B-7511-2008		Deutsche Forschungsgemeinschaft [GRK 782, ZE 890-1-1]; Grant Agency of the Czech Republic [P208/11/0161]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	T.Z. acknowledges the ongoing support of M. Suhm and funding by the Deutsche Forschungsgemeinschaft (GRK 782, grant ZE 890-1-1). P.S. acknowledges grant P208/11/0161 of Grant Agency of the Czech Republic. All information regarding the generation of the presented IR spectra from raw data are given in the text and the supplementary materials.	Alexander WA, 2012, SCIENCE, V335, P1072, DOI 10.1126/science.1215956; Bobbert C, 2002, EUR PHYS J D, V19, P183, DOI 10.1140/epjd/e20020070; Buch V, 2004, INT REV PHYS CHEM, V23, P375, DOI 10.1080/01442350412331316124; Buck U, 1998, PHYS REV LETT, V80, P2578, DOI 10.1103/PhysRevLett.80.2578; BUCK U, 1984, PHYS REV LETT, V52, P109, DOI 10.1103/PhysRevLett.52.109; BUCK U, 1994, J PHYS CHEM-US, V98, P5190, DOI 10.1021/j100071a005; Buck U, 2000, CHEM REV, V100, P3863, DOI 10.1021/cr990054v; Buck U, 2007, J PHYS CHEM A, V111, P12355, DOI 10.1021/jp075717o; Dauster I, 2008, PHYS CHEM CHEM PHYS, V10, P83, DOI 10.1039/b711568g; Delzeit L., 2001, J GEOPHYS RES-PLANET, V33, P379; Diken EG, 2004, J PHYS CHEM A, V108, P64, DOI 10.1021/jp0309973; Ferro Y, 2003, J CHEM PHYS, V118, P10461, DOI 10.1063/1.1573178; Forck RM, 2012, PHYS CHEM CHEM PHYS, V14, P9054, DOI 10.1039/c2cp41066d; Forck RM, 2012, PHYS CHEM CHEM PHYS, V14, P3004, DOI 10.1039/c2cp23301k; Forck RM, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3439393; Forysinski PW, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3559464; Gruenloh CJ, 1997, SCIENCE, V276, P1678, DOI 10.1126/science.276.5319.1678; Hamashima T, 2011, J PHYS CHEM A, V115, P620, DOI 10.1021/jp111586p; HAYNES DR, 1992, J PHYS CHEM-US, V96, P8502, DOI 10.1021/j100200a055; HERTEL IV, 1991, PHYS REV LETT, V67, P1767, DOI 10.1103/PhysRevLett.67.1767; Hock C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.073401; HUANG JF, 1995, J PHYS CHEM-US, V99, P3924, DOI 10.1021/j100012a010; Kim JH, 2009, J PHYS CHEM C, V113, P321, DOI 10.1021/jp807774v; Knipping EM, 2000, SCIENCE, V288, P301, DOI 10.1126/science.288.5464.301; Krischok S, 2003, NUCL INSTRUM METH B, V203, P124, DOI 10.1016/S0168-583X(02)02184-5; Kulmala M, 2003, SCIENCE, V302, P1000, DOI 10.1126/science.1090848; Liu K, 1996, SCIENCE, V271, P929, DOI 10.1126/science.271.5251.929; Mizuse K, 2009, J PHYS CHEM A, V113, P12134, DOI 10.1021/jp9061187; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; O'Brien JT, 2012, J AM CHEM SOC, V134, P10228, DOI 10.1021/ja303191r; Rodriguez O, 2011, J PHYS CHEM LETT, V2, P1444, DOI 10.1021/jz200530v; Roth W, 1998, CHEM PHYS, V239, P1, DOI 10.1016/S0301-0104(98)00252-3; SCHULZ CP, 1986, PHYS REV LETT, V57, P1703, DOI 10.1103/PhysRevLett.57.1703; Schutte S, 2002, INT J MASS SPECTROM, V220, P183, DOI 10.1016/S1387-3806(02)00670-X; Steinbach C, 2006, J PHYS CHEM A, V110, P3128, DOI 10.1021/jp054502g; Steinbach C, 2005, PHYS CHEM CHEM PHYS, V7, P986, DOI 10.1039/b419325n; Steinbach C, 2004, J PHYS CHEM A, V108, P6165, DOI 10.1021/jp049276+; TORCHET G, 1983, J CHEM PHYS, V79, P6196, DOI 10.1063/1.445803; Watanabe T, 1996, J CHEM PHYS, V105, P408, DOI 10.1063/1.471917; Zhang RY, 2012, CHEM REV, V112, P1957, DOI 10.1021/cr2001756	40	144	148	4	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1529	1532		10.1126/science.1225468	http://dx.doi.org/10.1126/science.1225468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997336				2022-12-28	WOS:000308912900049
J	Biswas, K; He, JQ; Blum, ID; Wu, CI; Hogan, TP; Seidman, DN; Dravid, VP; Kanatzidis, MG				Biswas, Kanishka; He, Jiaqing; Blum, Ivan D.; Wu, Chun-I; Hogan, Timothy P.; Seidman, David N.; Dravid, Vinayak P.; Kanatzidis, Mercouri G.			High-performance bulk thermoelectrics with all-scale hierarchical architectures	NATURE			English	Article							FIGURE; PBTE; MERIT	With about two-thirds of all used energy being lost as waste heat, there is a compelling need for high-performance thermoelectric materials that can directly and reversibly convert heat to electrical energy. However, the practical realization of thermoelectric materials is limited by their hitherto low figure of merit, ZT, which governs the Carnot efficiency according to the second law of thermodynamics. The recent successful strategy of nanostructuring to reduce thermal conductivity has achieved record-high ZT values in the range 1.5-1.8 at 750-900 kelvin(1-3), but still falls short of the generally desired threshold value of 2. Nanostructures in bulk thermoelectrics allow effective phonon scattering of a significant portion of the phonon spectrum, but phonons with long mean free paths remain largely unaffected. Here we show that heat-carrying phonons with long mean free paths can be scattered by controlling and fine-tuning the mesoscale architecture of nanostructured thermoelectric materials. Thus, by considering sources of scattering on all relevant length scales in a hierarchical fashion-from atomic-scale lattice disorder and nanoscale endotaxial precipitates to mesoscale grain boundaries-we achieve the maximum reduction in lattice thermal conductivity and a large enhancement in the thermoelectric performance of PbTe. By taking such a panoscopic approach to the scattering of heat-carrying phonons across integrated length scales, we go beyond nanostructuring and demonstrate a ZT value of similar to 2.2 at 915 kelvin in p-type PbTe endotaxially nanostructured with SrTe at a concentration of 4 mole per cent and mesostructured with powder processing and spark plasma sintering. This increase in ZT beyond the threshold of 2 highlights the role of, and need for, multiscale hierarchical architecture in controlling phonon scattering in bulk thermoelectrics, and offers a realistic prospect of the recovery of a significant portion of waste heat.	[Biswas, Kanishka; He, Jiaqing; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Wu, Chun-I; Hogan, Timothy P.] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Kanatzidis, Mercouri G.] Argonne Natl Lab, Mat Sci Div, Argonne, IL 60439 USA	Northwestern University; Michigan State University; United States Department of Energy (DOE); Argonne National Laboratory	Kanatzidis, MG (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	m-kanatzidis@northwestern.edu	He, Jiaqing/A-2245-2010; Blum, Ivan/C-6230-2013; Dravid, Vinayak/B-6688-2009; Seidman, David/B-6697-2009	He, Jiaqing/0000-0003-3954-6003; Blum, Ivan/0000-0002-4729-6510; 	Energy Frontier Research Center for Revolutionary Materials for Solid State Energy Conversion; US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001054]; ONR DURIP [N00014-0400798, N00014-0610539, N00014-0910781]; NSF-MRI [DMR-0420532]; MRSEC [DMR-1121262]; ISEN at Northwestern University	Energy Frontier Research Center for Revolutionary Materials for Solid State Energy Conversion; US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); ONR DURIP(Office of Naval Research); NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); MRSEC(National Science Foundation (NSF)); ISEN at Northwestern University	This work was supported by the Energy Frontier Research Center for Revolutionary Materials for Solid State Energy Conversion, funded by the US Department of Energy, Office of Science, Basic Energy Sciences under award number DE-SC0001054. TEM was performed in the (EPIC) (NIFTI) (Keck-II) facility of the NUANCE Center at Northwestern University. The spark plasma sintering system at Michigan State University is supported by ONR DURIP. APT was performed at NUCAPT and supported by NSF-MRI (DMR-0420532), ONR-DURIP (N00014-0400798, N00014-0610539, N00014-0910781), MRSEC (DMR-1121262) and ISEN at Northwestern University.	Airapetyants S. V., 1966, FIZ TVERD TELA+, V8, P1069; Biswas K, 2011, NAT CHEM, V3, P160, DOI [10.1038/nchem.955, 10.1038/NCHEM.955]; BLACHNIK R, 1974, Z NATURFORSCH B, VB 29, P625, DOI 10.1515/znb-1974-9-1012; Chen G, 2003, INT MATER REV, V48, P45, DOI 10.1179/095066003225010182; Crocker A. J., 1968, Journal de Physique, V29, pc4, DOI 10.1051/jphyscol:1968418; CROCKER AJ, 1968, J PHYS CHEM SOLIDS, V29, P155, DOI 10.1016/0022-3697(68)90265-5; Esfarjani K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085204; Girard SN, 2011, J AM CHEM SOC, V133, P16588, DOI 10.1021/ja206380h; Goldsmid H.J., 1964, THERMOELECTRIC REFRI; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Hytch MJ, 1998, ULTRAMICROSCOPY, V74, P131, DOI 10.1016/S0304-3991(98)00035-7; Johnsen S, 2011, J AM CHEM SOC, V133, P3460, DOI 10.1021/ja109138p; Martinez JI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045120; May AF, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125205; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Poudeu PFR, 2006, ANGEW CHEM INT EDIT, V45, P3835, DOI 10.1002/anie.200600865; Qiu B, 2012, COMP MATER SCI, V53, P278, DOI 10.1016/j.commatsci.2011.08.016; Ravich Y. I., 1970, SEMICONDUCTING LEAD, V5, P184; Rowe D.M., 2006, CRC HDB THERMOELECTR; Seidman DN, 2007, ANNU REV MATER RES, V37, P127, DOI 10.1146/annurev.matsci.37.052506.084200; Shi X, 2011, J AM CHEM SOC, V133, P7837, DOI 10.1021/ja111199y; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Tian ZT, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184303; Tritt, 2000, RECENT TRENDS THERMO; Tritt T. M., 2000, SEMICONDUCTORS SEMIM, V70; Tritt TM, 2001, SEMICONDUCT SEMIMET, V71, pIX; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Zhu GH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.196803	31	3152	3201	80	2292	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					414	418		10.1038/nature11439	http://dx.doi.org/10.1038/nature11439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996556				2022-12-28	WOS:000308860900041
J	Jack, A				Jack, Andrew			"World's pharmacy" faces new challenges from Western drug companies	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Jack A., 2012, FINANCIAL TIMES	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 17	2012	345								e6207	10.1136/bmj.e6207	http://dx.doi.org/10.1136/bmj.e6207			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JG	22988308				2022-12-28	WOS:000309160300005
J	Herzog, F; Kahraman, A; Boehringer, D; Mak, R; Bracher, A; Walzthoeni, T; Leitner, A; Beck, M; Hartl, FU; Ban, N; Malmstrom, L; Aebersold, R				Herzog, Franz; Kahraman, Abdullah; Boehringer, Daniel; Mak, Raymond; Bracher, Andreas; Walzthoeni, Thomas; Leitner, Alexander; Beck, Martin; Hartl, Franz-Ulrich; Ban, Nenad; Malmstroem, Lars; Aebersold, Ruedi			Structural Probing of a Protein Phosphatase 2A Network by Chemical Cross-Linking and Mass Spectrometry	SCIENCE			English	Article							MOLECULAR ARCHITECTURE; CRYSTAL-STRUCTURE; CHAPERONIN; COMPLEX; IDENTIFICATION; OPTIMIZATION; ALPHA-4; BINDING	The identification of proximate amino acids by chemical cross-linking and mass spectrometry (XL-MS) facilitates the structural analysis of homogeneous protein complexes. We gained distance restraints on a modular interaction network of protein complexes affinity-purified from human cells by applying an adapted XL-MS protocol. Systematic analysis of human protein phosphatase 2A (PP2A) complexes identified 176 interprotein and 570 intraprotein cross-links that link specific trimeric PP2A complexes to a multitude of adaptor proteins that control their cellular functions. Spatial restraints guided molecular modeling of the binding interface between immunoglobulin binding protein 1 (IGBP1) and PP2A and revealed the topology of TCP1 ring complex (TRiC) chaperonin interacting with the PP2A regulatory subunit 2ABG. This study establishes XL-MS as an integral part of hybrid structural biology approaches for the analysis of endogenous protein complexes.	[Herzog, Franz; Kahraman, Abdullah; Mak, Raymond; Walzthoeni, Thomas; Leitner, Alexander; Malmstroem, Lars; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Boehringer, Daniel; Ban, Nenad] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Beck, Martin] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Bracher, Andreas; Hartl, Franz-Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; European Molecular Biology Laboratory (EMBL); Max Planck Society	Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch	Herzog, Franz/G-4832-2012; Malmström, Lars/R-4991-2019; Beck, Martin/B-5589-2011; Leitner, Alexander/U-1601-2019; Hartl, F. Ulrich/Y-8206-2019	Herzog, Franz/0000-0001-8270-1449; Malmström, Lars/0000-0001-9885-9312; Beck, Martin/0000-0002-7397-1321; Leitner, Alexander/0000-0003-4126-0725; Kahraman, Abdullah/0000-0003-3523-4467; Mak, Raymond/0000-0002-7081-8671	EU; European Molecular Biology Organization; European Commission [FP7-PEOPLE-IEF]; European Research Council [Proteomics v.3.0.]	EU(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission)	We thank S. Hauri, A. Frei, and M. Gstaiger for support. Primary mass spectrometry data are available as mzXML files at www.peptideatlas.org/PASS/PASS00053. This work was supported by the EU FP7 project PROSPECTS. F. H. was supported by the European Molecular Biology Organization and by the European Commission (FP7-PEOPLE-IEF). R. A. was supported by the European Research Council advanced grant Proteomics v.3.0.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lauber MA, 2010, ANAL CHEM, V82, P7736, DOI 10.1021/ac101586z; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Zhang HZ, 2009, MOL CELL PROTEOMICS, V8, P409, DOI 10.1074/mcp.M800232-MCP200	37	303	308	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1348	1352		10.1126/science.1221483	http://dx.doi.org/10.1126/science.1221483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984071				2022-12-28	WOS:000308705000044
J	Rigotti, NA; Wakefield, M				Rigotti, Nancy A.; Wakefield, Melanie			Real People, Real Stories: A New Mass Media Campaign That Could Help Smokers Quit	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SMOKING-CESSATION; COMMUNICATION		[Rigotti, Nancy A.] Massachusetts Gen Hosp, Gen Med Div, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Canc Council Victoria, Ctr Behav Res Canc, Melbourne, Vic, Australia	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cancer Council Victoria	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Gen Med Div, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	nrigotti@partners.org	Wakefield, Melanie/E-5019-2012	Wakefield, Melanie/0000-0002-6183-5699	NHLBI NIH HHS [K24 HL004440] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004440] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Augustson Erik, 2012, Morbidity and Mortality Weekly Report, V61, P667; Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2; Brennan E, 2011, TOB CONTROL, V20, P412, DOI 10.1136/tc.2010.039321; Centers for Disease Control and Prevention, TIPS FORM SMOK CAMP; Dunlop S, 2008, MEDIA PSYCHOL, V11, P52, DOI 10.1080/15213260701853112; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; Durkin SJ, 2009, AM J PUBLIC HEALTH, V99, P2217, DOI 10.2105/AJPH.2009.161638; Farrelly MC, 2009, AM J PREV MED, V36, P379, DOI 10.1016/j.amepre.2009.01.019; National Cancer Institute, 2008, ROL MED PROM RED TOB; Niederdeppe J, 2011, SOC SCI MED, V72, P773, DOI 10.1016/j.socscimed.2010.12.025; Siegel M, 2000, AM J PUBLIC HEALTH, V90, P380, DOI 10.2105/AJPH.90.3.380; Sly DF, 2002, PREV MED, V35, P511, DOI 10.1006/pmed.2002.1100; Southwell BG, 2009, COMMUN THEOR, V19, P1, DOI 10.1111/j.1468-2885.2008.01329.x; U.S. Food and Drug Administration, 2012, TOB PROD CIG HLTH WA; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Vallone DM, 2011, AM J PUBLIC HEALTH, V101, P302, DOI 10.2105/AJPH.2009.190454; van den Putte B, 2011, J HEALTH COMMUN, V16, P470, DOI 10.1080/10810730.2010.546487; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4	18	23	24	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					907	U125		10.7326/0003-4819-156-1-201201010-00541	http://dx.doi.org/10.7326/0003-4819-156-1-201201010-00541			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	057SB	23007853				2022-12-28	WOS:000312583200021
J	Moon, TS; Lou, CB; Tamsir, A; Stanton, BC; Voigt, CA				Moon, Tae Seok; Lou, Chunbo; Tamsir, Alvin; Stanton, Brynne C.; Voigt, Christopher A.			Genetic programs constructed from layered logic gates in single cells	NATURE			English	Article							III SECRETION SYSTEM; SYNTHETIC BIOLOGY; ACTIVATION	Genetic programs function to integrate environmental sensors, implement signal processing algorithms and control expression dynamics(1). These programs consist of integrated genetic circuits that individually implement operations ranging from digital logic to dynamic circuits(2-6), and they have been used in various cellular engineering applications, including the implementation of process control in metabolic networks and the coordination of spatial differentiation in artificial tissues. A key limitation is that the circuits are based on biochemical interactions occurring in the confined volume of the cell, so the size of programs has been limited to a few circuits(1,7). Here we apply part mining and directed evolution to build a set of transcriptional AND gates in Escherichia coli. Each AND gate integrates two promoter inputs and controls one promoter output. This allows the gates to be layered by having the output promoter of an upstream circuit serve as the input promoter for a downstream circuit. Each gate consists of a transcription factor that requires a second chaperone protein to activate the output promoter. Multiple activator-chaperone pairs are identified from type III secretion pathways in different strains of bacteria. Directed evolution is applied to increase the dynamic range and orthogonality of the circuits. These gates are connected in different permutations to form programs, the largest of which is a 4-input AND gate that consists of 3 circuits that integrate 4 inducible systems, thus requiring 11 regulatory proteins. Measuring the performance of individual gates is sufficient to capture the behaviour of the complete program. Errors in the output due to delays (faults), a common problem for layered circuits, are not observed. This work demonstrates the successful layering of orthogonal logic gates, a design strategy that could enable the construction of large, integrated circuits in single cells.	[Moon, Tae Seok; Lou, Chunbo; Stanton, Brynne C.; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Tamsir, Alvin] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com		Lou, Chunbo/0000-0002-7941-6038; Moon, Tae Seok/0000-0001-8373-9051; hong, xizhi/0000-0001-6029-6761	Life Technologies; Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA) [CLIO N66001-12-C-4018]; Office of Naval Research [N00014-10-1-0245]; National Science Foundation (NSF) [CCF-0943385]; National Institutes of Health [AI067699]; NSF Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067699, R01AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095765] Funding Source: NIH RePORTER	Life Technologies; Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology Engineering Research Center (SynBERC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.A.V. is supported by Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA; CLIO N66001-12-C-4018), the Office of Naval Research (N00014-10-1-0245), the National Science Foundation (NSF; CCF-0943385), the National Institutes of Health (AI067699) and the NSF Synthetic Biology Engineering Research Center (SynBERC; SA5284-11210). The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred.	Abelson H, 2000, COMMUN ACM, V43, P74, DOI 10.1145/332833.332842; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Katz R. H., 1994, CONT LOGIC DESIGN; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mavris M, 2002, J BACTERIOL, V184, P6751, DOI 10.1128/JB.184.24.6751-6759.2002; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Temme K, 2008, J MOL BIOL, V377, P47, DOI 10.1016/j.jmb.2007.12.044; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Thibault J, 2009, J BIOL CHEM, V284, P15762, DOI 10.1074/jbc.M109.003533; Walker KA, 2004, J BACTERIOL, V186, P4056, DOI 10.1128/JB.186.13.4056-4066.2004; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516	28	362	379	3	297	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					249	253		10.1038/nature11516	http://dx.doi.org/10.1038/nature11516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23041931	Green Accepted, Green Submitted			2022-12-28	WOS:000310774300043
J	Tussiwand, R; Lee, WL; Murphy, TL; Mashayekhi, M; Wumesh, KC; Albring, JC; Satpathy, AT; Rotondo, JA; Edelson, BT; Kretzer, NM; Wu, XD; Weiss, LA; Glasmacher, E; Li, P; Liao, W; Behnke, M; Lam, SSK; Aurthur, CT; Leonard, WJ; Singh, H; Stallings, CL; Sibley, LD; Schreiber, RD; Murphy, KM				Tussiwand, Roxane; Lee, Wan-Ling; Murphy, Theresa L.; Mashayekhi, Mona; Wumesh, K. C.; Albring, Joern C.; Satpathy, Ansuman T.; Rotondo, Jeffrey A.; Edelson, Brian T.; Kretzer, Nicole M.; Wu, Xiaodi; Weiss, Leslie A.; Glasmacher, Elke; Li, Peng; Liao, Wei; Behnke, Michael; Lam, Samuel S. K.; Aurthur, Cora T.; Leonard, Warren J.; Singh, Harinder; Stallings, Christina L.; Sibley, L. David; Schreiber, Robert D.; Murphy, Kenneth M.			Compensatory dendritic cell development mediated by BATF-IRF interactions	NATURE			English	Article							NEGATIVE REGULATOR; B-ATF; CD8-ALPHA(+); TRANSCRIPTION; EXPRESSION; INFECTION; AP-1; REVEALS; MICE; ACTIVATION	The AP1 transcription factor Batf3 is required for homeostatic development of CD8 alpha(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens. Here we identify an alternative, Batf3-independent pathway in mice for CD8 alpha(+) dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-gamma. This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection. Reciprocally, physiological compensation between Batf and Batf3 also occurs in T cells for expression of IL-10 and CTLA4. Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation. Conceivably, manipulating this alternative pathway of dendritic cell development could be of value in augmenting immune responses to vaccines.	[Tussiwand, Roxane; Lee, Wan-Ling; Murphy, Theresa L.; Mashayekhi, Mona; Wumesh, K. C.; Albring, Joern C.; Satpathy, Ansuman T.; Rotondo, Jeffrey A.; Edelson, Brian T.; Kretzer, Nicole M.; Wu, Xiaodi; Lam, Samuel S. K.; Aurthur, Cora T.; Schreiber, Robert D.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Weiss, Leslie A.; Behnke, Michael; Stallings, Christina L.; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Glasmacher, Elke; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Roche Holding; Genentech; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Leonard, Warren/AAA-1397-2022; Schreiber, Robert D/A-1276-2013; Behnke, Michael S/R-8839-2016; Schreiber, Robert/Q-7550-2019; Glasmacher, Elke/B-8939-2015	Schreiber, Robert D/0000-0001-6311-0432; Behnke, Michael S/0000-0002-4668-8109; Glasmacher, Elke/0000-0003-1265-2543; Satpathy, Ansuman/0000-0002-5167-537X; Schreiber, Robert/0000-0003-1590-2341; Albring, Jorn/0000-0002-5534-7250; Tussiwand, Roxane/0000-0002-1712-868X; Mashayekhi, Mona/0000-0003-0331-2395; Lam, Siu Kit/0000-0003-1671-3999; Edelson, Brian/0000-0003-2856-7650	Howard Hughes Medical Institute; National Institutes of Health [AI076427-02]; Department of Defense [W81XWH-09-1-0185]; American Heart Association [12PRE8610005]; German Research Foundation [AL 1038/1-1]; American Society of Hematology; Cancer Research Institute; NCI Cancer Center [P30 CA91842]; NATIONAL CANCER INSTITUTE [R01CA043059, P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402, ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036629, R01AI076427, T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); German Research Foundation(German Research Foundation (DFG)); American Society of Hematology; Cancer Research Institute; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Howard Hughes Medical Institute, National Institutes of Health (AI076427-02) and Department of Defense (W81XWH-09-1-0185) (K.M.M.), the American Heart Association (12PRE8610005) (A.T.S.), German Research Foundation (AL 1038/1-1) (J.C.A), American Society of Hematology Scholar Award and Burroughs Welcome Fund Career Award for Medical Scientists (B.T.E.), and Cancer Research Institute predoctoral fellowship (W.-L.L.). We thank the ImmGen consortium<SUP>34</SUP>, M. White for blastocyst injections and generation of mouse chimaeras, the Alvin J. Siteman Cancer Center at Washington University School of Medicine for use of the Center for Biomedical Informatics and Multiplex Gene Analysis Genechip Core Facility. The Siteman Cancer Center is supported in part by the NCI Cancer Center Support Grant P30 CA91842. IL-12 was a gift from Pfizer.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Glasmacher E., SCIENCE IN PRESS; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kanbe E, 2004, BLOOD CELL MOL DIS, V33, P64, DOI 10.1016/j.bcmd.2004.04.001; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li P., 2012, NATURE; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Modlin RL, 1995, RES IMMUNOL, V146, P526, DOI 10.1016/0923-2494(96)83027-6; Ranganath S, 1998, J IMMUNOL, V161, P3822; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Su ZZ, 2008, P NATL ACAD SCI USA, V105, P20906, DOI 10.1073/pnas.0807975106; SZABO SJ, 1993, MOL CELL BIOL, V13, P5928; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300	46	280	288	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					502	+		10.1038/nature11531	http://dx.doi.org/10.1038/nature11531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22992524	Green Accepted			2022-12-28	WOS:000310196200034
J	Delescluse, M; Chamot-Rooke, N; Cattin, R; Fleitout, L; Trubienko, O; Vigny, C				Delescluse, Matthias; Chamot-Rooke, Nicolas; Cattin, Rodolphe; Fleitout, Luce; Trubienko, Olga; Vigny, Christophe			April 2012 intra-oceanic seismicity off Sumatra boosted by the Banda-Aceh megathrust	NATURE			English	Article							CENTRAL INDIAN-OCEAN; ANDAMAN EARTHQUAKE; FAULT REACTIVATION; STRESS TRANSFER; COSEISMIC SLIP; DEFORMATION; PLATE; AUSTRALIA; INVERSION; ZONES	Large earthquakes nucleate at tectonic plate boundaries, and their occurrence within a plate's interior remains rare and poorly documented, especially offshore. The two large earthquakes that struck the northeastern Indian Ocean on 11 April 2012 are an exception: they are the largest strike-slip events reported in historical times(1,2) and triggered large aftershocks worldwide(3). Yet they occurred within an intra-oceanic setting along the fossil fabric of the extinct Wharton basin, rather than on a discrete plate boundary(4-8). Here we show that the 11 April 2012 twin earthquakes are part of a continuing boost of the intraplate deformation between India and Australia that followed the Aceh 2004 and Nias 2005 megathrust earthquakes, subsequent to a stress transfer process recognized at other subduction zones(9,10). Using Coulomb stress change calculations, we show that the coseismic slips of the Aceh and Nias earthquakes can promote oceanic left-lateral strike-slip earthquakes on preexisting meridian-aligned fault planes. We further show that persistent viscous relaxation in the asthenospheric mantle several years after the Aceh megathrust explains the time lag between the 2004 megathrust and the 2012 intraplate events. On a short timescale, the 2012 events provide new evidence for the interplay between megathrusts at the subduction interface and intraplate deformation offshore. On a longer geological timescale, the Australian plate, driven by slab-pull forces at the Sunda trench, is detaching from the Indian plate, which is subjected to resisting forces at the Himalayan front(6,8,11).	[Delescluse, Matthias; Chamot-Rooke, Nicolas; Fleitout, Luce; Trubienko, Olga; Vigny, Christophe] Ecole Normale Super, Geol Lab, F-75005 Paris, France; [Delescluse, Matthias; Chamot-Rooke, Nicolas; Fleitout, Luce; Trubienko, Olga; Vigny, Christophe] CNRS, UMR8538, F-75005 Paris, France; [Cattin, Rodolphe] Univ Montpellier 2, F-34090 Montpellier, France; [Cattin, Rodolphe] CNRS, UMR5243, F-34090 Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Montpellier	Delescluse, M (corresponding author), Ecole Normale Super, Geol Lab, F-75005 Paris, France.	delescluse@geologie.ens.fr	Chamot-Rooke, Nicolas/A-6939-2008; Delescluse, Matthias/F-4678-2010	Chamot-Rooke, Nicolas/0000-0001-9924-749X; Delescluse, Matthias/0000-0002-8374-7358; Cattin, Rodolphe/0000-0002-9825-9568; Fleitout, Luce/0000-0003-1114-3616				Abercrombie RE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000674; Banerjee P, 2007, B SEISMOL SOC AM, V97, pS86, DOI 10.1785/0120050609; Briggs RW, 2006, SCIENCE, V311, P1897, DOI 10.1126/science.1122602; BULL JM, 1990, NATURE, V344, P855, DOI 10.1038/344855a0; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Cattin R, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002167; CHAMOTROOKE N, 1993, GEOLOGY, V21, P1043, DOI 10.1130/0091-7613(1993)021<1043:ISITCI>2.3.CO;2; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Cocco M, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000138; Delescluse M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035066; Delescluse M, 2007, GEOPHYS J INT, V168, P818, DOI 10.1111/j.1365-246X.2006.03181.x; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Deplus C, 2001, SCIENCE, V292, P1850, DOI 10.1126/science.1061082; Deplus C, 1998, GEOLOGY, V26, P131, DOI 10.1130/0091-7613(1998)026<0131:DEOADI>2.3.CO;2; DMOWSKA R, 1988, J GEOPHYS RES-SOLID, V93, P7869, DOI 10.1029/JB093iB07p07869; Fleitout L., 2012, GEOPH RES ABS, V14; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Gerbault M, 2000, EARTH PLANET SC LETT, V178, P165, DOI 10.1016/S0012-821X(00)00054-6; Graindorge D, 2008, EARTH PLANET SC LETT, V275, P201, DOI 10.1016/j.epsl.2008.04.053; HAINES AJ, 1993, J GEOPHYS RES-SOL EA, V98, P12057, DOI 10.1029/93JB00892; HWANG LJ, 1992, J GEOPHYS RES-SOL EA, V97, P19881, DOI 10.1029/92JB01817; Ji C, 2002, B SEISMOL SOC AM, V92, P1192, DOI 10.1785/0120000916; JI C, PRELIMINARY RESULT M; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; Lay T, 2011, EARTH PLANETS SPACE, V63, P713, DOI 10.5047/eps.2011.05.006; McGuire JJ, 2012, SCIENCE, V336, P1118, DOI 10.1126/science.1223983; Meng L, 2012, SCIENCE, V337, P724, DOI 10.1126/science.1224030; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Pollitz FF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024558; Rajendran K, 2011, B SEISMOL SOC AM, V101, P2568, DOI 10.1785/0120110002; REASENBERG PA, 1992, SCIENCE, V255, P1687, DOI 10.1126/science.255.5052.1687; Rhie J, 2007, B SEISMOL SOC AM, V97, pS115, DOI 10.1785/0120050620; Robinson DP, 2011, GEOPHYS J INT, V186, P1121, DOI 10.1111/j.1365-246X.2011.05092.x; Roeloffs E, 1996, ADV GEOPHYS, V37, P135, DOI 10.1016/S0065-2687(08)60270-8; Royer JY, 1997, GEOPHYS J INT, V129, P41, DOI 10.1111/j.1365-246X.1997.tb00937.x; Satriano C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052387; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; THATCHER W, 1984, J GEOPHYS RES, V89, P7631, DOI 10.1029/JB089iB09p07631; Tinnon MJ, 1995, J GEOPHYS RES-SOL EA, V100, P24315, DOI 10.1029/95JB02910; Vigny C, 2005, NATURE, V436, P201, DOI 10.1038/nature03937; Vigny C, 2011, SCIENCE, V332, P1417, DOI 10.1126/science.1204132; WATTS AB, 1980, J GEOPHYS RES, V85, P6369, DOI 10.1029/JB085iB11p06369; Z-set, 2011, Z SET MAT STRUCT AN	43	75	79	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					240	+		10.1038/nature11520	http://dx.doi.org/10.1038/nature11520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23023134				2022-12-28	WOS:000309733300045
J	Obama, B				Obama, Barack			Securing the Future of American Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	14	14	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1377	1381		10.1056/NEJMp1211514	http://dx.doi.org/10.1056/NEJMp1211514			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23013054				2022-12-28	WOS:000309652700001
J	Day, M; Shickle, D; Smith, K; Zakariasen, K; Oliver, T; Moskol, J				Day, Matthew; Shickle, Darren; Smith, Kevin; Zakariasen, Ken; Oliver, Tom; Moskol, Jacob			Time for heroes: public health leadership in the 21st century	LANCET			English	Editorial Material									[Day, Matthew; Shickle, Darren; Smith, Kevin] Univ Leeds, Acad Unit Publ Hlth, Leeds LS2 9LJ, W Yorkshire, England; [Zakariasen, Ken] Univ Alberta, Dept Publ Hlth Sci, Edmonton Clin Hlth Acad, Edmonton, AB T6G 2M7, Canada; [Oliver, Tom] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Moskol, Jacob] Univ Wisconsin, Global Hlth Inst, Madison, WI USA	University of Leeds; University of Alberta; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Day, M (corresponding author), Univ Leeds, Acad Unit Publ Hlth, Leeds LS2 9LJ, W Yorkshire, England.	matthew.day2@nhs.net	Smith, Kevin/AAX-6321-2021					COLLINS J, 2006, GOOD GREAT SOCIAL SE; Horton R, 2011, LANCET, V378, P1060, DOI 10.1016/S0140-6736(11)60976-8; POSNER BZ, 1988, EDUC PSYCHOL MEAS, V48, P483, DOI 10.1177/0013164488482024; Watkins MD, 2012, HARVARD BUS REV, V90, P64	4	12	12	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2012	380	9849					1205	1206		10.1016/S0140-6736(12)61604-3	http://dx.doi.org/10.1016/S0140-6736(12)61604-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	020NG	23040845				2022-12-28	WOS:000309817500004
J	Roehr, B				Roehr, Bob			Why the NFL is investing in health research	BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Lehman EJ, 2012, NEUROLOGY; NFL, WE CAN MAK GAM SAF; NFL. Mangini Lt. Co, 2012, KYL DISC HEAD INJ NF; Roehr B, AAAS BRIEFING RES DE; US Army, TBI MIL GRID PAN DIS	5	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 5	2012	345								e6626	10.1136/bmj.e6626	http://dx.doi.org/10.1136/bmj.e6626			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LO	23043091				2022-12-28	WOS:000309662300010
J	Koboldt, DC; Fulton, RS; McLellan, MD; Schmidt, H; Kalicki-Veizer, J; McMichael, JF; Fulton, LL; Dooling, DJ; Ding, L; Mardis, ER; Wilson, RK; Ally, A; Balasundaram, M; Butterfield, YSN; Carlsen, R; Carter, C; Chu, A; Chuah, E; Chun, HJE; Coope, RJN; Dhalla, N; Guin, R; Hirst, C; Hirst, M; Holt, RA; Lee, D; Li, HYI; Mayo, M; Moore, RA; Mungall, AJ; Pleasance, E; Robertson, AG; Schein, JE; Shafiei, A; Sipahimalani, P; Slobodan, JR; Stoll, D; Tam, A; Thiessen, N; Varhol, RJ; Wye, N; Zeng, T; Zhao, YJ; Birol, I; Jones, SJM; Marra, MA; Cherniack, AD; Saksena, G; Onofrio, RC; Pho, NH; Carter, SL; Schumacher, SE; Tabak, B; Hernandez, B; Gentry, J; Nguyen, H; Crenshaw, A; Ardlie, K; Beroukhim, R; Winckler, W; Getz, G; Gabriel, SB; Meyerson, M; Chin, L; Park, PJ; Kucherlapati, R; Hoadley, KA; Auman, JT; Fan, C; Turman, YJ; Shi, Y; Li, L; Topal, MD; He, XP; Chao, HH; Prat, A; Silva, GO; Iglesia, MD; Zhao, W; Usary, J; Berg, JS; Adams, M; Booker, J; Wu, JY; Gulabani, A; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; Parker, JS; Hayes, DN; Perou, CM; Malik, S; Mahurkar, S; Shen, H; Weisenberger, DJ; Triche, T; Lai, PH; Bootwalla, MS; Maglinte, DT; Berman, BP; Van den Berg, DJ; Baylin, SB; Laird, PW; Creighton, CJ; Donehower, LA; Getz, G; Noble, M; Voet, D; Saksena, G; Gehlenborg, N; DiCara, D; Zhang, JH; Zhang, HL; Wu, CJ; Liu, SY; Lawrence, MS; Zou, LH; Sivachenko, A; Lin, P; Stojanov, P; Jing, R; Cho, J; Sinha, R; Park, RW; Nazaire, MD; Robinson, J; Thorvaldsdottir, H; Mesirov, J; Park, PJ; Chin, L; Reynolds, S; Kreisberg, RB; Bernard, B; Bressler, R; Erkkila, T; Lin, J; Thorsson, V; Zhang, W; Shmulevich, I; Ciriello, G; Weinhold, N; Schultz, N; Gao, JJ; Cerami, E; Gross, B; Jacobsen, A; Sinha, R; Aksoy, BA; Antipin, Y; Reva, B; Shen, RL; Taylor, BS; Ladanyi, M; Sander, C; Anur, P; Spellman, PT; Lu, YL; Liu, WB; Verhaak, RRG; Mills, GB; Akbani, R; Zhang, NX; Broom, BM; Casasent, TD; Wakefield, C; Unruh, AK; Baggerly, K; Coombes, K; Weinstein, JN; Haussler, D; Benz, CC; Stuart, JM; Benz, SC; Zhu, JC; Szeto, CC; Scott, GK; Yau, C; Paul, EO; Carlin, D; Wong, C; Sokolov, A; Thusberg, J; Mooney, S; Ng, S; Goldstein, TC; Ellrott, K; Grifford, M; Wilks, C; Ma, S; Craft, B; Yan, CH; Hu, Y; Meerzaman, D; Gastier-Foster, JM; Bowen, J; Ramirez, NC; Black, AD; Pyatt, RE; White, P; Zmuda, EJ; Frick, J; Lichtenberg, T; Brookens, R; George, MM; Gerken, MA; Harper, HA; Leraas, KM; Wise, LJ; Tabler, TR; McAllister, C; Barr, T; Hart-Kothari, M; Tarvin, K; Saller, C; Sandusky, G; Mitchell, C; Iacocca, MV; Brown, J; Rabeno, B; Czerwinski, C; Petrelli, N; Dolzhansky, O; Abramov, M; Voronina, O; Potapova, O; Marks, JR; Suchorska, WM; Murawa, D; Kycler, W; Ibbs, M; Korski, K; Spychala, A; Murawa, P; Brzezinski, JJ; Perz, H; Lazniak, R; Teresiak, M; Tatka, H; Leporowska, E; Bogusz-Czerniewicz, M; Malicki, J; Mackiewicz, A; Wiznerowicz, M; Le, XV; Kohl, B; Tien, NV; Thorp, R; Bang, NV; Sussman, H; Phu, BD; Hajek, R; Hung, NP; Tran, VTP; Thang, HQ; Khan, KZ; Penny, R; Mallery, D; Curley, E; Shelton, C; Yena, P; Ingle, JN; Couch, FJ; Lingle, WL; King, TA; Gonzalez-Angulo, AM; Mills, GB; Dyer, MD; Liu, SY; Meng, XL; Patangan, M; Waldman, F; Stoppler, H; Rathmell, WK; Thorne, L; Huang, M; Boice, L; Hill, A; Morrison, C; Gaudioso, C; Bshara, W; Daily, K; Egea, SC; Pegram, MD; Gomez-Fernandez, C; Dhir, R; Bhargava, R; Brufsky, A; Shriver, CD; Hooke, JA; Campbell, JL; Mural, RJ; Hu, H; Somiari, S; Larson, C; Deyarmin, B; Kvecher, L; Kovatich, AJ; Ellis, MJ; King, TA; Hu, H; Couch, FJ; Mural, RJ; Stricker, T; White, K; Olopade, O; Ingle, JN; Luo, CQ; Chen, YQ; Marks, JR; Waldman, F; Wiznerowicz, M; Bose, R; Chang, LW; Beck, AH; Gonzalez-Angulo, AM; Pihl, T; Jensen, M; Sfeir, R; Kahn, A; Chu, A; Kothiyal, P; Wang, ZN; Snyder, E; Pontius, J; Ayala, B; Backus, M; Walton, J; Baboud, J; Berton, D; Nicholls, M; Srinivasan, D; Raman, R; Girshik, S; Kigonya, P; Alonso, S; Sanbhadti, R; Barletta, S; Pot, D; Sheth, M; Demchok, JA; Shaw, KRM; Yang, LM; Eley, G; Ferguson, ML; Tarnuzzer, RW; Zhang, JS; Dillon, LAL; Buetow, K; Fielding, P; Ozenberger, BA; Guyer, MS; Sofia, HJ; Palchik, JD				Koboldt, Daniel C.; Fulton, Robert S.; McLellan, Michael D.; Schmidt, Heather; Kalicki-Veizer, Joelle; McMichael, Joshua F.; Fulton, Lucinda L.; Dooling, David J.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Schein, Jacqueline E.; Shafiei, Arash; Sipahimalani, Payal; Slobodan, Jared R.; Stoll, Dominik; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zeng, Thomas; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.; Cherniack, Andrew D.; Saksena, Gordon; Onofrio, Robert C.; Pho, Nam H.; Carter, Scott L.; Schumacher, Steven E.; Tabak, Barbara; Hernandez, Bryan; Gentry, Jeff; Huy Nguyen; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Gabriel, Stacey B.; Meyerson, Matthew; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Hoadley, Katherine A.; Auman, J. Todd; Fan, Cheng; Turman, Yidi J.; Shi, Yan; Li, Ling; Topal, Michael D.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Usary, Jerry; Berg, Jonathan S.; Adams, Michael; Booker, Jessica; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Malik, Simeen; Mahurkar, Swapna; Shen, Hui; Weisenberger, Daniel J.; Triche, Timothy, Jr.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Berman, Benjamin P.; Van den Berg, David J.; Baylin, Stephen B.; Laird, Peter W.; Creighton, Chad J.; Donehower, Lawrence A.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Sinha, Raktim; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Reynolds, Sheila; Kreisberg, Richard B.; Bernard, Brady; Bressler, Ryan; Erkkila, Timo; Lin, Jake; Thorsson, Vesteinn; Zhang, Wei; Shmulevich, Ilya; Ciriello, Giovanni; Weinhold, Nils; Schultz, Nikolaus; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Sinha, Rileen; Aksoy, B. Arman; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Taylor, Barry S.; Ladanyi, Marc; Sander, Chris; Anur, Pavana; Spellman, Paul T.; Lu, Yiling; Liu, Wenbin; Verhaak, Roel R. G.; Mills, Gordon B.; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod D.; Wakefield, Chris; Unruh, Anna K.; Baggerly, Keith; Coombes, Kevin; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Scott, Gary K.; Yau, Christina; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Thusberg, Janita; Mooney, Sean; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian; Yan, Chunhua; Hu, Ying; Meerzaman, Daoud; Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron D.; Pyatt, Robert E.; White, Peter; Zmuda, Erik J.; Frick, Jessica; Lichtenberg, Taram.; Brookens, Robin; George, Myra M.; Gerken, Mark A.; Harper, Hollie A.; Leraas, Kristen M.; Wise, Lisa J.; Tabler, Teresa R.; McAllister, Cynthia; Barr, Thomas; Hart-Kothari, Melissa; Tarvin, Katie; Saller, Charles; Sandusky, George; Mitchell, Colleen; Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas; Dolzhansky, Oleg; Abramov, Mikhail; Voronina, Olga; Potapova, Olga; Marks, Jeffrey R.; Suchorska, Wiktoria M.; Murawa, Dawid; Kycler, Witold; Ibbs, Matthew; Korski, Konstanty; Spychala, Arkadiusz; Murawa, Pawel; Brzezinski, Jacek J.; Perz, Hanna; Lazniak, Radoslaw; Teresiak, Marek; Tatka, Honorata; Leporowska, Ewa; Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej; Wiznerowicz, Maciej; Xuan Van Le; Kohl, Bernard; Nguyen Viet Tien; Thorp, Richard; Nguyen Van Bang; Sussman, Howard; Bui Duc Phu; Hajek, Richard; Nguyen Phi Hung; Tran Viet The Phuong; Huynh Quyet Thang; Khan, Khurram Zaki; Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy; Ingle, James N.; Couch, Fergus J.; Lingle, Wilma L.; King, Tari A.; Gonzalez-Angulo, Ana Maria; Mills, Gordon B.; Dyer, Mary D.; Liu, Shuying; Meng, Xiaolong; Patangan, Modesto; Waldman, Frederic; Stoeppler, Hubert; Rathmell, W. Kimryn; Thorne, Leigh; Huang, Mei; Boice, Lori; Hill, Ashley; Morrison, Carl; Gaudioso, Carmelo; Bshara, Wiam; Daily, Kelly; Egea, Sophie C.; Pegram, Mark D.; Gomez-Fernandez, Carmen; Dhir, Rajiv; Bhargava, Rohit; Brufsky, Adam; Shriver, Craig D.; Hooke, Jeffrey A.; Campbell, Jamie Leigh; Mural, Richard J.; Hu, Hai; Somiari, Stella; Larson, Caroline; Deyarmin, Brenda; Kvecher, Leonid; Kovatich, Albert J.; Ellis, Matthew J.; King, Tari A.; Hu, Hai; Couch, Fergus J.; Mural, Richard J.; Stricker, Thomas; White, Kevin; Olopade, Olufunmilayo; Ingle, James N.; Luo, Chunqing; Chen, Yaqin; Marks, Jeffrey R.; Waldman, Frederic; Wiznerowicz, Maciej; Bose, Ron; Chang, Li-Wei; Beck, Andrew H.; Gonzalez-Angulo, Ana Maria; Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David; Sheth, Margi; Demchok, John A.; Shaw, Kenna R. Mills; Yang, Liming; Eley, Greg; Ferguson, Martin L.; Tarnuzzer, Roy W.; Zhang, Jiashan; Dillon, Laura A. L.; Buetow, Kenneth; Fielding, Peter; Ozenberger, Bradley A.; Guyer, Mark S.; Sofia, Heidi J.; Palchik, Jacqueline D.		Canc Genome Atlas Network	Comprehensive molecular portraits of human breast tumours	NATURE			English	Article							BASAL-LIKE; MUTATIONAL EVOLUTION; HIGH-FREQUENCY; PIK3CA GENE; LUMINAL-B; CANCER; SUPPRESSOR; SUBTYPES; PATHWAYS; TARGET	We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequencing, messenger RNA arrays, microRNA sequencing and reverse-phase protein arrays. Our ability to integrate information across platforms provided key insights into previously defined gene expression subtypes and demonstrated the existence of four main breast cancer classes when combining data from five platforms, each of which shows significant molecular heterogeneity. Somatic mutations in only three genes (TP53, PIK3CA and GATA3) occurred at >10% incidence across all breast cancers; however, there were numerous subtype-associated and novel gene mutations including the enrichment of specific mutations in GATA3, PIK3CA and MAP3K1 with the luminal A subtype. We identified two novel protein-expression-defined subgroups, possibly produced by stromal/microenvironmental elements, and integrated analyses identified specific signalling pathways dominant in each molecular subtype including a HER2/phosphorylated HER2/EGFR/phosphorylated EGFR signature within the HER2-enriched expression subtype. Comparison of basal-like breast tumours with high-grade serous ovarian tumours showed many molecular commonalities, indicating a related aetiology and similar therapeutic opportunities. The biological finding of the four main breast cancer subtypes caused by different subsets of genetic and epigenetic abnormalities raises the hypothesis that much of the clinically observable plasticity and heterogeneity occurs within, and not across, these major biological subtypes of breast cancer.	[Hoadley, Katherine A.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Berg, Jonathan S.; Adams, Michael; Weisenberger, Daniel J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Koboldt, Daniel C.; Fulton, Robert S.; McLellan, Michael D.; Schmidt, Heather; Kalicki-Veizer, Joelle; McMichael, Joshua F.; Fulton, Lucinda L.; Dooling, David J.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Mardis, Elaine R.; Wilson, Richard K.; Ellis, Matthew J.; Bose, Ron] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Schein, Jacqueline E.; Shafiei, Arash; Sipahimalani, Payal; Slobodan, Jared R.; Stoll, Dominik; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zeng, Thomas; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z, Canada; [Cherniack, Andrew D.; Saksena, Gordon; Onofrio, Robert C.; Pho, Nam H.; Carter, Scott L.; Schumacher, Steven E.; Tabak, Barbara; Hernandez, Bryan; Gentry, Jeff; Huy Nguyen; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Gabriel, Stacey B.; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Schumacher, Steven E.; Tabak, Barbara; Beroukhim, Rameen; Nguyen Phi Hung] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Meyerson, Matthew; Beck, Andrew H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chin, Lynda] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Park, Peter J.; Gehlenborg, Nils; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kucherlapati, Raju] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Hoadley, Katherine A.; Fan, Cheng; Turman, Yidi J.; Shi, Yan; Li, Ling; Topal, Michael D.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Usary, Jerry; Berg, Jonathan S.; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Malik, Simeen; Mahurkar, Swapna; Shen, Hui; Weisenberger, Daniel J.; Rathmell, W. Kimryn; Thorne, Leigh; Huang, Mei; Boice, Lori; Hill, Ashley] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Topal, Michael D.; Booker, Jessica; Weisenberger, Daniel J.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Shen, Hui] Univ N Carolina, Div Med Oncol, Dept Internal Med, Chapel Hill, NC 27599 USA; [Triche, Timothy, Jr.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Berman, Benjamin P.; Van den Berg, David J.; Laird, Peter W.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Creighton, Chad J.; Donehower, Lawrence A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Creighton, Chad J.; Donehower, Lawrence A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Hailei; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Sinha, Raktim; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Chin, Lynda] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Zhang, Juinhua; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Inst Appl Canc Sci, Houston, TX 77054 USA; [Wu, Chang-Jiun] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Reynolds, Sheila; Kreisberg, Richard B.; Bernard, Brady; Bressler, Ryan; Lin, Jake; Thorsson, Vesteinn; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Erkkila, Timo] Tampere Univ Technol, FIN-33101 Tampere, Finland; [Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Canc Genom Core Lab, Houston, TX 77030 USA; [Ciriello, Giovanni; Weinhold, Nils; Schultz, Nikolaus; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Sinha, Rileen; Aksoy, B. Arman; Antipin, Yevgeniy; Reva, Boris; Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Anur, Pavana; Spellman, Paul T.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Lu, Yiling; Mills, Gordon B.; Gonzalez-Angulo, Ana Maria] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Kleberg Ctr Mol Markers, Houston, TX 77030 USA; [Liu, Wenbin; Verhaak, Roel R. G.; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod D.; Wakefield, Chris; Unruh, Anna K.; Baggerly, Keith; Coombes, Kevin; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Haussler, David; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Scott, Gary K.; Yau, Christina; Thusberg, Janita; Mooney, Sean] Buck Inst Res Aging, Novato, CA 94945 USA; [Yan, Chunhua; Hu, Ying; Meerzaman, Daoud; Buetow, Kenneth] NCI, Ctr Bioinformat & Informat Technol, Rockville, MD 20852 USA; [Gastier-Foster, Julie M.; Ramirez, Nilsa C.; Pyatt, Robert E.; White, Peter] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron D.; Pyatt, Robert E.; White, Peter; Zmuda, Erik J.; Frick, Jessica; Lichtenberg, Taram.; Brookens, Robin; George, Myra M.; Gerken, Mark A.; Harper, Hollie A.; Leraas, Kristen M.; Wise, Lisa J.; Tabler, Teresa R.; McAllister, Cynthia; Barr, Thomas; Hart-Kothari, Melissa] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Tarvin, Katie] ABS Inc, Indianapolis, IN 46204 USA; [Saller, Charles] ABS Inc, Wilmington, DE 19801 USA; [Sandusky, George; Mitchell, Colleen] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas] Christiana Care, Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Dolzhansky, Oleg] Moscow Hlth Dept, Moscow City Clin Oncol Dispensary 1, Moscow 105005, Russia; [Dolzhansky, Oleg] Moscow Hlth Dept, Cent IHC Lab, Moscow 105005, Russia; [Abramov, Mikhail] Russian Canc Res Ctr, Moscow 115478, Russia; [Voronina, Olga; Potapova, Olga] Cureline Inc, San Francisco, CA 94080 USA; [Marks, Jeffrey R.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Suchorska, Wiktoria M.; Murawa, Dawid; Kycler, Witold; Ibbs, Matthew; Korski, Konstanty; Spychala, Arkadiusz; Murawa, Pawel; Brzezinski, Jacek J.; Perz, Hanna; Lazniak, Radoslaw; Teresiak, Marek; Tatka, Honorata; Leporowska, Ewa; Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej; Wiznerowicz, Maciej] Greater Poland Canc Ctr, PL-61866 Poznan, Poland; [Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej] Poznan Univ Med Sci, PL-61701 Poznan, Poland; [Xuan Van Le; Kohl, Bernard] ILSBio LLC, Chestertown, MD 21620 USA; [Nguyen Viet Tien] Minist Hlth, Hanoi, Vietnam; [Thorp, Richard; Khan, Khurram Zaki] ILSBio LLC, Karachi, Pakistan; [Nguyen Van Bang; Bui Duc Phu] Hue Cent Hosp, Hue City, Vietnam; [Sussman, Howard] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Hajek, Richard] Univ Texas MD Anderson Canc Ctr, Ctr Minor Hlth Res, Houston, TX 77030 USA; [Nguyen Phi Hung] Natl Canc Inst, Hanoi, Vietnam; [Tran Viet The Phuong] Ho Chi Minh City Canc Ctr, Ho Chi Minh City, Vietnam; [Huynh Quyet Thang] Can Tho Canc Ctr, Can Tho, Vietnam; [Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy] Int Genom Consortium, Phoenix, AZ 85004 USA; [Ingle, James N.; Couch, Fergus J.; Lingle, Wilma L.] Mayo Clin, Rochester, MN 55905 USA; [King, Tari A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10065 USA; [Mills, Gordon B.; Dyer, Mary D.; Liu, Shuying; Meng, Xiaolong; Patangan, Modesto] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Waldman, Frederic] Univ Calif San Francisco, San Francisco, CA 94143 USA; Canc Diagnost, San Juan Capistrano, CA 92675 USA; Quest Diagnost, Nichols Inst, San Juan Capistrano, CA 92675 USA; [Stoeppler, Hubert] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Thorne, Leigh; Huang, Mei; Boice, Lori] UNC Lineberger Canc Ctr, Dept Pathol, UNC Tissue Procurement Facil, Chapel Hill, NC 27599 USA; [Morrison, Carl; Gaudioso, Carmelo; Bshara, Wiam] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Daily, Kelly; Egea, Sophie C.; Pegram, Mark D.; Gomez-Fernandez, Carmen] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Pathol, Miami, FL 33136 USA; [Dhir, Rajiv] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Bhargava, Rohit; Brufsky, Adam] Univ Pittsburgh Med Ctr, Magee Womens Hosp, Pittsburgh, PA 15213 USA; [Shriver, Craig D.; Hooke, Jeffrey A.; Campbell, Jamie Leigh] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20899 USA; [Mural, Richard J.; Hu, Hai; Somiari, Stella; Larson, Caroline; Deyarmin, Brenda; Kvecher, Leonid; Luo, Chunqing; Chen, Yaqin] Windber Res Inst, Windber, PA 15963 USA; [Kovatich, Albert J.] MDR Global LLC, Windber, PA 15963 USA; [Ellis, Matthew J.; Bose, Ron] Washington Univ, Breast Canc Program, St Louis, MO 63110 USA; [Ellis, Matthew J.; Bose, Ron] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Stricker, Thomas; White, Kevin] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Olopade, Olufunmilayo] Univ Chicago, Ctr Clin Canc Genet, Chicago, IL 60637 USA; [Chang, Li-Wei] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David] SRA Int, Fairfax, VA 22033 USA; [Sheth, Margi; Demchok, John A.; Shaw, Kenna R. Mills; Yang, Liming; Tarnuzzer, Roy W.; Zhang, Jiashan; Dillon, Laura A. L.; Fielding, Peter] NCI, Canc Genome Atlas Program Off, Ctr Canc Genom, Bethesda, MD 20892 USA; [Eley, Greg] Scimentis LLC, TCGA, Statham, GA 30666 USA; [Ferguson, Martin L.] MLF Consulting, Arlington, MA 02474 USA; [Ozenberger, Bradley A.; Guyer, Mark S.; Sofia, Heidi J.; Palchik, Jacqueline D.] NHGRI, NIH, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); British Columbia Cancer Agency; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Institute for Systems Biology (ISB); Tampere University; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Oregon Health & Science University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Indiana University System; Indiana University Bloomington; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Duke University; Wielkopolskie Centrum Onkologii; Poznan University of Medical Sciences; Stanford University; University of Texas System; UTMD Anderson Cancer Center; International Genomics Consortium; Mayo Clinic; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Nichols Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Roswell Park Cancer Institute; University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Walter Reed National Military Medical Center; Windber Research Institute; Washington University (WUSTL); Washington University (WUSTL); University of Chicago; University of Chicago; Washington University (WUSTL); SRA International; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Perou, CM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	cperou@med.unc.edu	Lawrence, Michael/AAC-8202-2020; Gastier-Foster, Julie/E-3105-2011; Ibbs, Matthew/AAU-1511-2021; Wilson, Richard K./AAF-4139-2019; Van Den Berg, David J/G-8598-2017; Birol, Inanc/G-5440-2011; Mungall, Andrew J./U-7067-2018; Perou, Charles M/H-9934-2014; Schultz, Nikolaus/ABE-6347-2020; Cherniack, Andrew D./AAY-8132-2020; Holt, Robert A/C-3303-2009; BERMAN, BENJAMIN/AAT-3720-2021; Reva, Boris/AAB-8932-2022; Marra, Marco A/B-5987-2008; Mardis, Elaine/W-2202-2019; Auman, James/AAY-7748-2020; Shen, Hui/AAO-4387-2020; Mesirov, Jill/AGF-7626-2022; Reva, Boris A./B-6436-2014; White, Peter/E-4301-2011; Hirst, Martin/B-7684-2016; Schumacher, Steven/E-9821-2013; Brufsky, Adam/AAE-7470-2020; Suchorska, Wiktoria/CAG-0479-2022; Skanderup, Anders Jacobsen/K-1081-2013; Ganesh, Dunna Sai/AGX-5170-2022; Parker, Joel/AAG-1108-2019; Prat, Aleix/P-8561-2014; Jones, Steven J/C-3621-2009; Weisenberger, Daniel/AAA-8314-2020; , Pathology Services Core/CEZ-2246-2022; Ladanyi, Marc/AAG-8585-2019; Akbani, Rehan/AAG-1490-2019; Verhaak, Roel/ABE-7058-2020; Stojanov, Petar/GQI-4462-2022; Kucherlapati, Raju/ABC-8807-2021; Berman, Benjamin P/D-5942-2014; wang, edwin/G-5372-2010; Schein, Jacquie E/G-3674-2015; Cherniack, Andrew/AAC-5310-2019; Laird, Peter W/G-8683-2012; Gao, JianJiong/B-5673-2016	Ibbs, Matthew/0000-0003-2510-3447; Wilson, Richard K./0000-0002-1992-1358; Van Den Berg, David J/0000-0002-5404-5218; Birol, Inanc/0000-0003-0950-7839; Mungall, Andrew J./0000-0002-0905-2742; Perou, Charles M/0000-0001-9827-2247; Cherniack, Andrew D./0000-0003-0470-0111; Holt, Robert A/0000-0002-7259-1247; BERMAN, BENJAMIN/0000-0002-2099-9005; Marra, Marco A/0000-0001-7146-7175; Reva, Boris A./0000-0002-8805-389X; White, Peter/0000-0002-5218-5903; Schumacher, Steven/0000-0002-6819-5647; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Prat, Aleix/0000-0003-2377-540X; Jones, Steven J/0000-0003-3394-2208; Weisenberger, Daniel/0000-0001-8303-2603; Stojanov, Petar/0000-0001-7815-776X; Berman, Benjamin P/0000-0002-2099-9005; Laird, Peter W/0000-0001-9117-3641; Gao, JianJiong/0000-0002-5739-1781; Suchorska, Wiktoria/0000-0003-4742-2465; Berg, Jonathan/0000-0003-2360-2664; Stuart, Joshua/0000-0002-2171-565X; Sinha, Rileen/0000-0001-5497-5055; Triche, Tim/0000-0001-5665-946X; Casasent, Anna/0000-0002-7857-179X; Mahurkar-Joshi, Swapna/0000-0001-9591-4590; Gehlenborg, Nils/0000-0003-0327-8297; Brufsky, Adam/0000-0001-8080-7960; Hayes, D. Neil/0000-0001-6203-7771; Bowen, Jay/0000-0001-6861-9043; Ciriello, Giovanni/0000-0003-2021-8683; Shen, Hui/0000-0001-9767-4084; Malicki, Julian/0000-0002-5558-5558; Meyerson, Matthew/0000-0002-9133-8108; Park, Peter/0000-0001-9378-960X; Jensen, Mark/0000-0001-5215-101X; MCLELLAN, MICHAEL/0000-0002-2703-8784; Quyet Thang, Huynh/0000-0002-0788-6380; MOONEY, SEAN D/0000-0003-2654-0833; Stoll, Dominik/0000-0003-0701-4301; Pot, David/0000-0002-1480-9826; Hoadley, Katherine/0000-0002-1216-477X; Schultz, Nikolaus/0000-0002-0131-4904; Benz, Stephen/0000-0002-4067-0602; Hu, Hai/0000-0001-5345-8371; Coombes, Kevin/0000-0002-7630-2123; Weinstein, John/0000-0001-9401-6908; Tarnuzzer, Roy/0000-0002-3725-4173; Kovatich, Albert/0000-0002-5169-4087	USA National Institutes of Health [U24CA143883, U24CA143858, U24CA143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24CA143867, U24CA143866, U24CA143848, U24CA144025, U54HG003079, P50CA116201, P50CA58223]; Susan G. Komen for the Cure; US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [U24CA143866, U24CA143799, U24CA143867, P30CA016672, U24CA143882, U01CA084955, P30CA016086, K08CA148912, U24CA143883, U24CA143858, P50CA058223, U24CA143845, R01CA094143, U24CA143848, P30CA016058, U24CA143840, U24CA143835, P50CA116201, U24CA144025] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028, U54HG003067, U54HG003079] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009722] Funding Source: NIH RePORTER	USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M. Sheth and S. Lucas for administrative coordination of TCGA activities, and C. Gunter for critical reading of the manuscript. This work was supported by the following grants from the USA National Institutes of Health: U24CA143883, U24CA143858, U24CA143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24CA143867, U24CA143866, U24CA143848, U24CA144025, U54HG003079, P50CA116201 and P50CA58223. Additional support was provided by the Susan G. Komen for the Cure, the US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine, and the Breast Cancer Research Foundation. The views expressed in this paper are those of the authors and do not reflect the official policy of the Department of Defense, or US Government.	Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lara MF, 2008, MOL CARCINOGEN, V47, P209, DOI 10.1002/mc.20376; Li QY, 1997, NAT GENET, V15, P21; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Weigman VJ, 2012, BREAST CANCER RES TR, V133, P865, DOI 10.1007/s10549-011-1846-y	56	7902	8051	69	1469	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					61	70		10.1038/nature11412	http://dx.doi.org/10.1038/nature11412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23000897	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000309446800032
J	Polonsky, KS				Polonsky, Kenneth S.			The Past 200 Years in Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONVERTING-ENZYME-INHIBITION; INTENSIVE INSULIN THERAPY; MULTIFACTORIAL INTERVENTION; CARDIOVASCULAR-DISEASE; MOLECULAR-GENETICS; BARIATRIC SURGERY; MEDICAL THERAPY; TYPE-2; MELLITUS; NEPHROPATHY		Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Polonsky, KS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	polonsky@bsd.uchicago.edu						Ahlqvist E, 2011, CLIN CHEM, V57, P241, DOI 10.1373/clinchem.2010.157016; BANTING FG, 1991, CAN MED ASSOC J, V145, P1281; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Barnett AH, 2005, NEW ENGL J MED, V352, P1731; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Bliss M., 2007, DISCOVERY INSULIN, V25th; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; BROGARD JM, 1992, DIABETES METAB, V18, P104; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; CORI CF, 1946, ANNU REV BIOCHEM, V15, P193, DOI 10.1146/annurev.bi.15.070146.001205; DeFronzo RA, 2011, NEW ENGL J MED, V365, P189; DeFronzo RA, 2011, NEW ENGL J MED, V365, P869; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Dobson M., 1776, MED OBS INQ, V5, P218; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Fischer EH, 2010, BIOL CHEM, V391, P131, DOI [10.1515/BC.2010.011, 10.1515/bc.2010.011]; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Geyelin HR., 1922, J METAB RES, V2, P765, DOI DOI 10.1001/JAMA.1924.02660240028008; Himsworth HP, 1936, LANCET, V1, P127; Houssay BA, 1942, J EXP MED, V75, P93, DOI 10.1084/jem.75.1.93; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; NERUP J, 1974, LANCET, V2, P864; Ounissi-Benkalha H, 2008, TRENDS MOL MED, V14, P268, DOI 10.1016/j.molmed.2008.04.002; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Reaven GM, 2005, CELL METAB, V1, P9, DOI 10.1016/j.cmet.2004.12.001; ROBIN ED, 1979, JAMA-J AM MED ASSOC, V242, P1283, DOI 10.1001/jama.242.12.1283; SANGER F, 1945, BIOCHEM J, V39, P507, DOI 10.1042/bj0390507; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; STEINER DF, 1967, P NATL ACAD SCI USA, V57, P473, DOI 10.1073/pnas.57.2.473; Stolerman ES, 2009, NAT REV ENDOCRINOL, V5, P429, DOI 10.1038/nrendo.2009.129; Stoy J, 2012, REV ENDOCR METAB DIS, V13, P79, DOI 10.1007/s11154-011-9158-4; Stoy J, 2010, REV ENDOCR METAB DIS, V11, P205, DOI 10.1007/s11154-010-9151-3; SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; TAMBORLANE WV, 1979, NEW ENGL J MED, V300, P573, DOI 10.1056/NEJM197903153001101; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; von Mering J, 1890, ARCH EXP PATHOL PH, V26, P371; YALOW RS, 1959, NATURE, V184, P1648, DOI 10.1038/1841648b0	54	164	172	1	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1332	1340		10.1056/NEJMra1110560	http://dx.doi.org/10.1056/NEJMra1110560			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034021				2022-12-28	WOS:000309406100009
J	Lyle, M; Heusser, L; Ravelo, C; Yamamoto, M; Barron, J; Diffenbaugh, NS; Herbert, T; Andreasen, D				Lyle, Mitchell; Heusser, Linda; Ravelo, Christina; Yamamoto, Masanobu; Barron, John; Diffenbaugh, Noah S.; Herbert, Timothy; Andreasen, Dyke			Out of the Tropics: The Pacific, Great Basin Lakes, and Late Pleistocene Water Cycle in the Western United States	SCIENCE			English	Article							CALIFORNIA CURRENT SYSTEM; NORTH-AMERICA; SURFACE WATERS; CLIMATE-CHANGE; LAHONTAN; RECORD; OCEAN; OSCILLATIONS; TEMPERATURE; EVAPORATION	The water cycle in the western United States changed dramatically over glacial cycles. In the past 20,000 years, higher precipitation caused desert lakes to form which have since dried out. Higher glacial precipitation has been hypothesized to result from a southward shift of Pacific winter storm tracks. We compared Pacific Ocean data to lake levels from the interior west and found that Great Basin lake high stands are older than coastal wet periods at the same latitude. Westerly storms were not the source of high precipitation. Instead, air masses from the tropical Pacific were transported northward, bringing more precipitation into the Great Basin when coastal California was still dry. The changing climate during the deglaciation altered precipitation source regions and strongly affected the regional water cycle.	[Lyle, Mitchell] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Heusser, Linda] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Ravelo, Christina; Andreasen, Dyke] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Yamamoto, Masanobu] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Barron, John] US Geol Survey, Menlo Pk, CA 94025 USA; [Diffenbaugh, Noah S.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Diffenbaugh, Noah S.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Herbert, Timothy] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Texas A&M University System; Texas A&M University College Station; Columbia University; University of California System; University of California Santa Cruz; Hokkaido University; United States Department of the Interior; United States Geological Survey; Stanford University; Stanford University; Brown University	Lyle, M (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	mlyle@ocean.tamu.edu	Diffenbaugh, Noah S/I-5920-2014; Yamamoto, Masanobu/A-6990-2012	Diffenbaugh, Noah S/0000-0002-8856-4964; Yamamoto, Masanobu/0000-0003-1312-825X; Barron, John/0000-0002-9309-1145	U.S. National Science Foundation [EAR-0450211, OCE-9809438]	U.S. National Science Foundation(National Science Foundation (NSF))	We thank the Ocean Drilling Program and its successor program, IODP, for collecting and archiving the drill cores used. We also thank M. Reheis for her insights in a thorough internal U.S. Geological Surbey review. The U.S. National Science Foundation supported this research through grants EAR-0450211 and OCE-9809438.	Anderson RY, 2002, QUATERNARY RES, V57, P371, DOI 10.1006/qres.2002.2323; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; BENSON L V, 1991, Journal of Paleolimnology, V5, P115; Bradbury JP, 2004, J PALEOLIMNOL, V31, P167; Briggs RW, 2005, QUATERNARY RES, V64, P257, DOI 10.1016/j.yqres.2005.02.011; Broecker WS, 2009, QUATERNARY SCI REV, V28, P2557, DOI 10.1016/j.quascirev.2009.07.007; BROECKER WS, 1958, GEOL SOC AM BULL, V69, P1009, DOI 10.1130/0016-7606(1958)69[1009:RCOLLA]2.0.CO;2; Doose H, 1997, PALEOCEANOGRAPHY, V12, P615, DOI 10.1029/97PA00821; Freidel D. E., 1993, THESIS U OREGON; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Heusser L, 1998, PALEOCEANOGRAPHY, V13, P252, DOI 10.1029/98PA00670; Heusser L. E., 2000, P OC DRILL PROGR SCI, V167, P239; Heusser L.E., 1995, PROC OCEAN DRILL SCI, V146, P265; HEUSSER LE, 1979, SCIENCE, V204, P837, DOI 10.1126/science.204.4395.837; Heusser LE, 2000, PALAEOGEOGR PALAEOCL, V161, P407, DOI 10.1016/S0031-0182(00)00096-1; Hostetler S., 1990, CLIM DYNAM, V4, P207, DOI DOI 10.1007/BF00209522; Hostetler S.W., 1991, CLIM DYNAM, V6, P43, DOI DOI 10.1007/BF00210581; HOSTETLER SW, 1994, SCIENCE, V263, P665, DOI 10.1126/science.263.5147.665; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Kennett J. P., 1995, P OCEAN DRILLING P 2, V146; Kim SJ, 2008, CLIM DYNAM, V31, P1, DOI 10.1007/s00382-007-0332-z; Kreitz S.F, 2000, PROC OCEAN DRILL SCI, V167, P153; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Lyle M, 2001, GEOLOGY, V29, P1115, DOI 10.1130/0091-7613(2001)029<1115:ITAVKY>2.0.CO;2; Lyle M., 2000, P OCEAN DRILL PROGRA, V167, P163, DOI DOI 10.2973/ODP.PROC.SR.167.214.2000; Lyle M., 2000, P OCEAN DRILLING PRO, V167; Lyle M, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001836; McClymont EL, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002226; McIntyre A., 1976, Science, V191, P1131, DOI 10.1126/science.191.4232.1131; Mock CJ, 1996, J CLIMATE, V9, P1111, DOI 10.1175/1520-0442(1996)009<1111:CCASVO>2.0.CO;2; Oster JL, 2009, EARTH PLANET SC LETT, V288, P434, DOI 10.1016/j.epsl.2009.10.003; Pisias NG, 2001, QUATERNARY SCI REV, V20, P1561, DOI 10.1016/S0277-3791(01)00018-X; PRAHL FG, 1995, PALEOCEANOGRAPHY, V10, P763, DOI 10.1029/95PA01394; REA DK, 1988, PALAEOGEOGR PALAEOCL, V66, P1, DOI 10.1016/0031-0182(88)90076-4; SANCETTA C, 1992, QUATERNARY RES, V38, P359, DOI 10.1016/0033-5894(92)90044-J; Seki O, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015200; Toracinta ER, 2004, J CLIMATE, V17, P504, DOI 10.1175/1520-0442(2004)017<0504:ARTMCO>2.0.CO;2; Unterman MB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049599; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Whitlock C, 2000, PALAEOGEOGR PALAEOCL, V155, P7, DOI 10.1016/S0031-0182(99)00092-9; Winograd IJ, 2006, QUATERNARY RES, V66, P202, DOI 10.1016/j.yqres.2006.06.003; Yamamato M, 2007, QUATERNARY SCI REV, V26, P405, DOI 10.1016/j.quascirev.2006.07.014; Yamamoto M., 2005, GEOPHYS RES LETT, V32	43	99	100	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1629	1633		10.1126/science.1218390	http://dx.doi.org/10.1126/science.1218390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019644				2022-12-28	WOS:000309215400038
J	Zanetti, M; Mahadevan, NR				Zanetti, Maurizio; Mahadevan, Navin R.			Immune Surveillance from Chromosomal Chaos?	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CANCER; INFLAMMATION; PATHWAY; CELLS		[Zanetti, Maurizio] Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zanetti, M (corresponding author), Univ Calif San Diego, Dept Med, Immunol Lab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mzanetti@ucsd.edu						BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Butler NS, 2010, ADV EXP MED BIOL, V684, P42; Duesberg P, 2007, SCI AM, V296, P52, DOI 10.1038/scientificamerican0507-52; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gibbs WW, 2003, SCI AM, V289, P56, DOI 10.1038/scientificamerican0703-56; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	15	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1616	1617		10.1126/science.1228464	http://dx.doi.org/10.1126/science.1228464			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019639				2022-12-28	WOS:000309215400032
J	Spence, D				Spence, Des			Flattery will get you everywhere	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[No title captured]	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 20	2012	345								e6346	10.1136/bmj.e6346	http://dx.doi.org/10.1136/bmj.e6346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JJ	22996940				2022-12-28	WOS:000309160600010
J	Wirth, LJ; Plotkin, SR; Emerick, KS; Cunnane, ME; Faquin, WC				Wirth, Lori J.; Plotkin, Scott R.; Emerick, Kevin S.; Cunnane, Mary Elizabeth; Faquin, William C.			Case 29-2012: A 49-Year-Old Man with Pain and Cranial-Nerve Palsies after Treatment of Oral Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; NECK-CANCER; POSTOPERATIVE RADIOTHERAPY; INFRATEMPORAL FOSSA; CAVERNOUS SINUS; CHEMOTHERAPY; SURGERY; DIAGNOSIS		[Wirth, Lori J.] Massachusetts Gen Hosp, Dept Med Oncol, Boston, MA 02114 USA; [Plotkin, Scott R.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Emerick, Kevin S.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Faquin, William C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Emerick, Kevin S.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Cunnane, Mary Elizabeth] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; [Wirth, Lori J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Plotkin, Scott R.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Emerick, Kevin S.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Cunnane, Mary Elizabeth] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Faquin, William C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wirth, LJ (corresponding author), Massachusetts Gen Hosp, Dept Med Oncol, Boston, MA 02114 USA.			Plotkin, Scott/0000-0002-6109-6419	Bayer; Boehringer Ingelheim; Exelexis; Acceleron; Pfizer	Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Exelexis; Acceleron; Pfizer(Pfizer)	Dr. Wirth reports receiving consulting fees from Bayer, Boehringer Ingelheim, Exelexis, and Acceleron; Dr. Plotkin, grant support to his institution from Pfizer; Dr. Faquin, payment for expert opinions in legal cases concerning thyroid cancer and royalties from Springer; and Dr. Cunnane, payment from World-Care Clinical for interpreting results of imaging studies for clinical trials. No other potential conflict of interest relevant to this article was reported.	Abuzayed B, 2010, SURG RADIOL ANAT, V32, P499, DOI 10.1007/s00276-010-0651-3; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Beauchesne P, 2010, LANCET ONCOL, V11, P871, DOI 10.1016/S1470-2045(10)70034-6; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; DeAngelis LM, 2009, NEUROLOGIC COMPLICAT, P240; DeAngelis LM, 2009, NEUROLOGIC COMPLICAT, P369; Fagan JJ, 1998, ARCH OTOLARYNGOL, V124, P637, DOI 10.1001/archotol.124.6.637; Hall SF, 2000, LARYNGOSCOPE, V110, P2041, DOI 10.1097/00005537-200012000-00012; HUANG DT, 1992, INT J RADIAT ONCOL, V23, P737, DOI 10.1016/0360-3016(92)90646-Y; Langendijk JA, 2005, CANCER-AM CANCER SOC, V104, P1408, DOI 10.1002/cncr.21340; Lin C, 2012, INT J RADIAT ONCOL, V82, P334, DOI 10.1016/j.ijrobp.2010.09.040; Mansour OI, 2004, SKULL BASE-INTERD AP, V14, P143, DOI 10.1055/s-2004-832256; Mishra A, 2011, J LARYNGOL OTOL, V125, P638, DOI 10.1017/S002221511100003X; PETERS LJ, 1993, INT J RADIAT ONCOL, V26, P3, DOI 10.1016/0360-3016(93)90167-T; Reardon EJ, 2005, OTOLARYNG CLIN N AM, V38, P515, DOI 10.1016/j.otc.2004.10.027; Rogers LR, 2003, NEUROL CLIN, V21, P167, DOI 10.1016/S0733-8619(02)00066-X; Sechi G, 2007, LANCET NEUROL, V6, P442, DOI 10.1016/S1474-4422(07)70104-7; Sung A, 2010, LARYNGOSCOPE, V120, P282, DOI 10.1002/lary.20707; Tiwari R, 2000, SKULL BASE SURG, V10, P1, DOI 10.1055/s-2000-6789; Yovino S, 2010, HEAD NECK-J SCI SPEC, V32, P46, DOI 10.1002/hed.21141; Zhu JJ, 2004, NEUROSURGERY, V54, P492, DOI 10.1227/01.NEU.0000103674.30974.69	26	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1136	1147		10.1056/NEJMcpc1104565	http://dx.doi.org/10.1056/NEJMcpc1104565			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AS	22992078				2022-12-28	WOS:000308861800011
J	Ibarra, CA; Feng, XQ; Schoft, VK; Hsieh, TF; Uzawa, R; Rodrigues, JA; Zemach, A; Chumak, N; Machlicova, A; Nishimura, T; Rojas, D; Fischer, RL; Tamaru, H; Zilberman, D				Ibarra, Christian A.; Feng, Xiaoqi; Schoft, Vera K.; Hsieh, Tzung-Fu; Uzawa, Rie; Rodrigues, Jessica A.; Zemach, Assaf; Chumak, Nina; Machlicova, Adriana; Nishimura, Toshiro; Rojas, Denisse; Fischer, Robert L.; Tamaru, Hisashi; Zilberman, Daniel			Active DNA Demethylation in Plant Companion Cells Reinforces Transposon Methylation in Gametes	SCIENCE			English	Article							ARABIDOPSIS ENDOSPERM; GENOME; GLYCOSYLASE; CHROMATIN; STATES	The Arabidopsis thaliana central cell, the companion cell of the egg, undergoes DNA demethylation before fertilization, but the targeting preferences, mechanism, and biological significance of this process remain unclear. Here, we show that active DNA demethylation mediated by the DEMETER DNA glycosylase accounts for all of the demethylation in the central cell and preferentially targets small, AT-rich, and nucleosome-depleted euchromatic transposable elements. The vegetative cell, the companion cell of sperm, also undergoes DEMETER-dependent demethylation of similar sequences, and lack of DEMETER in vegetative cells causes reduced small RNA-directed DNA methylation of transposons in sperm. Our results demonstrate that demethylation in companion cells reinforces transposon methylation in plant gametes and likely contributes to stable silencing of transposable elements across generations.	[Ibarra, Christian A.; Feng, Xiaoqi; Hsieh, Tzung-Fu; Uzawa, Rie; Rodrigues, Jessica A.; Zemach, Assaf; Nishimura, Toshiro; Rojas, Denisse; Fischer, Robert L.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Schoft, Vera K.; Chumak, Nina; Machlicova, Adriana; Tamaru, Hisashi] Austrian Acad Sci, Gregor Mendel Inst, A-1030 Vienna, Austria	University of California System; University of California Berkeley; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	rfischer@berkeley.edu; hisashi.tamaru@gmi.oeaw.ac.at; danielz@berkeley.edu		Rodrigues, Jessica/0000-0002-1562-2211; Zilberman, Daniel/0000-0002-0123-8649; Feng, Xiaoqi/0000-0002-4008-1234; Hsieh, Tzung-Fu/0000-0001-7584-3721; Schoft, Vera/0000-0003-4857-3804; Zemach, Assaf/0000-0003-3282-4445	NIH [GM69415]; NSF [MCB-0918821, IOS-1025890]; Arnold and Mabel Beckman Foundation; Austrian Science Fund (FWF) [P21389-B03]; Ruth L. Kirschstein NIH Predoctoral Fellowship [GM093633]; Fulbright Scholarship; Jane Coffin Childs Memorial Fund; Robert and Colleen Haas Scholarship; Austrian Science Fund (FWF) [P 24918] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415, F31GM093633] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Arnold and Mabel Beckman Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Ruth L. Kirschstein NIH Predoctoral Fellowship; Fulbright Scholarship; Jane Coffin Childs Memorial Fund; Robert and Colleen Haas Scholarship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Harmer for assistance with the analysis of histone modifications, the BioOptics team at the Vienna Biocenter Campus for sorting sperm and vegetative cell nuclei, K. Slotkin for the LAT52p-amiRNA=GFP plasmid, and G. Drews for the DD45p-GFP transgenic line. This work was partially funded by an NIH grant (GM69415) to R. L. F., NSF grants (MCB-0918821 and IOS-1025890) to R. L. F. and D.Z., a Young Investigator Grant from the Arnold and Mabel Beckman Foundation to D.Z., an Austrian Science Fund (FWF) grant P21389-B03 to H. T., a Ruth L. Kirschstein NIH Predoctoral Fellowship (GM093633) to C. A. I., a Fulbright Scholarship to J.A.R., a fellowship from the Jane Coffin Childs Memorial Fund to A.Z., and a Robert and Colleen Haas Scholarship to D. R. Sequencing data are deposited in GEO (GSE38935).	Bauer MJ, 2011, CURR OPIN PLANT BIOL, V14, P162, DOI 10.1016/j.pbi.2011.02.006; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Qian WQ, 2012, SCIENCE, V336, P1445, DOI 10.1126/science.1219416; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Schoft VK, 2011, P NATL ACAD SCI USA, V108, P8042, DOI 10.1073/pnas.1105117108; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	14	323	330	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1360	1364		10.1126/science.1224839	http://dx.doi.org/10.1126/science.1224839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984074	Green Accepted			2022-12-28	WOS:000308705000047
J	Liu, W; Huang, XY; Cheng, MJ; Nielsen, RJ; Goddard, WA; Groves, JT				Liu, Wei; Huang, Xiongyi; Cheng, Mu-Jeng; Nielsen, Robert J.; Goddard, William A., III; Groves, John T.			Oxidative Aliphatic C-H Fluorination with Fluoride Ion Catalyzed by a Manganese Porphyrin	SCIENCE			English	Article							ELEMENTAL FLUORINE; MECHANISM; PHARMACEUTICALS; REACTIVITY; REAGENT; ACIDS	Despite the growing importance of fluorinated organic compounds in drug development, there are no direct protocols for the fluorination of aliphatic C-H bonds using conveniently handled fluoride salts. We have discovered that a manganese porphyrin complex catalyzes alkyl fluorination by fluoride ion under mild conditions in conjunction with stoichiometric oxidation by iodosylbenzene. Simple alkanes, terpenoids, and even steroids were selectively fluorinated at otherwise inaccessible sites in 50 to 60% yield. Decalin was fluorinated predominantly at the C2 and C3 methylene positions. Bornyl acetate was converted to exo-5-fluoro-bornyl acetate, and 5a-androstan-17-one was fluorinated selectively in the A ring. Mechanistic analysis suggests that the regioselectivity for C-H bond cleavage is directed by an oxomanganese(V) catalytic intermediate followed by F delivery via an unusual manganese(IV) fluoride that has been isolated and structurally characterized.	[Liu, Wei; Huang, Xiongyi; Groves, John T.] Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA; [Cheng, Mu-Jeng; Nielsen, Robert J.; Goddard, William A., III] CALTECH, Dept Chem, Mat & Proc Simulat Ctr MC 139 74, Pasadena, CA 91125 USA	Princeton University; California Institute of Technology	Groves, JT (corresponding author), Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA.	jtgroves@princeton.edu	Huang, Xiongyi/H-3079-2013; Groves, John T./GPP-7588-2022; Cheng, Mu-Jeng/I-7316-2012	Groves, John T./0000-0002-9944-5899; Huang, Xiongyi/0000-0001-7156-8881	NSF [CHE-0616633, CHE-1148597]; Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001298]; Division Of Chemistry [1148597] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to NSF (grants CHE-0616633 and CHE-1148597 to J.T.G.) for support of this research. DFT calculations, hydrocarbon C-H activation, and the CalTech-Princeton collaboration were supported by the Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences, under award no. DE-SC0001298 to W. A. G. and J.T.G. A patent application has been filed through Princeton University on methods and catalysts presented in this paper. We thank S. Semproni for assistance with the x-ray crystal structure of Mn<SUP>IV</SUP>(TMP)F<INF>2</INF>, data for which are available free of charge from the Cambridge Crystallographic Data Centre under reference no. CCDC 893742.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Auclair K, 2002, J AM CHEM SOC, V124, P6020, DOI 10.1021/ja025608h; Begue JP, 2006, J FLUORINE CHEM, V127, P992, DOI 10.1016/j.jfluchem.2006.05.006; Chambers RD, 2002, J CHEM SOC PERK T 1, P2190, DOI 10.1039/b204776b; Chen K, 2009, ANGEW CHEM INT EDIT, V48, P9705, DOI 10.1002/anie.200904474; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Eustaquio AS, 2010, J NAT PROD, V73, P378, DOI 10.1021/np900719u; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; GROVES JT, 1988, J AM CHEM SOC, V110, P8628, DOI 10.1021/ja00234a009; Harki DA, 2008, P NATL ACAD SCI USA, V105, P13039, DOI 10.1073/pnas.0806308105; Herrmann P, 2008, COLLECT CZECH CHEM C, V73, P1825, DOI 10.1135/cccc20081825; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hull KL, 2006, J AM CHEM SOC, V128, P7134, DOI 10.1021/ja061943k; Jin N, 2007, J AM CHEM SOC, V129, P12416, DOI 10.1021/ja0761737; Jin N, 2010, INORG CHEM, V49, P11516, DOI 10.1021/ic1015274; Kalow JA, 2010, J AM CHEM SOC, V132, P3268, DOI 10.1021/ja100161d; Kaskel S, 1997, Z ANORG ALLG CHEM, V623, P1259, DOI 10.1002/zaac.19976230813; Kaustov L, 1997, INORG CHEM, V36, P3503, DOI 10.1021/ic961207p; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Lewis JC, 2011, CHEM SOC REV, V40, P2003, DOI 10.1039/c0cs00067a; Liu W, 2010, J AM CHEM SOC, V132, P12847, DOI 10.1021/ja105548x; Lourie LF, 2006, J FLUORINE CHEM, V127, P377, DOI 10.1016/j.jfluchem.2005.12.027; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; O'Hagan D, 2002, NATURE, V416, P279, DOI 10.1038/416279a; Rentmeister A, 2009, NAT CHEM BIOL, V5, P26, DOI 10.1038/nchembio.128; Rozen S, 2005, EUR J ORG CHEM, V2005, P2433, DOI 10.1002/ejoc.200400876; ROZEN S, 1987, J ORG CHEM, V52, P2769, DOI 10.1021/jo00389a024; Rueda-Becerril M, 2012, J AM CHEM SOC, V134, P4026, DOI 10.1021/ja211679v; Sandford G, 2007, J FLUORINE CHEM, V128, P90, DOI 10.1016/j.jfluchem.2006.10.019; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; STAVBER S, 1989, TETRAHEDRON, V45, P2737, DOI 10.1016/S0040-4020(01)80103-4; Tang PP, 2010, J AM CHEM SOC, V132, P12150, DOI 10.1021/ja105834t; Umile TP, 2011, INORG CHEM, V50, P10353, DOI 10.1021/ic201430v; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Yin F, 2012, J AM CHEM SOC, V134, P10401, DOI 10.1021/ja3048255; Zanzonico PB, 2004, J NUCL MED, V45, P1966; Zhao YJ, 2012, ORG BIOMOL CHEM, V10, P479, DOI 10.1039/c1ob05840a	41	213	220	4	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1322	1325		10.1126/science.1222327	http://dx.doi.org/10.1126/science.1222327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984066				2022-12-28	WOS:000308705000037
J	Pearce, JM				Pearce, Joshua M.			Building Research Equipment with Free, Open-Source Hardware	SCIENCE			English	Editorial Material							TECHNOLOGY		Michigan Technol Univ, Dept Mat Sci & Engn, Houghton, MI 49931 USA	Michigan Technological University	Pearce, JM (corresponding author), Michigan Technol Univ, Dept Mat Sci & Engn, Houghton, MI 49931 USA.	pearce@mtu.edu	Pearce, J.M/C-9240-2013; Pearce, Joshua M/D-2052-2010	Pearce, J.M/0000-0001-9802-3056; Pearce, Joshua M/0000-0001-9802-3056				Deek P., 2007, OPEN SOURCE TECHNOLO; Jones R, 2011, ROBOTICA, V29, P177, DOI 10.1017/S026357471000069X; Lang TD, 2011, SCIENCE, V331, P714, DOI 10.1126/science.1199349; Mushtaq U., 2012, NANOTECHNOLOGY GLOBA, P191; Pearce Joshua M., 2012, Environment Development and Sustainability, V14, P425, DOI 10.1007/s10668-012-9337-9; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]	6	322	342	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1303	1304		10.1126/science.1228183	http://dx.doi.org/10.1126/science.1228183			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984059				2022-12-28	WOS:000308705000029
J	Dienstag, JL; Cosimi, AB				Dienstag, Jules L.; Cosimi, A. Benedict			Liver Transplantation - A Vision Realized	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dienstag, Jules L.] Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Cosimi, A. Benedict] Massachusetts Gen Hosp, Dept Surg, Transplantat Unit, Boston, MA 02114 USA; [Cosimi, A. Benedict] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Dienstag, JL (corresponding author), Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA.			Dienstag, Jules/0000-0001-7024-0980				BEECHER HK, 1968, NEW ENGL J MED, V278, P1425, DOI 10.1056/NEJM196806272782605; CALNE RY, 1979, LANCET, V2, P1033; STARZL TE, 1989, NEW ENGL J MED, V321, P1014, DOI 10.1056/NEJM198910123211505; STARZL TE, 1989, NEW ENGL J MED, V321, P1092, DOI 10.1056/NEJM198910193211606; STARZL TE, 1982, HEPATOLOGY, V2, P614; Starzl TE, 2010, HEPATOLOGY, V51, P1869, DOI 10.1002/hep.23595	6	51	54	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1483	1485		10.1056/NEJMp1210159	http://dx.doi.org/10.1056/NEJMp1210159			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	22992048				2022-12-28	WOS:000309904500005
J	Qin, JJ; Li, YR; Cai, ZM; Li, SH; Zhu, JF; Zhang, F; Liang, SS; Zhang, WW; Guan, YL; Shen, DQ; Peng, YQ; Zhang, DY; Jie, ZY; Wu, WX; Qin, YW; Xue, WB; Li, JH; Han, LC; Lu, DH; Wu, PX; Dai, YL; Sun, XJ; Li, ZS; Tang, AF; Zhong, SL; Li, XP; Chen, WN; Xu, R; Wang, MB; Feng, Q; Gong, MH; Yu, J; Zhang, YY; Zhang, M; Hansen, T; Sanchez, G; Raes, J; Falony, G; Okuda, S; Almeida, M; LeChatelier, E; Renault, P; Pons, N; Batto, JM; Zhang, ZX; Chen, H; Yang, RF; Zheng, WM; Li, SG; Yang, HM; Wang, J; Ehrlich, SD; Nielsen, R; Pedersen, O; Kristiansen, K; Wang, J				Qin, Junjie; Li, Yingrui; Cai, Zhiming; Li, Shenghui; Zhu, Jianfeng; Zhang, Fan; Liang, Suisha; Zhang, Wenwei; Guan, Yuanlin; Shen, Dongqian; Peng, Yangqing; Zhang, Dongya; Jie, Zhuye; Wu, Wenxian; Qin, Youwen; Xue, Wenbin; Li, Junhua; Han, Lingchuan; Lu, Donghui; Wu, Peixian; Dai, Yali; Sun, Xiaojuan; Li, Zesong; Tang, Aifa; Zhong, Shilong; Li, Xiaoping; Chen, Weineng; Xu, Ran; Wang, Mingbang; Feng, Qiang; Gong, Meihua; Yu, Jing; Zhang, Yanyan; Zhang, Ming; Hansen, Torben; Sanchez, Gaston; Raes, Jeroen; Falony, Gwen; Okuda, Shujiro; Almeida, Mathieu; LeChatelier, Emmanuelle; Renault, Pierre; Pons, Nicolas; Batto, Jean-Michel; Zhang, Zhaoxi; Chen, Hua; Yang, Ruifu; Zheng, Weimou; Li, Songgang; Yang, Huanming; Wang, Jian; Ehrlich, S. Dusko; Nielsen, Rasmus; Pedersen, Oluf; Kristiansen, Karsten; Wang, Jun			A metagenome-wide association study of gut microbiota in type 2 diabetes	NATURE			English	Article							OBESITY; DIVERSITY; BACTEREMIA; INFECTION; STRESS	Assessment and characterization of gut microbiota has become a major research area in human disease, including type 2 diabetes, the most prevalent endocrine disease worldwide. To carry out analysis on gut microbial content in patients with type 2 diabetes, we developed a protocol for a metagenome-wide association study (MGWAS) and undertook a two-stage MGWAS based on deep shotgun sequencing of the gut microbial DNA from 345 Chinese individuals. We identified and validated approximately 60,000 type-2-diabetes-associated markers and established the concept of a metagenomic linkage group, enabling taxonomic species-level analyses. MGWAS analysis showed that patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens, as well as an enrichment of other microbial functions conferring sulphate reduction and oxidative stress resistance. An analysis of 23 additional individuals demonstrated that these gut microbial markers might be useful for classifying type 2 diabetes.	[Qin, Junjie; Li, Yingrui; Li, Shenghui; Zhu, Jianfeng; Liang, Suisha; Zhang, Wenwei; Guan, Yuanlin; Shen, Dongqian; Peng, Yangqing; Zhang, Dongya; Jie, Zhuye; Wu, Wenxian; Qin, Youwen; Xue, Wenbin; Li, Junhua; Chen, Weineng; Xu, Ran; Wang, Mingbang; Feng, Qiang; Gong, Meihua; Yu, Jing; Zhang, Yanyan; Zhang, Ming; Zhang, Zhaoxi; Chen, Hua; Yang, Ruifu; Zheng, Weimou; Li, Songgang; Yang, Huanming; Wang, Jian; Kristiansen, Karsten; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Cai, Zhiming; Li, Zesong; Tang, Aifa; Zhong, Shilong] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen 518035, Peoples R China; [Zhang, Fan; Han, Lingchuan; Lu, Donghui; Wu, Peixian; Dai, Yali; Sun, Xiaojuan] Peking Univ, Shenzhen Hosp, Shenzhen 518036, Peoples R China; [Li, Xiaoping] Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangzhou 510080, Peoples R China; [Hansen, Torben; Pedersen, Oluf; Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2100 Copenhagen, Denmark; [Sanchez, Gaston; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94820 USA; [Sanchez, Gaston; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94820 USA; [Raes, Jeroen; Falony, Gwen; Okuda, Shujiro] VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Raes, Jeroen; Falony, Gwen; Okuda, Shujiro] Vrije Univ Brussel, Dept Appl Biol Sci DBIT, B-1050 Brussels, Belgium; [Almeida, Mathieu; LeChatelier, Emmanuelle; Renault, Pierre; Pons, Nicolas; Batto, Jean-Michel; Ehrlich, S. Dusko] INRA, F-78350 Jouy En Josas, France; [Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, DK-8000 Aarhus, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Beijing Genomics Institute (BGI); Shenzhen University; Peking University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Novo Nordisk Foundation; University of Copenhagen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Beijing Institute of Microbiology & Epidemiology; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn	Okuda, Shujiro/D-1700-2016; Ehrlich, S./Y-2423-2019; Wang, Mingbang/F-4457-2018; Wang, Jun/A-7261-2013; Qin, Youwen/AAY-1194-2021; Yang, Ruifu/A-2273-2011; LE CHATELIER, Emmanuelle/O-1243-2017; Pedersen, Oluf/Z-1731-2019; Li, Yingrui/K-1064-2015; Falony, Gwen/AAN-5011-2020; Nielsen, Rasmus/D-4405-2009; raes, jeroen/D-7835-2018; Li, Junhua/AAG-3919-2019; Kristiansen, Karsten/J-5148-2014; Pedersen, Oluf/AAG-8015-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Okuda, Shujiro/0000-0002-7704-8104; Ehrlich, S./0000-0002-7563-4046; Wang, Mingbang/0000-0002-5989-5377; Yang, Ruifu/0000-0003-3219-7269; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Pedersen, Oluf/0000-0002-3321-3972; Falony, Gwen/0000-0003-2450-0782; Nielsen, Rasmus/0000-0003-0513-6591; raes, jeroen/0000-0002-1337-041X; Li, Junhua/0000-0001-6784-1873; Kristiansen, Karsten/0000-0002-6024-0917; Qin, Youwen/0000-0003-3956-4711; Hansen, Torben/0000-0001-8748-3831; guan, yuanlin/0000-0002-4839-0146; Wang, Jun/0000-0002-2113-5874; Li, Shenghui/0000-0003-1071-8510; Liang, Suisha/0000-0003-0426-9827; Wang, Jun/0000-0002-8540-8931	Ministry of Science and Technology of China [2012AA02A201]; National Natural Science Foundation of China [30890032, 30725008, 30811130531, 31161130357]; Shenzhen Municipal Government of China [ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; European Commission [HEALTH-F4-2007-201052]; Novo Nordisk Foundation; Ministry of Science and Technology of China [2012AA02A201]; National Natural Science Foundation of China [30890032, 30725008, 30811130531, 31161130357]; Shenzhen Municipal Government of China [ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; European Commission [HEALTH-F4-2007-201052]; Novo Nordisk Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank L. Goodman for editing the manuscript and providing comments. This research was supported by the Ministry of Science and Technology of China, 863 program (2012AA02A201), the National Natural Science Foundation of China (30890032, 30725008, 30811130531, 31161130357), the Shenzhen Municipal Government of China (ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A), the Danish Strategic Research Council grant (2106-07-0021), the Ole Romer grant from Danish Natural Science Research Council, the Solexa project (272-07-0196), and the European Commission FP7 grant HEALTH-F4-2007-201052. The Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp, www.lucamp.org). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk). We are also indebted to many additional faculty and staff of BGI-Shenzhen who contributed to this work.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; BROOK I, 1995, J MED MICROBIOL, V42, P78, DOI 10.1099/00222615-42-2-78; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elsayed S, 2004, J CLIN MICROBIOL, V42, P4390, DOI 10.1128/JCM.42.9.4390-4392.2004; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kashyap P, 2011, NEUROGASTROENT MOTIL, V23, P111, DOI 10.1111/j.1365-2982.2010.01659.x; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li S., 2012, GIGASCIENCE; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MCCLEAN KL, 1994, CLIN INFECT DIS, V19, P100, DOI 10.1093/clinids/19.1.100; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Woo PCY, 2004, J CLIN MICROBIOL, V42, P5947, DOI 10.1128/JCM.42.12.5947-5949.2004; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S5; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	36	3759	4157	88	1494	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					55	60		10.1038/nature11450	http://dx.doi.org/10.1038/nature11450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23023125				2022-12-28	WOS:000309446800031
J	Statland, JM; Bundy, BN; Wang, YX; Rayan, DR; Trivedi, JR; Sansone, VA; Salajegheh, MK; Venance, SL; Ciafaloni, E; Matthews, E; Meola, G; Herbelin, L; Griggs, RC; Barohn, RJ; Hanna, MG				Statland, Jeffrey M.; Bundy, Brian N.; Wang, Yunxia; Rayan, Dipa Raja; Trivedi, Jaya R.; Sansone, Valeria A.; Salajegheh, Mohammad K.; Venance, Shannon L.; Ciafaloni, Emma; Matthews, Emma; Meola, Giovanni; Herbelin, Laura; Griggs, Robert C.; Barohn, Richard J.; Hanna, Michael G.		Consortium Clinical Neurol Channcl	Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; HEALTH SURVEY SF-36; INTRAINDIVIDUAL CHANGES; PARAMYOTONIA-CONGENITA; MUSCLE CHANNELOPATHIES; DYSTROPHY TYPE-1; CLINICAL-TRIALS; DIAGNOSIS; QUESTIONNAIRE; TOCAINIDE	Context Nondystrophic myotonias (NDMs) are rare diseases caused by mutations in skeletal muscle ion channels. Patients experience delayed muscle relaxation causing functionally limiting stiffness and pain. Mexiletine-induced sodium channel blockade reduced myotonia in small studies; however, as is common in rare diseases, larger studies of safety and efficacy have not previously been considered feasible. Objective To determine the effects of mexiletine for symptoms and signs of myotonia in patients with NDMs. Design, Setting, and Participants A randomized, double-blind, placebo-controlled 2-period crossover study at 7 neuromuscular referral centers in 4 countries of 59 patients with NDMs conducted between December 23, 2008, and March 30, 2011, as part of the National Institutes of Health-funded Rare Disease Clinical Research Network. Intervention Oral 200-mg mexiletine or placebo capsules 3 times daily for 4 weeks, followed by the opposite intervention for 4 weeks, with 1-week washout in between. Main Outcome Measures Patient-reported severity score of stiffness recorded on an interactive voice response (IVR) diary (scale of 1 = minimal to 9 = worst ever experienced). Secondary end points included IVR-reported changes in pain, weakness, and tiredness; clinical myotonia assessment; quantitative measure of handgrip myotonia; and Individualized Neuromuscular Quality of Life summary quality of life score (INQOL-QOL, percentage of maximal detrimental impact). Results Mexiletine significantly improved patient-reported severity score stiffness on the IVR diary. Because of a statistically significant interaction between treatment and period for this outcome, primary end point is presented by period (period 1 means were 2.53 for mexiletine and 4.21 for placebo; difference, -1.68; 95% CI, -2.66 to -0.706; P < .001; period 2 means were 1.60 for mexiletine and 5.27 for placebo; difference, -3.68; 95% CI, -3.85 to -0.139; P = .04). Mexiletine improved the INQOL-QOL score (mexiletine, 14.0 vs placebo, 16.7; difference, -2.69; 95% CI, -4.07 to -1.30; P < .001) and decreased handgrip myotonia on clinical examination (mexiletine, 0.164 seconds vs placebo, 0.494 seconds; difference, -0.330; 95% CI, -0.633 to -0.142; P < .001). The most common adverse effect was gastrointestinal (9 mexiletine and 1 placebo). Two participants experienced transient cardiac effects that did not require stopping the study (1 in each group). One serious adverse event was determined to be not study related. Conclusion In this preliminary study of patients with NDMs, the use of mexiletine compared with placebo resulted in improved patient-reported stiffness over 4 weeks of treatment, despite some concern about the maintenance of blinding.	[Statland, Jeffrey M.; Ciafaloni, Emma; Griggs, Robert C.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Bundy, Brian N.] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA; [Wang, Yunxia; Herbelin, Laura; Barohn, Richard J.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; [Rayan, Dipa Raja; Matthews, Emma; Hanna, Michael G.] UCL, Med Res Council, Ctr Neuromuscular Dis, Inst Neurol, London, England; [Trivedi, Jaya R.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Sansone, Valeria A.; Meola, Giovanni] Univ Milan, Dept Neurol, Ist Ricovero & Cura Carattere Sci, Policlin San Donato, Milan, Italy; [Salajegheh, Mohammad K.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Salajegheh, Mohammad K.] Harvard Univ, Sch Med, Boston, MA USA; [Venance, Shannon L.] London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada	University of Rochester; State University System of Florida; University of South Florida; University of Kansas; University of Kansas Medical Center; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Policlinico San Donato; University of Milan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; London Health Sciences Centre	Barohn, RJ (corresponding author), Univ Kansas, Med Ctr, Dept Neurol, 3599 Rainbow Blvd, Kansas City, KS 66160 USA.	rbarohn@kumc.edu	Hanna, Michael G/B-1995-2009; Matthews, Emma/AAH-6518-2020; Meola, Giovanni/K-4775-2016	Meola, Giovanni/0000-0001-6396-717X; Hart, Kimberly/0000-0002-3684-5326; Trivedi, Jaya/0000-0001-6112-2325; Griggs, Robert/0000-0001-7988-4854; Ciocca, Matteo/0000-0002-2114-4252; Hanna, Michael/0000-0003-0825-4075; Matthews, Emma/0000-0002-3810-306X; Jayaseelan, Dipa/0000-0002-1738-3402; Statland, Jeffrey/0000-0003-0790-5315	Genzyme; Wiley; AFM (the French Muscular Dystrophy Association); Andreoli; Carpenter's Cecil Essentials of Medicine; Cecil Textbook of Medicine; TaroPharma; Grifols; Food and Drug Administration Orphan Products Division [RO1 FD 003454]; National Center for Research Resources [U54 NS059065-05S1]; National Institutes of Health; University of Kansas Medical Center Clinical and Translational Science Awards (CTSA) [UL1 RR 033179 (UL1 TR 000001)]; University of Rochester CTSA [UL1 RR 024160]; University College London Medical Research Council Centre [G0601943]; NCRR/NIH from the University of Texas Southwestern CTSA [UL1 RR 024982]; National Institutes of Health Experimental Therapeutics in Neurological Disorders [T32 NS07338-20]; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish; FOOD AND DRUG ADMINISTRATION [R01FD003454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982, UL1RR033179, UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007338, U54NS059065] Funding Source: NIH RePORTER	Genzyme(Sanofi-AventisGenzyme Corporation); Wiley; AFM (the French Muscular Dystrophy Association); Andreoli; Carpenter's Cecil Essentials of Medicine; Cecil Textbook of Medicine; TaroPharma; Grifols; Food and Drug Administration Orphan Products Division; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Medical Center Clinical and Translational Science Awards (CTSA); University of Rochester CTSA; University College London Medical Research Council Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR/NIH from the University of Texas Southwestern CTSA; National Institutes of Health Experimental Therapeutics in Neurological Disorders; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Venance reported receiving reimbursement for travel from Genzyme and royalties from Wiley Publishing for her role as coeditor of Neurology in Practice: Neuromuscular Disorders. Dr Meola reported being supported in part by AFM (the French Muscular Dystrophy Association). Dr Griggs reported serving as chair of executive committee of the Muscle Study Group, which receives support from pharmaceutical companies; serving on scientific advisory boards for The National Hospital Queen Square and PTC Therapeutics; serving on the editorial boards of NeuroTherapeutics and Current Treatment Opinions in Neurology; receiving royalties from the publication of Andreoli and Carpenter's Cecil Essentials of Medicine, Eighth Edition (W.B. Saunders Company, 2000, 2004, 2007, and 2010) and Cecil Textbook of Medicine, 24th Edition (W.B. Saunders Company, 2000, 2004, 2008, and 2010); and receiving research support from TaroPharma. Dr Barohn reported receiving support from Grifols and Genzyme speakers bureau, and being a consultant for Pfizer, MedImmune, Novartis, and NuFactor. No other authors reported any financial disclosures.; This study was supported by grants RO1 FD 003454 from the Food and Drug Administration Orphan Products Division and U54 NS059065-05S1 from the National Center for Research Resources and the National Institutes of Health. Additional funding was provided in part by grants UL1 RR 033179 (which is now UL1 TR 000001) from the University of Kansas Medical Center Clinical and Translational Science Awards (CTSA), UL1 RR 024160 from the University of Rochester CTSA, G0601943 from the University College London Medical Research Council Centre, and UL1 RR 024982 NCRR/NIH from the University of Texas Southwestern CTSA. Dr Rayan is a Medical Research Council Clinical Training Fellow. Dr Statland is funded by grant T32 NS07338-20 from the National Institutes of Health Experimental Therapeutics in Neurological Disorders.	BROWN BW, 1980, BIOMETRICS, V36, P69, DOI 10.2307/2530496; Cella D, 2002, J CLIN EPIDEMIOL, V55, P285, DOI 10.1016/S0895-4356(01)00477-2; De Luca A, 2004, NEUROMUSCULAR DISORD, V14, P405, DOI 10.1016/j.nmd.2004.04.006; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Desaphy JF, 2001, NEUROLOGY, V57, P1849, DOI 10.1212/WNL.57.10.1849; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Fournier E, 2004, ANN NEUROL, V56, P650, DOI 10.1002/ana.20241; GRIGGS RC, 1975, AM J MED, V59, P37, DOI 10.1016/0002-9343(75)90319-8; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; JACKSON CE, 1994, MUSCLE NERVE, V17, P763, DOI 10.1002/mus.880170710; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; KWIECINSKI H, 1992, ACTA NEUROL SCAND, V86, P371, DOI 10.1111/j.1600-0404.1992.tb05103.x; LEYBURN P, 1959, BRAIN, V82, P81, DOI 10.1093/brain/82.1.81; LIANG MH, 1985, ARTHRITIS RHEUM, V28, P542, DOI 10.1002/art.1780280513; Logigian EL, 2010, NEUROLOGY, V74, P1441, DOI 10.1212/WNL.0b013e3181dc1a3a; Logigian EL, 2005, MUSCLE NERVE, V32, P35, DOI 10.1002/mus.20339; Matthews E, 2010, BRAIN, V133, P9, DOI 10.1093/brain/awp294; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mohammadi Bahram, 2005, Pharmacogenet Genomics, V15, P235, DOI 10.1097/01213011-200504000-00007; Moxiley RT, 2007, MUSCLE NERVE, V36, P320, DOI 10.1002/mus.20822; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Piantadosi S, 2005, WILEY SER PROBAB ST, P515; Senn S, 1997, STAT ISSUES DRUG DEV, P237; Statland JM, 2011, MUSCLE NERVE, V44, P30, DOI 10.1002/mus.22007; STREIB EW, 1987, MUSCLE NERVE, V10, P155, DOI 10.1002/mus.880100209; STREIB EW, 1987, MUSCLE NERVE, V10, P603, DOI 10.1002/mus.880100704; Tan SV, 2011, ANN NEUROL, V69, P328, DOI 10.1002/ana.22238; Trip J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004762.pub2; Vincent KA, 2007, NEUROLOGY, V68, P1051, DOI 10.1212/01.wnl.0000257819.47628.41; Wang GK, 2004, J PHYSIOL-LONDON, V554, P621, DOI 10.1113/jphysiol.2003.054973; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLAN AR, 1986, BIOMETRICS, V42, P593, DOI 10.2307/2531209; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2	35	110	112	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1357	1365		10.1001/jama.2012.12607	http://dx.doi.org/10.1001/jama.2012.12607			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032552	Green Accepted, Green Published			2022-12-28	WOS:000309369300030
J	Horton, R				Horton, Richard			Women's and children's health: no time for complacency	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; PROGRESS; TRENDS		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.	richard.horton@lancet.com						Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; [Anonymous], LEV TRENDS CHILD MOR; Ban Ki-moon., 2010, GLOBAL STRATEGY WOME; Carrera C, 2012, LANCET; Chopra M, 2012, LANCET; Cresswell JA, 2012, LANCET; Every Woman Every Child, 2019, WHAT IS EV WOM EV CH; Howden D, 2012, INDEPENDENT, P31; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3	14	3	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1123	1125		10.1016/S0140-6736(12)61613-4	http://dx.doi.org/10.1016/S0140-6736(12)61613-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	012SD	23021269				2022-12-28	WOS:000309255900004
J	Gough, D				Gough, Douglas			How Oblate Is the Sun?	SCIENCE			English	Editorial Material							GRAVITATIONAL QUADRUPOLE-MOMENT; SOLAR OBLATENESS; ROTATION		[Gough, Douglas] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Gough, Douglas] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0HA, England	University of Cambridge; University of Cambridge	Gough, D (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	douglas@ast.cam.ac.uk						Antia HM, 2008, ASTRON ASTROPHYS, V477, P657, DOI 10.1051/0004-6361:20078209; Beck JG, 2000, SOL PHYS, V191, P47, DOI 10.1023/A:1005226402796; Delaboudiniere JP, 1995, SOL PHYS, V162, P291, DOI 10.1007/BF00733432; DICKE RH, 1970, ASTROPHYS J, V159, P1, DOI 10.1086/150286; Fivian M, 2003, P SOC PHOTO-OPT INS, V4853, P60, DOI 10.1117/12.460365; Fivian MD, 2008, SCIENCE, V322, P560, DOI 10.1126/science.1160863; GOUGH DO, 1982, NATURE, V298, P334, DOI 10.1038/298334a0; Kuhn JR, 2012, SCIENCE, V337, P1638, DOI 10.1126/science.1223231; Kuhn J. R., 2001, ENCY ASTRONOMY ASTRO; Pijpers FP, 1998, MON NOT R ASTRON SOC, V297, pL76, DOI 10.1046/j.1365-8711.1998.01801.x; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Tassoul J.-L., 2000, STELLAR ROTATION	12	11	11	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1611	1613		10.1126/science.1226988	http://dx.doi.org/10.1126/science.1226988			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019636				2022-12-28	WOS:000309215400029
J	Garber, K				Garber, Ken			BIOCHEMISTRY A radical treatment	NATURE			English	Editorial Material																		Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278	9	18	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					S4	S6		10.1038/489S4a	http://dx.doi.org/10.1038/489S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013714	Bronze			2022-12-28	WOS:000309167100003
J	Gillies, D; O'Riordan, E				Gillies, Donna; O'Riordan, Elisabeth			Should intravenous catheters be replaced routinely?	LANCET			English	Editorial Material							RISK-FACTORS; PHLEBITIS; PREVENTION; GUIDELINES; TRIAL		[Gillies, Donna] Western Sydney Local Hlth Dist, Westmead, NSW 2145, Australia; [O'Riordan, Elisabeth] Childrens Hosp Westmead, Westmead, NSW, Australia	University of Sydney	Gillies, D (corresponding author), Western Sydney Local Hlth Dist, Westmead, NSW 2145, Australia.	donna_gillies@wsahs.nsw.gov.au		Gillies, Donna/0000-0002-6216-4559				Gillies D, 2005, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.PUB2:CD003588; Ho KHM, 2012, J CLIN NURS, V21, P1499, DOI 10.1111/j.1365-2702.2011.03974.x; Idvall E, 2006, J ADV NURS, V55, P715, DOI 10.1111/j.1365-2648.2006.03962.x; Lee WL, 2009, AM J INFECT CONTROL, V37, P683, DOI 10.1016/j.ajic.2009.02.009; Malach T, 2006, AM J INFECT CONTROL, V34, P308, DOI 10.1016/j.ajic.2005.10.002; Roca GM, 2012, MED CLIN-BARCELONA, V139, P185, DOI 10.1016/j.medcli.2011.12.021; Nassaji-Zavareh M., 2007, SMJ Singapore Medical Journal, V48, P733; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Powell J, 2008, J INFUS MURS, V31, P39, DOI 10.1097/01.NAN.0000308544.67744.50; Rickard CM, 2012, LANCET, V380, P1066, DOI 10.1016/S0140-6736(12)61082-4; Soifer NE, 1998, ARCH INTERN MED, V158, P473, DOI 10.1001/archinte.158.5.473; Sterba K G, 2001, J Infus Nurs, V24, P249, DOI 10.1097/00129804-200107000-00009; Tolentino ACM, 2010, ISPOR 13 ANN EUR C P, pA413; Webster J, 2010, COCHRANE DB SYST REV, V3	14	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2012	380	9847					1036	1038		10.1016/S0140-6736(12)61338-5	http://dx.doi.org/10.1016/S0140-6736(12)61338-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007VL	22998700				2022-12-28	WOS:000308916400006
J	[Anonymous]				[Anonymous]			Surgical outcomes and opportunities	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2012	380	9847					1031	1031						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007VL	22998695	Bronze			2022-12-28	WOS:000308916400001
J	Bygbjerg, IC				Bygbjerg, I. C.			Double Burden of Noncommunicable and Infectious Diseases in Developing Countries	SCIENCE			English	Editorial Material							LOW-BIRTH-WEIGHT; FETAL; POPULATION; TUBERCULOSIS; PREVENTION; MALARIA	On top of the unfinished agenda of infectious diseases in low- and middle-income countries, development, industrialization, urbanization, investment, and aging are drivers of an epidemic of noncommunicable diseases (NCDs). Malnutrition and infection in early life increase the risk of chronic NCDs in later life, and in adult life, combinations of major NCDs and infections, such as diabetes and tuberculosis, can interact adversely. Because intervention against either health problem will affect the other, intervening jointly against noncommunicable and infectious diseases, rather than competing for limited funds, is an important policy consideration requiring new thinking and approaches.	Univ Copenhagen, Copenhagen Sch Global Hlth, Dept Int Hlth Immunol & Microbiol, Fac Hlth Sci, DK-1014 Copenhagen K, Denmark	University of Copenhagen	Bygbjerg, IC (corresponding author), Univ Copenhagen, Copenhagen Sch Global Hlth, Dept Int Hlth Immunol & Microbiol, Fac Hlth Sci, 5 Oster Farimagsgade, DK-1014 Copenhagen K, Denmark.	iby@sund.ku.dk		Bygbjerg, Ib/0000-0001-9100-2754				Agrasada GV, 2011, ASIA PAC J CLIN NUTR, V20, P62; Allain TJ, 2011, TROP MED INT HEALTH, V16, P1077, DOI 10.1111/j.1365-3156.2011.02808.x; [Anonymous], WHOHTMTB201115; [Anonymous], 2005, PREV CHRON DIS VIT I; Barker D. J., 1986, J GERONTOL B-PSYCHOL, V327, P1077, DOI 10.1016/S0140-6736(86)91340-1; Bygbjerg Ib Christian, 2012, Ugeskr Laeger, V174, P1516; C. Y, 2008, PLOS MED, V15, pe152; Christensen DL, 2011, INT J GYNECOL OBSTET, V115, pS16, DOI 10.1016/S0020-7292(11)60006-4; Dartell M, 2012, SEX TRANSM DIS, V39, P201, DOI 10.1097/OLQ.0b013e31823b50ad; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Harries AD, 2011, INT J TUBERC LUNG D, V15, pi; Lau C, 2011, OBSTET GYNECOL, V117, P978, DOI 10.1097/AOG.0b013e318212140e; LEIKIN EL, 1987, OBSTET GYNECOL, V69, P570; Li L., 2012, TROP MED INT HEALTH, DOI [10.1111/j.13652012.03068.x, DOI 10.1111/J.13652012.03068.X]; Lutter CK, 2012, SCIENCE, V337, P1495, DOI 10.1126/science.1224616; Mathers C.D., 2005, UPDATED PROJECTIONS; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Philips I., 1968, BRIT MED J, V5589, P407; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Uplekar M, 2007, B WORLD HEALTH ORGAN, V85, P413, DOI 10.2471/BLT.07.041756; WHO, 2003, WHOCDSTB2003319, P319; WHO, MAL HIV AIDS INT IMP; WHO, 2011, UN HIGH LEV M NONC D; WHO UNAIDS, 2001, WHOCDSCPESMT200113 U, P13; World Bank, 2007, PUBL POL CHALL CHRON; World Health Organization, 1999, WORLD HLTH REP, P13; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	34	186	189	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1499	1501		10.1126/science.1223466	http://dx.doi.org/10.1126/science.1223466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997329	Green Submitted			2022-12-28	WOS:000308912900041
J	Ezzati, M; Riboli, E				Ezzati, Majid; Riboli, Elio			Can Noncommunicable Diseases Be Prevented? Lessons from Studies of Populations and Individuals	SCIENCE			English	Review							CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL CONCENTRATION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; LUNG-CANCER; GLOBAL EPIDEMIOLOGY; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; CERVICAL-CANCER; STOMACH-CANCER	Noncommunicable diseases (NCDs)-mainly cancers, cardiovascular diseases, diabetes, and chronic respiratory diseases-are responsible for about two-thirds of deaths worldwide, mostly in low- and middle-income countries. There is an urgent need for policies and strategies that prevent NCDs by reducing their major risk factors. Effective approaches for large-scale NCD prevention include comprehensive tobacco and alcohol control through taxes and regulation of sales and advertising; reducing dietary salt, unhealthy fats, and sugars through regulation and well-designed public education; increasing the consumption of fresh fruits and vegetables, healthy fats, and whole grains by lowering prices and improving availability; and implementing a universal, effective, and equitable primary-care system that reduces NCD risk factors, including cardiometabolic risk factors and infections that are precursors to NCDs, through clinical interventions.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, Sch Publ Hlth, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London W2 1PG, England	Imperial College London; Imperial College London	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, Sch Publ Hlth, London W2 1PG, England.	majid.ezzati@imperial.ac.uk		Riboli, Elio/0000-0001-6795-6080	UK Medical Research Council; National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London; Imperial College Healthcare NHS Trust; Medical Research Council [G0801056B] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London; Imperial College Healthcare NHS Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank G. Danaei, J. Powles, and J. Samet for valuable comments on an earlier draft and P. Asaria, G. Danaei, C. de Martel, P. Elliott, N. Ikeda, J. Kim, G. Mensah, A. Moran, D. Mozaffarian, J. Powles, P. Puska, J. Rehm, L. Riley, G. Roth, F. Sacks, J. Samet, J. Tuomilehto, and J. Yeh for suggestions for materials and readings related to specific topics. We thank C. Di Cesare, Y. Lu, and G. Stevens for materials and assistance with figures. M. Ezzati's research is partially supported by a Strategic Award from the UK Medical Research Council and by the National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London and Imperial College Healthcare NHS Trust.	Adler L., 1912, PRIMARY MALIGNANT GR; Allamani A., 2007, CONTEMP DRUG PROBL, V34, P187, DOI DOI 10.1177/009145090703400203; Angell SY, 2009, ANN INTERN MED, V151, P129, DOI 10.7326/0003-4819-151-2-200907210-00010; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; BAILIS R, 2005, LOGIC CIRCUITS CARBO, V308, P98, DOI DOI 10.1126/SCIENCE.1106881; BEAGLEHOLE R, 2008, J GERONTOL B-PSYCHOL, V372, P940; Brand DA, 2007, PLOS MED, V4, P752, DOI 10.1371/journal.pmed.0040151; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Centers for Disease C Prevention, 2003, MMWR-MORBID MORTAL W, V52, P868; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Cipriani F., 2007, CONTEMP DRUG PROBL, V34, P361; DANAEI G, 2011, J GERONTOL B-PSYCHOL, V378, P31, DOI DOI 10.1016/S0140-6736(11)60679-X; DANAEI G, 2011, J GERONTOL B-PSYCHOL, V377, P568, DOI DOI 10.1016/S0140-6736(10)62036-3; DANAEI G, 2005, J GERONTOL B-PSYCHOL, V366, P1784; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004; DAWBER TR, 1962, P ROY SOC MED, V55, P265, DOI 10.1177/003591576205500403; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; DOLL R, 2004, BMJ-BRIT MED J, V328, P1519, DOI DOI 10.1136/BMJ.38142.554479.AE; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; DOYLE JT, 1962, NEW ENGL J MED, V266, P796, DOI 10.1056/NEJM196204192661602; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; EZZATI M, 2003, J GERONTOL B-PSYCHOL, V362, P271; FARZADFAR F, 2011, J GERONTOL B-PSYCHOL, V377, P578, DOI DOI 10.1016/S0140-6736(10)62038-7; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; FINUCANE MM, 2011, J GERONTOL B-PSYCHOL, V377, P557, DOI DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; GORTMAKER SL, 2011, J GERONTOL B-PSYCHOL, V378, P838; Gouda HN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-88; Grad YH, 2012, AM J EPIDEMIOL, V175, P54, DOI 10.1093/aje/kwr288; Haruma K, 1997, J CLIN GASTROENTEROL, V25, P583, DOI 10.1097/00004836-199712000-00006; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; HIRAYAMA T, 1984, JPN J CLIN ONCOL, V14, P159; HOWSON CP, 1986, EPIDEMIOL REV, V8, P1; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; JACKSON R, 1987, INT J EPIDEMIOL, V16, P377, DOI 10.1093/ije/16.3.377; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LEWINGTON S, 2007, J GERONTOL B-PSYCHOL, V370, P1829; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MACMAHON S, 2005, J GERONTOL B-PSYCHOL, V365, P1108; Marshall B. J., 1984, J GERONTOL B-PSYCHOL, V323, P1311; MASTER AM, 1950, JAMA-J AM MED ASSOC, V143, P1464, DOI 10.1001/jama.1950.02910520006004; McKinnon B, 2011, INT J PUBLIC HEALTH, V56, P139, DOI 10.1007/s00038-010-0224-6; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; MULLER F. H., 1939, ZEITSCHR KREBSJORSCH, V49, P57; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Puska P, 2010, ANNU REV PUBL HEALTH, V31, P315, DOI 10.1146/annurev.publhealth.012809.103658; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sacks FM, 2010, NEW ENGL J MED, V362, P2102, DOI 10.1056/NEJMct0911013; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; STAMLER J, 2005, CORONARY HEART DIS E, P32; Stringhini S, 2012, STROKE, V43, P2283, DOI 10.1161/STROKEAHA.112.658468; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; TUOMILEHTO J, 1984, STROKE, V15, P823, DOI 10.1161/01.STR.15.5.823; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2011, GLOB STAT REP NONC D; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; ZARIDZE D, 2009, J GERONTOL B-PSYCHOL, V373, P2201; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	94	142	150	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1482	1487		10.1126/science.1227001	http://dx.doi.org/10.1126/science.1227001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997325	Green Published			2022-12-28	WOS:000308912900037
J	Finfer, S; Liu, B; Chittock, DR; Norton, R; Myburgh, JA; McArthur, C; Mitchell, I; Foster, D; Dhingra, V; Henderson, WR; Ronco, JJ; Bellomo, R; Cook, D; McDonald, E; Dodek, P; Hebert, PC; Heyland, DK; Robinson, BG				Finfer, Simon; Liu, Bette; Chittock, Dean R.; Norton, Robyn; Myburgh, John A.; McArthur, Colin; Mitchell, Imogen; Foster, Denise; Dhingra, Vinay; Henderson, William R.; Ronco, Juan J.; Bellomo, Rinaldo; Cook, Deborah; McDonald, Ellen; Dodek, Peter; Hebert, Paul C.; Heyland, Daren K.; Robinson, Bruce G.		NICE-SUGAR Study Investigators	Hypoglycemia and Risk of Death in Critically Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE INSULIN THERAPY; PREDISPOSING FACTORS; HOSPITAL MORTALITY; CARE-UNIT; HYPERGLYCEMIA; ASSOCIATION; DISEASE	BACKGROUND Whether hypoglycemia leads to death in critically ill patients is unclear. METHODS We examined the associations between moderate and severe hypoglycemia (blood glucose, 41 to 70 mg per deciliter [2.3 to 3.9 mmol per liter] and <= 40 mg per deciliter [2.2 mmol per liter], respectively) and death among 6026 critically ill patients in intensive care units (ICUs). Patients were randomly assigned to intensive or conventional glucose control. We used Cox regression analysis with adjustment for treatment assignment and for baseline and postrandomization covariates. RESULTS Follow-up data were available for 6026 patients: 2714 (45.0%) had moderate hypoglycemia, 2237 of whom (82.4%) were in the intensive-control group (i.e., 74.2% of the 3013 patients in the group), and 223 patients (3.7%) had severe hypoglycemia, 208 of whom (93.3%) were in the intensive-control group (i.e., 6.9% of the patients in this group). Of the 3089 patients who did not have hypoglycemia, 726 (23.5%) died, as compared with 774 of the 2714 with moderate hypoglycemia (28.5%) and 79 of the 223 with severe hypoglycemia (35.4%). The adjusted hazard ratios for death among patients with moderate or severe hypoglycemia, as compared with those without hypoglycemia, were 1.41 (95% confidence interval [CI], 1.21 to 1.62; P<0.001) and 2.10 (95% CI, 1.59 to 2.77; P<0.001), respectively. The association with death was increased among patients who had moderate hypoglycemia on more than 1 day (>1 day vs. 1 day, P = 0.01), those who died from distributive (vasodilated) shock (P<0.001), and those who had severe hypoglycemia in the absence of insulin treatment (hazard ratio, 3.84; 95% CI, 2.37 to 6.23; P<0.001). CONCLUSIONS In critically ill patients, intensive glucose control leads to moderate and severe hypoglycemia, both of which are associated with an increased risk of death. The association exhibits a dose-response relationship and is strongest for death from distributive shock. However, these data cannot prove a causal relationship.	[Finfer, Simon; Robinson, Bruce G.] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Finfer, Simon; Norton, Robyn] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Liu, Bette; Myburgh, John A.] Univ New S Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Liu, Bette] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Chittock, Dean R.] Vancouver Coastal Hlth, Vancouver, BC, Canada; [Myburgh, John A.] Univ New S Wales, St George Hosp, Sydney, NSW, Australia; [McArthur, Colin] Auckland City Hosp, Auckland, New Zealand; [Mitchell, Imogen] Canberra Hosp, Canberra, ACT, Australia; [Mitchell, Imogen] Australian Natl Univ, Canberra, ACT, Australia; [Foster, Denise; Dhingra, Vinay; Henderson, William R.; Ronco, Juan J.] Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; [Bellomo, Rinaldo] Univ Melbourne, Austin Hosp, Melbourne, Vic, Australia; [Cook, Deborah; McDonald, Ellen] McMaster Univ, Hamilton, ON, Canada; [Dodek, Peter] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Dodek, Peter] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hebert, Paul C.] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Heyland, Daren K.] Queens Univ, Kingston, ON, Canada	Royal North Shore Hospital; University of Sydney; George Institute for Global Health; University of Sydney; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; Vancouver Coastal Health Research Institute; St George Hospital; University of New South Wales Sydney; Auckland City Hospital; Australian National University; Canberra Hospital; Australian National University; University of British Columbia; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; McMaster University; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada	Finfer, S (corresponding author), Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia.	sfinfer@georgeinstitute.org.au	Liu, Bette C/A-7581-2013	Liu, Bette C/0000-0002-0787-5825; Bellomo, Rinaldo/0000-0002-1650-8939; Myburgh, John/0000-0003-4088-7016; Mitchell, Imogen/0000-0001-6013-4922; Finfer, Simon/0000-0002-2785-5864	Australian National Health and Medical Research Council; Health Research Council of New Zealand; Canadian Institutes of Health Research	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Australian National Health and Medical Research Council and others; NICE-SUGAR ClinicalTrials.gov number, NCT00220987.; Supported by grants from the Australian National Health and Medical Research Council, the Health Research Council of New Zealand, and the Canadian Institutes of Health Research.	Adler GK, 2009, DIABETES, V58, P360, DOI 10.2337/db08-1153; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Arabi YM, 2009, CRIT CARE MED, V37, P2536, DOI 10.1097/CCM.0b013e3181a381ad; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Bochicchio GV, 2007, J TRAUMA, V63, P1353, DOI 10.1097/TA.0b013e31815b83c4; Childs BP, 2005, DIABETES CARE, V28, P1245; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2009, CRIT CARE RESUSC, V11, P46; Freire AX, 2005, CHEST, V128, P3109, DOI 10.1378/chest.128.5.3109; Gill G, 2009, DIABETOLOGIA, V52, P42, DOI 10.1007/s00125-008-1177-7; Gruden G, 2012, DIABETES CARE, V35, P125, DOI 10.2337/dc11-1739; Hermanides J, 2010, CRIT CARE MED, V38, P1430, DOI 10.1097/CCM.0b013e3181de562c; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoedemaekers CWE, 2008, CRIT CARE MED, V36, P3062, DOI 10.1097/CCM.0b013e318186ffe6; Ichai C, 2010, CRIT CARE, V14, DOI 10.1186/cc9258; Inzucchi SE, 2006, NEW ENGL J MED, V355, P1903, DOI 10.1056/NEJMcp060094; KELLERWOOD ME, 1983, ENDOCRINOLOGY, V113, P491, DOI 10.1210/endo-113-2-491; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Scott MG, 2009, CLIN CHEM, V55, P18, DOI 10.1373/clinchem.2008.117291; Taylor Jodie H, 2005, Surg Infect (Larchmt), V6, P233, DOI 10.1089/sur.2005.6.233; The NICE SUGAR Study Investigators, AM J RESP CRIT CAR S; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vogelzang M, 2006, J TRAUMA, V60, P873, DOI 10.1097/01.ta.0000195715.63978.80; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; Wood-ward M, 2005, CRC TEXTS STAT SCI, P223; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865	35	593	615	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1108	1118		10.1056/NEJMoa1204942	http://dx.doi.org/10.1056/NEJMoa1204942			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AS	22992074				2022-12-28	WOS:000308861800006
J	Williams, Z				Williams, Zev			Inducing Tolerance to Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Albert Einstein Coll Med, Montefiore Med Ctr, Program Early & Recurrent Pregnancy Loss, Dept Obstet & Gynecol & Womens Hlth, New York, NY 10033 USA	Montefiore Medical Center; Yeshiva University	Williams, Z (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, Program Early & Recurrent Pregnancy Loss, Dept Obstet & Gynecol & Womens Hlth, New York, NY 10033 USA.				NICHD NIH HHS [K08 HD068546] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068546] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	4	74	86	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1159	1161		10.1056/NEJMcibr1207279	http://dx.doi.org/10.1056/NEJMcibr1207279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AS	22992082	Green Accepted			2022-12-28	WOS:000308861800016
J	Hawkes, N				Hawkes, Nigel			Can Jeremy Hunt please explain?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Hawkes N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6137; Hawkes N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5961	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 19	2012	345								e6208	10.1136/bmj.e6208	http://dx.doi.org/10.1136/bmj.e6208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JI	22993395				2022-12-28	WOS:000309160500011
J	Engelgau, MM; Gregg, EW				Engelgau, Michael M.; Gregg, Edward W.			Tackling the global diabetes burden: will screening help?	LANCET			English	Editorial Material							TYPE-2; ADULTS; PREVENTION; PREVALENCE		[Engelgau, Michael M.; Gregg, Edward W.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Engelgau, MM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.	mxe1@cdc.gov		Gregg, Edward/0000-0003-2381-6822				Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Chatterton H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4624; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Engelgau MM, 2005, ANN INTERN MED, V143, P301, DOI 10.7326/0003-4819-143-4-200508160-00011; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Mai KS, 2007, DIABETIC MED, V24, P1121, DOI 10.1111/j.1464-5491.2007.02238.x; Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008; Simmons RK, 2010, DIABETES OBES METAB, V12, P838, DOI 10.1111/j.1463-1326.2010.01244.x; Simmons RK, 2012, LANCET; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; World Health Organization, 2003, SCREEN TYP 2 DIAB; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	15	12	13	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2012	380	9855					1716	1718		10.1016/S0140-6736(12)61682-1	http://dx.doi.org/10.1016/S0140-6736(12)61682-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038CV	23040423				2022-12-28	WOS:000311153700006
J	Fox, CS; Matsushita, K; Woodward, M; Bilo, HJG; Chalmers, J; Lambers Heerspink, HJ; Lee, BJ; Perkins, RM; Rossing, P; Sairenchi, T; Tonelli, M; Vassalotti, JA; Yamagishi, K; Coresh, J; de Jong, PE; Wen, CP; Nelson, RG				Fox, Caroline S.; Matsushita, Kunihiro; Woodward, Mark; Bilo, Henk J. G.; Chalmers, John; Lambers Heerspink, Hiddo J.; Lee, Brian J.; Perkins, Robert M.; Rossing, Peter; Sairenchi, Toshimi; Tonelli, Marcello; Vassalotti, Joseph A.; Yamagishi, Kazumasa; Coresh, Josef; de Jong, Paul E.; Wen, Chi-Pang; Nelson, Robert G.		Chronic Kidney Dis Prognosis Conso	Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; ALL-CAUSE; ESTIMATED GFR; RISK; PREVALENCE; PROTEINURIA; PREDICTION; EQUATION	Background Chronic kidney disease is characterised by low estimated glomerular fi ltration rate (eGFR) and high albuminuria, and is associated with adverse outcomes. Whether these risks are modifi ed by diabetes is unknown. Methods We did a meta-analysis of studies selected according to Chronic Kidney Disease Prognosis Consortium criteria. Data transfer and analyses were done between March, 2011, and June, 2012. We used Cox proportional hazards models to estimate the hazard ratios (HR) of mortality and end-stage renal disease (ESRD) associated with eGFR and albuminuria in individuals with and without diabetes. Findings We analysed data for 1 024 977 participants (128 505 with diabetes) from 30 general population and highrisk cardiovascular cohorts and 13 chronic kidney disease cohorts. In the combined general population and highrisk cohorts with data for all-cause mortality, 75 306 deaths occurred during a mean follow-up of 8.5 years (SD 5.0). In the 23 studies with data for cardiovascular mortality, 21 237 deaths occurred from cardiovascular disease during a mean follow-up of 9.2 years (SD 4.9). In the general and high-risk cohorts, mortality risks were 1.2-1.9 times higher for participants with diabetes than for those without diabetes across the ranges of eGFR and albumin-tocreatinine ratio (ACR). With fi xed eGFR and ACR reference points in the diabetes and no diabetes groups, HR of mortality outcomes according to lower eGFR and higher ACR were much the same in participants with and without diabetes (eg, for all-cause mortality at eGFR 45 mL/min per 1.73 m y [vs 95 mL/min per 1.73 m y], HR 1.35; 95% CI 1.18-1.55; vs 1.33; 1.19-1.48 and at ACR 30 mg/g [vs 5 mg/g], 1.50; 1.35-1.65 vs 1.52; 1.38-1.67). The overall interactions were not signifi cant. We identifi ed much the same fi ndings for ESRD in the chronic kidney disease cohorts. Interpretation Despite higher risks for mortality and ESRD in diabetes, the relative risks of these outcomes by eGFR and ACR are much the same irrespective of the presence or absence of diabetes, emphasising the importance of kidney disease as a predictor of clinical outcomes.	[Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Boston, MA USA; [Matsushita, Kunihiro; Woodward, Mark; Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Woodward, Mark; Chalmers, John] Univ Sydney, George Inst Glocal Hlth, Sydney, NSW 2006, Australia; [Bilo, Henk J. G.] Isala Clin, Dept Internal Med, Zwolle, Netherlands; [Lambers Heerspink, Hiddo J.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [de Jong, Paul E.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Lee, Brian J.] Moanalua Med Ctr, Honolulu, HI USA; [Perkins, Robert M.] Geisinger Med Ctr, Dept Nephrol, Danville, PA 17822 USA; [Rossing, Peter] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rossing, Peter] Univ Aarhus, HEALTH, Aarhus, Denmark; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Sairenchi, Toshimi; Yamagishi, Kazumasa] Ibaraki Hlth Serv Assoc, Mito, Ibaraki, Japan; [Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Vassalotti, Joseph A.] Natl Kidney Fdn, New York, NY USA; [Yamagishi, Kazumasa] Univ Tsukuba, Fac Med, Dept Publ Hlth Med, Tsukuba, Ibaraki, Japan; [Yamagishi, Kazumasa] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Wen, Chi-Pang] China Med Univ Hosp, Taichung, Taiwan; [Wen, Chi-Pang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Nelson, Robert G.] NIDDKD, NIH, Phoenix, AZ USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Sydney; Isala Clinics; University of Groningen; University of Groningen; Geisinger Medical Center; Steno Diabetes Center; Aarhus University; Dokkyo Medical University; University of Alberta; University of Tsukuba; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Coresh, J (corresponding author), Chron Kidney Dis Prognosis Consortium Data Coordi, Baltimore, MD 21205 USA.	ckdpc@jhmi.edu	Schöttker, Ben/F-8183-2014; Brenner, Hermann/B-4627-2017; rossing, peter/AAZ-3415-2021; Stengel, Benedicte/G-5730-2015; Kronenberg, Florian/B-1736-2008; de Zeeuw, Dick/E-9080-2014; Woodward, Mark/D-8492-2015; Kikuya, Masahiro/X-5662-2018; Matsushita, Kunihiro/B-1021-2018; rossing, peter/AAH-7879-2021; Ärnlöv, Johan/AAF-2746-2019; Tonelli, Marcello/B-3028-2009; Bakker, Stephan J. L./J-4023-2015; Yamagishi, Kazumasa/ABD-6320-2021; Brenner, Hermann/ABE-6383-2020; Wetzels, Jack F.M./A-1720-2014; Heerspink, Hiddo J Lambers/K-3358-2014; Matsushita, Kunihiro/AAJ-5817-2020; Woodward, Mark/L-6817-2017; Froissart, Marc/L-7493-2014; Metzger, Marie/K-9772-2018	Schöttker, Ben/0000-0002-1217-4521; Brenner, Hermann/0000-0002-6129-1572; rossing, peter/0000-0002-1531-4294; Stengel, Benedicte/0000-0001-9469-0804; Kronenberg, Florian/0000-0003-2229-1120; de Zeeuw, Dick/0000-0003-3434-7777; Kikuya, Masahiro/0000-0002-3080-6107; Matsushita, Kunihiro/0000-0002-7179-718X; Ärnlöv, Johan/0000-0002-6933-4637; Tonelli, Marcello/0000-0002-0846-3187; Bakker, Stephan J. L./0000-0003-3356-6791; Yamagishi, Kazumasa/0000-0003-3301-5519; Brenner, Hermann/0000-0002-6129-1572; Wetzels, Jack F.M./0000-0002-0650-6921; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Matsushita, Kunihiro/0000-0002-7179-718X; Emberson, Jonathan/0000-0001-7792-9422; Townend, Jonathan/0000-0002-5881-5806; Froissart, Marc/0000-0002-4010-3173; Rothenbacher, Dietrich/0000-0002-3563-2791; Woodward, Mark/0000-0001-9800-5296; Chalmers, John/0000-0002-9931-0580; Vassalotti, Joseph A./0000-0001-8835-0192; Prescott, Gordon/0000-0002-9156-2361; Metzger, Marie/0000-0003-3597-5409; Kleefstra, Nanne/0000-0003-1473-8519; Sairenchi, Toshimi/0000-0001-8896-6501	US National Kidney Foundation; Amgen; US National Institutes of Health; Servier; Roche; Sanofi; Abbott; Kidney Disease; AstraZeneca; Bristol-Myers Squibb; Boehringer Ingelheim; Lilly; Novo Nordisk; Novartis; Pfizer; CTI Clinical Trial Services; Litholink Chronic Kidney Disease Advisory Board; US National Institutes of Health, and Amgen; Merck; Dutch Kidney Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085086, N01HC025195, N01HC095159, N01HC075150, N01HC055222, N01HC095169, N01HC015103, N01HC045133, N01HC085079, N01HC035129] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043232, R01HL068140, R01HL080295, ZIAHL006094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002904, R01DK031801, U01DK035073, K23DK067303, R01DK073217, ZIADK069062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007181, R01AG028507, R01AG015928, R01AG027058, R01AG023629, R01AG020098] Funding Source: NIH RePORTER; Chief Scientist Office [CZH/4/656] Funding Source: researchfish	US National Kidney Foundation; Amgen(Amgen); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Servier(Servier); Roche(Roche Holding); Sanofi; Abbott(Abbott Laboratories); Kidney Disease; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Lilly(Eli Lilly); Novo Nordisk(Novo Nordisk); Novartis(Novartis); Pfizer(Pfizer); CTI Clinical Trial Services; Litholink Chronic Kidney Disease Advisory Board; US National Institutes of Health, and Amgen; Merck(Merck & Company); Dutch Kidney Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chief Scientist Office	KM's institution has received grants from the US National Kidney Foundation, Amgen, and US National Institutes of Health. MW's institution has received a grant from Servier; he has received consultancy fees from Roche and speaker's fees from Sanofi and Servier. JCh's institution has received grants from Servier; and he has received speaker's fees from them. HJLH has served as a consultant for Abbott, Reata, Johnson & Johnson, and Vitae; and he has received speaker's fees from Abbott. BJL has received travel expenses from Kidney Disease: Improving Global Outcomes. RMP has received grants from the US National Kidney Foundation. PR's institution has received consultancy fees from Abbott, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Lilly, and Novo Nordisk, and has received grants from Abbott, Novartis, Pfizer, and speaker's fees from Abbott, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Lilly, and Novo Nordisk; he holds stock in Novo Nordisk. JAV has received consultancy fees from CTI Clinical Trial Services and Litholink Chronic Kidney Disease Advisory Board; his institution has received grants from the US National Institutes of Health; and he has received speaker's fees from Gore Creative Technologies and Elsevier. JCo's institution has received grants from the US National Kidney Foundation, US National Institutes of Health, and Amgen, and has received consultancy fees from Amgen and Merck. PEdJ's institution has received a grant from the Dutch Kidney Foundation. CSF, HJGB, TS, MT, KY, C-PW and RGN declare that they have no conflicts of interest.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Berhane AM, 2011, CLIN J AM SOC NEPHRO, V6, P2444, DOI 10.2215/CJN.00580111; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Lambers Heerspink HJ, 2010, J AM SOC NEPHROL, V21, P1355, DOI 10.1681/ASN.2010010063; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2002, NEW ENGL J MED, V347, P1505, DOI 10.1056/NEJMcp013462; Mahmoodi BK, 2012, LANCET; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Menon V, 2008, KIDNEY INT, V73, P1310, DOI 10.1038/ki.2008.67; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Nakayama M, 2011, HYPERTENS RES, V34, P1106, DOI 10.1038/hr.2011.96; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Norris K, 2006, AM J KIDNEY DIS, V48, P739, DOI 10.1053/j.ajkd.2006.08.004; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6	34	695	714	2	78	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1662	1673		10.1016/S0140-6736(12)61350-6	http://dx.doi.org/10.1016/S0140-6736(12)61350-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23013602	Green Accepted			2022-12-28	WOS:000310951400028
J	Netterstrom, B				Netterstrom, Bo			Job strain as a measure of exposure to psychological strain	LANCET			English	Editorial Material							ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL FACTORS; WORK; HEALTH; MODEL; RISK; TOOL		Bispebjerg Hosp, Dept Occupat & Environm Med, DK-2400 Copenhagen, Denmark	Aarhus University; University of Copenhagen; Bispebjerg Hospital	Netterstrom, B (corresponding author), Bispebjerg Hosp, Dept Occupat & Environm Med, DK-2400 Copenhagen, Denmark.	bo.netterstroem@regionh.dk						Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; de Lange Annet H, 2003, J Occup Health Psychol, V8, P282, DOI 10.1037/1076-8998.8.4.282; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694; Kivimaki M., 2012, LANCET; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; KRISTENSEN TS, 1995, STRESS MEDICINE, V11, P17, DOI 10.1002/smi.2460110104; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Netterstrom B, 2010, INT J OCCUP MED ENV, V23, P217, DOI 10.2478/v10001-010-0031-6; Siegrist J, 2005, PSYCHONEUROENDOCRINO, V30, P1033, DOI 10.1016/j.psyneuen.2005.03.017; Virtanen M, 2007, AM J PREV MED, V33, P182, DOI 10.1016/j.amepre.2007.05.003; Virtanen M, 2007, J AFFECT DISORDERS, V98, P189, DOI 10.1016/j.jad.2006.05.034	12	8	8	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 27	2012	380	9852					1455	1456		10.1016/S0140-6736(12)61512-8	http://dx.doi.org/10.1016/S0140-6736(12)61512-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	026JJ	22981902				2022-12-28	WOS:000310272000008
J	Litvak, V; Ratushny, AV; Lampano, AE; Schmitz, F; Huang, AC; Raman, A; Rust, AG; Bergthaler, A; Aitchison, JD; Aderem, A				Litvak, Vladimir; Ratushny, Alexander V.; Lampano, Aaron E.; Schmitz, Frank; Huang, Albert C.; Raman, Ayush; Rust, Alistair G.; Bergthaler, Andreas; Aitchison, John D.; Aderem, Alan			A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; HISTONE ACETYLATION; EXPRESSION; ACTIVATION; DATABASE; CELLS	Antiviral responses must be tightly regulated to defend rapidly against infection while minimizing inflammatory damage. Type 1 interferons (IFN-I) are crucial mediators of antiviral responses(1) and their transcription is regulated by a variety of transcription factors(2); principal among these is the family of interferon regulatory factors (IRFs)(3). The IRF gene regulatory networks are complex and contain multiple feedback loops. The tools of systems biology are well suited to elucidate the complex interactions that give rise to precise coordination of the interferon response. Here we have used an unbiased systems approach to predict that a member of the forkhead family of transcription factors, FOXO3, is a negative regulator of a subset of antiviral genes. This prediction was validated using macrophages isolated from Foxo3-null mice. Genome-wide location analysis combined with gene deletion studies identified the Irf7 gene as a critical target of FOXO3. FOXO3 was identified as a negative regulator of Irf7 transcription and we have further demonstrated that FOXO3, IRF7 and IFN-I forma coherent feed-forward regulatory circuit. Our data suggest that the FOXO3-IRF7 regulatory circuit represents a novel mechanism for establishing the requisite set points in the interferon pathway that balances the beneficial effects and deleterious sequelae of the antiviral response.	[Litvak, Vladimir; Ratushny, Alexander V.; Lampano, Aaron E.; Schmitz, Frank; Aitchison, John D.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Ratushny, Alexander V.; Huang, Albert C.; Raman, Ayush; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Rust, Alistair G.] Welcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Bergthaler, Andreas] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria	Center for Infectious Disease Research; Institute for Systems Biology (ISB); Wellcome Trust Sanger Institute; Austrian Academy of Sciences	Aderem, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	alan.aderem@seattlebiomed.org	Raman, Ayush/AAR-6165-2021; Bergthaler, Andreas/ABG-5047-2020	Raman, Ayush/0000-0003-2872-2307; Bergthaler, Andreas/0000-0003-0597-1976; Rust, Alistair/0000-0001-7287-192X	National Institutes of Health [R01AI025032, R01AI032972, HHSN272200700038C, HHSN272200800058C, U54GM103511]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025032, U19AI100627, R01AI032972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. A. Kennedy and J. J. Peschon for discussions and critical reading of the manuscript; and S. A. Danziger, T. Stolyar and E. van Gaver for technical assistance. This work was supported by grants and contracts from the National Institutes of Health (R01AI025032, R01AI032972, HHSN272200700038C, HHSN272200800058C and U54GM103511).	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Biobase, TRANSFAC PROF V9 3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chiang D Y, 2001, Bioinformatics, V17 Suppl 1, pS49; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dollar P., 2006, P DOLLARS IMAGE VIDE; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2004, BLOOD, V104, P462, DOI 10.1182/blood-2003-08-2990; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1363; MCLAREN LC, 1959, J EXP MED, V109, P475, DOI 10.1084/jem.109.5.475; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Smith K, 2003, POETRY REV, V93, P5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; Wang ST, 2011, GENE THER, V18, P372, DOI 10.1038/gt.2010.146	37	112	114	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					421	+		10.1038/nature11428	http://dx.doi.org/10.1038/nature11428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22982991	Green Accepted			2022-12-28	WOS:000309918500050
J	Weeks, ER				Weeks, Eric R.			Melting Colloidal Crystals from the Inside Out	SCIENCE			English	Editorial Material							SCIENCE		Emory Univ, Dept Phys, Atlanta, GA 30322 USA	Emory University	Weeks, ER (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	erweeks@emory.edu	Weeks, Eric R/I-8960-2019	Weeks, Eric R/0000-0003-1503-3633	Directorate For Engineering [0853837] Funding Source: National Science Foundation	Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; Bai XM, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.134109; Cahn RW, 2001, NATURE, V413, P582, DOI 10.1038/35098169; Forsblom M, 2005, NAT MATER, V4, P388, DOI 10.1038/nmat1375; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Gomez L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLEtt.90.095701; Jin ZH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055703; Lindemann F.A., 1910, PHYSICALISCHE Z, V5, P609; Lyon LA, 2009, CHEM SOC REV, V38, P865, DOI 10.1039/b715522k; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Rogers WB, 2011, P NATL ACAD SCI USA, V108, P15687, DOI 10.1073/pnas.1109853108; Wang ZR, 2012, SCIENCE, V338, P87, DOI 10.1126/science.1224763; WIDOM B, 1967, SCIENCE, V157, P375, DOI 10.1126/science.157.3787.375	13	2	2	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					55	56		10.1126/science.1228952	http://dx.doi.org/10.1126/science.1228952			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042877				2022-12-28	WOS:000309457400046
J	Guthrie, B; Payne, K; Alderson, P; McMurdo, MET; Mercer, SW				Guthrie, Bruce; Payne, Katherine; Alderson, Phil; McMurdo, Marion E. T.; Mercer, Stewart W.			Adapting clinical guidelines to take account of multimorbidity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; QUALITY; TRIALS		[Guthrie, Bruce; McMurdo, Marion E. T.] Univ Dundee, Med Res Inst, Populat Hlth Sci Div, Dundee DD2 4BF, Scotland; [Payne, Katherine] Univ Manchester, Sch Community Based Med, Manchester, Lancs, England; [Alderson, Phil] Natl Inst Hlth & Clin Excellence, Ctr Clin Practice, Manchester, Lancs, England; [Mercer, Stewart W.] Univ Glasgow, Glasgow, Lanark, Scotland	University of Dundee; University of Manchester; National Institute for Health & Care Excellence; University of Glasgow	Guthrie, B (corresponding author), Univ Dundee, Med Res Inst, Populat Hlth Sci Div, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022; Payne, Katherine/AAJ-3728-2020	Payne, Katherine/0000-0002-3938-4350; Mercer, Stewart William/0000-0002-1703-3664; Guthrie, Bruce/0000-0003-4191-4880	National Institute for Health Research [11/2003/27] Funding Source: researchfish; Chief Scientist Office [ARPG/07/01] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office		Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braithwaite RS, 2011, MED DECIS MAKING, V31, P582, DOI 10.1177/0272989X10386117; Braithwaite R Scott, 2009, Med Care, V47, P610, DOI 10.1097/MLR.0b013e31819748d5; Claxton K, 2008, PHARMACOECONOMICS, V26, P781, DOI 10.2165/00019053-200826090-00008; Grimshaw J M, 2004, Health Technol Assess, V8, piii; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; McMurdo MET, 2005, BMJ-BRIT MED J, V331, P1036, DOI 10.1136/bmj.331.7524.1036; National Institute for Health and Clinical Excellence, 2009, DEPR AD CHRON PHYS H; National Institute for Health and Clinical Excellence, 2006, ATR FIBR NAT CLIN GU; National Institute for Health and Clinical Excellence, 2008, OST CAR MAN OST AD; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; O'Brien R, 2011, CHRONIC ILLN, V7, P45, DOI 10.1177/1742395310382461; O'Hagan A., 2006, UNCERTAIN JUDGMENTS; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	22	287	291	3	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2012	345								e6341	10.1136/bmj.e6341	http://dx.doi.org/10.1136/bmj.e6341			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LH	23036829	Green Accepted			2022-12-28	WOS:000309661500009
J	Holmes, D				Holmes, David			Charles Newton: changing perceptions of neurodisability in Africa	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1139	1139		10.1016/S0140-6736(12)61654-7	http://dx.doi.org/10.1016/S0140-6736(12)61654-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021274				2022-12-28	WOS:000309255900014
J	Ball, LT; Lloyd-Jones, GC; Russell, CA				Ball, Liam T.; Lloyd-Jones, Guy C.; Russell, Christopher A.			Gold-Catalyzed Direct Arylation	SCIENCE			English	Article							(HETERO)ARENES; OXYARYLATION	Biaryls (two directly connected aromatic rings, Ar-1-Ar-2) are common motifs in pharmaceuticals, agrochemicals, and organic materials. Current methods for establishing the Ar-1-Ar-2 bond are dominated by the cross-coupling of aryl halides (Ar-1-X) with aryl metallics (Ar-2-M). We report that, in the presence of 1 to 2 mole percent of a gold catalyst and a mild oxidant, a wide range of arenes (Ar-1-H) undergo site-selective arylation by arylsilanes (Ar-2-SiMe3) to generate biaryls (Ar-1-Ar-2), with little or no homocoupling (Ar-1-Ar-1/Ar-2-Ar-2). Catalysis proceeds at room temperature and tolerates a broad range of functional groups, including those incompatible with cross-coupling. These features expedite biaryl preparation, as demonstrated by synthesis of the nonsteroidal anti-inflammatory diflunisal.					Lloyd-Jones, Guy/A-3417-2009	Russell, Christopher/0000-0003-2921-5278; Ball, Liam/0000-0003-3849-9006; Lloyd-Jones, Guy/0000-0003-2128-6864	Engineering and Physical Sciences Research Council [EP/G036764/1]; AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; Syngenta; University of Bristol; Royal Society	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Syngenta(Syngenta); University of Bristol; Royal Society(Royal Society of London)	Experimental procedures and compound characterization data are both presented in the supplementary materials. L. T. B., G.C.L.-J., and C. A. R contributed equally to the conception and direction of this work and to the preparation of the manuscript. L. T. B. conducted all of the experimental work. We thank Umicore AG & Co. KG for the generous donation of HAuCl<INF>4</INF>. L. T. B. thanks the Bristol Chemical Synthesis Doctoral Training Centre, funded by the Engineering and Physical Sciences Research Council (grant EP/G036764/1); AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; Syngenta; and the University of Bristol, for the provision of a Ph.D. studentship. G.C.L.-J. is a Royal Society Wolfson Research Merit Award holder.	Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Ball LT, 2012, CHEM-EUR J, V18, P2931, DOI 10.1002/chem.201103061; Ball LT, 2010, ORG LETT, V12, P4724, DOI 10.1021/ol1019162; Ciana CL, 2011, ANGEW CHEM INT EDIT, V50, P458, DOI 10.1002/anie.201004703; Funaki K, 2011, CHEM LETT, V40, P1050, DOI 10.1246/cl.2011.1050; Hachiya H, 2010, ANGEW CHEM INT EDIT, V49, P2202, DOI 10.1002/anie.200906996; HANNAH J, 1978, J MED CHEM, V21, P1093, DOI 10.1021/jm00209a001; Kar A, 2008, CHEM COMMUN, P386, DOI 10.1039/b714928j; Kar A, 2009, J ORGANOMET CHEM, V694, P524, DOI 10.1016/j.jorganchem.2008.11.016; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Li BJ, 2011, CHEM-EUR J, V17, P1728, DOI 10.1002/chem.201002273; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; McGlacken GP, 2009, CHEM SOC REV, V38, P2447, DOI 10.1039/b805701j; Neufeldt SR, 2012, ACCOUNTS CHEM RES, V45, P936, DOI 10.1021/ar300014f; NORMAN ROC, 1976, J CHEM SOC PERK T 1, P1983, DOI 10.1039/p19760001983; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Rombke P, 2001, J CHEM SOC DALTON, P2482, DOI 10.1039/b104001b; Ruyle W. V., 1973, U. S. Patent, Patent No. [3,714,226, 3714226]; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Taylor R., 1990, ELECTROPHILIC AROMAT; Tsuji J., 2004, PALLADIUM REAGENTS C; Wen J, 2008, ANGEW CHEM INT EDIT, V47, P8897, DOI 10.1002/anie.200802526; Yang SD, 2008, ANGEW CHEM INT EDIT, V47, P1473, DOI 10.1002/anie.200704619	24	266	274	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1644	1648		10.1126/science.1225709	http://dx.doi.org/10.1126/science.1225709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019647	Green Accepted			2022-12-28	WOS:000309215400042
J	Blount, ZD; Barrick, JE; Davidson, CJ; Lenski, RE				Blount, Zachary D.; Barrick, Jeffrey E.; Davidson, Carla J.; Lenski, Richard E.			Genomic analysis of a key innovation in an experimental Escherichia coli population	NATURE			English	Article							TERM EXPERIMENTAL EVOLUTION; CITRATE UTILIZATION; GENE; SEQUENCES; PROMOTER; DUPLICATION; ADAPTATION; AMPLIFICATION; SUPPRESSION; CONTINGENCY	Evolutionary novelties have been important in the history of life, but their origins are usually difficult to examine in detail. We previously described the evolution of a novel trait, aerobic citrate utilization (Cit(+)), in an experimental population of Escherichia coli. Here we analyse genome sequences to investigate the history and genetic basis of this trait. At least three distinct clades coexisted for more than 10,000 generations before its emergence. The Cit(+) trait originated in one clade by a tandem duplication that captured an aerobically expressed promoter for the expression of a previously silent citrate transporter. The clades varied in their propensity to evolve this novel trait, although genotypes able to do so existed in all three clades, implying that multiple potentiating mutations arose during the population's history. Our findings illustrate the importance of promoter capture and altered gene regulation in mediating the exaptation events that often underlie evolutionary innovations.	[Blount, Zachary D.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Blount, Zachary D.; Barrick, Jeffrey E.; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Davidson, Carla J.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada	Michigan State University; Michigan State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Calgary	Blount, ZD (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	blountza@msu.edu; lenski@msu.edu	Blount, Zachary/L-3130-2019; Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Lenski, Richard/0000-0002-1064-8375; Blount, Zachary/0000-0001-5153-0034	US National Science Foundation [DEB-1019989]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; US National Institutes of Health [K99-GM087550]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]; Rudolf Hugh Fellowship; DuVall Family Award; Ronald M. and Sharon Rogowski Fellowship; Barnett Rosenberg Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087550, K99GM087550] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Rudolf Hugh Fellowship; DuVall Family Award; Ronald M. and Sharon Rogowski Fellowship; Barnett Rosenberg Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Hajela, M. Kauth and S. Sleight for assistance, J. Meyer and J. Plucain for discussion, and C. Turner for comments on the paper. Sequencing services were provided by the MSU Research Technology Support Facility. We acknowledge support from the US National Science Foundation (DEB-1019989 to R. E. L.) including the BEACON Center for the Study of Evolution in Action (DBI-0939454), the US National Institutes of Health (K99-GM087550 to J. E. B.), the Defense Advanced Research Projects Agency (HR0011-09-1-0055 to R. E. L.), a Rudolf Hugh Fellowship (to Z.D.B.), a DuVall Family Award (to Z.D.B.), a Ronald M. and Sharon Rogowski Fellowship (to Z.D.B.) and a Barnett Rosenberg Fellowship (to Z.D.B).	ADAM D, 1993, SCIENCE, V259, P816, DOI 10.1126/science.8430335; Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick J. E., 2010, BRESEQ; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441; CHARLIER D, 1982, NUCLEIC ACIDS RES, V10, P5935, DOI 10.1093/nar/10.19.5935; Christensen W. B., 1949, RES B WELD COUNTY HL, V1, P3; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; HALL BG, 1982, J BACTERIOL, V151, P269, DOI 10.1128/JB.151.1.269-273.1982; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jacob F., 1982, POSSIBLE ACTUAL; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Koser SA, 1924, J BACTERIOL, V9, P59, DOI 10.1128/JB.9.1.59-77.1924; LARA FJS, 1952, J BACTERIOL, V63, P415, DOI 10.1128/JB.63.3.415-420.1952; Lenski R. E., 2004, PLANT BREED REV, V24, P225, DOI DOI 10.1002/9780470650288.CH8; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LUTGENS M, 1980, J GEN MICROBIOL, V119, P63; Mayr E., 1960, EVOLUTION DARWIN, P349; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Nizam SA, 2009, BIOCHEM ENG J, V44, P240, DOI 10.1016/j.bej.2008.12.017; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Pigliucci M, 2008, PHILOS SCI, V75, P887, DOI 10.1086/594532; Pos KM, 1998, J BACTERIOL, V180, P4160, DOI 10.1128/JB.180.16.4160-4165.1998; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Rozen DE, 2005, J MOL EVOL, V61, P171, DOI 10.1007/s00239-004-0322-2; Scheutz F., 2005, BERGEYS MANUAL SYSTE, VTwo Part B, P607, DOI [10.1002/9781118960608.gbm01147, DOI 10.1002/9781118960608.GBM01147]; SHANKAR S, 1995, MOL MICROBIOL, V17, P935, DOI 10.1111/j.1365-2958.1995.mmi_17050935.x; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Usakin LA, 2005, MOL BIOL EVOL, V22, P1555, DOI 10.1093/molbev/msi147; WHORISKEY SK, 1987, GENE DEV, V1, P227, DOI 10.1101/gad.1.3.227; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; ZHU LQ, 1992, GENE, V119, P101, DOI 10.1016/0378-1119(92)90072-W	52	369	372	3	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					513	+		10.1038/nature11514	http://dx.doi.org/10.1038/nature11514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22992527	Green Accepted			2022-12-28	WOS:000309167100040
J	Chaney, S				Chaney, Sarah			Curious appetites: surgery and the foreign body	LANCET			English	Editorial Material									UCL, Ctr Hist Psychol Disciplines, London WC1E 6BT, England	University of London; University College London	Chaney, S (corresponding author), UCL, Ctr Hist Psychol Disciplines, Mortimer St, London WC1E 6BT, England.	s.chaney@ucl.ac.uk		Chaney, Sarah/0000-0003-0335-9863				Armstrong Tim, 1998, MODERNISM TECHNOLOGY; Cappello M., 2011, SWALLOW FOREIGN BODI; Fraser I, 1939, BMJ-BRIT MED J, V1939, P967, DOI 10.1136/bmj.1.4088.967; Fraser M., 2005, BODY READER; Jackson C., 1924, FOREIGN BODIES AIR F	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2012	380	9847					1050	1051		10.1016/S0140-6736(12)61589-X	http://dx.doi.org/10.1016/S0140-6736(12)61589-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007VL	23012710				2022-12-28	WOS:000308916400013
J	Kirby, T				Kirby, Tony			Russell Gruen: precision and progress in trauma care Profile	LANCET			English	Biographical-Item																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2012	380	9847					1049	1049		10.1016/S0140-6736(12)61588-8	http://dx.doi.org/10.1016/S0140-6736(12)61588-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007VL	22998703				2022-12-28	WOS:000308916400012
J	Weber, T; Deutsch, C				Weber, Thomas; Deutsch, Curtis			Oceanic nitrogen reservoir regulated by plankton diversity and ocean circulation	NATURE			English	Article							TO-PHOSPHORUS STOICHIOMETRY; MARINE PROCHLOROCOCCUS; ELEMENTAL COMPOSITION; COMMUNITY STRUCTURE; NUTRIENT RATIOS; SOUTHERN-OCEAN; PHYTOPLANKTON; FIXATION; DENITRIFICATION; IRON	The average nitrogen-to-phosphorus ratio of marine phytoplankton (16N:1P) is closely matched to the nutrient content of mean ocean waters (14.3N:1P). This condition is thought to arise from biological control over the ocean's nitrogen budget, in which removal of bioavailable nitrogen by denitrifying bacteria ensures widespread selection for diazotrophic phytoplankton that replenish this essential nutrient when it limits the growth of other species(1-3). Here we show that in the context of a realistic ocean circulation model, and a uniform N:P ratio of plankton biomass, this feedback mechanism yields an oceanic nitrate deficit more than double its observed value. The critical missing phenomenon is diversity in the metabolic N: P requirement of phytoplankton, which has recently been shown to exhibit large-scale patterns associated with species composition(4). When we model these variations, such that diazotrophs compete with high N: P communities in subtropical regions, the ocean nitrogen inventory rises and may even exceed the average N: P ratio of plankton. The latter condition, previously considered impossible, is prevented in the modern ocean by shallow circulations that communicate stoichiometric signals from remote biomes dominated by diatoms with low N: P ratios. Large-scale patterns of plankton diversity and the circulation pathways connecting them are thus key factors determining the availability of fixed nitrogen in the ocean.	[Weber, Thomas; Deutsch, Curtis] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Weber, T (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	tweber@atmos.ucla.edu			NASA Earth Systems Science Fellowship; Gordon and Betty Moore Foundation	NASA Earth Systems Science Fellowship; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank T. DeVries for providing the ocean circulation model. This work was funded by a NASA Earth Systems Science Fellowship (T. W.) and a grant from the Gordon and Betty Moore Foundation (C.D.).	Alvain S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003154; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CODISPOTI LA, 1995, NATURE, V376, P724, DOI 10.1038/376724a0; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Deutsch C, 2012, ANNU REV MAR SCI, V4, P113, DOI 10.1146/annurev-marine-120709-142821; DeVries T, 2012, NAT GEOSCI, V5, P547, DOI [10.1038/ngeo1515, 10.1038/NGEO1515]; DeVries T, 2011, J PHYS OCEANOGR, V41, P2381, DOI 10.1175/JPO-D-10-05011.1; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; Green SE, 2006, DEEP-SEA RES PT II, V53, P620, DOI 10.1016/j.dsr2.2006.01.022; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Jin X, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002532; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Khatiwala S, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002923; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kustka A, 2002, RES MICROBIOL, V153, P255, DOI 10.1016/S0923-2508(02)01325-6; Kwon EY, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002631; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lenton TM, 2007, BIOGEOSCIENCES, V4, P353, DOI 10.5194/bg-4-353-2007; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; MARTIN JH, 1989, DEEP-SEA RES, V36, P649, DOI 10.1016/0198-0149(89)90144-1; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Mills MM, 2010, NAT GEOSCI, V3, P412, DOI 10.1038/NGEO856; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; REDFIELD AC, 1958, AM SCI, V46, P205; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403	38	76	78	6	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					419	U105		10.1038/nature11357	http://dx.doi.org/10.1038/nature11357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996557				2022-12-28	WOS:000308860900042
J	Morrato, EH; Allison, DB				Morrato, Elaine H.; Allison, David B.			FDA Approval of Obesity Drugs A Difference in Risk-Benefit Perceptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROFECOXIB		[Morrato, Elaine H.] Univ Colorado Denver, Dept Hlth Syst Management & Policy, Aurora, CO 80045 USA; [Allison, David B.] Univ Alabama Birmingham, Off Energet, Nutr & Obes Res Ctr, Birmingham, AL USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham	Morrato, EH (corresponding author), Univ Colorado Denver, Dept Hlth Syst Management & Policy, 13199 E Montview Blvd,Ste 300,Mail Stop F443, Aurora, CO 80045 USA.	elaine.morrato@ucdenver.edu		Allison, David/0000-0003-3566-9399	AHRQ HHS [K12 HS019464, K12HS019464] Funding Source: Medline; NIDDK NIH HHS [P30 DK056336, P30DK056336] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERLIN SB, 1990, SOC SERV REV, V64, P46, DOI 10.1086/603741; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, 2012, ETH SCI ISS STUD SAF; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; US Department of Health and Human Services Food and Drug Administration (FDA), 2012 M END MET DRUGS; [US Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER)], 2007, GUID IND DEV PROD WE	7	9	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1097	1098		10.1001/jama.2012.10007	http://dx.doi.org/10.1001/jama.2012.10007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AL	22990266	Green Accepted			2022-12-28	WOS:000308861000023
J	Appleby, J				Appleby, John			Is there equal pay in healthcare? Not if you are a doctor	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Connolly S, 2009, PAY GAP WOMEN MED AC; Fairfield H, 2010, NY TIMES        1121; Gainsbury S, 2012, FINANCIAL TIMES; ONS, 2012, ANN SURV HOURL EARN; ONS, 2011, ANN SURV HOURL EARN	5	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 18	2012	345								e6191	10.1136/bmj.e6191	http://dx.doi.org/10.1136/bmj.e6191			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JH	22990103				2022-12-28	WOS:000309160400013
J	Mariner, JC; House, JA; Mebus, CA; Sollod, AE; Chibeu, D; Jones, BA; Roeder, PL; Admassu, B; Van't Klooster, GGM				Mariner, Jeffrey C.; House, James A.; Mebus, Charles A.; Sollod, Albert E.; Chibeu, Dickens; Jones, Bryony A.; Roeder, Peter L.; Admassu, Berhanu; Van't Klooster, Gijs G. M.			Rinderpest Eradication: Appropriate Technology and Social Innovations	SCIENCE			English	Review							PARTICIPATORY EPIDEMIOLOGY; DISEASE SURVEILLANCE; PERSISTENCE; PREVENT; HUMANS; IMPACT; VIRUS	Rinderpest is only the second infectious disease to have been globally eradicated. In the final stages of eradication, the virus was entrenched in pastoral areas of the Greater Horn of Africa, a region with weak governance, poor security, and little infrastructure that presented profound challenges to conventional control methods. Although the eradication process was a development activity rather than scientific research, its success owed much to several seminal research efforts in vaccine development and epidemiology and showed what scientific decision-making and management could accomplish with limited resources. The keys to success were the development of a thermostable vaccine and the application of participatory epidemiological techniques that allowed veterinary personnel to interact at a grassroots level with cattle herders to more effectively target control measures.	[Mariner, Jeffrey C.; Sollod, Albert E.] Tufts Cummings Sch Vet Med, North Grafton, MA 01536 USA; [House, James A.; Mebus, Charles A.] US Anim & Plant Hlth Inspect Serv, USDA, Anim Dis Diagnost Lab, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA; [Chibeu, Dickens] African Union Interafrican Bur Anim Resources, Nairobi 00100, Kenya; [Jones, Bryony A.] Univ London, Royal Vet Coll, Hatfield AL9 7TA, Herts, England; [Roeder, Peter L.] Taurus Anim Hlth, Headley Down GU35 8SY, Hants, England; [Admassu, Berhanu] Friedman Sch Nutr Sci & Policy, Feinstein Int Ctr, Medford, MA 02155 USA; [Van't Klooster, Gijs G. M.] United Nations Food & Agr Org, Addis Ababa, Ethiopia	United States Department of Agriculture (USDA); African Union (AU); University of London; University of London Royal Veterinary College; Food & Agriculture Organization of the United Nations (FAO)	Mariner, JC (corresponding author), Tufts Cummings Sch Vet Med, North Grafton, MA 01536 USA.	j.mariner@cgiar.org		Jones, Bryony/0000-0003-4383-2504	U.S. Agency for International Development	U.S. Agency for International Development(United States Agency for International Development (USAID))	The eradication of rinderpest was a global undertaking that received support from a wide range of national governments and international agencies. Principal support for the later stages of eradication was provided by the European Union. The U.S. Agency for International Development supported research leading to the thermostable rinderpest vaccine. Preparation of this manuscript was supported by the International Livestock Research Institute and Tufts Cummings School of Veterinary Medicine.	Anderson J, 2011, VET REC, V169, P10, DOI 10.1136/vr.d4011; [Anonymous], 1993, ECONOMIST, V328, P79; Azhar M, 2010, AVIAN DIS, V54, P749, DOI 10.1637/8713-031809-Reg.1; Barrett T, 1999, ADV VIRUS RES, V53, P89, DOI 10.1016/S0065-3527(08)60344-9; Catley A, 2004, REV SCI TECH OIE, V23, P225, DOI 10.20506/rst.23.1.1476; Catley A, 2004, REV SCI TECH, V23, P391; Elsawalhy A., 2010, B ANIMAL HLTH PRODUC, V58, P185; FAO, 2011, FAO M GLOB DECL RIND; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Hussain M, 2008, REV SCI TECH OIE, V27, P869, DOI 10.20506/rst.27.3.1849; Hussain R. A. M., 2006, INT J AGRIC BIOL, V8, P648; IAFA, 1992, SER MON RIND THROUGH; Jones A., 1998, P 9 INT C ASS I TROP, VI, P107; Jost CC, 2007, REV SCI TECH OIE, V26, P537, DOI 10.20506/rst.26.3.1765; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Lancisi G. M., 1715, DISSERTATIO HIST BOV; Mack R., 1970, Tropical Animal Health and Production, V2, P210, DOI 10.1007/BF02356441; Mariner J. C., 2000, PARTICIPATORY EPIDEM; Mariner J. C., 1996, P FAO TECHNICAL CONS, P97; Mariner J. C., 1994, P 7 INT S VET EP EC, V18, P507; MARINER JC, 1990, VET MICROBIOL, V21, P195, DOI 10.1016/0378-1135(90)90032-Q; Mariner JC, 2005, PREV VET MED, V69, P245, DOI 10.1016/j.prevetmed.2005.02.001; Mariner JC, 2003, VET REC, V152, P641, DOI 10.1136/vr.152.21.641; MASIGA WN, 1993, P 7 ANN C ETH VET AS; MAY RM, 1984, MATH BIOSCI, V72, P83, DOI 10.1016/0025-5564(84)90063-4; Morens DM, 2011, J INFECT DIS, V204, P502, DOI 10.1093/infdis/jir327; PARC, 1990, PAN AFR RIND CAMP PR; PLOWRIGHT W., 1962, RES VET SCI, V3, P172; PLOWRIGHT W, 1984, J HYG-CAMBRIDGE, V92, P285, DOI 10.1017/S0022172400064524; Roeder P. L., 2011, VET MICROBIOL; Roeder P.L., 2009, GLOBAL EFFORT ERADIC; Rural Development International, 1991, EV PAN AFR RP CAMP; Rweyemamu M. M., 2005, MONOGRAPH SERIES BIO, P298; RWEYEMAMU MM, 1995, VET MICROBIOL, V44, P369, DOI 10.1016/0378-1135(95)00030-E; Scott G. R., 1992, EXP CONS STRAT GLOB; Sollod A E, 1991, Rev Sci Tech, V10, P89; Sollod A. E., 1982, P 3 INT S VET EP EC, V3, P482; Sollod A. E., 1981, PATTERNS DIS SYLVOPA; Spinage CA, 2003, CATTLE PLAGUE: A HISTORY, P3; Woolhouse MEJ, 1996, EPIDEMIOL INFECT, V116, P363, DOI 10.1017/S0950268800052699; Young J., 1994, ANIMAL HEALTHCARE TR, P1	41	100	100	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1309	1312		10.1126/science.1223805	http://dx.doi.org/10.1126/science.1223805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984063				2022-12-28	WOS:000308705000033
J	Lopes, RD; Al-Khatib, SM; Wallentin, L; Yang, HQ; Ansell, J; Bahit, MC; De Caterina, R; Dorian, P; Easton, JD; Erol, C; Ezekowitz, JA; Gersh, BJ; Granger, CB; Hohnloser, SH; Horowitz, J; Hylek, EM; McMurray, JJV; Mohan, P; Vinereanu, D; Alexander, JH				Lopes, Renato D.; Al-Khatib, Sana M.; Wallentin, Lars; Yang, Hongqiu; Ansell, Jack; Cecilia Bahit, M.; De Caterina, Raffaele; Dorian, Paul; Easton, J. Donald; Erol, Cetin; Ezekowitz, Justin A.; Gersh, Bernard J.; Granger, Christopher B.; Hohnloser, Stefan H.; Horowitz, John; Hylek, Elaine M.; McMurray, John J. V.; Mohan, Puneet; Vinereanu, Dragos; Alexander, John H.			Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial	LANCET			English	Article							ANTITHROMBOTIC THERAPY; STRATIFICATION SCHEMES; MEDICARE BENEFICIARIES; PREDICTING STROKE; TASK-FORCE; ANTICOAGULATION; THROMBOEMBOLISM; GUIDELINES; DABIGATRAN; MANAGEMENT	Background The Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial showed that apixaban is better than warfarin at prevention of stroke or systemic embolism, causes less bleeding, and results in lower mortality. We assessed in this trial's participants how results differed according to patients' CHADS(2), CHA(2)DS(2)VASc, and HAS-BLED scores, used to predict the risk of stroke and bleeding. Methods ARISTOTLE was a double-blind, randomised trial that enrolled 18 201 patients with atrial fibrillation in 39 countries. Patients were randomly assigned apixaban 5 mg twice daily (n=9120) or warfarin (target international normalised ratio 2.0-3.0; n=9081). The primary endpoint was stroke or systemic embolism. The primary safety outcome was major bleeding. We calculated CHADS(2), CHA(2)DS(2)VASc, and HAS-BLED scores of patients at randomisation. Efficacy analyses were by intention to treat, and safety analyses were of the population who received the study drug. ARISTOTLE is registered with ClinicalTrials.gov, number NCT00412984. Findings Apixaban significantly reduced stroke or systemic embolism with no evidence of a differential effect by risk of stroke (CHADS(2) 1, 2, or >= 3, p for interaction=0.4457; or CHA(2)DS(2)VASc 1, 2, or >= 3, p for interaction=0.1210) or bleeding (HAS-BLED 0-1, 2, or >= 3, p for interaction=0.9422). Patients who received apixaban had lower rates of major bleeding than did those who received warfarin, with no difference across all score categories (CHADS(2), p for interaction=0.4018; CHA(2)DS(2)VASc, p for interaction=0.2059; HAS-BLED, p for interaction=0.7127). The relative risk reduction in intracranial bleeding tended to be greater in patients with HAS-BLED scores of 3 or higher (hazard ratio [HR] 0.22, 95% CI 0.10-0.48) than in those with HAS-BLED scores of 0-1 (HR 0.66, 0.39-1.12; p for interaction=0.0604). Interpretation Because apixaban has benefits over warfarin that are consistent across patient risk of stroke and bleeding as assessed by the CHADS(2), CHA(2)DS(2)VASc, and HAS-BLED scores, these scores might be less relevant when used to tailor apixaban treatment to individual patients than they are for warfarin. Further improvement in risk stratification for both stroke and bleeding is needed, particularly for patients with atrial fibrillation at low risk for these events.	[Lopes, Renato D.; Al-Khatib, Sana M.; Yang, Hongqiu; Granger, Christopher B.; Alexander, John H.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA; [Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Ansell, Jack] Lenox Hill Hosp, New York, NY 10021 USA; [Cecilia Bahit, M.] ECLA Estudios Cardiol Latinoamer, Rosario, Santa Fe, Argentina; [De Caterina, Raffaele] Univ G dAnnunzio, Chieti, Italy; [Dorian, Paul] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Easton, J. Donald] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Erol, Cetin] Ankara Univ, TR-06100 Ankara, Turkey; [Ezekowitz, Justin A.] Univ Alberta, Edmonton, AB, Canada; [Gersh, Bernard J.] Mayo Clin, Rochester, MN USA; [Hohnloser, Stefan H.] Goethe Univ Frankfurt, Frankfurt, Germany; [Horowitz, John] Univ Adelaide, Adelaide, SA, Australia; [Hylek, Elaine M.] Boston Univ, Med Ctr, Boston, MA USA; [McMurray, John J. V.] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland; [Mohan, Puneet] Bristol Myers Squibb Co, Princeton, NJ USA; [Vinereanu, Dragos] Carol Davila Univ Med & Pharm, Bucharest, Romania	Duke University; Uppsala University; Northwell Health; G d'Annunzio University of Chieti-Pescara; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of California System; University of California San Francisco; Ankara University; University of Alberta; Mayo Clinic; Goethe University Frankfurt; University of Adelaide; Boston University; University of Glasgow; Bristol-Myers Squibb; Carol Davila University of Medicine & Pharmacy	Lopes, RD (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Box 3850, Durham, NC 27705 USA.	renato.lopes@duke.edu	Alexander, John/GVS-7271-2022; Ezekowitz, Justin A/C-4579-2013; Erol, Cetin/AAS-8128-2020; mcmurray, John/B-2467-2013; Granger, Christopher B/D-3458-2014; De Caterina, Raffaele/K-3857-2016	Ezekowitz, Justin A/0000-0002-2724-4086; mcmurray, John/0000-0002-6317-3975; Granger, Christopher B/0000-0002-0045-3291; De Caterina, Raffaele/0000-0003-1637-574X; Alexander, John/0000-0002-1444-2462; Hylek, Elaine/0000-0001-8263-8304; Erol, Cetin/0000-0001-7396-3818	Bristol-Myers Squibb; Pfizer; Boehringer Ingelheim; Bristol-Myers/Squibb; AstraZeneca; Merck/Schering-Plough; Boehringer-Ingelheim; Bristol-Myers Squibb/Pfizer; GlaxoSmithKline; Schering-Plough; Janssen Pharmaceuticals; Daiichi Sankyo; Bayer; Lilly; Novartis; Johnson Johnson; Brigham and Women's Hospital; Schering-Plough Research Institute; Medtronic Foundation; Merck; Sanofi-Aventis; Astellas; Medicines Company; Hoffmann-LaRoche; Otsuka Pharmacautical; Cardiome; St Jude Medical; Medtronic; Regado Biosciences; Bristol-Myers Squibb (Princeton, NJ, USA); Pfizer (New York, NY, USA)	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers/Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Merck/Schering-Plough(Merck & CompanySchering Plough Corporation); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb/Pfizer(Bristol-Myers SquibbPfizer); GlaxoSmithKline(GlaxoSmithKline); Schering-Plough(Merck & CompanySchering Plough Corporation); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bayer(Bayer AG); Lilly(Eli Lilly); Novartis(Novartis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Brigham and Women's Hospital; Schering-Plough Research Institute(Merck & Company); Medtronic Foundation; Merck(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Astellas(Astellas Pharmaceuticals); Medicines Company; Hoffmann-LaRoche(Hoffmann-La Roche); Otsuka Pharmacautical(Otsuka Pharmaceutical); Cardiome; St Jude Medical(St. Jude Medical); Medtronic(Medtronic); Regado Biosciences; Bristol-Myers Squibb (Princeton, NJ, USA)(Bristol-Myers Squibb); Pfizer (New York, NY, USA)(Pfizer)	Bristol-Myers Squibb and Pfizer.; RDL has received a research grant from Bristol-Myers Squibb and consulting fees from Pfizer and Boehringer Ingelheim. SMA-K has received research funding from Bristol-Myers/Squibb to co-chair the clinical events committee for the ARISTOTLE trial. LW has received research grants from AstraZeneca, Merck/Schering-Plough, Boehringer-Ingelheim, Bristol-Myers Squibb/Pfizer, and GlaxoSmithKline; has been a consultant for Merck/Schering-Plough, Regado Biosciences, Evolva, Portola, CSL Behring, Athera Biotechnologies, Boehringer-Ingelheim, AstraZeneca, GlaxoSmithKline, and Bristol-Myers Squibb/Pfizer; has received lecture fees from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb/Pfizer, GlaxoSmithKline, Schering-Plough; and has received honoraria from Boehringer Ingelheim, AstraZeneca, Bristol-Myers Squibb/Pfizer, GlaxoSmithKline, and Schering-Plough/Merck. JA has received consultant fees from Bristol-Myers Squibb, Pfizer, Janssen Pharmaceuticals, Boehringer-Ingelheim, and Daiichi Sankyo. MCB was part of the Steering Committee for the ARISTOTLE trial, of which Bristol-Myers Squibb paid for national coordination activities. RDC has received consultant and speaker fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Daiichi Sankyo, and Lilly; and research grants from AstraZeneca and Boehringer Ingelheim. PD has received consulting fees and honoraria from Bristol-Myers Squibb/Pfizer. JDE has received consulting or advisory board fees from AstraZeneca and Bristol-Myers Squibb; received data safety monitoring board fees from Novartis, Johnson & Johnson, Brigham and Women's Hospital, Schering-Plough Research Institute; and served on the adjudication committee for the Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial (National Institutes of Health). JAE has received a consulting fee and travel support from Bristol-Myers Squibb/Pfizer for the ARISTOTLE trial. BJG is a member of data safety monitoring boards for Baxter Healthcare Corporation, Ortho-McNeil Janssen Scientific Affairs, Amorcyte, Abbott Laboratories, GE Healthcare, St Jude Medical, Medispec, Merck & Co, and Boston Scientific. CBG has received grants from Bristol-Myers Squibb, Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, the Medtronic Foundation, Merck, Sanofi-Aventis, Astellas, and the Medicines Company; consulting fees from AstraZeneca, Boehringer Ingelhelm, Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-LaRoche, Novartis, Otsuka Pharmacautical, Sanofi-Aventis, Lilly, Pfizer, and the Medicines Company; and support for travel from Hoffmann-La Roche, Novartis, and Pfizer. SHH has received consulting fees from Sanofi-Aventis, Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, Bayer, and Cardiome; and lecture fees from Sanofi-Aventis, St Jude Medical, Medtronic, Boehringer Ingelheim, Bristol-Myers Squibb, and Pfizer. JH has received research support from Bristol-Myers Squibb. EMH has served as a consultant to Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, Johnson & Johnson, and Pfizer. JJVM's employer, Glasgow University, was paid by the study sponsors for his time spent as a member of the Executive Committee of ARISTOTLE, and his travel and accommodation related to ARISTOTLE Executive or Steering Committee meetings was paid by the study sponsors. PM is a full-time employee of Bristol-Myers Squibb and owns stock in the company as part of salary and compensation.; JHA has received research grants from Bristol-Myers Squibb, Merck/Schering-Plough, and Regado Biosciences; travel support from Bristol-Myers Squibb; and consulting fees from Bristol-Myers Squibb, Pfizer, Merck/Schering-Plough, AstraZeneca, Boehringer-Ingelheim, Ortho-McNeail-Janssen Pharmaceuticals, PolyMedix, Regado Biosciences, Bayer, and Daiichi-Sankyo. HY, CE, and DV declare that they have no conflicts of interest.; Bristol-Myers Squibb (Princeton, NJ, USA) and Pfizer (New York, NY, USA) funded the study, and the primary analyses were performed both at Bristol-Myers Squibb and at the Duke Clinical Research Institute (Durham, NC, USA).	Albers GW, 1996, ARCH INTERN MED, V156, P2311, DOI 10.1001/archinte.156.20.2311; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Cairns JA, 2011, CAN J CARDIOL, V27, P74, DOI 10.1016/j.cjca.2010.11.007; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Estes NAM, 2008, CIRCULATION, V117, P1101, DOI 10.1161/CIRCULATIONAHA.107.187192; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2008, STROKE, V39, P1901, DOI 10.1161/STROKEAHA.107.501825; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hughes M, 2007, QJM-INT J MED, V100, P599, DOI 10.1093/qjmed/hcm076; Hughes M, 2008, THROMB HAEMOSTASIS, V99, P295, DOI 10.1160/TH07-08-0508; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lip GYH, 2010, AM J MED, V123, P484, DOI 10.1016/j.amjmed.2009.12.013; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; Lopes RD, 2010, AM J MED, V123, P134, DOI 10.1016/j.amjmed.2009.09.015; Lopes RD, 2009, EUR HEART J, V30, P2019, DOI 10.1093/eurheartj/ehp213; Oldgren J, 2011, ANN INTERN MED, V155, P660, DOI 10.7326/0003-4819-155-10-201111150-00004; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2009, J AM COLL CARDIOL, V54, P1280, DOI 10.1016/j.jacc.2009.04.091; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2009, THROMB HAEMOSTASIS, V101, P367, DOI 10.1160/TH08-09-0592; Rietbrock S, 2008, AM HEART J, V156, P57, DOI 10.1016/j.ahj.2008.03.010; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; van Walraven C, 2003, ARCH INTERN MED, V163, P936, DOI 10.1001/archinte.163.8.936	37	149	157	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2012	380	9855					1749	1758		10.1016/S0140-6736(12)60986-6	http://dx.doi.org/10.1016/S0140-6736(12)60986-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CV	23036896				2022-12-28	WOS:000311153700031
J	Smith, BE; Braun, RE				Smith, Benjamin E.; Braun, Robert E.			Germ Cell Migration Across Sertoli Cell Tight Junctions	SCIENCE			English	Article							INTERCELLULAR BRIDGES; BARRIER; TESTIS; RAT; SPERMATOGENESIS	The blood-testis barrier includes strands of tight junctions between somatic Sertoli cells that restricts solutes from crossing the paracellular space, creating a microenvironment within seminiferous tubules and providing immune privilege to meiotic and postmeiotic cells. Large cysts of germ cells transit the Sertoli cell tight junctions (SCTJs) without compromising their integrity. We used confocal microscopy to visualize SCTJ components during germ cell cyst migration across the SCTJs. Cysts become enclosed within a network of transient compartments fully bounded by old and new tight junctions. Dissolution of the old tight junctions releases the germ cells into the adluminal compartment, thus completing transit across the blood-testis barrier. Claudin 3, a tight junction protein, is transiently incorporated into new tight junctions and then replaced by claudin 11.	[Smith, Benjamin E.; Braun, Robert E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA	University of Washington; University of Washington Seattle; Jackson Laboratory	Braun, RE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	bob.braun@jax.org			National Institute of Child Health and Human Development/NIH [HD12629]; National Cancer Institute [CA34196]; Jackson Laboratories shared services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD012629] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jackson Laboratories shared services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Lessard and J. Denegre for ssistance with confocal imaging and S. Leighton for artistic rendering of the images. This research was supported by a grant to R.E.B. from the National Institute of Child Health and Human Development/NIH (HD12629) as part of the Specialized Cooperative Centers Program in Reproduction Research and from the National Cancer Institute (CA34196) in support of The Jackson Laboratories shared services.	DYM M, 1977, BIOL REPROD, V17, P390, DOI 10.1095/biolreprod17.3.390; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; WEBER JE, 1987, AM J ANAT, V180, P1, DOI 10.1002/aja.1001800102	12	123	131	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					798	802		10.1126/science.1219969	http://dx.doi.org/10.1126/science.1219969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	22997133	Green Accepted			2022-12-28	WOS:000310839500044
J	Kramer, DB; Kesselheim, AS				Kramer, Daniel B.; Kesselheim, Aaron S.			User Fees and Beyond - The FDA Safety and Innovation Act of 2012	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kramer, Daniel B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kramer, DB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	NCATS NIH HHS [KL2 TR000168] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Alpert B, 2012, NEW ORELANS TIM 0524; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Roberts SA, 2011, HEALTH AFFAIR, V30, P1375, DOI 10.1377/hlthaff.2011.0231	3	22	22	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1277	1279		10.1056/NEJMp1207800	http://dx.doi.org/10.1056/NEJMp1207800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014WJ	23034017	Green Accepted, Bronze			2022-12-28	WOS:000309406100001
J	Wehner, MR; Shive, ML; Chen, MM; Han, JL; Qureshi, AA; Linos, E				Wehner, Mackenzie R.; Shive, Melissa L.; Chen, Mary-Margaret; Han, Jiali; Qureshi, Abrar A.; Linos, Eleni			Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BASAL-CELL CARCINOMA; RISK-FACTORS; ULTRAVIOLET-RADIATION; UNITED-STATES; RECENT TRENDS; YOUNG-WOMEN; BED USE; POPULATION; MELANOMA; EPIDEMIOLOGY	Objective To synthesise the literature on indoor tanning and non-melanoma skin cancer. Design Systematic review and meta-analysis. Data sources PubMed (1966 to present), Embase (1974 to present), and Web of Science (1898 to present). Study selection All articles that reported an original effect statistic for indoor tanning and non-melanoma skin cancer were included. Articles that presented no data, such as review articles and editorials, were excluded, as were articles in languages other than English. Data extraction Two investigators independently extracted data. Random effects meta-analysis was used to summarise the relative risk of ever use versus never use of indoor tanning. Dose-response effects and exposure to indoor tanning during early life were also examined. The population attributable risk fraction for the United States population was calculated. Results 12 studies with 9328 cases of non-melanoma skin cancer were included. Among people who reported ever using indoor tanning compared with those who never used indoor tanning, the summary relative risk for squamous cell carcinoma was 1.67 (95% confidence interval 1.29 to 2.17) and that for basal cell carcinoma was 1.29 (1.08 to 1.53). No significant heterogeneity existed between studies. The population attributable risk fraction for the United States was estimated to be 8.2% for squamous cell carcinoma and 3.7% for basal cell carcinoma. This corresponds to more than 170 000 cases of non-melanoma skin cancer each year attributable to indoor tanning. On the basis of data from three studies, use of indoor tanning before age 25 was more strongly associated with both squamous cell carcinoma (relative risk 2.02, 0.70 to 5.86) and basal cell carcinoma (1.40, 1.29 to 1.52). Conclusions Indoor tanning is associated with a significantly increased risk of both basal and squamous cell skin cancer. The risk is higher with use in early life (<25 years). This modifiable risk factor may account for hundreds of thousands of cases of non-melanoma skin cancer each year in the United States alone and many more worldwide. These findings contribute to the growing body of evidence on the harms of indoor tanning and support public health campaigns and regulation to reduce exposure to this carcinogen.	[Chen, Mary-Margaret; Linos, Eleni] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Wehner, Mackenzie R.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Wehner, Mackenzie R.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Shive, Melissa L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Han, Jiali; Qureshi, Abrar A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab,Dept Dermatol, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of California System; University of California San Francisco; Stanford University; University of Cambridge; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Linos, E (corresponding author), Univ Calif San Francisco, Dept Dermatol, 2340 Sutter St, San Francisco, CA 94143 USA.	iinose@derm.ucsf.edu	Linos, Eleni/C-4392-2014	Wehner, Mackenzie/0000-0002-5579-2282; , Eleni/0000-0003-2538-0700; Linos, Eleni/0000-0002-5856-6301	National Center for Research Resources of the National Institutes of Health [KL2RR024130]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [K24 AR052667]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR052667] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was supported by award number KL2RR024130 from the National Center for Research Resources of the National Institutes of Health, and by award number K24 AR052667 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. The study sponsors were not involved in the study design and the collection, analysis, and interpretation of data, nor the writing of the article or the decision to submit it for publication. The authors were independent from the study sponsors.	Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Asgari MM, 2011, NUTR CANCER, V63, P314, DOI 10.1080/01635581.2011.523496; AUBRY F, 1985, CANCER-AM CANCER SOC, V55, P907, DOI 10.1002/1097-0142(19850215)55:4<907::AID-CNCR2820550433>3.0.CO;2-5; Bajdik CD, 1996, BRIT J CANCER, V73, P1612, DOI 10.1038/bjc.1996.303; Bakos RM, 2011, EUR J DERMATOL, V21, P705, DOI 10.1684/ejd.2011.1436; Borner FU, 2009, BMC DERMATOL, V9, DOI 10.1186/1471-5945-9-6; Boldeman C, 2001, EUR J CANCER, V37, P2441, DOI 10.1016/S0959-8049(01)00310-0; Boyd AS, 2002, J AM ACAD DERMATOL, V46, P706, DOI 10.1067/mjd.2002.120467; Branstrom R, 2004, PREV MED, V39, P992, DOI 10.1016/j.ypmed.2004.04.004; Chen JG, 2001, DERMATOL SURG, V27, P1035, DOI 10.1046/j.1524-4725.2001.01004.x; Christenson LJ, 2005, JAMA-J AM MED ASSOC, V294, P681, DOI 10.1001/jama.294.6.681; Corona R, 2001, ARCH DERMATOL, V137, P1162; DIFFEY BL, 1991, J PHOTOCH PHOTOBIO B, V8, P219, DOI 10.1016/1011-1344(91)80062-M; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Ezzedine K, 2008, J EUR ACAD DERMATOL, V22, P186, DOI 10.1111/j.1468-3083.2007.02367.x; Ferrucci LM, 2011, J AM ACAD DERMATOL; France The International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer, 2007, International Journal of Cancer, V120, P1116, DOI 10.1002/ijc.22453; Francis K, 2010, AUST NZ J PUBL HEAL, V34, P427, DOI 10.1111/j.1753-6405.2010.00578.x; Gallagher RP, 2005, CANCER EPIDEM BIOMAR, V14, P562, DOI 10.1158/1055-9965.EPI-04-0564; Gerber B, 2002, PHOTOCHEM PHOTOBIOL, V76, P664, DOI 10.1562/0031-8655(2002)076<0664:UESOS>2.0.CO;2; Gon A, 2011, INT J DERMATOL, V50, P1286, DOI 10.1111/j.1365-4632.2011.04947.x; Guy GP, 2011, PHARMACOECONOMICS, V29, P863, DOI 10.2165/11589300-000000000-00000; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Hausauer AK, 2011, ARCH DERMATOL, V147, P783, DOI 10.1001/archdermatol.2011.44; Heckman CJ, 2008, J AM ACAD DERMATOL, V58, P769, DOI 10.1016/j.jaad.2008.01.020; HENDEE WR, 1989, JAMA-J AM MED ASSOC, V262, P380; HERITY B, 1989, IRISH MED J, V82, P151; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; HOGAN DJ, 1991, BRIT J DERMATOL, V125, P343, DOI 10.1111/j.1365-2133.1991.tb14169.x; Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186; Karagas MR, 2002, J NATL CANCER I, V94, P224, DOI 10.1093/jnci/94.3.224; Koster B, 2011, J EUR ACAD DERMATOL; Lawler SP, 2006, AUST NZ J PUBL HEAL, V30, P479, DOI 10.1111/j.1467-842X.2006.tb00468.x; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Mudigonda T, 2010, J NATL COMPR CANC NE, V8, P888, DOI 10.6004/jnccn.2010.0066; Nilsen LTN, 2008, PHOTOCHEM PHOTOBIOL, V84, P1100, DOI 10.1111/j.1751-1097.2008.00330.x; OLOUGHLIN C, 1985, IRISH J MED SCI, V154, P61, DOI 10.1007/BF02937144; Purdue MP, 2008, J INVEST DERMATOL, V128, P2905, DOI 10.1038/jid.2008.159; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P47, DOI 10.1111/j.1365-2133.2007.08273.x; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Rosso S, 1999, TUMORI, V85, P435, DOI 10.1177/030089169908500603; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Walther U, 2004, BRIT J DERMATOL, V151, P170, DOI 10.1111/j.1365-2133.2004.06030.x; Wang SQ, 2001, J AM ACAD DERMATOL, V44, P837, DOI 10.1067/mjd.2001.114594; Wei-Passanese EX, 2012, PHOTOCHEM PHOTOBIOL, V88, P483, DOI 10.1111/j.1751-1097.2012.01077.x; Zhang MF, 2012, J CLIN ONCOL, V30, P1588, DOI 10.1200/JCO.2011.39.3652	48	228	231	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2012	345								e5909	10.1136/bmj.e5909	http://dx.doi.org/10.1136/bmj.e5909			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KN	23033409	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000309659300001
J	Hsu, J; Pitt, C; Greco, G; Berman, P; Mills, A				Hsu, Justine; Pitt, Catherine; Greco, Giulia; Berman, Peter; Mills, Anne			Countdown to 2015: changes in official development assistance to maternal, newborn, and child health in 2009-10, and assessment of progress since 2003	LANCET			English	Article							AID	Background Tracking of financial resources to maternal, newborn, and child health provides crucial information to assess accountability of donors. We analysed official development assistance (ODA) flows to maternal, newborn, and child health for 2009 and 2010, and assessed progress since our monitoring began in 2003. Methods We coded and analysed all 2009 and 2010 aid activities from the database of the Organisation for Economic Co-operation and Development, according to a functional classification of activities and whether all or a proportion of the value of the disbursement contributed towards maternal, newborn, and child health. We analysed trends since 2003, and reported two indicators for monitoring donor disbursements: ODA to child health per child and ODA to maternal and newborn health per livebirth. We analysed the degree to which donors allocated ODA to 74 countries with the highest maternal and child mortality rates (Countdown priority countries) with time and by type of donor. Findings Donor disbursements to maternal, newborn, and child health activities in all countries continued to increase, to $6511 million in 2009, but slightly decreased for the first time since our monitoring started, to $6480 million in 2010. ODA for such activities to the 74 Countdown priority countries continued to increase in real terms, but its rate of increase has been slowing since 2008. We identified strong evidence that targeting of ODA to countries with high rates of maternal mortality improved from 2005 to 2010. Targeting of ODA to child health also improved but to a lesser degree. The share of multilateral funding continued to decrease but, relative to bilaterals and global health initiatives, was better targeted. Interpretation The recent slowdown in the rate of funding increases is worrying and likely to partly result from the present financial crisis. Tracking of donor aid should continue, to encourage donor accountability and to monitor performance in targeting aid flows to those in most need.	[Hsu, Justine; Pitt, Catherine; Greco, Giulia; Mills, Anne] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England; [Berman, Peter] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Hsu, J (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England.	justine.hsu@lshtm.ac.uk	Pitt, Catherine K/K-3001-2012	Pitt, Catherine K/0000-0003-4967-8966; Greco, Giulia/0000-0002-5448-9521; Mills, Anne/0000-0001-9863-9950; Hsu, Justine/0000-0002-1228-4042	Bill & Melinda Gates Foundation; World Bank; Government of Australia; Government of Canada; Government of Norway; Government of Sweden; Government of UK	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Bank(The World Bank India); Government of Australia; Government of Canada(CGIAR); Government of Norway; Government of Sweden; Government of UK	Bill & Melinda Gates Foundation; World Bank; Governments of Australia, Canada, Norway, Sweden, and the UK.	Alesina A, 2000, J ECON GROWTH, V5, P33, DOI 10.1023/A:1009874203400; [Anonymous], 2009, MOR MON HLTH MOR HLT; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Countdown to 2015 for Maternal and Child Survival, 2012, COUNTD 2015 MAT CHIL; Global Health Resource Tracking Working Group, 2007, FOLL MON BETT TRACK; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Grepin KA, 2012, HEALTH POLICY PLANN, V27, P527, DOI 10.1093/heapol/czr076; Hsu J, 2011, COMMISSION INFORM AC; Independent Expert Review Group, 2011, CONC NOT IND EXP REV; Kaiser Family Foundation, FUND PROGR US GLOB H; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; MAIZELS A, 1984, WORLD DEV, V12, P879, DOI 10.1016/0305-750X(84)90046-9; Maternal Mortality Estimation Inter-agency Group, TRENDS EST MAT MORT; OECD, 2008, ACCR AG ACT; OECD, DAC ANN AGGR DAT DAC; OECD, 2011, BUS PARTN EFF DEV CO; OECD, 2005, PARIS DECLARATION AI; OECD, CRED REP SYST CRS AI; ONE, 2012, 2012 DATA REP; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; PMNCH, 2011, ESS INT COMM GUID RE; PMNCH, 2010, BACKGR PAP GLOB STRA; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Schaferhoff M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000305; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Smith K, 2011, STAT REPORTING BILL; Smith K, 2010, DAC; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Stuckler D, 2011, B WORLD HEALTH ORGAN, V89, P252, DOI 10.2471/BLT.10.080663; The Global Campaign, 2010, PUTT GLOB STRAT WOM; The Global Fund, 21 BOARD M; The Global Fund, 25 BOARD M; UN, 2011, ESAPWP220 UN POP DIV; UN Inter-agency Group on Child Mortality Estimation, TRENDS UND 5 MORT RA; UNAIDS, 2010, UNAIDS REP GLOB AIDS; United Nations, 1994, INT C POP DEV; United Nations, 2010, GLOB STRAT WOM CHILD; WHO, 2009, CONSTR SCAL HLTH REL; WHO, GLOB HLTH EXP DAT; World Bank, 2009, HLTH SYST MILL DEV G	41	75	75	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2012	380	9848					1157	1168		10.1016/S0140-6736(12)61415-9	http://dx.doi.org/10.1016/S0140-6736(12)61415-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23000291				2022-12-28	WOS:000309255900033
J	Yang, HH; Kim, A; David, T; Palmer, D; Jin, TH; Tien, J; Huang, F; Cheng, T; Coughlin, SR; Jan, YN; Jan, LY				Yang, Huanghe; Kim, Andrew; David, Tovo; Palmer, Daniel; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Coughlin, Shaun R.; Jan, Yuh Nung; Jan, Lily Yeh			TMEM16F Forms a Ca2+-Activated Cation Channel Required for Lipid Scrambling in Platelets during Blood Coagulation	CELL			English	Article							ACTIVATED CHLORIDE CHANNELS; SCOTT-SYNDROME; EXPRESSION; TRPM5; MEMBRANES; CELLS	Collapse of membrane lipid asymmetry is a hallmark of blood coagulation. TMEM16F of the TMEM16 family that includes TMEM16A/B Ca2+-activated Cl- channels (CaCCs) is linked to Scott syndrome with deficient Ca2+-dependent lipid scrambling. We generated TMEM16F knockout mice that exhibit bleeding defects and protection in an arterial thrombosis model associated with platelet deficiency in Ca2+-dependent phosphatidylserine exposure and procoagulant activity and lack a Ca2+-activated cation current in the platelet precursor megakaryocytes. Heterologous expression of TMEM16F generates a small-conductance Ca2+-activated nonselective cation (SCAN) current with subpicosiemens single-channel conductance rather than a CaCC. TMEM16F-SCAN channels permeate both monovalent and divalent cations, including Ca2+, and exhibit synergistic gating by Ca2+ and voltage. We further pinpointed a residue in the putative pore region important for the cation versus anion selectivity of TMEM16F-SCAN and TMEM16A-CaCC channels. This study thus identifies a Ca2+-activated channel permeable to Ca2+ and critical for Ca2+-dependent scramblase activity during blood coagulation.	[Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; [Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; [Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94143 USA; [David, Tovo; Palmer, Daniel; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu	Palmer, Daniel/J-2967-2014; DAVID, Tovo/B-5573-2013; Palmer, Daniel/Q-7595-2016	Palmer, Daniel/0000-0002-7954-9332; Palmer, Daniel/0000-0002-7954-9332; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299; Yang, Huanghe/0000-0001-9521-9328; Tien, Jason/0000-0003-3853-0827	NIH [HL65185, MH65334]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065334, R37MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank David Gorczyca for help with confocal imaging; Xiuming Wong for help with cell culture; and Jianmin Cui, Ehud Isacoff, Min Li, Shi-Bing Yang, James Berg, and Christian Peters for suggestions and comments on the manuscript. We also thank Kevin Shannon and Ethan Weiss for sharing their CBC machine, Thrombinoscope, and other equipment. This study was supported by the NIH grant HL65185 to S.R.C. and MH65334 to L.Y.J. Y.N.J. and L.Y.J. are Howard Hughes Medical Institute investigators.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gurtovenko AA, 2010, CHEM REV, V110, P6077, DOI 10.1021/cr1000783; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Mahaut-Smith Martyn P, 2004, Methods Mol Biol, V273, P277; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Pena F, 2008, MINI-REV MED CHEM, V8, P812, DOI 10.2174/138955708784912166; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; ROSING J, 1985, BLOOD, V65, P319; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Teulon J, 2000, HANDB EXP PHARM, V147, P625; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671; Varga-Szabo D, 2011, CELL CALCIUM, V50, P270, DOI 10.1016/j.ceca.2011.04.002; WEISS HJ, 1979, AM J MED, V67, P206, DOI 10.1016/0002-9343(79)90392-9; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	38	285	289	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					111	122		10.1016/j.cell.2012.07.036	http://dx.doi.org/10.1016/j.cell.2012.07.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021219	Green Accepted, Bronze			2022-12-28	WOS:000309544200014
J	Graham-Rowe, D				Graham-Rowe, Duncan			THERAPEUTICS Strength in numbers	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S16	S17		10.1038/489S16a	http://dx.doi.org/10.1038/489S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013711	Bronze			2022-12-28	WOS:000309167100009
J	Chaccour, CJ; Kaur, H; Mabey, D; Del Pozo, JL				Chaccour, Carlos J.; Kaur, Harparkash; Mabey, David; Del Pozo, Jose L.			Travel and fake artesunate: a risky business	LANCET			English	Editorial Material									[Chaccour, Carlos J.] Univ Navarra Clin, Div Internal Med, Pamplona, Spain; [Chaccour, Carlos J.; Del Pozo, Jose L.] Univ Navarra Clin, Dept Med, Div Infect Dis, Pamplona, Spain; [Del Pozo, Jose L.] Univ Navarra Clin, Div Clin Microbiol & Parasitol, Pamplona, Spain; [Kaur, Harparkash; Mabey, David] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England	University of Navarra; University of Navarra; University of Navarra; University of London; London School of Hygiene & Tropical Medicine	Chaccour, CJ (corresponding author), Univ Navarra Clin, Div Internal Med & Infect Dis, Avda Pio XII 36, Pamplona, Spain.	cchaccour@unav.es	Chaccour, Carlos/I-4149-2018; Del Pozo, Jose L/Q-4442-2016	Chaccour, Carlos/0000-0001-9812-050X; Del Pozo, Jose L/0000-0002-5402-3334; Mabey, David/0000-0002-0031-8276				[Anonymous], GUID TREATM MAL; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352	5	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2012	380	9847					1120	1120		10.1016/S0140-6736(12)60649-7	http://dx.doi.org/10.1016/S0140-6736(12)60649-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007VL	22998721				2022-12-28	WOS:000308916400033
J	Rosenfeld, JV; Maas, AI; Bragge, P; Morganti-Kossmann, MC; Manley, GT; Gruen, RL				Rosenfeld, Jeffrey V.; Maas, Andrew I.; Bragge, Peter; Morganti-Kossmann, M. Cristina; Manley, Geoffrey T.; Gruen, Russell L.			Early management of severe traumatic brain injury	LANCET			English	Article							EARLY DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; PROGNOSTIC MODELS; CYCLOSPORINE-A; OXYGEN; HYPOTHERMIA; ERYTHROPOIETIN; MULTICENTER; MORTALITY; OUTCOMES	Severe traumatic brain injury remains a major health-care problem worldwide. Although major progress has been made in understanding of the pathophysiology of this injury, this has not yet led to substantial improvements in outcome. In this report, we address present knowledge and its limitations, research innovations, and clinical implications. Improved outcomes for patients with severe traumatic brain injury could result from progress in pharmacological and other treatments, neural repair and regeneration, optimisation of surgical indications and techniques, and combination and individually targeted treatments. Expanded classification of traumatic brain injury and innovations in research design will underpin these advances. We are optimistic that further gains in outcome for patients with severe traumatic brain injury will be achieved in the next decade.	[Rosenfeld, Jeffrey V.] Monash Univ, Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3181, Australia; [Rosenfeld, Jeffrey V.; Bragge, Peter; Morganti-Kossmann, M. Cristina; Gruen, Russell L.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3181, Australia; [Maas, Andrew I.] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I.] Univ Antwerp, Edegem, Belgium; [Manley, Geoffrey T.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; University of Antwerp; University of Antwerp; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Rosenfeld, JV (corresponding author), Alfred Hosp, Dept Surg, Melbourne, Vic 3004, Australia.	j.rosenfeld@alfred.org.au	Rosenfeld, Jeffrey V/B-7249-2011; Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264; Bragge, Peter/0000-0003-0745-5131; Morganti-Kossmann, Cristina/0000-0002-0807-2063	National Health and Medical Research Council Practitioner Fellowship	National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	We thank Ornella Clavisi for leading the searches and selection of studies; Marisa Chau, Emma Donoghue, Loyal Pattuwage and Loretta Piccenna for screening search outputs; Loyal Pattuwage for his assistance with referencing of appendix pp 3-7; and Sarah Aird for copy-editing of the manuscript. RLG is supported by a National Health and Medical Research Council Practitioner Fellowship.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Arikan R, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2008, J NEUROSURG, V109, P421, DOI 10.3171/JNS/2008/109/9/0421; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Christian E, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E9; CLIFTON GL, 2011, OPTN SRTR ANN REP, V10, P131, DOI DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Czeiter E, 2011, ACTA NEUROCHIR, V153, P1882; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; De Deyne CS, 2010, CURR OPIN ANESTHESIO, V23, P258, DOI 10.1097/ACO.0b013e328336ea44; Diaz-Arrastia R, 2012, BRAIN TISSUE OXYGEN; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Edwards P, 2005, LANCET, V365, P1957; Farin A, 2009, NEUROSURGERY, V65, P831, DOI 10.1227/01.NEU.0000351721.81175.0B; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Figaji AA, 2009, CHILD NERV SYST, V25, P1335, DOI 10.1007/s00381-009-0821-y; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020545; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; HARTINGS JA, 2011, OPTN SRTR ANN REP, V10, P1058, DOI DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Hutchinson PJ, 2011, RESCUEICP STUDY RAND; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kaitin KI, 2011, SCI AM, V305, P16, DOI 10.1038/scientificamerican0811-16; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lesko M, 2010, EMERG MED J, V27, pA2; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu J, 2005, ACT NEUR S, V95, P281; Maas A, 2011, LANCET NEUROL, V10, P111, DOI 10.1016/S1474-4422(10)70312-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Mendelow D, 2012, STITCH TRAUMA TRIAL; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; National Institute of Neurological Disorders and Stroke (NINDS), 2012, NINDS COMM DAT EL TR; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rayan N, 2012, J TRAUMA ACUTE CARE, V72, P585, DOI 10.1097/TA.0b013e318243da4d; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Ryynanen OP, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-62; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Simard JM, 2011, NEW ENGL J MED, V365, P374, DOI 10.1056/NEJMc1106421; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Walker PA, 2011, THERAPY, V8, P507; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Wright WL, 2007, J NEUROL SCI, V261, P10, DOI 10.1016/j.jns.2007.04.027; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061	112	306	327	3	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1088	1098		10.1016/S0140-6736(12)60864-2	http://dx.doi.org/10.1016/S0140-6736(12)60864-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007VL	22998718				2022-12-28	WOS:000308916400030
J	Cheng, JK				Cheng, Jennifer K.			Food for Thought	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital	Cheng, JK (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA.	jennifer.cheng@childrens.harvard.edu						American Academy of Pediatrics, PED GUID CHILDR OR H; Le Billon K, 2012, FRENCH KIDS EAT EVER, P320; Maier A, 2007, APPETITE, V49, P429, DOI 10.1016/j.appet.2007.02.007	3	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1101	1102		10.1001/jama.2012.7198	http://dx.doi.org/10.1001/jama.2012.7198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990268				2022-12-28	WOS:000308861000025
J	Pivec, R; Johnson, AJ; Mears, SC; Mont, MA				Pivec, Robert; Johnson, Aaron J.; Mears, Simon C.; Mont, Michael A.			Hip arthroplasty	LANCET			English	Article							FEMORAL-NECK FRACTURES; PERIPROSTHETIC FEMUR FRACTURE; CONCISE FOLLOW-UP; METAL-ION LEVELS; FAST-TRACK HIP; INTERNAL-FIXATION; BIPOLAR HEMIARTHROPLASTY; REVISION HIP; VANCOUVER CLASSIFICATION; INFILTRATION ANALGESIA	Total hip arthroplasty is a cost-effective surgical procedure undertaken to relieve pain and restore function to the arthritic hip joint. More than 1 million arthroplasties are done every year worldwide, and this number is projected to double within the next two decades. Symptomatic osteoarthritis is the indication for surgery in more than 90% of patients, and its incidence is increasing because of an ageing population and the obesity epidemic. Excellent functional outcomes are reported; however, careful patient selection is needed to achieve best possible results. The present economic situation in many developed countries will place increased pressure on containment of costs. Future demand for hip arthroplasty, especially in patients younger than 65 years, emphasises the need for objective outcome measures and joint registries that can track lifetime implant survivorship. New generations of bearing surfaces such as metal-on-metal, ceramic-on-ceramic, and metal-on-ceramic, and techniques such as resurfacing arthroplasty have the potential to improve outcomes and survivorship, but findings from prospective trials are needed to show efficacy. With the recall of some metal-on-metal bearings, new bearing surfaces have to be monitored carefully before they can be assumed to be better than traditional bearings.	[Pivec, Robert; Johnson, Aaron J.; Mont, Michael A.] Sinai Hosp, Rubin Inst Adv Orthoped, Ctr Joint Preservat & Replacement, Baltimore, MD 21215 USA; [Mears, Simon C.] Johns Hopkins Univ, Dept Orthoped Surg, Baltimore, MD USA	Sinai Hospital of Baltimore; Johns Hopkins University	Mont, MA (corresponding author), Sinai Hosp, Rubin Inst Adv Orthoped, Ctr Joint Preservat & Replacement, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.	mmont@lifebridgehealth.org			National Institutes of Health; Stryker; Sage Products; Ongoing Care Solutions; Janssen Pharmaceuticals; Wright Medical; TissueGene	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stryker; Sage Products(General Electric); Ongoing Care Solutions; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Wright Medical; TissueGene	MAM has received research and/or grant support from the National Institutes of Health, Stryker, Sage Products, Ongoing Care Solutions, Janssen Pharmaceuticals, Wright Medical, and TissueGene; is a consultant for Stryker, Sage Products, Janssen Pharmaceuticals, Salient Surgical, Ongoing Care Solutions, and TissueGene; and is on the editorial board of the Journal of Bone and Joint Surgery and American Journal of Orthopedics. SCM is on the editorial board of Journal of Geriatric Orthopaedics and Rehabilitation, Arthritis and Rheumatism. AJJ is a consultant for Sage Products and Ongoing Care Solutions. RP declares that he has no conflicts of interest.	Amstutz HC, 2010, J BONE JOINT SURG AM, V92A, P2663, DOI 10.2106/JBJS.I.01715; Andersen LO, 2011, ACTA ORTHOP, V82, P423, DOI 10.3109/17453674.2011.596063; Berry DJ, 1999, ORTHOP CLIN N AM, V30, P183, DOI 10.1016/S0030-5898(05)70073-0; Berry DJ, 1999, ORTHOPEDICS, V22, P805; Blomfeldt R, 2007, J BONE JOINT SURG BR, V89B, P160, DOI 10.1302/0301-620X.89B2.18576; Bolland BJRF, 2011, J BONE JOINT SURG BR, V93B, P608, DOI 10.1302/0301-620X.93B5.26309; Bottner F, 2005, HSS J, V1, P94, DOI 10.1007/s11420-005-0114-2; Boyer B, 2012, INT ORTHOP, V36, P511, DOI 10.1007/s00264-011-1289-4; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Bozic KJ, 2004, CLIN ORTHOP RELAT R, P18; Brady OH, 2000, J ARTHROPLASTY, V15, P59, DOI 10.1016/S0883-5403(00)91181-1; Braunstein V, 2009, ACTA ORTHOP, V80, P283, DOI 10.3109/17453670902988394; Callaghan JJ, 2009, J BONE JOINT SURG AM, V91A, P2617, DOI 10.2106/JBJS.H.01201; Callanan MC, 2011, CLIN ORTHOP RELAT R, V469, P319, DOI 10.1007/s11999-010-1487-1; Capozzi JD, 2010, J BONE JOINT SURG AM, V92A, P1330, DOI 10.2106/JBJS.I.01410; Caton J, 2011, INT ORTHOP, V35, P185, DOI 10.1007/s00264-010-1197-z; Chen AF, 2012, J ARTHROPLASTY, V27, P851, DOI 10.1016/j.arth.2012.01.011; Clifi B, 2000, J BONE JOINT SURG AM, V82A, P446, DOI 10.2106/00004623-200003000-00019; Crawford RE, 1997, ANN RHEUM DIS, V56, P455, DOI 10.1136/ard.56.8.455; Dale H, 2011, ACTA ORTHOP, V82, P646, DOI 10.3109/17453674.2011.636671; Darwiche H, 2010, CLIN ORTHOP RELAT R, V468, P2392, DOI 10.1007/s11999-010-1325-5; Davda K, 2011, J BONE JOINT SURG BR, V93B, P738, DOI 10.1302/0301-620X.93B6.25804; De Haan R, 2008, J BONE JOINT SURG BR, V90B, P1291, DOI 10.1302/0301-620X.90B10.20533; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; DELEE JG, 1976, CLIN ORTHOP RELAT R, P20; Dowsey MM, 2008, CLIN ORTHOP RELAT R, V466, P153, DOI 10.1007/s11999-007-0016-3; Dreinhofer KE, 2006, ANN RHEUM DIS, V65, P1346, DOI 10.1136/ard.2005.047811; Dreyer NA, 2009, JAMA-J AM MED ASSOC, V302, P790, DOI 10.1001/jama.2009.1092; Ebramzadeh E, 2011, ORTHOP CLIN N AM, V42, P241, DOI 10.1016/j.ocl.2011.01.001; Faraj Adnan A, 2003, Acta Orthop Belg, V69, P518; Freburger JK, 2000, PHYS THER, V80, P448, DOI 10.1093/ptj/80.5.448; FRICKER DC, 1990, BIOMATERIALS, V11, P495, DOI 10.1016/0142-9612(90)90064-W; Gandhi R, 2009, INT ORTHOP, V33, P593, DOI 10.1007/s00264-008-0539-6; Garbuz DS, 2010, CLIN ORTHOP RELAT R, V468, P318, DOI 10.1007/s11999-009-1029-x; Ghera S, 2009, HIP INT, V19, P215, DOI 10.1177/112070000901900305; Gillam MH, 2010, ACTA ORTHOP, V81, P548, DOI 10.3109/17453674.2010.524594; Gioe TJ, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e31812f7879; Gjertsen JE, 2010, J BONE JOINT SURG AM, V92A, P619, DOI 10.2106/JBJS.H.01750; Glyn-Jones S, 2008, J ARTHROPLASTY, V23, P337, DOI 10.1016/j.arth.2006.12.117; Gosvig KK, 2010, J BONE JOINT SURG AM, V92A, P1162, DOI 10.2106/JBJS.H.01674; Graves SE, 2010, ACTA ORTHOP, V81, P8, DOI 10.3109/17453671003667184; GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400; Hartman CW, 2011, J BONE JOINT SURG AM, V93A, P2311, DOI 10.2106/JBJS.9324icl; Havelin L I, 1999, Bull Hosp Jt Dis, V58, P139; Hayter CL, 2011, ORTHOP CLIN N AM, V42, P195, DOI 10.1016/j.ocl.2010.12.006; Hedbeck CJ, 2011, J BONE JOINT SURG AM, V93A, P445, DOI 10.2106/JBJS.J.00474; Hirakawa K, 2004, CLIN ORTHOP RELAT R, P10; Hooper GJ, 2011, J BONE JOINT SURG BR, V93B, P85, DOI 10.1302/0301-620X.93B1.24862; Hopley C, 2010, BMJ-BRIT MED J, V340, pc2332, DOI DOI 10.1136/BMJ.C2332; Hunter DJ, 2009, MED CLIN N AM, V93, P127, DOI [10.1016/j.rdc.2008.05.008, 10.1016/j.mcna.2008.07.009]; Husted H, 2010, ACTA ORTHOP, V81, P599, DOI 10.3109/17453674.2010.525196; Husted H, 2010, ARCH ORTHOP TRAUM SU, V130, P1185, DOI 10.1007/s00402-010-1131-2; Iannotti J P, 1986, J Arthroplasty, V1, P99, DOI 10.1016/S0883-5403(86)80047-X; Ishaque Bernd A, 2011, J Arthroplasty, V26, DOI 10.1016/j.arth.2010.05.021; Jacobs JJ, 2004, J ARTHROPLASTY, V19, P59, DOI 10.1016/j.arth.2004.09.019; Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P2046, DOI 10.1007/s11999-010-1251-6; Jameson SS, 2011, J BONE JOINT SURG BR, V93B, P876, DOI 10.1302/0301-620X.93B7.26657; Johnson AJ, 2011, BULL HOSP JT DIS, V69, pS16; Johnson AJ, 2011, BULL HOSP JT DIS, V69, pS27; Jones RE, 2004, CLIN ORTHOP RELAT R, P142; Keener JD, 2003, J BONE JOINT SURG AM, V85A, P1066, DOI 10.2106/00004623-200306000-00013; Kelley TC, 2009, J BONE JOINT SURG AM, V91A, P153, DOI 10.2106/JBJS.H.01463; Khanuja HS, 2011, J BONE JOINT SURG AM, V93A, P500, DOI 10.2106/JBJS.J.00774; Khatod M, 2006, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000218752.22613.78; Kop AM, 2009, J ARTHROPLASTY, V24, P1019, DOI 10.1016/j.arth.2008.09.009; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Kuzyk PRT, 2011, BULL HOSP JT DIS, V69, pS5; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Larsen K, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-144; Lavernia CJ, 1998, J ARTHROPLASTY, V13, P277, DOI 10.1016/S0883-5403(98)90172-3; Lee KJ, 2009, CLIN ORTHOP SURG, V1, P155, DOI 10.4055/cios.2009.1.3.155; Leenders T, 2002, Comput Aided Surg, V7, P99, DOI 10.1002/igs.10033; Leonardsson O, 2010, J BONE JOINT SURG BR, V92B, P406, DOI 10.1302/0301-620X.92B3.23036; Lewallen DG, 1998, AAOS INSTR COURS LEC, V47, P243; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014; Liebs TR, 2012, ARCH PHYS MED REHAB, V93, P192, DOI 10.1016/j.apmr.2011.09.011; Lindahl H, 2007, BONE, V40, P1294, DOI 10.1016/j.bone.2007.01.003; Lindahl H, 2007, INJURY, V38, P651, DOI 10.1016/j.injury.2007.02.048; Lindahl H, 2006, J BONE JOINT SURG AM, V88A, P1215, DOI 10.2106/JBJS.E.00457; Lindalen E, 2011, ACTA ORTHOP, V82, P639, DOI 10.3109/17453674.2011.623569; Lunn TH, 2011, REGION ANESTH PAIN M, V36, P424, DOI 10.1097/AAP.0b013e3182186866; Macpherson GJ, 2011, ARCH ORTHOP TRAUM SU, V131, P101, DOI 10.1007/s00402-010-1153-9; Malchau H, 1997, J ARTHROPLASTY, V12, P133, DOI 10.1016/S0883-5403(97)90059-0; Malkani AL, 2010, J ARTHROPLASTY, V25, P21, DOI 10.1016/j.arth.2010.04.014; Marino J, 2009, J BONE JOINT SURG AM, V91A, P29, DOI 10.2106/JBJS.H.00079; Mazoochian F, 2009, ARCH ORTHOP TRAUM SU, V129, P1633, DOI 10.1007/s00402-009-0870-4; Medicines and l&midot;&midot;lealthcare products Regulatory Agency, 2010, MDA2010033 MED HEALT; Meneghini RM, 2008, J ARTHROPLASTY, V23, P68, DOI 10.1016/j.arth.2008.05.014; Moojen DJF, 2010, ACTA ORTHOP, V81, P667, DOI 10.3109/17453674.2010.525201; Mumme T, 2005, ARCH ORTHOP TRAUM SU, V125, P322, DOI 10.1007/s00402-005-0810-x; MURRAY DG, 1995, JAMA-J AM MED ASSOC, V273, P1950, DOI 10.1001/jama.1995.03520480070043; National Joint Registry for England and Wales, 2010, 7 NAT JOINT REG ENGL; Nogler M, 2008, ACTA ORTHOP, V79, P789, DOI 10.1080/17453670810016867; Ogawa Hiroyasu, 2011, J Arthroplasty, V26, DOI 10.1016/j.arth.2010.05.012; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027; Ostlere S, 2011, AM J ROENTGENOL, V197, P558, DOI 10.2214/AJR.11.6840; Parratte S, 2007, J BONE JOINT SURG AM, V89A, P494, DOI 10.2106/JBJS.F.00529; Parvizi J, 2006, CLIN ORTHOP RELAT R, P60, DOI 10.1097/01.blo.0000218749.37860.7c; Parvizi J, 2006, CLIN ORTHOP RELAT R, P66, DOI 10.1097/01.blo.0000218751.14989.a6; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P1401, DOI 10.1007/s11999-011-1822-1; Pateder Dhruv B, 2007, Am J Orthop (Belle Mead NJ), V36, P591; Philipson MR, 2005, ANN ROY COLL SURG, V87, P109, DOI 10.1308/1478708051603; Rasquinha VJ, 2003, J ARTHROPLASTY, V18, P86, DOI 10.1016/S0883-5403(03)00300-0; Rayan F, 2008, J BONE JOINT SURG BR, V90B, P1576, DOI 10.1302/0301-620X.90B12.20681; Renkawitz T, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-192; Restrepo C, 2011, CLIN ORTHOP RELAT R, V469, P417, DOI 10.1007/s11999-010-1668-y; Rogmark C, 2003, ACTA ORTHOP SCAND, V74, P293, DOI 10.1080/00016470310014210; Rogmark C, 2002, J BONE JOINT SURG BR, V84B, P183, DOI 10.1302/0301-620X.84B2.11923; Rogmark C, 2006, ACTA ORTHOP, V77, P359, DOI 10.1080/17453670610046262; Rubash Harry E, 2009, J Bone Joint Surg Am, V91 Suppl 5, P17, DOI 10.2106/JBJS.I.00346; Saito N, 2004, J ARTHROPLASTY, V19, P334, DOI 10.1016/j.arth.2003.10.011; Sarvilinna R, 2004, ACTA ORTHOP SCAND, V75, P16, DOI 10.1080/00016470410001708030; Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255; Schmalzried Thomas P, 2009, Orthopedics, V32, DOI 10.3928/01477447-20090728-06; Sikes C Van, 2008, J Arthroplasty, V23, P59, DOI 10.1016/j.arth.2008.06.032; Singelyn FJ, 2005, REGION ANESTH PAIN M, V30, P452, DOI 10.1016/j.rapm.2005.05.008; Singh Jasvinder A, 2011, Open Orthop J, V5, P80, DOI 10.2174/1874325001105010080; SIOPACK JS, 1995, WESTERN J MED, V162, P243; Slover JD, 2008, J BONE JOINT SURG AM, V90A, P1492, DOI 10.2106/JBJS.G.00888; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Smith TO, 2011, INT ORTHOP, V35, P173, DOI 10.1007/s00264-010-1075-8; Smith TO, 2010, ACTA ORTHOP, V81, P684, DOI 10.3109/17453674.2010.533933; Spahn DR, 2010, ANESTHESIOLOGY, V113, P482, DOI 10.1097/ALN.0b013e3181e08e97; Springer BD, 2009, J ARTHROPLASTY, V24, P2, DOI 10.1016/j.arth.2009.04.032; Tanaka Y, 1998, BIO-MED MATER ENG, V8, P187; Tarnowski JR, 2008, ACTA ORTHOP BELG, V74, P125; Teeny SM, 2003, J ARTHROPLASTY, V18, P954, DOI 10.1016/j.arth.2003.09.001; Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023; Unlu E, 2007, CLIN REHABIL, V21, P706, DOI 10.1177/0269215507077302; Urquhart DM, 2010, J ARTHROPLASTY, V25, P1216, DOI 10.1016/j.arth.2009.08.011; Vekeman F, 2012, J MED EC, DOI 10.3111/13696998.2012.669438; Vergara I, 2011, CLIN ORTHOP RELAT R, V469, P1413, DOI 10.1007/s11999-010-1753-2; Waddell James, 2010, Am J Orthop (Belle Mead NJ), V39, P5; Wall SJ, 2008, J ARTHROPLASTY, V23, P55, DOI 10.1016/j.arth.2008.06.010; Zhang YQ, 2008, RHEUM DIS CLIN N AM, V34, P515, DOI 10.1016/j.rdc.2008.05.007; Zoccali C, 2009, INT ORTHOP, V33, P1, DOI 10.1007/s00264-008-0575-2	141	341	365	11	106	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2012	380	9855					1768	1777		10.1016/S0140-6736(12)60607-2	http://dx.doi.org/10.1016/S0140-6736(12)60607-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CV	23021846				2022-12-28	WOS:000311153700034
J	Vassiliou, VS; Flynn, PD				Vassiliou, Vassilis S.; Flynn, Paul D.			Apixaban in atrial fibrillation: does predicted risk matter?	LANCET			English	Editorial Material							WARFARIN		[Vassiliou, Vassilis S.] Cambridge Univ Hlth Partners, Papworth Hosp, Cambridge CB23 8RE, England; [Flynn, Paul D.] Cambridge Univ NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England	Papworth Hospital; Addenbrooke's Hospital; University of Cambridge	Vassiliou, VS (corresponding author), Cambridge Univ Hlth Partners, Papworth Hosp, Cambridge CB23 8RE, England.	vassiliou@doctors.org.uk	Vassiliou, Vass/AAZ-7358-2020	Vassiliou, Vass/0000-0002-4005-7752				Agnelli G, 2009, THROMB RES, V123, P488, DOI 10.1016/j.thromres.2008.02.017; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Lopes RD, 2012, LANCET; Mendelson G, 1998, J AM GERIATR SOC, V46, P1423, DOI 10.1111/j.1532-5415.1998.tb06011.x; Schofield FW, 1922, CAN VET RECORD, V3, P74; Schulman S, 2011, ANN INTERN MED, V155, P653, DOI 10.7326/0003-4819-155-10-201111150-00003; Wieloch M, 2011, EUR HEART J, V32, P2282, DOI 10.1093/eurheartj/ehr134; Wurster MW, 2012, AM J HEMATOL, V87, pS175	9	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2012	380	9855					1718	1720		10.1016/S0140-6736(12)61673-0	http://dx.doi.org/10.1016/S0140-6736(12)61673-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CV	23036897				2022-12-28	WOS:000311153700007
J	de Ligt, J; Willemsen, MH; van Bon, BWM; Kleefstra, T; Yntema, HG; Kroes, T; Vulto-van Silfhout, AT; Koolen, DA; de Vries, P; Gilissen, C; del Rosario, M; Hoischen, A; Scheffer, H; de Vries, BBA; Brunner, HG; Veltman, JA; Vissers, LELM				de Ligt, Joep; Willemsen, Marjolein H.; van Bon, Bregje W. M.; Kleefstra, Tjitske; Yntema, Helger G.; Kroes, Thessa; Vulto-van Silfhout, Anneke T.; Koolen, David A.; de Vries, Petra; Gilissen, Christian; del Rosario, Marisol; Hoischen, Alexander; Scheffer, Hans; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.; Vissers, Lisenka E. L. M.			Diagnostic Exome Sequencing in Persons with Severe Intellectual Disability	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DE-NOVO MUTATIONS; MENTAL-RETARDATION; GENETICS	Background The causes of intellectual disability remain largely unknown because of extensive clinical and genetic heterogeneity. Methods We evaluated patients with intellectual disability to exclude known causes of the disorder. We then sequenced the coding regions of more than 21,000 genes obtained from 100 patients with an IQ below 50 and their unaffected parents. A data-analysis procedure was developed to identify and classify de novo, autosomal recessive, and X-linked mutations. In addition, we used high-throughput resequencing to confirm new candidate genes in 765 persons with intellectual disability (a confirmation series). All mutations were evaluated by molecular geneticists and clinicians in the context of the patients' clinical presentation. Results We identified 79 de novo mutations in 53 of 100 patients. A total of 10 de novo mutations and 3 X-linked (maternally inherited) mutations that had been previously predicted to compromise the function of known intellectual-disability genes were found in 13 patients. Potentially causative de novo mutations in novel candidate genes were detected in 22 patients. Additional de novo mutations in 3 of these candidate genes were identified in patients with similar phenotypes in the confirmation series, providing support for mutations in these genes as the cause of intellectual disability. We detected no causative autosomal recessive inherited mutations in the discovery series. Thus, the total diagnostic yield was 16%, mostly involving de novo mutations. Conclusions De novo mutations represent an important cause of intellectual disability; exome sequencing was used as an effective diagnostic strategy for their detection. (Funded by the European Union and others.)	[de Ligt, Joep; Willemsen, Marjolein H.; van Bon, Bregje W. M.; Kleefstra, Tjitske; Yntema, Helger G.; Kroes, Thessa; Vulto-van Silfhout, Anneke T.; Koolen, David A.; de Vries, Petra; Gilissen, Christian; del Rosario, Marisol; Hoischen, Alexander; Scheffer, Hans; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci,Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci,Inst Genet & Metab Dis, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.veltman@gen.umcn.nl	Brunner, Han/C-9928-2013; Scheffer, Hans/E-4644-2012; Willemsen, Marjolein/G-9491-2013; van Bon, Bregje/D-3720-2013; Gilissen, Christian/E-5246-2012; Vissers, Lisenka ELM/A-2598-2015; Hoischen, Alexander/AGF-7293-2022; Koolen, D.A./L-4448-2015; Willemsen, Marjolein/R-5958-2019; Yntema, H.G./L-4771-2015; Kleefstra, Tjitske/G-2619-2012; Hoischen, Alexander/D-1282-2013; Veltman, Joris A/F-5128-2010; van Bon, Bregje/Q-2445-2015; AT, Vulto-van Silfhout/H-4199-2015	Scheffer, Hans/0000-0002-2986-0915; Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Veltman, Joris A/0000-0002-3218-8250; van Bon, Bregje/0000-0003-2234-0105; Kroes, Thessa/0000-0003-1416-5407; de Ligt, Joep/0000-0002-0348-419X	European Union; consortium Stronger on Your Own Feet; Netherlands Organization for Health Research and Development [ZonMW 907-00-365, 917-86-319, 916-12-095, 917-66-363, 916-86-016]; European Union-funded TECHGENE project [Health-F5-2009-223143]; GEUVADIS project [Health-F7-2010-261123]; European Research Council [DENOVO 281964];  [EU-7th-2010-241995]	European Union(European Commission); consortium Stronger on Your Own Feet; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Union-funded TECHGENE project; GEUVADIS project; European Research Council(European Research Council (ERC)European Commission); 	Funded by the European Union and others.; Supported by grants from the consortium Stronger on Your Own Feet (to Drs. Willemsen and Kleefstra), the Netherlands Organization for Health Research and Development (ZonMW 907-00-365, to Dr. Kleefstra; 917-86-319, to Ms. de Vries; 916-12-095, to Dr. Hoischen; 917-66-363, to Dr. Veltman; and 916-86-016, to Dr. Vissers), the GENCODYS project (EU-7th-2010-241995, to Drs. Vulto-van Silfout and Kleefstra), the European Union-funded TECHGENE project (Health-F5-2009-223143, to Mr. de Ligt and Drs. Brunner, Scheffer, and Veltman), the GEUVADIS project (Health-F7-2010-261123, to Dr. Veltman), and the European Research Council (DENOVO 281964, to Dr. Veltman).	Battaglia A, 2003, AM J MED GENET C, V117C, P3, DOI 10.1002/ajmg.c.10015; Bell J, 2007, PRACTICE GUIDELINES; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Catarino CB, 2011, BRAIN, V134, P2982, DOI 10.1093/brain/awr129; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Hamdan FF, 2011, AM J HUM GENET, V88, P516, DOI 10.1016/j.ajhg.2011.03.011; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hochstenbach R, 2009, EUR J MED GENET, V52, P161, DOI 10.1016/j.ejmg.2009.03.015; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MATSUNAGA E, 1981, AM J MED GENET, V8, P375, DOI 10.1002/ajmg.1320080403; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Moeschler JB, 2006, PEDIATRICS, V117, P2304, DOI 10.1542/peds.2006-1006; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Romano C, 2010, MONOGR HUM GENET, V18, P57; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shea Sarah E, 2006, Semin Pediatr Neurol, V13, P262, DOI 10.1016/j.spen.2006.09.010; Topper S, 2011, CLIN GENET, V80, P117, DOI 10.1111/j.1399-0004.2011.01720.x; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542	30	1068	1146	4	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1921	1929		10.1056/NEJMoa1206524	http://dx.doi.org/10.1056/NEJMoa1206524			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23033978	Bronze			2022-12-28	WOS:000311029300008
J	Yang, J; Loos, RJF; Powell, JE; Medland, SE; Speliotes, EK; Chasman, DI; Rose, LM; Thorleifsson, G; Steinthorsdottir, V; Maegi, R; Waite, L; Smith, AV; Yerges-Armstrong, LM; Monda, KL; Hadley, D; Mahajan, A; Li, G; Kapur, K; Vitart, V; Huffman, JE; Wang, SR; Palmer, C; Esko, T; Fischer, K; Zhao, JH; Demirkan, A; Isaacs, A; Feitosa, MF; Luan, J; Heard-Costa, NL; White, C; Jackson, AU; Preuss, M; Ziegler, A; Eriksson, J; Kutalik, Z; Frau, F; Nolte, IM; Van Vliet-Ostaptchouk, JV; Hottenga, JJ; Jacobs, KB; Verweij, N; Goel, A; Medina-Gomez, C; Estrada, K; Bragg-Gresham, JL; Sanna, S; Sidore, C; Tyrer, J; Teumer, A; Prokopenko, I; Mangino, M; Lindgren, CM; Assimes, TL; Shuldiner, AR; Hui, J; Beilby, JP; McArdle, WL; Hall, P; Haritunians, T; Zgaga, L; Kolcic, I; Polasek, O; Zemunik, T; Oostra, BA; Junttila, MJ; Groenberg, H; Schreiber, S; Peters, A; Hicks, AA; Stephens, J; Foad, NS; Laitinen, J; Pouta, A; Kaakinen, M; Willemsen, G; Vink, JM; Wild, SH; Navis, G; Asselbergs, FW; Homuth, G; John, U; Iribarren, C; Harris, T; Launer, L; Gudnason, V; O'Connell, JR; Boerwinkle, E; Cadby, G; Palmer, LJ; James, AL; Musk, AW; Ingelsson, E; Psaty, BM; Beckmann, JS; Waeber, G; Vollenweider, P; Hayward, C; Wright, AF; Rudan, I; Groop, LC; Metspalu, A; Khaw, KT; van Duijn, CM; Borecki, IB; Province, MA; Wareham, NJ; Tardif, JC; Huikuri, HV; Cupples, LA; Atwood, LD; Fox, CS; Boehnke, M; Collins, FS; Mohlke, KL; Erdmann, J; Schunkert, H; Hengstenberg, C; Stark, K; Lorentzon, M; Ohlsson, C; Cusi, D; Staessen, JA; Van der Klauw, MM; Pramstaller, PP; Kathiresan, S; Jolley, JD; Ripatti, S; Jarvelin, MR; de Geus, EJC; Boomsma, DI; Penninx, B; Wilson, JF; Campbell, H; Chanock, SJ; van der Harst, P; Hamsten, A; Watkins, H; Hofman, A; Witteman, JC; Zillikens, MC; Uitterlinden, AG; Rivadeneira, F; Zillikens, MC; Kiemeney, LA; Vermeulen, SH; Abecasis, GR; Schlessinger, D; Schipf, S; Stumvoll, M; Toenjes, A; Spector, TD; North, KE; Lettre, G; McCarthy, MI; Berndt, SI; Heath, AC; Madden, PAF; Nyholt, DR; Montgomery, GW; Martin, NG; McKnight, B; Strachan, DP; Hill, WG; Snieder, H; Ridker, PM; Thorsteinsdottir, U; Stefansson, K; Frayling, TM; Hirschhorn, JN; Goddard, ME; Visscher, PM				Yang, Jian; Loos, Ruth J. F.; Powell, Joseph E.; Medland, Sarah E.; Speliotes, Elizabeth K.; Chasman, Daniel I.; Rose, Lynda M.; Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Maegi, Reedik; Waite, Lindsay; Smith, Albert Vernon; Yerges-Armstrong, Laura M.; Monda, Keri L.; Hadley, David; Mahajan, Anubha; Li, Guo; Kapur, Karen; Vitart, Veronique; Huffman, Jennifer E.; Wang, Sophie R.; Palmer, Cameron; Esko, Toenu; Fischer, Krista; Zhao, Jing Hua; Demirkan, Ayse; Isaacs, Aaron; Feitosa, Mary F.; Luan, Jian'an; Heard-Costa, Nancy L.; White, Charles; Jackson, Anne U.; Preuss, Michael; Ziegler, Andreas; Eriksson, Joel; Kutalik, Zoltan; Frau, Francesca; Nolte, Ilja M.; Van Vliet-Ostaptchouk, Jana V.; Hottenga, Jouke-Jan; Jacobs, Kevin B.; Verweij, Niek; Goel, Anuj; Medina-Gomez, Carolina; Estrada, Karol; Bragg-Gresham, Jennifer Lynn; Sanna, Serena; Sidore, Carlo; Tyrer, Jonathan; Teumer, Alexander; Prokopenko, Inga; Mangino, Massimo; Lindgren, Cecilia M.; Assimes, Themistocles L.; Shuldiner, Alan R.; Hui, Jennie; Beilby, John P.; McArdle, Wendy L.; Hall, Per; Haritunians, Talin; Zgaga, Lina; Kolcic, Ivana; Polasek, Ozren; Zemunik, Tatijana; Oostra, Ben A.; Junttila, M. Juhani; Groenberg, Henrik; Schreiber, Stefan; Peters, Annette; Hicks, Andrew A.; Stephens, Jonathan; Foad, Nicola S.; Laitinen, Jaana; Pouta, Anneli; Kaakinen, Marika; Willemsen, Gonneke; Vink, Jacqueline M.; Wild, Sarah H.; Navis, Gerjan; Asselbergs, Folkert W.; Homuth, Georg; John, Ulrich; Iribarren, Carlos; Harris, Tamara; Launer, Lenore; Gudnason, Vilmundur; O'Connell, Jeffrey R.; Boerwinkle, Eric; Cadby, Gemma; Palmer, Lyle J.; James, Alan L.; Musk, Arthur W.; Ingelsson, Erik; Psaty, Bruce M.; Beckmann, Jacques S.; Waeber, Gerard; Vollenweider, Peter; Hayward, Caroline; Wright, Alan F.; Rudan, Igor; Groop, Leif C.; Metspalu, Andres; Khaw, Kay Tee; van Duijn, Cornelia M.; Borecki, Ingrid B.; Province, Michael A.; Wareham, Nicholas J.; Tardif, Jean-Claude; Huikuri, Heikki V.; Cupples, L. Adrienne; Atwood, Larry D.; Fox, Caroline S.; Boehnke, Michael; Collins, Francis S.; Mohlke, Karen L.; Erdmann, Jeanette; Schunkert, Heribert; Hengstenberg, Christian; Stark, Klaus; Lorentzon, Mattias; Ohlsson, Claes; Cusi, Daniele; Staessen, Jan A.; Van der Klauw, Melanie M.; Pramstaller, Peter P.; Kathiresan, Sekar; Jolley, Jennifer D.; Ripatti, Samuli; Jarvelin, Marjo-Riitta; de Geus, Eco J. C.; Boomsma, Dorret I.; Penninx, Brenda; Wilson, James F.; Campbell, Harry; Chanock, Stephen J.; van der Harst, Pim; Hamsten, Anders; Watkins, Hugh; Hofman, Albert; Witteman, Jacqueline C.; Zillikens, M. Carola; Uitterlinden, Andre G.; Rivadeneira, Fernando; Zillikens, M. Carola; Kiemeney, Lambertus A.; Vermeulen, Sita H.; Abecasis, Goncalo R.; Schlessinger, David; Schipf, Sabine; Stumvoll, Michael; Toenjes, Anke; Spector, Tim D.; North, Kari E.; Lettre, Guillaume; McCarthy, Mark I.; Berndt, Sonja I.; Heath, Andrew C.; Madden, Pamela A. F.; Nyholt, Dale R.; Montgomery, Grant W.; Martin, Nicholas G.; McKnight, Barbara; Strachan, David P.; Hill, William G.; Snieder, Harold; Ridker, Paul M.; Thorsteinsdottir, Unnur; Stefansson, Kari; Frayling, Timothy M.; Hirschhorn, Joel N.; Goddard, Michael E.; Visscher, Peter M.			FTO genotype is associated with phenotypic variability of body mass index	NATURE			English	Article							GENOME-WIDE ASSOCIATION; ENVIRONMENTAL SENSITIVITY; PHYSICAL-ACTIVITY; GENETIC-VARIATION; ADULT OBESITY; LOCI; VARIANTS; CHILDHOOD; SELECTION; TRAITS	There is evidence across several species for genetic control of phenotypic variation of complex traits(1-4), such that the variance among phenotypes is genotype dependent. Understanding genetic control of variability is important in evolutionary biology, agricultural selection programmes and human medicine, yet for complex traits, no individual genetic variants associated with variance, as opposed to the mean, have been identified. Here we perform a meta-analysis of genome-wide association studies of phenotypic variation using similar to 170,000 samples on height and body mass index (BMI) in human populations. We report evidence that the single nucleotide polymorphism (SNP) rs7202116 at the FTO gene locus, which is known to be associated with obesity (as measured by mean BMI for each rs7202116 genotype)(5-7), is also associated with phenotypic variability. We show that the results are not due to scale effects or other artefacts, and find no other experiment-wise significant evidence for effects on variability, either at loci other than FTO for BMI or at any locus for height. The difference in variance for BMI among individuals with opposite homozygous genotypes at the FTO locus is approximately 7%, corresponding to a difference of similar to 0.5 kilograms in the standard deviation of weight. Our results indicate that genetic variants can be discovered that are associated with variability, and that between-person variability in obesity can partly be explained by the genotype at the FTO locus. The results are consistent with reported FTO by environment interactions for BMI8, possibly mediated by DNA methylation(9,10). Our BMI results for other SNPs and our height results for all SNPs suggest that most genetic variants, including those that influence mean height or mean BMI, are not associated with phenotypic variance, or that their effects on variability are too small to detect even with samples sizes greater than 100,000.	[Yang, Jian; Powell, Joseph E.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Yang, Jian; Powell, Joseph E.; Medland, Sarah E.; Nyholt, Dale R.; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Loos, Ruth J. F.; Zhao, Jing Hua; Luan, Jian'an; Wareham, Nicholas J.] Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Loos, Ruth J. F.] Mt Sinai Sch Med, New York, NY 10029 USA; [Speliotes, Elizabeth K.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Speliotes, Elizabeth K.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Chasman, Daniel I.; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Chasman, Daniel I.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur] deCODE Genet, IS-101 Reykjavik, Iceland; [Maegi, Reedik; Esko, Toenu; Fischer, Krista; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50410 Tartu, Estonia; [Maegi, Reedik; Mahajan, Anubha; Lindgren, Cecilia M.; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Waite, Lindsay; Frayling, Timothy M.] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert Vernon] Univ Iceland, IS-101 Reykjavik, Iceland; [Yerges-Armstrong, Laura M.; O'Connell, Jeffrey R.] Univ Maryland, Dept Med, Sch Med, Baltimore, MD 21201 USA; [Monda, Keri L.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Hadley, David; Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England; [Li, Guo] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Kapur, Karen; Kutalik, Zoltan; Jacobs, Kevin B.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Kapur, Karen; Kutalik, Zoltan; Jacobs, Kevin B.] Swiss Inst Bioinformat, CH-1005 Lausanne, Switzerland; [Vitart, Veronique; Huffman, Jennifer E.; Hayward, Caroline; Wright, Alan F.] Univ Edinburgh, MRC HGU, MRC IGMM, Edinburgh EH8 9AG, Midlothian, Scotland; [Wang, Sophie R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wang, Sophie R.; Palmer, Cameron] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Wang, Sophie R.; Palmer, Cameron] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Wang, Sophie R.; Palmer, Cameron] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Wang, Sophie R.; Palmer, Cameron; Hirschhorn, Joel N.] Broad Inst, Metab Initiat, Cambridge, MA 02142 USA; [Wang, Sophie R.; Palmer, Cameron; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Demirkan, Ayse; Isaacs, Aaron; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Subdiv Genet Epidemiol, Rotterdam, Netherlands; [Feitosa, Mary F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Preuss, Michael] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Preuss, Michael; Ziegler, Andreas; Van Vliet-Ostaptchouk, Jana V.] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23562 Lubeck, Germany; [Eriksson, Joel; Hottenga, Jouke-Jan; Lorentzon, Mattias; Ohlsson, Claes] Univ Gothenburg, Ctr Bone & Arthrit Res, Inst Med, Sahlgrenska Acad, S-41345 Gothenburg, Sweden; [Frau, Francesca; Verweij, Niek; Cusi, Daniele] Univ Milan, Dept Hlth Sci, I-20133 Milan, Italy; [Nolte, Ilja M.; Goel, Anuj; Snieder, Harold] Univ Groningen, Unit Genet Epidemiol & Bioinformat, Dept Epidemiol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Medina-Gomez, Carolina; Van der Klauw, Melanie M.] Univ Groningen, Dept Endocrinol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Medina-Gomez, Carolina] Univ Groningen, LifeLines Cohort Study, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Estrada, Karol; Kaakinen, Marika; Willemsen, Gonneke; Vink, Jacqueline M.; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Bragg-Gresham, Jennifer Lynn] SAIC Frederick Inc, Core Genotyping Facil, NCI Frederick, Frederick, MD 21702 USA; [van der Harst, Pim] Univ Groningen, Dept Cardiol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Zillikens, M. Carola] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Hofman, Albert; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Witteman, Jacqueline C.; Rivadeneira, Fernando] Netherlands Consortiumfor Healthy Aging, Netherlands Genom Initiat, NL-2300 RC Leiden, Netherlands; [Sanna, Serena; Abecasis, Goncalo R.] Univ Michigan, Biostat Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sidore, Carlo] CNR, Ist Ric Genet & Biomed, I-09042 Monserrato, Italy; [Sidore, Carlo] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Tyrer, Jonathan] Univ Cambridge, Dept Oncol, Cambridge CB1 8RN, England; [Teumer, Alexander; Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Prokopenko, Inga] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7BN, England; [Mangino, Massimo; Toenjes, Anke] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Hui, Jennie; Beilby, John P.] Univ Western Australia, PathWest Lab Med WA, Nedlands, WA 6009, Australia; [Hui, Jennie] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [McArdle, Wendy L.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Hall, Per; Groenberg, Henrik; Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Haritunians, Talin] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; [Zgaga, Lina; Wild, Sarah H.; Rudan, Igor; Wilson, James F.; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Kolcic, Ivana; Polasek, Ozren; Zemunik, Tatijana] Univ Split, Fac Med, Split 21000, Croatia; [Junttila, M. Juhani; Huikuri, Heikki V.] Univ Oulu, Dept Internal Med, Inst Clin Med, Oulu 90014, Finland; [Peters, Annette] Univ Kiel, Inst Klin Mol Biol, D-24098 Kiel, Germany; [Peters, Annette] Munich Heart Alliance, D-80802 Munich, Germany; [Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, I-39100 Bolzano, Italy; [Stephens, Jonathan] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Stephens, Jonathan; Jolley, Jennifer D.] NHS Blood & Transplant, Cambridge CB2 0PT, England; [Foad, Nicola S.] Finnish Inst Occupat Hlth, Oulu 90220, Finland; [Laitinen, Jaana] Natl Inst Hlth & Welf, Oulu 90101, Finland; [Laitinen, Jaana] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu 90014, Finland; [Pouta, Anneli] Univ Oulu, Inst Hlth Sci, Bioctr, Oulu 90014, Finland; [Navis, Gerjan] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, NL-3508 GA Utrecht, Netherlands; [John, Ulrich] Univ Med Greifswald, Inst Epidemiol & Social Med, D-17475 Greifswald, Germany; [Iribarren, Carlos] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Harris, Tamara; Launer, Lenore] NIA, NIH, Bethesda, MD 20892 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Houston, TX 77030 USA; [Cadby, Gemma; Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [James, Alan L.; Musk, Arthur W.] Univ Western Australia, Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Beckmann, Jacques S.] CHUV Univ Hosp, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] Univ Lausanne Hosp, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Groop, Leif C.] Lund Univ, Ctr Diabet, Dept Clin Sci, S-20502 Malmo, Sweden; [Khaw, Kay Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Borecki, Ingrid B.; Province, Michael A.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Tardif, Jean-Claude] Univ Montreal, Dept Med, Montreal, PQ H4J 1C5, Canada; [Tardif, Jean-Claude; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Fox, Caroline S.] Boston Univ, Framingham, MA 01702 USA; [Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, Deutsch Zentrum Herz Kreislauf Forsch DZHK, D-23562 Lubeck, Germany; [Hengstenberg, Christian; Stark, Klaus] Klin & Poliklin Innere Med II, D-93053 Regensburg, Germany; [Staessen, Jan A.] Katholieke Univ Leuven, Dept Cardiovasc Dis, B-3000 Louvain, Belgium; [Cupples, L. Adrienne; Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; [Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Ctr Biomed, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23562 Lubeck, Germany; [Kathiresan, Sekar] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kathiresan, Sekar] MIT, Cambridge, MA 02142 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland, FIMM, FIN-00014 Helsinki, Finland; [Ripatti, Samuli] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki 00271, Finland; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Penninx, Brenda] Univ Groningen, Dept Psychiat, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands; [Chanock, Stephen J.; Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20852 USA; [Hamsten, Anders] Karolinska Inst, S-17177 Stockholm, Sweden; [Hamsten, Anders] Dept Med, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden; [Kiemeney, Lambertus A.; Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Schlessinger, David] NIA, NIH, Bethesda, MD 20892 USA; [Schipf, Sabine] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Stumvoll, Michael] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Stumvoll, Michael] Univ Leipzig, IFB Adipos Dis, D-04103 Leipzig, Germany; [Spector, Tim D.; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Spector, Tim D.; North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27514 USA; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7LJ, England; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [McKnight, Barbara] Washington Univ, Dept Biostat, St Louis, MO 63110 USA; [Hill, William G.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Frayling, Timothy M.] Univ Exeter, Inst Biomed & Clin Sci, Peninsula Med Sch, Exeter EX1 2LU, Devon, England; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Melbourne, Vic 3010, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic 3083, Australia; [Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Cambridge; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Tartu; University of Oxford; Wellcome Centre for Human Genetics; Icelandic Heart Association; University of Iceland; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of London; University of Washington; University of Washington Seattle; University of Lausanne; Swiss Institute of Bioinformatics; University of Edinburgh; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Erasmus University Rotterdam; Erasmus MC; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Lubeck; University of Gothenburg; University of Milan; University of Groningen; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; University of Cambridge; Greifswald Medical School; University of Oxford; University of London; King's College London; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Western Australia; University of Western Australia; University of Bristol; Karolinska Institutet; Cedars Sinai Medical Center; University of Edinburgh; University of Zagreb; University of Split; University of Oulu; University of Kiel; Munich Heart Alliance; European Academy of Bozen-Bolzano; University of Cambridge; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Groningen; Utrecht University; Utrecht University Medical Center; Greifswald Medical School; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Texas System; University of Texas Health Science Center Houston; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Western Australia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Lund University; University of Cambridge; Washington University (WUSTL); Universite de Montreal; Universite de Montreal; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of North Carolina; University of North Carolina Chapel Hill; German Centre for Cardiovascular Research; University of Lubeck; KU Leuven; Maastricht University; European Academy of Bozen-Bolzano; Krankenhaus Bozen; University of Lubeck; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Helsinki; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; Imperial College London; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Greifswald Medical School; Leipzig University; Leipzig University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford; Washington University (WUSTL); Washington University (WUSTL); University of Edinburgh; University of Iceland; University of Exeter; University of Melbourne; University of Queensland	Yang, J (corresponding author), Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.		Staessen, Jan A/A-1065-2011; Powell, Joseph/G-3027-2014; Palmer, Lyle John/N-1948-2019; de Geus, Eco J.C./M-9318-2015; Erdmann, Jeanette/A-4417-2009; Boomsma, Dorret I/AAX-4470-2020; Berndt, Sonja I/J-8423-2016; Stark, Klaus/L-7367-2013; Hengstenberg, Christian/U-5485-2019; Peters, Annette/A-6117-2011; Khaw, Kay-Tee/AAZ-3209-2021; Prokopenko, Inga/AAU-9895-2020; Polasek, Ozren/B-6002-2011; Colaus, PsyColaus/K-6607-2013; Hui, Jennie/A-9543-2013; Smith, Albert Vernon/K-5150-2015; Wilson, James F/A-5704-2009; Verweij, Niek/A-4499-2017; sanna, serena/H-3009-2019; van der Klauw, M. M./A-2138-2014; Stefansson, Kari/AAE-7187-2019; Zemunik, Tatijana/D-8584-2017; Visscher, Peter/ABB-6151-2020; Medland, Sarah E/C-7630-2013; Gudnason, Vilmundur/K-6885-2015; Mägi, Reedik/AAJ-9679-2021; Prokopenko, Inga/H-3241-2014; Montgomery, Grant W/B-7148-2008; Sidore, Carlo/AAV-7967-2020; Kiemeney, Lambertus A./D-3357-2009; Hicks, Andrew Anthony/E-9518-2017; Nyholt, Dale Robert/J-3174-2017; Ripatti, Samuli/H-9446-2014; Lorentzon, Mattias/W-7878-2019; Mangino, Massimo/F-5134-2011; Campbell, Harry/E-2959-2010; Erdmann, Jeanette/P-7513-2014; Teumer, Alexander/S-7438-2019; DEMIRKAN, AYSE/G-9313-2016; Stumvoll, Michael/ABE-1121-2021; Feitosa, Mary F/K-8044-2012; Vermeulen, Sita H./L-4716-2015; Gudnason, Vilmundur/AAE-7126-2019; Medland, Sarah/AAT-7595-2020; Assimes, Themistocles Leonard/D-9696-2015; Zgaga, Lina/Q-9415-2018; Pramstaller, Peter P/C-2357-2008; Cadby, Gemma/AAE-3849-2022; Beckmann, Jacques S/A-9772-2008; Hayward, Caroline/M-8818-2016; Verweij, Niek/ABC-6249-2021; Abecasis, Goncalo R/B-7840-2010; Medina-Gomez, Carolina/I-1725-2019; Kolcic, Ivana/E-2713-2017; Asselbergs, Folkert W./ABD-6752-2021; Ohlsson, Claes/AGP-3544-2022; Ohlsson, Claes/HIR-6959-2022; Yang, Jian/A-5852-2010; Loos, Ruth J F/Q-2862-2016; Martin, Nicholas/R-9235-2019; Loos, Ruth/GON-5877-2022; Rudan, Igor/I-1467-2012; Kutalik, Zoltan/HHZ-5697-2022; Rivadeneira, Fernando/O-5385-2015; Palmer, Lyle John/K-3196-2014; Penninx, Brenda WJH/S-7627-2017; McCarthy, Mark/M-3763-2015; Ziegler, Andreas/G-4246-2012	Staessen, Jan A/0000-0002-3026-1637; Powell, Joseph/0000-0001-9031-6356; Palmer, Lyle John/0000-0002-1628-3055; de Geus, Eco J.C./0000-0001-6022-2666; Stark, Klaus/0000-0002-7832-1942; Peters, Annette/0000-0001-6645-0985; Polasek, Ozren/0000-0002-5765-1862; Hui, Jennie/0000-0002-1653-2496; Smith, Albert Vernon/0000-0003-1942-5845; Wilson, James F/0000-0001-5751-9178; sanna, serena/0000-0002-3768-1749; van der Klauw, M. M./0000-0001-7178-009X; Zemunik, Tatijana/0000-0001-8120-2891; Visscher, Peter/0000-0002-2143-8760; Medland, Sarah E/0000-0003-1382-380X; Gudnason, Vilmundur/0000-0001-5696-0084; Prokopenko, Inga/0000-0003-1624-7457; Montgomery, Grant W/0000-0002-4140-8139; Sidore, Carlo/0000-0001-7504-7477; Kiemeney, Lambertus A./0000-0002-2368-1326; Hicks, Andrew Anthony/0000-0001-6320-0411; Nyholt, Dale Robert/0000-0001-7159-3040; Ripatti, Samuli/0000-0002-0504-1202; Lorentzon, Mattias/0000-0003-0749-1431; Mangino, Massimo/0000-0002-2167-7470; Campbell, Harry/0000-0002-6169-6262; Erdmann, Jeanette/0000-0002-4486-6231; Teumer, Alexander/0000-0002-8309-094X; Stumvoll, Michael/0000-0001-6225-8240; Feitosa, Mary F/0000-0002-0933-2410; Vermeulen, Sita H./0000-0003-4913-8601; Gudnason, Vilmundur/0000-0001-5696-0084; Medland, Sarah/0000-0003-1382-380X; Assimes, Themistocles Leonard/0000-0003-2349-0009; Zgaga, Lina/0000-0003-4089-9703; Beckmann, Jacques S/0000-0002-9741-1900; Hayward, Caroline/0000-0002-9405-9550; Verweij, Niek/0000-0002-4303-7685; Medina-Gomez, Carolina/0000-0001-7999-5538; Kolcic, Ivana/0000-0001-7918-6052; Asselbergs, Folkert W./0000-0002-1692-8669; Ohlsson, Claes/0000-0002-9633-2805; Ohlsson, Claes/0000-0002-9633-2805; Yang, Jian/0000-0003-2001-2474; Loos, Ruth J F/0000-0002-8532-5087; Martin, Nicholas/0000-0003-4069-8020; Rudan, Igor/0000-0001-6993-6884; Kutalik, Zoltan/0000-0001-8285-7523; Rivadeneira, Fernando/0000-0001-9435-9441; Palmer, Lyle John/0000-0002-1628-3055; Penninx, Brenda WJH/0000-0001-7779-9672; Goel, Anuj/0000-0003-2307-4021; Lindgren, Cecilia/0000-0002-4903-9374; Kaakinen, Marika/0000-0002-9228-0462; Waeber, Gerard/0000-0003-4193-788X; Jones, Lindsay/0000-0002-4219-8356; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; John, Ulrich/0000-0003-0587-5298; Demirkan, Ayse/0000-0002-7546-0867; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Jacobs, Kevin/0000-0002-4657-6473; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Pramstaller, Peter P/0000-0002-9831-8302; Esko, Tonu/0000-0003-1982-6569; Mahajan, Anubha/0000-0001-5585-3420; Van Duijn, Cornelia/0000-0002-2374-9204; Shuldiner, Alan/0000-0001-9921-4305; Magi, Reedik/0000-0002-2964-6011; Abecasis, Goncalo/0000-0003-1509-1825; Cupples, L. Adrienne/0000-0003-0273-7965; McCarthy, Mark/0000-0002-4393-0510; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Heard-Costa, Nancy/0000-0001-9730-0306; Wang, Sophie Ran/0000-0002-7897-8389; Watkins, Hugh/0000-0002-5287-9016; Ziegler, Andreas/0000-0002-8386-5397; Willemsen, Gonneke/0000-0003-3755-0236; Goddard, Michael/0000-0001-9917-7946; Beilby, John/0000-0002-4915-2254; Preuss, Michael/0000-0001-5266-8465	Australian National Health and Medical Research Council (NHMRC) [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672, 613601, 1011506]; US National Institutes of Health [AA07535, AA10248, AA014041, AA13320, AA13321, AA13326, DA12854, GM057091]; Australian Research Council (ARC) [DP1093502]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195, N01HC045133, N01HC015103, N01HC075150, N01HC085079, N01HC035129, N01HC055222] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176, U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679, R01HL087676, R01HL075366, R01HL080295, U01HL084756, U01HL084729, R01HL087647, R01HL043851, R01HL105756, R01HL086694, R01HL064278, R01HL087652, U01HL054527, R01HL059367, U01HL072515, R01HL087641, U01HL069757] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651, ZIAHG000024, N01HG065403, U01HG006513, U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR059469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK073490, P30DK072488, R01DK075787, U01DK062418, K23DK080145, R01DK072193, P30DK020572, R01DK075681, F32DK079466, R01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629, ZIAAG000675, R01AG015928, N01AG012100, R01AG020098, R01AG027058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, K05AA017688, R01AA007535, R01AA013321, R01AA013326, R01AA014041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0801056B, MC_PC_U127561128, G0601261, MC_U106179471, G1000143, MC_U127561128, G0401527] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; MRC [G0601261, MC_PC_U127561128, MC_U127561128] Funding Source: UKRI	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC)(Australian Research Council); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge funding from the Australian National Health and Medical Research Council (NHMRC grants 241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672, 613601 and 1011506), the US National Institutes of Health (grants AA07535, AA10248, AA014041, AA13320, AA13321, AA13326, DA12854 and GM057091) and the Australian Research Council (ARC grant DP1093502). A detailed list of acknowledgements by study is provided in the Supplementary Information. We apologize to authors whose work we could not cite owing to space restrictions.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Almen MS, 2012, GENOMICS, V99, P132, DOI 10.1016/j.ygeno.2011.12.007; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hill WG, 2010, GENET RES, V92, P381, DOI 10.1017/S0016672310000546; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jimenez-Gomez JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002295; JINKS JL, 1973, HEREDITY, V30, P33, DOI 10.1038/hdy.1973.4; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MARTIN NG, 1983, CLIN GENET, V24, P1; Ordas B, 2008, GENET RES, V90, P385, DOI 10.1017/S0016672308009762; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Ronnegard L, 2011, GENETICS, V188, P435, DOI 10.1534/genetics.111.127068; Ros M, 2004, GENETICS, V168, P2089, DOI 10.1534/genetics.104.032672; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Silventoinen K, 2009, AM J CLIN NUTR, V90, P1096, DOI 10.3945/ajcn.2009.27689; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Struchalin MV, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-92; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Visscher PM, 2010, BEHAV GENET, V40, P728, DOI 10.1007/s10519-010-9362-0; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028764; Wolc A, 2009, POULTRY SCI, V88, P1156, DOI 10.3382/ps.2008-00547; Yang Y, 2011, GENET RES, V93, P125, DOI 10.1017/S0016672311000012	36	277	291	1	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					267	+		10.1038/nature11401	http://dx.doi.org/10.1038/nature11401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22982992	Green Published, Green Accepted			2022-12-28	WOS:000309733300051
J	Petersen, LR; Fischer, M				Petersen, Lyle R.; Fischer, Marc			Unpredictable and Difficult to Control - The Adolescence of West Nile Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Petersen, Lyle R.; Fischer, Marc] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA	Petersen, LR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.							[Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P529; Carney RM, 2008, EMERG INFECT DIS, V14, P747, DOI 10.3201/eid1405.071347; Duprey Z, 2008, J AM MOSQUITO CONTR, V24, P42, DOI 10.2987/5559.1; Petersen LR, 2012, EPIDEMIOL I IN PRESS; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419	5	38	38	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1281	1284		10.1056/NEJMp1210537	http://dx.doi.org/10.1056/NEJMp1210537			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23013055				2022-12-28	WOS:000309406100003
J	Heath, I				Heath, Iona			The problem of diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk						Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Scheper-Hughes N, 2004, ANN NY ACAD SCI, V1036, P13, DOI 10.1196/annals.1330.002; Ulvestad Elling, 2012, Methods Mol Biol, V934, P21, DOI 10.1007/978-1-62703-071-7_2	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	2012	345								e6595	10.1136/bmj.e6595	http://dx.doi.org/10.1136/bmj.e6595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KZ	23034847				2022-12-28	WOS:000309660600014
J	Maher, J				Maher, Julie			Lack of Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Tufts Med Ctr, Boston, MA USA	Tufts Medical Center	Maher, J (corresponding author), Tufts Med Ctr, Boston, MA USA.							Cohen JG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.019	1	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1331	1332		10.1001/2012.jama.12096	http://dx.doi.org/10.1001/2012.jama.12096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032548				2022-12-28	WOS:000309369300026
J	Murdoch, DR; Slow, S; Chambers, ST; Jennings, LC; Stewart, AW; Priest, PC; Florkowski, CM; Livesey, JH; Camargo, CA; Scragg, R				Murdoch, David R.; Slow, Sandy; Chambers, Stephen T.; Jennings, Lance C.; Stewart, Alistair W.; Priest, Patricia C.; Florkowski, Christopher M.; Livesey, John H.; Camargo, Carlos A., Jr.; Scragg, Robert			Effect of Vitamin D-3 Supplementation on Upper Respiratory Tract Infections in Healthy Adults The VIDARIS Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							YOUNG FINNISH MEN; SYMPTOM SURVEY; COMMUNITY; CHOLECALCIFEROL; TUBERCULOSIS; ASSOCIATION; PREVENTION; PNEUMONIA; FRACTURES; DISEASE	Context Observational studies have reported an inverse association between serum 25-hydroxyvitamin D (25-OHD) levels and incidence of upper respiratory tract infections (URTIs). However, results of clinical trials of vitamin D supplementation have been inconclusive. Objective To determine the effect of vitamin D supplementation on incidence and severity of URTIs in healthy adults. Design, Setting, and Participants Randomized, double-blind, placebo-controlled trial conducted among 322 healthy adults between February 2010 and November 2011 in Christchurch, New Zealand. Intervention Participants were randomly assigned to receive an initial dose of 200 000 IU oral vitamin D-3, then 200 000 IU 1 month later, then 100 000 IU monthly (n = 161), or placebo administered in an identical dosing regimen (n = 161), for a total of 18 months. Main Outcome Measures The primary end point was number of URTI episodes. Secondary end points were duration of URTI episodes, severity of URTI episodes, and number of days of missed work due to URTI episodes. Results The mean baseline 25-OHD level of participants was 29 (SD, 9) ng/mL. Vitamin D supplementation resulted in an increase in serum 25-OHD levels that was maintained at greater than 48 ng/mL throughout the study. There were 593 URTI episodes in the vitamin D group and 611 in the placebo group, with no statistically significant differences in the number of URTIs per participant (mean, 3.7 per person in the vitamin D group and 3.8 per person in the placebo group; risk ratio, 0.97; 95% CI, 0.85-1.11), number of days of missed work as a result of URTIs (mean, 0.76 days in each group; risk ratio, 1.03; 95% CI, 0.81-1.30), duration of symptoms per episode (mean, 12 days in each group; risk ratio, 0.96; 95% CI, 0.73-1.25), or severity of URTI episodes. These findings remained unchanged when the analysis was repeated by season and by baseline 25-OHD levels. Conclusion In this trial, monthly administration of 100 000 IU of vitamin D did not reduce the incidence or severity of URTIs in healthy adults.	[Murdoch, David R.; Slow, Sandy; Chambers, Stephen T.; Jennings, Lance C.; Florkowski, Christopher M.] Univ Otago, Dept Pathol, Christchurch 8011, New Zealand; [Murdoch, David R.; Jennings, Lance C.; Florkowski, Christopher M.; Livesey, John H.] Christchurch Hosp, Canterbury Hlth Labs, Christchurch, New Zealand; [Chambers, Stephen T.] Christchurch Hosp, Dept Infect Dis, Christchurch, New Zealand; [Stewart, Alistair W.; Scragg, Robert] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Priest, Patricia C.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Camargo, Carlos A., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA USA	University of Otago; Canterbury Health Laboratories; Christchurch Hospital New Zealand; Christchurch Hospital New Zealand; University of Auckland; University of Otago; Harvard University; Harvard Medical School; Massachusetts General Hospital	Murdoch, DR (corresponding author), Univ Otago, Dept Pathol, POB 4345, Christchurch 8011, New Zealand.	david.murdoch@otago.ac.nz	Murdoch, David/A-2012-2009; Camargo, Carlos A./C-2145-2008; Florkowski, Christopher/ABF-9504-2020	Camargo, Carlos A./0000-0002-5071-7654; Chambers, Stephen/0000-0002-0698-3285; Scragg, Robert/0000-0003-0013-2620	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	The study was funded by the Health Research Council of New Zealand.	Avenell A, 2007, AGE AGEING, V36, P574, DOI 10.1093/ageing/afm091; Barrett B, 2005, J CLIN EPIDEMIOL, V58, P609, DOI 10.1016/j.jclinepi.2004.11.019; Barrett B, 2008, QUAL LIFE RES, V17, P75, DOI 10.1007/s11136-007-9277-2; Barrett B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-76; Barrett B, 2012, ANN FAM MED, V10, P337, DOI 10.1370/afm.1376; Barrett Bruce, 2002, J Fam Pract, V51, P265; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, 2011, DIET REF INT CALC VI; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Ilahi M, 2008, AM J CLIN NUTR, V87, P688, DOI 10.1093/ajcn/87.3.688; JENNINGS LC, 1978, J HYG-CAMBRIDGE, V81, P49, DOI 10.1017/S0022172400053766; Karatekin G, 2009, EUR J CLIN NUTR, V63, P473, DOI 10.1038/sj.ejcn.1602960; Khoo AL, 2012, CRIT REV MICROBIOL, V38, P122, DOI 10.3109/1040841X.2011.622716; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Laaksi I, 2010, J INFECT DIS, V202, P809, DOI 10.1086/654881; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Martineau AR, 2012, LANCET, V379, P1373, DOI 10.1016/S0140-6736(12)60405-X; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Vieth R, 2001, AM J CLIN NUTR, V73, P288; Wilbur AK, 2007, TUBERCULOSIS, V87, P329, DOI 10.1016/j.tube.2007.01.001	28	157	165	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1333	1339		10.1001/jama.2012.12505	http://dx.doi.org/10.1001/jama.2012.12505			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032549	Bronze			2022-12-28	WOS:000309369300027
J	Williams, SN				Williams, Simon Nicholas			A tax on indoor tanning would reduce demand in Europe	BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS MALIGNANT-MELANOMA		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Williams, SN (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	simonwilliams@northwestern.edu		Williams, Simon/0000-0003-2854-9946				Autier P, 2011, LANCET, V377, P1299, DOI 10.1016/S0140-6736(10)61966-6; Committee on medical aspects of radiation in the environment (COMARE), 2009, THIRTEENTH REPORT; European Cancer Observatory, 2008, CANCER MELANOMA OF S; Gallus S, 2006, TOB CONTROL, V15, P114, DOI 10.1136/tc.2005.012468; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; Health Wellbeing and Local Government Committee National Assembly for Wales, INQUIRY INTO THE USE; Jain N, 2012, ARCH DERMATOL, V148, P122, DOI 10.1001/archderm.148.1.122; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Robinson JK, 2008, ARCH DERMATOL, V144, P484, DOI 10.1001/archderm.144.4.484; The Sunbed Association UK, 1996, CONSUMER RESEARCH ON	11	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 2	2012	345								e6550	10.1136/bmj.e6550	http://dx.doi.org/10.1136/bmj.e6550			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KN	23033417				2022-12-28	WOS:000309659300005
J	Newton, CR; Garcia, HH				Newton, Charles R.; Garcia, Hector H.			Epilepsy in poor regions of the world	LANCET			English	Article							SUB-SAHARAN AFRICA; TREATMENT GAP; ANTIEPILEPTIC DRUGS; DEMONSTRATION PROJECT; DEVELOPING-COUNTRIES; UNPROVOKED SEIZURES; CONVULSIVE EPILEPSY; FALCIPARUM-MALARIA; STATUS EPILEPTICUS; COST-EFFECTIVENESS	Epilepsy is a common disorder, particularly in poor areas of the world, and can have a devastating effect on people with the disorder and their families. The burden of epilepsy in low-income countries is more than twice that found in high-income countries, probably because the incidence of risk factors is higher. Many of these risk factors can be prevented with inexpensive interventions, but there are only a few studies that have assessed the effect of reducing risk factors on the burden of epilepsy. The mortality associated with epilepsy in low-income countries is substantially higher than in less impoverished countries and most deaths seem to be related to untreated epilepsy (eg, as a result of falls or status epilepticus), but the risk factors for death have not been adequately examined. Epilepsy is associated with substantial stigma in low-income countries, which acts as a barrier to patients accessing biomedical treatment and becoming integrated within society. Seizures can be controlled by inexpensive antiepileptic drugs, but the supply and quality of these drugs can be erratic in poor areas. The treatment gap for epilepsy is high (>60%) in deprived areas, but this could be reduced with low-cost interventions. The substantial burden of epilepsy in poor regions of the world can be reduced by preventing the risk factors, reducing stigma, improving access to biomedical diagnosis and treatment, and ensuring that there is a continuous supply of good quality antiepileptic drugs.	[Newton, Charles R.] Muhimbili Wellcome Programme, Dar Es Salaam, Tanzania; [Newton, Charles R.] Kenya Med Res Programme, Ctr Geog Med Coast, Kilifi, Kenya; [Newton, Charles R.] UCL, Inst Child Hlth, Neurosci Unit, London, England; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England; [Garcia, Hector H.] Inst Nacl Ciencias Neurol, Cysticercosis Unit, Lima, Peru; [Garcia, Hector H.] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru	University of London; University College London; University of Oxford; Universidad Peruana Cayetano Heredia	Newton, CR (corresponding author), POB 230, Kilifi, Kenya.	mail@crjnewton.com	Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507	Wellcome Trust, UK [083744, 091077]	Wellcome Trust, UK(Wellcome Trust)	CRN (No. 083744) and HHG (091077) are funded by the Wellcome Trust, UK. We thank Karren Visser for her comments and for proofreading the manuscript.	Aarli JA, 2007, NEUROLOGY, V69, P1715, DOI 10.1212/01.wnl.0000285102.47543.02; Adelow C, 2009, EPILEPSIA, V50, P1094, DOI 10.1111/j.1528-1167.2008.01726.x; ANNEGERS JF, 1988, NEUROLOGY, V38, P1407, DOI 10.1212/WNL.38.9.1407; [Anonymous], WHO MENT HLTH GAP AC; [Anonymous], WORLDW AED DAT; Asadi-Pooya AA, 2008, EPILEPSIA, V49, P381, DOI 10.1111/j.1528-1167.2007.01383.x; AWARITEFE A, 1989, CULT MED PSYCHIAT, V13, P449, DOI 10.1007/BF00052051; Aziz H, 1997, EPILEPSIA, V38, P1069, DOI 10.1111/j.1528-1157.1997.tb01195.x; Baker GA, 2000, EPILEPSIA, V41, P98, DOI 10.1111/j.1528-1157.2000.tb01512.x; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Baskind R, 2005, EPILEPSY BEHAV, V7, P68, DOI 10.1016/j.yebeh.2005.04.009; Baskind R, 2005, EPILEPSIA, V46, P1121, DOI 10.1111/j.1528-1167.2005.03505.x; Benn EKT, 2008, EPILEPSIA, V49, P1431, DOI 10.1111/j.1528-1167.2008.01564.x; Berhanu S, 2009, SEIZURE-EUR J EPILEP, V18, P100, DOI 10.1016/j.seizure.2008.07.002; Bhalla D, 2011, EXPERT REV NEUROTHER, V11, P861, DOI [10.1586/ERN.11.51, 10.1586/ern.11.51]; Birbeck GL, 2008, EPILEPSIA, V49, P1642, DOI 10.1111/j.1528-1167.2008.01580_3.x; Birbeck GL, 2008, AM J TROP MED HYG, V79, P168, DOI 10.4269/ajtmh.2008.79.168; Birbeck GL, 2012, EPILEPSIA, V53, P207, DOI 10.1111/j.1528-1167.2011.03335.x; Birbeck GL, 2011, NEUROLOGY, V77, P2067, DOI 10.1212/WNL.0b013e31823b47c2; Birbeck GL, 2010, EPILEPSY CURR, V10, P75, DOI 10.1111/j.1535-7511.2010.01362.x; Bruckner TA, 2011, B WORLD HEALTH ORGAN, V89, P184, DOI 10.2471/BLT.10.082784; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burton KJ, 2012, EPILEPSIA, V53, P752, DOI 10.1111/j.1528-1167.2011.03395.x; Cameron A, 2012, EPILEPSIA, V53, P962, DOI 10.1111/j.1528-1167.2012.03446.x; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; Chen CC, 2012, EPILEPSIA, V53, P283, DOI 10.1111/j.1528-1167.2011.03332.x; Chisholm D, 2005, EPILEPSIA, V46, P751, DOI 10.1111/j.1528-1167.2005.52704.x; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Chomba EN, 2010, AM J TROP MED HYG, V83, P571, DOI 10.4269/ajtmh.2010.10-0100; COCKERELL OC, 1995, J NEUROL NEUROSUR PS, V58, P570, DOI 10.1136/jnnp.58.5.570; Cornacchio ALP, 2011, J CAN DENT ASSOC, V77, P1; Crepin S, 2009, CLIN NUTR, V28, P219, DOI 10.1016/j.clnu.2009.03.010; Das K, 2007, SEIZURE-EUR J EPILEP, V16, P601, DOI 10.1016/j.seizure.2007.04.008; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Del Brutto OH, 2005, EPILEPSIA, V46, P583, DOI 10.1111/j.0013-9580.2005.36504.x; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Global Health Progress, SAN AV IMP EP PROGR; Goel D, 2011, NEUROL INDIA, V59, P37, DOI 10.4103/0028-3886.76855; Gourie-Devi M, 2003, EPILEPSIA, V44, P58, DOI 10.1046/j.1528-1157.44.s.1.12.x; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Jenssen T, 2011, CAUSES EPILEPSY COMM, P618; Jilek-Aall LM, 50 YEARS EP CLIN RES; Kaiser C, 2007, T ROY SOC TROP MED H, V101, P48, DOI 10.1016/j.trstmh.2006.06.003; Kannoth S, 2009, EPILEPSY BEHAV, V16, P58, DOI 10.1016/j.yebeh.2009.07.019; Kariuki SM, 2011, BRAIN, V134, P1519, DOI 10.1093/brain/awr051; Kendall-Taylor N, 2008, EPILEPSIA, V49, P1638, DOI 10.1111/j.1528-1167.2008.01580_1.x; Kengne AP, 2008, EPILEPSIA, V49, P1639, DOI 10.1111/j.1528-1167.2008.01580_2.x; Laroche ML, 2005, EPILEPSIA, V46, P1293, DOI 10.1111/j.1528-1167.2005.01805.x; Li LM, 2007, ARQ NEURO-PSIQUIAT, V65, P58, DOI 10.1590/S0004-282X2007001000010; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Mbuba CK, 2012, LANCET NEUROL, V11, P688, DOI 10.1016/S1474-4422(12)70155-2; Mbuba CK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000162; McLauchlan Duncan James, 2012, Pract Neurol, V12, P154, DOI 10.1136/practneurol-2012-000244; Medina MT, 2011, EPILEPSIA, V52, P1177, DOI 10.1111/j.1528-1167.2010.02945.x; Meinardi H, 2001, EPILEPSIA, V42, P136, DOI 10.1046/j.1528-1157.2001.32800.x; Menon B, 2009, EPILEPSY RES, V87, P1, DOI 10.1016/j.eplepsyres.2009.08.007; Meyer AC, 2010, B WORLD HEALTH ORGAN, V88, P260, DOI 10.2471/BLT.09.064147; Montano SM, 2005, NEUROLOGY, V65, P229, DOI 10.1212/01.wnl.0000168828.83461.09; Mu J, 2011, NEUROLOGY, V77, P132, DOI 10.1212/WNL.0b013e318223c784; Nayel MH, 2000, EPILEPSIA, V41, pS28, DOI 10.1111/j.1528-1157.2000.tb01542.x; Newton CRJC, 2009, EPILEPSIA, V50, P54, DOI 10.1111/j.1528-1167.2009.02364.x; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Nizamie SH, 2009, EPILEPSY RES, V84, P146, DOI 10.1016/j.eplepsyres.2009.01.008; Nuhu FT, 2010, ANN AFR MED, V9, P170, DOI 10.4103/1596-3519.68360; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Organization WH, 2006, NEUR DIS PUBL HLTH C, DOI 10.1001/archneurol.2007.19; Pal Deb K, 2006, Paediatr Perinat Drug Ther, V7, P31, DOI 10.1185/146300905X75361; Pan American Health Organization, 2011, PAHO STRAT PLAN EP; PLACENCIA M, 1995, NEUROEPIDEMIOLOGY, V14, P147, DOI 10.1159/000109790; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Qiu J, 2009, LANCET NEUROL, V8, P420, DOI 10.1016/S1474-4422(09)70096-1; Radhakrishnan K, 2000, EPILEPSIA, V41, P1027, DOI 10.1111/j.1528-1157.2000.tb00289.x; Radhakrishnan K, 2009, NAT REV NEUROL, V5, P323, DOI 10.1038/nrneurol.2009.53; Radhakrishnan K, 2009, NEUROL INDIA, V57, P4, DOI 10.4103/0028-3886.48791; Salvarani CP, 2009, SURG NEUROL, V72, P6, DOI 10.1016/j.surneu.2007.10.008; Sander JW, 2004, EPILEPSIA, V45, P28, DOI 10.1111/j.0013-9580.2004.455005.x; SENANAYAKE N, 1993, B WORLD HEALTH ORGAN, V71, P247; Silberberg D, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P351; The World Bank, COUNTR EC; Wang WZ, 2008, B WORLD HEALTH ORGAN, V86, P964, DOI 10.2471/BLT.07.047050; WHO, 2001, ATL MENT HLTH RES WO; WHO, 2008, MHGAP MENTAL HLTH GA; WHO, 2005, ATL EP CAR WORLD 200; Wilmshurst J, 2005, DEV MED CHILD NEUROL, V47, P219, DOI 10.1017/S0012162205000423; Winkler AS, 2011, J NEUROL SCI, V300, P47, DOI 10.1016/j.jns.2010.10.004; Winkler AS, 2009, EPILEPSIA, V50, P987, DOI 10.1111/j.1528-1167.2008.01867.x; Yemadje LP, 2011, EPILEPSIA, V52, P1376, DOI 10.1111/j.1528-1167.2011.03099.x	91	244	251	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2012	380	9848					1193	1201		10.1016/S0140-6736(12)61381-6	http://dx.doi.org/10.1016/S0140-6736(12)61381-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021288	Green Submitted			2022-12-28	WOS:000309255900037
J	Gopnik, A				Gopnik, Alison			Scientific Thinking in Young Children: Theoretical Advances, Empirical Research, and Policy Implications	SCIENCE			English	Review							PRESCHOOLERS CAUSAL INFERENCES; COGNITIVE-DEVELOPMENT; PROBABILISTIC MODELS; 8-MONTH-OLD INFANTS; PLAY; INTERVENTIONS; STATISTICS	New theoretical ideas and empirical research show that very young children's learning and thinking are strikingly similar to much learning and thinking in science. Preschoolers test hypotheses against data and make causal inferences; they learn from statistics and informal experimentation, and from watching and listening to others. The mathematical framework of probabilistic models and Bayesian inference can describe this learning in precise ways. These discoveries have implications for early childhood education and policy. In particular, they suggest both that early childhood experience is extremely important and that the trend toward more structured and academic early childhood programs is misguided.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Gopnik, A (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	gopnik@socrates.berkeley.edu			NSF [BCS-1023875]; James S. McDonnell Causal Learning Collaborative	NSF(National Science Foundation (NSF)); James S. McDonnell Causal Learning Collaborative	Supported by NSF grant BCS-1023875 and by the James S. McDonnell Causal Learning Collaborative, which also supported almost all the ideas and research reported here, both by myself and others. I acknowledge and deeply thank the other members of the Collaborative and the James S. McDonnell Foundation itself.	[Anonymous], 2000, CAUSALITY; Bonawitz E, 2011, COGNITION, V120, P322, DOI 10.1016/j.cognition.2010.10.001; Buchsbaum D, 2012, PHILOS T R SOC B, V367, P2202, DOI 10.1098/rstb.2012.0122; Buchsbaum D, 2011, COGNITION, V120, P331, DOI 10.1016/j.cognition.2010.12.001; Carey S., 2009, ORIGIN CONCEPTS; Cook C, 2011, COGNITION, V120, P341, DOI 10.1016/j.cognition.2011.03.003; Eberhardt F, 2007, PHILOS SCI, V74, P981, DOI 10.1086/525638; Glymour C., 2001, MINDS ARROWS BAYES N, DOI 10.7551/mitpress/4638.001.0001; Goodman N.D., 2008, P 24 C UNCERTAINTY A, P220; Goodman ND, 2011, PSYCHOL REV, V118, P110, DOI 10.1037/a0021336; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; Gopnik A., 1997, WORDS THOUGHTS THEOR; Gopnik A, 2007, DEVELOPMENTAL SCI, V10, P281, DOI 10.1111/j.1467-7687.2007.00584.x; Gopnik A, 2012, PSYCHOL BULL, V138, P1085, DOI 10.1037/a0028044; Griffiths TL, 2009, PSYCHOL REV, V116, P661, DOI 10.1037/a0017201; Gweon H, 2011, SCIENCE, V332, P1524, DOI 10.1126/science.1204493; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kuhn D., 2005, ED THINKING; Kushnir T, 2010, PSYCHOL SCI, V21, P1134, DOI 10.1177/0956797610376652; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; Lucas C., 2010, P 32 ANN C COGN SCI, P28; Piaget Jean, 1929, CHILDS CONCEPTION WO; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Scheines R., 2007, CAUSAL LEARNING, P119; Schulz LE, 2007, DEV PSYCHOL, V43, P1124, DOI 10.1037/0012-1649.43.5.1124; Schulz LE, 2007, DEVELOPMENTAL SCI, V10, P322, DOI 10.1111/j.1467-7687.2007.00587.x; Schulz LE, 2008, COGNITION, V109, P211, DOI 10.1016/j.cognition.2008.07.017; Schulz LE, 2006, CHILD DEV, V77, P427, DOI 10.1111/j.1467-8624.2006.00880.x; Shafto P, 2012, PERSPECT PSYCHOL SCI, V7, P341, DOI 10.1177/1745691612448481; Sobel DM, 2006, DEV PSYCHOL, V42, P1103, DOI 10.1037/0012-1649.42.6.1103; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; Spirtes P., 2000, CAUSATION PREDICTION; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; WELLMAN HM, 1992, ANNU REV PSYCHOL, V43, P337, DOI 10.1146/annurev.ps.43.020192.002005; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105; Xu F, 2011, COGNITION, V120, P299, DOI 10.1016/j.cognition.2011.06.008	40	156	163	8	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1623	1627		10.1126/science.1223416	http://dx.doi.org/10.1126/science.1223416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	012DJ	23019643				2022-12-28	WOS:000309215400036
J	Guillette, LJ; Iguchi, T				Guillette, Louis J., Jr.; Iguchi, Taisen			Life in a Contaminated World	SCIENCE			English	Editorial Material							ENDOCRINE-DISRUPTING CHEMICALS; ATRAZINE		[Guillette, Louis J., Jr.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29412 USA; [Guillette, Louis J., Jr.] Hollings Marine Lab, Charleston, SC 29412 USA; [Iguchi, Taisen] Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Medical University of South Carolina; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Guillette, LJ (corresponding author), Med Univ S Carolina, Dept Obstet & Gynecol, 221 Ft Johnson Rd, Charleston, SC 29412 USA.	guillett@musc.edu	Iguchi, Taisen/AAL-4225-2021					Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; Carr JA, 2003, ENVIRON TOXICOL CHEM, V22, P396, DOI [10.1897/1551-5028(2003)022&lt;0396:ROLXLT&gt;2.0.CO;2, 10.1002/etc.5620220222]; Carson Rachel, 1994, SILENT SPRING; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Crews D, 2011, ENVIRON HEALTH PERSP, V119, P1208, DOI 10.1289/ehp.1103451; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Gore AC, 2010, FRONT NEUROENDOCRIN, V31, P395, DOI 10.1016/j.yfrne.2010.07.003; Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485; Hamlin HJ, 2011, BIRTH DEFECTS RES C, V93, P19, DOI 10.1002/bdrc.20202; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hayes TB, 2004, BIOSCIENCE, V54, P1138, DOI 10.1641/0006-3568(2004)054[1138:TINDTD]2.0.CO;2; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kloas W, 2009, ANN NY ACAD SCI, V1163, P437, DOI 10.1111/j.1749-6632.2009.04456.x; Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Rahman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040825; Sharpe RM, 2011, NAT REV ENDOCRINOL, V7, P633, DOI 10.1038/nrendo.2011.165; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Spearow JL, 1999, SCIENCE, V285, P1259, DOI 10.1126/science.285.5431.1259; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050	22	51	52	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1614	1615		10.1126/science.1226985	http://dx.doi.org/10.1126/science.1226985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019638				2022-12-28	WOS:000309215400031
J	McClelland, JL				McClelland, James L.			R. Duncan Luce (1925-2012)	SCIENCE			English	Biographical-Item									Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	McClelland, JL (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	mcclelland@stanford.edu		McClelland, James/0000-0002-8217-405X					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1619	1619		10.1126/science.1229851	http://dx.doi.org/10.1126/science.1229851			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019641				2022-12-28	WOS:000309215400034
J	Spann, NJ; Garmire, LX; McDonald, JG; Myers, DS; Milne, SB; Shibata, N; Reichart, D; Fox, JN; Shaked, I; Heudobler, D; Raetz, CRH; Wang, EW; Kelly, SL; Sullards, MC; Murphy, RC; Merrill, AH; Brown, HA; Dennis, EA; Li, AC; Ley, K; Tsimikas, S; Fahy, E; Subramaniam, S; Quehenberger, O; Russell, DW; Glass, CK				Spann, Nathanael J.; Garmire, Lana X.; McDonald, Jeffrey G.; Myers, David S.; Milne, Stephen B.; Shibata, Norihito; Reichart, Donna; Fox, Jesse N.; Shaked, Iftach; Heudobler, Daniel; Raetz, Christian R. H.; Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Murphy, Robert C.; Merrill, Alfred H., Jr.; Brown, H. Alex; Dennis, Edward A.; Li, Andrew C.; Ley, Klaus; Tsimikas, Sotirios; Fahy, Eoin; Subramaniam, Shankar; Quehenberger, Oswald; Russell, David W.; Glass, Christopher K.			Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR LXR-ALPHA; ATHEROSCLEROTIC PLAQUES; LDL RECEPTOR; CHOLESTEROL; PROTEIN; GENE; MICE; IDENTIFICATION; PATHOGENESIS	Inflammation and macrophage foam cells are characteristic features of atherosclerotic lesions, but the mechanisms linking cholesterol accumulation to inflammation and LXR-dependent response pathways are poorly understood. To investigate this relationship, we utilized lipidomic and transcriptomic methods to evaluate the effect of diet and LDL receptor genotype on macrophage foam cell formation within the peritoneal cavities of mice. Foam cell formation was associated with significant changes in hundreds of lipid species and unexpected suppression, rather than activation, of inflammatory gene expression. We provide evidence that regulated accumulation of desmosterol underlies many of the homeostatic responses, including activation of LXR target genes, inhibition of SREBP target genes, selective reprogramming of fatty acid metabolism, and suppression of inflammatory-response genes, observed in macrophage foam cells. These observations suggest that macrophage activation in atherosclerotic lesions results from extrinsic, proinflammatory signals generated within the artery wall that suppress homeostatic and anti-inflammatory functions of desmosterol.	[Spann, Nathanael J.; Shibata, Norihito; Reichart, Donna; Fox, Jesse N.; Heudobler, Daniel; Subramaniam, Shankar; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Garmire, Lana X.; Fahy, Eoin; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dennis, Edward A.; Subramaniam, Shankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Li, Andrew C.; Tsimikas, Sotirios; Quehenberger, Oswald; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [McDonald, Jeffrey G.; Russell, David W.] UT SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; [Myers, David S.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Dept Pharmacol, Nashville, TN 37232 USA; [Raetz, Christian R. H.] Duke Univ, Dept Biochem, Sch Med, DUMC, Durham, NC 27710 USA; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Chem, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biochem, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Shaked, Iftach; Ley, Klaus] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; La Jolla Institute for Immunology	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Shaked, Iftach/AAS-9961-2020; Murphy, Robert/AAO-5349-2020; Shaked, Iftach/GNM-9959-2022; Glass, Christopher/AAI-3933-2021; Dennis, Edward A./M-5554-2019	Murphy, Robert/0000-0002-9430-6515; Glass, Christopher/0000-0003-4344-3592; Dennis, Edward A./0000-0003-3738-3140; SHIBATA, NORIHITO/0000-0001-5792-8510; Merrill, Alfred/0000-0002-6673-968X; Russell, David/0000-0002-0277-403X	NIH [GM U54 069338, PO1 HC088093, P01 DK074868]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115232, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were primarily supported by NIH grant GM U54 069338 to the LIPID MAPS Consortium. Additional support was provided by NIH grants PO1 HC088093 and P01 DK074868. N.J.S. was supported by an NIH training grant. We thank Hanna Lesch for critical comments, L. Bautista for assistance with preparation of the manuscript, and Dr. Peter Tontonoz for providing LXR DKO mice for macrophage isolation.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; AVIGAN J, 1960, BIOCHEM BIOPH RES CO, V2, P63, DOI 10.1016/0006-291X(60)90266-7; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Blake GJ, 2003, J AM COLL CARDIOL, V41, p37S, DOI 10.1016/S0735-1097(02)02953-4; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	41	375	391	0	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					138	152		10.1016/j.cell.2012.06.054	http://dx.doi.org/10.1016/j.cell.2012.06.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021221	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000309544200016
J	Dielmann, F; Back, O; Henry-Ellinger, M; Jerabek, P; Frenking, G; Bertrand, G				Dielmann, Fabian; Back, Olivier; Henry-Ellinger, Martin; Jerabek, Paul; Frenking, Gernot; Bertrand, Guy			A Crystalline Singlet Phosphinonitrene: A Nitrogen Atom-Transfer Agent	SCIENCE			English	Article							(SALEN)RUTHENIUM(VI) NITRIDO COMPLEX; DIRECT SPECTROSCOPIC OBSERVATION; TRANSITION-METALS; CARBENE; N-(2,2,6,6-TETRAMETHYLPIPERIDYL)NITRENE; N-(2,2,5,5-TETRAMETHYLPYRROLIDYL)NITRENE; REACTIVITY; SPECTRUM; P=N	A variety of transition metal-nitrido complexes (metallonitrenes) have been isolated and studied in the context of modeling intermediates in biological nitrogen fixation by the nitrogenase enzymes and the industrial Haber-Bosch hydrogenation of nitrogen gas into ammonia. In contrast, nonmetallic nitrenes have so far only been spectroscopically observed at low temperatures, despite their intermediacy in a range of organic reactions. Here, we report the synthesis of a bis(imidazolidin-2-iminato)phosphinonitrene, which is stable at room temperature in solution and can even be isolated in the solid state. The bonding between phosphorus and nitrogen is analogous to that observed for metallonitrenes. We also show that this nitrido phosphorus derivative can be used to transfer a nitrogen atom to organic fragments, a difficult task for transition metal-nitrido complexes.	[Dielmann, Fabian; Back, Olivier; Henry-Ellinger, Martin; Bertrand, Guy] Univ Calif Riverside, Dept Chem, CNRS, Joint Res Chem Lab,UMI 2957, Riverside, CA 92521 USA; [Dielmann, Fabian; Henry-Ellinger, Martin; Bertrand, Guy] Univ Calif San Diego, Dept Chem & Biochem, CNRS, Joint Res Chem Lab,UMI 3555, La Jolla, CA 92093 USA; [Jerabek, Paul; Frenking, Gernot] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany	University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University of California System; University of California San Diego; Philipps University Marburg	Bertrand, G (corresponding author), Univ Calif Riverside, Dept Chem, CNRS, Joint Res Chem Lab,UMI 2957, Riverside, CA 92521 USA.	guybertrand@ucsd.edu	Jerabek, Paul/B-6741-2013	Jerabek, Paul/0000-0002-2995-9755; Dielmann, Fabian/0000-0002-7025-5450	NSF [CHE-1112133, CHE-0924410]; U.S. Department of Energy [DE-FG02-09ER16069]; Alexander von Humboldt Foundation; Direct For Mathematical & Physical Scien [1305106] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the NSF (grants CHE-1112133 and CHE-0924410) and the U.S. Department of Energy (grant DE-FG02-09ER16069) for financial support and the Alexander von Humboldt Foundation for a postdoctoral fellowship (to F.D.). Metrical data for the solid-state structures of 1, 2, and 3 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-884584, CCDC-884585, and CCDC-884586, respectively.	AHLRICHS R, 1985, J AM CHEM SOC, V107, P6494, DOI 10.1021/ja00309a012; Allcock HR, 2012, POLYM CHEM-UK, V3, P578, DOI 10.1039/c1py00468a; Amin AM, 2009, DES MONOMERS POLYM, V12, P357, DOI 10.1163/138577209X12486896623373; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; BACEIREDO A, 1984, J AM CHEM SOC, V106, P6088, DOI 10.1021/ja00332a061; Back O, 2011, CHEM SCI, V2, P858, DOI 10.1039/c1sc00027f; Berry JF, 2009, COMMENT INORG CHEM, V30, P28, DOI 10.1080/02603590902768875; Burck S, 2008, DALTON T, P3478, DOI 10.1039/b717219b; DERVAN PB, 1981, J AM CHEM SOC, V103, P1120, DOI 10.1021/ja00395a021; DiezGonzalez S, 2011, RSC CATAL SER, P1; Droge T, 2010, ANGEW CHEM INT EDIT, V49, P6940, DOI 10.1002/anie.201001865; Eikey RA, 2003, COORDIN CHEM REV, V243, P83, DOI 10.1016/S0010-8545(03)00048-1; Grossmann A, 2012, ANGEW CHEM INT EDIT, V51, P314, DOI 10.1002/anie.201105415; Hayton TW, 2010, DALTON T, V39, P1145, DOI 10.1039/b909238b; Hindi KM, 2009, CHEM REV, V109, P3859, DOI 10.1021/cr800500u; HINSBERG WD, 1982, J AM CHEM SOC, V104, P766, DOI 10.1021/ja00367a020; HINSBERG WD, 1978, J AM CHEM SOC, V100, P1608, DOI 10.1021/ja00473a051; HOFFMANN MR, 1991, J CHEM PHYS, V94, P8029, DOI 10.1063/1.460137; IGAU A, 1989, ANGEW CHEM INT EDIT, V28, P621, DOI 10.1002/anie.198906211; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Kwong HK, 2009, INORG CHEM, V48, P3080, DOI 10.1021/ic802338f; Lavallo V, 2004, J AM CHEM SOC, V126, P8670, DOI 10.1021/ja047503f; MacKay BA, 2004, CHEM REV, V104, P385, DOI 10.1021/cr020610c; Man WL, 2004, J AM CHEM SOC, V126, P15336, DOI 10.1021/ja045845f; Mandal SK, 2012, ACCOUNTS CHEM RES, V45, P298, DOI 10.1021/ar2001759; Martin D, 2011, CHEM SCI, V2, P389, DOI 10.1039/c0sc00388c; Melaimi M, 2010, ANGEW CHEM INT EDIT, V49, P8810, DOI 10.1002/anie.201000165; Niecke E., 1990, MULTIPLE BONDS LOW C, P293; Platz M.S., 2004, REACTIVE INTERMEDIAT, P501; Power PP, 2010, NATURE, V463, P171, DOI 10.1038/nature08634; Saouma CT, 2011, COORDIN CHEM REV, V255, P920, DOI 10.1016/j.ccr.2011.01.009; Scepaniak JJ, 2011, ANGEW CHEM INT EDIT, V50, P6630, DOI 10.1002/anie.201102028; Schoeller W, 2001, EUR J INORG CHEM, P845; SCHULTZ PG, 1980, J AM CHEM SOC, V102, P878, DOI 10.1021/ja00522a090; SICARD G, 1984, ANGEW CHEM INT EDIT, V23, P459, DOI 10.1002/anie.198404591; Silvia JS, 2009, J AM CHEM SOC, V131, P446, DOI 10.1021/ja807767w; Stephan DW, 2010, ANGEW CHEM INT EDIT, V49, P46, DOI 10.1002/anie.200903708; Tamm M, 2007, ORG BIOMOL CHEM, V5, P523, DOI 10.1039/b615418b; Tapu D, 2009, CHEM REV, V109, P3385, DOI 10.1021/cr800521g; Trambitas AG, 2011, ORGANOMETALLICS, V30, P1122, DOI 10.1021/om1011243; Tran BL, 2010, J AM CHEM SOC, V132, P1458, DOI 10.1021/ja908303k; Wentrup C, 2011, ACCOUNTS CHEM RES, V44, P393, DOI 10.1021/ar700198z; Wu XA, 2011, BEILSTEIN J ORG CHEM, V7, P82, DOI 10.3762/bjoc.7.12; Yao SL, 2011, ORGANOMETALLICS, V30, P1748, DOI 10.1021/om200017h; Zeng XQ, 2009, ANGEW CHEM INT EDIT, V48, P4828, DOI 10.1002/anie.200901380	46	102	102	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1526	1528		10.1126/science.1226022	http://dx.doi.org/10.1126/science.1226022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997335				2022-12-28	WOS:000308912900048
J	Marteau, TM; Hollands, GJ; Fletcher, PC				Marteau, Theresa M.; Hollands, Gareth J.; Fletcher, Paul C.			Changing Human Behavior to Prevent Disease: The Importance of Targeting Automatic Processes	SCIENCE			English	Editorial Material							CHILDRENS TASTE; SOCIAL-BEHAVIOR; HABITS; METAANALYSIS; PREFERENCES; INTENTIONS; ALCOHOL	Much of the global burden of disease is associated with behaviors-overeating, smoking, excessive alcohol consumption, and physical inactivity-that people recognize as health-harming and yet continue to engage in, even when undesired consequences emerge. To date, interventions aimed at changing such behaviors have largely encouraged people to reflect on their behaviors. These approaches are often ineffectual, which is in keeping with the observation that much human behavior is automatic, cued by environmental stimuli, resulting in actions that are largely unaccompanied by conscious reflection. We propose that interventions targeting these automatic bases of behaviors may be more effective. We discuss specific interventions and suggest ways to determine whether and how interventions that target automatic processes can enhance global efforts to prevent disease.	[Marteau, Theresa M.; Hollands, Gareth J.] Univ Cambridge, Behav & Hlth Res Unit, Inst Publ Hlth, Cambridge CB2 0SR, England; [Fletcher, Paul C.] Univ Cambridge, Dept Psychiat, Cambridge CB2 0SR, England	University of Cambridge; University of Cambridge	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Inst Publ Hlth, Cambridge CB2 0SR, England.	theresa.marteau@medschl.cam.ac.uk	; Fletcher, Paul/F-5380-2011	Hollands, Gareth/0000-0002-0492-3924; Fletcher, Paul/0000-0001-8257-1517; Marteau, Theresa/0000-0003-3025-1129	Wellcome Trust [095692] Funding Source: Medline; Department of Health [107/0001] Funding Source: Medline	Wellcome Trust(Wellcome Trust); Department of Health		Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Benden ME, 2011, AM J PUBLIC HEALTH, V101, P1433, DOI 10.2105/AJPH.2010.300072; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; de Wit S, 2009, PSYCHOL RES-PSYCH FO, V73, P463, DOI 10.1007/s00426-009-0230-6; Dijksterhuis A, 2010, ANNU REV PSYCHOL, V61, P467, DOI 10.1146/annurev.psych.093008.100445; Engels RCME, 2009, ALCOHOL ALCOHOLISM, V44, P244, DOI 10.1093/alcalc/agp003; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; French SA, 2010, J OCCUP ENVIRON MED, V52, pS29, DOI 10.1097/JOM.0b013e3181c5c476; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hollands G. J., 2012, ALTERING CHOICE ARCH; Hollands GJ, 2011, HEALTH PSYCHOL, V30, P195, DOI 10.1037/a0022261; Kahneman D., 2011, THINKING FAST SLOW; Kutner M, 2006, 2006483 NCES US DEP; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; Moodie C, 2012, PLAIN TOBACCO PACKAG; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Papies EK, 2012, CURR OBES REP, V1, P99, DOI 10.1007/s13679-012-0009-8; Reitzel LR, 2011, AM J PUBLIC HEALTH, V101, P315, DOI 10.2105/AJPH.2010.191676; Roberto CA, 2010, PEDIATRICS, V126, P88, DOI 10.1542/peds.2009-3433; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; Rossen, 2003, SCAND J NUTR, V47, P26, DOI DOI 10.1080/11026480310004262; Rozin P, 2011, JUDGM DECIS MAK, V6, P323; Schnall S, 2010, PERCEPTION, V39, P464, DOI 10.1068/p6445; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Spears D, 2010, EC DECISION MAKING P; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; VANHOUTEN R, 1981, J APPL BEHAV ANAL, V14, P377, DOI 10.1901/jaba.1981.14-377; Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; WILLIAMS J, 2003, SKILLS LIFE SURVEY N; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843	36	476	482	4	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1492	1495		10.1126/science.1226918	http://dx.doi.org/10.1126/science.1226918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997327	Green Published			2022-12-28	WOS:000308912900039
J	Running, SW				Running, Steven W.			A Measurable Planetary Boundary for the Biosphere	SCIENCE			English	Editorial Material							NET PRIMARY PRODUCTION; HUMAN APPROPRIATION; ECOSYSTEMS		Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA	University of Montana System; University of Montana	Running, SW (corresponding author), Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA.	swr@ntsg.umt.edu						Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Meadows D., 1972, LIMITS GROWTH; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Smith WK, 2012, BIOSCIENCE, V62, P911, DOI 10.1525/bio.2012.62.10.11; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Turner GM, 2008, GLOBAL ENVIRON CHANG, V18, P397, DOI 10.1016/j.gloenvcha.2008.05.001; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	12	192	215	3	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1458	1459		10.1126/science.1227620	http://dx.doi.org/10.1126/science.1227620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997311				2022-12-28	WOS:000308912900025
J	Fyke, J; Eby, M				Fyke, J.; Eby, M.			Comment on "Climate Sensitivity Estimated from Temperature Reconstructions of the Last Glacial Maximum"	SCIENCE			English	Editorial Material									[Fyke, J.] Los Alamos Natl Lab, Los Alamos, NM 87544 USA; [Eby, M.] Univ Victoria, Victoria, BC, Canada	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Victoria	Fyke, J (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87544 USA.	fyke@lanl.gov	Eby, Michael/H-5278-2013					Bartlein PJ, 2011, CLIM DYNAM, V37, P775, DOI 10.1007/s00382-010-0904-1; de Vernal A, 2006, QUATERNARY SCI REV, V25, P2820, DOI 10.1016/j.quascirev.2006.06.006; Schmittner A, 2011, SCIENCE, V334, P1385, DOI 10.1126/science.1203513; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686	5	10	10	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100								10.1126/science.1221371	http://dx.doi.org/10.1126/science.1221371			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984053				2022-12-28	WOS:000308705000021
J	McClelland, L				McClelland, Laura			Terminally ill people shouldn't have to travel abroad for assisted dying	BRITISH MEDICAL JOURNAL			English	Editorial Material									Prince Charles Hosp, Merthyr Tydfil, M Glam, Wales		McClelland, L (corresponding author), Prince Charles Hosp, Merthyr Tydfil, M Glam, Wales.	doctormac@doctors.org.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6201	10.1136/bmj.e6201	http://dx.doi.org/10.1136/bmj.e6201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BZ	22983534				2022-12-28	WOS:000308865100006
J	Elias, M; Wellner, A; Goldin-Azulay, K; Chabriere, E; Vorholt, JA; Erb, TJ; Tawfik, DS				Elias, Mikael; Wellner, Alon; Goldin-Azulay, Korina; Chabriere, Eric; Vorholt, Julia A.; Erb, Tobias J.; Tawfik, Dan S.			The molecular basis of phosphate discrimination in arsenate-rich environments	NATURE			English	Article							BETA-SEMIALDEHYDE DEHYDROGENASE; HYDROGEN-BONDS; ESCHERICHIA-COLI; TRANSPORT-SYSTEMS; ACTIVE-TRANSPORT; PROTEIN; SPECIFICITY; BACTERIA; RECEPTOR; GFAJ-1	Arsenate and phosphate are abundant on Earth and have striking similarities: nearly identical pK(a) values(1,2), similarly charged oxygen atoms, and thermochemical radii that differ by only 4% (ref. 3). Phosphate is indispensable and arsenate is toxic, but this extensive similarity raises the question whether arsenate may substitute for phosphate in certain niches(4,5). However, whether it is used or excluded, discriminating phosphate from arsenate is a paramount challenge. Enzymes that utilize phosphate, for example, have the same binding mode and kinetic parameters as arsenate, and the latter's presence therefore decouples metabolism(6,7). Can proteins discriminate between these two anions, and how would they do so? In particular, cellular phosphate uptake systems face a challenge in arsenate-rich environments. Here we describe a molecular mechanism for this process. We examined the periplasmic phosphate-binding proteins (PBPs) of the ABC-type transport system that mediates phosphate uptake into bacterial cells, including two PBPs from the arsenate-rich Mono Lake Halomonas strain GFAJ-1. All PBPs tested are capable of discriminating phosphate over arsenate at least 500-fold. The exception is one of the PBPs of GFAJ-1 that shows roughly 4,500-fold discrimination and its gene is highly expressed under phosphate-limiting conditions. Sub-angstrom-resolution structures of Pseudomonas fluorescens PBP with both arsenate and phosphate show a unique mode of binding that mediates discrimination. An extensive network of dipole-anion interactions(8,9), and of repulsive interactions, results in the 4% larger arsenate distorting a unique low-barrier hydrogen bond. These features enable the phosphate transport system to bind phosphate selectively over arsenate (at least 10(3) excess) even in highly arsenate-rich environments.	[Elias, Mikael; Wellner, Alon; Goldin-Azulay, Korina; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Chabriere, Eric] Univ Aix Marseille 2, CNRS, Fac Med & Pharm, Unite Rech Malad Infect & Trop Emergentes, F-13385 Marseille, France; [Vorholt, Julia A.; Erb, Tobias J.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Weizmann Institute of Science; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Swiss Federal Institutes of Technology Domain; ETH Zurich	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	mikael.elias@weizmann.ac.il; tawfik@weizmann.ac.il	Elias, Mikael/C-8484-2011; Erb, Tobias/J-5214-2013; Elias, Mikael/AAH-9385-2021; Vorholt, Julia/K-3514-2016	Elias, Mikael/0000-0003-0406-7539; Erb, Tobias/0000-0003-3685-0894; Elias, Mikael/0000-0003-0406-7539; Vorholt, Julia/0000-0002-6011-4910; WELLNER, ALON/0000-0001-5247-189X	Israel Science Foundation; Intra-European Fellowships Marie Curie program [252836]; Eidgenossische Technische Hochschule fellowship	Israel Science Foundation(Israel Science Foundation); Intra-European Fellowships Marie Curie program; Eidgenossische Technische Hochschule fellowship	We thank G. Gotthard for valuable inputs, C. Jelsch for help with the software Mopro, and A. Toth-Petroczy for help with the phylogenetic analysis. Financial support by the Israel Science Foundation is gratefully acknowledged. M. E. is a fellow supported by the Intra-European Fellowships Marie Curie program (grant No. 252836). D. S. T. is the Nella and Leon Benoziyo Professor of Biochemistry. T.J.E. was supported by an Eidgenossische Technische Hochschule fellowship.	Ahn S, 2007, FEBS LETT, V581, P3455, DOI 10.1016/j.febslet.2007.06.050; Butt AS, 2011, WORLD J MICROB BIOT, V27, P2435, DOI 10.1007/s11274-011-0716-4; Cleland WW, 2000, ARCH BIOCHEM BIOPHYS, V382, P1, DOI 10.1006/abbi.2000.2011; Dixon HBF, 1997, ADV INORG CHEM, V44, P191; Erb TJ, 2012, SCIENCE, V337, P467, DOI 10.1126/science.1218455; Faehnle CR, 2004, ACTA CRYSTALLOGR D, V60, P2320, DOI 10.1107/S0907444904026411; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim EE, 2012, CURR MED IMAGING REV, V8, P1; Kish MM, 1999, INORG CHEM, V38, P818, DOI 10.1021/ic981082j; KLINE PC, 1993, BIOCHEMISTRY-US, V32, P13212, DOI 10.1021/bi00211a033; Kohn RA, 1998, J ANIM SCI, V76, P1702; LARSEN EH, 1992, MIKROCHIM ACTA, V109, P47, DOI 10.1007/BF01243209; Ledvina PS, 1996, P NATL ACAD SCI USA, V93, P6786, DOI 10.1073/pnas.93.13.6786; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Liebschner D, 2009, J AM CHEM SOC, V131, P7879, DOI 10.1021/ja901900y; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Reaves ML, 2012, SCIENCE, V337, P470, DOI 10.1126/science.1219861; STEINER T, 1994, ACTA CRYSTALLOGR B, V50, P348, DOI 10.1107/S0108768193011966; Tanabe M, 2007, ACTA CRYSTALLOGR D, V63, P1185, DOI 10.1107/S0907444907048299; Tawfik DS, 2011, BIOCHEMISTRY-US, V50, P1128, DOI 10.1021/bi200002a; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; Wang ZM, 1997, NAT STRUCT BIOL, V4, P519, DOI 10.1038/nsb0797-519; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; WILLSKY GR, 1980, J BACTERIOL, V144, P366, DOI 10.1128/JB.144.1.366-374.1980; WILLSKY GR, 1980, J BACTERIOL, V144, P356, DOI 10.1128/JB.144.1.356-365.1980; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258	30	144	149	3	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					134	137		10.1038/nature11517	http://dx.doi.org/10.1038/nature11517			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23034649				2022-12-28	WOS:000310434500045
J	Schlebusch, CM; Skoglund, P; Sjodin, P; Gattepaille, LM; Hernandez, D; Jay, F; Li, S; De Jongh, M; Singleton, A; Blum, MGB; Soodyall, H; Jakobsson, M				Schlebusch, Carina M.; Skoglund, Pontus; Sjodin, Per; Gattepaille, Lucie M.; Hernandez, Dena; Jay, Flora; Li, Sen; De Jongh, Michael; Singleton, Andrew; Blum, Michael G. B.; Soodyall, Himla; Jakobsson, Mattias			Genomic Variation in Seven Khoe-San Groups Reveals Adaptation and Complex African History	SCIENCE			English	Article							POPULATIONS; GENOTYPE	The history of click-speaking Khoe-San, and African populations in general, remains poorly understood. We genotyped similar to 2.3 million single-nucleotide polymorphisms in 220 southern Africans and found that the Khoe-San diverged from other populations >= 100,000 years ago, but population structure within the Khoe-San dated back to about 35,000 years ago. Genetic variation in various sub-Saharan populations did not localize the origin of modern humans to a single geographic region within Africa; instead, it indicated a history of admixture and stratification. We found evidence of adaptation targeting muscle function and immune response; potential adaptive introgression of protection from ultraviolet light; and selection predating modern human diversification, involving skeletal and neurological development. These new findings illustrate the importance of African genomic diversity in understanding human evolutionary history.	[Schlebusch, Carina M.; Skoglund, Pontus; Sjodin, Per; Gattepaille, Lucie M.; Li, Sen; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Hernandez, Dena; Singleton, Andrew] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Jay, Flora] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [De Jongh, Michael] Univ S Africa, Dept Anthropol & Archaeol, ZA-0001 Pretoria, South Africa; [Blum, Michael G. B.] Univ Grenoble 1, Ctr Natl Rech Sci, Lab TIMC IMAG UMR 5525, Grenoble, France; [Soodyall, Himla] Univ Witwatersrand, Human Genom Divers & Dis Res Unit, Div Human Genet, Sch Pathol,Fac Hlth Sci, Johannesburg, South Africa; [Soodyall, Himla] Natl Hlth Lab Serv, Johannesburg, South Africa; [Jakobsson, Mattias] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden	Uppsala University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California Berkeley; University of South Africa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); University of Witwatersrand; National Health Laboratory Service; Uppsala University	Schlebusch, CM (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Norbyvagen 18D, S-75236 Uppsala, Sweden.	carina.schlebusch@ebc.uu.se; mattias.jakobsson@ebc.uu.se	Singleton, Andrew B/C-3010-2009; Jakobsson, Mattias/A-6116-2011; Blum, Michael/F-9978-2010; Gattepaille, Lucie/V-3229-2019; Schlebusch, Carina/B-3411-2010	Jakobsson, Mattias/0000-0001-7840-7853; Blum, Michael/0000-0003-4174-7373; Schlebusch, Carina/0000-0002-8160-9621; jay, flora/0000-0001-5884-4730; Skoglund, Pontus/0000-0002-3021-5913	Wenner-Gren Foundation; Intramural Research Program of the National Institute on Aging; NIH; U.S. Department of Health and Human Services [Z01 AG000932-04]; Medical Research Council of South Africa; National Health Laboratory Service; STINT; Swedish Research Council; Erik Philip Sorensen Foundation; NATIONAL INSTITUTE ON AGING [Z01AG000932] Funding Source: NIH RePORTER	Wenner-Gren Foundation; Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; Medical Research Council of South Africa(South African Medical Research Council); National Health Laboratory Service; STINT; Swedish Research Council(Swedish Research CouncilEuropean Commission); Erik Philip Sorensen Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank participants who donated blood samples, T. Jenkins, and B. Henn. Approved by the Working Group of Indigenous Minorities in Southern Africa (WIMSA) and the South African San Council; we thank them for facilitating sampling trips. Computations were performed at the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) in Uppsala, Sweden (project number p2011187). This work was supported by the Wenner-Gren Foundation (C. S.); the Intramural Research Program of the National Institute on Aging, NIH, U.S. Department of Health and Human Services, grant Z01 AG000932-04 (A. S.); the Medical Research Council of South Africa and National Health Laboratory Service (H. S.); STINT (M. B. and M.J.); the Swedish Research Council (M.J.); and the Erik Philip Sorensen Foundation (M.J.). H. S. retains governance of the DNA samples. Author contributions were as follows: conception and design of study: C. M. S., P.Sk., and M.J.; sample collection, preparation, and description: C. M. S., M.D.J., and H. S.; genotyping: D. H. and A. S.; data preparation: C. M. S., P.Sk., D. H., and M.J.; population structure analysis: C. M. S., P.Sk., L. M. G., S. L., F.J., M. B., and M.J.; model-based inference: P.Sk. and M.J.; language/geography comparisons: F.J., C. M. S., and M. B.; diversity statistics: C. M. S., P.Sk., L. M. G., P.Sj., and M.J.; Selection scans: P.Sj., P.Sk., C. M. S., and M.J.. The paper was written by C. M. S., P.Sk., and M.J. with contributions from all authors. Genotype data are available at the Arrayexpress database (www.ebi.ac.uk/arrayexpress/, accession no. E-MTAB-1259) and at www.ebc.uu.se/Research/IEG/evbiol/research/Jakobsson/data/.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barham L., 2008, 1 AFRICANS; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; Falk D, 2012, P NATL ACAD SCI USA, V109, P8467, DOI 10.1073/pnas.1119752109; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hill AD, 2007, AM J MED GENET A, V143A, P1692, DOI 10.1002/ajmg.a.31776; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nurse GT., 1985, PEOPLES SO AFRICA TH; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	29	245	250	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					374	379		10.1126/science.1227721	http://dx.doi.org/10.1126/science.1227721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22997136	Green Accepted, Green Published			2022-12-28	WOS:000309955800039
J	Berton, O; Hahn, CG; Thase, ME				Berton, Olivier; Hahn, Chang-Gyu; Thase, Michael E.			Are We Getting Closer to Valid Translational Models for Major Depression?	SCIENCE			English	Editorial Material							MEDIAL PREFRONTAL CORTEX; SOCIAL DEFEAT STRESS; ANTIDEPRESSANT RESPONSES; NUCLEUS-ACCUMBENS; COGNITIVE BIAS; ANIMAL-MODELS; BEHAVIOR; SEROTONIN; NEURONS; IDENTIFICATION	Advances in characterizing the neuropathology and functional dysconnectivity of depression and promising trials with emerging circuit-targeted and fast-onset therapeutics are providing unprecedented opportunities to gain deeper insight into the neurobiology of this devastating and pervasive disorder. Because of practical and ethical limitations to dissecting these mechanisms in humans, continued progress will critically depend on our ability to emulate aspects of depressive symptomatology and treatment response in nonhuman organisms. Although various experimental models are currently available, they often draw skepticism from both clinicians and basic research scientists. We review recent progress and highlight some of the best leads to diversify and improve discovery end points for preclinical depression research.	[Berton, Olivier; Hahn, Chang-Gyu] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Hahn, Chang-Gyu; Thase, Michael E.] Univ Penn, Dept Psychiat, Mood & Anxiety Disorders Treatment & Res Program, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Berton, O (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	bertonol@mail.med.upenn.edu			U.S. National Institute of Mental Health, NIH [MH087581]; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087581] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health, NIH; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Preparation of this Review was supported by grant MH087581 from the U.S. National Institute of Mental Health, NIH, and by an award from the International Mental Health Research Organization. The authors thank I. Lucki and B. Brookshire for their comments during preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Amemori KI, 2012, NAT NEUROSCI, V15, P776, DOI 10.1038/nn.3088; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bogdan R., 2012, NEUROBIOL DIS; Borgmann-Winter KE, 2009, NEUROSCIENCE, V158, P642, DOI 10.1016/j.neuroscience.2008.09.059; Buckholtz JW, 2012, NEURON, V74, P990, DOI 10.1016/j.neuron.2012.06.002; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Cohn J. K., 2010, 3 C AFF COMP INT INT; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cusi AM, 2012, J PSYCHIATR NEUROSCI, V37, P154, DOI 10.1503/jpn.100179; Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; Der-Avakian A, 2012, TRENDS NEUROSCI, V35, P68, DOI 10.1016/j.tins.2011.11.005; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; Dzirasa K, 2011, J NEUROSCI METH, V195, P36, DOI 10.1016/j.jneumeth.2010.11.014; Espallergues J, 2012, J NEUROSCI, V32, P4400, DOI 10.1523/JNEUROSCI.5634-11.2012; Ferdowsian HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019855; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Glessner JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015463; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Hamani C, 2010, EUR J NEUROSCI, V32, P1109, DOI 10.1111/j.1460-9568.2010.07414.x; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hariri AR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000811; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kohli MA, 2011, NEURON, V70, P252, DOI 10.1016/j.neuron.2011.04.005; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lobo MK, 2012, BIOL PSYCHIAT, V71, P1068, DOI 10.1016/j.biopsych.2011.12.026; Malatynska E, 2005, PHARMACOL BIOCHEM BE, V82, P306, DOI 10.1016/j.pbb.2005.08.020; MCKINNEY WT, 1971, AM J PSYCHIAT, V127, P1313, DOI 10.1176/ajp.127.10.1313; Narayanan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022600; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Porteous DJ, 2011, TRENDS MOL MED, V17, P699, DOI 10.1016/j.molmed.2011.09.002; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Richter SH, 2012, COGN AFFECT BEHAV NE, V12, P527, DOI 10.3758/s13415-012-0101-2; Rucker JJ, 2011, MOL PSYCHIAT; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shivel CA, 2012, EXP NEUROL, V233, P87, DOI 10.1016/j.expneurol.2011.09.026; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Sun H, 2012, NEUROPSYCHOPHARMACOL; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Thase M., 2008, HDB DEPRESSION, P187; Thomson P. A., 2012, MOL PSYCHIAT; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Warden M. R., 2011, 2011 NEUR M PLANN; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109; Willard SL, 2011, MENOPAUSE, V18, P582, DOI 10.1097/gme.0b013e3181fcb47e; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027253; Ziv L., 2012, MOL PSYCHIAT	61	111	116	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					75	79		10.1126/science.1222940	http://dx.doi.org/10.1126/science.1222940			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042886				2022-12-28	WOS:000309457400055
J	Costentin, C; Drouet, S; Robert, M; Saveant, JM				Costentin, Cyrille; Drouet, Samuel; Robert, Marc; Saveant, Jean-Michel			A Local Proton Source Enhances CO2 Electroreduction to CO by a Molecular Fe Catalyst	SCIENCE			English	Article							ELECTROCHEMICAL REDUCTION; CARBON-DIOXIDE; ELECTROCATALYTIC REDUCTION; PALLADIUM COMPLEX; PORPHYRINS; CONVERSION	Electrochemical conversion of carbon dioxide (CO2) to carbon monoxide (CO) is a potentially useful step in the desirable transformation of the greenhouse gas to fuels and commodity chemicals. We have found that modification of iron tetraphenylporphyrin through the introduction of phenolic groups in all ortho and ortho' positions of the phenyl groups considerably speeds up catalysis of this reaction by the electrogenerated iron(0) complex. The catalyst, which uses one of the most earth-abundant metals, manifests a CO faradaic yield above 90% through 50 million turnovers over 4 hours of electrolysis at low overpotential (0.465 volt), with no observed degradation. The basis for the enhanced activity appears to be the high local concentration of protons associated with the phenolic hydroxyl substituents.	[Costentin, Cyrille; Drouet, Samuel; Robert, Marc; Saveant, Jean-Michel] Univ Paris Diderot, Lab Electrochim Mol, Unite Mixte Rech Univ CNRS 7591, F-75205 Paris 13, France	UDICE-French Research Universities; Universite Paris Cite	Costentin, C (corresponding author), Univ Paris Diderot, Lab Electrochim Mol, Unite Mixte Rech Univ CNRS 7591, Batiment Lavoisier,15 Rue Jean de Baif, F-75205 Paris 13, France.	cyrille.costentin@univ-paris-diderot.fr; saveant@univ-paris-diderot.fr			Agence Nationale de la Recherche [ANR 2010 BLAN 0808]	Agence Nationale de la Recherche(French National Research Agency (ANR))	Partial financial support from the Agence Nationale de la Recherche (ANR 2010 BLAN 0808) is gratefully acknowledged.	Bard A. J., 1995, STANDARD POTENTIALS; BELEY M, 1986, J AM CHEM SOC, V108, P7461, DOI 10.1021/ja00284a003; Benson EE, 2009, CHEM SOC REV, V38, P89, DOI 10.1039/b804323j; Bhugun I, 1996, J PHYS CHEM-US, V100, P19981, DOI 10.1021/jp9618486; BHUGUN I, 1994, J AM CHEM SOC, V116, P5015, DOI 10.1021/ja00090a068; Bhugun I, 1996, J AM CHEM SOC, V118, P1769, DOI 10.1021/ja9534462; Bourrez M, 2011, ANGEW CHEM INT EDIT, V50, P9903, DOI 10.1002/anie.201103616; Carver CT, 2012, J AM CHEM SOC, V134, P5444, DOI 10.1021/ja211987f; Chen ZF, 2011, CHEM COMMUN, V47, P12607, DOI 10.1039/c1cc15071e; Cole EB, 2010, J AM CHEM SOC, V132, P11539, DOI 10.1021/ja1023496; Costentin C, 2012, J AM CHEM SOC, V134, P11235, DOI 10.1021/ja303560c; Costentin C, 2011, P NATL ACAD SCI USA, V108, P8559, DOI 10.1073/pnas.1104952108; DuBois DL, 2011, EUR J INORG CHEM, P1017, DOI 10.1002/ejic.201001081; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Froehlich JD, 2012, INORG CHEM, V51, P3932, DOI 10.1021/ic3001619; HAMMOUCHE M, 1988, J ELECTROANAL CHEM, V249, P347, DOI 10.1016/0022-0728(88)80372-3; HAWECKER J, 1984, J CHEM SOC CHEM COMM, P328, DOI 10.1039/c39840000328; LAMY E, 1977, J ELECTROANAL CHEM, V78, P403, DOI 10.1016/0368-1874(77)80196-2; Raebiger JW, 2006, ORGANOMETALLICS, V25, P3345, DOI 10.1021/om060228g; Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786; Saveant JM, 2008, CHEM REV, V108, P2348, DOI 10.1021/cr068079z; STEFFEY BD, 1995, ORGANOMETALLICS, V14, P4937, DOI 10.1021/om00010a066	22	864	875	36	1201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					90	94		10.1126/science.1224581	http://dx.doi.org/10.1126/science.1224581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042890				2022-12-28	WOS:000309457400059
J	McCartney, M				McCartney, Margaret			Taking ecstasy on television: a show trial	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Channel 4, DRUGS LIV ECST TRIAL; Laughland O., 2012, GUARDIAN	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 1	2012	345								e6621	10.1136/bmj.e6621	http://dx.doi.org/10.1136/bmj.e6621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KB	23028102				2022-12-28	WOS:000309657900003
J	Senovilla, L; Vitale, I; Martins, I; Tailler, M; Pailleret, C; Michaud, M; Galluzzi, L; Adjemian, S; Kepp, O; Niso-Santano, M; Shen, SS; Marino, G; Criollo, A; Boileve, A; Job, B; Ladoire, S; Ghiringhelli, F; Sistigu, A; Yamazaki, T; Rello-Varona, S; Locher, C; Poirier-Colame, V; Talbot, M; Valent, A; Berardinelli, F; Antoccia, A; Ciccosanti, F; Fimia, GM; Piacentini, M; Fueyo, A; Messina, NL; Li, M; Chan, CJ; Sigl, V; Pourcher, G; Ruckenstuhl, C; Carmona-Gutierrez, D; Lazar, V; Penninger, JM; Madeo, F; Lopez-Otin, C; Smyth, MJ; Zitvogel, L; Castedo, M; Kroemer, G				Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Job, Bastien; Ladoire, Sylvain; Ghiringhelli, Francois; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Talbot, Monique; Valent, Alexander; Berardinelli, Francesco; Antoccia, Antonio; Ciccosanti, Fabiola; Fimia, Gian Maria; Piacentini, Mauro; Fueyo, Antonio; Messina, Nicole L.; Li, Ming; Chan, Christopher J.; Sigl, Verena; Pourcher, Guillaume; Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Lazar, Vladimir; Penninger, Josef M.; Madeo, Frank; Lopez-Otin, Carlos; Smyth, Mark J.; Zitvogel, Laurence; Castedo, Maria; Kroemer, Guido			An Immunosurveillance Mechanism Controls Cancer Cell Ploidy	SCIENCE			English	Article							CALRETICULIN EXPOSURE; ADAPTIVE IMMUNITY; IMMUNOGENICITY; TETRAPLOIDY; CLEARANCE; MITOSIS; DEATH; P53	Cancer cells accommodate multiple genetic and epigenetic alterations that initially activate intrinsic (cell-autonomous) and extrinsic (immune-mediated) oncosuppressive mechanisms. Only once these barriers to oncogenesis have been overcome can malignant growth proceed unrestrained. Tetraploidization can contribute to oncogenesis because hyperploid cells are genomically unstable. We report that hyperploid cancer cells become immunogenic because of a constitutive endoplasmic reticulum stress response resulting in the aberrant cell surface exposure of calreticulin. Hyperploid, calreticulin-exposing cancer cells readily proliferated in immunodeficient mice and conserved their increased DNA content. In contrast, hyperploid cells injected into immunocompetent mice generated tumors only after a delay, and such tumors exhibited reduced DNA content, endoplasmic reticulum stress, and calreticulin exposure. Our results unveil an immunosurveillance system that imposes immunoselection against hyperploidy in carcinogen-and oncogene-induced cancers.	[Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Job, Bastien; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Talbot, Monique; Lazar, Vladimir; Zitvogel, Laurence; Castedo, Maria; Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Rello-Varona, Santiago; Castedo, Maria; Kroemer, Guido] INSERM, U848, Villejuif, France; [Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Pourcher, Guillaume; Zitvogel, Laurence; Castedo, Maria] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Job, Bastien; Lazar, Vladimir] Unite Genom Fonct & Bioinformat, Villejuif, France; [Job, Bastien; Lazar, Vladimir] Genom Platform, Villejuif, France; [Ladoire, Sylvain; Ghiringhelli, Francois] Georges Francois Leclerc Ctr, Dept Med Oncol, Dijon, France; [Ladoire, Sylvain; Ghiringhelli, Francois] Univ Burgundy, CRI 866, Avenir Team, INSERM, Dijon, France; [Sistigu, Antonella; Yamazaki, Takahiro; Locher, Clara; Poirier-Colame, Vichnou; Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Valent, Alexander] Dept Biol & Pathol Med, Villejuif, France; [Berardinelli, Francesco; Antoccia, Antonio] Univ Roma Tre, Dipartimento Biol, Rome, Italy; [Ciccosanti, Fabiola; Fimia, Gian Maria; Piacentini, Mauro] Natl Inst Infect Dis L Spallanzani, Rome, Italy; [Piacentini, Mauro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Fueyo, Antonio] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Biol Func, Oviedo, Spain; [Messina, Nicole L.; Li, Ming; Chan, Christopher J.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia; [Messina, Nicole L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Chan, Christopher J.] Monash Univ, Dept Immunol, Prahran, Vic, Australia; [Sigl, Verena; Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Pourcher, Guillaume] Antoine Beclere Hosp, AP HP, Dept Minimal Invas Surg, Clamart, France; [Pourcher, Guillaume] INSERM, U972, F-94275 Le Kremlin Bicetre, France; [Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Madeo, Frank] Inst Mol Biosci, Graz, Austria; [Lopez-Otin, Carlos] Univ Oviedo, IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Centre Georges-Francois Leclerc; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Roma Tre University; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oviedo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), Inst Gustave Roussy, Villejuif, France.	zitvogel@igr.fr; castedo@igr.fr; kroemer@orange.fr	Kepp, Oliver/GPX-8627-2022; GARCÍA, GUILLERMO MARIÑO/J-1726-2012; Sistigu, Antonella/J-8934-2018; Ciccosanti, Fabiola/B-5284-2017; Piacentini, Mauro/I-2411-2016; Penninger, Josef M/I-6860-2013; Galluzzi, Lorenzo/AAG-6294-2019; Lazar, Vladimir/AAV-2087-2020; Galluzzi, Lorenzo/AAG-6432-2019; marino, guillermo/HGB-8664-2022; Galluzzi, Lorenzo/AAH-3286-2021; Smyth, Mark J/H-8709-2014; Lazar, Vladimir/AAQ-2086-2020; Niso-Santano, Mireia/AAO-1285-2021; Senovilla, Laura/AAX-5599-2021; Vitale, Ilio/M-3960-2017; KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/K-2709-2012; ADJEMIAN, Sandy/K-7632-2012; Rello-Varona, Santi/A-4882-2009; Locher, Clara/ABF-3635-2020; GARCÍA, GUILLERMO MARIÑO/AAI-8015-2020; Fimia, Gian Maria/K-3232-2016; Berardinelli, Francesco/AAP-2355-2021; Kroemer, Guido/AAY-9859-2020; López-Otín, Carlos/AAB-2106-2020; SHEN, Shensi/AAW-2735-2020; Kepp, Oliver/N-2763-2017; Fueyo, Antonio/ABH-3243-2020	GARCÍA, GUILLERMO MARIÑO/0000-0003-1960-1677; Sistigu, Antonella/0000-0002-2528-1238; Ciccosanti, Fabiola/0000-0003-0481-6878; Piacentini, Mauro/0000-0003-2919-1296; Penninger, Josef M/0000-0002-8194-3777; Smyth, Mark J/0000-0001-7098-7240; Vitale, Ilio/0000-0002-5918-1841; KROEMER, Guido/0000-0002-9334-4405; Galluzzi, Lorenzo/0000-0003-2257-8500; ADJEMIAN, Sandy/0000-0001-5594-5499; Rello-Varona, Santi/0000-0002-7500-5522; Locher, Clara/0000-0002-8212-4351; Fimia, Gian Maria/0000-0003-4438-3325; Berardinelli, Francesco/0000-0002-3094-4139; López-Otín, Carlos/0000-0001-6964-1904; SHEN, Shensi/0000-0002-5087-8220; Kepp, Oliver/0000-0002-6081-9558; Fueyo, Antonio/0000-0002-7121-9398; Messina, Nicole/0000-0001-8404-4462; Niso-Santano, Mireia/0000-0002-6506-422X; ZITVOGEL, laurence/0000-0003-1596-0998; LADOIRE, Sylvain/0000-0002-0331-9194; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Pourcher, Guillaume/0000-0001-9788-628X; Senovilla, Laura/0000-0001-6887-2436; ghiringhelli, francois/0000-0002-5465-8305; Ruckenstuhl, Christoph/0000-0002-4338-4679; Madeo, Frank/0000-0002-5070-1329; Criollo, Alfredo/0000-0002-2737-7751	Ligue Nationale contre le Cancer (LNC, Equipe labelisee); Agence Nationale pour la Recherche (ANR); European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain); Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Canceropole Ile-de-France; Fondation Bettencourt-Schueller; LabEx Immuno-Oncology; Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF) [LIPOTOX, P23490-B12, P24381-B20, W 1226-B18]; FRM; LNC; Junta de Extremadura (Spain); European Molecular Biology Organization; National Health and Medical Research Council (NH and MRC) Australia; Leukemia Foundation of Australia, Monash University; Cancer Research Institute; Austrian Academy of Sciences; Advanced European Research Council; European Union INFLA-CARE network; Austrian Science Fund (FWF) [P 23490] Funding Source: researchfish	Ligue Nationale contre le Cancer (LNC, Equipe labelisee); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Fondation Bettencourt-Schueller; LabEx Immuno-Oncology; Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); FRM(Fondation pour la Recherche Medicale); LNC; Junta de Extremadura (Spain); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Health and Medical Research Council (NH and MRC) Australia; Leukemia Foundation of Australia, Monash University; Cancer Research Institute; Austrian Academy of Sciences; Advanced European Research Council(European Research Council (ERC)); European Union INFLA-CARE network; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to M. L. Albert (Institut Pasteur, Paris) for Ifnar1<SUP>-/-</SUP> and Ifng<SUP>-/-</SUP> mice, M. Colonna (Washington University School of Medicine, St. Louis, MO) for Cd226<SUP>-/-</SUP> mice (Dnam-1<SUP>-/-</SUP> mice), S. B. Horwitz (Albert Einstein College of Medicine, New York) for epothilone B-resistant A549 cells, R. Prywes (Columbia University, New York) for the GFP-ATF6-encoding plasmid, J. Yuan (Massachusetts Institute of Technology, Boston) for the XBP1-DBD-Venus-encoding construct, T. Reid (NIH, Bethesda, MD) for DLD-1 and DLD1+7 cell lines, and D. Metivier for assistance with fluorescence-activated cell sorting (FACS) experiments. G. K. is supported by the Ligue Nationale contre le Cancer (LNC, Equipe labelisee), Agence Nationale pour la Recherche (ANR), European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa), Canceropole Ile-de-France, Fondation Bettencourt-Schueller, and the LabEx Immuno-Oncology. F. M. is grateful to the Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF, grants LIPOTOX, P23490-B12, P24381-B20, and W 1226-B18). L. S. and M. M. are supported by FRM. I. V., I. M., M. T., and S. A. are supported by LNC. M. N.-S. is supported by a postdoctoral contract of Junta de Extremadura (Spain) and G. M. by European Molecular Biology Organization. M. J. S. was supported by National Health and Medical Research Council (NH and MRC) Australia and the Victorian Cancer Agency. C. J. C. was supported by Leukemia Foundation of Australia, Monash University. N. M. was supported by Cancer Research Institute. J. M. P. and V. S. are supported by the Austrian Academy of Sciences, an Advanced European Research Council grant, and the European Union INFLA-CARE network. L. S., I. V., I. M., M. T., C. P., M. M., S. A., O.K., M. N.-S., S. S., G. M., A. C., A. B., B.J., S. L., F. G., A. S., T.Y., S.R.-V., C. L., V.P.-C., M. T., A. V., F. B., A. A., F. C., G. M. F., M. P., A. F., N.L.M., M. L., C.J.C., V. S., G. P., V. L., J.M.P., C.L.-O., M.J.S., and M. C. performed experiments. L. S., C. R., D. C.-G., F. M., L.Z., M. C., and G. K. designed the study. L. S., L.Z., M. C., and G. K. analyzed results. L. S., L. G., and G. K. assembled the figures and wrote the paper. The authors declare no conflicts of interest.	Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Ladoire S, 2011, CLIN BREAST CANCER, V11, P235, DOI 10.1016/j.clbc.2011.06.002; Ladoire S, 2011, J PATHOL, V224, P389, DOI 10.1002/path.2866; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Sengupta K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000199; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Wakita D, 2009, CARCINOGENESIS, V30, P1408, DOI 10.1093/carcin/bgp144; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	34	297	303	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1678	1684		10.1126/science.1224922	http://dx.doi.org/10.1126/science.1224922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019653				2022-12-28	WOS:000309215400052
J	Hernandez, JIG; Ruiz-Lapuente, P; Tabernero, HM; Montes, D; Canal, R; Mendez, J; Bedin, LR				Gonzalez Hernandez, Jonay I.; Ruiz-Lapuente, Pilar; Tabernero, Hugo M.; Montes, David; Canal, Ramon; Mendez, Javier; Bedin, Luigi R.			No surviving evolved companions of the progenitor of SN 1006	NATURE			English	Article							IA SUPERNOVAE; CHEMICAL ABUNDANCES; BINARY COMPANIONS; SN-1006 REMNANT; WHITE-DWARFS; STAR; IMPACT; SPECTROSCOPY; SEARCH; 2011FE	Type Ia supernovae are thought to occur when a white dwarf made of carbon and oxygen accretes sufficient mass to trigger a thermonuclear explosion(1). The accretion could be slow, from an unevolved (main-sequence) or evolved (subgiant or giant) star(2,3) (the single-degenerate channel), or rapid, as the primary star breaks up a smaller orbiting white dwarf(3,4) (the double-degenerate channel). A companion star will survive the explosion only in the single-degenerate channel(5). Both channels might contribute to the production of type Ia supernovae(6,7), but the relative proportions of their contributions remain a fundamental puzzle in astronomy. Previous searches for remnant companions have revealed one possible case for SN 1572 (refs 8, 9), although that has been questioned(10). More recently, observations have restricted surviving companions to be small, main-sequence stars(11-13), ruling out giant companions but still allowing the single-degenerate channel. Here we report the results of a search for surviving companions of the progenitor of SN 1006 (ref. 14). None of the stars within 4 arc minutes of the apparent site of the explosion is associated with the supernova remnant, and we can firmly exclude all giant and subgiant stars from being companions of the progenitor. In combination with previous results, our findings indicate that fewer than 20 per cent of type Ia supernovae occur through the single-degenerate channel.	[Gonzalez Hernandez, Jonay I.] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Gonzalez Hernandez, Jonay I.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Ruiz-Lapuente, Pilar] CSIC, Inst Fis Fundamental, E-28006 Madrid, Spain; [Ruiz-Lapuente, Pilar; Canal, Ramon; Mendez, Javier] Univ Barcelona, Dept Astron, Inst Ciencies Cosmos, E-08028 Barcelona, Spain; [Tabernero, Hugo M.; Montes, David] Univ Complutense Madrid, Dept Astrofis & Ciencias Atmosfera, Fac Ciencias Fis, E-28040 Madrid, Spain; [Mendez, Javier] Isaac Newton Grp Telescopes, Santa Cruz De La Palma, Spain; [Bedin, Luigi R.] INAF Osservatorio Astron Padova, I-35122 Padua, Italy	Instituto de Astrofisica de Canarias; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Fundamental (IFF); University of Barcelona; Complutense University of Madrid; Isaac Newton Group of Telescopes; Istituto Nazionale Astrofisica (INAF)	Hernandez, JIG (corresponding author), Inst Astrofis Canarias, E-38205 Tenerife, Spain.	jonay@iac.es; pilar@am.ub.es	Hernández, Jonay I. González/L-3556-2014; Montes, David/B-9329-2014; Montes, David/N-2760-2019; Ruiz-Lapuente, Pilar/N-7475-2018; Canal, Ramón/N-7351-2018; Tabernero, Hugo/ABI-6402-2020	Hernández, Jonay I. González/0000-0002-0264-7356; Montes, David/0000-0002-7779-238X; Montes, David/0000-0002-7779-238X; Tabernero, Hugo/0000-0002-8087-4298; Ruiz-Lapuente, Pilar/0000-0001-9046-4420; Canal, Ramon/0000-0002-0465-2829; bedin, luigi/0000-0003-4080-6466	Spanish Ministerio de Ciencia e Innovacion (MICINN); Universidad Complutense de Madrid (UCM); Comunidad de Madrid	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad Complutense de Madrid (UCM); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN), the Universidad Complutense de Madrid (UCM) and the Comunidad de Madrid, and is based on observations collected with the UVES spectrograph at the VLT/UT2 8.2-m Kueyen Telescope (ESO run ID, 69.D-0397(A)) at the Paranal Observatory, Chile. We are grateful to the Cerro Paranal Observatory staff and to the User Support Department of ESO for their help.	Allen GE, 2001, ASTROPHYS J, V558, P739, DOI 10.1086/322470; BRANCH D, 1995, PUBL ASTRON SOC PAC, V107, P1019, DOI 10.1086/133657; Brandt TD, 2010, ASTRON J, V140, P804, DOI 10.1088/0004-6256/140/3/804; Cutri R.M., 2003, 2MASS ALL SKY CATALO; Edwards ZI, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L19; Greggio L, 2010, MON NOT R ASTRON SOC, V406, P22, DOI 10.1111/j.1365-2966.2010.16371.x; Hernandez JIG, 2009, ASTROPHYS J, V691, P1, DOI 10.1088/0004-637X/691/1/1; Kasen D, 2010, ASTROPHYS J, V708, P1025, DOI 10.1088/0004-637X/708/2/1025; Kerzendorf WE, 2009, ASTROPHYS J, V701, P1665, DOI 10.1088/0004-637X/701/2/1665; Kurucz R. L., 1993, ATLAS9 STELLAR ATMOS; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Marietta E, 2000, ASTROPHYS J SUPPL S, V128, P615, DOI 10.1086/313392; Monet D. G., 1998, BAAS, V30, P1427; Neves V, 2009, ASTRON ASTROPHYS, V497, P563, DOI 10.1051/0004-6361/200811328; Nomoto K, 2007, ASTROPHYS J, V663, P1269, DOI 10.1086/518465; Nugent PE, 2011, NATURE, V480, P344, DOI 10.1038/nature10644; Pakmor R, 2008, ASTRON ASTROPHYS, V489, P943, DOI 10.1051/0004-6361:200810456; Pakmor R, 2010, NATURE, V463, P61, DOI 10.1038/nature08642; Pan KC, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/151; Podsiadlowski P., 2003, EVOLUTION APPEARANCE; Ruiz-Lapuente P, 2004, NATURE, V431, P1069, DOI 10.1038/nature03006; RuizLapuente P, 1997, SCIENCE, V276, P1813, DOI 10.1126/science.276.5320.1813; Schaefer BE, 2012, NATURE, V481, P164, DOI 10.1038/nature10692; Stephenson FR, 2010, ASTRON GEOPHYS, V51, P27; Sternberg A, 2011, SCIENCE, V333, P856, DOI 10.1126/science.1203836; Tabernero H. M., 2012, ASTRON ASTR IN PRESS; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565; Winkler PF, 2005, ASTROPHYS J, V624, P189, DOI 10.1086/429155; Winkler PF, 2003, ASTROPHYS J, V585, P324, DOI 10.1086/345985	30	70	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					533	536		10.1038/nature11447	http://dx.doi.org/10.1038/nature11447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23018963	Green Accepted, Green Submitted			2022-12-28	WOS:000309167100043
J	Hoofnagle, JH; Nelson, KE; Purcell, RH				Hoofnagle, Jay H.; Nelson, Kenrad E.; Purcell, Robert H.			CURRENT CONCEPTS Hepatitis E	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NON-B HEPATITIS; E VIRUS-INFECTION; UNITED-STATES; NON-A; IGG SEROPREVALENCE; RISK-FACTORS; PATIENT; DISEASE; FOOD; EPIDEMIOLOGY		[Hoofnagle, Jay H.] NIDDKD, Liver Dis Res Branch, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA; [Purcell, Robert H.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Nelson, Kenrad E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hoofnagle, JH (corresponding author), NIDDKD, Liver Dis Res Branch, Div Digest Dis & Nutr, NIH, Rm 9A27,31 Ctr Dr, Bethesda, MD 20892 USA.	hoofnaglej@extra.niddk.nih.gov						Ahmad I, 2011, VIRUS RES, V161, P47, DOI 10.1016/j.virusres.2011.02.011; Alric L, 2010, ANN INTERN MED, V153, P135, DOI 10.7326/0003-4819-153-2-201007200-00256; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Borgen K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-61; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Chandra NS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-213; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Davern TJ, 2011, GASTROENTEROLOGY, V141, P1665, DOI 10.1053/j.gastro.2011.07.051; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Feagins AR, 2008, INT J FOOD MICROBIOL, V123, P32, DOI 10.1016/j.ijfoodmicro.2007.11.068; Fontana RJ, HEPATITIS E CAUSE AC; Gerolami R, 2011, J CLIN VIROL, V52, P60, DOI 10.1016/j.jcv.2011.06.004; Tallon AIG, 2011, GASTROENT HEPAT-BARC, V34, P398, DOI 10.1016/j.gastrohep.2011.02.011; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Holmberg SD, HEPATITIS E US; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; Kamar N, 2010, GASTROENTEROLOGY, V139, P1612, DOI 10.1053/j.gastro.2010.08.002; Kase JA, 2009, J WATER HEALTH, V7, P344, DOI 10.2166/wh.2009.137; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Labrique AB, 2010, AM J EPIDEMIOL, V172, P952, DOI 10.1093/aje/kwq225; Mast EE, 1998, HEPATOLOGY, V27, P857, DOI 10.1002/hep.510270331; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; Matsubayashi K, 2008, TRANSFUSION, V48, P1368, DOI 10.1111/j.1537-2995.2008.01722.x; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Ollier L, 2009, ANN INTERN MED, V150, P430, DOI 10.7326/0003-4819-150-6-200903170-00026; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purcell RH, 2011, EMERG INFECT DIS, V17, P2216, DOI 10.3201/eid1712.110482; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Sainokami S, 2004, J GASTROENTEROL, V39, P640, DOI 10.1007/s00535-003-1359-5; Schlauder GG, 1998, J GEN VIROL, V79, P447, DOI 10.1099/0022-1317-79-3-447; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Takahashi H, 2012, ARCH VIROL, V157, P235, DOI 10.1007/s00705-011-1153-2; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Thomas DL, 1997, J CLIN MICROBIOL, V35, P1244, DOI 10.1128/JCM.35.5.1244-1247.1997; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; WONG DC, 1980, LANCET, V2, P876; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Xu C, ASSESSMENT HEV PREVA; Zhang SJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-152; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	55	361	377	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1237	1244		10.1056/NEJMra1204512	http://dx.doi.org/10.1056/NEJMra1204512			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	23013075				2022-12-28	WOS:000309161100010
J	Sahoo, SK; Planavsky, NJ; Kendall, B; Wang, XQ; Shi, XY; Scott, C; Anbar, AD; Lyons, TW; Jiang, GQ				Sahoo, Swapan K.; Planavsky, Noah J.; Kendall, Brian; Wang, Xinqiang; Shi, Xiaoying; Scott, Clint; Anbar, Ariel D.; Lyons, Timothy W.; Jiang, Ganqing			Ocean oxygenation in the wake of the Marinoan glaciation	NATURE			English	Article							EVOLUTION; MOLYBDENUM; OXIDATION; VANADIUM	Metazoans are likely to have their roots in the Cryogenian period(1-3), but there is a marked increase in the appearance of novel animal and algae fossils shortly after the termination of the late Cryogenian (Marinoan) glaciation about 635 million years ago(4-6). It has been suggested that an oxygenation event in the wake of the severe Marinoan glaciation was the driving factor behind this early diversification of metazoans and the shift in ecosystem complexity(7,8). But there is little evidence for an increase in oceanic or atmospheric oxygen following the Marinoan glaciation, or for a direct link between early animal evolution and redox conditions in general(9). Models linking trends in early biological evolution to shifts in Earth system processes thus remain controversial(10). Here we report geochemical data from early Ediacaran organic-rich black shales (similar to 635-630 million years old) of the basal Doushantuo Formation in South China. High enrichments of molybdenum and vanadium and low pyrite sulphur isotope values (Delta S-34 values >= 65 per mil) in these shales record expansion of the oceanic inventory of redox-sensitive metals and the growth of the marine sulphate reservoir in response to a widely oxygenated ocean. The data provide evidence for an early Ediacaran oxygenation event, which pre-dates the previous estimates for post-Marinoan oxygenation(11-13) by more than 50 million years. Our findings seem to support a link between the most severe glaciations in Earth's history, the oxygenation of the Earth's surface environments, and the earliest diversification of animals.	[Sahoo, Swapan K.; Jiang, Ganqing] Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA; [Planavsky, Noah J.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Kendall, Brian; Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Wang, Xinqiang; Shi, Xiaoying] China Univ Geosci, Sch Earth Sci & Resources, Beijing 10008, Peoples R China; [Scott, Clint] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ H3A 2A7, Canada; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California Riverside; Arizona State University; Arizona State University-Tempe; China University of Geosciences; McGill University; Arizona State University; Arizona State University-Tempe	Jiang, GQ (corresponding author), Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA.	Ganqing.Jiang@unlv.edu	Jiang, Ganqing/AAX-7756-2020; Jiang, Ganqing/GZM-7526-2022; Wang, Xinqiang/AAK-6472-2020; Wang, Xinqiang/T-8002-2017; Jiang, Ganqing/A-9557-2011; Kendall, Brian S/I-6820-2012	Jiang, Ganqing/0000-0002-6627-2848; Wang, Xinqiang/0000-0001-8437-5034; Wang, Xinqiang/0000-0001-8437-5034; Jiang, Ganqing/0000-0002-6627-2848; Sahoo, Swapan/0000-0003-3560-1589; Kendall, Brian/0000-0002-8914-2309	National Science Foundation Division of Earth Science; NASA Astrobiology programme; National Natural Science Foundation of China; Division Of Earth Sciences [0746035] Funding Source: National Science Foundation	National Science Foundation Division of Earth Science(National Science Foundation (NSF)); NASA Astrobiology programme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by the National Science Foundation Division of Earth Science, NASA Astrobiology programme and National Natural Science Foundation of China. We are grateful to S. Xiao for input, discussions and editing the palaeontological text. We thank C. Reinhard, G. Love, A. Mix, J. Morford, D. Adams, J. Owens, C. Li and L. Och for discussions and S. Bates, G. Gordon and J. Owens for assistance with laboratory analyses. We thank M. Wille for comments and suggestions.	Algeo TJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001112; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; CALVERT SE, 1993, MAR GEOL, V113, P67, DOI 10.1016/0025-3227(93)90150-T; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2005, ADV MAR BIOL, V48, P1; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; EMERSON SR, 1991, MAR CHEM, V34, P177, DOI 10.1016/0304-4203(91)90002-E; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Hastings DW, 1996, PALEOCEANOGRAPHY, V11, P665, DOI 10.1029/96PA01985; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Jiang GQ, 2011, GONDWANA RES, V19, P831, DOI 10.1016/j.gr.2011.01.006; Jiang GQ, 2010, EARTH PLANET SC LETT, V299, P159, DOI 10.1016/j.epsl.2010.08.031; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Lyons TW, 2009, ANNU REV EARTH PL SC, V37, P507, DOI 10.1146/annurev.earth.36.031207.124233; Maloof AC, 2010, NAT GEOSCI, V3, P653, DOI 10.1038/NGEO934; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; Miller CA, 2011, GEOCHIM COSMOCHIM AC, V75, P7146, DOI 10.1016/j.gca.2011.09.005; Och LM, 2012, EARTH-SCI REV, V110, P26, DOI 10.1016/j.earscirev.2011.09.004; Pecoits E, 2012, SCIENCE, V336, P1693, DOI 10.1126/science.1216295; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Planavsky NJ, 2010, NATURE, V467, P1088, DOI 10.1038/nature09485; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Sim MS, 2011, SCIENCE, V333, P74, DOI 10.1126/science.1205103; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682; Yuan XL, 2011, NATURE, V470, P390, DOI 10.1038/nature09810	32	348	375	16	289	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					546	549		10.1038/nature11445	http://dx.doi.org/10.1038/nature11445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23018964				2022-12-28	WOS:000309167100046
J	Yuan, H; Myers, S; Wang, JG; Zhou, D; Woo, JA; Kallakury, B; Ju, A; Bazylewicz, M; Carter, YM; Albanese, C; Grant, N; Shad, A; Dritschilo, A; Liu, XF; Schlegel, R				Yuan, Hang; Myers, Scott; Wang, Jingang; Zhou, Dan; Woo, Jennifer A.; Kallakury, Bhaskar; Ju, Andrew; Bazylewicz, Michael; Carter, Yvonne M.; Albanese, Christopher; Grant, Nazaneen; Shad, Aziza; Dritschilo, Anatoly; Liu, Xuefeng; Schlegel, Richard			Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPITHELIAL-CELLS; CARCINOMA; LUNG; INVOLVEMENT; VORINOSTAT; INHIBITORS; APOPTOSIS; PATIENT; INDUCE; DNA	A patient with a 20-year history of recurrent respiratory papillomatosis had progressive, bilateral tumor invasion of the lung parenchyma. We used conditional reprogramming to generate cell cultures from the patient's normal and tumorous lung tissue. Analysis revealed that the laryngeal tumor cells contained a wild-type 7.9-kb human papillomavirus virus type 11 (HPV-11) genome, whereas the pulmonary tumor cells contained a 10.4-kb genome. The increased size of the latter viral genome was due to duplication of the promoter and oncogene regions. Chemosensitivity testing identified vorinostat as a potential therapeutic agent. At 3 months after treatment initiation, tumor sizes had stabilized, with durable effects at 15 months.	[Yuan, Hang; Wang, Jingang; Zhou, Dan; Woo, Jennifer A.; Kallakury, Bhaskar; Albanese, Christopher; Liu, Xuefeng; Schlegel, Richard] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20057 USA; [Myers, Scott; Shad, Aziza] Georgetown Univ, Med Ctr, Dept Pediat Oncol, Washington, DC 20057 USA; [Ju, Andrew; Dritschilo, Anatoly] Georgetown Univ, Med Ctr, Dept Radiat Med, Washington, DC 20057 USA; [Bazylewicz, Michael] Georgetown Univ, Med Ctr, Dept Radiol, Washington, DC 20057 USA; [Carter, Yvonne M.] Georgetown Univ, Med Ctr, Dept Surg, Washington, DC 20057 USA; [Grant, Nazaneen] Georgetown Univ, Med Ctr, Dept Otolaryngol, Washington, DC 20057 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University	Schlegel, R (corresponding author), Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20057 USA.	xl24@georgetown.edu; schleger@georgetown.edu			Office of the Director, National Institutes of Health [R01 OD011168]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011168] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by a grant from the Office of the Director, National Institutes of Health (R01 OD011168, to Dr. Schlegel).	Buck CB, 2005, METH MOLEC MED, V119, P445; BYRNE JC, 1987, NEW ENGL J MED, V317, P873, DOI 10.1056/NEJM198710013171406; Chow LT, 2010, APMIS, V118, P422, DOI 10.1111/j.1600-0463.2010.02625.x; Cook JR, 2000, MODERN PATHOL, V13, P914, DOI 10.1038/modpathol.3880164; DARMANN K, 1986, VIROLOGY, V151, P124, DOI 10.1016/0042-6822(86)90110-8; DELIUS H, 1994, VIROLOGY, V204, P447, DOI 10.1006/viro.1994.1552; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; DILORENZO TP, 1992, J GEN VIROL, V73, P423, DOI 10.1099/0022-1317-73-2-423; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Finzer P, 2001, ONCOGENE, V20, P4768, DOI 10.1038/sj.onc.1204652; Gelinas JF, 2008, INT J PEDIATR OTORHI, V72, P433, DOI 10.1016/j.ijporl.2007.12.003; Goon P, 2008, EUR ARCH OTO-RHINO-L, V265, P147, DOI 10.1007/s00405-007-0546-z; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Pransky SM, 2003, LARYNGOSCOPE, V113, P1583, DOI 10.1097/00005537-200309000-00032; Silver RD, 2003, OTOLARYNG HEAD NECK, V129, P622, DOI 10.1016/j.otohns.2003.08.018; Wiegmans AP, 2011, CANCER RES, V71, P3603, DOI 10.1158/0008-5472.CAN-10-3289	19	115	128	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1220	1227		10.1056/NEJMoa1203055	http://dx.doi.org/10.1056/NEJMoa1203055			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	23013073	Green Accepted, Bronze			2022-12-28	WOS:000309161100008
J	Kocher, B; Emanuel, EJ				Kocher, Bob; Emanuel, Ezekiel J.			Overcoming the Pricing Power of Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] Univ Penn, Off Provost, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Kocher, Bob] Venrock, Palo Alto, CA USA	University of Pennsylvania; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Off Provost, 122 Coll Hall, Philadelphia, PA 19104 USA.	vp-global@upenn.edu						Bazinsky KR, 2012, JAMA-J AM MED ASSOC, V307, P1261, DOI 10.1001/jama.2012.364; Centers for Medicare and Medicaid Services, NAT HLTH EXP PROJ 20; Irving Levin & Associates, DEC REV HOSP M A DEA; Kocher R, 2011, NEW ENGL J MED, V364, P1790, DOI 10.1056/NEJMp1101959; PricewaterhouseCoopers, MED COST TREND NUMB; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Robinson J, REGULATORS SEEK COOL	7	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1213	1214		10.1001/2012.jama.11910	http://dx.doi.org/10.1001/2012.jama.11910			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011709				2022-12-28	WOS:000309103600021
J	Cresswell, JE; Thompson, HM				Cresswell, James E.; Thompson, Helen M.			Comment on "A Common Pesticide Decreases Foraging Success and Survival in Honey Bees"	SCIENCE			English	Editorial Material							NEONICOTINOIDS; INSECTICIDES		[Cresswell, James E.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Cresswell, James E.] Univ Calcutta, Ctr Pollinat Studies, Kolkata 700019, India; [Thompson, Helen M.] Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England	University of Exeter; University of Calcutta; Food & Environment Research Agency	Cresswell, JE (corresponding author), Univ Exeter, Coll Life & Environm Sci, Stocker Rd, Exeter EX4 4QD, Devon, England.	j.e.cresswell@ex.ac.uk	Thompson, Helen/H-7753-2013	Thompson, Helen/0000-0001-5137-5214				Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hoyle M, 2007, ECOL APPL, V17, P2123, DOI 10.1890/06-1972.1; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Nauen R, 2011, RSC GREEN CHEM SER, V11, P132; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Rueppell O, 2009, EXP GERONTOL, V44, P447, DOI 10.1016/j.exger.2009.04.003; WINSTON ML, 1981, OECOLOGIA, V48, P407, DOI 10.1007/BF00346502	13	46	47	4	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101								10.1126/science.1224618	http://dx.doi.org/10.1126/science.1224618			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997307				2022-12-28	WOS:000308912900020
J	Selkoe, DJ				Selkoe, Dennis J.			Preventing Alzheimer's Disease	SCIENCE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; LEISURE ACTIVITIES; PHYSICAL-ACTIVITY; OLDER-ADULTS; RISK; MODEL; THERAPEUTICS; BIOMARKERS; OLIGOMERS	Despite intensive laboratory and clinical research over three decades, an effective treatment to delay the onset and progression of Alzheimer's disease is not at hand. Recent clinical trial failures suggest that we must treat the disease earlier than in its mild to moderate stages, and major progress in validating presymptomatic biomarkers now makes secondary prevention trials possible. We will learn more about the natural history of the disease and any partial therapeutic responses from detailed analyses of recent trial results. This process will likely position the field for success, but only with much greater investment in all aspects of Alzheimer research and with careful design of future trials.	Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu						Alzheimer Research Forum, 2012, ALZHEIMER RES F 0515; Alzheimer Research Forum, 2011, ALZHEIMER RES F 1227; Bateman R. J., 2012, NEW ENGL J MED; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Blennow K., ARCH NEUROL; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Brown MS, 1996, SCIENCE, V272, P629, DOI 10.1126/science.272.5262.629; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Intlekofer K. A., NEUROBIOL DIS; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; LANDAU SM, 2012, ARCH NEUROL; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; Morris J. C., 2011, NEUROBIOL AGING S1, V32, pS1; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Muller U. C., 2012, BIOL ALZHEIMERS DIS, P231; NIH Fogarty International Center, 2012, 1 EV ALZH PREV TRIAL; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; Pankevich D. E., 2012, ALZHEIMERS DIAGNOSTI; RINNE JO, 2010, OPTN SRTR ANN REP, V9, P363, DOI DOI 10.1016/S1474-4422(10)70043-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wimo A, 2010, WORLD ALZHEIMER REPO; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004	44	296	306	2	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1488	1492		10.1126/science.1228541	http://dx.doi.org/10.1126/science.1228541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997326	Green Published			2022-12-28	WOS:000308912900038
J	Basu, J; Betts, T				Basu, Joyee; Betts, Timothy			A heart stopping performance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LONG-QT SYNDROME; SUDDEN CARDIAC DEATH; HIGH-RISK PATIENTS; MANAGEMENT; STATEMENT		[Basu, Joyee] Stoke Mandeville Hosp, Aylesbury HP21 8AL, Bucks, England; [Betts, Timothy] John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford	Basu, J (corresponding author), Stoke Mandeville Hosp, Aylesbury HP21 8AL, Bucks, England.	joyeebasu11@yahoo.co.uk		Betts, Timothy/0000-0001-9063-9905				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Behr ER, 2009, INHERITED HEART COND; Chopra N, 2011, CURR OPIN CARDIOL, V26, P196, DOI 10.1097/HCO.0b013e3283459893; Garratt CJ, 2010, EUROPACE, V12, P1156, DOI 10.1093/europace/euq261; Goldenberg I, 2010, J CARDIOVASC ELECTR, V21, P893, DOI 10.1111/j.1540-8167.2010.01737.x; Hobbs JB, 2006, JAMA-J AM MED ASSOC, V296, P1249, DOI 10.1001/jama.296.10.1249; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Priori SG, 2008, NEW ENGL J MED, V348, P1866; Rautaharju PM, 2009, CIRCULATION, V119, pE241, DOI 10.1161/CIRCULATIONAHA.108.191096; Resuscitation Council (UK), RES GUID 2010 AD ADV; Schwartz PJ, 2001, CIRCULATION, V103, P89; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Schwartz PJ, 2011, J PHARM THER, V131, P171; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Zipes DP, 2006, EUROPACE, V8, P746, DOI 10.1093/europace/eul108	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2012	345								e6076	10.1136/bmj.e6076	http://dx.doi.org/10.1136/bmj.e6076			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JJ	22996936				2022-12-28	WOS:000309160600001
J	Koller, MT; Leening, MJG; Wolbers, M; Steyerberg, EW; Hunink, MGM; Schoop, R; Hofman, A; Bucher, HC; Psaty, BM; Lloyd-Jones, DM; Witteman, JCM				Koller, Michael T.; Leening, Maarten J. G.; Wolbers, Marcel; Steyerberg, Ewout W.; Hunink, M. G. Myriam; Schoop, Rotraut; Hofman, Albert; Bucher, Heiner C.; Psaty, Bruce M.; Lloyd-Jones, Donald M.; Witteman, Jacqueline C. M.			Development and Validation of a Coronary Risk Prediction Model for Older US and European Persons in the Cardiovascular Health Study and the Rotterdam Study	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-DISEASE; COMPETING RISKS; SUBDISTRIBUTION HAZARDS; PREVENTION; DETERMINANTS; METHODOLOGY; IMPUTATION; PROFILE; EVENTS; SCORES	Background: Risk scores for prediction of coronary heart disease (CHD) in older adults are needed. Objective: To develop a sex-specific CHD risk prediction model for older adults that accounts for competing risks for death. Design: 2 observational cohort studies, using data from 4946 participants in the Cardiovascular Health Study (CHS) and 4303 participants in the Rotterdam Study (RS). Setting: Community settings in the United States (CHS) and Rotterdam, the Netherlands (RS). Participants: Persons aged 65 years or older who were free of cardiovascular disease. Measurements: A composite of nonfatal myocardial infarction and coronary death. Results: During a median follow-up of 16.5 and 14.9 years, 1166 CHS and 698 RS participants had CHD events, respectively. Deaths from noncoronary causes largely exceeded the number of CHD events, complicating accurate CHD risk predictions. The prediction model had moderate ability to discriminate between events and nonevents (c-statistic, 0.63 in both U.S. and European men and 0.67 and 0.68 in U.S. and European women). The model was well-calibrated; predicted risks were in good agreement with ob-served risks. Compared with the Framingham point scores, the prediction model classified elderly U.S. persons into higher risk categories but elderly European persons into lower risk categories. Differences in classification accuracy were not consistent and depended on cohort and sex. Adding newer cardiovascular risk markers to the model did not substantially improve performance. Limitation: The model may be less applicable in nonwhite populations, and the comparison Framingham model was not designed for adults older than 79 years. Conclusion: A CHD risk prediction model that accounts for deaths from noncoronary causes among older adults provided well-calibrated risk estimates but was not substantially more accurate than Framingham point scores. Moreover, adding newer risk markers did not improve accuracy. These findings emphasize the difficulties of predicting CHD risk in elderly persons and the need to improve these predictions.	[Koller, Michael T.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; Erasmus MC, Rotterdam, Netherlands; Hosp Trop Dis, Ho Chi Minh City, Vietnam; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Freiburg, D-79106 Freiburg, Germany; Univ Washington, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98195 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Basel; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; University of Freiburg; University of Washington; University of Washington Seattle; Group Health Cooperative; Northwestern University; Feinberg School of Medicine	Koller, MT (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Hebelstr 10,Petersgraben 4, CH-4031 Basel, Switzerland.	mkoller@uhbs.ch	Koller, Michael/AEN-1656-2022; Steyerberg, Ewout W/C-1509-2018	Koller, Michael/0000-0001-5574-2341; Steyerberg, Ewout W/0000-0002-7787-0122; Leening, Maarten J. G./0000-0002-4143-4839; Lloyd-Jones, Donald/0000-0003-0847-6110	National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; Netherlands Organisation for Scientific Research; Netherlands Organisation for Health Research and Development; University of Basel research foundation; Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation; National Heart, Lung, and Blood Institute [N01-HC-80007, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; Netherlands Organisation for Health Research and Development [80-82500-98-10208, 918-76-619]; Erasmus Medical Center; Erasmus University Rotterdam; Research Institute for Diseases in the Elderly; Ministry of Education, Culture, and Science; Ministry of Health, Welfare, and Sports; European Commission; Municipality of Rotterdam, the Netherlands; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045133, N01HC085086, N01HC085079, N01HC075150, N01HC055222, N01HC015103, N01HC035129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, U01HL080295] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); University of Basel research foundation; Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Erasmus Medical Center; Erasmus University Rotterdam; Research Institute for Diseases in the Elderly; Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam, the Netherlands(Netherlands Government); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; The Netherlands Organisation for Scientific Research; and the Netherlands Organisation for Health Research and Development.; By the University of Basel research foundation (Dr. Koller); Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation (Drs. Koller and Bucher); the Wellcome Trust (Dr. Wolbers); contracts N01-HC-80007, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and grant U01 HL080295 from the National Heart, Lung, and Blood Institute, with additional contributions from the National Institute of Neurological Disorders and Stroke, the Netherlands Organisation for Scientific Research and the Netherlands Organisation for Health Research and Development (ZonMW grant 80-82500-98-10208 and Vici grant 918-76-619). The RS is supported by the Erasmus Medical Center and Erasmus University Rotterdam; the Netherlands Organisation for Scientific Research; the Netherlands Organisation for Health Research and Development; the Research Institute for Diseases in the Elderly; the Ministry of Education, Culture, and Science; the Ministry of Health, Welfare, and Sports; the European Commission (DG XII); and the Municipality of Rotterdam, the Netherlands.	Allignol A, 2010, BIOSTATISTICS, V11, P674, DOI 10.1093/biostatistics/kxq018; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Andrawes WF, 2005, DRUG AGING, V22, P859, DOI 10.2165/00002512-200522100-00005; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Beyersmann J, 2007, STAT MED, V26, P5360, DOI 10.1002/sim.3006; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Collaborative Health Studies Coordinating Center, 1998, CARD HLTH STUD DESCR; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; Dornbrook-Lavender KA, 2003, ANN PHARMACOTHER, V37, P1654, DOI 10.1345/aph.1D025; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Franklin SS, 2001, CIRCULATION, V103, P1245; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrell Jr. FE, 2001, STAT MED; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Koller MT, 2008, CIRCULATION, V117, P1918, DOI 10.1161/CIRCULATIONAHA.107.742155; Koller MT, 2007, AM HEART J, V154, P87, DOI 10.1016/j.ahj.2007.03.022; Koller MT, 2012, STAT MED, V31, P1089, DOI 10.1002/sim.4384; Kuller LH, 2006, CIRCULATION, V113, P598, DOI 10.1161/CIRCULATIONAHA.105.604595; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Leening MJG, 2012, EUR J EPIDEMIOL, V27, P173, DOI 10.1007/s10654-012-9668-8; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Meijer WT, 2000, ARCH INTERN MED, V160, P2934, DOI 10.1001/archinte.160.19.2934; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2011, INT J EPIDEMIOL, V40, P1106, DOI 10.1093/ije/dyr083; Pepe MS, 2011, AM J EPIDEMIOL, V173, P1327, DOI 10.1093/aje/kwr013; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ruan PK, 2008, STAT MED, V27, P5709, DOI 10.1002/sim.3402; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; van Buuren S, 2011, J STAT SOFTW, V45, P1; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056	52	55	55	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6					389	U38		10.7326/0003-4819-157-6-201209180-00002	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00002			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986376	Green Accepted			2022-12-28	WOS:000308912800013
J	Ryan, O; Shapiro, RS; Kurat, CF; Mayhew, D; Baryshnikova, A; Chin, B; Lin, ZY; Cox, MJ; Vizeacoumar, F; Cheung, D; Bahr, S; Tsui, K; Tebbji, F; Sellam, A; Istel, F; Schwarzmuller, T; Reynolds, TB; Kuchler, K; Gifford, DK; Whiteway, M; Giaever, G; Nislow, C; Costanzo, M; Gingras, AC; Mitra, RD; Andrews, B; Fink, GR; Cowen, LE; Boone, C				Ryan, Owen; Shapiro, Rebecca S.; Kurat, Christoph F.; Mayhew, David; Baryshnikova, Anastasia; Chin, Brian; Lin, Zhen-Yuan; Cox, Michael J.; Vizeacoumar, Frederick; Cheung, Doris; Bahr, Sondra; Tsui, Kyle; Tebbji, Faiza; Sellam, Adnane; Istel, Fabian; Schwarzmueller, Tobias; Reynolds, Todd B.; Kuchler, Karl; Gifford, David K.; Whiteway, Malcolm; Giaever, Guri; Nislow, Corey; Costanzo, Michael; Gingras, Anne-Claude; Mitra, Robi David; Andrews, Brenda; Fink, Gerald R.; Cowen, Leah E.; Boone, Charles			Global Gene Deletion Analysis Exploring Yeast Filamentous Growth	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; HYPHAL DEVELOPMENT; FUNGAL DEVELOPMENT; KINASE; FLO11; SPECIFICITY; PATHWAY	The dimorphic switch from a single-cell budding yeast to a filamentous form enables Saccharomyces cerevisiae to forage for nutrients and the opportunistic pathogen Candida albicans to invade human tissues and evade the immune system. We constructed a genome-wide set of targeted deletion alleles and introduced them into a filamentous S. cerevisiae strain, Sigma 1278b. We identified genes involved in morphologically distinct forms of filamentation: haploid invasive growth, biofilm formation, and diploid pseudohyphal growth. Unique genes appear to underlie each program, but we also found core genes with general roles in filamentous growth, including MFG1 (YDL233w), whose product binds two morphogenetic transcription factors, Flo8 and Mss11, and functions as a critical transcriptional regulator of filamentous growth in both S. cerevisiae and C. albicans.	[Chin, Brian; Gifford, David K.; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ryan, Owen; Kurat, Christoph F.; Baryshnikova, Anastasia; Cox, Michael J.; Cheung, Doris; Bahr, Sondra; Nislow, Corey; Costanzo, Michael; Andrews, Brenda; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Ryan, Owen; Shapiro, Rebecca S.; Baryshnikova, Anastasia; Cox, Michael J.; Giaever, Guri; Nislow, Corey; Gingras, Anne-Claude; Andrews, Brenda; Cowen, Leah E.; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ryan, Owen; Kurat, Christoph F.; Baryshnikova, Anastasia; Cox, Michael J.; Cheung, Doris; Bahr, Sondra; Tsui, Kyle; Giaever, Guri; Nislow, Corey; Costanzo, Michael; Andrews, Brenda; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Mayhew, David; Mitra, Robi David] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63108 USA; [Mayhew, David; Mitra, Robi David] Washington Univ, Ctr Genome Sci & Syst Biol, Sch Med, St Louis, MO 63108 USA; [Lin, Zhen-Yuan; Vizeacoumar, Frederick; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Tsui, Kyle; Giaever, Guri] Univ Toronto, Dept Pharm, Toronto, ON M5S 3E1, Canada; [Tebbji, Faiza; Sellam, Adnane; Whiteway, Malcolm] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Tebbji, Faiza; Whiteway, Malcolm] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Sellam, Adnane] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1B1, Canada; [Istel, Fabian; Schwarzmueller, Tobias; Kuchler, Karl] Med Univ Vienna, Christian Doppler Lab Infect Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Reynolds, Todd B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Gifford, David K.; Fink, Gerald R.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Gifford, David K.; Fink, Gerald R.] Harvard Univ, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Toronto; University of Toronto; University of Toronto; Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Research Council Canada; McGill University; McGill University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Tennessee System; University of Tennessee Knoxville; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; leah.cowen@utoronto.ca; charlie.boone@utoronto.ca	Gingras, Anne-Claude/ABA-8341-2020; Young, Richard A/F-6495-2012; Shapiro, Rebecca/I-9247-2019; kuchler, karl/AAL-6937-2020; Sellam, Adnane/H-9765-2013; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Young, Richard A/0000-0001-8855-8647; Shapiro, Rebecca/0000-0002-7119-8865; kuchler, karl/0000-0003-2719-5955; Gingras, Anne-Claude/0000-0002-6090-4437; Vizeacoumar, Frederick/0000-0002-4676-2911; Mitra, Robi/0000-0002-2680-4264; Reynolds, Todd/0000-0002-2867-7182; Sellam, Adnane/0000-0002-0506-7752; Cowen, Leah/0000-0001-5797-0110; Tebbji, Faiza/0000-0002-7359-727X; Kurat, Christoph/0000-0003-0962-3258	Canadian Institutes of Heath Research [MOP-97939]; Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 204899-05]; Howard Hughes Medical Institute Research Scholar; Burroughs Wellcome Fund; Canada Research Chair in Microbial Genomics and Infectious Disease; NSERC [355965-2009]; NIH [GM40266, GM035010]; National Human Genome Research Institute; European Molecular Biology Organization; Austrian Science Fund (FWF) [I 746] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, R01GM035010, R37GM035010] Funding Source: NIH RePORTER	Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Howard Hughes Medical Institute Research Scholar; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canada Research Chair in Microbial Genomics and Infectious Disease(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Johnston for inspiring the calling-card analysis and M. Usaj for assistance with image and data processing. Supported by the Canadian Institutes of Heath Research (MOP-97939) (C. B. and B. A.), Natural Sciences and Engineering Research Council (NSERC) of Canada (RGPIN 204899-05) (C. B.), Howard Hughes Medical Institute Research Scholar (C. B.), Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (L. E. C.), Canada Research Chair in Microbial Genomics and Infectious Disease (L. E. C.), NSERC Discovery Grant (355965-2009) (L. E. C.), and NIH (GM40266 and GM035010) (G. R. F.). C.N. and G. G. are supported by a grant from the National Human Genome Research Institute. R. S. S. is supported by an NSERC Canada Graduate Scholarship. C. F. K. is supported by a European Molecular Biology Organization long-term fellowship Raw images and data derived from haploid invasive growth, pseudohyphal growth and biofilm formation assays can be downloaded from http://spidey.ccbr.utoronto.ca/data/ryan_et_al/.	Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Bastidas RJ, 2009, P NATL ACAD SCI USA, V106, P351, DOI 10.1073/pnas.0811994106; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Su C, 2009, EUKARYOT CELL, V8, P1780, DOI 10.1128/EC.00190-09; van Dyk D, 2005, GENETICS, V169, P91, DOI 10.1534/genetics.104.033704; Wang HY, 2011, GENOME RES, V21, P748, DOI 10.1101/gr.114850.110; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	23	137	142	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1353	1356		10.1126/science.1224339	http://dx.doi.org/10.1126/science.1224339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984072				2022-12-28	WOS:000308705000045
J	Stern, P				Stern, Peter			Defeating the Dementors INTRODUCTION	SCIENCE			English	Editorial Material																			0	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					67	67		10.1126/science.338.6103.67	http://dx.doi.org/10.1126/science.338.6103.67			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015PC	23042883				2022-12-28	WOS:000309457400052
J	Holmqvist, ME; Neovius, M; Eriksson, J; Mantel, A; Wallberg-Jonsson, S; Jacobsson, LTH; Askling, J				Holmqvist, Marie E.; Neovius, Martin; Eriksson, Jonas; Mantel, Angla; Wallberg-Jonsson, Solveig; Jacobsson, Lennart T. H.; Askling, Johan			Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION	Context Recent reports suggest that rheumatoid arthritis (RA) may be a risk factor for venous thromboembolism (VTE), particularly in conjunction with hospitalization. Using hospitalization data to identify RA and VTE may identify patients when they are at elevated risk for other reasons, obscuring the incompletely understood underlying association between RA and VTE and leading to inappropriate institution or timing of interventions. Objective To estimate risks for VTE in patients with RA, including the relation of these risks to disease duration and hospitalization. Design, Setting, and Patients Prospective, population-based cohort study of 1 prevalent RA cohort (n = 37 856), 1 incident RA cohort (n = 7904), and matched general population comparison cohorts, all from Sweden, with follow-up from 1997 through 2010. Main Outcome Measure First-time VTE. Results Patients with prevalent RA were at greater risk of VTE than the general population (rate, 5.9 [95% CI, 5.1-6.6] vs 2.8 [95% CI, 2.6-3.1] per 1000 person-years (adjusted hazard ratio [HR], 2.0 [95% CI, 1.9-2.2]; P < .001). By the time of RA symptom onset, there was no statistically significant association between a history of VTE and RA (odds ratio, 1.2 [95% CI, 1.0-1.4]; P = .08; 150 events in the RA cohort vs 587 in the comparison cohort). Counting from RA diagnosis, an increased rate in the RA cohort vs the comparison cohort (3.8 [95% CI, 2.5-5.2] vs 2.4 [95% CI, 1.9-2.9] per 1000 person-years; HR, 1.6 [95% CI, 1.1-2.5]; P = .02) was detected within the first year and did not increase further during the first decade. Although rates for VTE following hospitalization were higher, the 1-year rate of VTE per 1000 person-years was not higher in the RA cohort than in the comparison cohort after hospital discharge (11.8 [95% CI, 8.6-15.1] vs 13.1 [11.3-14.8]; HR, 1.0 [95% CI, 0.7-1.4]; P = .90). The rates of VTE increased with age but were largely similar across sex and rheumatoid factor status, as were the HRs for VTE across age, sex, and rheumatoid factor status. Conclusions Compared with the general population, Swedish patients with RA had an elevated risk for VTE that was stable over the first 10 years after diagnosis. Although hospitalization was a risk factor for VTE the first year after discharge, the excess risk was not greater in patients with RA than in the general population. JAMA. 2012;308(13):1350-1356	[Holmqvist, Marie E.; Neovius, Martin; Eriksson, Jonas; Mantel, Angla; Askling, Johan] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Askling, Johan] Karolinska Inst, Dept Med Solna, Rheumatol Unit, SE-17176 Stockholm, Sweden; [Wallberg-Jonsson, Solveig] Univ Hosp, Inst Publ Hlth & Clin Med Rheumatol, Umea, Sweden; [Jacobsson, Lennart T. H.] Malmo Univ Hosp, Rheumatol Unit, Dept Med, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Umea University; Lund University; Skane University Hospital	Holmqvist, ME (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, T2 01, SE-17176 Stockholm, Sweden.	marie.holmqvist@ki.se		Neovius, Martin/0000-0003-2300-3055; Holmqvist, Marie/0000-0001-8996-5260	Schering-Plough; AstraZeneca; Novo Nordisk; Pfizer; Roche; Swedish Research Council; Swedish program on Chronic inflammation (Combine); Swedish Foundation for Strategic Research	Schering-Plough(Merck & CompanySchering Plough Corporation); AstraZeneca(AstraZeneca); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish program on Chronic inflammation (Combine); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Neovius reported participating in advisory boards for Pfizer (rheumatology) and Abbott (nonrheumatology) (unrelated to the current work); participating in research projects fully or partly funded by Schering-Plough, AstraZeneca, Novo Nordisk, Pfizer, and Roche (unrelated to the current work); and serving as a consultant (unrelated to rheumatology since 2008) to Pfizer, sanofi-aventis, and Abbott. Dr Wallberg-Jonsson reported serving as an invited speaker at a seminar organized by Roche (unrelated to the current work); contributing to patient information days organized by the Swedish Rheumatism Association (unrelated to the current work); receiving royalties for writing book chapters meant for education in rheumatology and cardiology; and receiving funding from Roche to travel to a conference in 2012. Dr Askling reported receiving grants within a public-private research consortium partly financed by Pfizer and AstraZeneca (unrelated to the current work); serving as an invited speaker at meeting organized by Merck on an unrelated topic; and serving as a member of a safety advisory committee at AstraZeneca.; This research was funded by the Swedish Research Council, Swedish program on Chronic inflammation (Combine), and Swedish Foundation for Strategic Research.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bacani AK, 2012, ARTHRITIS RHEUM-US, V64, P53, DOI 10.1002/art.33322; Bremell T, 2009, SRF REUMA B J SWEDIS, V732, P19; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mameli A, 2009, CLIN EXP RHEUMATOL, V27, P846; Matta F, 2009, THROMB HAEMOSTASIS, V101, P134, DOI 10.1160/TH08-08-0551; McEntegart A, 2001, RHEUMATOLOGY, V40, P640, DOI 10.1093/rheumatology/40.6.640; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Sanjeevi CB, 2012, LANCET, V379, P200, DOI 10.1016/S0140-6736(11)61510-9; Seriolo B, 1999, RHEUMATOLOGY, V38, P675, DOI 10.1093/rheumatology/38.7.675; Swedish National Board of Health and Wellfare (Social Styrelsen), NAT PAT REG SOC STYR; WALLBERGJONSSON S, 1993, CLIN RHEUMATOL, V12, P318, DOI 10.1007/BF02231572; World Health Organization (WHO), INT CLASS DIS IDC; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5; Zoller B, 2012, LANCET, V379, P244, DOI 10.1016/S0140-6736(11)61306-8	16	97	98	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1350	1356		10.1001/2012.jama.11741	http://dx.doi.org/10.1001/2012.jama.11741			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032551				2022-12-28	WOS:000309369300029
J	Dolgin, E				Dolgin, Elie			DEVICES Artificial inspiration	NATURE			English	Editorial Material							LUNG TRANSPLANTATION											Bonser RS, 2012, LANCET, V380, P747, DOI 10.1016/S0140-6736(12)60160-3; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Hoganson DM, 2011, LAB CHIP, V11, P700, DOI 10.1039/c0lc00158a; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Potkay JA, 2011, LAB CHIP, V11, P2901, DOI 10.1039/c1lc20020h	6	2	2	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S12	S14		10.1038/489S12a	http://dx.doi.org/10.1038/489S12a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013709	Bronze			2022-12-28	WOS:000309167100007
J	Kirwan, ML; Mudd, SM				Kirwan, Matthew L.; Mudd, Simon M.			Response of salt-marsh carbon accumulation to climate change	NATURE			English	Article							COASTAL WETLANDS; SPARTINA-ALTERNIFLORA; DECOMPOSITION; PRODUCTIVITY; FEEDBACK; DIOXIDE; DRAG	About half of annual marine carbon burial takes place in shallow water ecosystems where geomorphic and ecological stability is driven by interactions between the flow of water, vegetation growth and sediment transport(1). Although the sensitivity of terrestrial and deep marine carbon pools to climate change has been studied for decades, there is little understanding of how coastal carbon accumulation rates will change and potentially feed back on climate(2,3). Here we develop a numerical model of salt marsh evolution, informed by recent measurements of productivity and decomposition, and demonstrate that competition between mineral sediment deposition and organic-matter accumulation determines the net impact of climate change on carbon accumulation in intertidal wetlands. We find that the direct impact of warming on soil carbon accumulation rates is more subtle than the impact of warming-driven sea level rise, although the impact of warming increases with increasing rates of sea level rise. Our simulations suggest that the net impact of climate change will be to increase carbon burial rates in the first half of the twenty-first century, but that carbon-climate feedbacks are likely to diminish over time.	[Kirwan, Matthew L.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 24151 USA; [Mudd, Simon M.] Univ Edinburgh, Sch GeoSci, Edinburgh EH8 9XP, Midlothian, Scotland; [Mudd, Simon M.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA	University of Virginia; University of Edinburgh; University of California System; University of California Santa Barbara	Kirwan, ML (corresponding author), Univ Virginia, Dept Environm Sci, POB 400123, Charlottesville, VA 24151 USA.	mlk4n@virginia.edu	Mudd, Simon M/F-8521-2010	Mudd, Simon M/0000-0002-1357-8501	USGS Global Change Research Program	USGS Global Change Research Program(United States Geological Survey)	We appreciate reviews by S. Bridgham and L. Larsen. This work was supported by the USGS Global Change Research Program.	BAES CF, 1977, AM SCI, V65, P310; Baisden WT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001823; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Charles H, 2009, ECOL APPL, V19, P1758, DOI 10.1890/08-0172.1; Cherry JA, 2009, J ECOL, V97, P67, DOI 10.1111/j.1365-2745.2008.01449.x; Chmura GL, 2013, OCEAN COAST MANAGE, V83, P25, DOI 10.1016/j.ocecoaman.2011.09.006; Choi YH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002261; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Elsey-Quirk T, 2011, WETLANDS, V31, P87, DOI 10.1007/s13157-010-0139-2; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Idaszkin YL, 2011, PLANT ECOL, V212, P553, DOI 10.1007/s11258-010-9844-4; Kirwan ML, 2011, BIOGEOSCIENCES, V8, P987, DOI 10.5194/bg-8-987-2011; Kirwan ML, 2012, J ECOL, V100, P764, DOI 10.1111/j.1365-2745.2012.01957.x; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001566; Mudd SM, 2009, ESTUAR COAST SHELF S, V82, P377, DOI 10.1016/j.ecss.2009.01.028; Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; Powlson D. S., 1996, EVALUATION SOIL ORGA; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Shugart H.H., 2011, GLOBAL CHANGE TERRES; Tanino Y, 2008, J HYDRAUL ENG-ASCE, V134, P34, DOI 10.1061/(ASCE)0733-9429(2008)134:1(34); Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Wolf AA, 2007, GLOBAL CHANGE BIOL, V13, P2036, DOI 10.1111/j.1365-2486.2007.01407.x	32	196	208	22	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					550	+		10.1038/nature11440	http://dx.doi.org/10.1038/nature11440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23018965				2022-12-28	WOS:000309167100047
J	Torchia, D; Schachner, LA				Torchia, Daniele; Schachner, Lawrence A.			X-Chromosomal Translocation and Segmental Hypopigmentation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Torchia, Daniele; Schachner, Lawrence A.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Torchia, D (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.	daniele.torchia@gmail.com		Torchia, Daniele/0000-0002-3030-5222					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1245	1245		10.1056/NEJMicm1009599	http://dx.doi.org/10.1056/NEJMicm1009599			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	23013076				2022-12-28	WOS:000309161100011
J	Avidan, MS; Kheterpal, S				Avidan, Michael S.; Kheterpal, Sachin			Perioperative mortality in developed and developing countries	LANCET			English	Editorial Material							CARE		[Avidan, Michael S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Kheterpal, Sachin] Univ Michigan, Sch Med, Ann Arbor, MI USA	Washington University (WUSTL); University of Michigan System; University of Michigan	Avidan, MS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	avidanm@anest.wustl.edu		Avidan, Michael/0000-0001-6248-044X				Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Bijker JB, 2009, ANESTHESIOLOGY, V111, P1217, DOI 10.1097/ALN.0b013e3181c14930; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Jhanji S, 2008, ANAESTHESIA, V63, P695, DOI 10.1111/j.1365-2044.2008.05560.x; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kertai MD, 2011, ANESTHESIOLOGY, V114, P545, DOI 10.1097/ALN.0b013e31820c2b57; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Lanier WL, 2006, AM SURGEON, V72, P985; Pearse RM, 2006, CRIT CARE, V10, DOI 10.1186/cc4928; Pearse RM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5759; Phillips O C, 1974, Clin Anesth, V10, P220; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	13	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1038	1039		10.1016/S0140-6736(12)61271-9	http://dx.doi.org/10.1016/S0140-6736(12)61271-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007VL	22998701				2022-12-28	WOS:000308916400007
J	Rickard, CM; Webster, J; Wallis, MC; Marsh, N; McGrail, MR; French, V; Foster, L; Gallagher, P; Gowardman, JR; Zhang, L; McClymont, A; Whitby, M				Rickard, Claire M.; Webster, Joan; Wallis, Marianne C.; Marsh, Nicole; McGrail, Matthew R.; French, Venessa; Foster, Lynelle; Gallagher, Peter; Gowardman, John R.; Zhang, Li; McClymont, Alice; Whitby, Michael			Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial	LANCET			English	Article							INTRAVASCULAR CATHETER; PHLEBITIS; PREVENTION; INFECTION; COMPLICATIONS; TRANSPARENT; GUIDELINES; DEVICES; GAUZE; RISK	Background The millions of peripheral intravenous catheters used each year are recommended for 72-96 h replacement in adults. This routine replacement increases health-care costs and staff workload and requires patients to undergo repeated invasive procedures. The effectiveness of the practice is not well established. Our hypothesis was that clinically indicated catheter replacement is of equal benefit to routine replacement. Methods This multicentre, randomised, non-blinded equivalence trial recruited adults (>= 18 years) with an intravenous catheter of expected use longer than 4 days from three hospitals in Queensland, Australia, between May 20, 2008, and Sept 9, 2009. Computer-generated random assignment (1:1 ratio, no blocking, stratified by hospital, concealed before allocation) was to clinically indicated replacement, or third daily routine replacement. Patients, clinical staff, and research nurses could not be masked after treatment allocation because of the nature of the intervention. The primary outcome was phlebitis during catheterisation or within 48 h after removal. The equivalence margin was set at 3%. Primary analysis was by intention to treat. Secondary endpoints were catheter-related bloodstream and local infections, all bloodstream infections, catheter tip colonisation, infusion failure, catheter numbers used, therapy duration, mortality, and costs. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12608000445370. Findings All 3283 patients randomised (5907 catheters) were included in our analysis (1593 clinically indicated; 1690 routine replacement). Mean dwell time for catheters in situ on day 3 was 99 h (SD 54) when replaced as clinically indicated and 70 h (13) when routinely replaced. Phlebitis occurred in 114 of 1593 (7%) patients in the clinically indicated group and in 114 of 1690 (7%) patients in the routine replacement group, an absolute risk difference of 0.41% (95% CI -1.33 to 2.15%), which was within the prespecified 3% equivalence margin. No serious adverse events related to study interventions occurred. Interpretation Peripheral intravenous catheters can be removed as clinically indicated; this policy will avoid millions of catheter insertions, associated discomfort, and substantial costs in both equipment and staff workload. Ongoing close monitoring should continue with timely treatment cessation and prompt removal for complications.	[Rickard, Claire M.; Webster, Joan; Wallis, Marianne C.; Marsh, Nicole; Gowardman, John R.; Zhang, Li; Whitby, Michael] Griffith Univ, Griffith Hlth Inst, Res Ctr Clin & Community Practice Innovat, Nathan, Qld 4111, Australia; [Rickard, Claire M.; Webster, Joan; Wallis, Marianne C.; Marsh, Nicole] Griffith Univ, Griffith Hlth Inst, Natl Hlth & Med Res Council Ctr Res Excellence Nu, Nathan, Qld 4111, Australia; [Rickard, Claire M.; Webster, Joan; Marsh, Nicole; McClymont, Alice] Royal Brisbane & Womens Hosp, Ctr Clin Nursing, Res & Dev Unit, Herston, Qld, Australia; [Gowardman, John R.] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Herston, Qld, Australia; [McGrail, Matthew R.] Monash Univ, Gippsland Med Sch, Churchill, Vic, Australia; [Rickard, Claire M.; French, Venessa; Gallagher, Peter; Whitby, Michael] Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [Wallis, Marianne C.; Foster, Lynelle] Gold Coast Hosp, Southport, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; Menzies Health Institute Queensland; Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; Federation University Australia; Monash University; Gold Coast University Hospital	Rickard, CM (corresponding author), Griffith Univ, Griffith Hlth Inst, Res Ctr Clin & Community Practice Innovat, Nathan, Qld 4111, Australia.	c.rickard@griffith.edu.au	Wallis, Marianne C/C-5452-2013; Rickard, Claire M./C-3440-2008; Whitby, Michael/B-7231-2011; Wallis, Marianne/AAF-9899-2021; McGrail, Matthew/I-1738-2013	Wallis, Marianne C/0000-0003-2753-1066; Rickard, Claire M./0000-0002-6341-7415; Wallis, Marianne/0000-0003-2753-1066; McGrail, Matthew/0000-0002-6901-8845; Marsh, Nicole/0000-0002-5779-1304	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Australian National Health and Medical Research Council.	Bausone-Gazda D, 2010, J INFUS MURS, V33, P371, DOI 10.1097/NAN.0b013e3181f85be2; Bravery Karen, 2006, Br J Nurs, V15, P1244; Bregenzer T, 1998, ARCH INTERN MED, V158, P151, DOI 10.1001/archinte.158.2.151; Cook D, 1997, CRIT CARE MED, V25, P1417, DOI 10.1097/00003246-199708000-00033; Cornely OA, 2002, INFECT CONT HOSP EP, V23, P249, DOI 10.1086/502044; Elliott TSJ, 1997, EUR J CLIN MICROBIOL, V16, P210, DOI 10.1007/BF01709583; Gallant P, 2006, J INFUS MURS, V29, P338, DOI 10.1097/00129804-200611000-00004; GAUKROGER PB, 1988, ANAESTH INTENS CARE, V16, P265, DOI 10.1177/0310057X8801600305; Grune F, 2004, INFECTION, V32, P30, DOI 10.1007/s15010-004-1037-4; Johansson ME, 2009, J CLIN NURS, V18, P3366, DOI 10.1111/j.1365-2702.2009.02973.x; Lee WL, 2009, AM J INFECT CONTROL, V37, P683, DOI 10.1016/j.ajic.2009.02.009; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Maki Dennis G, 2008, BMJ, V337, pa630, DOI 10.1136/bmj.a630; MAKI DG, 1991, ANN INTERN MED, V114, P845, DOI 10.7326/0003-4819-114-10-845; MAKI DG, 1987, JAMA-J AM MED ASSOC, V258, P2396, DOI 10.1001/jama.258.17.2396; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; Malach T, 2006, AM J INFECT CONTROL, V34, P308, DOI 10.1016/j.ajic.2005.10.002; Chico-Padron RM, 2011, J NURS CARE QUAL, V26, P371, DOI 10.1097/NCQ.0b013e318210741b; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; O'Grady NP, 2002, INFECT CONT HOSP EP, V23, P759, DOI 10.1086/502007; Palese A, 2011, J INFUS MURS, V34, P319, DOI 10.1097/NAN.0b013e3182290a20; Powell J, 2008, J INFUS MURS, V31, P39, DOI 10.1097/01.NAN.0000308544.67744.50; Rickard CM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-53; Schears GJ, 2006, J INFUS MURS, V29, P225, DOI 10.1097/00129804-200607000-00009; Schultz Alyce A, 2005, Evid Based Nurs, V8, P8, DOI 10.1136/ebn.8.1.8; Smith B, 2006, J INFUS MURS, V29, P14, DOI 10.1097/00129804-200601000-00004; Soifer NE, 1998, ARCH INTERN MED, V158, P473, DOI 10.1001/archinte.158.5.473; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Van Donk P, 2009, INFECT CONT HOSP EP, V30, P915, DOI 10.1086/599776; Webster J, 2007, INT J NURS STUD, V44, P664, DOI 10.1016/j.ijnurstu.2006.02.003; Webster J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007798.pub4; Webster J, 2008, BMJ-BRIT MED J, V337, pCP1, DOI 10.1136/bmj.a339; Zhang L, 2011, INT J ANTIMICROB AG, V38, P9, DOI 10.1016/j.ijantimicag.2011.01.020; Zingg Walter, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS38, DOI 10.1016/S0924-8579(09)70565-5	35	217	232	2	96	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1066	1074		10.1016/S0140-6736(12)61082-4	http://dx.doi.org/10.1016/S0140-6736(12)61082-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007VL	22998716	Green Published			2022-12-28	WOS:000308916400027
J	Zheng, W; Postman, M; Zitrin, A; Moustakas, J; Shu, XW; Jouvel, S; Host, O; Molino, A; Bradley, L; Coe, D; Moustakas, LA; Carrasco, M; Ford, H; Benitez, N; Lauer, TR; Seitz, S; Bouwens, R; Koekemoer, A; Medezinski, E; Bartelmann, M; Broadhurst, T; Donahue, M; Grillo, C; Infante, L; Jha, SW; Kelson, DD; Lahav, O; Lemze, D; Melchior, P; Meneghetti, M; Merten, J; Nonino, M; Ogaz, S; Rosati, P; Umetsu, K; van der Wel, A				Zheng, Wei; Postman, Marc; Zitrin, Adi; Moustakas, John; Shu, Xinwen; Jouvel, Stephanie; Host, Ole; Molino, Alberto; Bradley, Larry; Coe, Dan; Moustakas, Leonidas A.; Carrasco, Mauricio; Ford, Holland; Benitez, Narciso; Lauer, Tod R.; Seitz, Stella; Bouwens, Rychard; Koekemoer, Anton; Medezinski, Elinor; Bartelmann, Matthias; Broadhurst, Tom; Donahue, Megan; Grillo, Claudio; Infante, Leopoldo; Jha, Saurabh W.; Kelson, Daniel D.; Lahav, Ofer; Lemze, Doron; Melchior, Peter; Meneghetti, Massimo; Merten, Julian; Nonino, Mario; Ogaz, Sara; Rosati, Piero; Umetsu, Keiichi; van der Wel, Arjen			A magnified young galaxy from about 500 million years after the Big Bang	NATURE			English	Article							SIMILAR-TO 7; STELLAR POPULATION SYNTHESIS; DEEP SURVEY; CLUSTER; BRIGHT; DISCOVERY; HUBBLE; MACS; REIONIZATION; CALIBRATION	Re-ionization of the intergalactic medium occurred in the early Universe at redshift z approximate to 6-11, following the formation of the first generation of stars(1). Those young galaxies (where the bulk of stars formed) at a cosmic age of less than about 500 million years (z less than or similar to 10) remain largely unexplored because they are at or beyond the sensitivity limits of existing large telescopes. Understanding the properties of these galaxies is critical to identifying the source of the radiation that re-ionized the intergalactic medium. Gravitational lensing by galaxy clusters allows the detection of high-redshift galaxies fainter than what otherwise could be found in the deepest images of the sky(2). Here we report multiband observations of the cluster MACS J1149+2223 that have revealed (with high probability) a gravitationally magnified galaxy from the early Universe, at a redshift of z = 9.6 +/- 0.2 (that is, a cosmic age of 490 +/- 15 million years, or 3.6 per cent of the age of the Universe). We estimate that it formed less than 200 million years after the Big Bang (at the 95 per cent confidence level), implying a formation redshift of less than or similar to 14. Given the small sky area that our observations cover, faint galaxies seem to be abundant at such a young cosmic age, suggesting that they may be the dominant source for the early re-ionization of the intergalactic medium.	[Zheng, Wei; Ford, Holland; Medezinski, Elinor; Lemze, Doron] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Postman, Marc; Bradley, Larry; Coe, Dan; Koekemoer, Anton; Ogaz, Sara] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Zitrin, Adi; Bartelmann, Matthias] Heidelberg Univ, Inst Theoret Astrophys, D-69120 Heidelberg, Germany; [Moustakas, John] Siena Coll, Dept Phys & Astron, Loudonville, NY 12211 USA; [Shu, Xinwen] Univ Sci & Technol China, Dept Astron, Hefei 230026, Anhui, Peoples R China; [Jouvel, Stephanie; Host, Ole; Lahav, Ofer] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Jouvel, Stephanie] Inst Ciencies Espai, Bellaterra 08193, Spain; [Molino, Alberto; Benitez, Narciso] Inst Astrofis Andalucia, E-18008 Granada, Spain; [Moustakas, Leonidas A.; Merten, Julian] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Carrasco, Mauricio; Infante, Leopoldo] Pontificia Univ Catolica Chile, Dept Astron & Astrofis, Santiago 22, Chile; [Lauer, Tod R.] Natl Opt Astron Observ, Tucson, AZ 85726 USA; [Seitz, Stella] Univ Sternwarte Munchen, D-81679 Munich, Germany; [Bouwens, Rychard] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Broadhurst, Tom] Univ Basque Country, Dept Theoret Phys, Bilbao 48080, Spain; [Broadhurst, Tom] Basque Fdn Sci, Ikerbasque, Bilbao 48011, Spain; [Donahue, Megan] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Grillo, Claudio] Univ Copenhagen, Dark Cosmol Ctr, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Jha, Saurabh W.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Kelson, Daniel D.] Observ Carnegie Inst Sci, Pasadena, CA 91101 USA; [Melchior, Peter] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Nonino, Mario] INAF Osservatorio Astron Trieste, I-40131 Trieste, Italy; [Meneghetti, Massimo] INAF Osservatorio Astron Bologna, I-40127 Bologna, Italy; [Rosati, Piero] European So Observ, D-85748 Garching, Germany; [Umetsu, Keiichi] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [van der Wel, Arjen] Max Planck Inst Astron, D-69117 Heidelberg, Germany	Johns Hopkins University; Space Telescope Science Institute; Ruprecht Karls University Heidelberg; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Pontificia Universidad Catolica de Chile; National Optical Astronomy Observatory; University of Munich; Leiden University; Leiden University - Excl LUMC; University of Basque Country; Basque Foundation for Science; Michigan State University; University of Copenhagen; Niels Bohr Institute; Rutgers State University New Brunswick; Carnegie Institution for Science; University System of Ohio; Ohio State University; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); European Southern Observatory; Academia Sinica - Taiwan; Max Planck Society	Zheng, W (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.	zheng@pha.jhu.edu	Umetsu, Keiichi/AAZ-7589-2020; Shu, Xinwen/ABG-3953-2020; Bartelmann, Matthias/A-5336-2014; Meneghetti, Massimo/AAB-4321-2020; Molino Benito, Alberto/F-5298-2014; Meneghetti, Massimo/O-8139-2015; Rosati, Piero/ABI-7507-2020; Shu, Xinwen/D-7294-2017; Koekemoer, Anton M./F-8400-2014; Zitrin, Adi/M-3402-2018; Moustakas, Leonidas A/F-3052-2014; Broadhurst, Thomas/AAF-9891-2019; van der Wel, Arjen/G-8365-2011; Grillo, Claudio/E-6223-2015; Benitez, Narciso/C-2065-2017	Umetsu, Keiichi/0000-0002-7196-4822; Meneghetti, Massimo/0000-0003-1225-7084; Molino Benito, Alberto/0000-0002-3630-0940; Meneghetti, Massimo/0000-0003-1225-7084; Shu, Xinwen/0000-0002-7020-4290; Koekemoer, Anton M./0000-0002-6610-2048; Zitrin, Adi/0000-0002-0350-4488; Moustakas, Leonidas A/0000-0003-3030-2360; Broadhurst, Thomas/0000-0002-8785-8979; van der Wel, Arjen/0000-0002-5027-0135; Grillo, Claudio/0000-0002-5926-7143; Jha, Saurabh/0000-0001-8738-6011; Nonino, Mario/0000-0001-6342-9662; Donahue, Megan/0000-0002-2808-0853; Bartelmann, Matthias/0000-0001-6951-3582; Benitez, Narciso/0000-0002-0403-7455; Melchior, Peter/0000-0002-8873-5065; Lauer, Tod/0000-0003-3234-7247; Coe, Dan/0000-0001-7410-7669; Bradley, Larry/0000-0002-7908-9284; Moustakas, John/0000-0002-2733-4559	NASA [NAS 5-26555]; NSF [AST-0908246]; Baden Wurttemberg Stiftung; Science and Technology Facilities Council [ST/F001991/1, ST/J001511/1] Funding Source: researchfish; STFC [ST/F001991/1, ST/J001511/1] Funding Source: UKRI	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Baden Wurttemberg Stiftung; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The CLASH programme (GO-12065) is based on observations made with the NASA/ESA Hubble Space Telescope. The Space Telescope Science Institute is operated by the Association of Universities for Research in Astronomy, Inc. under NASA contract NAS 5-26555. This work is also based in part on archival data obtained with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. J.M. acknowledges support from NSF grant AST-0908246. A. Z. is supported by research contract Internationale Spitzenforschung II-1 of the Baden Wurttemberg Stiftung.	Benitez N, 2000, ASTROPHYS J, V536, P571, DOI 10.1086/308947; Bouwens RJ, 2011, NATURE, V469, P504, DOI 10.1038/nature09717; Bouwens RJ, 2010, ASTROPHYS J LETT, V708, pL69, DOI 10.1088/2041-8205/708/2/L69; Bradley LD, 2008, ASTROPHYS J, V678, P647, DOI 10.1086/533519; Bradley LD, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/3; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Conroy C, 2010, ASTROPHYS J, V712, P833, DOI 10.1088/0004-637X/712/2/833; Ebeling H, 2001, ASTROPHYS J, V553, P668, DOI 10.1086/320958; Fioc M, 1997, ASTRON ASTROPHYS, V326, P950; Ilbert O, 2006, ASTRON ASTROPHYS, V457, P841, DOI 10.1051/0004-6361:20065138; Jullo E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/447; Kneib JP, 2011, ASTRON ASTROPHYS REV, V19, P1, DOI 10.1007/s00159-011-0047-3; Kneib JP, 2004, ASTROPHYS J, V607, P697, DOI 10.1086/386281; Koekemoer AM, 2007, ASTROPHYS J SUPPL S, V172, P196, DOI 10.1086/520086; Labbe I, 2010, ASTROPHYS J LETT, V716, pL103, DOI 10.1088/2041-8205/716/2/L103; Labbe I, 2010, ASTROPHYS J LETT, V708, pL26, DOI 10.1088/2041-8205/708/1/L26; Moustakas J., 2011, ASTROPHYS J UNPUB; Oesch PA, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/110; Polletta M, 2007, ASTROPHYS J, V663, P81, DOI 10.1086/518113; Postman M, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/25; Richard J, 2011, MON NOT R ASTRON SOC, V414, pL31, DOI 10.1111/j.1745-3933.2011.01050.x; Robertson BE, 2010, NATURE, V468, P49, DOI 10.1038/nature09527; Smith GP, 2009, ASTROPHYS J LETT, V707, pL163, DOI 10.1088/0004-637X/707/2/L163; Wuyts S, 2008, ASTROPHYS J, V682, P985, DOI 10.1086/588749; Zackrisson E., 2012, DETECTING GRAVITATIO; Zheng W, 2009, ASTROPHYS J, V697, P1907, DOI 10.1088/0004-637X/697/2/1907; Zitrin A, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L9; Zitrin A, 2011, MON NOT R ASTRON SOC, V410, P1939, DOI 10.1111/j.1365-2966.2010.17574.x; Zitrin A, 2009, ASTROPHYS J LETT, V703, pL132, DOI 10.1088/0004-637X/703/2/L132	30	234	234	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					406	408		10.1038/nature11446	http://dx.doi.org/10.1038/nature11446			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996554	Green Submitted			2022-12-28	WOS:000308860900039
J	Lader, E				Lader, Ellis			Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU, Sch Med, Kingston, NY USA	New York University	Lader, E (corresponding author), NYU, Sch Med, Kingston, NY USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-11	10.7326/0003-4819-157-6-201209180-02011	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986403				2022-12-28	WOS:000308912800010
J	Lake, A				Lake, Anthony			A tipping point for child survival, health, and nutrition	LANCET			English	Editorial Material									UNICEF, New York, NY 10017 USA	UNICEF	Lake, A (corresponding author), UNICEF, New York, NY 10017 USA.	alake@unicef.org						Amouzou A, 2012, LANCET; [Anonymous], LEV TRENDS CHILD MOR; Carrera C, 2012, LANCET; Chopra M, 2012, LANCET; United Nations Children's Fund (UNICEF), COMM CHILD SURV PROM; Victora CG, 2012, LANCET; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	7	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1286	1287		10.1016/S0140-6736(12)61539-6	http://dx.doi.org/10.1016/S0140-6736(12)61539-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	022BZ	22999429				2022-12-28	WOS:000309931400005
J	Romney, M				Romney, Mitt			Replacing Obamacare with Real Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	7	7	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1377	1381		10.1056/NEJMp1211516	http://dx.doi.org/10.1056/NEJMp1211516			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23013052				2022-12-28	WOS:000309652700002
J	Iizuka, Y; Uemura, R; Motoyama, H; Suzuki, T; Miyake, T; Hirabayashi, M; Hondoh, T				Iizuka, Yoshinori; Uemura, Ryu; Motoyama, Hideaki; Suzuki, Toshitaka; Miyake, Takayuki; Hirabayashi, Motohiro; Hondoh, Takeo			Sulphate-climate coupling over the past 300,000 years in inland Antarctica	NATURE			English	Article							ICE-CORE; SEA-SALT; OCEANIC PHYTOPLANKTON; AEROSOL; SULFUR; DUST; PERIOD; CYCLE	Sulphate aerosols, particularly micrometre-sized particles of sulphate salt and sulphate-adhered dust, can act as cloud condensation nuclei, leading to increased solar scattering that cools Earth's climate(1,2). Evidence for such a coupling may lie in the sulphate record from polar ice cores, but previous analyses of melted ice-core samples have provided only sulphate ion concentrations, which may be due to sulphuric acid(3). Here we present profiles of sulphate salt and sulphate-adhered dust fluxes over the past 300,000 years from the Dome Fuji ice core in inland Antarctica. Our results show a nearly constant flux of sulphate-adhered dust through glacial and interglacial periods despite the large increases in total dust flux during glacial maxima(4). The sulphate salt flux, however, correlates inversely with temperature, suggesting a climatic coupling between particulate sulphur and temperature. For example, the total sulphate salt flux during the Last Glacial Maximum averages 5.78 mg m(-2) yr(-1), which is almost twice the Holocene value. Although it is based on a modern analogue with considerable uncertainties when applied to the ice-core record, this analysis indicates that the glacial-to-interglacial decrease in sulphate would lessen the aerosol indirect effects on cloud lifetime and albedo, leading to an Antarctic warming of 0.1 to 5 kelvin.	[Iizuka, Yoshinori; Hondoh, Takeo] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Uemura, Ryu] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Okinawa 9030213, Japan; [Motoyama, Hideaki; Miyake, Takayuki; Hirabayashi, Motohiro] Natl Inst Polar Res, Tokyo 1908518, Japan; [Suzuki, Toshitaka] Yamagata Univ, Dept Earth & Environm Sci, Fac Sci, Yamagata 9908560, Japan	Hokkaido University; University of the Ryukyus; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Yamagata University	Iizuka, Y (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	iizuka@lowtem.hokudai.ac.jp	Iizuka, Yoshinori/D-9112-2012; Uemura, Ryu/C-9793-2012; HONDOH, TAKEO/E-7551-2011; Uemura, Ryu/AGR-0677-2022	Iizuka, Yoshinori/0000-0001-7241-6062; Uemura, Ryu/0000-0002-4236-0085; HONDOH, TAKEO/0000-0003-4129-022X; Uemura, Ryu/0000-0002-4236-0085	Ministry of Education, Culture, Sports, Science and Technology(MEXT) [14GS0202, 23680001, 21221002]; Japan Society for the Promotion of Science (JSPS); Institute of Low Temperature Science, Hokkaido University	Ministry of Education, Culture, Sports, Science and Technology(MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute of Low Temperature Science, Hokkaido University	We thank all members of the JARE and the Ice Core Consortium for work at Dome Fuji; T. Takemura, R. Kudo, Y. Fujiyoshi and T. Aoki for comments on radiative forcing of aerosols; H. Ohno and T. Sakurai for comments on microparticles in the Dome Fuji ice core; K. Goto-Azuma, T. Kuramoto and H. Yamada for data management of ion and dust concentrations in the Dome Fuji ice core; and Y. Fujii for data on ion concentrations in the Site J firn core, used to calculate sulphate salts. Y.I. thanks M. Furusaki for help with EDS analyses and J. Nelson for help with revising the manuscript. This study was supported by Creative Scientific Research (grant number 14GS0202), Young Scientists (A) (grant number 23680001) and Scientific Research (S) (grant number 21221002), provided by the Ministry of Education, Culture, Sports, Science and Technology(MEXT), the Japan Society for the Promotion of Science (JSPS) and the Grant for Joint Research Program of the Institute of Low Temperature Science, Hokkaido University.	ANDREAE MO, 1986, SCIENCE, V232, P1620, DOI 10.1126/science.232.4758.1620; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; BODHAINE BA, 1995, J GEOPHYS RES-ATMOS, V100, P8967, DOI 10.1029/95JD00513; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Delmonte B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033382; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fujii Y., 2003, MEM NATL I PLR R SI, V57, P46; Fujii Y., 2001, MEM NATL I POLAR RES, V54, P209; Iizuka Y, 2006, J GLACIOL, V52, P58, DOI 10.3189/172756506781828926; Iizuka Y, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016378; Iizuka Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009018; Iizuka Y, 2009, J GLACIOL, V55, P552, DOI 10.3189/002214309788816696; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Kaufmann P, 2010, QUATERNARY SCI REV, V29, P313, DOI 10.1016/j.quascirev.2009.11.009; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; LEGRAND MR, 1988, ATMOS ENVIRON, V22, P317, DOI 10.1016/0004-6981(88)90037-6; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; Manktelow PT, 2010, ATMOS CHEM PHYS, V10, P365, DOI 10.5194/acp-10-365-2010; Masson-Delmotte V, 2006, CLIM DYNAM, V26, P513, DOI [10.1007/s00382-005-0081-9, 10.1007/S00382-005-0081-9]; Penner JE, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P289; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Rothlisberger R, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003604; Rothlisberger R, 2002, ANN GLACIOL-SER, V35, P209, DOI 10.3189/172756402781817220; Sakurai T, 2011, J GLACIOL, V57, P1027, DOI 10.3189/002214311798843403; Tsai IC, 2010, ATMOS CHEM PHYS, V10, P3693, DOI 10.5194/acp-10-3693-2010; Watanabe O., 2003, MEM NATL I POLAR RES, V57, P1; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614	28	28	29	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					81	84		10.1038/nature11359	http://dx.doi.org/10.1038/nature11359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038469	Green Submitted			2022-12-28	WOS:000309446800036
J	MacArthur, GJ; Minozzi, S; Martin, N; Vickerman, P; Deren, S; Bruneau, J; Degenhardt, L; Hickman, M				MacArthur, Georgie J.; Minozzi, Silvia; Martin, Natasha; Vickerman, Peter; Deren, Sherry; Bruneau, Julie; Degenhardt, Louisa; Hickman, Matthew			Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C-VIRUS; RISK BEHAVIOR; ANTIRETROVIRAL THERAPY; METHADONE TREATMENT; SAN-FRANCISCO; VACCINE TRIAL; NEW-YORK; USERS; INFECTION	Objective To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design Systematic review and meta-analysis of prospective published and unpublished observational studies. Data sources Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction. Review methods We selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model. Results Twelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23 608 person years of follow-up. Opiate substitution treatment was associated with a 54% reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95% confidence interval 0.32 to 0.67; P<0.001). There was evidence of heterogeneity between studies (I-2=60%, chi(2)=20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment. Conclusion Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment.	[MacArthur, Georgie J.; Martin, Natasha; Vickerman, Peter; Hickman, Matthew] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Minozzi, Silvia] Cochrane Drugs & Alcohol Grp, Dept Epidemiol, Lazio Reg Hlth Serv, Rome, Italy; [Martin, Natasha] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Vickerman, Peter] London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1, England; [Deren, Sherry] NYU, Coll Nursing, Ctr Drug Use & HIV Res, New York, NY USA; [Bruneau, Julie] Ctr Hosp Univ Montreal, Res Ctr CRCHUM, Montreal, PQ, Canada; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, NHMRC, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, NHMRC, Melbourne, Vic, Australia	University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; New York University; Universite de Montreal; University of New South Wales Sydney; University of Sydney; University of Melbourne	MacArthur, GJ (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England.	georgie.macarthur@bristol.ac.uk	Hickman, Matthew/Y-2400-2019; Minozzi, Silvia/ABG-1115-2020; Degenhardt, Louisa J/D-4515-2012	Hickman, Matthew/0000-0001-9864-459X; Minozzi, Silvia/0000-0003-0471-8581; Degenhardt, Louisa J/0000-0002-8513-2218; Vickerman, Peter/0000-0002-8291-5890; Martin, Natasha/0000-0001-8344-1810; MacArthur, Georgie/0000-0003-2047-6519	South West Public Health Training Scheme; MRC New Investigators Award [G0701627]; Nationally Integrated Quantitative Understanding of Addiction Harm (NIQUAD) MRC addiction research cluster; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); UKCRC Public Health Research: Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council [RES-590-28-0005]; Medical Research Council; Welsh Assembly Government; Wellcome Trust under UK Clinical Research Collaboration [WT087640MA]; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0701627, G1000021] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G1000021, G0701627] Funding Source: researchfish	South West Public Health Training Scheme; MRC New Investigators Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nationally Integrated Quantitative Understanding of Addiction Harm (NIQUAD) MRC addiction research cluster(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); UKCRC Public Health Research: Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Assembly Government; Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GJM is funded by the South West Public Health Training Scheme; PV is funded by an MRC New Investigators Award (G0701627); MH is supported by the Nationally Integrated Quantitative Understanding of Addiction Harm (NIQUAD) MRC addiction research cluster. The work was undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research: Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (RES-590-28-0005), Medical Research Council, the Welsh Assembly Government and the Wellcome Trust (WT087640MA), under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in the design, execution, and writing up of the study.	Bruandet A, 2006, REV EPIDEMIOL SANTE, V54, p1S15; Bruneau J, 2011, AM J EPIDEMIOL, V173, P1049, DOI 10.1093/aje/kwq479; Celentano DD, 1999, AM J EPIDEMIOL, V149, P15; CHITWOOD DD, 1995, AM J PUBLIC HEALTH, V85, P1538, DOI 10.2105/AJPH.85.11.1538; Cochrane Effectiveness of Practice and Organisation of Care, 2009, SUGG RISK BIAS CRIT; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Deren S, 2004, JAIDS-J ACQ IMM DEF, V36, P1067, DOI 10.1097/00126334-200408150-00010; Des Jarlais DC, 2000, AM J PUBLIC HEALTH, V90, P352, DOI 10.2105/AJPH.90.3.352; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; European Centre for Monitoring of Drugs and Drug Addiction European Centre for Disease Control and Prevention, 2012, JOINT EMCDDA ECDC RA; Farrell M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2823; Gandhi DH, 2003, ADDICTION, V98, P453, DOI 10.1046/j.1360-0443.2003.00334.x; Gowing L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub4; Hall W, 2010, ADDICTION, V105, P1332, DOI 10.1111/j.1360-0443.2010.02919.x; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Hedrich D, 2012, ADDICTION, V107, P501, DOI 10.1111/j.1360-0443.2011.03676.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Judd A, 2005, BMJ-BRIT MED J, V330, P24, DOI 10.1136/bmj.38286.841227.7C; Kerr T, 2006, JAIDS-J ACQ IMM DEF, V41, P119, DOI 10.1097/01.qai.0000179429.57531.47; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; KITAYAPORN D, 1994, AIDS, V8, P1443, DOI 10.1097/00002030-199410000-00011; Kumar MS, 2012, INT J DRUG POLICY, V23, P169, DOI 10.1016/j.drugpo.2011.11.002; Larney S, 2010, ADDICTION, V105, P216, DOI 10.1111/j.1360-0443.2009.02826.x; Liu HJ, 2006, DRUG ALCOHOL DEPEN, V84, P114, DOI 10.1016/j.drugalcdep.2006.01.004; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mattick RP, 2008, COCHRANE DB SYST REV, V3; McFarland W, 2000, J ACQ IMMUN DEF SYND, V23, P426; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; MOSS AR, 1994, AIDS, V8, P223, DOI 10.1097/00002030-199402000-00010; Nelson KE, 2002, AM J EPIDEMIOL, V156, P641, DOI 10.1093/aje/kwf086; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Palmateer N, 2010, ADDICTION, V105, P844, DOI 10.1111/j.1360-0443.2009.02888.x; Peters AD, 1998, DRUG ALCOHOL DEPEN, V50, P47, DOI 10.1016/S0376-8716(97)00161-0; Rhoades HM, 1998, AM J PUBLIC HEALTH, V88, P34, DOI 10.2105/AJPH.88.1.34; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Rhodes T, 2006, ADDICTION, V101, P252, DOI 10.1111/j.1360-0443.2006.01317.x; Rhodes T, 2010, BM, V341, P129; Rhodes TE, 2002, COMMENTARY, V113, P16; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Schaub M, 2009, EUR ADDICT RES, V15, P157, DOI 10.1159/000217586; SERPELLONI G, 1994, AIDS CARE, V6, P215, DOI 10.1080/09540129408258632; Sharma M, 2007, INT J DRUG POLICY, V18, P92, DOI 10.1016/j.drugpo.2006.11.012; Sharma M, 2009, AIDS, V23, P1405, DOI 10.1097/QAD.0b013e32832bd7c9; SKIDMORE CA, 1990, SCOT MED J, V35, P100, DOI 10.1177/003693309003500402; Smyth BP, 2003, J EPIDEMIOL COMMUN H, V57, P310, DOI 10.1136/jech.57.4.310; Sorensen JL, 2000, DRUG ALCOHOL DEPEN, V59, P17, DOI 10.1016/S0376-8716(99)00104-0; Stachowiak JA, 2006, DRUG ALCOHOL DEPEN, V82, pS7, DOI 10.1016/S0376-8716(06)80002-5; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Suntharasamai P, 2009, ADDICTION, V104, P235, DOI 10.1111/j.1360-0443.2008.02436.x; Teesson M, 2006, DRUG ALCOHOL DEPEN, V83, P174, DOI 10.1016/j.drugalcdep.2005.11.009; The Warsaw Declaration, 2003, P 2 INT POL DIAL HIV; Tilson H, 2007, PREVENTING HIV INFEC; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Uuskula A, 2007, INT J STD AIDS, V18, P41, DOI 10.1258/095646207779949907; van Beek I, 1998, BMJ-BRIT MED J, V317, P433, DOI 10.1136/bmj.317.7156.433; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Wiessing L, 2011, EUROSURVEILLANCE, V16, P9; Wiessing L, 2008, Euro Surveill, V13; Wiessing L, 2009, AM J PUBLIC HEALTH, V99, P1049, DOI 10.2105/AJPH.2008.141846; WILLIAMS AB, 1992, AIDS CARE, V4, P35, DOI 10.1080/09540129208251618; Yin W, 2010, INT J EPIDEMIOL, V39, pii37; ZANGERLE R, 1992, J ACQ IMMUN DEF SYND, V5, P865; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	72	297	298	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2012	345								e5945	10.1136/bmj.e5945	http://dx.doi.org/10.1136/bmj.e5945			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LH	23038795	Green Accepted, hybrid, Green Published, Green Submitted			2022-12-28	WOS:000309661500001
J	Machin, JT; Wordsworth, DR; Raja, S; Burtt, S				Machin, John T.; Wordsworth, David R.; Raja, Senthooran; Burtt, Simon			Hip pain in an adolescent after injury while playing football	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFERIOR ILIAC SPINE; AVULSION FRACTURES; PELVIS; ATHLETE		[Machin, John T.; Wordsworth, David R.; Raja, Senthooran; Burtt, Simon] Luton & Dunstable Hosp NHS Fdn Trust, Dept Trauma & Orthopaed, Luton, Beds, England		Machin, JT (corresponding author), 15 Denholme Rd, London W9 3HU, England.	johnmachin@doctors.org.uk						Clancy W G Jr, 1976, Am J Sports Med, V4, P214, DOI 10.1177/036354657600400504; FERNBACH SK, 1981, AM J ROENTGENOL, V137, P581, DOI 10.2214/ajr.137.3.581; Kocher MS, 2006, CLIN SPORT MED, V25, P241, DOI 10.1016/j.csm.2006.01.001; METZMAKER JN, 1985, AM J SPORT MED, V13, P349, DOI 10.1177/036354658501300510; Miller MD, 2008, REV ORTHOPEDICS, P509; Moeller James L, 2003, Curr Sports Med Rep, V2, P110; Perry DC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3565; Rajasekhar C, 2001, INT ORTHOP, V24, P364, DOI 10.1007/s002640000184; Rossi F, 2001, SKELETAL RADIOL, V30, P127, DOI 10.1007/s002560000319; Saluan PM, 1997, ORTHOPEDICS, V20, P558; Sanders TG, 2008, SEMIN MUSCULOSKEL R, V12, P42, DOI 10.1055/s-2008-1067936; SUNDAR M, 1994, SKELETAL RADIOL, V23, P85, DOI 10.1007/BF00563198; VESELKO M, 1994, J TRAUMA, V36, P444, DOI 10.1097/00005373-199403000-00039; WATERS PM, 1988, CLIN SPORT MED, V7, P513; Weinstein SL, 1984, AAOS INSTRUCTIONAL C, V33	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 26	2012	345								e6265	10.1136/bmj.e6265	http://dx.doi.org/10.1136/bmj.e6265			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OV	23015300				2022-12-28	WOS:000309386300005
J	Vonlanthen, R; Clavien, PA				Vonlanthen, Rene; Clavien, Pierre-Alain			What factors affect mortality after surgery?	LANCET			English	Editorial Material							HOSPITAL QUALITY; SURGICAL MORTALITY; UNITED-STATES; COMPLICATIONS; IMPACT; CLASSIFICATION; CANCER; EUROPE; VOLUME; CARE		[Vonlanthen, Rene; Clavien, Pierre-Alain] Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Clavien, PA (corresponding author), Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland.	clavien@access.uzh.ch						Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birkmeyer JD, 2012, ANN SURG, V255, P1, DOI 10.1097/SLA.0b013e3182402c17; CLAVIEN PA, 1992, SURGERY, V111, P518; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Dimick JB, 2010, J AM COLL SURGEONS, V210, P503, DOI 10.1016/j.jamcollsurg.2010.01.018; Fong Y, 2005, ANN SURG, V242, P540, DOI 10.1097/01.sla.0000184190.20289.4b; Ghaferi AA, 2012, SURG ONCOL CLIN N AM, V21, P389, DOI 10.1016/j.soc.2012.03.006; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Mckay A, 2008, ANN SURG ONCOL, V15, P1348, DOI 10.1245/s10434-008-9838-9; Muller MK, 2009, LANGENBECK ARCH SURG, V394, P31, DOI 10.1007/s00423-008-0352-0; Numata Y, 2006, J ADV NURS, V55, P435, DOI 10.1111/j.1365-2648.2006.03941.x; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Rawlinson A, 2011, ANN ROY COLL SURG, V93, P583, DOI 10.1308/147870811X605219; Vonlanthen R, 2011, ANN SURG, V254, P907, DOI 10.1097/SLA.0b013e31821d4a43; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	16	14	15	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2012	380	9847					1034	1036		10.1016/S0140-6736(12)61417-2	http://dx.doi.org/10.1016/S0140-6736(12)61417-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007VL	22998699				2022-12-28	WOS:000308916400005
J	Yu, R; Yin, L; Sullivan, NS; Xia, JS; Huan, C; Paduan, A; Oliveira, NF; Haas, S; Steppke, A; Miclea, CF; Weickert, F; Movshovich, R; Mun, ED; Scott, BL; Zapf, VS; Roscilde, T				Yu, Rong; Yin, Liang; Sullivan, Neil S.; Xia, J. S.; Huan, Chao; Paduan-Filho, Armando; Oliveira, Nei F., Jr.; Haas, Stephan; Steppke, Alexander; Miclea, Corneliu F.; Weickert, Franziska; Movshovich, Roman; Mun, Eun-Deok; Scott, Brian L.; Zapf, Vivien S.; Roscilde, Tommaso			Bose glass and Mott glass of quasiparticles in a doped quantum magnet	NATURE			English	Article							EINSTEIN CONDENSATION; LOCALIZATION; DISORDER; PHASE; TRANSITION; SYSTEMS; BOSONS	The low-temperature states of bosonic fluids exhibit fundamental quantum effects at the macroscopic scale: the best-known examples are Bose-Einstein condensation and superfluidity, which have been tested experimentally in a variety of different systems. When bosons interact, disorder can destroy condensation, leading to a 'Bose glass'. This phase has been very elusive in experiments owing to the absence of any broken symmetry and to the simultaneous absence of a finite energy gap in the spectrum. Here we report the observation of a Bose glass of field-induced magnetic quasiparticles in a doped quantum magnet (bromine-doped dichloro-tetrakis-thiourea-nickel, DTN). The physics of DTN in a magnetic field is equivalent to that of a lattice gas of bosons in the grand canonical ensemble; bromine doping introduces disorder into the hopping and interaction strength of the bosons, leading to their localization into a Bose glass down to zero field, where it becomes an incompressible Mott glass. The transition from the Bose glass (corresponding to a gapless spin liquid) to the Bose-Einstein condensate (corresponding to a magnetically ordered phase) is marked by a universal exponent that governs the scaling of the critical temperature with the applied field, in excellent agreement with theoretical predictions. Our study represents a quantitative experimental account of the universal features of disordered bosons in the grand canonical ensemble.	[Roscilde, Tommaso] Ecole Normale Super Lyon, Lab Phys, CNRS, UMR5672, F-69364 Lyon, France; [Yu, Rong] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Yin, Liang; Sullivan, Neil S.; Xia, J. S.; Huan, Chao] Univ Florida, Dept Phys, Gainesville, FL 32611 USA; [Yin, Liang; Sullivan, Neil S.; Xia, J. S.; Huan, Chao] Univ Florida, Natl High Magnet Field Lab, Gainesville, FL 32611 USA; [Paduan-Filho, Armando; Oliveira, Nei F., Jr.] Univ Sao Paulo, Inst Fis, BR-05315970 Sao Paulo, Brazil; [Haas, Stephan] Univ So Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA; [Steppke, Alexander] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Miclea, Corneliu F.; Weickert, Franziska; Movshovich, Roman; Mun, Eun-Deok; Scott, Brian L.; Zapf, Vivien S.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Miclea, Corneliu F.] Natl Inst Mat Phys, Bucharest 077125, Romania	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); Rice University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade de Sao Paulo; University of Southern California; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; National Institute of Materials Physics - Romania	Roscilde, T (corresponding author), Ecole Normale Super Lyon, Lab Phys, CNRS, UMR5672, 46 Allee Italie, F-69364 Lyon, France.	tommaso.roscilde@ens-lyon.fr	Scott, Brian/D-8995-2017; Steppke, Alexander/K-4171-2015; Paduan-Filho, Armando/H-2443-2011; Miclea, Corneliu Florin/R-8783-2017; Zapf, Vivien/K-5645-2013; YIN, LIANG/G-7585-2011; Weickert, Franziska/F-3557-2015; Huan, Chao/F-4735-2014; Yu, Rong/K-5854-2012; Yu, Rong/H-3355-2016	Scott, Brian/0000-0003-0468-5396; Steppke, Alexander/0000-0001-6495-3917; Paduan-Filho, Armando/0000-0003-1303-5731; Miclea, Corneliu Florin/0000-0002-7414-3173; Zapf, Vivien/0000-0002-8375-4515; Weickert, Franziska/0000-0002-1545-9645; Huan, Chao/0000-0002-0696-4412; Movshovich, Roman/0000-0002-3667-634X	FAPESP; CNPq; NSF [DMR 0654118, DMR-1006985]; State of Florida; DOE [20100043DR, DE-FG03-01ER45908, DE-FG02-05ER46240]; UEFISCDI [RP-10]; INCITE of the Office of Science, DOE [MAT013]; Robert A. Welch Foundation [C-1411]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSF(National Science Foundation (NSF)); State of Florida; DOE(United States Department of Energy (DOE)); UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); INCITE of the Office of Science, DOE(United States Department of Energy (DOE)); Robert A. Welch Foundation(The Welch Foundation)	Work at the High Magnetic Field Laboratory at the Physics Institute of the University of Sao Paulo was supported in part by the Brazilian agencies FAPESP and CNPq. Measurements at the NHMFL High B/T and pulsed field facilities were supported by NSF grant DMR 0654118, by the State of Florida, and by the DOE. Work at LANL was supported by the NSF, and by the DOE's Laboratory Directed Research and Development programme under 20100043DR. C. F. M. acknowledges support by UEFISCDI (project RP-10). The numerical simulations were performed on the computer facilities of the NCCS at the Oak Ridge National Laboratories, and supported by INCITE Award MAT013 of the Office of Science, DOE. Further theory work was supported by the DOE (grant DE-FG03-01ER45908 and DE-FG02-05ER46240), the NSF (grant DMR-1006985) and by the Robert A. Welch Foundation (grant C-1411).	Altman E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.150402; Balabanyan KG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.055701; Bouadim K, 2011, NAT PHYS, V7, P884, DOI [10.1038/nphys2037, 10.1038/NPHYS2037]; Crowell PA, 1997, PHYS REV B, V55, P12620, DOI 10.1103/PhysRevB.55.12620; Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; Fallani L, 2008, ADV ATOM MOL OPT PHY, V56, P119, DOI 10.1016/S1049-250X(08)00012-8; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; GIAMARCHI T, 1988, PHYS REV B, V37, P325, DOI 10.1103/PhysRevB.37.325; Giamarchi T, 2008, NAT PHYS, V4, P198, DOI 10.1038/nphys893; Hong T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.060410; Kawashima N, 2004, J PHYS SOC JPN, V73, P3219, DOI 10.1143/JPSJ.73.3219; KRAMER B, 1993, REP PROG PHYS, V56, P1469, DOI 10.1088/0034-4885/56/12/001; Manaka H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077204; Nohadani O, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.227201; Orignac E, 1999, PHYS REV LETT, V83, P2378, DOI 10.1103/PhysRevLett.83.2378; Prokof'ev N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.015703; Roscilde T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.207206; Roscilde T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047205; Roscilde T, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144418; Sacepe B, 2011, NAT PHYS, V7, P239, DOI 10.1038/NPHYS1892; Sanchez-Palencia L, 2010, NAT PHYS, V6, P87, DOI 10.1038/NPHYS1507; Weickert F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184408; Yin L, 2010, J LOW TEMP PHYS, V158, P710, DOI 10.1007/s10909-009-0029-2; Yin L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.187205; Yu R, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/10009; Yu R., 2012, QUANTUM CRITICAL SCA; Zapf VS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.077204; Zvyagin SA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.047205; Zvyagin SA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.092413	29	97	99	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					379	384		10.1038/nature11406	http://dx.doi.org/10.1038/nature11406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996552	Green Submitted			2022-12-28	WOS:000308860900035
J	Neeland, IJ; Turer, AT; Ayers, CR; Powell-Wiley, TM; Vega, GL; Farzaneh-Far, R; Grundy, SM; Khera, A; McGuire, DK; de Lemos, JA				Neeland, Ian J.; Turer, Aslan T.; Ayers, Colby R.; Powell-Wiley, Tiffany M.; Vega, Gloria L.; Farzaneh-Far, Ramin; Grundy, Scott M.; Khera, Amit; McGuire, Darren K.; de Lemos, James A.			Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; SEX-DIFFERENCES; PLASMA-LEVELS; ASSOCIATION; TISSUE; POPULATION; PREVALENCE; PREDICTION; MORTALITY	Context The risk of type 2 diabetes mellitus is heterogeneous among obese individuals. Factors that discriminate prediabetes or diabetes risk within this population have not been well characterized. A dysfunctional adiposity phenotype, characterized by excess visceral fat and insulin resistance, may contribute to diabetes development in those with obesity. Objective To investigate associations between adiposity phenotypes and risk for incident prediabetes and diabetes in a multiethnic, population-based cohort of obese adults. Design, Setting, and Participants Among 732 obese participants (body mass index >= 30) aged 30 to 65 years without diabetes or cardiovascular disease enrolled between 2000 and 2002 in the Dallas Heart Study, we measured body composition by dual energy x-ray absorptiometry and magnetic resonance imaging (MRI); circulating adipokines and biomarkers of insulin resistance, dyslipidemia, and inflammation; and subclinical atherosclerosis and cardiac structure and function by computed tomography and MRI. Main Outcome Measures Incidence of diabetes through a median 7.0 years (interquartile range, 6.6-7.6) of follow-up. In a subgroup of 512 participants with normal fasting glucose values at baseline, incidence of the composite of prediabetes or diabetes was determined. Results Of the 732 participants (mean age, 43 years; 65% women; 71% non-white), 84 (11.5%) developed diabetes. In multivariable analysis, higher baseline visceral fat mass (odds ratio [OR] per 1 SD [1.4 kg], 2.4; 95% CI, 1.6-3.7), fructosamine level (OR per 1 SD [1.1 mu mol/L], 2.0; 95% CI, 1.4-2.7), fasting glucose level (OR per 1 SD [1.1 mu mol/L], 1.9; 95% CI, 1.4-2.6), family history of diabetes (OR, 2.3; 95% CI, 1.3-4.3), systolic blood pressure (OR per 10 mm Hg, 1.3; 95% CI, 1.1-1.5), and weight gain over follow-up (OR per 1 kg, 1.06; 95% CI, 1.02-1.10) were independently associated with diabetes, with no associations observed for body mass index, total body fat, or abdominal subcutaneous fat. Among the 512 participants with normal baseline glucose values, the composite outcome of prediabetes or diabetes occurred in 39.1% and was independently associated with baseline measurements of visceral fat mass; levels of fasting glucose, insulin, and fructosamine; older age; non-white race; family history of diabetes; and weight gain over follow-up (P < .05 for each) but not with measurements of general adiposity. Conclusion Excess visceral fat and insulin resistance, but not general adiposity, were independently associated with incident prediabetes and type 2 diabetes mellitus in obese adults. JAMA. 2012;308(11):1150-1159 www.jama.com	[Neeland, Ian J.; Turer, Aslan T.; Ayers, Colby R.; Farzaneh-Far, Ramin; Khera, Amit; McGuire, Darren K.; de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Ayers, Colby R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Vega, Gloria L.; Grundy, Scott M.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Powell-Wiley, Tiffany M.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	de Lemos, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021; McGuire, Darren K./AAL-4172-2021		F. Hoffmann LaRoche; Genentech; sanofi-aventis; Daiichi Sankyo; Novo Nordisk; Tethys Bioscience; Roche Diagnostics; Abbott Diagnostics; Alere; AstraZeneca; Donald W. Reynolds Foundation; US Public Health Service General Clinical Research Center [M01-RR00633]; National Institutes of Health (NIH) [UL1DE019584, PL1DK081182]; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007360]; Division of Intramural Research of the NHLBI of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	F. Hoffmann LaRoche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech); sanofi-aventis(Sanofi-Aventis); Daiichi Sankyo(Daiichi Sankyo Company Limited); Novo Nordisk(Novo Nordisk); Tethys Bioscience; Roche Diagnostics; Abbott Diagnostics(Abbott Laboratories); Alere; AstraZeneca(AstraZeneca); Donald W. Reynolds Foundation; US Public Health Service General Clinical Research Center(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Intramural Research of the NHLBI of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr McGuire reported having received consulting income from F. Hoffmann LaRoche, Genentech, sanofi-aventis, Daiichi Sankyo, Novo Nordisk, and Tethys Bioscience. Dr de Lemos reported having received grant support from Roche Diagnostics, Abbott Diagnostics, and Alere; consulting income from Tethys Bioscience, AstraZeneca, and Daiichi Sankyo; and lecture honoraria from Bristol-Myers Squibb/sanofi-aventis. No other disclosures were reported.; Grant support for the Dallas Heart Study was provided by the Donald W. Reynolds Foundation and by US Public Health Service General Clinical Research Center grant M01-RR00633, with additional support for the present study provided by grants UL1DE019584 and PL1DK081182 from the National Institutes of Health (NIH). Dr Neeland is supported by award T32HL007360 from the National Heart, Lung, and Blood Institute (NHLBI). Dr Powell-Wiley is funded by the Division of Intramural Research of the NHLBI of the NIH. Biomarker measurements were supported by investigator-initiated grants from Alere and Roche Diagnostics.	Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; Abdullah SM, 2007, ATHEROSCLEROSIS, V195, P404, DOI 10.1016/j.atherosclerosis.2006.10.022; Abdullah SM, 2005, AM J CARDIOL, V96, P1284, DOI 10.1016/j.amjcard.2005.06.073; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Garber Alan J, 2008, Endocr Pract, V14, P933; Genuth S, 2003, DIABETES CARE, V26, P3160; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jain T, 2004, J AM COLL CARDIOL, V44, P1011, DOI 10.1016/j.jacc.2004.05.069; Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Rohatgi A, 2009, ATHEROSCLEROSIS, V203, P569, DOI 10.1016/j.atherosclerosis.2008.07.015; Ross R, 2002, AM J PHYSIOL-ENDOC M, V282, pE657, DOI 10.1152/ajpendo.00469.2001; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tikuisis P, 2001, EUR J APPL PHYSIOL, V85, P264, DOI 10.1007/s004210100484; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Turer AT, 2011, DIABETOLOGIA, V54, P2515, DOI 10.1007/s00125-011-2252-z; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	40	411	431	3	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1150	1159		10.1001/2012.jama.11132	http://dx.doi.org/10.1001/2012.jama.11132			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990274	Green Accepted, Bronze			2022-12-28	WOS:000308861000031
J	Kahan, BC; Morris, TP				Kahan, Brennan C.; Morris, Tim P.			Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COVARIATE ADJUSTMENT; ALLOCATION; POWER	Objectives To assess how often stratified randomisation is used, whether analysis adjusted for all balancing variables, and whether the method of randomisation was adequately reported, and to reanalyse a previously reported trial to assess the impact of ignoring balancing factors in the analysis. Design Review of published trials and reanalysis of a previously reported trial. Setting Four leading general medical journals (BMJ, Journal of the American Medical Association, Lancet, and New England Journal of Medicine) and the second Multicenter Intrapleural Sepsis Trial (MIST2). Participants 258 trials published in 2010 in the four journals. Cluster randomised, crossover, non-randomised, single arm, and phase I or II trials were excluded, as were trials reporting secondary analyses, interim analyses, or results that had been previously published in 2010. Main outcome measures Whether the method of randomisation was adequately reported, how often balanced randomisation was used, and whether balancing factors were adjusted for in the analysis. Results Reanalysis of MIST2 showed that an unadjusted analysis led to larger P values and a loss of power. The review of published trials showed that balanced randomisation was common, with 163 trials (63%) using at least one balancing variable. The most common methods of balancing were stratified permuted blocks (n=85) and minimisation (n=27). The method of randomisation was unclear in 37% of trials. Most trials that balanced on centre or prognostic factors were not adequately analysed; only 26% of trials adjusted for all balancing factors in their primary analysis. Trials that did not adjust for balancing factors in their analysis were less likely to show a statistically significant result (unadjusted 57% v adjusted 78%, P=0.02). Conclusion Balancing on centre or prognostic factors is common in trials but often poorly described, and the implications of balancing are poorly understood. Trialists should adjust their primary analysis for balancing factors to obtain correct P values and confidence intervals and to avoid an unnecessary loss in power.	[Kahan, Brennan C.; Morris, Tim P.] MRC Clin Trials Unit, London WC2B 6NH, England	Medical Research Council Clinical Trials Unit	Kahan, BC (corresponding author), MRC Clin Trials Unit, Aviat House,125 Kingsway, London WC2B 6NH, England.	brk@ctu.mrc.ac.uk	Morris, Tim/AAY-5573-2021	Morris, Tim/0000-0001-5850-3610	MRC [MC-US-A737-0012]; Medical Research Council [MC_EX_G0800814] Funding Source: researchfish; MRC [MC_EX_G0800814] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Both authors are employed by the MRC Clinical Trials Unit. TPM is funded by an MRC studentship (MC-US-A737-0012).	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; [Anonymous], 1999, STAT MED, V18, P1905; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Hernandez AV, 2004, J CLIN EPIDEMIOL, V57, P454, DOI 10.1016/j.jclinepi.2003.09.014; Hewitt CE, 2006, BMJ-BRIT MED J, V332, P1506, DOI 10.1136/bmj.332.7556.1506; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Kennes LN, 2011, STAT MED, V30, P2573, DOI 10.1002/sim.4279; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Parzen M, 1998, BIOMETRICAL J, V40, P385, DOI 10.1002/(SICI)1521-4036(199808)40:4<385::AID-BIMJ385>3.0.CO;2-#; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Raab GM, 2000, CONTROL CLIN TRIALS, V21, P330, DOI 10.1016/S0197-2456(00)00061-1; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Schulz KF, 2002, LANCET, V359, P966, DOI 10.1016/S0140-6736(02)08029-7; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Turner EL, 2012, J CLIN EPIDEMIOL, V65, P474, DOI 10.1016/j.jclinepi.2011.08.012	17	177	178	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2012	345								e5840	10.1136/bmj.e5840	http://dx.doi.org/10.1136/bmj.e5840			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BZ	22983531	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000308865100001
J	Walejko, GK; Hughes, ME; Howieson, SV; Shipp, SS				Walejko, Gina K.; Hughes, Mary E.; Howieson, Susannah V.; Shipp, Stephanie S.			Federal Laboratory-Business Commercialization Partnerships	SCIENCE			English	Editorial Material									[Walejko, Gina K.; Hughes, Mary E.; Howieson, Susannah V.; Shipp, Stephanie S.] Sci & Technol Policy Inst, Inst Def Anal, Washington, DC 20006 USA		Walejko, GK (corresponding author), Sci & Technol Policy Inst, Inst Def Anal, Washington, DC 20006 USA.	gwalejko@ida.org		Shipp, Stephanie S./0000-0002-2142-2136				[Anonymous], 2008, FED REG, V73, P72036; [Anonymous], 2011, PRESIDENTIAL MEMORAN; [Anonymous], 2010, USDAS AGR RES SERVIC; Congressional Research Service, 2011, TECHN TRANSF US FED; DOE, 2012, EN INN PORT; Gaul G., 1995, PHILADELPHIA INQUIRE; Harrer B., 2011, AGREEMENT EXECUTION; Hughes M. E., 2011, P4728 IDA NS; Jaffe AB, 2000, RES POLICY, V29, P531, DOI 10.1016/S0048-7333(99)00088-8; Jansen C., 2007, FLC ANN M ARL TX 15; Michael T., 2008, INNOVATION; National Science and Technology Council Interagency Working Group on Federal Laboratory Reform, 1995, IMPR FED LAB M CHALL; National Science Foundation National Center for Science and Engineering Statistics, 2012, FISC YEARS 2009 11; Office of Technology Transfer (OTT), 2012, LIC OPP; OTT NIH, 2011, EL RES MAT CAT ERMA; Palmintera D., 2003, PARTNERS MISSION FED, pvii; Secretary of Energy Advisory Board Task Force, 1995, ALT FUT DEP EN NAT L; Technology Partnerships Office NIST, 2010, NEW APPR TECH TRANSF; U.S. Government Accountability Office, 2002, TECHN TRANSF SEV FAC; U.S. Office of Science and Technology Policy, 1983, REP WHIT HOUS SCI CO; Wessner C., 2002, GOVT IND PARTNERSHIP; Zielinski P., 2012, FLC ANN M PITTSB PA	22	2	2	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1297	1298		10.1126/science.1221962	http://dx.doi.org/10.1126/science.1221962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	004TW	22984055				2022-12-28	WOS:000308705000025
J	Sneddon, JB; Borowiak, M; Melton, DA				Sneddon, Julie B.; Borowiak, Malgorzata; Melton, Douglas A.			Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme	NATURE			English	Article							DIFFERENTIATION; MOUSE; EXPRESSION; DERIVATION; ENDODERM	One goal of regenerative medicine, to use stem cells to replace cells lost by injury or disease, depends on producing an excess of the relevant cell for study or transplantation. To this end, the stepwise differentiation of stem cells into specialized derivatives has been successful for some cell types(1-3), but a major problem remains the inefficient conversion of cells from one stage of differentiation to the next. If specialized cells are to be produced in large numbers it will be necessary to expand progenitor cells, without differentiation, at some steps of the process. Using the pancreatic lineage as a model for embryonic-stem-cell differentiation, we demonstrate that this is a solvable problem. Co-culture with organ-matched mesenchyme permits proliferation and self-renewal of progenitors, without differentiation, and enables an expansion of more than a million-fold for human endodermal cells with full retention of their developmental potential. This effect is specific both to the mesenchymal cell and to the progenitor being amplified. Progenitors that have been serially expanded on mesenchyme give rise to glucose-sensing, insulin-secreting cells when transplanted in vivo. Theoretically, the identification of stage-specific renewal signals can be incorporated into any scheme for the efficient production of large numbers of differentiated cells from stem cells and may therefore have wide application in regenerative biology.	[Sneddon, Julie B.; Borowiak, Malgorzata; Melton, Douglas A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University	Melton, DA (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Borowiak, Malgorzata/0000-0002-5829-1213	National Institutes of Health [5 U42 RR006042-20, K08 DK084206]; Howard Hughes Medical Institute; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Morrison for providing the Sox17-GFP reporter mouse ESC line and K. Kaestner for the Ngn3-GFP knock-in mouse ESCs. We also thank J. LaVecchio, G. Buruzula and B. Tilton for support for cell sorting, A. Kweudjeu for help with gene-expression experiments and human ESC culture, and C. Xie, C. Balatbat and K. Koszka for technical assistance. We are grateful to A. Tward and D. Cohen for critical reading of the manuscript. We thank J. Annes for assistance in obtaining human tissue samples and acknowledge the use of human tissues provided by the National Disease Research Interchange (NDRI), with support from National Institutes of Health grants 5 U42 RR006042-20 and K08 DK084206. J.B.S. is supported by the Howard Hughes Medical Institute. M.B. was supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust. D.A.M. is an investigator of the Howard Hughes Medical Institute.	Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; JAMES R, 1991, J BIOL CHEM, V266, P3246; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Thompson D.W, 1917, GROWTH FORM; WESSELLS NK, 1967, DEV BIOL, V15, P237, DOI 10.1016/0012-1606(67)90042-5; Yamashita YM, 2005, INT J HEMATOL, V82, P377, DOI 10.1532/IJH97.05097	25	102	145	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					765	+		10.1038/nature11463	http://dx.doi.org/10.1038/nature11463			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23041930	Green Accepted			2022-12-28	WOS:000311606000047
J	Connerth, M; Tatsuta, T; Haag, M; Klecker, T; Westermann, B; Langer, T				Connerth, Melanie; Tatsuta, Takashi; Haag, Mathias; Klecker, Till; Westermann, Benedikt; Langer, Thomas			Intramitochondrial Transport of Phosphatidic Acid in Yeast by a Lipid Transfer Protein	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CARDIOLIPIN BIOSYNTHESIS; MITOCHONDRIA; PHOSPHOLIPIDS; TRAFFICKING; UPS1P; SYNTHASE; BIOLOGY; TAM41	Mitochondria are dynamic organelles whose function depends on intramitochondrial phospholipid synthesis and the supply of membrane lipids from the endoplasmic reticulum. How phospholipids are transported to and in-between mitochondrial membranes remained unclear. We identified Ups1, a yeast member of a conserved family of intermembrane space proteins, as a lipid transfer protein that can shuttle phosphatidic acid between mitochondrial membranes. Lipid transfer required the dynamic assembly of Ups1 with Mdm35 and allowed conversion of phosphatidic acid to cardiolipin in the inner membrane. High cardiolipin concentrations prevented membrane dissociation of Ups1, leading to its proteolysis and inhibiting transport of phosphatidic acid and cardiolipin synthesis. Thus, intramitochondrial lipid trafficking may involve a regulatory feedback mechanism that limits the accumulation of cardiolipin in mitochondria.	[Connerth, Melanie; Tatsuta, Takashi; Haag, Mathias; Langer, Thomas] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Klecker, Till; Westermann, Benedikt] Univ Bayreuth, Inst Cell Biol, D-95440 Bayreuth, Germany; [Klecker, Till; Westermann, Benedikt] Univ Bayreuth, Electron Microscopy Lab, D-95440 Bayreuth, Germany; [Langer, Thomas] Max Planck Inst Biol Aging, D-50931 Cologne, Germany	University of Cologne; University of Bayreuth; University of Bayreuth; Max Planck Society	Langer, T (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany.	thomas.langer@uni-koeln.de	Westermann, Benedikt/H-7766-2013; Klecker, Till/L-6637-2017	Westermann, Benedikt/0000-0002-2991-1604; Klecker, Till/0000-0003-0149-042X; Langer, Thomas/0000-0003-1250-1462	Deutsche Forschungsgemeinschaft [SFB635, FOR885]; European Research Council [233078]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank G. Zimmer for technical assistance, S. Geimer for advice on electron microscopy, T. Endo for sharing unpublished results, and J. Nunnari for yeast strains. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB635, FOR885) and the European Research Council (AdG No. 233078) to T.L.	Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Harada Y, 2010, BIOCHEM BIOPH RES CO, V392, P228, DOI 10.1016/j.bbrc.2010.01.024; Janitor M, 1996, FEMS MICROBIOL LETT, V140, P43; KASPER AM, 1981, BIOCHIM BIOPHYS ACTA, V664, P22, DOI 10.1016/0005-2760(81)90025-4; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	21	170	174	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					815	818		10.1126/science.1225625	http://dx.doi.org/10.1126/science.1225625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23042293				2022-12-28	WOS:000310839500049
J	Grivennikov, SI; Wang, KP; Mucida, D; Stewart, CA; Schnabl, B; Jauch, D; Taniguchi, K; Yu, GY; Osterreicher, CH; Hung, KE; Datz, C; Feng, Y; Fearon, ER; Oukka, M; Tessarollo, L; Coppola, V; Yarovinsky, F; Cheroutre, H; Eckmann, L; Trinchieri, G; Karin, M				Grivennikov, Sergei I.; Wang, Kepeng; Mucida, Daniel; Stewart, C. Andrew; Schnabl, Bernd; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Oesterreicher, Christoph H.; Hung, Kenneth E.; Datz, Christian; Feng, Ying; Fearon, Eric R.; Oukka, Mohamed; Tessarollo, Lino; Coppola, Vincenzo; Yarovinsky, Felix; Cheroutre, Hilde; Eckmann, Lars; Trinchieri, Giorgio; Karin, Michael			Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth	NATURE			English	Article							PROMOTES COLON TUMORIGENESIS; COLORECTAL-CANCER; HELPER-CELLS; CUTTING EDGE; MOUSE MODEL; MICE; INFLAMMATION; COLITIS; DIFFERENTIATION; CARCINOGENESIS	Approximately 2% of colorectal cancer is linked to pre-existing inflammation known as colitis-associated cancer, but most develops in patients without underlying inflammatory bowel disease. Colorectal cancer often follows a genetic pathway whereby loss of the adenomatous polyposis coli (APC) tumour suppressor and activation of beta-catenin are followed by mutations in K-Ras, PIK3CA and TP53, as the tumour emerges and progresses(1,2). Curiously, however, 'inflammatory signature' genes characteristic of colitis-associated cancer are also upregulated in colorectal cancer(3,4). Further, like most solid tumours, colorectal cancer exhibits immune/inflammatory infiltrates(5), referred to as 'tumour-elicited inflammation'(6). Although infiltrating CD4(+) T(H)1 cells and CD8(+) cytotoxic T cells constitute a positive prognostic sign in colorectal cancer(7,8), myeloid cells and T-helper interleukin (IL)-17-producing (T(H)17) cells promote tumorigenesis(5,6), and a 'T(H)17 expression signature' in stage I/II colorectal cancer is associated with a drastic decrease in disease-free survival(9). Despite its pathogenic importance, the mechanisms responsible for the appearance of tumour-elicited inflammation are poorly understood. Many epithelial cancers develop proximally to microbial communities, which are physically separated from immune cells by an epithelial barrier(10). We investigated mechanisms responsible for tumour-elicited inflammation in a mouse model of colorectal tumorigenesis, which, like human colorectal cancer, exhibits upregulation of IL-23 and IL-17. Here we show that IL-23 signalling promotes tumour growth and progression, and development of a tumoural IL-17 response. IL-23 is mainly produced by tumour-associated myeloid cells that are likely to be activated by microbial products, which penetrate the tumours but not adjacent tissue. Both early and late colorectal neoplasms exhibit defective expression of several barrier proteins. We propose that barrier deterioration induced by colorectal-cancer-initiating genetic lesions results in adenoma invasion by microbial products that trigger tumour-elicited inflammation, which in turn drives tumour growth.	[Grivennikov, Sergei I.; Wang, Kepeng; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Grivennikov, Sergei I.; Wang, Kepeng; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Karin, Michael] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; [Wang, Kepeng] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China; [Mucida, Daniel; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, La Jolla, CA 92093 USA; [Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Stewart, C. Andrew; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Expt Immunol Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Schnabl, Bernd; Oesterreicher, Christoph H.; Eckmann, Lars] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Taniguchi, Koji] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Oesterreicher, Christoph H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Hung, Kenneth E.] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA; [Datz, Christian] Paracelsus Med Univ, Oberndorf Hosp, Dept Internal Med, Salzburg, Austria; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Oukka, Mohamed] Seattle Childrens Res Inst, Seattle, WA 98105 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA; [Coppola, Vincenzo] Ohio State Univ, Ctr Comprehens Canc, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; La Jolla Institute for Immunology; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; Keio University; Medical University of Vienna; Tufts Medical Center; Paracelsus Private Medical University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019; Wang, Kepeng/F-8363-2014; Trinchieri, Giorgio/F-9369-2015; Coppola, Vincenzo/D-5352-2014; Yu, Guann-Yi/O-5139-2019; Stewart, Charles/G-2470-2012; Coppola, Vincenzo/E-2917-2011	Grivennikov, Sergei/0000-0003-2987-0555; Wang, Kepeng/0000-0001-6428-4709; Trinchieri, Giorgio/0000-0001-5892-7464; Coppola, Vincenzo/0000-0001-6163-1779; Yu, Guann-Yi/0000-0002-0580-8282; Coppola, Vincenzo/0000-0001-6163-1779; Yarovinsky, Felix/0000-0001-5825-8002; Mucida, Daniel/0000-0002-0000-0452	Crohn's and Colitis Foundation of America [2693]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [K99-DK088589]; University of California, San Diego, Digestive Disease Research Development Center Pilot Grant [DK080506]; Croucher Foundation; China Postdoctoral Science Foundation [20110490919]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; SPAR Austria; NIH [R01CA082223, AI043477, DK035108]; American Association for Cancer Research [07-60-21-KARI]; NATIONAL CANCER INSTITUTE [ZIABC010793, ZICBC011265, R01CA082223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI050265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK088589, R24DK080506, K08DK081830, P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020703] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California, San Diego, Digestive Disease Research Development Center Pilot Grant; Croucher Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; SPAR Austria; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank eBioscience, GeneTex, Santa Cruz, BioLegend and Cell Signaling for antibodies; Genentech and Amgen for Il23<SUP>-/-</SUP> and Il17ra<SUP>-/-</SUP> mice, respectively, and S. Reid and E. Southon for the help in generating Il23r<SUP>F/F</SUP> mice. This work was supported by Crohn's and Colitis Foundation of America (Career Development Award number 2693), NIH/National Institute of Diabetes and Digestive and Kidney Diseases (K99-DK088589) and a University of California, San Diego, Digestive Disease Research Development Center Pilot Grant (DK080506) to S. I. G.; Croucher Foundation and China Postdoctoral Science Foundation (20110490919) to K. W.; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation to K. T.; SPAR Austria to C. D.; NIH (R01CA082223) to E. R. F.; and NIH (AI043477; DK035108) and American Association for Cancer Research (07-60-21-KARI) grants to M. K., who is an American Cancer Society Research Professor. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Dove WF, 1997, CANCER RES, V57, P812; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hoshino K, 1999, J IMMUNOL, V162, P5041; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Reichling T, 2005, CANCER RES, V65, P166; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Tanaka T, 2006, INT J CANCER, V118, P25, DOI 10.1002/ijc.21282; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang XX, 2011, THESCIENTIFICWORLDJO, V11, P826, DOI 10.1100/tsw.2011.86; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	44	858	889	6	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					254	+		10.1038/nature11465	http://dx.doi.org/10.1038/nature11465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23034650	Green Accepted			2022-12-28	WOS:000310774300044
J	Tan-Wong, SM; Zaugg, JB; Camblong, J; Xu, ZY; Zhang, DW; Mischo, HE; Ansari, AZ; Luscombe, NM; Steinmetz, LM; Proudfoot, NJ				Tan-Wong, Sue Mei; Zaugg, Judith B.; Camblong, Jurgi; Xu, Zhenyu; Zhang, David W.; Mischo, Hannah E.; Ansari, Aseem Z.; Luscombe, Nicholas M.; Steinmetz, Lars M.; Proudfoot, Nick J.			Gene Loops Enhance Transcriptional Directionality	SCIENCE			English	Article							RNA-POLYMERASE-II; COMPLEX; METHYLATION; TERMINATION; PROMOTERS; SSU72; CEREVISIAE; INITIATION; UPSTREAM; RECRUITS	Eukaryotic genomes are extensively transcribed, forming both messenger RNAs (mRNAs) and noncoding RNAs (ncRNAs). ncRNAs made by RNA polymerase II often initiate from bidirectional promoters (nucleosome-depleted chromatin) that synthesize mRNA and ncRNA in opposite directions. We demonstrate that, by adopting a gene-loop conformation, actively transcribed mRNA encoding genes restrict divergent transcription of ncRNAs. Because gene-loop formation depends on a protein factor (Ssu72) that coassociates with both the promoter and the terminator, the inactivation of Ssu72 leads to increased synthesis of promoter-associated divergent ncRNAs, referred to as Ssu72-restricted transcripts (SRTs). Similarly, inactivation of individual gene loops by gene mutation enhances SRT synthesis. We demonstrate that gene-loop conformation enforces transcriptional directionality on otherwise bidirectional promoters.	[Xu, Zhenyu; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Tan-Wong, Sue Mei; Camblong, Jurgi; Mischo, Hannah E.; Proudfoot, Nick J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Zaugg, Judith B.; Luscombe, Nicholas M.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Zhang, David W.; Ansari, Aseem Z.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Luscombe, Nicholas M.] UCL, Genet Inst, London WC1E 6BT, England; [Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England	European Molecular Biology Laboratory (EMBL); University of Oxford; European Molecular Biology Laboratory (EMBL); University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; Cancer Research UK	Steinmetz, LM (corresponding author), European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de; nicholas.proudfoot@path.ox.ac.uk	Ansari, Aseem/AAF-4945-2019	Proudfoot, Nicholas/0000-0001-8646-3222; Steinmetz, Lars/0000-0002-3962-2865; Zaugg, Judith B./0000-0001-8324-4040	Wellcome Trust; NIH; Deutsche Forschungsgemeinschaft; European Molecular Biology Laboratory; Swiss National Fonds; European Molecular Biology Organization; Direct For Biological Sciences [0747197] Funding Source: National Science Foundation; Cancer Research UK [16358] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Laboratory; Swiss National Fonds(Swiss National Science Foundation (SNSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Cancer Research UK(Cancer Research UK)	We thank B. Dichtl and J. Kufel for strains and H. Wijayatilake for FMP27 and beta-globin 3C reagents. This work was supported by the Wellcome Trust (N.J.P.), the NIH and Deutsche Forschungsgemeinschaft (L. M. S.), European Molecular Biology Laboratory (J.B.Z., N.M.L., L. M. S.), and the Swiss National Fonds and European Molecular Biology Organization (J. C.). Genomic data are deposited at http://steinmetzlab.embl.de/proudfoot_lab/index.html (E-TABM-936).	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Carninci P, 2009, NATURE, V457, P974, DOI 10.1038/457974b; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Medler S, 2011, J BIOL CHEM, V286, P33709, DOI 10.1074/jbc.M110.193870; Murray SC, 2012, NUCLEIC ACIDS RES, V40, P2432, DOI 10.1093/nar/gkr1121; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687	25	164	168	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					671	675		10.1126/science.1224350	http://dx.doi.org/10.1126/science.1224350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23019609	Green Accepted, Green Submitted			2022-12-28	WOS:000310516000054
J	Li, P; Spolski, R; Liao, W; Wang, L; Murphy, TL; Murphy, KM; Leonard, WJ				Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Murphy, Theresa L.; Murphy, Kenneth M.; Leonard, Warren J.			BATF-JUN is critical for IRF4-mediated transcription in T cells	NATURE			English	Article							B-ATF; IL-21; GENE; DIFFERENTIATION; MODULATION; ACTIVATION; EXPRESSION; RESPONSES; IRF-4; STAT3	Interferon regulatory factor 4 (IRF4) is an IRF family transcription factor with critical roles in lymphoid development and in regulating the immune response(1,2). IRF4 binds DNA weakly owing to a carboxy-terminal auto-inhibitory domain, but cooperative binding with factors such as PU.1 or SPIB in B cells increases binding affinity(3), allowing IRF4 to regulate genes containing ETS-IRF composite elements (EICEs; 5'-GGAAnnGAAA-3')(1). Here we show that in mouse CD4(+) T cells, where PU.1/SPIB expression is low, and in B cells, where PU.1 is well expressed, IRF4 unexpectedly can cooperate with activator protein-1 (AP1) complexes to bind to AP1-IRF4 composite (5'-TGAnTCA/GAAA-3') motifs that we denote as AP1-IRF composite elements (AICEs). Moreover, BATF-JUN family protein complexes cooperate with IRF4 in binding to AICEs in pre-activated CD4(+) T cells stimulated with IL-21 and in T(H)17 differentiated cells. Importantly, BATF binding was diminished in Irf4(-/-) T cells and IRF4 binding was diminished in Batf(-/-) T cells, consistent with functional cooperation between these factors. Moreover, we show that AP1 and IRF complexes cooperatively promote transcription of the Il10 gene, which is expressed in T(H)17 cells and potently regulated by IL-21. These findings reveal that IRF4 can signal via complexes containing ETS or AP1 motifs depending on the cellular context, thus indicating new approaches for modulating IRF4-dependent transcription.	[Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Li, P (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	lip3@nhlbi.nih.gov; wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022		Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIAHL005402, ZICHL006058, ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH (P.L., R.S., W.L., L.W. and W.J.L.) and the Howard Hughes Medical Institute (T.L.M. and K.M.M.). We thank J.-X. Lin for valuable suggestions, critical comments and RNA-Seq data for pro-B/pre-B-enriched populations. We thank J. Zhu and Y. Wakabayashi, NHLBI DNA Sequencing Core, for excellent services, K. Ozato and Y. Hiroaki, NICHD, for Irf4<SUP>-/-</SUP> mice, and J. Thierry-Mieg and D. Thierry-Mieg, NCBI, for early analysis of ChIP-Seq data from ref. 14.	Altin JA, 2012, J IMMUNOL, V188, P5478, DOI 10.4049/jimmunol.1102994; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pernis AB, 2002, J INTERF CYTOK RES, V22, P111, DOI 10.1089/107999002753452728; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tominaga N, 2003, INT IMMUNOL, V15, P1, DOI 10.1093/intimm/dxg001; Tussiwand R., 2012, NATURE; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	33	278	286	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					543	+		10.1038/nature11530	http://dx.doi.org/10.1038/nature11530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22992523	Green Accepted			2022-12-28	WOS:000310196200043
J	Chakkalakal, JV; Jones, KM; Basson, MA; Brack, AS				Chakkalakal, Joe V.; Jones, Kieran M.; Basson, M. Albert; Brack, Andrew S.			The aged niche disrupts muscle stem cell quiescence	NATURE			English	Article							FIBROBLAST-GROWTH-FACTOR; SATELLITE CELLS; SELF-RENEWAL; PROGENITOR CELLS; PROGRESSION; MYOGENESIS; SPROUTY; DIFFERENTIATION; HETEROGENEITY; CONTRIBUTES	The niche is a conserved regulator of stem cell quiescence and function. During ageing, stem cell function declines. To what extent and by what means age-related changes within the niche contribute to this phenomenon are unknown. Here we demonstrate that the aged muscle stem cell niche, the muscle fibre, expresses Fgf2 under homeostatic conditions, driving a subset of satellite cells to break quiescence and lose their self-renewing capacity. We show in mice that relatively dormant aged satellite cells robustly express sprouty 1 (Spry1), an inhibitor of fibroblast growth factor (FGF) signalling. Increasing FGF signalling in aged satellite cells under homeostatic conditions by removing Spry1 results in the loss of quiescence, satellite cell depletion and diminished regenerative capacity. Conversely, reducing niche-derived FGF activity through inhibition of Fgfr1 signalling or overexpression of Spry1 in satellite cells prevents their depletion. These experiments identify an age-dependent change in the stem cell niche that directly influences stem cell quiescence and function.	[Chakkalakal, Joe V.; Brack, Andrew S.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Jones, Kieran M.; Basson, M. Albert] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England; [Brack, Andrew S.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Brack, Andrew S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; University of London; King's College London; Harvard University; Harvard University; Harvard Medical School	Brack, AS (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	Brack.Andrew@mgh.harvard.edu	Chakkalakal, Joe/ABD-2865-2020	Chakkalakal, Joe/0000-0002-8440-7312; Basson, M. Albert/0000-0001-9834-7528	MGH; Harvard Stem Cell Institute; NIH [R01 AR060868, R01 AR061002]; Wellcome Trust [WT091475]; MGH ECOR Postdoctoral Fellow Award; BBSRC Doctoral Training Award [BB/F017626/1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060868, R01AR061002] Funding Source: NIH RePORTER	MGH; Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MGH ECOR Postdoctoral Fellow Award; BBSRC Doctoral Training Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Hock, K. Hochedlinger and R. Friesel for the generous provision of reagents, and G. Estrada for technical assistance. We are also grateful to L. Prickett-Rice, K. Folz-Donahue and M. Weglarz for cell sorting. This work was supported by MGH start-up funds, Harvard Stem Cell Institute grants and NIH grants (R01 AR060868, R01 AR061002) (A. S. B.); a Wellcome Trust grant (WT091475) (M. A. B.); and an MGH ECOR Postdoctoral Fellow Award (J.V.C.) and a BBSRC Doctoral Training Award (BB/F017626/1) (K.M.J.).	Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; BISCHOFF R, 1990, DEVELOPMENT, V109, P943; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Buono M, 2010, J EXP MED, V207, P1647, DOI 10.1084/jem.20091022; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Flanagan-Steet H, 2000, DEV BIOL, V218, P21, DOI 10.1006/dbio.1999.9535; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kudla AJ, 1998, J CELL BIOL, V142, P241, DOI 10.1083/jcb.142.1.241; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; LEFAUCHEUR JP, 1995, J NEUROIMMUNOL, V57, P85, DOI 10.1016/0165-5728(94)00166-L; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Ono Y, 2012, J CELL SCI, V125, P1309, DOI 10.1242/jcs.096198; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xu XL, 2002, GENESIS, V32, P85, DOI 10.1002/gene.10028; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yang XH, 2008, DEV BIOL, V321, P64, DOI 10.1016/j.ydbio.2008.05.555; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	55	506	527	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					355	+		10.1038/nature11438	http://dx.doi.org/10.1038/nature11438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023126	Green Submitted, Green Accepted			2022-12-28	WOS:000309918500036
J	Holmes, D				Holmes, David			Profile George Alleyne: the champ	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2012	380	9849					1221	1221		10.1016/S0140-6736(12)61701-2	http://dx.doi.org/10.1016/S0140-6736(12)61701-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020NG	23040848	Bronze			2022-12-28	WOS:000309817500012
J	Eisch, AJ; Petrik, D				Eisch, Amelia J.; Petrik, David			Depression and Hippocampal Neurogenesis: A Road to Remission?	SCIENCE			English	Editorial Material							ANTIDEPRESSANT TREATMENT; ADULT NEUROGENESIS; CELL-PROLIFERATION; PATTERN SEPARATION; STRESS RESPONSES; GRANULE CELLS; ANIMAL-MODEL; BEHAVIOR; BRAIN; QUESTIONS	Adult-generated hippocampal neurons are required for mood control and antidepressant efficacy, raising hopes that someday we can harness the power of new neurons to treat mood disorders such as depression. However, conflicting findings from preclinical research-involving stress, depression, and neurogenesis-highlight the complexity of considering neurogenesis as a road to remission from depression. To reconcile differences in the literature, we introduce the "neurogenic interactome," a platform from which to consider the diverse and dynamic factors regulating neurogenesis. We propose consideration of the varying perspectives-system, region, and local regulation of neurogenesis-offered by the interactome and exchange of ideas between the fields of learning and memory and mood disorder research to clarify the role of neurogenesis in the etiology and treatment of depression.	[Eisch, Amelia J.; Petrik, David] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Eisch, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	amelia.eisch@utsouthwestern.edu		Petrik, David/0000-0003-3026-0770; Eisch, Amelia/0000-0001-6476-5385	NIH; National Alliance for Research on Schizophrenia and Depression; NASA; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA023555, R01DA016765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the NIH, National Alliance for Research on Schizophrenia and Depression and NASA. The authors thank J. Hsieh, S. Padrick, and C. Tamminga for feedback and helpful discussions. We apologize to all the authors whose work we could not cite and discuss because of limitations of space and scope.	Anacker C, 2012, MOL PSYCHIATR, V17, P9, DOI 10.1038/mp.2011.133; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Christensen T, 2011, NEUROSCIENCE, V196, P66, DOI 10.1016/j.neuroscience.2011.08.024; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Jayatissa MN, 2010, STRESS, V13, P95, DOI 10.3109/10253890902951786; Kirby ED, 2012, MOL PSYCHIATR, V17, P527, DOI 10.1038/mp.2011.71; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lyons DM, 2010, P NATL ACAD SCI USA, V107, P14823, DOI 10.1073/pnas.0914568107; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Parihar VK, 2011, MOL PSYCHIATR, V16, P171, DOI 10.1038/mp.2009.130; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Tanti A, 2010, BRIT J PHARMACOL, V159, P1187, DOI 10.1111/j.1476-5381.2009.00585.x	26	347	367	9	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					72	75		10.1126/science.1222941	http://dx.doi.org/10.1126/science.1222941			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042885	Green Accepted			2022-12-28	WOS:000309457400054
J	Greenwood, B; Owusu-Agyei, S				Greenwood, Brian; Owusu-Agyei, Seth			Malaria in the Post-Genome Era	SCIENCE			English	Editorial Material							RESISTANCE; SEQUENCE		[Greenwood, Brian] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London NW3 5AB, England; [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo 200, Ghana	University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre	Greenwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London NW3 5AB, England.	brian.greenwood@lshtm.ac.uk; seth.owusu-agyei@kintamp-hrc.org		Owusu-Agyei, Seth/0000-0002-0807-1781				Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; D'Souza BJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-28; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; WHO, 2011, WORLD MALARIA REPORT 2011, P1	13	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					49	50		10.1126/science.1229177	http://dx.doi.org/10.1126/science.1229177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042872				2022-12-28	WOS:000309457400041
J	Stallard, P; Sayal, K; Phillips, R; Taylor, JA; Spears, M; Anderson, R; Araya, R; Lewis, G; Millings, A; Montgomery, AA				Stallard, Paul; Sayal, Kapil; Phillips, Rhiannon; Taylor, John A.; Spears, Melissa; Anderson, Rob; Araya, Ricardo; Lewis, Glyn; Millings, Abigail; Montgomery, Alan A.			Classroom based cognitive behavioural therapy in reducing symptoms of depression in high risk adolescents: pragmatic cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDHOOD; PREVENTION; OUTCOMES; CHILDREN; INTERVENTION; PROGRAMS	Objective To compare the effectiveness of classroom based cognitive behavioural therapy with attention control and usual school provision for adolescents at high risk of depression. Design Three arm parallel cluster randomised controlled trial. Setting Eight UK secondary schools. Participants Adolescents (n = 5030) aged 12-16 years in school year groups 8-11. Year groups were randomly assigned on a 1:1:1 ratio to cognitive behavioural therapy, attention control, or usual school provision. Allocation was balanced by school, year, number of students and classes, frequency of lessons, and timetabling. Participants were not blinded to treatment allocation. Interventions Cognitive behavioural therapy, attention control, and usual school provision provided in classes to all eligible participants. Main outcome measures Outcomes were collected by self completed questionnaire administered by researchers. The primary outcome was symptoms of depression assessed at 12 months by the short mood and feelings questionnaire among those identified at baseline as being at high risk of depression. Secondary outcomes included negative thinking, self worth, and anxiety. Analyses were undertaken on an intention to treat basis and accounted for the clustered nature of the design. Results 1064 (21.2%) adolescents were identified at high risk of depression: 392 in the classroom based cognitive behavioural therapy arm, 374 in the attention control arm, and 298 in the usual school provision arm. At 12 months adjusted mean scores on the short mood and feelings questionnaire did not differ for cognitive behavioural therapy versus attention control (-0.63, 95% confidence interval -1.85 to 0.58, P = 0.41) or for cognitive behavioural therapy versus usual school provision (0.97, -0.20 to 2.15, P = 0.12). Conclusion In adolescents with depressive symptoms, outcomes were similar for attention control, usual school provision, and cognitive behavioural therapy. Classroom based cognitive behavioural therapy programmes may result in increased self awareness and reporting of depressive symptoms but should not be undertaken without further evaluation and research.	[Stallard, Paul; Phillips, Rhiannon; Millings, Abigail] Univ Bath, Dept Hlth, Child & Adolescent Mental Hlth Res Grp, Bath BA2 7AY, Avon, England; [Sayal, Kapil; Taylor, John A.] Univ Nottingham, Sect Dev Psychiat, Nottingham NG7 2RD, England; [Sayal, Kapil; Taylor, John A.] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2RD, England; [Spears, Melissa; Montgomery, Alan A.] Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England; [Anderson, Rob] Univ Exeter, Sch Med, Exeter EX4 4QJ, Devon, England; [Araya, Ricardo; Lewis, Glyn] Univ Bristol, Acad Unit Psychiat, Bristol BS8 1TH, Avon, England	University of Bath; University of Nottingham; University of Nottingham; University of Bristol; University of Exeter; University of Bristol	Stallard, P (corresponding author), Univ Bath, Dept Hlth, Child & Adolescent Mental Hlth Res Grp, Bath BA2 7AY, Avon, England.	p.stallard@bath.ac.uk	Lewis, Glyn/E-9944-2012; Araya, Ricardo/S-3144-2019; Phillips, Rhiannon/F-7733-2013	Lewis, Glyn/0000-0001-5205-8245; Araya, Ricardo/0000-0002-0420-5148; Phillips, Rhiannon/0000-0002-4256-4598; Millings, Abigail/0000-0002-7849-6048; Sayal, Kapil/0000-0002-2050-4316; Montgomery, Alan/0000-0003-0450-1606	East Midlands Hub of the NIHR Mental Health Research Network; National Institute of Health Research Health Technology Assessment [06/37/04]; MRC [G0800800] Funding Source: UKRI; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [06/37/04] Funding Source: researchfish	East Midlands Hub of the NIHR Mental Health Research Network; National Institute of Health Research Health Technology Assessment; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the schools and students who participated in this project, the facilitators who helped with intervention delivery, the East Midlands Hub of the NIHR Mental Health Research Network for their administrative and research support, the support and guidance of the trial steering committee and data monoitoring ethic committee, and in particular their respective chairs, Laurence Moore and David Gunnell.; This study was funded by the National Institute of Health Research Health Technology Assessment (06/37/04). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. The sponsor of the study had no role in study design, data collection, data analysis, interpretation of data, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Angold A, 1995, INT J METHOD PSYCH, V5, P237; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Calear AL, 2010, J ADOLESCENCE, V33, P429, DOI 10.1016/j.adolescence.2009.07.004; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; Dunn V, 2006, BRIT J PSYCHIAT, V188, P216, DOI 10.1192/bjp.188.3.216; Fergusson DM, 2005, ARCH GEN PSYCHIAT, V62, P66, DOI 10.1001/archpsyc.62.1.66; Giesen F, 2007, J PAEDIATR CHILD H, V43, P785, DOI 10.1111/j.1440-1754.2007.01196.x; Gledhill J, 2011, SOC PSYCH PSYCH EPID, V46, P993, DOI 10.1007/s00127-010-0271-6; GOODENOW C, 1993, PSYCHOL SCHOOLS, V30, P79, DOI 10.1002/1520-6807(199301)30:1<79::AID-PITS2310300113>3.0.CO;2-X; HARRINGTON R, 1990, ARCH GEN PSYCHIAT, V47, P465; Kennard BD, 2006, CHILD ADOL PSYCH CL, V15, P1057, DOI 10.1016/j.chc.2006.05.003; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Lewinsohn PM, 2000, AM J PSYCHIAT, V157, P1584, DOI 10.1176/appi.ajp.157.10.1584; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Logan DE, 2002, J AM ACAD CHILD PSY, V41, P296, DOI 10.1097/00004583-200203000-00009; Merry S, 2004, J AM ACAD CHILD PSY, V43, P538, DOI 10.1097/00004583-200405000-00007; Merry S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003380.PUB2; Merry SN, COCHRANE DATABASE SY, V2100; Moor S, 2007, J ADOLESCENCE, V30, P81, DOI 10.1016/j.adolescence.2005.12.001; Raab GM, 2001, STAT MED, V20, P351, DOI 10.1002/1097-0258(20010215)20:3<351::AID-SIM797>3.0.CO;2-C; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI DOI 10.1515/9781400876136; Sawyer MG, 2006, J CHILD PSYCHOL PSYC, V74, P401; Sayal K, 2010, ARCH PEDIAT ADOL MED, V164, P462, DOI 10.1001/archpediatrics.2010.40; Schniering CA, 2002, BEHAV RES THER, V40, P1091, DOI 10.1016/S0005-7967(02)00022-0; Shapiro Elaine, 1997, POWERFUL PLACEBO ANC; Shochet I.M., 2004, INT J MENT HEALTH PR, V6, P17, DOI [10.1080/14623730.2004.9721935, DOI 10.1080/14623730.2004.9721935]; Stallard P, 2012, BRIT J PSYCHIAT, V201, P18; Stallard P, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-114; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; VERNBERG EM, 1990, J ABNORM CHILD PSYCH, V18, P187, DOI 10.1007/BF00910730	32	69	69	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2012	345								e6058	10.1136/bmj.e6058	http://dx.doi.org/10.1136/bmj.e6058			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LO	23043090	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000309662300001
J	Parekh, R; Beaconsfield, T; Kong, WM				Parekh, Ravi; Beaconsfield, Tina; Kong, Wing May			A woman with neck pain and shortness of breath	BRITISH MEDICAL JOURNAL			English	Editorial Material							GRAVES-DISEASE; HYPERTHYROIDISM; MANAGEMENT; THYROIDITIS; DIAGNOSIS		[Parekh, Ravi] NW London Hosp NHS Trust, Cent Middlesex Hosp, London NW10 7NS, England; [Parekh, Ravi] Univ London Imperial Coll Sci Technol & Med, Fac Med, Cent Middlesex Hosp, London, England	Imperial College London; Imperial College London	Parekh, R (corresponding author), NW London Hosp NHS Trust, Cent Middlesex Hosp, London NW10 7NS, England.	r.parekh@imperial.ac.uk		Parekh, Ravi/0000-0003-0219-4956				Becker DV, 1999, PROCEDURE GUIDELINE; Bindra A, 2006, AM FAM PHYSICIAN, V73, P1769; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Fatourechi V, 2003, J CLIN ENDOCR METAB, V88, P2100, DOI 10.1210/jc.2002-021799; FRANKLYN JA, 1994, NEW ENGL J MED, V330, P1731; Hubbard JGH, 2009, SPRINGER SPEC SURG S, P1, DOI 10.1007/978-1-84628-881-4; Lazarus JH, 1997, LANCET, V349, P339, DOI 10.1016/S0140-6736(96)08015-4; Marqusee E, 2000, ANN INTERN MED, V133, P696, DOI 10.7326/0003-4819-133-9-200011070-00011; Okosieme OE, 2010, CLIN ENDOCRINOL, V72, P122, DOI 10.1111/j.1365-2265.2009.03623.x; Pearce EN, 2006, BMJ-BRIT MED J, V332, P1369, DOI 10.1136/bmj.332.7554.1369; Streetman DD, 2003, ANN PHARMACOTHER, V37, P1100, DOI 10.1345/aph.1C299; Takasu N, 1997, J ENDOCRINOL INVEST, V20, P452, DOI 10.1007/BF03348001; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707	14	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 3	2012	345								e6553	10.1136/bmj.e6553	http://dx.doi.org/10.1136/bmj.e6553			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KZ	23034846				2022-12-28	WOS:000309660600004
J	Schaeffner, ES; Ebert, N; Delanaye, P; Frei, U; Gaedeke, J; Jakob, O; Kuhlmann, MK; Schuchardt, M; Tolle, M; Ziebig, R; van der Giet, M; Martus, P				Schaeffner, Elke S.; Ebert, Natalie; Delanaye, Pierre; Frei, Ulrich; Gaedeke, Jens; Jakob, Olga; Kuhlmann, Martin K.; Schuchardt, Mirjam; Toelle, Markus; Ziebig, Reinhard; van der Giet, Markus; Martus, Peter			Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CYSTATIN-C; CREATININE-BASED FORMULAS; CKD-EPI; IOHEXOL CLEARANCE; PLASMA-CLEARANCE; ESTIMATING GFR; RENAL-DISEASE; POPULATION; PREVALENCE	Background: In older adults, current equations to estimate glomerular filtration rate (GFR) are not validated and may misclassify elderly persons in terms of their stage of chronic kidney disease. Objective: To derive the Berlin Initiative Study (BIS) equation, a novel estimator of GFR in elderly participants. Design: Cross-sectional. Data were split for analysis into 2 sets for equation development and internal validation. Setting: Random community-based population of a large insurance company. Participants: 610 participants aged 70 years or older (mean age, 78.5 years). Intervention: Iohexol plasma clearance measurement as gold standard. Measurements: GFR, measured as the plasma clearance of the endogenous marker iohexol, to compare performance of existing equations of estimated GFR with measured GFR of the gold standard; estimation of measured GFR from standardized creatinine and cystatin C levels, sex, and age in the learning sample; and comparison of the BIS equations (BIS1: creatinine-based; BIS2: creatinine- and cystatin C-based) with other estimating equations and determination of bias, precision, and accuracy in the validation sample. Results: The new BIS2 equation yielded the smallest bias followed by the creatinine- based BIS1 and Cockcroft-Gault equations. All other equations considerably overestimated GFR. The BIS equations confirmed a high prevalence of persons older than 70 years with a GFR less than 60 mL/min per 1.73 m(2) (BIS1, 50.4%; BIS2, 47.4%; measured GFR, 47.9%). The total misclassification rate for this criterion was smallest for the BIS2 equation (11.6%), followed by the cystatin C equation 2 (15.1%) proposed by the Chronic Kidney Disease Epidemiology Collaboration. Among the creatinine- based equations, BIS1 had the smallest misclassification rate (17.2%), followed by the Chronic Kidney Disease Epidemiology Collaboration equation (20.4%). Limitation: There was no validation by an external data set. Conclusion: The BIS2 equation should be used to estimate GFR in persons aged 70 years or older with normal or mild to moderately reduced kidney function. If cystatin C is not available, the BIS1 equation is an acceptable alternative.	Charite, Vivantes Klinikum Friedrichshain, Inst Biostat & Clin Epidemiol,Lab Berlin, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; Univ Liege, CHU Sart Tilman, Liege, Belgium; Univ Tubingen, UKT Tubingen, Inst Med Biostat, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Liege; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schaeffner, ES (corresponding author), Charite Hosp, Campus Virchow Klinikum, Div Nephrol & Intens Care Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	elke.schaeffner@charite.de	Tölle, Markus/GPP-7157-2022; Schuchardt, Mirjam/AAS-3704-2021; Delanaye, Pierre/T-4225-2019	Delanaye, Pierre/0000-0002-1480-5761; Schaeffner, Elke/0000-0002-7925-4577; Ebert, Natalie/0000-0002-4463-3315; van der Giet, Markus/0000-0003-3590-5451; Schuchardt, Mirjam/0000-0001-7388-9611	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine; Dr. Werner Jackstadt Foundation	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine; Dr. Werner Jackstadt Foundation	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine.; By the Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine and the Dr. Werner Jackstadt Foundation.	Agarwal R, 2003, AM J KIDNEY DIS, V41, P752, DOI 10.1016/S0272-6386(03)00022-2; ARVIDSSON A, 1990, SCAND J CLIN LAB INV, V50, P757, DOI 10.3109/00365519009091069; Botev R, 2011, CLIN J AM SOC NEPHRO, V6, P937, DOI 10.2215/CJN.09241010; Brandstrom E, 1998, NEPHROL DIAL TRANSPL, V13, P1176, DOI 10.1093/ndt/13.5.1176; BROCHNER.J, 1972, SCAND J CLIN LAB INV, V30, P271, DOI 10.3109/00365517209084290; BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6; Campbell KH, 2008, CURR OPIN NEPHROL HY, V17, P298, DOI 10.1097/MNH.0b013e3282f5dd90; Cavalier E, 2008, CLIN CHIM ACTA, V396, P80, DOI 10.1016/j.cca.2008.07.011; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Delanaye P, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-8; Delanaye P, 2008, CLIN CHIM ACTA, V398, P118, DOI 10.1016/j.cca.2008.09.001; Finney H, 1999, ARCH GERONTOL GERIAT, V29, P75, DOI 10.1016/S0167-4943(99)00025-4; Fliser D, 2001, AM J KIDNEY DIS, V37, P79, DOI 10.1053/ajkd.2001.20591; FRENNBY B, 1994, INVEST RADIOL, V29, pS234, DOI 10.1097/00004424-199406001-00079; Garg AX, 2004, KIDNEY INT, V65, P649, DOI 10.1111/j.1523-1755.2004.00412.x; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P1151, DOI 10.1001/jama.2010.303; Inker LA, 2011, AM J KIDNEY DIS, V58, P682, DOI 10.1053/j.ajkd.2011.05.019; Johnson D, 2005, NEPHROLOGY CARLTO S4, V10, pS157; KRUTZEN E, 1984, J LAB CLIN MED, V104, P955; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Newman DJ, 2002, ANN CLIN BIOCHEM, V39, P89, DOI 10.1258/0004563021901847; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; OLSSON B, 1983, INVEST RADIOL, V18, P177, DOI 10.1097/00004424-198303000-00015; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rule AD, 2010, CLIN J AM SOC NEPHRO, V5, P951, DOI 10.2215/CJN.03110410; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Schaeffner ES, 2010, EUR J EPIDEMIOL, V25, P203, DOI 10.1007/s10654-010-9424-x; Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385; Segarra A, 2011, CLIN J AM SOC NEPHRO, V6, P2411, DOI 10.2215/CJN.01150211; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Shastri S, 2011, CLIN J AM SOC NEPHRO, V6, P1410, DOI 10.2215/CJN.08801010; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Smith HW., 1951, KIDNEY STRUCTURE FUN, P552; Spinler SA, 1998, ANN PHARMACOTHER, V32, P1275, DOI 10.1345/aph.18122; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stolz A, 2010, TRANSPLANTATION, V89, P440, DOI 10.1097/TP.0b013e3181ca7d1b; van den Brand JAJG, 2011, NEPHROL DIAL TRANSPL, V26, P3176, DOI 10.1093/ndt/gfr003; Van Pottelbergh C, 2011, Adv Gerontol, V24, P108; Van Pottelbergh G, 2011, AGE AGEING, V40, P401, DOI 10.1093/ageing/afr033; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	55	381	399	2	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					471	U54		10.7326/0003-4819-157-7-201210020-00003	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016MQ	23027318	Green Submitted			2022-12-28	WOS:000309523200002
J	Sanda, S				Sanda, Soumana			Niger's success in child survival	LANCET			English	Editorial Material									Minist Publ Hlth, Niamey, Niger		Sanda, S (corresponding author), Minist Publ Hlth, BP 623, Niamey, Niger.	soumana_sanda@yahoo.fr						Amouzou A, 2012, LANCET; Countdown to 2015, 2012, BUILD FUT WOM CHILDR	2	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1127	1128		10.1016/S0140-6736(12)61514-1	http://dx.doi.org/10.1016/S0140-6736(12)61514-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	012SD	22999431				2022-12-28	WOS:000309255900006
J	Rajan, A; Perrimon, N				Rajan, Akhila; Perrimon, Norbert			Drosophila Cytokine Unpaired 2 Regulates Physiological Homeostasis by Remotely Controlling Insulin Secretion	CELL			English	Article							JAK/STAT PATHWAY; IMAGINAL DISKS; LIFE-SPAN; IN-VIVO; CELLS; GROWTH; MELANOGASTER; METABOLISM; PEPTIDES; NEURONS	In Drosophila, the fat body (FB), a functional analog of the vertebrate adipose tissue, is the nutrient sensor that conveys the nutrient status to the insulin-producing cells (IPCs) in the fly brain to release Drosophila insulin-like peptides (Dilps). Dilp secretion in turn regulates energy balance and promotes systemic growth. We identify Unpaired 2 (Upd2), a protein with similarities to type I cytokines, as a secreted factor produced by the FB in the fed state. When upd2 function is perturbed specifically in the FB, it results in a systemic reduction in growth and alters energy metabolism. Upd2 activates JAK/STAT signaling in a population of GABAergic neurons that project onto the IPCs. This activation relieves the inhibitory tone of the GABAergic neurons on the IPCs, resulting in the secretion of Dilps. Strikingly, we find that human Leptin can rescue the upd2 mutant phenotypes, suggesting that Upd2 is the functional homolog of Leptin.	[Rajan, Akhila; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rajan, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	akhila@genetics.med.harvard.edu; perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X	National Institutes of Health [5P01CA120964, 5R01DK088718]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Zeidler, E. Bach, B. Hassan, B. White, B. Al-Anzi, M. Pankratz, P. Shen, J. Wang, D. Krantz, J. Simpson, A. Gould, E. Hafen, H. Stocker, P. Leopold, G. Technau, and E. Olson for reagents. We thank the Transgenic RNAi Resource Project, NIG-Fly Stock Center (Japan), and the Bloomington Stock Center for flies, the Developmental Studies Hybridoma Bank for monoclonal antibodies, and the Drosophila RNAi Screening Center (Harvard Medical School) for dsRNA reagents and plate-reader equipment. We also thank C. Villalta for performing embryonic microinjections to create the human Leptin transgenic flies, F. Demontis and C. Pitsouli for critical comments on the manuscript, Y. Kwon for advice on the STAT luciferase assay, I. Droujinine for discussions and help with the diet experiments, and P. Raghavan and F. Wirtz-Peitz for insightful comments and discussions during the course of this work. This work was supported by the National Institutes of Health (5P01CA120964 and 5R01DK088718). N.P. is a Howard Hughes Medical Institute investigator.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Caton PW, 2011, DIABETOLOGIA, V54, P3083, DOI 10.1007/s00125-011-2288-0; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; DasGupta R., 2005, SCI STKE, pcm5; DAVIS KT, 1977, SCIENCE, V196, P438, DOI 10.1126/science.403606; de Haas Y, 2011, J DAIRY SCI, V94, P6122, DOI 10.3168/jds.2011-4439; DINARELLO CA, 1986, ANNU REV MED, V37, P173; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Fei H, 2010, J EXP BIOL, V213, P1717, DOI 10.1242/jeb.036053; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kahn CR, 2005, JOSLINS DIABETES MEL; Karsten P, 2006, CELL SIGNAL, V18, P819, DOI 10.1016/j.cellsig.2005.07.006; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; RODGERS ME, 1977, CELL, V12, P915, DOI 10.1016/0092-8674(77)90155-6; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Wright VM, 2011, CELL SIGNAL, V23, P920, DOI 10.1016/j.cellsig.2011.01.020; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou XB, 2005, LECT NOTES COMPUT SC, V3749, P885	47	312	320	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					123	137		10.1016/j.cell.2012.08.019	http://dx.doi.org/10.1016/j.cell.2012.08.019			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021220	Green Accepted, Bronze			2022-12-28	WOS:000309544200015
J	Angell, SY; Danel, I; DeCock, KM				Angell, S. Y.; Danel, I.; DeCock, K. M.			Global Indicators and Targets for Noncommunicable Diseases	SCIENCE			English	Editorial Material									[Angell, S. Y.; Danel, I.; DeCock, K. M.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Angell, SY (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA 30333 USA.	sangell@cdc.gov						Bloom DE, 2011, GLOBAL EC BURDEN NON; Carin B., 2012, POST 2015 GOALS TARG; Edvardsson K, 2005, SOC CHOICE WELFARE, V24, P343, DOI 10.1007/s00355-003-0309-8; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; WHO, 2012, COMPR GLOB MON FRAM; WHO, 2011, PROP NONC DIS TARG W; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 1998, HLTH PROM GLOSS; You D., 2011, LEVELS TRENDS CHILD, P33	9	13	16	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1456	1457		10.1126/science.1228293	http://dx.doi.org/10.1126/science.1228293			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997310				2022-12-28	WOS:000308912900024
J	Hayward, G; Thompson, M; Hay, AD				Hayward, Gail; Thompson, Matthew; Hay, Alastair D.			What factors influence prognosis in children with acute cough and respiratory tract infection in primary care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNITY-ACQUIRED PNEUMONIA; C-REACTIVE PROTEIN; PRESCHOOL-CHILDREN; PROSPECTIVE COHORT; EMERGENCY-DEPARTMENT; CLINICAL PREDICTORS; CHEST RADIOGRAPHS; ANTIBIOTIC USE; DIAGNOSIS; SYMPTOMS		[Hayward, Gail; Thompson, Matthew] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Hay, Alastair D.] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England	University of Oxford; University of Bristol	Hayward, G (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England.	gail.hayward@phc.ox.ac.uk	Hay, Alastair/L-1818-2019	Hayward, Gail/0000-0003-0852-627X; Hay, Alastair/0000-0003-3012-375X	National Institute for Health Research [CDF-2009-02-10, RP-PG-0608-10018] Funding Source: researchfish; Department of Health [CDF-2009-02-10, RP-PG-0608-10018] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; CRAIN EF, 1991, PEDIATRICS, V88, P821; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; GROSSMAN LK, 1988, ANN EMERG MED, V17, P43, DOI 10.1016/S0196-0644(88)80502-X; Hay AD, 2005, FAM PRACT, V22, P367, DOI 10.1093/fampra/cmi035; Hay AD, 2004, BRIT J GEN PRACT, V54, P9; Hay AD, 2002, BRIT J GEN PRACT, V52, P401; Hay Alastair D, 2004, BMC Fam Pract, V5, P4, DOI 10.1186/1471-2296-5-4; Hay AD, 2007, BRIT J GEN PRACT, V57, P530; Heiskanen-Kosma T, 2000, SCAND J INFECT DIS, V32, P399, DOI 10.1080/003655400750044971; Hollinghurst S, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-10; Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x; HOWIE JGR, 1976, BRIT MED J, V2, P1061, DOI 10.1136/bmj.2.6043.1061; LEVENTHAL JM, 1982, CLIN PEDIATR, V21, P730, DOI 10.1177/000992288202101205; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; Lynch T, 2004, PEDIATRICS, V113, pE186, DOI 10.1542/peds.113.3.e186; Mahabee-Gittens EM, 2005, CLIN PEDIATR, V44, P427, DOI 10.1177/000992280504400508; Mathews B, 2009, PEDIATRICS, V124, pE29, DOI 10.1542/peds.2008-2062; National Institute for Health and Care Excellence, 2008, RESP TRACT INF ANT P; Neuman MI, 2011, PEDIATRICS, V128, P246, DOI 10.1542/peds.2010-3367; Rothrock SG, 2001, PEDIATR EMERG CARE, V17, P240, DOI 10.1097/00006565-200108000-00003; Shah S, 2010, PEDIATR INFECT DIS J, V29, P406, DOI 10.1097/INF.0b013e3181cb45a7; SINGAL BM, 1989, ANN EMERG MED, V18, P13, DOI 10.1016/S0196-0644(89)80304-X; Tanen DA, 2002, AM J EMERG MED, V20, P521, DOI 10.1053/ajem.2002.34794; TAYLOR JA, 1995, ARCH PEDIAT ADOL MED, V149, P283, DOI 10.1001/archpedi.1995.02170150063011; Thompson M, 2009, ARCH DIS CHILD, V94, P361, DOI 10.1136/adc.2008.145011; Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; VANDENBRUEL A, 2010, J GERONTOL B-PSYCHOL, V375, P834, DOI DOI 10.1016/S0140-6736(09)62000-6; ZUKIN DD, 1986, ANN EMERG MED, V15, P792	32	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2012	345								e6212	10.1136/bmj.e6212	http://dx.doi.org/10.1136/bmj.e6212			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JJ	22996938				2022-12-28	WOS:000309160600003
J	Brezina, PR; Brezina, DS; Kearns, WG				Brezina, Paul R.; Brezina, Dawn S.; Kearns, William G.			Preimplantation genetic testing	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IN-VITRO FERTILIZATION; MATERNAL AGE; DIAGNOSIS; ANEUPLOIDY; EMBRYOS; PGD		[Brezina, Paul R.] Fertil Associates Memphis, Memphis, TN 38120 USA; [Brezina, Dawn S.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Kearns, William G.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Endocrinol & Infertil, Baltimore, MD 21205 USA; [Kearns, William G.] LabCorp, Ctr Preimplantat Genet, Rockville, MD USA	Duke University; Johns Hopkins University	Brezina, PR (corresponding author), Fertil Associates Memphis, Memphis, TN 38120 USA.	pbrezina@fertilitymemphis.com	Kearns, William/AAE-7699-2020					[Anonymous], 2009, Obstet Gynecol, V113, P766, DOI 10.1097/AOG.0b013e31819e9f05; Branicki W, 2011, HUM GENET, V129, P443, DOI 10.1007/s00439-010-0939-8; Brezina PR, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/686253; Brezina PR, 2011, FERTIL STERIL, V95, P1867, DOI 10.1016/j.fertnstert.2011.01.001; Checa MA, 2009, J ASSIST REPROD GEN, V26, P273, DOI 10.1007/s10815-009-9328-4; Forman EJ, 2012, HUM REPROD, V27, P1217, DOI 10.1093/humrep/des020; Ginsburg ES, 2011, FERTIL STERIL, V96, P865, DOI 10.1016/j.fertnstert.2011.07.1139; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Hanson C, 2009, HUM REPROD, V24, P2960, DOI 10.1093/humrep/dep264; Harper JC, 2012, HUM REPROD UPDATE, V18, P234, DOI 10.1093/humupd/dmr052; Harper JC, 2012, HUM GENET, V131, P175, DOI 10.1007/s00439-011-1056-z; Harton GL, 2011, HUM REPROD, V26, P41, DOI 10.1093/humrep/deq265; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; Hodes-Wertz B, 2012, FERTIL STERIL; Kuliev A, 2005, REPROD BIOMED ONLINE, V11, P362, DOI 10.1016/S1472-6483(10)60845-0; Laurie AD, 2010, J THROMB HAEMOST, V8, P783, DOI 10.1111/j.1538-7836.2010.03768.x; Malm H, 2012, AM J BIOETHICS, V12, P19, DOI 10.1080/15265161.2012.656816; Mastenbroek S, 2011, HUM REPROD UPDATE, V17, P454, DOI 10.1093/humupd/dmr003; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Rechitsky S, 2001, MOL CELL ENDOCRINOL, V183, pS65, DOI 10.1016/S0303-7207(01)00576-7; Schoolcraft WB, 2010, FERTIL STERIL, V94, P1700, DOI 10.1016/j.fertnstert.2009.10.015; Schoolcraft WB, 2009, FERTIL STERIL, V92, P157, DOI 10.1016/j.fertnstert.2008.05.029; Sermon K, 2004, LANCET, V363, P1633, DOI 10.1016/S0140-6736(04)16209-0; Sharp RR, 2010, REPROD BIOMED ONLINE, V21, P838, DOI 10.1016/j.rbmo.2010.09.009; Soc Assisted Reprod Technology, 2008, FERTIL STERIL, V90, pS136, DOI 10.1016/j.fertnstert.2008.08.062; Tobler KJ, 2012, FERTIL STERIL, V98, pS54, DOI 10.1016/j.fertnstert.2012.07.197; Treff NR, 2010, MOL HUM REPROD, V16, P583, DOI 10.1093/molehr/gaq039; Van Rij MC, 2012, EUR J HUM GENET, V20, P368, DOI 10.1038/ejhg.2011.202; Verlinsky Y, 2004, JAMA-J AM MED ASSOC, V291, P2079, DOI 10.1001/jama.291.17.2079; VERLINSKY Y, 1992, PRENATAL DIAG, V12, P103, DOI 10.1002/pd.1970120205; Wells D, 2008, MOL HUM REPROD, V14, P703, DOI 10.1093/molehr/gan062; Wilton L, 2002, PRENATAL DIAG, V22, P512, DOI 10.1002/pd.388; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24; Zhao YL, 2011, BBA-GEN SUBJECTS, V1810, P843, DOI 10.1016/j.bbagen.2011.05.001	34	43	45	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2012	345								e5908	10.1136/bmj.e5908	http://dx.doi.org/10.1136/bmj.e5908			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JH	22990995				2022-12-28	WOS:000309160400003
J	Horton, MR; Santopietro, V; Mathew, L; Horton, KM; Polito, AJ; Liu, MC; Danoff, SK; Lechtzin, N				Horton, Maureen R.; Santopietro, Victoria; Mathew, Leena; Horton, Karen M.; Polito, Albert J.; Liu, Mark C.; Danoff, Sonye K.; Lechtzin, Noah			Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; RESPIRATORY QUESTIONNAIRE; PHASE-II; DISEASES; LUNG; PATHOGENESIS; PIRFENIDONE; GUIDELINES; MANAGEMENT; INHIBITOR	Background: Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disorder of unknown cause with no effective treatment. Cough affects up to 80% of patients with IPF, is frequently disabling, and lacks effective therapy. Objective: To determine the efficacy of thalidomide in suppressing cough in patients with IPF. Design: 24-week, double-blind, 2-treatment, 2-period crossover trial. (ClinicalTrials.gov registration number: NCT00600028) Setting: 1 university center. Participants: 98 participants were screened, 24 were randomly assigned, 23 received treatment (78.3% men; mean age, 67.6 years; mean FVC, 70.4% predicted), and 20 completed both treatment periods. Measurements: The primary end point was cough-specific quality of life measured by the Cough Quality of Life Questionnaire (CQLQ). Secondary end points were visual analogue scale of cough and the St. George's Respiratory Questionnaire (SGRQ). For all measures, lower scores equaled improved cough or respiratory quality of life. Results: CQLQ scores significantly improved with thalidomide (mean difference vs. placebo, -11.4 [95% CI, -15.7 to -7.0]; P < 0.001). Thalidomide also significantly improved scores on the visual analogue scale of cough (mean difference vs. placebo, -31.2 [CI, -45.2 to -17.2]; P < 0.001). In participants receiving thalidomide, scores from the total SGRQ, SGRQ symptom domain, and SGRQ impact domain improved compared with those of participants receiving placebo. Adverse events were reported in 74% of patients receiving thalidomide and 22% receiving placebo; constipation, dizziness, and malaise were more frequent with thalidomide. Limitation: This was a single-center study of short duration and small sample size focused on symptom-specific quality of life. Conclusion: Thalidomide improved cough and respiratory quality of life in patients with IPF. A larger trial is warranted to assess these promising results.	Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Mercy Med Ctr, Baltimore, MD USA	Johns Hopkins University; Mercy Medical Center - Maryland	Horton, MR (corresponding author), 1830 E Monument St,5th Floor, Baltimore, MD 21205 USA.	mhorton2@jhmi.edu; nlechtz1@jhmi.edu		Danoff, Sonye K./0000-0001-9172-8977	Celgene Corporation	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	Financial Support: Celgene Corporation.	Azuma A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-143; Brown KK, 2006, CHEST, V129, p180S, DOI 10.1378/chest.129.1_suppl.180S; Cundari S, 2009, MINI-REV MED CHEM, V9, P760, DOI 10.2174/138955709788452595; De Vries J, 2000, RESP MED, V94, P273, DOI 10.1053/rmed.1999.0736; Eisen T, 2000, BRIT J CANCER, V82, P812, DOI 10.1054/bjoc.1999.1004; Fahim A, 2011, MEDICINA-LITHUANIA, V47, P200, DOI 10.3390/medicina47040028; Figg WD, 2001, CLIN CANCER RES, V7, P1888; French CT, 2002, CHEST, V121, P1123, DOI 10.1378/chest.121.4.1123; Hope-Gill BDM, 2003, AM J RESP CRIT CARE, V168, P995, DOI 10.1164/rccm.200304-597OC; Horton MR, 2008, THORAX, V63, P749, DOI 10.1136/thx.2008.098699; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kaur A, 2003, ANN PHARMACOTHER, V37, P1040, DOI 10.1345/aph.1D003; Key Angela L, 2010, Cough, V6, P4, DOI 10.1186/1745-9974-6-4; King TE, 2005, AM J RESP CRIT CARE, V172, P268, DOI 10.1164/rccm.200503-483OE; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; KING TE, 2009, J GERONTOL B-PSYCHOL, V374, P222, DOI DOI 10.1016/S0140-6736(09)60551-1; Lutherer LO, 2011, THORAX, V66, P446, DOI 10.1136/thx.2010.135947; Madison JM, 2005, CURR OPIN PULM MED, V11, P412, DOI 10.1097/01.mcp.0000174249.07762.37; Meinert CL., 1986, CLIN TRIALS DESIGN C; Nishiyama O, 2005, RESP MED, V99, P408, DOI 10.1016/j.rmed.2004.09.005; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Polley L, 2008, CHEST, V134, P295, DOI 10.1378/chest.07-0141; Raghu G, 2004, CLIN CHEST MED, V25, P621, DOI 10.1016/j.ccm.2004.08.002; Raghu G, 2010, EUR RESPIR J, V35, P118, DOI 10.1183/09031936.00188108; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Raj A. A., 2009, V187, P311, DOI 10.1007/978-3-540-79842-2_16; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Ryerson CJ, 2011, RESPIROLOGY, V16, P969, DOI 10.1111/j.1440-1843.2011.01996.x; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Senn S, 2002, CROSS OVER TRIALS CL; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Swigris JJ, 2010, RESP MED, V104, P296, DOI 10.1016/j.rmed.2009.09.006; Swigris JJ, 2005, THORAX, V60, P588, DOI 10.1136/thx.2004.035220; TAUSSIG HB, 1962, SCI AM, V207, P29, DOI 10.1038/scientificamerican0862-29; Yorke J, 2010, THORAX, V65, P921, DOI 10.1136/thx.2010.139121; Zisman DA, 2010, NEW ENGL J MED, V363, P620, DOI 10.1056/NEJMoa1002110	39	129	136	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6					398	U49		10.7326/0003-4819-157-6-201209180-00003	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986377				2022-12-28	WOS:000308912800014
J	Lu, P; Wang, YZ; Graham, L; McHale, K; Gao, MY; Wu, D; Brock, J; Blesch, A; Rosenzweig, ES; Havton, LA; Zheng, BH; Conner, JM; Marsala, M; Tuszynski, MH				Lu, Paul; Wang, Yaozhi; Graham, Lori; McHale, Karla; Gao, Mingyong; Wu, Di; Brock, John; Blesch, Armin; Rosenzweig, Ephron S.; Havton, Leif A.; Zheng, Binhai; Conner, James M.; Marsala, Martin; Tuszynski, Mark H.			Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord Injury	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; PROMOTE AXONAL REGENERATION; ADULT-RAT; NEUROTROPHIC FACTORS; FUNCTIONAL RECOVERY; WHITE-MATTER; NEURONS; FETAL; NOGO; DIFFERENTIATION	Neural stem cells (NSCs) expressing GFP were embedded into fibrin matrices containing growth factor cocktails and grafted to sites of severe spinal cord injury. Grafted cells differentiated into multiple cellular phenotypes, including neurons, which extended large numbers of axons over remarkable distances. Extending axons formed abundant synapses with host cells. Axonal growth was partially dependent on mammalian target of rapamycin (mTOR), but not Nogo signaling. Grafted neurons supported formation of electrophysiological relays across sites of complete spinal transection, resulting in functional recovery. Two human stem cell lines (566RSC and HUES7) embedded in growth-factor-containing fibrin exhibited similar growth, and 566RSC cells supported functional recovery. Thus, properties intrinsic to early-stage neurons can overcome the inhibitory milieu of the injured adult spinal cord to mount remarkable axonal growth, resulting in formation of new relay circuits that significantly improve function. These therapeutic properties extend across stem cell sources and species.	[Lu, Paul; Wang, Yaozhi; Graham, Lori; McHale, Karla; Gao, Mingyong; Wu, Di; Brock, John; Blesch, Armin; Rosenzweig, Ephron S.; Zheng, Binhai; Conner, James M.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Lu, Paul; Tuszynski, Mark H.] Vet Adm Med Ctr, San Diego, CA 92161 USA; [Havton, Leif A.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Havton, Leif A.] Univ Calif Irvine, Dept Anat & Neurobiol, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Blesch, Armin] Univ Heidelberg Hosp, Spinal Cord Injury Ctr, D-69120 Heidelberg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Irvine; University of California System; University of California Irvine; Ruprecht Karls University Heidelberg	Lu, P (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	plu@ucsd.edu; mtuszynski@ucsd.edu	Rosenzweig, Ephron/AAI-7541-2020	Blesch, Armin/0000-0003-1133-1174; Gao, Mingyong/0000-0002-8824-7600; Rosenzweig, Ephron/0000-0002-0370-9643	Veterans Administration; NIH [NS09881]; Canadian Spinal Research Organization; The Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054734, R01NS049881, F31NS009881] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Spinal Research Organization; The Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Ramsey Samara for electrophysiological assistance; Janet Weber, Andrea Chan, and Jeffrey Kwan for technical assistance; the Rat Resource and Research Center, University of Missouri, Columbia, MO, for providing GFP rats; and Dr. Farquhar for use of the electron microscopy core facility. Human neural stem cells were a gift from NeuralStem, Inc. This work was supported by the Veterans Administration, NIH (NS09881), Canadian Spinal Research Organization, The Craig H. Neilsen Foundation, and the Bernard and Anne Spitzer Charitable Trust. The authors declare that they have no competing financial interests.	Bamber NI, 1999, NEURAL PLAST, V6, P103, DOI 10.1155/NP.1999.103; Baska KM, 2008, J CELL PHYSIOL, V215, P684, DOI 10.1002/jcp.21349; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; Boulis NM, 2012, NAT REV NEUROL, V8, P172, DOI 10.1038/nrneurol.2011.191; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Bryda EC, 2006, BIOTECHNIQUES, V41, P715, DOI 10.2144/000112289; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Giovanini MA, 1997, EXP NEUROL, V148, P523, DOI 10.1006/exnr.1997.6703; Grumbles RM, 2009, J NEUROPATH EXP NEUR, V68, P736, DOI 10.1097/NEN.0b013e3181a9360f; Harris Joseph, 2007, J Vis Exp, P305, DOI 10.3791/305; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Miller KE, 1998, BRAIN RES BULL, V47, P43, DOI 10.1016/S0361-9230(98)00065-3; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Theele DP, 1996, EXP NEUROL, V142, P128, DOI 10.1006/exnr.1996.0184; Tuszynski MH, 2008, CNS REGENERATION: BASIC SCIENCE AND CLINICAL ADVANCES, 2ND EDITION, P319, DOI 10.1016/B978-012373994-0.50015-4; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	42	584	607	20	226	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1264	1273		10.1016/j.cell.2012.08.020	http://dx.doi.org/10.1016/j.cell.2012.08.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980985	Green Accepted, Bronze			2022-12-28	WOS:000308928100018
J	Tritsch, NX; Ding, JB; Sabatini, BL				Tritsch, Nicolas X.; Ding, Jun B.; Sabatini, Bernardo L.			Dopaminergic neurons inhibit striatal output through non-canonical release of GABA	NATURE			English	Article							NUCLEUS-ACCUMBENS; DORSAL STRIATUM; GLUTAMATE; RAT; CORELEASE; NEUROTRANSMISSION; COLOCALIZATION; EXPRESSION; CIRCUITS; PATHWAY	The substantia nigra pars compacta and ventral tegmental area contain the two largest populations of dopamine-releasing neurons in the mammalian brain. These neurons extend elaborate projections in the striatum, a large subcortical structure implicated in motor planning and reward-based learning. Phasic activation of dopaminergic neurons in response to salient or reward-predicting stimuli is thought to modulate striatal output through the release of dopamine to promote and reinforce motor action(1-4). Here we show that activation of dopamine neurons in striatal slices rapidly inhibits action potential firing in both direct-and indirect-pathway striatal projection neurons through vesicular release of the inhibitory transmitter GABA (gamma-aminobutyric acid). GABA is released directly from dopaminergic axons but in a manner that is independent of the vesicular GABA transporter VGAT. Instead, GABA release requires activity of the vesicular monoamine transporter VMAT2, which is the vesicular transporter for dopamine. Furthermore, VMAT2 expression in GABAergic neurons lacking VGAT is sufficient to sustain GABA release. Thus, these findings expand the repertoire of synaptic mechanisms used by dopamine neurons to influence basal ganglia circuits, show a new substrate whose transport is dependent on VMAT2 and demonstrate that GABA can function as a bona fide co-transmitter in monoaminergic neurons.	[Tritsch, Nicolas X.; Ding, Jun B.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Tritsch, Nicolas/U-5266-2019; Ding, Jun/B-2513-2009	Ding, Jun/0000-0003-0690-1312; Tritsch, Nicolas/0000-0003-3181-7681	Nancy Lurie Marks Family Foundation; National Institutes of Health [NS046579, 4R00NS075136]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R00NS075136, R01NS046579] Funding Source: NIH RePORTER	Nancy Lurie Marks Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank A. Saunders and Y. Kozorovitskiy for generating and characterizing the AAV-DIO-EGFP and AAV-DIO-VGAT constructs, D. Sulzer and H. Zhang for assistance with amperometry, R. Shah and C. Johnson for technical support, and members of the laboratory for discussions. This work was supported by a Nancy Lurie Marks Family Foundation postdoctoral fellowship (N.X.T.) and by grants from the National Institutes of Health (NS046579 to B. L. S. and 4R00NS075136 to J.B.D.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bentivoglio M, 2005, HAND CHEM N, V21, P1; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broadbelt KG, 2010, AUTON NEUROSCI-BASIC, V154, P30, DOI 10.1016/j.autneu.2009.10.002; Chuhma N, 2004, J NEUROSCI, V24, P972, DOI 10.1523/JNEUROSCI.4317-03.2004; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Gonzalez-Hernandez T, 2004, MOVEMENT DISORD, V19, P1029, DOI 10.1002/mds.20206; Hirasawa H, 2009, J NEUROPHYSIOL, V102, P146, DOI 10.1152/jn.00130.2009; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; IIJIMA K, 1993, HISTOL HISTOPATHOL, V8, P581; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maher BJ, 2008, J NEUROPHYSIOL, V99, P1559, DOI 10.1152/jn.00636.2007; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ramirez M, 2001, BRAIN RES, V917, P139, DOI 10.1016/S0006-8993(01)02794-9; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Trottier S, 2002, BRAIN RES, V939, P52, DOI 10.1016/S0006-8993(02)02546-5; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yelin R, 1995, FEBS LETT, V377, P201, DOI 10.1016/0014-5793(95)01346-6	36	359	362	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					262	+		10.1038/nature11466	http://dx.doi.org/10.1038/nature11466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23034651	Green Submitted, Green Accepted			2022-12-28	WOS:000309733300050
J	Erne, BV; Graff, M; Klemm, W; Danzl, JG; Leschber, G				Erne, Barbara V.; Graff, Mareike; Klemm, Wolfram; Danzl, Johann G.; Leschber, Gunda			Bulla in the lung	LANCET			English	Editorial Material							CARCINOMA; CANCER		[Erne, Barbara V.; Graff, Mareike; Klemm, Wolfram; Leschber, Gunda] ELK Berlin Chest Hosp, Dept Thorac Surg, D-13125 Berlin, Germany; [Danzl, Johann G.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Erne, BV (corresponding author), ELK Berlin Chest Hosp, Dept Thorac Surg, Lindenberger Weg 27, D-13125 Berlin, Germany.	barbara.erne@elk-berlin.de	Danzl, Johann/N-9987-2015; Danzl, Johann Georg/AGX-2475-2022	Danzl, Johann/0000-0001-8559-3973; Danzl, Johann Georg/0000-0001-8559-3973; Erne, Barbara/0000-0001-7669-8896				Asai N, 2011, J BRAS PNEUMOL, V37, P404, DOI 10.1590/S1806-37132011000300018; GOLDSTEIN MJ, 1968, AM REV RESPIR DIS, V97, P1062; Hirai Shinji, 2005, Ann Thorac Cardiovasc Surg, V11, P109; Ogawa D, 1999, RESPIRATION, V66, P555, DOI 10.1159/000029436; TSUTSUI M, 1988, ANN THORAC SURG, V46, P679, DOI 10.1016/S0003-4975(10)64733-9	5	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2012	380	9849					1280	1280		10.1016/S0140-6736(12)60690-4	http://dx.doi.org/10.1016/S0140-6736(12)60690-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020NG	23040862				2022-12-28	WOS:000309817500034
J	Leathers, ML; Olson, CR				Leathers, Marvin L.; Olson, Carl R.			In Monkeys Making Value-Based Decisions, LIP Neurons Encode Cue Salience and Not Action Value	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; REWARD VALUE; ATTENTION; CHOICE; NEUROBIOLOGY; INFORMATION	In monkeys deciding between alternative saccadic eye movements, lateral intraparietal (LIP) neurons representing each saccade fire at a rate proportional to the value of the reward expected upon its completion. This observation has been interpreted as indicating that LIP neurons encode saccadic value and that they mediate value-based decisions between saccades. Here, we show that LIP neurons representing a given saccade fire strongly not only if it will yield a large reward but also if it will incur a large penalty. This finding indicates that LIP neurons are sensitive to the motivational salience of cues. It is compatible neither with the idea that LIP neurons represent action value nor with the idea that value-based decisions take place in LIP neurons.	[Leathers, Marvin L.; Olson, Carl R.] Carnegie Mellon Univ, Mellon Inst, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Leathers, Marvin L.; Olson, Carl R.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Leathers, ML (corresponding author), Carnegie Mellon Univ, Mellon Inst, Ctr Neural Basis Cognit, Room 115,4400 5th Ave, Pittsburgh, PA 15213 USA.	mleathers@cnbc.cmu.edu			NIH [RO1 EY018620, P50 MH45156, P30 EY08098, P41RR03631]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003631] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008098, R01EY018620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Ruff for comments and K. McCracken for technical assistance. Support: NIH RO1 EY018620 and NIH P50 MH45156. Technical support: NIH P30 EY08098 and P41RR03631.	Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Arcizet F, 2011, CEREB CORTEX, V21, P2498, DOI 10.1093/cercor/bhr035; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Berridge KC, 2003, WELL BEING FDN HEDON, P525; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Brosch T, 2011, NEUROPSYCHOLOGIA, V49, P1779, DOI 10.1016/j.neuropsychologia.2011.02.056; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cai X., 2010, NEUR M SOC NEUR SA D; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Lim SL, 2009, P NATL ACAD SCI USA, V106, P16841, DOI 10.1073/pnas.0904551106; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Mirpour K, 2012, P NATL ACAD SCI USA, V109, P10083, DOI 10.1073/pnas.1120763109; O'Brien JL, 2012, PSYCHOL SCI, V23, P359, DOI 10.1177/0956797611429800; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Wallis JD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00124; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107	30	98	98	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					132	135		10.1126/science.1226405	http://dx.doi.org/10.1126/science.1226405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042897	Green Accepted			2022-12-28	WOS:000309457400070
J	Jockers, ML; Sag, M; Schultz, J				Jockers, Matthew L.; Sag, Matthew; Schultz, Jason			Don't let copyright block data mining	NATURE			English	Editorial Material									[Jockers, Matthew L.] Univ Nebraska, Lincoln, NE 68583 USA; [Sag, Matthew] Loyola Univ, Chicago, IL 60611 USA; [Schultz, Jason] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of Nebraska System; University of Nebraska Lincoln; Loyola University Chicago; University of California System; University of California Berkeley	Jockers, ML (corresponding author), Univ Nebraska, Lincoln, NE 68583 USA.	mjockers@unl.edu	Jockers, Matthew/Q-6768-2019	Jockers, Matthew/0000-0001-5599-3706				Hargreaves Ian, 2011, DIGITAL OPPORTUNITY; Jockers M. L., 2012, PREPRINT SOCIAL SCI	2	1	1	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					29	30		10.1038/490029a	http://dx.doi.org/10.1038/490029a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038448	hybrid			2022-12-28	WOS:000309446800013
J	Patel, K				Patel, Kinesh			Tax calories to end the buffet syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 3	2012	345								e6674	10.1136/bmj.e6674	http://dx.doi.org/10.1136/bmj.e6674			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KZ	23034861				2022-12-28	WOS:000309660600002
J	Amouzou, A; Habi, O; Bensaid, K				Amouzou, Agbessi; Habi, Oumarou; Bensaid, Khaled		Niger Countdown Case Study Working	Reduction in child mortality in Niger: a Countdown to 2015 country case study	LANCET			English	Article							SURVIVAL; NEWBORN	Background The Millennium Development Goal 4 (MDG 4) is to reduce by two-thirds the mortality rate of children younger than 5 years, between 1990 and 2015. The 2012 Countdown profile shows that Niger has achieved far greater reductions in child mortality and gains in coverage for interventions in child survival than neighbouring countries in west Africa. Countdown therefore invited Niger to do an in-depth analysis of their child survival programme between 1998 and 2009. Methods We developed new estimates of child and neonatal mortality for 1998-2009 using a 2010 household survey. We recalculated coverage indicators using eight nationally-representative surveys for that period, and documented maternal, newborn, and child health programmes and policies since 1995. We used the Lives Saved Tool (LiST) to estimate the child lives saved in 2009. Findings The mortality rate in children younger than 5 years declined significantly from 226 deaths per 1000 livebirths (95% CI 207-246) in 1998 to 128 deaths (117-140) in 2009, an annual rate of decline of 5.1%. Stunting prevalence decreased slightly in children aged 24-35 months, and wasting declined by about 50% with the largest decreases in children younger than 2 years. Coverage increased greatly for most child survival interventions in this period. Results from LiST show that about 59 000 lives were saved in children younger than 5 years in 2009, attributable to the introduction of insecticide-treated bednets (25%); improvements in nutritional status (19%); vitamin A supplementation (9%); treatment of diarrhoea with oral rehydration salts and zinc, and careseeking for fever, malaria, or childhood pneumonia (22%); and vaccinations (11%). Interpretation Government policies supporting universal access, provision of free health care for pregnant women and children, and decentralised nutrition programmes permitted Niger to decrease child mortality at a pace that exceeds that needed to meet the MDG 4.	[Amouzou, Agbessi] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Habi, Oumarou] Inst Natl Stat Niger, Niamey, Niger; [Bensaid, Khaled] UN Childrens Fund UNICEF Niger, Niamey, Niger	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Amouzou, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, 615 N Wolfe St, Baltimore, MD 21205 USA.	aamouzou@jhsph.edu		Amouzou, Agbessi/0000-0002-6262-3866	Bill & Melinda Gates Foundation; World Bank; Government of Australia; Government of Canada; Government of Norway; Government of Sweden; Government of UK; UNICEF; Child Health Epidemiology Reference Group (CHERG) by the Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Bank(The World Bank India); Government of Australia; Government of Canada(CGIAR); Government of Norway; Government of Sweden; Government of UK; UNICEF; Child Health Epidemiology Reference Group (CHERG) by the Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation; World Bank; Governments of Australia, Canada, Norway, Sweden, and the UK; and UNICEF.; The case study was supported through Countdown to 2015 for Maternal and Child Survival by the Bill & Melinda Gates Foundation, the World Bank, and the Governments of Australia, Canada, Norway, Sweden, and the UK. Mortality analyses were supported by the Canadian International Development Agency through the Real-Time Results Tracking project, implemented by the Institute for International Programs at The Johns Hopkins Bloomberg School of Public Health. The application of the Lives Saved Tool (LiST) was supported through the Child Health Epidemiology Reference Group (CHERG) by the Bill & Melinda Gates Foundation. We thank the Government of Niger and especially the Ministry of Health for their assistance in compiling, reviewing, and interpreting the data presented here. The work could not have been done without the full support of the Niger National Institute of Statistics and its Director-General; of UNICEF-Niger, its Country Representative (Guido Cornale) and Deputy Representative (Isselmou Boukhari). UNICEF-Niger provided technical inputs and essential support on the ground for this effort. Catherine Pitt helped us with the estimates of official development assistance. WHO and the Health Systems and Policy Working Group of the Countdown to 2015 provided feedback on the case study design, and Bernadette Daelmans assisted in the identification of the programme documentation consultants.	Attama S, 1999, ENQUETE DEMOGRAPHIQU, P2; Bensaid K, DOCUMENTATION CHILD; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Bryce J, 2011, INT HEALTH, V3, P139, DOI 10.1016/j.inhe.2011.04.003; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; Commission on Information and Accountability for Women's and Children's Health, 2011, COMM INF ACC WOM CHI; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Fox M, 2011, BMC PUBLIC HLTH S3, V11, pS1; Global Health Workforce Alliance, 2010, GLOBAL EXPERIENCE CO; Institut National de la Statistique, 2011, ENQ NAT BES SOINS OB; Institut National de la Statistique du Niger (INS), 2007, TROIS ENQ NAT BUDG C; Institut National de la Statistique du Niger (INS), 2010, PROJ ACT POP NIG 200; Institut National de la Statistique du Niger (INS), 2005, ENQ NAT COND VIE MEN; Institut National de la Statistique (INS), 2011, ENQ NAT SURV ENF 0 5; Institut National de la Statistique (INS) et Macro International Inc, 2007, ENQ DEM SANT IND MUL; Inter-agency Group on Mortality Estimation, STAT AR CHILD SURV H; International Development Association and the International Monetary Fund, 2000, DEC POINT DOC ENH HE; Lohr SL, 2009, SAMPLING DESIGN DESI; McPake B, 2011, HEALTH POLICY PLANN, V26, pII104, DOI 10.1093/heapol/czr064; Ministere de la Sante, 2012, ACC ATT OBJ MILL DEV; Ministere de la Sante Publique et de la Lutte contre les Endemies, 2011, COMPT NAT SANT EX 20; Ministere de la Sante Publique et de la Lutte contre les Endemies, 2005, COMPT NAT SANT EX 20; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Preston SH, 2010, DEMOGRAPHY MEASURING; Programme National de Lutte contre le Paludisme, 2011, SIT PAL NIG 2000 201; Requejo J, 2012, COUNTDOWN REPORT 201; Sachdev HPS, 2010, INT J EPIDEMIOL S1, V39, P1; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; United Nations Development Programme, HUM DEV REP 2011; WHO, WHO CHILD GROWTH STA; WHO, GLOB HLTH EXP DAT NA	33	102	103	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2012	380	9848					1169	1178		10.1016/S0140-6736(12)61376-2	http://dx.doi.org/10.1016/S0140-6736(12)61376-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	22999428				2022-12-28	WOS:000309255900034
J	Seifert, AW; Kiama, SG; Seifert, MG; Goheen, JR; Palmer, TM; Maden, M				Seifert, Ashley W.; Kiama, Stephen G.; Seifert, Megan G.; Goheen, Jacob R.; Palmer, Todd M.; Maden, Malcolm			Skin shedding and tissue regeneration in African spiny mice (Acomys)	NATURE			English	Article							HAIR FOLLICLE DEVELOPMENT; LIMB REGENERATION; WOUND REPAIR; DIFFERENTIATION; EXPRESSION; AUTOTOMY; NEWT	Evolutionary modification has produced a spectrum of animal defence traits to escape predation, including the ability to autotomize body parts to elude capture(1,2). After autotomy, the missing part is either replaced through regeneration (for example, in urodeles, lizards, arthropods and crustaceans) or permanently lost (such as in mammals). Although most autotomy involves the loss of appendages (legs, chelipeds, antennae or tails, for example), skin autotomy can occur in certain taxa of scincid and gekkonid lizards(3). Here we report the first demonstration of skin autotomy in Mammalia (African spiny mice, Acomys). Mechanical testing showed a propensity for skin to tear under very low tension and the absence of a fracture plane. After skin loss, rapid wound contraction was followed by hair follicle regeneration in dorsal skin wounds. Notably, we found that regenerative capacity in Acomys was extended to ear holes, where the mice exhibited complete regeneration of hair follicles, sebaceous glands, dermis and cartilage. Salamanders capable of limb regeneration form a blastema (a mass of lineage-restricted progenitor cells(4)) after limb loss, and our findings suggest that ear tissue regeneration in Acomys may proceed through the assembly of a similar structure. This study underscores the importance of investigating regenerative phenomena outside of conventional model organisms, and suggests that mammals may retain a higher capacity for regeneration than was previously believed. As re-emergent interest in regenerative medicine seeks to isolate molecular pathways controlling tissue regeneration in mammals, Acomys may prove useful in identifying mechanisms to promote regeneration in lieu of fibrosis and scarring.	[Seifert, Ashley W.; Seifert, Megan G.; Palmer, Todd M.; Maden, Malcolm] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Seifert, Ashley W.; Kiama, Stephen G.] Univ Nairobi, Dept Vet Anat & Physiol, Nairobi 00010, Kenya; [Seifert, Ashley W.; Seifert, Megan G.; Goheen, Jacob R.; Palmer, Todd M.] Mpala Res Ctr, Nanyuki 10400, Kenya; [Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Goheen, Jacob R.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA	State University System of Florida; University of Florida; University of Nairobi; University of Wyoming; University of Wyoming	Seifert, AW (corresponding author), Univ Florida, Dept Biol, 223 Bartram Hall,POB 118525, Gainesville, FL 32610 USA.	seifert@ufl.edu	Palmer, Todd/GRS-0639-2022; Kiama, Stephen Gitahi/C-9595-2016	Seifert, Ashley/0000-0001-6576-3664; Kiama, Stephen Gitahi/0000-0002-0217-6283; Palmer, Todd/0000-0001-5710-9750	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK074367] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK074367] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; [Anonymous], 1979, STEREOLOGICAL METHOD; BAUER AM, 1989, J EXP BIOL, V145, P79; BILLINGHAM RE, 1956, NATURE, V177, P791, DOI 10.1038/177791b0; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; BREEDIS C, 1954, CANCER RES, V14, P575; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; CHALKLEY DT, 1954, J MORPHOL, V94, P21, DOI 10.1002/jmor.1050940103; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; DUBOST G, 1987, J ZOOL, V212, P563, DOI 10.1111/j.1469-7998.1987.tb02924.x; GLOBUS M, 1980, DEV BIOL, V75, P358, DOI 10.1016/0012-1606(80)90169-4; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kiama SG, 2001, J ZOOL, V254, P521, DOI 10.1017/S0952836901001029; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Muneoka Ken, 2008, Birth Defects Research, V84, P265, DOI 10.1002/bdrc.20137; Neufeld DA, 1996, ANAT RECORD, V246, P155; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Shargal E, 1999, J ZOOL, V249, P187, DOI 10.1111/j.1469-7998.1999.tb00757.x; Soo C, 2000, PLAST RECONSTR SURG, V105, P638, DOI 10.1097/00006534-200002000-00024; VOGEL HG, 1974, CONNECT TISSUE RES, V2, P177, DOI 10.3109/03008207409152242; Vorontsova M. A., 1960, ASEXUAL PROPAGATION, P377; Yannas I.V., 2001, REGENERATION SKIN	31	327	333	8	348	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					561	+		10.1038/nature11499	http://dx.doi.org/10.1038/nature11499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	23018966	Green Accepted			2022-12-28	WOS:000311781500003
J	Spence, D				Spence, Des			What happened to caring?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 26	2012	345								e6485	10.1136/bmj.e6485	http://dx.doi.org/10.1136/bmj.e6485			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OV	23015303				2022-12-28	WOS:000309386300008
J	Rayner, G				Rayner, Geof			Does celebrity involvement in public health campaigns deliver long term benefit? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									City Univ London, London EC1V 0HB, England	City University London	Rayner, G (corresponding author), City Univ London, London EC1V 0HB, England.	mail@rayner.uk.com						Frank Robert, 1996, WINNER TAKE ALL SOC; Rayner G, 2012, ECOLOGICAL PUBLIC HEALTH: RESHAPING THE CONDITIONS FOR GOOD HEALTH, P1	2	6	6	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2012	345								e6362	10.1136/bmj.e6362	http://dx.doi.org/10.1136/bmj.e6362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23015035				2022-12-28	WOS:000309385500007
J	Manikam, L; Richards, PJ; Jordan, T				Manikam, L.; Richards, P. J.; Jordan, T.			An unusual finding on a pelvic radiograph	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MAFFUCCIS-SYNDROME; CHONDROSARCOMA; MANAGEMENT; BIOPSY; TUMORS; HEAD; NECK; BONE		[Manikam, L.; Jordan, T.] Univ Hosp N Staffordshire NHS Trust, Dept Resp Med, Stoke On Trent ST4 6QG, Staffs, England; [Richards, P. J.] Univ Hosp N Staffordshire NHS Trust, Dept Radiol, Stoke On Trent ST4 6QG, Staffs, England	University Hospital of North Staffordshire NHS Trust; University Hospital of North Staffordshire NHS Trust	Manikam, L (corresponding author), Univ Hosp N Staffordshire NHS Trust, Dept Resp Med, Stoke On Trent ST4 6QG, Staffs, England.	logan.manikam@doctors.org.uk		Manikam, Logan/0000-0001-5288-3325	National Institute for Health Research [ACF-2011-21-013] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Altay M, 2007, J ORTHOP SCI, V12, P415, DOI 10.1007/s00776-007-1152-z; Brien EW, 1997, SKELETAL RADIOL, V26, P325, DOI 10.1007/s002560050246; BURKEY BB, 1990, LARYNGOSCOPE, V100, P1301; CHRISTMAN JE, 1990, GYNECOL ONCOL, V37, P290, DOI 10.1016/0090-8258(90)90350-T; FERLITO A, 1984, AM J OTOLARYNG, V5, P350, DOI 10.1016/S0196-0709(84)80005-8; Flemming DJ, 2000, SEMIN MUSCULOSKEL R, V4, P1089; Franco RA, 2002, J VOICE, V16, P92, DOI 10.1016/S0892-1997(02)00077-2; Hwang F, 2009, BRIT J RADIOL, V82, P178; HYDE GE, 1995, AM J OTOLARYNG, V16, P272, DOI 10.1016/0196-0709(95)90157-4; Manaster BJ, 2002, MUSCULOSKELETAL IMAG, P1; Mavrogenis AF, 2010, J BONE JOINT SURG AM, V92A, P1507, DOI 10.2106/JBJS.I.00693; Moore BA, 2003, OTOLARYNG HEAD NECK, V128, P583, DOI 10.1016/S0194-5998(02)23292-1; Muller P E, 2003, Acta Orthop Belg, V69, P112; Murphey MD, 2003, RADIOGRAPHICS, V23, P1245, DOI 10.1148/rg.235035134; Normand AN, 2007, CLIN ORTHOP RELAT R, P146, DOI 10.1097/BLO.0b013e3180619554; Pansuriya TC, 2010, INT J CLIN EXP PATHO, V3, P557; Parlier-Cuau C, 2011, EUR J RADIOL, V77, P6, DOI 10.1016/j.ejrad.2010.06.051; RESNICK D, 1996, BONE JOINT IMAGING, P991; Silve C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-37; Wang XL, 2001, EUR RADIOL, V11, P1054, DOI 10.1007/s003300000651	20	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2012	345								e6261	10.1136/bmj.e6261	http://dx.doi.org/10.1136/bmj.e6261			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OE	23007625				2022-12-28	WOS:000309384600004
J	Crisp, N				Crisp, Nigel			Patient power needs to be built on strong intellectual foundations: an essay by Nigel Crisp	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									House Lords, London SW1A 0PW, England		Crisp, N (corresponding author), House Lords, London SW1A 0PW, England.	nigel.crisp@zen.co.uk		Crisp, Nigel/0000-0002-9452-095X				Ahuja A, 2012, PROSPECT, P17; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Cayton H, 2008, ADV OPPORTUNITY HLTH; Cayton H, 2006, PATIENT EDUC COUNS, V62, P288, DOI 10.1016/j.pec.2006.06.016; Charlesworth A, 2012, REFINING PAYMENT HEA; Coulter A, 2011, ENGAGING PATIENTS HE; Crisp N, 2006, 24 HOURS SAVE NHS CH; Crisp Nigel., 2010, TURNING WORLD UPSIDE; Davies P, 2012, BMJ-BRIT MED J, V345, pe4095; Economist Intelligence Unit, 2011, FUT HEALTHC EUR; Institute for Healthcare Improvement, 2011, ANN REP 2011; May C, 2009, BRIT MED J, V339, P485, DOI DOI 10.1177/1742395312463411; Mulley AG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4073; Osborn R, 2012, J AMBUL CARE MANAG, V35, P118, DOI 10.1097/JAC.0b013e31824a579b; Sen A., 1999, DEVEPLOPMENT FREEDOM; Thomas H, 2007, HLTH SERVICE J	16	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 21	2012	345								e6177	10.1136/bmj.e6177	http://dx.doi.org/10.1136/bmj.e6177			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JL	23002127				2022-12-28	WOS:000309160800001
J	Thompson, AW; Foster, RA; Krupke, A; Carter, BJ; Musat, N; Vaulot, D; Kuypers, MMM; Zehr, JP				Thompson, Anne W.; Foster, Rachel A.; Krupke, Andreas; Carter, Brandon J.; Musat, Niculina; Vaulot, Daniel; Kuypers, Marcel M. M.; Zehr, Jonathan P.			Unicellular Cyanobacterium Symbiotic with a Single-Celled Eukaryotic Alga	SCIENCE			English	Article							PHYTOPLANKTON; FIXATION	Symbioses between nitrogen (N)(2)-fixing prokaryotes and photosynthetic eukaryotes are important for nitrogen acquisition in N-limited environments. Recently, a widely distributed planktonic uncultured nitrogen-fixing cyanobacterium (UCYN-A) was found to have unprecedented genome reduction, including the lack of oxygen-evolving photosystem II and the tricarboxylic acid cycle, which suggested partnership in a symbiosis. We showed that UCYN-A has a symbiotic association with a unicellular prymnesiophyte, closely related to calcifying taxa present in the fossil record. The partnership is mutualistic, because the prymnesiophyte receives fixed N in exchange for transferring fixed carbon to UCYN-A. This unusual partnership between a cyanobacterium and a unicellular alga is a model for symbiosis and is analogous to plastid and organismal evolution, and if calcifying, may have important implications for past and present oceanic N-2 fixation.	[Thompson, Anne W.; Carter, Brandon J.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Foster, Rachel A.; Krupke, Andreas; Musat, Niculina; Kuypers, Marcel M. M.] Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany; [Vaulot, Daniel] Univ Paris 06, F-29680 Roscoff, France; [Vaulot, Daniel] CNRS, UMR 7144, Biol Stn, F-29680 Roscoff, France	University of California System; University of California Santa Cruz; Max Planck Society; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Musat, Niculina/ABA-2180-2021; Zehr, Jonathan P/B-3513-2014; Vaulot, Daniel/T-6649-2019	Musat, Niculina/0000-0001-9539-189X; Zehr, Jonathan P/0000-0002-5691-5408; Vaulot, Daniel/0000-0002-0717-5685; Thompson, Anne/0000-0002-2022-9553; Foster, Rachel/0000-0002-8696-1835	Gordon and Betty Moore Foundation; NSF Center for Microbial Oceanography: Research and Education (C-MORE); Max Planck Society; PHYTOMETAGENE (JST-CNRS); METAPICO (Genoscope); Micro B3; European Union [287589]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF Center for Microbial Oceanography: Research and Education (C-MORE)(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); PHYTOMETAGENE (JST-CNRS); METAPICO (Genoscope); Micro B3; European Union(European Commission)	D. Bottjer and M. Hogan provided advice for <SUP>15</SUP>N<INF>2</INF> additions. Water samples were collected with the help of S. Curless, M. Church, S. Wilson, S. Tozzi, and the captain and crew of the research vessel Kilo Moana. On-board flow cytometry was made possible by K. Doggett and D. Karl. Funding was provided by the Gordon and Betty Moore Foundation (J.P.Z.) and the NSF Center for Microbial Oceanography: Research and Education (C-MORE). The Max Planck Society sponsored the HISH-SIMS analysis. We thank G. Lavik (Max Planck Institute, Bremen) for advice and suggestions for data analysis. J. Waterbury provided the scientific name for UCYN-A. D. V. was supported by PHYTOMETAGENE (JST-CNRS), METAPICO (Genoscope), and Micro B3 (funded by the European Union, contract 287589). BIOSOPE metagenome sequencing was performed at Genoscope (French National Sequencing Center) by J. Poulain. We thank H. Claustre, A. Sciandra, D. Marie, and all other BIOSOPE cruise participants. GenBank accession nos.: JX291679 to JX291804 and JX291547 to JX291678 (see table S4 for details).	Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; Bothe H, 2010, ARCH MICROBIOL, V192, P783, DOI 10.1007/s00203-010-0621-5; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Carpenter EJ, 2002, CYANOBACTERIA IN SYMBIOSIS, P11; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; DEFLANDRE G, 1947, CR HEBD ACAD SCI, V225, P439; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Foster RA, 2006, J PHYCOL, V42, P453, DOI 10.1111/j.1529-8817.2006.00206.x; Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26; GRAN H. H., 1935, JOUR BIOL BD CANADA, V1, P279; GREEN JC, 1972, J MAR BIOL ASSOC UK, V52, P469, DOI 10.1017/S002531540001883X; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hagino K, 2009, MAR MICROPALEONTOL, V72, P210, DOI 10.1016/j.marmicro.2009.06.001; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Medlin LK, 2008, MAR MICROPALEONTOL, V67, P69, DOI 10.1016/j.marmicro.2007.08.007; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Saez AG, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P251; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Siesser W.G., 1992, Proceedings of the Ocean Drilling Program Scientific Results, V122, P653, DOI 10.2973/odp.proc.sr.122.163.1992; Takano Y, 2006, MAR MICROPALEONTOL, V60, P145, DOI 10.1016/j.marmicro.2006.04.002; TAYLOR FJR, 1982, ANN I OCEANOGR PARIS, V58, P61; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236	32	316	329	6	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1546	1550		10.1126/science.1222700	http://dx.doi.org/10.1126/science.1222700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997339				2022-12-28	WOS:000308912900053
J	Davis, A; Madhvani, K; Lee, L				Davis, A.; Madhvani, K.; Lee, L.			Investigating fertility problems	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED OVARIAN HYPERSTIMULATION; GENERAL INFERTILITY POPULATION; STIMULATING-HORMONE LEVELS; CITRATE CHALLENGE TEST; REPRODUCTIVE-PERFORMANCE; PROGNOSTIC ASSESSMENT; UTERINE ANOMALIES; RESERVE; WOMEN; HYSTEROSALPINGOGRAPHY		[Davis, A.; Lee, L.] St Georges Hosp NHS Trust, London, England; [Madhvani, K.] Poole Hosp NHS Fdn Trust, Poole, Dorset, England	St Georges University London	Davis, A (corresponding author), St Georges Hosp NHS Trust, London, England.	adavis@doctors.org.uk						ACIEN P, 1993, HUM REPROD, V8, P122, DOI 10.1093/oxfordjournals.humrep.a137860; Airoldi J, 2005, OBSTET GYNECOL, V106, P553, DOI 10.1097/01.AOG.0000173987.59595.e2; [Anonymous], 2004, FERT ASS TREATM PEOP; BONGAARTS J, 1975, DEMOGRAPHY, V12, P645, DOI 10.2307/2060719; Carrascosa PM, 2010, RADIOGRAPHICS, V30, P643, DOI 10.1148/rg.303095732; Chalazonitis A, 2009, CURR PROBL DIAGN RAD, V38, P199, DOI 10.1067/j.cpradiol.2008.02.003; Collins JA, 1988, CURR PROB OBST GYN F, V11, P6; Donnez J, 2002, HUM REPROD, V17, P1424, DOI 10.1093/humrep/17.6.1424; Eng C. W., 2007, SMJ Singapore Medical Journal, V48, P368; Gnoth C, 2005, HUM REPROD, V20, P1144, DOI 10.1093/humrep/deh870; Hart R, 2001, HUM REPROD, V16, P2411, DOI 10.1093/humrep/16.11.2411; HEINONEN PK, 1982, ACTA OBSTET GYN SCAN, V61, P157, DOI 10.3109/00016348209156548; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Levi AJ, 2001, FERTIL STERIL, V76, P666, DOI 10.1016/S0015-0282(01)02017-9; LOUMAYE E, 1990, FERTIL STERIL, V53, P295; NAVOT D, 1987, LANCET, V2, P645; SCOTT RT, 1989, FERTIL STERIL, V51, P651; SCOTT RT, 1993, OBSTET GYNECOL, V82, P539; SCOTT RT, 1995, FERTIL STERIL, V63, P1; SCOTT RT, 1995, HUM REPROD, V10, P1706, DOI 10.1093/oxfordjournals.humrep.a136159; Sharara FI, 1998, AM J OBSTET GYNECOL, V179, P804, DOI 10.1016/S0002-9378(98)70087-0; Stovall DW, 1998, HUM REPROD, V13, P192, DOI 10.1093/humrep/13.1.192; SWART P, 1995, FERTIL STERIL, V64, P486, DOI 10.1016/S0015-0282(16)57781-4; TANBO T, 1992, FERTIL STERIL, V57, P819; te Velde ER, 2000, LANCET, V355, P1928, DOI 10.1016/S0140-6736(00)02320-5; Watrelot A, 2003, BEST PRACT RES CL OB, V17, P187, DOI 10.1016/S1521-6934(02)00131-1	26	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 20	2012	345								e6173	10.1136/bmj.e6173	http://dx.doi.org/10.1136/bmj.e6173			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JJ	22996937				2022-12-28	WOS:000309160600002
J	Greene, JA; Jones, DS; Podolsky, SH				Greene, Jeremy A.; Jones, David S.; Podolsky, Scott H.			200TH ANNIVERSARY ARTICLE Therapeutic Evolution and the Challenge of Rational Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD 21218 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA; [Jones, David S.; Podolsky, Scott H.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Podolsky, Scott H.] Countway Lib Med, Ctr Hist Med, Boston, MA USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Harvard University	Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD 21218 USA.							Brandt Allan M, 1985, NO MAGIC BULLET SOCI; Jones DS, 2002, B HIST MED, V76, P749, DOI 10.1353/bhm.2002.0186; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Pernick M, 1987, CALCULUS SUFFERING P; Rosenberg CE, 1979, THERAPEUTIC REVOLUTI, P9; Warner John Harley, 1987, THERAPEUTIC PERSPECT	6	12	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1077	1082		10.1056/NEJMp1113570	http://dx.doi.org/10.1056/NEJMp1113570			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AS	22992071	Green Published			2022-12-28	WOS:000308861800001
J	Neugut, AI; Accordino, MK				Neugut, Alfred I.; Accordino, Melissa K.			Review: CT screening for lung cancer reduced mortality in 1 large trial but not in 2 smaller trials	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Neugut, Alfred I.; Accordino, Melissa K.] Columbia Univ, Med Ctr, New York, NY 10027 USA	Columbia University	Neugut, AI (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.							Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010	1	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-6	10.7326/0003-4819-157-6-201209180-02006	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986398				2022-12-28	WOS:000308912800005
J	Roland, M; Abel, G				Roland, Martin; Abel, Gary			Reducing emergency admissions: are we on the right track?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED-TRIAL; HOSPITALIZATIONS; IMPACT; CARE		[Roland, Martin; Abel, Gary] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 8PN, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 8PN, England.	mr108@cam.ac.uk	Abel, Gary/ABE-1765-2021	Abel, Gary/0000-0003-2231-5161; Roland, Martin/0000-0002-8533-3060				Blunt I, 2010, TRENDS EMERGENCY ADM; Bottle A, 2006, J ROY SOC MED, V99, P406, DOI 10.1258/jrsm.99.8.406; Department of Health, 2010, PAYM RES BACKGR; Evidence Adoption Centre, 2011, EFF PRED MOD TOOLS I; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; King's Health Partners, INT CAR PROGR; Munro J, 2005, BRIT J GEN PRACT, V55, P790; NHS Information Centre, 2011, HOSP EP STAT HEADL F; Northamptonshire Observatory, JOINT STRAT NEEDS AS; Nuffield Trust, 2011, PRED RISK HLTH CAR O; Ovretveit J, 2009, REV EVIDENCE WHICH I, P95; Powell Davies G, 2006, COORDINATION CARE PR; Purdy S, 2012, INTERVENTIONS REDUCE; Purdy S., 2010, AVOIDING HOSP ADMISS; Roland M, 2005, BRIT MED J, V330, P289, DOI 10.1136/bmj.330.7486.289; Roland M., 2012, INT J INTEGRATED CAR, V12; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sargent P, 2008, J NURS MANAGE, V16, P38, DOI 10.1111/j.1365-2934.2007.00785.x; Takahashi PY, 2012, ARCH INTERN MED, V172, P773, DOI 10.1001/archinternmed.2012.256; Wennberg D, 2006, COMBINED PREDICTIVE	21	78	78	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 18	2012	345								e6017	10.1136/bmj.e6017	http://dx.doi.org/10.1136/bmj.e6017			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JH	22990102				2022-12-28	WOS:000309160400006
J	Gross, TP; Crowley, J				Gross, Thomas P.; Crowley, Jay			Unique Device Identification in the Service of Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gross, Thomas P.; Crowley, Jay] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Gross, TP (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA.							[Anonymous], 2012, PROP RUL UN DEV ID S; Food and Drug Administration, 2012, STRENGTH OUR NAT SYS; Hauser RG, 2012, NEW ENGL J MED, V366, P873, DOI 10.1056/NEJMp1114695; Institute of Medicine, 2011, MED DEV PUBL HLTH FD	4	19	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1583	1585		10.1056/NEJMp1113608	http://dx.doi.org/10.1056/NEJMp1113608			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23013051				2022-12-28	WOS:000310131700004
J	Hagberg, CE; Mehlem, A; Falkevall, A; Muhl, L; Fam, BC; Ortsater, H; Scotney, P; Nyqvist, D; Samen, E; Lu, L; Stone-Elander, S; Proietto, J; Andrikopoulos, S; Sjoholm, A; Nash, A; Eriksson, U				Hagberg, Carolina E.; Mehlem, Annika; Falkevall, Annelie; Muhl, Lars; Fam, Barbara C.; Ortsater, Henrik; Scotney, Pierre; Nyqvist, Daniel; Samen, Erik; Lu, Li; Stone-Elander, Sharon; Proietto, Joseph; Andrikopoulos, Sofianos; Sjoholm, Ake; Nash, Andrew; Eriksson, Ulf			Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes	NATURE			English	Article							GROWTH-FACTOR-B; OXIDATIVE-PHOSPHORYLATION; GLUCOSE-PRODUCTION; SKELETAL-MUSCLE; METABOLISM; TOLERANCE; ISOFORMS	The prevalence of type 2 diabetes is rapidly increasing, with severe socioeconomic impacts(1,2). Excess lipid deposition in peripheral tissues impairs insulin sensitivity and glucose uptake, and has been proposed to contribute to the pathology of type 2 diabetes(3-5). However, few treatment options exist that directly target ectopic lipid accumulation(6). Recently it was found that vascular endothelial growth factor B (VEGF-B) controls endothelial uptake and transport of fatty acids in heart and skeletal muscle(7). Here we show that decreased VEGF-B signalling in rodent models of type 2 diabetes restores insulin sensitivity and improves glucose tolerance. Genetic deletion of Vegfb in diabetic db/db mice prevented ectopic lipid deposition, increased-muscle glucose uptake and maintained normoglycaemia. Pharmacological inhibition of VEGF-B signalling by antibody administration to db/db mice enhanced glucose tolerance, preserved pancreatic islet architecture, improved beta-cell function and ameliorated dyslipidaemia, key elements of type 2 diabetes and the metabolic syndrome. The potential use of VEGF-B neutralization in type 2 diabetes was further elucidated in rats fed a high-fat diet, in which it normalized insulin sensitivity and increased glucose uptake in skeletal muscle and heart. Our results demonstrate that the vascular endothelium can function as an efficient barrier to excess muscle lipid uptake even under conditions of severe obesity and type 2 diabetes, and that this barrier can be maintained by inhibition of VEGF-B signalling. We propose VEGF-B antagonism as a novel pharmacological approach for type 2 diabetes, targeting the lipid-transport properties of the endothelium to improve muscle insulin sensitivity and glucose disposal.	[Hagberg, Carolina E.; Mehlem, Annika; Falkevall, Annelie; Muhl, Lars; Nyqvist, Daniel; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Tissue Biol Grp, SE-17177 Stockholm, Sweden; [Hagberg, Carolina E.; Falkevall, Annelie; Muhl, Lars] Karolinska Inst, Stockholm Branch, Ludwig Inst Canc Res Ltd, SE-17177 Stockholm, Sweden; [Fam, Barbara C.; Proietto, Joseph; Andrikopoulos, Sofianos] Univ Melbourne, Dept Med AH, Heidelberg, Vic 3091, Australia; [Ortsater, Henrik; Sjoholm, Ake] Karolinska Inst, Dept Clin Sci & Educ, Diabet Res Unit, SE-11883 Stockholm, Sweden; [Scotney, Pierre; Nash, Andrew] CSL Ltd, Parkville, Vic 3052, Australia; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Univ Hosp, Dept Neuroradiol, SE-17176 Stockholm, Sweden; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Univ Hosp, Karolinska Expt Res & Imaging Ctr, SE-17176 Stockholm, Sweden; [Samen, Erik; Stone-Elander, Sharon] Karolinska Inst, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research; University of Melbourne; Karolinska Institutet; CSL; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Eriksson, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Tissue Biol Grp, SE-17177 Stockholm, Sweden.	ulf.pe.eriksson@ki.se	Mehlem, Annika/AAB-4883-2022	Nyqvist, Daniel/0000-0002-6527-6716; Hagberg, Carolina/0000-0002-5497-2855	Frans Wilhelm och Waldemar von Frenckells Fond; Wilhelm och Else Stockmanns Stiftelse; Swedish Society for Medical Research; Ludwig Institute for Cancer Research; Novo Nordisk Foundation; Swedish Cancer Foundation; Swedish Research Council; Torsten och Ragnar Soderbergs Stiftelser; Dr Peter Wallenbergs Foundation for Economics and Technology; Swedish Heart and Lung Foundation; Diabetes Foundation; Karolinska Institutet	Frans Wilhelm och Waldemar von Frenckells Fond; Wilhelm och Else Stockmanns Stiftelse; Swedish Society for Medical Research; Ludwig Institute for Cancer Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten och Ragnar Soderbergs Stiftelser; Dr Peter Wallenbergs Foundation for Economics and Technology; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Diabetes Foundation; Karolinska Institutet(Karolinska Institutet)	We thank S. Wittgren and A. Gustafsson for technical assistance, and G. Christofori for the RIP VEGF-B mice. C.E.H. was supported by the Frans Wilhelm och Waldemar von Frenckells Fond and Wilhelm och Else Stockmanns Stiftelse. D.N. was supported by the Swedish Society for Medical Research. This study was supported by the Ludwig Institute for Cancer Research, the Novo Nordisk Foundation, the Swedish Cancer Foundation, the Swedish Research Council, Torsten och Ragnar Soderbergs Stiftelser, Dr Peter Wallenbergs Foundation for Economics and Technology, the Swedish Heart and Lung Foundation, the Diabetes Foundation and Karolinska Institutet.	Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Albrecht I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014109; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bostrom P, 2010, DIABETES, V59, P1870, DOI 10.2337/db09-1503; Chaggar PS, 2009, DIABETES VASC DIS RE, V6, P146, DOI 10.1177/1479164109338772; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fujimoto WY., 2000, AM J MED S6A, V108, p9S, DOI DOI 10.1016/S0002-9343(00)00337-5; GENUTH SM, 1971, ENDOCRINOLOGY, V88, P1230, DOI 10.1210/endo-88-5-1230; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Lamont BJ, 2003, DIABETOLOGIA, V46, P1338, DOI 10.1007/s00125-003-1180-y; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Mangiafico SP, 2011, J ENDOCRINOL, V210, P335, DOI 10.1530/JOE-11-0126; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muoio DM, 2010, NEW ENGL J MED, V363, P291, DOI 10.1056/NEJMcibr1005397; NOLAN CJ, 1994, DIABETOLOGIA, V37, P976, DOI 10.1007/s001250050207; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schmitz-Peiffer C, 2010, DIABETES, V59, P2351, DOI 10.2337/db10-0912; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046/j.1440-1681.2002.03769.x; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Visinoni S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1132, DOI 10.1152/ajpendo.90552.2008; Wong N, 2011, ENDOCRINOLOGY, V152, P3690, DOI 10.1210/en.2011-0288; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	38	201	218	4	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					426	+		10.1038/nature11464	http://dx.doi.org/10.1038/nature11464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023133				2022-12-28	WOS:000309918500051
J	Korkhov, VM; Mireku, SA; Locher, KP				Korkhov, Vladimir M.; Mireku, Samantha A.; Locher, Kaspar P.			Structure of AMP-PNP-bound vitamin B-12 transporter BtuCD-F	NATURE			English	Article							ABC TRANSPORTER; ATP-BINDING; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; MECHANISM; DOMAIN; INTERMEDIATE; SUGGEST; SYSTEM	The ATP-binding cassette (ABC) transporter BtuCD mediates the uptake of vitamin B-12 across the inner membrane of Escherichia coli. Previous structures have shown the conformations of apo states, but the transport mechanism has remained unclear. Here we report the 3.5 angstrom crystal structure of the transporter-binding protein complex BtuCD-BtuF (BtuCD-F) trapped in an beta-gamma-imidoadenosine 5'-phosphate (AMP-PNP)-bound intermediate state. Although the ABC domains (BtuD subunits) form the expected closed sandwich dimer, the membrane-spanning BtuC subunits adopt a new conformation, with the central translocation pathway sealed by a previously unrecognized cytoplasmic gate. A fully enclosed cavity is thus formed approximately halfway across the membrane. It is large enough to accommodate a vitamin B-12 molecule, and radioligand trapping showed that liposome-reconstituted BtuCD-F indeed contains bound B-12 in the presence of AMP-PNP. In combination with engineered disulphide crosslinking and functional assays, our data suggest an unexpected peristaltic transport mechanism that is distinct from those observed in other ABC transporters.	[Korkhov, Vladimir M.; Mireku, Samantha A.; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Korkhov, Volodymyr/0000-0002-0962-9433	NCCR Structural Biology Zurich; Swiss National Science Foundation [SNF 31003A-131075/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the beamline staff at the Swiss Light Source for assistance with data collection. We are grateful to R. Schibli and M. Badertscher for access to the gamma counter. This research was supported by the NCCR Structural Biology Zurich and Swiss National Science Foundation (grant SNF 31003A-131075/1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEVEAUX LC, 1985, J BACTERIOL, V162, P888, DOI 10.1128/JB.162.3.888-896.1985; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Korkhov VM, 2012, FEBS LETT, V586, P972, DOI 10.1016/j.febslet.2012.02.042; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Newstead S, 2009, STRUCTURE, V17, P1213, DOI 10.1016/j.str.2009.07.009; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Pattery T, 1999, MOL MICROBIOL, V33, P791, DOI 10.1046/j.1365-2958.1999.01526.x; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	44	123	126	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					367	+		10.1038/nature11442	http://dx.doi.org/10.1038/nature11442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23000901				2022-12-28	WOS:000309918500038
J	Chopra, M; Sharkey, A; Dalmiya, N; Anthony, D; Binkin, N				Chopra, Mickey; Sharkey, Alyssa; Dalmiya, Nita; Anthony, David; Binkin, Nancy		UNICEF Equity Child Survival Hlth	Strategies to improve health coverage and narrow the equity gap in child survival, health, and nutrition	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; ALMA-ATA; IMMUNIZATION SERVICES; HIV PREVENTION; CARE SERVICES; RURAL-AREAS; INTERVENTIONS; WORKERS; QUALITY; REMOTE	Implementation of innovative strategies to improve coverage of evidence-based interventions, especially in the most marginalised populations, is a key focus of policy makers and planners aiming to improve child survival, health, and nutrition. We present a three-step approach to improvement of the effective coverage of essential interventions. First, we identify four different intervention delivery channels-ie, clinical or curative, outreach, community-based preventive or promotional, and legislative or mass media. Second, we classify which interventions' deliveries can be improved or changed within their channel or by switching to another channel. Finally, we do a meta-review of both published and unpublished reviews to examine the evidence for a range of strategies designed to overcome supply and demand bottlenecks to effective coverage of interventions that improve child survival, health, and nutrition. Although knowledge gaps exist, several strategies show promise for improving coverage of effective interventions- and, in some cases, health outcomes in children-including expanded roles for lay health workers, task shifting, reduction of financial barriers, increases in human-resource availability and geographical access, and use of the private sector. Policy makers and planners should be informed of this evidence as they choose strategies in which to invest their scarce resources.	[Chopra, Mickey; Sharkey, Alyssa] UNICEF, Hlth Sect, New York, NY 10017 USA; [Dalmiya, Nita] UNICEF, Nutr Sect, New York, NY 10017 USA; [Anthony, David] UNICEF, Policy Planning & Programme Monitoring Sect, New York, NY 10017 USA; [Binkin, Nancy] San Diego State Univ, Div Epidemiol & Biostat, San Diego, CA 92182 USA	UNICEF; UNICEF; UNICEF; California State University System; San Diego State University	Sharkey, A (corresponding author), UNICEF, Hlth Sect, 3 UN Plaza, New York, NY 10017 USA.	asharkey@unicef.org	O'Connell, Thomas S./AAZ-1965-2020	O'Connell, Thomas S./0000-0002-6003-008X				Abroms LC, 2008, ANNU REV PUBL HEALTH, V29, P219, DOI 10.1146/annurev.publhealth.29.020907.090824; Akhtar S, 2011, FOOD RES INT, V44, P652, DOI 10.1016/j.foodres.2010.12.033; Alshamsan R, 2010, J HEALTH SERV RES PO, V15, P178, DOI 10.1258/jhsrp.2010.009113; Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1321; [Anonymous], 2010, GLOBAL EXPERIENCE CO; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2010, LANCET, V375, P1142, DOI 10.1016/S0140-6736(10)60324-8; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Carrera C, 2012, LANCET; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Christopher JB, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-27; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Doherty T, 2010, TROP MED INT HEALTH, V15, P296, DOI 10.1111/j.1365-3156.2009.02454.x; Dolea C, 2009, INCREASING ACCESS HL; Dolea C, 2010, B WORLD HEALTH ORGAN, V88, P379, DOI 10.2471/BLT.09.070607; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Farmer AP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub2; Forde I, 2011, 4 WHO SOC DET HLTH; Frehywot S, 2010, B WORLD HEALTH ORGAN, V88, P364, DOI 10.2471/BLT.09.071605; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gordon R, 2006, PUBLIC HEALTH, V120, P1133, DOI 10.1016/j.puhe.2006.10.008; Gosden T, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002215; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Gruen R L, 2004, Cochrane Database Syst Rev, pCD003798, DOI 10.1002/14651858.CD003798.pub2; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Gwatkin D. R., 2005, Reaching the poor with health, nutrition, and population services: what works, what doesn't and why, P47; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kruk ME, 2010, SOC SCI MED, V70, P904, DOI 10.1016/j.socscimed.2009.11.025; Lagarde M, 2011, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD009094; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008133; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Laven Gillian, 2003, Aust J Rural Health, V11, P277, DOI 10.1111/j.1440-1584.2003.00534.x; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lehmann U, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-19; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Liu XZ, 2008, HEALTH POLICY PLANN, V23, P1, DOI 10.1093/heapol/czm042; Maternal Mortality Estimation Inter-agency Group, 2010, TRENDS MAT MORT 1990; Meng QY, 2011, HEALTH POLICY PLANN, V26, P93, DOI 10.1093/heapol/czq038; OPIYO N, 2010, COCHRANE DB SYST REV, V4; Oxman A. D., 2008, OVERVIEW RES EFFECTS; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Pegurri E, 2005, VACCINE, V23, P1624, DOI 10.1016/j.vaccine.2004.02.029; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; Piot M, 1967, SIMULATION MODEL CAS; Ridde V, 2011, HEALTH POLICY PLANN, V26, P1, DOI 10.1093/heapol/czq021; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Ryman T, 2010, J PUBLIC HEALTH-UK, V32, P18, DOI 10.1093/pubmed/fdp048; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; Shea B, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S5; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; United Nations Inter-agency Group for Child Mortality Estimation Levels & Trends in Child Mortality, 2011, LEV TRENDS CHILD MOR; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; Williams Nia, 2011, JRSM Short Rep, V2, P81, DOI 10.1258/shorts.2011.011112; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; Wilson NW, 2009, RURAL REMOTE HEALTH, V9; World Bank, 2004, WORLD DEV REP 2004 M, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X]	78	86	86	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2012	380	9850					1331	1340		10.1016/S0140-6736(12)61423-8	http://dx.doi.org/10.1016/S0140-6736(12)61423-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	022BZ	22999430	Green Submitted			2022-12-28	WOS:000309931400032
J	Granger, EM; Bevis, TH; Saka, Y; Southerland, SA; Sampson, V; Tate, RL				Granger, E. M.; Bevis, T. H.; Saka, Y.; Southerland, S. A.; Sampson, V.; Tate, R. L.			The Efficacy of Student-Centered Instruction in Supporting Science Learning	SCIENCE			English	Article							INQUIRY; DISCOVERY; ATTITUDES	Transforming science learning through student-centered instruction that engages students in a variety of scientific practices is central to national science-teaching reform efforts. Our study employed a large-scale, randomized-cluster experimental design to compare the effects of student-centered and teacher-centered approaches on elementary school students' understanding of space-science concepts. Data included measures of student characteristics and learning and teacher characteristics and fidelity to the instructional approach. Results reveal that learning outcomes were higher for students enrolled in classrooms engaging in scientific practices through a student-centered approach; two moderators were identified. A statistical search for potential causal mechanisms for the observed outcomes uncovered two potential mediators: students' understanding of models and evidence and the self-efficacy of teachers.	[Granger, E. M.; Bevis, T. H.] Florida State Univ, Off Sci Teaching Activ, Tallahassee, FL 32306 USA; [Southerland, S. A.; Sampson, V.] Florida State Univ, FSU Teach Sch Teacher Educ, Tallahassee, FL 32306 USA; [Tate, R. L.] Florida State Univ, Tallahassee, FL 32312 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Granger, EM (corresponding author), Florida State Univ, Off Sci Teaching Activ, Tallahassee, FL 32306 USA.	granger@bio.fsu.edu	Saka, Yavuz/AAH-9452-2020	Southerland, Sherry/0000-0002-0824-4611	Florida Center for Research in Science, Technology, Engineering, and Mathematics Education [FL DOE 371-96700-7SF01, 371-96700-8SS01, 371-96700-9SF01]	Florida Center for Research in Science, Technology, Engineering, and Mathematics Education	This work was supported by a grant from the Florida Center for Research in Science, Technology, Engineering, and Mathematics Education (FL DOE 371-96700-7SF01, 371-96700-8SS01, and 371-96700-9SF01). Data are archived in the supplementary materials.	Blanchard MR, 2010, SCI EDUC, V94, P577, DOI 10.1002/sce.20390; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Donovan M. S., 2005, STUDENTS LEARN SCI C; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; Granger E., 2007, MODELS EVIDENCE QUES; Kirschner PA, 2006, EDUC PSYCHOL-US, V41, P75, DOI 10.1207/s15326985ep4102_1; Klahr D, 2004, PSYCHOL SCI, V15, P661, DOI 10.1111/j.0956-7976.2004.00737.x; Lawrence Hall of Science, 2007, GREAT EXPL MATH SCI; Lee O, 2006, SCIENCE EDUCATION AND STUDENT DIVERSITY: SYNTHESIS AND RESEARCH AGENDA, P1, DOI 10.2277/ 0521859611; Leonard W. H., 1981, J RES SCI TEACH, V18, P497; LEONARD WH, 1983, J RES SCI TEACH, V20, P807, DOI 10.1002/tea.3660200903; Lynch S, 2005, J RES SCI TEACH, V42, P912, DOI 10.1002/tea.20080; Lynch S., 2006, ANN M AM ED RES ASS; Marx RW, 2004, J RES SCI TEACH, V41, P1063, DOI 10.1002/tea.20039; Michaels S., 2008, REDDY SET SCI PUTTIN; Muthen L.K., 2020, MPLUS; National Academy of Sciences , 2010, RISING GATHERING STO; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; Raudenbush S.W., 2004, HLM 6 HIERARCHICAL L; Sadler P., 2007, MISCONCEPTION ORIENT; Sawada D., 2002, SCH SCI MATH, V102, P245, DOI [10.1111/j.1949-8594.2002.tb17883.x, DOI 10.1111/J.1949-8594.2002.TB17883.X]; Schwartz R.S., 2008, INT C NAT ASS RES SC; Shymansky JA, 2004, J RES SCI TEACH, V41, P771, DOI 10.1002/tea.20025; Smith LK, 2007, J RES SCI TEACH, V44, P396, DOI 10.1002/tea.20165; Tschannen-Moran M, 2001, TEACH TEACH EDUC, V17, P783, DOI 10.1016/S0742-051X(01)00036-1; US Congress Joint Economic Committee, 2012, STEM ED PREP JOBS FU; Viadero D., 2009, ED WEEK, V28, P14; Warrington M, 2000, BRIT EDUC RES J, V26, P393, DOI 10.1080/01411920050030914	28	36	38	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					105	108		10.1126/science.1223709	http://dx.doi.org/10.1126/science.1223709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015PC	23042893				2022-12-28	WOS:000309457400063
J	Liao, EC; Chang, KC				Liao, En-Chih; Chang, Ke-Chang			Mites in the External Auditory Canal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liao, En-Chih] Taichung Vet Gen Hosp, Taichung, Taiwan; [Chang, Ke-Chang] Natl Yang Ming Univ Hosp, Yilan, Taiwan	Taichung Veterans General Hospital	Liao, EC (corresponding author), Taichung Vet Gen Hosp, Taichung, Taiwan.	postdream8@hotmail.com							0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					E19	E19		10.1056/NEJMicm1010983	http://dx.doi.org/10.1056/NEJMicm1010983			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034045				2022-12-28	WOS:000309406100011
J	Vijay, R; Macklin, C; Slichter, DH; Weber, SJ; Murch, KW; Naik, R; Korotkov, AN; Siddiqi, I				Vijay, R.; Macklin, C.; Slichter, D. H.; Weber, S. J.; Murch, K. W.; Naik, R.; Korotkov, A. N.; Siddiqi, I.			Stabilizing Rabi oscillations in a superconducting qubit using quantum feedback	NATURE			English	Article							HOMODYNE DETECTION; TIME	The act of measurement bridges the quantum and classical worlds by projecting a superposition of possible states into a single (probabilistic) outcome. The timescale of this 'instantaneous' process can be stretched using weak measurements(1,2), such that it takes the form of a gradual random walk towards a final state. Remarkably, the interim measurement record is sufficient to continuously track and steer the quantum state using feedback(3-8). Here we implement quantum feedback control in a solid-state system, namely a superconducting quantum bit (qubit) coupled to a microwave cavity(9). A weak measurement of the qubit is implemented by probing the cavity with microwave photons, maintaining its average occupation at less than one photon. These photons are then directed to a high-bandwidth, quantum-noise-limited amplifier(10,11), which allows real-time monitoring of the state of the cavity (and, hence, that of the qubit) with high fidelity. We demonstrate quantum feedback control by inhibiting the decay of Rabi oscillations, allowing them to persist indefinitely(12). Such an ability permits the active suppression of decoherence and enables a method of quantum error correction based on weak continuous measurements(13,14). Other applications include quantum state stabilization(4,7,15), entanglement generation using measurement(16), state purification(17) and adaptive measurements(18,19).	[Vijay, R.; Macklin, C.; Slichter, D. H.; Weber, S. J.; Murch, K. W.; Naik, R.; Siddiqi, I.] Univ Calif Berkeley, Dept Phys, Quantum Nanoelect Lab, Berkeley, CA 94720 USA; [Korotkov, A. N.] Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA	University of California System; University of California Berkeley; University of California System; University of California Riverside	Vijay, R (corresponding author), Univ Calif Berkeley, Dept Phys, Quantum Nanoelect Lab, Berkeley, CA 94720 USA.	rvijay@berkeley.edu; irfan@berkeley.edu	Slichter, Daniel/A-2870-2013; Siddiqi, Irfan/E-5548-2015	Slichter, Daniel/0000-0002-1228-0631; Naik, Ravi/0000-0003-2337-7321	US Army Research Office [W911NF-11-1-0029]; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office; Hertz Foundation; ARO MURI	US Army Research Office; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office; Hertz Foundation; ARO MURI(MURI)	We thank M. Sarovar for several discussions and Z. Minev for assistance with numerical simulations. This research was supported in part (R.V., C.M. and I.S.) by the US Army Research Office (W911NF-11-1-0029) and the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office (K.W.M., S.J.W. and A.N.K.). All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI or the US government. D.H.S. acknowledges support from a Hertz Foundation Fellowship endowed by Big George Ventures. A.N.K. also acknowledges funding from an ARO MURI.	Ahn C, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.042301; [Anonymous], 2004, QUANTUM NOISE; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Combes J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010504; Cook RL, 2007, NATURE, V446, P774, DOI 10.1038/nature05655; Hatridge M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134501; Hofmann HF, 1998, PHYS REV A, V57, P4877, DOI 10.1103/PhysRevA.57.4877; Jacobs K, 2007, QUANTUM INF COMPUT, V7, P127; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Korotkov AN, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.165310; Korotkov AN, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115403; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Palacios-Laloy A, 2010, NAT PHYS, V6, P442, DOI 10.1038/NPHYS1641; Ruskov R, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.241305; Ruskov R, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.041401; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Schrodinger E, 1935, P AM PHILOS SOC, V124, P323, DOI DOI 10.1007/BF01493128; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Slichter D.H., 2012, PREPRINT; Smith WP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.133601; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Tornberg L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012329; Vijay R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110502; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wang J, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.063810; WISEMAN HM, 1993, PHYS REV LETT, V70, P548, DOI 10.1103/PhysRevLett.70.548; Wiseman HM, 2009, QUANTUM MEASUREMENT	29	328	334	7	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					77	80		10.1038/nature11505	http://dx.doi.org/10.1038/nature11505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038468	Green Submitted			2022-12-28	WOS:000309446800035
J	Boyce, N				Boyce, Niall			The psychiatrist who wanted to believe	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Boyce, N (corresponding author), The Lancet, London NW1 7BY, England.	niall.boyce@lancet.com						Cornell P, 2012, SAUCER COUNTRY; Linse, 2002, SKEPTIC ENCY PSEUDOS; Mack John. E., 1994, ABDUCTION HUMAN ENCO; Santomauro J, 2007, TALL TALES MIND BRAI, P380	4	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1140	1141		10.1016/S0140-6736(12)61655-9	http://dx.doi.org/10.1016/S0140-6736(12)61655-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	012SD	23029669	Bronze			2022-12-28	WOS:000309255900015
J	Ekiert, DC; Kashyap, AK; Steel, J; Rubrum, A; Bhabha, G; Khayat, R; Lee, JH; Dillon, MA; O'Neil, RE; Faynboym, AM; Horowitz, M; Horowitz, L; Ward, AB; Palese, P; Webby, R; Lerner, RA; Bhatt, RR; Wilson, IA				Ekiert, Damian C.; Kashyap, Arun K.; Steel, John; Rubrum, Adam; Bhabha, Gira; Khayat, Reza; Lee, Jeong Hyun; Dillon, Michael A.; O'Neil, Ryann E.; Faynboym, Aleksandr M.; Horowitz, Michael; Horowitz, Lawrence; Ward, Andrew B.; Palese, Peter; Webby, Richard; Lerner, Richard A.; Bhatt, Ramesh R.; Wilson, Ian A.			Cross-neutralization of influenza A viruses mediated by a single antibody loop	NATURE			English	Article							POTENT NEUTRALIZATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HEMAGGLUTININ; EPITOPE; SYSTEM; BROAD; RECOGNITION; INSERTIONS; DELETIONS	Immune recognition of protein antigens relies on the combined interaction of multiple antibody loops, which provide a fairly large footprint and constrain the size and shape of protein surfaces that can be targeted. Single protein loops can mediate extremely high-affinity binding, but it is unclear whether such a mechanism is available to antibodies. Here we report the isolation and characterization of an antibody called C05, which neutralizes strains from multiple subtypes of influenza A virus, including H1, H2 and H3. X-ray and electron microscopy structures show that C05 recognizes conserved elements of the receptor-binding site on the haemagglutinin surface glycoprotein. Recognition of the haemagglutinin receptor-binding site is dominated by a single heavy-chain complementarity-determining region 3 loop, with minor contacts from heavy-chain complementarity-determining region 1, and is sufficient to achieve nanomolar binding with a minimal footprint. Thus, binding predominantly with a single loop can allow antibodies to target small, conserved functional sites on otherwise hypervariable antigens.	[Ekiert, Damian C.; Bhabha, Gira; Khayat, Reza; Lee, Jeong Hyun; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kashyap, Arun K.; Dillon, Michael A.; O'Neil, Ryann E.; Faynboym, Aleksandr M.; Horowitz, Michael; Horowitz, Lawrence; Bhatt, Ramesh R.] Sea Lane Biotechnol, Mountain View, CA 94043 USA; [Steel, John; Palese, Peter] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Rubrum, Adam; Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Lerner, Richard A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ramesh.bhatt@sealanebio.com; wilson@scripps.edu	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014; Webby, Richard J/N-5657-2018	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Palese, Peter/0000-0002-0337-5823; Lee, Jeong Hyun/0000-0001-7371-845X; Ekiert, Damian/0000-0002-2570-0404	National Institutes of Health (NIH) [P01AI058113]; Achievement Rewards for College Scientists Foundation [GM080209]; NIH Molecular Evolution Training Program; Skaggs Institute; Northeast Biodefense Center [U54-AI057158-Lipkin]; National Institute of Allergy and Infectious Diseases (NIAID) [U01AI070373]; Center for Research on Influenza Pathogenesis NIAID [HHSN266200700010C]; DOE Office of Biological and Environmental Research; NIH, National Center for Research Resources, Biomedical Technology Program; National Institute of General Medical Sciences (NIGMS); National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NIH though the P41 program at the National Center for Research Resources [RR017573]; NIH [U54 GM094586]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, P01AI058113, U01AI070373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, T32GM080209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); NIH Molecular Evolution Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; Northeast Biodefense Center; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Research on Influenza Pathogenesis NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH though the P41 program at the National Center for Research Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tien and D. Marciano for automated crystal screening, the staff of the Advanced Photon Source (APS) GM/CA-CAT and Stanford Synchrotron Radiation Lightsource (SSRL) BL11-1 for beamline support, X. Dai and R. Stanfield for assistance with data collection and processing, M. Hothorn for assistance with ITC experiments, J. Paulson and D. Burton for comments and discussion, A. Estelles and R. Briante, L. Xu, S. Wang and D. Corn for technical support and P. Foremanfor assistance with animal study design. This project was funded in part by National Institutes of Health (NIH) grant P01AI058113 (I. A. W.), a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D. C. E.), grant GM080209 from the NIH Molecular Evolution Training Program (D. C. E.), the Skaggs Institute (I. A. W.), a career development fellowship from the Northeast Biodefense Center (U54-AI057158-Lipkin) (J. S.), National Institute of Allergy and Infectious Diseases (NIAID) grant U01AI070373 (R. W.), and Center for Research on Influenza Pathogenesis NIAID contract HHSN266200700010C (P. P.). Portions of this research were carried out at the SSRL, a national user facility operated by Stanford University on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences (NIGMS). The GM/CA-CAT 23-ID-B beamline has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The electron microscopy data presented here was collected at the National Resource for Automated Molecular Microscopy, which is supported by the NIH though the P41 program (RR017573) at the National Center for Research Resources. The JCSG is supported by NIH grant U54 GM094586. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. This is publication 21421 from The Scripps Research Institute.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee HK, 2004, ANGEW CHEM INT EDIT, V43, P1000, DOI 10.1002/anie.200353105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MIYAZAKI J, 1989, GENE, V79, P269; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; Smith T, 1996, BRIT MED J, V312, P383; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	50	342	371	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					526	+		10.1038/nature11414	http://dx.doi.org/10.1038/nature11414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22982990	Green Accepted			2022-12-28	WOS:000309167100042
J	Silverman, EK				Silverman, Edwin K.			PERSPECTIVE How can genetics help?	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; GENOME		[Silverman, Edwin K.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Silverman, Edwin K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Silverman, EK (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	ed.silverman@channing.harvard.edu						Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	8	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S7	S7		10.1038/489S7a	http://dx.doi.org/10.1038/489S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013715				2022-12-28	WOS:000309167100004
J	White, K; Grossman, D; Hopkins, K; Potter, JE				White, Kari; Grossman, Daniel; Hopkins, Kristine; Potter, Joseph E.			Cutting Family Planning in Texas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNINTENDED PREGNANCIES		[White, Kari] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Sch Publ Hlth, Birmingham, AL 35294 USA; [Grossman, Daniel] Ibis Reprod Hlth, Oakland, CA USA; [Grossman, Daniel] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Hopkins, Kristine; Potter, Joseph E.] Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA; [Hopkins, Kristine; Potter, Joseph E.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	White, K (corresponding author), Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Sch Publ Hlth, Birmingham, AL 35294 USA.			Potter, Joseph/0000-0002-8960-813X; Hopkins, Kristine/0000-0001-6277-7833	NICHD NIH HHS [R24 HD042849] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042849] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Foster DG, 2011, OBSTET GYNECOL, V117, P566, DOI 10.1097/AOG.0b013e3182056309; Frost JJ, 2008, J HEALTH CARE POOR U, V19, P778, DOI 10.1353/hpu.0.0060; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	5	26	26	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1179	1181		10.1056/NEJMp1207920	http://dx.doi.org/10.1056/NEJMp1207920			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JO	23013071	Green Published, Green Accepted			2022-12-28	WOS:000309161100002
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING The key to longevity	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Black D, 1982, INEQUALITIES HLTH BL; Kamerow D, 2007, BRIT MED J, V334, P126, DOI 10.1136/bmj.39097.516609.59; Link BG, 2005, POLICY CHALLENGES MO, P71; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Tavernise Sabrina, 2012, NEW YORK TIMES  0112, pA1	6	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6456	10.1136/bmj.e6456	http://dx.doi.org/10.1136/bmj.e6456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014907				2022-12-28	WOS:000309385500013
J	Ormerod, P				Ormerod, Paul			Social networks can spread the Olympic effect	NATURE			English	Editorial Material									Volterra Consulting, London, England		Ormerod, P (corresponding author), Volterra Consulting, London, England.	pormerod@volterra.co.uk							0	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					337	337		10.1038/489337a	http://dx.doi.org/10.1038/489337a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AK	22996511	Bronze			2022-12-28	WOS:000308860900006
J	Smieja, M				Smieja, Marek			Review: Oseltamivir relieves symptoms but does not reduce hospitalizations in influenza	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS		McMaster Univ, Hamilton, ON, Canada	McMaster University	Smieja, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-5	10.7326/0003-4819-157-6-201209180-02005	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986397				2022-12-28	WOS:000308912800004
J	Wagschal, A; Rousset, E; Basavarajaiah, P; Contreras, X; Harwig, A; Laurent-Chabalier, S; Nakamura, M; Chen, X; Zhang, K; Meziane, O; Boyer, F; Parrinello, H; Berkhout, B; Terzian, C; Benkirane, M; Kiernan, R				Wagschal, Alexandre; Rousset, Emilie; Basavarajaiah, Poornima; Contreras, Xavier; Harwig, Alex; Laurent-Chabalier, Sabine; Nakamura, Mirai; Chen, Xin; Zhang, Ke; Meziane, Oussama; Boyer, Frederic; Parrinello, Hugues; Berkhout, Ben; Terzian, Christophe; Benkirane, Monsef; Kiernan, Rosemary			Microprocessor, Setx, Xrn2, and Rrp6 Co-operate to Induce Premature Termination of Transcription by RNAPII	CELL			English	Article							POLYMERASE-II; PAUSE SITES; HIV-1; GENE; COMPLEX; INTERFERENCE; RECRUITMENT; PROTEASOME; INITIATION; DOMAIN	Transcription elongation is increasingly recognized as an important mechanism of gene regulation. Here, we show that microprocessor controls gene expression in an RNAi-independent manner. Microprocessor orchestrates the recruitment of termination factors Setx and Xrn2, and the 30-50 exoribonuclease, Rrp6, to initiate RNAPII pausing and premature termination at the HIV-1 promoter through cleavage of the stem-loop RNA, TAR. Rrp6 further processes the cleavage product, which generates a small RNA that is required to mediate potent transcriptional repression and chromatin remodeling at the HIV-1 promoter. Using chromatin immunoprecipitation coupled to high-throughput sequencing (ChIP-seq), we identified cellular gene targets whose transcription is modulated by microprocessor. Our study reveals RNAPII pausing and premature termination mediated by the co-operative activity of ribonucleases, Drosha/Dgcr8, Xrn2, and Rrp6, as a regulatory mechanism of RNAPII-dependent transcription elongation.	[Wagschal, Alexandre; Laurent-Chabalier, Sabine; Zhang, Ke; Meziane, Oussama; Benkirane, Monsef; Kiernan, Rosemary] CNRS UPR1142, Inst Genet Humaine, Mol Virol Lab, F-34396 Montpellier, France; [Harwig, Alex; Berkhout, Ben] Univ Amsterdam, Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Boyer, Frederic; Terzian, Christophe] Univ Lyon 1, INRA, EPHE, ENVL,Retrovirus & Pathol Comparee, F-69366 Lyon 07, France; [Parrinello, Hugues] MGX Montpellier GenomiX, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Amsterdam; INRAE; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Claude Bernard Lyon 1; VetAgro Sup; Universite de Montpellier	Kiernan, R (corresponding author), CNRS UPR1142, Inst Genet Humaine, Mol Virol Lab, F-34396 Montpellier, France.	rosemary.kiernan@igh.cnrs.fr	contreras, xavier/ABA-3533-2020; Boyer, Frédéric/Y-2184-2018; Kiernan, Rosemary/GXV-8695-2022; Harwig, Alex/AAG-9952-2020; Boyer, Frédéric/AAR-8176-2020	contreras, xavier/0000-0003-0748-6923; Boyer, Frédéric/0000-0003-0021-9590; Boyer, Frédéric/0000-0003-0021-9590; Harwig, Alex/0000-0002-1117-9216; Kiernan, Rosemary/0000-0001-6645-0686	ERC [250333]; ANR-BLAN [0040]; Sidaction; ANRS; FRM "equipe labellisee''; ANR; ERC; CNRS; FRM; RTRS grand Sud; The Netherlands Organization for Scientific Research (NWO-CW); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); ANR-BLAN(French National Research Agency (ANR)); Sidaction; ANRS(ANRSFrench National Research Agency (ANR)); FRM "equipe labellisee''; ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); FRM(Fondation pour la Recherche Medicale); RTRS grand Sud; The Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Molecular Virology and Gene Regulation labs for critical reading of the manuscript, N. Kim for Drosha WT and mutant plasmids, and S. Emiliani for HeLa-LTR-luc. ChIP-seq experiments were performed using MGX-Montpellier facilities. This work was supported by grants from the ERC (250333), ANR-BLAN-0040, Sidaction, ANRS, and FRM "equipe labellisee'' to M.B. and ANRS and Sidaction to R.K. A.W. was supported by ANR and ERC; E.R. and M.N. by Sidaction; P.B. by ANRS; S.L.-C. by ERC; X. Chen by CNRS and FRM; K.Z. by CNRS; O.M. by RTRS grand Sud; and B.B. by The Netherlands Organization for Scientific Research (NWO-CW, Top grant).	Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; de Parseval N, 2001, VIROLOGY, V279, P558, DOI 10.1006/viro.2000.0737; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim KY, 2011, CELL, V144, P745, DOI 10.1016/j.cell.2011.01.034; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Nakamura M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-13; Nechaev Sergei, 2011, Biochim Biophys Acta, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Seitz H, 2006, CELL, V125, P827, DOI 10.1016/j.cell.2006.05.018; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Wagschal Alexandre, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4767; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	126	126	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1147	1157		10.1016/j.cell.2012.08.004	http://dx.doi.org/10.1016/j.cell.2012.08.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980978	Bronze, Green Accepted			2022-12-28	WOS:000308928100009
J	Zijlstra, AA; Davis, RJ				Zijlstra, Albert A.; Davis, Richard J.			Sir Bernard Lovell (1913-2012) RETROSPECTIVE	SCIENCE			English	Biographical-Item									[Zijlstra, Albert A.; Davis, Richard J.] Univ Manchester, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England	University of Manchester; Jodrell Bank Centre for Astrophysics	Zijlstra, AA (corresponding author), Univ Manchester, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England.	albert.zijlstra@manchester.ac.uk							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1307	1307		10.1126/science.1229080	http://dx.doi.org/10.1126/science.1229080			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984062				2022-12-28	WOS:000308705000032
J	Dethoff, EA; Petzold, K; Chugh, J; Casiano-Negroni, A; Al-Hashimi, HM				Dethoff, Elizabeth A.; Petzold, Katja; Chugh, Jeetender; Casiano-Negroni, Anette; Al-Hashimi, Hashim M.			Visualizing transient low-populated structures of RNA	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 TAR RNA; RELAXATION DISPERSION NMR; LEAD-DEPENDENT RIBOZYME; 16S RIBOSOMAL-RNA; NUCLEOCAPSID PROTEIN; MOLECULAR-DYNAMICS; SPIN RELAXATION; INITIATION SITE; LOOP SEQUENCE	The visualization of RNA conformational changes has provided fundamental insights into how regulatory RNAs carry out their biological functions. The RNA structural transitions that have been characterized so far involve long-lived species that can be captured by structure characterization techniques. Here we report the nuclear magnetic resonance visualization of RNA transitions towards 'invisible' excited states (ESs), which exist in too little abundance (2-13%) and for too short a duration (45-250 ms) to allow structural characterization by conventional techniques. Transitions towards ESs result in localized rearrangements in base-pairing that alter building block elements of RNA architecture, including helix-junction-helix motifs and apical loops. The ES can inhibit function by sequestering residues involved in recognition and signalling or promote ATP-independent strand exchange. Thus, RNAs do not adopt a single conformation, but rather exist in rapid equilibrium with alternative ESs, which can be stabilized by cellular cues to affect functional outcomes.	[Dethoff, Elizabeth A.; Petzold, Katja; Chugh, Jeetender; Casiano-Negroni, Anette; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	hashimi@umich.edu	Petzold, Katja/E-9816-2011; Chugh, Jeetender/S-4436-2019; Petzold, Katja/M-7298-2015	Petzold, Katja/0000-0001-9470-0347; Chugh, Jeetender/0000-0002-9996-5202; Petzold, Katja/0000-0001-9470-0347	Michigan Economic Development Cooperation; Michigan Technology Tri-Corridor; Swedish Research Council [VR-K2011-78PK-21662-0-12]; US National Institutes of Health [R01 Al066975]; University of Michigan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER	Michigan Economic Development Cooperation; Michigan Technology Tri-Corridor; Swedish Research Council(Swedish Research CouncilEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E.A.D., K.P. and J.C contributed equally to this work. We thank members of the Al-Hashimi laboratory for input. We acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for the support of the purchase of a 600 MHz spectrometer. K.P. is supported by a postdoctoral Fellowship from the Swedish Research Council (VR-K2011-78PK-21662-0-12). This work was supported by the US National Institutes of Health (R01 Al066975) and by a Rackham Graduate Student Research Grant awarded by the University of Michigan.	Baldwin AJ, 2009, J AM CHEM SOC, V131, P11939, DOI 10.1021/ja903896p; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Blad H, 2005, J MOL BIOL, V353, P540, DOI 10.1016/j.jmb.2005.08.030; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Dahlquist KD, 2000, J MOL BIOL, V299, P1, DOI 10.1006/jmbi.2000.3672; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dethoff EA, 2008, BIOPHYS J, V95, P3906, DOI 10.1529/biophysj.108.140285; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Fares C, 2007, J AM CHEM SOC, V129, P15814, DOI 10.1021/ja0727417; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; GHOSE R, 1994, J AM CHEM SOC, V116, P8827, DOI 10.1021/ja00098a060; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoogstraten CG, 2000, BIOCHEMISTRY-US, V39, P9951, DOI 10.1021/bi0007627; JAEGER JA, 1993, BIOCHEMISTRY-US, V32, P12522, DOI 10.1021/bi00097a032; Johnson JE, 2008, J AM CHEM SOC, V130, P16757, DOI 10.1021/ja805759z; Kipper K, 2009, J MOL BIOL, V385, P405, DOI 10.1016/j.jmb.2008.10.065; Korzhnev DM, 2005, J AM CHEM SOC, V127, P713, DOI 10.1021/ja0446855; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Kulinski T, 2003, J BIOL CHEM, V278, P38892, DOI 10.1074/jbc.M301939200; Lawrence DC, 2003, J MOL BIOL, V326, P529, DOI 10.1016/S0022-2836(02)01305-0; Legault P, 1997, J AM CHEM SOC, V119, P6621, DOI 10.1021/ja9640051; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Moore MD, 2009, AIDS REV, V11, P91; Mujeeb A, 2007, NUCLEIC ACIDS RES, V35, P2026, DOI 10.1093/nar/gkm097; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; OConnor M, 1997, NUCLEIC ACIDS RES, V25, P1185, DOI 10.1093/nar/25.6.1185; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Richter S, 2002, BIOCHEMISTRY-US, V41, P6391, DOI 10.1021/bi0159579; Rist MJ, 2002, BIOCHEMISTRY-US, V41, P14762, DOI 10.1021/bi0267240; Romanowska J, 2008, J PHYS CHEM B, V112, P15227, DOI 10.1021/jp806814s; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Shandrick S, 2004, ANGEW CHEM INT EDIT, V43, P3177, DOI 10.1002/anie.200454217; Snoussi K, 2001, BIOCHEMISTRY-US, V40, P8898, DOI 10.1021/bi010385d; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun XY, 2007, NUCLEIC ACIDS RES, V35, P1698, DOI 10.1093/nar/gkm020; Takahashi KI, 2000, RNA, V6, P96, DOI 10.1017/S1355838200991635; Turner KB, 2007, J MOL BIOL, V369, P812, DOI 10.1016/j.jmb.2007.03.065; Ulyanov NB, 2006, J BIOL CHEM, V281, P16168, DOI 10.1074/jbc.M601711200; Vallurupalli P, 2011, J PHYS CHEM B, V115, P14891, DOI 10.1021/jp209610v; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722; Yuan YQ, 2003, BIOCHEMISTRY-US, V42, P5259, DOI 10.1021/bi034084a	53	143	143	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					724	+		10.1038/nature11498	http://dx.doi.org/10.1038/nature11498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23041928	Green Accepted			2022-12-28	WOS:000311606000037
J	Smith, AJ; Dieppe, P; Howard, PW; Blom, AW				Smith, Alison J.; Dieppe, Paul; Howard, Peter W.; Blom, Ashley W.		Natl Joint Registry England Wales	Failure rates of metal-on-metal hip resurfacings: analysis of data from the National Joint Registry for England and Wales	LANCET			English	Article							ARTHROPLASTY REGISTER; SURVIVAL; BEARINGS; OUTCOMES; PATIENT; 5-YEAR	Background Implant survival after conventional total hip replacement (THR) is often poor in younger patients, so alternatives such as hip resurfacing, with various sizes to fit over the femoral head, have been explored. We assessed the survival of different sizes of metal-on-metal resurfacing in men and women, and compared this survival with those for conventional stemmed THRs. Methods We analysed the National Joint Registry for England and Wales (NJR) for primary THRs undertaken between 2003 and 2011. Our analysis involved multivariable flexible parametric survival models to estimate the covariate-adjusted cumulative incidence of revision adjusting for the competing risk of death. Findings The registry included 434 560 primary THRs, of which 31 932 were resurfacings. In women, resurfacing resulted in worse implant survival than did conventional THR irrespective of head size. Predicted 5-year revision rates in 55-year-old women were 8.3% (95% CI 7.2-9.7) with a 42 mm resurfacing head, 6.1% (5.3-7.0) with a 46 mm resurfacing head, and 1.5% (0.8-2.6) with a 28 mm cemented metal-on-polyethylene stemmed THR. In men with smaller femoral heads, resurfacing resulted in poor implant survival. Predicted 5-year revision rates in 55-year-old men were 4.1% (3.3-4.9) with a 46 mm resurfacing head, 2.6% (2.2-3.1) with a 54 mm resurfacing head, and 1.9% (1.5-2.4) with a 28 mm cemented metal-on-polyethylene stemmed THR. Of male resurfacing patients, only 23% (5085 of 22076) had head sizes of 54 mm or above. Interpretation Hip resurfacing only resulted in similar implant survivorship to other surgical options in men with large femoral heads, and inferior implant survivorship in other patients, particularly women. We recommend that resurfacing is not undertaken in women and that preoperative measurement is used to assess suitability in men. Before further new implant technology is introduced we need to learn the lessons from resurfacing and metal-on-metal bearings.	[Smith, Alison J.; Blom, Ashley W.] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol BS10 5NB, Avon, England; [Dieppe, Paul] Univ Plymouth, Peninsula Med Sch, Exeter, Devon, England; [Dieppe, Paul] Univ Exeter, Peninsula Med Sch, Exeter, Devon, England; [Howard, Peter W.] Royal Derby Hosp, Derby, England	University of Bristol; University of Exeter; University of Plymouth; University of Exeter; University of Nottingham	Blom, AW (corresponding author), Univ Bristol, Southmead Hosp, Musculoskeletal Res Unit, Avon Orthopaed Ctr Lower Level,Sch Clin Sci, Bristol BS10 5NB, Avon, England.	ashley.blom@bristol.ac.uk		Blom, Ashley/0000-0002-9940-1095	National Joint Registry for England and Wales	National Joint Registry for England and Wales	National Joint Registry for England and Wales.	Baker R, 2011, ACTA ORTHOP, V82, P669, DOI 10.3109/17453674.2011.636681; Beaule PE, 2004, CLIN ORTHOP RELAT R, P87; Coviello E., 2009, STCOMPADJ STATA MODU; De Smet K, 2010, J BONE JOINT SURG BR, V92B, P335, DOI 10.1302/0301-620X.92B3.23946; de Steiger RN, 2011, J BONE JOINT SURG AM, V93A, P2287, DOI [10.2106/JBJS.J.01727, 10.2106/JBJSJ.01727]; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Isaac GH, 2006, P I MECH ENG H, V220, P119, DOI 10.1243/095441105X68953; Jiang Y, 2011, J ARTHROPLASTY, V26, P419, DOI 10.1016/j.arth.2010.07.008; Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]; Ladon D, 2004, J ARTHROPLASTY, V19, P78, DOI 10.1016/j.arth.2004.09.010; Landgraeber S, 2011, ACTA BIOMATER, V7, P1364, DOI 10.1016/j.actbio.2010.11.016; Macpherson GJ, 2011, ARCH ORTHOP TRAUM SU, V131, P101, DOI 10.1007/s00402-010-1153-9; National Joint Registry for England and Wales, 2011, 8TH ANNUAL REPORT; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Pollard TCB, 2006, J BONE JOINT SURG BR, V88B, P592, DOI 10.1302/0301-620X.88B5.17354; Puolakka TJS, 2001, ACTA ORTHOP SCAND, V72, P433, DOI 10.1080/000164701753532745; Rolfson O, 2011, J BONE JOINT SURG BR, V93B, P867, DOI 10.1302/0301-620X.93B7.25737; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Shimmin AJ, 2010, J BONE JOINT SURG BR, V92B, P469, DOI 10.1302/0301-620X.92B4.22967; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Smith TO, 2010, ACTA ORTHOP, V81, P684, DOI 10.3109/17453674.2010.533933; Treacy RBC, 2011, J BONE JOINT SURG BR, V93B, P27, DOI 10.1302/0301-620X.93B1.24134; van der Weegen W, 2011, J BONE JOINT SURG BR, V93B, P298, DOI 10.1302/0301-620X.93B3.25594; van Gerwen M, 2010, ACTA ORTHOP, V81, P680, DOI 10.3109/17453674.2010.501742; Vendittoli PA, 2006, J BONE JOINT SURG BR, V88B, P997, DOI 10.1302/0301-620X.88B8; Wylde V, 2011, J BONE JOINT SURG BR, V93B, P569, DOI 10.1302/0301-620X.93B5.26687	27	196	200	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2012	380	9855					1759	1766		10.1016/S0140-6736(12)60989-1	http://dx.doi.org/10.1016/S0140-6736(12)60989-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CV	23036895				2022-12-28	WOS:000311153700032
J	Mahmoodi, BK; Matsushita, K; Woodward, M; Blankestijn, PJ; Cirillo, M; Ohkubo, T; Rossing, P; Sarnak, MJ; Stengel, B; Yamagishi, K; Yamashita, K; Zhang, LX; Coresh, J; de Jong, PE; Astor, BC				Mahmoodi, Bakhtawar K.; Matsushita, Kunihiro; Woodward, Mark; Blankestijn, Peter J.; Cirillo, Massimo; Ohkubo, Takayoshi; Rossing, Peter; Sarnak, Mark J.; Stengel, Benedicte; Yamagishi, Kazumasa; Yamashita, Kentaro; Zhang, Luxia; Coresh, Josef; de Jong, Paul E.; Astor, Brad C.		Chronic Kidney Dis Prognosis Conso	Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; BLOOD-PRESSURE; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; DIABETIC-NEPHROPATHY; REVERSE EPIDEMIOLOGY; RISK; PREVALENCE; EQUATION	Background Hypertension is the most prevalent comorbidity in individuals with chronic kidney disease. However, whether the association of the kidney disease measures, estimated glomerular filtration rate (eGFR) and albuminuria, with mortality or end-stage renal disease (ESRD) differs by hypertensive status is unknown. Methods We did a meta-analysis of studies selected according to Chronic Kidney Disease Prognosis Consortium criteria. Data transfer and analyses were done between March, 2011, and June, 2012. We used Cox proportional hazards models to estimate the hazard ratios (HR) of mortality and ESRD associated with eGFR and albuminuria in individuals with and without hypertension. Findings We analysed data for 45 cohorts (25 general population, seven high-risk, and 13 chronic kidney disease) with 1 127 656 participants, 364 344 of whom had hypertension. Low eGFR and high albuminuria were associated with mortality irrespective of hypertensive status in the general population and high-risk cohorts. All-cause mortality risk was 1.1-1.2 times higher in individuals with hypertension than in those without hypertension at preserved eGFR. A steeper relative risk gradient in individuals without hypertension than in those with hypertension at eGFR range 45-75 mL/min per 1.73 m(2) led to much the same mortality risk at lower eGFR. With a reference eGFR of 95 mL/min per 1.73 m(2) in each group to explicitly assess interaction, adjusted HR for all-cause mortality at eGFR 45 mL/min per 1.73 m(2) was 1.77 (95% CI 1.57-1.99) in individuals without hypertension versus 1.24 (1.11-1.39) in those with hypertension (p for overall interaction=0.0003). Similarly, for albumin-creatinine ratio of 300 mg/g (vs 5 mg/g), HR was 2.30 (1.98-2.68) in individuals without hypertension versus 2.08 (1.84-2.35) in those with hypertension (p for overall interaction=0.019). We recorded much the same results for cardiovascular mortality. The associations of eGFR and albuminuria with ESRD, however, did not differ by hypertensive status. Results for chronic kidney disease cohorts were similar to those for general and high-risk population cohorts. Interpretation Chronic kidney disease should be regarded as at least an equally relevant risk factor for mortality and ESRD in individuals without hypertension as it is in those with hypertension.	[Mahmoodi, Bakhtawar K.; Matsushita, Kunihiro; Woodward, Mark; Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Mahmoodi, Bakhtawar K.; de Jong, Paul E.] Univ Groningen, Dept Nephrol, Univ Med Ctr Groningen, Groningen, Netherlands; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Blankestijn, Peter J.] Univ Med Ctr, Dept Nephrol, Utrecht, Netherlands; [Cirillo, Massimo] Univ Salerno, Dept Med, I-84100 Salerno, Italy; [Ohkubo, Takayoshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Ohkubo, Takayoshi] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 52021, Japan; [Rossing, Peter] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rossing, Peter] Univ Aarhus, HEALTH, Aarhus, Denmark; [Sarnak, Mark J.] Tufts Med Ctr, Div Nephrol, Boston, MA USA; [Stengel, Benedicte] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Stengel, Benedicte] Univ Paris Sud, UMRS 1018, Villejuif, France; [Yamagishi, Kazumasa] Univ Tsukuba, Fac Med, Dept Publ Hlth Med, Tsukuba, Ibaraki, Japan; [Yamagishi, Kazumasa] Ibaraki Hlth Serv Assoc, Mito, Ibaraki, Japan; [Yamagishi, Kazumasa] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Yamashita, Kentaro] Nagoya Univ, Dept Publ Hlth & Hlth Syst, Nagoya, Aichi 4648601, Japan; [Zhang, Luxia] Peking Univ, Div Renal, Hosp 1, Beijing 100871, Peoples R China; [Astor, Brad C.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Astor, Brad C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Groningen; George Institute for Global Health; University of Sydney; Utrecht University; Utrecht University Medical Center; University of Salerno; Tohoku University; Shiga University of Medical Science; Steno Diabetes Center; Aarhus University; Tufts Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Tsukuba; Nagoya University; Peking University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Coresh, J (corresponding author), Chron Kidney Dis Prognosis Consortium Data Coordi, Baltimore, MD 21205 USA.	ckdpc@jhmi.edu	Matsushita, Kunihiro/B-1021-2018; Wetzels, Jack F.M./A-1720-2014; Woodward, Mark/L-6817-2017; Yamagishi, Kazumasa/ABD-6320-2021; Schöttker, Ben/F-8183-2014; Stengel, Benedicte/G-5730-2015; Kikuya, Masahiro/X-5662-2018; de Zeeuw, Dick/E-9080-2014; Brenner, Hermann/B-4627-2017; rossing, peter/AAZ-3415-2021; Woodward, Mark/D-8492-2015; Matsushita, Kunihiro/AAJ-5817-2020; Mahmoodi, Bakhtawar/ABA-7050-2020; Kronenberg, Florian/B-1736-2008; rossing, peter/AAH-7879-2021; Brenner, Hermann/ABE-6383-2020; Ärnlöv, Johan/AAF-2746-2019; Metzger, Marie/K-9772-2018; Froissart, Marc/L-7493-2014; Cirillo, Massimo/G-5480-2018	Matsushita, Kunihiro/0000-0002-7179-718X; Wetzels, Jack F.M./0000-0002-0650-6921; Yamagishi, Kazumasa/0000-0003-3301-5519; Schöttker, Ben/0000-0002-1217-4521; Stengel, Benedicte/0000-0001-9469-0804; Kikuya, Masahiro/0000-0002-3080-6107; de Zeeuw, Dick/0000-0003-3434-7777; Brenner, Hermann/0000-0002-6129-1572; rossing, peter/0000-0002-1531-4294; Matsushita, Kunihiro/0000-0002-7179-718X; Kronenberg, Florian/0000-0003-2229-1120; Brenner, Hermann/0000-0002-6129-1572; Ärnlöv, Johan/0000-0002-6933-4637; Sairenchi, Toshimi/0000-0001-8896-6501; Metzger, Marie/0000-0003-3597-5409; Kimm, Heejin/0000-0003-4526-0570; Townend, Jonathan/0000-0002-5881-5806; Jee, Sun Ha/0000-0001-9519-3068; Luxia, Zhang/0000-0003-2349-2936; Prescott, Gordon/0000-0002-9156-2361; Froissart, Marc/0000-0002-4010-3173; Woodward, Mark/0000-0001-9800-5296; Kleefstra, Nanne/0000-0003-1473-8519; Cirillo, Massimo/0000-0002-6409-3504; Rothenbacher, Dietrich/0000-0002-3563-2791; Emberson, Jonathan/0000-0001-7792-9422	Netherlands Organization for Scientific Research; Dutch Kidney Foundation; NFK; Amgen; NIH; Servier; Roche; Sanofi; Netherlands Heart Foundation; Sanofi-Aventis; Pfizer; Merck Sharp Dohme Japan; Dainippon Sumitomo Pharma; Tanabe Mitsubishi Pharma; Daiichi Sankyo Pharma; Asterasu Pharma; Kyowa Hakkou Kirin Pharma; Takeda Pharma; Bayer Health Care; Abbott; AstraZeneca; Bristol-Myers Squibb; Boehringer Ingelheim; Lilly; Novo Nordisk; Novartis; Baxter; Fresenius; GlaxoSmithKline; Merck Sharp Dohme; Merck; Dutch Kidney Foundation (Nierstichting Nederland); US National Kidney Foundation; Chief Scientist Office [CZH/4/656] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC075150, N01HC025195, N01HC035129, N01HC095159, N01HC095169, N01HC085079, N01HC015103, N01HC045133, N01HC085086] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043232, R01HL068140, R01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002904, R01DK031801, U01DK035073, R01DK073217, K23DK067303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027058, R01AG023629, R01AG007181, R01AG020098, R01AG028507, R01AG015928] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation; NFK; Amgen(Amgen); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Servier(Servier); Roche(Roche Holding); Sanofi; Netherlands Heart Foundation(Netherlands Heart Foundation); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Merck Sharp Dohme Japan; Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Tanabe Mitsubishi Pharma; Daiichi Sankyo Pharma(Daiichi Sankyo Company Limited); Asterasu Pharma(Dexcel Pharma); Kyowa Hakkou Kirin Pharma; Takeda Pharma(Takeda Pharmaceutical Company Ltd); Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Lilly(Eli Lilly); Novo Nordisk(Novo Nordisk); Novartis(Novartis); Baxter; Fresenius; GlaxoSmithKline(GlaxoSmithKline); Merck Sharp Dohme(Merck & Company); Merck(Merck & Company); Dutch Kidney Foundation (Nierstichting Nederland); US National Kidney Foundation; Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	BKM's institution has received grants from the Netherlands Organization for Scientific Research and the Dutch Kidney Foundation. KM's institution has received grants from NFK, Amgen, and NIH. MW's institution has received a grant from Servier; he has received consultancy fees from Roche and speaker's fees from Sanofi and Servier. PJB has received grants from the Dutch Kidney Foundation, the Netherlands Heart Foundation, Amgen, Sanofi-Aventis, and Pfizer, and has received consulting fees and travel expenses from Amgen. TO has received speaker's fees from Merck Sharp & Dohme Japan, Dainippon Sumitomo Pharma, Tanabe Mitsubishi Pharma, Daiichi Sankyo Pharma, Asterasu Pharma, Kyowa Hakkou Kirin Pharma, Takeda Pharma, and Bayer Health Care. PR's institution has received consultancy fees from Abbott, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Lilly, and Novo Nordisk, and has received grants from Abbott, Novartis, Pfizer, and speaker's fees from Abbott, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Lilly, and Novo Nordisk; he holds stock in Novo Nordisk. BS's institution has received grants from Roche, Amgen, Baxter, Fresenius, GlaxoSmithKline, Merck Sharp & Dohme, and Sanofi. JC's institution has received grants from NFK, NIH, and Amgen, and he has received consultancy fees from Amgen and Merck. PEdJ's institution has received a grant from the Dutch Kidney Foundation (Nierstichting Nederland). MC, MJS, KaY, KeY, LZ, and BCA declare that they have no conflicts of interest.; The Chronic Kidney Disease Prognosis Consortium data coordinating center is underpinned by a programme grant from the US National Kidney Foundation (funding sources include Abbott and Amgen). Various sources (appendix pp 46-48) have supported enrolment and data collection including laboratory measurements, and follow-up in the collaborating cohorts of the Chronic Kidney Disease Prognosis Consortium. BKM's fellowship at Johns Hopkins School of Public Health is supported by grants of Netherlands Organization for Scientific Research and the Dutch Kidney Foundation.	Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Borsboom H, 2005, NETH J MED, V63, P399; Brotman DJ, 2010, J AM SOC NEPHROL, V21, P1560, DOI 10.1681/ASN.2009111112; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clase CM, 2011, ANN INTERN MED, V154, P310, DOI 10.7326/0003-4819-154-5-201103010-00005; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Couser WG, 2007, J AM SOC NEPHROL, V18, P2803, DOI 10.1681/ASN.2007080964; Crowe E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1530; El Nahas M, 2010, KIDNEY INT, V78, P14, DOI 10.1038/ki.2010.123; Fox CS, 2012, LANCET; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Guder G, 2009, CIRC-HEART FAIL, V2, P563, DOI 10.1161/CIRCHEARTFAILURE.108.825059; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hallan SI, 2010, J NEPHROL, V23, P147; Kovesdy CP, 2006, NEPHROL DIAL TRANSPL, V21, P1257, DOI 10.1093/ndt/gfk057; Kovesdy CP, 2007, SEMIN DIALYSIS, V20, P566, DOI 10.1111/j.1525-139X.2007.00335.x; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Ritz E, 2010, CLIN NEPHROL, V74, pS39; Sarafidis PA, 2008, AM J HYPERTENS, V21, P922, DOI 10.1038/ajh.2008.206; Tocci G, 2011, AM J HYPERTENS, V24, P582, DOI 10.1038/ajh.2011.8; Turnbull F, 2003, LANCET, V362, P1527; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Weiss JW, 2010, AM J KIDNEY DIS, V56, P1062, DOI 10.1053/j.ajkd.2010.07.018; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	34	302	314	5	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1649	1661		10.1016/S0140-6736(12)61272-0	http://dx.doi.org/10.1016/S0140-6736(12)61272-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23013600	Green Accepted			2022-12-28	WOS:000310951400027
J	Costello, C; Ovando, D; Hilborn, R; Gaines, SD; Deschenes, O; Lester, SE				Costello, Christopher; Ovando, Daniel; Hilborn, Ray; Gaines, Steven D.; Deschenes, Olivier; Lester, Sarah E.			Status and Solutions for the World's Unassessed Fisheries	SCIENCE			English	Article							MARINE PROTECTED AREAS; GLOBAL FISHERIES; CATCHES; COLLAPSE; IMPACTS; TRENDS	Recent reports suggest that many well-assessed fisheries in developed countries are moving toward sustainability. We examined whether the same conclusion holds for fisheries lacking formal assessment, which comprise >80% of global catch. We developed a method using species' life-history, catch, and fishery development data to estimate the status of thousands of unassessed fisheries worldwide. We found that small unassessed fisheries are in substantially worse condition than assessed fisheries, but that large unassessed fisheries may be performing nearly as well as their assessed counterparts. Both small and large stocks, however, continue to decline; 64% of unassessed stocks could provide increased sustainable harvest if rebuilt. Our results suggest that global fishery recovery would simultaneously create increases in abundance (56%) and fishery yields (8 to 40%).	[Costello, Christopher; Ovando, Daniel; Gaines, Steven D.; Lester, Sarah E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Deschenes, Olivier] Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93106 USA; [Lester, Sarah E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Costello, C (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	costello@bren.ucsb.edu	Gaines, Steven/Y-3234-2019; Hilborn, Ray W/D-6332-2013	Ovando, Dan/0000-0003-2120-7345	Waitt Foundation; Moore Foundation; Walton Foundation; Oak Foundation; Packard Foundation; California Environmental Associates; NSF [1041570]	Waitt Foundation; Moore Foundation(Gordon and Betty Moore Foundation); Walton Foundation; Oak Foundation; Packard Foundation(The David & Lucile Packard Foundation); California Environmental Associates; NSF(National Science Foundation (NSF))	We thank seminar participants at the University of British Columbia, S. R. Walton, A. Leland, T. Branch, Y. Ye, and T. Essington for helpful suggestions. We gratefully acknowledge the Waitt, Moore, Walton, Oak, and Packard Foundations, California Environmental Associates, and NSF grant 1041570 (to R.H.) for financial support. Detailed results, as well as the locations of source data used in this analysis, can be found in the supplementary materials and methods and text.	Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Arnason R, 2009, SUNKEN BILLIONS EC J; Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Cancino JP, 2007, MAR RESOUR ECON, V22, P391, DOI 10.1086/mre.22.4.42629569; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Costello C, 2010, AUST J AGR RESOUR EC, V54, P321, DOI 10.1111/j.1467-8489.2010.00495.x; FAO, 2011, TOT FISH PROD 1950 2; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Froese R, 2014, FISHBASE; Garibaldi L, 2012, MAR POLICY, V36, P760, DOI 10.1016/j.marpol.2011.10.024; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; McClanahan TR, 2011, CONSERV BIOL, V25, P945, DOI 10.1111/j.1523-1739.2011.01694.x; Ovando D., 2012, MAR POLICY; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Ricard D., 2011, FISH FISH, DOI [10.1111/j.14672011.00435.x, DOI 10.1111/J.14672011.00435.X]; Srinivasan U. Thara, 2010, Journal of Bioeconomics, V12, P183, DOI 10.1007/s10818-010-9090-9; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Thorson JT, 2012, CAN J FISH AQUAT SCI, V69, P645, DOI 10.1139/F2012-016; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Wilson JR, 2010, MAR COAST FISH, V2, P14, DOI 10.1577/C08-026.1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	26	502	521	9	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					517	520		10.1126/science.1223389	http://dx.doi.org/10.1126/science.1223389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23019613				2022-12-28	WOS:000310195800055
J	Carrera, C; Azrack, A; Begkoyian, G; Pfaffmann, J; Ribaira, E; O'Connell, T; Doughty, P; Aung, KM; Prieto, L; Rasanathan, K; Sharkey, A; Chopra, M; Knippenberg, R				Carrera, Carlos; Azrack, Adeline; Begkoyian, Genevieve; Pfaffmann, Jerome; Ribaira, Eric; O'Connell, Thomas; Doughty, Patricia; Aung, Kyaw Myint; Prieto, Lorena; Rasanathan, Kumanan; Sharkey, Alyssa; Chopra, Mickey; Knippenberg, Rudolf			The comparative cost-effectiveness of an equity-focused approach to child survival, health, and nutrition: a modelling approach	LANCET			English	Article							LIVES SAVED TOOL; MILLENNIUM DEVELOPMENT GOALS; NEONATAL DEATHS; NATIONAL CAUSES; PRETERM BIRTH; MORTALITY; INTERVENTIONS; COVERAGE; NEWBORN; TRENDS	Progress on child mortality and undernutrition has seen widening inequities and a concentration of child deaths and undernutrition in the most deprived communities, threatening the achievement of the Millennium Development Goals. Conversely, a series of recent process and technological innovations have provided effective and efficient options to reach the most deprived populations. These trends raise the possibility that the perceived trade-off between equity and efficiency no longer applies for child health-that prioritising services for the poorest and most marginalised is now more effective and cost effective than mainstream approaches. We tested this hypothesis with a mathematical-modelling approach by comparing the cost-effectiveness in terms of child deaths and stunting events averted between two approaches (from 2011-15 in 14 countries and one province): an equity-focused approach that prioritises the most deprived communities, and a mainstream approach that is representative of current strategies. We combined some existing models, notably the Marginal Budgeting for Bottlenecks Toolkit and the Lives Saved Tool, to do our analysis. We showed that, with the same level of investment, disproportionately higher effects are possible by prioritising the poorest and most marginalised populations, for averting both child mortality and stunting. Our results suggest that an equity-focused approach could result in sharper decreases in child mortality and stunting and higher cost-effectiveness than mainstream approaches, while reducing inequities in effective intervention coverage, health outcomes, and out-of-pocket spending between the most and least deprived groups and geographic areas within countries. Our findings should be interpreted with caution due to uncertainties around some of the model parameters and baseline data. Further research is needed to address some of these gaps in the evidence base. Strategies for improving child nutrition and survival, however, should account for an increasing prioritisation of the most deprived communities and the increased use of community-based interventions.	[Carrera, Carlos; O'Connell, Thomas; Doughty, Patricia; Rasanathan, Kumanan; Sharkey, Alyssa; Chopra, Mickey; Knippenberg, Rudolf] UNICEF, New York, NY USA; [Azrack, Adeline] UNICEF Ghana, Accra, Ghana; [Begkoyian, Genevieve] UNICEF S Asia Reg Off, Kathmandu, Nepal; [Pfaffmann, Jerome] UNICEF W & Cent Africa Off, Dakar, Senegal; [Ribaira, Eric] UNICEF E & So Africa Off, Nairobi, Kenya; [Aung, Kyaw Myint] UNICEF E Asia & Pacific Reg Off, Bangkok, Thailand; [Prieto, Lorena] Univ ESAN, Lima, Peru	UNICEF; Universidad ESAN	Carrera, C (corresponding author), UNICEF, 3 United Nations Plaza, New York, NY USA.	ccarrera@unicef.org	O'Connell, Thomas S./AAZ-1965-2020; Prieto, Ana Lorena/AAD-6328-2021	O'Connell, Thomas S./0000-0002-6003-008X; Prieto, Ana Lorena/0000-0002-6134-0987				Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Amouzou A, 2010, INT J EPIDEMIOL, V39, P186, DOI 10.1093/ije/dyq034; Attama S, 1998, ENQUETE DEMOGRAPHIQU; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Barros FC, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P49; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Chopra M, 2012, LANCET; Cossa HA, 1998, MOCAMBIQUE INQUERITO; Cousens S, 2010, INT J EPIDEMIOL, V39, P134, DOI 10.1093/ije/dyq030; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Fox MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-I1; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Gonzalez R, 2009, AM J PUBLIC HEALTH, V99, P1220, DOI 10.2105/AJPH.2008.143578; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; Hosseinpoor AR, 2011, B WORLD HEALTH ORGAN, V89, P881, DOI 10.2471/BLT.11.087536; Institut National de la Statistique (INS) Macro International Inc, 2007, ENQ DEM SANT IND MUL; Instituto Nacional de Estatistica Ministerio da Saude Mocambique ORC Macro, 2005, MOC ORC MACR MOC INQ; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lagarde M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009094; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Limwattananon S, 2010, B WORLD HEALTH ORGAN, V88, P420, DOI 10.2471/BLT.09.068791; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Meessen B, 2011, HEALTH POLICY PLANN, V26, pII16, DOI 10.1093/heapol/czr062; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Munos MK, 2010, INT J EPIDEMIOL, V39, P56, DOI 10.1093/ije/dyq022; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Pagel C, 2009, LANCET, V374, P1441, DOI 10.1016/S0140-6736(09)61566-X; Ross JS, 2004, AM J PUBLIC HEALTH, V94, P1174, DOI 10.2105/AJPH.94.7.1174; Steinglass R, 2011, INT J EPIDEMIOL, V40, P519, DOI 10.1093/ije/dyq173; Sudfeld CR, 2010, INT J EPIDEMIOL, V39, P48, DOI 10.1093/ije/dyq021; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Traa BS, 2010, INT J EPIDEMIOL, V39, P70, DOI 10.1093/ije/dyq024; UNFPA, 2008, REPR HLTH COST TOOL; United Nations Children's Fund (UNICEF), 2010, PROGR CHILDR ACH MDG; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; You D., 2011, LEVELS TRENDS CHILD; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8	48	58	58	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2012	380	9850					1341	1351		10.1016/S0140-6736(12)61378-6	http://dx.doi.org/10.1016/S0140-6736(12)61378-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	22999434				2022-12-28	WOS:000309931400033
J	Yue, H; Lay, T; Koper, KD				Yue, Han; Lay, Thorne; Koper, Keith D.			En echelon and orthogonal fault ruptures of the 11 April 2012 great intraplate earthquakes	NATURE			English	Article							INDIAN-OCEAN; DEFORMATION; SUMATRA; MOTION; PLATE; CONSTRAINTS; SEISMICITY; CAPRICORN; BOUNDARY; MODEL	The Indo-Australian plate is undergoing distributed internal deformation caused by the lateral transition along its northern boundary-from an environment of continental collision to an island arc subduction zone(1,2). On 11 April 2012, one of the largest strike-slip earthquakes ever recorded (seismic moment magnitude M-w 8.7) occurred about 100-200 kilometres southwest of the Sumatra subduction zone. Occurrence of great intraplate strike-slip faulting located seaward of a subduction zone is unusual. It results from northwest-southeast compression within the plate caused by the India-Eurasia continental collision to the northwest, together with northeast-southwest extension associated with slab pull stresses as the plate underthrusts Sumatra to the northeast. Here we use seismic wave analyses to reveal that the 11 April 2012 event had an extraordinarily complex four-fault rupture lasting about 160 seconds, and was followed approximately two hours later by a great (M-w 8.2) aftershock. The mainshock rupture initially expanded bilaterally with large slip (20-30 metres) on a right-lateral strike-slip fault trending west-northwest to east-southeast (WNW-ESE), and then bilateral rupture was triggered on an orthogonal left-lateral strike-slip fault trending north-northeast to south-southwest (NNE-SSW) that crosses the first fault. This was followed by westward rupture on a second WNW-ESE strike-slip fault offset about 150 kilometres towards the southwest from the first fault. Finally, rupture was triggered on another en echelon WNW-ESE fault about 330 kilometres west of the epicentre crossing the Ninetyeast ridge. The great aftershock, with an epicentre located 185 kilometres to the SSW of the mainshock epicentre, ruptured bilaterally on a NNE-SSW fault. The complex faulting limits our resolution of the slip distribution. These great ruptures on a lattice of strike-slip faults that extend through the crust and a further 30-40 kilometres into the upper mantle represent large lithospheric deformation that may eventually lead to a localized boundary between the Indian and Australian plates.	[Yue, Han; Lay, Thorne] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Koper, Keith D.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	University of California System; University of California Santa Cruz; Utah System of Higher Education; University of Utah	Lay, T (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	tlay@ucsc.edu	Lay, Thorne/ABE-6272-2021		NSF [EAR0635570, EAR0951558]; Directorate For Geosciences [0951558] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank H. Kanamori, Z. Duputel and G. Hayes for discussions and exchanges of information about this event. A. Hutko provided early short-period back-projection results. We thank R. Abercrombie for comments on this paper. This work made use of GMT and SAC software and Federation of Digital Seismic Networks (FDSN) seismic data. The Incorporated Research Institutions for Seismology (IRIS) Data Management System (DMS), the European ORFEUS Data Center and the NIED F-net Data Centre were used to access the data. This work was supported by NSF grant EAR0635570 (T.L.) and EAR0951558 (K.D.K.).	Abercrombie RE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000674; Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; [Anonymous], 1990, J HIM GEOL; BENMENAHEM A, 1975, PHYS EARTH PLANET IN, V9, P265, DOI 10.1016/0031-9201(74)90056-9; CHEN WP, 1977, J GEOPHYS RES, V82, P2945, DOI 10.1029/JB082i020p02945; Delescluse M, 2007, GEOPHYS J INT, V168, P818, DOI 10.1111/j.1365-246X.2006.03181.x; Delescluse M, 2012, NATURE, V490, P240, DOI 10.1038/nature11520; DeMets C, 2003, CURR SCI INDIA, V85, P339; Duputel Z., 2012, EARTH PLANET SCI LET, V351-352; GORDON RG, 1990, TECTONICS, V9, P409, DOI 10.1029/TC009i003p00409; Gordon RG, 1998, NATURE, V395, P370, DOI 10.1038/26463; Hjorleifsdottir V, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005975; Incorporated Research Institutions for Seismology, 2012, BACK PROJ MW 8 7 W C; Ishii M, 2005, NATURE, V435, P933, DOI 10.1038/nature03675; KANAMORI H, 1977, J GEOPHYS RES, V82, P2981, DOI 10.1029/JB082i020p02981; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Kiser E., PRELIMINARY RUPTURE; Koper KD, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049689; Koper KD, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008576; Kruger F, 2005, NATURE, V435, P937, DOI 10.1038/nature03696; Lay T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009133; Lay T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006280; McGuire JJ, 2012, SCIENCE, V336, P1118, DOI 10.1126/science.1223983; Meng L, 2012, SCIENCE, V337, P724, DOI 10.1126/science.1224030; Meng L., BACK PROJECTION RESU; MINSTER JB, 1978, J GEOPHYS RES, V83, P5331, DOI 10.1029/JB083iB11p05331; Robinson DP, 2001, SCIENCE, V292, P1145, DOI 10.1126/science.1059395; Royer JY, 1997, SCIENCE, V277, P1268, DOI 10.1126/science.277.5330.1268; Shapiro NM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033381; STEIN S, 1978, J GEOPHYS RES, V83, P2233, DOI 10.1029/JB083iB05p02233; VANDECAR JC, 1990, B SEISMOL SOC AM, V80, P150; VELASCO AA, 1994, B SEISMOL SOC AM, V84, P735; Wang D., RUPTURE PROCESS APRI; WIENS DA, 1985, GEOPHYS RES LETT, V12, P429, DOI 10.1029/GL012i007p00429; Xu Y, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002335	35	165	175	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					245	+		10.1038/nature11492	http://dx.doi.org/10.1038/nature11492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23023129				2022-12-28	WOS:000309733300046
J	Southwick, SM; Charney, DS				Southwick, Steven M.; Charney, Dennis S.			The Science of Resilience: Implications for the Prevention and Treatment of Depression	SCIENCE			English	Editorial Material							STRESS	Human responses to stress and trauma vary widely. Some people develop trauma-related psychological disorders, such as posttraumatic stress disorder (PTSD) and depression; others develop mild to moderate psychological symptoms that resolve rapidly; still others report no new psychological symptoms in response to traumatic stress. Individual variability in how animals and humans respond to stress and trauma depends on numerous genetic, developmental, cognitive, psychological, and neurobiological risk and protective factors.	[Charney, Dennis S.] Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Psychiat, Dept Neurosci, New York, NY 10029 USA; [Charney, Dennis S.] Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Southwick, Steven M.] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Southwick, Steven M.] Yale Univ, Yale Child Study Ctr, US Dept Vet Affairs VA, Natl Ctr Posttraumat Stress Disorder,VA Connectic, West Haven, CT 06516 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; Yale University	Charney, DS (corresponding author), Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Psychiat, Dept Neurosci, 1 Gustave L Levy Pl,Box 1217, New York, NY 10029 USA.	dennis.charney@mssm.edu						American Psychological Association, 2010, ROAD RES; Benight CC, 2011, RESILIENCE MENTAL HL, P45, DOI DOI 10.1017/CBO9780511994791.005; Brunwasser SM, 2009, J CONSULT CLIN PSYCH, V77, P1042, DOI 10.1037/a0017671; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Cornum R, 2011, AM PSYCHOL, V66, P4, DOI 10.1037/a0021420; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Fava GA, 2009, J PERS, V77, P1903, DOI 10.1111/j.1467-6494.2009.00604.x; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Forgeard MJC, 2011, CLIN PSYCHOL-SCI PR, V18, P275, DOI 10.1111/j.1468-2850.2011.01259.x; Jasinska AJ, 2012, TRENDS NEUROSCI, V35, P395, DOI 10.1016/j.tins.2012.01.001; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Maddi SR, 2008, AM PSYCHOL, V63, P563, DOI 10.1037/0003-066X.63.6.563; Meaney MJ, 2010, NAT NEUROSCI, V13, P1313, DOI 10.1038/nn1110-1313; Norris F. H., 2011, RESILIENCE MENTAL HL; Rende R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00050; Southwick SM, 2012, RESILIENCE: THE SCIENCE OF MASTERING LIFE'S GREATEST CHALLENGES, P1, DOI 10.1017/CBO9781139013857; Troy A. S., 2011, RESILIENCE MENTAL HL, P30, DOI [10.1017/CBO9780511994791.004, DOI 10.1017/CBO9780511994791.004, 10.1007/s12671-011-0043-8.]	20	434	458	8	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					79	82		10.1126/science.1222942	http://dx.doi.org/10.1126/science.1222942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042887				2022-12-28	WOS:000309457400056
J	Sapart, CJ; Monteil, G; Prokopiou, M; van de Wal, RSW; Kaplan, JO; Sperlich, P; Krumhardt, KM; van der Veen, C; Houweling, S; Krol, MC; Blunier, T; Sowers, T; Martinerie, P; Witrant, E; Dahl-Jensen, D; Rockmann, T				Sapart, C. J.; Monteil, G.; Prokopiou, M.; van de Wal, R. S. W.; Kaplan, J. O.; Sperlich, P.; Krumhardt, K. M.; van der Veen, C.; Houweling, S.; Krol, M. C.; Blunier, T.; Sowers, T.; Martinerie, P.; Witrant, E.; Dahl-Jensen, D.; Rockmann, T.			Natural and anthropogenic variations in methane sources during the past two millennia	NATURE			English	Article							NORTHERN-HEMISPHERE; HOLOCENE; CLIMATE; POLLUTION; GREENLAND; RECORDS; ICE	Methane is an important greenhouse gas that is emitted from multiple natural and anthropogenic sources. Atmospheric methane concentrations have varied on a number of time scales in the past, but what has caused these variations is not always well understood(1-8). The different sources and sinks of methane have specific isotopic signatures, and the isotopic composition of methane can therefore help to identify the environmental drivers of variations in atmospheric methane concentrations(9). Here we present high-resolution carbon isotope data (delta C-13 content) for methane from two ice cores from Greenland for the past two millennia. We find that the delta C-13 content underwent pronounced centennial-scale variations between 100 BC and AD 1600. With the help of two-box model calculations, we show that the centennial-scale variations in isotope ratios can be attributed to changes in pyrogenic and biogenic sources. We find correlations between these source changes and both natural climate variability-such as the Medieval Climate Anomaly and the Little Ice Age-and changes in human population and land use, such as the decline of the Roman empire and the Han dynasty, and the population expansion during the medieval period.	[Sapart, C. J.; Monteil, G.; Prokopiou, M.; van de Wal, R. S. W.; van der Veen, C.; Houweling, S.; Krol, M. C.; Rockmann, T.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands; [Kaplan, J. O.; Krumhardt, K. M.] Ecole Polytech Fed Lausanne, ARVE Grp, Stn 2, CH-1015 Lausanne, Switzerland; [Sperlich, P.; Blunier, T.; Dahl-Jensen, D.] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen, Denmark; [Houweling, S.] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Sowers, T.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Martinerie, P.] UJF Grenoble 1, CNRS, UMR 5183, LGGE, F-38041 Grenoble, France; [Witrant, E.] UJF Grenoble 1, CNRS, UMR 5216, Grenoble Image Parole Signal Automat GIPSA Lab, F-38402 St Martin Dheres, France	Utrecht University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Copenhagen; Niels Bohr Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Sapart, CJ (corresponding author), Univ Utrecht, Inst Marine & Atmospher Res Utrecht, Princetonpl 5, NL-3584 CC Utrecht, Netherlands.	c.j.sapart@uu.nl	Dahl-Jensen, Dorthe/AAO-6951-2020; van der Veen, Carina/F-5344-2011; Röckmann, Thomas/F-4479-2015; Blunier, Thomas/M-4609-2014; Sperlich, Peter/B-4646-2018; van de wal, roderik/D-1705-2011; Kaplan, Jed O./P-1796-2015; Dahl-Jensen, Dorthe/N-4401-2016; Martinerie, Patricia/N-5731-2017; Krol, Maarten C./E-3414-2013	Dahl-Jensen, Dorthe/0000-0002-1474-1948; Röckmann, Thomas/0000-0002-6688-8968; Blunier, Thomas/0000-0002-6065-7747; van de wal, roderik/0000-0003-2543-3892; Kaplan, Jed O./0000-0001-9919-7613; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Martinerie, Patricia/0000-0002-6820-2296; Krol, Maarten C./0000-0002-3506-2477; Sperlich, Peter/0000-0003-1455-0903; Sapart, Celia Julia/0000-0003-0745-4825	Dutch Science Foundation (NOW) [851.30.020, 865.07.001]; Belgium (FNRS-CFB); Belgium (FWO); Canada (NRCan/GSC); China (CAS); Denmark (FIST); France (IPEV); France (CNRS/INSU); France (CEA); France (ANR); Germany (AWI); Iceland (RannIs); Japan (NIPR); Korea (KOPRI); The Netherlands (NWO/ALW); Sweden (VR); Switzerland (SNF); UK (NERC); USA (US NSF, Office of Polar Programs) [ARC0806407]; Swiss National Science Foundation [PP0022_119049]; FIRB project CASTANEA [RBID08LNFJ]; Office of Polar Programs (OPP) [0806407] Funding Source: National Science Foundation	Dutch Science Foundation (NOW)(Netherlands Organization for Scientific Research (NWO)); Belgium (FNRS-CFB)(Fonds de la Recherche Scientifique - FNRS); Belgium (FWO)(FWO); Canada (NRCan/GSC)(Natural Resources Canada); China (CAS)(Chinese Academy of Sciences); Denmark (FIST)(Department of Science & Technology (India)); France (IPEV); France (CNRS/INSU); France (CEA); France (ANR)(French National Research Agency (ANR)); Germany (AWI); Iceland (RannIs); Japan (NIPR); Korea (KOPRI); The Netherlands (NWO/ALW)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Sweden (VR)(Swedish Research Council); Switzerland (SNF); UK (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); USA (US NSF, Office of Polar Programs); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FIRB project CASTANEA; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank M. Bigler for sharing NEEM CFA dust and ion data; the NEEM community for providing us with ice core samples; and O. Pechony, J. Marlon and Z. Wang for sharing data on fire activity and the charcoal index. This project was supported by the Dutch Science Foundation (NOW; projects 851.30.020 and 865.07.001). NEEM is directed and organized by the Center of Ice and Climate at the Niels Bohr Institute and the US NSF, Office of Polar Programs; it is supported by funding agencies and institutions in Belgium (FNRS-CFB and FWO), Canada (NRCan/GSC), China (CAS), Denmark (FIST), France (IPEV, CNRS/INSU, CEA and ANR), Germany (AWI), Iceland (RannIs), Japan (NIPR), Korea (KOPRI), The Netherlands (NWO/ALW), Sweden (VR), Switzerland (SNF), the UK (NERC) and the USA (US NSF, Office of Polar Programs, ARC0806407). J.O.K. and K.M.K. were supported by the Swiss National Science Foundation (grant PP0022_119049) and FIRB project CASTANEA (RBID08LNFJ).	Akagi SK, 2011, ATMOS CHEM PHYS, V11, P4039, DOI 10.5194/acp-11-4039-2011; BLUNIER T, 1995, NATURE, V374, P46, DOI 10.1038/374046a0; Brannvall ML, 1999, ENVIRON SCI TECHNOL, V33, P4391, DOI 10.1021/es990279n; Buizert C., 2011, ATMOS CHEM PHYS DISC, V11, P15975, DOI DOI 10.5194/ACPD-11-15975-2011; Burns SJ, 2011, HOLOCENE, V21, P735, DOI 10.1177/0959683611400194; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; Craddock P. T., 2008, HDB ENG TECHNOLOGY C, P98; Etiope G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033623; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; Helama S, 2009, GEOLOGY, V37, P175, DOI 10.1130/G25329A.1; Hong SM, 1996, SCIENCE, V272, P246, DOI 10.1126/science.272.5259.246; Houweling S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002961; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Ljungqvist FC, 2010, GEOGR ANN A, V92A, P339, DOI 10.1111/j.1468-0459.2010.00399.x; Meure CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026152; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Mischler JA, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003460; Mitchell LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001441; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Ringeval B, 2011, BIOGEOSCIENCES, V8, P2137, DOI 10.5194/bg-8-2137-2011; Ruddiman WF, 2001, QUATERNARY SCI REV, V20, P1769, DOI 10.1016/S0277-3791(01)00067-1; Sapart CJ, 2011, ATMOS MEAS TECH, V4, P2607, DOI 10.5194/amt-4-2607-2011; Sapart C. J., 2012, ATMOS CHEM PHYS DISC, V12, P9587, DOI DOI 10.5194/ACPD-12-9587-2012; Schmidt GA, 2012, GEOSCI MODEL DEV, V5, P185, DOI 10.5194/gmd-5-185-2012; SCHWANDER J, 1993, J GEOPHYS RES-ATMOS, V98, P2831, DOI 10.1029/92JD02383; Singarayer JS, 2011, NATURE, V470, P82, DOI 10.1038/nature09739; Sowers T, 2010, QUATERNARY SCI REV, V29, P213, DOI 10.1016/j.quascirev.2009.05.023	30	85	89	9	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					85	88		10.1038/nature11461	http://dx.doi.org/10.1038/nature11461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038470				2022-12-28	WOS:000309446800037
J	Nolan, JP; Soar, J; Perkins, GD				Nolan, Jerry P.; Soar, Jasmeet; Perkins, Gavin D.			Cardiopulmonary resuscitation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HOSPITAL CARDIAC-ARREST; CHEST-COMPRESSION; COUNCIL GUIDELINES; LIFE-SUPPORT; SURVIVAL; DEFIBRILLATION; OUTCOMES; CARE; CPR; BYSTANDERS		[Nolan, Jerry P.] Royal United Hosp NHS Trust, Bath BA1 3NG, Avon, England; [Soar, Jasmeet] N Bristol NHS Trust, Southmead Hosp, Bristol, Avon, England; [Perkins, Gavin D.] Univ Warwick, Warwick Med Sch, Warwick, England	North Bristol NHS Trust; Southmead Hospital; University of Warwick	Nolan, JP (corresponding author), Royal United Hosp NHS Trust, Bath BA1 3NG, Avon, England.	jerry.nolan@nhs.net	Soar, Jasmeet/HGA-2279-2022; Nolan, Jerry P./ABF-2561-2020; Perkins, Gavin/E-7613-2010	Soar, Jasmeet/0000-0001-5970-6073; Nolan, Jerry/0000-0003-3141-3812; Perkins, Gavin/0000-0003-3027-7548				Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Cheskes S, 2011, CIRCULATION, V124, P58, DOI 10.1161/CIRCULATIONAHA.110.010736; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Deakin CD, 2010, RESUSCITATION, V81, P1293, DOI 10.1016/j.resuscitation.2010.08.008; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Edelson DP, 2006, RESUSCITATION, V71, P137, DOI 10.1016/j.resuscitation.2006.04.008; Elliott VJ, 2011, RESUSCITATION, V82, P247, DOI 10.1016/j.resuscitation.2010.10.030; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Heradstveit BE, 2012, RESUSCITATION, V83, P813, DOI 10.1016/j.resuscitation.2012.02.021; Hostler David, 2011, BMJ, V342, pd512, DOI 10.1136/bmj.d512; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; Hulleman M, 2012, CIRCULATION, V126, P815, DOI 10.1161/CIRCULATIONAHA.111.089425; Idris AH, 2012, CIRCULATION, V125, P3004, DOI 10.1161/CIRCULATIONAHA.111.059535; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Jones DA, 2011, NEW ENGL J MED, V365, P139, DOI 10.1056/NEJMra0910926; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Lloyd MS, 2008, CIRCULATION, V117, P2510, DOI 10.1161/CIRCULATIONAHA.107.763011; Meaney PA, 2010, CRIT CARE MED, V38, P101, DOI 10.1097/CCM.0b013e3181b43282; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Nichol G, 2010, CIRCULATION, V121, P709, DOI 10.1161/CIR.0b013e3181cdb7db; Nolan J, 2010, RESUSCITATION, V81, P1, DOI 10.1016/j.resuscitation.2009.11.016; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Nolan JP, 2010, RESUSCITATION, V81, pE26, DOI 10.1016/j.resuscitation.2010.08.022; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Ogawa T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7106; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Perkins GD, 2006, RESUSCITATION, V70, P432, DOI 10.1016/j.resuscitation.2006.01.015; Perkins GD, 2012, ANN INTERN MED, V157, P19, DOI 10.7326/0003-4819-157-1-201207030-00005; Perkins GD, 2010, CURR OPIN CRIT CARE, V16, P203, DOI 10.1097/MCC.0b013e328339cf59; Stiell IG, 2012, CRIT CARE MED, V40, P1192, DOI 10.1097/CCM.0b013e31823bc8bb; Tanabe S, 2012, J EMERGENCY MED; Wang HE, 2012, RESUSCITATION, V83, P1061, DOI 10.1016/j.resuscitation.2012.05.018; Wang HE, 2009, ANN EMERG MED, V54, P645, DOI 10.1016/j.annemergmed.2009.05.024; Yeung J, 2009, RESUSCITATION, V80, P743, DOI 10.1016/j.resuscitation.2009.04.012	37	18	18	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	2012	345								e6122	10.1136/bmj.e6122	http://dx.doi.org/10.1136/bmj.e6122			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KZ	23034844				2022-12-28	WOS:000309660600001
J	Camilli, R; Bowen, A; Reddy, CM; Seewald, JS; Yoerger, DR				Camilli, R.; Bowen, A.; Reddy, C. M.; Seewald, J. S.; Yoerger, D. R.			When Scientific Research and Legal Practice Collide	SCIENCE			English	Editorial Material							INDUSTRY; SCIENCE		[Camilli, R.; Bowen, A.; Yoerger, D. R.] Woods Hole Oceanog Inst, Appl Ocean Phys & Engn Dept, Woods Hole, MA 02543 USA; [Reddy, C. M.; Seewald, J. S.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Camilli, R (corresponding author), Woods Hole Oceanog Inst, Appl Ocean Phys & Engn Dept, Woods Hole, MA 02543 USA.	rcamilli@whoi.edu		Reddy, Christopher/0000-0002-7814-2071				[Anonymous], 2010, DEEPW HOR OIL SPILL, P4; Camilli R., 2010, SIZING BP OIL SPILL; Camilli R., 2010, PRELIMINARY REPORT W; Camilli R, 2012, P NATL ACAD SCI USA, V109, P20235, DOI 10.1073/pnas.1100385108; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Friedman LC, 2005, AM J PUBLIC HEALTH, V95, pS16, DOI 10.2105/AJPH.2004.046227; Gaisch H., 1977, INT COMMITTEE SMOKIN; Griffiths SK, 2012, ENVIRON SCI TECHNOL, V46, P5616, DOI 10.1021/es204569t; Gruning T, 2006, AM J PUBLIC HEALTH, V96, P20, DOI 10.2105/AJPH.2004.061507; Hardell L, 2007, AM J IND MED, V50, P227, DOI 10.1002/ajim.20357; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; National Commission on the BP Deepwater Horizon Oil Spill and Offshore Drilling, 2011, DEEP WAT GULF OIL DI, P392; Oldenburg CM, 2012, P NATL ACAD SCI USA, V109, P20254, DOI 10.1073/pnas.1105165108; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Rodgman F. A., 1962, SMOKING HLTH PROBLEM	16	3	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1608	1609		10.1126/science.1225644	http://dx.doi.org/10.1126/science.1225644			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019634				2022-12-28	WOS:000309215400027
J	Chen, SX; Cherry, A; Tari, PK; Podgorski, K; Kwong, YKK; Haas, K				Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt			The Transcription Factor MEF2 Directs Developmental Visually Driven Functional and Structural Metaplasticity	CELL			English	Article							LONG-TERM DEPRESSION; DENDRITIC ARBOR GROWTH; IN-VIVO; SYNAPTIC PLASTICITY; CORTICAL CIRCUITS; EMBRYONIC BRAIN; NERVOUS-SYSTEM; NMDA RECEPTOR; CORTEX; DIFFERENTIATION	Natural sensory input shapes both structure and function of developing neurons, but how early experience-driven morphological and physiological plasticity are interrelated remains unclear. Using rapid time-lapse two-photon calcium imaging of network activity and single-neuron growth within the unanesthetized developing brain, we demonstrate that visual stimulation induces coordinated changes to neuronal responses and dendritogenesis. Further, we identify the transcription factor MEF2A/2D as a major regulator of neuronal response to plasticity-inducing stimuli directing both structural and functional changes. Unpatterned sensory stimuli that change plasticity thresholds induce rapid degradation of MEF2A/2D through a classical apoptotic pathway requiring NMDA receptors and caspases-9 and -3/7. Knockdown of MEF2A/2D alone is sufficient to induce a metaplastic shift in threshold of both functional and morphological plasticity. These findings demonstrate how sensory experience acting through altered levels of the transcription factor MEF2 fine-tunes the plasticity thresholds of brain neurons during neural circuit formation.	[Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada; [Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	Haas, K (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada.	kurt.haas@ubc.ca	Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560; Chen, Simon/0000-0002-7595-7443; Podgorski, Kaspar/0000-0002-0374-2005	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Tula Foundation; EJLB Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Tula Foundation; EJLB Foundation	This work was funded by grants from the Canadian Institutes of Health Research (CIHR), the Michael Smith Foundation for Health Research (MSFHR), the Tula Foundation, and the EJLB Foundation.	Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; COLEMAN PD, 1968, J ANAT, V102, P363; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Dunfield D, 2010, NAT PROTOC, V5, P841, DOI 10.1038/nprot.2010.10; Dunfield D, 2009, NEURON, V64, P240, DOI 10.1016/j.neuron.2009.08.034; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Hossain S, 2012, DEV NEUROBIOL, V72, P615, DOI 10.1002/dneu.20959; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liu XF, 2009, J NEUROSCI, V29, P12229, DOI 10.1523/JNEUROSCI.2842-09.2009; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Philpot BD, 2003, J NEUROSCI, V23, P5583; Podgorski K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001236; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	46	42	43	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					41	55		10.1016/j.cell.2012.08.028	http://dx.doi.org/10.1016/j.cell.2012.08.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021214	Bronze			2022-12-28	WOS:000309544200009
J	Lang, M; Murat, S; Clark, AG; Gouppil, G; Blais, C; Matzkin, LM; Guittard, E; Yoshiyama-Yanagawa, T; Kataoka, H; Niwa, R; Lafont, R; Dauphin-Villemant, C; Orgogozo, V				Lang, Michael; Murat, Sophie; Clark, Andrew G.; Gouppil, Geraldine; Blais, Catherine; Matzkin, Luciano M.; Guittard, Emilie; Yoshiyama-Yanagawa, Takuji; Kataoka, Hiroshi; Niwa, Ryusuke; Lafont, Rene; Dauphin-Villemant, Chantal; Orgogozo, Virginie			Mutations in the neverland Gene Turned Drosophila pachea into an Obligate Specialist Species	SCIENCE			English	Article							CACTUS; OXYGENASE; PATHWAYS; STEROL	Most living species exploit a limited range of resources. However, little is known about how tight associations build up during evolution between such specialist species and the hosts they use. We examined the dependence of Drosophila pachea on its single host, the senita cactus. Several amino acid changes in the Neverland oxygenase rendered D. pachea unable to transform cholesterol into 7-dehydrocholesterol (the first reaction in the steroid hormone biosynthetic pathway in insects) and thus made D. pachea dependent on the uncommon sterols of its host plant. The neverland mutations increase survival on the cactus's unusual sterols and are in a genomic region that faced recent positive selection. This study illustrates how relatively few genetic changes in a single gene may restrict the ecological niche of a species.	[Lang, Michael; Murat, Sophie; Gouppil, Geraldine; Orgogozo, Virginie] Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Inst Jacques Monod,UMR7592, F-75205 Paris 13, France; [Murat, Sophie; Blais, Catherine; Guittard, Emilie; Lafont, Rene; Dauphin-Villemant, Chantal; Orgogozo, Virginie] Univ Paris 06, CNRS, F-75005 Paris, France; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Matzkin, Luciano M.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Yoshiyama-Yanagawa, Takuji; Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yoshiyama-Yanagawa, Takuji; Kataoka, Hiroshi] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778562, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Cornell University; University of Alabama System; University of Alabama Huntsville; University of Tsukuba; University of Tokyo	Orgogozo, V (corresponding author), Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Inst Jacques Monod,UMR7592, 15 Rue Helene Brion, F-75205 Paris 13, France.	virginie.orgogozo@normalesup.org	LAFONT, Rene/GYA-4891-2022; Matzkin, Luciano/B-3168-2013; Matzkin, Luciano/AAI-2913-2020	Matzkin, Luciano/0000-0002-3580-9171; Lang, Michael/0000-0002-2297-5680; Crilat, Emilie/0000-0001-8796-5582; Courtier-Orgogozo, Virginie/0000-0002-9297-9230	CNRS ATIP-AVENIR; French Foreign Ministry postdoctoral fellowship; NIH [AI064950]; Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS); NSF [DEB-1020009]; JSPS; Ministry of Education, Culture, Sports, Science and Technology in Japan; Amylin Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064950] Funding Source: NIH RePORTER	CNRS ATIP-AVENIR; French Foreign Ministry postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS); NSF(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Amylin Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Joron for the linkage disequilibrium heat map; M.-A. Felix, N. Gompel, and C. Desplan for comments on the manuscript; C. Parada for help with field work; T. A. Markow for D. pachea samples; C. S. Thummel and the San Diego Drosophila Species Stock Center for flies; Y. Hiromi for reagents; T. Blasco for liquid chromatography tandem mass spectrometry analyses; and M. Gho for hosting V.O. in 2009-2010. Supported by CNRS ATIP-AVENIR (to V.O.), French Foreign Ministry postdoctoral fellowship (to M. L.), NIH grant AI064950 (to A. G. C.), Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS) (to H. K. and C. D.-V.), NSF award DEB-1020009 (to L. M. M.), JSPS postdoctoral fellowship (to T.Y.-Y.), Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology in Japan (to R. N.), and Amylin Endowment (to T. A. Markow). The nvd sequences were deposited in GenBank under accession nos. JF764559 to JF764595 and JX066807 to JX067384. The authors declare no conflict of interest. V.O. conceived the study and wrote the paper. M. L., C. B., R. L., C. D.-V., L. M. M., H. K., and R. N. provided technical support and conceptual advice for designing the experiments. V.O., M. L., G. G., S. M., L. M. M., C. B., E. G., T.Y.-Y., C. D.-V., and R. N. performed the experiments. A. G. C. did the population genetics analysis.	Blais C, 2010, J CHROMATOGR B, V878, P925, DOI 10.1016/j.jchromb.2010.02.018; CAMPBELL CE, 1980, PHYTOCHEMISTRY, V19, P2777, DOI 10.1016/S0031-9422(00)83969-2; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; GOODNIGHT KC, 1971, LIPIDS, V6, P166, DOI 10.1007/BF02533031; HEED WB, 1965, SCIENCE, V149, P758, DOI 10.1126/science.149.3685.758; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Lwoff A, 1944, EVOLUTION PHYSL ETUD; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; PITNICK S, 1994, ANN ENTOMOL SOC AM, V87, P307, DOI 10.1093/aesa/87.3.307; Romero P, 2005, GENOME BIOL, V6; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Voet D., 1995, BIOCHEMISTRY; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	16	64	64	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1658	1661		10.1126/science.1224829	http://dx.doi.org/10.1126/science.1224829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019649	Green Accepted			2022-12-28	WOS:000309215400046
J	Paige, SL; Thomas, S; Stoick-Cooper, CL; Wang, H; Maves, L; Sandstrom, R; Pabon, L; Reinecke, H; Pratt, G; Keller, G; Moon, RT; Stamatoyannopoulos, J; Murry, CE				Paige, Sharon L.; Thomas, Sean; Stoick-Cooper, Cristi L.; Wang, Hao; Maves, Lisa; Sandstrom, Richard; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Keller, Gordon; Moon, Randall T.; Stamatoyannopoulos, John; Murry, Charles E.			A Temporal Chromatin Signature in Human Embryonic Stem Cells Identifies Regulators of Cardiac Development	CELL			English	Article							CARDIOVASCULAR PROGENITOR CELLS; DIRECTED DIFFERENTIATION; PLURIPOTENT; METHYLATION; ZEBRAFISH; POLYCOMB; GENES; EXPRESSION; PROMOTERS; MOUSE	Directed differentiation of human embryonic stem cells(ESCs) into cardiovascular cells provides a model for studying molecular mechanisms of human cardiovascular development. Although it is known that chromatin modification patterns in ESCs differ markedly from those in lineage-committed progenitors and differentiated cells, the temporal dynamics of chromatin alterations during differentiation along a defined lineage have not been studied. We show that differentiation of human ESCs into cardiovascular cells is accompanied by programmed temporal alterations in chromatin structure that distinguish key regulators of cardiovascular development from other genes. We used this temporal chromatin signature to identify regulators of cardiac development, including the homeobox gene MEIS2. Using the zebrafish model, we demonstrate that MEIS2 is critical for proper heart tube formation and subsequent cardiac looping. Temporal chromatin signatures should be broadly applicable to other models of stem cell differentiation to identify regulators and provide key insights into major developmental decisions.	[Wang, Hao; Sandstrom, Richard; Moon, Randall T.; Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA; [Paige, Sharon L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Paige, Sharon L.; Stoick-Cooper, Cristi L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Moon, Randall T.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Paige, Sharon L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA; [Stoick-Cooper, Cristi L.] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA; [Stoick-Cooper, Cristi L.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Stamatoyannopoulos, John] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98109 USA; [Thomas, Sean] Gladstone Inst, San Francisco, CA 94158 USA; [Maves, Lisa] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Keller, Gordon] Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON M5G 2C4, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; The J David Gladstone Institutes; Fred Hutchinson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Stamatoyannopoulos, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA.	jstam@u.washington.edu; murry@uw.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Sandstrom, Richard/0000-0002-3356-1547; Pratt, Gabriel/0000-0003-1670-4507; Keller, Gordon/0000-0001-9309-9297	NIH [P01 GM081719, U01 HL100405, P01 HL094374, R01 HL084642, R01 HL64387, R03 AR057477, F30 HL095343]; UW ENCODE Center [U54HG004592];  [R90HG004152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084642, F30HL095343, U01HL100405, R01HL064387, P01HL094374] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, R90HG004152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW ENCODE Center; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Nina Tan, Mark Saiget, James Fugate, Kristen Lee, Rajinder Kaul, and Stanley Kim for technical expertise. This work was supported by NIH grants P01 GM081719, U01 HL100405, P01 HL094374, R01 HL084642, R01 HL64387, R03 AR057477, and UW ENCODE Center (U54HG004592). S.P. was supported through NIH F30 HL095343. H.W. was supported by R90HG004152. R.T.M. is an investigator of the HHMI.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Collas P, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12517; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Maves L, 2009, DEV BIOL, V333, P409, DOI 10.1016/j.ydbio.2009.07.004; Mazzarella L, 2011, BLOOD, V117, P83, DOI 10.1182/blood-2010-03-273128; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minehata K, 2008, BIOCHEM BIOPH RES CO, V374, P647, DOI 10.1016/j.bbrc.2008.07.075; Mobius W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000891; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Rada-Iglesias A, 2011, GENOME MED, V3, DOI 10.1186/gm252; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Takeuchi JK, 2003, DEVELOPMENT, V130, P5953, DOI 10.1242/dev.00797; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zerucha T, 2001, MECH DEVELOP, V102, P247, DOI 10.1016/S0925-4773(01)00299-4	42	240	249	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					221	232		10.1016/j.cell.2012.08.027	http://dx.doi.org/10.1016/j.cell.2012.08.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	22981225	Green Accepted, Bronze			2022-12-28	WOS:000309544200022
J	Duncan, SR				Duncan, Steven R.			PERSPECTIVE Clues, not conclusions	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE		Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Duncan, SR (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	duncsr@upmc.edu						Agusti A, 2003, THORAX, V58, P832, DOI 10.1136/thorax.58.10.832; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935	5	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S15	S15		10.1038/489S15a	http://dx.doi.org/10.1038/489S15a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013710	Bronze			2022-12-28	WOS:000309167100008
J	Bainbridge, D; Martin, J; Arango, M; Cheng, D				Bainbridge, Daniel; Martin, Janet; Arango, Miguel; Cheng, Davy		Evidence-based Peri-operative Clin	Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis	LANCET			English	Article							OPERATIVE MORTALITY; PATIENT SAFETY; SURGERY; MODEL; VOLUME; MYTH	Background The magnitude of risk of death related to surgery and anaesthesia is not well understood. We aimed to assess whether the risk of perioperative and anaesthetic-related mortality has decreased over the past five decades and whether rates of decline have been comparable in developed and developing countries. Methods We did a systematic review to identify all studies published up to February, 2011, in any language, with a sample size of over 3000 that reported perioperative mortality across a mixed surgical population who had undergone general anaesthesia. Using standard forms, two authors independently identified studies for inclusion and extracted information on rates of anaesthetic-related mortality, perioperative mortality, cardiac arrest, American Society of Anesthesiologists (ASA) physical status, geographic location, human development index (HDI), and year. The primary outcome was anaesthetic sole mortality. Secondary outcomes were anaesthetic contributory mortality, total perioperative mortality, and cardiac arrest. Meta-regression was done to ascertain weighted event rates for the outcomes. Findings 87 studies met the inclusion criteria, within which there were more than 21.4 million anaesthetic administrations given to patients undergoing general anaesthesia for surgery. Mortality solely attributable to anaesthesia declined over time, from 357 per million (95% CI 324-394) before the 1970s to 52 per million (42-64) in the 1970s-80s, and 34 per million (29-39) in the 1990s-2000s (p<0.00001). Total perioperative mortality decreased over time, from 10 603 per million (95% CI 10 423-10 784) before the 1970s, to 4533 per million (4405-4664) in the 1970s-80s, and 1176 per million (1148-1205) in the 1990s-2000s (p<0.0001). Meta-regression showed a significant relation between risk of perioperative and anaesthetic-related mortality and HDI (all p<0.00001). Baseline risk status of patients who presented for surgery as shown by the ASA score increased over the decades (p<0.0001). Interpretation Despite increasing patient baseline risk, perioperative mortality has declined significantly over the past 50 years, with the greatest decline in developed countries. Global priority should be given to reducing total perioperative and anaesthetic-related mortality by evidence-based best practice in developing countries.	[Bainbridge, Daniel; Martin, Janet; Arango, Miguel; Cheng, Davy] Univ Western Ontario, Dept Anesthesia & Perioperat Med, London, ON, Canada; [Martin, Janet] Univ Western Ontario, Dept Clin Epidemiol & Biostat, London, ON, Canada	Western University (University of Western Ontario); McMaster University; Western University (University of Western Ontario)	Bainbridge, D (corresponding author), Univ Hosp, London Hlth Sci Ctr, Dept Anesthesia & Perioperat Med, 339 Windermere Rd,Room C3-106, London, ON N6A 5A5, Canada.	daniel.bainbridge@lhsc.on.ca		Martin, Janet/0000-0002-3599-8427; Bainbridge, Daniel/0000-0003-3422-788X	University of Western Ontario; Department of Anesthesia and Perioperative Medicine, University of Western Ontario, London, ON, Canada	University of Western Ontario; Department of Anesthesia and Perioperative Medicine, University of Western Ontario, London, ON, Canada	University of Western Ontario.; Funding support was provided by the Department of Anesthesia and Perioperative Medicine, University of Western Ontario, London, ON, Canada.	[Anonymous], 2010, HUM DEV REP 2010 20; Bickler SW, 2008, LANCET, V372, P90, DOI 10.1016/S0140-6736(08)60924-1; Braz LG, 2009, CLINICS, V64, P999, DOI 10.1590/S1807-59322009001000011; Chu KM, 2010, ARCH SURG-CHICAGO, V145, P721, DOI 10.1001/archsurg.2010.137; Cooper JB, 2002, ANESTHESIOLOGY, V97, P1335, DOI 10.1097/00000542-200212000-00003; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Deshpande JK, 2011, ANESTH ANALG, V112, P1259, DOI 10.1213/ANE.0b013e3182182199; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Gaba DM, 2000, BRIT MED J, V320, P785, DOI 10.1136/bmj.320.7237.785; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ikkersheim DE, 2011, BMJ QUAL SAF, V20, P785, DOI 10.1136/bmjqs.2010.045187; Jacobs DO, 2009, NEW ENGL J MED, V361, P1398, DOI 10.1056/NEJMe0907193; Lagasse RS, 2002, ANESTHESIOLOGY, V97, P1609, DOI 10.1097/00000542-200212000-00038; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; McIntyre T, 2010, ARCH SURG-CHICAGO, V145, P715, DOI 10.1001/archsurg.2010.145; Mellin-Olsen J, 2010, EUR J ANAESTH, V27, P592, DOI 10.1097/EJA.0b013e32833b1adf; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; World Federation of Societies of Anaesthesiologists, 2008, INT STAND SAF PRACT	23	330	343	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1075	1081		10.1016/S0140-6736(12)60990-8	http://dx.doi.org/10.1016/S0140-6736(12)60990-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007VL	22998717				2022-12-28	WOS:000308916400028
J	Balogh, ZJ; Reumann, MK; Gruen, RL; Mayer-Kuckuk, P; Schuetz, MA; Harris, IA; Gabbe, BJ; Bhandari, M				Balogh, Zsolt J.; Reumann, Marie K.; Gruen, Russell L.; Mayer-Kuckuk, Philipp; Schuetz, Michael A.; Harris, Ian A.; Gabbe, Belinda J.; Bhandari, Mohit			Advances and future directions for management of trauma patients with musculoskeletal injuries	LANCET			English	Article							EARLY TOTAL CARE; FEMORAL-SHAFT FRACTURES; LOCKING PLATE FIXATION; MESENCHYMAL STEM-CELLS; PELVIC RING FRACTURES; DAMAGE CONTROL; RANDOMIZED-TRIAL; POLYTRAUMA PATIENTS; MULTIPLE INJURIES; INTERNAL-FIXATION	Musculoskeletal injuries are the most common reason for operative procedures in severely injured patients and are major determinants of functional outcomes. In this paper, we summarise advances and future directions for management of multiply injured patients with major musculoskeletal trauma. Improved understanding of fracture healing has created new possibilities for management of particularly challenging problems, such as delayed union and non union of fractures and large bone defects. Optimum timing of major orthopaedic interventions is guided by increased knowledge about the immune response after injury. Individual treatment should be guided by trading off the benefits of early definitive skeletal stabilisation, and the potentially life-threatening risks of systemic complications such as fat embolism, acute lung injury, and multiple organ failure. New methods for measurement of fracture healing and function and quality of life outcomes pave the way for landmark trials that will guide the future management of musculoskeletal injuries.	[Balogh, Zsolt J.] John Hunter Hosp, Dept Traumatol, Newcastle, NSW 2310, Australia; [Balogh, Zsolt J.] Univ Newcastle, Newcastle, NSW 2310, Australia; [Reumann, Marie K.; Gruen, Russell L.; Gabbe, Belinda J.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3181, Australia; [Mayer-Kuckuk, Philipp] Hosp Special Surg, Bone Cell Biol & Imaging Lab, New York, NY USA; [Schuetz, Michael A.] Queensland Univ Technol, Princess Alexandra Hosp, Brisbane, Qld 4001, Australia; [Harris, Ian A.] Univ New S Wales, S Western Sydney Clin Sch, Dept Orthopaed, Liverpool Hosp, Sydney, NSW 2052, Australia; [Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bhandari, Mohit] McMaster Univ, Dept Surg, Div Orthopaed, Hamilton, ON L8S 4L8, Canada	John Hunter Hospital; University of Newcastle; Florey Institute of Neuroscience & Mental Health; Monash University; Queensland University of Technology (QUT); Liverpool Hospital; University of New South Wales Sydney; Monash University; McMaster University	Balogh, ZJ (corresponding author), John Hunter Hosp, Dept Traumatol, Newcastle, NSW 2310, Australia.	zsolt.balogh@hnehealth.nsw.gov.au	Bhandari, Mohit/AAQ-1675-2021; Balogh, Zsolt/A-2002-2010; Schuetz, Michael/J-1025-2012	Balogh, Zsolt/0000-0002-0277-4822; Schuetz, Michael/0000-0003-2808-0631; Gabbe, Belinda/0000-0001-7096-7688	Smith and Nephew; Stryker; DePuy; Amgen; Eli Lilly; Australian National Health and Medical Research Council	Smith and Nephew; Stryker; DePuy; Amgen(Amgen); Eli Lilly(Eli Lilly); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	MB has received research funding and fees for consultancy from Smith and Nephew, Stryker, DePuy, Amgen, and Eli Lilly. All other authors declare that they have no conflicts of interest.; We thank the Victorian State Trauma Registry and the Victorian Orthopaedic Trauma Outcomes Registry for the original data presented in the introduction and outcomes sections; Susan Liew, Adele Boskey, Jeffrey Rosenfeld, Peter Bragge, and Nerida Butcher for critical reading of the manuscript; Ornella Clavisi, Loretta Piccenna, and Manda Kaled for article searches and retrieval; and Sarah Aird for copy editing the manuscript. RG is supported by a Practitioner Fellowship from the Australian National Health and Medical Research Council.	Arora R, 2011, J BONE JOINT SURG AM, V93A, P2146, DOI 10.2106/JBJS.J.01597; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Balogh Z, 2005, J TRAUMA, V58, P778, DOI 10.1097/01.TA.0000158251.40760.B2; Balogh Z, 2007, J TRAUMA, V63, P1066, DOI 10.1097/TA.0b013e3181589fa4; Balogh Z, 2010, ANZ J SURG, V80, P119, DOI 10.1111/j.1445-2197.2010.05221.x; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bellabarba C, 2010, SPINE, V35, pS138, DOI 10.1097/BRS.0b013e3181d830c1; Betz OB, 2007, GENE THER, V14, P1039, DOI 10.1038/sj.gt.3302956; Bhandari M, 2003, J ORTHOP TRAUMA, V17, P353, DOI 10.1097/00005131-200305000-00006; Bhandari M, 2002, J ORTHOP TRAUMA, V16, P562, DOI 10.1097/00005131-200209000-00004; Bhandari M, 2011, ANN M AM AC ORTH SUR, P387; Bhandari M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-85; Bhandari M, 2008, J BONE JOINT SURG AM, V90A, P2567, DOI 10.2106/JBJS.G.01694; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; Buckley R, 2011, J BONE JOINT SURG BR, V93B, P722, DOI 10.1302/0301-620X.93B6.26322; Burlew CC, 2011, J AM COLL SURGEONS, V212, P628, DOI 10.1016/j.jamcollsurg.2010.12.020; Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023; Chan S, 2007, J BONE JOINT SURG AM, V89A, P1970, DOI 10.2106/JBJS.F.01591; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Corrales LA, 2008, J BONE JOINT SURG AM, V90A, P1862, DOI 10.2106/JBJS.G.01580; Desai KH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001093; Dowrick AS, 2006, J BONE JOINT SURG BR, V88B, P524, DOI 10.1302/0301-620X.88B4; Dutton RP, 2012, BRIT J SURG, V99, P21, DOI 10.1002/bjs.7731; Enders GH, 2009, J CLIN INVEST, V119, P758, DOI 10.1172/JCI38973; Enninghorst N, 2010, J TRAUMA, V68, P935, DOI 10.1097/TA.0b013e3181d27b48; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Gabbe BJ, 2013, ANN SURG, V257, P166, DOI 10.1097/SLA.0b013e31825d7422; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Garratt AN, 2002, BMJ-BRIT MED J, V324, P1417, DOI 10.1136/bmj.324.7351.1417; Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2; Giannoudis PV, 2006, INJURY, V37, pS50, DOI 10.1016/j.injury.2006.08.040; Giannoudis PV, 1999, J BONE JOINT SURG BR, V81B, P356, DOI 10.1302/0301-620X.81B2.8988; Giannoudis PV, 2004, INJURY, V35, P671, DOI 10.1016/j.injury.2004.03.003; Griffin XL, 2012, COCHRANE DB SYST REV, V2; GROGAARD B, 1990, ARCH ORTHOP TRAUM SU, V109, P268, DOI 10.1007/BF00419942; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Guo JJ, 2010, J BONE JOINT SURG BR, V92B, P984, DOI 10.1302/0301-620X.92B7.22959; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Heetveld MJ, 2004, WORLD J SURG, V28, P904, DOI 10.1007/s00268-004-7357-9; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Joslin CC, 2008, CLIN BIOMECH, V23, P329, DOI 10.1016/j.clinbiomech.2007.09.013; Kooistra BW, 2010, J ORTHOP TRAUMA, V24, pS81, DOI 10.1097/BOT.0b013e3181ca3fd1; Li XD, 2011, J BONE MINER RES, V26, P2610, DOI 10.1002/jbmr.472; Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z; Lochner HV, 2001, J BONE JOINT SURG AM, V83A, P1650, DOI 10.2106/00004623-200111000-00005; Lyons RA, 2010, INT J INJ CONTROL SA, V17, P145, DOI 10.1080/17457300903453104; Madanat R, 2006, SCAND J SURG, V95, P119, DOI 10.1177/145749690609500207; Malviya A, 2011, INJURY, V42, P1368, DOI 10.1016/j.injury.2011.06.198; Mauffrey C, 2012, J BONE JOINT SURG BR, V94B, P704, DOI 10.1302/0301-620X.94B5.28498; Mckee MD, 2009, J SHOULDER ELB SURG, V18, P3, DOI 10.1016/j.jse.2008.06.005; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Morley JR, 2008, J BONE JOINT SURG BR, V90B, P393, DOI 10.1302/0301-620X.90B3.19688; Morshed S, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.G.01556; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nicholas B, 2011, ANZ J SURG, V81, P148, DOI 10.1111/j.1445-2197.2010.05582.x; Nikolaou VS, 2009, INJURY, V40, P663, DOI 10.1016/j.injury.2008.10.035; O'Toole RV, 2009, J ORTHOP TRAUMA, V23, P716, DOI 10.1097/BOT.0b013e3181ab2c90; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; PANJABI MM, 1985, J ORTHOP RES, V3, P212, DOI 10.1002/jor.1100030211; Pape HC, 2007, ANN SURG, V246, P491, DOI 10.1097/SLA.0b013e3181485750; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Pape HC, 2009, J AM ACAD ORTHOP SUR, V17, P541, DOI 10.5435/00124635-200909000-00001; Pape HC, 2003, J TRAUMA, V55, P7, DOI 10.1097/01.TA.0000075787.69695.4E; Pape HC, 2002, J TRAUMA, V53, P452, DOI 10.1097/00005373-200209000-00010; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Recknagel S, 2012, J ORTHOP RES, V30, P581, DOI 10.1002/jor.21561; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050; Reumann MK, 2010, J APPL PHYSIOL, V109, P1930, DOI 10.1152/japplphysiol.00839.2010; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Russell N, 2009, EUR J ORTHOP SURG TR, V19, P75, DOI 10.1007/s00590-008-0372-z; Scalea TM, 2000, J TRAUMA, V48, P613, DOI 10.1097/00005373-200004000-00006; Schenker ML, 2012, J BONE JOINT SURG AM, V94A, P1057, DOI 10.2106/JBJS.K.00582; Sibai T, 2011, CLIN ORTHOP RELAT R, V469, P2215, DOI 10.1007/s11999-010-1722-9; Smith TO, 2009, INJURY, V40, P1049, DOI 10.1016/j.injury.2009.01.005; Tagil M, 2010, BONE, V46, P852, DOI 10.1016/j.bone.2009.11.009; Tan SLE, 2009, INJURY, V40, P683, DOI 10.1016/j.injury.2009.01.003; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Vallier HA, 2011, J ORTHOP TRAUMA, V25, P736, DOI 10.1097/BOT.0b013e318213f709; Wehling P, 2009, HUM GENE THER, V20, P97, DOI 10.1089/hum.2008.075; WHO, 2001, WHO INT CLASS FUNCT; WOODRUFF MA, 2010, LOGIC CIRCUITS CARBO, V35, P1217, DOI DOI 10.1016/J.PROGPOLYMSCI.2010.04.002; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou F, 2012, J ORTHOP TRAUMA, V26, P155, DOI 10.1097/BOT.0b013e318225f793	90	79	86	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1109	1119		10.1016/S0140-6736(12)60991-X	http://dx.doi.org/10.1016/S0140-6736(12)60991-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007VL	22998720				2022-12-28	WOS:000308916400032
J	Kaelin, CB; Xu, X; Hong, LZ; David, VA; McGowan, KA; Schmidt-Kuntzel, A; Roelke, ME; Pino, J; Pontius, J; Cooper, GM; Manuel, H; Swanson, WF; Marker, L; Harper, CK; van Dyk, A; Yue, BS; Mullikin, JC; Warren, WC; Eizirik, E; Kos, L; O'Brien, SJ; Barsh, GS; Menotti-Raymond, M				Kaelin, Christopher B.; Xu, Xiao; Hong, Lewis Z.; David, Victor A.; McGowan, Kelly A.; Schmidt-Kuentzel, Anne; Roelke, Melody E.; Pino, Javier; Pontius, Joan; Cooper, Gregory M.; Manuel, Hermogenes; Swanson, William F.; Marker, Laurie; Harper, Cindy K.; van Dyk, Ann; Yue, Bisong; Mullikin, James C.; Warren, Wesley C.; Eizirik, Eduardo; Kos, Lidia; O'Brien, Stephen J.; Barsh, Gregory S.; Menotti-Raymond, Marilyn			Specifying and Sustaining Pigmentation Patterns in Domestic and Wild Cats	SCIENCE			English	Article							COAT COLOR; SKIN COLOR; EXPRESSION; GENETICS; FAMILY; MODEL	Color markings among felid species display both a remarkable diversity and a common underlying periodicity. A similar range of patterns in domestic cats suggests a conserved mechanism whose appearance can be altered by selection. We identified the gene responsible for tabby pattern variation in domestic cats as Transmembrane aminopeptidase Q (Taqpep), which encodes a membrane-bound metalloprotease. Analyzing 31 other felid species, we identified Taqpep as the cause of the rare king cheetah phenotype, in which spots coalesce into blotches and stripes. Histologic, genomic expression, and transgenic mouse studies indicate that paracrine expression of Endothelin3 (Edn3) coordinates localized color differences. We propose a two-stage model in which Taqpep helps to establish a periodic pre-pattern during skin development that is later implemented by differential expression of Edn3.	[Kaelin, Christopher B.; Cooper, Gregory M.; Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Kaelin, Christopher B.; Hong, Lewis Z.; McGowan, Kelly A.; Manuel, Hermogenes; Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Xu, Xiao; David, Victor A.; Schmidt-Kuentzel, Anne; Roelke, Melody E.; Pino, Javier; O'Brien, Stephen J.; Menotti-Raymond, Marilyn] Frederick Natl Lab Canc Res, Lab Genom Divers, Frederick, MD 21702 USA; [Xu, Xiao; Yue, Bisong] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Sichuan, Peoples R China; [Schmidt-Kuentzel, Anne; Marker, Laurie] Cheetah Conservat Fund, Otjiwarongo, Namibia; [Roelke, Melody E.; Pontius, Joan] Frederick Natl Lab Canc Res, SAIC Frederick, Frederick, MD 21702 USA; [Pino, Javier; Kos, Lidia] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Swanson, William F.] Cincinnati Zoo & Bot Garden, Ctr Conservat & Res Endangered Wildlife, Cincinnati, OH 45220 USA; [Harper, Cindy K.] Univ Pretoria, Fac Vet Sci Onderstepoort, Vet Genet Lab, ZA-0002 Pretoria, South Africa; [van Dyk, Ann] Ann van Dyk Cheetah Ctr, De Wildt, South Africa; [Mullikin, James C.] NHGRI, Comparat Genom Unit, NIH, Rockville, MD 20892 USA; [Warren, Wesley C.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Eizirik, Eduardo] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, BR-90619900 Porto Alegre, RS, Brazil; [Eizirik, Eduardo] Inst Pro Carnivoros, Atibaia, Brazil	HudsonAlpha Institute for Biotechnology; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sichuan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; State University System of Florida; Florida International University; University of Pretoria; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Pontificia Universidade Catolica Do Rio Grande Do Sul	O'Brien, SJ (corresponding author), St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Informat, St Petersburg, Russia.	lgdchief@gmail.com; gbarsh@hudsonalpha.org	Eizirik, Eduardo/K-8034-2012; David, Victor A/I-9330-2012; OBRIEN, STEPHEN/ABD-1346-2020	Eizirik, Eduardo/0000-0002-9658-0999; OBRIEN, STEPHEN/0000-0001-7857-0757; O'Brien, Stephen J./0000-0001-7353-8301; Yue, Bisong/0000-0001-6731-538X	Wild Cat Education and Conservation Fund; HudsonAlpha Institute for Biotechnology; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; federal funds [N01-CO-12400]; Genentech; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, U54HG003079] Funding Source: NIH RePORTER	Wild Cat Education and Conservation Fund; HudsonAlpha Institute for Biotechnology; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); federal funds; Genentech(Roche HoldingGenentech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank San Jose Animal Care and Services, Fix Our Ferals, the Berkeley East-Bay Humane Society, Pets In Need, the Monterey Animal Hospital, and the City of Huntsville Animal Shelter for assistance with sample collection; the Wild Cat Education and Conservation Fund for contributing king cheetah samples; R. Finn for assistance with Norwegian Forest Cat samples and phenotypes; H. Flick for domestic cat photographs; and J. C. Kaelin for help with feral cat sample collection. We thank the Production Sequencing Group of the Washington University School of Medicine Genome Center for cDNA sequencing. Namibian samples were collected with the approval of the Ministry of Environment and Tourism (permit 1532). Supported in part by the HudsonAlpha Institute for Biotechnology and by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, using federal funds under contract N01-CO-12400. L.Z.H. and J.P. were supported by fellowships from Genentech and the National Institutes of Health, respectively. A.vD. is the founder and director of the Ann van Dyk Cheetah Centre, a nonprofit conservation organization. DNA sequence data for this study are available at http://genome.wustl.edu/genomes/view/felis_catus/ and the NIH Short Read Archive (SRA056885).	April CS, 2006, PIGM CELL RES, V19, P194, DOI 10.1111/j.1600-0749.2006.00305.x; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Eizirik E, 2010, GENETICS, V184, P267, DOI 10.1534/genetics.109.109629; Garcia RJ, 2008, J INVEST DERMATOL, V128, P131, DOI 10.1038/sj.jid.5700948; Hong LZ, 2011, GENOME RES, V21, P1905, DOI 10.1101/gr.122135.111; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; KOBAYASHI T, 1995, J CELL SCI, V108, P2301; LOMAX TD, 1988, J HERED, V79, P21, DOI 10.1093/oxfordjournals.jhered.a110438; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Peterschmitt M, 2009, ANIM GENET, V40, P547, DOI 10.1111/j.1365-2052.2009.01864.x; Pocock R. I., 1927, P ZOOL SOC LOND, V97, P245; Searle A.G., 1968, COMP GENETICS COAT C; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Van Raamsdonk CD, 2009, PIGM CELL MELANOMA R, V22, P819, DOI 10.1111/j.1755-148X.2009.00609.x; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; VANAARDE RJ, 1986, J ZOOL, V209, P573, DOI 10.1111/j.1469-7998.1986.tb03612.x; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757	21	82	96	11	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1536	1541		10.1126/science.1220893	http://dx.doi.org/10.1126/science.1220893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997338	Green Accepted, Green Submitted			2022-12-28	WOS:000308912900051
J	Farrell, L				Farrell, Liam			House call	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 19	2012	345								e6069	10.1136/bmj.e6069	http://dx.doi.org/10.1136/bmj.e6069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JI	22993394				2022-12-28	WOS:000309160500009
J	McCartney, M				McCartney, Margaret			Cosmetic approval	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2009, OFFICIAL J EUROPEA L, V342, P59; Aveda, FAQ; Church and Dwight, FEMFRESH DAILY INTIM; Johnson and Johnson, JOHNS BAB OIL; Unilever, PERSL NONB	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6046	10.1136/bmj.e6046	http://dx.doi.org/10.1136/bmj.e6046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BZ	22983532				2022-12-28	WOS:000308865100002
J	Li, MQ; Kao, E; Gao, X; Sandig, H; Limmer, K; Pavon-Eternod, M; Jones, TE; Landry, S; Pan, T; Weitzman, MD; David, M				Li, Manqing; Kao, Elaine; Gao, Xia; Sandig, Hilary; Limmer, Kirsten; Pavon-Eternod, Mariana; Jones, Thomas E.; Landry, Sebastien; Pan, Tao; Weitzman, Matthew D.; David, Michael			Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11	NATURE			English	Article							INFLUENZA-A VIRUS; EXPORT PATHWAY; NUCLEAR EXPORT; MESSENGER-RNA; GENE; BIAS; IMMUNODEFICIENCY; ACTIVATION; EXPRESSION; SELECTION	In mammals, one of the most pronounced consequences of viral infection is the induction of type I interferons, cytokines with potent antiviral activity. Schlafen (Slfn) genes are a subset of interferon-stimulated early response genes (ISGs) that are also induced directly by pathogens via the interferon regulatory factor 3 (IRF3) pathway(1). However, many ISGs are of unknown or incompletely understood function. Here we show that human SLFN11 potently and specifically abrogates the production of retroviruses such as human immunodeficiency virus 1 (HIV-1). Our study revealed that SLFN11 has no effect on the early steps of the retroviral infection cycle, including reverse transcription, integration and transcription. Rather, SLFN11 acts at the late stage of virus production by selectively inhibiting the expression of viral proteins in a codon-usage-dependent manner. We further find that SLFN11 binds transfer RNA, and counteracts changes in the tRNA pool elicited by the presence of HIV. Our studies identified a novel antiviral mechanism within the innate immune response, in which SLFN11 selectively inhibits viral protein synthesis in HIV-infected cells by means of codon-bias discrimination.	[Li, Manqing; Kao, Elaine; Gao, Xia; Sandig, Hilary; Limmer, Kirsten; David, Michael] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Pavon-Eternod, Mariana; Jones, Thomas E.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Landry, Sebastien; Weitzman, Matthew D.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [David, Michael] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Chicago; Salk Institute; University of California System; University of California San Diego	David, M (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	midavid@ucsd.edu		Li, Manqing/0000-0002-7593-7979	NIH [AI81019, AI074967, P01AI090935, R01GM101982, R21AI088490, P30AI36214]; HINT Program [NIH P01AI090935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI090935, P30AI036214, R01AI074967, R21AI081019, R21AI088490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HINT Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Smith for help with the HIV replication studies; M. Wood for performing the electron microscope analysis; D. Xu and D.-Y. Song for technical assistance; and J. Young, J. Guatelli, D. Smith, M. Kaul and S. Chanda for discussion. This work was supported in part by NIH AI81019 and AI074967 to M. D. W., NIH P01AI090935, R01GM101982 and R21AI088490 to M. D., and by resources from the UCSD Center for AIDS Research, NIH P30AI36214, and the HINT Program, NIH P01AI090935. The authors declare no competing financial interests.	Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705; COCCIA EM, 1994, J BIOL CHEM, V269, P23087; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Forsberg R, 2003, MOL BIOL EVOL, V20, P1252, DOI 10.1093/molbev/msg149; Frelin L, 2004, GENE THER, V11, P522, DOI 10.1038/sj.gt.3302184; Fritz CC, 1996, CURR BIOL, V6, P848, DOI 10.1016/S0960-9822(02)00608-5; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; GRANTHAM R, 1986, NATURE, V319, P727, DOI 10.1038/319727b0; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Kofman Alexander, 2003, Tsitologiia, V45, P86; KYPR J, 1987, NATURE, V327, P20, DOI 10.1038/327020a0; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Meintjes Peter L., 2005, Journal of Bioinformatics and Computational Biology, V3, P157, DOI 10.1142/S0219720005000953; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhou T, 2005, BIOSYSTEMS, V81, P77, DOI 10.1016/j.biosystems.2005.03.002	28	212	221	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					125	U145		10.1038/nature11433	http://dx.doi.org/10.1038/nature11433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23000900	Green Accepted			2022-12-28	WOS:000310434500043
J	Sugihara, G; May, R; Ye, H; Hsieh, CH; Deyle, E; Fogarty, M; Munch, S				Sugihara, George; May, Robert; Ye, Hao; Hsieh, Chih-hao; Deyle, Ethan; Fogarty, Michael; Munch, Stephan			Detecting Causality in Complex Ecosystems	SCIENCE			English	Article							SARDINE SARDINOPS-SAGAX; PACIFIC SARDINE; ANCHOVY POPULATIONS; TIME-SERIES; FLUCTUATIONS; DYNAMICS; CHAOS; SYSTEMS	Identifying causal networks is important for effective policy and management recommendations on climate, epidemiology, financial regulation, and much else. We introduce a method, based on nonlinear state space reconstruction, that can distinguish causality from correlation. It extends to nonseparable weakly connected dynamic systems (cases not covered by the current Granger causality paradigm). The approach is illustrated both by simple models (where, in contrast to the real world, we know the underlying equations/relations and so can check the validity of our method) and by application to real ecological systems, including the controversial sardine-anchovy-temperature problem.	[Sugihara, George; Ye, Hao; Deyle, Ethan] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [May, Robert] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei 106, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 106, Taiwan; [Fogarty, Michael] NOAA, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA; [Munch, Stephan] NOAA, SW Fisheries Sci Ctr, Santa Cruz, CA 95060 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Oxford; National Taiwan University; National Taiwan University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu; chsieh@ntu.edu.tw	Deyle, Ethan R/AAR-8749-2021; Hsieh, Chih-hao/B-3797-2008; Ye, Hao/HGD-5399-2022	Hsieh, Chih-hao/0000-0001-5935-7272; Ye, Hao/0000-0002-8630-1458	NSF [DEB-1020372]; NSF/NOAA CAMEO Award [NA08OAR4320894]; McQuown Chair in Natural Science; Sugihara Family Trust; National Taiwan University; National Science Council of Taiwan; NSF graduate research fellowships; EPA STAR graduate fellowship	NSF(National Science Foundation (NSF)); NSF/NOAA CAMEO Award; McQuown Chair in Natural Science; Sugihara Family Trust; National Taiwan University(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NSF graduate research fellowships(National Science Foundation (NSF)); EPA STAR graduate fellowship(United States Environmental Protection Agency)	We thank S. Sandin, L. Kaufman, A. MacCall, J. Melack, J. Schnute, L. Richards, A. Rosenberg, M. Kumagai, H. Liu, I. Altman, B. Fissel, S. Glaser, B. Carr, E. Klein, L. Storch, S. Kealhofer, M. Kogler, and C. Perretti for their comments and assistance with this work, and P. Sugihara for developing and producing the initial animations for movies S1 and S2. Supported by NSF grant DEB-1020372, NSF/NOAA CAMEO Award NA08OAR4320894, the McQuown Chair in Natural Science, the Sugihara Family Trust, and Quantitative Advisors (http://qadvisors.com) (G. S.); National Taiwan University and the National Science Council of Taiwan (C. H.); NSF graduate research fellowships (H.Y. and E. D.); and an EPA STAR graduate fellowship (E.D.).	ASCIOTI FA, 1993, J PLANKTON RES, V15, P603, DOI 10.1093/plankt/15.6.603; BAUMGARTNER TR, 1992, CAL COOP OCEAN FISH, V33, P24; Berkeley G., 1710, TREATISE PRINCIPLES; Bischi G. I., 2010, NONLINEAR DYNAMICS E; BROCK WA, 1988, J MONETARY ECON, V22, P71, DOI 10.1016/0304-3932(88)90170-5; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Committee on Major U. S. Oceanographic Research Programs, 1999, GLOB OC SCI INT APPR; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; JACOBSON LD, 1995, CAN J FISH AQUAT SCI, V52, P566, DOI 10.1139/f95-057; Josic K, 2000, NONLINEARITY, V13, P1321, DOI 10.1088/0951-7715/13/4/318; Lasker R., 1983, P JOINT OC ASS 1982, P110; LLOYD AL, 1995, J THEOR BIOL, V173, P217, DOI 10.1006/jtbi.1995.0058; Lo TT, 2010, ATMOS SCI LETT, V11, P210, DOI 10.1002/asl.275; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McClatchie S, 2010, CAN J FISH AQUAT SCI, V67, P1782, DOI 10.1139/F10-101; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Murphy G. I., 1964, MIN M MAR RES COMM, V7, P1; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Patil DAS, 2001, MON WEATHER REV, V129, P2116, DOI 10.1175/1520-0493(2001)129<2116:ILDNBI>2.0.CO;2; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; Veilleux B. G., 1976, THESIS U ALBERTA; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387	30	1025	1055	62	684	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					496	500		10.1126/science.1227079	http://dx.doi.org/10.1126/science.1227079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	22997134				2022-12-28	WOS:000310195800049
J	Jin, MS; Oldham, ML; Zhang, QJ; Chen, J				Jin, Mi Sun; Oldham, Michael L.; Zhang, Qiuju; Chen, Jue			Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans	NATURE			English	Article							DRUG-BINDING POCKET; ATPASE ACTIVITY; ALTERNATING ACCESS; NUCLEOTIDE-BINDING; MEMBRANE; RESISTANCE; MUTATIONS; MUTANTS; CELLS; PURIFICATION	P-glycoprotein (P-gp) is an ATP-binding cassette transporter that confers multidrug resistance in cancer cells(1,2). It also affects the absorption, distribution and clearance of cancer-unrelated drugs and xenobiotics. For these reasons, the structure and function of P-gp have been studied extensively for decades(3). Here we present biochemical characterization of P-gp from Caenorhabditis elegans and its crystal structure at a resolution of 3.4 angstroms. We find that the apparent affinities of P-gp for anticancer drugs actinomycin D and paclitaxel are approximately 4,000 and 100 times higher, respectively, in the membrane bilayer than in detergent. This affinity enhancement highlights the importance of membrane partitioning when a drug accesses the transporter in the membrane(4). Furthermore, the transporter in the crystal structure opens its drug pathway at the level of the membrane's inner leaflet. In the helices flanking the opening to the membrane, we observe extended loops that may mediate drug binding, function as hinges to gate the pathway or both. We also find that the interface between the transmembrane and nucleotide-binding domains, which couples ATP hydrolysis to transport, contains a ball-and-socket joint and salt bridges similar to the ATP-binding cassette importers(5), suggesting that ATP-binding cassette exporters and importers may use similar mechanisms to achieve alternating access for transport. Finally, a model of human P-gp derived from the structure of C. elegans P-gp not only is compatible with decades of biochemical analysis(6-12), but also helps to explain perplexing functional data regarding the Phe335Ala mutant(13,14). These results increase our understanding of the structure and function of this important molecule.	[Jin, Mi Sun; Chen, Jue] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Oldham, Michael L.; Zhang, Qiuju; Chen, Jue] Howard Hughes Med Inst, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Howard Hughes Medical Institute	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu	zhang, qiu/GXG-5600-2022		Howard Hughes Medical Institute; Purdue Center for Cancer Research [NCI CCSG CA23168]; National Research Foundation of Korea; International Human Frontier Science Program; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Purdue Center for Cancer Research; National Research Foundation of Korea(National Research Foundation of Korea); International Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the beamline staff of the GM/CA CAT at the Advanced Photon System for assistance with data collection, Y.-K. Cho for assistance with protein purification and A. Davidson for comments on the manuscript. We also thank the MacKinnon laboratory for reagents and advice on the P. pastoris expression system. This work was supported by Howard Hughes Medical Institute (J.C.), Purdue Center for Cancer Research (NCI CCSG CA23168), and postdoctoral fellowships from the National Research Foundation of Korea and the International Human Frontier Science Program (M.S.J.).	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARRIGOS M, 1993, BIOCHEM BIOPH RES CO, V196, P1034, DOI 10.1006/bbrc.1993.2355; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; HAMADA H, 1988, J BIOL CHEM, V263, P1454; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kim IW, 2008, MINI-REV MED CHEM, V8, P193; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2005, BIOCHEM BIOPH RES CO, V329, P419, DOI 10.1016/j.bbrc.2005.01.134; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1993, J BIOL CHEM, V268, P19965; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	35	366	374	2	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					566	+		10.1038/nature11448	http://dx.doi.org/10.1038/nature11448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23000902	Green Accepted			2022-12-28	WOS:000310196200048
J	Freeman, MF; Gurgui, C; Helf, MJ; Morinaka, BI; Uria, AR; Oldham, NJ; Sahl, HG; Matsunaga, S; Piel, J				Freeman, Michael F.; Gurgui, Cristian; Helf, Maximilian J.; Morinaka, Brandon I.; Uria, Agustinus R.; Oldham, Neil J.; Sahl, Hans-Georg; Matsunaga, Shigeki; Piel, Joern			Metagenome Mining Reveals Polytheonamides as Posttranslationally Modified Ribosomal Peptides	SCIENCE			English	Article							MARINE SPONGE; ANTIMICROBIAL PEPTIDE; BACTERIAL SYMBIONT; GENE-CLUSTER; RADICAL SAM; BIOSYNTHESIS; SUPERFAMILY; FAMILY; ACIDS	It is held as a paradigm that ribosomally synthesized peptides and proteins contain only L-amino acids. We demonstrate a ribosomal origin of the marine sponge-derived polytheonamides, exceptionally potent, giant natural-product toxins. Isolation of the biosynthetic genes from the sponge metagenome revealed a bacterial gene architecture. Only six candidate enzymes were identified for 48 posttranslational modifications, including 18 epimerizations and 17 methylations of nonactivated carbon centers. Three enzymes were functionally validated, which showed that a radical S-adenosylmethionine enzyme is responsible for the unidirectional epimerization of multiple and different amino acids. Collectively, these complex alterations create toxins that function as unimolecular minimalistic ion channels with near-femtomolar activity. This study broadens the biosynthetic scope of ribosomal systems and creates new opportunities for peptide and protein bioengineering.	[Freeman, Michael F.; Gurgui, Cristian; Helf, Maximilian J.; Morinaka, Brandon I.; Uria, Agustinus R.; Piel, Joern] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; [Oldham, Neil J.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; [Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-53115 Bonn, Germany; [Matsunaga, Shigeki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Piel, Joern] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	University of Bonn; University of Nottingham; University of Bonn; University of Tokyo; Swiss Federal Institutes of Technology Domain; ETH Zurich	Piel, J (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	joern.piel@uni-bonn.de	Freeman, Michael/AIA-1555-2022	Freeman, Michael/0000-0002-0491-9618; Uria, Agustinus R./0000-0002-9223-7464; Oldham, Neil/0000-0001-8024-4563; Morinaka, Brandon/0000-0001-8239-619X; Helf, Maximilian/0000-0002-1393-3999	German Federal Ministry of Education and Research (BMBF) [GenBioCom: 0315581I]; Deutsche Forschungsgemeinschaft [PI 430/8-1, PI 430/9-1, FOR 854, SFB 813]; Japan Society for the Promotion of Science; German Academic Exchange Service (DAAD); Humboldt Foundation; Human Frontier Science Program	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Humboldt Foundation(Alexander von Humboldt Foundation); Human Frontier Science Program(Human Frontier Science Program)	We thank M. Josten for antibiotic activity testing, M. Engeser and C. Sondag for MALDI measurements, A. Schneider for high-performance liquid chromatography measurements, U. Deppenmeier and P. Schweiger for Western blot analysis, and T. Gulder for comments on the manuscript. This work was supported by grants from the German Federal Ministry of Education and Research (BMBF) (GenBioCom: 0315581I) to J.P., the Deutsche Forschungsgemeinschaft to J.P. (PI 430/8-1, PI 430/9-1, FOR 854, SFB 813) and H.-G. S. (FOR 854), the Japan Society for the Promotion of Science to J.P. and S. M., and fellowships by the German Academic Exchange Service (DAAD) to A. R. U., the Humboldt Foundation to B. I. M., and the Human Frontier Science Program to M. F. F. The data reported in this paper are reported in the supplementary materials and archived in GenBank under accession no. JX456532. J.P., C. G., M. F. F., A. R. U., and M.J.H. are inventors on European Patent Application no. 11 180 107.2. filed by Rheinische Friedrich-Wilhelms-Universitat Bonn through PROvendis GmbH titled "Biosynthetic gene cluster for the production of peptide-protein analogs."	Claesen J, 2010, P NATL ACAD SCI USA, V107, P16297, DOI 10.1073/pnas.1008608107; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Hamada T, 2005, J AM CHEM SOC, V127, P110, DOI 10.1021/ja045749e; Hamada T, 2010, J AM CHEM SOC, V132, P12941, DOI 10.1021/ja104616z; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Inoue M, 2010, NAT CHEM, V2, P280, DOI [10.1038/nchem.554, 10.1038/NCHEM.554]; Iwamoto M, 2010, FEBS LETT, V584, P3995, DOI 10.1016/j.febslet.2010.08.007; Jilek A, 2008, MONATSH CHEM, V139, P1, DOI 10.1007/s00706-007-0780-5; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kusebauch B, 2009, ANGEW CHEM INT EDIT, V48, P5001, DOI 10.1002/anie.200900277; Long PF, 2005, CHEMBIOCHEM, V6, P1760, DOI 10.1002/cbic.200500210; MATSUNAGA S, 1984, TETRAHEDRON LETT, V25, P5165, DOI 10.1016/S0040-4039(01)81553-7; Matsuoka S, 2011, ANGEW CHEM, V123, P4981; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Murphy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020852; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Shen GZ, 2008, J BACTERIOL, V190, P4808, DOI 10.1128/JB.00436-08; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Ueoka R, 2010, J AM CHEM SOC, V132, P17692, DOI 10.1021/ja109275z; Velasquez JE, 2011, CHEM BIOL, V18, P857, DOI 10.1016/j.chembiol.2011.05.007; You YO, 2007, BIOCHEMISTRY-US, V46, P5991, DOI 10.1021/bi602663x; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	30	222	224	3	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					387	390		10.1126/science.1226121	http://dx.doi.org/10.1126/science.1226121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22983711				2022-12-28	WOS:000309955800042
J	Rowe, JH; Ertelt, JM; Xin, LJ; Way, SS				Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing			Pregnancy imprints regulatory memory that sustains anergy to fetal antigen	NATURE			English	Article							T-CELLS; FOXP3(+); PREECLAMPSIA; EXPRESSION; TOLERANCE; EXPANSION; SELECTION; SYSTEM	Pregnancy is an intricately orchestrated process where immune effector cells with fetal specificity are selectively silenced. This requires the sustained expansion of immune-suppressive maternal FOXP3(+) regulatory T cells (T-reg cells), because even transient partial ablation triggers fetal-specific effector T-cell activation and pregnancy loss(1,2). In turn, many idiopathic pregnancy complications proposed to originate from disrupted fetal tolerance are associated with blunted maternal T-reg expansion(3-5). Importantly, however, the antigen specificity and cellular origin of maternal Treg cells that accumulate during gestation remain incompletely defined. Here we show that pregnancy selectively stimulates the accumulation of maternal FOXP3(+) CD4 cells with fetal specificity using tetramer-based enrichment that allows the identification of rare endogenous T cells(6). Interestingly, after delivery, fetal-specific T-reg cells persist at elevated levels, maintain tolerance to pre-existing fetal antigen, and rapidly re-accumulate during subsequent pregnancy. The accelerated expansion of T-reg cells during secondary pregnancy was driven almost exclusively by proliferation of fetal-specific FOXP3(+) cells retained from prior pregnancy, whereas induced FOXP3 expression and proliferation of pre-existing FOXP3(+) cells each contribute to T-reg expansion during primary pregnancy. Furthermore, fetal resorption in secondary compared with primary pregnancy becomes more resilient to partial maternal FOXP3(+) cell ablation. Thus, pregnancy imprints FOXP3(+) CD4 cells that sustain protective regulatory memory to fetal antigen. We anticipate that these findings will spark further investigation on maternal regulatory T-cell specificity that unlocks new strategies for improving pregnancy outcomes and novel approaches for therapeutically exploiting T-reg cell memory.	[Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Ctr Immunol,Dept Pediat, Minneapolis, MN 55455 USA; [Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Ctr Immunol,Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Way, SS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	singsing.way@cchmc.org		Way, Sing Sing/0000-0001-8948-1952	NIH-NIAID [R01AI087830, R01AI100934]; NIH-NIDDK [F30DK084674]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087830, R01AI100934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084674] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Jenkins for providing 2W1S-expressing mice, and A. Rudensky for providing Foxp3<SUP>DTR</SUP> mice. This research was supported by NIH-NIAID awards R01AI087830 and R01AI100934 (S.S.W.), and NIH-NIDDK award F30DK084674 (J.H.R.). S.S.W. holds an Investigator in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Prins JR, 2009, HYPERTENS PREGNANCY, V28, P300, DOI 10.1080/10641950802601237; Robertson SA, 2010, J REPROD IMMUNOL, V85, P51, DOI 10.1016/j.jri.2010.01.008; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; WIRTH R, 1986, J BACTERIOL, V165, P831, DOI 10.1128/jb.165.3.831-836.1986	34	340	349	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					102	U119		10.1038/nature11462	http://dx.doi.org/10.1038/nature11462			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23023128	Green Accepted			2022-12-28	WOS:000309446800041
J	Zhang, GF; Fang, XD; Guo, XM; Li, L; Luo, RB; Xu, F; Yang, PC; Zhang, LL; Wang, XT; Qi, HG; Xiong, ZQ; Que, HY; Xie, YL; Holland, PWH; Paps, J; Zhu, YB; Wu, FC; Chen, YX; Wang, JF; Peng, CF; Meng, J; Yang, L; Liu, J; Wen, B; Zhang, N; Huang, ZY; Zhu, QH; Feng, Y; Mount, A; Hedgecock, D; Xu, Z; Liu, YJ; Domazet-Loso, T; Du, YS; Sun, XQ; Zhang, SD; Liu, BH; Cheng, PZ; Jiang, XT; Li, J; Fan, DD; Wang, W; Fu, WJ; Wang, T; Wang, B; Zhang, JB; Peng, ZY; Li, YX; Li, N; Wang, JP; Chen, MS; He, Y; Tan, FJ; Song, XR; Zheng, QM; Huang, RL; Yang, HL; Du, XD; Chen, L; Yang, M; Gaffney, PM; Wang, S; Luo, LH; She, ZC; Ming, Y; Huang, W; Zhang, S; Huang, BY; Zhang, Y; Qu, T; Ni, PX; Miao, GY; Wang, JY; Wang, Q; Steinberg, CEW; Wang, HY; Li, N; Qian, LM; Zhang, GJ; Li, YR; Yang, HM; Liu, X; Wang, J; Yin, Y; Wang, J				Zhang, Guofan; Fang, Xiaodong; Guo, Ximing; Li, Li; Luo, Ruibang; Xu, Fei; Yang, Pengcheng; Zhang, Linlin; Wang, Xiaotong; Qi, Haigang; Xiong, Zhiqiang; Que, Huayong; Xie, Yinlong; Holland, Peter W. H.; Paps, Jordi; Zhu, Yabing; Wu, Fucun; Chen, Yuanxin; Wang, Jiafeng; Peng, Chunfang; Meng, Jie; Yang, Lan; Liu, Jun; Wen, Bo; Zhang, Na; Huang, Zhiyong; Zhu, Qihui; Feng, Yue; Mount, Andrew; Hedgecock, Dennis; Xu, Zhe; Liu, Yunjie; Domazet-Loso, Tomislav; Du, Yishuai; Sun, Xiaoqing; Zhang, Shoudu; Liu, Binghang; Cheng, Peizhou; Jiang, Xuanting; Li, Juan; Fan, Dingding; Wang, Wei; Fu, Wenjing; Wang, Tong; Wang, Bo; Zhang, Jibiao; Peng, Zhiyu; Li, Yingxiang; Li, Na; Wang, Jinpeng; Chen, Maoshan; He, Yan; Tan, Fengji; Song, Xiaorui; Zheng, Qiumei; Huang, Ronglian; Yang, Hailong; Du, Xuedi; Chen, Li; Yang, Mei; Gaffney, Patrick M.; Wang, Shan; Luo, Longhai; She, Zhicai; Ming, Yao; Huang, Wen; Zhang, Shu; Huang, Baoyu; Zhang, Yong; Qu, Tao; Ni, Peixiang; Miao, Guoying; Wang, Junyi; Wang, Qiang; Steinberg, Christian E. W.; Wang, Haiyan; Li, Ning; Qian, Lumin; Zhang, Guojie; Li, Yingrui; Yang, Huanming; Liu, Xiao; Wang, Jian; Yin, Ye; Wang, Jun			The oyster genome reveals stress adaptation and complexity of shell formation	NATURE			English	Article							TRANSPOSABLE ELEMENTS; CRASSOSTREA-GIGAS; BIVALVE MOLLUSKS; PARAHOX GENES; PROTEINS; SEQUENCE; EVOLUTION; DISCOVERY; APOPTOSIS; PATHWAY	The Pacific oyster Crassostrea gigas belongs to one of the most species-rich but genomically poorly explored phyla, the Mollusca. Here we report the sequencing and assembly of the oyster genome using short reads and a fosmid-pooling strategy, along with transcriptomes of development and stress response and the proteome of the shell. The oyster genome is highly polymorphic and rich in repetitive sequences, with some transposable elements still actively shaping variation. Transcriptome studies reveal an extensive set of genes responding to environmental stress. The expansion of genes coding for heat shock protein 70 and inhibitors of apoptosis is probably central to the oyster's adaptation to sessile life in the highly stressful intertidal zone. Our analyses also show that shell formation in molluscs is more complex than currently understood and involves extensive participation of cells and their exosomes. The oyster genome sequence fills a void in our understanding of the Lophotrochozoa.	[Fang, Xiaodong; Luo, Ruibang; Yang, Pengcheng; Xiong, Zhiqiang; Xie, Yinlong; Zhu, Yabing; Chen, Yuanxin; Peng, Chunfang; Yang, Lan; Wen, Bo; Huang, Zhiyong; Feng, Yue; Liu, Yunjie; Sun, Xiaoqing; Liu, Binghang; Jiang, Xuanting; Fan, Dingding; Fu, Wenjing; Wang, Bo; Peng, Zhiyu; Li, Na; Chen, Maoshan; Tan, Fengji; Zheng, Qiumei; Yang, Hailong; Chen, Li; Luo, Longhai; Ming, Yao; Zhang, Shu; Zhang, Yong; Ni, Peixiang; Wang, Junyi; Li, Ning; Zhang, Guojie; Li, Yingrui; Yang, Huanming; Wang, Jian; Yin, Ye; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Zhang, Guofan; Li, Li; Xu, Fei; Zhang, Linlin; Wang, Xiaotong; Qi, Haigang; Que, Huayong; Wu, Fucun; Wang, Jiafeng; Meng, Jie; Liu, Jun; Zhang, Na; Zhu, Qihui; Du, Yishuai; Zhang, Shoudu; Cheng, Peizhou; Li, Juan; Wang, Wei; Wang, Tong; Zhang, Jibiao; Li, Yingxiang; Wang, Jinpeng; Song, Xiaorui; Huang, Ronglian; Du, Xuedi; Yang, Mei; She, Zhicai; Huang, Wen; Huang, Baoyu; Qu, Tao; Miao, Guoying; Wang, Qiang; Wang, Haiyan; Liu, Xiao] Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China; [Guo, Ximing; He, Yan; Wang, Shan; Qian, Lumin] Rutgers State Univ, Inst Marine & Coastal Sci, Haskin Shellfish Res Lab, Port Norris, NJ 08349 USA; [Luo, Ruibang; Xie, Yinlong; Liu, Binghang] HKU BGI Bioinformat Algorithms & Core Technol Res, Hong Kong, Hong Kong, Peoples R China; [Holland, Peter W. H.; Paps, Jordi] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Mount, Andrew] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Hedgecock, Dennis] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Xu, Zhe] Atlantic Cape Community Coll, Mays Landing, NJ 08330 USA; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Lab Evolutionary Genet, HR-10002 Zagreb, Croatia; [Gaffney, Patrick M.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Steinberg, Christian E. W.] Humboldt Univ Berlin Arboretum, Inst Biol, D-12437 Berlin, Germany; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute of Oceanology, CAS; Rutgers State University New Brunswick; University of Hong Kong; University of Oxford; Clemson University; University of Southern California; Rudjer Boskovic Institute; University of Delaware; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	gzhang@qdio.ac.cn; xguo@hsrl.rutgers.edu; yinye@genomics.org.cn; wangj@genomics.org.cn	Li, Yingrui/K-1064-2015; Wu, Fucun/AAY-6115-2021; Xu, Fei/A-1736-2012; Guo, Ximing/K-3804-2012; Steinberg, Christian/O-8572-2019; Fang, Xiaodong/K-6743-2018; Paps, Jordi/B-2098-2012; li, li/GPX-3938-2022; Li, Li/AEM-3636-2022; yang, hailong/GXH-9625-2022; Yang, Pengcheng/N-1037-2014; Zhang, Linlin/I-4970-2014; Wen, Bo/I-1259-2019; Zhang, Guojie/B-6188-2014; li, li/HII-4157-2022; huang, wen/GXW-0661-2022; LI, LI/GVS-5344-2022; Peng, Zhiyu/GXV-5301-2022; Zhang, Guojie/J-7273-2019; Hedgecock, Dennis/I-8655-2012; Wang, Jun/A-7261-2013; wang, junyi/GYA-3213-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Xu, Fei/0000-0002-0981-8429; Guo, Ximing/0000-0002-6758-2709; Fang, Xiaodong/0000-0001-7061-3337; Paps, Jordi/0000-0003-2636-6636; Yang, Pengcheng/0000-0001-5496-8357; Zhang, Linlin/0000-0003-0247-7710; Wen, Bo/0000-0003-2261-3150; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Hedgecock, Dennis/0000-0002-3995-646X; Steinberg, Christian E.W./0000-0002-3132-8901; Wang, Jinpeng/0000-0003-1892-0246; Wang, Jun/0000-0002-8540-8931; CHEN, MAOSHAN/0000-0002-3827-4969; Wang, Jun/0000-0002-2113-5874; Luo, Ruibang/0000-0001-9711-6533; liu, bh/0000-0002-4948-2835; Holland, Peter/0000-0003-1533-9376; Mount, Andrew/0000-0002-3376-1135; Li, Yingxiang/0000-0001-6671-2965	National High-Technology Research and Development Program of China (863 program) [2010AA10A110]; National Basic Research Program of China (973 Program) [2010CB126401, 2010CB126402]; 863 program [2012AA10A405]; Basic Research Program by Shenzhen City [JC2010526019]; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; Mollusc Research and Development Center; CARS; Shenzhen Key Laboratory of Gene Bank for National Life Science; Taishan Scholar and Scholar Climbing Programs of Shandong; US Department of Agriculture [2009-35205-05052, NJ32108]; Chinese Academy of Science Marine Functional Genomics Oversea Team; Taishan Scholar Fund; European Research Council (EU FP7 ERC) [[268513]11]; Beatriu de Pinos of the Generalitat de Catalunya [2009 BP-DGR]; Dalian Zhangzidao Fishery Group Co. Ltd	National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); Basic Research Program by Shenzhen City; Shenzhen Key Laboratory of Transomics Biotechnologies; Mollusc Research and Development Center; CARS; Shenzhen Key Laboratory of Gene Bank for National Life Science; Taishan Scholar and Scholar Climbing Programs of Shandong; US Department of Agriculture(United States Department of Agriculture (USDA)); Chinese Academy of Science Marine Functional Genomics Oversea Team; Taishan Scholar Fund; European Research Council (EU FP7 ERC)(European Research Council (ERC)); Beatriu de Pinos of the Generalitat de Catalunya; Dalian Zhangzidao Fishery Group Co. Ltd	We acknowledge H. Wu, F. Zhang, Q. Tang, Z. Zhu, X. Xu, H. Lin, J. Lei, Z. Xiang, N. Li, J. Xiang and J. Jia for their support of the oyster genome project. We thank F. Han, X. Liu, R. Wu, L. Wang, Y. Wu, L. Yan, H. Niu, H. Li, Y. Wang, J. Liang, Z. Jia, J. Davis and Taylor Shellfish Farms for assistance with DNA, RNA and protein extraction, data analysis and oyster culture, and Y. Lu, C. Lin, H. Peng, Y. Ren, X. Xu, R. Chen and D. Zhang for library construction and sequencing. We thank L. Song, B. Z. Liu, Q. Li, Z. Yu, C. Ke, J. Yu, B. Liu, X. Sun, R. W. Chapman, Y. Han, S. R. Wessler, D. Arendt, E. H. Davidson, J. S. Evans, B. Brown, P. Boudry and B. Lieb for discussions. We thank other faculty and staff at the Institute of Oceanology, Chinese Academy of Science, BGI-Shenzhen and Rutgers who contributed to the oyster genome project. We acknowledge grant support from the National High-Technology Research and Development Program of China (863 program; 2010AA10A110), National Basic Research Program of China (973 Program; 2010CB126401 and 2010CB126402), 863 program (2012AA10A405), Basic Research Program Supported by Shenzhen City (JC2010526019), Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A), National Natural Science Foundation of China(40730845), Mollusc Research and Development Center, CARS, Shenzhen Key Laboratory of Gene Bank for National Life Science, Taishan Scholar and Scholar Climbing Programs of Shandong. X.G. acknowledges funding from the US Department of Agriculture (2009-35205-05052 and NJ32108) and the Chinese Academy of Science Marine Functional Genomics Oversea Team and Taishan Scholar Fund; P.W.H.H. acknowledges funding from the European Research Council (EU FP7 ERC grant [268513]11); and J.P. acknowledges funding from Beatriu de Pinos of the Generalitat de Catalunya (2009 BP-DGR). We are grateful to Dalian Zhangzidao Fishery Group Co. Ltd for providing support.	Barucca M, 2003, GENE, V317, P97, DOI 10.1016/S0378-1119(03)00657-7; Bender CE, 2012, P NATL ACAD SCI USA, V109, P4904, DOI 10.1073/pnas.1120680109; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Galtsoff P.S., 1964, FISHERY B FISH WILDL, V64, P1, DOI DOI 10.1111/J.1439-0388.2007.00702.X; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Harris R. S., 2007, THESIS PENNSYLVANIA; Hedgecock D, 2005, J SHELLFISH RES, V24, P429, DOI 10.2983/0730-8000(2005)24[429:TCFSTP]2.0.CO;2; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kitzman J. O., 2010, NAT BIOTECHNOL, V29, P59; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Li B., 2012, GENOME DARWINS FINCH, DOI [10.5524/100040, DOI 10.5524/100040]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI RQ, 2010, GENOME RES, V20, P265, DOI DOI 10.1101/GR.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; McGoldrick DJ, 1997, GENETICS, V146, P321; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Mount AS, 2010, US patent, Patent No. [2010/0150982 A1, 20100150982]; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Ponder Winston F., 2008, P1; Sauvage C, 2007, GENE, V406, P13, DOI 10.1016/j.gene.2007.05.011; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; WAITE JH, 1983, MOLLUSCA, V1, P467; Walters ET, 2009, BRAIN BEHAV EVOLUT, V74, P206, DOI 10.1159/000258667; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	47	1476	1581	48	676	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					49	54		10.1038/nature11413	http://dx.doi.org/10.1038/nature11413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22992520	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000309446800030
J	Shukla, S				Shukla, Shubhlakshmi			Africa's changing mosquito dynamics	LANCET			English	Editorial Material							HIGHLANDS		The Lancet, London NW1 7BY, England		Shukla, S (corresponding author), The Lancet, London NW1 7BY, England.	shubhs82@gmail.com						[Anonymous], KEN MAL FACT SHEET; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; London School of Hygiene and Tropical Medicine, NEW MAL TRANSM MOSQ; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Stevenson J, 2012, EMERG INFECT DIS, V18, P1547, DOI 10.3201/eid1809.120283; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2012, MAL FACT SHEET	8	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2012	380	9848					1130	1131		10.1016/S0140-6736(12)61617-1	http://dx.doi.org/10.1016/S0140-6736(12)61617-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021271				2022-12-28	WOS:000309255900008
J	Lin, CY; Loven, J; Rahl, PB; Paranal, RM; Burge, CB; Bradner, JE; Lee, TI; Young, RA				Lin, Charles Y.; Loven, Jakob; Rahl, Peter B.; Paranal, Ronald M.; Burge, Christopher B.; Bradner, James E.; Lee, Tong Ihn; Young, Richard A.			Transcriptional Amplification in Tumor Cells with Elevated c-Myc	CELL			English	Article							RECRUITS P-TEFB; GENE-EXPRESSION; NEOPLASTIC PHENOTYPE; RIBOSOMAL DNA; COPY-NUMBER; CANCER; MAX; BINDING; ACTIVATION; PROTEIN	Elevated expression of the c-Myc transcription factor occurs frequently in human cancers and is associated with tumor aggression and poor clinical outcome. The effect of high levels of c-Myc on global gene regulation is poorly understood but is widely thought to involve newly activated or repressed "Myc target genes." We report here that in tumor cells expressing high levels of c-Myc the transcription factor accumulates in the promoter regions of active genes and causes transcriptional amplification, producing increased levels of transcripts within the cell's gene expression program. Thus, rather than binding and regulating a new set of genes, c-Myc amplifies the output of the existing gene expression program. These results provide an explanation for the diverse effects of oncogenic c-Myc on gene expression in different tumor cells and suggest that transcriptional amplification reduces rate-limiting constraints for tumor cell growth and proliferation.	[Lin, Charles Y.; Loven, Jakob; Rahl, Peter B.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Burge, Christopher B.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Paranal, Ronald M.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Bradner, James E.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Burge, Christopher B./AAH-2177-2020; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	National Institutes of Health [HG002668, CA146445]; Swedish Research Council [VR-B0086301]; American Cancer Society [PF-11-042- 01-DMC]; Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA146445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Society(American Cancer Society); Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank John Minna and Chi Dang for cell lines; Ernest Martinez for constructs; David Orlando for bioinformatics support; Tom Volkert, Jennifer Love, Sumeet Gupta, and Vidya Dhanapal at the Whitehead Genome Technologies Core for Solexa sequencing; Nancy Hannett for cloning support; Jessica Reddy for assistance with FACS; Darin Fogg, Amins Corporation, and Nathan Elliott, NanoString, for excellent technical support; and Michael Cole and members of the Young, Burge and Bradner labs for helpful discussion. This work was supported by National Institutes of Health grants HG002668 (R.A.Y.) and CA146445 (R.A.Y., T.I.L.), Swedish Research Council Postdoctoral Fellowship VR-B0086301 (J.L.), American Cancer Society Postdoctoral Fellowship PF-11-042- 01-DMC (P.B.R.) and Damon-Runyon Cancer Research Foundation (J.E.B). J.E.B. and R.A.Y. are founders of Syros Pharmaceuticals.	Amati B, 2001, BBA-REV CANCER, V1471, pM135, DOI 10.1016/S0304-419X(01)00020-8; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cowling Victoria H, 2010, Genes Cancer, V1, P576; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Farina A, 2004, PROTEIN EXPRES PURIF, V34, P215, DOI 10.1016/j.pep.2003.11.021; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; HIRVONEN HE, 1994, BRIT J CANCER, V69, P16, DOI 10.1038/bjc.1994.3; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hurlin PJ, 2004, INT REV CYTOL, V238, P183, DOI 10.1016/S0074-7696(04)38004-6; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; JOHNSON BE, 1987, J CLIN INVEST, V79, P1629, DOI 10.1172/JCI112999; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kuttler F, 2006, GENOME DYN, V1, P171, DOI 10.1159/000092507; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Peterson CW, 2011, FRONT BIOSCI-LANDMRK, V16, P2206, DOI 10.2741/3848; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	78	991	1014	6	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					56	67		10.1016/j.cell.2012.08.026	http://dx.doi.org/10.1016/j.cell.2012.08.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021215	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000309544200010
J	Willyard, C				Willyard, Cassandra			DIAGNOSIS To catch a killer	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S8	S9		10.1038/489S8a	http://dx.doi.org/10.1038/489S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013716	Bronze			2022-12-28	WOS:000309167100005
J	Waxman, DA				Waxman, Daniel A.			Worlds Apart	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Waxman, Daniel A.] RAND Corp, Pardee RAND Grad Sch, Santa Monica, CA 90406 USA; [Waxman, Daniel A.] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA	RAND Corporation; Pardee RAND Graduate School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Waxman, DA (corresponding author), RAND Corp, Pardee RAND Grad Sch, Santa Monica, CA 90406 USA.	dwaxman@rand.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1219	1220		10.1001/jama.2012.9980	http://dx.doi.org/10.1001/jama.2012.9980			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011711				2022-12-28	WOS:000309103600024
J	Shields, B; Wacogne, I; Wright, CM				Shields, Brian; Wacogne, Ian; Wright, Charlotte M.			Weight faltering and failure to thrive in infancy and early childhood	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; WHO GROWTH CHARTS; BIRTH COHORT; RISK-FACTORS; CHILDREN; POPULATION; GAIN; MANAGEMENT; COMMUNITY; TERM		[Shields, Brian; Wacogne, Ian] Birmingham Childrens Hosp, Dept Gen Paediat, Birmingham B4 6NH, W Midlands, England; [Wright, Charlotte M.] Univ Glasgow, Paediat Epidemiol & Community Hlth Unit, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland	University of Birmingham; University of Glasgow	Wacogne, I (corresponding author), Birmingham Childrens Hosp, Dept Gen Paediat, Birmingham B4 6NH, W Midlands, England.	Ian.wacogne@bch.nhs.uk		Wacogne, Ian/0000-0001-7978-9566				BLACK MM, 1995, PEDIATRICS, V95, P807; Boddy J, 2000, J CHILD PSYCHOL PSYC, V41, P1003, DOI 10.1017/S002196309900637X; Cole TJ, 2012, ARCH DIS CHILD-FETAL, V97, pF219, DOI 10.1136/adc.2010.205864; COLE TJ, 1995, ARCH DIS CHILD, V73, P8, DOI 10.1136/adc.73.1.8; Committee on Medical Aspects of Food Policy, 1991, DIET REF VAL FOOD EN; Corbett SS, 2004, J CHILD PSYCHOL PSYC, V45, P641, DOI 10.1111/j.1469-7610.2004.00253.x; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; DOWDNEY L, 1987, J CHILD PSYCHOL PSYC, V28, P529, DOI 10.1111/j.1469-7610.1987.tb00221.x; Drewett R, 2004, J CHILD PSYCHOL PSYC, V45, P359, DOI 10.1111/j.1469-7610.2004.00226.x; Drewett RF, 1999, J CHILD PSYCHOL PSYC, V40, P551, DOI 10.1111/1469-7610.00473; Emond A, 2007, ARCH DIS CHILD, V92, P115, DOI 10.1136/adc.2005.091496; Emond AM, 2007, PEDIATRICS, V120, pe1051, DOI 10.1542/peds.2006-2295; HEPTINSTALL E, 1987, HUM NUTR-APPL NUTR, V41A, P390; HOMER C, 1981, AM J DIS CHILD, V135, P848, DOI 10.1001/archpedi.1981.02130330058019; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Kasese-Hara M, 2002, J CHILD PSYCHOL PSYC, V43, P449, DOI 10.1111/1469-7610.00036; McDougall P, 2009, ARCH DIS CHILD, V94, P549, DOI 10.1136/adc.2008.139063; O'Brien LM, 2004, PEDIATRICS, V113, P1242, DOI 10.1542/peds.113.5.1242; Olsen EM, 2007, ARCH DIS CHILD, V92, P109, DOI 10.1136/adc.2005.080333; Olsen EM, 2010, PAEDIATR PERINAT EP, V24, P370, DOI 10.1111/j.1365-3016.2010.01118.x; Parkinson K, 2002, J REPROD INFANT PSYC, V20, P173; Parkinson KN, 2004, J CHILD PSYCHOL PSYC, V45, P1030, DOI 10.1111/j.1469-7610.2004.t01-1-00294.x; Perrin EC, 2003, CRITERIA DETERMINING, V72; Poustie VJ, 2006, BMJ-BRIT MED J, V332, P632, DOI 10.1136/bmj.38737.600880.AE; Raynor P, 1999, ARCH DIS CHILD, V80, P500, DOI 10.1136/adc.80.6.500; Reilly SM, 1999, DEV MED CHILD NEUROL, V41, P115, DOI 10.1017/S0012162299000225; Robertson J, 2011, APPETITE, V56, P753, DOI 10.1016/j.appet.2011.02.016; Rudolf MCJ, 2005, ARCH DIS CHILD, V90, P925, DOI 10.1136/adc.2004.050179; SILLS RH, 1978, AM J DIS CHILD, V132, P967, DOI 10.1001/archpedi.1978.02120350031003; SKUSE D, 1993, ARCH DIS CHILD, V69, P604, DOI 10.1136/adc.69.5.604; Skuse D H, 1995, J Med Screen, V2, P145; UK Department of Health, 2009, US NEW UK WHO 0 4 YE; Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854; Wright C, 2000, CHILD CARE HLTH DEV, V26, P5, DOI 10.1046/j.1365-2214.2000.00135.x; Wright CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1140; Wright CM, 2006, ARCH DIS CHILD, V91, P312, DOI 10.1136/adc.2005.077750; WRIGHT CM, 1994, ACTA PAEDIATR, V83, P351, DOI 10.1111/j.1651-2227.1994.tb18118.x; WRIGHT CM, 1994, ACTA PAEDIATR, V83, P357, DOI 10.1111/j.1651-2227.1994.tb18119.x; Wright CM, 2000, ARCH DIS CHILD, V82, P5, DOI 10.1136/adc.82.1.5; Wright CM, 1998, BRIT MED J, V317, P571, DOI 10.1136/bmj.317.7158.571; Wright CM, 2012, P NUTR SOC IN PRESS	41	37	37	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e5931	10.1136/bmj.e5931	http://dx.doi.org/10.1136/bmj.e5931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014901	Green Accepted			2022-12-28	WOS:000309385500003
J	White, AE; Harper, JW				White, Anne E.; Harper, J. Wade			Emerging Anatomy of the BAP1 Tumor Suppressor System	SCIENCE			English	Editorial Material							BRCA1-ASSOCIATED PROTEIN-1; UBIQUITIN HYDROLASE; MUTATIONS; MESOTHELIOMA; PREDISPOSE; REGULATOR; COMPLEX; HCF-1		[White, Anne E.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	White, AE (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Ferris, Laura/I-7689-2012	Harper, Jeffrey/0000-0002-6944-7236				Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Eletr ZM, 2011, CELL BIOCHEM BIOPHYS, V60, P3, DOI 10.1007/s12013-011-9184-6; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	15	29	30	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1463	1464		10.1126/science.1228463	http://dx.doi.org/10.1126/science.1228463			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997315				2022-12-28	WOS:000308912900029
J	Launius, RD				Launius, Roger D.			Neil Armstrong (1930-2012)	NATURE			English	Biographical-Item									Smithsonian Inst, Div Space Hist, Natl Air & Space Museum, Washington, DC 20560 USA	Smithsonian Institution	Launius, RD (corresponding author), Smithsonian Inst, Div Space Hist, Natl Air & Space Museum, Washington, DC 20560 USA.	launiusr@si.edu		Launius, Roger/0000-0003-1633-1253					0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					368	368		10.1038/489368a	http://dx.doi.org/10.1038/489368a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996544	Bronze			2022-12-28	WOS:000308860900028
J	Hesselink, G; Schoonhoven, L; Barach, P; Spijker, A; Gademan, P; Kalkman, C; Liefers, J; Vernooij-Dassen, M; Wollersheim, H				Hesselink, Gijs; Schoonhoven, Lisette; Barach, Paul; Spijker, Anouk; Gademan, Petra; Kalkman, Cor; Liefers, Janine; Vernooij-Dassen, Myrra; Wollersheim, Hub			Improving Patient Handovers From Hospital to Primary Care A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							LIAISON PHARMACY SERVICE; PATIENTS AFTER-DISCHARGE; ADVERSE DRUG EVENTS; QUALITY-OF-LIFE; HEART-FAILURE; FOLLOW-UP; EMERGENCY-DEPARTMENT; GERIATRIC ASSESSMENT; SUPPORTED DISCHARGE; TRANSITIONAL CARE	Background: Evidence shows that suboptimum handovers at hospital discharge lead to increased rehospitalizations and decreased quality of health care. Purpose: To systematically review interventions that aim to improve patient discharge from hospital to primary care. Data Sources: PubMed, CINAHL, PsycInfo, the Cochrane Library, and EMBASE were searched for studies published between January 1990 and March 2011. Study Selection: Randomized, controlled trials of interventions that aimed to improve handovers between hospital and primary care providers at hospital discharge. Data Extraction: Two reviewers independently abstracted data on study objectives, setting and design, intervention characteristics, and outcomes. Studies were categorized according to methodological quality, sample size, intervention characteristics, outcome, statistical significance, and direction of effects. Data Synthesis: Of the 36 included studies, 25 (69.4%) had statistically significant effects in favor of the intervention group and 34 (94.4%) described multicomponent interventions. Effective interventions included medication reconciliation; electronic tools to facilitate quick, clear, and structured summary generation; discharge planning; shared involvement in follow-up by hospital and community care providers; use of electronic discharge notifications; and Web-based access to discharge information for general practitioners. Statistically significant effects were mostly found in reducing hospital use (for example, rehospitalizations), improvement of continuity of care (for example, accurate discharge information), and improvement of patient status after discharge (for example, satisfaction). Limitations: Heterogeneity of the interventions and study characteristics made meta-analysis impossible. Most studies had diffuse aims and poor descriptions of the specific intervention components. Conclusion: Many interventions have positive effects on patient care. However, given the complexity of interventions and outcome measures, the literature does not permit firm conclusions about which interventions have these effects.	[Hesselink, Gijs] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Utrecht, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Hesselink, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, POB 9101,IQ 114, NL-6500 HB Nijmegen, Netherlands.	g.hesselink@iq.umcn.nl	Vernooij-Dassen, M.J.F.J./H-8107-2014; Wollersheim, H.C.H./L-4769-2015; Spijker, Anouk/AAD-7834-2020; Barach, Paul/AAX-5315-2020; Hesselink, Gijs/E-1619-2016; Liefers, Janine/I-4359-2016; Schoonhoven, Lisette/O-3330-2013; Kalkman, Cor/O-3215-2019; Barach, paul/B-9915-2016	Barach, Paul/0000-0002-7906-698X; Liefers, Janine/0000-0003-2719-547X; Kalkman, Cor/0000-0002-8372-6960; Barach, paul/0000-0002-7906-698X; Hesselink, Gijs/0000-0003-2532-0724	European Union, the Framework Programme of the European Commission; European Union, the Framework Programme of the European Commission [FP7-HEALTH-F2-2008-223409]; European Union, the Framework Programme of the European Health Commission	European Union, the Framework Programme of the European Commission; European Union, the Framework Programme of the European Commission; European Union, the Framework Programme of the European Health Commission	By the European Union, the Framework Programme of the European Commission (FP7-HEALTH-F2-2008-223409).; Mr. Hesselink: Grant (money to institution): European Union, the Framework Programme of the European Health Commission; Support for travel to meetings for the study or other purposes: European Union, the Framework Programme of the European Health Commission. Dr. Schoonhoven: Grant (money to institution): European Union, the Framework Programme of the European Health Commission. Dr. Barach: Grant (money to institution): European Union, the Framework Programme of the European Health Commission; Support for travel to meetings for the study or other purposes: European Union, the Framework Programme of the European Health Commission. Dr. Gademan: Grant (money to institution): European Union, the Framework Programme of the European Health Commission. Dr. Kalkman: Grant (money to institution): European Union; Support for travel to meetings for the study or other purposes: European Union. Dr. Vernooij-Dassen: Grant (money to institution): European Union; Support for travel to meetings for the study or other purposes: European Union; Employment: Radboud University Nijmegen; Grants/grants pending (money to institution): European Union. Dr. Wollersheim: Grant (money to institution): European Union, the Framework Programme of the European Health Commission; Support for travel to meetings for the study or other purposes: European Union, the Framework Programme of the European Health Commission. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-2696.	Afilalo Marc, 2007, CJEM, V9, P79; Akbari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471.pub2; Arbaje AI, 2010, J AM GERIATR SOC, V58, P364, DOI 10.1111/j.1532-5415.2009.02682.x; Arora VM, 2009, J HOSP MED, V4, P433, DOI 10.1002/jhm.573; Atwal A, 2002, J ADV NURS, V39, P450, DOI 10.1046/j.1365-2648.2002.02310.x; Avlund K., 2002, SCAND J OCCUP THER, V9, P17; Bolas H, 2004, PHARM WORLD SCI, V26, P114, DOI 10.1023/B:PHAR.0000018601.11248.89; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Brand Sarah L, 2006, Intensive Crit Care Nurs, V22, P106, DOI 10.1016/j.iccn.2005.04.003; Caplan GA, 2004, J AM GERIATR SOC, V52, P1417, DOI 10.1111/j.1532-5415.2004.52401.x; Chen YF, 2010, INT J MED INFORM, V79, P167, DOI 10.1016/j.ijmedinf.2009.12.006; Chiu WK, 2007, PROF CASE MANAG, V12, P330; Clare J, 1998, Aust J Adv Nurs, V16, P7; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Connolly M, 2009, J CLIN NURS, V18, P549, DOI 10.1111/j.1365-2702.2008.02551.x; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Crotty Maria, 2004, Am J Geriatr Pharmacother, V2, P257, DOI 10.1016/j.amjopharm.2005.01.001; Eggink RN, 2010, PHARM WORLD SCI, V32, P759, DOI 10.1007/s11096-010-9433-6; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Graumlich JF, 2009, J HOSP MED, V4, P356, DOI [10.1002/jhm.469, 10.1002/jhm.565]; Grimshaw J, 2003, QUAL SAF HEALTH CARE, V12, P298, DOI 10.1136/qhc.12.4.298; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Harrison MB, 2002, MED CARE, V40, P271, DOI 10.1097/00005650-200204000-00003; Helleso R, 2004, INT J MED INFORM, V73, P569, DOI 10.1016/j.ijmedinf.2004.04.009; Helleso Ragnhild, 2010, Int J Integr Care, V10, pe036; Indredavik B, 2000, STROKE, V31, P2989, DOI 10.1161/01.STR.31.12.2989; Institute for Healthcare Improvement, 2012, STAT ACT AV REH STAA; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Johnson JK, 2009, QUAL SAF HEALTH CARE, V18, P244, DOI 10.1136/qshc.2009.032946; King TL, 2008, IMPACT NURSE DRIVEN; Koehler BE, 2009, J HOSP MED, V4, P211, DOI 10.1002/jhm.427; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kwok T, 2004, J AM GERIATR SOC, V52, P1240, DOI 10.1111/j.1532-5415.2004.52351.x; Lalonde L, 2008, AM J HEALTH-SYST PH, V65, P1451, DOI 10.2146/ajhp070565; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; Lim WK, 2003, MED J AUSTRALIA, V178, P262, DOI 10.5694/j.1326-5377.2003.tb05191.x; Lin PC, 2009, J CLIN NURS, V18, P1632, DOI 10.1111/j.1365-2702.2008.02695.x; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maslove DM, 2009, J GEN INTERN MED, V24, P995, DOI 10.1007/s11606-009-1053-2; Mayo NE, 2008, AGE AGEING, V37, P32, DOI 10.1093/ageing/afm133; McInnes E, 1999, FAM PRACT, V16, P289, DOI 10.1093/fampra/16.3.289; McKenna H, 2000, J CLIN NURS, V9, P594, DOI 10.1046/j.1365-2702.2000.00384.x; McKeown F, 2007, J CLIN NURS, V16, P469, DOI 10.1111/j.1365-2702.2006.01556.x; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Mistiaen P, 1997, J ADV NURS, V25, P1233, DOI 10.1046/j.1365-2648.1997.19970251233.x; Mistiaen P, 2007, HOSP DISCHARGE PROBL; Mistiaen P, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-47; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Murtaugh CM, 2002, MED CARE, V40, P227; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Nazareth I, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.1.33; Parker S G, 2002, Health Technol Assess, V6, P1; Preen DB, 2005, INT J QUAL HEALTH C, V17, P43, DOI 10.1093/intqhc/mzi002; Raduma-Tomas MA, 2011, BMJ QUAL SAF, V20, P128, DOI 10.1136/bmjqs.2009.034389; RICH MW, 1993, J GEN INTERN MED, V8, P585, DOI 10.1007/BF02599709; Rutherford A, 2001, Aust Fam Physician, V30, P1101; Rytter L, 2010, SCAND J PRIM HEALTH, V28, P146, DOI 10.3109/02813431003764466; Schnipper JL, 2009, ARCH INTERN MED, V169, P771, DOI 10.1001/archinternmed.2009.51; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Shyu YIL, 2010, J AM GERIATR SOC, V58, P1081, DOI 10.1111/j.1532-5415.2010.02882.x; Siu AL, 1996, ARCH INTERN MED, V156, P76, DOI 10.1001/archinte.156.1.76; Society of Hospital Medicine, 2008, BOOSTING CAR TRANS R; Tripp JS, 2009, DEV EVALUATION NOTIF; van Walraven C, 2002, J GEN INTERN MED, V17, P186, DOI 10.1046/j.1525-1497.2002.10741.x; van Walraven C, 1999, CAN MED ASSOC J, V160, P319; Vuong T., 2008, INT J PHARM PRACT, V16, P127, DOI [DOI 10.1211/ijpp.16.3.0002, 10.1211/ijpp.16.3.0002]; Wells M, 2004, BRIT J CANCER, V91, P651, DOI 10.1038/sj.bjc.6601998	71	213	219	1	57	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6					417	U81		10.7326/0003-4819-157-6-201209180-00006	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00006			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007UB	22986379	Green Published			2022-12-28	WOS:000308912800016
J	Lian, CG; Xu, YF; Ceol, C; Wu, FZ; Larson, A; Dresser, K; Xu, WQ; Tan, L; Hu, YG; Zhan, Q; Lee, CW; Hu, D; Lian, BQ; Kleffel, S; Yang, YJ; Neiswender, J; Khorasani, AJ; Fang, R; Lezcano, C; Duncan, LM; Scolyer, RA; Thompson, JF; Kakavand, H; Houvras, Y; Zon, LI; Mihm, MC; Kaiser, UB; Schatton, T; Woda, BA; Murphy, GF; Shi, YJG				Lian, Christine Guo; Xu, Yufei; Ceol, Craig; Wu, Feizhen; Larson, Allison; Dresser, Karen; Xu, Wenqi; Tan, Li; Hu, Yeguang; Zhan, Qian; Lee, Chung-wei; Hu, Di; Lian, Bill Q.; Kleffel, Sonja; Yang, Yijun; Neiswender, James; Khorasani, Abraham J.; Fang, Rui; Lezcano, Cecilia; Duncan, Lyn M.; Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr; Houvras, Yariv; Zon, Leonard I.; Mihm, Martin C., Jr.; Kaiser, Ursula B.; Schatton, Tobias; Woda, Bruce A.; Murphy, George F.; Shi, Yujiang G.			Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma	CELL			English	Article							GENE-EXPRESSION; DNA-METHYLATION; ONCOMETABOLITE 2-HYDROXYGLUTARATE; CELL-LINES; 5-METHYLCYTOSINE; MUTATIONS; TET1; DIFFERENTIATION; IDENTIFICATION; PROGRESSION	DNA methylation at the 5 position of cytosine (5-mC) is a key epigenetic mark that is critical for various biological and pathological processes. 5-mC can be converted to 5-hydroxymethylcytosine (5-hmC) by the ten-eleven translocation (TET) family of DNA hydroxylases. Here, we report that "loss of 5-hmC'' is an epigenetic hallmark of melanoma, with diagnostic and prognostic implications. Genome-wide mapping of 5-hmC reveals loss of the 5-hmC landscape in the melanoma epigenome. We show that downregulation of isocitrate dehydrogenase 2 (IDH2) and TET family enzymes is likely one of the mechanisms underlying 5-hmC loss in melanoma. Rebuilding the 5-hmC landscape in melanoma cells by reintroducing active TET2 or IDH2 suppresses melanoma growth and increases tumor-free survival in animal models. Thus, our study reveals a critical function of 5-hmC in melanoma development and directly links the IDH and TET activity-dependent epigenetic pathway to 5-hmC-mediated suppression of melanoma progression, suggesting a new strategy for epigenetic cancer therapy.	[Lian, Christine Guo; Zhan, Qian; Lee, Chung-wei; Lezcano, Cecilia; Murphy, George F.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA; [Lian, Christine Guo; Xu, Yufei; Hu, Yeguang; Hu, Di; Lian, Bill Q.; Khorasani, Abraham J.; Fang, Rui; Kaiser, Ursula B.; Shi, Yujiang G.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens,Dept Med, Boston, MA 02115 USA; [Ceol, Craig; Houvras, Yariv; Zon, Leonard I.] Harvard Univ, Sch Med, Howard Hughes Med Inst,Harvard Stem Cell Inst, Stem Cell Program & Hematol Oncol,Childrens Hosp, Boston, MA 02115 USA; [Duncan, Lyn M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA; [Larson, Allison; Kleffel, Sonja; Mihm, Martin C., Jr.; Schatton, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Ceol, Craig; Neiswender, James] Univ Massachusetts, Dept Canc Biol, Worcester, MA 01605 USA; [Dresser, Karen; Woda, Bruce A.] Univ Massachusetts, Dept Pathol, Worcester, MA 01605 USA; [Lian, Bill Q.] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA; [Wu, Feizhen; Xu, Wenqi; Tan, Li; Shi, Yujiang G.] Fudan Univ, Inst Biomed Sci, Lab Epigenet, Shanghai 200032, Peoples R China; [Yang, Yijun] ZIOPHARM Oncol Inc, Charlestown, MA 02129 USA; [Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr] Univ Sydney, Melanoma Inst Australia, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia; [Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Houvras, Yariv] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Houvras, Yariv] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Houvras, Yariv] New York Presbyterian Hosp, New York, NY 10065 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Fudan University; Melanoma Institute Australia; University of Sydney; University of Sydney; Cornell University; Cornell University; NewYork-Presbyterian Hospital	Murphy, GF (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA.	gmurphy@rics.bwh.harvard.edu; yujiang_shi@hms.harvard.edu	Scolyer, Richard/AAE-8511-2019; Woda, Bruce/AAS-5898-2020; Larson, Allison/N-4263-2015; Schatton, Tobias/N-9898-2018; Wu, Feizhen/R-6415-2019; Thompson, John/F-9075-2013; Wu, Feizhen/AGR-5215-2022	Scolyer, Richard/0000-0002-8991-0013; Larson, Allison/0000-0001-8534-7078; Schatton, Tobias/0000-0003-1386-680X; Wu, Feizhen/0000-0002-1265-9887; Thompson, John/0000-0002-2816-2496; Lian, Christine/0000-0003-4626-1612; Kakavand, Hojabr/0000-0002-3458-7853; Neiswender, James/0000-0003-4135-6479; Houvras, Yariv/0000-0003-0751-3215	National Institutes of Health (NIH) [GM078458]; NIH-NCI [5P50CA093683-09]; Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education [985]; NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078458, F32GM070690] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education(Ministry of Education, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. David E. Fisher for his critical reading of the manuscript. This project was supported by grant number GM078458 from National Institutes of Health (NIH) to Y.G.S., grant number 5P50CA093683-09 from NIH-NCI to SPORE Core, and Brigham and Women's Hospital Biomedical Research Institute fund to sustain research excellence, and Chinese Ministry of Education Project 985 to Biomedical Core Facility, Fudan University. Y.G.S. is a PEW scholar. The authors acknowledge Dr. David E. Elder, Dr. Victor G. Prieto, and Dr. Jeffrey E. Gershenwald in the the development of the SPORE TMA.	Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Conway K, 2011, PIGM CELL MELANOMA R, V24, P352, DOI 10.1111/j.1755-148X.2011.00828.x; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Haffner MC, 2011, ONCOTARGET, V2, P627; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Marks R, 2000, CLIN EXP DERMATOL, V25, P459, DOI 10.1046/j.1365-2230.2000.00693.x; Paz MF, 2003, CANCER RES, V63, P1114; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shibata T, 2011, AM J PATHOL, V178, P1395, DOI 10.1016/j.ajpath.2010.12.011; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang H, 2012, ONCOGENE; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156	36	563	589	4	118	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1135	1146		10.1016/j.cell.2012.07.033	http://dx.doi.org/10.1016/j.cell.2012.07.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980977	Green Accepted, Bronze			2022-12-28	WOS:000308928100008
J	Oda, Y; Fukuda, H				Oda, Yoshihisa; Fukuda, Hiroo			Initiation of Cell Wall Pattern by a Rho- and Microtubule-Driven Symmetry Breaking	SCIENCE			English	Article							ARABIDOPSIS; PLANTS; POLARITY; GTPASE; ROP; GROWTH; EXPRESSION; PROTEINS; FAMILY; DOMAIN	A specifically patterned cell wall is a determinant of plant cell shape. Yet, the precise mechanisms that underlie initiation of cell wall patterning remain elusive. By using a reconstitution assay, we revealed that ROPGEF4 (Rho of plant guanine nucleotide exchange factor 4) and ROPGAP3 [ROP guanosine triphosphatase (GTPase)-activating protein 3] mediate local activation of the plant Rho GTPase ROP11 to initiate distinct pattern of secondary cell walls in xylem cells. The activated ROP11 recruits MIDD1 to induce local disassembly of cortical microtubules. Conversely, cortical microtubules eliminate active ROP11 from the plasma membrane through MIDD1. Such a mutual inhibitory interaction between active ROP domains and cortical microtubules establishes the distinct pattern of secondary cell walls. This Rho-based regulatory mechanism shows how plant cells initiate and control cell wall patterns to form various cell shapes.	[Oda, Yoshihisa; Fukuda, Hiroo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Oda, Yoshihisa] Japan Sci & Technol Corp JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Oda, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	oda@biol.s.u-tokyo.ac.jp; fukuda@biol.s.u-tokyo.ac.jp		Oda, Yoshihisa/0000-0001-6934-4424	Ministry of Education, Science, Sports and Culture of Japan [19060009]; Japan Society for the Promotion of Science [23227001, 22870005]; NC-CARP project; JST, Precursory Research for Embryonic Science and Technology (PRESTO) [20103]; Grants-in-Aid for Scientific Research [19060016] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NC-CARP project; JST, Precursory Research for Embryonic Science and Technology (PRESTO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Chua of the Rockefeller University for providing the pER8 vector; U. Grossniklaus of the University of Zurich for providing the pMDC7 vector; T. Nakagawa of Shimane University for providing the pGWB vectors; Y. Ohya of the University of Tokyo for critical reading of this manuscript; A. Nakano, T. Ueda, and S. Betsuyaku of the University of Tokyo for technical advice; and Y. Nakashima for technical assistance. This work was supported partly by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (19060009) to H. F.; from the Japan Society for the Promotion of Science to H. F. (23227001) and Y.O. (22870005) and the NC-CARP project; and from JST, Precursory Research for Embryonic Science and Technology (PRESTO) to Y.O. (20103).	Berken A, 2005, NATURE, V436, P1176, DOI 10.1038/nature03883; Dettmer J, 2011, CURR OPIN CELL BIOL, V23, P686, DOI 10.1016/j.ceb.2011.09.006; Dong JA, 2010, CURR TOP DEV BIOL, V91, P267, DOI 10.1016/S0070-2153(10)91009-0; Gu Y, 2006, PLANT CELL, V18, P366, DOI 10.1105/tpc.105.036434; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Lavy M, 2007, CURR BIOL, V17, P947, DOI 10.1016/j.cub.2007.04.038; Lavy M, 2006, PLANT J, V46, P934, DOI 10.1111/j.1365-313X.2006.02749.x; Li SD, 2008, MOL PLANT, V1, P1021, DOI 10.1093/mp/ssn051; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Mucha E, 2010, EUR J CELL BIOL, V89, P906, DOI 10.1016/j.ejcb.2010.08.003; Oda Y, 2010, CURR BIOL, V20, P1197, DOI 10.1016/j.cub.2010.05.038; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Rasmussen CG, 2011, ANNU REV PLANT BIOL, V62, P387, DOI 10.1146/annurev-arplant-042110-103802; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu G, 2000, PLANT PHYSIOL, V124, P1625, DOI 10.1104/pp.124.4.1625; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	23	172	186	6	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1333	1336		10.1126/science.1222597	http://dx.doi.org/10.1126/science.1222597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984069				2022-12-28	WOS:000308705000040
J	Glasmacher, E; Agrawal, S; Chang, AB; Murphy, TL; Zeng, WW; Vander Lugt, B; Khan, AA; Ciofani, M; Spooner, CJ; Rutz, S; Hackney, J; Nurieva, R; Escalante, CR; Ouyang, WJ; Littman, DR; Murphy, KM; Singh, H				Glasmacher, Elke; Agrawal, Smita; Chang, Abraham B.; Murphy, Theresa L.; Zeng, Wenwen; Vander Lugt, Bryan; Khan, Aly A.; Ciofani, Maria; Spooner, Chauncey J.; Rutz, Sascha; Hackney, Jason; Nurieva, Roza; Escalante, Carlos R.; Ouyang, Wenjun; Littman, Dan R.; Murphy, Kenneth M.; Singh, Harinder			A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1-IRF Complexes	SCIENCE			English	Article							TRANSCRIPTION FACTOR IRF4; FACTOR BATF CONTROLS; CELL-DIFFERENTIATION; FAMILY; ACTIVATION; EXPRESSION; PROGRAM; ABSENCE; MEMBER; ROLES	Interferon regulatory factor 4 (IRF4) and IRF8 regulate B, T, macrophage, and dendritic cell differentiation. They are recruited to cis-regulatory Ets-IRF composite elements by PU.1 or Spi-B. How these IRFs target genes in most T cells is enigmatic given the absence of specific Ets partners. Chromatin immunoprecipitation sequencing in T helper 17 (T(H)17) cells reveals that IRF4 targets sequences enriched for activating protein 1 (AP-1)-IRF composite elements (AICEs) that are co-bound by BATF, an AP-1 factor required for T(H)17, B, and dendritic cell differentiation. IRF4 and BATF bind cooperatively to structurally divergent AICEs to promote gene activation and T(H)17 differentiation. The AICE motif directs assembly of IRF4 or IRF8 with BATF heterodimers and is also used in T(H)2, B, and dendritic cells. This genomic regulatory element and cognate factors appear to have evolved to integrate diverse immunomodulatory signals.	[Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Glasmacher, Elke; Agrawal, Smita; Chang, Abraham B.; Zeng, Wenwen; Vander Lugt, Bryan; Spooner, Chauncey J.; Rutz, Sascha; Ouyang, Wenjun; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Khan, Aly A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Khan, Aly A.] Univ Chicago, Inst Syst & Genom Biol, Chicago, IL 60637 USA; [Ciofani, Maria] NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; [Hackney, Jason] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Nurieva, Roza] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Escalante, Carlos R.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23219 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Roche Holding; Genentech; University of Chicago; University of Chicago; Howard Hughes Medical Institute; New York University; Roche Holding; Genentech; University of Texas System; UTMD Anderson Cancer Center; Virginia Commonwealth University	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@pathology.wustl.edu; harindsi@gene.com	Glasmacher, Elke/B-8939-2015; Ouyang, Wenjun/ABA-8763-2020; Zeng, Wenwen/D-7276-2017	Glasmacher, Elke/0000-0003-1265-2543; Zeng, Wenwen/0000-0001-8544-3318; Ciofani, Maria/0000-0001-6472-5260; Hackney, Jason/0000-0002-5922-563X; Ouyang, Wenjun/0000-0002-1811-5864	NIH [RC1 AI087266, RC4 AI092765]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092765, RC1AI087266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Dong for insightful discussions and suggestions and the fluorescence-activated cell sorting (FACS), antibody engineering, DNA sequencing, microarray, and oligonucleotide synthesis facilities at Genentech for providing valuable reagents and technical assistance. The data presented in the manuscript are tabulated in the main paper and the supplementary materials. Reagents will be provided upon request. D.R.L. and K.M.M. are Howard Hughes Medical Institute investigators. D.R.L. also acknowledges funding from NIH grants RC1 AI087266 and RC4 AI092765, and M. C. was supported by a fellowship from the Crohn's and Colitis Foundation of America. Genentech, Incorporated, has filed a provisional patent application that is focused on targeting of IRF4-BATF complexes in the context of T<INF>H</INF>17-mediated inflammatory or autoimmune diseases. The complete gene expression and ChIPseq data sets can be accessed at www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE40483.	Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	27	232	240	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					975	980		10.1126/science.1228309	http://dx.doi.org/10.1126/science.1228309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	22983707	Green Accepted			2022-12-28	WOS:000311083600051
J	Upton, JP; Wang, LK; Han, D; Wang, ES; Huskey, NE; Lim, L; Truitt, M; McManus, MT; Ruggero, D; Goga, A; Papa, FR; Oakes, SA				Upton, John-Paul; Wang, Likun; Han, Dan; Wang, Eric S.; Huskey, Noelle E.; Lim, Lionel; Truitt, Morgan; McManus, Michael T.; Ruggero, Davide; Goga, Andrei; Papa, Feroz R.; Oakes, Scott A.			IRE1 alpha Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; CELL-DEATH; PROTEIN; APOPTOSIS; REQUIRES; PATHWAY	The endoplasmic reticulum (ER) is the primary organelle for folding and maturation of secretory and transmembrane proteins. Inability tomeet protein-folding demand leads to "ER stress," and activates IRE1 alpha, an ER transmembrane kinase-endoribonuclease (RNase). IRE1 alpha promotes adaptation through splicing Xbp1 mRNA or apoptosis through incompletely understood mechanisms. Here, we found that sustained IRE1 alpha RNase activation caused rapid decay of select microRNAs (miRs -17, -34a, -96, and -125b) that normally repress translation of Caspase-2 mRNA, and thus sharply elevates protein levels of this initiator protease of the mitochondrial apoptotic pathway. In cell-free systems, recombinant IRE1 alpha endonucleolytically cleaved microRNA precursors at sites distinct from DICER. Thus, IRE1 alpha regulates translation of a proapoptotic protein through terminating microRNA biogenesis, and noncoding RNAs are part of the ER stress response.	[Wang, Likun; Han, Dan; Huskey, Noelle E.; Lim, Lionel; Goga, Andrei; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Upton, John-Paul; Wang, Eric S.; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [McManus, Michael T.; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Wang, Likun; Han, Dan; McManus, Michael T.] Univ Calif San Francisco, Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA; [Upton, John-Paul; Huskey, Noelle E.; Lim, Lionel; Truitt, Morgan; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Wang, Likun; Han, Dan; Ruggero, Davide; Goga, Andrei; Oakes, Scott A.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu; scott.oakes@ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Papa, Feroz/0000-0002-3684-9108	NIH [DP2OD001925, R01CA136577, R01CA136717, R01DK080955, R01CA154916, GM080783, DK063720, R01CA140456]; Leukemia & Lymphoma Society Scholar Award; Howard Hughes Medical Institute Physician-Scientist Early Career Award; American Cancer Society Research Scholar Award; Burroughs Wellcome Foundation; Hillblom Foundation; Juvenile Diabetes Research Foundation; Partnership for Cures; National Science Foundation; Susan G. Komen Foundation; A*STAR Fellowship; NATIONAL CANCER INSTITUTE [R01CA154916, R01CA136717, R01CA136577, R01CA140456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080955, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); American Cancer Society Research Scholar Award(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Hillblom Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Partnership for Cures; National Science Foundation(National Science Foundation (NSF)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); A*STAR Fellowship(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Kaufman for Atf6a<SUP>-/-</SUP> MEFs and D. Ron for Perk<SUP>-/-</SUP> and Ire1 alpha<SUP>-/-</SUP> MEFs. The work was supported by NIH: DP2OD001925 (F.R.P), R01CA136577 (S.A.O.), R01CA136717 (A.G.), R01DK080955 (F.R.P), R01CA154916 (D.R.), GM080783 (M.T.M.), DK063720 (M.T.M.), and R01CA140456 (D.R.); Leukemia & Lymphoma Society Scholar Award (D.R.); Howard Hughes Medical Institute Physician-Scientist Early Career Award (S.A.O.); American Cancer Society Research Scholar Award (S.A.O.); Burroughs Wellcome Foundation (F.R.P.); Hillblom Foundation (F.R.P.); Juvenile Diabetes Research Foundation (F.R.P); Partnership for Cures (F.R.P); National Science Foundation (E.S.W.); Susan G. Komen Foundation (A.G.); and an A*STAR Fellowship (L.L.). J-P.U., L.W., D.H., E.S.W., N.H., and M.T. designed and performed experiments and contributed to the manuscript. L.L., M.T.M., D.R., and A.G. contributed key ideas, reagents, and data interpretation. F.R.P. and S.A.O. designed the study and wrote the manuscript. There are no conflicts of interest.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reyes NA, 2010, J CLIN INVEST, V120, P3673, DOI 10.1172/JCI42986; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	24	445	461	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					818	822		10.1126/science.1226191	http://dx.doi.org/10.1126/science.1226191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23042294	Green Accepted			2022-12-28	WOS:000310839500050
J	Caine, ED				Caine, Eric D.			Self-harm behaviour: rethinking physical and mental health	LANCET			English	Editorial Material							SUICIDE; SCHIZOPHRENIA; ADOLESCENCE; MORTALITY; COHORT; PEOPLE		[Caine, Eric D.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14624 USA; [Caine, Eric D.] Univ Rochester, Med Ctr, Injury Control Res Ctr Suicide Prevent, Rochester, NY 14624 USA; [Caine, Eric D.] Vet Hlth Adm Med Ctr, Ctr Excellence Suicide Prevent, Canandaigua, NY USA	University of Rochester; University of Rochester; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caine, ED (corresponding author), Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14624 USA.	eric_caine@urmc.rochester.edu						Bergen H, 2012, LANCET; Caine ED, 2011, ROUT STUD PUB HLTH, P303; Caine ED, 2010, PSYCHIAT SERV, V61, P1171, DOI 10.1176/ps.2010.61.12.1171; Centers for Disease Control and Prevention, 2012, WEB BAS INJ STAT QUE; Crosby A., 2011, SELF DIRECTED VIOLEN; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Hawton K, 2006, INT J GERIATR PSYCH, V21, P572, DOI 10.1002/gps.1526; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hawton K, 2012, LANCET, V379, P198, DOI 10.1016/S0140-6736(11)61260-9; Hoang U, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5422; Knox KL, 2005, AM J PUBLIC HEALTH, V95, P1898, DOI 10.2105/AJPH.2004.047217; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123	13	2	2	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1536	1538		10.1016/S0140-6736(12)61509-8	http://dx.doi.org/10.1016/S0140-6736(12)61509-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030VR	22995671				2022-12-28	WOS:000310598700008
J	Li, W; Shuai, L; Wan, HF; Dong, MZ; Wang, M; Sang, LS; Feng, CJ; Luo, GZ; Li, TD; Li, X; Wang, LB; Zheng, QY; Sheng, C; Wu, HJ; Liu, ZH; Liu, L; Wang, L; Wang, XJ; Zhao, XY; Zhou, Q				Li, Wei; Shuai, Ling; Wan, Haifeng; Dong, Mingzhu; Wang, Meng; Sang, Lisi; Feng, Chunjing; Luo, Guan-Zheng; Li, Tianda; Li, Xin; Wang, Libin; Zheng, Qin-Yuan; Sheng, Chao; Wu, Hua-Jun; Liu, Zhonghua; Liu, Lei; Wang, Liu; Wang, Xiu-Jie; Zhao, Xiao-Yang; Zhou, Qi			Androgenetic haploid embryonic stem cells produce live transgenic mice	NATURE			English	Article							MOUSE EMBRYOS; GENERATION; EMBRYOGENESIS; PLURIPOTENT; DERIVATION; OOCYTES; GENOME; EXPRESSION; INJECTION; DEVELOP	Haploids and double haploids are important resources for studying recessive traits and have large impacts on crop breeding(1), but natural haploids are rare in animals. Mammalian haploids are restricted to germline cells and are occasionally found in tumours with massive chromosome loss(2,3). Recent success in establishing haploid embryonic stem (ES) cells in medaka fish(4) and mice(5,6) raised the possibility of using engineered mammalian haploid cells in genetic studies. However, the availability and functional characterization of mammalian haploid ES cells are still limited. Here we show that mouse androgenetic haploid ES (ahES) cell lines can be established by transferring sperm into an enucleated oocyte. The ahES cells maintain haploidy and stable growth over 30 passages, express pluripotent markers, possess the ability to differentiate into all three germ layers in vitro and in vivo, and contribute to germlines of chimaeras when injected into blastocysts. Although epigenetically distinct from sperm cells, the ahES cells can produce viable and fertile progenies after intracytoplasmic injection into mature oocytes. The oocyte-injection procedure can also produce viable transgenic mice from genetically engineered ahES cells. Our findings show the developmental pluripotency of androgenentic haploids and provide a new tool to quickly produce genetic models for recessive traits. They may also shed new light on assisted reproduction.	[Li, Wei; Shuai, Ling; Wan, Haifeng; Dong, Mingzhu; Sang, Lisi; Feng, Chunjing; Li, Tianda; Li, Xin; Wang, Libin; Zheng, Qin-Yuan; Sheng, Chao; Liu, Lei; Wang, Liu; Zhao, Xiao-Yang; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Li, Wei; Wan, Haifeng; Dong, Mingzhu; Sang, Lisi; Feng, Chunjing; Wang, Libin; Zheng, Qin-Yuan; Wu, Hua-Jun] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Shuai, Ling; Li, Tianda; Li, Xin; Sheng, Chao; Liu, Zhonghua] NE Agr Univ China, Coll Life Sci, Harbin 150030, Peoples R China; [Wang, Meng; Luo, Guan-Zheng; Wu, Hua-Jun; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol Syst Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	xyzhao@ioz.ac.cn; qzhou@ioz.ac.cn	Liu, Zhunghua/F-2485-2010; Wang, Xiu-Jie/L-1312-2019	Liu, Zhunghua/0000-0002-9199-6493; Shuai, Ling/0000-0003-0671-7478; ZHAO, Xiao-Yang/0000-0003-2544-8293	National Science Foundation of China [90919060]; China National Basic Research Program [2012CBA01300]; Chinese Academy of Sciences [XDA01020100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank all members of the Group of Reproductive Engineering for discussion and help. This study was supported by a grant from the National Science Foundation of China 90919060 (to Q.Z.) and the China National Basic Research Program 2012CBA01300 (to Q.Z.), and a grant from the Strategic Priority Research Program of the Chinese Academy of Sciences XDA01020100 (to Q.Z.). We thank Fluidigm Corporation for their support in the utilization of BioMark HD system. We thank Eppendorf and Leica for supporting the facility.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Germana MA, 2011, PLANT CELL REP, V30, P839, DOI 10.1007/s00299-011-1061-7; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Loren J, 2006, REPRODUCTION, V131, P259, DOI 10.1530/rep.1.00894; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; Maruotti J, 2010, STEM CELLS, V28, P743, DOI 10.1002/stem.400; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; TARKOWSKI AK, 1977, J EMBRYOL EXP MORPH, V38, P187; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhao XY, 2010, STEM CELL REV REP, V6, P390, DOI 10.1007/s12015-010-9160-3; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	31	127	157	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					407	+		10.1038/nature11435	http://dx.doi.org/10.1038/nature11435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023130				2022-12-28	WOS:000309918500047
J	Barrett, TA				Barrett, Terrence A.			Intestinal Wound Healing Requires a Wnt Balancing Act	SCIENCE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; THERAPY; CELLS		Northwestern Univ, Sch Med, Div Gastroenterol, Dept Med & Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University	Barrett, TA (corresponding author), Northwestern Univ, Sch Med, Div Gastroenterol, Dept Med & Microbiol Immunol, Chicago, IL 60611 USA.	tbarrett@nmff.org		Barrett, Terrence/0000-0001-6428-3271				Atreya R, 2011, GASTROENTEROLOGY, V141, P2026, DOI 10.1053/j.gastro.2011.08.032; Behm BW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006893; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; De Cruz P, 2013, INFLAMM BOWEL DIS, V19, P429, DOI 10.1002/ibd.22977; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Modigliani R, 1996, GASTROENTEROLOGY, V110, P688, DOI 10.1053/gast.1996.v110.pm8608877; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Shenoy AK, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-107; Thiele K, 1999, GUT, V45, P693, DOI 10.1136/gut.45.5.693; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910	14	5	5	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					51	52		10.1126/science.1229414	http://dx.doi.org/10.1126/science.1229414			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042874				2022-12-28	WOS:000309457400043
J	Cohen, MR				Cohen, Marlene R.			When Attention Wanders	SCIENCE			English	Editorial Material							VISUAL-CORTEX; NEURONAL RESPONSES; AREA V4; PERFORMANCE; MECHANISMS; MOTION; SPACE; MIND		Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cohen, MR (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	cohenm@pitt.edu			NATIONAL EYE INSTITUTE [R01EY005911, R00EY020844, K99EY020844] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01EY005911, 5R00EY020844-04, K99EY020844-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Assad JA, 2003, CURR OPIN NEUROBIOL, V13, P194, DOI 10.1016/S0959-4388(03)00045-X; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cohen MR, 2011, J NEUROSCI, V31, P15802, DOI 10.1523/JNEUROSCI.3063-11.2011; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hayden BY, 2009, VISION RES, V49, P1182, DOI 10.1016/j.visres.2008.06.011; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	22	3	3	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					58	59		10.1126/science.1229552	http://dx.doi.org/10.1126/science.1229552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042879				2022-12-28	WOS:000309457400048
J	Schwabe, RF; Wang, TC				Schwabe, Robert F.; Wang, Timothy C.			Bacteria Deliver a Genotoxic Hit	SCIENCE			English	Editorial Material							COLON-CANCER; PROMOTES; TUMORIGENESIS; MICROBIOTA; INFECTION; COLITIS; DISEASE; CELLS		[Schwabe, Robert F.; Wang, Timothy C.] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University	Schwabe, RF (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	tcw21@columbia.edu	Schwabe, Robert/AAY-6506-2021	Wang, Timothy/0000-0001-5730-3019	NCI NIH HHS [U01 CA164337] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; REDDY BS, 1975, CANCER RES, V35, P287; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	15	25	25	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					52	53		10.1126/science.1229905	http://dx.doi.org/10.1126/science.1229905			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042875				2022-12-28	WOS:000309457400044
J	Reed, M; Huang, J; Graetz, I; Brand, R; Hsu, J; Fireman, B; Jaffe, M				Reed, Mary; Huang, Jie; Graetz, Ilana; Brand, Richard; Hsu, John; Fireman, Bruce; Jaffe, Marc			Outpatient Electronic Health Records and the Clinical Care and Outcomes of Patients With Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; INFORMATION-TECHNOLOGY; AMBULATORY-CARE; IMPACT	Background: Physicians can receive federal payments for meaningful use of complete certified electronic health records (EHRs). Evidence is limited on how EHR use affects clinical care and outcomes. Objective: To examine the association between use of a commercially available certified EHR and clinical care processes and disease control in patients with diabetes. Design: Quasi-experimental design with outpatient EHR implementation sequentially across 17 medical centers. Multivariate analyses adjusted for patient characteristics, medical center, time trends, and facility-level clustering. Setting: Kaiser Permanente Northern California, an integrated delivery system. Patients: 169 711 patients with diabetes mellitus. Intervention: Use of a commercially available certified EHR. Measurements: Drug treatment intensification and hemoglobin A(1c) (HbA(1c)) and low-density lipoprotein cholesterol (LDL-C) testing and values. Results: Use of an EHR was associated with statistically significant improvements in treatment intensification after HbA(1c) values of 9% or greater (odds ratio, 1.10 [95% CI, 1.05 to 1.15]) or LDL-C values of 2.6 to 3.3 mmol/L (100 to 129 mg/dL) (odds ratio, 1.06 [CI, 1.00 to 1.12]); increases in 1-year retesting for HbA(1c) and LDL-C levels among all patients, with the most dramatic change among patients with the worst disease control (HbA(1c) levels >= 9% or LDL-C levels >= 3.4 mmol/ L [>= 130 mg/dL]); and decreased 90-day retesting among patients with HbA(1c) levels less than 7% or LDL-C levels less than 2.6 mmol/ L (<100 mg/dL). The EHR was also associated with statistically significant reductions in HbA(1c) and LDL-C levels, with the largest reductions among patients with the worst control (0.06-mmol/ L [2.19-mg/dL] reduction among patients with baseline LDL-C levels >= 3.4 mmol/ L [>= 130 mg/dL]; P < 0.001). Limitation: The EHR was implemented in a setting with strong baseline performance on cardiovascular care quality measures. Conclusion: Use of a commercially available certified EHR was associated with improved drug treatment intensification, monitoring, and physiologic control among patients with diabetes, with greater improvements among patients with worse control and less testing in patients already meeting guideline-recommended glycemic and lipid targets.	[Reed, Mary] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Permanente Med Grp Inc, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Permanente Medical Groups	Reed, M (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	mary.e.reed@kp.org	Graetz, Ilana/N-1189-2016	Graetz, Ilana/0000-0003-3664-5815; Jaffe, Marc/0000-0002-5049-7815	National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK R01DK085070]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085070] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases.; By the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK R01DK085070).	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Brailer DJ, 2010, HEALTH AFFAIR, V29, P586, DOI 10.1377/hlthaff.2010.0274; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Cameron A., 2010, HDB EMPIRICAL EC FIN, V3666, P1, DOI [10.1201/b10440-2, DOI 10.1201/B10440-2]; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Costa BM, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-72; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Herrin J, 2012, HEALTH SERV RES, V47, P1522, DOI 10.1111/j.1475-6773.2011.01370.x; Jha AK, 2010, JAMA-J AM MED ASSOC, V304, P1709, DOI 10.1001/jama.2010.1497; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Mangione CM, 2006, ANN INTERN MED, V145, P107, DOI 10.7326/0003-4819-145-2-200607180-00008; O'Connor PJ, 2005, ANN FAM MED, V3, P300, DOI 10.1370/afm.327; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sequist TD, 2005, J AM MED INFORM ASSN, V12, P431, DOI 10.1197/jamia.M1788; Sharma M, 2009, ANN INTERN MED, V151, P622, DOI 10.7326/0003-4819-151-9-200911030-00144; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; StataCorp, 2007, STAT BAS REF MAN REL; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Zhou L, 2009, J AM MED INFORM ASSN, V16, P457, DOI 10.1197/jamia.M3128	21	79	79	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					482	U66		10.7326/0003-4819-157-7-201210020-00004	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	016MQ	23027319	Green Accepted			2022-12-28	WOS:000309523200003
J	Tharmalingam, H; Morris, TC; Farnsworth, J; Kanfer, EJ				Tharmalingam, Hannah; Morris, Thomas C.; Farnsworth, Joanna; Kanfer, Edward J.			Headache and visual aura in an immunocompromised patient	BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE-MARROW-TRANSPLANTATION; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; CENTRAL-NERVOUS-SYSTEM; CRYPTOCOCCAL MENINGITIS; LYMPHOPROLIFERATIVE DISORDERS; TUBERCULOUS MENINGITIS; ADULTS; RISK; CT; TOXOPLASMOSIS		[Tharmalingam, Hannah; Morris, Thomas C.; Farnsworth, Joanna; Kanfer, Edward J.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England	Imperial College London	Tharmalingam, H (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Du Cane Rd, London W12 0HS, England.	hannahtharmalingam@doctors.org.uk						[Anonymous], WHOHTMTB20103; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Buell JF, 2005, TRANSPL P, V37, P954, DOI 10.1016/j.transproceed.2004.12.130; Curtis RE, 1999, BLOOD, V94, P2208; DOORLY TP, 1987, J NEUROL NEUROSUR PS, V50, P1048, DOI 10.1136/jnnp.50.8.1048; Gross TG, 1999, BONE MARROW TRANSPL, V23, P251, DOI 10.1038/sj.bmt.1701554; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Hasegawa W, 2005, BONE MARROW TRANSPL, V35, P51, DOI 10.1038/sj.bmt.1704706; Kolb HJ, 1999, ANN INTERN MED, V131, P738, DOI 10.7326/0003-4819-131-10-199911160-00004; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mwaba P, 2001, POSTGRAD MED J, V77, P769, DOI 10.1136/pmj.77.914.769; ODONNELL MR, 1994, J CLIN ONCOL, V12, P827, DOI 10.1200/JCO.1994.12.4.827; Ozates M, 2000, ACTA RADIOL, V41, P13; POPOVICH MJ, 1990, AM J ROENTGENOL, V154, P603, DOI 10.2214/ajr.154.3.2106227; PORTER SB, 1992, NEW ENGL J MED, V327, P1643, DOI 10.1056/NEJM199212033272306; Saha DC, 2009, J MED MICROBIOL, V58, P1098, DOI 10.1099/jmm.0.007328-0; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Wasay M, 2003, J NEUROIMAGING, V13, P240, DOI 10.1177/1051228403013003007	20	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 2	2012	345								e6507	10.1136/bmj.e6507	http://dx.doi.org/10.1136/bmj.e6507			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KN	23033365				2022-12-28	WOS:000309659300007
J	Du, JM; Zhong, XH; Bernatavichute, YV; Stroud, H; Feng, SH; Caro, E; Vashisht, AA; Terragni, J; Chin, HG; Tu, A; Hetzel, J; Wohlschlegel, JA; Pradhan, S; Patel, DJ; Jacobsen, SE				Du, Jiamu; Zhong, Xuehua; Bernatavichute, Yana V.; Stroud, Hume; Feng, Suhua; Caro, Elena; Vashisht, Ajay A.; Terragni, Jolyon; Chin, Hang Gyeong; Tu, Andy; Hetzel, Jonathan; Wohlschlegel, James A.; Pradhan, Sriharsa; Patel, Dinshaw J.; Jacobsen, Steven E.			Dual Binding of Chromomethylase Domains to H3K9me2-Containing Nucleosomes Directs DNA Methylation in Plants	CELL			English	Article							HISTONE H3; STRUCTURAL BASIS; BAH DOMAIN; ARABIDOPSIS; RECOGNITION; MAINTENANCE; UHRF1; DIMETHYLATION; SPECIFICITY; MECHANISM	DNA methylation and histone modification exert epigenetic control over gene expression. CHG methylation by CHROMOMETHYLASE3 (CMT3) depends on histone H3K9 dimethylation (H3K9me2), but the mechanism underlying this relationship is poorly understood. Here, we report multiple lines of evidence that CMT3 interacts with H3K9me2-containing nucleosomes. CMT3 genome locations nearly perfectly correlated with H3K9me2, and CMT3 stably associated with H3K9me2-containing nucleosomes. Crystal structures of maize CMT3 homolog ZMET2, in complex with H3K9me2 peptides, showed that ZMET2 binds H3K9me2 via both bromo adjacent homology (BAH) and chromo domains. The structures reveal an aromatic cage within both BAH and chromo domains as interaction interfaces that capture H3K9me2. Mutations that abolish either interaction disrupt CMT3 binding to nucleosomes and show a complete loss of CMT3 activity in vivo. Our study establishes dual recognition of H3K9me2 marks by BAH and chromo domains and reveals a distinct mechanism of interplay between DNA methylation and histone modification.	[Du, Jiamu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Zhong, Xuehua; Bernatavichute, Yana V.; Stroud, Hume; Feng, Suhua; Caro, Elena; Tu, Andy; Hetzel, Jonathan; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Terragni, Jolyon; Chin, Hang Gyeong; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA	Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New England Biolabs	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; jacobsen@ucla.edu	Du, Jiamu/G-3308-2010; Caro, Elena/G-6352-2012; Caro, Elena/D-2611-2014; Stroud, Hume/ABF-1325-2021; Du, Jiamu/I-1334-2013	Caro, Elena/0000-0002-1034-1621; Du, Jiamu/0000-0002-1337-0786	Ruth L. Kirschstein National Research Service Award [F32GM096483-01]; Leukemia & Lymphoma Society; Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH [GM089778, GM60398]; UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778, F32GM096483, R01GM060398, R37GM060398] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anders Lindroth and Debasis Patnak for initiating CMT3 in vitro activity assays, staff members at APS for support in diffraction data collection and at UCLA BSCRC BioSequencing core for high-throughput sequencing, and Nathan Springer and Shawn Kaeppler for providing ZMET2 gene. We are also grateful to Lianna Johnson for help with histone peptide array experiments, Greg Horwitz for help with baculoviral protein expression, and their critical reading of this manuscript. X.Z. is supported by Ruth L. Kirschstein National Research Service Award (F32GM096483-01). S.F. is supported by Leukemia & Lymphoma Society. This work was supported by the Abby Rockefeller Mauze Trust and the Maloris and STARR foundations to D.J.P., NIH grant GM089778 and the UCLA Jonsson Cancer Center to J.A.W., and NIH grant GM60398 to S.E.J. S.E.J. is an Investigator at the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bartee L, 2001, NUCLEIC ACIDS RES, V29, P2127, DOI 10.1093/nar/29.10.2127; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chang YQ, 2011, J MOL BIOL, V408, P807, DOI 10.1016/j.jmb.2011.03.018; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012	41	309	318	2	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					167	180		10.1016/j.cell.2012.07.034	http://dx.doi.org/10.1016/j.cell.2012.07.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021223	Bronze, Green Accepted			2022-12-28	WOS:000309544200018
J	Littlewood, TD; Kreuzaler, P; Evan, GI				Littlewood, Trevor D.; Kreuzaler, Peter; Evan, Gerard I.			All Things to All People	CELL			English	Editorial Material								Myc is an enigma wrapped in a mystery. Attempts to identify Myc target genes, particularly in cancer, have been fraught with dead ends and context-specific functions. Lin et al. and Nie et al. address this conundrum by showing that Myc acts to amplify the output of existing transcriptionally active genes.	[Littlewood, Trevor D.; Kreuzaler, Peter; Evan, Gerard I.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Evan, GI (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	gie20@cam.ac.uk		Kreuzaler, Peter/0000-0001-8684-9424	Cancer Research UK [13061, 12077] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030	6	23	25	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					11	13		10.1016/j.cell.2012.09.006	http://dx.doi.org/10.1016/j.cell.2012.09.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021211	Bronze			2022-12-28	WOS:000309544200006
J	Gornall, J				Gornall, Jonathan			SMOKING CESSATION Electronic cigarettes: medical device or consumer product?	BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						MHRA, 2010, PUBL CONS MLX 364 RE; MHRA, 2010, DRUG SAFETY UPDATE, V3, P6; MHRA (Medicines Healthcare products Regulatory Agency), 2010, CONS LETT MLX 364 RE	3	5	5	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6417	10.1136/bmj.e6417	http://dx.doi.org/10.1136/bmj.e6417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014904				2022-12-28	WOS:000309385500010
J	Ginn, S				Ginn, Stephen			Prison environment and health	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Ginn, S (corresponding author), BMJ, London WC1H 9JR, England.	mail@stephenginn.com						Berman G., 2012, PRISON POPULATION ST; Edwards A, 1982, PRISONS 2 CENTURIES; HM Chief Inspector of Prisons, 1996, PAT PRIS NEW STRAT H; International centre for prison studies, WORLD PRIS BRIEF; International Centre for Prison Studies, 2012, WORLD PRIS BRIEF ENG; Jewkes Y., 2005, CRIMINAL JUSTICE MAT, V59; Ministry of Justice, POP CAP BRIEF FRID 1; Ministry of Justice, 2012, PRIS POP MONTHL B; Ministry of Justice, 2012, OFF MAN STAT Q B; Northern Ireland Prison Service, AN NIPS PRIS POP 1 7; Office for National Statistics, CRIM ENGL WAL Q 1 RE; Prison Reform Trust, 2012, BROML BRIEF PRIS FAC; Scottish Prison Service, 2012, PRIS POP FRID 6 JUL; Sim J., 1990, MED POWER PRISONS; Smith R., 1984, PRISON HEALTHCARE	15	28	28	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 17	2012	345								e5921	10.1136/bmj.e5921	http://dx.doi.org/10.1136/bmj.e5921			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JG	22988305				2022-12-28	WOS:000309160300002
J	Stevens, PE; Farmer, CK				Stevens, Paul E.; Farmer, Christopher K.			Association of kidney disease measures with poor outcomes	LANCET			English	Editorial Material							COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA		[Stevens, Paul E.; Farmer, Christopher K.] E Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England		Stevens, PE (corresponding author), E Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England.	paul.stevens@ekht.nhs.uk		Farmer, Christopher/0000-0003-1736-8242				Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Crowe E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1530; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fox CS, 2012, LANCET; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Glassock RJ, 2010, CURR OPIN NEPHROL HY, V19, P123, DOI 10.1097/MNH.0b013e328335f951; Kidney Disease Improving Global Outcomes, KDIGO CLIN PRACT GUI; Lentine KL, 2012, ADV CHRONIC KIDNEY D, V19, P220, DOI 10.1053/j.ackd.2011.09.005; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levin A, 2011, NAT REV NEPHROL, V7, P446, DOI 10.1038/nrneph.2011.86; Mahmoodi BK, 2012, LANCET; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1628	1630		10.1016/S0140-6736(12)61300-2	http://dx.doi.org/10.1016/S0140-6736(12)61300-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23013601				2022-12-28	WOS:000310951400007
J	Colbert, JA				Colbert, James A.			Preexposure Prophylaxis for HIV Prevention - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION											Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Karim SSA, 2012, NEW ENGL J MED, V367, P462, DOI 10.1056/NEJMclde1207706; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	3	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15								10.1056/NEJMclde1211517	http://dx.doi.org/10.1056/NEJMclde1211517			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23013053				2022-12-28	WOS:000309652700017
J	de Ruyter, JC; Olthof, MR; Seidell, JC; Katan, MB				de Ruyter, Janne C.; Olthof, Margreet R.; Seidell, Jacob C.; Katan, Martijn B.			A Trial of Sugar-free or Sugar-Sweetened Beverages and Body Weight in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MASS INDEX; NONNUTRITIVE SWEETENERS; INTERNATIONAL SURVEY; PRESCHOOL-CHILDREN; CLINICAL-TRIALS; ENERGY-BALANCE; US CHILDREN; FOOD-INTAKE; CONSUMPTION; OBESITY	Background The consumption of beverages that contain sugar is associated with overweight, possibly because liquid sugars do not lead to a sense of satiety, so the consumption of other foods is not reduced. However, data are lacking to show that the replacement of sugar-containing beverages with noncaloric beverages diminishes weight gain. Methods We conducted an 18-month trial involving 641 primarily normal-weight children from 4 years 10 months to 11 years 11 months of age. Participants were randomly assigned to receive 250 ml (8 oz) per day of a sugar-free, artificially sweetened beverage (sugar-free group) or a similar sugar-containing beverage that provided 104 kcal (sugar group). Beverages were distributed through schools. At 18 months, 26% of the children had stopped consuming the beverages; the data from children who did not complete the study were imputed. Results The z score for the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) increased on average by 0.02 SD units in the sugar-free group and by 0.15 SD units in the sugar group; the 95% confidence interval (CI) of the difference was -0.21 to -0.05. Weight increased by 6.35 kg in the sugar-free group as compared with 7.37 kg in the sugar group (95% CI for the difference, -1.54 to -0.48). The skinfold-thickness measurements, waist-to-height ratio, and fat mass also increased significantly less in the sugar-free group. Adverse events were minor. When we combined measurements at 18 months in 136 children who had discontinued the study with those in 477 children who completed the study, the BMI z score increased by 0.06 SD units in the sugar-free group and by 0.12 SD units in the sugar group (P = 0.06). Conclusions Masked replacement of sugar-containing beverages with noncaloric beverages reduced weight gain and fat accumulation in normal-weight children. (Funded by the Netherlands Organization for Health Research and Development and others; DRINK ClinicalTrials.gov number, NCT00893529.)	[de Ruyter, Janne C.] Vrije Univ Amsterdam, Fac Earth & Life Sci, EMGO Inst Hlth & Care Res, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	de Ruyter, JC (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, EMGO Inst Hlth & Care Res, Dept Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	j.c.de.ruyter@vu.nl	Katan, Martijn/ABB-6613-2021; seidell, jacob c/N-7427-2013; seidell, jacob/AAF-5362-2019	seidell, jacob/0000-0002-9262-9062; , Margreet/0000-0002-1982-9244	Netherlands Organization for Health Research and Development [120520010]; Netherlands Heart Foundation [2008B096]; Royal Netherlands Academy of Arts and Sciences [ISK/741/PAH]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); Royal Netherlands Academy of Arts and Sciences	Supported by grants from the Netherlands Organization for Health Research and Development (120520010), the Netherlands Heart Foundation (2008B096), and the Royal Netherlands Academy of Arts and Sciences (ISK/741/PAH).	Ajala O, 2011, INT J PEDIATR OBES, V6, P223, DOI 10.3109/17477166.2011.583662; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Berkey CS, 2007, ANN EPIDEMIOL, V17, P44, DOI 10.1016/j.annepidem.2006.07.014; Blundell JE, 1996, INT J OBESITY, V20, pS12; Buyken AE, 2009, AM J CLIN NUTR, V89, P221, DOI 10.3945/ajcn.2008.26733; Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Ruyter JC, 2012, CONTEMP CLIN TRIALS, V33, P247, DOI 10.1016/j.cct.2011.10.007; DEURENBERG P, 1990, BRIT J NUTR, V63, P293, DOI 10.1079/BJN19900116; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Dubois L, 2007, J AM DIET ASSOC, V107, P924, DOI 10.1016/j.jada.2007.03.004; Ducher G, 2009, AM J CLIN NUTR, V90, P1104, DOI 10.3945/ajcn.2009.28025; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Fergusson D, 2004, BRIT MED J, V328, P432, DOI 10.1136/bmj.37952.631667.EE; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Foreyt J, 2012, J NUTR, V142, p1155S, DOI 10.3945/jn.111.149609; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; Hrobjartsson A, 2007, INT J EPIDEMIOL, V36, P654, DOI 10.1093/ije/dym020; James J, 2004, BRIT MED J, V328, P1236; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Mattes R, 2006, PHYSIOL BEHAV, V89, P66, DOI 10.1016/j.physbeh.2006.01.023; McIntyre MH, 2012, ANN HUM BIOL, V39, P264, DOI 10.3109/03014460.2012.678661; McIntyre MH, 2011, ANN HUM BIOL, V38, P716, DOI 10.3109/03014460.2011.613853; Mumby HS, 2011, J OBES, V2011, DOI 10.1155/2011/180729; Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020; O'Connor TM, 2006, PEDIATRICS, V118, pE1010, DOI 10.1542/peds.2005-2348; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Ong KK, 2009, J CLIN ENDOCR METAB, V94, P1527, DOI 10.1210/jc.2008-2489; Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536; Pepino MY, 2011, CURR OPIN CLIN NUTR, V14, P391, DOI 10.1097/MCO.0b013e3283468e7e; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; Raben A, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.5961; Renwick AG, 2010, BRIT J NUTR, V104, P1415, DOI 10.1017/S0007114510002540; Roberts A, 2000, FOOD CHEM TOXICOL, V38, pS31, DOI 10.1016/S0278-6915(00)00026-0; Rush EC, 2003, EUR J CLIN NUTR, V57, P1394, DOI 10.1038/sj.ejcn.1601701; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; TREMBLAY A, 1992, AM J CLIN NUTR, V56, P857, DOI 10.1093/ajcn/56.5.857; Treuth MS, 2003, AM J CLIN NUTR, V78, P1212, DOI 10.1093/ajcn/78.6.1212; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; Yang DJ, 2009, J AGR FOOD CHEM, V57, P3022, DOI 10.1021/jf803988u	51	540	549	11	239	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1397	1406		10.1056/NEJMoa1203034	http://dx.doi.org/10.1056/NEJMoa1203034			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	22998340	Green Published, Bronze			2022-12-28	WOS:000309652700006
J	Pomeranz, JL; Brownell, KD				Pomeranz, Jennifer L.; Brownell, Kelly D.			Portion Sizes and Beyond - Government's Legal Authority to Regulate Food-Industry Practices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pomeranz, Jennifer L.; Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA	Yale University	Pomeranz, JL (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA.								0	18	18	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1383	1385		10.1056/NEJMp1208167	http://dx.doi.org/10.1056/NEJMp1208167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	22998343				2022-12-28	WOS:000309652700004
J	Qi, QB; Chu, AY; Kang, JH; Jensen, MK; Curhan, GC; Pasquale, LR; Ridker, PM; Hunter, DJ; Willett, WC; Rimm, EB; Chasman, DI; Hu, FB; Qi, L				Qi, Qibin; Chu, Audrey Y.; Kang, Jae H.; Jensen, Majken K.; Curhan, Gary C.; Pasquale, Louis R.; Ridker, Paul M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Chasman, Daniel I.; Hu, Frank B.; Qi, Lu			Sugar-Sweetened Beverages and Genetic Risk of Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; WEIGHT-GAIN; FOOD-INTAKE; VARIANTS; HEALTH; REPRODUCIBILITY; VALIDITY; DISEASE	BACKGROUND Temporal increases in the consumption of sugar-sweetened beverages have paralleled the rise in obesity prevalence, but whether the intake of such beverages interacts with the genetic predisposition to adiposity is unknown. METHODS We analyzed the interaction between genetic predisposition and the intake of sugar-sweetened beverages in relation to body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) and obesity risk in 6934 women from the Nurses' Health Study (NHS) and in 4423 men from the Health Professionals Follow-up Study (HPFS) and also in a replication cohort of 21,740 women from the Women's Genome Health Study (WGHS). The genetic-predisposition score was calculated on the basis of 32 BMI-associated loci. The intake of sugar-sweetened beverages was examined prospectively in relation to BMI. RESULTS In the NHS and HPFS cohorts, the genetic association with BMI was stronger among participants with higher intake of sugar-sweetened beverages than among those with lower intake. In the combined cohorts, the increases in BMI per increment of 10 risk alleles were 1.00 for an intake of less than one serving per month, 1.12 for one to four servings per month, 1.38 for two to six servings per week, and 1.78 for one or more servings per day (P < 0.001 for interaction). For the same categories of intake, the relative risks of incident obesity per increment of 10 risk alleles were 1.19 (95% confidence interval [CI], 0.90 to 1.59), 1.67 (95% CI, 1.28 to 2.16), 1.58 (95% CI, 1.01 to 2.47), and 5.06 (95% CI, 1.66 to 15.5) (P = 0.02 for interaction). In the WGHS cohort, the increases in BMI per increment of 10 risk alleles were 1.39, 1.64, 1.90, and 2.53 across the four categories of intake (P = 0.001 for interaction); the relative risks for incident obesity were 1.40 (95% CI, 1.19 to 1.64), 1.50 (95% CI, 1.16 to 1.93), 1.54 (95% CI, 1.21 to 1.94), and 3.16 (95% CI, 2.03 to 4.92), respectively (P = 0.007 for interaction). CONCLUSIONS The genetic association with adiposity appeared to be more pronounced with greater intake of sugar-sweetened beverages. (Funded by the National Institutes of Health and others.)	[Qi, Qibin; Jensen, Majken K.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Curhan, Gary C.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chu, Audrey Y.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Dis, Boston, MA 02115 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Kang, Jae H.; Curhan, Gary C.; Pasquale, Louis R.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Pasquale, Louis R.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Qi, L (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	nhlqi@channing.harvard.edu	Qi, Qibin/H-9055-2012	Jensen, Majken Karoline/0000-0003-4729-7545; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health; National Institutes of Health [DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, 5P30DK46200, U54CA155626, DK58845, U01HG004728-02, EY015473, DK70756, DK46200, HL043851, HL69757, CA047988]; Merck Research Laboratories; American Heart Association Scientist Development Award [0730094N]; Research to Prevent Blindness award; Harvard Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; Amgen; Genzyme; Isis Pharmaceuticals; Vascular Biogenics; Merck; Abbott; Novartis; AstraZeneca; Novo Nordisk; California Walnut Commission; Kellogg; NATIONAL CANCER INSTITUTE [P01CA055075, P01CA087969, R01CA049449, U01CA049449, U54CA155626, R01CA047988] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015473] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL069757, R01HL034594, R01HL071981, T32HL007575, R01HL073168, R01HL088521, U01HL069757, R01HL043851] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004728, U01HG004399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756, K24DK080140, R01DK091718, R01DK058845, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); American Heart Association Scientist Development Award(American Heart Association); Research to Prevent Blindness award(Research to Prevent Blindness (RPB)); Harvard Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; Amgen(Amgen); Genzyme(Sanofi-AventisGenzyme Corporation); Isis Pharmaceuticals; Vascular Biogenics; Merck(Merck & Company); Abbott(Abbott Laboratories); Novartis(Novartis); AstraZeneca(AstraZeneca); Novo Nordisk(Novo Nordisk); California Walnut Commission; Kellogg; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.; Supported by grants (DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, 5P30DK46200, U54CA155626, DK58845, U01HG004728-02, EY015473, DK70756, and DK46200) from the National Institutes of Health, with additional support for genotyping from Merck Research Laboratories; an American Heart Association Scientist Development Award (0730094N, to Dr. L. Qi); and a Research to Prevent Blindness award and a Harvard Ophthalmology Scholar Award (both to Dr. Pasquale) from the Harvard Glaucoma Center of Excellence. The WGHS is supported by grants (HL043851, HL69757, and CA047988) from the National Institutes of Health, with collaborative scientific support and funding for genotyping provided by Amgen.; Dr. Ridker reports receiving consulting fees from Genzyme, Isis Pharmaceuticals, Vascular Biogenics, Merck, and Abbott and grant support to his institution from Novartis and AstraZeneca and being listed as a co-inventor on patents held by his institution that relate to the use of inflammatory biomarkers in cardiovascular disease and diabetes (patent and royalty payments are received by Brigham and Women's Hospital); Dr. Hu, receiving consulting fees from Novo Nordisk and grant support to his institution from Merck and the California Walnut Commission; and Dr. L. Qi, receiving lecture fees from Kellogg. No other potential conflict of interest relevant to this article was reported.	Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Jonsson A, 2010, DIABETOLOGIA, V53, P1244, DOI 10.1007/s00125-010-1709-9; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Popkin BM, 2010, PHYSIOL BEHAV, V100, P4, DOI 10.1016/j.physbeh.2009.12.022; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Rampersaud E, 2009, ARCH INTERN MED, V169, P453; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tan JT, 2008, DIABETES, V57, P2851, DOI 10.2337/db08-0214; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	44	368	381	4	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1387	1396		10.1056/NEJMoa1203039	http://dx.doi.org/10.1056/NEJMoa1203039			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	22998338	Green Accepted			2022-12-28	WOS:000309652700005
J	Meyer, L; Ghez, AM; Schodel, R; Yelda, S; Boehle, A; Lu, JR; Do, T; Morris, MR; Becklin, EE; Matthews, K				Meyer, L.; Ghez, A. M.; Schoedel, R.; Yelda, S.; Boehle, A.; Lu, J. R.; Do, T.; Morris, M. R.; Becklin, E. E.; Matthews, K.			The Shortest-Known-Period Star Orbiting Our Galaxy's Supermassive Black Hole	SCIENCE			English	Article							SAGITTARIUS-A-ASTERISK; GALACTIC-CENTER; STELLAR ORBITS; PROPER MOTIONS; MILKY; S2	Stars with short orbital periods at the center of our Galaxy offer a powerful probe of a supermassive black hole. Over the past 17 years, the W. M. Keck Observatory has been used to image the galactic center at the highest angular resolution possible today. By adding to this data set and advancing methodologies, we have detected S0-102, a star orbiting our Galaxy's supermassive black hole with a period of just 11.5 years. S0-102 doubles the number of known stars with full phase coverage and periods of less than 20 years. It thereby provides the opportunity, with future measurements, to resolve degeneracies in the parameters describing the central gravitational potential and to test Einstein's theory of general relativity in an unexplored regime.	[Meyer, L.; Ghez, A. M.; Yelda, S.; Boehle, A.; Morris, M. R.; Becklin, E. E.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Schoedel, R.] Inst Astrofis Andalucia CSIC, Granada 18008, Spain; [Lu, J. R.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Do, T.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Do, T.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Matthews, K.] CALTECH, Div Math Phys & Astron, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Hawaii System; University of California System; University of California Irvine; University of Toronto; California Institute of Technology	Ghez, AM (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	ghez@astro.ucla.edu	; Schoedel, Rainer/D-4751-2014	Do, Tuan/0000-0001-9554-6062; Schoedel, Rainer/0000-0001-5404-797X; Morris, Mark/0000-0002-6753-2066; Lu, Jessica/0000-0001-9611-0009	NSF [AST 0909218]; Levine-Leichtman Family Foundation; W. M. Keck Foundation; Ramon y Cajal program; Spanish Ministerio de Economia y Competitividad [AYA2010-17631, AYA2009-13036, PA1002584]; Junta de Andalucia [P08-TIC-4075]	NSF(National Science Foundation (NSF)); Levine-Leichtman Family Foundation; W. M. Keck Foundation(W.M. Keck Foundation); Ramon y Cajal program(Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia(Junta de Andalucia)	We thank the staff of the Keck Observatory for all their help in obtaining the new observations. Support for this work was provided by NSF grant AST 0909218, the Levine-Leichtman Family Foundation, and the W. M. Keck Foundation. R.S. acknowledges support by the Ramon y Cajal program; by grants AYA2010-17631, AYA2009-13036, and PA1002584 of the Spanish Ministerio de Economia y Competitividad; and by grant P08-TIC-4075 of the Junta de Andalucia. The W. M. Keck Observatory is operated as a scientific partnership among the California Institute of Technology, the University of California, and the National Aeronautics and Space Administration. The observatory was made possible by the generous financial support of the W. M. Keck Foundation. The authors wish to recognize and acknowledge the very significant cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. The data described in the paper are presented in the supplementary materials.	Angelil R, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L19; Angelil R, 2010, ASTROPHYS J, V720, P1303, DOI 10.1088/0004-637X/720/2/1303; Diolaiti E, 2000, ASTRON ASTROPHYS SUP, V147, P335, DOI 10.1051/aas:2000305; Eckart A, 1997, MON NOT R ASTRON SOC, V284, P576, DOI 10.1093/mnras/284.3.576; Eckart A, 2002, MON NOT R ASTRON SOC, V331, P917, DOI 10.1046/j.1365-8711.2002.05237.x; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; Ghez AM, 2000, NATURE, V407, P349, DOI 10.1038/35030032; Ghez AM, 2005, ASTROPHYS J, V635, P1087, DOI 10.1086/497576; Ghez AM, 2003, ASTROPHYS J, V586, pL127, DOI 10.1086/374804; Ghez AM, 1998, ASTROPHYS J, V509, P678, DOI 10.1086/306528; Gillessen S, 2009, ASTROPHYS J LETT, V707, pL114, DOI 10.1088/0004-637X/707/2/L114; Gillessen S, 2009, ASTROPHYS J, V692, P1075, DOI 10.1088/0004-637X/692/2/1075; Gualandris A, 2010, MON NOT R ASTRON SOC, V409, P1146, DOI 10.1111/j.1365-2966.2010.17373.x; Hartkopf WI, 2001, ASTRON J, V122, P3472, DOI 10.1086/323921; Hornstein SD, 2007, ASTROPHYS J, V667, P900, DOI 10.1086/520762; Jaroszynski M, 1998, ACTA ASTRONOM, V48, P653; Lu JR, 2009, ASTROPHYS J, V690, P1463, DOI 10.1088/0004-637X/690/2/1463; Matthews K, 1996, PUBL ASTRON SOC PAC, V108, P615, DOI 10.1086/133773; Matthews K., 1994, ASTRONOMY INFRARED A, P239; Merritt D, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.062002; Miralda-Escude J, 2000, ASTROPHYS J, V545, P847, DOI 10.1086/317837; MORRIS M, 1993, ASTROPHYS J, V408, P496, DOI 10.1086/172607; Rubilar GF, 2001, ASTRON ASTROPHYS, V374, P95, DOI 10.1051/0004-6361:20010640; Schodel R, 2002, NATURE, V419, P694, DOI 10.1038/nature01121; Weinberg NN, 2005, ASTROPHYS J, V622, P878, DOI 10.1086/428079; Will CM, 2006, LIVING REV RELATIV, V9, DOI 10.12942/lrr-2006-3; Zucker S, 2006, ASTROPHYS J, V639, pL21, DOI 10.1086/501436	29	151	152	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					84	87		10.1126/science.1225506	http://dx.doi.org/10.1126/science.1225506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042888	Green Accepted, Green Submitted			2022-12-28	WOS:000309457400057
J	Emmerich, J; Dumarcet, N; Lorence, A				Emmerich, Joseph; Dumarcet, Nathalie; Lorence, Annie			France's New Framework for Regulating Off-Label Drug Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Emmerich, Joseph; Dumarcet, Nathalie; Lorence, Annie] Agence Natl Securite Med & Prod Sante, St Denis, France		Emmerich, J (corresponding author), Agence Natl Securite Med & Prod Sante, St Denis, France.							Eichler HG, 2008, NAT REV DRUG DISCOV, V7, P818, DOI 10.1038/nrd2664; FERNER RE, 1996, PRESCRIBERS J, V36, P73; Mello MM, 2009, NEW ENGL J MED, V360, P1557, DOI 10.1056/NEJMhle0807695; Mullard A, 2011, LANCET, V377, P890, DOI 10.1016/S0140-6736(11)60334-6; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107	5	43	49	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1279	1281		10.1056/NEJMp1208347	http://dx.doi.org/10.1056/NEJMp1208347			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014WJ	23034018				2022-12-28	WOS:000309406100002
J	Victora, CG; Barros, AJD; Axelson, H; Bhutta, ZA; Chopra, M; Franca, GVA; Kerber, K; Kirkwood, BR; Newby, H; Ronsmans, C; Boerma, JT				Victora, Cesar G.; Barros, Aluisio J. D.; Axelson, Henrik; Bhutta, Zulfiqar A.; Chopra, Mickey; Franca, Giovanny V. A.; Kerber, Kate; Kirkwood, Betty R.; Newby, Holly; Ronsmans, Carine; Boerma, J. Ties			How changes in coverage affect equity in maternal and child health interventions in 35 Countdown to 2015 countries: an analysis of national surveys	LANCET			English	Article							SOCIOECONOMIC INEQUALITIES; INEQUITIES; MORTALITY; NEWBORN; WEALTH; TRENDS; INCOME	Background Achievement of global health goals will require assessment of progress not only nationally but also for population subgroups. We aimed to assess how the magnitude of socioeconomic inequalities in health changes in relation to different rates of national progress in coverage of interventions for the health of mothers and children. Methods We assessed coverage in low-income and middle-income countries for which two Demographic Health Surveys or Multiple Indicator Cluster Surveys were available. We calculated changes in overall coverage of skilled birth attendants, measles vaccination, and a composite coverage index, and examined coverage of a newly introduced intervention, use of insecticide-treated bednets by children. We stratified coverage data according to asset-based wealth quintiles, and calculated relative and absolute indices of inequality. We adjusted correlation analyses for time between surveys and baseline coverage levels. Findings We included 35 countries with surveys done an average of 9.1 years apart. Pro-rich inequalities were very prevalent. We noted increased coverage of skilled birth attendants, measles vaccination, and the composite index in most countries from the first to the second survey, while inequalities were reduced. Rapid changes in overall coverage were associated with improved equity. These findings were not due to a capping effect associated with limited scope for improvement in rich households. For use of insecticide-treated bednets, coverage was high for the richest households, but countries making rapid progress did almost as well in reaching the poorest groups. National increases in coverage were primarily driven by how rapidly coverage increased in the poorest quintiles. Interpretation Equity should be accounted for when planning the scaling up of interventions and assessing national progress.	[Victora, Cesar G.; Barros, Aluisio J. D.; Franca, Giovanny V. A.] Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96020220 Pelotas, Brazil; [Axelson, Henrik] Lund Univ, Dept Econ, Lund, Sweden; [Axelson, Henrik] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan; [Chopra, Mickey; Newby, Holly] UN Childrens Fund, New York, NY USA; [Kerber, Kate] Save Children, Cape Town, South Africa; [Kirkwood, Betty R.; Ronsmans, Carine] London Sch Hyg & Trop Med, London WC1, England; [Boerma, J. Ties] WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland	Universidade Federal de Pelotas; Lund University; Aga Khan University; Save the Children; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Victora, CG (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96020220 Pelotas, Brazil.	cvictora@gmail.com	Victora, Cesar Gomes/Y-2455-2019; de França, Giovanny Vinícius Araújo/L-7385-2018; Victora, Cesar G/D-4476-2013; Barros, Aluisio JD/A-7417-2008	Victora, Cesar Gomes/0000-0002-2465-2180; de França, Giovanny Vinícius Araújo/0000-0002-7530-2017; Victora, Cesar G/0000-0002-2465-2180; Barros, Aluisio JD/0000-0002-2022-8729; Kirkwood, Betty/0000-0001-5274-6072	Bill & Melinda Gates Foundation; World Bank; Government of Australia; Government of Brazil; Government of Canada; Government of Norway; Government of Sweden; Government of UK	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Bank(The World Bank India); Government of Australia; Government of Brazil; Government of Canada(CGIAR); Government of Norway; Government of Sweden; Government of UK	Bill & Melinda Gates Foundation; World Bank; Governments of Australia, Brazil, Canada, Norway, Sweden, and UK.	[Anonymous], 2012, REPORT SECRETARY GEN; [Anonymous], 2008, ASSESSING ASSET INDI; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Commission on information and accountability for women's and children's health, 2011, KEEP PROM MEAS RES; Feng XL, 2011, B WORLD HEALTH ORGAN, V89, P432, DOI 10.2471/BLT.10.085274; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Horta BL, 2011, ATHEROSCLEROSIS, V219, P815, DOI 10.1016/j.atherosclerosis.2011.08.018; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Rutstein S. O., 2004, DHS WEALTH INDEX; Speybroeck N, 2012, INT J PUBLIC HEALTH, V57, P855, DOI 10.1007/s00038-012-0386-5; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; WHO/UNICEF, 2012, COUNTD 2015 BUILD FU	22	169	171	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1149	1156		10.1016/S0140-6736(12)61427-5	http://dx.doi.org/10.1016/S0140-6736(12)61427-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	012SD	22999433				2022-12-28	WOS:000309255900032
J	Nie, ZQ; Hu, GQ; Wei, G; Cui, KR; Yamane, A; Resch, W; Wang, RN; Green, DR; Tessarollo, L; Casellas, R; Zhao, KJ; Levens, D				Nie, Zuqin; Hu, Gangqing; Wei, Gang; Cui, Kairong; Yamane, Arito; Resch, Wolfgang; Wang, Ruoning; Green, Douglas R.; Tessarollo, Lino; Casellas, Rafael; Zhao, Keji; Levens, David			c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells	CELL			English	Article							GRAPHICAL USER-INTERFACE; TRANSCRIPTION FACTOR MYC; LYMPHOMA CELLS; RNA-POLYMERASE; ACTIVATION; MOUSE; FIBROBLASTS; ONCOGENES; REVEALS; GENOME	The c-Myc HLH-bZIP protein has been implicated in physiological or pathological growth, proliferation, apoptosis, metabolism, and differentiation at the cellular, tissue, or organismal levels via regulation of numerous target genes. No principle yet unifies Myc action due partly to an incomplete inventory and functional accounting of Myc's targets. To observe Myc target expression and function in a system where Myc is temporally and physiologically regulated, the transcriptomes and the genome-wide distributions of Myc, RNA polymerase II, and chromatin modifications were compared during lymphocyte activation and in ES cells as well. A remarkably simple rule emerged from this quantitative analysis: Myc is not an on-off specifier of gene activity, but is a nonlinear amplifier of expression, acting universally at active genes, except for immediate early genes that are strongly induced before Myc. This rule of Myc action explains the vast majority of Myc biology observed in literature.	[Hu, Gangqing; Wei, Gang; Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, Bethesda, MD 20892 USA; [Nie, Zuqin; Levens, David] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Casellas, Rafael] NIAMS, Genom & Immun Sect, Bethesda, MD 20892 USA; [Wang, Ruoning; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Tessarollo, Lino] NCI, Neural Dev Sect, FNL, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov; levens@helix.nih.gov	Green, Douglas R/N-8083-2018; Levens, David/C-9216-2009; Hu, Gangqing/ABA-3507-2020; Wang, Ruoning/C-1683-2014; HU, GANGQING/K-5849-2012; Yamane, Arito/A-2959-2013	Green, Douglas R/0000-0002-7332-1417; Levens, David/0000-0002-7616-922X; HU, GANGQING/0000-0001-5453-6888; Resch, Wolfgang/0000-0001-7594-5963	NIH, National Cancer Institute, Center for Cancer Research; NHLBI; NIAMS; NATIONAL CANCER INSTITUTE [ZICBC011265, ZIABC011465] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank our colleagues, especially Eric Batchelor and Dan Larson for insight and valuable discussions. D.L. thanks Dirk Eick for insightful discussion. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, of NHLBI and of NIAMS. We thank the DNA Sequencing Core Facility of NHLBI for sequencing some of the ChIP-Seq libraries.	Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Alon U, 2007, INTRO SYSTEMS BIOL D; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bui Thi V, 2010, Genes Cancer, V1, P568; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Chung HJ, 2005, MOL CELLS, V20, P157; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; James L, 2002, P NATL ACAD SCI USA, V99, P10429, DOI 10.1073/pnas.162369299; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Levens David, 2010, Genes Cancer, V1, P547; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Mehmet H, 1997, CELL GROWTH DIFFER, V8, P187; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; TONINI GP, 1987, CANCER RES, V47, P4544; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wasylishen Amanda R, 2010, Genes Cancer, V1, P532, DOI 10.1177/1947601910378024; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	58	721	739	4	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					68	79		10.1016/j.cell.2012.08.033	http://dx.doi.org/10.1016/j.cell.2012.08.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021216	Green Accepted, Bronze			2022-12-28	WOS:000309544200011
J	Woo, DH; Han, KS; Shim, JW; Yoon, BE; Kim, E; Bae, JY; Oh, SJ; Hwang, EM; Marmorstein, AD; Bae, YC; Park, JY; Lee, CJ				Woo, Dong Ho; Han, Kyung-Seok; Shim, Jae Wan; Yoon, Bo-Eun; Kim, Eunju; Bae, Jin Young; Oh, Soo-Jin; Hwang, Eun Mi; Marmorstein, Alan D.; Bae, Yong Chul; Park, Jae-Yong; Lee, C. Justin			TREK-1 and Best1 Channels Mediate Fast and Slow Glutamate Release in Astrocytes upon GPCR Activation	CELL			English	Article							RAT HIPPOCAMPAL SLICES; K+ CHANNELS; SYNAPTIC-TRANSMISSION; ANION CHANNEL; RECEPTORS; EXOCYTOSIS; INHIBITION; NEURONS; CA2+; FREQUENCY	Astrocytes release glutamate upon activation of various GPCRs to exert important roles in synaptic functions. However, the molecular mechanism of release has been controversial. Here, we report two kinetically distinct modes of nonvesicular, channel-mediated glutamate release. The fast mode requires activation of G(alpha i), dissociation of G(beta gamma), and subsequent opening of glutamate-permeable, two-pore domain potassium channel TREK-1 through direct interaction between G(beta gamma) and N terminus of TREK-1. The slow mode is Ca2+ dependent and requires G(alpha q) activation and opening of glutamate-permeable, Ca2+-activated anion channel Best1. Ultrastructural analyses demonstrate that TREK-1 is preferentially localized at cell body and processes, whereas Best1 is mostly found in microdomains of astrocytes near synapses. Diffusion modeling predicts that the fast mode can target neuronal mGluR with peak glutamate concentration of 100 mu M, whereas slow mode targets neuronal NMDA receptors at around 1 mu M. Our results reveal two distinct sources of astrocytic glutamate that can differentially influence neighboring neurons.	[Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Kim, Eunju; Oh, Soo-Jin; Hwang, Eun Mi; Park, Jae-Yong; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Kim, Eunju; Oh, Soo-Jin; Hwang, Eun Mi; Park, Jae-Yong; Lee, C. Justin] Korea Inst Sci & Technol, WCI Ctr Funct Connect, Seoul 136791, South Korea; [Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Lee, C. Justin] Univ Sci & Technol UST, Neurosci Program, Taejon 305350, South Korea; [Shim, Jae Wan] Korea Inst Sci & Technol, Future Convergence Res Div, Seoul 136791, South Korea; [Shim, Jae Wan] Univ Sci & Technol, Seoul 136791, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Med Res Ctr Neural Dysfunct, Inst Hlth Sci, Dept Physiol,Sch Med, Jinju 660751, South Korea; [Bae, Jin Young; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurobiol, BK21, Taegu 700412, South Korea; [Oh, Soo-Jin] Seoul Natl Univ, Dent Res Inst, Sch Dent, Dept Cell & Dev Biol, Seoul 110749, South Korea; [Marmorstein, Alan D.] Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85711 USA; [Marmorstein, Alan D.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85711 USA	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); University of Science & Technology (UST); Korea Institute of Science & Technology (KIST); Gyeongsang National University; Kyungpook National University; Seoul National University (SNU); University of Arizona; University of Arizona	Park, JY (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea.	jaeyong@gnu.ac.kr; cjl@kist.re.kr	Lee, C. Justin/AAC-1663-2019; Hwang, Eun Mi/HHN-3030-2022	Lee, C Justin/0000-0002-3555-0980; Park, Jae-Yong/0000-0001-7698-7890	World Class Institute [WCI 2009-003]; MRC [2012-0000305]; NRF [2010-0029460]; MEST of Korea; NIH [R01-EY013160]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY013160] Funding Source: NIH RePORTER	World Class Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NRF; MEST of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the World Class Institute (WCI 2009-003), MRC (2012-0000305), and Basic Science Research (2010-0029460) Programs of the NRF funded by the MEST of Korea and also by NIH (R01-EY013160) and a grant from Research to Prevent Blindness to the Department of Ophthalmology and Vision Science at the University of Arizona. We thank George Augustine, Larry Cohen, and Keiko Tanaka for careful editing of the manuscript. We thank Taekeun Kim for technical support for immunocytochemistry, Nammi Park for technical support for Y2H, Lucie Langevin for providing clone of pRK-beta-Ark-C terminus, and Nevin A. Lambert for pCDNA3.1-SS-ECFP-TM-Gi1-CG(GiCG) and pCDNA3.1-SS-ECFP-TM-Gs.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bluml K, 1997, EMBO J, V16, P4908, DOI 10.1093/emboj/16.16.4908; Brenner T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1480, DOI 10.1152/ajpendo.90652.2008; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; FARINELLI SE, 1992, J NEUROCHEM, V58, P1905, DOI 10.1111/j.1471-4159.1992.tb10068.x; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Greenwood IA, 2007, TRENDS PHARMACOL SCI, V28, P1, DOI 10.1016/j.tips.2006.11.004; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hollenberg MD, 1997, CAN J PHYSIOL PHARM, V75, P832, DOI 10.1139/cjpp-75-7-832; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Innocenti B, 2000, J NEUROSCI, V20, P1800; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kim E, 2010, BIOCHEM BIOPH RES CO, V395, P244, DOI 10.1016/j.bbrc.2010.03.171; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Li DD, 2012, J PHYSIOL-LONDON, V590, P855, DOI 10.1113/jphysiol.2011.219345; Li X, 2005, J BIOL CHEM, V280, P23945, DOI 10.1074/jbc.M414078200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; Obrenovitch TP, 2001, METHODS, V23, P63, DOI 10.1006/meth.2000.1106; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Wang HS, 1997, CIRC RES, V81, P711; WEST RE, 1985, J BIOL CHEM, V260, P4428; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yoon BE, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-42; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	51	216	218	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					25	40		10.1016/j.cell.2012.09.005	http://dx.doi.org/10.1016/j.cell.2012.09.005			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021213	Bronze			2022-12-28	WOS:000309544200008
J	Rogers, JA				Rogers, John A.			Nanometer-Scale Printing	SCIENCE			English	Editorial Material							SELF-ASSEMBLED MONOLAYERS		Univ Illinois, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Urbana, IL 61801 USA.	jrogers@uiuc.edu	huang, yonggang/O-6236-2019; Rogers, John/L-2798-2016					Delamarche E, 1998, J PHYS CHEM B, V102, P3324, DOI 10.1021/jp980556x; Geissler M, 2003, LANGMUIR, V19, P6301, DOI 10.1021/la034464x; Liao WS, 2012, SCIENCE, V337, P1517, DOI 10.1126/science.1221774; Loo YL, 2002, J AM CHEM SOC, V124, P7654, DOI 10.1021/ja026355v; Love JC, 2002, J AM CHEM SOC, V124, P1576, DOI 10.1021/ja012569l; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Madou MJ., 2011, FUNDAMENTALS MICROFA, V2; Meitl MA, 2006, NAT MATER, V5, P33, DOI 10.1038/nmat1532; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q	9	9	10	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1459	1460		10.1126/science.1228493	http://dx.doi.org/10.1126/science.1228493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997312				2022-12-28	WOS:000308912900026
J	Trasande, L; Attina, TM; Blustein, J				Trasande, Leonardo; Attina, Teresa M.; Blustein, Jan			Association Between Urinary Bisphenol A Concentration and Obesity Prevalence in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; TEMPORAL VARIABILITY; PRESCHOOL-CHILDREN; ADIPOSE-TISSUE; TOBACCO-SMOKE; UNITED-STATES; EXPOSURE; WOMEN; ADIPOCYTES; DISEASE	Context Bisphenol A (BPA), a manufactured chemical, is found in canned food, polycarbonate-bottled liquids, and other consumer products. In adults, elevated urinary BPA concentrations are associated with obesity and incident coronary artery disease. BPA exposure is plausibly linked to childhood obesity, but evidence is lacking to date. Objective To examine associations between urinary BPA concentration and body mass outcomes in children. Design, Setting, and Participants Cross-sectional analysis of a nationally representative subsample of 2838 participants aged 6 through 19 years randomly selected for measurement of urinary BPA concentration in the 2003-2008 National Health and Nutrition Examination Surveys. Main Outcome Measures Body mass index (BMI), converted to sex-and age-standardized z scores and used to classify participants as overweight (BMI >= 85th percentile for age/sex) or obese (BMI >= 95th percentile). Results Median urinary BPA concentration was 2.8 ng/mL (interquartile range, 1.5-5.6). Of the participants, 1047 (34.1% [SE, 1.5%]) were overweight and 590 (17.8% [SE, 1.3%]) were obese. Controlling for race/ethnicity, age, caregiver education, poverty to income ratio, sex, serum cotinine level, caloric intake, television watching, and urinary creatinine level, children in the lowest urinary BPA quartile had a lower estimated prevalence of obesity (10.3% [95% CI, 7.5%-13.1%]) than those in quartiles 2 (20.1% [95% CI, 14.5%-25.6%]), 3 (19.0% [95% CI, 13.7%-24.2%]), and 4 (22.3% [95% CI, 16.6%-27.9%]). Similar patterns of association were found in multivariable analyses examining the association between quartiled urinary BPA concentration and BMI z score and in analyses that examined the logarithm of urinary BPA concentration and the prevalence of obesity. Obesity was not associated with exposure to other environmental phenols commonly used in other consumer products, such as sunscreens and soaps. In stratified analysis, significant associations between urinary BPA concentrations and obesity were found among whites (P < .001) but not among blacks or Hispanics. Conclusions Urinary BPA concentration was significantly associated with obesity in this cross-sectional study of children and adolescents. Explanations of the association cannot rule out the possibility that obese children ingest food with higher BPA content or have greater adipose stores of BPA. JAMA. 2012;308(11):1113-1121 www.jama.com	[Trasande, Leonardo; Attina, Teresa M.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Trasande, Leonardo] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Blustein, Jan] NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USA; [Trasande, Leonardo; Blustein, Jan] NYU, Wagner Sch Publ Serv, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Trasande, L (corresponding author), NYU, Dept Pediat, Sch Med, 227 E 30th St,Room 711, New York, NY 10016 USA.	leonardo.trasande@nyumc.org	Trasande, Leonardo/ABE-6339-2020	Trasande, Leonardo/0000-0002-1928-597X				[Anonymous], NHANES 2003 2004 ENV; BEARER CF, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432337; Birnbaum LS, 2012, ENVIRON HEALTH PERSP, V120, pA143, DOI 10.1289/ehp.1205179; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Centers for Disease Control and Prevention, 2012, OV NHANES SURV DES W; Centers for Disease Control and Prevention, MEAS GUID DIET REC I; Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147; Elobeid MA, 2008, CURR OPIN ENDOCRINOL, V15, P403, DOI 10.1097/MED.0b013e32830ce95c; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FLEISS JL, 1977, AM J PUBLIC HEALTH, V67, P1188, DOI 10.2105/AJPH.67.12.1188; Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lim DS, 2009, J TOXICOL ENV HEAL A, V72, P1327; Lohman T.J., 1998, ANTHROPOMETRIC STAND; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Masuno H, 2002, J LIPID RES, V43, P676; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Mendoza JA, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-44; Nepomnaschy PA, 2009, ENVIRON RES, V109, P734, DOI 10.1016/j.envres.2009.04.004; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Sakurai K, 2004, BRIT J PHARMACOL, V141, P209, DOI 10.1038/sj.bjp.0705520; Schecter A, 2010, ENVIRON SCI TECHNOL, V44, P9425, DOI 10.1021/es102785d; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Tavernise S., 2012, NY TIMES        1121; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Thomson BM, 2005, FOOD ADDIT CONTAM, V22, P65, DOI 10.1080/02652030400027920; Trasande L, 2009, ENVIRON HEALTH PERSP, V117, P159, DOI 10.1289/ehp.11839; Update on Bisphenol A for Use in Food Contact Applications, 2012, UPD BISPH US FOOD CO; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; White House Task Force on Childhood Obesity, 2010, SOLV PROBL CHILDH OB; Wilson KM, 2011, NICOTINE TOB RES, V13, P800, DOI 10.1093/ntr/ntr076; Wilson NK, 2007, ENVIRON RES, V103, P9, DOI 10.1016/j.envres.2006.04.006; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014	47	327	345	4	140	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1113	1121		10.1001/2012.jama.11461	http://dx.doi.org/10.1001/2012.jama.11461			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990270	Bronze			2022-12-28	WOS:000308861000027
J	Bettger, JP; Alexander, KP; Dolor, RJ; Olson, DM; Kendrick, AS; Wing, L; Coeytaux, RR; Graffagnino, C; Duncan, PW				Bettger, Janet Prvu; Alexander, Karen P.; Dolor, Rowena J.; Olson, DaiWai M.; Kendrick, Amy S.; Wing, Liz; Coeytaux, Remy R.; Graffagnino, Carmelo; Duncan, Pamela W.			Transitional Care After Hospitalization for Acute Stroke or Myocardial Infarction A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; EARLY SUPPORTED DISCHARGE; INPATIENT NEUROLOGICAL REHABILITATION; FOLLOW-UP; UNIT SERVICE; COUNSELING INTERVENTION; CARDIAC PATIENTS; INTEGRATED CARE; FAMILY SUPPORT; CLINICAL-TRIAL	Background: Transitional care is a time-limited service to prevent discontinuous care and adverse outcomes, including rehospitalization. Purpose: To describe transitional care interventions and evidence of benefit or harm in patients hospitalized for acute stroke or myocardial infarction (MI). Data Sources: Cumulative Index to Nursing and Allied Health Literature, MEDLINE, Cochrane Database of Systematic Reviews, and EMBASE, supplemented with manual searches of reference lists of relevant studies and review articles (January 2000 to March 2012). Study Selection: 6 reviewers screened 5857 citations to identify English-language reports of trials or observational studies that compared transitional care with usual care among adults hospitalized for stroke or MI and that reported patient, caregiver, process, or systems outcomes within 1 year of hospital discharge. Data Extraction: Data on study design, quality, population, intervention characteristics, and patient-and system-level outcomes were extracted by 3 reviewers and confirmed by 1 additional reviewer. Data Synthesis: 62 articles representing 44 studies of transitional care for either acute stroke (27 studies) or MI (17 studies). Four intervention types were studied: hospital-initiated support (n = 14), patient and family education (n = 7), community-based support (n = 20), and chronic disease management (n = 3). Most studies (68%) were of fair quality. Overall, moderate-strength evidence showed that hospital-initiated support reduced length of stay for patients who had a stroke, and low-strength evidence showed that it reduced mortality for patients who had an MI. Evidence about benefits of other interventions and harms from transitional care services was insufficient. Limitations: Few studies had high-quality research designs. The usual care comparator was often poorly defined. Applicability to U.S. clinical practice was limited; only 6 studies were conducted in the United States. Conclusion: Available evidence shows that hospital-initiated transitional care can improve some outcomes in adults hospitalized for stroke or MI. Finding additional transitional care interventions that improve functional outcomes and prevent rehospitalizations and adverse events is a high priority for the growing population of patients who have an MI or a stroke.	Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; Wake Forest Baptist Med Ctr, Sticht Ctr Aging Geriatr & Gerontol, Winston Salem, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Wake Forest University; Wake Forest Baptist Medical Center	Bettger, JP (corresponding author), Duke Univ, Med Ctr, Duke Univ Sch Nursing, Box 3322,307 Trent Dr, Durham, NC 27710 USA.	janet.bettger@duke.edu	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X; Kendrick, Amy/0000-0001-8769-1702; Duncan, Pamela/0000-0002-4838-3253; Dolor, Rowena/0000-0001-7317-9468	AHRQ, U.S. Department of Health and Human Services [290-2007-10066-I]; Agency for Healthcare Research and Quality	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded by the AHRQ (contract 290-2007-10066-I), U.S. Department of Health and Human Services.; Primary Funding Source: Agency for Healthcare Research and Quality.	Adams K., 2003, PRIORITY AREAS NATL; Agency for Healthcare Research and Quality, 2008, METH GUID EFF COMP E; Allen K, 2009, J STROKE CEREBROVASC, V18, P443, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.002; Allen Kyle R, 2002, J Stroke Cerebrovasc Dis, V11, P88, DOI 10.1053/jscd.2002.127106; Askim T, 2004, CLIN REHABIL, V18, P238, DOI 10.1191/0269215504cr752oa; Askim T, 2006, J REHABIL MED, V38, P368, DOI 10.1080/16501970600780294; Ayana M, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-1; Bambauer KZ, 2005, PSYCHOSOM MED, V67, P539, DOI 10.1097/01.psy.0000171810.37958.61; Bautz-Holter E, 2002, DISABIL REHABIL, V24, P348, DOI 10.1080/09638280110093677; Boult C, 2009, J AM GERIATR SOC, V57, P2328, DOI 10.1111/j.1532-5415.2009.02571.x; Campaign for Better Care, COMM BAS CAR TRANS P; Carroll DL, 2007, J CARDIOVASC NURS, V22, P313, DOI 10.1097/01.JCN.0000278955.44759.73; Claiborne N, 2006, HEALTH SOC WORK, V31, P87, DOI 10.1093/hsw/31.2.87; Clark MS, 2003, CLIN REHABIL, V17, P703, DOI 10.1191/0269215503cr681oa; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Silva RCE, 2008, CLINICS, V63, P489, DOI 10.1590/S1807-59322008000400013; Donnelly M, 2004, STROKE, V35, P127, DOI 10.1161/01.STR.0000106911.96026.8F; Eagle KA, 2005, J AM COLL CARDIOL, V46, P1242, DOI 10.1016/j.jacc.2004.12.083; Ertel KA, 2007, CLIN REHABIL, V21, P511, DOI 10.1177/0269215507078312; Fjaertoft H, 2005, CEREBROVASC DIS, V19, P376, DOI 10.1159/000085543; Fjaertoft H, 2004, CLIN REHABIL, V18, P580, DOI 10.1191/0269215504cr773oa; Fjaertoft H, 2003, STROKE, V34, P2687, DOI 10.1161/01.STR.0000095189.21659.4F; Geddes JML, 2001, CLIN REHABIL, V15, P589, DOI 10.1191/0269215501cr452oa; Grasel E, 2006, CLIN REHABIL, V20, P577, DOI 10.1191/0269215506cr978oa; Grasel E, 2005, CLIN REHABIL, V19, P725, DOI 10.1191/0269215505cr900oa; Hall Jane P, 2002, Heart Lung Circ, V11, P10, DOI 10.1046/j.1444-2892.2002.00105.x; Hanssen TA, 2007, EUR J CARDIOV PREV R, V14, P429, DOI 10.1097/HJR.0b013e32801da123; Ho PM, 2007, AM HEART J, V154, P489, DOI 10.1016/j.ahj.2007.05.018; Hoenig H, 2000, ARCH PHYS MED REHAB, V81, P853, DOI 10.1053/apmr.2000.5569; Holmqvist LW, 2000, SCAND J REHABIL MED, V32, P173, DOI 10.1080/003655000750060922; Indredavik B, 2000, STROKE, V31, P2989, DOI 10.1161/01.STR.31.12.2989; Johnston M, 2007, DISABIL REHABIL, V29, P1117, DOI 10.1080/03323310600950411; Joubert J, 2006, J CLIN NEUROSCI, V13, P84, DOI 10.1016/j.jocn.2005.07.003; Joubert J, 2009, J NEUROL NEUROSUR PS, V80, P279, DOI 10.1136/jnnp.2008.148122; Joubert J, 2008, CEREBROVASC DIS, V26, P199, DOI 10.1159/000145328; Konetzka RT, 2008, MED CARE RES REV, V65, P40, DOI 10.1177/1077558707307569; Kovoor P, 2006, AM J CARDIOL, V97, P952, DOI 10.1016/j.amjcard.2005.10.040; Krumholz HM, 2006, CIRCULATION, V114, P1432, DOI 10.1161/CIRCULATIONAHA.106.177322; Luszczynska A, 2006, SOC SCI MED, V62, P900, DOI 10.1016/j.socscimed.2005.06.043; Mant J, 2000, LANCET, V356, P808, DOI 10.1016/S0140-6736(00)02655-6; Mant J, 2005, J NEUROL NEUROSUR PS, V76, P1006, DOI 10.1136/jnnp.2004.048991; Mayo NE, 2000, STROKE, V31, P1016, DOI 10.1161/01.STR.31.5.1016; McDonald KM, 2007, AHRQ PUBLICATION, V04(07)-0051-7; National Quality Forum, 2009, MEAS FRAM EV EFF PAT; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; Naylor MD, 2011, HEALTH AFFAIR, V30, P746, DOI 10.1377/hlthaff.2011.0041; Naylor Mary D, 2002, Annu Rev Nurs Res, V20, P127; Olson DM, 2011, AHRQ PUBLICATION, V11(2)-E011; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Ricauda NA, 2004, J AM GERIATR SOC, V52, P278, DOI 10.1111/j.1532-5415.2004.52069.x; Sinclair AJ, 2005, AGE AGEING, V34, P338, DOI 10.1093/ageing/afi116; Sulch D, 2000, STROKE, V31, P1929, DOI 10.1161/01.STR.31.8.1929; Teng J, 2003, STROKE, V34, P528, DOI 10.1161/01.STR.0000049767.14156.2C; Torp CR, 2006, STROKE, V37, P1514, DOI 10.1161/01.STR.0000221793.81260.ed; von Koch L, 2001, CEREBROVASC DIS, V12, P131, DOI 10.1159/000047692; von Koch L, 2000, CLIN REHABIL, V14, P574, DOI 10.1191/0269215500cr364oa; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	57	95	96	2	44	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6					407	U61		10.7326/0003-4819-157-6-201209180-00004	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007UB	22986378				2022-12-28	WOS:000308912800015
J	Verma, S; Miles, D; Gianni, L; Krop, IE; Welslau, M; Baselga, J; Pegram, M; Oh, DY; Dieras, V; Guardino, E; Fang, L; Lu, MW; Olsen, S; Blackwell, K				Verma, Sunil; Miles, David; Gianni, Luca; Krop, Ian E.; Welslau, Manfred; Baselga, Jose; Pegram, Mark; Oh, Do-Youn; Dieras, Veronique; Guardino, Ellie; Fang, Liang; Lu, Michael W.; Olsen, Steven; Blackwell, Kim		EMILIA Study Grp	Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II; CAPECITABINE; LAPATINIB; ANTIBODY; RECEPTOR; THERAPY; PLUS	Background Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate incorporating the human epidermal growth factor receptor 2 (HER2)-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1. The antibody and the cytotoxic agent are conjugated by means of a stable linker. Methods We randomly assigned patients with HER2-positive advanced breast cancer, who had previously been treated with trastuzumab and a taxane, to T-DM1 or lapatinib plus capecitabine. The primary end points were progression-free survival (as assessed by independent review), overall survival, and safety. Secondary end points included progression-free survival (investigator-assessed), the objective response rate, and the time to symptom progression. Two interim analyses of overall survival were conducted. Results Among 991 randomly assigned patients, median progression-free survival as assessed by independent review was 9.6 months with T-DM1 versus 6.4 months with lapatinib plus capecitabine (hazard ratio for progression or death from any cause, 0.65; 95% confidence interval [CI], 0.55 to 0.77; P<0.001), and median overall survival at the second interim analysis crossed the stopping boundary for efficacy (30.9 months vs. 25.1 months; hazard ratio for death from any cause, 0.68; 95% CI, 0.55 to 0.85; P<0.001). The objective response rate was higher with T-DM1 (43.6%, vs. 30.8% with lapatinib plus capecitabine; P<0.001); results for all additional secondary end points favored T-DM1. Rates of grade 3 or 4 adverse events were higher with lapatinib plus capecitabine than with T-DM1 (57% vs. 41%). The incidences of thrombocytopenia and increased serum aminotransferase levels were higher with T-DM1, whereas the incidences of diarrhea, nausea, vomiting, and palmar-plantar erythrodysesthesia were higher with lapatinib plus capecitabine. Conclusions T-DM1 significantly prolonged progression-free and overall survival with less toxicity than lapatinib plus capecitabine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane. (Funded by F. Hoffmann-La Roche/Genentech; EMILIA ClinicalTrials.gov number, NCT00829166.)	[Verma, Sunil] Sunnybrook Odette Canc Ctr, Toronto, ON M4N 3M5, Canada; [Miles, David] Mt Vernon Canc Ctr, Northwood, Middx, England; [Gianni, Luca] Hosp San Raffaele, I-20132 Milan, Italy; [Krop, Ian E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Baselga, Jose] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Welslau, Manfred] Med Off Hematol, Aschaffenburg, Germany; [Pegram, Mark] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Oh, Do-Youn] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Guardino, Ellie; Fang, Liang; Lu, Michael W.; Olsen, Steven] Genentech Inc, San Francisco, CA 94080 USA; [Dieras, Veronique] Inst Curie, Paris, France; [Blackwell, Kim] Duke Univ, Med Ctr, Durham, NC USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Mount Vernon Cancer Centre; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; University of Miami; Seoul National University (SNU); Roche Holding; Genentech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Duke University	Verma, S (corresponding author), Sunnybrook Odette Canc Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	sunil.verma@sunnybrook.ca		GIANNI, LUCA/0000-0002-2372-9625	F. Hoffmann-La Roche/Genentech; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	F. Hoffmann-La Roche/Genentech(Hoffmann-La RocheRoche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by F. Hoffmann-La Roche/Genentech; EMILIA ClinicalTrials.gov number, NCT00829166.	Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; FDA, 2009, GUID IND DRUG IND LI; Geyer CE, 2007, NEW ENGL J MED, V356, P1487; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Junttila TT, 2011, BREAST CANCER RES TR, V128, P347, DOI 10.1007/s10549-010-1090-x; Kocsis J, 2011, EUR MULT CANC C STOC; Krop IE, 2012, J CLIN ONCOL, V30, P3234, DOI 10.1200/JCO.2011.40.5902; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205	15	2256	2354	25	355	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1783	1791		10.1056/NEJMoa1209124	http://dx.doi.org/10.1056/NEJMoa1209124			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23020162	Green Accepted			2022-12-28	WOS:000310773200005
J	Huang, XH; Kurata, N; Wei, XH; Wang, ZX; Wang, A; Zhao, Q; Zhao, Y; Liu, KY; Lu, HY; Li, WJ; Guo, YL; Lu, YQ; Zhou, CC; Fan, DL; Weng, QJ; Zhu, CR; Huang, T; Zhang, L; Wang, YC; Feng, L; Furuumi, H; Kubo, T; Miyabayashi, T; Yuan, XP; Xu, Q; Dong, GJ; Zhan, QL; Li, CY; Fujiyama, A; Toyoda, A; Lu, TT; Feng, Q; Qian, Q; Li, JY; Han, B				Huang, Xuehui; Kurata, Nori; Wei, Xinghua; Wang, Zi-Xuan; Wang, Ahong; Zhao, Qiang; Zhao, Yan; Liu, Kunyan; Lu, Hengyun; Li, Wenjun; Guo, Yunli; Lu, Yiqi; Zhou, Congcong; Fan, Danlin; Weng, Qijun; Zhu, Chuanrang; Huang, Tao; Zhang, Lei; Wang, Yongchun; Feng, Lei; Furuumi, Hiroyasu; Kubo, Takahiko; Miyabayashi, Toshie; Yuan, Xiaoping; Xu, Qun; Dong, Guojun; Zhan, Qilin; Li, Canyang; Fujiyama, Asao; Toyoda, Atsushi; Lu, Tingting; Feng, Qi; Qian, Qian; Li, Jiayang; Han, Bin			A map of rice genome variation reveals the origin of cultivated rice	NATURE			English	Article							WIDE ASSOCIATION; ARABIDOPSIS-THALIANA; ORYZA-RUFIPOGON; GENETIC-CONTROL; OPEN SOFTWARE; GRAIN LENGTH; WILD-RICE; MAJOR QTL; DOMESTICATION; POPULATIONS	Crop domestications are long-term selection experiments that have greatly advanced human civilization. The domestication of cultivated rice (Oryza sativa L.) ranks as one of the most important developments in history. However, its origins and domestication processes are controversial and have long been debated. Here we generate genome sequences from 446 geographically diverse accessions of the wild rice species Oryza rufipogon, the immediate ancestral progenitor of cultivated rice, and from 1,083 cultivated indica and japonica varieties to construct a comprehensive map of rice genome variation. In the search for signatures of selection, we identify 55 selective sweeps that have occurred during domestication. In-depth analyses of the domestication sweeps and genome-wide patterns reveal that Oryza sativa japonica rice was first domesticated from a specific population of O. rufipogon around the middle area of the Pearl River in southern China, and that Oryza sativa indica rice was subsequently developed from crosses between japonica rice and local wild rice as the initial cultivars spread into South East and South Asia. The domestication-associated traits are analysed through high-resolution genetic mapping. This study provides an important resource for rice breeding and an effective genomics approach for crop domestication research.	[Huang, Xuehui; Wang, Zi-Xuan; Wang, Ahong; Zhao, Qiang; Zhao, Yan; Liu, Kunyan; Lu, Hengyun; Li, Wenjun; Guo, Yunli; Lu, Yiqi; Zhou, Congcong; Fan, Danlin; Weng, Qijun; Zhu, Chuanrang; Huang, Tao; Zhang, Lei; Wang, Yongchun; Feng, Lei; Zhan, Qilin; Li, Canyang; Lu, Tingting; Feng, Qi; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai 200233, Peoples R China; [Kurata, Nori; Wang, Zi-Xuan; Furuumi, Hiroyasu; Kubo, Takahiko; Miyabayashi, Toshie; Fujiyama, Asao; Toyoda, Atsushi] Natl Inst Genet, Plant Genet Lab, Mishima, Shizuoka 4118540, Japan; [Kurata, Nori; Wang, Zi-Xuan; Furuumi, Hiroyasu; Kubo, Takahiko; Miyabayashi, Toshie; Fujiyama, Asao; Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Wei, Xinghua; Yuan, Xiaoping; Xu, Qun; Dong, Guojun; Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Han, Bin] Chinese Acad Sci, Beijing Inst Genom, Beijing 100029, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Han, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai 200233, Peoples R China.	bhan@ncgr.ac.cn	Li, Jiayang/AAG-4377-2020; qian, qian/AAH-8708-2021	Huang, Xuehui/0000-0003-0529-1532; Han, Bin/0000-0001-8695-0274	National Bioresource Project; MEXT; Systems Functional Genetics Project of the Transdisciplinary Research Integration Center, ROIS, Japan; Ministry of Science and Technology of China [2011CB100205, 2012AA10A302, 2012AA10A304]; Ministry of Agriculture of China [2011ZX08009-002, 2011ZX08001-004]; National Natural Science Foundation of China [31121063]; Chinese Academy of Sciences	National Bioresource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Systems Functional Genetics Project of the Transdisciplinary Research Integration Center, ROIS, Japan; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank the China National Rice Research Institute for providing all cultivated rice germplasm and Chinese wild rice accessions. The rest of the wild rice accessions were distributed from the Rice Collection of National Institute of Genetics jointly supported by the National Bioresource Project, MEXT, and Systems Functional Genetics Project of the Transdisciplinary Research Integration Center, ROIS, Japan. We thank Z. Ning, Y. Minobe and A. Osbourn for their advice and assistance in this work. This work was supported by the Ministry of Science and Technology of China (2011CB100205, 2012AA10A302 and 2012AA10A304), the Ministry of Agriculture of China (2011ZX08009-002 and 2011ZX08001-004), the National Natural Science Foundation of China (31121063) and the Chinese Academy of Sciences (to B.H.).	Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chen KY, 2007, SCIENCE, V318, P643, DOI 10.1126/science.1148428; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; CHURCHILL GA, 1994, GENETICS, V138, P963; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Hernandez RD, 2008, BIOINFORMATICS, V24, P2786, DOI 10.1093/bioinformatics/btn522; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Lu TT, 2008, DNA RES, V15, P285, DOI 10.1093/dnares/dsn018; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; McCombie W. R., 2007, CURR PROTOC BIOINFOR, V17; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Oka H. I., 1988, Origin of cultivated rice.; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sang T, 2007, J INTEGR PLANT BIOL, V49, P760, DOI 10.1111/j.1744-7909.2007.00510.x; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tadege M, 2003, PLANT BIOTECHNOL J, V1, P361, DOI 10.1046/j.1467-7652.2003.00034.x; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Wang S., 2007, WINDOWS QTL CARTOGRA; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Zhang LB, 2009, NEW PHYTOL, V184, P708, DOI 10.1111/j.1469-8137.2009.02984.x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	62	983	1083	46	670	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					497	+		10.1038/nature11532	http://dx.doi.org/10.1038/nature11532			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23034647	hybrid, Green Published			2022-12-28	WOS:000310196200033
J	Itsathitphaisarn, O; Wing, RA; Eliason, WK; Wang, JM; Steitz, TA				Itsathitphaisarn, Ornchuma; Wing, Richard A.; Eliason, William K.; Wang, Jimin; Steitz, Thomas A.			The Hexameric Helicase DnaB Adopts a Nonplanar Conformation during Translocation	CELL			English	Article							ESCHERICHIA-COLI; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; PROTEIN; COMPLEX; PRIMASE; DOMAIN; SITE	DNA polymerases can only synthesize nascent DNA from single-stranded DNA (ssDNA) templates. In bacteria, the unwinding of parental duplex DNA is carried out by the replicative DNA helicase (DnaB) that couples NTP hydrolysis to 5' to 3' translocation. The crystal structure of the DnaB hexamer in complex with GDP-AlF4 and ssDNA reported here reveals that DnaB adopts a closed spiral staircase quaternary structure around an A-form ssDNA with each C-terminal domain coordinating two nucleotides of ssDNA. The structure not only provides structural insights into the translocation mechanism of superfamily IV helicases but also suggests that members of this superfamily employ a translocation mechanismthat is distinct from other helicase super-families. We propose a hand-over-hand mechanism in which sequential hydrolysis of NTP causes a sequential 5' to 3' movement of the subunits along the helical axis of the staircase, resulting in the unwinding of two nucleotides per subunit.	[Itsathitphaisarn, Ornchuma; Wing, Richard A.; Eliason, William K.; Wang, Jimin; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Eliason, William K.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu		Wing, Richard/0000-0001-5642-9349	NIH [RO1 GM057510]; Royal Thai Government Scholarship; Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510, P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government Scholarship; Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at APS beamline 24-ID and at NSLS beamlines X-25 and X-29. This work was supported by NIH RO1 GM057510 to T. A. S., the Royal Thai Government Scholarship to O.I., and by Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ayora S, 2002, NUCLEIC ACIDS RES, V30, P2280, DOI 10.1093/nar/30.11.2280; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 1999, J BIOL CHEM, V274, P6889, DOI 10.1074/jbc.274.11.6889; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mesa P, 2006, J MOL BIOL, V357, P1077, DOI 10.1016/j.jmb.2005.12.027; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P4051, DOI 10.1093/nar/gkf527; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998a; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	48	158	159	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					267	277		10.1016/j.cell.2012.09.014	http://dx.doi.org/10.1016/j.cell.2012.09.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23022319	Green Accepted, Bronze			2022-12-28	WOS:000309981000007
J	Karlsson, MP; Tervo, DGR; Karpova, AY				Karlsson, Mattias P.; Tervo, Dougal G. R.; Karpova, Alla Y.			Network Resets in Medial Prefrontal Cortex Mark the Onset of Behavioral Uncertainty	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; DECISION-MAKING; NEURAL ACTIVITY; NOREPINEPHRINE; INFORMATION; ENVIRONMENT; DYNAMICS; NEURONS; CONTEXT; REWARD	Regions within the prefrontal cortex are thought to process beliefs about the world, but little is known about the circuit dynamics underlying the formation and modification of these beliefs. Using a task that permits dissociation between the activity encoding an animal's internal state and that encoding aspects of behavior, we found that transient increases in the volatility of activity in the rat medial prefrontal cortex accompany periods when an animal's belief is modified after an environmental change. Activity across the majority of sampled neurons underwent marked, abrupt, and coordinated changes when prior belief was abandoned in favor of exploration of alternative strategies. These dynamics reflect network switches to a state of instability, which diminishes over the period of exploration as new stable representations are formed.	[Karlsson, Mattias P.; Tervo, Dougal G. R.; Karpova, Alla Y.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Karpova, AY (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	karpovaa@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank N. Ozel and B. Shields for technical help; K. Vicari for task illustration; and T. Jessell, W. Denk, V. Jayaraman, A. Leonardo, J. Dudman, E. Pastalkova, G. Murphy, K. Svoboda, R. Desimone, S. Druckmann, S. Eddy, and N. Spruston for comments on the manuscript. Supported by the Howard Hughes Medical Institute.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; EDWARDS W, 1961, ANNU REV PSYCHOL, V12, P473, DOI 10.1146/annurev.ps.12.020161.002353; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Holroyd CB, 2008, CORTEX, V44, P548, DOI 10.1016/j.cortex.2007.08.013; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pearce JM, 2001, ANNU REV PSYCHOL, V52, P111, DOI 10.1146/annurev.psych.52.1.111; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	28	129	131	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					135	139		10.1126/science.1226518	http://dx.doi.org/10.1126/science.1226518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042898				2022-12-28	WOS:000309457400071
J	Sheinin, MY; Wang, MD				Sheinin, Maxim Y.; Wang, Michelle D.			A DNA Twist Diffuses and Hops	SCIENCE			English	Editorial Material									[Sheinin, Maxim Y.; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA	Cornell University; Cornell University; Howard Hughes Medical Institute	Sheinin, MY (corresponding author), Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.	mwang@physics.cornell.edu	Sheinin, Maxim/A-1024-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059849] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM059849] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Daniels BC, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041924; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Liu Y, 2001, P NATL ACAD SCI USA, V98, P14883, DOI 10.1073/pnas.261477898; Marko JF, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011908; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; van Loenhout MTJ, 2012, SCIENCE, V338, P94, DOI 10.1126/science.1225810; VINOGRAD J, 1965, P NATL ACAD SCI USA, V53, P1104, DOI 10.1073/pnas.53.5.1104	7	4	4	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					56	57		10.1126/science.1228656	http://dx.doi.org/10.1126/science.1228656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042878	Green Accepted			2022-12-28	WOS:000309457400047
J	Moseley, RH; Manoogian, B; Shehab, T; Saint, S				Moseley, Richard H.; Manoogian, Beth; Shehab, Thomas; Saint, Sanjay			An Intricate Interplay	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONALCOHOLIC FATTY LIVER; AUTOIMMUNE HEPATITIS; ALANINE AMINOTRANSFERASE; DIAGNOSIS; STEATOHEPATITIS; MANAGEMENT; STATINS; DISEASE		[Moseley, Richard H.; Saint, Sanjay] Univ Michigan, Sch Med, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Moseley, Richard H.; Manoogian, Beth; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Shehab, Thomas] Huron Gastroenterol, Ypsilanti, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Moseley, RH (corresponding author), 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	rmoseley@umich.edu	Saint, Sanjay/AAF-5126-2019					Bjornsson E, 2010, HEPATOLOGY, V51, P2040, DOI 10.1002/hep.23588; Chalasani N, 2005, HEPATOLOGY, V41, P690, DOI 10.1002/hep.20671; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Gassert DJ, 2007, DIGEST DIS SCI, V52, P2433, DOI 10.1007/s10620-006-9665-4; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Ioannou GN, 2005, GASTROENTEROLOGY, V128, P627, DOI 10.1053/j.gastro.2004.12.004; Kessler WR, 2004, CLIN GASTROENTEROL H, V2, P625, DOI 10.1016/S1542-3565(04)00246-0; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Nathwani RA, 2005, AM J GASTROENTEROL, V100, P295, DOI 10.1111/j.1572-0241.2005.40793.x; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Russo MW, 2009, SEMIN LIVER DIS, V29, P412, DOI 10.1055/s-0029-1240010; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603	15	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1342	1347		10.1056/NEJMcps1011784	http://dx.doi.org/10.1056/NEJMcps1011784			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034023				2022-12-28	WOS:000309406100012
J	Shah, SJ				Shah, Sanjiv J.			Pulmonary Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESERVED EJECTION FRACTION; RIGHT HEART CATHETERIZATION; CAPILLARY WEDGE PRESSURE; ARTERY SYSTOLIC PRESSURE; DOPPLER-ECHOCARDIOGRAPHY; VASCULAR-DISEASE; FAILURE; MORTALITY; SURVIVAL; DIAGNOSIS	Pulmonary hypertension (PH), defined as elevated pulmonary artery pressure, is common in the general population and associated with increased mortality. Accordingly, physicians commonly encounter patients with dyspnea, exercise intolerance, and/or right heart failure who have elevated pulmonary artery systolic pressure (PASP) on echocardiography. Although pulmonary arterial vasodilators may often be considered in this setting, these drugs have been predominantly tested in the subset of PH patients with pulmonary arterial hypertension (PAH). Elevated PASP alone is not sufficient for the diagnosis of PAH, and secondary causes of PASP elevation, most commonly left heart disease, are far more prevalent than isolated PAH. Treatment of this more common group of patients with PH due to left heart disease is challenging because there are few evidence-based treatment options, and pulmonary vasodilator therapy may lead to worsening symptoms. Therefore, improving symptoms and avoiding adverse outcomes in patients with PH requires the following: (1) understanding the optimal use of echocardiography for the diagnosis of PH; (2) recognizing the utility and proper interpretation of invasive hemodynamic testing prior to starting pulmonary vasodilator therapy; (3) differentiating PAH from pulmonary venous hypertension due to left heart disease; and (4) understanding the appropriate treatment strategies for PH and resultant right heart failure. JAMA. 2012;308(13):1366-1374	Northwestern Univ, Div Cardiol, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Shah, SJ (corresponding author), Northwestern Univ, Div Cardiol, Dept Med, Feinberg Sch Med, 676 N St Clair St,Ste 600, Chicago, IL 60611 USA.	sanjiv.shah@northwestern.edu	Shah, Sanjiv J./AFQ-9480-2022		National Institutes of Health [R01 HL107577]; American Heart Association [0835488N]; Gilead Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Gilead Sciences(Gilead Sciences); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shah reported having received grants from the National Institutes of Health, American Heart Association, and Gilead Sciences and having served on an advisory board for Bristol-Myers Squibb,; Dr Shah is supported by research grants from the National Institutes of Health (R01 HL107577), American Heart Association (0835488N), and Gilead Sciences.	Abdelwhab S, 2008, AM J NEPHROL, V28, P990, DOI 10.1159/000146076; Anand I, 2004, LANCET, V364, P347, DOI 10.1016/S0140-6736(04)16723-8; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; Campo A, 2010, AM J RESP CRIT CARE, V182, P252, DOI 10.1164/rccm.200912-1820OC; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Cuttica MJ, 2010, RESP MED, V104, P1877, DOI 10.1016/j.rmed.2010.05.009; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Delgado JF, 2005, EUR J HEART FAIL, V7, P1011, DOI 10.1016/j.ejheart.2004.10.021; Farzaneh-Far R, 2008, AM J CARDIOL, V101, P762, DOI 10.1016/j.amjcard.2007.11.010; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Fonseca GHH, 2012, EUR RESPIR J, V39, P112, DOI 10.1183/09031936.00134410; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Gaine S, 2000, JAMA-J AM MED ASSOC, V284, P3160, DOI 10.1001/jama.284.24.3160; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Giardini A, 2011, CHEST, V140, P270, DOI 10.1378/chest.11-0344; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Guazzi M, 2007, J AM COLL CARDIOL, V50, P2136, DOI 10.1016/j.jacc.2007.07.078; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; Guglin M, 2010, J CARD FAIL, V16, P461, DOI 10.1016/j.cardfail.2010.01.003; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Haddad F, 2011, PROG CARDIOVASC DIS, V54, P154, DOI 10.1016/j.pcad.2011.06.003; Halpern SD, 2009, CHEST, V136, P37, DOI 10.1378/chest.08-2784; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Hoeper MM, 2009, J AM COLL CARDIOL, V54, pS85, DOI 10.1016/j.jacc.2009.04.008; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Leung CC, 2010, AM J CARDIOL, V106, P284, DOI 10.1016/j.amjcard.2010.02.039; Lewis GD, 2007, CIRCULATION, V115, P59, DOI 10.1161/CIRCULATIONAHA.106.626226; Machado RF, 2010, CHEST, V137, p30S, DOI 10.1378/chest.09-3057; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Mehari A, 2012, JAMA-J AM MED ASSOC, V307, P1254, DOI 10.1001/jama.2012.358; Minai OA, 2009, AM J CARDIOL, V104, P1300, DOI 10.1016/j.amjcard.2009.06.048; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; Rich S, 2008, CIRCULATION, V118, P2190, DOI 10.1161/CIRCULATIONAHA.107.723007; Ristow B, 2007, J AM COLL CARDIOL, V49, P43, DOI 10.1016/j.jacc.2006.04.108; Robbins IM, 2009, CHEST, V136, P31, DOI 10.1378/chest.08-2008; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Ryan JJ, 2012, AM HEART J, V163, P589, DOI 10.1016/j.ahj.2012.01.024; Shah SJ, 2008, CIRCULATION, V117, P2475, DOI 10.1161/CIRCULATIONAHA.107.719500; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stone AC, 2011, LUNG, V189, P207, DOI 10.1007/s00408-011-9293-4; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275; Testani JM, 2010, AM J CARDIOL, V105, P1192, DOI 10.1016/j.amjcard.2009.11.048; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709; Thenappan T, 2011, CIRC-HEART FAIL, V4, P257, DOI 10.1161/CIRCHEARTFAILURE.110.958801; TRYKA AF, 1985, HUM PATHOL, V16, P65, DOI 10.1016/S0046-8177(85)80215-X; van Wolferen SA, 2008, EUR HEART J, V29, P120, DOI 10.1093/eurheartj/ehm567	56	58	63	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1366	1374		10.1001/jama.2012.12347	http://dx.doi.org/10.1001/jama.2012.12347			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032553				2022-12-28	WOS:000309369300031
J	Vohra, P				Vohra, Pankaj			Why this love for antibiotics in India?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Max Healthcare, New Delhi, India		Vohra, P (corresponding author), Max Healthcare, New Delhi, India.	pankajvohramd@yahoo.com						Bate R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006003; Dutta S, 2006, DIAGN MICR INFEC DIS, V56, P359, DOI 10.1016/j.diagmicrobio.2006.06.024; Ganguly NK, 2011, INDIAN J MED RES, V134, P281; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 2	2012	345								e6209	10.1136/bmj.e6209	http://dx.doi.org/10.1136/bmj.e6209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KN	23033364				2022-12-28	WOS:000309659300006
J	Bhutta, ZA; Chopra, M				Bhutta, Zulfiqar A.; Chopra, Mickey			The Countdown for 2015: what lies ahead?	LANCET			English	Editorial Material							UPDATED SYSTEMATIC ANALYSIS; CHILD SURVIVAL; NEWBORN; INTERVENTIONS; MORTALITY; HEALTH; DEATH		[Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan; [Chopra, Mickey] UNICEF, New York, NY USA	Aga Khan University; UNICEF	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Amouzou A, 2012, LANCET; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Countdown to 2015, 2012, ACC MAT NEWB CHILD S; Countdown to 2015, 2012, BUILD FUT WOM CHILDR; Glass RI, 2012, JAMA-J AM MED ASSOC, V308, P141, DOI 10.1001/jama.2012.7357; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Shonkoff JP, 2012, PEDIATRICS, V129, pE460, DOI 10.1542/peds.2011-0366; Victora C, 2012, LANCET, V379, P2121, DOI 10.1016/S0140-6736(12)60914-3; Victora CG, 2012, LANCET	15	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1125	1127		10.1016/S0140-6736(12)61382-8	http://dx.doi.org/10.1016/S0140-6736(12)61382-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	012SD	22999432				2022-12-28	WOS:000309255900005
J	Wedeen, VJ; Rosene, DL; Wang, RP; Dai, GP; Mortazavi, F; Hagmann, P; Kaas, JH; Tseng, WYI				Wedeen, Van J.; Rosene, Douglas L.; Wang, Ruopeng; Dai, Guangping; Mortazavi, Farzad; Hagmann, Patric; Kaas, Jon H.; Tseng, Wen-Yih I.			Response to Comment on "The Geometric Structure of the Brain Fiber Pathways"	SCIENCE			English	Editorial Material							DIFFUSION; ARCHITECTURE	In response to Catani et al., we show that corticospinal pathways adhere via sharp turns to two local grid orientations; that our studies have three times the diffusion resolution of those compared; and that the noted technical concerns, including crossing angles, do not challenge the evidence of mathematically specific geometric structure. Thus, the geometric thesis gives the best account of the available evidence.	[Wedeen, Van J.; Wang, Ruopeng; Dai, Guangping] Harvard Univ, Dept Radiol, Sch Med, Charlestown, MA 02129 USA; [Wedeen, Van J.; Wang, Ruopeng; Dai, Guangping] Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Wedeen, Van J.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Rosene, Douglas L.; Mortazavi, Farzad] Boston Univ, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Hagmann, Patric] Univ Hosp Ctr, Dept Radiol, CH-1011 Lausanne, Switzerland; [Hagmann, Patric] Univ Lausanne CHUV UNL, CH-1011 Lausanne, Switzerland; [Kaas, Jon H.] Vanderbilt Univ, Dept Psychol, Coll Arts & Sci, Nashville, TN 37240 USA; [Tseng, Wen-Yih I.] Natl Taiwan Univ, Dept Radiol, Ctr Optoelect Biomed, Coll Med, Taipei 100, Taiwan	Harvard University; Harvard University; Boston University; Vanderbilt University; National Taiwan University	Wedeen, VJ (corresponding author), Harvard Univ, Dept Radiol, Sch Med, Bldg 129 13th St,2nd Floor, Charlestown, MA 02129 USA.	van@nmr.mgh.harvard.edu	Mortazavi, Farzad/AFT-4660-2022; Mortazavi, Farzad/AAI-8136-2021; Rosene, Douglas L/G-1973-2015	Mortazavi, Farzad/0000-0002-1911-5428; Mortazavi, Farzad/0000-0002-1911-5428; Tseng, Wen-Yih Isaac/0000-0002-2314-6868; Rosene, Douglas/0000-0001-8719-1441	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, P41RR023953] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY002686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH093765, R01MH064044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016446] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR023953, P41 RR014075] Funding Source: Medline; NEI NIH HHS [R01 EY002686] Funding Source: Medline; NIMH NIH HHS [R01 MH064044, U01 MH093765] Funding Source: Medline; NINDS NIH HHS [R01 NS016446] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BURNSIDE MB, 1968, DEV BIOL, V18, P537, DOI 10.1016/0012-1606(68)90025-0; Catani M, 2012, SCIENCE, V337, DOI 10.1126/science.1223425; KRIEG WJS, 1954, CONNECTIONS FRONTAL; Nieuwenhuys R, 2009, BRAIN STRUCT FUNCT, V214, P79, DOI 10.1007/s00429-009-0223-7; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen V. J., 2011, INT SOC MAG RESON ME, V19, P1965; Wedeen V. J., 1995, P 1 INT C FUNCT MAP, VP1, P69; Wedeen V. J., 1876, INT SOC MAG RESON ME, V20; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897	14	20	20	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102								10.1126/science.1223493	http://dx.doi.org/10.1126/science.1223493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019633	Green Submitted, Green Accepted			2022-12-28	WOS:000309215400024
J	Wiessner, P; Pupu, N				Wiessner, Polly; Pupu, Nitze			Toward Peace: Foreign Arms and Indigenous Institutions in a Papua New Guinea Society	SCIENCE			English	Article								In 1990, shotguns and M-16s were adopted into Enga warfare, setting off some 15 years of devastation as youths (similar to 17 to 28) took charge of interclan warfare. In response, people called on elder leaders to adapt customary institutions to restore peace; subsequently, war deaths and the frequency of war declined radically. Data from precolonial warfare, 501 recent wars, and 129 customary court sessions allow us to consider (i) the principles and values behind customary institutions for peace, (ii) their effectiveness, (iii) how they interact with and compare to state institutions of today, and (iv) how such institutions might have shaped our human behavioral repertoire to make life in state societies possible.	[Wiessner, Polly] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Pupu, Nitze] Enga Take Anda, Wabag, Enga Province, Papua N Guinea	Utah System of Higher Education; University of Utah	Wiessner, P (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	wiessner@soft-link.com			Enga Provincial Government; University of Utah	Enga Provincial Government; University of Utah	Many participated in the research on Enga warfare over 25 years. A. Tumu, W. Tumu, L. Kyalae, L. Yongape, A. Yongapen, and B. Letakali worked on aspects of the research for the past 10 to 25 years; to them we are most grateful. Thanks go S. Hrdy for valuable discussion, to the anonymous reviewers, and to V. Goodman for assistance with data analysis. We are indebted to the Enga Provincial Government for continued interest in our work and payment of salaries at the Enga Take Anda. This research was partially supported by a research award from the University of Utah. The data set containing information on tribal wars from 1991 to 2011 is given in the supplementary materials. It includes case number, district, year of onset of the war, triggering incident, and number of deaths. Names of warring clans and districts have been removed to meet confidentiality requirements. Transcripts from OMS court sittings and the corresponding data set are not included, because it is not possible to remove identifiers from these recent, serious and sensitive cases. Details on how individual researchers can obtain access to certain materials that cannot be made public are provided in the supplementary materials.	Alpers P, 2005, SPECIAL REPORT; [Anonymous], 1984, BLOOD REVENGE; BALLARD C, 2005, OCEANIA MONOGRAPH U, V56; Boehm Christopher, 2012, MORAL ORIGINS; Clark G, 2007, PRINC ECON HIST W WO; de Waal Frans, 2009, THE AGE OF EMPATHY; Dinnen S., 2000, LAW ORDER WEAK STATE; Fry Douglas P., 2005, HUMAN POTENTIAL PEAC; Garap S., 2004, WOMEN PEACE; Gibbs P., 2004, CATALYST, V34, P3; Goddard Michael., 2009, SUBSTANTIAL JUSTICE; GORDON R, 1985, LAW ORDER NEW GUINEA; Greif A, 2006, POLIT ECON I DECIS, P1, DOI 10.1017/CBO9780511791307; Hewlett B. S., 2005, HUNTER GATHERER CHIL; Hrdy, 2009, MOTHERS OTHERS; Hvistendahl M, 2011, SCIENCE, V333, P552, DOI 10.1126/science.333.6042.552; Jameson K., 2010, VALUES VIOLENCE, P189; Keeley LH., 1996, WAR CIVILIZATION; Kelly R.C., 2000, WARLESS SOC ORIGIN W; Ketan Joseph, 2004, NAME MUST NOT GO; KNAUFT BM, 1990, OCEANIA, V60, P250, DOI 10.1002/j.1834-4461.1990.tb01557.x; Koch K.-F., 1974, WAR PEACE JALEMO; Konner M., 2010, EVOLUTION CHILDHOOD; Lawler A, 2012, SCIENCE, V336, P832, DOI 10.1126/science.336.6083.832; Lawler A, 2012, SCIENCE, V336, P829, DOI 10.1126/science.336.6083.829; Lee R., 1992, DOBE JUHOANSI; McCullough M. E., 2008, REVENGE; Meggitt M., 1965, LINEAGE SYSTEM MAE E; Meggitt Mervyn, 1977, BLOOD IS THEIR ARGUM; Merlan Francesca, 1991, KU WARU LANGUAGE SEG; Nesse RM, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P137; North D.C., 1990, I I CHANGE EC PERFOR; Pinker S., 2011, BETTER ANGELS OUR NA; Strathern A., 2011, PEACE MAKING IMAGINA; Tumu Akii, 1998, HIST VINES; Urdal H, 2006, INT STUD QUART, V50, P607, DOI 10.1111/j.1468-2478.2006.00416.x; Wiessner P, 2006, J ANTHROPOL RES, V62, P165, DOI 10.3998/jar.0521004.0062.203; Wiessner P, 2002, CURR ANTHROPOL, V43, P233, DOI 10.1086/338301; Wiessner Pauline, 2010, 20103 STAT SOC GOV M; Wrangham RW, 2004, ANN NY ACAD SCI, V1036, P233, DOI 10.1196/annals.1330.015; Young D., 2004, OUR LAND IS GREEN BL	41	30	30	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1651	1654		10.1126/science.1221685	http://dx.doi.org/10.1126/science.1221685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	012DJ	23019648				2022-12-28	WOS:000309215400044
J	Kesselheim, AS; Robertson, CT; Myers, JA; Rose, SL; Gillet, V; Ross, KM; Glynn, RJ; Joffe, S; Avorn, J				Kesselheim, Aaron S.; Robertson, Christopher T.; Myers, Jessica A.; Rose, Susannah L.; Gillet, Victoria; Ross, Kathryn M.; Glynn, Robert J.; Joffe, Steven; Avorn, Jerry			A Randomized Study of How Physicians Interpret Research Funding Disclosures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONFLICTS-OF-INTEREST; BIOMEDICAL-RESEARCH; CLINICAL-TRIALS; VENOUS THROMBOEMBOLISM; INDUSTRY RELATIONSHIPS; ROFECOXIB LITIGATION; FINANCIAL TIES; DOCUMENTS; CLINICALTRIALS.GOV; ROSUVASTATIN	BACKGROUND The effects of clinical-trial funding on the interpretation of trial results are poorly understood. We examined how such support affects physicians' reactions to trials with a high, medium, or low level of methodologic rigor. METHODS We presented 503 board-certified internists with abstracts that we designed describing clinical trials of three hypothetical drugs. The trials had high, medium, or low methodologic rigor, and each report included one of three support disclosures: funding from a pharmaceutical company, NIH funding, or none. For both factors studied (rigor and funding), one of the three possible variations was randomly selected for inclusion in the abstracts. Follow-up questions assessed the physicians' impressions of the trials' rigor, their confidence in the results, and their willingness to prescribe the drugs. RESULTS The 269 respondents (53.5% response rate) perceived the level of study rigor accurately. Physicians reported that they would be less willing to prescribe drugs tested in low-rigor trials than those tested in medium-rigor trials (odds ratio, 0.64; 95% confidence interval [CI], 0.46 to 0.89; P = 0.008) and would be more willing to prescribe drugs tested in high-rigor trials than those tested in medium-rigor trials (odds ratio, 3.07; 95% CI, 2.18 to 4.32; P<0.001). Disclosure of industry funding, as compared with no disclosure of funding, led physicians to downgrade the rigor of a trial (odds ratio, 0.63; 95% CI, 0.46 to 0.87; P = 0.006), their confidence in the results (odds ratio, 0.71; 95% CI, 0.51 to 0.98; P = 0.04), and their willingness to prescribe the hypothetical drugs (odds ratio, 0.68; 95% CI, 0.49 to 0.94; P = 0.02). Physicians were half as willing to prescribe drugs studied in industry-funded trials as they were to prescribe drugs studied in NIH-funded trials (odds ratio, 0.52; 95% CI, 0.37 to 0.71; P<0.001). These effects were consistent across all levels of methodologic rigor. CONCLUSIONS Physicians discriminate among trials of varying degrees of rigor, but industry sponsorship negatively influences their perception of methodologic quality and reduces their willingness to believe and act on trial findings, independently of the trial's quality. These effects may influence the translation of clinical research into practice.	[Kesselheim, Aaron S.; Myers, Jessica A.; Gillet, Victoria; Glynn, Robert J.; Avorn, Jerry] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA; [Kesselheim, Aaron S.; Myers, Jessica A.; Gillet, Victoria; Glynn, Robert J.; Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA; [Kesselheim, Aaron S.; Robertson, Christopher T.; Rose, Susannah L.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Joffe, Steven] Dana Farber Canc Inst, Boston, MA 02115 USA; [Robertson, Christopher T.] Univ Arizona, James E Rogers Coll Law, Tucson, AZ USA; [Rose, Susannah L.] Cleveland Clin, Dept Bioeth, Cleveland, OH USA; [Ross, Kathryn M.] Amer Board Internal Med, Philadelphia, PA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; University of Arizona; Cleveland Clinic Foundation; American Board of Internal Medicine	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017; Joffe, Steven/H-3941-2019	Kesselheim, Aaron/0000-0002-8867-2666; Joffe, Steven/0000-0002-0667-7384	Edmond J. Safra Center for Ethics at Harvard University; Agency for Healthcare Research and Quality [K08HS18465-01]; Robert Wood Johnson Foundation Investigator Award in Health Policy Research; Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; National Cancer Institute [2R25CA092203-08]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA092203] Funding Source: NIH RePORTER	Edmond J. Safra Center for Ethics at Harvard University; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Foundation Investigator Award in Health Policy Research(Robert Wood Johnson Foundation (RWJF)); Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a grant from the Edmond J. Safra Center for Ethics at Harvard University, a career development award from the Agency for Healthcare Research and Quality (K08HS18465-01) and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research (both to Dr. Kesselheim), a fellowship at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School (to Dr. Robertson), and a grant from the National Cancer Institute (2R25CA092203-08, to Dr. Rose).	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Angell M, 2008, JAMA-J AM MED ASSOC, V300, P1069, DOI 10.1001/jama.300.9.1069; [Anonymous], 2011, J GERONTOL B; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Association of American Medical Colleges, 2008, 2008 PHYS SPEC DAT; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; Avorn J, 2005, POWERFUL MED BENEFIT; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Boozang KM, 2010, LIMITS DISCLOSURE RE; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Campbell, 2010, ARCH INTERN MED, V170, P1966; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Campbell EG, 2010, ARCH INTERN MED, V170, P1820, DOI 10.1001/archinternmed.2010.383; Chaudhry S, 2002, BRIT MED J, V325, P1391, DOI 10.1136/bmj.325.7377.1391; Clancy C, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001235; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Contract Pharma, 2009, 2009 TOP 20 PHARM CO; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Drazen JM, 2010, NEW ENGL J MED, V363, P188, DOI 10.1056/NEJMe1006030; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-28; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Glaser BE, 2005, SCI ENG ETHICS, V11, P553, DOI 10.1007/s11948-005-0026-z; Glynn RJ, 2007, ANN INTERN MED, V147, P525, DOI 10.7326/0003-4819-147-8-200710160-00004; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; Golder S, 2008, BRIT J CLIN PHARMACO, V66, P767, DOI 10.1111/j.1365-2125.2008.03272.x; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Institute of Medicine Board on Health Sciences Policy, 2009, CONFL INT MED RES ED; Irvin RS, 2009, CHEST, V136, P253, DOI 10.1378/chest.09-0890; Irwin RS, 2009, CHEST, V136, P653; Kritek P, 2009, NEW ENGL J MED, V360, pE14, DOI 10.1056/NEJMe086509; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Lacasse Jeffrey R, 2011, BMC Res Notes, V4, P27, DOI 10.1186/1756-0500-4-27; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Madigan D, 2012, AM HEART J, V164, P186, DOI 10.1016/j.ahj.2012.05.002; Pearson SD, 2006, ARCH INTERN MED, V166, P623, DOI 10.1001/archinte.166.6.623; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2726; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Robertson CT, 2011, AM J LAW MED, V37, P358, DOI 10.1177/009885881103700207; Rose SL, 2010, J CLIN ONCOL, V28, P1316, DOI 10.1200/JCO.2008.21.6606; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Sage WM, 2007, TEX LAW REV, V85, P1413; Saint S, 2000, J GEN INTERN MED, V15, P881, DOI 10.1046/j.1525-1497.2000.00202.x; Schroter S, 2004, BRIT MED J, V328, P742, DOI 10.1136/bmj.38035.705185.F6; Silverman GK, 2010, J MED ETHICS, V36, P265, DOI 10.1136/jme.2009.034496; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Weng W, 2010, ACADEMYHEALTH ANN RE; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065; Zhang Y, 2011, AM ED RES ASS M NEW; Zinner DE, 2009, HEALTH AFFAIR, V28, P1814, DOI 10.1377/hlthaff.28.6.1814	58	137	138	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1119	1127		10.1056/NEJMsa1202397	http://dx.doi.org/10.1056/NEJMsa1202397			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AS	22992075	Green Accepted			2022-12-28	WOS:000308861800007
J	Foster, EA; Franks, DW; Mazzi, S; Darden, SK; Balcomb, KC; Ford, JKB; Croft, DP				Foster, Emma A.; Franks, Daniel W.; Mazzi, Sonia; Darden, Safi K.; Balcomb, Ken C.; Ford, John K. B.; Croft, Darren P.			Adaptive Prolonged Postreproductive Life Span in Killer Whales	SCIENCE			English	Article							MENOPAUSE; HUMANS		[Foster, Emma A.; Darden, Safi K.; Croft, Darren P.] Univ Exeter, Ctr Res Anim Behav, Coll Life & Environm Sci, Exeter EX4 4QG, Devon, England; [Foster, Emma A.; Balcomb, Ken C.] Ctr Whale Res, Friday Harbor, WA 98250 USA; [Franks, Daniel W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Mazzi, Sonia] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England; [Ford, John K. B.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada	University of Exeter; University of York - UK; University of York - UK; Fisheries & Oceans Canada	Croft, DP (corresponding author), Univ Exeter, Ctr Res Anim Behav, Coll Life & Environm Sci, Exeter EX4 4QG, Devon, England.	d.p.croft@exeter.ac.uk	Croft, Darren P/B-5503-2009; Darden, Safi/C-5940-2016	Croft, Darren P/0000-0001-6869-5097; Darden, Safi/0000-0002-2567-7902; Franks, Daniel Wayne/0000-0002-4832-7470	Biotechnology and Biological Sciences Research Council; Leverhulme Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust)	We thank our colleagues for their important roles in data collection over the past 35 years, particularly M. Bigg, D. Ellifrit, G. Ellis, E. Heydenrich, and A. van Ginneken and the Biotechnology and Biological Sciences Research Council and the Leverhulme Trust for funding. Data are available in the supplementary materials.	Baird RW, 2000, CETACEAN SOCIETIES, P127; Bigg M.A., 1990, REP INT WHALING COMM, V12, P384; Cant MA, 2008, P NATL ACAD SCI USA, V105, P5332, DOI 10.1073/pnas.0711911105; Ford MJ, 2011, J HERED, V102, P537, DOI 10.1093/jhered/esr067; Hill K, 2012, NATURE, V483, P160, DOI 10.1038/483160a; Johnstone RA, 2010, P ROY SOC B-BIOL SCI, V277, P3765, DOI 10.1098/rspb.2010.0988; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Ward EJ, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-4	9	114	117	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1313	1313		10.1126/science.1224198	http://dx.doi.org/10.1126/science.1224198			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984064	Green Submitted			2022-12-28	WOS:000308705000034
J	Jonas, DE; Garbutt, JC; Amick, HR; Brown, JM; Brownley, KA; Council, CL; Viera, AJ; Wilkins, TM; Schwartz, CJ; Richmond, EM; Yeatts, J; Evans, TS; Wood, SD; Harris, RP				Jonas, Daniel E.; Garbutt, James C.; Amick, Halle R.; Brown, Janice M.; Brownley, Kimberly A.; Council, Carol L.; Viera, Anthony J.; Wilkins, Tania M.; Schwartz, Cody J.; Richmond, Emily M.; Yeatts, John; Evans, Tammeka Swinson; Wood, Sally D.; Harris, Russell P.			Behavioral Counseling After Screening for Alcohol Misuse in Primary Care: A Systematic Review and Meta-analysis for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; BRIEF PHYSICIAN ADVICE; AT-RISK DRINKING; GENERAL-PRACTICE PATIENTS; BENEFIT-COST-ANALYSIS; BRIEF INTERVENTION; HAZARDOUS DRINKING; OLDER-ADULTS; PROBLEM DRINKERS; HEAVY DRINKING	Background: Alcohol misuse, which includes the full spectrum from risky drinking to alcohol dependence, is a leading cause of preventable death in the United States. Purpose: To evaluate the benefits and harms of behavioral counseling interventions for adolescents and adults who misuse alcohol. Data Sources: MEDLINE, EMBASE, the Cochrane Library, CINAHL, PsycINFO, International Pharmaceutical Abstracts, and reference lists of published literature (January 1985 through January 2012, limited to English-language articles). Study Selection: Controlled trials at least 6 months' duration that enrolled persons with alcohol misuse identified by screening in primary care settings and evaluated behavioral counseling interventions. Data Extraction: One reviewer extracted data and a second checked accuracy. Two independent reviewers assigned quality ratings and graded the strength of the evidence. Data Synthesis: The 23 included trials generally excluded persons with alcohol dependence. The best evidence was for brief (10- to 15-minute) multicontact interventions. Among adults receiving behavioral interventions, consumption decreased by 3.6 drinks per week from baseline (weighted mean difference, 3.6 drinks/wk [95% CI, 2.4 to 4.8 drinks/wk]; 10 trials; 4332 participants), 12% fewer adults reported heavy drinking episodes (risk difference, 0.12 [CI, 0.07 to 0.16]; 7 trials; 2737 participants), and 11% more adults reported drinking less than the recommended limits (risk difference, 0.11 [CI, 0.08 to 0.13]; 9 trials; 5973 participants) over 12 months compared with control participants (moderate strength of evidence). Evidence was insufficient to draw conclusions about accidents, injuries, or alcohol-related liver problems. Trials enrolling young adults or college students showed reduced consumption and fewer heavy drinking episodes (moderate strength of evidence). Little or no evidence of harms was found. Limitations: Results may be biased to the null because the behavior of control participants could have been affected by alcohol misuse assessments. In addition, evidence is probably inapplicable to persons with alcohol dependence and selective reporting may have occurred. Conclusion: Behavioral counseling interventions improve behavioral outcomes for adults with risky drinking.	[Jonas, Daniel E.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Res Triangle Inst Int, Res Triangle Pk, NC USA; Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute	Jonas, DE (corresponding author), Univ N Carolina, Dept Med, 5034 Old Clin Bldg,CB 7110, Chapel Hill, NC 27599 USA.	daniel_jonas@med.unc.edu		Schwartz, Cody/0000-0003-3661-4066; Brownley, Kim/0000-0002-5635-9229; Yeatts, John/0000-0002-9148-6151	AHRQ [290-2007-10056-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By AHRQ, contract 290-2007-10056-I.	Agency for Healthcare Research and Quality, 2010, AHRQ EHCP METH GUID; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDERSON P, 1992, BRIT J ADDICT, V87, P891; [Anonymous], 2009, SYSTEMATIC REV CRDS; Armstrong MA, 2009, SOC WORK HEALTH CARE, V48, P90, DOI 10.1080/00981380802451210; Babor TF, 2000, J STUD ALCOHOL, V61, P55, DOI 10.15288/jsa.2000.61.55; Babor TF, 1996, AM J PUBLIC HEALTH, V86, P948; Berg AO, 2004, ANN INTERN MED, V140, P554, DOI 10.7326/0003-4819-140-7-200404060-00016; Bischof G, 2008, DRUG ALCOHOL DEPEN, V93, P244, DOI 10.1016/j.drugalcdep.2007.10.003; Bondy SJ, 1999, CAN J PUBLIC HEALTH, V90, P264, DOI 10.1007/BF03404129; Budd K W, 2000, J Obstet Gynecol Neonatal Nurs, V29, P129, DOI 10.1111/j.1552-6909.2000.tb02032.x; Bull LBH, 1999, AM J PREV MED, V16, P240; Centers for Disease Control and Prevention, 2012, FASTSTATS ALC US; Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V52, P441; Chang G, 1999, ADDICTION, V94, P1499, DOI 10.1046/j.1360-0443.1999.941014996.x; Chang G, 2005, OBSTET GYNECOL, V105, P991, DOI 10.1097/01.AOG.0000157109.05453.84; Chang G, 1999, AM J ADDICTION, V8, P87; Chang G, 1998, OBSTET GYNECOL, V91, P892, DOI 10.1016/S0029-7844(98)00088-X; Chang G, 2000, J SUBST ABUSE TREAT, V18, P365, DOI 10.1016/S0740-5472(99)00105-1; Chang G, 2006, J SUBST ABUSE TREAT, V31, P419, DOI 10.1016/j.jsat.2006.05.016; Cherpitel CJ, 2008, J STUD ALCOHOL DRUGS, V69, P535, DOI 10.15288/jsad.2008.69.535; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Counsell C, 1997, ANN INTERN MED, V127, P380, DOI 10.7326/0003-4819-127-5-199709010-00008; Curry SJ, 2003, HEALTH PSYCHOL, V22, P156, DOI 10.1037/0278-6133.22.2.156; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P902, DOI 10.1097/01.ALC.0000164544.45746.A7; Del Boca FK, 2000, ADDICTION, V95, pS347; Fleming MF, 2002, ALCOHOL CLIN EXP RES, V26, P36, DOI 10.1111/j.1530-0277.2002.tb02429.x; Fleming MF, 1999, J FAM PRACTICE, V48, P378; Fleming MF, 2000, MED CARE, V38, P7, DOI 10.1097/00005650-200001000-00003; Fleming MF, 2008, ALCOHOL CLIN EXP RES, V32, P1600, DOI 10.1111/j.1530-0277.2008.00738.x; Fleming Michael F., 1997, JAMA (Journal of the American Medical Association), V277, P1039, DOI 10.1001/jama.277.13.1039; Fleming MF, 2010, J STUD ALCOHOL DRUGS, V71, P23, DOI 10.15288/jsad.2010.71.23; Floyd RL, 2007, AM J PREV MED, V32, P1, DOI 10.1016/j.amepre.2006.08.028; Flynn HA, 2003, ALCOHOL CLIN EXP RES, V27, P81, DOI 10.1097/01.ALC.0000046595.47491.37; Freeborn DK, 2000, J BEHAV HEALTH SER R, V27, P446, DOI 10.1007/BF02287826; Gordon AJ, 2003, SUBST USE MISUSE, V38, P1017, DOI 10.1081/JA-120017649; Grant TM, 2005, AM J DRUG ALCOHOL AB, V31, P471, DOI 10.1081/ADA-200056813; Grossberg PM, 2004, ANN FAM MED, V2, P474, DOI 10.1370/afm.122; Grothues JA, 2008, DRUG ALCOHOL DEPEN, V94, P214, DOI 10.1016/j.drugalcdep.2007.11.015; HALMESMAKI E, 1988, BRIT J OBSTET GYNAEC, V95, P243, DOI 10.1111/j.1471-0528.1988.tb06864.x; Handmaker NS, 1999, J STUD ALCOHOL, V60, P285, DOI 10.15288/jsa.1999.60.285; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holman CDJ, 1996, MED J AUSTRALIA, V164, P141, DOI 10.5694/j.1326-5377.1996.tb122011.x; Isaac M, 1994, ICD 10 SYMPTOM GLOSS; Janca A., 1994, ICD 10 SYMPTOM CHECK; Jonas DE, 2012, AHRQ PUBLICATION; Kypri K, 2004, ADDICTION, V99, P1410, DOI 10.1111/j.1360-0443.2004.00847.x; Kypri K, 2008, ARCH INTERN MED, V168, P530, DOI 10.1001/archinternmed.2007.109; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Lin JC, 2010, J GEN INTERN MED, V25, P334, DOI 10.1007/s11606-009-1223-2; Lock CA, 2006, J ADV NURS, V54, P426, DOI 10.1111/j.1365-2648.2006.03836.x; Maisto SA, 2001, AM J ADDICTION, V10, P218; Manwell LB, 2000, ALCOHOL CLIN EXP RES, V24, P1517, DOI 10.1097/00000374-200010000-00009; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023748; MEBERG A, 1986, ACTA OBSTET GYN SCAN, V65, P861, DOI 10.3109/00016348609157039; Miller WR, 2001, J STUD ALCOHOL, V62, P211, DOI 10.15288/jsa.2001.62.211; Moore AA, 2011, ADDICTION, V106, P111, DOI 10.1111/j.1360-0443.2010.03229.x; Mundt MP, 2005, J STUD ALCOHOL, V66, P389, DOI 10.15288/jsa.2005.66.389; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Noknoy S, 2010, ALCOHOL ALCOHOLISM, V45, P263, DOI 10.1093/alcalc/agq013; O'Connor MJ, 2007, AM J PUBLIC HEALTH, V97, P252, DOI 10.2105/AJPH.2005.077222; Ockene JK, 1999, ARCH INTERN MED, V159, P2198, DOI 10.1001/archinte.159.18.2198; Ockene JK, 2009, ANN BEHAV MED, V37, P335, DOI 10.1007/s12160-009-9108-5; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Reiff-Hekking S, 2005, J GEN INTERN MED, V20, P7, DOI 10.1111/j.1525-1497.2005.21240.x; Reinhardt S, 2008, ALCOHOL ALCOHOLISM, V43, P334, DOI 10.1093/alcalc/agn004; REYNOLDS KD, 1995, INT J ADDICT, V30, P427, DOI 10.3109/10826089509048735; RICHMOND R, 1995, ADDICTION, V90, P119, DOI 10.1046/j.1360-0443.1995.90111915.x; Rubio G, 2010, AM J MED, V123, P72, DOI 10.1016/j.amjmed.2009.08.012; Saitz R, 2003, ANN INTERN MED, V138, P372, DOI 10.7326/0003-4819-138-5-200303040-00006; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Saitz R, 2010, DRUG ALCOHOL REV, V29, P631, DOI 10.1111/j.1465-3362.2010.00217.x; Schaus JF, 2009, J STUD ALCOHOL DRUGS, P131, DOI 10.15288/jsads.2009.s16.131; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Scott E, 1991, Drug Alcohol Rev, V10, P313; Senft RA, 1997, AM J PREV MED, V13, P464, DOI 10.1016/S0749-3797(18)30143-0; Shalala DE, 2000, 10 US DEP HLTH HUM S; United States Department of Veterans Affairs, 2010, AUDIT C FREQ ASK QUE; Vinson DC, 2010, ANN FAM MED, V8, P484, DOI 10.1370/afm.1175; WALLACE P, 1988, BRIT MED J, V297, P663, DOI 10.1136/bmj.297.6649.663; WATERSON EJ, 1990, SOC SCI MED, V30, P349, DOI 10.1016/0277-9536(90)90190-4; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4; Wilton G, 2009, MCN-AM J MATERN-CHIL, V34, P297, DOI 10.1097/01.NMC.0000360422.06486.c4	86	287	289	2	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					645	+		10.7326/0003-4819-157-9-201211060-00544	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00544			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033GX	23007881				2022-12-28	WOS:000310783300005
J	Gittis, A				Gittis, Aryn			Striatal Interneurons: Causes of or Cures for Movement Disorders?	SCIENCE			English	Editorial Material							BASAL GANGLIA; INHIBITION; DOPAMINE		[Gittis, Aryn] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Gittis, Aryn] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gittis, A (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.		Gittis, Aryn/I-6128-2016	Gittis, Aryn/0000-0002-3591-5775	NINDS NIH HHS [R00 NS076524] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; Gittis AH, 2011, NEURON, V71, P858, DOI 10.1016/j.neuron.2011.06.035; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365	10	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103								10.1126/science.1229852	http://dx.doi.org/10.1126/science.1229852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042880				2022-12-28	WOS:000309457400049
J	Little, RJ; D'Agostino, R; Cohen, ML; Dickersin, K; Emerson, SS; Farrar, JT; Frangakis, C; Hogan, JW; Molenberghs, G; Murphy, SA; Neaton, JD; Rotnitzky, A; Scharfstein, D; Shih, WCJ; Siegel, JP; Stern, H				Little, Roderick J.; D'Agostino, Ralph; Cohen, Michael L.; Dickersin, Kay; Emerson, Scott S.; Farrar, John T.; Frangakis, Constantine; Hogan, Joseph W.; Molenberghs, Geert; Murphy, Susan A.; Neaton, James D.; Rotnitzky, Andrea; Scharfstein, Daniel; Shih, Weichung J.; Siegel, Jay P.; Stern, Hal			The Prevention and Treatment of Missing Data in Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DROPOUT RATES; METAANALYSIS; PLACEBO; DRUGS		[Little, Roderick J.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Murphy, Susan A.] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [D'Agostino, Ralph] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Cohen, Michael L.] Natl Res Council Natl Acad, Washington, DC USA; [Dickersin, Kay] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Frangakis, Constantine; Scharfstein, Daniel] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Emerson, Scott S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Farrar, John T.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Hogan, Joseph W.] Brown Univ, Ctr Stat Sci, Program Publ Hlth, Providence, RI 02912 USA; [Molenberghs, Geert] Univ Hasselt, Int Inst Biostat & Stat Bioinformat, Louvain, Belgium; [Molenberghs, Geert] Katholieke Univ Leuven, Louvain, Belgium; [Neaton, James D.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Rotnitzky, Andrea] Univ Torcuato Di Tella, Dept Econ, Buenos Aires, DF, Argentina; [Shih, Weichung J.] Univ Med & Dent New Jersey, Sch Publ Hlth, Dept Biostat, New Brunswick, NJ USA; [Siegel, Jay P.] Johnson & Johnson Consumer Prod Inc, Radnor, PA USA; [Stern, Hal] Univ Calif Irvine, Dept Stat, Irvine, CA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston University; National Academies of Sciences, Engineering & Medicine; Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Pennsylvania; Brown University; Hasselt University; KU Leuven; University of Minnesota System; University of Minnesota Twin Cities; Universidad Torcuato Di Tella; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johnson & Johnson; Johnson & Johnson USA; University of California System; University of California Irvine	Little, RJ (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.		Farrar, John T/AAP-4788-2021; Hogan, Joseph/J-4579-2014	Farrar, John T/0000-0001-8656-5157; Murphy, Susan A/0000-0002-2032-4286; Hogan, Joseph/0000-0001-7959-7361	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102710, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC1AA019186, P01AA019072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA010075] Funding Source: NIH RePORTER; NIAAA NIH HHS [RC1 AA019186, P01 AA019072] Funding Source: Medline; NIAID NIH HHS [P30 AI042853, R01 AI102710] Funding Source: Medline; NIDA NIH HHS [P50 DA010075] Funding Source: Medline; NIMH NIH HHS [R01 MH080015] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1998, INT C HARM TOP E9; [Anonymous], 2001, ICH HARM TRIP GUID C; *COMM ASS SYST PRO, 2002, RESP RES SYST APPR P; Committee for Medicinal Products for Human Use, 2009, GUID MISS DAT CONF C; Emanuel EJ, 2005, AM J BIOETHICS, V5, P9, DOI 10.1080/15265160500244959; Emanuel EJ, 2006, AM J BIOETHICS, V6, P54; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Kemmler G, 2005, ARCH GEN PSYCHIAT, V62, P1305, DOI 10.1001/archpsyc.62.12.1305; Lagakos SW, 2006, NEW ENGL J MED, V355, P113, DOI 10.1056/NEJMp068137; Lipinski MJ, 2009, AM J CARDIOL, V104, P1708, DOI 10.1016/j.amjcard.2009.07.055; Little RJ, 2012, STAT MED; Little RJ, 2002, STAT INFERENCE MISSI, V2nd; Lurie I, 2010, J NERV MENT DIS, V198, P116, DOI 10.1097/NMD.0b013e3181cc41b6; Molnar Frank J, 2009, Open Med, V3, pe31; National Research Council, 2010, PREVENTION TREATMENT; O'Neill RT, 2012, CLIN PHARMACOL THER, V91, P550, DOI 10.1038/clpt.2011.340; Rabinowitz J, 2009, SCHIZOPHRENIA BULL, V35, P775, DOI 10.1093/schbul/sbn005; Raboud JM, 1996, J ACQ IMMUN DEF SYND, V12, P46, DOI 10.1097/00042560-199605010-00007; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054	20	880	897	4	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1355	1360		10.1056/NEJMsr1203730	http://dx.doi.org/10.1056/NEJMsr1203730			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034025	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000309406100016
J	Franklin, PD; Allison, JJ; Ayers, DC				Franklin, Patricia D.; Allison, Jeroan J.; Ayers, David C.			Beyond Joint Implant Registries A Patient-Centered Research Consortium for Comparative Effectiveness in Total Joint Replacement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Franklin, Patricia D.; Ayers, David C.] Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01655 USA; [Allison, Jeroan J.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Franklin, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, 55 Lake Ave N, Worcester, MA 01655 USA.	patricia.franklin@umassmed.edu		Ayers, David/0000-0001-5458-7052; Allison, Jeroan/0000-0003-4472-2112; Franklin, Patricia D/0000-0002-4441-0533	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P50HS018910] Funding Source: NIH RePORTER; AHRQ HHS [P50 HS018910] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AHRQ research grants search results, AHRQ RES GRANTS SEAR; ASR hip replacement recall media guide, ASR HIP REPL REC MED; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Rising JP, 2012, NEW ENGL J MED, V367, DOI 10.1056/NEJMp1206794	4	72	72	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1217	1218		10.1001/jama.2012.12568	http://dx.doi.org/10.1001/jama.2012.12568			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011710	Green Accepted			2022-12-28	WOS:000309103600023
J	Graber, ML; Wachter, RM; Cassel, CK				Graber, Mark L.; Wachter, Robert M.; Cassel, Christine K.			Bringing Diagnosis Into the Quality and Safety Equations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ERROR; CARE		[Graber, Mark L.] RTI Int, St James, NY 11780 USA; [Wachter, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA USA	Research Triangle Institute; University of California System; University of California San Francisco; American Board of Internal Medicine	Graber, ML (corresponding author), RTI Int, 1 Breezy Hollow, St James, NY 11780 USA.	mgraber@rti.org		Graber, Mark/0000-0002-3600-0446				[Anonymous], DAILY MAIL MAILONLIN; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Kostopoulou O, 2008, FAM PRACT, V25, P400, DOI 10.1093/fampra/cmn071; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P2405, DOI 10.1001/jama.288.19.2405-JLT1120-2-3; McDonald O, PHYS PERSPECTIVES PR; Nuland S.B., 1994, HOW WE DIE	7	86	86	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1211	1212		10.1001/2012.jama.11913	http://dx.doi.org/10.1001/2012.jama.11913			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011708				2022-12-28	WOS:000309103600020
J	O'Neill, D				O'Neill, Desmond			PERSONAL VIEW Medical screening of older drivers is not evidence based	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SAFETY; RISK; INJURIES		Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland.	doneill@tcd.ie						Baster N, 2012, ITS MY CHOICE; Carr D.B., 2010, PHYS GUID ASS COUNS; Foley DJ, 2002, AM J PUBLIC HEALTH, V92, P1284, DOI 10.2105/AJPH.92.8.1284; Freeman EE, 2006, AM J PUBLIC HEALTH, V96, P1254, DOI 10.2105/AJPH.2005.069146; Freund K, 2010, GENERATIONS, V34, P76; HakamiesBlomqvist L, 1996, J AM GERIATR SOC, V44, P650, DOI 10.1111/j.1532-5415.1996.tb01826.x; Henretig FM, 2011, PEDIATRICS, V128, P289, DOI 10.1542/peds.2011-0046; Kua A, 2007, J SAFETY RES, V38, P81, DOI 10.1016/j.jsr.2007.01.002; Kulikov E, 2011, J AGING SOC POLICY, V23, P1, DOI 10.1080/08959420.2011.531991; Langford J, 2006, ACCIDENT ANAL PREV, V38, P574, DOI 10.1016/j.aap.2005.12.002; Langford J, 2004, ACCIDENT ANAL PREV, V36, P993, DOI 10.1016/j.aap.2003.11.003; Langford J, 2008, TRAFFIC INJ PREV, V9, P181, DOI 10.1080/15389580801975632; Li GH, 2003, ACCIDENT ANAL PREV, V35, P227, DOI 10.1016/S0001-4575(01)00107-5; Marottoli RA, 2007, J GEN INTERN MED, V22, P590, DOI 10.1007/s11606-007-0134-3; Martin A, 2005, BRIT MED J, V330, P3682; Mitchell CGB, 2008, TRAFFIC INJ PREV, V9, P360, DOI 10.1080/15389580801895160; Morris Andrew, 2003, Annu Proc Assoc Adv Automot Med, V47, P165; [Organisation for Economic Cooperation and Development (OECD) International Transport Forum], 2012, PED SAF URB SPAC HLT; Palacio A, 2009, ACCIDENT ANAL PREV, V41, P1, DOI 10.1016/j.aap.2008.08.016; Rosenbloom S, 2001, TRANSPORTATION, V28, P375, DOI 10.1023/A:1011802707259; Siren A, 2012, ACCIDENT ANAL PREV, V45, P634, DOI 10.1016/j.aap.2011.09.032	21	16	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2012	345								e6371	10.1136/bmj.e6371	http://dx.doi.org/10.1136/bmj.e6371			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23015037				2022-12-28	WOS:000309385500009
J	Beasley, AJ; Schreier, EJ				Beasley, Anthony J.; Schreier, Ethan J.			The United States must rejoin the SKA	NATURE			English	Editorial Material												tbeasley@nrao.edu							0	0	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					363	363		10.1038/489363a	http://dx.doi.org/10.1038/489363a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AK	22996534				2022-12-28	WOS:000308860900018
J	Rand, DG; Greene, JD; Nowak, MA				Rand, David G.; Greene, Joshua D.; Nowak, Martin A.			Spontaneous giving and calculated greed	NATURE			English	Article							EVOLUTION; COOPERATION; SYSTEMS	Cooperation is central to human social behaviour(1-9). However, choosing to cooperate requires individuals to incur a personal cost to benefit others. Here we explore the cognitive basis of cooperative decision-making in humans using a dual-process framework(10-18). We ask whether people are predisposed towards selfishness, behaving cooperatively only through active self-control; or whether they are intuitively cooperative, with reflection and prospective reasoning favouring 'rational' self-interest. To investigate this issue, we perform ten studies using economic games. We find that across a range of experimental designs, subjects who reach their decisions more quickly are more cooperative. Furthermore, forcing subjects to decide quickly increases contributions, whereas instructing them to reflect and forcing them to decide slowly decreases contributions. Finally, an induction that primes subjects to trust their intuitions increases contributions compared with an induction that promotes greater reflection. To explain these results, we propose that cooperation is intuitive because cooperative heuristics are developed in daily life where cooperation is typically advantageous. We then validate predictions generated by this proposed mechanism. Our results provide convergent evidence that intuition supports cooperation in social dilemmas, and that reflection can undermine these cooperative impulses.	[Rand, David G.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.; Greene, Joshua D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Rand, David G.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Yale University; Harvard University; Harvard University	Rand, DG (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	drand@fas.harvard.edu	Rand, David G./B-3716-2009; Nowak, Martin A/A-6977-2008	Rand, David G./0000-0002-2821-468X; Rand, David/0000-0001-8975-2783	National Science Foundation [SES-0821978]; John Templeton Foundation; Direct For Social, Behav & Economic Scie [0821978] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank H. Ahlblad, O. Amir, F. Fu, O. Hauser, J. Horton and R. Kane for assistance with carrying out the experiments, and P. Blake, S. Bowles, N. Christakis, F. Cushman, A. Dreber, T. Ellingsen, F. Fu, D. Fudenberg, O. Hauser, J. Jordan, M. Johannesson, M. Manapat, J. Paxton, A. Peysakhovich, A. Shenhav, J. Sirlin-Rand, M. van Veelen and O. Wurzbacher for discussion and comments. This work was supported in part by a National Science Foundation grant (SES-0821978 to J. D. G.). D. G. R. and M. A. N. are supported by grants from the John Templeton Foundation.	Benhabib J, 2005, GAME ECON BEHAV, V52, P460, DOI 10.1016/j.geb.2004.10.004; Bowles S, 2002, EC EVOLVING COMPLEX, V3, P339; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Pfeiffer T., 2012, J R SOC INTERFACE; Plessner H, 2008, INTUITION IN JUDGMENT AND DECISION MAKING, P1; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Richerson P. J., 2005, NOT GENES ALONE CULT; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448	30	715	737	33	412	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					427	430		10.1038/nature11467	http://dx.doi.org/10.1038/nature11467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AK	22996558				2022-12-28	WOS:000308860900044
J	Takahashi, S; Brunel, LC; Edwards, DT; van Tol, J; Ramian, G; Han, S; Sherwin, MS				Takahashi, S.; Brunel, L. -C.; Edwards, D. T.; van Tol, J.; Ramian, G.; Han, S.; Sherwin, M. S.			Pulsed electron paramagnetic resonance spectroscopy powered by a free-electron laser	NATURE			English	Article							SPIN-RESONANCE; DISTANCE MEASUREMENTS; GENERATION; SPECTROMETER; COMPOSITES; SWITCHES; FIELD; ESR	Electron paramagnetic resonance (EPR) spectroscopy interrogates unpaired electron spins in solids and liquids to reveal local structure and dynamics; for example, EPR has elucidated parts of the structure of protein complexes that other techniques in structural biology have not been able to reveal(1-4). EPR can also probe the interplay of light and electricity in organic solar cells(5-7) and light-emitting diodes(8), and the origin of decoherence in condensed matter, which is of fundamental importance to the development of quantum information processors(9-13). Like nuclear magnetic resonance, EPR spectroscopy becomes more powerful at high magnetic fields and frequencies, and with excitation by coherent pulses rather than continuous waves. However, the difficulty of generating sequences of powerful pulses at frequencies above 100 gigahertz has, until now, confined high-power pulsed EPR to magnetic fields of 3.5 teslas and below. Here we demonstrate that one-kilowatt pulses from a free-electron laser can power a pulsed EPR spectrometer at 240 gigahertz (8.5 teslas), providing transformative enhancements over the alternative, a state-of-the-art similar to 30-milliwatt solid-state source. Our spectrometer can rotate spin-1/2 electrons through pi/2 in only 6 nanoseconds (compared to 300 nanoseconds with the solid-state source). Fourier-transform EPR on nitrogen impurities in diamond demonstrates excitation and detection of EPR lines separated by about 200 megahertz. We measured decoherence times as short as 63 nanoseconds, in a frozen solution of nitroxide free-radicals at temperatures as high as 190 kelvin. Both free-electron lasers and the quasi-optical technology developed for the spectrometer are scalable to frequencies well in excess of one terahertz, opening the way to high-power pulsed EPR spectroscopy up to the highest static magnetic fields currently available.	[Takahashi, S.; Brunel, L. -C.; Han, S.; Sherwin, M. S.] Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA; [Takahashi, S.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Edwards, D. T.; Sherwin, M. S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [van Tol, J.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Han, S.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Southern California; University of California System; University of California Santa Barbara; State University System of Florida; Florida State University; University of California System; University of California Santa Barbara	Sherwin, MS (corresponding author), Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA.	sherwin@physics.ucsb.edu	van Tol, Johan/G-4190-2011; Han, Songi/E-4723-2012; Sherwin, Mark S/Q-4762-2017; Takahashi, Susumu/K-2616-2014; Takahashi, Susumu/ABI-2675-2020	van Tol, Johan/0000-0001-6972-2149; Han, Songi/0000-0001-6489-6246; Sherwin, Mark S/0000-0002-3869-1893; Takahashi, Susumu/0000-0002-1302-2845; Takahashi, Susumu/0000-0002-1302-2845; EDWARDS, DEVIN/0000-0002-2612-9561	NSF [CHE-0821589, DMR-0520481, DMR-0703925]; W. M. Keck Foundation; Division Of Chemistry [0821589] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NSF (CHE-0821589, DMR-0520481 and DMR-0703925) and the W. M. Keck Foundation. We thank D. Enyeart, S. El Abbadi, N. Krauss, K. Akabori, M. Anholm, T. Visher, J. Bricker and G. Kontsevich for support of the development and operation of the FEL.	Borbat PP, 1999, CHEM PHYS LETT, V313, P145, DOI 10.1016/S0009-2614(99)00972-0; Cruickshank PAS, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3239402; Doty MF, 2004, REV SCI INSTRUM, V75, P2921, DOI 10.1063/1.1783594; Dyakonov V, 1999, PHYS REV B, V59, P8019, DOI 10.1103/PhysRevB.59.8019; Earle KA, 2005, MAGN RESON CHEM, V43, pS256, DOI 10.1002/mrc.1684; Freed JH, 2000, ANNU REV PHYS CHEM, V51, P655, DOI 10.1146/annurev.physchem.51.1.655; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hegmann FA, 1996, P SOC PHOTO-OPT INS, V2842, P90; Hofbauer W, 2004, REV SCI INSTRUM, V75, P1194, DOI 10.1063/1.1710700; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Lyon SA, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.052338; McCamey DR, 2008, NAT MATER, V7, P723, DOI 10.1038/nmat2252; Mitsudo S., 2010, P IRMMW THZ 2010; Nanni E. A., 2010, 2010 IEEE INT VAC EL; Ogiwara T, 2005, CHEM PHYS LETT, V411, P378, DOI 10.1016/j.cplett.2005.06.066; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Rabi II, 1937, PHYS REV, V51, P0652, DOI 10.1103/PhysRev.51.652; RAMIAN G, 1992, NUCL INSTRUM METH A, V318, P225, DOI 10.1016/0168-9002(92)91056-F; ROLLAND C, 1986, J OPT SOC AM B, V3, P1625, DOI 10.1364/JOSAB.3.001625; Saxena S, 1996, CHEM PHYS LETT, V251, P102, DOI 10.1016/0009-2614(96)00075-9; SMILOWITZ L, 1993, PHYS REV B, V47, P13835, DOI 10.1103/PhysRevB.47.13835; Smith GM, 1998, REV SCI INSTRUM, V69, P3924, DOI 10.1063/1.1149200; Takahashi S, 2011, NATURE, V476, P76, DOI 10.1038/nature10314; Takahashi S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801700; Takahashi S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3270041; Takahashi S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047601; van Tol J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942533; van Tol J, 2009, APPL MAGN RESON, V36, P259, DOI 10.1007/s00723-009-0014-6	29	56	57	4	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					409	413		10.1038/nature11437	http://dx.doi.org/10.1038/nature11437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996555				2022-12-28	WOS:000308860900040
J	Abbasi, A; Peelen, LM; Corpeleijn, E; van der Schouw, YT; Stolk, RP; Spijkerman, AMW; van der A, DL; Moons, KGM; Navis, G; Bakker, SJL; Beulens, JWJ				Abbasi, Ali; Peelen, Linda M.; Corpeleijn, Eva; van der Schouw, Yvonne T.; Stolk, Ronald P.; Spijkerman, Annemieke M. W.; van der A, Daphne L.; Moons, Karel G. M.; Navis, Gerjan; Bakker, Stephan J. L.; Beulens, Joline W. J.			Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIFE-STYLE FACTORS; IDENTIFYING INDIVIDUALS; CLINICAL-PRACTICE; MELLITUS; SCORES; POPULATION; PERFORMANCE; GLUCOSE; TOOL; PREVALENCE	Objective To identify existing prediction models for the risk of development of type 2 diabetes and to externally validate them in a large independent cohort. Data sources Systematic search of English, German, and Dutch literature in PubMed until February 2011 to identify prediction models for diabetes. Design Performance of the models was assessed in terms of discrimination (C statistic) and calibration (calibration plots and Hosmer-Lemeshow test). The validation study was a prospective cohort study, with a case cohort study in a random subcohort. Setting Models were applied to the Dutch cohort of the European Prospective Investigation into Cancer and Nutrition cohort study (EPIC-NL). Participants 38 379 people aged 20-70 with no diabetes at baseline, 2506 of whom made up the random subcohort. Outcome measure Incident type 2 diabetes. Results The review identified 16 studies containing 25 prediction models. We considered 12 models as basic because they were based on variables that can be assessed non-invasively and 13 models as extended because they additionally included conventional biomarkers such as glucose concentration. During a median follow-up of 10.2 years there were 924 cases in the full EPIC-NL cohort and 79 in the random subcohort. The C statistic for the basic models ranged from 0.74 (95% confidence interval 0.73 to 0.75) to 0.84 (0.82 to 0.85) for risk at 7.5 years. For prediction models including biomarkers the C statistic ranged from 0.81 (0.80 to 0.83) to 0.93 (0.92 to 0.94). Most prediction models overestimated the observed risk of diabetes, particularly at higher observed risks. After adjustment for differences in incidence of diabetes, calibration improved considerably. Conclusions Most basic prediction models can identify people at high risk of developing diabetes in a time frame of five to 10 years. Models including biomarkers classified cases slightly better than basic ones. Most models overestimated the actual risk of diabetes. Existing prediction models therefore perform well to identify those at high risk, but cannot sufficiently quantify actual risk of future diabetes.	[Abbasi, Ali; Corpeleijn, Eva; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Abbasi, Ali; Navis, Gerjan; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Abbasi, Ali; Peelen, Linda M.; van der Schouw, Yvonne T.; Moons, Karel G. M.; Beulens, Joline W. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [van der A, Daphne L.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr & Hlth, Bilthoven, Netherlands	University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Abbasi, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	a.abbasi@umcg.nl	Bakker, Stephan J. L./J-4023-2015; Abbasi, Ali/N-7707-2013; Stolk, Ronald P/B-2341-2013; van der Schouw, Yvonne T./F-8327-2014	Bakker, Stephan J. L./0000-0003-3356-6791; Stolk, Ronald P/0000-0002-0518-1205; van der Schouw, Yvonne T./0000-0002-4605-435X; Beulens, Joline/0000-0002-4181-0937; ABBASI, ALI/0000-0002-6452-4765; Corpeleijn, Eva/0000-0002-2974-3305	Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Centre for Translational Molecular Medicine (project PREDICCt) [01C-104-07]; Europe against Cancer Programme of the European Commission (SANCO); Dutch Ministry of Health; Dutch Cancer Society; Netherlands Organization for Health Research and Development (ZonMW); World Cancer Research Fund (WCRF); Netherlands Organization for Scientific Research project [9120.8004, 918.10.615]	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Centre for Translational Molecular Medicine (project PREDICCt); Europe against Cancer Programme of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Netherlands Organization for Scientific Research project	This study was funded by the Netherlands Heart Foundation, the Dutch Diabetes Research Foundation and the Dutch Kidney Foundation, the Centre for Translational Molecular Medicine (project PREDICCt, grant 01C-104-07), Europe against Cancer Programme of the European Commission (SANCO), the Dutch Ministry of Health, the Dutch Cancer Society, the Netherlands Organization for Health Research and Development (ZonMW), and World Cancer Research Fund (WCRF), and the Netherlands Organization for Scientific Research project (9120.8004 and 918.10.615). None of the study sponsors had a role in the study design, data collection, analysis and interpretation, report writing, or the decision to submit the report for publication	Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Alssema M, 2011, DIABETOLOGIA, V54, P1004, DOI 10.1007/s00125-010-1990-7; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Joseph J, 2010, SCAND J PUBLIC HEALT, V38, P768, DOI 10.1177/1403494810380299; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knowler WC., 2009, LANCET, V374, P1677, DOI [10.1016/S0140-6736(09)61457-4, DOI 10.1016/S0140-6736(09)61457-4, 10.1016/B978-0-323-29738-7]; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LIDDELL FDK, 1984, J EPIDEMIOL COMMUN H, V38, P85, DOI 10.1136/jech.38.1.85; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Mann DM, 2010, AM J EPIDEMIOL, V171, P980, DOI 10.1093/aje/kwq030; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; McGeechan K, 2008, ARCH INTERN MED, V168, P2304, DOI 10.1001/archinte.168.21.2304; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Noble Douglas, 2011, BMJ, V343, pd7163, DOI 10.1136/bmj.d7163; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; Rathmann W, 2005, ARCH INTERN MED, V165, P436, DOI 10.1001/archinte.165.4.436; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rosella LC, 2011, J EPIDEMIOL COMMUN H, V65, P613, DOI 10.1136/jech.2009.102244; Schmid R, 2012, ARCH INTERN MED, V172, P188, DOI 10.1001/archinte.172.2.188; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Simmons RK, 2007, DIABETIC MED, V24, P830, DOI 10.1111/j.1464-5491.2007.02173.x; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Sluijs I, 2010, NETH J MED, V68, P333; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; STERN MP, 1993, DIABETES, V42, P706, DOI 10.2337/diabetes.42.5.706; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; van Dieren S, 2011, DIABETOLOGIA, V54, P73, DOI 10.1007/s00125-010-1945-z; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Volovics A, 1997, BIOMETRICAL J, V39, P195, DOI 10.1002/bimj.4710390208; von Eckardstein A, 2000, J CLIN ENDOCR METAB, V85, P3101, DOI 10.1210/jc.85.9.3101; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wannamethee SG, 2011, DIABETIC MED, V28, P23, DOI 10.1111/j.1464-5491.2010.03171.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	59	193	197	0	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2012	345								e5900	10.1136/bmj.e5900	http://dx.doi.org/10.1136/bmj.e5900			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JH	22990994	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000309160400002
J	Kessler, R				Kessler, Rodger			CBT by telephone for depression improved adherence compared with face-to-face CBT in primary care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Vermont, Coll Med, Burlington, VT 05405 USA	University of Vermont	Kessler, R (corresponding author), Univ Vermont, Coll Med, Burlington, VT 05405 USA.							Auxier A, 2012, TRANSLATIONAL B 0606; Kessler R, 2008, COLLABORATIVE MED CA; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045	3	1	1	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-12	10.7326/0003-4819-157-6-201209180-02012	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986404				2022-12-28	WOS:000308912800011
J	Simmons, RK; Echouffo-Tcheugui, JB; Sharp, SJ; Sargeant, LA; Williams, KM; Prevost, AT; Kinmonth, AL; Wareham, NJ; Griffin, SJ				Simmons, Rebecca K.; Echouffo-Tcheugui, Justin B.; Sharp, Stephen J.; Sargeant, Lincoln A.; Williams, Kate M.; Prevost, A. Toby; Kinmonth, Ann Louise; Wareham, Nicholas J.; Griffin, Simon J.			Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial	LANCET			English	Article							CORONARY-HEART-DISEASE; FOLLOW-UP; CANCER MORTALITY; PROGRAMS; PEOPLE; IMPACT; DEATH; RISK; CARE	Background The increasing prevalence of type 2 diabetes poses a major public health challenge. Population-based screening and early treatment for type 2 diabetes could reduce this growing burden. However, uncertainty persists around the benefits of screening for type 2 diabetes. We assessed the effect of a population-based stepwise screening programme on mortality. Methods In a pragmatic parallel group, cluster-randomised trial, 33 general practices in eastern England were randomly assigned by the method of minimisation in an unbalanced design to: screening followed by intensive multifactorial treatment for people diagnosed with diabetes (n=15); screening plus routine care of diabetes according to national guidelines (n=13); and a no-screening control group (n=5). The study population consisted of 20 184 individuals aged 40-69 years (mean 58 years), at high risk of prevalent undiagnosed diabetes, on the basis of a previously validated risk score. In screening practices, individuals were invited to a stepwise programme including random capillary blood glucose and glycated haemoglobin (HbA(1c)) tests, a fasting capillary blood glucose test, and a confirmatory oral glucose tolerance test. The primary outcome was all-cause mortality. All participants were flagged for mortality surveillance by the England and Wales Office of National Statistics. Analysis was by intention-to-screen and compared all-cause mortality rates between screening and control groups. This study is registered, number ISRCTN86769081. Findings Of 16 047 high-risk individuals in screening practices, 15 089 (94%) were invited for screening during 2001-06, 11 737 (73%) attended, and 466 (3%) were diagnosed with diabetes. 4137 control individuals were followed up. During 184 057 person-years of follow up (median duration 9.6 years [IQR 8.9-9.9]), there were 1532 deaths in the screening practices and 377 in control practices (mortality hazard ratio [HR] 1.06, 95% CI 0.90-1.25). We noted no significant reduction in cardiovascular (HR 1.02, 95% CI 0.75-1.38), cancer (1.08, 0.90-1.30), or diabetes-related mortality (1.26, 0.75-2.10) associated with invitation to screening. Interpretation In this large UK sample, screening for type 2 diabetes in patients at increased risk was not associated with a reduction in all-cause, cardiovascular, or diabetes-related mortality within 10 years. The benefits of screening might be smaller than expected and restricted to individuals with detectable disease.	[Griffin, Simon J.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge CB2 0QQ, England; [Williams, Kate M.; Prevost, A. Toby; Kinmonth, Ann Louise] Univ Cambridge, Primary Care Unit, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; [Prevost, A. Toby] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; King's College London	Griffin, SJ (corresponding author), Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Hills Rd, Cambridge CB2 0QQ, England.	simon.griffin@mrc-epid.cam.ac.uk	Echouffo-Tcheugui, Justin/AGD-6195-2022; Griffin, Simon J/K-3106-2013	Echouffo-Tcheugui, Justin/0000-0002-8460-1617; Griffin, Simon J/0000-0002-2157-4797; Prevost, A. Toby/0000-0003-1723-0796; Simmons, Rebecca/0000-0002-7726-8529; Williams, Kate/0000-0002-6188-9363	Wellcome Trust [G061895]; UK Medical Research Council; National Health Service; UK National Institute for Health Research; University of Aarhus, Denmark; Bio-Rad; Ely Lilly; Novo Nordisk; Medical Research Council [G0001164]; National Institute for Health Research; Gates Cambridge Trust; NIHR Research funds; Department of Health NIHR Programme [RP-PG-0606-1259]; NIHR Biomedical Research Centre; NIHR [RP-PG-0606-1259]; Medical Research Council [MC_U106179471, MC_U106179474, G0200391] Funding Source: researchfish; National Institute for Health Research [08/116/300, RP-PG-0606-1259] Funding Source: researchfish; MRC [MC_U106179474, G0200391, G0001164] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Service; UK National Institute for Health Research(National Institute for Health Research (NIHR)); University of Aarhus, Denmark; Bio-Rad; Ely Lilly; Novo Nordisk(Novo Nordisk); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Gates Cambridge Trust; NIHR Research funds; Department of Health NIHR Programme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Wellcome Trust; UK Medical Research Council; National Health Service research and development support; UK National Institute for Health Research; University of Aarhus, Denmark; Bio-Rad.; SJG received an honorarium and reimbursement of travel expenses from Ely Lilly associated with membership of an independent data monitoring committee for a randomised trial of a medication to lower glucose. He has received payment from Novo Nordisk for a lecture given at a postgraduate educational meeting in 2010. ALK has received payment from Novo Nordisk for giving a lecture. The remaining authors declare that they have no conflicts of interest.; ADDITION-Cambridge was supported by the Wellcome Trust (grant reference No G061895) the Medical Research Council (grant reference no: G0001164), National Health Service R&D support funding (including the Primary Care Research and Diabetes Research Networks), and the National Institute for Health Research. JBE-T was funded by a scholarship from the Gates Cambridge Trust. We received an unrestricted grant from University of Aarhus, Denmark, to support the ADDITION-Cambridge trial. Bio-Rad provided equipment to undertake capillary glucose screening by HbA<INF>1c</INF> in general practice. ALK is a National Institute for Health Research (NIHR) Senior Investigator. The Primary Care Research Unit is supported by NIHR Research funds. SJG receives support from the Department of Health NIHR Programme Grant funding scheme (RP-PG-0606-1259). ATP was supported by the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. This article presents independent research funded by the NIHR under the Programme Grants for Applied Research programme (RP-PG-0606-1259]. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. We thank the independent trial steering committee (Nigel Stott [Chair], John Weinman, Richard Himsworth, and Paul Little) and all participants, practice nurses, and general practitioners in the ADDITION-Cambridge study. The Primary Care Research Unit at the University of Cambridge and the Medical Research Council Epidemiology Unit in Cambridge jointly coordinated the study. Aside from the authors, the ADDITION-Cambridge study team has included Rebecca Abbott, Amanda Adler, Judith Argles, Gisela Baker, Rebecca Bale, Ros Barling, Daniel Barnes, Mark Betts, Sue Boase, Clare Boothby, Sandra Bovan, Ryan Butler, James Brimbicombe, Parinya Chamnan, Sean Dinneen, Pesheya Doubleday, Sue Emms, Mark Evans, Tom Fanshawe, Francis Finucane, Philippa Gash, Julie Grant, Wendy Hardeman, Robert Henderson, Susie Hennings, Garry King, Georgina Lewis, Christine May Hall, Joanna Mitchell, Richard Parker, Nicola Popplewell, Emanuella De Lucia Rolfe, Megan Smith, Stephen Sutton, Liz White and Fiona Whittle. We also wish to thank the Cambridge University Hospitals NHS Foundation Trust Department of Clinical Biochemistry and the NIHR Cambridge Biomedical Research Centre Core Biochemistry Assay Laboratory for carrying out the biochemical assays and the following groups within the MRC Epidemiology Unit: data management (Adam Dickinson), information technology (Iain Morrison), technical (Matt Sims), and field epidemiology (Paul Roberts, Kim Mwanza, and James Sylvester). The National Primary Care Database is a product of the National Primary Care Research and Development Centre (NPCRDC) at the University of Manchester. It was devised by Deborah Baker. The database was constructed by Justin Hayes at the Regional Research Laboratory, School of Geography, University of Manchester; SEE IT consultancy designed and built the map interface. We thank Andrew Wagner, Mark Hann, and David Reeves (NPCRDC) for cleaning and validating the data sets. Andrew Wagner is the database manager.	Alberti KG, 1999, DEFINITION DIAGNOS 1; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Chang HJ, 2000, PREV MED, V31, P396, DOI 10.1006/pmed.2000.0728; Department of Health, 2008, PUTT PREV 1 VASC CHE; Diabetes United Kingdom, 2008, EARL ID PEOPL TYP 2; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Echouffo-Tcheugui JB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-136; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 2000, LANCET, V355, P253; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Hain D, 2007, BRIEF IND MULT DEPR; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Kuo HS, 1999, INT J EPIDEMIOL, V28, P233, DOI 10.1093/ije/28.2.233; Marteau TM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2138; McIntosh A, 2001, CLIN GUIDELINES EVID; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Paddison CAM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4535; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Rahman M, 2012, DIABETOLOGIA, V55, P1651, DOI 10.1007/s00125-011-2441-9; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sargeant LA, 2010, DIABETIC MED, V27, P995, DOI 10.1111/j.1464-5491.2010.03056.x; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Simmons RK, 2011, DIABETOLOGIA, V54, P312, DOI 10.1007/s00125-010-1949-8; Simmons RK, 2010, DIABETES OBES METAB, V12, P838, DOI 10.1111/j.1463-1326.2010.01244.x; Spijkerman A, 2002, J MED SCREEN, V9, P187, DOI 10.1136/jms.9.4.187; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Thomason MJ, 2005, DIABETIC MED, V22, P1031, DOI 10.1111/j.1464-5491.2005.01584.x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1	38	151	152	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2012	380	9855					1741	1748		10.1016/S0140-6736(12)61422-6	http://dx.doi.org/10.1016/S0140-6736(12)61422-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CV	23040422	Green Published, Green Submitted			2022-12-28	WOS:000311153700030
J	Hao, QZ; Wang, L; Oldfield, F; Peng, SZ; Qin, L; Song, Y; Xu, B; Qiao, YS; Bloemendal, J; Guo, ZT				Hao, Qingzhen; Wang, Luo; Oldfield, Frank; Peng, Shuzhen; Qin, Li; Song, Yang; Xu, Bing; Qiao, Yansong; Bloemendal, Jan; Guo, Zhengtang			Delayed build-up of Arctic ice sheets during 400,000-year minima in insolation variability	NATURE			English	Article							CHINESE LOESS; CLIMATE VARIABILITY; ANTARCTIC CLIMATE; GRAIN-SIZE; VOLUME; TEMPERATURE; GREENLAND; RECORD	Knowledge of the past variability of climate at high northern latitudes during astronomical analogues of the present interglacial(1) may help to inform our understanding of future climate change. Unfortunately, long-term continuous records of ice-sheet variability in the Northern Hemisphere only are scarce because records of benthic O-18 content represent an integrated signal of changes in ice volume in both polar regions(2). However, variations in Northern Hemisphere ice sheets influence the Siberian High(3) (an atmospheric pressure system), so variations in the East Asian winter monsoon (EAWM)-as recorded in the aeolian dust deposits on the Chinese Loess Plateau-can serve as a useful proxy of Arctic climate variability before the ice-core record begins. Here we present an EAWM proxy record using grain-size variations in two parallel loess sections representative of sequences across the whole of the Chinese Loess Plateau over the past 900,000 years. The results show that during periods of low eccentricity and precessional variability at approximately 400,000-year intervals, the grain-size-inferred intensity of the EAWM remains weak for up to 20,000 years after the end of the interglacial episode of high summer monsoon activity and strong pedogenesis. In contrast, there is a rapid increase in the EAWM after the end of most other interglacials. We conclude that, for both the 400,000-year interglacials, the weak EAWM winds maintain a mild, non-glacial climate at high northern latitudes for much longer than expected from the conventional loess and marine oxygen isotope records. During these times, the less-severe summer insolation minima at 65 degrees N (ref. 4) would have suppressed ice and snow accumulation, leading to a weak Siberian High and, consequently, weak EAWM winds.	[Hao, Qingzhen; Wang, Luo; Song, Yang; Xu, Bing; Guo, Zhengtang] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China; [Oldfield, Frank; Bloemendal, Jan] Univ Liverpool, Sch Environm Sci, Liverpool L69 7ZT, Merseyside, England; [Peng, Shuzhen] Taishan Univ, Key Lab Tourism & Resources Environm Univ Shandon, Tai An 271021, Shandong, Peoples R China; [Qin, Li] China Three Gorges Museum, Chongqing Three Gorges Inst Paleoanthropol, Chongqing 400015, Peoples R China; [Song, Yang] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Qiao, Yansong] Chinese Acad Geol Sci, Inst Geomech, Beijing 100081, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; University of Liverpool; Taishan University; Chongqing Three Gorges University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Geological Sciences	Hao, QZ (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, POB 9825, Beijing 100029, Peoples R China.	haoqz@mail.iggcas.ac.cn; oldfield.f@gmail.com	Guo, Zhengtang/B-6854-2008; Hao, Qingzhen/E-4605-2010; Wang, Luo/A-1430-2009; Song, Yang/AAU-8660-2021	Guo, Zhengtang/0000-0003-2259-9715; Hao, Qingzhen/0000-0002-6281-5817; Wang, Luo/0000-0003-2217-8478; Qin, Li/0000-0002-8957-6705; Yang, Song/0000-0003-1728-687X	National Natural Science Foundation of China [41172323]; Ministry of Science and Technology [2010CB950204]; Ministry of Land and Resources [201211077]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Land and Resources; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (grant 41172323), Ministry of Science and Technology (grant 2010CB950204), Ministry of Land and Resources (grant 201211077), and the Chinese Academy of Sciences.	Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; An Z.S., 1990, QUATERN INT, V7, P91, DOI DOI 10.1016/1040-6182(90)90042-3; Berger A, 2002, SCIENCE, V297, P1287, DOI 10.1126/science.1076120; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; DING ZL, 1995, QUATERNARY RES, V44, P149, DOI 10.1006/qres.1995.1059; Ding ZL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000725; Droxler A. W., 2003, AM GEOPHYSICAL UNION, V137, P1; Howard WR, 1997, NATURE, V388, P418, DOI 10.1038/41201; Huybrechts P, 1999, J CLIMATE, V12, P2169, DOI 10.1175/1520-0442(1999)012<2169:TDROTG>2.0.CO;2; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; KUKLA G, 1989, PALAEOGEOGR PALAEOCL, V72, P203, DOI 10.1016/0031-0182(89)90143-0; Kutzbach J, 1998, QUATERNARY SCI REV, V17, P473, DOI 10.1016/S0277-3791(98)00009-2; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Liu T.S., 1985, LOESS ENV; Liu TS, 1998, ANNU REV EARTH PL SC, V26, P111, DOI 10.1146/annurev.earth.26.1.111; Loutre MF, 2003, GLOBAL PLANET CHANGE, V36, P209, DOI 10.1016/S0921-8181(02)00186-8; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Milankovitch M., 1941, KONIGLICH SERBISCHE, V132; Nugteren G, 2004, GLOBAL PLANET CHANGE, V41, P185, DOI 10.1016/j.gloplacha.2004.01.005; Panagiotopoulos F, 2005, J CLIMATE, V18, P1411, DOI 10.1175/JCLI3352.1; PORTER SC, 1995, NATURE, V375, P305, DOI 10.1038/375305a0; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Ruddiman WF, 2003, QUATERNARY SCI REV, V22, P1597, DOI 10.1016/S0277-3791(03)00087-8; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Sun YB, 2006, QUATERNARY SCI REV, V25, P33, DOI 10.1016/j.quascirev.2005.07.005; Vettoretti G, 2004, QUATERNARY SCI REV, V23, P499, DOI 10.1016/j.quascirev.2003.08.008; ZHOU LP, 1990, NATURE, V346, P737, DOI 10.1038/346737a0	30	240	294	13	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					393	396		10.1038/nature11493	http://dx.doi.org/10.1038/nature11493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23034648				2022-12-28	WOS:000309918500044
J	Lemos, JC; Wanat, MJ; Smith, JS; Reyes, BAS; Hollon, NG; Van Bockstaele, EJ; Chavkin, C; Phillips, PEM				Lemos, Julia C.; Wanat, Matthew J.; Smith, Jeffrey S.; Reyes, Beverly A. S.; Hollon, Nick G.; Van Bockstaele, Elisabeth J.; Chavkin, Charles; Phillips, Paul E. M.			Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive	NATURE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DOPAMINERGIC-NEURONS; FACTOR RECEPTORS; BEHAVIOR; ANXIETY; ACTIVATION; DEPRESSION; MOUSE	Stressors motivate an array of adaptive responses ranging from 'fight or flight' to an internal urgency signal facilitating long-term goals(1). However, traumatic or chronic uncontrollable stress promotes the onset of major depressive disorder, in which acute stressors lose their motivational properties and are perceived as insurmountable impediments(2). Consequently, stress-induced depression is a debilitating human condition characterized by an affective shift from engagement of the environment to withdrawal(3). An emerging neurobiological substrate of depression and associated pathology is the nucleus accumbens, a region with the capacity to mediate a diverse range of stress responses by interfacing limbic, cognitive and motor circuitry(4). Here we report that corticotropin-releasing factor (CRF), a neuropeptide released in response to acute stressors(5) and other arousing environmental stimuli(6), acts in the nucleus accumbens of naive mice to increase dopamine release through coactivation of the receptors CRFR1 and CRFR2. Remarkably, severe-stress exposure completely abolished this effect without recovery for at least 90 days. This loss of CRF's capacity to regulate dopamine release in the nucleus accumbens is accompanied by a switch in the reaction to CRF from appetitive to aversive, indicating a diametric change in the emotional response to acute stressors. Thus, the current findings offer a biological substrate for the switch in affect which is central to stress-induced depressive disorders.	[Lemos, Julia C.; Wanat, Matthew J.; Hollon, Nick G.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Lemos, Julia C.; Wanat, Matthew J.; Smith, Jeffrey S.; Hollon, Nick G.; Chavkin, Charles; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Lemos, Julia C.; Hollon, Nick G.; Chavkin, Charles; Phillips, Paul E. M.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Reyes, Beverly A. S.; Van Bockstaele, Elisabeth J.] Thomas Jefferson Univ, Farber Inst Neurosci, Dept Neurosci, Philadelphia, PA 19107 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Jefferson University	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Wanat, Matthew/0000-0003-1643-6557; Lemos, Julia/0000-0002-5442-8876; Hollon, Nick/0000-0003-4827-1582; Smith, Jeffrey/0000-0003-2840-2899	National Institutes of Health [F31-MH086269, F32-DA026273, R01-DA009082, R01-DA030074, R01-MH079292, R01-DA016782]; National Science Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH086269, R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026273, K05DA020570, R01DA030074, R01DA016782, R01DA009082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants F31-MH086269 (J.C.L.), F32-DA026273 (M.J.W.), R01-DA009082 (E.J.V.B.), R01-DA030074 (C. C.), R01-MH079292 and R01-DA016782 (P. E. M. P.), the National Science Foundation (N.G.H.) and NARSAD (P. E. M. P.). We thank C. Zietz, M. Miyatake and P. Groblewski for assisting with histological verification of cannula placement, H. Gill for help with data analysis, D. Messinger for breeding and genotyping mice and N. Stella for use of a microscope. We thank M. Darvas and R. Palmiter for providing Th<SUP>fs/fs</SUP>; Dbh<SUP>Th/+</SUP> mice. We thank R. Sapolsky, J. Day, S. Sesack, M. Soden, C. Walker and E. Horne for useful suggestions and insights.	Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; CADOR M, 1992, BRAIN RES, V597, P304, DOI 10.1016/0006-8993(92)91487-Y; Chaki S, 2004, EUR J PHARMACOL, V485, P145, DOI 10.1016/j.ejphar.2003.11.032; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; CORYELL W, 1994, ARCH GEN PSYCHIAT, V51, P405; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; FINK JS, 1980, NEUROSCI LETT, V17, P61, DOI 10.1016/0304-3940(80)90062-2; Gallagher JP, 2008, EUR J PHARMACOL, V583, P215, DOI 10.1016/j.ejphar.2007.11.075; Gelenberg Alan J, 2010, J Clin Psychiatry, V71, pe02, DOI 10.4088/JCP.8001tx16c; Iredale PA, 1997, MOL PHARMACOL, V51, P794, DOI 10.1124/mol.51.5.794; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P768; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lex A, 2008, LEARN MEMORY, V15, P483, DOI 10.1101/lm.978708; Lim MM, 2007, HORM BEHAV, V51, P508, DOI 10.1016/j.yhbeh.2007.01.006; Merali Z, 2004, NEUROPSYCHOPHARMACOL, V29, P1409, DOI 10.1038/sj.npp.1300441; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; OLDFIELD EH, 1985, NEUROENDOCRINOLOGY, V40, P84, DOI 10.1159/000124056; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Peters A., 1991, FINE STRUCTURE NERVO; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Reyes BAS, 2008, ENDOCRINOLOGY, V149, P122, DOI 10.1210/en.2007-0705; Reyes BAS, 2006, EUR J NEUROSCI, V23, P2991, DOI 10.1111/j.1460-9568.2006.04820.x; Steckler T, 1999, BIOL PSYCHIAT, V46, P1480, DOI 10.1016/S0006-3223(99)00170-5; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Torres G, 1998, NEUROSCIENCE, V87, P463, DOI 10.1016/S0306-4522(98)00147-X; VANBOCKSTAELE EJ, 1994, J COMP NEUROL, V341, P1, DOI 10.1002/cne.903410102; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; Waselus M, 2009, BIOL PSYCHIAT, V66, P76, DOI 10.1016/j.biopsych.2009.02.014	35	185	189	5	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					402	+		10.1038/nature11436	http://dx.doi.org/10.1038/nature11436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22992525	Green Accepted, Green Published			2022-12-28	WOS:000309918500046
J	Ciofani, M; Madar, A; Galan, C; Sellars, M; Mace, K; Pauli, F; Agarwal, A; Huang, WD; Parkurst, CN; Muratet, M; Newberry, KM; Meadows, S; Greenfield, A; Yang, Y; Jain, P; Kirigin, FK; Birchmeier, C; Wagner, EF; Murphy, KM; Myers, RM; Bonneau, R; Littman, DR				Ciofani, Maria; Madar, Aviv; Galan, Carolina; Sellars, MacLean; Mace, Kieran; Pauli, Florencia; Agarwal, Ashish; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Newberry, Kim M.; Meadows, Sarah; Greenfield, Alex; Yang, Yi; Jain, Preti; Kirigin, Francis K.; Birchmeier, Carmen; Wagner, Erwin F.; Murphy, Kenneth M.; Myers, Richard M.; Bonneau, Richard; Littman, Dan R.			A Validated Regulatory Network for Th17 Cell Specification	CELL			English	Article							ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; FACTOR BATF CONTROLS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; HELPER-CELLS; T-H-17 CELLS; NUCLEAR RECEPTORS; C-MAF; DIFFERENTIATION	Th17 cells have critical roles in mucosal defense and are major contributors to inflammatory disease. Their differentiation requires the nuclear hormone receptor ROR gamma t working with multiple other essential transcription factors (TFs). We have used an iterative systems approach, combining genome-wide TF occupancy, expression profiling of TF mutants, and expression time series to delineate the Th17 global transcriptional regulatory network. We find that cooperatively bound BATF and IRF4 contribute to initial chromatin accessibility and, with STAT3, initiate a transcriptional program that is then globally tuned by the lineage-specifying TF ROR gamma t, which plays a focal deterministic role at key loci. Integration of multiple data sets allowed inference of an accurate predictive model that we computationally and experimentally validated, identifying multiple new Th17 regulators, including Fosl2, a key determinant of cellular plasticity. This interconnected network can be used to investigate new therapeutic approaches to manipulate Th17 functions in the setting of inflammatory disease.	[Madar, Aviv; Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10003 USA; [Ciofani, Maria; Galan, Carolina; Sellars, MacLean; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Yang, Yi; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol, New York, NY 10016 USA; [Ciofani, Maria; Galan, Carolina; Sellars, MacLean; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Yang, Yi; Littman, Dan R.] NYU, Sch Med, Med Skirball Inst, New York, NY 10016 USA; [Kirigin, Francis K.] NYU, Sch Med, Computat Biol Program, Sackler Inst, New York, NY 10016 USA; [Madar, Aviv; Mace, Kieran; Agarwal, Ashish; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Pauli, Florencia; Newberry, Kim M.; Meadows, Sarah; Greenfield, Alex; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Birchmeier, Carmen] Max Delbruck Mol Med, Dev Biol, D-13125 Berlin, Germany; [Wagner, Erwin F.] Spanish Natl Canc Res Ctr CNIO, Canc Cell Biol Programme, E-28029 Madrid, Spain; [Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA	New York University; New York University; New York University; New York University; New York University; HudsonAlpha Institute for Biotechnology; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centro Nacional de Investigaciones Oncologicas (CNIO); Washington University (WUSTL)	Bonneau, R (corresponding author), NYU, Courant Inst Math Sci, Dept Comp Sci, 251 Mercer St, New York, NY 10003 USA.	bonneau@nyu.edu; dan.littman@med.nyu.edu	Bonneau, Richard/GZL-2900-2022; Madar, Aviv/AAO-1540-2020; Bonneau, Richard/ABD-6737-2021; Madar, Aviv/D-1023-2013	Wagner, Erwin F/0000-0001-7872-0196; Mace, Kieran/0000-0002-8131-3118; Ciofani, Maria/0000-0001-6472-5260; Pauli Behn, Florencia/0000-0002-8984-4044	NIH [RC1 AI087266, RC4 AI092765, PN2 EY016586, IU54CA143907-01, EY016586-06]; NSF [IOS-1126971]; Leukemia and Lymphoma Society; Crohn's and Colitis Foundation of America; National Arthritis Research Foundation; Cancer Research Institute; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586, PN1EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092765, RC1AI087266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Crohn's and Colitis Foundation of America; National Arthritis Research Foundation; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Andrew Sczesnak for generating TDF files and for multiple other contributions to data analysis during the course of the study. We thank R. Dalla Favera for providing IRF4 mutant mice; O. Uluckan and S. Wurm for coordinating shipping of AP-1 mutant mice; K. Ward for system administration; and K. Gunsalus and M. Dustin for helpful discussions. Support was provided by NIH grants RC1 AI087266 and RC4 AI092765 (A. A., D. R. L, R. B, and R. M. M.), PN2 EY016586 (A. G., A. M, and R. B.), and IU54CA143907-01 and EY016586-06 (A. G. and R. B.); NSF grant IOS-1126971 (R. B.); fellowships from the Leukemia and Lymphoma Society and Crohn's and Colitis Foundation of America (M. C.), the National Arthritis Research Foundation (Y.Y.); and Irvington Institute Fellowships from the Cancer Research Institute (M. S. and W. H.).	Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hindorff L, 2012, CATALOG PUBLISHED GE; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ho IC, 1999, COLD SPRING HARB SYM, V64, P573, DOI 10.1101/sqb.1999.64.573; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	753	780	0	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					289	303		10.1016/j.cell.2012.09.016	http://dx.doi.org/10.1016/j.cell.2012.09.016			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23021777	Green Accepted, Bronze			2022-12-28	WOS:000309981000009
J	Prettyman, TH; Mittlefehldt, DW; Yamashita, N; Lawrence, DJ; Beck, AW; Feldman, WC; McCoy, TJ; McSween, HY; Toplis, MJ; Titus, TN; Tricarico, P; Reedy, RC; Hendricks, JS; Forni, O; Le Corre, L; Li, JY; Mizzon, H; Reddy, V; Raymond, CA; Russell, CT				Prettyman, Thomas H.; Mittlefehldt, David W.; Yamashita, Naoyuki; Lawrence, David J.; Beck, Andrew W.; Feldman, William C.; McCoy, Timothy J.; McSween, Harry Y.; Toplis, Michael J.; Titus, Timothy N.; Tricarico, Pasquale; Reedy, Robert C.; Hendricks, John S.; Forni, Olivier; Le Corre, Lucille; Li, Jian-Yang; Mizzon, Hugau; Reddy, Vishnu; Raymond, Carol A.; Russell, Christopher T.			Elemental Mapping by Dawn Reveals Exogenic H in Vesta's Regolith	SCIENCE			English	Article							ASTEROID 4 VESTA; BASALTIC ACHONDRITE; GAMMA-RAY; MINERALOGY; METEORITES; MISSION; WATER	Using Dawn's Gamma Ray and Neutron Detector, we tested models of Vesta's evolution based on studies of howardite, eucrite, and diogenite (HED) meteorites. Global Fe/O and Fe/Si ratios are consistent with HED compositions. Neutron measurements confirm that a thick, diogenitic lower crust is exposed in the Rheasilvia basin, which is consistent with global magmatic differentiation. Vesta's regolith contains substantial amounts of hydrogen. The highest hydrogen concentrations coincide with older, low-albedo regions near the equator, where water ice is unstable. The young, Rheasilvia basin contains the lowest concentrations. These observations are consistent with gradual accumulation of hydrogen by infall of carbonaceous chondrites-observed as clasts in some howardites-and subsequent removal or burial of this material by large impacts.	[Prettyman, Thomas H.; Yamashita, Naoyuki; Feldman, William C.; Tricarico, Pasquale; Reedy, Robert C.; Li, Jian-Yang] Planetary Sci Inst, Tucson, AZ 85719 USA; [Mittlefehldt, David W.] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [Lawrence, David J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Beck, Andrew W.; McCoy, Timothy J.] Smithsonian Inst, Washington, DC 20560 USA; [McSween, Harry Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Toplis, Michael J.; Forni, Olivier; Mizzon, Hugau] Univ Toulouse, CNRS, Inst Rech Astrophys & Planetol, Toulouse, France; [Titus, Timothy N.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Hendricks, John S.] TechSource, Los Alamos, NM 87544 USA; [Le Corre, Lucille; Reddy, Vishnu] Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; [Reddy, Vishnu] Univ N Dakota, Dept Space Studies, Grand Forks, ND USA; [Raymond, Carol A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Russell, Christopher T.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	National Aeronautics & Space Administration (NASA); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Smithsonian Institution; University of Tennessee System; University of Tennessee Knoxville; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; United States Department of the Interior; United States Geological Survey; Max Planck Society; University of North Dakota Grand Forks; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Prettyman, TH (corresponding author), Planetary Sci Inst, 1700 E Ft Lowell,Suite 106, Tucson, AZ 85719 USA.	prettyman@psi.edu	Russell, Christopher T/E-7745-2012; Lawrence, David J/E-7463-2015; Tricarico, Pasquale/AAX-3321-2021; Beck, Andrew W/J-7215-2015	Russell, Christopher T/0000-0003-1639-8298; Lawrence, David J/0000-0002-7696-6667; Tricarico, Pasquale/0000-0001-6540-512X; Beck, Andrew W/0000-0003-4455-2299; Reddy, Vishnu/0000-0002-7743-3491; Li, Jian-Yang/0000-0003-3841-9977; Forni, Olivier/0000-0001-6772-9689; Prettyman, Thomas/0000-0003-0072-2831; Reedy, Robert/0000-0002-2189-1303; Le Corre, Lucille/0000-0003-0349-7932; McCoy, Timothy/0000-0002-4573-3553	Jet Propulsion Laboratory (JPL), California Institute of Technology; NASA; NASA Dawn Participating Scientist Program; NASA Discovery Program Office	Jet Propulsion Laboratory (JPL), California Institute of Technology; NASA(National Aeronautics & Space Administration (NASA)); NASA Dawn Participating Scientist Program; NASA Discovery Program Office	We thank the Dawn team for spacecraft and instrument operations at Vesta. Portions of this work were performed by the Planetary Science Institute under contract with the Jet Propulsion Laboratory (JPL), California Institute of Technology; by JPL under contract with NASA; and by the NASA Dawn Participating Scientist Program. D. Bazell and P. Peplowski of Johns Hopkins University Applied Physics Laboratory assisted in fast-neutron data analysis. The Dawn mission is led by the University of California, Los Angeles, and managed by JPL under the auspices of the NASA Discovery Program Office. The Dawn data are archived with the NASA Planetary Data System.	Asphaug E, 1997, METEORIT PLANET SCI, V32, P965, DOI 10.1111/j.1945-5100.1997.tb01584.x; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Burbine TH, 2006, METEORIT PLANET SCI, V41, P1139, DOI 10.1111/j.1945-5100.2006.tb00511.x; Bustin R., 1992, 2 C LUN BAS SPAC ACT, P437; Clark BE, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002200; Cloutis EA, 2010, METEORIT PLANET SCI, V45, P1668, DOI 10.1111/j.1945-5100.2010.01065.x; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; Denevi B., 2012, SCIENCE; Drake MJ, 2001, METEORIT PLANET SCI, V36, P501, DOI 10.1111/j.1945-5100.2001.tb01892.x; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Gounelle M, 2003, GEOCHIM COSMOCHIM AC, V67, P507, DOI 10.1016/S0016-7037(02)00985-7; Hasegawa S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018627; Herrin J. S., 2011, P LUNAR PLANET SCI C, V42, P2806; HOUSEN KR, 1982, ANNU REV EARTH PL SC, V10, P355, DOI 10.1146/annurev.ea.10.050182.002035; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Keil K., 2002, ASTEROIDS 3, P573; Li JY, 2010, ICARUS, V208, P238, DOI 10.1016/j.icarus.2010.02.008; Lodders K., 1998, PLANETARY SCI COMPAN; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McSween Harry Y.  Jr., 2011, Space Science Reviews, V163, P141, DOI 10.1007/s11214-010-9637-z; Mittlefehldt D. W., 2007, TREATISE GEOCHEMISTR, P291; Mittlefehldt D. W., 1998, REV MINERAL, V36, P1; Mittlefehldt DW, 2005, METEORIT PLANET SCI, V40, P665, DOI 10.1111/j.1945-5100.2005.tb00972.x; Prettyman TH, 2011, SPACE SCI REV, V163, P371, DOI 10.1007/s11214-011-9862-0; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Rivkin AS, 2006, ICARUS, V180, P464, DOI 10.1016/j.icarus.2005.09.012; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; Schultz L, 2004, METEORIT PLANET SCI, V39, P1889, DOI 10.1111/j.1945-5100.2004.tb00083.x; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; Usui T, 2010, METEORIT PLANET SCI, V45, P1170, DOI 10.1111/j.1945-5100.2010.01071.x; Warren PH, 2009, GEOCHIM COSMOCHIM AC, V73, P5918, DOI 10.1016/j.gca.2009.06.030; Zolensky ME, 1996, METEORIT PLANET SCI, V31, P518, DOI 10.1111/j.1945-5100.1996.tb02093.x	36	169	171	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					242	246		10.1126/science.1225354	http://dx.doi.org/10.1126/science.1225354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22997135				2022-12-28	WOS:000309712300042
J	Lenzer, J				Lenzer, Jeanne			Unnecessary care: are doctors in denial and is profit driven healthcare to blame?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jeanne.lenzer@gmail.com						[Anonymous], 2012, DOCTORS STRIKE BACK; Brownlee S., 2007, OVERTREATED WHY TOO; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Chustecka Z, 2011, DRAFT GUIDELINES REC; Morrison RS, 1996, NEW ENGL J MED, V335, P1755, DOI 10.1056/NEJM199612053352308; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Public Citizen, 2000, CIT BETT MED TRUTH D; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005	9	19	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2012	345								e6230	10.1136/bmj.e6230	http://dx.doi.org/10.1136/bmj.e6230			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KN	23033411				2022-12-28	WOS:000309659300008
J	Mehmood, S; Phair, A; Sahely, S; Ong, A; Law, A; Onwudike, M; Ferguson, G				Mehmood, Sajid; Phair, Alison; Sahely, Shafi; Ong, Angelia; Law, Amanda; Onwudike, Madu; Ferguson, Graeme			Appendiceal intussusception caused by endometriosis	LANCET			English	Editorial Material									[Mehmood, Sajid; Phair, Alison; Sahely, Shafi] Bolton NHS Fdn Trust, Royal Bolton Hosp, Dept Gen Surg, Bolton, England; [Ong, Angelia] Bolton NHS Fdn Trust, Royal Bolton Hosp, Dept Pathol, Bolton, England; [Law, Amanda] Bolton NHS Fdn Trust, Royal Bolton Hosp, Dept Radiol, Bolton, England; [Onwudike, Madu; Ferguson, Graeme] Bolton NHS Fdn Trust, Royal Bolton Hosp, Dept Gen Surg, Bolton, England	Royal Bolton Hospital; Royal Bolton Hospital; Royal Bolton Hospital; Royal Bolton Hospital	Mehmood, S (corresponding author), Royal Bolton Hosp, Dept Gen & Vasc Surg, Minerva Rd, Bolton BL4 OJR, England.	drsajidm@hotmail.com						Duncan James E, 2005, JSLS, V9, P488; FAZIO RA, 1982, AM J GASTROENTEROL, V77, P556; Hanly AM, 2011, COLORECTAL DIS, V13, P225, DOI 10.1111/j.1463-1318.2010.02192.x; Moradi P, 2007, ANZ J SURG, V77, P758, DOI 10.1111/j.1445-2197.2007.04232.x; Saleem A, 2011, INT J SURG CASE REP, V2, P16, DOI 10.1016/j.ijscr.2010.11.001	5	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2012	380	9848					1202	1202		10.1016/S0140-6736(12)60819-8	http://dx.doi.org/10.1016/S0140-6736(12)60819-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021289				2022-12-28	WOS:000309255900038
J	Samstein, RM; Arvey, A; Josefowicz, SZ; Peng, X; Reynolds, A; Sandstrom, R; Neph, S; Sabo, P; Kim, JM; Liao, W; Li, MO; Leslie, C; Stamatoyannopoulos, JA; Rudensky, AY				Samstein, Robert M.; Arvey, Aaron; Josefowicz, Steven Z.; Peng, Xiao; Reynolds, Alex; Sandstrom, Richard; Neph, Shane; Sabo, Peter; Kim, Jeong M.; Liao, Will; Li, Ming O.; Leslie, Christina; Stamatoyannopoulos, John A.; Rudensky, Alexander Y.			Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage Specification	CELL			English	Article							TRANSCRIPTION FACTOR FOXP3; GLUCOCORTICOID-RECEPTOR BINDING; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; RISK LOCI; CHROMATIN ACCESSIBILITY; DNA ELEMENTS; CBF-BETA; DIFFERENTIATION; DOMAIN	Regulatory T (Treg) cells, whose identity and function are defined by the transcription factor Foxp3, are indispensable for immune homeostasis. It is unclear whether Foxp3 exerts its Treg lineage specification function through active modification of the chromatin landscape and establishment of new enhancers or by exploiting a pre-existing enhancer landscape. Analysis of the chromatin accessibility of Foxp3-bound enhancers in Treg and Foxp3-negative T cells showed that Foxp3 was bound overwhelmingly to preaccessible enhancers occupied by its cofactors in precursor cells or a structurally related predecessor. Furthermore, the bulk of Foxp3-bound Treg cell enhancers lacking in Foxp3(-) CD4(+) cells became accessible upon T cell receptor activation prior to Foxp3 expression, and only a small subset associated with several functionally important genes were exclusively Treg cell specific. Thus, in a late cellular differentiation process, Foxp3 defines Treg cell functionality in an "opportunistic" manner by largely exploiting the preformed enhancer network instead of establishing a new enhancer landscape.	[Reynolds, Alex; Sandstrom, Richard; Neph, Shane; Sabo, Peter; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Samstein, Robert M.; Arvey, Aaron; Josefowicz, Steven Z.; Peng, Xiao; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Samstein, Robert M.; Josefowicz, Steven Z.; Peng, Xiao; Li, Ming O.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Leslie, Christina] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Kim, Jeong M.] Genentech Inc, San Francisco, CA 94080 USA; [Liao, Will] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	jstam@u.washington.edu; rudenska@mskcc.org		josefowicz, steven/0000-0001-7453-779X; Samstein, Robert/0000-0001-6860-2401; Sandstrom, Richard/0000-0002-3356-1547; li, ming/0000-0002-1383-0535; Arvey, Aaron/0000-0002-8789-0290	NIH [DK091968, 5R37AI034206]; MSTP [GM07739]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034206, R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Rudra and A. Chaudhry for helpful discussions. This work was supported by NIH DK091968 grant and MSTP grant GM07739 (both R.M.S.) and also by NIH 5R37AI034206 grant (A.Y.R.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	48	328	335	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					153	166		10.1016/j.cell.2012.06.053	http://dx.doi.org/10.1016/j.cell.2012.06.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021222	Bronze, Green Accepted			2022-12-28	WOS:000309544200017
J	Ye, L; Kleiner, S; Wu, J; Sah, R; Gupta, RK; Banks, AS; Cohen, P; Khandekar, MJ; Bostrom, P; Mepani, RJ; Laznik, D; Kamenecka, TM; Song, XY; Liedtke, W; Mootha, VK; Puigserver, P; Griffin, PR; Clapham, DE; Spiegelman, BM				Ye, Li; Kleiner, Sandra; Wu, Jun; Sah, Rajan; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Kamenecka, Theodore M.; Song, Xinyi; Liedtke, Wolfgang; Mootha, Vamsi K.; Puigserver, Pere; Griffin, Patrick R.; Clapham, David E.; Spiegelman, Bruce M.			TRPV4 Is a Regulator of Adipose Oxidative Metabolism, Inflammation, and Energy Homeostasis	CELL			English	Article							DIET-INDUCED OBESITY; WHITE FAT DEPOTS; BROWN ADIPOCYTES; INSULIN-RESISTANCE; CATION CHANNEL; GENE-EXPRESSION; PROTEIN-KINASE; TISSUE; ACTIVATION; MICE	PGC1 alpha is a key transcriptional coregulator of oxidative metabolism and thermogenesis. Through a high-throughput chemical screen, we found that molecules antagonizing the TRPVs (transient receptor potential vanilloid), a family of ion channels, induced PGC1 alpha expression in adipocytes. In particular, TRPV4 negatively regulated the expression of PGC1 alpha, UCP1, and cellular respiration. Additionally, it potently controlled the expression of multiple proinflammatory genes involved in the development of insulin resistance. Mice with a null mutation for TRPV4 or wild-type mice treated with a TRPV4 antagonist showed elevated thermogenesis in adipose tissues and were protected from diet-induced obesity, adipose inflammation, and insulin resistance. This role of TRPV4 as a cell-autonomous mediator for both the thermogenic and proinflammatory programs in adipocytes could offer a target for treating obesity and related metabolic diseases.	[Ye, Li; Kleiner, Sandra; Wu, Jun; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Puigserver, Pere; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ye, Li; Kleiner, Sandra; Wu, Jun; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Puigserver, Pere; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Sah, Rajan; Clapham, David E.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cardiol,Boston Childrens Hosp, Boston, MA 02115 USA; [Sah, Rajan; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kamenecka, Theodore M.; Song, Xinyi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Liedtke, Wolfgang] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Scripps Research Institute; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Gupta, Rana/R-3051-2019; Banks, Alexander/B-4832-2012; Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Liedtke, Wolfgang/GNH-1878-2022	Banks, Alexander/0000-0003-1787-6925; Clapham, David/0000-0002-4459-9428; Gupta, Rana/0000-0002-9001-4531	NIH [DK031405, DK080261];  [5R90DK071507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071507, R24DK080261, R01DK031405, K01DK094824, R37DK031405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Zoltan Arany (Beth Israel Deaconess Medical Center) and Bridget Wagner (The Broad Institute) for help with screen setup and Dr. Kai Cui (Duke University) for assistance with statistical analysis. We are grateful to Drs. Patrick Seale and Chih-Hao Lee for useful discussion. We also thank Yingying Zhang, Diti Bhowmick, and Lingling Dai for technical assistance. L.Y. was supported by the Interdisciplinary Training grant 5R90DK071507. This work was supported by NIH grants DK031405 and DK080261 (B.M.S.). B.M.S., V.K.M., and P.R.G. are consultants and shareholders in Ember Therapeutics, Inc.	Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jia L, 2010, J LIPID RES, V51, P3024, DOI 10.1194/jlr.M008599; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Li JJ, 2009, ENVIRON HEALTH PERSP, V117, P400, DOI 10.1289/ehp.0800311; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sell H, 2009, P NUTR SOC, V68, P378, DOI 10.1017/S0029665109990218; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	56	239	248	13	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					96	110		10.1016/j.cell.2012.08.034	http://dx.doi.org/10.1016/j.cell.2012.08.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021218	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000309544200013
J	Agren, T; Engman, J; Frick, A; Bjorkstrand, J; Larsson, EM; Furmark, T; Fredrikson, M				Agren, Thomas; Engman, Jonas; Frick, Andreas; Bjorkstrand, Johannes; Larsson, Elna-Marie; Furmark, Tomas; Fredrikson, Mats			Disruption of Reconsolidation Erases a Fear Memory Trace in the Human Amygdala	SCIENCE			English	Article							EXTINCTION; RESPONSES; ANXIETY; DISORDER; RELAPSE; PHOBIA; RETURN	Memories become labile when recalled. In humans and rodents alike, reactivated fear memories can be attenuated by disrupting reconsolidation with extinction training. Using functional brain imaging, we found that, after a conditioned fear memory was formed, reactivation and reconsolidation left a memory trace in the basolateral amygdala that predicted subsequent fear expression and was tightly coupled to activity in the fear circuit of the brain. In contrast, reactivation followed by disrupted reconsolidation suppressed fear, abolished the memory trace, and attenuated fear-circuit connectivity. Thus, as previously demonstrated in rodents, fear memory suppression resulting from behavioral disruption of reconsolidation is amygdala-dependent also in humans, which supports an evolutionarily conserved memory-update mechanism.	[Agren, Thomas; Engman, Jonas; Frick, Andreas; Bjorkstrand, Johannes; Furmark, Tomas; Fredrikson, Mats] Uppsala Univ, Dept Psychol, SE-75142 Uppsala, Sweden; [Larsson, Elna-Marie] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, SE-75142 Uppsala, Sweden	Uppsala University; Uppsala University	Agren, T (corresponding author), Uppsala Univ, Dept Psychol, SE-75142 Uppsala, Sweden.	thomas.agren@psyk.uu.se	Frick, Andreas/D-1882-2015; Agren, Thomas/AAC-4901-2022	Frick, Andreas/0000-0003-2516-9075; Furmark, Tomas/0000-0001-6821-9058	Swedish Research Council; Heumanska stiftelsen; Swedish Council for Working Life and Social Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heumanska stiftelsen; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	We thank the Swedish Research Council, Heumanska stiftelsen, and the Swedish Council for Working Life and Social Research for support.	Agren T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.5; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Boschen MJ, 2009, AUST NZ J PSYCHIAT, V43, P89, DOI 10.1080/00048670802607154; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Brunet A, 2011, J CLIN PSYCHOPHARM, V31, P547, DOI 10.1097/JCP.0b013e318222f360; Cheng DT, 2007, LEARN MEMORY, V14, P485, DOI 10.1101/lm.632007; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Furmark T, 2002, ARCH GEN PSYCHIAT, V59, P425, DOI 10.1001/archpsyc.59.5.425; Furmark T, 1997, NEUROREPORT, V8, P3957, DOI 10.1097/00001756-199712220-00021; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Knight DC, 2005, NEUROIMAGE, V26, P1193, DOI 10.1016/j.neuroimage.2005.03.020; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Neumann DL, 2010, BEHAV RES THER, V48, P565, DOI 10.1016/j.brat.2010.03.002; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83	23	216	227	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1550	1552		10.1126/science.1223006	http://dx.doi.org/10.1126/science.1223006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997340				2022-12-28	WOS:000308912900054
J	Wyse, DG				Wyse, D. George			Short-term was less effective than long-term flecainide for preventing recurrent AF after cardioversion	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION		Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	Wyse, DG (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.							Raitt MH, 2004, J CARDIOVASC ELECTR, V15, P507, DOI 10.1046/j.1540-8167.2004.03217.x; Zimetbaum P, 2012, CIRCULATION, V125, P381, DOI 10.1161/CIRCULATIONAHA.111.019927	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-9	10.7326/0003-4819-157-6-201209180-02009	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986401				2022-12-28	WOS:000308912800008
J	Perez, R				Perez, Ruben			Discriminating Chemical Bonds	SCIENCE			English	Editorial Material							ATOMIC-FORCE MICROSCOPY; MOLECULE		[Perez, Ruben] Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain; [Perez, Ruben] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	Autonomous University of Madrid; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Perez, R (corresponding author), Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain.	ruben.perez@uam.es	Perez, Ruben/F-1849-2010	Perez, Ruben/0000-0001-5896-541X				Barth C, 2011, ADV MATER, V23, P477, DOI 10.1002/adma.201002270; Custance O, 2009, NAT NANOTECHNOL, V4, P803, DOI [10.1038/nnano.2009.347, 10.1038/NNANO.2009.347]; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Gross L, 2009, SCIENCE, V324, P1428, DOI 10.1126/science.1172273; Mohn F, 2012, NAT NANOTECHNOL, V7, P227, DOI [10.1038/NNANO.2012.20, 10.1038/nnano.2012.20]; Morita S, 2009, NANOSCI TECHNOL, V2, P1, DOI 10.1007/978-3-642-01495-6_1; Ondracek M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.176101; Pauling L., 1960, NATURE CHEM BOND; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530	10	6	6	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1305	1306		10.1126/science.1227726	http://dx.doi.org/10.1126/science.1227726			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984061				2022-12-28	WOS:000308705000031
J	Rizo, J				Rizo, Josep			Staging Membrane Fusion	SCIENCE			English	Editorial Material							SNARE COMPLEX; NEUROTRANSMITTER RELEASE; ENERGETICS; PROTEINS; BINDING		[Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rizo, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	jose@arnie.swmed.edu						Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Liu W, 2009, J Nanoneurosci, V1, P120; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200	13	8	9	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1300	1301		10.1126/science.1228654	http://dx.doi.org/10.1126/science.1228654			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984057				2022-12-28	WOS:000308705000027
J	Spence, D				Spence, Des			Good medicine: homeopathy	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2010, NHS NEWS        0727; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; NHS Health and Social Care Information Centre, 2011, PRESCR COST AN ENGL; Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483	4	4	4	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6184	10.1136/bmj.e6184	http://dx.doi.org/10.1136/bmj.e6184			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BZ	22983533				2022-12-28	WOS:000308865100004
J	Young, NE; Briner, JP; Rood, DH; Finkel, RC				Young, Nicolas E.; Briner, Jason P.; Rood, Dylan H.; Finkel, Robert C.			Glacier Extent During the Younger Dryas and 8.2-ka Event on Baffin Island, Arctic Canada	SCIENCE			English	Article							ABRUPT CLIMATE-CHANGE; LAURENTIDE; GREENLAND; SEASONALITY; LANDSCAPES; INTERVAL; RETREAT; HISTORY; END	Greenland ice cores reveal that mean annual temperatures during the Younger Dryas (YD) cold interval-about 12.9 to 11.7 thousand years ago (ka)-and the similar to 150-year-long cold reversal that occurred 8.2 thousand years ago were similar to 15 degrees and 3 degrees to 4 degrees C colder than today, respectively. Reconstructing ice-sheet response to these climate perturbations can help evaluate ice-sheet sensitivity to climate change. Here, we report the widespread advance of Laurentide Ice Sheet outlet glaciers and independent mountain glaciers on Baffin Island, Arctic Canada, in response to the 8.2-ka event and show that mountain glaciers during the 8.2-ka event were larger than their YD predecessors. In contrast to the wintertime bias of YD cooling, we suggest that cooling during the 8.2-ka event was more evenly distributed across the seasons.	[Young, Nicolas E.; Briner, Jason P.] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Rood, Dylan H.] SUERC, Accelerator Mass Spectrometry Lab, E Kilbride, Lanark, Scotland; [Rood, Dylan H.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Finkel, Robert C.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Scottish Universities Research & Reactor Center; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Young, NE (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10964 USA.	nicolasy@ldeo.columbia.edu			U.S. National Science Foundation [ARC-909334, BCS-1002597, BCS-752848]	U.S. National Science Foundation(National Science Foundation (NSF))	We thank M. Badding, D. Bedard, S. McGrane, N. Michelutti, and E. Thomas, who aided in sample collection. We also thank G. Miller for insightful discussions and the helpful comments from two anonymous reviewers. This work was funded in part by U.S. National Science Foundation awards ARC-909334, BCS-1002597, and BCS-752848 to J.P.B.	Alley R., 2003, EOS T AM GEOPHYS UN, V84; Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Alley RB, 2005, QUATERNARY SCI REV, V24, P1123, DOI 10.1016/j.quascirev.2004.12.004; Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; ANDREWS JT, 1978, ARCTIC ALPINE RES, V10, P617, DOI 10.2307/1550683; ANDREWS JT, 1995, PALEOCEANOGRAPHY, V10, P943, DOI 10.1029/95PA01426; Axford Y, 2009, QUATERNARY RES, V71, P142, DOI 10.1016/j.yqres.2008.09.006; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Bjorck S, 2002, GEOLOGY, V30, P427, DOI 10.1130/0091-7613(2002)030<0427:AMYDSC>2.0.CO;2; Born A, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC003024; Briner JP, 2007, J QUATERNARY SCI, V22, P223, DOI 10.1002/jqs.1057; Briner JP, 2009, NAT GEOSCI, V2, P496, DOI 10.1038/ngeo556; Briner JP, 2006, GEOL SOC AM BULL, V118, P406, DOI 10.1130/B25716.1; Briner JP, 2005, CAN J EARTH SCI, V42, P67, DOI 10.1139/E04-102; Broecker WS, 2010, QUATERNARY SCI REV, V29, P1078, DOI 10.1016/j.quascirev.2010.02.019; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; FALCONER G, 1965, SCIENCE, V147, P608, DOI 10.1126/science.147.3658.608; Hillaire-Marcel C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030396; Kaplan MR, 2010, NATURE, V467, P194, DOI 10.1038/nature09313; KAPSNER WR, 1995, NATURE, V373, P52, DOI 10.1038/373052a0; Kelly MA, 2008, QUATERNARY SCI REV, V27, P2273, DOI 10.1016/j.quascirev.2008.08.004; Kobashi T, 2007, QUATERNARY SCI REV, V26, P1212, DOI 10.1016/j.quascirev.2007.01.009; Koerner RM, 2005, ANN GLACIOL-SER, V42, P417, DOI 10.3189/172756405781813122; Lohne OS, 2012, J QUATERNARY SCI, V27, P81, DOI 10.1002/jqs.1516; LOWELL TV, 2005, EOS, V86, P365, DOI DOI 10.1029/2005EO400001; Miller G. H., 1974, GEOLOGY, V2, P125; Oerlemans J., 2001, GLACIERS CLIMATE CHA; Putnam AE, 2010, NAT GEOSCI, V3, P700, DOI 10.1038/NGEO962; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Smith J. E., 1966, THESIS MCGILL U MONT; Vinther BM, 2009, NATURE, V461, P385, DOI 10.1038/nature08355; Young NE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049639	35	42	42	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1330	1333		10.1126/science.1222759	http://dx.doi.org/10.1126/science.1222759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984068				2022-12-28	WOS:000308705000039
J	Dowlatshahi, D; Hogan, MJ; Sharma, M; Stotts, G; Blacquiere, D; Chakraborty, S				Dowlatshahi, Dar; Hogan, Matthew J.; Sharma, Mukul; Stotts, Grant; Blacquiere, Dylan; Chakraborty, Santanu			Ongoing bleeding in acute intracerebral haemorrhage	LANCET			English	Editorial Material									[Dowlatshahi, Dar] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Dowlatshahi, Dar; Hogan, Matthew J.; Sharma, Mukul; Stotts, Grant; Blacquiere, Dylan] Univ Ottawa, Div Neurol, Dept Med, Ottawa, ON, Canada; [Chakraborty, Santanu] Univ Ottawa, Div Neuroradiol, Dept Med Imaging, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Dowlatshahi, D (corresponding author), Ottawa Hosp, Res Inst, Civ Campus C2182,1053 Carling Ave, Ottawa, ON, Canada.	ddowlat@ottawahospital.on.ca	Hogan, Matthew/AAP-4735-2020; Demchuk, Andrew M/E-1103-2012	Hogan, Matthew/0000-0003-4660-8743; Demchuk, Andrew M/0000-0002-4930-7789; Dowlatshahi, Dar/0000-0003-1379-3612; Sharma, Mukul/0000-0002-6119-342X; Chakraborty, Santanu/0000-0002-2975-2260					0	17	19	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					152	152		10.1016/S0140-6736(12)60829-0	http://dx.doi.org/10.1016/S0140-6736(12)60829-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23000292				2022-12-28	WOS:000313420900031
J	Doronin, K; Flatt, JW; Di Paolo, NC; Khare, R; Kalyuzhniy, O; Acchione, M; Sumida, JP; Ohto, U; Shimizu, T; Akashi-Takamura, S; Miyake, K; MacDonald, JW; Bammler, TK; Beyer, RP; Farin, FM; Stewart, PL; Shayakhmetov, DM				Doronin, Konstantin; Flatt, Justin W.; Di Paolo, Nelson C.; Khare, Reeti; Kalyuzhniy, Oleksandr; Acchione, Mauro; Sumida, John P.; Ohto, Umeharu; Shimizu, Toshiyuki; Akashi-Takamura, Sachiko; Miyake, Kensuke; MacDonald, James W.; Bammler, Theo K.; Beyer, Richard P.; Farin, Frederico M.; Stewart, Phoebe L.; Shayakhmetov, Dmitry M.			Coagulation Factor X Activates Innate Immunity to Human Species C Adenovirus	SCIENCE			English	Article							GENE-TRANSFER; IMMUNOCOMPROMISED PATIENTS; VIRUS-INFECTION; IN-VIVO; BINDING; HEXON; TRIGGERS; VECTORS; PATIENT; CELL	Although coagulation factors play a role in host defense for "living fossils" such as horseshoe crabs, the role of the coagulation system in immunity in higher organisms remains unclear. We modeled the interface of human species C adenovirus (HAdv) interaction with coagulation factor X (FX) and introduced a mutation that abrogated formation of the HAdv-FX complex. In vivo genome-wide transcriptional profiling revealed that FX-binding-ablated virus failed to activate a distinct network of nuclear factor kappa B-dependent early-response genes that are activated by HAdv-FX complex downstream of TLR4/MyD88/TRIF/TRAF6 signaling. Our study implicates host factor "decoration" of the virus as a mechanism to trigger an innate immune sensor that responds to a misplacement of coagulation FX from the blood into intracellular macrophage compartments upon virus entry into the cell.	[Doronin, Konstantin; Di Paolo, Nelson C.; Khare, Reeti; Shayakhmetov, Dmitry M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Flatt, Justin W.; Stewart, Phoebe L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Flatt, Justin W.; Stewart, Phoebe L.] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Kalyuzhniy, Oleksandr] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Acchione, Mauro; Sumida, John P.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ohto, Umeharu; Shimizu, Toshiyuki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Dept Microbiol & Immunol, Div Innate Immun, Minato Ku, Tokyo 1088639, Japan; [Miyake, Kensuke] Univ Tokyo, Lab Innate Immun, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [MacDonald, James W.; Bammler, Theo K.; Beyer, Richard P.; Farin, Frederico M.] Univ Washington, Funct Genom & Prote Core Facil, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Case Western Reserve University; Case Western Reserve University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo; RIKEN; University of Tokyo; University of Tokyo; University of Washington; University of Washington Seattle	Shayakhmetov, DM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	dshax@uw.edu		Flatt, Justin/0000-0003-3227-8763; Flatt, Justin/0000-0003-2985-0386; Kalyuzhniy, Oleksandr/0000-0002-5273-1951; Flatt, Justin/0000-0001-5406-8156	U.S. NIH [AI065429, CA141439]; University of Washington National Institute of Environmental Health Sciences [P30ES07033]; Washington State Life Sciences Discovery Fund; Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility; NATIONAL CANCER INSTITUTE [R01CA141439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington National Institute of Environmental Health Sciences; Washington State Life Sciences Discovery Fund; Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Akira (Osaka University, Japan) for providing mice deficient in MyD88, MD2, TLR4, TLR7/8, and TLR9; J.-I. Inoue (University of Tokyo, Japan) for TRAF6-deficient mice; R.A. Flavell (Yale University, CT) for Caspase-1-deficient mice; and V. Dixit (Roche, CA) for ASC-deficient mice. We acknowledge the assistance of D. R. Williams during cryo-EM data acquisition. The cryo-EM data was collected while J.W.F. and P.L.S. were at Vanderbilt University. We thank M. D. Hollenberg (University of Calgary, Canada), A. Aderem, and D. Zak (SeattleBioMed, USA) for helpful discussion and L. K. Baldwin for manuscript editing. This study was supported by U.S. NIH grants AI065429 and CA141439 to D.M.S., the University of Washington National Institute of Environmental Health Sciences-sponsored Center for Ecogenetics & Environmental Health (P30ES07033), and Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility, which is funded by the Washington State Life Sciences Discovery Fund. D.M.S. and P.L.S. designed the research; K.D., J.W.F., N.C.D.P., R.K., M.A., J.P.S., and O.K. conducted experiments and collected and analyzed the data; U.O, T.S., S.A.-T., and K.M. expressed, purified, and provided critical reagents; J.W.M., T.K.B., R.P.B., and F.M.F. collected and processed all the microarray data; and P.S. and D.S. wrote the paper. The data are tabulated in the main paper and supplementary materials. The cryo-EM structure has been deposited in the Electron Microscopy Data Bank with accession no. EMD-5494. The microarray data have been submitted in Minimum Information About a Microarray Experiment (MIAME)-compliant format to the Gene Expression Omnibus database (accession no. GSE36078).	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Ardehali H, 2001, TRANSPLANTATION, V71, P998, DOI 10.1097/00007890-200104150-00029; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kim YJ, 2007, SEMIN RESP CRIT CARE, V28, P222, DOI 10.1055/s-2007-976494; Leen AM, 2005, BRIT J HAEMATOL, V128, P135, DOI 10.1111/j.1365-2141.2004.05218.x; Livingston JR, 2006, BIOCHEM J, V393, P529, DOI 10.1042/BJ20051313; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Morral N, 2002, HUM GENE THER, V13, P143, DOI 10.1089/10430340152712692; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	21	109	112	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					795	798		10.1126/science.1226625	http://dx.doi.org/10.1126/science.1226625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23019612	Green Accepted			2022-12-28	WOS:000310839500043
J	Baudouin, SJ; Gaudias, J; Gerharz, S; Hatstatt, L; Zhou, KK; Punnakkal, P; Tanaka, KF; Spooren, W; Hen, R; De Zeeuw, CI; Vogt, K; Scheiffele, P				Baudouin, Stephane J.; Gaudias, Julien; Gerharz, Stefan; Hatstatt, Laetitia; Zhou, Kuikui; Punnakkal, Pradeep; Tanaka, Kenji F.; Spooren, Will; Hen, Rene; De Zeeuw, Chris I.; Vogt, Kaspar; Scheiffele, Peter			Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism	SCIENCE			English	Article							LONG-TERM DEPRESSION; RARE DE-NOVO; NEUROLIGIN-3; MUTATIONS; RECEPTOR; PROTEIN	The genetic heterogeneity of autism poses a major challenge for identifying mechanism-based treatments. A number of rare mutations are associated with autism, and it is unclear whether these result in common neuronal alterations. Monogenic syndromes, such as fragile X, include autism as one of their multifaceted symptoms and have revealed specific defects in synaptic plasticity. We discovered an unexpected convergence of synaptic pathophysiology in a nonsyndromic form of autism with those in fragile X syndrome. Neuroligin-3 knockout mice (a model for nonsyndromic autism) exhibited disrupted heterosynaptic competition and perturbed metabotropic glutamate receptor-dependent synaptic plasticity, a hallmark of fragile X. These phenotypes could be rescued by reexpression of neuroligin-3 in juvenile mice, highlighting the possibility of reverting neuronal circuit alterations in autism after the completion of development.	[Baudouin, Stephane J.; Gaudias, Julien; Gerharz, Stefan; Hatstatt, Laetitia; Punnakkal, Pradeep; Vogt, Kaspar; Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland; [Zhou, Kuikui; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA; [Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Spooren, Will] Hoffmann La Roche AG, Basel, Switzerland; [De Zeeuw, Chris I.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Basel; Erasmus University Rotterdam; Erasmus MC; Columbia University; Keio University; Roche Holding; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	peter.scheiffele@unibas.ch	baudouin, stephane/I-4372-2012	Scheiffele, Peter/0000-0002-9516-9399; Vogt, Kaspar/0000-0002-0859-876X; baudouin, stephane/0000-0001-6902-6071; Tanaka, Kenji/0000-0003-2511-0057	Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; European Research Council (European Community); SystemsX grant; EU-AIMS (European Autism Interventions); Innovative Medicines Initiative [115300]; European Union; European Federation of Pharmaceutical Industries and Associations companies'; NCCR Synapsy; Swiss National Science Foundation; Kanton Basel-Stadt	Dutch Organization for Medical Sciences (ZonMw)(Netherlands Organization for Health Research and Development); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; European Research Council (European Community)(European CommissionEuropean Research Council (ERC)); SystemsX grant; EU-AIMS (European Autism Interventions); Innovative Medicines Initiative; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations companies'; NCCR Synapsy; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt	We are grateful to our colleagues Arber, Barde, Gosh, Sylwestrak, Witte, and Xiao for comments on the manuscript; to Ponti, Genoud, Sauder, Ahrne, Ehrenfeuchter, and Stiefvater for technical help; and Zeilhofer, Fritschy, Brose, and Sans for sharing reagents. C.D.Z. was supported by the Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; and the European Research Council-advanced, CEREBNET, and C7 programs (European Community). This work was supported by a SystemsX grant (P.S. and W.S.); by EU-AIMS (European Autism Interventions), which receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115300, the resources of which are composed of financial contributions from the European Union's Seventh Framework Programme (grant FP7/2007-2013), from the European Federation of Pharmaceutical Industries and Associations companies' in-kind contributions, and from Autism Speaks, resulting in a total of (sic)29.6 million; by NCCR Synapsy; the Swiss National Science Foundation; and Kanton Basel-Stadt.	American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	30	208	212	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					128	132		10.1126/science.1224159	http://dx.doi.org/10.1126/science.1224159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22983708				2022-12-28	WOS:000309457400069
J	Delbanco, T; Walker, J; Bell, SK; Darer, JD; Elmore, JG; Farag, N; Feldman, HJ; Mejilla, R; Ngo, L; Ralston, JD; Ross, SE; Trivedi, N; Vodicka, E; Leveille, SG				Delbanco, Tom; Walker, Jan; Bell, Sigall K.; Darer, Jonathan D.; Elmore, Joann G.; Farag, Nadine; Feldman, Henry J.; Mejilla, Roanne; Ngo, Long; Ralston, James D.; Ross, Stephen E.; Trivedi, Neha; Vodicka, Elisabeth; Leveille, Suzanne G.			Inviting Patients to Read Their Doctors' Notes: A Quasi-experimental Study and a Look Ahead	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTRONIC MEDICAL-RECORD; CONGESTIVE-HEART-FAILURE; RANDOMIZED-TRIAL; CANCER-PATIENTS; VISIT NOTES; ACCESS; CAREGIVERS; ONLINE; FAMILY; CARE	Background: Little information exists about what primary care physicians (PCPs) and patients experience if patients are invited to read their doctors' office notes. Objective: To evaluate the effect on doctors and patients of facilitating patient access to visit notes over secure Internet portals. Design: Quasi-experimental trial of PCPs and patient volunteers in a year-long program that provided patients with electronic links to their doctors' notes. Setting: Primary care practices at Beth Israel Deaconess Medical Center (BIDMC) in Massachusetts, Geisinger Health System (GHS) in Pennsylvania, and Harborview Medical Center (HMC) in Washington. Participants: 105 PCPs and 13 564 of their patients who had at least 1 completed note available during the intervention period. Measurements: Portal use and electronic messaging by patients and surveys focusing on participants' perceptions of behaviors, benefits, and negative consequences. Results: 11 797 of 13 564 patients with visit notes available opened at least 1 note (84% at BIDMC, 92% at GHS, and 47% at HMC). Of 5391 patients who opened at least 1 note and completed a postintervention survey, 77% to 87% across the 3 sites reported that open notes helped them feel more in control of their care; 60% to 78% of those taking medications reported increased medication adherence; 26% to 36% had privacy concerns; 1% to 8% reported that the notes caused confusion, worry, or offense; and 20% to 42% reported sharing notes with others. The volume of electronic messages from patients did not change. After the intervention, few doctors reported longer visits (0% to 5%) or more time addressing patients' questions outside of visits (0% to 8%), with practice size having little effect; 3% to 36% of doctors reported changing documentation content; and 0% to 21% reported taking more time writing notes. Looking ahead, 59% to 62% of patients believed that they should be able to add comments to a doctor's note. One out of 3 patients believed that they should be able to approve the notes' contents, but 85% to 96% of doctors did not agree. At the end of the experimental period, 99% of patients wanted open notes to continue and no doctor elected to stop. Limitations: Only 3 geographic areas were represented, and most participants were experienced in using portals. Doctors volunteering to participate and patients using portals and completing surveys may tend to offer favorable feedback, and the response rate of the patient surveys (41%) may further limit generalizability. Conclusion: Patients accessed visit notes frequently, a large majority reported clinically relevant benefits and minimal concerns, and virtually all patients wanted the practice to continue. With doctors experiencing no more than a modest effect on their work lives, open notes seem worthy of widespread adoption.	[Walker, Jan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; Geisinger Hlth Syst, Danville, PA USA; Univ Washington, Harborview Med Ctr, Sch Med, Seattle, WA 98104 USA; Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; Univ Colorado, Hlth Sci Ctr, Aurora, CO USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston; Geisinger Health System; Harborview Medical Center; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Colorado System; University of Colorado Anschutz Medical Campus	Walker, J (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	jwalker1@bidmc.harvard.edu	Leveille, Suzanne G/ACS-6588-2022	Leveille, Suzanne G/0000-0003-0427-1580; Trivedi, Neha/0000-0003-1006-1408	Robert Wood Johnson Foundation; Drane Family Fund; Richard and Florence Koplow Charitable Foundation; National Cancer Institute [K05 CA 104699]; Robert Wood Johnson Foundation's Pioneer Portfolio grant [65921]; NATIONAL CANCER INSTITUTE [K05CA104699] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Drane Family Fund; Richard and Florence Koplow Charitable Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert Wood Johnson Foundation's Pioneer Portfolio grant(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Robert Wood Johnson Foundation, the Drane Family Fund, the Richard and Florence Koplow Charitable Foundation, and the National Cancer Institute.; All investigators were supported by The Robert Wood Johnson Foundation's Pioneer Portfolio grant 65921. Dr. Delbanco and Ms. Walker were also supported by the Drane Family Fund and the Richard and Florence Koplow Charitable Foundation. Dr. Elmore was also supported by the National Cancer Institute (K05 CA 104699).	Auerbach DI, 2011, HEALTH AFFAIR, V30, P1630, DOI 10.1377/hlthaff.2011.0585; Bevans M, 2012, JAMA-J AM MED ASSOC, V307, P398, DOI 10.1001/jama.2012.29; Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; Delbanco T, 2010, ANN INTERN MED, V153, P121, DOI 10.7326/0003-4819-153-2-201007200-00008; Earnest MA, 2004, J AM MED INFORM ASSN, V11, P410, DOI 10.1197/jamia.M1479; Feeley TW, 2011, ANN INTERN MED, V155, P853, DOI 10.7326/0003-4819-155-12-201112200-00010; Grunfeld E, 2004, CAN MED ASSOC J, V170, P1795, DOI 10.1503/cmaj.1031205; Hassol A, 2004, J AM MED INFORM ASSN, V11, P505, DOI 10.1197/jamia.M1593; Kind EA, 2011, MAYO CLIN PROC, V86, P397, DOI 10.4065/mcp.2010.0785; Leveille SG, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-32; Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220; Ralston JD, 2004, BMJ-BRIT MED J, V328, P1159, DOI 10.1136/bmj.328.7449.1159; Rodrigue JR, 2010, PROG TRANSPLANT, V20, P335, DOI 10.7182/prtr.20.4.g65r17525j278251; Ross SE, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e12; Ross SE, 2003, J AM MED INFORM ASSN, V10, P129, DOI 10.1197/jamia.M1147; SAS Inst, 2000, SAS STAT US GUID VER; Stokes ME, 2000, CATEGORICAL DATA ANA; Walker J, 2011, ANN INTERN MED, V155, P811, DOI 10.7326/0003-4819-155-12-201112200-00003; Walker J, 2009, J GEN INTERN MED, V24, P727, DOI 10.1007/s11606-009-0973-1	19	424	426	5	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					461	U36		10.7326/0003-4819-157-7-201210020-00002	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	016MQ	23027317	Green Accepted			2022-12-28	WOS:000309523200001
J	Hwang, SW; Tao, H; Kim, DH; Cheng, HY; Song, JK; Rill, E; Brenckle, MA; Panilaitis, B; Won, SM; Kim, YS; Song, YM; Yu, KJ; Ameen, A; Li, R; Su, YW; Yang, MM; Kaplan, DL; Zakin, MR; Slepian, MJ; Huang, YG; Omenetto, FG; Rogers, JA				Hwang, Suk-Won; Tao, Hu; Kim, Dae-Hyeong; Cheng, Huanyu; Song, Jun-Kyul; Rill, Elliott; Brenckle, Mark A.; Panilaitis, Bruce; Won, Sang Min; Kim, Yun-Soung; Song, Young Min; Yu, Ki Jun; Ameen, Abid; Li, Rui; Su, Yewang; Yang, Miaomiao; Kaplan, David L.; Zakin, Mitchell R.; Slepian, Marvin J.; Huang, Yonggang; Omenetto, Fiorenzo G.; Rogers, John A.			A Physically Transient Form of Silicon Electronics	SCIENCE			English	Article							CRYSTALLINE SILICON; SILK FIBROIN; OXIDE	A remarkable feature of modern silicon electronics is its ability to remain physically invariant, almost indefinitely for practical purposes. Although this characteristic is a hallmark of applications of integrated circuits that exist today, there might be opportunities for systems that offer the opposite behavior, such as implantable devices that function for medically useful time frames but then completely disappear via resorption by the body. We report a set of materials, manufacturing schemes, device components, and theoretical design tools for a silicon-based complementary metal oxide semiconductor (CMOS) technology that has this type of transient behavior, together with integrated sensors, actuators, power supply systems, and wireless control strategies. An implantable transient device that acts as a programmable nonantibiotic bacteriocide provides a system-level example.	[Tao, Hu; Brenckle, Mark A.; Panilaitis, Bruce; Yang, Miaomiao; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Hwang, Suk-Won; Rill, Elliott; Kim, Yun-Soung; Song, Young Min; Ameen, Abid; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Hwang, Suk-Won; Rill, Elliott; Kim, Yun-Soung; Song, Young Min; Ameen, Abid; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Kim, Dae-Hyeong] Seoul Natl Univ, Sch Chem & Biol Engn, Ctr Nanoparticle Res,Inst Basic Sci, WCU Program Chem Convergence Energy & Environm, Seoul 151741, South Korea; [Cheng, Huanyu; Li, Rui; Su, Yewang; Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Cheng, Huanyu; Li, Rui; Su, Yewang; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Song, Jun-Kyul; Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Won, Sang Min; Yu, Ki Jun; Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Li, Rui] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dept Engn Mech, Dalian 116024, Peoples R China; [Zakin, Mitchell R.] Nano Terra, Brighton, MA 02135 USA; [Slepian, Marvin J.] Univ Arizona, Dept Med, Sarver Heart Ctr, Tucson, AZ 85724 USA; [Slepian, Marvin J.] Univ Arizona, Dept Biomed Engn, Sarver Heart Ctr, Tucson, AZ 85724 USA; [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys, Medford, MA 02155 USA	Tufts University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Northwestern University; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Dalian University of Technology; University of Arizona; University of Arizona; Tufts University	Omenetto, FG (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	fiorenzo.omenetto@tufts.edu; jrogers@uiuc.edu	Li, Rui/C-2155-2009; huang, yonggang/O-6236-2019; Slepian, Marvin/ABG-8305-2020; Cheng, Huanyu/J-7379-2015; Sunny, QI/M-5188-2019; Su, Yewang/GXF-2357-2022; Tao, Hu/C-1528-2013; Song, Young Min/B-2215-2010; Huang, Yonggang/B-6998-2009; Rogers, John/L-2798-2016; Brenckle, Mark/I-5931-2014; HWANG, SUKWON/Q-8329-2018	Slepian, Marvin/0000-0002-7864-6691; Cheng, Huanyu/0000-0001-6075-4208; Sunny, QI/0000-0002-5817-1609; Song, Young Min/0000-0002-4473-6883; Brenckle, Mark/0000-0002-5535-1110; HWANG, SUKWON/0000-0002-6883-201X; Kim, Dae-Hyeong/0000-0002-4722-1893; Li, Rui/0000-0001-6051-4204	Defense Advanced Research Projects Agency; NSF INSPIRE; Air Force Office of Scientific Research Multi University Research Initiative program; National Institutes of Health [EB002520]; U.S. Department of Energy; Division Of Materials Research [1242240] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF INSPIRE; Air Force Office of Scientific Research Multi University Research Initiative program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work on materials, integration schemes, manufacturing approaches, and design strategies was supported by the Defense Advanced Research Projects Agency. The theoretical analysis and associated experiments were supported by an NSF INSPIRE grant. The techniques for creating and manipulating Si nanomembranes were developed in work supported by an Air Force Office of Scientific Research Multi University Research Initiative program. The animal studies were funded by the National Institutes of Health (grant EB002520). The facilities for characterization and analysis were provided by the Material Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign, both of which are supported by the U.S. Department of Energy.	Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; [Anonymous], 1996, Am J Infect Control, V24, P380; Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322; Chung HJ, 2011, ADV FUNCT MATER, V21, P3029, DOI 10.1002/adfm.201100124; Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a; ILER RK, 1973, J COLLOID INTERF SCI, V43, P399, DOI 10.1016/0021-9797(73)90386-X; Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Legnani C, 2008, THIN SOLID FILMS, V517, P1016, DOI 10.1016/j.tsf.2008.06.011; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; MORITA M, 1990, J APPL PHYS, V68, P1272, DOI 10.1063/1.347181; RIMSTIDT JD, 1980, GEOCHIM COSMOCHIM AC, V44, P1683, DOI 10.1016/0016-7037(80)90220-3; Santra S, 2010, IEEE SENS J, V10, P997, DOI 10.1109/JSEN.2009.2037822; SEIDEL H, 1990, J ELECTROCHEM SOC, V137, P3612, DOI 10.1149/1.2086277; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Won SM, 2011, IEEE T ELECTRON DEV, V58, P4074, DOI 10.1109/TED.2011.2164923	17	855	892	41	857	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1640	1644		10.1126/science.1226325	http://dx.doi.org/10.1126/science.1226325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019646	Green Accepted			2022-12-28	WOS:000309215400041
J	Voigt, P; LeRoy, G; Drury, WJ; Zee, BM; Son, J; Beck, DB; Young, NL; Garcia, BA; Reinberg, D				Voigt, Philipp; LeRoy, Gary; Drury, William J., III; Zee, Barry M.; Son, Jinsook; Beck, David B.; Young, Nicolas L.; Garcia, Benjamin A.; Reinberg, Danny			Asymmetrically Modified Nucleosomes	CELL			English	Article							HISTONE MODIFICATIONS; DNA-REPLICATION; CHROMATIN-STRUCTURE; BINDING MODULES; CELL-CYCLE; METHYLATION; GENOME; GENES; MARKS; INFORMATION	Mononucleosomes, the basic building blocks of chromatin, contain two copies of each core histone. The associated posttranslational modifications regulate essential chromatin-dependent processes, yet whether each histone copy is identically modified in vivo is unclear. We demonstrate that nucleosomes in embryonic stem cells, fibroblasts, and cancer cells exist in both symmetrically and asymmetrically modified populations for histone H3 lysine 27 di/trimethylation (H3K27me2/3) and H4K20me1. Further, we obtained direct physical evidence for bivalent nucleosomes carrying H3K4me3 or H3K36me3 along with H3K27me3, albeit on opposite H3 tails. Bivalency at target genes was resolved upon differentiation of ES cells. Polycomb repressive complex 2-mediated methylation of H3K27 was inhibited when nucleosomes contain symmetrically, but not asymmetrically, placed H3K4me3 or H3K36me3. These findings uncover a potential mechanism for the incorporation of bivalent features into nucleosomes and demonstrate how asymmetry might set the stage to diversify functional nucleosome states.	[Voigt, Philipp; Drury, William J., III; Son, Jinsook; Beck, David B.; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; [LeRoy, Gary; Zee, Barry M.; Young, Nicolas L.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Schultz Lab 415, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; New York University; Princeton University	Reinberg, D (corresponding author), NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, 522 1st Ave, New York, NY 10016 USA.	danny.reinberg@nyumc.org		Voigt, Philipp/0000-0003-4366-0490; Reinberg, Danny/0000-0003-4288-2016; Young, Nicolas/0000-0002-3323-2815; Zee, Barry/0000-0002-3123-8375	Deutsche Akademie der Naturforscher Leopoldina [LPDS 2009-5]; Empire State Training Program in Stem Cell Research (NYSTEM) [C026880]; Howard Hughes Medical Institute; National Institute of Health [GM064844, R37GM037120]; NSF [CBET-0941143]; American Society for Mass Spectrometry; NIH Office of the Director [DP2OD007447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM064844] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	Deutsche Akademie der Naturforscher Leopoldina; Empire State Training Program in Stem Cell Research (NYSTEM); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Society for Mass Spectrometry; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Till Bartke and Tony Kouzarides for the H4 Delta(1-27)I28C construct. We are grateful to Dr. Inti De La Rosa Velazquez for advice on sequential ChIP experiments. We thank Drs. W.W. Tee and R. Bonasio for helpful discussions and Dr. L. Vales for critical reading of the manuscript. P.V. is supported by fellowships from the Deutsche Akademie der Naturforscher Leopoldina (LPDS 2009-5) and the Empire State Training Program in Stem Cell Research (NYSTEM, contract # C026880). Work in the Reinberg laboratory is funded by the Howard Hughes Medical Institute and the National Institute of Health (grants GM064844 and R37GM037120). The Garcia laboratory is supported by grants from the NSF (Early Faculty Career award and CBET-0941143), the American Society for Mass Spectrometry, and the NIH Office of the Director (DP2OD007447).	Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen XZ, 2011, EMBO REP, V12, P244, DOI 10.1038/embor.2011.6; DiMaggio PA, 2009, MOL CELL PROTEOMICS, V8, P2527, DOI 10.1074/mcp.M900144-MCP200; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Voigt P, 2011, CHEMBIOCHEM, V12, P236, DOI 10.1002/cbic.201000493; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	36	281	285	1	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					181	193		10.1016/j.cell.2012.09.002	http://dx.doi.org/10.1016/j.cell.2012.09.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021224	Green Accepted, Bronze			2022-12-28	WOS:000309544200019
J	Yonezawa, H; Nakane, D; Wheatley, TA; Iwasawa, K; Takeda, S; Arao, H; Ohki, K; Tsumura, K; Berry, DW; Ralph, TC; Wiseman, HM; Huntington, EH; Furusawa, A				Yonezawa, Hidehiro; Nakane, Daisuke; Wheatley, Trevor A.; Iwasawa, Kohjiro; Takeda, Shuntaro; Arao, Hajime; Ohki, Kentaro; Tsumura, Koji; Berry, Dominic W.; Ralph, Timothy C.; Wiseman, Howard M.; Huntington, Elanor H.; Furusawa, Akira			Quantum-Enhanced Optical-Phase Tracking	SCIENCE			English	Article							LIMIT	Tracking a randomly varying optical phase is a key task in metrology, with applications in optical communication. The best precision for optical-phase tracking has until now been limited by the quantum vacuum fluctuations of coherent light. Here, we surpass this coherent-state limit by using a continuous-wave beam in a phase-squeezed quantum state. Unlike in previous squeezing-enhanced metrology, restricted to phases with very small variation, the best tracking precision (for a fixed light intensity) is achieved for a finite degree of squeezing because of Heisenberg's uncertainty principle. By optimizing the squeezing, we track the phase with a mean square error 15 +/- 4% below the coherent-state limit.	[Wiseman, Howard M.] Griffith Univ, Ctr Quantum Dynam, Brisbane, Qld 4111, Australia; [Wheatley, Trevor A.; Ralph, Timothy C.; Huntington, Elanor H.] Australian Res Council, Ctr Quantum Computat & Commun Technol, Canberra, ACT, Australia; [Yonezawa, Hidehiro; Nakane, Daisuke; Wheatley, Trevor A.; Iwasawa, Kohjiro; Takeda, Shuntaro; Arao, Hajime; Furusawa, Akira] Univ Tokyo, Dept Appl Phys, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Wiseman, Howard M.] Griffith Univ, Ctr Quantum Computat & Commun Technol, Brisbane, Qld 4111, Australia; [Wheatley, Trevor A.; Huntington, Elanor H.] Univ New S Wales, Sch Engn & Informat Technol, Univ Coll, Canberra, ACT 2600, Australia; [Ohki, Kentaro] Kyoto Univ, Dept Appl Math & Phys, Sch Informat, Sakyo Ku, Kyoto 6068501, Japan; [Tsumura, Koji] Univ Tokyo, Dept Informat Phys & Comp, Bunkyo Ku, Tokyo 1130033, Japan; [Berry, Dominic W.] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Berry, Dominic W.] Macquarie Univ, Dept Phys & Astron, N Ryde, NSW 2109, Australia; [Ralph, Timothy C.] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia	Griffith University; University of Tokyo; Griffith University; Australian Defense Force Academy; University of New South Wales Sydney; Kyoto University; University of Tokyo; University of Waterloo; Macquarie University; University of Queensland	Wiseman, HM (corresponding author), Griffith Univ, Ctr Quantum Dynam, Brisbane, Qld 4111, Australia.	h.wiseman@griffith.edu.au; akiraf@ap.t.u-tokyo.ac.jp	Ralph, Timothy C/A-1858-2011; Yonezawa, Hidehiro/C-4260-2015; Takeda, Shuntaro/A-3318-2015; Wiseman, Howard M/A-7266-2008; Nakane, Daisuke/P-1325-2019; Huntington, Elanor/G-4081-2010; Wheatley, Trevor/P-8746-2019; Berry, Dominic/AAC-5385-2020; Furusawa, Akira/P-5787-2014	Ralph, Timothy C/0000-0003-0692-8427; Yonezawa, Hidehiro/0000-0002-5522-1439; Wiseman, Howard M/0000-0001-6815-854X; Nakane, Daisuke/0000-0002-8201-2608; Huntington, Elanor/0000-0002-7154-0042; Wheatley, Trevor/0000-0002-6878-2446; Furusawa, Akira/0000-0002-6176-6742; Ohki, Kentaro/0000-0002-5607-109X; Berry, Dominic/0000-0003-3446-1449	Project for Developing Innovation Systems; Global Center of Excellence; Advanced Photon Science Alliance; Funding Program for World-Leading Innovative R&D on Science and Technology; Ministry of Internal Affairs and Communications of Japan; Australian Research Council [CE110001029, DP1094650, FT100100761]; Grants-in-Aid for Scientific Research [22560439] Funding Source: KAKEN	Project for Developing Innovation Systems; Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Photon Science Alliance; Funding Program for World-Leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Internal Affairs and Communications of Japan; Australian Research Council(Australian Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Project for Developing Innovation Systems, Grants-in-Aid for Scientific Research, Global Center of Excellence, Advanced Photon Science Alliance, Funding Program for World-Leading Innovative R&D on Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Strategic Information and Communications R and D Promotion program of the Ministry of Internal Affairs and Communications of Japan, and the Australian Research Council projects CE110001029, DP1094650, and FT100100761.	Abadie J, 2011, NAT PHYS, V7, P962, DOI [10.1038/NPHYS2083, 10.1038/nphys2083]; Armen MA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.133602; Berry DW, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063824; Berry DW, 2000, PHYS REV LETT, V85, P5098, DOI 10.1103/PhysRevLett.85.5098; Berry DW, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.043803; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Chen J, 2012, NAT PHOTONICS, V6, P374, DOI [10.1038/NPHOTON.2012.113, 10.1038/nphoton.2012.113]; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Giovannetti V, 2011, NAT PHOTONICS, V5, P222, DOI [10.1038/NPHOTON.2011.35, 10.1038/nphoton.2011.35]; Goda K, 2008, NAT PHYS, V4, P472, DOI 10.1038/nphys920; Helstrom CW, 1976, QUANTUM DETECTION ES; Higgins BL, 2007, NATURE, V450, P393, DOI 10.1038/nature06257; Inoue K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.037902; Nagata T, 2007, SCIENCE, V316, P726, DOI 10.1126/science.1138007; Slavik R, 2010, NAT PHOTONICS, V4, P690, DOI 10.1038/NPHOTON.2010.203; Tsang M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.090401; Tsang M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.250403; Tsang M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053843; Wheatley TA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.093601; Wiseman H. M., 2010, QUANTUM MEASUREMENT; Wiseman HM, 1998, PHYS REV A, V57, P2169, DOI 10.1103/PhysRevA.57.2169; WISEMAN HM, 1995, PHYS REV LETT, V75, P4587, DOI 10.1103/PhysRevLett.75.4587; Xiang GY, 2011, NAT PHOTONICS, V5, P43, DOI 10.1038/NPHOTON.2010.268	25	159	161	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1514	1517		10.1126/science.1225258	http://dx.doi.org/10.1126/science.1225258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997332	Green Published, Green Submitted			2022-12-28	WOS:000308912900045
J	Arnold, A; Arnold, W				Arnold, Andreas; Arnold, Wolfgang			A Tickling in the Ear	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arnold, Andreas] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Arnold, Wolfgang] Tech Univ Munich, Munich, Germany	University of Bern; University Hospital of Bern; Technical University of Munich	Arnold, A (corresponding author), Univ Hosp Bern, CH-3010 Bern, Switzerland.	andreas.arnold@insel.ch	Arnold, Andreas/H-2749-2012	Arnold, Andreas/0000-0002-9349-3312					0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					E17	E17		10.1056/NEJMicm1114612	http://dx.doi.org/10.1056/NEJMicm1114612			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AS	22992100	Green Published			2022-12-28	WOS:000308861800010
J	Gold, R; Kappos, L; Arnold, DL; Bar-Or, A; Giovannoni, G; Selmaj, K; Tornatore, C; Sweetser, MT; Yang, M; Sheikh, SI; Dawson, KT				Gold, Ralf; Kappos, Ludwig; Arnold, Douglas L.; Bar-Or, Amit; Giovannoni, Gavin; Selmaj, Krzysztof; Tornatore, Carlo; Sweetser, Marianne T.; Yang, Minhua; Sheikh, Sarah I.; Dawson, Katherine T.		DEFINE Study Investigators	Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OXIDATIVE STRESS; CONTROLLED TRIAL; FINGOLIMOD; DISABILITY	BACKGROUND BG-12 (dimethyl fumarate) was shown to have antiinflammatory and cytoprotective properties in preclinical experiments and to result in significant reductions in disease activity on magnetic resonance imaging (MRI) in a phase 2, placebo-controlled study involving patients with relapsing-remitting multiple sclerosis. METHODS We conducted a randomized, double-blind, placebo-controlled phase 3 study involving patients with relapsing-remitting multiple sclerosis. Patients were randomly assigned to receive oral BG-12 at a dose of 240 mg twice daily, BG-12 at a dose of 240 mg three times daily, or placebo. The primary end point was the proportion of patients who had a relapse by 2 years. Other end points included the annualized relapse rate, the time to confirmed progression of disability, and findings on MRI. RESULTS The estimated proportion of patients who had a relapse was significantly lower in the two BG-12 groups than in the placebo group (27% with BG-12 twice daily and 26% with BG-12 thrice daily vs. 46% with placebo, P<0.001 for both comparisons). The annualized relapse rate at 2 years was 0.17 in the twice-daily BG-12 group and 0.19 in the thrice-daily BG-12 group, as compared with 0.36 in the placebo group, representing relative reductions of 53% and 48% with the two BG-12 regimens, respectively (P<0.001 for the comparison of each BG-12 regimen with placebo). The estimated proportion of patients with confirmed progression of disability was 16% in the twice-daily BG-12 group, 18% in the thrice-daily BG-12 group, and 27% in the placebo group, with significant relative risk reductions of 38% with BG-12 twice daily (P = 0.005) and 34% with BG-12 thrice daily (P = 0.01). BG-12 also significantly reduced the number of gadolinium-enhancing lesions and of new or enlarging T-2-weighted hyperintense lesions (P<0.001 for the comparison of each BG-12 regimen with placebo). Adverse events associated with BG-12 included flushing and gastrointestinal events, such as diarrhea, nausea, and upper abdominal pain, as well as decreased lymphocyte counts and elevated liver aminotransferase levels. CONCLUSIONS In patients with relapsing-remitting multiple sclerosis, both BG-12 regimens, as compared with placebo, significantly reduced the proportion of patients who had a relapse, the annualized relapse rate, the rate of disability progression, and the number of lesions on MRI.	[Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-44791 Bochum, Germany; [Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Arnold, Douglas L.] NeuroRx Res, Montreal, PQ, Canada; [Arnold, Douglas L.; Bar-Or, Amit] McGill Univ, Montreal Neurol Hosp & Inst, Montreal, PQ, Canada; [Giovannoni, Gavin] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England; [Selmaj, Krzysztof] Med Univ Lodz, Lodz, Poland; [Tornatore, Carlo] Georgetown Univ Hosp, Washington, DC 20007 USA; [Sweetser, Marianne T.; Yang, Minhua; Sheikh, Sarah I.; Dawson, Katherine T.] Biogen Idec Inc, Weston, MA USA	Ruhr University Bochum; University of Basel; University of Basel; McGill University; University of London; Queen Mary University London; Medical University Lodz; Georgetown University; Biogen	Gold, R (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Gudrunstr 56, D-44791 Bochum, Germany.	ralf.gold@ruhr-uni-bochum.de	Brassat, David/L-2173-2014; Bar-Or, Amit/AIC-1416-2022; Belachew, Shibeshih/V-9185-2019; Nehrych, Tetyana I/L-7555-2016; Rodriguez-Leyva, Ildefonso/G-8398-2018; LICEND, CEMND/F-1296-2015; Groppa, Stanislav/AAM-5905-2020; Dubois, Benedicte/A-4338-2019	Belachew, Shibeshih/0000-0003-3976-1950; Nehrych, Tetyana I/0000-0003-0170-511X; Rodriguez-Leyva, Ildefonso/0000-0002-3316-1471; Groppa, Stanislav/0000-0002-2120-2408; Dubois, Benedicte/0000-0003-0604-8702; Pozzilli, Carlo/0000-0002-6360-4798; lebrun-frenay, christine/0000-0002-3713-2416; Chan, Andrew/0000-0003-3434-7283; antel, jack/0000-0002-5148-0636; Selmaj, Krzysztof/0000-0003-1213-7218; Pandit, Lekha/0000-0002-2269-5312; Arnold, Douglas/0000-0003-4266-0106; Turcani, Peter/0000-0002-4868-6836; Milo, Ron/0000-0001-8556-2579; Schneider, Hauke/0000-0002-9641-0922	Biogen Idec	Biogen Idec(Biogen)	Funded by Biogen Idec; DEFINE ClinicalTrials.gov number, NCT00420212.	[Anonymous], 1996, ICH HARM TRIP GUID G; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Francis G, 2001, NEUROLOGY, V56, P1628; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Jacobs LD, 1996, ANN NEUROL, V40, P480; Johnson DA, 2010, TOXICOL SCI, V114, P237, DOI 10.1093/toxsci/kfp274; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 2009, LANCET, V373, P1340; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PRISMS Study Grp, 2001, NEUROLOGY, V57, P1146; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Vollmer TL, 2011, MULT SCLER J, V17, pS507; World Medical Association, DECL HELS ETH PRINC	21	1166	1208	3	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1098	1107		10.1056/NEJMoa1114287	http://dx.doi.org/10.1056/NEJMoa1114287			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AS	22992073	Bronze			2022-12-28	WOS:000308861800005
J	Gross, L; Mohn, F; Moll, N; Schuler, B; Criado, A; Guitian, E; Pena, D; Gourdon, A; Meyer, G				Gross, Leo; Mohn, Fabian; Moll, Nikolaj; Schuler, Bruno; Criado, Alejandro; Guitian, Enrique; Pena, Diego; Gourdon, Andre; Meyer, Gerhard			Bond-Order Discrimination by Atomic Force Microscopy	SCIENCE			English	Article							CHEMICAL-STRUCTURE; CRYSTAL-STRUCTURE; SINGLE; RESOLUTION; C60; BUCKMINSTERFULLERENE; MOLECULES; LENGTHS	We show that the different bond orders of individual carbon-carbon bonds in polycyclic aromatic hydrocarbons and fullerenes can be distinguished by noncontact atomic force microscopy (AFM) with a carbon monoxide (CO)-functionalized tip. We found two different contrast mechanisms, which were corroborated by density functional theory calculations: The greater electron density in bonds of higher bond order led to a stronger Pauli repulsion, which enhanced the brightness of these bonds in high-resolution AFM images. The apparent bond length in the AFM images decreased with increasing bond order because of tilting of the CO molecule at the tip apex.	[Criado, Alejandro; Guitian, Enrique; Pena, Diego] Univ Santiago de Compostela, CIQUS, E-15782 Santiago De Compostela, Spain; [Gross, Leo; Mohn, Fabian; Moll, Nikolaj; Schuler, Bruno; Meyer, Gerhard] IBM Res Zurich, CH-8803 Ruschlikon, Switzerland; [Gourdon, Andre] CEMES CNRS, F-31055 Toulouse, France	Universidade de Santiago de Compostela; CiQUS; International Business Machines (IBM); Centre National de la Recherche Scientifique (CNRS)	Gross, L (corresponding author), IBM Res Zurich, CH-8803 Ruschlikon, Switzerland.	lgr@zurich.ibm.com	Schuler, Bruno/B-8545-2012; Peña, Diego/D-2051-2009; Criado, Alejandro/I-9826-2017; Gross, Leo/E-1789-2011; Guitián, Enrique/H-9018-2015; Gross, Leo/M-8564-2019; Gourdon, André/C-9799-2009; Criado, Alejandro/HDO-0316-2022; Moll, Nikolaj/C-5674-2013	Schuler, Bruno/0000-0002-9641-0340; Peña, Diego/0000-0003-3814-589X; Criado, Alejandro/0000-0002-9732-513X; Gross, Leo/0000-0002-5337-4159; Guitián, Enrique/0000-0003-4785-3812; Gross, Leo/0000-0002-5337-4159; Gourdon, André/0000-0002-0370-1019; Criado, Alejandro/0000-0002-9732-513X; Moll, Nikolaj/0000-0001-5645-4667	European Union [243421, 214954]; European Research Council; Spanish Ministry of Economy and Competitiveness (MINECO) [CTQ2010-18208]; Xunta de Galicia [10PXIB2200222PR]; Fondo Europeo de Desarrollo Regional (FEDER)	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness (MINECO); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	We thank R. Allenspach, J. Repp, and A. Curioni for comments and European Union projects ARTIST (contract no. 243421) and HERODOT (contract no. 214954), the European Research Council advanced grant CEMAS, the Spanish Ministry of Economy and Competitiveness (MINECO, CTQ2010-18208), Xunta de Galicia (10PXIB2200222PR), and Fondo Europeo de Desarrollo Regional (FEDER) for financial support.	Alemani M, 2006, J AM CHEM SOC, V128, P14446, DOI 10.1021/ja065449s; Ashino M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.136101; Buhl M, 2001, CHEM REV, V101, P1153, DOI 10.1021/cr990332q; Comstock MJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038301; Criado A, 2010, CHEM-EUR J, V16, P9736, DOI 10.1002/chem.201001057; DAVID WIF, 1991, NATURE, V353, P147, DOI 10.1038/353147a0; FAGAN PJ, 1991, SCIENCE, V252, P1160, DOI 10.1126/science.252.5009.1160; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; GODDARD R, 1995, J AM CHEM SOC, V117, P30, DOI 10.1021/ja00106a004; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Guo CS, 2010, LANGMUIR, V26, P16271, DOI 10.1021/la101317s; HEDBERG K, 1991, SCIENCE, V254, P410, DOI 10.1126/science.254.5030.410; Larsson JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115434; LIU SZ, 1991, SCIENCE, V254, P408, DOI 10.1126/science.254.5030.408; Mohn F, 2012, NAT NANOTECHNOL, V7, P227, DOI [10.1038/NNANO.2012.20, 10.1038/nnano.2012.20]; Mohn F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3619829; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Narita S, 2000, J MOL STRUC-THEOCHEM, V532, P37, DOI 10.1016/S0166-1280(00)00563-7; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pauling L, 1935, J AM CHEM SOC, V57, P2705, DOI 10.1021/ja01315a105; Pavlicek N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086101; Pawlak R, 2011, ACS NANO, V5, P6349, DOI 10.1021/nn201462g; Schleyer PV, 2001, CHEM REV, V101, P1115, DOI 10.1021/cr0103221; Schull G, 2011, NANO LETT, V11, P3142, DOI 10.1021/nl201185y; Sedlar J, 2006, CHEM PHYS LETT, V427, P418, DOI 10.1016/j.cplett.2006.06.026; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Sun ZX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046104; Ugeda MM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.116803; Wang HT, 2012, NANO LETT, V12, P141, DOI 10.1021/nl2031629; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850	31	357	364	8	472	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1326	1329		10.1126/science.1225621	http://dx.doi.org/10.1126/science.1225621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984067				2022-12-28	WOS:000308705000038
J	Lee, MM; Teuscher, J; Miyasaka, T; Murakami, TN; Snaith, HJ				Lee, Michael M.; Teuscher, Joel; Miyasaka, Tsutomu; Murakami, Takurou N.; Snaith, Henry J.			Efficient Hybrid Solar Cells Based on Meso-Superstructured Organometal Halide Perovskites	SCIENCE			English	Article							PHOTOVOLTAIC CELLS; DYE; POLYMER; SEMICONDUCTORS; SPECTROSCOPY; PERFORMANCE; TRANSPORT; ELECTROLUMINESCENCE; ELECTRODES; CHANNELS	The energy costs associated with separating tightly bound excitons (photoinduced electron-hole pairs) and extracting free charges from highly disordered low-mobility networks represent fundamental losses for many low-cost photovoltaic technologies. We report a low-cost, solution-processable solar cell, based on a highly crystalline perovskite absorber with intense visible to near-infrared absorptivity, that has a power conversion efficiency of 10.9% in a single-junction device under simulated full sunlight. This "meso-superstructured solar cell" exhibits exceptionally few fundamental energy losses; it can generate open-circuit photovoltages of more than 1.1 volts, despite the relatively narrow absorber band gap of 1.55 electron volts. The functionality arises from the use of mesoporous alumina as an inert scaffold that structures the absorber and forces electrons to reside in and be transported through the perovskite.	[Lee, Michael M.; Teuscher, Joel; Snaith, Henry J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Miyasaka, Tsutomu; Murakami, Takurou N.] Toin Univ Yokohama, Grad Sch Engn, Aoba Ku, Yokohama, Kanagawa 2258503, Japan; [Murakami, Takurou N.] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058565, Japan	University of Oxford; Toin University of Yokohama; National Institute of Advanced Industrial Science & Technology (AIST)	Snaith, HJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	h.snaith1@physics.ox.ac.uk	Murakami, Takurou/L-4546-2018; Miyasaka, Tsutomu/AAW-4175-2020; Snaith, Henry J/A-7367-2016	Murakami, Takurou/0000-0002-2066-3982; Miyasaka, Tsutomu/0000-0001-8535-7911; Snaith, Henry J/0000-0001-8511-790X	European Research Council (HYPER project) [279881]; Strategic International Research Cooperative Program of the UK Engineering and Physical Sciences Research Council; Japan Science and Technology Agency; funding program for World-Leading Innovative R&D on Science and Technology (FIRST Program), Japan	European Research Council (HYPER project); Strategic International Research Cooperative Program of the UK Engineering and Physical Sciences Research Council; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); funding program for World-Leading Innovative R&D on Science and Technology (FIRST Program), Japan	Supported by the European Research Council (HYPER project no. 279881), the Strategic International Research Cooperative Program of the UK Engineering and Physical Sciences Research Council, and the Japan Science and Technology Agency. T. M. thanks the funding program for World-Leading Innovative R&D on Science and Technology (FIRST Program), Japan, for hybrid solar cell research. We thank the New Energy and Industrial Technology Development Organization for support. M. M. L. is grateful for support from the Simms Bursary granted by Merton College, Oxford. We thank S. K. Pathak for assistance with x-ray diffraction measurements and analysis, and A. Abrusci, J. Ball, P. Docampo, A. Hey, T. Leijtens, N. Noel, and A. Kojima for valuable discussions. The University of Oxford has filed three patents related to this work.	Abrusci A, 2011, ENERG ENVIRON SCI, V4, P3051, DOI 10.1039/c1ee01135a; Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936; Barkhouse DAR, 2012, PROG PHOTOVOLTAICS, V20, P6, DOI 10.1002/pip.1160; Bisquert J, 2003, PHYS CHEM CHEM PHYS, V5, P5360, DOI 10.1039/b310907k; Boschloo G, 2008, INORG CHIM ACTA, V361, P729, DOI 10.1016/j.ica.2007.05.040; Burschka J, 2011, J AM CHEM SOC, V133, P18042, DOI 10.1021/ja207367t; Chang JA, 2012, NANO LETT, V12, P1863, DOI 10.1021/nl204224v; Chondroudis K, 1999, CHEM MATER, V11, P3028, DOI 10.1021/cm990561t; Chung I, 2012, NATURE, V485, P486, DOI 10.1038/nature11067; Dennler G, 2009, ADV MATER, V21, P1323, DOI 10.1002/adma.200801283; Ding IK, 2009, ADV FUNCT MATER, V19, P2431, DOI 10.1002/adfm.200900541; Docampo P, 2012, ADV FUNCT MATER, V22, P5010, DOI 10.1002/adfm.201201223; Docampo P, 2010, ADV FUNCT MATER, V20, P1787, DOI 10.1002/adfm.200902089; ERA M, 1995, APPL PHYS LETT, V67, P2436, DOI 10.1063/1.114599; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; HALLS JJM, 1995, NATURE, V376, P498, DOI 10.1038/376498a0; Han LY, 2012, ENERG ENVIRON SCI, V5, P6057, DOI 10.1039/c2ee03418b; Hardin BE, 2012, NAT PHOTONICS, V6, P162, DOI [10.1038/NPHOTON.2012.22, 10.1038/nphoton.2012.22]; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Ip AH, 2012, NAT NANOTECHNOL, V7, P577, DOI [10.1038/nnano.2012.127, 10.1038/NNANO.2012.127]; ISHIHARA T, 1990, PHYS REV B, V42, P11099, DOI 10.1103/PhysRevB.42.11099; Itzhaik Y, 2009, J PHYS CHEM C, V113, P4254, DOI 10.1021/jp900302b; Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945; KAVAN L, 1995, ELECTROCHIM ACTA, V40, P643, DOI 10.1016/0013-4686(95)90400-W; Kojima A, 2012, CHEM LETT, V41, P397, DOI 10.1246/cl.2012.397; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Leijtens T, 2012, ACS NANO, V6, P1455, DOI 10.1021/nn204296b; Melas-Kyriazi J, 2011, ADV ENERGY MATER, V1, P407, DOI 10.1002/aenm.201100046; MITZI DB, 1994, NATURE, V369, P467, DOI 10.1038/369467a0; Nelson J, 1999, PHYS REV B, V59, P15374, DOI 10.1103/PhysRevB.59.15374; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; POGLITSCH A, 1987, J CHEM PHYS, V87, P6373, DOI 10.1063/1.453467; ROTHENBERGER G, 1992, J PHYS CHEM-US, V96, P5983, DOI 10.1021/j100193a062; Snaith HJ, 2012, ENERG ENVIRON SCI, V5, P6513, DOI 10.1039/c2ee03429h; Snaith HJ, 2010, ADV FUNCT MATER, V20, P13, DOI 10.1002/adfm.200901476; Snaith HJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/42/424003; Todorov TK, 2010, ADV MATER, V22, pE156, DOI 10.1002/adma.200904155; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789	39	8106	8298	293	8298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					643	647		10.1126/science.1228604	http://dx.doi.org/10.1126/science.1228604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23042296				2022-12-28	WOS:000310516000047
J	Southwell, DG; Paredes, MF; Galvao, RP; Jones, DL; Froemke, RC; Sebe, JY; Alfaro-Cervello, C; Tang, YS; Garcia-Verdugo, JM; Rubenstein, JL; Baraban, SC; Alvarez-Buylla, A				Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Froemke, Robert C.; Sebe, Joy Y.; Alfaro-Cervello, Clara; Tang, Yunshuo; Garcia-Verdugo, Jose M.; Rubenstein, John L.; Baraban, Scott C.; Alvarez-Buylla, Arturo			Intrinsically determined cell death of developing cortical interneurons	NATURE			English	Article							FLUORESCENT PROTEIN EXPRESSION; GABAERGIC NEURONS; NERVOUS-SYSTEM; ES CELLS; MICE; ADULT; BRAIN; TRKC; NEUROGENESIS; RECEPTORS	Cortical inhibitory circuits are formed by gamma-aminobutyric acid (GABA)-secreting interneurons, a cell population that originates far from the cerebral cortex in the embryonic ventral forebrain. Given their distant developmental origins, it is intriguing how the number of cortical interneurons is ultimately determined. One possibility, suggested by the neurotrophic hypothesis(1-5), is that cortical interneurons are overproduced, and then after their migration into cortex the excess interneurons are eliminated through a competition for extrinsically derived trophic signals. Here we characterize the developmental cell death of mouse cortical interneurons in vivo, in vitro and after transplantation. We found that 40% of developing cortical interneurons were eliminated through Bax (Bcl-2-associated X)-dependent apoptosis during postnatal life. When cultured in vitro or transplanted into the cortex, interneuron precursors died at a cellular age similar to that at which endogenous interneurons died during normal development. Over transplant sizes that varied 200-fold, a constant fraction of the transplanted population underwent cell death. The death of transplanted neurons was not affected by the cell-autonomous disruption of TrkB (tropomyosin kinase receptor B), the main neurotrophin receptor expressed by neurons of the central nervous system(6-8). Transplantation expanded the cortical interneuron population by up to 35%, but the frequency of inhibitory synaptic events did not scale with the number of transplanted interneurons. Taken together, our findings indicate that interneuron cell death is determined intrinsically, either cell-autonomously or through a population-autonomous competition for survival signals derived from other interneurons.	[Southwell, Derek G.; Jones, Daniel L.; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosci, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Rubenstein, John L.; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Southwell, Derek G.; Tang, Yunshuo] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Paredes, Mercedes F.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, Dept Otolaryngol, San Francisco, CA 94143 USA; [Froemke, Robert C.] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Alfaro-Cervello, Clara; Garcia-Verdugo, Jose M.] Univ Valencia, CIBERNED, Inst Cavanilles, Valencia 46071, Spain; [Tang, Yunshuo] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBERNED; University of Valencia; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Southwell, DG (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	dereksouthwell@gmail.com; abuylla@stemcell.ucsf.edu	Galvão, Rogério/AAD-9875-2019; Alfaro-Cervello, Clara/D-1900-2015; García-Verdugo, José Manuel/L-8421-2017	Galvão, Rogério/0000-0002-0819-7114; García-Verdugo, José Manuel/0000-0001-9872-6499; Alfaro-Cervello, Clara/0000-0002-3737-4028; Froemke, Robert/0000-0002-1230-6811; Southwell, Derek/0000-0001-6465-3869; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Baraban, Scott/0000-0003-1975-9781	California Institute for Regenerative Medicine [TR2-01749]; National Institute of Neurologic Disorders and Stroke [F32NS061497]; John G. Bowes Research Fund; Spanish Ministry of Science and Innovation [SAF-2008-01274]; National Institutes of Health [R01 NS071785, R01 NS048528]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071785, F32NS061497, R01NS048528] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John G. Bowes Research Fund; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Yanagawa for GAD67-GFP mice, L. Reichardt for TrkB mutant mice and R. Romero for technical contributions. D. G. S. and M. F. P. were supported by training grants from the California Institute for Regenerative Medicine. J.Y.S. was supported by a fellowship from the National Institute of Neurologic Disorders and Stroke (F32NS061497). This work was supported by the California Institute for Regenerative Medicine (A.A.-B., TR2-01749), the John G. Bowes Research Fund (A.A.-B.), the Spanish Ministry of Science and Innovation (J.M.G-V., SAF-2008-01274), and the National Institutes of Health (J. L. R., S. C. B. and A.A.-B., R01 NS071785; A.A.-B., R01 NS048528).	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Boya Patricia, 2005, Birth Defects Research, V75, P281, DOI 10.1002/bdrc.20054; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Gorba T, 1999, EUR J NEUROSCI, V11, P1179, DOI 10.1046/j.1460-9568.1999.00551.x; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Polleux F, 2002, DEVELOPMENT, V129, P3147; Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	24	204	206	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					109	U172		10.1038/nature11523	http://dx.doi.org/10.1038/nature11523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23041929	Green Accepted, Green Submitted			2022-12-28	WOS:000310434500040
J	Phillips, CJ; Greene, JA; Podolsky, SH				Phillips, Christopher J.; Greene, Jeremy A.; Podolsky, Scott H.			Moneyball and Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Phillips, Christopher J.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Welch Lib, Inst Hist Med, Baltimore, MD USA; [Podolsky, Scott H.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Podolsky, Scott H.] Countway Med Lib, Ctr Hist Med, Boston, MA USA	Harvard University; Johns Hopkins University; Harvard University; Harvard Medical School	Phillips, CJ (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.			Phillips, Christopher/0000-0002-3251-4765				Bean RB, 1950, W OSLER APHORISMS HI; FEINSTEIN AR, 1977, CLIN PHARMACOL THER, V21, P482; Lerner B.H., 2006, ILLNESS GOES PUBLIC; Lewis M., 2003, MONEYBALL ART WINNIN; Porter M.E., 2006, REDEFINING HLTH CARE	5	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1581	1583		10.1056/NEJMp1211131	http://dx.doi.org/10.1056/NEJMp1211131			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23033979				2022-12-28	WOS:000310131700003
J	Doeleman, SS; Fish, VL; Schenck, DE; Beaudoin, C; Blundell, R; Bower, GC; Broderick, AE; Chamberlin, R; Freund, R; Friberg, P; Gurwell, MA; Ho, PTP; Honma, M; Inoue, M; Krichbaum, TP; Lamb, J; Loeb, A; Lonsdale, C; Marrone, DP; Moran, JM; Oyama, T; Plambeck, R; Primiani, RA; Rogers, AEE; Smythe, DL; SooHoo, J; Strittmatter, P; Tilanus, RPJ; Titus, M; Weintroub, J; Wright, M; Young, KH; Ziurys, LM				Doeleman, Sheperd S.; Fish, Vincent L.; Schenck, David E.; Beaudoin, Christopher; Blundell, Ray; Bower, Geoffrey C.; Broderick, Avery E.; Chamberlin, Richard; Freund, Robert; Friberg, Per; Gurwell, Mark A.; Ho, Paul T. P.; Honma, Mareki; Inoue, Makoto; Krichbaum, Thomas P.; Lamb, James; Loeb, Abraham; Lonsdale, Colin; Marrone, Daniel P.; Moran, James M.; Oyama, Tomoaki; Plambeck, Richard; Primiani, Rurik A.; Rogers, Alan E. E.; Smythe, Daniel L.; SooHoo, Jason; Strittmatter, Peter; Tilanus, Remo P. J.; Titus, Michael; Weintroub, Jonathan; Wright, Melvyn; Young, Ken H.; Ziurys, Lucy M.			Jet-Launching Structure Resolved Near the Supermassive Black Hole in M87	SCIENCE			English	Article							SGR-A-ASTERISK; INNER JET; RADIO JET; ACCRETION; STABILITY; EVOLUTION; HORIZON	Approximately 10% of active galactic nuclei exhibit relativistic jets, which are powered by the accretion of matter onto supermassive black holes. Although the measured width profiles of such jets on large scales agree with theories of magnetic collimation, the predicted structure on accretion disk scales at the jet launch point has not been detected. We report radio interferometry observations, at a wavelength of 1.3 millimeters, of the elliptical galaxy M87 that spatially resolve the base of the jet in this source. The derived size of 5.5 +/- 0.4 Schwarzschild radii is significantly smaller than the innermost edge of a retrograde accretion disk, suggesting that the M87 jet is powered by an accretion disk in a prograde orbit around a spinning black hole.	[Doeleman, Sheperd S.; Fish, Vincent L.; Schenck, David E.; Beaudoin, Christopher; Lonsdale, Colin; Rogers, Alan E. E.; Smythe, Daniel L.; SooHoo, Jason; Titus, Michael] MIT, Haystack Observ, Westford, MA 01886 USA; [Doeleman, Sheperd S.; Blundell, Ray; Gurwell, Mark A.; Loeb, Abraham; Moran, James M.; Primiani, Rurik A.; Weintroub, Jonathan; Young, Ken H.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Schenck, David E.; Freund, Robert; Marrone, Daniel P.; Strittmatter, Peter; Ziurys, Lucy M.] Univ Arizona, Arizona Radio Observ, Steward Observ, Tucson, AZ 85721 USA; [Bower, Geoffrey C.; Plambeck, Richard; Wright, Melvyn] Univ Calif Berkeley, Dept Astron, Hearst Field Annex, Berkeley, CA 94720 USA; [Broderick, Avery E.] Perimeter Inst, N Waterloo, ON N2L 2Y5, Canada; [Broderick, Avery E.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Chamberlin, Richard] Caltech Submillimeter Observ, Hilo, HI 96720 USA; [Friberg, Per; Tilanus, Remo P. J.] Joint Astron Ctr, James Clerk Maxwell Telescope, Hilo, HI 96720 USA; [Ho, Paul T. P.; Inoue, Makoto] Natl Taiwan Univ, Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Honma, Mareki] Natl Astron Observ, Mitaka, Tokyo 1818588, Japan; [Honma, Mareki] Grad Univ Adv Studies, Mitaka, Tokyo 1818588, Japan; [Krichbaum, Thomas P.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Lamb, James] CALTECH, Owens Valley Radio Observ, Big Pine, CA 93513 USA; [Tilanus, Remo P. J.] Netherlands Org Sci Res, NL-2509 AC The Hague, Netherlands	Massachusetts Institute of Technology (MIT); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Radio Astronomy Observatory (NRAO); University of Arizona; University of California System; University of California Berkeley; Perimeter Institute for Theoretical Physics; University of Waterloo; California Institute of Technology; Academia Sinica - Taiwan; National Taiwan University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Graduate University for Advanced Studies - Japan; Max Planck Society; California Institute of Technology	Doeleman, SS (corresponding author), MIT, Haystack Observ, Route 40, Westford, MA 01886 USA.	sdoeleman@haystack.mit.edu	Ho, Paul/AAZ-5108-2020; Bower, Geoffrey/ABC-8386-2020; Lamb, James/AAY-1701-2021	Ho, Paul/0000-0002-3412-4306; Bower, Geoffrey/0000-0003-4056-9982; Moran, James/0000-0002-3882-4414; Marrone, Daniel/0000-0002-2367-1080; Krichbaum, T. P./0000-0002-4892-9586; Rogers, Alan/0000-0003-1941-7458; SooHoo, Jason/0000-0003-1938-0720; Fish, Vincent/0000-0002-7128-9345; Gurwell, Mark/0000-0003-0685-3621	NSF; NSF University Radio Observatories (URO) [AST-1140030]; ATI [AST-0905844]; CARMA partner universities; Direct For Mathematical & Physical Scien [0905844, 1140031, 1211539, 0908731] Funding Source: National Science Foundation; Division Of Astronomical Sciences [0838258] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF University Radio Observatories (URO); ATI; CARMA partner universities; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	High-frequency VLBI work at the MIT Haystack Observatory is supported by grants from NSF. The Submillimeter Array is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics. The Submillimeter Telescope is operated by the Arizona Radio Observatory (ARO). ARO is partially supported through the NSF University Radio Observatories (URO: grant AST-1140030) and ATI (grant AST-0905844) programs. The James Clerk Maxwell Telescope is operated by the Joint Astronomy Centre on behalf of the Science and Technology Facilities Council of the UK, the Netherlands Organisation for Scientific Research, and the National Research Council of Canada. Funding for ongoing CARMA development and operations is supported by NSF and the CARMA partner universities. We thank the NASA Geodesy Program for loan of the CARMA Hydrogen Maser; J. Test, P. Yamaguchi, G. Reiland, J. Hoge, and M. Hodges for technical assistance; the staff at all participating facilities; J. Gracia and J. McKinney for providing jet simulation data used in this work; and Xilinx, Inc., for equipment donations. Data used in this paper are available in the supplementary materials.	Asada K, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/2/L28; BIRETTA JA, 1995, ASTROPHYS J, V447, P582, DOI 10.1086/175901; Biretta JA, 2002, NEW ASTRON REV, V46, P239, DOI 10.1016/S1387-6473(01)00188-9; Blakeslee JP, 2009, ASTROPHYS J, V694, P556, DOI 10.1088/0004-637X/694/1/556; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Broderick A, 2003, MON NOT R ASTRON SOC, V342, P1280, DOI 10.1046/j.1365-8711.2003.06618.x; Broderick AE, 2006, MON NOT R ASTRON SOC, V367, P905, DOI 10.1111/j.1365-2966.2006.10152.x; Broderick AE, 2009, ASTROPHYS J, V701, P1357, DOI 10.1088/0004-637X/701/2/1357; Broderick AE, 2009, ASTROPHYS J, V697, P1164, DOI 10.1088/0004-637X/697/2/1164; Clery D, 2012, SCIENCE, V335, P391, DOI 10.1126/science.335.6067.391; De Villiers JP, 2005, ASTROPHYS J, V620, P878, DOI 10.1086/427142; Dexter J, 2012, MON NOT R ASTRON SOC, V421, P1517, DOI 10.1111/j.1365-2966.2012.20409.x; Falcke H, 2000, ASTROPHYS J, V528, pL13, DOI 10.1086/312423; Fragile PC, 2009, ASTROPHYS J LETT, V706, pL246, DOI 10.1088/0004-637X/706/2/L246; Gammie CF, 2004, ASTROPHYS J, V602, P312, DOI 10.1086/380996; Garofalo D, 2010, MON NOT R ASTRON SOC, V406, P975, DOI 10.1111/j.1365-2966.2010.16797.x; Gebhardt K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/119; Gracia J, 2009, ASTROPHYS J, V695, P503, DOI 10.1088/0004-637X/695/1/503; Hada K, 2011, NATURE, V477, P185, DOI 10.1038/nature10387; Hardee PE, 2007, ASTROPHYS J, V664, P26, DOI 10.1086/518409; Johannsen T, 2010, ASTROPHYS J, V718, P446, DOI 10.1088/0004-637X/718/1/446; Junor W, 1999, NATURE, V401, P891, DOI 10.1038/44780; Kovalev YY, 2007, ASTROPHYS J, V668, pL27, DOI 10.1086/522603; Krichbaum TP, 2006, J PHYS CONF SER, V54, P328, DOI 10.1088/1742-6596/54/1/052; Ly C, 2007, ASTROPHYS J, V660, P200, DOI 10.1086/512846; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; Marshall HL, 2002, ASTROPHYS J, V564, P683, DOI 10.1086/324396; McKinney JC, 2006, MON NOT R ASTRON SOC, V368, P1561, DOI 10.1111/j.1365-2966.2006.10256.x; McKinney JC, 2009, MON NOT R ASTRON SOC, V394, pL126, DOI 10.1111/j.1745-3933.2009.00625.x; Meier DL, 2001, SCIENCE, V291, P84, DOI 10.1126/science.291.5501.84; Perlman ES, 2001, ASTROPHYS J, V551, P206, DOI 10.1086/320052; Richstone D, 1998, NATURE, V395, pA14; Tchekhovskoy A, 2012, MON NOT R ASTRON SOC, V423, pL55, DOI 10.1111/j.1745-3933.2012.01256.x	34	309	309	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					355	358		10.1126/science.1224768	http://dx.doi.org/10.1126/science.1224768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23019611	Green Accepted			2022-12-28	WOS:000309955800034
J	Erickson, GM; Krick, BA; Hamilton, M; Bourne, GR; Norell, MA; Lilleodden, E; Sawyer, WG				Erickson, Gregory M.; Krick, Brandon A.; Hamilton, Matthew; Bourne, Gerald R.; Norell, Mark A.; Lilleodden, Erica; Sawyer, W. Gregory			Complex Dental Structure and Wear Biomechanics in Hadrosaurid Dinosaurs	SCIENCE			English	Article							CONTACT; SURFACE	Mammalian grinding dentitions are composed of four major tissues that wear differentially, creating coarse surfaces for pulverizing tough plants and liberating nutrients. Although such dentition evolved repeatedly in mammals (such as horses, bison, and elephants), a similar innovation occurred much earlier (similar to 85 million years ago) within the duck-billed dinosaur group Hadrosauridae, fueling their 35-million-year occupation of Laurasian megaherbivorous niches. How this complexity was achieved is unknown, as reptilian teeth are generally two-tissue structures presumably lacking biomechanical attributes for grinding. Here we show that hadrosaurids broke from the primitive reptilian archetype and evolved a six-tissue dental composition that is among the most sophisticated known. Three-dimensional wear models incorporating fossilized wear properties reveal how these tissues interacted for grinding and ecological specialization.	[Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Krick, Brandon A.; Hamilton, Matthew; Sawyer, W. Gregory] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Bourne, Gerald R.] Colorado Sch Mines, Dept Met & Mat Engn, Golden, CO 80401 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Lilleodden, Erica] Helmholtz Zentrum Geesthacht, Inst Mat Res, Geesthacht, Germany	State University System of Florida; Florida State University; State University System of Florida; University of Florida; Colorado School of Mines; American Museum of Natural History (AMNH); Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Bourne, Gerald/B-7219-2008; Sawyer, W Gregory/A-7983-2008	Bourne, Gerald/0000-0001-6977-2138; Lilleodden, Erica/0000-0002-4014-0986; Sawyer, W Gregory/0000-0002-4461-7227; Krick, Brandon/0000-0003-3191-5433	NSF [EAR 0959029]; Directorate For Geosciences [1226730] Funding Source: National Science Foundation; Division Of Earth Sciences [1226704] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank W. Nix, A. Prieto-Marquez, P. Lee, P. Druckenmiller, C. Taylor, and E. McCumiskey for their assistance and NSF (grant EAR 0959029 to G.M.E. and M.A.N.) for research funding. Data described in the paper are archived by the Computer Support Group of the Department of Biological Science at Florida State University as databases S1 to S19.	ARCHARD JF, 1953, J APPL PHYS, V24, P981, DOI 10.1063/1.1721448; ARCHARD JF, 1956, PROC R SOC LON SER-A, V236, P397, DOI 10.1098/rspa.1956.0144; Butler RJ, 2010, P ROY SOC B-BIOL SCI, V277, P375, DOI 10.1098/rspb.2009.1494; Currey JD, 2003, ARCH ORAL BIOL, V48, P439, DOI 10.1016/S0003-9969(03)00037-2; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Evans DC, 2005, LIFE O PAST, P349; Hillson S., 1986, TEETH; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; Johnson WM, 2007, J MATER SCI-MATER M, V18, P591, DOI 10.1007/s10856-007-2306-4; KHRUSCHOV MM, 1974, WEAR, V28, P69, DOI 10.1016/0043-1648(74)90102-1; Leidy J., 1865, SMITHSONIAN CONTRIBU, V14, P1; Lucas P., 2004, DENT FUNCTIONAL MORP; Lull R.S., 1942, SPEC PAP GEOL SOC AM, V40; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; Ostrom JH., 1961, B AM MUS NAT HIST, V122, P1; Peyer B, 1968, COMP ODONTOLOGY; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Reisz Robert R., 2000, P9, DOI 10.1017/CBO9780511549717.003; Sawyer WG, 2004, TRIBOL LETT, V17, P139, DOI 10.1023/B:TRIL.0000032438.56992.be; Schmidt W.J., 1971, POLARIZING MICROSCOP; Schwenk K., 2000, FEEDING FUNCTION EVO; Tweet JS, 2008, PALAIOS, V23, P624, DOI 10.2110/palo.2007.p07-044r; WEISHAMPEL D B, 1983, Acta Palaeontologica Polonica, V28, P271; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106	24	85	85	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					98	101		10.1126/science.1224495	http://dx.doi.org/10.1126/science.1224495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042891	Green Submitted			2022-12-28	WOS:000309457400061
J	Koo, JW; Mazei-Robison, MS; Chaudhury, D; Juarez, B; LaPlant, Q; Ferguson, D; Feng, J; Sun, HS; Scobie, KN; Damez-Werno, D; Crumiller, M; Ohnishi, YN; Ohnishi, YH; Mouzon, E; Dietz, DM; Lobo, MK; Neve, RL; Russo, SJ; Han, MH; Nestler, EJ				Koo, Ja Wook; Mazei-Robison, Michelle S.; Chaudhury, Dipesh; Juarez, Barbara; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Ohnishi, Yoshinori N.; Ohnishi, Yoko H.; Mouzon, Ezekiell; Dietz, David M.; Lobo, Mary Kay; Neve, Rachael L.; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.			BDNF Is a Negative Modulator of Morphine Action	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; NEUROTROPHIC FACTOR; COCAINE REWARD; BEHAVIORAL-RESPONSES; GENE-EXPRESSION; DELTA-FOSB; NEURONS; BRAIN	Brain-derived neurotrophic factor (BDNF) is a key positive regulator of neural plasticity, promoting, for example, the actions of stimulant drugs of abuse such as cocaine. We discovered a surprising opposite role for BDNF in countering responses to chronic morphine exposure. The suppression of BDNF in the ventral tegmental area (VTA) enhanced the ability of morphine to increase dopamine (DA) neuron excitability and promote reward. In contrast, optical stimulation of VTA DA terminals in nucleus accumbens (NAc) completely reversed the suppressive effect of BDNF on morphine reward. Furthermore, we identified numerous genes in the NAc, a major target region of VTA DA neurons, whose regulation by BDNF in the context of chronic morphine exposure mediated this counteractive function. These findings provide insight into the molecular basis of morphine-induced neuroadaptations in the brain's reward circuitry.	[Koo, Ja Wook; Mazei-Robison, Michelle S.; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Mouzon, Ezekiell; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Koo, Ja Wook; Mazei-Robison, Michelle S.; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Mouzon, Ezekiell; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Chaudhury, Dipesh; Juarez, Barbara; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Ohnishi, Yoshinori N.] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 8300011, Japan; [Ohnishi, Yoko H.] Kyushu Univ, Dept Med Biophys & Radiat Biol, Higashi Ku, Fukuoka 8128582, Japan; [Dietz, David M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Lobo, Mary Kay] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Kurume University; Kyushu University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Maryland; University of Maryland Baltimore; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	Eric.Nestler@mssm.edu	Mazei-Robison, Michelle/I-4304-2017; Han, Ming-Hu/G-8836-2012; Lobo, Mary Kay/K-7734-2015; Dietz, David/J-9458-2015; Russo, Scott/R-7107-2019; Dietz, David/AAW-4574-2021	Mazei-Robison, Michelle/0000-0002-2372-1420; Lobo, Mary Kay/0000-0002-9419-2079; Dietz, David/0000-0002-6927-9236; Russo, Scott/0000-0002-6470-1805; Dietz, David/0000-0002-6927-9236; Ferguson, Deveroux/0000-0001-9302-5992; Juarez, Barbara/0000-0001-7897-8031; Sun, Haosheng/0000-0003-3919-559X	National Institute on Drug Abuse; Dutch Scientific Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092306, T32MH087004, K99MH094405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R01DA014133] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Dutch Scientific Organization(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. E. Burger-Caplan and N. Mensah for excellent technical assistance. This work was supported by grants from the National Institute on Drug Abuse (E.J.N. and M.S.M.-R.) and a Rubicon Grant from the Dutch Scientific Organization (C.S.L.).	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Badiani A, 2011, NAT REV NEUROSCI, V12, P685, DOI 10.1038/nrn3104; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Boye SM, 2001, NEUROPHARMACOLOGY, V40, P792, DOI 10.1016/S0028-3908(01)00003-X; Chu NN, 2008, ADDICT BIOL, V13, P47, DOI 10.1111/j.1369-1600.2007.00092.x; Desai NS, 1999, LEARN MEMORY, V6, P284; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Horger BA, 1999, J NEUROSCI, V19, P4110; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; KADDIS FG, 1995, BRAIN RES, V697, P76, DOI 10.1016/0006-8993(95)00786-P; Korostynski M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r128; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Krishnan V, 2008, BIOL PSYCHIAT, V64, P691, DOI 10.1016/j.biopsych.2008.06.003; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 1999, BIOL PSYCHIAT, V46, P1131, DOI 10.1016/S0006-3223(99)00158-4; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Numan S, 1998, J NEUROSCI, V18, P10700; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vargas-Perez H, 2009, SCIENCE, V324, P1732, DOI 10.1126/science.1168501; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267	40	129	139	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					124	128		10.1126/science.1222265	http://dx.doi.org/10.1126/science.1222265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042896	Green Accepted			2022-12-28	WOS:000309457400068
J	Sutton, MD; Briggs, DEG; Siveter, DJ; Siveter, DJ; Sigwart, JD				Sutton, Mark D.; Briggs, Derek E. G.; Siveter, David J.; Siveter, Derek J.; Sigwart, Julia D.			A Silurian armoured aplacophoran and implications for molluscan phylogeny	NATURE			English	Article							INVERTEBRATE EVOLUTION; VERMIFORM MOLLUSK; ACAENOPLAX; POLYCHAETE; FOSSILS; ORIGIN; CHITON	The Mollusca is one of the most diverse, important and well-studied invertebrate phyla; however, relationships among major molluscan taxa have long been a subject of controversy(1-9). In particular, the position of the shell-less vermiform Aplacophora and its relationship to the better-known Polyplacophora (chitons) have been problematic: Aplacophora has been treated as a paraphyletic or monophyletic group at the base of the Mollusca(3,6,8), proximate to other derived clades such as Cephalopoda(2,3,10), or as sister group to the Polyplacophora, forming the clade Aculifera(1,5,7,11,12). Resolution of this debate is required to allow the evolutionary origins of Mollusca to be reconstructed with confidence. Recent fossil finds(13-16) support the Aculifera hypothesis, demonstrating that the Palaeozoic-era palaeoloricate 'chitons' included taxa combining certain polyplacophoran and aplacophoran characteristics(5). However, fossils combining an unambiguously aplacophoran-like body with chiton-like valves have remained elusive. Here we describe such a fossil, Kulindroplax perissokomos gen. et sp. nov., from the Herefordshire Lagerstatte(17,18) (about 425 million years BP), a Silurian deposit preserving a marine biota(18) in unusual three-dimensional detail. The specimen is reconstructed three-dimensionally through physical-optical tomography(19). Phylogenetic analysis indicates that this and many other palaeoloricate chitons are crown-group aplacophorans.	[Sutton, Mark D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2BP, England; [Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Siveter, David J.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Siveter, Derek J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England; [Siveter, Derek J.] Univ Museum Nat Hist, Oxford OX1 3PW, England; [Sigwart, Julia D.] Queens Univ Belfast, Sch Biol Sci, Marine Lab, Portaferry BT22 1PF, North Ireland	Imperial College London; Yale University; Yale University; University of Leicester; University of Oxford; University of Oxford; Queens University Belfast	Sutton, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2BP, England.	m.sutton@imperial.ac.uk	Sigwart, Julia D/J-2928-2014	Sigwart, Julia D/0000-0002-3005-6246	Natural Environmental Research Council (NERC) [NE/F018037/1]; NERC [NE/F01693X/1, NE/F018037/1] Funding Source: UKRI; Natural Environment Research Council [NE/F01693X/1, NE/F018037/1] Funding Source: researchfish	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Natural Environmental Research Council (NERC Grant NE/F018037/1) supported this research. K. Saunders, K. Davies, C. Dean, D. Legg and C. Lewis provided technical assistance, and the staff of Tarmac Western and the late R. Fenn facilitated the fieldwork.	Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Briggs DEG, 2008, AM SCI, V96, P474, DOI 10.1511/2008.75.474; Cherns L, 1998, PALAEONTOLOGY, V41, P545; Donovan SK, 2010, GEOLOGY, V38, P935, DOI 10.1130/G31296.1; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; McAlester A. L., 1965, Palaeontology, V8, P231; Meyer A, 2011, METHODS ECOL EVOL, V2, P34, DOI 10.1111/j.2041-210X.2010.00052.x; Morris SC, 2007, SCIENCE, V315, P1255, DOI 10.1126/science.1137187; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Salvini-Plawen Luitfried v., 1996, P29; SCHELTEMA AH, 1993, BIOL BULL, V184, P57, DOI 10.2307/1542380; Scheltema AH, 2002, INVERTEBR BIOL, V121, P1; Sigwart JD, 2007, P R SOC B, V274, P2413, DOI 10.1098/rspb.2007.0701; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Steiner G, 2001, NATURE, V414, P601, DOI 10.1038/414601a; Sutton M, 2001, NATURE, V414, P602, DOI 10.1038/414602a; Sutton M. D., 2012, PALAEONTOLOGIA ELECT, V15, p5T; Sutton MD, 2008, P ROY SOC B-BIOL SCI, V275, P1587, DOI 10.1098/rspb.2008.0263; Sutton MD, 2012, PALAEONTOLOGY, V55, P401, DOI 10.1111/j.1475-4983.2011.01126.x; Sutton MD, 2004, PALAEONTOLOGY, V47, P293, DOI 10.1111/j.0031-0239.2004.00374.x; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; Telford MJ, 2011, CURR BIOL, V21, pR964, DOI 10.1016/j.cub.2011.10.029; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Vinther J, 2012, P ROY SOC B-BIOL SCI, V279, P1259, DOI 10.1098/rspb.2011.1773; von Salvini-Plawen Luitfried, 2003, Iberus, V21, P67; Wilson NG, 2010, MOL PHYLOGENET EVOL, V54, P187, DOI 10.1016/j.ympev.2009.07.028	29	53	54	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					94	97		10.1038/nature11328	http://dx.doi.org/10.1038/nature11328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038472				2022-12-28	WOS:000309446800039
J	Valet, JP; Fournier, A; Courtillot, V; Herrero-Bervera, E				Valet, Jean-Pierre; Fournier, Alexandre; Courtillot, Vincent; Herrero-Bervera, Emilio			Dynamical similarity of geomagnetic field reversals	NATURE			English	Article							EARTHS MAGNETIC-FIELD; NON-DIPOLE FIELD; LAVA FLOWS; POLARITY TRANSITIONS; SECULAR VARIATION; RECORDS; HAWAII; PALEOINTENSITY; EXCURSIONS; DIRECTIONS	No consensus has been reached so far on the properties of the geomagnetic field during reversals or on the main features that might reveal its dynamics. A main characteristic of the reversing field is a large decrease in the axial dipole and the dominant role of non-dipole components(1-3). Other features strongly depend on whether they are derived from sedimentary or volcanic records. Only thermal remanent magnetization of lava flows can capture faithful records of a rapidly varying non-dipole field, but, because of episodic volcanic activity, sequences of overlying flows yield incomplete records. Here we show that the ten most detailed volcanic records of reversals can be matched in a very satisfactory way, under the assumption of a common duration, revealing common dynamical characteristics. We infer that the reversal process has remained unchanged, with the same time constants and durations, at least since 180 million years ago. We propose that the reversing field is characterized by three successive phases: a precursory event, a 1806 polarity switch and a rebound. The first and third phases reflect the emergence of the non-dipole field with large-amplitude secular variation. They are rarely both recorded at the same site owing to the rapidly changing field geometry and last for less than 2,500 years. The actual transit between the two polarities does not last longer than 1,000 years and might therefore result from mechanisms other than those governing normal secular variation. Such changes are too brief to be accurately recorded by most sediments.	[Valet, Jean-Pierre; Fournier, Alexandre; Courtillot, Vincent] Univ Paris Diderot, CNRS, UMR 7154, Inst Phys Globe Paris, F-75238 Paris 05, France; [Herrero-Bervera, Emilio] Univ Hawaii Manoa, SOEST Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; University of Hawaii System; University of Hawaii Manoa	Valet, JP (corresponding author), Univ Paris Diderot, CNRS, UMR 7154, Inst Phys Globe Paris, 1 Rue Jussieu, F-75238 Paris 05, France.	valet@ipgp.fr	Fournier, Alexandre/A-5774-2011; Valet, Jean-Pierre/A-6332-2011	Fournier, Alexandre/0000-0003-3276-0496; 	Directorate For Geosciences [1114065] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Amit H, 2010, SPACE SCI REV, V155, P293, DOI 10.1007/s11214-010-9695-2; Aubert J, 2009, GEOPHYS J INT, V179, P1414, DOI 10.1111/j.1365-246X.2009.04361.x; BLOXHAM J, 1992, J GEOPHYS RES-SOL EA, V97, P19537, DOI 10.1029/92JB01591; Brown MC, 2007, GEOPHYS J INT, V168, P541, DOI 10.1111/j.1365-246X.2006.03234.x; Channell JET, 2004, GEOPHYS J INT, V158, P489, DOI 10.1111/j.1365-246X.2004.02329.x; CHAUVIN A, 1990, J GEOPHYS RES-SOLID, V95, P2727, DOI 10.1029/JB095iB03p02727; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Clement BM, 2004, NATURE, V428, P637, DOI 10.1038/nature02459; Coe RS, 2004, EARTH PLANET SC LETT, V222, P667, DOI 10.1016/j.epsl.2004.03.003; DAGLEY P, 1974, GEOPHYS J ROY ASTR S, V36, P577, DOI 10.1111/j.1365-246X.1974.tb00614.x; Hagstrum JT, 1995, J GEOPHYS RES-SOL EA, V100, P24393, DOI 10.1029/95JB02913; Hartl P, 1996, EARTH PLANET SC LETT, V138, P121, DOI 10.1016/0012-821X(95)00231-Z; Herrero-Bervera E, 2005, EARTH PLANET SC LETT, V234, P279, DOI 10.1016/j.epsl.2005.02.032; Herrero-Bervera E, 1999, PHYS EARTH PLANET IN, V115, P119, DOI 10.1016/S0031-9201(99)00074-6; Herrero-Bervera E, 1999, EARTH PLANET SC LETT, V171, P139, DOI 10.1016/S0012-821X(99)00145-4; Heunemann C, 2004, EARTH PLANET SC LETT, V218, P197, DOI 10.1016/S0012-821X(03)00642-3; Hoffman KA, 2008, SCIENCE, V321, P1800, DOI 10.1126/science.1159777; HULOT G, 1994, PHYS EARTH PLANET IN, V82, P167, DOI 10.1016/0031-9201(94)90070-1; Jackson A., 2007, TREAT GEOPHYS, V5, P147, DOI 10.1016/B978-044452748-6.00090-0; Jacobs JA, 1994, REVERSALS EARTHS MAG; Jarboe NA, 2011, GEOPHYS J INT, V186, P580, DOI 10.1111/j.1365-246X.2011.05086.x; KENT DV, 1995, EARTH PLANET SC LETT, V129, P135, DOI 10.1016/0012-821X(94)00236-R; Korte M, 2011, EARTH PLANET SC LETT, V312, P497, DOI 10.1016/j.epsl.2011.10.031; LANGEREIS CG, 1992, NATURE, V358, P226, DOI 10.1038/358226a0; Leonhardt R, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000322; Lhuillier F, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047356; Mochizuki N, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008093; Moulin M, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003910; Narteau C, 2007, EARTH PLANET SC LETT, V262, P66, DOI 10.1016/j.epsl.2007.07.007; Nimmo F., 2015, TREATISE GEOPHYS, P27, DOI DOI 10.1016/B978-044452748-6.00128-0; Olson PL, 2011, EARTH PLANET SC LETT, V304, P168, DOI 10.1016/j.epsl.2011.01.031; Petrelis F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.144503; PREVOT M, 1985, J GEOPHYS RES-SOLID, V90, P417, DOI 10.1029/JB090iB12p10417; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; Riisager J, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002124; ROBERTS PH, 1965, J GEOMAGN GEOELECTR, V17, P137, DOI 10.5636/jgg.17.137; Singer BS, 2005, NATURE, V434, P633, DOI 10.1038/nature03431; Valet JP, 2008, PHYS EARTH PLANET IN, V169, P178, DOI 10.1016/j.pepi.2008.07.031	38	78	82	5	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					89	+		10.1038/nature11491	http://dx.doi.org/10.1038/nature11491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038471				2022-12-28	WOS:000309446800038
J	Baker, CR; Booth, LN; Sorrells, TR; Johnson, AD				Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.			Protein Modularity, Cooperative Binding, and Hybrid Regulatory States Underlie Transcriptional Network Diversification	CELL			English	Article							HOMEO DOMAIN PROTEIN; CELL-TYPE; SACCHAROMYCES-CEREVISIAE; REPRESSOR ALPHA-2; YEAST ALPHA-2; EVOLUTION; HOMEODOMAIN; CIRCUIT; LOCUS; GENE	We examine how different transcriptional network structures can evolve from an ancestral network. By characterizing how the ancestral mode of gene regulation for genes specific to a-type cells in yeast species evolved from an activating paradigm to a repressing one, we show that regulatory protein modularity, conversion of one cis-regulatory sequence to another, distribution of binding energy among protein-protein and protein-DNA interactions, and exploitation of ancestral network features all contribute to the evolution of a novel regulatory mode. The formation of this derived mode of regulation did not disrupt the ancestral mode and thereby created a hybrid regulatory state where both means of transcription regulation (ancestral and derived) contribute to the conserved expression pattern of the network. Finally, we show how this hybrid regulatory state has resolved in different ways in different lineages to generate the diversity of regulatory network structures observed in modern species.	[Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94102 USA; [Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94102 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94102 USA.	ajohnson@cgl.ucsf.edu		Sorrells, Trevor/0000-0002-3527-8622	National Institute of Health [RO1 GM057049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM057049] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Chiraj Dalal, Clarissa Nobile, and Brian Tuch for critically reading the manuscript and Jennifer Garcia, Victor Hanson-Smith, Oliver Homann, Quinn Mitrovich, and Brian Tuch for their generous and helpful advice concerning experimental and computational procedures. We thank Peter Philippsen for kindly sharing genomic DNA and sequences from Ashbya gossypii. This work was supported by RO1 GM057049 from the National Institute of Health. The authors declare no conflict of interest. C.R.B. performed reporter assays and the Mcm1 ancestral gene reconstruction. L.N.B. performed experiments in L. kluyveri and K. wickerhamii. L.N.B. and T.R.S. performed K. lactis experiments. Data were analyzed and computation experiments performed by C.R.B., L.N.B., and T.R.S. All authors contributed to the design of the study and wrote the article.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Booth LN, 2010, NATURE, V468, P959, DOI 10.1038/nature09560; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; MADHANI HD, 2007, A ALPHA YEAST MODEL; MAK A, 1993, GENE DEV, V7, P1862, DOI 10.1101/gad.7.10.1862; Mead J, 1996, MOL CELL BIOL, V16, P2135; SMITH DL, 1994, EMBO J, V13, P2378, DOI 10.1002/j.1460-2075.1994.tb06521.x; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T; Wohlbach DJ, 2009, CURR OPIN GENET DEV, V19, P571, DOI 10.1016/j.gde.2009.09.007; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	38	70	70	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					80	95		10.1016/j.cell.2012.08.018	http://dx.doi.org/10.1016/j.cell.2012.08.018			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021217	Green Accepted, Bronze			2022-12-28	WOS:000309544200012
J	Deeks, SG; Gandhi, RT; Chae, CU; Lewandrowski, KB				Deeks, Steven G.; Gandhi, Rajesh T.; Chae, Claudia U.; Lewandrowski, Kent B.			Case 30-2012: A 54-Year-Old Woman with HIV Infection, Dyspnea, and Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	5th Annual Workshop on Advanced Clinical Care AIDS	OCT 06-07, 2011	Durban, SOUTH AFRICA	Harvard Univ Ctr AIDS Res, McCord Hosp Durban, Univ KwaZulu Natal, So African HIV Clin Soc, KwaZulu Natal Dept Hlth			INDIVIDUAL ANTIRETROVIRAL DRUGS; MYOCARDIAL-INFARCTION RATES; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; RISK-FACTORS; ABACAVIR; INFLAMMATION; ASSOCIATION; THERAPY		[Deeks, Steven G.] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [Gandhi, Rajesh T.; Chae, Claudia U.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lewandrowski, Kent B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gandhi, Rajesh T.] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Gandhi, Rajesh T.; Chae, Claudia U.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lewandrowski, Kent B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	San Francisco General Hospital Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Deeks, SG (corresponding author), San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA.							Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Baum PD, 2011, AIDS, V25, P2243, DOI 10.1097/QAD.0b013e32834d3cc3; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Dube MP, 2011, BEST PRACT RES CL EN, V25, P429, DOI 10.1016/j.beem.2011.04.004; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Lo J, 2011, CURR OPIN ENDOCRINOL, V18, P144, DOI 10.1097/MED.0b013e328344556e; Mallolas J, 2009, JAIDS-J ACQ IMM DEF, V51, P29, DOI 10.1097/QAI.0b013e31819a226f; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McComsey GA, 2012, AIDS, V26, P1371, DOI 10.1097/QAD.0b013e328354f4fb; Mohammed AA, 2010, CARDIOL REV, V18, P12, DOI 10.1097/CRD.0b013e3181c42f96; Moore RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021843; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Phillips AN, 2008, ANTIVIR THER, V13, P177; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Saenger AK, 2008, CIRCULATION, V118, P2200, DOI 10.1161/CIRCULATIONAHA.108.773218; Soriano V, 2008, J ANTIMICROB CHEMOTH, V61, P200, DOI 10.1093/jac/dkm413; Stanley TL, 2012, J INFECT DIS, V205, pS383, DOI 10.1093/infdis/jis205; Stanley TL, 2009, AIDS, V23, P1349, DOI 10.1097/QAD.0b013e32832ba904; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2010, JAIDS-J ACQ IMM DEF, V55, P615, DOI 10.1097/QAI.0b013e3181f4b752; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	41	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1246	1254		10.1056/NEJMcpc1200090	http://dx.doi.org/10.1056/NEJMcpc1200090			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	011JO	23013077				2022-12-28	WOS:000309161100013
J	Babu, MM; Kriwacki, RW; Pappu, RV				Babu, M. Madan; Kriwacki, Richard W.; Pappu, Rohit V.			Versatility from Protein Disorder	SCIENCE			English	Editorial Material							INTRINSICALLY UNSTRUCTURED PROTEINS; RECOGNITION; CHARGE; MOTIFS		[Babu, M. Madan] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA; [Pappu, Rohit V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	MRC Laboratory Molecular Biology; St Jude Children's Research Hospital; Washington University (WUSTL)	Babu, MM (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	madanm@mrc-lmb.cam.ac.uk; richard.kriwacki@stjude.org; pappu@wustl.edu	Mohan, Babu P./I-7362-2019; Kriwacki, Richard/N-8154-2018	Kriwacki, Richard/0000-0002-9798-6018	MRC [MC_U105185859] Funding Source: UKRI; Div Of Molecular and Cellular Bioscience [1121867] Funding Source: National Science Foundation; Medical Research Council [MC_U105185859] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Mitrea D. M., 2012, PAC S BIOCOMPUT, V17, P152; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Pajkos M, 2012, MOL BIOSYST, V8, P296, DOI 10.1039/c1mb05246b; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747	16	158	159	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1460	1461		10.1126/science.1228775	http://dx.doi.org/10.1126/science.1228775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997313				2022-12-28	WOS:000308912900027
J	Sedrakyan, A				Sedrakyan, Art			Hip resurfacing: a complex challenge for device regulation	LANCET			English	Editorial Material							NATIONAL JOINT REGISTRY; METAL; IMPLANTS; ENGLAND; WALES; RATES		[Sedrakyan, Art] Weill Cornell Med Coll, Patient Centered Comparat Effectiveness Program, New York, NY 10065 USA; [Sedrakyan, Art] Weill Cornell Med Coll, Med Device Epidemiol Sci & Infrastruct Ctr, New York, NY 10065 USA	Cornell University; Cornell University	Sedrakyan, A (corresponding author), Weill Cornell Med Coll, Patient Centered Comparat Effectiveness Program, New York, NY 10065 USA.	ars2013@med.cornell.edu						Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Food and Drug Administration, PREM APPR PMA; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Makela T, 2012, BRIT MED J, V345, pe4646; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; McMinn DJW, 2011, INT ORTHOP, V35, P231, DOI 10.1007/s00264-010-1148-8; Meier B, 2012, NY TIMES; MHRA, 2012, MDA2012036 MHRA; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; Smith AJ, 2012, LANCET; Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Tower SS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e430	15	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 17	2012	380	9855					1720	1722		10.1016/S0140-6736(12)61270-7	http://dx.doi.org/10.1016/S0140-6736(12)61270-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038CV	23036898				2022-12-28	WOS:000311153700008
J	Rauch, A; Wieczorek, D; Graf, E; Wieland, T; Endele, S; Schwarzmayr, T; Albrecht, B; Bartholdi, D; Beygo, J; Di Donato, N; Dufke, A; Cremer, K; Hempel, M; Horn, D; Hoyer, J; Joset, P; Ropke, A; Moog, U; Riess, A; Thiel, CT; Tzschach, A; Wiesener, A; Wohlleber, E; Zweier, C; Ekici, AB; Zink, AM; Rump, A; Meisinger, C; Grallert, H; Sticht, H; Schenck, A; Engels, H; Rappold, G; Schrock, E; Wieacker, P; Riess, O; Meitinger, T; Reis, A; Strom, TM				Rauch, Anita; Wieczorek, Dagmar; Graf, Elisabeth; Wieland, Thomas; Endele, Sabine; Schwarzmayr, Thomas; Albrecht, Beate; Bartholdi, Deborah; Beygo, Jasmin; Di Donato, Nataliya; Dufke, Andreas; Cremer, Kirsten; Hempel, Maja; Horn, Denise; Hoyer, Juliane; Joset, Pascal; Ropke, Albrecht; Moog, Ute; Riess, Angelika; Thiel, Christian T.; Tzschach, Andreas; Wiesener, Antje; Wohlleber, Eva; Zweier, Christiane; Ekici, Arif B.; Zink, Alexander M.; Rump, Andreas; Meisinger, Christa; Grallert, Harald; Sticht, Heinrich; Schenck, Annette; Engels, Hartmut; Rappold, Gudrun; Schrock, Evelin; Wieacker, Peter; Riess, Olaf; Meitinger, Thomas; Reis, Andre; Strom, Tim M.			Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study	LANCET			English	Article							DE-NOVO MUTATIONS; MENTAL-RETARDATION; NONSENSE MUTATION; DELINEATION; RECEPTOR; PATIENT; REGION; RATES	Background The genetic cause of intellectual disability in most patients is unclear because of the absence of morphological clues, information about the position of such genes, and suitable screening methods. Our aim was to identify de-novo variants in individuals with sporadic non-syndromic intellectual disability. Methods In this study, we enrolled children with intellectual disability and their parents from ten centres in Germany and Switzerland. We compared exome sequences between patients and their parents to identify de-novo variants. 20 children and their parents from the KORA Augsburg Diabetes Family Study were investigated as controls. Findings We enrolled 51 participants from the German Mental Retardation Network. 45 (88%) participants in the case group and 14 (70%) in the control group had de-novo variants. We identified 87 de-novo variants in the case group, with an exomic mutation rate of 1.71 per individual per generation. In the control group we identifi ed 24 de-novo variants, which is 1.2 events per individual per generation. More participants in the case group had loss-of-function variants than in the control group (20/51 vs 2/20; p=0.022), suggesting their contribution to disease development. 16 patients carried de-novo variants in known intellectual disability genes with three recurrently mutated genes (STXBP1, SYNGAP1, and SCN2A). We deemed at least six loss-of-function mutations in six novel genes to be disease causing. We also identifi ed several missense alterations with potential pathogenicity. Interpretation After exclusion of copy-number variants, de-novo point mutations and small indels are associated with severe, sporadic non-syndromic intellectual disability, accounting for 45-55% of patients with high locus heterogeneity. Autosomal recessive inheritance seems to contribute little in the outbred population investigated. The large number of de-novo variants in known intellectual disability genes is only partially attributable to known non-specific phenotypes. Several patients did not meet the expected syndromic manifestation, suggesting a strong bias in present clinical syndrome descriptions.	[Rauch, Anita; Joset, Pascal] Univ Zurich, Inst Med Genet, Zurich, Switzerland; [Rauch, Anita] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Rauch, Anita] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Rauch, Anita; Endele, Sabine; Hoyer, Juliane; Thiel, Christian T.; Wiesener, Antje; Zweier, Christiane; Ekici, Arif B.; Riess, Olaf] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Wieczorek, Dagmar; Albrecht, Beate; Beygo, Jasmin; Cremer, Kirsten] Univ Klinikum Essen, Inst Human Genet, Essen, Germany; [Graf, Elisabeth; Wieland, Thomas; Schwarzmayr, Thomas; Meitinger, Thomas; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Di Donato, Nataliya; Rump, Andreas; Schrock, Evelin] Tech Univ Dresden, Inst Clin Genet, D-01062 Dresden, Germany; [Dufke, Andreas; Riess, Angelika; Tzschach, Andreas; Riess, Olaf] Univ Tubingen, Inst Human Genet, Tubingen, Germany; [Hempel, Maja; Meitinger, Thomas; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Horn, Denise] Univ Med Berlin, Charite, Inst Med Genet, Berlin, Germany; [Ropke, Albrecht; Wieacker, Peter] Univ Munster, Inst Human Genet, D-4400 Munster, Germany; [Moog, Ute; Rappold, Gudrun] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Wohlleber, Eva; Zink, Alexander M.; Engels, Hartmut] Univ Bonn, Inst Human Genet, Bonn, Germany; [Meisinger, Christa] Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Grallert, Harald] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci,Donders Inst Brain Cogn, NL-6525 ED Nijmegen, Netherlands	University of Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Erlangen Nuremberg; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Eberhard Karls University of Tubingen; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Ruprecht Karls University Heidelberg; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Radboud University Nijmegen	Strom, TM (corresponding author), Helmholtz Zentrum Munchen, Inst Human Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	timstrom@helmholtz-muenchen.de	Meitinger, Thomas/O-1318-2015; Tzschach, Andreas/I-2648-2019; Ekici, Arif B/C-3971-2013; Di Donato, Nataliya/G-2357-2019; Zink, Alexander/B-2305-2013; Schenck, Annette/E-4514-2012; Rauch, Anita/C-5568-2014; Reis, André/D-2309-2009; Grallert, Harald/B-3424-2013; Zweier, Christiane/F-2202-2015; Meisinger, Christine/B-5358-2014; Wieczorek, Dagmar/AAU-6008-2021; Thiel, Christian T/H-8964-2012	Tzschach, Andreas/0000-0002-6840-965X; Ekici, Arif B/0000-0001-6099-7066; Di Donato, Nataliya/0000-0001-9439-4677; Schenck, Annette/0000-0002-6918-3314; Rauch, Anita/0000-0003-2930-3163; Reis, André/0000-0002-6301-6363; Zweier, Christiane/0000-0001-8002-2020; Wieczorek, Dagmar/0000-0003-2812-6492; Thiel, Christian T/0000-0003-3817-7277; Meitinger, Thomas/0000-0002-8838-8403; Sticht, Heinrich/0000-0001-5644-045X; Meisinger, Christa/0000-0002-9026-6544; Rump, Andreas/0000-0001-7116-6364	German Ministry of Education and Research [01GS08160, 01GR0802, 01GM0867]; European Commission 7th Framework Program [261123]; Swiss National Science Foundation [320030_135669]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission 7th Framework Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank all patients and their families for participating in this study. This work was supported by the German Ministry of Education and Research (01GS08160, 01GR0802, and 01GM0867), the European Commission 7th Framework Program (261123, GEUVADIS), and the Swiss National Science Foundation (320030_135669).	American Psychiatric Association, 2000, DESK REF DIAGN CRIT; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Ballif BC, 2012, HUM GENET, V131, P145, DOI 10.1007/s00439-011-1073-y; Braun KV, 2005, PAEDIATR PERINAT EP, V19, P69, DOI 10.1111/j.1365-3016.2004.00597.x; Buschdorf JP, 2004, J MOL MED, V82, P135, DOI 10.1007/s00109-003-0497-9; Buysse K, 2008, AM J MED GENET A, V146A, P1330, DOI 10.1002/ajmg.a.32267; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Dorflinger U, 1999, MOL CELL BIOL, V19, P3736; Duning K, 2008, J NEUROCHEM, V105, P351, DOI 10.1111/j.1471-4159.2007.05138.x; Gradilla AC, 2011, GENETICS, V189, P871, DOI 10.1534/genetics.111.132191; Hamdan FF, 2009, ANN NEUROL, V65, P748, DOI 10.1002/ana.21625; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Subramanian S, 2003, GENOME RES, V13, P838, DOI 10.1101/gr.1152803; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Zweier C, 2008, J MED GENET, V45, P738, DOI 10.1136/jmg.2008.060129	40	731	752	1	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1674	1682		10.1016/S0140-6736(12)61480-9	http://dx.doi.org/10.1016/S0140-6736(12)61480-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23020937				2022-12-28	WOS:000310951400029
J	Bedell, VM; Wang, Y; Campbell, JM; Poshusta, TL; Starker, CG; Krug, RG; Tan, WF; Penheiter, SG; Ma, AC; Leung, AYH; Fahrenkrug, SC; Carlson, DF; Voytas, DF; Clark, KJ; Essner, JJ; Ekker, SC				Bedell, Victoria M.; Wang, Ying; Campbell, Jarryd M.; Poshusta, Tanya L.; Starker, Colby G.; Krug, Randall G., II; Tan, Wenfang; Penheiter, Sumedha G.; Ma, Alvin C.; Leung, Anskar Y. H.; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.; Clark, Karl J.; Essner, Jeffrey J.; Ekker, Stephen C.			In vivo genome editing using a high-efficiency TALEN system	NATURE			English	Article							ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; DNA-BINDING SPECIFICITY; ZEBRAFISH; EFFECTORS; CELLS	The zebrafish (Danio rerio) is increasingly being used to study basic vertebrate biology and human disease with a rich array of in vivo genetic and molecular tools. However, the inability to readily modify the genome in a targeted fashion has been a bottleneck in the field. Here we show that improvements in artificial transcription activator-like effector nucleases (TALENs) provide a powerful new approach for targeted zebrafish genome editing and functional genomic applications(1-5). Using the GoldyTALEN modified scaffold and zebrafish delivery system, we show that this enhanced TALEN toolkit has a high efficiency in inducing locus-specific DNA breaks in somatic and germline tissues. At some loci, this efficacy approaches 100%, including biallelic conversion in somatic tissues that mimics phenotypes seen using morpholino-based targeted gene knockdowns(6). With this updated TALEN system, we successfully used single-stranded DNA oligonucleotides to precisely modify sequences at predefined locations in the zebrafish genome through homology-directed repair, including the introduction of a custom-designed EcoRV site and a modified loxP (mloxP) sequence into somatic tissue in vivo. We further show successful germline transmission of both EcoRV and mloxP engineered chromosomes. This combined approach offers the potential to model genetic variation as well as to generate targeted conditional alleles.	[Bedell, Victoria M.; Campbell, Jarryd M.; Poshusta, Tanya L.; Krug, Randall G., II; Penheiter, Sumedha G.; Ma, Alvin C.; Clark, Karl J.; Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wang, Ying; Essner, Jeffrey J.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Starker, Colby G.; Tan, Wenfang; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Starker, Colby G.; Tan, Wenfang; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.] Univ Minnesota, Dept Anim Sci, Minneapolis, MN 55455 USA; [Ma, Alvin C.; Leung, Anskar Y. H.] Univ Hong Kong, LKS Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Fahrenkrug, Scott C.; Carlson, Daniel F.] Recombinetics Inc, St Paul, MN 55114 USA	Mayo Clinic; Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong	Ekker, SC (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	ekker.stephen@mayo.edu	Leung, Andrew Yee Tak/X-4743-2019; Ma, Alvin/AAM-5951-2021	Ekker, Stephen/0000-0003-0726-4212; /0000-0002-4800-2844; Bedell, Victoria/0000-0002-8959-6431; Essner, Jeffrey/0000-0001-8816-3848; Fahrenkrug, Scott/0000-0002-7176-6551; Voytas, Daniel/0000-0002-4944-1224; Clark, Karl/0000-0002-9637-0967; Starker, Colby/0000-0002-6774-7227	State of Minnesota [H001274506]; NIH [GM63904, P30DK084567, DK083219, DA032194, R41HL108440, GM088424]; Mayo Foundation; NSF [DBI0923827]; Research Grant Council, The University of Hong Kong [HKU771611, HKU771110, HKU769809M]; Tang King Yin Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL108440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK083219, P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088424, R56GM063904, R01GM063904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032194] Funding Source: NIH RePORTER	State of Minnesota(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NSF(National Science Foundation (NSF)); Research Grant Council, The University of Hong Kong; Tang King Yin Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	State of Minnesota grant H001274506 to S. C. E. and D. F. V.; NIH GM63904 to S. C. E.; NIH grant P30DK084567 to S. C. E. and K.J.C.; NIH grant DK083219 to V. M. B.; Mayo Foundation; NIH DA032194 to K.J.C.; NIH grant R41HL108440 to D. F. C. and S. C. F.; NIH grant GM088424 to J.J.E.; NSF grant DBI0923827 to D. F. V.; General Research Fund (HKU771611, HKU771110, HKU769809M) from the Research Grant Council, The University of Hong Kong and the Tang King Yin Research Fund to A. C. M. and A.Y.H.L. We thank G. Davis for discussion on ssDNA use with custom restriction enzymes, H. J. Fadel for in vitro RNA synthesis, and S. Westcot for comments on this manuscript. We thank G. Moulder for help in DNA analyses and members of the Mayo Clinic Zebrafish Core Facility for excellent animal care.	Bedell VM, 2012, DEVELOPMENT, V139, P793, DOI 10.1242/dev.071720; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Thomson JG, 2003, GENESIS, V36, P162, DOI 10.1002/gene.10211; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785	27	695	823	13	476	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					114	U133		10.1038/nature11537	http://dx.doi.org/10.1038/nature11537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23000899	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000310434500041
J	Kivimaki, M; Nyberg, ST; Batty, GD; Fransson, EI; Heikkila, K; Alfredsson, L; Bjorner, JB; Borritz, M; Burr, H; Casini, A; Clays, E; De Bacquer, D; Dragano, N; Ferrie, JE; Geuskens, GA; Goldberg, M; Hamer, M; Hooftman, WE; Houtman, IL; Joensuu, M; Jokela, M; Kittel, F; Knutsson, A; Koskenvuo, M; Koskinen, A; Kouvonen, A; Kumari, M; Madsen, IEH; Marmot, MG; Nielsen, ML; Nordin, M; Oksanen, T; Pentti, J; Rugulies, R; Salo, P; Siegrist, J; Singh-Manoux, A; Suominen, SB; Vaananen, A; Vahtera, J; Virtanen, M; Westerholm, PJM; Westerlund, H; Zins, M; Steptoe, A; Theorell, T				Kivimaeki, Mika; Nyberg, Solja T.; Batty, G. David; Fransson, Eleonor I.; Heikkila, Katriina; Alfredsson, Lars; Bjorner, Jakob B.; Borritz, Marianne; Burr, Hermann; Casini, Annalisa; Clays, Els; De Bacquer, Dirk; Dragano, Nico; Ferrie, Jane E.; Geuskens, Goedele A.; Goldberg, Marcel; Hamer, Mark; Hooftman, Wendela E.; Houtman, Irene L.; Joensuu, Matti; Jokela, Markus; Kittel, France; Knutsson, Anders; Koskenvuo, Markku; Koskinen, Aki; Kouvonen, Anne; Kumari, Meena; Madsen, Ida E. H.; Marmot, Michael G.; Nielsen, Martin L.; Nordin, Maria; Oksanen, Tuula; Pentti, Jaana; Rugulies, Reiner; Salo, Paula; Siegrist, Johannes; Singh-Manoux, Archana; Suominen, Sakari B.; Vaananen, Ari; Vahtera, Jussi; Virtanen, Marianna; Westerholm, Peter J. M.; Westerlund, Hugo; Zins, Marie; Steptoe, Andrew; Theorell, Tores		IPD-Work Consortium	Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; PROSPECTIVE COHORT; WORK STRESS; FOLLOW-UP; CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL RISK; SOCIAL SUPPORT; WHITEHALL-II; 52 COUNTRIES; BASE-LINE	Background Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias. We analysed the relation between job strain and coronary heart disease with a meta-analysis of published and unpublished studies. Methods We used individual records from 13 European cohort studies (1985-2006) of men and women without coronary heart disease who were employed at time of baseline assessment. We measured job strain with questions from validated job-content and demand-control questionnaires. We extracted data in two stages such that acquisition and harmonisation of job strain measure and covariables occurred before linkage to records for coronary heart disease. We defined incident coronary heart disease as the first non-fatal myocardial infarction or coronary death. Findings 30 214 (15%) of 197 473 participants reported job strain. In 1.49 million person-years at risk (mean follow-up 7.5 years [SD 1.7]), we recorded 2358 events of incident coronary heart disease. After adjustment for sex and age, the hazard ratio for job strain versus no job strain was 1.23 (95% CI 1.10-1.37). This effect estimate was higher in published (1.43, 1.15-1.77) than unpublished (1.16, 1.02-1.32) studies. Hazard ratios were likewise raised in analyses addressing reverse causality by exclusion of events of coronary heart disease that occurred in the first 3 years (1.31, 1.15-1.48) and 5 years (1.30, 1.13-1.50) of follow-up. We noted an association between job strain and coronary heart disease for sex, age groups, socioeconomic strata, and region, and after adjustments for socioeconomic status, and lifestyle and conventional risk factors. The population attributable risk for job strain was 3.4%. Interpretation Our findings suggest that prevention of workplace stress might decrease disease incidence; however, this strategy would have a much smaller effect than would tackling of standard risk factors, such as smoking.	[Kivimaeki, Mika; Batty, G. David; Ferrie, Jane E.; Hamer, Mark; Kumari, Meena; Marmot, Michael G.; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Kivimaeki, Mika; Jokela, Markus] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Kivimaeki, Mika; Nyberg, Solja T.; Heikkila, Katriina; Joensuu, Matti; Koskinen, Aki; Vaananen, Ari; Virtanen, Marianna] Finnish Inst Occupat Hlth, Helsinki, Finland; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Fransson, Eleonor I.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Fransson, Eleonor I.; Westerlund, Hugo; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Bjorner, Jakob B.; Madsen, Ida E. H.; Rugulies, Reiner] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Borritz, Marianne; Nielsen, Martin L.] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Burr, Hermann] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany; [Casini, Annalisa; Kittel, France] Univ Libre Brussels, Sch Publ Hlth, Brussels, Belgium; [Clays, Els; De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Dragano, Nico; Siegrist, Johannes] Univ Dusseldorf, Dept Med Sociol, D-40225 Dusseldorf, Germany; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England; [Geuskens, Goedele A.; Hooftman, Wendela E.; Houtman, Irene L.] TNO, Hoofddorp, Netherlands; [Goldberg, Marcel; Zins, Marie] Versailles St Quentin Univ, Versailles, France; [Goldberg, Marcel; Singh-Manoux, Archana; Zins, Marie] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Koskenvuo, Markku] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kouvonen, Anne] Queens Univ Belfast, Sch Sociol Social Policy & Social Work, Belfast, Antrim, North Ireland; [Nordin, Maria] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Oksanen, Tuula; Pentti, Jaana; Salo, Paula; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Salo, Paula] Univ Turku, Dept Psychol, Turku, Finland; [Suominen, Sakari B.; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Suominen, Sakari B.] Folkhalsan Res Ctr, Helsinki, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; [Westerholm, Peter J. M.] Uppsala Univ, Uppsala, Sweden	University of London; University College London; University of Helsinki; Finnish Institute of Occupational Health; University of Edinburgh; Karolinska Institutet; Jonkoping University; Stockholm University; National Research Centre for the Working Environment; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Universite Libre de Bruxelles; Ghent University; Heinrich Heine University Dusseldorf; University of Bristol; Netherlands Organization Applied Science Research; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Mid-Sweden University; University of Helsinki; Queens University Belfast; Umea University; Finnish Institute of Occupational Health; University of Copenhagen; University of Copenhagen; University of Turku; University of Turku; Folkhalsan Research Center; University of Turku; Uppsala University	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Ferrie, Jane/AAZ-2009-2020; Steptoe, Andrew/Y-2440-2019; Casini, Annalisa/ABG-2250-2020; Zins, Marie/AAX-6551-2021; Singh-Manoux, Archana/F-6804-2013; Salo, Paula/D-6649-2013; Goldberg, Marcel/I-7834-2012; Siegrist, Johannes/AAL-6814-2021; Hamer, Mark/C-1602-2008; Batty, GD/Y-4401-2018; Hamer, Mark/AAJ-6814-2021; Rugulies, Reiner/E-8140-2010; Nielsen, Martin Lindhardt/E-3071-2012; Westerlund, Hugo/A-3049-2012; De Bacquer, Dirk/HGU-3191-2022; Fransson, Eleonor I/J-7792-2013; Vahtera, Jussi/J-3271-2013; Oksanen, Tuula/AAK-5599-2021; Jokela, Markus/A-4669-2009; Kivimaki, Mika/B-3607-2012; Marmot, M G/Y-3920-2019; Alfredsson, Lars/AAC-9007-2019	Casini, Annalisa/0000-0002-3539-4500; Singh-Manoux, Archana/0000-0002-1244-5037; Salo, Paula/0000-0002-0812-277X; Goldberg, Marcel/0000-0002-6161-5880; Siegrist, Johannes/0000-0002-7530-4178; Hamer, Mark/0000-0002-8726-7992; Batty, GD/0000-0003-1822-5753; Hamer, Mark/0000-0002-8726-7992; Rugulies, Reiner/0000-0002-7752-131X; Nielsen, Martin Lindhardt/0000-0002-1523-0453; Westerlund, Hugo/0000-0002-8806-5698; Fransson, Eleonor I/0000-0001-9042-4832; Jokela, Markus/0000-0003-0117-0012; Kivimaki, Mika/0000-0002-4699-5627; Marmot, M G/0000-0002-2431-6419; Alfredsson, Lars/0000-0003-1688-6697; Suominen, Sakari B./0000-0001-6648-603X; Heikkila, Katriina/0000-0001-6269-6881; Vahtera, Jussi/0000-0002-6036-061X; Steptoe, Andrew/0000-0001-7808-4943; Burr, Hermann/0000-0002-3864-6347; Kumari, Meena/0000-0001-9716-1035; De Bacquer, Dirk/0000-0002-3202-7238; Clays, Els/0000-0002-1092-945X; Kouvonen, Anne/0000-0001-6997-8312; Theorell, Tores/0000-0003-1956-7931; Madsen, Ida/0000-0003-3635-3900	Finnish Work Environment Fund; Swedish Research Council for Working Life and Social Research; German Social Accident Insurance; Danish National Research Centre for the Working Environment; BUPA Foundation [22094477]; Ministry of Social Affairs and Employment; Medical Research Council; Wellcome Trust; US National Institutes of Health; EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund, Denmark; Academy of Finland [132944]; Dutch Ministry of Social Affairs and Employment, Netherlands; Medical Research Council, UK; US National Institutes of Health [R01HL036310, R01AG034454]; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [G8802774, G0100222, G19/35, G0902037] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	Finnish Work Environment Fund; Swedish Research Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); German Social Accident Insurance; Danish National Research Centre for the Working Environment; BUPA Foundation; Ministry of Social Affairs and Employment; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund, Denmark; Academy of Finland(Academy of Finland); Dutch Ministry of Social Affairs and Employment, Netherlands; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Finnish Work Environment Fund, the Academy of Finland, the Swedish Research Council for Working Life and Social Research, the German Social Accident Insurance, the Danish National Research Centre for the Working Environment, the BUPA Foundation, the Ministry of Social Affairs and Employment, the Medical Research Council, the Wellcome Trust, and the US National Institutes of Health.; The IPD-Work Consortium is supported by the EU New OSH ERA research programme (funded by the Finnish Work Environment Fund, Finland, the Swedish Research Council for Working Life and Social Research, Sweden, the German Social Accident Insurance, Germany, the Danish Work Environment Research Fund, Denmark), the Academy of Finland (grant number 132944), the BUPA Foundation (grant number 22094477), and the Dutch Ministry of Social Affairs and Employment, Netherlands. MK is supported by the Medical Research Council, UK, and the US National Institutes of Health (R01HL036310, R01AG034454). GDB is a Wellcome Trust Fellow. Funding bodies for each participating cohort study are listed on their websites.	ALFREDSSON L, 1985, INT J EPIDEMIOL, V14, P378, DOI 10.1093/ije/14.3.378; Alfredsson L, 2002, SCAND J WORK ENV HEA, V28, P238, DOI 10.5271/sjweh.671; Andre-Petersson L, 2007, SOC SCI MED, V64, P830, DOI 10.1016/j.socscimed.2006.10.020; Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; De Bacquer D, 2005, AM J EPIDEMIOL, V161, P434, DOI 10.1093/aje/kwi040; De Groot W, 2001, DUTCH SYSTEM OFFICIA; Eaker ED, 2004, AM J EPIDEMIOL, V159, P950, DOI 10.1093/aje/kwh127; Feveile H, 2007, STAT TRANSIT, V8, P441; Fransson EI, AM J EPIDEM IN PRESS; Fransson EI, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-62; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Hammar N, 1998, OCCUP ENVIRON MED, V55, P548, DOI 10.1136/oem.55.8.548; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035463; HooffM van, 2008, NETHERLANDS WORKING; Karasek R., 1990, HLTH WORK STRESS PRO; Kivimaki M, 2008, J EPIDEMIOL COMMUN H, V62, P372, DOI 10.1136/jech.2007.063578; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Lee S, 2003, AM J PREV MED, V24, P113, DOI 10.1016/S0749-3797(02)00582-2; Li J, 2002, CIRCULATION, V106, P1634, DOI 10.1161/01.CIR.0000031569.45667.58; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Netterstrom B, 2006, EUR J CARDIOV PREV R, V13, P414, DOI 10.1097/00149831-200606000-00018; Netterstrom B, 2010, INT J OCCUP MED ENV, V23, P217, DOI 10.2478/v10001-010-0031-6; Nielsen ML, 2002, WORK STRESS, V16, P191, DOI 10.1080/02678370210164003; Nyberg ST, 2012, J INTERN MED, V272, P65, DOI 10.1111/j.1365-2796.2011.02482.x; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Trudel X, 2010, PSYCHOSOM MED, V72, P786, DOI 10.1097/PSY.0b013e3181eaf327; Tsutsumi A, 2006, SOC SCI MED, V63, P1276, DOI 10.1016/j.socscimed.2006.03.028; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Uchiyama S, 2005, J OCCUP HEALTH, V47, P102, DOI 10.1539/joh.47.102; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Vaananen A, 2009, PREV MED, V49, P142, DOI 10.1016/j.ypmed.2009.06.026; Vahtera J, 2004, BMJ-BRIT MED J, V328, P555, DOI 10.1136/bmj.37972.496262.0D; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; *WHO, 1997, INT CLASS DIS; WHO, 2010, INT STAT CLASS DIS R; World Health Organization, 1995, PHYS STAT US INT ANT; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	50	621	635	5	197	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 27	2012	380	9852					1491	1497		10.1016/S0140-6736(12)60994-5	http://dx.doi.org/10.1016/S0140-6736(12)60994-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	026JJ	22981903	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000310272000029
J	Ohsawa, S; Sato, Y; Enomoto, M; Nakamura, M; Betsumiya, A; Igaki, T				Ohsawa, Shizue; Sato, Yoshitaka; Enomoto, Masato; Nakamura, Mai; Betsumiya, Aya; Igaki, Tatsushi			Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila	NATURE			English	Article							STEM-CELL PROLIFERATION; TISSUE OVERGROWTH; OXIDATIVE STRESS; PATHWAY; CANCER; REGENERATION; GROWTH; COOPERATION; INVASION; MIDGUT	Mitochondrial respiratory function is frequently impaired in human cancers(1-4). However, the mechanisms by which mitochondrial dysfunction contributes to tumour progression remain elusive. Here we show in Drosophila imaginal epithelium that defects in mitochondrial function potently induce tumour progression of surrounding tissue in conjunction with oncogenic Ras. Our data show that Ras activation and mitochondrial dysfunction cooperatively stimulate production of reactive oxygen species, which causes activation of c-Jun amino (N)-terminal kinase (JNK) signalling. JNK cooperates with oncogenic Ras to inactivate the Hippo pathway, leading to upregulation of its targets Unpaired (an interleukin-6 homologue) and Wingless (a Wnt homologue). Mitochondrial dysfunction in Ras-activated cells further cooperates with Ras signalling in neighbouring cells with normal mitochondrial function, causing benign tumours to exhibit metastatic behaviour. Our findings provide a mechanistic basis for interclonal tumour progression driven by mitochondrial dysfunction and oncogenic Ras.	[Ohsawa, Shizue; Sato, Yoshitaka; Enomoto, Masato; Nakamura, Mai; Betsumiya, Aya; Igaki, Tatsushi] Kobe Univ, Grad Sch Med, Div Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Igaki, Tatsushi] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kobe University; Japan Science & Technology Agency (JST)	Igaki, T (corresponding author), Kobe Univ, Grad Sch Med, Div Genet, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	igaki@med.kobe-u.ac.jp	Sato, Yoshitaka/P-9728-2015	Sato, Yoshitaka/0000-0002-8541-6413; Igaki, Tatsushi/0000-0001-5839-9526	Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Japan Society for the Promotion of Science for Young Scientists; Japan Science and Technology Agency; G-COE program for Global Center for Education and Research in Integrative Membrane Biology; Fumi Yamamura Memorial Foundation for Female Natural Scientists; Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Human Frontier Science Program Career Development Award	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); G-COE program for Global Center for Education and Research in Integrative Membrane Biology; Fumi Yamamura Memorial Foundation for Female Natural Scientists; Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Human Frontier Science Program Career Development Award	We thank J. Pastor-Pareja and M. Miura for comments on the manuscript; T. Sawada and K. Takino for technical support; D. Harrison, T. Orr-Weaver and H. Richardson for antibodies; T. Adachi-Yamada, U. Banerjee, D. Bohmann, F. Missirlis, M. Miura, H. Sun, T. Xu, Y. Hiromi, the Bloomington Stock Center, the Vienna Drosophila RNAi Center, the National Institute of Genetics Stock Center and the Drosophila Genetic Resource Center for fly stocks. We also thank T. Xu for encouragement. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to S.O., M.E. and T.I, a Grant-in-Aid for Scientific Research on Innovative Areas from the MEXT to S.O. and T.I., the Japan Society for the Promotion of Science for Young Scientists to S.O. and M. E., the Japan Science and Technology Agency to T.I., the G-COE program for Global Center for Education and Research in Integrative Membrane Biology to S.O. and T.I., the Fumi Yamamura Memorial Foundation for Female Natural Scientists to S.O, the Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists to S.O., the Takeda Science Foundation to S.O. and T.I., the Astellas Foundation for Research on Metabolic Disorders to T.I., the Kanae Foundation for the Promotion of Medical Science to T.I., the Senri Life Science Foundation to T.I. and a Human Frontier Science Program Career Development Award to T.I.	Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; Giebel B, 2006, CURR BIOL, V16, pR91, DOI 10.1016/j.cub.2006.01.022; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	29	142	143	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					547	+		10.1038/nature11452	http://dx.doi.org/10.1038/nature11452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023132				2022-12-28	WOS:000310196200044
J	Chau, AH; Walter, JM; Gerardin, J; Tang, C; Lim, WA				Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Tang, Chao; Lim, Wendell A.			Designing Synthetic Regulatory Networks Capable of Self-Organizing Cell Polarization	CELL			English	Article							SEGMENT POLARITY NETWORK; PAR PROTEINS; SYMMETRY-BREAKING; PATTERN-FORMATION; BUDDING YEAST; SMALL GTPASES; BIOLOGY; ESTABLISHMENT; ORGANIZATION; RECONSTITUTION	How cells form global, self-organized structures using genetically encoded molecular rules remains elusive. Here, we take a synthetic biology approach to investigate the design principles governing cell polarization. First, using a coarse-grained computational model, we searched for all possible simple networks that can achieve polarization. All solutions contained one of three minimal motifs: positive feedback, mutual inhibition, or inhibitor with positive feedback. These minimal motifs alone could achieve polarization under limited conditions; circuits that combined two or more of these motifs were significantly more robust. With these design principles as a blueprint, we experimentally constructed artificial polarization networks in yeast, using a toolkit of chimeric signaling proteins that spatially direct the synthesis and degradation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3). Circuits with combinatorial motifs yielded clear foci of synthetic PIP3 that can persist for nearly an hour. Thus, by harnessing localization-regulated signaling molecules, we can engineer simple molecular circuits that reliably execute spatial self-organized programs.	[Tang, Chao; Lim, Wendell A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Chau, Angela H.] Univ Calif San Francisco, UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA 94158 USA; [Gerardin, Jaline] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Tang, Chao] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Tang, Chao] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Peking University; Peking University	Tang, C (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	tangc@pku.edu.cn; lim@cmp.ucsf.edu		Tang, Chao/0000-0003-1474-3705; Gerardin, Jaline/0000-0001-8071-9928	Achievement Rewards for College Scientists (ARCS) Foundation; NIH NRSA [5F32GM093475]; NSF [DMR-0804183, CMMI-0941355]; NIH [P50 GM081879, PN2 EY016546, RO1 GM062583]; National Natural Science Foundation of China [10721403]; NSF Synthetic Biology Engineering Research Center [EEC-0540879]; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093475, R01GM062583, P50GM081879, R01GM055040] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0804183] Funding Source: National Science Foundation	Achievement Rewards for College Scientists (ARCS) Foundation; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF Synthetic Biology Engineering Research Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Thanks to C. Baker, H. El-Samad, A. Houk, C. Lee, W. Ma, L. Maibaum, W. Marshall, K. Mostov, D. Mullins, C. Oguz, C. Voigt, O. Weiner, and the Lim lab for valuable comments and discussion. We thank M. Molina, V. Cid, L. Chan, E. Bi, and O. Weiner for strains and plasmids. Thanks to J. Baker-LePain and the QB3 shared computing cluster for technical support of the computational work and the Shokat lab for PI3K inhibitor. This work was supported by an Achievement Rewards for College Scientists (ARCS) Foundation scholarship (A. H. C.), NIH NRSA fellowship 5F32GM093475 (J. M. W.), an NSF Graduate Research Fellowship (J. G.), NIH grant P50 GM081879 (W. A. L. and C. T.), NIH grants PN2 EY016546 and RO1 GM062583 (W. A. L.), NSF grants DMR-0804183 and CMMI-0941355 (C. T.), National Natural Science Foundation of China grant 10721403 (C. T.), and the NSF Synthetic Biology Engineering Research Center EEC-0540879 (W. A. L.).	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Beatty A, 2010, DEVELOPMENT, V137, P3995, DOI 10.1242/dev.056028; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Doe CQ, 2001, NAT CELL BIOL, V3, pE7, DOI 10.1038/35050684; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoege C, 2010, CURR BIOL, V20, P1296, DOI 10.1016/j.cub.2010.05.061; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inagaki N, 2011, DEV NEUROBIOL, V71, P584, DOI 10.1002/dneu.20837; Irazoqui JE, 2004, J CELL SCI, V117, P2169, DOI 10.1242/jcs.00953; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Mogilner A, 2012, SCIENCE, V336, P175, DOI 10.1126/science.1216380; Mogilner A, 2011, TRENDS CELL BIOL, V21, P692, DOI 10.1016/j.tcb.2011.09.007; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rafelski SM, 2008, NAT REV MOL CELL BIO, V9, P593, DOI 10.1038/nrm2460; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	53	116	117	1	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					320	332		10.1016/j.cell.2012.08.040	http://dx.doi.org/10.1016/j.cell.2012.08.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23039994	Bronze, Green Accepted			2022-12-28	WOS:000309981000011
J	Denevi, BW; Blewett, DT; Buczkowski, DL; Capaccioni, F; Capria, MT; De Sanctis, MC; Garry, WB; Gaskell, RW; Le Corre, L; Li, JY; Marchi, S; McCoy, TJ; Nathues, A; O'Brien, DP; Petro, NE; Pieters, CM; Preusker, F; Raymond, CA; Reddy, V; Russell, CT; Schenk, P; Scully, JEC; Sunshine, JM; Tosi, F; Williams, DA; Wyrick, D				Denevi, B. W.; Blewett, D. T.; Buczkowski, D. L.; Capaccioni, F.; Capria, M. T.; De Sanctis, M. C.; Garry, W. B.; Gaskell, R. W.; Le Corre, L.; Li, J. -Y.; Marchi, S.; McCoy, T. J.; Nathues, A.; O'Brien, D. P.; Petro, N. E.; Pieters, C. M.; Preusker, F.; Raymond, C. A.; Reddy, V.; Russell, C. T.; Schenk, P.; Scully, J. E. C.; Sunshine, J. M.; Tosi, F.; Williams, D. A.; Wyrick, D.			Pitted Terrain on Vesta and Implications for the Presence of Volatiles	SCIENCE			English	Article							CARBONACEOUS CHONDRITES; ASTEROID 4-VESTA; CERES; DAWN; MARS	We investigated the origin of unusual pitted terrain on asteroid Vesta, revealed in images from the Dawn spacecraft. Pitted terrain is characterized by irregular rimless depressions found in and around several impact craters, with a distinct morphology not observed on other airless bodies. Similar terrain is associated with numerous martian craters, where pits are thought to form through degassing of volatile-bearing material heated by the impact. Pitted terrain on Vesta may have formed in a similar manner, which indicates that portions of the surface contain a relatively large volatile component. Exogenic materials, such as water-rich carbonaceous chondrites, may be the source of volatiles, suggesting that impactor materials are preserved locally in relatively high abundance on Vesta and that impactor composition has played an important role in shaping the asteroid's geology.	[Denevi, B. W.; Blewett, D. T.; Buczkowski, D. L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Capaccioni, F.; Capria, M. T.; De Sanctis, M. C.; Tosi, F.] Ist Nazl Astrofis, Ist Astrofis & Planetol Spaziali, Rome, Italy; [Garry, W. B.; Gaskell, R. W.; Li, J. -Y.; O'Brien, D. P.] Planetary Sci Inst, Tucson, AZ USA; [Le Corre, L.; Nathues, A.; Reddy, V.] Max Planck Inst Solar Syst Res, Katlenburg Lindau, Germany; [Li, J. -Y.; Sunshine, J. M.] Univ Maryland, College Pk, MD 20742 USA; [Marchi, S.] NASA, Lunar Sci Inst, Boulder, CO USA; [McCoy, T. J.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Petro, N. E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Pieters, C. M.] Brown Univ, Providence, RI 02912 USA; [Preusker, F.] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetary Res, Berlin, Germany; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Reddy, V.] Univ N Dakota, Grand Forks, ND 58201 USA; [Russell, C. T.; Scully, J. E. C.] Univ Calif Los Angeles, Los Angeles, CA USA; [Schenk, P.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Williams, D. A.] Arizona State Univ, Tempe, AZ USA; [Wyrick, D.] SW Res Inst, San Antonio, TX USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Istituto Nazionale Astrofisica (INAF); Max Planck Society; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); Smithsonian Institution; Smithsonian National Museum of Natural History; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Brown University; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of North Dakota Grand Forks; University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe; Southwest Research Institute	Denevi, BW (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA.	brett.denevi@jhuapl.edu	Garry, Brent/I-5920-2013; Denevi, Brett W./I-6502-2012; Scully, Jennifer/L-5092-2019; Nathues, Andreas/AAW-4340-2020; Buczkowski, Debra L/I-7842-2015; Russell, Christopher T/E-7745-2012; Blewett, David T/I-4904-2012; Petro, Noah E/F-5340-2013; De Sanctis, Maria Cristina/G-5232-2013; Tosi, Federico/F-2321-2018	Denevi, Brett W./0000-0001-7837-6663; Buczkowski, Debra L/0000-0002-4729-7804; Russell, Christopher T/0000-0003-1639-8298; Blewett, David T/0000-0002-9241-6358; De Sanctis, Maria Cristina/0000-0002-3463-4437; Tosi, Federico/0000-0003-4002-2434; capria, maria teresa/0000-0002-9814-9588; McCoy, Timothy/0000-0002-4573-3553; Reddy, Vishnu/0000-0002-7743-3491; Le Corre, Lucille/0000-0003-0349-7932; Li, Jian-Yang/0000-0003-3841-9977; Sunshine, Jessica/0000-0002-9413-8785; Capaccioni, Fabrizio/0000-0003-1631-4314; Petro, Noah/0000-0003-4676-077X	Dawn at Vesta Participating Scientist program; NASA; Italian Space Agency	Dawn at Vesta Participating Scientist program; NASA(National Aeronautics & Space Administration (NASA)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	We thank the Dawn Science, Instrument, and Operations Teams and the Dawn at Vesta Participating Scientist program for support. A portion of this work was performed at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA, and portions were supported by the Italian Space Agency. Dawn data are archived with the NASA Planetary Data System.	BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Boyce JM, 2012, ICARUS, V221, P262, DOI 10.1016/j.icarus.2012.07.027; Cloutis EA, 2011, ICARUS, V216, P309, DOI 10.1016/j.icarus.2011.09.009; De Sanctis MC, 2011, SPACE SCI REV, V163, P329, DOI 10.1007/s11214-010-9668-5; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; Gaskell RW, 2008, METEORIT PLANET SCI, V43, P1049, DOI 10.1111/j.1945-5100.2008.tb00692.x; Hartmann WK, 2010, ICARUS, V208, P621, DOI 10.1016/j.icarus.2010.03.030; Hasegawa S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018627; Herrin J. S., 2011, 42 ANN LUN PLAN SCI; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Le Feuvre M, 2008, ICARUS, V197, P291, DOI 10.1016/j.icarus.2008.04.011; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; McCord T. B., 2012, 43 ANN LUN PLAN SCI; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McEwen AS, 2007, SCIENCE, V317, P1706, DOI 10.1126/science.1143987; Mittlefehldt D. W., 1998, PLANETARY MAT; Mouginis-Mark PJ, 2007, METEORIT PLANET SCI, V42, P1615, DOI 10.1111/j.1945-5100.2007.tb00594.x; Prettyman TH, 2012, SCIENCE, V338, P242, DOI 10.1126/science.1225354; Reddy V., 2012, 43 ANN LUN PLAN SCI; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Rivkin AS, 2006, ICARUS, V180, P464, DOI 10.1016/j.icarus.2005.09.012; Rubin AE, 2007, GEOCHIM COSMOCHIM AC, V71, P2361, DOI 10.1016/j.gca.2007.02.008; Rubin AE, 2009, METEORIT PLANET SCI, V44, P701, DOI 10.1111/j.1945-5100.2009.tb00764.x; Russell CT, 2011, SPACE SCI REV, V163, P3, DOI 10.1007/s11214-011-9836-2; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; Sierks H, 2011, SPACE SCI REV, V163, P263, DOI 10.1007/s11214-011-9745-4; Tornabene LL, 2012, ICARUS, V220, P348, DOI 10.1016/j.icarus.2012.05.022; Wilson L, 1996, J GEOPHYS RES-PLANET, V101, P18927, DOI 10.1029/96JE01390	28	76	77	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					246	249		10.1126/science.1225374	http://dx.doi.org/10.1126/science.1225374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22997131	Green Accepted			2022-12-28	WOS:000309712300043
J	Farley, T				Farley, Thomas			Support Regulation of Sugar-Sweetened Beverages	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New York City Dept Hlth & Mental Hyg, New York, NY USA	New York City Department of Health & Mental Hygiene	Farley, T (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY USA.								0	12	12	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1464	1465						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	22998342				2022-12-28	WOS:000309652700015
J	Zust, T; Heichinger, C; Grossniklaus, U; Harrington, R; Kliebenstein, DJ; Turnbull, LA				Zuest, Tobias; Heichinger, Christian; Grossniklaus, Ueli; Harrington, Richard; Kliebenstein, Daniel J.; Turnbull, Lindsay A.			Natural Enemies Drive Geographic Variation in Plant Defenses	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; EVOLUTIONARY DYNAMICS; GENETIC DIVERSITY; LOCAL ADAPTATION; GREEN PEACH; GLUCOSINOLATE; POPULATIONS; POLYMORPHISM; RESISTANCE; HERBIVORY	Plants defend themselves against attack by natural enemies, and these defenses vary widely across populations. However, whether communities of natural enemies are a sufficiently potent force to maintain polymorphisms in defensive traits is largely unknown. Here, we exploit the genetic resources of Arabidopsis thaliana, coupled with 39 years of field data on aphid abundance, to (i) demonstrate that geographic patterns in a polymorphic defense locus (GS-ELONG) are strongly correlated with changes in the relative abundance of two specialist aphids; and (ii) demonstrate differential selection by the two aphids on GS-ELONG, using a multigeneration selection experiment. We thereby show a causal link between variation in abundance of the two specialist aphids and the geographic pattern at GS-ELONG, which highlights the potency of natural enemies as selective forces.	[Zuest, Tobias; Turnbull, Lindsay A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Zuest, Tobias; Turnbull, Lindsay A.] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8057 Zurich, Switzerland; [Heichinger, Christian; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Heichinger, Christian; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Harrington, Richard] Rothamsted Res, Rothamsted Insect Survey, AgroEcol Dept, Harpenden AL5 2JQ, Herts, England; [Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kliebenstein, Daniel J.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DynaMo Ctr Excellence, DK-1871 Copenhagen, Denmark	University of Zurich; University of Zurich; University of Zurich; University of Zurich; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of California System; University of California Davis; University of Copenhagen	Zust, T (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	tobias.zuest@cornell.edu	Grossniklaus, Ueli/E-9995-2016; Turnbull, Lindsay A./A-2680-2012	Grossniklaus, Ueli/0000-0002-0522-8974; Zust, Tobias/0000-0001-7142-8731; Kliebenstein, Daniel/0000-0001-5759-3175	Forschungskredit of the University of Zurich; Swiss National Science Foundation [31-107531]; U.S. NSF [DBI0820580]; European Research Council; University of Zurich; Biotechnology and Biological Sciences Research Council; Lawes Agricultural Trust; EU EXAMINE Project [EVK2-1999-00151]; BBSRC [BBS/E/C/00005191, BBS/E/C/00004957] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00006003, BBS/E/C/00005191, BBS/E/C/00004957] Funding Source: researchfish	Forschungskredit of the University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); University of Zurich; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lawes Agricultural Trust; EU EXAMINE Project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Forschungskredit of the University of Zurich (T.Z.) and by Swiss National Science Foundation grant 31-107531 (L.A.T.), by U.S. NSF grant DBI0820580 (D.J.K.), an Advanced Grant of the European Research Council (U.G.), and a special grant of the University of Zurich in commemoration of Prof. Christine B. Muller. The Rothamsted Insect Survey is supported by a Biotechnology and Biological Sciences Research Council National Capability Grant and the Lawes Agricultural Trust. We thank members of the EU EXAMINE Project (EVK2-1999-00151) for use of data and A. A. Agrawal, S. West, J. Levine, and two anonymous reviewers for comments that improved the manuscript. All data presented in this paper and R code of all analyses are provided in the supplementary materials.	Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bidart-Bouzat MG, 2008, J CHEM ECOL, V34, P1026, DOI 10.1007/s10886-008-9498-z; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DELOACH CJ, 1974, ANN ENTOMOL SOC AM, V67, P332, DOI 10.1093/aesa/67.3.332; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7	24	197	198	8	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					116	119		10.1126/science.1226397	http://dx.doi.org/10.1126/science.1226397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042895	Green Accepted			2022-12-28	WOS:000309457400066
J	Mavilio, F				Mavilio, Fulvio			Gene therapies need new development models	NATURE			English	Editorial Material									[Mavilio, Fulvio] Genethon, Evry, France; [Mavilio, Fulvio] Univ Modena & Reggio Emilia, Modena, Italy	Universita di Modena e Reggio Emilia	Mavilio, F (corresponding author), Genethon, Evry, France.	fmavilio@genethon.fr	MAVILIO, Fulvio/J-6125-2013	Mavilio, Fulvio/0000-0003-0459-4320					0	12	13	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					7	7		10.1038/490007a	http://dx.doi.org/10.1038/490007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038429	Bronze			2022-12-28	WOS:000309446800004
J	McCartney, M				McCartney, Margaret			Is the USA's problem ours too?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2011, NEW VAL BAS APPR PRI; Athey VL, 2012, THORAX, V67, P412, DOI 10.1136/thoraxjnl-2011-200714; Chauhan M, 2012, J PUBLIC HLTH OXF; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Dyer C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2489; Gray DP, 2003, J ROY SOC MED, V96, P160, DOI 10.1258/jrsm.96.4.160	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 3	2012	345								e6617	10.1136/bmj.e6617	http://dx.doi.org/10.1136/bmj.e6617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KZ	23034855				2022-12-28	WOS:000309660600006
J	Addicott, R				Addicott, Rachael			What accountable care organizations will mean for physicians	BRITISH MEDICAL JOURNAL			English	Editorial Material								The development of accountable care organizations (ACOs) in the United States has created a climate where the financial success of an entire provider network depends on each physician pulling his or her weight, creating considerable pressure to perform. The use of ACOs in Medicare is still at an early stage, with the launch of 88 new ACOs in July bringing the total number to 153.(1) However, the developments and challenges experienced by the 221 organizations already operating as ACOs in the commercial health sector can provide insights into how they affect physicians.(2) The fundamental ethos of an ACO is that the contracted providers are eligible to share in a proportion of any savings made in the cost of provision, on the condition that certain quality standards are met. To achieve the intended cost savings, ACO providers typically work together to develop a care management approach targeted at patients at risk of potentially avoidable admissions or emergency department visits. Such care management is either preventive (proactively contacting patients with a high risk profile and deriving a community based care plan) or reactive (care coordinators based in a hospital intercept patients and direct them to other resources).	Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Addicott, R (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	rachael.addicott@gmail.com			Harkness fellowship award from Commonwealth Fund	Harkness fellowship award from Commonwealth Fund	The author has completed the ICMJE unified disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declares the project on which this article is based was funded through a Harkness fellowship award from the Commonwealth Fund. RA has no financial relationships with any organisation that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	Muhlestein D, 2012, GROWTH DISPERSION AC	1	4	4	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 1	2012	345								e6461	10.1136/bmj.e6461	http://dx.doi.org/10.1136/bmj.e6461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KB	23028098				2022-12-28	WOS:000309657900006
J	Catani, M; Bodi, I; Dell'Acqua, F				Catani, Marco; Bodi, Istvan; Dell'Acqua, Flavio			Comment on "The Geometric Structure of the Brain Fiber Pathways"	SCIENCE			English	Editorial Material							DIFFUSION MRI; TRACTOGRAPHY	Wedeen et al. (Reports, 30 March 2012, p. 1628) proposed a geometrical grid pattern in the brain that could help the understanding of the brain's organization and connectivity. We show that whole-brain fiber crossing quantification does not support their theory. Our results suggest that the grid pattern is most likely an artifact attributable to the limitations of their method.	[Catani, Marco; Dell'Acqua, Flavio] Kings Coll London, NATBRAINLAB, Dept Neuroimaging, Inst Psychiat, London SE5 8AF, England; [Catani, Marco] Kings Coll London, NATBRAINLAB, Dept Forens & Neurodev Sci, Inst Psychiat, London SE5 8AF, England; [Bodi, Istvan] Kings Coll London, Dept Clin Neurosci, London SE5 8AF, England; [Dell'Acqua, Flavio] S London & Maudsley NHS Fdn Trust, NIHR, Biomed Res Ctr Mental Hlth, London SE5 8AF, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Catani, M (corresponding author), Kings Coll London, NATBRAINLAB, Dept Neuroimaging, Inst Psychiat, London SE5 8AF, England.	m.catani@iop.kcl.ac.uk	Catani, Marco/AFK-2769-2022; Dell'Acqua, Flavio/I-1407-2012; Catani, Marco/H-7801-2012; Bodi, Istvan/H-8092-2019; Catani, Marco/AAG-1094-2022	Catani, Marco/0000-0002-5488-6463; Catani, Marco/0000-0002-5488-6463; Bodi, Istvan/0000-0002-2533-4758; Catani, Marco/0000-0002-5488-6463; Dell'Acqua, Flavio/0000-0001-5313-5476	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH093765] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR-023953, P41 RR-14075] Funding Source: Medline; NIMH NIH HHS [R01-MH652456, U01 MH093765] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aldhous P, 2012, NEW SCI, V214, P14, DOI 10.1016/S0262-4079(12)60876-8; Alexander D. C., 2011, DIFFUSION MRI; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; CRICK F, 1993, NATURE, V361, P109, DOI 10.1038/361109a0; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Dell'Acqua F, 2010, NEUROIMAGE, V49, P1446, DOI 10.1016/j.neuroimage.2009.09.033; Ghuhbegovic N., 1980, HUMAN BRAIN; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Mazzarello P., 2010, GOLGI BIOGRAPHY FOUN; Ozarslan E, 2006, NEUROIMAGE, V31, P1086, DOI 10.1016/j.neuroimage.2006.01.024; Takahashi E, 2011, CEREB CORTEX, V21, P200, DOI 10.1093/cercor/bhq084; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642	15	47	47	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102								10.1126/science.1223425	http://dx.doi.org/10.1126/science.1223425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019632				2022-12-28	WOS:000309215400023
J	Galvez, T; Gilleron, J; Zerial, M; O'Sullivan, GA				Galvez, Thierry; Gilleron, Jerome; Zerial, Marino; O'Sullivan, Gregory A.			SnapShot: Mammalian Rab Proteins in Endocytic Trafficking	CELL			English	Editorial Material									[Galvez, Thierry; Gilleron, Jerome; Zerial, Marino; O'Sullivan, Gregory A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Galvez, T (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Gilleron, Jerome/GRX-8574-2022; O'Sullivan, Gregory A/F-8355-2011	Gilleron, Jerome/0000-0002-6389-8685; O'Sullivan, Gregory A/0000-0003-0428-041X; galvez, thierry/0000-0003-2800-3732				Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Pfeffer SR, 2011, COLD SPRING HARB PER, V3; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	4	46	47	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					234	U244	234.e2	10.1016/j.cell.2012.09.013	http://dx.doi.org/10.1016/j.cell.2012.09.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021225	Bronze			2022-12-28	WOS:000309544200023
J	Zhen, Y; Aardema, ML; Medina, EM; Schumer, M; Andolfatto, P				Zhen, Ying; Aardema, Matthew L.; Medina, Edgar M.; Schumer, Molly; Andolfatto, Peter			Parallel Molecular Evolution in an Herbivore Community	SCIENCE			English	Article							OUABAIN-BINDING-SITE; CARDIAC-GLYCOSIDES; MORPHOLOGICAL EVOLUTION; GASTRIC H,K-ATPASE; DANAUS-PLEXIPPUS; K+-ATPASE; EVO-DEVO; INSENSITIVITY; NA+,K+-ATPASE; NA,K-ATPASE	Numerous insects have independently evolved the ability to feed on plants that produce toxic secondary compounds called cardenolides and can sequester these compounds for use in their defense. We surveyed the protein target for cardenolides, the alpha subunit of the sodium pump, Na+, K+-ATPase (ATP alpha), in 14 species that feed on cardenolide-producing plants and 15 outgroups spanning three insect orders. Despite the large number of potential targets for modulating cardenolide sensitivity, amino acid substitutions associated with host-plant specialization are highly clustered, with many parallel substitutions. Additionally, we document four independent duplications of ATPa with convergent tissue-specific expression patterns. We find that unique substitutions are disproportionately associated with recent duplications relative to parallel substitutions. Together, these findings support the hypothesis that adaptation tends to take evolutionary paths that minimize negative pleiotropy.	[Zhen, Ying; Aardema, Matthew L.; Schumer, Molly; Andolfatto, Peter] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Zhen, Ying; Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Medina, Edgar M.] Univ Los Andes, Dept Ciencias Biol, Bogota 11001, Colombia	Princeton University; Princeton University; Universidad de los Andes (Colombia)	Andolfatto, P (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pandolfa@princeton.edu	Zhen, Ying/M-4705-2016	Schumer, Molly/0000-0002-2075-5668; Medina, Edgar M./0000-0002-5518-5933; Andolfatto, Peter/0000-0003-3393-4574	International Centre for Genetic Engineering and Biotechnology (ICGEB) [CRP/COL09-01]; NSF [DEB-0946398]; NIH [R01-GM083228]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083228] Funding Source: NIH RePORTER	International Centre for Genetic Engineering and Biotechnology (ICGEB); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to M. and K. Kardestuncer for collecting the hickory tussock moths; A. Briscoe for providing queen, solider, and tiger-mimic queen butterfly tissue samples; D. Stern for the suggestion of trying de novo assembly of RNA-seq data; and M. Przeworski for helpful discussions and comments on the manuscript. Funded in part by an International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant (No. CRP/COL09-01) to E. M. M. and NSF grant DEB-0946398 and NIH grant R01-GM083228 to P. A. All raw sequence data generated in this study can be downloaded at http://genomics-pubs. princeton.edu/insect_genomics/data.shtml, and assemblies of ATP alpha have been submitted to GenBank under accession nos. JQ771496 to 527.	Aardema ML, 2012, MOL ECOL, V21, P340, DOI 10.1111/j.1365-294X.2011.05379.x; Agrawal AA, 2004, AM NAT, V164, P113, DOI 10.1086/420980; ALROBAI AA, 1993, COMP BIOCHEM PHYS B, V106, P805, DOI 10.1016/0305-0491(93)90034-3; CANFIELD VA, 1992, NEW BIOL, V4, P339; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; Crow JF, 2008, ANNU REV GENET, V42, P1, DOI 10.1146/annurev.genet.42.110807.091612; De Pont JJHHM, 2009, PFLUG ARCH EUR J PHY, V457, P623, DOI 10.1007/s00424-008-0467-8; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HOLZINGER F, 1992, FEBS LETT, V314, P477, DOI 10.1016/0014-5793(92)81530-Y; Holzinger F, 1996, J CHEM ECOL, V22, P1921, DOI 10.1007/BF02028512; Kimura M., 1983, NEUTRAL THEORY MOL E; Labeyrie E, 2004, MOL BIOL EVOL, V21, P218, DOI 10.1093/molbev/msg240; Lynch M, 2007, ORIGINS GENOME ARCHI; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Mebs D, 2000, CHEMOECOLOGY, V10, P201, DOI 10.1007/PL00001823; Moore DJ, 2009, BIOL LETTERS, V5, P513, DOI 10.1098/rsbl.2009.0281; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Stern DL, 2011, EVOLUTION DEV PREDIC; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; VAUGHAN GL, 1977, J INSECT PHYSIOL, V23, P585, DOI 10.1016/0022-1910(77)90052-X; Wright S., 1968, EVOLUTION GENETICS P, P373; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	34	172	174	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1634	1637		10.1126/science.1226630	http://dx.doi.org/10.1126/science.1226630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019645	Green Accepted			2022-12-28	WOS:000309215400039
J	Brody, H				Brody, Herb			CHRONIC OBSTRUCTIVE PULMONARY DISEASE	NATURE			English	Editorial Material																			0	7	8	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S1	S1		10.1038/489S1a	http://dx.doi.org/10.1038/489S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013707	Bronze			2022-12-28	WOS:000309167100001
J	Yang, QT; Li, P				Yang, Qintai; Li, Peng			A Laryngeal Fluke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yang, Qintai; Li, Peng] Sun Yat Sen Univ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yang, QT (corresponding author), Sun Yat Sen Univ, Guangzhou 510275, Guangdong, Peoples R China.	lp76@163.net		Yang, Qintai/0000-0003-3377-737X					0	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					E18	E18		10.1056/NEJMicm1102441	http://dx.doi.org/10.1056/NEJMicm1102441			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	23013100				2022-12-28	WOS:000309161100012
J	Carville, S; Padhi, S; Reason, T; Underwood, M				Carville, Serena; Padhi, Smita; Reason, Tim; Underwood, Martin		Guideline Dev Grp	Diagnosis and management of headaches in young people and adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Underwood, Martin] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Carville, Serena; Padhi, Smita; Reason, Tim] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of Warwick; Royal College of Physicians	Underwood, M (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England.	m.underwood@warwick.ac.uk	Whitehouse, William P/F-9065-2017; Underwood, Martin/D-6364-2015	Whitehouse, William P/0000-0001-5207-5731; Underwood, Martin/0000-0002-0309-1708				Dias S, 2011, 2 NICE DSU; Faculty of Sexual and Reproductive Healthcare clinical guidance, 2011, DRUG INT HORM CONTR; International Headache Society, IHS CLASS ICHD 2; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P385, DOI 10.1136/jnnp.2005.073221; National Institute for Health and Clinical Excellence, 2012, HEAD DIAGN MAN HEAD; National Institute for Health and Clinical Excellence, 2012, BOT TOX TYP A PREV H; Weatherall MW, 2006, J ROY COLL PHYS EDIN, V36, P196	7	41	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2012	345								e5765	10.1136/bmj.e5765	http://dx.doi.org/10.1136/bmj.e5765			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JI	22993393				2022-12-28	WOS:000309160500002
J	Klein, L				Klein, Liviu			Review: New oral anticoagulants reduced stroke and systemic embolism compared with warfarin in AF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION; RISK		[Klein, Liviu] Univ California San Francisco, San Francisco, CA USA	University of California System; University of California San Francisco	Klein, L (corresponding author), Univ California San Francisco, San Francisco, CA USA.							Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134	3	2	2	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-2	10.7326/0003-4819-157-6-201209180-02002	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986394				2022-12-28	WOS:000308912800001
J	Caplan, AL				Caplan, Arthur L.			The art of medicine Not my turn	LANCET			English	Editorial Material									NYU, Dept Populat Hlth, Div Med Eth, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Caplan, AL (corresponding author), NYU, Dept Populat Hlth, Div Med Eth, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	Arthur.Caplan@nyumc.org							0	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					968	969		10.1016/S0140-6736(12)61526-8	http://dx.doi.org/10.1016/S0140-6736(12)61526-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	005JF	22988581				2022-12-28	WOS:000308746000016
J	Bar-Peled, L; Schweitzer, LD; Zoncu, R; Sabatini, DM				Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.			Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels tomTORC1	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GTP-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; CENTROSOME DYNAMICS; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; CELLULAR TARGET; LATE ENDOSOMES; COMPLEX	The mTOR Complex 1 (mTORC1) pathway regulates cell growth in response to numerous cues, including amino acids, which promote mTORC1 translocation to the lysosomal surface, its site of activation. The heterodimeric RagA/B-RagC/D GTPases, the Ragulator complex that tethers the Rags to the lysosome, and the v-ATPase form a signaling system that is necessary for amino acid sensing by mTORC1. Amino acids stimulate the binding of guanosine triphosphate to RagA and RagB but the factors that regulate Rag nucleotide loading are unknown. Here, we identify HBXIP and C7orf59 as two additional Ragulator components that are required for mTORC1 activation by amino acids. The expanded Ragulator has nucleotide exchange activity toward RagA and RagB and interacts with the Rag heterodimers in an amino acid-and v-ATPase-dependent fashion. Thus, we provide mechanistic insight into how mTORC1 senses amino acids by identifying Ragulator as a guanine nucleotide exchange factor (GEF) for the Rag GTPases.	[Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	NIH [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; LAM Foundation; NCI [F31CA167872]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE [R01CA103866, F31CA167872, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); LAM Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Sabatini Lab for helpful suggestions, John Doench for technical assistance, and Eric Spooner for mass spectrometric analyses of samples. This work was supported by grants from the NIH (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D.M.S., awards from the LAM Foundation to D.M.S., and fellowship support from the NCI (F31CA167872) to L.D.S. and from the LAM Foundation and the Jane Coffin Childs Memorial Fund for Medical Research to R.Z.D. M.S. is an investigator of the Howard Hughes Medical Institute.	Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bowman AB, 1999, J CELL BIOL, V146, P165; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fiegen D., 2006, PROTEINS CELL REGUL, V4, P45; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hirose E, 1998, J CELL SCI, V111, P11; HOFFENBERG S, 1995, BIOCHEM BIOPH RES CO, V215, P241, DOI 10.1006/bbrc.1995.2459; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; JOHN J, 1993, J BIOL CHEM, V268, P923; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Lunin VV, 2004, J BIOL CHEM, V279, P23422, DOI 10.1074/jbc.M401648200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schmidt G, 1996, ONCOGENE, V12, P87; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Wang FZ, 2007, ACTA PHARMACOL SIN, V28, P431, DOI 10.1111/j.1745-7254.2007.00531.x; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Zhang BL, 2005, BIOCHEMISTRY-US, V44, P2566, DOI 10.1021/bi048755w; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	611	645	5	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1196	1208		10.1016/j.cell.2012.07.032	http://dx.doi.org/10.1016/j.cell.2012.07.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980980	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000308928100013
J	Okazaki, K; Ota, Y; Kotani, Y; Malaeb, W; Ishida, Y; Shimojima, T; Kiss, T; Watanabe, S; Chen, CT; Kihou, K; Lee, CH; Iyo, A; Eisaki, H; Saito, T; Fukazawa, H; Kohori, Y; Hashimoto, K; Shibauchi, T; Matsuda, Y; Ikeda, H; Miyahara, H; Arita, R; Chainani, A; Shin, S				Okazaki, K.; Ota, Y.; Kotani, Y.; Malaeb, W.; Ishida, Y.; Shimojima, T.; Kiss, T.; Watanabe, S.; Chen, C. -T.; Kihou, K.; Lee, C. H.; Iyo, A.; Eisaki, H.; Saito, T.; Fukazawa, H.; Kohori, Y.; Hashimoto, K.; Shibauchi, T.; Matsuda, Y.; Ikeda, H.; Miyahara, H.; Arita, R.; Chainani, A.; Shin, S.			Octet-Line Node Structure of Superconducting Order Parameter in KFe2As2	SCIENCE			English	Article							BA0.6K0.4FE2AS2; GAPS	In iron-pnictide superconductivity, the interband interaction between the hole and electron Fermi surfaces (FSs) is believed to play an important role. However, KFe2As2 has three zone-centered hole FSs and no electron FS but still exhibits superconductivity. Our ultrahigh-resolution laser angle-resolved photoemission spectroscopy unveils that KFe2As2 is a nodal s-wave superconductor with highly unusual FS-selective multi-gap structure: a nodeless gap on the inner FS, an unconventional gap with "octet-line nodes" on the middle FS, and an almost-zero gap on the outer FS. This gap structure may arise from the frustration between competing pairing interactions on the hole FSs causing the eightfold sign reversal. Our results suggest that the A(1g) superconducting symmetry is universal in iron-pnictides, in spite of the variety of gap functions.	[Okazaki, K.; Ota, Y.; Kotani, Y.; Malaeb, W.; Ishida, Y.; Shin, S.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Okazaki, K.; Kotani, Y.; Shin, S.] Japan Sci & Technol Agcy JST, Chiyoda Ku, Tokyo 1020075, Japan; [Malaeb, W.; Kihou, K.; Lee, C. H.; Iyo, A.; Eisaki, H.; Fukazawa, H.; Kohori, Y.; Shin, S.] JST, Transformat Res Project Iron Pnictides TRIP, Chiyoda Ku, Tokyo 1020075, Japan; [Shimojima, T.; Miyahara, H.; Arita, R.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Kiss, T.] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan; [Watanabe, S.] Univ Tokyo, Res Inst Sci & Technol, Chiba 2788510, Japan; [Chen, C. -T.] Chinese Acad Sci, Beijing Ctr Crystal R&D, Beijing 100190, Peoples R China; [Kihou, K.; Lee, C. H.; Iyo, A.; Eisaki, H.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Saito, T.; Fukazawa, H.; Kohori, Y.] Chiba Univ, Dept Phys, Chiba 2638522, Japan; [Hashimoto, K.; Shibauchi, T.; Matsuda, Y.; Ikeda, H.] Kyoto Univ, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan; [Chainani, A.; Shin, S.] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Chainani, A.] Tohoku Univ, Dept Phys, Aoba Ku, Sendai, Miyagi 9808578, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; Osaka University; University of Tokyo; Chinese Academy of Sciences; National Institute of Advanced Industrial Science & Technology (AIST); Chiba University; Kyoto University; RIKEN; Tohoku University	Okazaki, K (corresponding author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	okazaki@issp.u-tokyo.ac.jp; shin@issp.u-tokyo.ac.jp	SHIN, SHIK/ABH-1500-2020; Shimojima, Takahiro/D-3888-2017; Shibauchi, Takasada/B-9349-2008; Okazaki, Kozo/H-8862-2012; Chainani, Ashish/ABH-8078-2020; Eisaki, Hiroshi/F-6317-2018; Matsuda, Yuji/ABH-7166-2020; Ota, Yuichi/L-7968-2018; Lee, Chul-Ho/I-7162-2018; Ishida, Yukiaki/D-4261-2016; Chainani, Ashish/B-3071-2011; Arita, Ryotaro/D-5965-2012; Hashimoto, Kenichiro/C-4925-2012; Iyo, Akira/L-6417-2018; Kihou, Kunihiro/AAQ-3541-2020; Hiroaki, Ikeda/F-2635-2018; Miyahara, Hideyuki/P-8789-2019	Shimojima, Takahiro/0000-0002-2162-4539; Shibauchi, Takasada/0000-0001-5831-4924; Okazaki, Kozo/0000-0002-2334-918X; Eisaki, Hiroshi/0000-0002-8299-6416; Matsuda, Yuji/0000-0001-9947-9418; Ota, Yuichi/0000-0003-4183-9550; Lee, Chul-Ho/0000-0001-6918-976X; Ishida, Yukiaki/0000-0002-0980-7041; Chainani, Ashish/0000-0002-5639-5393; Arita, Ryotaro/0000-0001-5725-072X; Hashimoto, Kenichiro/0000-0003-4651-4077; Iyo, Akira/0000-0002-9610-647X; Kihou, Kunihiro/0000-0003-3065-4147; Ikeda, Hiroaki/0000-0002-9258-9478	Japan Society for the Promotion of Science (JSPS) through its FIRST Program; JSPS [24340090]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21540351, 22684016, 20102005, 21102505]; KAKENHI from JSPS; Grants-in-Aid for Scientific Research [23654118] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) through its FIRST Program; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI from JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Kuroki, T. Yoshida, and S. Kittaka for valuable discussions; A. V. Chubukov for valuable comments; and T. Kondo for reading the manuscript and comments. This research is supported by the Japan Society for the Promotion of Science (JSPS) through its FIRST Program. C. H. L. was additionally supported by Grant-in-Aid for Scientific Research B (No. 24340090) from JSPS. H. F. was additionally supported by Grants-in-Aid for Scientic Research (21540351 and 22684016) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and JSPS and Innovative Areas "Heavy Electrons" (20102005 and 21102505) from MEXT. T. S. was additionally supported by Grant-in-Aid for the Global COE program "The Next Generation of Physics, Spun from Universality and Emergence" from MEXT, and KAKENHI from JSPS.	Ding H, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/47001; Dong JK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.087005; DYNES RC, 1978, PHYS REV LETT, V41, P1509, DOI 10.1103/PhysRevLett.41.1509; Fletcher JD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147001; Fukazawa H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.083712; Graser S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/025016; Hashimoto K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.014526; Hashimoto K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.220501; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kihou K, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.124713; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Lee CH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.067003; Maiti S, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.014511; Maiti S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.147002; Maiti S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214515; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Nakayama K, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/67002; Shimojima T, 2011, SCIENCE, V332, P564, DOI 10.1126/science.1202150; Suzuki K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144514; Terashima T, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.053702; Thomale R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.117001	21	194	194	3	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1314	1317		10.1126/science.1222793	http://dx.doi.org/10.1126/science.1222793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984065				2022-12-28	WOS:000308705000035
J	Agrawal, AA; Hastings, AP; Johnson, MTJ; Maron, JL; Salminen, JP				Agrawal, Anurag A.; Hastings, Amy P.; Johnson, Marc T. J.; Maron, John L.; Salminen, Juha-Pekka			Insect Herbivores Drive Real-Time Ecological and Evolutionary Change in Plant Populations	SCIENCE			English	Article							RESISTANCE; ELLAGITANNINS; COMMUNITIES; DEFENSE	Insect herbivores are hypothesized to be major factors affecting the ecology and evolution of plants. We tested this prediction by suppressing insects in replicated field populations of a native plant, Oenothera biennis, which reduced seed predation, altered interspecific competitive dynamics, and resulted in rapid evolutionary divergence. Comparative genotyping and phenotyping of nearly 12,000 O. biennis individuals revealed that in plots protected from insects, resistance to herbivores declined through time owing to changes in flowering time and lower defensive ellagitannins in fruits, whereas plant competitive ability increased. This independent real-time evolution of plant resistance and competitive ability in the field resulted from the relaxation of direct selective effects of insects on plant defense and through indirect effects due to reduced herbivory on plant competitors.	[Agrawal, Anurag A.; Hastings, Amy P.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Agrawal, Anurag A.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Johnson, Marc T. J.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Maron, John L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Salminen, Juha-Pekka] Univ Turku, Dept Chem, Lab Organ Chem & Chem Biol, FI-20014 Turku, Finland	Cornell University; Cornell University; University of Toronto; University Toronto Mississauga; University of Montana System; University of Montana; University of Turku	Agrawal, AA (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	agrawal@cornell.edu	Salminen, Juha-Pekka/N-3313-2017; Agrawal, Anurag A/Y-2497-2019	Salminen, Juha-Pekka/0000-0002-2912-7094; Agrawal, Anurag A/0000-0003-0095-1220	University of Turku; U.S. NSF [EAGER DEB-0950231]; Natural Sciences and Engineering Research Council of Canada; Government of Ontario; Connaught Early Researcher Award; NSF [DEB 0614406, DEB-0915409]; Academy of Finland [258992]; Direct For Biological Sciences [1118783] Funding Source: National Science Foundation	University of Turku; U.S. NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Government of Ontario; Connaught Early Researcher Award; NSF(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Alfano, F. Chen, S. Cook-Patton, P. Cooper, T. Dodge, N. Durfee, A. Erwin, M. Falise, J. Goldstein, E. Kearney, A. Knight, S. McArt, J. Peters, S. Rasmann, A. Smith, T. Ramsey, E. Reyes, M. Weber, and E. Woods for help with field work and discussion; T. Zhao, J. Yi, and A. Koivuniemi for assistance with chemical analyses; and J. Good, N. Hairston, S. McArt, T. Zust, and the Plant Interactions Group at Cornell University for comments. Molecular work for this study was conducted in the Evolutionary Genetics Core Facility at Cornell University with support from V. Askinazi, S. Bogdanowicz, R. Harrison, E. Larson, and E. Reyes. Chemical analyses on an ultraperformance liquid chromatography-mass spectrometry system were made possible by a Strategic Research Grant of University of Turku. This study was primarily supported by a U.S. NSF grant (EAGER DEB-0950231), and for this we thank L. Gough. M.T.J.J. was supported by the Natural Sciences and Engineering Research Council of Canada, the Government of Ontario, and a Connaught Early Researcher Award; J.L.M. was supported by NSF grants DEB 0614406 and DEB-0915409; J.-P.S was supported by the Academy of Finland (grant 258992). Data sets for genotype frequencies described in this paper are available in the DRYAD data repository under http://dx.doi.org/10.5061/dryad.6331s. This paper is dedicated to Paul Feeny and Dick Root.	Agrawal AA, 2004, ECOLOGY, V85, P2118, DOI 10.1890/03-4084; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Agrawal AA, 2013, AM NAT, V181, pS35, DOI 10.1086/666727; Barbehenn RV, 2006, J CHEM ECOL, V32, P2253, DOI 10.1007/s10886-006-9143-7; Bode RF, 2012, J ECOL, V100, P795, DOI 10.1111/j.1365-2745.2012.01958.x; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Desurmont GA, 2011, P NATL ACAD SCI USA, V108, P7070, DOI 10.1073/pnas.1102891108; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fornoni J, 2004, EVOLUTION, V58, P1696, DOI 10.1111/j.0014-3820.2004.tb00455.x; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Johnson MTJ, 2009, J EVOLUTION BIOL, V22, P1295, DOI 10.1111/j.1420-9101.2009.01747.x; Johnson MTJ, 2009, PHILOS T R SOC B, V364, P1593, DOI 10.1098/rstb.2008.0334; Karonen M, 2010, RAPID COMMUN MASS SP, V24, P3151, DOI 10.1002/rcm.4756; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Uriarte M, 2002, ECOLOGY, V83, P2649, DOI 10.1890/0012-9658(2002)083[2649:AMOSEO]2.0.CO;2; Zangerl AR, 2005, P NATL ACAD SCI USA, V102, P15529, DOI 10.1073/pnas.0507805102	24	293	298	11	520	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					113	116		10.1126/science.1225977	http://dx.doi.org/10.1126/science.1225977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042894				2022-12-28	WOS:000309457400065
J	Gerstner, W; Sprekeler, H; Deco, G				Gerstner, Wulfram; Sprekeler, Henning; Deco, Gustavo			Theory and Simulation in Neuroscience	SCIENCE			English	Review							LARGE-SCALE SIMULATIONS; SYNAPTIC PLASTICITY; SPIKING NEURONS; NEURAL-NETWORKS; ASSOCIATIVE MEMORY; RECURRENT NETWORK; DECISION-MAKING; MODEL; DYNAMICS; REWARD	Modeling work in neuroscience can be classified using two different criteria. The first one is the complexity of the model, ranging from simplified conceptual models that are amenable to mathematical analysis to detailed models that require simulations in order to understand their properties. The second criterion is that of direction of workflow, which can be from microscopic to macroscopic scales (bottom-up) or from behavioral target functions to properties of components (top-down). We review the interaction of theory and simulation using examples of top-down and bottom-up studies and point to some current developments in the fields of computational and theoretical neuroscience.	[Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, CH-1015 Lausanne, Switzerland; [Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Brain Mind Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Sprekeler, Henning] Tech Univ Berlin, D-10587 Berlin, Germany; [Sprekeler, Henning] Humboldt Univ, D-10115 Berlin, Germany; [Sprekeler, Henning] Bernstein Ctr Computat Neurosci Berlin, D-10115 Berlin, Germany; [Deco, Gustavo] Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona 08018, Spain; [Deco, Gustavo] Inst Catalana Recerca & Estudis Avancats, Barcelona 2308010, Spain	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Technical University of Berlin; Humboldt University of Berlin; Pompeu Fabra University; ICREA	Gerstner, W (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, CH-1015 Lausanne, Switzerland.	wulfram.gerstner@epfl.ch	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; DECO, GUSTAVO/A-6341-2008	DECO, GUSTAVO/0000-0002-8995-7583; Sprekeler, Henning/0000-0003-0690-3553	European Research Council [268689, 295129]; European Community [243914, 269921]; Swiss National Science Foundation [200020, 132871]; Spanish Ministerio de Economia y Competitividad [CDS-2007-00012, SAF2010-16085]; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); ICREA(ICREA)	Supported by European Research Council grants 268689 (W.G.) and 295129 (G.D.); the European Community's Seventh Framework Program (grant agreement 243914, Brain-I-Nets, W.G. and H.S.; grant agreement 269921, BrainScaleS, W.G. and G.D.); Swiss National Science Foundation grants 200020 and 132871; and Spanish Ministerio de Economia y Competitividad grants CDS-2007-00012 and SAF2010-16085. We thank T. Vogels for helpful discussions.	Abbott LF, 2008, NEURON, V60, P489, DOI 10.1016/j.neuron.2008.10.019; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Amit DJ, 1997, NETWORK-COMP NEURAL, V8, P373, DOI 10.1088/0954-898X/8/4/003; AMIT DJ, 1987, PHYS REV A, V35, P2293, DOI 10.1103/PhysRevA.35.2293; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; Ananthanarayanan R, 2009, PROCEEDINGS OF THE CONFERENCE ON HIGH PERFORMANCE COMPUTING NETWORKING, STORAGE AND ANALYSIS; ANDERSON J A, 1972, Mathematical Biosciences, V14, P197, DOI 10.1016/0025-5564(72)90075-2; APICELLA P, 1991, EXP BRAIN RES, V85, P491; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Barto AG, 2003, DISCRETE EVENT DYN S, V13, P343; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Bertsekas D. P., 1976, DYNAMIC PROGRAMMING; Bialek W., 1996, SPIKES EXPLORING NEU; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bower J. M., 1995, BOOK GENESIS; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; COHEN MA, 1983, IEEE T SYST MAN CYB, V13, P815, DOI 10.1109/TSMC.1983.6313075; Davison Andrew P, 2008, Front Neuroinform, V2, P11, DOI 10.3389/neuro.11.011.2008; Deco G, 2009, PROG NEUROBIOL, V88, P1, DOI 10.1016/j.pneurobio.2009.01.006; DERRIDA B, 1987, EUROPHYS LETT, V4, P167, DOI 10.1209/0295-5075/4/2/007; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Fremaux N, 2010, J NEUROSCI, V30, P13326, DOI 10.1523/JNEUROSCI.6249-09.2010; Furber S., 2009, APPL CONCURRENCY SYS, DOI 10.1109/ACSD.2009.17; Fusi S, 1999, NEURAL COMPUT, V11, P633, DOI 10.1162/089976699300016601; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; GERSTNER W, 1992, NETWORK-COMP NEURAL, V3, P139, DOI 10.1088/0954-898X/3/2/004; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Gleeson P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000815; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOLOMB D, 1990, PHYS REV A, V41, P1843, DOI 10.1103/PhysRevA.41.1843; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Hebb Donald O., 1949, ORG BEHAV; Helmholtz H., 1913, LEHRE TONEMPFINDUNGE; Herz AVM, 2006, SCIENCE, V314, P80, DOI 10.1126/science.1127240; Herzog MH, 2012, VISION RES, V61, P95, DOI 10.1016/j.visres.2011.11.001; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huys QJM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000379; Indiveri G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00073; Izhikevich E., 2005, SIMULATION LARGE SCA; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jeffery KJ, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/182602; Jolivet R, 2004, J NEUROPHYSIOL, V92, P959, DOI 10.1152/jn.00190.2004; Kistler WM, 1997, NEURAL COMPUT, V9, P1015, DOI 10.1162/neco.1997.9.5.1015; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; KOHONEN T, 1972, IEEE T COMPUT, VC 21, P353, DOI 10.1109/TC.1972.5008975; Lang S, 2011, NEURAL NETWORKS, V24, P998, DOI 10.1016/j.neunet.2011.06.013; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Legenstein R, 2010, J NEUROSCI, V30, P8400, DOI 10.1523/JNEUROSCI.4284-09.2010; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; LITTLE W A, 1974, Mathematical Biosciences, V19, P101, DOI 10.1016/0025-5564(74)90031-5; Loewenstein Y, 2006, P NATL ACAD SCI USA, V103, P15224, DOI 10.1073/pnas.0505220103; Mach E., 1906, ANAL EMPFINDUNGEN; Mahadevan S, 2007, J MACH LEARN RES, V8, P2169; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mead C.A., 1989, ANALOG VLSI NEURAL S; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Millner S., 2010, ADV NEURAL INFORM PR; Niebur E., 1994, ADV NEURAL INFORM PR, V6, P904; OBERMAYER K, 1990, PARALLEL COMPUT, V14, P381, DOI 10.1016/0167-8191(90)90088-Q; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ramaswamy S, 2012, J PHYSIOL-LONDON, V590, P737, DOI 10.1113/jphysiol.2011.219576; Ranjan Rajnish, 2011, Front Neuroinform, V5, P36, DOI 10.3389/fninf.2011.00036; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; ROCHESTER N, 1956, IRE T INFORM THEOR, V2, P80, DOI 10.1109/TIT.1956.1056810; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Schemmel J, 2007, IEEE INT SYMP CIRC S, P3367, DOI 10.1109/ISCAS.2007.378289; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Segev C, 1989, METHODS NEURONAL MOD, P9; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; TRAUB RD, 1988, IEEE ENG MED BIOL, V7, P31, DOI 10.1109/51.20378; Triesch J, 2007, NEURAL COMPUT, V19, P885, DOI 10.1162/neco.2007.19.4.885; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909; Xin M., 2010, COMPUT SCI ENG, V12, P91	110	98	99	4	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					60	65		10.1126/science.1227356	http://dx.doi.org/10.1126/science.1227356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042882	Green Submitted			2022-12-28	WOS:000309457400051
J	Wang, ZR; Wang, F; Peng, Y; Zheng, ZY; Han, YL				Wang, Ziren; Wang, Feng; Peng, Yi; Zheng, Zhongyu; Han, Yilong			Imaging the Homogeneous Nucleation During the Melting of Superheated Colloidal Crystals	SCIENCE			English	Article							PHASE-TRANSITION; STABILITY LIMIT; CATASTROPHE; SCIENCE; GROWTH; BULK	The nucleation process is crucial to many phase transitions, but its kinetics are difficult to predict and measure. We superheated and melted the interior of thermal-sensitive colloidal crystals and investigated by means of video microscopy the homogeneous melting at single-particle resolution. The observed nucleation precursor was local particle-exchange loops surrounded by particles with large displacement amplitudes rather than any defects. The critical size, incubation time, and shape and size evolutions of the nucleus were measured. They deviate from the classical nucleation theory under strong superheating, mainly because of the coalescence of nuclei. The superheat limit agrees with the measured Born and Lindemann instabilities.	[Wang, Ziren; Wang, Feng; Peng, Yi; Zheng, Zhongyu; Han, Yilong] Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Zheng, Zhongyu] Chinese Acad Sci, Inst Mech, Beijing 100190, Peoples R China	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Mechanics, CAS	Han, YL (corresponding author), Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China.	yilong@ust.hk		Wang, Ziren/0000-0003-0617-6560; Peng, Yi/0000-0003-1132-7140	Research Grants Council of Hong Kong [601208, 601911]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council of Hong Kong (General Research Fund 601208 and 601911), and we thank A. Alsayed and A. Yodh for providing the NIPA colloids.	Aaronson HI, 2010, MECHANISMS OF DIFFUSIONAL PHASE TRANSFORMATIONS IN METALS AND ALLOYS, P1, DOI 10.1201/b15829; Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; Auer S, 2001, NATURE, V409, P1020, DOI 10.1038/35059035; Bai XM, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.134109; Bai XM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.052108; Banhart F, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.185502; Burakovsky L, 2000, PHYS REV B, V61, P15011, DOI 10.1103/PhysRevB.61.15011; Cahn RW, 2001, NATURE, V413, P582, DOI 10.1038/35098169; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; DAEGES J, 1986, PHYS LETT A, V119, P79, DOI 10.1016/0375-9601(86)90418-4; Dash JG, 1999, REV MOD PHYS, V71, P1737, DOI 10.1103/RevModPhys.71.1737; Davidchack RL, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3514144; DENTON AR, 1989, PHYS REV A, V39, P4701, DOI 10.1103/PhysRevA.39.4701; FECHT HJ, 1988, NATURE, V334, P50, DOI 10.1038/334050a0; Forsblom M, 2005, NAT MATER, V4, P388, DOI 10.1038/nmat1375; Gallington LC, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3427247; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Gomez L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLEtt.90.095701; HERMAN JW, 1992, PHYS REV LETT, V69, P1228, DOI 10.1103/PhysRevLett.69.1228; Jin ZH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055703; LAAKSONEN A, 1995, ANNU REV PHYS CHEM, V46, P489, DOI 10.1146/annurev.pc.46.100195.002421; Larsen AE, 1997, NATURE, V385, P230, DOI 10.1038/385230a0; Lu K, 1998, PHYS REV LETT, V80, P4474, DOI 10.1103/PhysRevLett.80.4474; Luo SN, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.134206; Mei QS, 2007, PROG MATER SCI, V52, P1175, DOI 10.1016/j.pmatsci.2007.01.001; Moroni D, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.235703; Ostwald W., 1897, Z PHYS CHEM, V22, P289, DOI [DOI 10.1515/ZPCH-1897-2233, 10.1515/zpch-1897-2233]; Peng Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011404; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Savage JR, 2006, SCIENCE, V314, P795, DOI 10.1126/science.1128649; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; TALLON JL, 1989, NATURE, V342, P658, DOI 10.1038/342658a0; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	34	120	120	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					87	90		10.1126/science.1224763	http://dx.doi.org/10.1126/science.1224763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042889	Green Submitted			2022-12-28	WOS:000309457400058
J	Bangalore, S; Steg, PG; Deedwania, P; Crowley, K; Eagle, KA; Goto, S; Ohman, EM; Cannon, CP; Smith, SC; Zeymer, U; Hoffman, EB; Messerli, FH; Bhatt, DL				Bangalore, Sripal; Steg, Ph Gabriel; Deedwania, Prakash; Crowley, Kevin; Eagle, Kim A.; Goto, Shinya; Ohman, E. Magnus; Cannon, Christopher P.; Smith, Sidney C., Jr.; Zeymer, Uwe; Hoffman, Elaine B.; Messerli, Franz H.; Bhatt, Deepak L.		REACH Registry Investigators	beta-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENT RATES; BLOOD-PRESSURE; PROPENSITY SCORE; HEART-FAILURE; HYPERTENSION; RISK; THERAPY; ASSOCIATION; CARVEDILOL	Context beta-Blockers remain the standard of care after a myocardial infarction (MI). However, the benefit of beta-blocker use in patients with coronary artery disease (CAD) but no history of MI, those with a remote history of MI, and those with only risk factors for CAD is unclear. Objective To assess the association of beta-blocker use with cardiovascular events in stable patients with a prior history of MI, in those with CAD but no history of MI, and in those with only risk factors for CAD. Design, Setting, and Patients Longitudinal, observational study of patients in the Reduction of Atherothrombosis for Continued Health (REACH) registry who were divided into 3 cohorts: known prior MI (n = 14 043), known CAD without MI (n = 12 012), or those with CAD risk factors only (n = 18 653). Propensity score matching was used for the primary analyses. The last follow-up data collection was April 2009. Main Outcome Measures The primary outcome was a composite of cardiovascular death, nonfatal MI, or nonfatal stroke. The secondary outcome was the primary outcome plus hospitalization for atherothrombotic events or a revascularization procedure. Results Among the 44 708 patients, 21 860 were included in the propensity score-matched analysis. With a median follow-up of 44 months (interquartile range, 35-45 months), event rates were not significantly different in patients with beta-blocker use compared with those without beta-blocker use for any of the outcomes tested, even in the prior MI cohort (489 [16.93%] vs 532 [18.60%], respectively; hazard ratio [HR], 0.90 [95% CI, 0.79-1.03]; P = .14). In the CAD without MI cohort, the associated event rates were not significantly different in those with beta-blocker use for the primary outcome (391 [12.94%]) vs without beta-blocker use (405 [13.55%]) (HR, 0.92[95% CI, 0.79-1.08]; P = .31), with higher rates for the secondary outcome (1101 [30.59%] vs 1002 [27.84%]; odds ratio [OR], 1.14 [95% CI, 1.03-1.27]; P = .01) and for the tertiary outcome of hospitalization (870 [24.17%] vs 773 [21.48%]; OR, 1.17 [95% CI, 1.04-1.30]; P = .01). In the cohort with CAD risk factors only, the event rates were higher for the primary outcome with beta-blocker use (467 [14.22%]) vs without beta-blocker use (403 [12.11%]) (HR, 1.18 [95% CI, 1.02-1.36]; P = .02), for the secondary outcome (870 [22.01%] vs 797 [20.17%]; OR, 1.12 [95% CI, 1.00-1.24]; P = .04) but not for the tertiary outcomes of MI (89 [2.82%] vs 68 [2.00%]; HR, 1.36 [95% CI, 0.97-1.90]; P = .08) and stroke (210 [6.55%] vs 168 [5.12%]; HR, 1.22 [95% CI, 0.99-1.52]; P = .06). However, in those with recent MI (<= 1 year), beta-blocker use was associated with a lower incidence of the secondary outcome (OR, 0.77 [95% CI, 0.64-0.92]). Conclusion In this observational study of patients with either CAD risk factors only, known prior MI, or known CAD without MI, the use of beta-blockers was not associated with a lower risk of composite cardiovascular events. JAMA. 2012;308(13):1340-1349	[Bangalore, Sripal] NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY 10016 USA; [Steg, Ph Gabriel] Univ Paris Diderot, Hosp Bichat, AP HP, INSERM,U698, Paris, France; [Deedwania, Prakash] Univ Calif San Francisco, Dept Internal Med Cardiol, Sch Med, Fresno, CA USA; [Crowley, Kevin; Cannon, Christopher P.; Hoffman, Elaine B.; Bhatt, Deepak L.] TIMI Study Grp, Boston, MA USA; [Eagle, Kim A.] Univ Michigan Hlth Syst, Cardiovasc Ctr, Ann Arbor, MI USA; [Goto, Shinya] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Ohman, E. Magnus] Duke Univ, Med Ctr, Durham, NC USA; [Cannon, Christopher P.; Bhatt, Deepak L.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Cannon, Christopher P.; Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Sidney C., Jr.] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC USA; [Zeymer, Uwe] Herzzentrum Ludwigshafen, Ludwigshafen, Germany; [Zeymer, Uwe] Inst Herzinfarktforsch Ludwigshafen, Ludwigshafen, Germany; [Messerli, Franz H.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA USA	New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Tokai University; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Institute Heart Attack Research; Mount Sinai St. Luke's; Mount Sinai West; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Bangalore, S (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, 550 1st Ave, New York, NY 10016 USA.	sripalbangalore@gmail.com	Messerli, Franz/AAR-4783-2021; Bangalore, Sripal/B-6246-2013; Cannon, Christopher P/AAY-7644-2020; STEG, Philippe Gabriel/Z-1567-2019; Goto, Shinya/AAU-6045-2020; Statsenko, Mikhail E./N-7573-2015	Cannon, Christopher P/0000-0003-4596-2791; Goto, Shinya/0000-0002-6821-1504; Statsenko, Mikhail E./0000-0002-3306-0312; Bangalore, Sripal/0000-0001-9485-0652; STEG, Philippe Gabriel/0000-0001-6896-2941	sanofi-aventis; Servier [U-698]; New York University School of Medicine; Ablynx; Amarin; Amgen; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Meyers Squibb; Daiichi Sankyo; Eisai; GlaxoSmithKline; Lilly; Medtronic; Merck Sharp Dohme; Novartis; Otsuka; Pfizer; Roche; Medicines Company; Forest Pharmaceuticals; Daichii Sankyo; Asteras; Medtronics Japan; Mitsubishi Tanabe; Takeda; Mochida; Eli Lilly Company; Maquet; Accumetrics; Essentials; Merck; Regeneron; Ethicon; Waksman Foundation (Tokyo, Japan)	sanofi-aventis(Sanofi-Aventis); Servier(Servier); New York University School of Medicine; Ablynx(Ablynx); Amarin; Amgen(Amgen); Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Meyers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Medtronic(Medtronic); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Roche(Roche Holding); Medicines Company; Forest Pharmaceuticals; Daichii Sankyo(Daiichi Sankyo Company Limited); Asteras; Medtronics Japan; Mitsubishi Tanabe(Mitsubishi Tanabe Pharma Corporation); Takeda(Takeda Pharmaceutical Company Ltd); Mochida; Eli Lilly Company(Eli Lilly); Maquet; Accumetrics; Essentials; Merck(Merck & Company); Regeneron(Regeneron); Ethicon; Waksman Foundation (Tokyo, Japan)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Steg reported receiving a research grant from sanofi-aventis and Servier awarded to INSERM U-698 and the New York University School of Medicine; serving as a consultant or receiving speakers fees from Ablynx, Amarin, Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Meyers Squibb, Daiichi Sankyo, Eisai, GlaxoSmithKline, Lilly, Medtronic, Merck Sharp & Dohme, Novartis, Otsuka, Pfizer, Roche, sanofi-aventis, Servier, the Medicines Company; and holding stock in Aterovax. Dr Deedwania reported serving as a consultant or receiving speakers fees from Forest Pharmaceuticals, Novartis, Daichii Sankyo, Servier, and Pfizer. Dr Goto reported receiving consulting fees and honoraria from Eisai, sanofi-aventis, Otsuka, Bayer, Novartis, AstraZeneca, Asteras, Pfizer, Medtronics Japan, Mitsubishi Tanabe, Takeda, Daiichi Sankyo, Mochida, Merck Sharp & Dohme; and receiving research grants from sanofi-aventis, Eisai, Boehringer Ingelheim, Otsuka, and Daiichi Sankyo. Dr Ohman reported receiving research grants from Daiichi Sankyo, Eli Lilly & Company, Maquet; serving as a consultant to AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, LipoScience, Merck, Pozen, Roche, sanofi-aventis, the Medicines Company, and WebMD; and serving on the speakers bureau for Boehringer Ingelheim, Gilead Sciences, and the Medicines Company. Dr Cannon reported receiving research grants or support from Accumetrics, AstraZeneca, Essentials, GlaxoSmithKline, Merck, Regeneron, sanofi-aventis, and Takeda; serving on advisory boards (but funds donated to charity) for Bristol-Myers Squibb, Alnylam, Pfizer, and CSL; receiving honoraria for the development of independent educational symposia for Pfizer and AstraZeneca; and serving as a clinical advisor for and owning equity in Automedics Medical Systems. Dr Bhatt reported serving on an advisory board for Medscape Cardiology; serving on the boards of directors for Boston VA Research Institute and the Society of Chest Pain Centers; serving as chair for the American Heart Association Get With The Guidelines Science Subcommittee; receiving honoraria from the American College of Cardiology for serving as editor of Clinical Trials, Cardiosource, Duke Clinical Research Institute for serving on clinical trial steering committees, Slack Publications for serving as chief medical editor of Cardiology Today Intervention, and WebMD for serving on continuing medical education steering committees; serving as senior associate editor for the Journal of Invasive Cardiology; receiving research grants from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, sanofi-aventis, and the Medicines Company; and unfunded research from FlowCo, PLx Pharma, and Takeda. Drs Bangalore, Eagle, Smith Jr, Zeymer, Hoffman, and Messerli and Mr Crowley did not report any disclosures.; The REACH Registry is sponsored by sanofi-aventis, Bristol-Myers Squibb, and the Waksman Foundation (Tokyo, Japan) and is endorsed by the World Heart Federation. Statistical analyses of the REACH database by TIMI Study Group statisticians were funded by sanofi-aventis.	Ahmed A, 2006, EUR HEART J, V27, P1431, DOI 10.1093/eurheartj/ehi890; Bangalore S, 2008, INT J CLIN PRACT, V62, P1643, DOI 10.1111/j.1742-1241.2008.01916.x; Bangalore S, 2007, J HUM HYPERTENS, V21, P259, DOI 10.1038/sj.jhh.1002144; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1482, DOI 10.1016/j.jacc.2008.06.048; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1062, DOI 10.1016/j.jacc.2008.05.057; Bangalore S, 2008, AM HEART J, V156, P241, DOI 10.1016/j.ahj.2008.02.023; Bangalore S, 2007, AM J CARDIOL, V100, P1254, DOI 10.1016/j.amjcard.2007.05.057; Bangalore S, 2007, J AM COLL CARDIOL, V50, P563, DOI 10.1016/j.jacc.2007.04.060; Bangalore S, 2006, J AM COLL CARDIOL, V48, P1284, DOI 10.1016/j.jacc.2006.06.038; Bangalore Sripal, 2007, Curr Cardiol Rep, V9, P441, DOI 10.1007/BF02938387; Bangalore Sripal, 2006, Anadolu Kardiyol Derg, V6, P358; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bradley HA, 2006, J HYPERTENS, V24, P2131, DOI 10.1097/01.hjh.0000249685.58370.28; Chen J, 2000, ARCH INTERN MED, V160, P947, DOI 10.1001/archinte.160.7.947; Chen ZM, 2005, LANCET, V366, P1622; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hirata K, 2005, J HYPERTENS, V23, P551, DOI 10.1097/01.hjh.0000160211.56103.48; Jonsson G, 2005, CARDIOLOGY, V103, P148, DOI 10.1158/000084584; Kramer JM, 2006, AM HEART J, V152, P454, DOI 10.1016/j.ahj.2006.02.030; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Meine TJ, 2005, AM HEART J, V149, P1043, DOI 10.1016/j.ahj.2005.02.010; Messerli FH, 2002, JAMA-J AM MED ASSOC, V288, P1845; Messerli FH, 2008, J AM COLL CARDIOL, V51, P330, DOI 10.1016/j.jacc.2007.09.040; Morgan T, 2004, AM J HYPERTENS, V17, P118, DOI 10.1016/j.amjhyper.2003.09.012; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Rubin DB., 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; SNOW PJD, 1965, LANCET, V2, P551; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Weir MR, 2000, AM HEART J, V139, P174, DOI 10.1016/S0002-8703(00)90325-9; Wiysonge CS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002003.pub2; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; [No title captured]	46	318	332	0	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1340	1349		10.1001/jama.2012.12559	http://dx.doi.org/10.1001/jama.2012.12559			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032550	Bronze			2022-12-28	WOS:000309369300028
J	Detsky, AS; Verma, AA				Detsky, Allan S.; Verma, Amol A.			A New Model for Medical Education Celebrating Restraint	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE		[Detsky, Allan S.; Verma, Amol A.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.; Verma, Amol A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.; Verma, Amol A.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca		Verma, Amol/0000-0001-6857-931X				[Anonymous], PRIC EXC ID WAST HEA; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Crosson FJ, CHANGE MICROENVIRONM; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007	7	46	46	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1329	1330		10.1001/2012.jama.11869	http://dx.doi.org/10.1001/2012.jama.11869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032547				2022-12-28	WOS:000309369300025
J	Goldstein, L				Goldstein, Lawrence			Know your representatives	NATURE			English	Editorial Material									[Goldstein, Lawrence] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Goldstein, Lawrence] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Goldstein, L (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu						Goldstein LSB, 2012, MOL BIOL CELL, V23, P3279, DOI 10.1091/mbc.E12-01-0064; Goldstein LSB, 2011, MOL BIOL CELL, V22, P3943, DOI 10.1091/mbc.E11-05-0473; Pielke R, 2007, NATURE, V450, P347, DOI 10.1038/450347a; US Department of Health and Human Services, 2012, IMP NIH RES	4	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					494	495		10.1038/489494a	http://dx.doi.org/10.1038/489494a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23018948	Bronze			2022-12-28	WOS:000309167100023
J	Hughes, V				Hughes, Virginia			PUBLIC HEALTH Where there's smoke	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; COPD; EXPOSURE; CHINA; RISK											Han Jing-Xiu, 2006, Wei Sheng Yan Jiu, V35, P609; He Y, 2012, CHEST; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Jiang Y, 2007, AM J PREV MED, V33, P15, DOI 10.1016/j.amepre.2007.02.037; Yin P, 2007, LANCET, V370, P751, DOI 10.1016/S0140-6736(07)61378-6; Zheng JP, 2008, LANCET, V371, P2013, DOI 10.1016/S0140-6736(08)60869-7; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou YM, 2006, RESPIROLOGY, V11, P603, DOI 10.1111/j.1440-1843.2006.00897.x	8	14	14	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					S18	S20		10.1038/489S18a	http://dx.doi.org/10.1038/489S18a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	011LT	23013712	Bronze			2022-12-28	WOS:000309167100010
J	Oettl, A				Oettl, Alexander			Honour the helpful	NATURE			English	Editorial Material									Georgia Inst Technol, Scheller Coll Business, Atlanta, GA 30308 USA	University System of Georgia; Georgia Institute of Technology	Oettl, A (corresponding author), Georgia Inst Technol, Scheller Coll Business, Atlanta, GA 30308 USA.	alex.oettl@scheller.gatech.edu		Oettl, Alexander/0000-0001-8908-4674				Oettl A, 2012, MANAGE SCI, V58, P1122, DOI 10.1287/mnsc.1110.1470	1	10	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					496	497		10.1038/489496a	http://dx.doi.org/10.1038/489496a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	011LT	23018949	Bronze			2022-12-28	WOS:000309167100024
J	Ferner, R				Ferner, Robin			DRUG TALES AND OTHER STORIES Susceptibilities	BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Arie S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e951; Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; BATEMAN DN, 1989, Q J MED, V71, P307; Chan A, 2011, ANN NEUROL, V70, P684, DOI 10.1002/ana.22502; Lehr D., 1957, CAL W MED, V69, P417; Lewin L, 1881, NEBENWIRKUNGEN ARZNE; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; Patel T, 2012, CLIN EXP DERMATOL, V37, P718, DOI 10.1111/j.1365-2230.2012.04403.x	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6420	10.1136/bmj.e6420	http://dx.doi.org/10.1136/bmj.e6420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014905				2022-12-28	WOS:000309385500011
J	Pearse, RM; Moreno, RP; Bauer, P; Pelosi, P; Metnitz, P; Spies, C; Vallet, B; Vincent, JL; Hoeft, A; Rhodes, A				Pearse, Rupert M.; Moreno, Rui P.; Bauer, Peter; Pelosi, Paolo; Metnitz, Philipp; Spies, Claudia; Vallet, Benoit; Vincent, Jean-Louis; Hoeft, Andreas; Rhodes, Andrew		Trial Grp European Soc Intensive; Trial Grp European Soc	Mortality after surgery in Europe: a 7 day cohort study	LANCET			English	Article							SURGICAL QUALITY IMPROVEMENT; LONG-TERM SURVIVAL; NONCARDIAC SURGERY; CRITICAL-CARE; POSTOPERATIVE COMPLICATIONS; INPATIENT SURGERY; CANCER-SURGERY; MAJOR SURGERY; RISK; POPULATION	Background Clinical outcomes after major surgery are poorly described at the national level. Evidence of heterogeneity between hospitals and health-care systems suggests potential to improve care for patients but this potential remains unconfirmed. The European Surgical Outcomes Study was an international study designed to assess outcomes after non-cardiac surgery in Europe. Methods We did this 7 day cohort study between April 4 and April 11, 2011. We collected data describing consecutive patients aged 16 years and older undergoing inpatient non-cardiac surgery in 498 hospitals across 28 European nations. Patients were followed up for a maximum of 60 days. The primary endpoint was in-hospital mortality. Secondary outcome measures were duration of hospital stay and admission to critical care. We used chi(2) and Fisher's exact tests to compare categorical variables and the t test or the Mann-Whitney U test to compare continuous variables. Significance was set at p<0.05. We constructed multilevel logistic regression models to adjust for the differences in mortality rates between countries. Findings We included 46 539 patients, of whom 1855 (4%) died before hospital discharge. 3599 (8%) patients were admitted to critical care after surgery with a median length of stay of 1.2 days (IQR 0.9-3.6). 1358 (73%) patients who died were not admitted to critical care at any stage after surgery. Crude mortality rates varied widely between countries (from 1.2% [95% CI 0.0-3.0] for Iceland to 21.5% [16.9-26.2] for Latvia). After adjustment for confounding variables, important differences remained between countries when compared with the UK, the country with the largest dataset (OR range from 0.44 [95% CI 0.19-1.05; p=0.06] for Finland to 6.92 [2.37-20.27; p=0.0004] for Poland). Interpretation The mortality rate for patients undergoing inpatient non-cardiac surgery was higher than anticipated. Variations in mortality between countries suggest the need for national and international strategies to improve care for this group of patients.	[Pearse, Rupert M.] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Moreno, Rui P.] Ctr Hosp Lisboa Cent, Hosp Sao Jose, EPE, UCINC, Lisbon, Portugal; [Bauer, Peter] Med Univ Vienna, Sect Med Stat, Vienna, Austria; [Metnitz, Philipp] Med Univ Vienna, Dept Anaesthesia & Gen Intens Care, Vienna, Austria; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, IRCCS AOU San Martino IST, Genoa, Italy; [Spies, Claudia] Charite, D-13353 Berlin, Germany; [Vallet, Benoit] Univ Hosp, Lille, France; [Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Hosp, Brussels, Belgium; [Hoeft, Andreas] Univ Bonn, Dept Anaesthesiol, Bonn, Germany; [Rhodes, Andrew] St Georges Healthcare NHS Trust, London, England; [Rhodes, Andrew] St Georges Univ London, London, England	University of London; Queen Mary University London; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Medical University of Vienna; Medical University of Vienna; University of Genoa; IRCCS AOU San Martino IST; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite de Lille - ISITE; CHU Lille; Universite Libre de Bruxelles; University of Bonn; St Georges University London; St Georges University London	Pearse, RM (corresponding author), Royal London Hosp, Adult Crit Care Unit, London E1 1BB, England.	r.pearse@qmul.ac.uk	Rocco, Patricia/I-7460-2012; Monedero, Pablo/A-1696-2008; Koulenti, Despoina/D-4851-2010; Forget, Patrice/AAO-6918-2020; Ercole, Ari/B-6288-2009; Arteta Arteta, Donaldo/D-3894-2014; Castellani, Gianluca/ACH-4208-2022; Colomina, Maria J/C-4207-2014; Szakmany, Tamas/I-5546-2019; Pickkers, P./H-8080-2014; Cecconi, Maurizio/A-6241-2012; Mouton, Ronelle/A-9934-2012; Afshari, Arash/ABD-2969-2021; Hoste, Eric/A-6353-2008; Kirk-Bayley, Justin/A-1608-2013; Grasso, Salvatore/AAF-3696-2020; Stourac, Petr/J-3610-2012; Zupcic, Miroslav/Q-4604-2018; De Neve, Nikolaas/AAG-9589-2019; Ciobotaru, Oana Roxana/D-5789-2019; Tomescu, Cleopatra M/F-5197-2011; Rhodes, Andrew/G-4265-2011; Fernández-Garcia, Raquel/C-9750-2016; Lupu, Mary-Nicoleta/AAD-1420-2020; Sander, Michael/H-5434-2012; CORNECI, DAN/ABG-1803-2021; Wittmann, Maria/AAN-5276-2021; albaladejo, pierre/M-6901-2014; Moller, Kirsten/A-4751-2009; FERNÁNDEZ-GARCÍA, RAQUEL/F-5649-2015; Barrasa, Helena/W-5284-2018; Aldecoa, Cesar/G-6779-2016; de Nadal, Miriam/J-8127-2017; Grocott, Michael/C-4394-2008; Hagau, Natalia/B-7787-2012; Papathanakos, Georgios/AAN-1857-2021; Trenado Álvarez, Josep/Y-8823-2018; Wittmann, Maria/I-2125-2018; turi, stefano/AAC-2115-2019; Rello, Jordi/P-2402-2019; Oldner, Anders/Q-4353-2018; Šribar, Andrej/AAJ-8840-2020; Rylander, Christian/AAV-3713-2020; Webb, Stephen T/H-5480-2011; Heller, Axel R./A-2800-2013; Tomescu, Dana/J-9941-2013; Ristescu, Anca Irina/AAF-9010-2019; Pearse, Rupert/H-5426-2011; Spies, Claudia/AAJ-5412-2020; Grigoras, Ioana/A-5355-2015; Momeni, Mona/ABH-7592-2020; Malbrain, Manu LNG/B-3680-2017; Gkiokas, Georgios/AAE-6312-2020; Monti, Giacomo/AAN-2213-2020; Berger-Estilita, Joana/AAB-4497-2021; Bento, Luis/L-6623-2018; Montgomery, Jane/B-8022-2012; Smith, Fang G/H-8451-2018; RUIZ CASTRO, MANUEL/B-4695-2017; Vizcaychipi, Marcela/H-5487-2011	Rocco, Patricia/0000-0003-1412-7136; Monedero, Pablo/0000-0002-1596-5644; Koulenti, Despoina/0000-0003-4364-2612; Forget, Patrice/0000-0001-5772-8439; Ercole, Ari/0000-0001-8350-8093; Arteta Arteta, Donaldo/0000-0001-8909-563X; Castellani, Gianluca/0000-0001-5535-7056; Colomina, Maria J/0000-0003-0106-0956; Szakmany, Tamas/0000-0003-3632-8844; Pickkers, P./0000-0002-1104-4303; Cecconi, Maurizio/0000-0002-4376-6538; Mouton, Ronelle/0000-0001-9562-8199; Hoste, Eric/0000-0001-9301-8055; Kirk-Bayley, Justin/0000-0001-9493-045X; Grasso, Salvatore/0000-0002-0287-0232; Stourac, Petr/0000-0003-1944-5926; Zupcic, Miroslav/0000-0002-1989-7255; Ciobotaru, Oana Roxana/0000-0001-9173-6205; Rhodes, Andrew/0000-0002-8737-574X; Fernández-Garcia, Raquel/0000-0003-1275-8399; Sander, Michael/0000-0003-1677-3609; CORNECI, DAN/0000-0002-1170-0614; Wittmann, Maria/0000-0003-4786-7712; Moller, Kirsten/0000-0003-3058-1072; FERNÁNDEZ-GARCÍA, RAQUEL/0000-0003-1275-8399; Barrasa, Helena/0000-0003-2841-6035; Aldecoa, Cesar/0000-0001-9096-0387; de Nadal, Miriam/0000-0002-4559-2463; Grocott, Michael/0000-0002-9484-7581; Papathanakos, Georgios/0000-0003-2521-5326; Trenado Álvarez, Josep/0000-0002-2930-0766; Wittmann, Maria/0000-0003-4786-7712; turi, stefano/0000-0001-7365-3510; Rello, Jordi/0000-0003-0676-6210; Oldner, Anders/0000-0003-1600-9221; Rylander, Christian/0000-0002-4534-7150; Webb, Stephen T/0000-0002-2413-7883; Heller, Axel R./0000-0001-6144-3874; Tomescu, Dana/0000-0001-9673-5754; Ristescu, Anca Irina/0000-0003-0622-8068; Pearse, Rupert/0000-0002-4373-5934; Spies, Claudia/0000-0002-1062-0495; Grigoras, Ioana/0000-0001-9412-9574; Momeni, Mona/0000-0003-1965-2335; Malbrain, Manu LNG/0000-0002-1816-5255; Monti, Giacomo/0000-0002-3885-9238; Berger-Estilita, Joana/0000-0002-8695-4264; Tommasino, Concezione/0000-0001-8856-6866; Gonzalez Gallego, Miguel Angel/0000-0002-3115-5801; Petrucci, Nicola/0000-0002-0344-3478; Kyprianou, Theodoros/0000-0001-8272-7630; BELENGUER-MUNCHARAZ, ALBERTO/0000-0002-8693-9806; Jevdjic, Jasna/0000-0002-7471-5784; Vanlinthout, Luc/0000-0002-4541-5037; Martin-Villen, Luis/0000-0002-8397-4497; Schneider, Gerhard/0000-0002-4903-0118; Nanas, Serafim/0000-0003-4666-4550; Patel, Jaimin/0000-0003-4120-3923; KOUKOUBANI, TRIANTAFYLLIA/0000-0003-3658-1794; Cota Delgado, Francisco/0000-0002-8334-5340; Kvolik, Slavica/0000-0002-5244-9585; Sribar, Andrej/0000-0002-6517-9895; Forfori, Francesco/0000-0001-8201-8076; Parekh, Dhruv/0000-0002-1508-8362; Ruberto, Franco/0000-0001-7282-9457; Bestle, Morten/0000-0001-6585-2659; Jhanji, Shaman/0000-0002-1116-628X; KATSENOS, CHRYSOSTOMOS/0000-0002-1219-6544; Pottecher, Julien/0000-0001-6073-4354; Stephane, de Rudnicki/0000-0002-2520-8380; Agarwal, Banwari/0000-0001-5508-2590; Dieleman, Jan/0000-0001-5867-9341; Jawad, Monir/0000-0002-2544-5095; Papaioannou, Alexandra/0000-0002-5710-4279; Schuttler, Jurgen/0000-0001-5088-2169; Barros, Nelson/0000-0001-7919-2591; Tomic Mahecic, Tina/0000-0003-2470-6238; Bento, Luis/0000-0002-0260-003X; Mirkovic, Ivan/0000-0002-9462-2067; Kazune, Sigita/0000-0002-7010-3238; Barrio, Javier/0000-0002-1254-7252; Andrea, Bianchin/0000-0001-6108-8286; antonio, artigas/0000-0002-8029-1017; Fusari, Maurizio/0000-0001-7596-1090; Montgomery, Jane/0000-0001-6309-5930; Kotanidou, Anastasia/0000-0003-4703-0082; Couper, Keith/0000-0003-2123-2022; Van Obbergh, Luc/0000-0002-0040-2558; Gracia, Isabel/0000-0001-8442-8247; , Planas/0000-0001-8567-1441; borrat, xavier/0000-0002-9348-9284; Amaniti, Aikaterini/0000-0003-0028-3779; Tena, Beatriz/0000-0001-9325-0858; PRIMIERI, Paolo/0000-0001-6411-3125; Smith, Fang G/0000-0002-8095-0609; White, Stuart/0000-0002-0258-8210; Abelli, Marianna/0000-0002-3877-7048; Della Corte, Francesco/0000-0003-1736-2318; Page, Valerie/0000-0002-1506-2533; MERCIER, Frederic/0000-0002-1289-2849; clausen, nicola groes/0000-0002-3590-5171; Preckel, Benedikt/0000-0003-4412-9183; POVES ALVAREZ, RODRIGO/0000-0002-2208-8969; Seron, Carlos/0000-0002-8068-5016; Poelaert, Jan/0000-0002-0065-2899; Yeung, Joyce/0000-0003-2950-4758; RUIZ CASTRO, MANUEL/0000-0003-0471-1697; Nolan, Jerry/0000-0003-3141-3812; CABALLERO, JESUS/0000-0001-9005-9687; Simurina, Tatjana/0000-0002-2657-5537; Vizcaychipi, Marcela/0000-0001-7894-873X; Udristioiu, Aurelian/0000-0001-8375-8287; MASCIA, Antonio/0000-0002-4173-396X; Pelosi, Paolo/0000-0001-5055-3023; Libert, Nicolas/0000-0003-2085-8031	European Society of Intensive Care Medicine; European Society of Anaesthesiology; National Institute for Health Research [CS/08/08/17] Funding Source: researchfish	European Society of Intensive Care Medicine; European Society of Anaesthesiology; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. RP is a National Institute for Health Research (UK) Clinician Scientist.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Bilimoria KY, 2008, J CLIN ONCOL, V26, P4626, DOI 10.1200/JCO.2007.15.6356; Canet J, 2010, ANESTHESIOLOGY, V113, P1338, DOI 10.1097/ALN.0b013e3181fc6e0a; Care quality commission, 2012, HEART SURG UK; Clement ND, 2012, J BONE JOINT SURG BR, V94B, P200, DOI 10.1302/0301-620X.94B2.28114; Derogar M, 2012, J CLIN ONCOL, V30, P1615, DOI 10.1200/JCO.2011.40.3568; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Findlay GP, 2011, KNOWING RISK REV PER; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Glance LG, 2012, ANN SURG, V255, P696, DOI 10.1097/SLA.0b013e31824b45af; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jhanji S, 2008, ANAESTHESIA, V63, P695, DOI 10.1111/j.1365-2044.2008.05560.x; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Noordzij PG, 2010, ANESTHESIOLOGY, V112, P1105, DOI 10.1097/ALN.0b013e3181d5f95c; Pearse RM, 2006, CRIT CARE, V10, DOI 10.1186/cc4928; Pearse RM, 2008, CRIT CARE MED, V36, P1323, DOI 10.1097/CCM.0b013e31816a091b; Pearse RM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5759; Pearse RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2865; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Rowell KS, 2007, J AM COLL SURGEONS, V204, P1293, DOI 10.1016/j.jamcollsurg.2007.03.024; Squadrone V, 2005, JAMA-J AM MED ASSOC, V293, P589, DOI 10.1001/jama.293.5.589; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Yu PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010607	29	790	822	5	257	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1059	1065		10.1016/S0140-6736(12)61148-9	http://dx.doi.org/10.1016/S0140-6736(12)61148-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007VL	22998715	Green Published, Green Submitted			2022-12-28	WOS:000308916400026
J	Adams, TD; Davidson, LE; Litwin, SE; Kolotkin, RL; LaMonte, MJ; Pendleton, RC; Strong, MB; Vinik, R; Wanner, NA; Hopkins, PN; Gress, RE; Walker, JM; Cloward, TV; Nuttall, RT; Hammoud, A; Greenwood, JLJ; Crosby, RD; McKinlay, R; Simper, SC; Smith, SC; Hunt, SC				Adams, Ted D.; Davidson, Lance E.; Litwin, Sheldon E.; Kolotkin, Ronette L.; LaMonte, Michael J.; Pendleton, Robert C.; Strong, Michael B.; Vinik, Russell; Wanner, Nathan A.; Hopkins, Paul N.; Gress, Richard E.; Walker, James M.; Cloward, Tom V.; Nuttall, R. Tom; Hammoud, Ahmad; Greenwood, Jessica L. J.; Crosby, Ross D.; McKinlay, Rodrick; Simper, Steven C.; Smith, Sherman C.; Hunt, Steven C.			Health Benefits of Gastric Bypass Surgery After 6 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ROUX-EN-Y; CARDIOVASCULAR RISK-FACTORS; TYPE-2 DIABETES-MELLITUS; LIFE-STYLE INTERVENTION; BARIATRIC SURGERY; MEDICAL THERAPY; UNITED-STATES; OBESITY; WEIGHT; MORBIDITY	Context Extreme obesity is associated with health and cardiovascular disease risks. Although gastric bypass surgery induces rapid weight loss and ameliorates many of these risks in the short term, long-term outcomes are uncertain. Objective To examine the association of Roux-en-Y gastric bypass (RYGB) surgery with weight loss, diabetes mellitus, and other health risks 6 years after surgery. Design, Setting, and Participants A prospective Utah-based study conducted between July 2000 and June 2011 of 1156 severely obese (body mass index [BMI] >= 35) participants aged 18 to 72 years (82% women; mean BMI, 45.9; 95% CI, 31.2-60.6) who sought and received RYGB surgery (n = 418), sought but did not have surgery (n = 417; control group 1), or who were randomly selected from a population-based sample not seeking weight loss surgery (n = 321; control group 2). Main Outcome Measures Weight loss, diabetes, hypertension, dyslipidemia, and health-related quality of life were compared between participants having RYGB surgery and control participants using propensity score adjustment. Results Six years after surgery, patients who received RYGB surgery (with 92.6% follow-up) lost 27.7% (95% CI, 26.6%-28.9%) of their initial body weight compared with 0.2% (95% CI, -1.1% to 1.4%) gain in control group 1 and 0% (95% CI, -1.2% to 1.2%) in control group 2. Weight loss maintenance was superior in patients who received RYGB surgery, with 94% (95% CI, 92%-96%) and 76% (95% CI, 72%-81%) of patients receiving RYGB surgery maintaining at least 20% weight loss 2 and 6 years after surgery, respectively. Diabetes remission rates 6 years after surgery were 62% (95% CI, 49%-75%) in the RYGB surgery group, 8% (95% CI, 0%-16%) in control group 1, and 6% (95% CI, 0%-13%) in control group 2, with remission odds ratios (ORs) of 16.5 (95% CI, 4.7-57.6; P < .001) vs control group 1 and 21.5 (95% CI, 5.4-85.6; P < .001) vs control group 2. The incidence of diabetes throughout the course of the study was reduced after RYGB surgery (2%; 95% CI, 0%-4%; vs 17%; 95% CI, 10%-24%; OR, 0.11; 95% CI, 0.04-0.34 compared with control group 1 and 15%; 95% CI, 9%-21%; OR, 0.21; 95% CI, 0.060.67 compared with control group 2; both P < .001). The numbers of participants with bariatric surgery-related hospitalizations were 33 (7.9%), 13 (3.9%), and 6 (2.0%) for the RYGB surgery group and 2 control groups, respectively. Conclusion Among severely obese patients, compared with nonsurgical control patients, the use of RYGB surgery was associated with higher rates of diabetes remission and lower risk of cardiovascular and other health outcomes over 6 years. JAMA. 2012;308(11):1122-1131 www.jama.com	[Adams, Ted D.; Davidson, Lance E.; Litwin, Sheldon E.; Pendleton, Robert C.; Strong, Michael B.; Vinik, Russell; Wanner, Nathan A.; Hopkins, Paul N.; Gress, Richard E.; Walker, James M.; Hunt, Steven C.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84108 USA; [Hammoud, Ahmad] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84108 USA; [Greenwood, Jessica L. J.] Univ Utah, Sch Med, Dept Family & Prevent Med, Salt Lake City, UT 84108 USA; [Adams, Ted D.] Intermt Healthcare, Intermt Hlth & Fitness Inst, LDS Hosp, Salt Lake City, UT USA; [Walker, James M.; Cloward, Tom V.; Nuttall, R. Tom] Intermt Healthcare, Intermt Sleep Disorders Ctr, Salt Lake City, UT USA; [McKinlay, Rodrick; Simper, Steven C.; Smith, Sherman C.] Rocky Mt Associated Phy Inc, Salt Lake City, UT USA; [Litwin, Sheldon E.] Georgia Hlth Sci Univ, Dept Med, Augusta, GA USA; [Kolotkin, Ronette L.] Duke Univ Hlth Syst, Obes & Qual Life Consulting, Durham, NC USA; [Kolotkin, Ronette L.] Duke Univ Hlth Syst, Dept Community & Family Med, Durham, NC USA; [LaMonte, Michael J.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Crosby, Ross D.] Univ N Dakota, Sch Med, Neuropsychiat Res Inst, Fargo, ND USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center; University System of Georgia; Augusta University; Duke University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Neuropsychiatric Research Institute; University of North Dakota Grand Forks	Adams, TD (corresponding author), Univ Utah, Sch Med, Dept Internal Med, 420 Chipeta Way,Room 1160, Salt Lake City, UT 84108 USA.	ted.adams@utah.edu	Davidson, Lance E./AAA-9689-2019; LaMonte, Mike/AAC-9953-2021	Davidson, Lance E./0000-0002-1383-0666; Crosby, Ross/0000-0001-9131-1629; Kolotkin, Ronette/0000-0002-1300-2131	National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases [DK-55006]; Public Health Service from the National Center for Research Resources [M01-RR00064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001065, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055006, Z01DK055006] Funding Source: NIH RePORTER	National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Public Health Service from the National Center for Research Resources; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK-55006 from the National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases and Public Health Service research grant M01-RR00064 from the National Center for Research Resources.	Adams TD, 2005, CONTEMP CLIN TRIALS, V26, P534, DOI 10.1016/j.cct.2005.05.003; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Adams TD, 2010, OBESITY, V18, P121, DOI 10.1038/oby.2009.178; Benraouane F, 2011, CURR OPIN CARDIOL, V26, P555, DOI 10.1097/HCO.0b013e32834b7fc4; Bocchieri LE, 2002, OBES SURG, V12, P781, DOI 10.1381/096089202320995556; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Crosby RD, 2004, J CLIN EPIDEMIOL, V57, P1153, DOI 10.1016/j.jclinepi.2004.04.004; DiGiorgi M, 2010, SURG OBES RELAT DIS, V6, P249, DOI 10.1016/j.soard.2009.09.019; Dixon JB, 2012, OBES REV, V13, P57, DOI 10.1111/j.1467-789X.2011.00928.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Espeland M, 2007, DIABETES CARE, V30, P1374; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Horm J., 1996, NATL DEATH INDEX PLU, pA5; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kushner RF, 2006, MAYO CLIN PROC, V81, pS46; Madala MC, 2008, J AM COLL CARDIOL, V52, P979, DOI 10.1016/j.jacc.2008.04.067; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Smith SC, 2004, OBES SURG, V14, P73, DOI 10.1381/096089204772787329; SMITH SC, 1995, OBES SURG, V5, P314, DOI 10.1381/096089295765557700; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Torquati A, 2005, J GASTROINTEST SURG, V9, P1112, DOI 10.1016/j.gassur.2005.07.016; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; Wee CC, 2008, J AM COLL CARDIOL, V52, P620, DOI 10.1016/j.jacc.2008.05.021; WILLIAMS RR, 1988, AM J PUBLIC HEALTH, V78, P1283, DOI 10.2105/AJPH.78.10.1283; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Wittgrove AC, 2000, OBES SURG, V10, P233, DOI 10.1381/096089200321643511; Zimmet P, 2012, NEW ENGL J MED, V366, P1635, DOI 10.1056/NEJMe1202443	40	449	456	3	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1122	1131		10.1001/2012.jama.11164	http://dx.doi.org/10.1001/2012.jama.11164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990271	Green Accepted			2022-12-28	WOS:000308861000028
J	Farley, TA				Farley, Thomas A.			The Role of Government in Preventing Excess Calorie Consumption The Example of New York City	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Farley, TA (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,8th Floor, Queens, NY 11101 USA.	tfarley@health.nyc.gov						Alcorn T, 2012, LANCET, V379, P2037, DOI 10.1016/S0140-6736(12)60879-4; [Anonymous], 2010, REP DIET GUID ADV D; Bauerlein Valerie, 2011, WALL STREET J; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Rolls BJ, 2007, OBESITY, V15, P1535, DOI 10.1038/oby.2007.182	8	14	14	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1093	1094		10.1001/2012.jama.11623	http://dx.doi.org/10.1001/2012.jama.11623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990264				2022-12-28	WOS:000308861000021
J	Hiatt, WR; Goldfine, AB; Kaul, S				Hiatt, William R.; Goldfine, Allison B.; Kaul, Sanjay			Cardiovascular Risk Assessment in the Development of New Drugs for Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hiatt, William R.] Univ Colorado, Sch Med, CPC Clin Res, Aurora, CO 80045 USA; [Hiatt, William R.] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO 80045 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Kaul, Sanjay] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Hiatt, WR (corresponding author), Univ Colorado, Sch Med, CPC Clin Res, 13199 E Montview Blvd,Ste 200, Aurora, CO 80045 USA.	will.hiatt@ucdenver.edu		Goldfine, Allison/0000-0002-0345-1048				[Anonymous], GUID IND DIAB MELL E; Hiatt WR, 2012, CIRCULATION, V125, P1171, DOI 10.1161/CIRCULATIONAHA.111.023499; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; US Food and Drug Administration, CLIN BRIEF DOC NEW D; US Food and Drug Administration, GUID IND DEV PROD WE	5	13	13	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1099	1100		10.1001/jama.2012.9931	http://dx.doi.org/10.1001/jama.2012.9931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990267				2022-12-28	WOS:000308861000024
J	Livingston, EH; Zylke, JW				Livingston, Edward H.; Zylke, Jody W.			Progress in Obesity Research Reasons for Optimism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; CARDIOMETABOLIC RISK-FACTORS; WEIGHT-LOSS MAINTENANCE; BODY-MASS INDEX; BARIATRIC SURGERY; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; ADULTS; ADOLESCENTS; PREVALENCE					edward.livingston@jamanetwork.org						Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Davis CL, 2012, JAMA-J AM MED ASSOC, V308, P1103, DOI 10.1001/2012.jama.10762; Dixon JB, 2012, JAMA-J AM MED ASSOC, V308, P1142, DOI 10.1001/2012.jama.11580; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Farley TA, 2012, JAMA-J AM MED ASSOC, V308, P1093, DOI 10.1001/2012.jama.11623; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Hiatt WR, 2012, JAMA-J AM MED ASSOC, V308, P1099, DOI 10.1001/jama.2012.9931; Jakicic JM, 2012, JAMA-J AM MED ASSOC, V307, P2617, DOI 10.1001/jama.2012.6866; King WC, 2012, JAMA-J AM MED ASSOC, V307, P2516, DOI 10.1001/jama.2012.6147; Maciejewski ML, 2011, JAMA-J AM MED ASSOC, V305, P2419, DOI 10.1001/jama.2011.817; Morrato EH, 2012, JAMA-J AM MED ASSOC, V308, P1097, DOI 10.1001/jama.2012.10007; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Neovius M, 2012, JAMA-J AM MED ASSOC, V308, P1132, DOI 10.1001/2012.jama.11792; O'Brien PE, 2010, JAMA-J AM MED ASSOC, V303, P519, DOI 10.1001/jama.2010.81; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Rock CL, 2010, JAMA-J AM MED ASSOC, V304, P1803, DOI 10.1001/jama.2010.1503; Rodgers GP, 2012, JAMA-J AM MED ASSOC, V308, P1095, DOI 10.1001/2012.jama.11853; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461	26	10	11	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1162	1164		10.1001/2012.jama.12203	http://dx.doi.org/10.1001/2012.jama.12203			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990276				2022-12-28	WOS:000308861000033
J	Alberts, MJ				Alberts, Mark J.			Citicoline did not improve recovery at 90 days after moderate-to-severe acute ischemic stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Alberts, MJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							Davalos A, 2002, STROKE, V33, P2850, DOI 10.1161/01.STR.0000038691.03334.71; Meretoja A, 2010, STROKE, V41, P1102, DOI 10.1161/STROKEAHA.109.577718; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90	3	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-13	10.7326/0003-4819-157-6-201209180-02013	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986405				2022-12-28	WOS:000308912800012
J	Johnson, BE				Johnson, Bruce E.			Review: Teriparatide reduces fractures in postmenopausal women with osteoporosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Johnson, Bruce E.] Virginia Tech Carilion Sch Med, Roanoke, VA USA		Johnson, BE (corresponding author), Virginia Tech Carilion Sch Med, Roanoke, VA USA.							Bauer DC, 2012, ARCH INTERN MED, V172, P936, DOI 10.1001/archinternmed.2012.1827; Meier RPH, 2012, ARCH INTERN MED, V172, P930, DOI 10.1001/archinternmed.2012.1796; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619	3	1	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-4	10.7326/0003-4819-157-6-201209180-02004	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986396				2022-12-28	WOS:000308912800003
J	Lader, E				Lader, Ellis			Glargine did not reduce CV events more than standard care in patients with dysglycemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GLUCOSE CONTROL		NYU, Sch Med, Kingston, NY USA	New York University	Lader, E (corresponding author), NYU, Sch Med, Kingston, NY USA.							Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sobel BE, 2011, CIRCULATION, V124, P695, DOI 10.1161/CIRCULATIONAHA.110.014860	7	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-10	10.7326/0003-4819-157-6-201209180-02010	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986402				2022-12-28	WOS:000308912800009
J	Buganim, Y; Faddah, DA; Cheng, AW; Itskovich, E; Markoulaki, S; Ganz, K; Klemm, SL; van Oudenaarden, A; Jaenisch, R				Buganim, Yosef; Faddah, Dina A.; Cheng, Albert W.; Itskovich, Elena; Markoulaki, Styliani; Ganz, Kibibi; Klemm, Sandy L.; van Oudenaarden, Alexander; Jaenisch, Rudolf			Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase	CELL			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; MOUSE; GENERATION; NETWORKS; STATE	During cellular reprogramming, only a small fraction of cells become induced pluripotent stem cells (iPSCs). Previous analyses of gene expression during reprogramming were based on populations of cells, impeding single-cell level identification of reprogramming events. We utilized two gene expression technologies to profile 48 genes in single cells at various stages during the reprogramming process. Analysis of early stages revealed considerable variation in gene expression between cells in contrast to late stages. Expression of Esrrb, Utf1, Lin28, and Dppa2 is a better predictor for cells to progress into iPSCs than expression of the previously suggested reprogramming markers Fbxo15, Fgf4, and Oct4. Stochastic gene expression early in reprogramming is followed by a late hierarchical phase with Sox2 being the upstream factor in a gene expression hierarchy. Finally, downstream factors derived from the late phase, which do not include Oct4, Sox2, Klf4, c-Myc, and Nanog, can activate the pluripotency circuitry.	[Buganim, Yosef; Faddah, Dina A.; Cheng, Albert W.; Itskovich, Elena; Markoulaki, Styliani; Ganz, Kibibi; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Faddah, Dina A.; van Oudenaarden, Alexander; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert W.] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Klemm, Sandy L.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Cheng, Albert/0000-0003-2653-5743	NIH Kirschstein NRSA [1 F32 GM099153-01A1]; NSF; Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; NIH [HD 045022, R37CA084198, 1DP1OD003936]; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R37CA084198, U54CA143874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099153] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	NIH Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Yarden Katz, Sovan Sarkar, Malkiel Cohen, Bryce Carey, and Jonathan Friedman for fruitful discussions, Patti Wisniewski and Chad Araneo for their help with cell sorting, and Stuart Levine for help with pilot Fluidigm experiments. Y.B. was supported by an NIH Kirschstein NRSA (1 F32 GM099153-01A1). D.A.F. is a Vertex Scholar and was supported by an NSF Graduate Research Fellowship and Jerome and Florence Brill Graduate Student Fellowship. A.W.C. was supported by a Croucher and Ludwig Research Fellowship. R.J. is an adviser to Stemgent and cofounder of Fate Therapeutics. This work was supported by NIH grants HD 045022 and R37CA084198 to R.J. and the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874) and a NIH Pioneer award (1DP1OD003936) to A.v.O.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	43	606	630	9	165	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1209	1222		10.1016/j.cell.2012.08.023	http://dx.doi.org/10.1016/j.cell.2012.08.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980981	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000308928100014
J	Kastenmuller, W; Torabi-Parizi, P; Subramanian, N; Lammermann, T; Germain, RN				Kastenmueller, Wolfgang; Torabi-Parizi, Parizad; Subramanian, Naeha; Laemmermann, Tim; Germain, Ronald N.			A Spatially-Organized Multicellular Innate Immune Response in Lymph Nodes Limits Systemic Pathogen Spread	CELL			English	Article							CD8(+) T-CELLS; VACCINIA VIRUS; MACROPHAGE POLARIZATION; SUBCAPSULAR SINUS; MIGRATION; INFECTION; RECOGNITION; LYMPHOCYTES; ACTIVATION; MECHANISM	The lymphatic network that transports interstitial fluid and antigens to lymph nodes constitutes a conduit system that can be hijacked by invading pathogens to achieve systemic spread unless dissemination is blocked in the lymph node itself. Here, we show that a network of diverse lymphoid cells (natural killer cells, gamma delta T cells, natural killer T cells, and innate-like CD8+ T cells) are spatially prepositioned close to lymphatic sinus-lining sentinel macrophages where they can rapidly and efficiently receive inflammasome-generated IL-18 and additional cytokine signals from the pathogen-sensing phagocytes. This leads to rapid IFN gamma secretion by the strategically positioned innate lymphocytes, fostering antimicrobial resistance in the macrophage population. Interference with this innate immune response loop allows systemic spread of lymph-borne bacteria. These findings extend our understanding of the functional significance of cellular positioning and local intercellular communication within lymph nodes while emphasizing the role of these organs as highly active locations of innate host defense.	[Kastenmueller, Wolfgang; Torabi-Parizi, Parizad; Subramanian, Naeha; Laemmermann, Tim; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kastenmuller, W (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	kastenmullerw@mail.nih.gov; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; Lämmermann, Tim/AAD-7453-2022	Subramanian, Naeha/0000-0003-3754-0521	NIAID; NIH; DFG; International Human Frontier Science Program;  [KA 3091/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); International Human Frontier Science Program(Human Frontier Science Program); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program, NIAID, NIH, DFG, KA 3091/1-1 to W.K. and by a fellowship grant from the International Human Frontier Science Program to T.L. We thank A. Sher, Y. Belkaid, and K. Abdi for kindly providing mouse strains, B. Moss for generously providing pLW-73, E. Miao and B. Borlee for generously providing PA strains and E. Long for critically reading this manuscript. The authors would also like to thank Austin Rinker for technical support.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BODEY GP, 1983, REV INFECT DIS, V5, P279; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dayer JM, 2003, EUR RESPIR J, V22, p10S, DOI 10.1183/09031936.03.00000403b; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2010, EUR J IMMUNOL, V40, P2103, DOI 10.1002/eji.201040482; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; SENKEVICH TG, 1995, J VIROL, V69, P4103, DOI 10.1128/JVI.69.7.4103-4111.1995; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Symons JA, 2002, J GEN VIROL, V83, P2833, DOI 10.1099/0022-1317-83-11-2833; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	55	263	265	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1235	1248		10.1016/j.cell.2012.07.021	http://dx.doi.org/10.1016/j.cell.2012.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980983	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000308928100016
J	Abascal, W; Esteves, E; Goja, B; Mora, FG; Lorenzo, A; Sica, A; Triunfo, P; Harris, JE				Abascal, Winston; Esteves, Elba; Goja, Beatriz; Gonzalez Mora, Franco; Lorenzo, Ana; Sica, Amanda; Triunfo, Patricia; Harris, Jeffrey E.			Tobacco control campaign in Uruguay: a population-based trend analysis	LANCET			English	Article							CIGARETTE-SMOKING; CONTROL PROGRAM; PREVALENCE; DECREASE; IMPACT; BRAZIL; PRICE	Background In 2005, Uruguay initiated a series of comprehensive anti-smoking measures. We aimed to assess the effect of Uruguay's anti-tobacco campaign. Methods We did a population-based trend analysis, using neighbouring Argentina, which has not instituted such extensive anti-tobacco measures, as a control. We assessed three key endpoints in both countries: per-person consumption of cigarettes, as measured by tax records; the prevalence of tobacco use in adolescents, as measured by school-based surveys; and the prevalence of tobacco use in adults, as measured by nationwide household-based surveys. Findings During 2005-11, per-person consumption of cigarettes in Uruguay decreased by 4.3% per year (95% CI 2.4 to 6.2), whereas per-person consumption in Argentina increased by 0.6% per year (-1.2 to 2.5; p=0.002 for difference in trends). During 2003-09, the 30-day prevalence of tobacco use in Uruguayan students aged 13 years, 15 years, and 17 years decreased by an estimated 8.0% per year (4.5 to 11.6), compared with a decrease of 2.5% annually (0.5 to 4.5) in Argentinian students during 2001-09 (p=0.02 for difference in trends). From 2005 to 2011, the prevalence of current tobacco use in Uruguay decreased annually by an estimated 3.3% (2.4 to 4.1), compared with an annual decrease in Argentina of 1.7% (0.8 to 2.6; p=0.02 for difference in trends). Interpretation Uruguay's comprehensive tobacco-control campaign has been associated with a substantial, unprecedented decrease in tobacco use. Decreases in tobacco use in other low-income and middle-income countries of the magnitude seen in Uruguay would have a substantial effect on the future global burden of tobacco-related diseases.	[Harris, Jeffrey E.] MIT, Dept Econ, Cambridge, MA 02139 USA; [Abascal, Winston; Lorenzo, Ana] Minist Publ Hlth, Natl Programme Tobacco Control, Montevideo, Uruguay; [Esteves, Elba] Natl Resources Fund, Tobacco Treatment Programme, Montevideo, Uruguay; [Goja, Beatriz; Gonzalez Mora, Franco] Univ Republica, Fac Med, Montevideo, Uruguay; [Triunfo, Patricia] Univ Republica, Fac Social Sci, Dept Econ, Montevideo, Uruguay; [Sica, Amanda] Honorary Commiss Fight Canc, Educ Tech & Vocat Training Area, Montevideo, Uruguay	Massachusetts Institute of Technology (MIT); Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Harris, JE (corresponding author), MIT, Dept Econ, Cambridge, MA 02139 USA.	jeffrey@mit.edu			J William Fulbright Foreign Scholarship Board [4695]; Bureau of Education and Cultural Affairs of the US Department of State; JEH's travel; J William Fulbright Foreign Scholarship Board; US Department of State	J William Fulbright Foreign Scholarship Board; Bureau of Education and Cultural Affairs of the US Department of State; JEH's travel; J William Fulbright Foreign Scholarship Board; US Department of State	A Fulbright Specialist grant from the J William Fulbright Foreign Scholarship Board (number 4695) and the Bureau of Education and Cultural Affairs of the US Department of State, supported JEH's travel to and stay in Uruguay. We thank Maximo Rossi for providing valuable suggestions for the design of our study. We thank Laura Nalbarte, Hector Suarez, and Eugenio Martinez for providing survey data.; J William Fulbright Foreign Scholarship Board and the US Department of State.	Biener L, 2000, BRIT MED J, V321, P351, DOI 10.1136/bmj.321.7257.351; Blanco-Marquizo A, 2010, TOB CONTROL, V19, P231, DOI 10.1136/tc.2009.034769; Boado M, 2010, TENDENCIAS MED, V18, P26; Comision Economica para America Latina (CEPAL), 2006, STAT APP TABL 29 SCH; Conte Grand M, 2005, U CEMA SERIE DOCUMEN; Ferrante D, 2011, REV ARGENT SALUD PUB, V2, P34; Fong GT, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2010.036483; Galduroz JCF, 2007, ADDICT BEHAV, V32, P1309, DOI 10.1016/j.addbeh.2006.09.004; Gartner CE, 2009, TOB CONTROL, V18, P183, DOI 10.1136/tc.2008.027615; Gonzalez-Rozada M, 2006, EC TOBACCO CONTROL S; International Tobacco Control Policy Evaluation Project, 2010, ITC UR SUMM; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Lance PM, 2004, J HEALTH ECON, V23, P173, DOI 10.1016/j.jhealeco.2003.09.004; Legislatura de la Ciudad Autonoma de Buenos Aires, 2005, LEG CIUD AUT BUEN AI; Lencucha R, 2010, LANCET, V376, P852, DOI 10.1016/S0140-6736(10)61256-1; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Martinez Eugenio, 2006, Prev Control, V2, P187, DOI 10.1016/j.precon.2007.07.002; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miguez H, 2000, PSICOACTIVA, V18, P1; Monteiro CA, 2007, B WORLD HEALTH ORGAN, V85, P527, DOI 10.2471/BLT.06.039073; Ramos A, 2006, EC TOBACCO CONTROL S; Republica Argentina, 2011, B OFICIAL REPUBLICA, V32, P1; SANDOYA EDGARDO, 2011, Rev.Urug.Cardiol., V26, P201; Schenker N, 2010, STAT MED, V29, P533, DOI 10.1002/sim.3809; Sebrie EM, 2012, TOB CONTROL, DOI [10.1136/tobaccocontrol-2011-050134, DOI 10.1136/TOBACCOCONTR0L-2011-050134]; Stillman FA, 2003, JNCI-J NATL CANCER I, V95, P1681, DOI 10.1093/jnci/djg098; Sweet M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4270; Szklo AS, 2012, PREV MED, V54, P162, DOI 10.1016/j.ypmed.2011.12.005; Tsai YW, 2005, HEALTH ECON, V14, P627, DOI 10.1002/hec.972; Wade B, 2011, EUR J PUBLIC HEALTH, V21, P366, DOI 10.1093/eurpub/ckq098; Warren Charles W, 2009, Glob Health Promot, V16, P38, DOI 10.1177/1757975909342192; White VM, 2011, ADDICTION, V106, P1493, DOI 10.1111/j.1360-0443.2011.03429.x; WHO, 2011, PART WHO FRAM CONV T; World Health Organization, 2019, WHO REPORT GLOBAL TO	35	53	59	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1575	1582		10.1016/S0140-6736(12)60826-5	http://dx.doi.org/10.1016/S0140-6736(12)60826-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030VR	22981904				2022-12-28	WOS:000310598700033
J	Silva, GAE; Valente, JG				Azevedo e Silva, Gulnar; Valente, Joaquim Goncalves			Tobacco control: learning from Uruguay	LANCET			English	Editorial Material									[Azevedo e Silva, Gulnar; Valente, Joaquim Goncalves] Univ Estado Rio De Janeiro, Inst Social Med, BR-20550900 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Silva, GAE (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, BR-20550900 Rio De Janeiro, Brazil.	gulnar@ims.uerj.br						Abascal W, 2012, LANCET; Azevedo e Silva G, 2011, REV BRAS EPIDEMIO S1, V14, P103, DOI DOI 10.1590/S1415-790X2011000500011; Brazilian Institute of Geography and Statistics, 2008, NAT SURV HOUS SAMPL; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Framework Convention Alliance, STAT WHO FRAM CONV T; Ministry of Health National institute of Cancer, FRAM CONV TOB CONTR; Monteiro CA, 2007, B WORLD HEALTH ORGAN, V85, P527, DOI 10.2471/BLT.06.039073; Moore K, 2012, INT J PUBLIC HEALTH, V57, P777, DOI 10.1007/s00038-012-0378-5; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; United Nations Development Programme, HUM DEV REP; Warner KE, 2012, TOB CONTROL, V21, P103, DOI 10.1136/tobaccocontrol-2011-050396; World Health Organization, 2019, WHO REP GLOB TOB EP	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1538	1540		10.1016/S0140-6736(12)61143-X	http://dx.doi.org/10.1016/S0140-6736(12)61143-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030VR	22981901				2022-12-28	WOS:000310598700009
J	Zhang, QC; Petrey, D; Deng, L; Qiang, L; Shi, Y; Thu, CA; Bisikirska, B; Lefebvre, C; Accili, D; Hunter, T; Maniatis, T; Califano, A; Honig, B				Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Qiang, Li; Shi, Yu; Thu, Chan Aye; Bisikirska, Brygida; Lefebvre, Celine; Accili, Domenico; Hunter, Tony; Maniatis, Tom; Califano, Andrea; Honig, Barry			Structure-based prediction of protein-protein interactions on a genome-wide scale	NATURE			English	Article							NETWORKS; DATABASE; SEQUENCES; CONTEXT	The genome-wide identification of pairs of interacting proteins is an important step in the elucidation of cell regulatory mechanisms(1,2). Much of our present knowledge derives from high-throughput techniques such as the yeast two-hybrid assay and affinity purification(3), as well as from manual curation of experiments on individual systems(4). A variety of computational approaches based, for example, on sequence homology, gene co-expression and phylogenetic profiles, have also been developed for the genome-wide inference of protein-protein interactions (PPIs)(5,6). Yet comparative studies suggest that the development of accurate and complete repertoires of PPIs is still in its early stages(7-9). Here we show that three-dimensional structural information can be used to predict PPIs with an accuracy and coverage that are superior to predictions based on non-structural evidence. Moreover, an algorithm, termed PrePPI, which combines structural information with other functional clues, is comparable in accuracy to high-throughput experiments, yielding over 30,000 high-confidence interactions for yeast and over 300,000 for human. Experimental tests of a number of predictions demonstrate the ability of the PrePPI algorithm to identify unexpected PPIs of considerable biological interest. The surprising effectiveness of three-dimensional structural information can be attributed to the use of homology models combined with the exploitation of both close and remote geometric relationships between proteins.	[Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Thu, Chan Aye; Maniatis, Tom; Califano, Andrea; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zhang, Qiangfeng Cliff; Petrey, Donald; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Bisikirska, Brygida; Lefebvre, Celine; Califano, Andrea; Honig, Barry] Columbia Univ, Columbia Initiat Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Deng, Lei] Tongji Univ, Dept Comp Sci & Technol, Shanghai 201804, Peoples R China; [Qiang, Li; Accili, Domenico] Columbia Univ, Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Shi, Yu; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Lefebvre, Celine; Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Tongji University; Columbia University; Salk Institute; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	califano@c2b2.columbia.edu; bh6@columbia.edu	Zhang, Qiangfeng/C-2902-2011; Lefebvre, Celine/E-6290-2013; Califano, Andrea/F-7239-2012; Shi, Yu/N-4319-2019; dong, minghui/D-1806-2015	Shi, Yu/0000-0001-6742-9598; Califano, Andrea/0000-0003-4742-3679; Qiang, Li/0000-0001-8322-1797	National Institutes of Health [GM030518, GM094597, CA121852, DK057539, CA082683, R01NS043915]; China Scholarship Council [2010626059]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA082683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030518, R01GM030518, U54GM094597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health grants GM030518 and GM094597 (B.H.), CA121852 (A.C. and B.H.), DK057539 (D.A.), CA082683 (T.H.), R01NS043915 (T.M.). L.D. thanks the China Scholarship Council scholarship 2010626059. We thank U. Pieper from A. Sali's laboratory for help with ModBase, and H. Lee for help with SkyBase.	Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Davis FP, 2006, NUCLEIC ACIDS RES, V34, P2943, DOI 10.1093/nar/gkl353; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Enault F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-247; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Mirkovic N, 2007, PROTEINS, V66, P766, DOI 10.1002/prot.21191; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Salwinski L, 2003, CURR OPIN STRUC BIOL, V13, P377, DOI 10.1016/S0959-440X(03)00070-8; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107	44	464	487	10	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					556	+		10.1038/nature11503	http://dx.doi.org/10.1038/nature11503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023127	Green Accepted			2022-12-28	WOS:000310196200046
J	Chang, JC; Lockner, DA; Reches, Z				Chang, J. C.; Lockner, D. A.; Reches, Z.			Rapid Acceleration Leads to Rapid Weakening in Earthquake-Like Laboratory Experiments	SCIENCE			English	Article							RUPTURE; SLIP; GOUGE; LUBRICATION; FRACTURE; POWDER; ZONE	After nucleation, a large earthquake propagates as an expanding rupture front along a fault. This front activates countless fault patches that slip by consuming energy stored in Earth's crust. We simulated the slip of a fault patch by rapidly loading an experimental fault with energy stored in a spinning flywheel. The spontaneous evolution of strength, acceleration, and velocity indicates that our experiments are proxies of fault-patch behavior during earthquakes of moment magnitude (M-w) = 4 to 8. We show that seismically determined earthquake parameters (e.g., displacement, velocity, magnitude, or fracture energy) can be used to estimate the intensity of the energy release during an earthquake. Our experiments further indicate that high acceleration imposed by the earthquake's rupture front quickens dynamic weakening by intense wear of the fault zone.	[Chang, J. C.; Reches, Z.] Univ Oklahoma, Norman, OK 73019 USA; [Lockner, D. A.] US Geol Survey, Menlo Pk, CA 94022 USA	University of Oklahoma System; University of Oklahoma - Norman; United States Department of the Interior; United States Geological Survey	Reches, Z (corresponding author), Univ Oklahoma, 100 E Boyd St, Norman, OK 73019 USA.	reches@ou.edu		Chang, Jefferson/0000-0002-1258-589X	NSF [0732715, 1045414, NEHRP2011, G11AP20008]	NSF(National Science Foundation (NSF))	We thank J. Young, J. Fineberg, and E. Aharonov, and T. Shimamoto and two anonymous reviewers for their thoughtful reviews. This work was supported by NSF Geosciences awards 0732715 and 1045414 and NEHRP2011 award G11AP20008.	Andrews DJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003191; Fukuyama E, 2010, INT J FRACTURE, V163, P15, DOI 10.1007/s10704-009-9417-5; Goldsby DL, 2011, SCIENCE, V334, P216, DOI 10.1126/science.1207902; GRADY DE, 1985, J APPL PHYS, V58, P1210, DOI 10.1063/1.336139; Han R, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006136; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Kanamori H, 2006, GEOPHYS MONOGR SER, V170, P3, DOI 10.1029/170GM03; LOCKNER DA, 1983, J GEOPHYS RES, V88, P4313, DOI 10.1029/JB088iB05p04313; Niemeijer A, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008181; Ohnaka M, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2000JB000123; OHNAKA M, 1989, J GEOPHYS RES-SOLID, V94, P4089, DOI 10.1029/JB094iB04p04089; OKUBO PG, 1981, GEOPHYS RES LETT, V8, P887, DOI 10.1029/GL008i008p00887; OLGAARD DL, 1983, INT J ROCK MECH MIN, V20, P11, DOI 10.1016/0148-9062(83)91610-8; Reches Z, 2005, EARTH PLANET SC LETT, V235, P361, DOI 10.1016/j.epsl.2005.04.009; Reches Z, 2010, NATURE, V467, P452, DOI 10.1038/nature09348; Sone H, 2009, NAT GEOSCI, V2, P705, DOI 10.1038/NGEO637; Tinti E, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003644; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Wilson B, 2005, NATURE, V434, P749, DOI 10.1038/nature03433; Wornyoh EYA, 2007, J TRIBOL-T ASME, V129, P438, DOI 10.1115/1.2647859	20	47	49	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					101	105		10.1126/science.1221195	http://dx.doi.org/10.1126/science.1221195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042892				2022-12-28	WOS:000309457400062
J	Duman, RS; Aghajanian, GK				Duman, Ronald S.; Aghajanian, George K.			Synaptic Dysfunction in Depression: Potential Therapeutic Targets	SCIENCE			English	Review							BDNF VAL66MET POLYMORPHISM; GLYCOGEN-SYNTHASE KINASE-3; MAJOR DEPRESSION; PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; STRUCTURAL PLASTICITY; MESSENGER-RNA; NMDA RECEPTOR; STRESS; HIPPOCAMPUS	Basic and clinical studies demonstrate that depression is associated with reduced size of brain regions that regulate mood and cognition, including the prefrontal cortex and the hippocampus, and decreased neuronal synapses in these areas. Antidepressants can block or reverse these neuronal deficits, although typical antidepressants have limited efficacy and delayed response times of weeks to months. A notable recent discovery shows that ketamine, a N-methyl-D-aspartate receptor antagonist, produces rapid (within hours) antidepressant responses in patients who are resistant to typical antidepressants. Basic studies show that ketamine rapidly induces synaptogenesis and reverses the synaptic deficits caused by chronic stress. These findings highlight the central importance of homeostatic control of mood circuit connections and form the basis of a synaptogenic hypothesis of depression and treatment response.	[Duman, Ronald S.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06508 USA	Yale University; Yale University	Duman, RS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Pk St, New Haven, CT 06508 USA.	ronald.duman@yale.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093897] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH093897] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ampuero E, 2010, NEUROSCIENCE, V169, P98, DOI 10.1016/j.neuroscience.2010.04.035; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bath KG, 2012, NEUROPSYCHOPHARMACOL, V37, P1297, DOI 10.1038/npp.2011.318; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Beurel E, 2011, MOL PSYCHIATR, V16, P1068, DOI 10.1038/mp.2011.47; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Drevets WC, 2010, BIOL PSYCHIAT, V67, P432, DOI 10.1016/j.biopsych.2009.11.021; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Duric V., 2012, INT J NEUROPSYCHOPHA, P1; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Dwyer JM, 2012, INT J NEUROPSYCHOPH, V15, P429, DOI 10.1017/S1461145711001702; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Feyissa AM, 2009, PROG NEURO-PSYCHOPH, V33, P70, DOI 10.1016/j.pnpbp.2008.10.005; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Jourdi H, 2009, J NEUROSCI, V29, P8688, DOI 10.1523/JNEUROSCI.6078-08.2009; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Koike H, 2011, NEUROPHARMACOLOGY, V61, P1419, DOI 10.1016/j.neuropharm.2011.08.034; Krishnan V, 2008, BIOL PSYCHIAT, V64, P691, DOI 10.1016/j.biopsych.2008.06.003; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Liu RJ, 2012, BIOL PSYCHIAT, V71, P996, DOI 10.1016/j.biopsych.2011.09.030; Machado-Vieira R, 2012, PHARMACOL BIOCHEM BE, V100, P678, DOI 10.1016/j.pbb.2011.09.010; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; Magarinos AM, 2011, HIPPOCAMPUS, V21, P253, DOI 10.1002/hipo.20744; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Perlman G, 2012, J AFFECT DISORDERS, V139, P75, DOI 10.1016/j.jad.2012.01.044; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Son H, 2012, P NATL ACAD SCI USA, V109, P11378, DOI 10.1073/pnas.1201191109; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhao J, 2012, J AFFECT DISORDERS, V138, P494, DOI 10.1016/j.jad.2012.01.013	54	812	863	17	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					68	72		10.1126/science.1222939	http://dx.doi.org/10.1126/science.1222939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042884	Green Accepted			2022-12-28	WOS:000309457400053
J	Strader, J; Chomiuk, L; Maccarone, TJ; Miller-Jones, JCA; Seth, AC				Strader, Jay; Chomiuk, Laura; Maccarone, Thomas J.; Miller-Jones, James C. A.; Seth, Anil C.			Two stellar-mass black holes in the globular cluster M22	NATURE			English	Article							X-RAY BINARIES; STAR-CLUSTERS; QUIESCENCE; EMISSION; CATALOG; JETS	Hundreds of stellar-mass black holes probably form in a typical globular star cluster, with all but one predicted to be ejected through dynamical interactions(1-3). Some observational support for this idea is provided by the lack of X-ray-emitting binary stars comprising one black hole and one other star ('black-hole/X-ray binaries') in Milky Way globular clusters, even though many neutron-star/X-ray binaries are known(4). Although a few black holes have been seen in globular clusters around other galaxies(5,6), the masses of these cannot be determined, and some may be intermediate-mass black holes that form through exotic mechanisms(7). Here we report the presence of two flat-spectrum radio sources in the Milky Way globular cluster M22, and we argue that these objects are black holes of stellar mass (each similar to 10-20 times more massive than the Sun) that are accreting matter. We find a high ratio of radio-to-X-ray flux for these black holes, consistent with the larger predicted masses of black holes in globular clusters compared to those outside(8). The identification of two black holes in one cluster shows that ejection of black holes is not as efficient as predicted by most models(1,2,4), and we argue that M22 may contain a total population of similar to 5-100 black holes. The large core radius of M22 could arise from heating produced by the black holes(9).	[Strader, Jay; Chomiuk, Laura] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Strader, Jay; Chomiuk, Laura] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Chomiuk, Laura] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Maccarone, Thomas J.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Miller-Jones, James C. A.] Curtin Univ Technol, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Seth, Anil C.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA	Michigan State University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Radio Astronomy Observatory (NRAO); University of Southampton; Curtin University; Utah System of Higher Education; University of Utah	Strader, J (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	strader@pa.msu.edu	Miller-Jones, James C. A./B-2411-2013	Miller-Jones, James C. A./0000-0003-3124-2814; Seth, Anil/0000-0003-0248-5470				Anderson J, 2008, ASTRON J, V135, P2055, DOI 10.1088/0004-6256/135/6/2055; Belczynski K, 2010, ASTROPHYS J, V714, P1217, DOI 10.1088/0004-637X/714/2/1217; Corbel S, 2006, ASTROPHYS J, V636, P971, DOI 10.1086/498230; Gallo E, 2006, MON NOT R ASTRON SOC, V370, P1351, DOI 10.1111/j.1365-2966.2006.10560.x; Gallo E, 2005, MON NOT R ASTRON SOC, V356, P1017, DOI 10.1111/j.1365-2966.2004.08503.x; Gallo E, 2003, MON NOT R ASTRON SOC, V344, P60, DOI 10.1046/j.1365-8711.2003.06791.x; Irwin JA, 2010, ASTROPHYS J LETT, V712, pL1, DOI 10.1088/2041-8205/712/1/L1; Ivanova N, 2010, ASTROPHYS J, V717, P948, DOI 10.1088/0004-637X/717/2/948; Kalogera V, 2004, ASTROPHYS J, V601, pL171, DOI 10.1086/382042; Kording EG, 2011, MON NOT R ASTRON SOC, V418, pL129, DOI 10.1111/j.1745-3933.2011.01158.x; KULKARNI SR, 1993, NATURE, V364, P421, DOI 10.1038/364421a0; Lynch RS, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/89; Maccarone TJ, 2007, NATURE, V445, P183, DOI 10.1038/nature05434; Maccarone TJ, 2003, ASTRON ASTROPHYS, V409, P697, DOI 10.1051/0004-6361:20031146; Maccarone T, 2007, ASTRON GEOPHYS, V48, P12; Mackey AD, 2008, MON NOT R ASTRON SOC, V386, P65, DOI 10.1111/j.1365-2966.2008.13052.x; McLaughlin DE, 2005, ASTROPHYS J SUPPL S, V161, P304, DOI 10.1086/497429; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Migliari S, 2006, MON NOT R ASTRON SOC, V366, P79, DOI 10.1111/j.1365-2966.2005.09777.x; Miller-Jones JCA, 2008, MON NOT R ASTRON SOC, V388, P1751, DOI 10.1111/j.1365-2966.2008.13495.x; Miller-Jones JCA, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L18; Monaco L, 2004, MON NOT R ASTRON SOC, V349, P1278, DOI 10.1111/j.1365-2966.2004.07599.x; Repetto S., 2012, MON NOT R A IN PRESS; SIGURDSSON S, 1993, NATURE, V364, P423, DOI 10.1038/364423a0; Strader J, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/2/L27; Tauris T.M., 2006, COMPACT STELLAR XRAY, P623; Zwart SFP, 2000, ASTROPHYS J, V528, pL17, DOI 10.1086/312422; Zwart SFP, 2004, NATURE, V428, P724, DOI 10.1038/nature02448	29	170	171	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					71	73		10.1038/nature11490	http://dx.doi.org/10.1038/nature11490			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038466	Green Submitted			2022-12-28	WOS:000309446800033
J	Heckel, DG				Heckel, David G.			Insecticide Resistance After Silent Spring	SCIENCE			English	Editorial Material							BT COTTON; EVOLUTION; MUTATIONS; APHID		Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Max Planck Society	Heckel, DG (corresponding author), Max Planck Inst Chem Ecol, Dept Entomol, Hans Knoll Str 8, D-07745 Jena, Germany.	heckel@ice.mpg.de	Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150				Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Beckie HJ, 2011, PEST MANAG SCI, V67, P1037, DOI 10.1002/ps.2195; Carson Rachel, 1994, SILENT SPRING; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Devonshire AL, 1998, PHILOS T R SOC B, V353, P1677, DOI 10.1098/rstb.1998.0318; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Guillette LJ, 2012, SCIENCE, V337, P1614, DOI 10.1126/science.1226985; James C., 2004, GLOBAL STATUS COMMER; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Mahon RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039192; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Perry T, 2012, PESTIC BIOCHEM PHYS, V102, P56, DOI 10.1016/j.pestbp.2011.10.010; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109	22	134	141	6	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1613	1614		10.1126/science.1226994	http://dx.doi.org/10.1126/science.1226994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019637	Green Submitted			2022-12-28	WOS:000309215400030
J	Hyatt, LA				Hyatt, Laura A.			Personal Plants: Making Botany Meaningful by Experimentation	SCIENCE			English	Editorial Material									Rider Univ, Coll Liberal Arts Educ & Sci, Lawrenceville, NJ 08648 USA	Rider University	Hyatt, LA (corresponding author), Rider Univ, Coll Liberal Arts Educ & Sci, 2083 Lawrenceville Rd, Lawrenceville, NJ 08648 USA.	lhyatt@rider.edu						Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Houghton RA, 1998, GLOBAL BIOGEOCHEM CY, V12, P25, DOI 10.1029/97GB02729; Senchina D. S., 2008, PLANT SCI B, V54, P50; UNO GE, 1994, AM BIOL TEACH, V56, P263, DOI 10.2307/4449818; World Health Organization/UN Food and Agriculture Organization, 2003, WHO TECH REP SER	5	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1620	1621		10.1126/science.1215226	http://dx.doi.org/10.1126/science.1215226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019642				2022-12-28	WOS:000309215400035
J	Fradkin, JE; Roberts, BT; Rodgers, GP				Fradkin, Judith E.; Roberts, B. Tibor; Rodgers, Griffin P.			What's Preventing Us from Preventing Type 2 Diabetes?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fradkin, Judith E.] NIDDKD, Div Diabet Endocrinol & Metab Dis, NIH, Bethesda, MD 20892 USA; [Roberts, B. Tibor] NIDDKD, Off Sci Program & Policy Anal, NIH, Bethesda, MD 20892 USA; [Rodgers, Griffin P.] NIDDKD, Off Director, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Fradkin, JE (corresponding author), NIDDKD, Div Diabet Endocrinol & Metab Dis, NIH, Bethesda, MD 20892 USA.							Centers for Disease Control and Prevention, NAT DIAB PREV PROGR; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Huang ES, 2009, HEALTH AFFAIR, V28, pW978, DOI 10.1377/hlthaff.28.5.w978; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512	5	29	29	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1177	1179		10.1056/NEJMp1208169	http://dx.doi.org/10.1056/NEJMp1208169			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JO	23013070				2022-12-28	WOS:000309161100001
J	Gruen, RL; Fitzgerald, MC				Gruen, Russell L.; Fitzgerald, Mark C.			Towards a maturation of trauma research	LANCET			English	Editorial Material							MANAGEMENT		[Gruen, Russell L.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; Monash Univ, Alfred Hosp, Alfred Trauma Serv, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Gruen, RL (corresponding author), Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia.	r.gruen@alfred.org.au		Fitzgerald, Mark/0000-0003-0183-7761				Balogh ZJ, 2012, LANCET, V380, P1109, DOI 10.1016/S0140-6736(12)60991-X; Bhandari M, 2008, J BONE JOINT SURG AM, V90A, P2567, DOI 10.2106/JBJS.G.01694; Brohi K, 2012, BRIT J SURG, V99, P4, DOI 10.1002/bjs.7791; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fitzgerald M, 2011, ARCH SURG-CHICAGO, V146, P218, DOI 10.1001/archsurg.2010.333; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Moore FA, 2006, J TRAUMA, V61, P82, DOI 10.1097/01.ta.0000225933.08478.65; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; World Health Organization, 2008, GLOB BURD DIS 2004 U	11	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1033	1034		10.1016/S0140-6736(12)61418-4	http://dx.doi.org/10.1016/S0140-6736(12)61418-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007VL	22998698				2022-12-28	WOS:000308916400004
J	Redwine, WB; Hernandez-Lopez, R; Zou, SR; Huang, JL; Reck-Peterson, SL; Leschziner, AE				Redwine, William B.; Hernandez-Lopez, Rogelio; Zou, Sirui; Huang, Julie; Reck-Peterson, Samara L.; Leschziner, Andres E.			Structural Basis for Microtubule Binding and Release by Dynein	SCIENCE			English	Article							MOLECULAR-DYNAMICS; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; COILED-COIL; ACTIVATION; MICROSCOPY; MECHANISM; TRANSPORT; FAMILY; DOMAIN	Cytoplasmic dynein is a microtubule-based motor required for intracellular transport and cell division. Its movement involves coupling cycles of track binding and release with cycles of force-generating nucleotide hydrolysis. How this is accomplished given the similar to 25 nanometers separating dynein's track- and nucleotide-binding sites is not understood. Here, we present a subnanometer-resolution structure of dynein's microtubule-binding domain bound to microtubules by cryo-electron microscopy that was used to generate a pseudo-atomic model of the complex with molecular dynamics. We identified large rearrangements triggered by track binding and specific interactions, confirmed by mutagenesis and single-molecule motility assays, which tune dynein's affinity for microtubules. Our results provide a molecular model for how dynein's binding to microtubules is communicated to the rest of the motor.	[Redwine, William B.; Hernandez-Lopez, Rogelio; Leschziner, Andres E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Redwine, William B.; Zou, Sirui; Huang, Julie; Reck-Peterson, Samara L.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Leschziner, AE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	aleschziner@mcb.harvard.edu	Zou, Sirui/R-1437-2017	Zou, Sirui/0000-0002-3282-6064; Reck-Peterson, Samara/0000-0002-1553-465X; Leschziner, Andres/0000-0002-7732-7023; Hernandez-Lopez, Rogelio/0000-0003-3968-4908	National Science Foundation [ECS-0335765]; Rita Allen Foundation; Harvard Armenise Foundation; NIH [1 DP2 OD004268-1]; Alfred P. Sloan Foundation; Consejo Nacional de Ciencia y Tecnologia; Fundacion Mexico en Harvard; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Rita Allen Foundation; Harvard Armenise Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Mexico en Harvard; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Carter (Laboratory of Molecular Biology-Medical Research Council) for reagents and advice, C. Sindelar (Yale), V. Ramey [University of California (UC)-Berkeley], E. Egelman (University of Virginia), and R. Sinkovits (UC-San Diego) for sharing processing scripts and helpful advice; M. Sotomayor (Harvard) and R. Gaudet (Harvard) for advice concerning MD; J. Hogle (Harvard), M. Strauss (Harvard), and M. Wolf (Harvard) for help with film and the use of a film scanner; and E. Nogales (UC-Berkeley), N. Francis (Harvard), and D. Pellman (Harvard) for critically reading the manuscript, as well as all the members of the Leschziner and Reck-Peterson Labs for advice and helpful discussions. EM data were collected at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. CNS is part of Harvard University. MD simulations were run on the Odyssey cluster supported by the Faculty of Arts and Sciences Science Division Research Computing Group, Harvard University. S.L.R.-P. is funded by the Rita Allen Foundation, the Harvard Armenise Foundation, and an NIH New Innovator award (1 DP2 OD004268-1). A.E.L. was funded in part by a Research Fellowship from the Alfred P. Sloan Foundation. R.H.-L. was supported in part by Consejo Nacional de Ciencia y Tecnologia and Fundacion Mexico en Harvard. The cryo-EM map was deposited at the EM Data Bank (EMDB-5439) and pseudo-atomic models at the Protein Data Bank (PDB-3J1T and -3J1U).	Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Laib JA, 2009, P NATL ACAD SCI USA, V106, P3190, DOI 10.1073/pnas.0809849106; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; McNaughton L, 2010, J BIOL CHEM, V285, P15994, DOI 10.1074/jbc.M109.083535; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Uchimura S, 2010, EMBO J, V29, P1167, DOI 10.1038/emboj.2010.25; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; WANG Z., 2000, BIOPHYS J, V78, P1955; Wells DB, 2010, BIOPHYS J, V99, P629, DOI 10.1016/j.bpj.2010.04.038; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045	36	113	113	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1532	1536		10.1126/science.1224151	http://dx.doi.org/10.1126/science.1224151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997337	Green Accepted, Green Published			2022-12-28	WOS:000308912900050
J	Sampson, RJ				Sampson, Robert J.			Moving and the Neighborhood Glass Ceiling	SCIENCE			English	Editorial Material							CONCENTRATED DISADVANTAGE		[Sampson, Robert J.] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Sampson, Robert J.] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sampson, RJ (corresponding author), Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA.	rsampson@wjh.harvard.edu	Sampson, Robert J./AAB-7369-2020					Fry Richard, 2012, RISE RESIDENTIAL SEG; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; MASSEY DS, 1990, AM J SOCIOL, V96, P329, DOI 10.1086/229532; MAYER SE, 1989, SCIENCE, V243, P1441, DOI 10.1126/science.243.4897.1441; Sampson RJ., 2012, GREAT AMERICAN CITY; Sampson RJ, 2008, AM J SOCIOL, V114, P189, DOI 10.1086/589843; Sampson RJ, 2008, P NATL ACAD SCI USA, V105, P845, DOI 10.1073/pnas.0710189104; Sharkey P, 2008, AM J SOCIOL, V113, P931, DOI 10.1086/522804; *US BUR CENS, 2005, AM COMM SURV; Wilson R., 1987, TRULY DISADVANTAGED; Wodtke GT, 2011, AM SOCIOL REV, V76, P713, DOI 10.1177/0003122411420816	12	21	22	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1464	1465		10.1126/science.1227881	http://dx.doi.org/10.1126/science.1227881			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997316				2022-12-28	WOS:000308912900030
J	Prochazka, AV; Caverly, TJ				Prochazka, Allan V.; Caverly, T. J.			Review: Varenicline is better than bupropion but not nicotine patch for smoking abstinence in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS; CESSATION; RISK				Prochazka, AV (corresponding author), Denver VA Med Ctr, Denver, CO USA.							Etter JF, 2006, ARCH INTERN MED, V166, P1553, DOI 10.1001/archinte.166.15.1553; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5	4	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-7	10.7326/0003-4819-157-6-201209180-02007	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986399				2022-12-28	WOS:000308912800006
J	Yang, JY; Zhao, XB; Cheng, K; Du, HY; Ouyang, YD; Chen, JJ; Qiu, SQ; Huang, JY; Jiang, YH; Jiang, LW; Ding, JH; Wang, J; Xu, CG; Li, XH; Zhang, QF				Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Jiang, Liwen; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa			A Killer-Protector System Regulates Both Hybrid Sterility and Segregation Distortion in Rice	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; INDICA-JAPONICA HYBRIDS; ORYZA-SATIVA L.; WIDE-COMPATIBILITY; REPRODUCTIVE BARRIER; S-5 LOCUS; GENE; INCOMPATIBILITY; ARABIDOPSIS; STRESS	Hybrid sterility is a major form of postzygotic reproductive isolation that restricts gene flow between populations. Cultivated rice (Oryza sativa L.) consists of two subspecies, indica and japonica; inter-subspecific hybrids are usually sterile. We show that a killer-protector system at the S5 locus encoded by three tightly linked genes [Open Reading Frame 3 (ORF3) to ORF5] regulates fertility in indica-japonica hybrids. During female sporogenesis, the action of ORF5+ (killer) and ORF4+ (partner) causes endoplasmic reticulum (ER) stress. ORF3+ (protector) prevents ER stress and produces normal gametes, but ORF3- cannot prevent ER stress, resulting in premature programmed cell death and leads to embryo-sac abortion. Preferential transmission of ORF3+ gametes results in segregation distortion in the progeny. These results add to our understanding of differences between indica and japonica rice and may aid in rice genetic improvement.	[Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Peoples R China; [Jiang, Liwen] Chinese Univ Hong Kong, Sch Life Sci, Shatin 999077, Hong Kong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Chinese University of Hong Kong	Zhang, QF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	qifazh@mail.hzau.edu.cn	Yang, Jiangyi/J-5383-2013; Zhao, Xiaobo/K-4182-2012; Zhao, Xiaobo/AAZ-5503-2021; Zhao, Xiaobo/AAR-3217-2021; JIANG, Liwen/S-6046-2018	Zhao, Xiaobo/0000-0002-6012-0261; JIANG, Liwen/0000-0002-7829-1472; Jiang, Yunhe/0000-0002-7599-1422; Yang, Jiangyi/0000-0002-5626-1037	National Natural Science Foundation [31130032, 30921091]; 863 Project [2012AA100103]; 111 Project of China [B07041]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); 111 Project of China(Ministry of Education, China - 111 Project)	We thank D. S. Brar of the International Rice Research Institute for providing the rice seeds, and S. Luan of University of California, Berkeley, USA for discussion. This research was supported by grants from the National Natural Science Foundation (31130032 and 30921091), the 863 Project (2012AA100103), and the 111 Project (B07041) of China. All of the DNA sequences obtained in this study have been deposited in the GenBank from accession codes JX138498 to JX138505. A patent for the ORF5 sequence has been approved by the State Intellectual Property Office of China (ZL200710053552.9).	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Blanvillain R, 2011, EMBO J, V30, P1173, DOI 10.1038/emboj.2011.14; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Burt A, 2006, GENES CONFLICT BIOL; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Coyne J.A., 2004, SPECIATION; Du HY, 2011, NEW PHYTOL, V191, P275, DOI 10.1111/j.1469-8137.2011.03691.x; Hayashi S, 2012, PLANT J, V69, P946, DOI 10.1111/j.1365-313X.2011.04844.x; Ikehashi H., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P119, DOI 10.1142/9789812814265_0011; Koide Y, 2008, GENETICS, V180, P409, DOI 10.1534/genetics.108.090126; Lee S, 2004, PLANT MOL BIOL, V54, P755, DOI 10.1023/B:PLAN.0000040904.15329.29; Li H, 2011, PLANT PHYSIOL, V156, P615, DOI 10.1104/pp.111.175760; Liu KD, 1996, EUPHYTICA, V90, P275, DOI 10.1007/BF00027476; Liu KD, 1997, THEOR APPL GENET, V95, P809, DOI 10.1007/s001220050629; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; Oono Y, 2010, PLANT BIOTECHNOL J, V8, P691, DOI 10.1111/j.1467-7652.2010.00502.x; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Ouyang YD, 2009, CHINESE SCI BULL, V54, P2332, DOI 10.1007/s11434-009-0371-4; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Qiu SQ, 2005, THEOR APPL GENET, V111, P1080, DOI 10.1007/s00122-005-0033-0; Wakasa Y, 2011, PLANT J, V65, P675, DOI 10.1111/j.1365-313X.2010.04453.x; Wang CM, 2005, GENET RES, V86, P97, DOI 10.1017/S0016672305007779; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Yamagata Y, 2010, P NATL ACAD SCI USA, V107, P1494, DOI 10.1073/pnas.0908283107; YANAGIHARA S, 1995, THEOR APPL GENET, V90, P182, DOI 10.1007/BF00222200; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	32	171	210	14	262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1336	1340		10.1126/science.1223702	http://dx.doi.org/10.1126/science.1223702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984070				2022-12-28	WOS:000308705000041
J	Bergen, H; Hawton, K; Waters, K; Ness, J; Cooper, J; Steeg, S; Kapur, N				Bergen, Helen; Hawton, Keith; Waters, Keith; Ness, Jennifer; Cooper, Jayne; Steeg, Sarah; Kapur, Navneet			Premature death after self-harm: a multicentre cohort study	LANCET			English	Article							FOLLOW-UP; SUICIDE; MORTALITY; ENGLAND; TRENDS	Background People who self-harm have an increased risk of premature death. The aim of this study was to investigate cause-specific premature death in individuals who self-harm, including associations with socioeconomic deprivation. Methods We undertook a cohort study of patients of all ages presenting to emergency departments in Oxford, Manchester, and Derby, UK, after self-poisoning or self-injury between Jan 1, 2000, and Dec 31, 2007. Postcodes of individuals' place of residence were linked to the Index of Multiple Deprivation 2007 in England. Mortality information was supplied by the Medical Research Information Service of the National Health Service. Patients were followed up to the end of 2009. We calculated age-standardised mortality ratios (SMRs) and years of life lost (YLL), and we tested for associations with socioeconomic deprivation. Findings 30 950 individuals presented with self-harm and were followed up for a median of 6.0 years (IQR 3.9-7.9). 1832 (6.1%) patients died before the end of follow-up. Death was more likely in patients than in the general population (SMR 3.6, 95% CI 3.5-3.8), and occurred more in males (4.1, 3.8-4.3) than females (3.2, 2.9-3.4). Deaths due to natural causes were 2-7.5 times more frequent than was expected. For individuals who died of any cause, mean YLL was 31.4 years (95% CI 30.5-32.2) for male patients and 30.7 years (29.5-31.9) for female patients. Mean YLL for natural-cause deaths was 25.9 years (25.7-26.0) for male patients and 25.5 years (25.2-25.8) for female patients, and for external-cause deaths was 40.2 years (40.0-40.3) and 40.0 years (39.7-40.5), respectively. Disease of the circulatory (13.1% in males; 13.0% in females) and digestive (11.7% in males; 17.8% in females) systems were major contributors to YLL from natural causes. All-cause mortality increased with each quartile of socioeconomic deprivation in male patients (chi(2) trend 39.6; p<0.0001), female patients (13.9; p=0.0002), and both sexes combined (55.4; p<0.0001). Socioeconomic deprivation was related to mortality in both sexes combined from natural causes (51.0; p<0.0001) but not from external causes (0.30; p=0.58). Alcohol problems were associated with death from digestive-system disease, drug misuse with mental and behavioural disorders, and physical health problems with circulatory-system disease. Interpretation Physical health and life expectancy are severely compromised in individuals who self-harm compared with the general population. In the management of self-harm, clinicians assessing patients' psychosocial problems should also consider their physical needs.	[Bergen, Helen; Hawton, Keith] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England; [Waters, Keith; Ness, Jennifer] Derbyshire Healthcare NHS Fdn Trust, Mental Hlth Liaison Team, Royal Derby Hosp, Derby, England; [Cooper, Jayne; Steeg, Sarah; Kapur, Navneet] Univ Manchester, Ctr Suicide Prevent, Manchester, Lancs, England	University of Oxford; University of Nottingham; University of Manchester	Hawton, K (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Waters, Keith/AAH-5503-2019	Waters, Keith/0000-0002-5031-0870; Ness, Jennifer/0000-0002-7445-4510; Steeg, Sarah/0000-0002-7935-1414; Kapur, Nav/0000-0002-3100-3234	Department of Health Policy Research Programme	Department of Health Policy Research Programme	This study was funded by the Department of Health Policy Research Programme. KH is a National Institute for Health Research Senior Investigator. From Oxford, we thank Deborah Casey, Elizabeth Bale, and members of the general hospital psychiatric services for their assistance with data collection, and statisticians from the Centre for Statistics in Medicine, University of Oxford, for statistical advice; from Manchester, the clinicians completing assessment forms, the research team for data collection, Elizabeth Murphy, Iain Donaldson, Victoria Matthews, and Stella Dickson; and from Derby, clinicians, and clerical and administrative staff in the Emergency Department and Mental Health Liaison Team.	Bergen H, 2012, PSYCHOL MED, V42, P727, DOI 10.1017/S0033291711001747; Bergen H, 2012, J AFFECT DISORDERS, V136, P526, DOI 10.1016/j.jad.2011.10.036; Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Breakwell C, 2009, HLTH STAT Q, V33, P6; Carter G, 2005, AUST NZ J PSYCHIAT, V39, P101, DOI 10.1111/j.1440-1614.2005.01515.x; Department of Health, MULT STUD SELF HARM; Gunnell D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6030; GUNNELL DJ, 1995, BRIT MED J, V311, P226, DOI 10.1136/bmj.311.6999.226; Hall DJ, 1998, BRIT J PSYCHIAT, V172, P239, DOI 10.1192/bjp.172.3.239; Haw C, 2005, SOC PSYCH PSYCH EPID, V40, P964, DOI 10.1007/s00127-005-0981-3; Haw C, 2001, BRIT J PSYCHIAT, V178, P48, DOI 10.1192/bjp.178.1.48; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Hawton K, 2001, SOC PSYCH PSYCH EPID, V36, P437, DOI 10.1007/s001270170021; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; HAWTON K, 1988, BRIT J PSYCHIAT, V152, P359, DOI 10.1192/bjp.152.3.359; Karasouli E, 2011, SOC PSYCH PSYCH EPID, V46, P455, DOI 10.1007/s00127-010-0213-3; Mok PLH, 2012, BRIT J PSYCHIAT, V200, P245, DOI 10.1192/bjp.bp.111.092908; Naylor C, 2012, LONG TERM CONDITION; Neeleman J, 1998, LANCET, V351, P93, DOI 10.1016/S0140-6736(97)06364-2; Neeleman J, 2001, INT J EPIDEMIOL, V30, P154, DOI 10.1093/ije/30.1.154; NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637; Office for National Statistics, 2010, IND MULT DEPR IMD 20; Office for National Statistics, HIGHL; Office for National Statistics, 2010, ENGL INT LIF TABL 19; Ostamo A, 2001, SOC PSYCH PSYCH EPID, V36, P29, DOI 10.1007/s001270050287; Reith DM, 2004, AUST NZ J PSYCHIAT, V38, P520, DOI 10.1111/j.1440-1614.2004.01405.x; Ridsdale B, 2010, MORTALITY CAUSE DEAT; Romeri Ester, 2006, Health Stat Q, P19; Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7; Skegg K, 2004, SUICIDE LIFE-THREAT, V34, P187, DOI 10.1521/suli.34.2.187.32790; Thomas B, 2010, BMJ-BRIT MED J, V341, P291; Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100	33	170	171	2	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1568	1574		10.1016/S0140-6736(12)61141-6	http://dx.doi.org/10.1016/S0140-6736(12)61141-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030VR	22995670				2022-12-28	WOS:000310598700032
J	Mudd, PA; Martins, MA; Ericsen, AJ; Tully, DC; Power, KA; Bean, AT; Piaskowski, SM; Duan, LJ; Seese, A; Gladden, AD; Weisgrau, KL; Furlott, JR; Kim, YI; de Santana, MGV; Rakasz, E; Capuano, S; Wilson, NA; Bonaldo, MC; Galler, R; Allison, DB; Piatak, M; Haase, AT; Lifson, JD; Allen, TM; Watkins, DI				Mudd, Philip A.; Martins, Mauricio A.; Ericsen, Adam J.; Tully, Damien C.; Power, Karen A.; Bean, Alex T.; Piaskowski, Shari M.; Duan, Lijie; Seese, Aaron; Gladden, Adrianne D.; Weisgrau, Kim L.; Furlott, Jessica R.; Kim, Young-il; Veloso de Santana, Marlon G.; Rakasz, Eva; Capuano, Saverio, III; Wilson, Nancy A.; Bonaldo, Myrna C.; Galler, Ricardo; Allison, David B.; Piatak, Michael, Jr.; Haase, Ashley T.; Lifson, Jeffrey D.; Allen, Todd M.; Watkins, David I.			Vaccine-induced CD8(+) T cells control AIDS virus replication	NATURE			English	Article							MAMU-B-ASTERISK-08-POSITIVE MACAQUES; IMMUNODEFICIENCY; SIV; RESPONSES; HIV; INFECTION; DISEASE; ESCAPE; HOST	Developing a vaccine for human immunodeficiency virus(HIV) may be aided by a complete understanding of those rare cases in which some HIV-infected individuals control replication of the virus(1-3). Most of these elite controllers express the histocompatibility alleles HLA-B*57 or HLA-B*27 (ref. 3). These alleles remain by far the most robust associations with low concentrations of plasma virus(4,5), yet the mechanism of control in these individuals is not entirely clear. Here we vaccinate Indian rhesus macaques that express Mamu-B*08, an animal model for HLA-B*27-mediated elite control(6), with three Mamu-B*08-restricted CD8(+) T-cell epitopes, and demonstrate that these vaccinated animals control replication of the highly pathogenic clonal simian immunodeficiency virus (SIV) mac239 virus. High frequencies of CD8(+) T cells against these Vif and Nef epitopes in the blood, lymph nodes and colon were associated with viral control. Moreover, the frequency of the CD8(+) T-cell response against the Nef RL10 epitope (Nef amino acids 137-146) correlated significantly with reduced acute phase viraemia. Finally, two of the eight vaccinees lost control of viral replication in the chronic phase, concomitant with escape in all three targeted epitopes, further implicating these three CD8(+) T-cell responses in the control of viral replication. Our findings indicate that narrowly targeted vaccine-induced virus-specific CD8(+) T-cell responses can control replication of the AIDS virus.	[Martins, Mauricio A.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Mudd, Philip A.; Ericsen, Adam J.; Bean, Alex T.; Piaskowski, Shari M.; Weisgrau, Kim L.; Furlott, Jessica R.; Wilson, Nancy A.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53711 USA; [Mudd, Philip A.] Univ Wisconsin Madison, Med Scientist Training Program, Madison, WI 53705 USA; [Tully, Damien C.; Power, Karen A.; Seese, Aaron; Gladden, Adrianne D.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA; [Duan, Lijie; Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Kim, Young-il] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Veloso de Santana, Marlon G.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil; [Rakasz, Eva; Capuano, Saverio, III; Wilson, Nancy A.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53711 USA; [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA	University of Miami; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Fundacao Oswaldo Cruz; University of Wisconsin System; University of Wisconsin Madison; Fundacao Oswaldo Cruz; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Watkins, DI (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	dwatkins@med.miami.edu	Ericsen, Adam/AAW-1187-2020; Galler, Ricardo/B-3280-2014; Martins, Mauricio/AAU-9226-2020; Bonaldo, Myrna C/D-9494-2013; Bonaldo, Myrna/AAE-2799-2021; Allen, Todd/F-5473-2011; Rakasz, Eva G/H-9197-2019; Veloso de Santana, Marlon Gilsepp/H-8146-2017	Ericsen, Adam/0000-0003-4176-8270; Martins, Mauricio/0000-0001-8336-216X; Allen, Todd/0000-0002-6609-1318; Allison, David/0000-0003-3566-9399; Mudd, Philip/0000-0002-3860-5473; Tully, Damien/0000-0002-7620-9340; Veloso de Santana, Marlon Gilsepp/0000-0002-3427-841X; Wilson, Nancy/0000-0002-9472-6026	National Institutes of Health (NIH) [R37 AI052056, RO1 AI076114, RR015371, HHSN261200800001E]; FAPERJ; INCTV; CNPq; MCT; FIOCRUZ; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015371, P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985, R37AI052056, R01AI076114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCTV; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCT; FIOCRUZ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank M. Stevenson, M. Reynolds, N. Maness and J. Sacha for discussions and suggestions. We also thank D. Evans, L. Heyer and Z. R. Bergman for facilitating the experiments. This work was funded in part by National Institutes of Health (NIH) grants R37 AI052056, RO1 AI076114, RR015371, contract number HHSN261200800001E and FAPERJ, INCTV, CNPq, MCT and FIOCRUZ.	Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115; Cline AN, 2005, J MED PRIMATOL, V34, P303; Dang Q, 2008, ADV PHARMACOL, V56, P369, DOI 10.1016/S1054-3589(07)56012-6; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470; Mudd PA, 2011, CURR OPIN HIV AIDS, V6, P197, DOI 10.1097/COH.0b013e3283453e16; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Tsukamoto T, 2009, J VIROL, V83, P9339, DOI 10.1128/JVI.01120-09; Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09	24	143	149	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					129	U152		10.1038/nature11443	http://dx.doi.org/10.1038/nature11443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23023123	Green Accepted			2022-12-28	WOS:000310434500044
J	Pollitz, FF; Stein, RS; Sevilgen, V; Burgmann, R				Pollitz, Fred F.; Stein, Ross S.; Sevilgen, Volkan; Buergmann, Roland			The 11 April 2012 east Indian Ocean earthquake triggered large aftershocks worldwide	NATURE			English	Article							DENALI FAULT EARTHQUAKE; SEISMICITY; CALIFORNIA; LANDERS; SLIP	Large earthquakes trigger very small earthquakes globally during passage of the seismic waves and during the following several hours to days(1-10), but so far remote aftershocks of moment magnitude M >= 5.5 have not been identified(11), with the lone exception of an M = 6.9 quake remotely triggered by the surface waves from an M = 6.6 quake 4,800 kilometres away(12). The 2012 east Indian Ocean earthquake that had a moment magnitude of 8.6 is the largest strike-slip event ever recorded. Here we show that the rate of occurrence of remote M >= 5.5 earthquakes (>1,500 kilometres from the epicentre) increased nearly fivefold for six days after the 2012 event, and extended in magnitude to M <= 7. These global aftershocks were located along the four lobes of Love-wave radiation; all struck where the dynamic shear strain is calculated to exceed 10(-7) for at least 100 seconds during dynamic-wave passage. The other M >= 8.5 main-shocks during the past decade are thrusts; after these events, the global rate of occurrence of remote M >= 5.5 events increased by about one-third the rate following the 2012 shock and lasted for only two days, a weaker but possibly real increase. We suggest that the unprecedented delayed triggering power of the 2012 earthquake may have arisen because of its strike-slip source geometry or because the event struck at a time of an unusually low global earthquake rate, perhaps increasing the number of nucleation sites that were very close to failure.	[Pollitz, Fred F.; Stein, Ross S.] US Geol Survey, Menlo Pk, CA 94025 USA; [Sevilgen, Volkan] Seism Net, San Carlos, CA 94070 USA; [Buergmann, Roland] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Berkeley	Pollitz, FF (corresponding author), US Geol Survey, 345 Middlefield Rd,MS 977, Menlo Pk, CA 94025 USA.	fpollitz@usgs.gov	Burgmann, Roland/AAE-5138-2022	Burgmann, Roland/0000-0002-3560-044X				Brodsky EE, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003211; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Dahlen F. A., 1998, THEORETICAL GLOBAL S; Delescluse M, 2012, NATURE, V490, P240, DOI 10.1038/nature11520; DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; Engdahl ER, 2002, INT HDB EARTHQUAKE E, P665, DOI DOI 10.1016/S0074-6142(02)80244-3; FRIEDERICH W, 1995, GEOPHYS J INT, V122, P537, DOI 10.1111/j.1365-246X.1995.tb07012.x; GARDNER JK, 1974, B SEISMOL SOC AM, V64, P1363; Gomberg J, 2005, NATURE, V437, P830, DOI [10.1038/437830a, 10.1038/nature04167]; Gomberg J, 2001, NATURE, V411, P462, DOI 10.1038/35078053; Gomberg J, 2004, NATURE, V427, P621, DOI 10.1038/nature02335; Gonzalez-Huizar H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051015; Gonzalez-Huizar H, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2009JB007000; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; HILL DP, 2007, TREATISE GEOPHYS, V4, P258; Husen S, 2004, GEOLOGY, V32, P537, DOI 10.1130/G20381.1; Incorporated Research Institutions for Seismology, 2012, BACK PROJ MW 8 7 OFF; Jaeger J. C., 1984, FUNDAMENTALS ROCK ME, V33; KANAMORI H, 1977, J GEOPHYS RES, V82, P2981, DOI 10.1029/JB082i020p02981; Kilb D, 2000, NATURE, V408, P570, DOI 10.1038/35046046; Kiser E., 2012, PRELIMINARY RUPTURE; Koss H., 2012, GLOBAL CMT PROJECT M; Lin CH, 2012, TERR ATMOS OCEAN SCI, V23, P283, DOI 10.3319/TAO.2012.01.12.01(T); McGuire JJ, 2012, SCIENCE, V336, P1118, DOI 10.1126/science.1223983; Meng L, 2012, SCIENCE, V337, P724, DOI 10.1126/science.1224030; Pankow KL, 2004, B SEISMOL SOC AM, V94, pS332, DOI 10.1785/0120040609; Parsons T, 2011, NAT GEOSCI, V4, P312, DOI [10.1038/ngeo1110, 10.1038/NGEO1110]; Peng ZG, 2010, NAT GEOSCI, V3, P599, DOI 10.1038/NGEO940; Peng ZG, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006049; Prejean SG, 2004, B SEISMOL SOC AM, V94, pS348, DOI 10.1785/0120040610; Shelly DR, 2011, NAT GEOSCI, V4, P384, DOI [10.1038/ngeo1141, 10.1038/NGEO1141]; Velasco AA, 2004, B SEISMOL SOC AM, V94, pS293, DOI 10.1785/0120040624; Velasco AA, 2008, NAT GEOSCI, V1, P375, DOI 10.1038/ngeo204; Wang D., 2012, RUPTURE PROCESS APRI; Yue H., NATURE	35	123	125	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					250	+		10.1038/nature11504	http://dx.doi.org/10.1038/nature11504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23023131				2022-12-28	WOS:000309733300047
J	Shimamoto, T; Togo, T				Shimamoto, Toshihiko; Togo, Tetsuhiro			Earthquakes in the Lab	SCIENCE			English	Editorial Material							FAULTS; LUBRICATION; SLIP		[Shimamoto, Toshihiko; Togo, Tetsuhiro] China Earthquake Adm, Inst Geol, State Key Lab Earthquake Dynam, Beijing 100029, Peoples R China	China Earthquake Administration	Shimamoto, T (corresponding author), China Earthquake Adm, Inst Geol, State Key Lab Earthquake Dynam, Beijing 100029, Peoples R China.	shima_kyoto@yahoo.co.jp	Togo, Tetsuhiro/M-8785-2018	Togo, Tetsuhiro/0000-0002-0652-1347	Grants-in-Aid for Scientific Research [21107004] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Chang JC, 2012, SCIENCE, V338, P101, DOI 10.1126/science.1221195; Di Toro G, 2006, SCIENCE, V311, P647, DOI 10.1126/science.1121012; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Fukuyama E, 2010, INT J FRACTURE, V163, P15, DOI 10.1007/s10704-009-9417-5; Han R, 2007, SCIENCE, V316, P878, DOI 10.1126/science.1139763; Han R, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006136; Hirose T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003207; Mizoguchi K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027931; Reches Z, 2010, NATURE, V467, P452, DOI 10.1038/nature09348; Sone H, 2009, NAT GEOSCI, V2, P705, DOI 10.1038/NGEO637; Tinti E, 2005, B SEISMOL SOC AM, V95, P1211, DOI 10.1785/0120040177; Togo T, 2012, J STRUCT GEOL, V38, P139, DOI 10.1016/j.jsg.2011.12.014	12	12	13	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					54	55		10.1126/science.1227085	http://dx.doi.org/10.1126/science.1227085			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042876				2022-12-28	WOS:000309457400045
J	Bynum, W				Bynum, William			What makes a great lab?	NATURE			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Bynum, W (corresponding author), UCL, London WC1E 6BT, England.	w.bynum@ucl.ac.uk							0	6	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					31	32		10.1038/490031a	http://dx.doi.org/10.1038/490031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038449				2022-12-28	WOS:000309446800014
J	Boal, AK; Rosenzweig, AC				Boal, Amie K.; Rosenzweig, Amy C.			A Radical Route for Nitrogenase Carbide Insertion	SCIENCE			English	Editorial Material							FEMO-COFACTOR; STRUCTURAL BASIS; MOFE-PROTEIN; MECHANISM; CARBON		[Boal, Amie K.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Boal, AK (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	a-boal@northwestern.edu; amyr@northwestern.edu						Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Wiig JA, 2012, SCIENCE, V337, P1672, DOI 10.1126/science.1224603; Wiig JA, 2011, P NATL ACAD SCI USA, V108, P8623, DOI 10.1073/pnas.1102773108; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	13	12	12	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1617	1618		10.1126/science.1229088	http://dx.doi.org/10.1126/science.1229088			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019640				2022-12-28	WOS:000309215400033
J	Venditti, R; Scanu, T; Santoro, M; Di Tullio, G; Spaar, A; Gaibisso, R; Beznoussenko, GV; Mironov, AA; Mironov, A; Zelante, L; Piemontese, MR; Notarangelo, A; Malhotra, V; Vertel, BM; Wilson, C; De Matteis, MA				Venditti, Rossella; Scanu, Tiziana; Santoro, Michele; Di Tullio, Giuseppe; Spaar, Alexander; Gaibisso, Renato; Beznoussenko, Galina V.; Mironov, Alexander A.; Mironov, Alexander, Jr.; Zelante, Leopoldo; Piemontese, Maria Rosaria; Notarangelo, Angelo; Malhotra, Vivek; Vertel, Barbara M.; Wilson, Cathal; De Matteis, Maria Antonietta			Sedlin Controls the ER Export of Procollagen by Regulating the Sar1 Cycle	SCIENCE			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA-TARDA; COPII; PROTEIN; MUTATION; COL2A1; SEC23; COAT	Newly synthesized proteins exit the endoplasmic reticulum (ER) via coat protein complex II (COPII) vesicles. Procollagen (PC), however, forms prefibrils that are too large to fit into typical COPII vesicles; PC thus needs large transport carriers, which we term megacarriers. TANGO1 assists PC packing, but its role in promoting the growth of megacarriers is not known. We found that TANGO1 recruited Sedlin, a TRAPP component that is defective in spondyloepiphyseal dysplasia tarda (SEDT), and that Sedlin was required for the ER export of PC. Sedlin bound and promoted efficient cycling of Sar1, a guanosine triphosphatase that can constrict membranes, and thus allowed nascent carriers to grow and incorporate PC prefibrils. This joint action of TANGO1 and Sedlin sustained the ER export of PC, and its derangement may explain the defective chondrogenesis underlying SEDT.	[Venditti, Rossella; Santoro, Michele; Wilson, Cathal; De Matteis, Maria Antonietta] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Scanu, Tiziana; Di Tullio, Giuseppe; Spaar, Alexander; Gaibisso, Renato; Beznoussenko, Galina V.; Mironov, Alexander A.; Mironov, Alexander, Jr.] Consorzio Mario Negri Sud, I-66030 Chieti, Italy; [Zelante, Leopoldo; Piemontese, Maria Rosaria; Notarangelo, Angelo] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, I-71013 Foggia, Italy; [Malhotra, Vivek] Ctr Regulacio Genom, Dept Cell & Dev Biol, Barcelona 08010, Spain; [Malhotra, Vivek] Pg Lluis Co 23, Inst Catalana Recerca Estudis Avancats, Barcelona 08010, Spain; [Vertel, Barbara M.] Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, N Chicago, IL 60064 USA	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consorzio Mario Negri Sud; IRCCS Casa Sollievo Della Sofferenza; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Rosalind Franklin University Medical & Science	De Matteis, MA (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	dematteis@tigem.it	Venditti, Rossella/AAT-4281-2020; Malhotra, Vivek/O-9811-2014; De Matteis, Maria Antonietta/AHE-5161-2022	Venditti, Rossella/0000-0002-1884-6501; Malhotra, Vivek/0000-0001-6198-7943; De Matteis, Maria Antonietta/0000-0003-0053-3061; Notarangelo, Angelantonio/0000-0002-1540-8530; Mironov, Aleksandr/0000-0002-1497-328X; Wilson, Cathal/0000-0002-0637-8608	Telethon EM Core Facility [GTF08001]; Telethon [GSP08002, GGP06166]; AIRC [IG 8623]; Programma Operativo Nazionale [01_00862]; Telethon grant [GGP07075]; NIH [NIH/AR053696]; Plan Nacional [BFU2008-00414]; Consolider [CSD2009-00016]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents; AGAUR-Catalan Government [SGR2009-1488]; European Research Council [268692]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053696] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Telethon EM Core Facility(Fondazione Telethon); Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); Programma Operativo Nazionale; Telethon grant(Fondazione Telethon); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional; Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents; AGAUR-Catalan Government; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ICREA(ICREA)	We thank A. Luini, G. D'Angelo, B. Franco, and G. Manco for insightful discussions; the Telethon EM Core Facility (project no. GTF08001) for the EM analysis; J. Gecz for the Sedlin cDNAs; R. Schekman for the Sar1A cDNA; W. Balch for the Sar1B and Sec23 cDNAs; and J. Kimura for the use of Rx chondrocytes. Supported by Telethon grants GSP08002 and GGP06166, AIRC grant IG 8623, and Programma Operativo Nazionale grant 01_00862 (M. A. D. M.), Telethon grant GGP07075 (C. W.), NIH grant NIH/AR053696 (B. M. V.), and grants from Plan Nacional (BFU2008-00414), Consolider (CSD2009-00016), Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents (SGR2009-1488; AGAUR-Catalan Government), the European Research Council (268692). (V. M.), and an AIRC fellowship (R.V.).	Bacia K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00017; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BLEASEL JF, 1995, J RHEUMATOL, V22, P255; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Pepperkok R, 1998, J CELL SCI, V111, P1877; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Scrivens PJ, 2009, TRAFFIC, V10, P724, DOI 10.1111/j.1600-0854.2009.00906.x; Tiller GE, 2001, AM J HUM GENET, V68, P1398, DOI 10.1086/320594; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zankl A, 2004, AM J MED GENET A, V129A, P144, DOI 10.1002/ajmg.a.30222	19	121	126	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1668	1672		10.1126/science.1224947	http://dx.doi.org/10.1126/science.1224947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019651	Green Accepted			2022-12-28	WOS:000309215400049
J	Wamstad, JA; Alexander, JM; Truty, RM; Shrikumar, A; Li, FG; Eilertson, KE; Ding, HM; Wylie, JN; Pico, AR; Capra, JA; Erwin, G; Kattman, SJ; Keller, GM; Srivastava, D; Levine, SS; Pollard, KS; Holloway, AK; Boyer, LA; Bruneau, BG				Wamstad, Joseph A.; Alexander, Jeffrey M.; Truty, Rebecca M.; Shrikumar, Avanti; Li, Fugen; Eilertson, Kirsten E.; Ding, Huiming; Wylie, John N.; Pico, Alexander R.; Capra, John A.; Erwin, Genevieve; Kattman, Steven J.; Keller, Gordon M.; Srivastava, Deepak; Levine, Stuart S.; Pollard, Katherine S.; Holloway, Alisha K.; Boyer, Laurie A.; Bruneau, Benoit G.			Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE MODIFICATIONS; NONCODING RNAS; CHROMATIN SIGNATURES; HEART; TRANSCRIPTION; ENHANCERS; DIFFERENTIATION; MOUSE; GATA4	Heart development is exquisitely sensitive to the precise temporal regulation of thousands of genes that govern developmental decisions during differentiation. However, we currently lack a detailed understanding of how chromatin and gene expression patterns are coordinated during developmental transitions in the cardiac lineage. Here, we interrogated the transcriptome and several histone modifications across the genome during defined stages of cardiac differentiation. We find distinct chromatin patterns that are coordinated with stage-specific expression of functionally related genes, including many human disease-associated genes. Moreover, we discover a novel preactivation chromatin pattern at the promoters of genes associated with heart development and cardiac function. We further identify stage-specific distal enhancer elements and find enriched DNA binding motifs within these regions that predict sets of transcription factors that orchestrate cardiac differentiation. Together, these findings form a basis for understanding developmentally regulated chromatin transitions during lineage commitment and the molecular etiology of congenital heart disease.	[Wamstad, Joseph A.; Shrikumar, Avanti; Li, Fugen; Ding, Huiming; Levine, Stuart S.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Alexander, Jeffrey M.; Truty, Rebecca M.; Eilertson, Kirsten E.; Wylie, John N.; Pico, Alexander R.; Capra, John A.; Erwin, Genevieve; Srivastava, Deepak; Pollard, Katherine S.; Holloway, Alisha K.; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Alexander, Jeffrey M.; Srivastava, Deepak; Bruneau, Benoit G.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Erwin, Genevieve] Univ Calif San Francisco, Integrat Program Quantitat Biol, San Francisco, CA 94158 USA; [Kattman, Steven J.; Keller, Gordon M.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Srivastava, Deepak; Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu; bbruneau@gladstone.ucsf.edu	Pico, Alexander/HCH-4305-2022; Alexander, Jeffrey/D-8809-2015; Holloway, Alisha/H-9574-2013; Capra, Tony/C-7784-2013	Alexander, Jeffrey/0000-0002-2258-5738; Holloway, Alisha/0000-0001-9810-389X; Keller, Gordon/0000-0001-9309-9297; Bruneau, Benoit/0000-0002-0804-7597; Eilertson, Kirsten/0000-0003-4850-1210; Pico, Alexander/0000-0001-5706-2163; Levine, Stuart/0000-0001-7363-562X	NHLBI Bench to Bassinet Program [U01HL098179]; NIH [F32-HL104913]; Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association; Massachusetts Life Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL104913, U01HL098179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER	NHLBI Bench to Bassinet Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association(American Heart Association); Massachusetts Life Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Sukonnik for cloning enhancer fragments; S. Thomas (Gladstone Bioinformatics Core) for help with Figure 3; J. Wythe and P. Devine for the modified pGL3 constructs; M. Cleary, E.N. Olson, and D. Wotton for constructs; and Bruneau, Boyer, and Pollard lab members for helpful discussions. This work was supported by the NHLBI Bench to Bassinet Program (U01HL098179, to B.G.B., L.A.B., K.S.P., and D.S.), NIH F32-HL104913 (J.A.W.), the Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association Established Investigator Award (B.G.B.), by William H. Younger, Jr. (B.G.B.) and Massachusetts Life Sciences Center (L.A.B.). L.A.B. is a Pew Scholar in the Biomedical Sciences. D. S. is a scientific founder of iPierian, and member of the Scientific Advisory Boards of iPieirian and RegeneRx Biopharmaceuticals.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pollard KS., 2005, BIOINFORMATICS COMPU, P251; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou PZ, 2012, CURR TOP DEV BIOL, V100, P143, DOI 10.1016/B978-0-12-387786-4.00005-1; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	52	438	447	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					206	220		10.1016/j.cell.2012.07.035	http://dx.doi.org/10.1016/j.cell.2012.07.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	22981692	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000309544200021
J	Wrighton, KC; Thomas, BC; Sharon, I; Miller, CS; Castelle, CJ; VerBerkmoes, NC; Wilkins, MJ; Hettich, RL; Lipton, MS; Williams, KH; Long, PE; Banfield, JF				Wrighton, Kelly C.; Thomas, Brian C.; Sharon, Itai; Miller, Christopher S.; Castelle, Cindy J.; VerBerkmoes, Nathan C.; Wilkins, Michael J.; Hettich, Robert L.; Lipton, Mary S.; Williams, Kenneth H.; Long, Philip E.; Banfield, Jillian F.			Fermentation, Hydrogen, and Sulfur Metabolism in Multiple Uncultivated Bacterial Phyla	SCIENCE			English	Article							PYROCOCCUS-FURIOSUS; MICROBIAL COMMUNITY; DIVISION OP11; GENOMES; RECONSTRUCTION; ARCHAEAL; OKLAHOMA; GENES	BD1-5, OP11, and OD1 bacteria have been widely detected in anaerobic environments, but their metabolisms remain unclear owing to lack of cultivated representatives and minimal genomic sampling. We uncovered metabolic characteristics for members of these phyla, and a new lineage, PER, via cultivation-independent recovery of 49 partial to near-complete genomes from an acetate-amended aquifer. All organisms were nonrespiring anaerobes predicted to ferment. Three augment fermentation with archaeal-like hybrid type II/III ribulose-1,5-bisphosphate carboxylase-oxygenase (RuBisCO) that couples adenosine monophosphate salvage with CO2 fixation, a pathway not previously described in Bacteria. Members of OD1 reduce sulfur and may pump protons using archaeal-type hydrogenases. For six organisms, the UGA stop codon is translated as tryptophan. All bacteria studied here may play previously unrecognized roles in hydrogen production, sulfur cycling, and fermentation of refractory sedimentary carbon.	[Wrighton, Kelly C.; Thomas, Brian C.; Sharon, Itai; Miller, Christopher S.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Castelle, Cindy J.; Williams, Kenneth H.; Long, Philip E.; Banfield, Jillian F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [VerBerkmoes, Nathan C.; Hettich, Robert L.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Wilkins, Michael J.; Lipton, Mary S.] Pacific NW Natl Lab, Richland, WA 99352 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Wilkins, Michael/A-9358-2013; Lipton, Mary S/H-3913-2012; Wrighton, Kelly C/ABD-6621-2021; Hettich, Robert L/N-1458-2016; Williams, Kenneth Hurst/O-5181-2014; Long, Philip E/F-5728-2013	Wrighton, Kelly C/0000-0003-0434-4217; Hettich, Robert L/0000-0001-7708-786X; Williams, Kenneth Hurst/0000-0002-3568-1155; Long, Philip E/0000-0003-4152-5682; Miller, Christopher/0000-0002-9448-8144; Banfield, Jill/0000-0001-8203-8771; Wilkins, Michael/0000-0002-3595-0853	U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program; DOE Knowledgebase Program; EMBO; U.S. DOE [DE-AC02-05CH11231]	U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program; DOE Knowledgebase Program; EMBO(European Molecular Biology Organization (EMBO)); U.S. DOE(United States Department of Energy (DOE))	We thank F. Larimer for RuBisCO analyses input; M. Shah for proteomic support; C. Thrash, P. Hugenholtz, and J. Eisen for manuscript suggestions; and the U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program for funding, the DOE Knowledgebase Program for funding GGkbase, and EMBO for a fellowship to I. S. The Rifle, Colorado, Integrated Field Research Center Project is managed by Lawrence Berkeley National Laboratory for the U.S. DOE (contract no. DE-AC02-05CH11231). Portions of this work were performed in the Environmental Molecular Science Laboratory, a DOE national scientific user facility at Pacific Northwest National Laboratory. The sequences were deposited in the National Center for Biotechnology Information Sequence Read Archive (accession no. SRA050978.1). This Whole-Genome Shotgun project has been deposited at GenBank under the accession no. AMFJ00000000. The version described in this paper is the first version, AMFJ01000000. Genomic and proteomic data can be accessed via http://geomicrobiology.berkeley.edu/rifle/acd_ggkbase.html.	Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Elshahed MS, 2005, APPL ENVIRON MICROB, V71, P7598, DOI 10.1128/AEM.71.11.7598-7602.2005; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kanai T, 2011, J BACTERIOL, V193, P3109, DOI 10.1128/JB.01072-10; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; Mai XH, 1996, J BACTERIOL, V178, P5897, DOI 10.1128/jb.178.20.5897-5903.1996; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Schocke L, 1998, EUR J BIOCHEM, V256, P589, DOI 10.1046/j.1432-1327.1998.2560589.x; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van Haaster DJ, 2008, J BACTERIOL, V190, P1584, DOI 10.1128/JB.01562-07; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11	28	429	435	10	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1661	1665		10.1126/science.1224041	http://dx.doi.org/10.1126/science.1224041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019650				2022-12-28	WOS:000309215400047
J	Chapman, S				Chapman, Simon			Does celebrity involvement in public health campaigns deliver long term benefit? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER DIAGNOSIS; IMPACT		Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					[Anonymous], VERY GOOD PUNTER SPE; Bhattacharya A, 2012, GUARDIAN; Chapman S, 2005, MED J AUSTRALIA, V183, P247, DOI 10.5694/j.1326-5377.2005.tb07029.x; Chapman S, 2001, HEALTH PROMOT INT, V16, P333, DOI 10.1093/heapro/16.4.333; Chapman S, 2009, MED J AUSTRALIA, V191, P620, DOI 10.5694/j.1326-5377.2009.tb03354.x; Kelaher M, 2008, INT J EPIDEMIOL, V37, P1326, DOI 10.1093/ije/dyn090; MacArthur GJ, 2011, J MED SCREEN, V18, P204, DOI 10.1258/jms.2011.011092	7	10	10	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6364	10.1136/bmj.e6364	http://dx.doi.org/10.1136/bmj.e6364			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23015036				2022-12-28	WOS:000309385500008
J	Randall, DW; Fickling, WE				Randall, David W.; Fickling, William E.			PICTURE QUIZ A swollen leg in the middle of the night	BRITISH MEDICAL JOURNAL			English	Editorial Material							GAS-GANGRENE; INFECTIONS		[Randall, David W.; Fickling, William E.] Queens Univ Hosp, Romford RM7 0AG, Essex, England		Randall, DW (corresponding author), Queens Univ Hosp, Romford RM7 0AG, Essex, England.	drandall@uclh.nhs.uk						Gibson Michael A, 2008, Cases J, V1, P300, DOI 10.1186/1757-1626-1-300; Jackisch T, 2006, ZBL CHIR, V131, P84, DOI 10.1055/s-2006-921399; Jamieson NF, 2001, POSTGRAD MED J, V77, P47, DOI 10.1136/pmj.77.903.47; MEYER RD, 1976, SOUTHERN MED J, V69, P1178, DOI 10.1097/00007611-197609000-00025; Schneeweiss S, 2009, ALIMENT PHARM THER, V30, P253, DOI 10.1111/j.1365-2036.2009.04037.x	5	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6189	10.1136/bmj.e6189	http://dx.doi.org/10.1136/bmj.e6189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014902				2022-12-28	WOS:000309385500005
J	Huang, Z; Kang, SK; Banno, M; Yamaguchi, T; Lee, D; Seok, C; Yashima, E; Lee, M				Huang, Zhegang; Kang, Seong-Kyun; Banno, Motonori; Yamaguchi, Tomoko; Lee, Dongseon; Seok, Chaok; Yashima, Eiji; Lee, Myongsoo			Pulsating Tubules from Noncovalent Macrocycles	SCIENCE			English	Article							ASSEMBLING ORGANIC NANOTUBES; PROTEIN; PORES; WATER; C-60	Despite recent advances in synthetic nanometer-scale tubular assembly, conferral of dynamic response characteristics to the tubules remains a challenge. Here, we report on supramolecular nanotubules that undergo a reversible contraction-expansion motion accompanied by an inversion of helical chirality. Bent-shaped aromatic amphiphiles self-assemble into hexameric macrocycles in aqueous solution, forming chiral tubules by spontaneous one-dimensional stacking with a mutual rotation in the same direction. The adjacent aromatic segments within the hexameric macrocycles reversibly slide along one another in response to external triggers, resulting in pulsating motions of the tubules accompanied by a chiral inversion. The aromatic interior of the self-assembled tubules encapsulates hydrophobic guests such as carbon-60 (C-60). Using a thermal trigger, we could regulate the C-60-C-60 interactions through the pulsating motion of the tubules.	[Huang, Zhegang; Kang, Seong-Kyun; Lee, Dongseon; Seok, Chaok; Lee, Myongsoo] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Banno, Motonori; Yamaguchi, Tomoko; Yashima, Eiji] Nagoya Univ, Dept Mol Design & Engn, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Huang, Zhegang] Harbin Inst Technol, Dept Chem, Harbin 150001, Peoples R China	Seoul National University (SNU); Nagoya University; Harbin Institute of Technology	Lee, M (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea.	myongslee@snu.ac.kr	Yashima, Eiji/H-5380-2011; Yashima, Eiji/D-4942-2018	Yashima, Eiji/0000-0001-6307-198X; Yashima, Eiji/0000-0001-6307-198X; Huang, Zhegang/0000-0003-0093-7867	National Research Foundation of Korea (NRF); Korean government (MEST) [2012-0001240]; Ministry of Education and Human Resources Development	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Education and Human Resources Development(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	We thank S. Lacher for helpful comments on the manuscript. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012-0001240). We acknowledge a fellowship of the BK21 program from the Ministry of Education and Human Resources Development.	Aidas K, 2007, LITH J PHYS, V47, P443, DOI 10.3952/lithjphys.47421; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Eisele DM, 2009, NAT NANOTECHNOL, V4, P658, DOI 10.1038/nnano.2009.227; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Hecht S, 2003, ANGEW CHEM INT EDIT, V42, P6021, DOI 10.1002/anie.200352983; Henze O, 2006, J AM CHEM SOC, V128, P5923, DOI 10.1021/ja0607234; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Iyoda M, 2011, ANGEW CHEM INT EDIT, V50, P10522, DOI 10.1002/anie.201006198; Kim HJ, 2010, ANGEW CHEM INT EDIT, V49, P8471, DOI 10.1002/anie.201003779; Kim JK, 2008, ANGEW CHEM INT EDIT, V47, P4662, DOI 10.1002/anie.200705863; KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653; MARX JL, 1973, LOGIC CIRCUITS CARBO, V181, P1236; Messmore BW, 2005, J AM CHEM SOC, V127, P7992, DOI 10.1021/ja051183y; Miranda FF, 2009, SMALL, V5, P2077, DOI 10.1002/smll.200900667; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Pantos GD, 2007, ANGEW CHEM INT EDIT, V46, P2238, DOI 10.1002/anie.200604891; Percec V, 2004, NATURE, V430, P764, DOI 10.1038/nature02770; Percec V, 2008, J AM CHEM SOC, V130, P7503, DOI 10.1021/ja801863e; Peterca M, 2011, J AM CHEM SOC, V133, P2311, DOI 10.1021/ja110753s; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Schappacher M, 2008, SCIENCE, V319, P1512, DOI 10.1126/science.1153848; Shao H, 2010, ANGEW CHEM INT EDIT, V49, P7688, DOI 10.1002/anie.201003415; Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j; Sicilia MC, 2005, J PHYS CHEM A, V109, P8341, DOI 10.1021/jp050530n; Wolffs M, 2005, J AM CHEM SOC, V127, P13484, DOI 10.1021/ja054406t; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Yamaguchi T, 2003, J AM CHEM SOC, V125, P13934, DOI 10.1021/ja038178j	28	240	243	9	317	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1521	1526		10.1126/science.1224741	http://dx.doi.org/10.1126/science.1224741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997334				2022-12-28	WOS:000308912900047
J	Neovius, M; Narbro, K; Keating, C; Peltonen, M; Sjoholm, K; Agren, G; Sjostrom, L; Carlsson, L				Neovius, Martin; Narbro, Kristina; Keating, Catherine; Peltonen, Markku; Sjoholm, Kajsa; Agren, Goran; Sjostrom, Lars; Carlsson, Lena			Health Care Use During 20 Years Following Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SWEDISH OBESE SUBJECTS; BODY-MASS INDEX; RANDOMIZED-TRIALS; COST DATA; INTERVENTION; MORTALITY; SWEDEN; ADULTS; IMPACT	Context Bariatric surgery results in sustained weight loss; reduced incidence of diabetes, cardiovascular events, and cancer; and improved survival. The long-term effect on health care use is unknown. Objective To assess health care use over 20 years by obese patients treated conventionally or with bariatric surgery. Design, Setting, and Participants The Swedish Obese Subjects study is an ongoing, prospective, nonrandomized, controlled intervention study conducted in the Swedish health care system that included 2010 adults who underwent bariatric surgery and 2037 contemporaneously matched controls recruited between 1987 and 2001. Inclusion criteria were age 37 years to 60 years and body mass index of 34 or higher in men and 38 or higher in women. Exclusion criteria were identical in both groups. Interventions Of the surgery patients, 13% underwent gastric bypass, 19% gastric banding, and 68% vertical-banded gastroplasty. Controls received conventional obesity treatment. Main Outcome Measures Annual hospital days (follow-up years 1 to 20; data capture 1987-2009; median follow-up 15 years) and nonprimary care outpatient visits (years 2-20; data capture 2001-2009; median follow-up 9 years) were retrieved from the National Patient Register, and drug costs from the Prescribed Drug Register (years 7-20; data capture 2005-2011; median follow-up 6 years). Registry linkage was complete for more than 99% of patients (4044 of 4047). Mean differences were adjusted for baseline age, sex, smoking, diabetes status, body mass index, inclusion period, and (for the inpatient care analysis) hospital days the year before the index date. Results In the 20 years following their bariatric procedure, surgery patients used a total of 54 mean cumulative hospital days compared with 40 used by those in the control group (adjusted difference, 15; 95% CI, 2-27; P = .03). During the years 2 through 6, surgery patients had an accumulated annual mean of 1.7 hospital days vs 1.2 days among control patients (adjusted difference, 0.5; 95% CI, 0.2 to 0.7; P < .001). From year 7 to 20, both groups had a mean annual 1.8 hospital days (adjusted difference, 0.0; 95% CI, -0.3 to 0.3; P = .95). Surgery patients had a mean annual 1.3 nonprimary care outpatient visits during the years 2 through 6 vs 1.1 among the controls (adjusted difference, 0.3; 95% CI, 0.1 to 0.4; P = .003), but from year 7, the 2 groups did not differ (1.8 vs 1.9 mean annual visits; adjusted difference, -0.2; 95% CI, -0.4 to 0.1; P = .12). From year 7 to 20, the surgery group incurred a mean annual drug cost of US $930; the control patients, $1123 (adjusted difference, -$228; 95% CI, -$335 to -$121; P < .001). Conclusions Compared with controls, surgically treated patients used more inpatient and nonprimary outpatient care during the first 6-year period after undergoing bariatric surgery but not thereafter. Drug costs from years 7 through 20 were lower for surgery patients than for control patients.	[Neovius, Martin; Sjoholm, Kajsa; Sjostrom, Lars; Carlsson, Lena] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Neovius, Martin] Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Narbro, Kristina] Reg Secretariat, Dept Healthcare, Gothenburg, Sweden; [Keating, Catherine] Deakin Univ, Melbourne, Vic, Australia; [Peltonen, Markku] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Agren, Goran] Orebro Univ Hosp, Dept Surg, Orebro, Sweden	University of Gothenburg; Karolinska Institutet; Deakin University; Finland National Institute for Health & Welfare; Orebro University	Neovius, M (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit T2, SE-17176 Stockholm, Sweden.	martin.neovius@ki.se	Peltonen, Markku/F-3037-2015; Carlsson, Lena/F-7570-2018	Peltonen, Markku/0000-0002-3767-4223; Carlsson, Lena/0000-0003-4145-6242; Neovius, Martin/0000-0003-2300-3055; Sjoholm, Kajsa/0000-0003-0146-8193	sanofi-aventis; Johnson Johnson; Astra Zeneca; Biovitrum; Bristol-Myers Squibb; GlaxoSmithKline; Lenimen; Merck; Novo Nordisk; Hoffmann-LaRoche; Servier; Abbott; Itrim International; Strategic Health Resources; Cambridge Weight Plan; Allergan Australia; Arbetsmarknadens Forsakrings- och Aktiebolag (AFA); Swedish Medical Research Council [K2012-55X-22082-01-3, K2010-55X-11285-13, K2008-65X-20753-01-4]; Swedish Research Council; Swedish Foundation for Strategic Research; Swedish federal government under the LUA/ALF; Swedish State	sanofi-aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Astra Zeneca(AstraZeneca); Biovitrum; Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Lenimen; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Hoffmann-LaRoche(Hoffmann-La Roche); Servier(Servier); Abbott(Abbott Laboratories); Itrim International; Strategic Health Resources; Cambridge Weight Plan; Allergan Australia(AbbVieAllergan); Arbetsmarknadens Forsakrings- och Aktiebolag (AFA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish federal government under the LUA/ALF; Swedish State	All authors have completed and submitted the ICMJE Form for Disclosure of potential conflicts of interest. Dr Carlsson reported having served as a consultant for Astra Zeneca and holding stocks in Sahltech. Dr Sjostrom reported obtaining unrestricted Swedish Obese Subjects grants from sanofi-aventis and Johnson & Johnson since 2007; receiving lecture and consulting fees from Astra Zeneca, Biovitrum, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Lenimen, Merck, Novo Nordisk, Hoffmann-LaRoche, sanofi-aventis, and Servier; and holding stocks in Lenimen and being chairman of its board. Dr Neovius has received lecture and consulting fees from Abbott, sanofi-aventis, Itrim International, and Strategic Health Resources; research grants from Cambridge Weight Plan and Novo Nordisk; and royalty payments for co-authoring chapters in a Swedish textbook on obesity. Dr Narbro has received royalty payments for co-authoring a chapter in a Swedish textbook on obesity. Keating leads an independent research grant from Allergan Australia. Dr Sjoholm reported holding stocks in Pfizer. All other authors declared no conflicts of interest.; This analysis based on a registry linkage of the Swedish Obese Subjects study data to the National Patient Register and the Prescribed Drug Register was supported by a grant from Arbetsmarknadens Forsakrings- och Aktiebolag (AFA) to Drs Narbro and Neovius.; The Swedish Obese Subjects study was supported by grants K2012-55X-22082-01-3, K2010-55X-11285-13, K2008-65X-20753-01-4 from the Swedish Medical Research Council, the Swedish Research Council, the Swedish Foundation for Strategic Research to Sahlgrenska Centre for Cardiovascular and Metabolic Research, and the Swedish federal government under the LUA/ALF agreement (Drs Carlsson and Sjostrom). These research grants applied for as ordinary Research Council grants are paid by the Swedish State to the university hospitals as compensation for teaching costs. Unconditional support was also obtained from Hoffmann-LaRoche, Astra Zeneca, Cederroths, sanofi-aventis, and Johnson & Johnson.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Agren G, 2002, OBES RES, V10, P1276, DOI 10.1038/oby.2002.173; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; ApotekensService, 2012, DRUG PRIC IND LAK; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Narbro K, 2002, ARCH INTERN MED, V162, P2061, DOI 10.1001/archinte.162.18.2061; Neovius M, 2008, INT J OBESITY, V32, P832, DOI 10.1038/sj.ijo.0803784; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Sampalis JS, 2004, OBES SURG, V14, P939, DOI 10.1381/0960892041719662; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2000, ENDOCRINE, V13, P213, DOI 10.1385/ENDO:13:2:213; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; WAALER HT, 1984, ACTA MED SCAND, P1; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918	26	104	111	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1132	1141		10.1001/2012.jama.11792	http://dx.doi.org/10.1001/2012.jama.11792			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990272	Bronze			2022-12-28	WOS:000308861000029
J	Bellelli, G; Trabucchi, M				Bellelli, Giuseppe; Trabucchi, Marco			Dialogue on Geriatrics: How Should We Fix the Problem?	ANNALS OF INTERNAL MEDICINE			English	Letter									[Bellelli, Giuseppe] Univ Milano Bicocca, Geriatr Clin, Dept Hlth Sci, Monza, Italy; [Trabucchi, Marco] Geriatr Res Grp, Brescia, Italy	University of Milano-Bicocca	Bellelli, G (corresponding author), Univ Milano Bicocca, Geriatr Clin, Dept Hlth Sci, Monza, Italy.		Bellelli, Giuseppe/H-6443-2019	Bellelli, Giuseppe/0000-0001-5430-0947				Leipzig RM, 2012, ANN INTERN MED, V156, P657, DOI 10.7326/0003-4819-156-9-201205010-00010	1	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6					458	458		10.7326/0003-4819-157-6-201209180-00021	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986390	Green Published			2022-12-28	WOS:000308912800028
J	Hall, WJ				Hall, William J.			Telemonitoring did not reduce hospitalizations or ED visits in high-risk elderly patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA	University of Rochester	Hall, WJ (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.								0	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-8	10.7326/0003-4819-157-6-201209180-02008	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986400				2022-12-28	WOS:000308912800007
J	Rasmussen, TA; Jorgensen, MRS; Bjerrum, S; Jensen-Fangel, S; Stovring, H; Ostergaard, L; Sogaard, OS				Rasmussen, Thomas A.; Jorgensen, Martin R. S.; Bjerrum, Stephanie; Jensen-Fangel, Soren; Stovring, Henrik; Ostergaard, Lars; Sogaard, Ole S.			Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							GUILLAIN-BARRE-SYNDROME; INFLUENZA-A H1N1; RUBELLA VACCINATION; TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; FEBRILE SEIZURES; MMR VACCINATION; ADVERSE EVENTS; AUTISM; MEASLES	Objectives To predict the number of selected outcomes temporally associated but not caused by vaccination, to aid causality assessment of adverse events arising after mass immunisation in a paediatric population. Design Nationwide population based cohort study. Setting Denmark. Participants All liveborn infants delivered after 1 January 1980. Study population was followed from date of birth until hospital admission for selected outcome diagnoses, death, first emigration, age 18 years, or 31 December 2009. The study population was subject to vaccines used in standard childhood immunisation in Denmark, with 82-93% vaccine coverage. Main outcome measures Incidence of acute infectious and post-infectious polyneuritis (Guillain-Barre syndrome), acute transverse myelitis, optic polyneuritis, facial nerve palsy, anaphylactic shock, seizure, multiple sclerosis, autoimmune thrombocytopenia, type 1 diabetes mellitus, juvenile and rheumatoid arthritis, narcolepsy, and death of unknown cause stratified by sex, age, and season. We predicted the number of events for a hypothetical vaccine cohort of 1 000 000 people for follow-up periods of up to 182 days. Results The study included 2 300 227 liveborn infants, yielding 37 262 404 person years of follow-up; median follow-up was 16.8 person years. Incidence of outcome diagnoses spanned from 0.32 per 100 000 patient years for autoimmune thrombocytopenia to 189.82 per 100 000 patient years for seizure. Seasonal differences were most pronounced for anaphylactic shock, seizure, and multiple sclerosis. Even for rare outcomes, numerous events were predicted in the hypothetical vaccine cohort. We predicted that 20 cases of type 1 diabetes mellitus, 19 of juvenile or rheumatoid arthritis, eight of facial nerve palsy, and five of multiple sclerosis per 1 000 000 children would occur within 42 days after vaccination. Conclusions Incorporating exact background rates of disease based on age, sex, and seasonal distribution could strengthen vaccine safety assessment, and provides an evidence based focus for discussing the incremental risk of newly introduced vaccines.	[Rasmussen, Thomas A.; Jensen-Fangel, Soren; Ostergaard, Lars; Sogaard, Ole S.] Aarhus Univ Hosp, Dept Infect Dis, DK-8200 Aarhus N, Denmark; [Jorgensen, Martin R. S.] Aarhus Univ Hosp, Aalborg Hosp, Dept Infect Dis, Aalborg, Denmark; [Bjerrum, Stephanie] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark; [Stovring, Henrik] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Copenhagen; Aarhus University	Rasmussen, TA (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, DK-8200 Aarhus N, Denmark.	thomrasm@rm.dk	Søgaard, Ole S/P-6058-2016; Støvring, Henrik/I-4683-2012; Ostergaard, Lars/AAA-3020-2020; Søgaard, Ole Schmeltz/AEP-7968-2022; Støvring, Henrik/H-5754-2019	Støvring, Henrik/0000-0002-5821-2351; Ostergaard, Lars/0000-0003-2459-0511; Søgaard, Ole Schmeltz/0000-0001-9107-2023; Støvring, Henrik/0000-0002-5821-2351; Bjerrum, Stephanie/0000-0002-9046-6255; Rasmussen, Thomas Aagaard/0000-0001-5354-2442; Ostergaard, Lars/0000-0002-7619-605X	Department of Infectious Diseases, Aarhus University Hospital, Denmark; Aarhus University Hospital	Department of Infectious Diseases, Aarhus University Hospital, Denmark; Aarhus University Hospital	The study was funded by the Department of Infectious Diseases, Aarhus University Hospital, Denmark.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from Aarhus University Hospital for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], 2011, PRESCRIRE INT, V20, P154; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Berlin JA, 2008, AM J PUBLIC HEALTH, V98, P1366, DOI 10.2105/AJPH.2007.124537; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Choe YJ, 2011, VACCINE, V29, P2066, DOI 10.1016/j.vaccine.2011.01.007; Christiansen CF, 2010, NEUROEPIDEMIOLOGY, V35, P267, DOI 10.1159/000320245; Deeks SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-329; DeStefano F, 2010, LANCET, V375, P1146, DOI 10.1016/S0140-6736(09)61917-6; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Arcond MF, 2011, MEDICINA-BUENOS AIRE, V71, P161; Folkenberg M, 2011, VACCINE, V29, P1180, DOI 10.1016/j.vaccine.2010.12.008; Haba-Rubio J, 2011, REV NEUROL-FRANCE, V167, P563, DOI 10.1016/j.neurol.2011.04.003; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Huang WT, 2010, LANCET, V375, P1164, DOI 10.1016/S0140-6736(10)60515-6; Hviid A, 2008, AM J EPIDEMIOL, V168, P1277, DOI 10.1093/aje/kwn253; Institute of Medicine, 2010, ADV EFF VACC EV CAUS; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Jiang GX, 1997, J NEUROL NEUROSUR PS, V62, P447, DOI 10.1136/jnnp.62.5.447; Klein NP, 2010, VACCINE, V28, P1062, DOI 10.1016/j.vaccine.2009.10.115; Kokia ES, 2007, VACCINE, V25, P8557, DOI 10.1016/j.vaccine.2007.10.021; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lieu TA, 2007, MED CARE, V45, pS89, DOI 10.1097/MLR.0b013e3180616c0a; Lower Johannes, 2008, MMW Fortschr Med, V150, P6; Madsen KM, 2004, DRUG SAFETY, V27, P831, DOI 10.2165/00002018-200427120-00001; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Mitrakrishnan S, 2011, VACCINE, V29, P6369, DOI 10.1016/j.vaccine.2011.04.126; Norgaard M, 2007, PHARMACOEPIDEM DR S, V16, pS220; Norgaard M, 2011, BLOOD, V117, P3514, DOI 10.1182/blood-2010-10-312819; Salmon DA, 2011, PEDIATRICS, V127, pS78, DOI 10.1542/peds.2010-1722L; Sato N, 2011, INTERNAL MED, V50, P503, DOI 10.2169/internalmedicine.50.4340; Siegrist CA, 2007, PEDIATR INFECT DIS J, V26, P979, DOI 10.1097/INF.0b013e318149dfea; Statens Serum Institut, 2011, HPV VACC COV 2010; Statens Serum Institut, 2011, PCV COV INV PNEUM DI; Statens Serum Institut, VACC SURV; Statens Serum Institut, 2011, DTAP IPV HIB VACC CO; Statens Serum Institut, 2011, MMR VACC COV 2010; Sun YL, 2012, JAMA-J AM MED ASSOC, V307, P823, DOI 10.1001/jama.2012.165; Svanstrom H, 2010, DRUG SAFETY, V33, P1015, DOI 10.2165/11537630-000000000-00000; Thomsen RW, 2004, DIABETES CARE, V27, P70, DOI 10.2337/diacare.27.1.70; Vestergaard M, 2006, J CLIN EPIDEMIOL, V59, P61, DOI 10.1016/j.jclinepi.2005.05.008; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8; Wijnans L, 2011, VACCINE, V29, P7559, DOI 10.1016/j.vaccine.2011.08.016; Williams SE, 2011, VACCINE; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Yin JK, 2011, INFLUENZA OTHER RESP, V5, P299, DOI 10.1111/j.1750-2659.2011.00229.x	45	16	16	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 17	2012	345								e5823	10.1136/bmj.e5823	http://dx.doi.org/10.1136/bmj.e5823			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JG	22988304	Green Published, hybrid			2022-12-28	WOS:000309160300001
J	Mattiroli, F; Vissers, JHA; van Dijk, WJ; Ikpa, P; Citterio, E; Vermeulen, W; Marteijn, JA; Sixma, TK				Mattiroli, Francesca; Vissers, Joseph H. A.; van Dijk, Willem J.; Ikpa, Pauline; Citterio, Elisabetta; Vermeulen, Wim; Marteijn, Jurgen A.; Sixma, Titia K.			RNF168 Ubiquitinates K13-15 on H2A/H2AX to Drive DNA Damage Signaling	CELL			English	Article							X-RAY SOLUTION; DEPENDENT MONOUBIQUITYLATION; HOMOLOGOUS RECOMBINATION; HISTONE UBIQUITYLATION; H2A UBIQUITINATION; CONTAINING PROTEIN; 53BP1 RECRUITMENT; RING FINGER; LIGASE; REPAIR	Ubiquitin-dependent signaling during the DNA damage response (DDR) to double-strand breaks (DSBs) is initiated by two E3 ligases, RNF8 and RNF168, targeting histone H2A and H2AX. RNF8 is the first ligase recruited to the damage site, and RNF168 follows RNF8-dependent ubiquitination. This suggests that RNF8 initiates H2A/H2AX ubiquitination with K63-linked ubiquitin chains and RNF168 extends them. Here, we show that RNF8 is inactive toward nucleosomal H2A, whereas RNF168 catalyzes the monoubiquitination of the histones specifically on K13-15. Structure-based mutagenesis of RNF8 and RNF168 RING domains shows that a charged residue determines whether nucleosomal proteins are recognized. We find that K63 ubiquitin chains are conjugated to RNF168-dependent H2A/H2AX monoubiquitination at K13-15 and not on K118-119. Using a mutant of RNF168 unable to target histones but still catalyzing ubiquitin chains at DSBs, we show that ubiquitin chains per se are insufficient for signaling, but RNF168 target ubiquitination is required for DDR.	[Mattiroli, Francesca; van Dijk, Willem J.; Ikpa, Pauline; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Mattiroli, Francesca; van Dijk, Willem J.; Ikpa, Pauline; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Vissers, Joseph H. A.; Citterio, Elisabetta] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Vermeulen, Wim; Marteijn, Jurgen A.] Erasmus MC, Dept Genet, NL-3015 GE Rotterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.sixma@nki.nl	Marteijn, Jurgen A/B-5696-2014; Vissers, Joseph/AAB-7160-2019; Vermeulen, Wim/W-8708-2019; Mattiroli, Francesca/AAT-1489-2020	Marteijn, Jurgen A/0000-0001-9321-518X; Vissers, Joseph/0000-0003-0435-6824; Vermeulen, Wim/0000-0003-3616-734X; Mattiroli, Francesca/0000-0002-1574-7217; Ikpa, Pauline/0000-0002-3523-6318; Sixma, Titia K/0000-0001-6180-0632; Citterio, Elisabetta/0000-0003-2347-3495	ERC; EU project Ubiregulators [KWF 2006-3476]; Dutch Organization for Scientific Research ZonMW Veni [917-96-120]; NWO Vidi [864.08.011]; KWF [2007-3877]	ERC(European Research Council (ERC)European Commission); EU project Ubiregulators; Dutch Organization for Scientific Research ZonMW Veni; NWO Vidi(Netherlands Organization for Scientific Research (NWO)); KWF	We thank A. Perrakis, P. Rucktooa, and R. Joosten for crystallography support, J. Smit for contribution to E1 and E2 purifications, M. Uckelmann for contribution to in vitro specificity, D. Svergun and F. Groothuizen for assistance in SAXS measurements and analysis, J. Lukas, R. Klevit, L. Penengo, K. Luger, M. Peuscher, and J. Jacobs for plasmids, J. van der Knaap for providing Drosophila oligonucleosomes enriched in ubiquitinated H2B, G. Smeenk for help with gH2AX IPs, R. Hibbert for PCNA and Rad6 samples, J. Chen for anti-RAP80 antibodies, A. Nussenzweig for H2ax<SUP>-/-</SUP> MEFs, Genentech for K63-specific antibodies, W.A. van Cappellen of the Optical Imaging Centre, ErasmusMC, for help with the quantification of foci, and T. Brummelkamp, F. van Leeuwen, colleagues and members of the Sixma laboratory for critical reading of the manuscript. These studies were funded by the ERC Advanced grant, EU project Ubiregulators, KWF 2006-3476 to T.K.S., Dutch Organization for Scientific Research ZonMW Veni 917-96-120 to J.A.M., NWO Vidi 864.08.011 to E.C., and KWF 2007-3877. F.M. designed and performed all experiments and wrote the manuscript. J.H.A.V. contributed to cell-based experiments and discussions. J.A.M., W.V., and E.C. supervised immunofluorescence experiments and imaging. J.A.M. performed quantifications of immunofluorescence data. W.J.vD. assisted in purification and western blots. P.I. cloned and purified the RNF8 RING domain. T.K.S. designed and supervised experiments and wrote the manuscript. All authors critically read the paper.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Hibbert RG, 2009, DNA REPAIR, V8, P525, DOI 10.1016/j.dnarep.2009.01.014; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUNT LT, 1977, BIOCHEM BIOPH RES CO, V74, P650, DOI 10.1016/0006-291X(77)90352-7; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Ramadan K, 2012, CELL CYCLE, V11, P1062, DOI 10.4161/cc.11.6.19446; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shiloh Y, 2011, FEBS LETT, V585, P2795, DOI 10.1016/j.febslet.2011.07.034; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	62	419	453	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1182	1195		10.1016/j.cell.2012.08.005	http://dx.doi.org/10.1016/j.cell.2012.08.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980979	Bronze			2022-12-28	WOS:000308928100012
J	Antunes, H; Nascimento, J; Peixoto, P				Antunes, Henedina; Nascimento, Joao; Peixoto, Paula			Peutz-Jeghers syndrome: capsule endoscopy to stage disease	LANCET			English	Editorial Material									[Antunes, Henedina; Nascimento, Joao] Hosp Braga, Dept Pediat, Gastroenterol Hepatol & Nutr Unit, P-4701901 Braga, Portugal; [Peixoto, Paula] Hosp Braga, Dept Gastroenterol, P-4701901 Braga, Portugal; [Antunes, Henedina] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Antunes, Henedina] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal	Hospital de Braga; Hospital de Braga; Universidade do Minho	Antunes, H (corresponding author), Hosp Braga, Dept Pediat, Gastroenterol Hepatol & Nutr Unit, Apartado 2056, P-4701901 Braga, Portugal.	henedinaantunes@gmail.com	Nascimento, Joao/J-1509-2019	Antunes, Henedina/0000-0002-1035-0173					0	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2013	381	9864					E5	E5		10.1016/S0140-6736(12)60830-7	http://dx.doi.org/10.1016/S0140-6736(12)60830-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23040456	Green Submitted, Bronze			2022-12-28	WOS:000314578900003
J	Gecz, J; Haan, E				Gecz, Jozef; Haan, Eric			New mutations and sporadic intellectual disability	LANCET			English	Editorial Material							DE-NOVO MUTATIONS; MENTAL-RETARDATION; DISEASE		[Gecz, Jozef; Haan, Eric] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Gecz, Jozef; Haan, Eric] Womens & Childrens Hosp, SA Pathol, Adelaide, SA 5006, Australia	University of Adelaide; SA Pathology; Womens & Childrens Hospital Australia	Gecz, J (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia.	jozef.gecz@adelaide.edu.au	Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861				Braun KV, 2005, PAEDIATR PERINAT EP, V19, P69, DOI 10.1111/j.1365-3016.2004.00597.x; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Leonard H, 2003, PAEDIATR PERINAT EP, V17, P58, DOI 10.1046/j.1365-3016.2003.00469.x; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Rauch A, 2012, LANCET; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712	13	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1630	1631		10.1016/S0140-6736(12)61603-1	http://dx.doi.org/10.1016/S0140-6736(12)61603-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23020936				2022-12-28	WOS:000310951400008
J	Flaherty, KT; Infante, JR; Daud, A; Gonzalez, R; Kefford, RF; Sosman, J; Hamid, O; Schuchter, L; Cebon, J; Ibrahim, N; Kudchadkar, R; Burris, HA; Falchook, G; Algazi, A; Lewis, K; Long, GV; Puzanov, I; Lebowitz, P; Singh, A; Little, S; Sun, P; Allred, A; Ouellet, D; Kim, KB; Patel, K; Weber, J				Flaherty, Keith T.; Infante, Jeffery R.; Daud, Adil; Gonzalez, Rene; Kefford, Richard F.; Sosman, Jeffrey; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Ibrahim, Nageatte; Kudchadkar, Ragini; Burris, Howard A., III; Falchook, Gerald; Algazi, Alain; Lewis, Karl; Long, Georgina V.; Puzanov, Igor; Lebowitz, Peter; Singh, Ajay; Little, Shonda; Sun, Peng; Allred, Alicia; Ouellet, Daniele; Kim, Kevin B.; Patel, Kiran; Weber, Jeffrey			Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOSE-ESCALATION TRIAL; CELL LUNG-CANCER; RAF INHIBITORS; METASTATIC MELANOMA; IMPROVED SURVIVAL; RESISTANCE; KINASE; EFFICACY; PATHWAY; SAFETY	Background Resistance to therapy with BRAF kinase inhibitors is associated with reactivation of the mitogen-activated protein kinase (MAPK) pathway. To address this problem, we conducted a phase 1 and 2 trial of combined treatment with dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK) inhibitor. Methods In this open-label study involving 247 patients with metastatic melanoma and BRAF V600 mutations, we evaluated the pharmacokinetic activity and safety of oral dabrafenib (75 or 150 mg twice daily) and trametinib (1, 1.5, or 2 mg daily) in 85 patients and then randomly assigned 162 patients to receive combination therapy with dabrafenib (150 mg) plus trametinib (1 or 2 mg) or dabrafenib monotherapy. The primary end points were the incidence of cutaneous squamous-cell carcinoma, survival free of melanoma progression, and response. Secondary end points were overall survival and pharmacokinetic activity. Results Dose-limiting toxic effects were infrequently observed in patients receiving combination therapy with 150 mg of dabrafenib and 2 mg of trametinib (combination 150/2). Cutaneous squamous-cell carcinoma was seen in 7% of patients receiving combination 150/2 and in 19% receiving monotherapy (P = 0.09), whereas pyrexia was more common in the combination 150/2 group than in the monotherapy group (71% vs. 26%). Median progression-free survival in the combination 150/2 group was 9.4 months, as compared with 5.8 months in the monotherapy group (hazard ratio for progression or death, 0.39; 95% confidence interval, 0.25 to 0.62; P<0.001). The rate of complete or partial response with combination 150/2 therapy was 76%, as compared with 54% with monotherapy (P = 0.03). Conclusions Dabrafenib and trametinib were safely combined at full monotherapy doses. The rate of pyrexia was increased with combination therapy, whereas the rate of proliferative skin lesions was nonsignificantly reduced. Progression-free survival was significantly improved. (Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT01072175.)	[Kudchadkar, Ragini; Weber, Jeffrey] Univ S Florida, H Lee Moffitt Canc Ctr, Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Ibrahim, Nageatte] Dana Farber Canc Inst, Boston, MA 02115 USA; [Infante, Jeffery R.; Burris, Howard A., III] Vanderbilt Univ, Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA; [Sosman, Jeffrey; Puzanov, Igor] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Daud, Adil; Algazi, Alain] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Gonzalez, Rene; Lewis, Karl] Univ Colorado, Ctr Canc, Aurora, CO USA; [Kefford, Richard F.; Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Westmead Inst Canc Res, Sydney, NSW 2006, Australia; [Kefford, Richard F.; Long, Georgina V.] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia; [Cebon, Jonathan] Austin Hosp, Ludwig Inst Canc Res, Heidelberg, Vic 3084, Australia; [Hamid, Omid] Angeles Clin & Res Inst, Los Angeles, CA USA; [Schuchter, Lynn] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Falchook, Gerald] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Kim, Kevin B.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Div Canc Med, Houston, TX 77030 USA; [Lebowitz, Peter; Singh, Ajay; Little, Shonda; Sun, Peng; Allred, Alicia; Ouellet, Daniele; Patel, Kiran] GlaxoSmithKline, Collegeville, PA USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Sarah Cannon Research Institute; Tennessee Oncology; Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; Melanoma Institute Australia; University of Sydney; University of Sydney; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Angeles Clinic & Research Institute; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; GlaxoSmithKline	Weber, J (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA.	jeffrey.weber@moffitt.org	gonzález, rene/W-2081-2019; Long, Georgina V/C-1771-2013; PUZANOV, IGOR/AAP-2966-2020; Cebon, Jonathan S/H-1643-2013; Daud, Adil/T-3079-2019	Long, Georgina V/0000-0001-8894-3545; PUZANOV, IGOR/0000-0002-9803-3497; Daud, Adil/0000-0002-6617-8421; Kefford, Richard/0000-0001-9251-9229; Cebon, Jonathan/0000-0002-3898-950X	GlaxoSmithKline; NATIONAL CANCER INSTITUTE [K24CA097588, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by GlaxoSmithKline.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kwak EL, 2011, NEW ENGL J MED, V364, P588; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023	27	539	569	3	132	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1694	1703		10.1056/NEJMoa1210093	http://dx.doi.org/10.1056/NEJMoa1210093			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23020132	Green Accepted			2022-12-28	WOS:000310440800006
J	Jeste, DV				Jeste, Dilip V.			Mental health and the 2012 US election	LANCET			English	Editorial Material									Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA	University of California System; University of California San Diego	Jeste, DV (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA.	djeste@ucsd.edu						[Anonymous], 2012, 112 HOUS REPR; Blumenthal D, 2011, NEW ENGL J MED, V365, P2047, DOI 10.1056/NEJMp1111239; Friedman R. A., 2012, NY TIMES; Jeste DV, 2011, PSYCHIAT CLIN N AM, V34, pXIII, DOI 10.1016/j.psc.2011.01.001; Jeste DV, 1999, ARCH GEN PSYCHIAT, V56, P848, DOI 10.1001/archpsyc.56.9.848; Jones David K, 2012, N Engl J Med, V366, pe7, DOI 10.1056/NEJMp1114858; Kessler RC, 2001, HEALTH SERV RES, V36, P987; Massachusetts Taxpayer Foundation, MASS HLTH REF SPEND; Moran M, 2012, PSYCHIAT NEWS, V47, p1a; National Institute of Mental Health, NUMB COUNT MENT DIS; Zapata Daniela, 2012, 17893 NBER	11	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2012	380	9849					1206	1208		10.1016/S0140-6736(12)61516-5	http://dx.doi.org/10.1016/S0140-6736(12)61516-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	020NG	23040846				2022-12-28	WOS:000309817500005
J	Coste, B				Coste, Bertrand			The Cellular Feeling of Pressure	SCIENCE			English	Editorial Material							CHANNELS; CURRENTS; PIEZO		Res Ctr Neurobiol Neurophysiol Marseilles, Marseille, France		Coste, B (corresponding author), Res Ctr Neurobiol Neurophysiol Marseilles, Marseille, France.							Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	9	1	1	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103								10.1126/science.1229853	http://dx.doi.org/10.1126/science.1229853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042881				2022-12-28	WOS:000309457400050
J	Wynia, MK; Von Kohorn, I; Mitchell, PH				Wynia, Matthew K.; Von Kohorn, Isabelle; Mitchell, Pamela H.			Challenges at the Intersection of Team-Based and Patient-Centered Health Care Insights From an IOM Working Group	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wynia, Matthew K.] Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA; [Von Kohorn, Isabelle] Natl Acad, Inst Med, Washington, DC USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA	American Medical Association; National Academies of Sciences, Engineering & Medicine; University of Washington; University of Washington Seattle	Wynia, MK (corresponding author), 515 N State St, Chicago, IL 60654 USA.	matthew.wynia@ama-assn.org	Wynia, Matthew/T-2210-2019					Briggs MH, 1999, CHILD ADOL PSYCH CL, V8, P365; Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; Interprofessional Education Collaborative, COR COMP INT COLL PR; Mitchell P, 2012, NAM PERSPECT, DOI DOI 10.31478/201210C; Mitchell PH, 2012, HLTH AFFAIRS BL 0504; *OFF DIS PREV HLTH, QUICK GUID HLTH LIT	6	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1327	1328		10.1001/jama.2012.12601	http://dx.doi.org/10.1001/jama.2012.12601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032546				2022-12-28	WOS:000309369300024
J	Lin, JJ; Mula, M; Hermann, BP				Lin, Jack J.; Mula, Marco; Hermann, Bruce P.			Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan	LANCET			English	Article							TEMPORAL-LOBE EPILEPSY; SEIZURE-RELATED FACTORS; BENIGN CHILDHOOD EPILEPSY; QUALITY-OF-LIFE; PSYCHIATRIC COMORBIDITY; PRESCHOOL-CHILDREN; MAJOR DEPRESSION; RISK-FACTOR; EXECUTIVE DYSFUNCTION; COGNITIVE IMPAIRMENT	Epilepsy is a common neurological disorder that is complicated by psychiatric, cognitive, and social comorbidities that have become a major target of concern and investigation in view of their adverse effect on the course and quality of life. In this report we define the specific psychiatric, cognitive, and social comorbidities of paediatric and adult epilepsy, their epidemiology, and real life effects; examine the relation between epilepsy syndromes and the risk of neurobehavioural comorbidities; address the lifespan effect of epilepsy on brain neurodevelopment and brain ageing and the risk of neurobehavioural comorbidities; consider the overarching effect of broader brain disorders on both epilepsy and neurobehavioural comorbidities; examine directions of causality and the contribution of selected epilepsy-related characteristics; and outline clinic-friendly screening approaches for these problems and recommended pharmacological, behavioural, and educational interventions.	[Hermann, Bruce P.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53705 USA; [Lin, Jack J.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Mula, Marco] Amedeo Avogadro Univ, Dept Neurol, Novara, Italy	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of Eastern Piedmont Amedeo Avogadro	Hermann, BP (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 1685 Highland Ave, Madison, WI 53705 USA.	hermann@neurology.wisc.edu	Hermann, Bruce/ACM-4355-2022; Mula, Marco/K-3974-2019	Mula, Marco/0000-0002-9415-3395	National Institutes of Health (NIH) [K23 NS060993]; NINDS [2RO1-44351]; Clinical and Translational Science Award (CTSA); National Center for Research Resources (NCRR) [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044351, K23NS060993] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are supported by grants from the National Institutes of Health (NIH) including K23 NS060993 (JJL) and NINDS 2RO1-44351 (BPH). BPH is also supported by the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR) grant 1UL1RR025011, and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding source played no role in the interpretation of the studies present or the preparation and writing of this review. We thank Maria Thom and Sanjay Sisodiya for providing images for figure 3A.	Adachi N, 2000, NEUROLOGY, V55, P1310, DOI 10.1212/WNL.55.9.1310; Adachi N, 2011, EPILEPSIA, V52, P1239, DOI 10.1111/j.1528-1167.2011.03039.x; Adelow C, 2012, NEUROLOGY, V78, P396, DOI 10.1212/WNL.0b013e318245f461; Aksoy-Poyraz C, 2008, EPILEPSY BEHAV, V13, P707, DOI 10.1016/j.yebeh.2008.07.001; Alfstad KA, 2011, EPILEPSIA, V52, P1231, DOI 10.1111/j.1528-1167.2011.03042.x; Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023; Austin JK, 2001, PEDIATRICS, V107, P115, DOI 10.1542/peds.107.1.115; Barry JJ, 2008, EPILEPSY BEHAV, V13, pS1, DOI 10.1016/j.yebeh.2008.04.005; Baune BT, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.18; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Berg AT, 2008, EPILEPSIA, V49, P608, DOI 10.1111/j.1528-1167.2007.01461.x; Berg AT, 2007, DEV MED CHILD NEUROL, V49, P487, DOI 10.1111/j.1469-8749.2007.00487.x; Berg AT, 2005, DEV MED CHILD NEUROL, V47, P749, DOI 10.1017/S001216220500157X; Binnie CD, 2003, LANCET NEUROL, V2, P725, DOI 10.1016/S1474-4422(03)00584-2; Blumer D, 2002, EPILEPSY BEHAV, V3, P232, DOI 10.1016/S1525-5050(02)00006-9; BOURGEOIS BFD, 1983, ANN NEUROL, V14, P438, DOI 10.1002/ana.410140407; Bulteau C, 2000, DEV MED CHILD NEUROL, V42, P319, DOI 10.1017/S0012162200000566; Butler T, 2012, EPILEPSY BEHAV, V23, P64, DOI 10.1016/j.yebeh.2011.10.001; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Caplan R, 2005, EPILEPSIA, V46, P720, DOI 10.1111/j.1528-1167.2005.43604.x; Caplan R, 2008, EPILEPSIA, V49, P1838, DOI 10.1111/j.1528-1167.2008.01680.x; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Chang BS, 2007, NEUROLOGY, V69, P2146, DOI 10.1212/01.wnl.0000286365.41070.54; Chang YT, 2011, EPILEPSIA, V52, P2036, DOI 10.1111/j.1528-1167.2011.03268.x; Chen SH, 2012, NEUROIMAGE, V60, P299, DOI 10.1016/j.neuroimage.2011.11.092; Christodoulou JA, 2012, EPILEPSIA, V53, P1024, DOI 10.1111/j.1528-1167.2012.03466.x; Cohen R, 2013, J CHILD NEUROL, V28, P120, DOI 10.1177/0883073812440327; Crail-Melendez D, 2012, EPILEPSY BEHAV, V23, P52, DOI 10.1016/j.yebeh.2011.11.001; Dabbs K, 2012, EPILEPSIA, V53, P1033, DOI 10.1111/j.1528-1167.2012.03447.x; Davies S, 2003, DEV MED CHILD NEUROL, V45, P292, DOI 10.1017/S0012162203000550; Araujo GMD, 2007, EPILEPSY BEHAV, V10, P437, DOI 10.1016/j.yebeh.2007.01.016; DIKMEN S, 1975, EPILEPSIA, V16, P73, DOI 10.1111/j.1528-1157.1975.tb04723.x; Dodrill CB, 2004, EPILEPSY BEHAV, V5, pS21, DOI 10.1016/j.yebeh.2003.11.004; Dunn DW, 2003, DEV MED CHILD NEUROL, V45, P50, DOI 10.1017/S0012162203000094; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; ELLENBERG JH, 1986, NEW ENGL J MED, V314, P1085, DOI 10.1056/NEJM198604243141705; England MJ, 2012, EPILEPSY SPECTRUM; Ettinger A, 2004, NEUROLOGY, V63, P1008, DOI 10.1212/01.WNL.0000138430.11829.61; Ettinger AB, 2005, NEUROLOGY, V65, P535, DOI 10.1212/01.wnl.0000172917.70752.05; Fastenau PS, 2009, NEUROLOGY, V73, P526, DOI 10.1212/WNL.0b013e3181b23551; Finegersh A, 2011, EPILEPSIA, V52, P689, DOI 10.1111/j.1528-1167.2010.02928.x; Fisekovic S, 2007, BOSNIAN J BASIC MED, V7, P140, DOI 10.17305/bjbms.2007.3069; FORSGREN L, 1990, EPILEPSY RES, V6, P66, DOI 10.1016/0920-1211(90)90010-S; Pascalicchio TF, 2007, EPILEPSY BEHAV, V10, P263, DOI 10.1016/j.yebeh.2006.11.012; Freitag H, 2005, EPILEPSIA, V46, P561, DOI 10.1111/j.0013-9580.2005.03504.x; Gilliam FG, 2006, LANCET NEUROL, V5, P399, DOI 10.1016/S1474-4422(06)70415-X; Gilliam FG, 2004, NEUROLOGY, V62, P23, DOI 10.1212/WNL.62.1.23; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hamberger MJ, 2007, EPILEPSIA, V48, P1283, DOI 10.1111/j.1528-1167.2007.01114.x; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Helmstaedter C., 2011, NEUROPSYCHOLOGY CARE; Helmstaedter C, 2008, EPILEPSY BEHAV, V12, P402, DOI 10.1016/j.yebeh.2007.11.010; Hermann B, 2008, EPILEPSIA, V49, P731, DOI 10.1111/j.1528-1167.2007.01435.x; Hermann BP, 2006, ANN NEUROL, V60, P80, DOI 10.1002/ana.20872; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Hesdorffer DC, 2012, EPILEPSIA, V53, P301, DOI 10.1111/j.1528-1167.2011.03351.x; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hesdorffer DC, 2004, ARCH GEN PSYCHIAT, V61, P731, DOI 10.1001/archpsyc.61.7.731; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.3.CO;2-5; Hoie B, 2006, DEV MED CHILD NEUROL, V48, P519, DOI 10.1017/S0012162206001095; Hoie B, 2006, DEV MED CHILD NEUROL, V48, P213, DOI 10.1017/S0012162206000454; Hoie B, 2005, SEIZURE-EUR J EPILEP, V14, P223, DOI 10.1016/j.seizure.2004.10.006; Hoppe C, 2011, NAT REV NEUROL, V7, P462, DOI 10.1038/nrneurol.2011.104; Jackson DC, 2011, EPILEPSIA, V52, P2225, DOI 10.1111/j.1528-1167.2011.03323.x; Jacoby A, 2011, EPILEPSIA, V52, P965, DOI 10.1111/j.1528-1167.2010.02973.x; Jennum P, 2011, EPILEPSIA, V52, P949, DOI 10.1111/j.1528-1167.2010.02946.x; Jokeit H, 1999, J NEUROL NEUROSUR PS, V67, P44, DOI 10.1136/jnnp.67.1.44; Jones JE, 2007, EPILEPSIA, V48, P2357; Jones JE, 2005, J NEUROPSYCH CLIN N, V17, P172, DOI 10.1176/appi.neuropsych.17.2.172; Jones JE, 2005, EPILEPSIA, V46, P731, DOI 10.1111/j.1528-1167.2005.49704.x; Kanemoto K, 1999, EPILEPSIA, V40, P107, DOI 10.1111/j.1528-1157.1999.tb01996.x; Kanner AM, 2012, EPILEPSIA, V53, P1104, DOI 10.1111/j.1528-1167.2012.03488.x; Kavros PM, 2008, EPILEPSIA, V49, P1570, DOI 10.1111/j.1528-1167.2008.01610.x; Kerr MP, 2011, EPILEPSIA, V52, P2133, DOI 10.1111/j.1528-1167.2011.03276.x; Kessler RC, 2012, MOL PSYCHIATR, V17, P748, DOI 10.1038/mp.2011.56; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Koorenhof L, 2012, SEIZURE-EUR J EPILEP, V21, P178, DOI 10.1016/j.seizure.2011.12.001; Krishnamoorthy ES, 2007, EPILEPSY BEHAV, V10, P349, DOI 10.1016/j.yebeh.2006.10.002; Krishnamoorthy ES, 2006, EPILEPSIA, V47, P3, DOI 10.1111/j.1528-1167.2006.00679.x; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lin JJ, 2012, EPILEPSIA, V53, P677, DOI 10.1111/j.1528-1167.2012.03422.x; Liu JYW, 2012, BRAIN, V135, P3115, DOI 10.1093/brain/aws147; LOGSDAIL SJ, 1988, BRIT J PSYCHIAT, V152, P246, DOI 10.1192/bjp.152.2.246; Lossius MI, 2006, EPILEPSY BEHAV, V9, P286, DOI 10.1016/j.yebeh.2006.06.018; Lothe A, 2008, BRAIN, V131, P2765, DOI 10.1093/brain/awn194; Martinovic Z, 2001, SEIZURE-EUR J EPILEP, V10, P42, DOI 10.1053/seiz.2000.0479; McAfee AT, 2007, EPILEPSIA, V48, P1075, DOI 10.1111/j.1528-1167.2007.01108.x; MCDERMOTT S, 1995, J EPILEPSY, V8, P110, DOI 10.1016/0896-6974(95)00019-A; Mintzer S, 2002, EPILEPSY BEHAV, V3, P330, DOI 10.1016/S1525-5050(02)00045-8; Monjauze C, 2005, BRAIN LANG, V92, P300, DOI 10.1016/j.bandl.2004.07.001; Mula M, 2002, CLIN NEUROPHARMACOL, V25, P280, DOI 10.1097/00002826-200209000-00012; Mula M, 2008, EPILEPSIA, V49, P650, DOI 10.1111/j.1528-1167.2007.01434.x; Mula M, 2008, CURR DRUG METAB, V9, P730, DOI 10.2174/138920008786049311; Mula M, 2011, DRUG HEALTHC PATIENT, V3, P15, DOI 10.2147/DHPS.S13070; Mula M, 2009, EPILEPTIC DISORD, V11, P1, DOI 10.1684/epd.2009.0238; Mula M, 2008, EXPERT OPIN PHARMACO, V9, P3159, DOI 10.1517/14656560802587024 ; Oostrom KJ, 2005, BRAIN, V128, P1546, DOI 10.1093/brain/awh494; Oostrom KJ, 2003, PEDIATRICS, V112, P1338, DOI 10.1542/peds.112.6.1338; Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x; Perucca P, 2011, NEUROLOGY, V76, P273, DOI 10.1212/WNL.0b013e318207b073; Prince D A, 1986, Adv Neurol, V44, P275; Pulsipher DT, 2011, NEUROLOGY, V76, P28, DOI 10.1212/WNL.0b013e318203e8f3; Pulsipher DT, 2009, EPILEPSIA, V50, P1210, DOI 10.1111/j.1528-1167.2008.01952.x; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Rai D, 2012, EPILEPSIA, V53, P1095, DOI 10.1111/j.1528-1167.2012.03500.x; Rantanen K, 2011, EPILEPSIA, V52, P1499, DOI 10.1111/j.1528-1167.2011.03092.x; Rantanen K, 2010, J NEUROPSYCHOL, V4, P71, DOI 10.1348/174866409X451465; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Riley JD, 2011, EPILEPSY BEHAV, V21, P80, DOI 10.1016/j.yebeh.2011.03.013; Riley JD, 2010, EPILEPSIA, V51, P536, DOI 10.1111/j.1528-1167.2009.02508.x; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Rutter M, 1970, NEUROPSYCHIATRIC STU; Schneider J.W., 1983, HAVING EPILEPSY EXPE; Schoenfeld J, 1999, DEV MED CHILD NEUROL, V41, P724, DOI 10.1017/S0012162299001486; Seidenberg M, 2007, NEUROPSYCHOL REV, V17, P445, DOI 10.1007/s11065-007-9042-x; SHEWMON DA, 1988, ELECTROEN CLIN NEURO, V69, P338, DOI 10.1016/0013-4694(88)90005-3; Smith AB, 2012, EPILEPSIA, V53, P705, DOI 10.1111/j.1528-1167.2011.03371.x; Smith ML, 2004, EPILEPSIA, V45, P650, DOI 10.1111/j.0013-9580.2004.21903.x; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Tosun D, 2011, BRAIN, V134, P1003, DOI 10.1093/brain/awr027; Tovia E, 2011, EPILEPSIA, V52, P1483, DOI 10.1111/j.1528-1167.2011.03136.x; Vasconcellos E, 2001, EPILEPSIA, V42, P268; Weber B, 2007, BRAIN, V130, P3149, DOI 10.1093/brain/awm186; Wotton CJ, 2012, EPILEPSIA, V53, pe71, DOI 10.1111/j.1528-1167.2011.03390.x	126	294	308	4	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2012	380	9848					1180	1192		10.1016/S0140-6736(12)61455-X	http://dx.doi.org/10.1016/S0140-6736(12)61455-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021287	Green Accepted			2022-12-28	WOS:000309255900036
J	Audet, M; Bouvier, M				Audet, Martin; Bouvier, Michel			Restructuring G-Protein-Coupled Receptor Activation	CELL			English	Review							BETA(2) ADRENERGIC-RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ADENOSINE A(2A) RECEPTOR; LIPIDIC CUBIC PHASES; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; BETA(1)-ADRENERGIC RECEPTOR; MEMBRANE-PROTEINS; ANTAGONIST; COMPLEX	G-protein-coupled receptors serve as key signal transduction conduits, linking extracellular inputs with diverse cellular responses. These receptors eluded structural characterization for decades following their identification. A landmark structure of rhodopsin provided a basis for structure-function studies and homology modeling, but advances in receptor biology suffered from a lack of receptor-specific structural insights. The recent explosion in GPCR structures confirms some features predicted by rhodopsin-based models, and more importantly, it reveals unexpected ligand-binding modes and critical aspects of the receptor activation process. The new structures also promise to foster studies testing emerging models for GPCR function such as receptor dimerization and ligand-biased signaling.	[Audet, Martin; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bouvier, M (corresponding author), Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100				Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Audet M, 2008, NAT CHEM BIOL, V4, P397, DOI 10.1038/nchembio.97; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	45	196	206	2	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					14	23		10.1016/j.cell.2012.09.003	http://dx.doi.org/10.1016/j.cell.2012.09.003			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021212	Bronze			2022-12-28	WOS:000309544200007
J	Cram, P; Lu, X; Kates, SL; Singh, JA; Li, Y; Wolf, BR				Cram, Peter; Lu, Xin; Kates, Stephen L.; Singh, Jasvinder A.; Li, Yue; Wolf, Brian R.			Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURGICAL-SITE INFECTIONS; SURGEON PROCEDURE VOLUME; TOTAL HIP-ARTHROPLASTY; LENGTH-OF-STAY; UNITED-STATES; JOINT REPLACEMENT; ADMINISTRATIVE DATA; COST-EFFECTIVENESS; EXPLICIT CRITERIA; HOSPITAL-VOLUME	Context Total knee arthroplasty (TKA) is one of the most common and costly surgical procedures performed in the United States. Objective To examine longitudinal trends in volume, utilization, and outcomes for primary and revision TKA between 1991 and 2010 in the US Medicare population. Design, Setting, and Participants Observational cohort of 3 271 851 patients (aged >= 65 years) who underwent primary TKA and 318 563 who underwent revision TKA identified in Medicare Part A data files. Main Outcome Measures We examined changes in primary and revision TKA volume, per capita utilization, hospital length of stay (LOS), readmission rates, and adverse outcomes. Results Between 1991 and 2010 annual primary TKA volume increased 161.5% from 93 230 to 243 802 while per capita utilization increased 99.2% (from 31.2 procedures per 10 000 Medicare enrollees in 1991 to 62.1 procedures per 10 000 in 2010). Revision TKA volume increased 105.9% from 9650 to 19 871 while per capita utilization increased 59.4% (from 3.2 procedures per 10 000 Medicare enrollees in 1991 to 5.1 procedures per 10 000 in 2010). For primary TKA, LOS decreased from 7.9 days (95% CI, 7.8-7.9) in 1991-1994 to 3.5 days (95% CI, 3.5-3.5) in 2007-2010 (P<.001). For primary TKA, rates of adverse outcomes resulting in readmission remained stable between 1991-2010, but rates of all-cause 30-day readmission increased from 4.2%(95% CI, 4.1%-4.2%) to 5.0%(95% CI, 4.9%-5.0%) (P<.001). For revision TKA, the decrease in hospital LOS was accompanied by an increase in all-cause 30-day readmission from 6.1%(95% CI, 5.9%-6.4%) to 8.9% (95% CI, 8.7%-9.2%) (P<.001) and an increase in readmission for wound infection from 1.4% (95% CI, 1.3%-1.5%) to 3.0% (95% CI, 2.9%-3.1%) (P<.001). Conclusions Increases in TKA volume have been driven by both increases in the number of Medicare enrollees and in per capita utilization. We also observed decreases in hospital LOS that were accompanied by increases in hospital readmission rates. JAMA. 2012;308(12):1227-1236 www.jama.com	[Cram, Peter; Lu, Xin] Univ Iowa, Carver Coll Med, Div Gen Internal Med, Dept Internal Med, Iowa City, IA 52242 USA; [Wolf, Brian R.] Univ Iowa, Carver Coll Med, Dept Orthopaed Surg, Iowa City, IA 52242 USA; [Cram, Peter] Iowa City Vet Adm Med Ctr, CADRE, Iowa City, IA USA; [Kates, Stephen L.] Univ Rochester, Dept Orthopaed Surg, Rochester, NY USA; [Li, Yue] Univ Rochester, Dept Community & Prevent Med, Rochester, NY USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] Birmingham Vet Affairs Med Ctr, Birmingham, W Midlands, England	University of Iowa; University of Iowa; University of Rochester; University of Rochester; University of Alabama System; University of Alabama Birmingham	Cram, P (corresponding author), Univ Iowa, Carver Coll Med, Div Gen Internal Med, Dept Internal Med, 200 Hawkins Dr,6GH SE, Iowa City, IA 52242 USA.	peter-cram@uiowa.edu	Cram, Peter/K-4472-2014; Singh, Jasvinder/R-6172-2019	Cram, Peter/0000-0002-1910-346X; Singh, Jasvinder/0000-0003-3485-0006; Wolf, Brian/0000-0002-2529-8056	NIAMS [AR062133]; Department of Veterans Affairs; Consumers Union; Vanguard Health Inc; AHRQ; Synthes USA; American Geriatrics Society; John Hartford Foundation; AO Research Foundation; Allergan; Wyeth; Amgen; Takeda; NHLBI [R01 HL085347]; NIA [R01 AG033035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR062133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033035] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Veterans Affairs(US Department of Veterans Affairs); Consumers Union; Vanguard Health Inc; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Synthes USA; American Geriatrics Society; John Hartford Foundation; AO Research Foundation; Allergan(AbbVieAllergan); Wyeth(Wyeth); Amgen(Amgen); Takeda(Takeda Pharmaceutical Company Ltd); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Cram reported that he is supported by a K24 award from NIAMS (AR062133) and by the Department of Veterans Affairs and that he has received consulting fees from The Consumers Union (publisher of Consumer Reports magazine) and Vanguard Health Inc for work advice on quality improvement initiatives. Dr Kates reported that he receives institutional research funding from AHRQ, Synthes USA, the American Geriatrics Society, the John Hartford Foundation, and the AO Research Foundation. Dr Singh reported that he receives institutional research funding from AHRQ, US Food and Drug Administration, NIA, Takeda Pharmaceuticals, and Savient Pharmaceuticals; is a consultant for Takeda, Novartis, Savient, URL, and Ardea; has received travel grants from Allergan, Wyeth, Amgen, and Takeda; and has received speaker honoraria from Abbott. No other authors reported disclosures.; This work is funded in-part by grants R01 HL085347 from NHLBI and R01 AG033035 from NIA.	Baicker K, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1107671; Bini SA, 2011, J ARTHROPLASTY, V26, P124, DOI 10.1016/j.arth.2011.03.043; Borrero S, 2006, J GEN INTERN MED, V21, pS54, DOI 10.1111/j.1525-1497.2006.00375.x; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Buntin MB, 2009, HEALTH SERV RES, V44, P1188, DOI 10.1111/j.1475-6773.2009.00968.x; Calderwood MS, 2012, INFECT CONT HOSP EP, V33, P40, DOI 10.1086/663207; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Chan L, 1997, NEW ENGL J MED, V337, P978, DOI 10.1056/NEJM199710023371406; Chernew M, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1110593; Cobos R, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-249; Cram P, 2007, J BONE JOINT SURG AM, V89A, P1675, DOI 10.2106/JBJS.F.00873; Cram P, 2012, GERIATR ORTHOP SURG, V3, P17, DOI 10.1177/2151458511435723; Cram P, 2012, J ARTHROPLASTY, V27, P278, DOI 10.1016/j.arth.2011.04.043; Cram P, 2011, JAMA-J AM MED ASSOC, V305, P1560, DOI 10.1001/jama.2011.478; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Dieppe P, 2011, INT J RHEUM DIS, V14, P175, DOI 10.1111/j.1756-185X.2011.01611.x; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Escobar A, 2003, INT J TECHNOL ASSESS, V19, P57, DOI 10.1017/S0266462303000060; Escobar A, 2007, J EVAL CLIN PRACT, V13, P429, DOI 10.1111/j.1365-2753.2006.00733.x; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Freid Virginia M, 2010, NCHS Data Brief, P1; Glance LG, 2008, MED CARE, V46, P112, DOI 10.1097/MLR.0b013e318158aed6; Glance LG, 2006, HEALTH SERV RES, V41, P231, DOI 10.1111/j.1475-6773.2005.00419.x; Gossec L, 2011, OSTEOARTHR CARTILAGE, V19, P147, DOI 10.1016/j.joca.2010.10.025; Hagen TP, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c165; Hausmann LRM, 2010, J GEN INTERN MED, V25, P982, DOI 10.1007/s11606-010-1399-5; Healy WL, 2010, CLIN ORTHOP RELAT R, P6; Ibrahim SA, 2002, MED CARE, V40, P44; Iorio R, 2010, J ARTHROPLASTY, V25, P1005, DOI 10.1016/j.arth.2010.08.009; Jain NB, 2005, ARTHRITIS RHEUM-US, V52, P3928, DOI 10.1002/art.21420; Jones A, 2005, ARTHRIT RHEUM-ARTHR, V53, P979, DOI 10.1002/art.21596; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; Khatod M, 2008, ACTA ORTHOP, V79, P812, DOI 10.1080/17453670810016902; Kim S, 2008, ARTHRIT RHEUM-ARTHR, V59, P481, DOI 10.1002/art.23525; Krummenauer F, 2009, EUR J MED RES, V14, P76, DOI 10.1186/2047-783X-14-2-76; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lonner Jess H, 2009, Am J Orthop (Belle Mead NJ), V38, P497; Losina E, 2004, ARTHRITIS RHEUM-US, V50, P1338, DOI 10.1002/art.20148; Losina E, 2012, J BONE JOINT SURG AM, V94A, P201, DOI [10.2106/JBJS.J.01958, 10.2106/JBJS.K.00009, 10.2106/JBJS.J.101958]; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Manley M, 2009, J ARTHROPLASTY, V24, P1061, DOI 10.1016/j.arth.2008.06.011; McCall N, 2003, MILBANK Q, V81, P277, DOI 10.1111/1468-0009.t01-1-00054; *MEDPAC, 2003, REP C VAR INN MED; Memtsoudis SG, 2009, J ARTHROPLASTY, V24, P518, DOI 10.1016/j.arth.2008.01.307; Miller DC, 2011, HEALTH AFFAIR, V30, P2107, DOI 10.1377/hlthaff.2011.0783; MITCHELL JB, 1994, MED CARE, V32, pJS38; Naylor CD, 1996, QUAL HEALTH CARE, V5, P20, DOI 10.1136/qshc.5.1.20; Paxton EW, 2012, PHARMACOEPIDEM DR S, V21, P53, DOI 10.1002/pds.3228; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schweizer ML, 2011, INFECT CONT HOSP EP, V32, P148, DOI 10.1086/657936; Shahian DM, 2005, ANN THORAC SURG, V80, P2106, DOI 10.1016/j.athoracsur.2005.06.078; Silverman E, 2004, J HEALTH ECON, V23, P369, DOI 10.1016/j.jhealeco.2003.09.007; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Thomas C, 2004, J HOSP INFECT, V57, P25, DOI 10.1016/j.jhin.2004.01.025; Vaughan-Sarrazin Mary S, 2011, Medicare Medicaid Res Rev, V1, pE1, DOI 10.5600/mmrr.001.03.a02; Welch H, 2011, OVERDIAGNOSED MAKING	60	565	584	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1227	1236		10.1001/2012.jama.11153	http://dx.doi.org/10.1001/2012.jama.11153			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011713	Green Accepted			2022-12-28	WOS:000309103600026
J	Klein, M; Gogenur, I; Rosenberg, J				Klein, Mads; Gogenur, Ismail; Rosenberg, Jacob			Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIVARIATE-ANALYSIS; RISK; INHIBITORS; CYCLOOXYGENASE; SURGERY; DEATH; COMPLICATIONS; SELECTIVITY; DICLOFENAC; KETOROLAC	Objectives To evaluate the effect of postoperative use of non-steroidal anti-inflammatory drugs (NSAIDs) on anastomotic leakage requiring reoperation after colorectal resection. Design Cohort study based on data from a prospective clinical database and electronically registered medical records. Setting Six major colorectal centres in eastern Denmark. Participants 2766 patients (1441 (52%) men) undergoing elective operation for colorectal cancer with colonic or rectal resection and primary anastomosis between 1 January 2006 and 31 December 2009. Median age was 70 years (interquartile range 62-77). Intervention Postoperative use of NSAID (defined as at least two days of NSAID treatment in the first seven days after surgery). Main outcome measures Frequency of clinical anastomotic leakage verified at reoperation; mortality at 30 days. Results Of 2756 patients with available data and included in the final analysis, 1871 (68%) did not receive postoperative NSAID treatment (controls) and 885 (32%) did. In the NSAID group, 655 (74%) patients received ibuprofen and 226 (26%) received diclofenac. Anastomotic leakage verified at reoperation was significantly increased among patients receiving diclofenac and ibuprofen treatment, compared with controls (12.8% and 8.2% v 5.1%; P<0.001). After unadjusted analyses and when compared with controls, more patients had anastomotic leakage after treatment with diclofenac (7.8% (95% confidence interval 3.9% to 12.8%)) and ibuprofen (3.2% (1.0% to 5.7%)). But after multivariate logistic regression analysis, only diclofenac treatment was a risk factor for leakage (odds ratio 7.2 (95% confidence interval 3.8 to 13.4), P<0.001; ibuprofen 1.5 (0.8 to 2.9), P=0.18). Other risk factors for anastomotic leakage were male sex, rectal (v colonic) anastomosis, and blood transfusion. 30 day mortality was comparable in the three groups (diclofenac 1.8% v ibuprofen 4.1% v controls 3.2%; P=0.20). Conclusions Diclofenac treatment could result in an increased proportion of patients with anastomotic leakage after colorectal surgery. Cyclo-oxygenase-2 selective NSAIDs should be used with caution after colorectal resections with primary anastomosis. Large scale, randomised controlled trials are urgently needed.	[Klein, Mads; Gogenur, Ismail; Rosenberg, Jacob] Univ Copenhagen, Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Klein, M (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark.	madsklein1@gmail.com		Gogenur, Ismail/0000-0002-3753-268X; Rosenberg, Jacob/0000-0002-0063-1086				Alves A, 2002, WORLD J SURG, V26, P499, DOI 10.1007/s00268-001-0256-4; [Anonymous], 2009, YEARL REP 2009; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Cahill RA, 2004, BRIT J SURG, V91, P1613, DOI 10.1002/bjs.4722; Choi HK, 2006, DIS COLON RECTUM, V49, P1719, DOI 10.1007/s10350-006-0703-2; Christensen HK, 2011, EUR SURG RES, V46, P156, DOI 10.1159/000324406; Fosbol EL, 2010, EXPERT OPIN DRUG SAF, V9, P893, DOI 10.1517/14740338.2010.501331; Gillis JC, 1997, DRUGS, V53, P139, DOI 10.2165/00003495-199753010-00012; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Golub R, 1997, J AM COLL SURGEONS, V184, P364; Gorissen KJ, 2012, BRIT J SURG, V99, P721, DOI 10.1002/bjs.8691; Guenaga KK, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001544.pub3, DOI 10.1002/14651858.CD001544.PUB3]]; Haag MDM, 2008, ARCH INTERN MED, V168, P1219, DOI 10.1001/archinte.168.11.1219; Holte K, 2007, BRIT J ANAESTH, V99, P500, DOI 10.1093/bja/aem211; Holte K, 2009, BRIT J SURG, V96, P650, DOI 10.1002/bjs.6598; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Inan Aydin, 2006, Int J Surg, V4, P222, DOI 10.1016/j.ijsu.2006.01.002; Iversen LH, 2008, BRIT J SURG, V95, P1012, DOI 10.1002/bjs.6114; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kendall SJH, 2000, CLIN ORTHOP RELAT R, P145; Kingham TP, 2009, J AM COLL SURGEONS, V208, P269, DOI 10.1016/j.jamcollsurg.2008.10.015; Klein M, 2012, EUR SURG RES, V48, P73, DOI 10.1159/000336208; Klein M, 2009, DIGEST SURG, V26, P27, DOI 10.1159/000193329; Lipska MA, 2006, ANZ J SURG, V76, P579, DOI 10.1111/j.1445-2197.2006.03780.x; Makela JT, 2003, DIS COLON RECTUM, V46, P653, DOI 10.1097/01.DCR.0000059328.10563.8C; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nickelsen Thomas N, 2004, Ugeskr Laeger, V166, P3092; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; PEEL ALG, 1991, ANN ROY COLL SURG, V73, P385; Schlachta CM, 2007, SURG ENDOSC, V21, P2212, DOI 10.1007/s00464-007-9335-4; Stottmeier S, 2011, COLORECTAL DIS, V13, P500, DOI 10.1111/j.1463-1318.2010.02274.x; Winkelmayer WC, 2004, NEPHROL DIAL TRANSPL, V19, P1671, DOI 10.1093/ndt/gfh104	36	103	105	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 26	2012	345								e6166	10.1136/bmj.e6166	http://dx.doi.org/10.1136/bmj.e6166			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014OV	23015299	hybrid, Green Published			2022-12-28	WOS:000309386300004
J	Mills, EJ; Ioannidis, JPA; Thorlund, K; Schunemann, HJ; Puhan, MA; Guyatt, GH				Mills, Edward J.; Ioannidis, John P. A.; Thorlund, Kristian; Schuenemann, Holger J.; Puhan, Milo A.; Guyatt, Gordon H.			How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MIXED TREATMENT COMPARISONS; RANDOMIZED-TRIALS; META-REGRESSION; EFFICACY; INCONSISTENCY; COMBINATION; BENEFITS; DISEASE; EXACERBATIONS; SURVIVAL	Multiple treatment comparison (MTC) meta-analysis uses both direct (head-to-head) randomized clinical trial (RCT) evidence as well as indirect evidence from RCTs to compare the relative effectiveness of all included interventions. The methodological quality of MTCs may be difficult for clinicians to interpret because the number of interventions evaluated may be large and the methodological approaches may be complex. Clinicians and others evaluating an MTC should be aware of the potential biases that can affect the interpretation of these analyses. Readers should consider whether the primary studies are sufficiently homogeneous to combine; whether the different interventions are sufficiently similar in their populations, study designs, and outcomes; and whether the direct evidence is sufficiently similar to the indirect evidence to consider combining. This article uses the existing Users' Guides format to address study validity, interpretation of results, and application to a patient scenario. JAMA. 2012;308(12):1246-1253 www.jama.com	[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 7K4, Canada; [Mills, Edward J.; Thorlund, Kristian; Schuenemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Puhan, Milo A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	University of Ottawa; McMaster University; Stanford University; Stanford University; Stanford University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Room 031,Thompson Hall,35 Univ Private, Ottawa, ON K1N 7K4, Canada.	edward.mills@uottawa.ca	Puhan, Milo/ABE-6298-2020; Ioannidis, John P. A./G-9836-2011	Puhan, Milo/0000-0003-4721-1879; Schunemann, Holger/0000-0003-3211-8479	Merck Co Inc; Pfizer Ltd; Novartis; Takeda; Canadian Institutes of Health Research (CIHR) Drug Safety & Effectiveness Network (DSEN) NETMAN; CIHR through a Canada Research Chair; CIHR DSEN NETMAN project	Merck Co Inc(Merck & Company); Pfizer Ltd(Pfizer); Novartis(Novartis); Takeda(Takeda Pharmaceutical Company Ltd); Canadian Institutes of Health Research (CIHR) Drug Safety & Effectiveness Network (DSEN) NETMAN(Canadian Institutes of Health Research (CIHR)); CIHR through a Canada Research Chair(Canadian Institutes of Health Research (CIHR)); CIHR DSEN NETMAN project(Canadian Institutes of Health Research (CIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Mills reported consulting for Merck & Co Inc, Pfizer Ltd, Novartis and Takeda on MTC issues; receiving grant funding from the Canadian Institutes of Health Research (CIHR) Drug Safety & Effectiveness Network (DSEN) NETMAN project to developmethods and educational materials on MTCs; and receiving salary support from the CIHR through a Canada Research Chair. Dr Ioannidis reported receiving grant funding from the CIHR DSEN NETMAN project to develop methods and educational materials on MTCs. Dr Thorlund reported consulting to Merck & Co Inc, Pfizer Ltd, Novartis, Takeda, or GlaxoSmithKline on MTC issues; receiving grant funding from the CIHR DSEN NETMAN project to develop methods and educational materials on MTCs; and receiving salary support from the CIHR DSEN NETMAN project. Dr Schunemann is a coinvestigator on a grant from the CIHR DSEN NETMAN project to develop methods and educational materials on MTCs. Dr Guyatt reported consulting to Bristol-Myers Squibb and UpToDate Inc on MTC issues and is a coinvestigator on a grant from the CIHR DSEN NETMAN project to develop methods and educational materials on MTCs.	Aaron SD, 2008, THORAX, V63, P122, DOI 10.1136/thx.2007.082636; Baldwin D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1199; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Devereaux PJ, 2004, J CLIN EPIDEMIOL, V57, P1232, DOI 10.1016/j.jclinepi.2004.03.017; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Diels J, 2011, VALUE HEALTH, V14, pA266, DOI 10.1016/j.jval.2011.08.195; Estellat C, 2012, ARCH INTERN MED, V172, P237, DOI 10.1001/archinternmed.2011.1209; Ford AC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2313; Gartlehner G, 2008, DRUG CLASS REV 2 GEN; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Golfinopoulos V, 2007, LANCET ONCOL, V8, P898, DOI 10.1016/S1470-2045(07)70281-4; Guyatt G, 2008, USERS GUIDES MED LIT, P67; Hernandez AV, 2008, AM HEART J, V156, P23, DOI 10.1016/j.ahj.2008.03.002; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis John P A, 2008, Philos Ethics Humanit Med, V3, P14, DOI 10.1186/1747-5341-3-14; Ioannidis JPA, 2009, LANCET, V373, P1759, DOI 10.1016/S0140-6736(09)60974-0; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jansen J, 2011, 19 COCHR C OCT 19 22; Kyrgiou M, 2006, JNCI-J NATL CANCER I, V98, P1655, DOI 10.1093/jnci/djj443; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Mills EJ, 2011, QJM-INT J MED, V104, P109, DOI 10.1093/qjmed/hcq165; Mills EJ, 2012, ANN MED, V44, P588, DOI 10.3109/07853890.2012.705016; Mills Edward J, 2011, Clin Epidemiol, V3, P193, DOI 10.2147/CLEP.S16526; Mills Edward J, 2011, Clin Epidemiol, V3, P107, DOI 10.2147/CLEP.S16235; Mills EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016237; Mills EJ, 2012, 2012 CADTH S APR 15; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Nixon RM, 2007, STAT MED, V26, P1237, DOI 10.1002/sim.2624; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Puhan MA, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-2; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Schmitz S, 2012, ANN RHEUM DIS, V71, P225, DOI 10.1136/annrheumdis-2011-200228; Sciarretta S, 2011, ARCH INTERN MED, V171, P384, DOI 10.1001/archinternmed.2010.427; Smith GD, 2001, SYSTEMATIC REV HLTH, P143; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song Fujian, 2011, BMJ, V343, pd4909, DOI 10.1136/bmj.d4909; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zhang WY, 1996, J CLIN PHARM THER, V21, P261, DOI 10.1111/j.1365-2710.1996.tb01148.x	54	259	265	2	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1246	1253		10.1001/2012.jama.11228	http://dx.doi.org/10.1001/2012.jama.11228			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011714				2022-12-28	WOS:000309103600028
J	Wang, B; Xu, SB; Wu, LG				Wang, Bin; Xu, Shibin; Wu, Liguang			Intensified Arabian Sea tropical storms	NATURE			English	Letter							BLACK CARBON		[Wang, Bin; Xu, Shibin] Univ Hawaii Manoa, Dept Meteorol, Honolulu, HI 96822 USA; [Wang, Bin; Xu, Shibin] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Wang, Bin; Wu, Liguang] Nanjing Univ Informat Sci & Technol, Minist Educ, Key Lab Meteorol Disaster, Nanjing 210044, Jiangsu, Peoples R China; [Xu, Shibin] Ocean Univ China, Phys Oceanog Lab, Qingdao 266100, Peoples R China	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Nanjing University of Information Science & Technology; Ocean University of China	Wang, B (corresponding author), Univ Hawaii Manoa, Dept Meteorol, Honolulu, HI 96822 USA.	wangbin@hawaii.edu						Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Emanuel K. A., 2004, P 26 C HURR TROP MET, P240; Evan AT, 2011, NATURE, V479, P94, DOI 10.1038/nature10552; Evan AT, 2011, J CLIMATE, V24, P140, DOI 10.1175/2010JCLI3611.1; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; Kajikawa Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050540; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/BAMS-83-11-1631(2002)083<1631:NAR>2.3.CO;2, 10.1175/Bams-83-11-1631]; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Lau KM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027546; LEPAGE Y, 1973, BIOMETRIKA, V60, P113, DOI 10.2307/2334912; Meehl G. A., 2007, CLIMATE CHANGE 2007, P499; Meehl GA, 2008, J CLIMATE, V21, P2869, DOI 10.1175/2007JCLI1777.1; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Wang B, 2012, CLIM DYNAM, V39, P1123, DOI 10.1007/s00382-011-1266-z	15	44	46	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					E1	E2		10.1038/nature11470	http://dx.doi.org/10.1038/nature11470			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996560				2022-12-28	WOS:000308860900001
J	Hayashi, K; Ogushi, S; Kurimoto, K; Shimamoto, S; Ohta, H; Saitou, M				Hayashi, Katsuhiko; Ogushi, Sugako; Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi; Saitou, Mitinori			Offspring from Oocytes Derived from in Vitro Primordial Germ Cell-like Cells in Mice	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; MOUSE	Reconstitution of female germ cell development in vitro is a key challenge in reproductive biology and medicine. We show here that female (XX) embryonic stem cells and induced pluripotent stem cells in mice are induced into primordial germ cell-like cells (PGCLCs), which, when aggregated with female gonadal somatic cells as reconstituted ovaries, undergo X-reactivation, imprint erasure, and cyst formation, and exhibit meiotic potential. Upon transplantation under mouse ovarian bursa, PGCLCs in the reconstituted ovaries mature into germinal vesicle-stage oocytes, which then contribute to fertile offspring after in vitro maturation and fertilization. Our culture system serves as a robust foundation for the investigation of key properties of female germ cells, including the acquisition of totipotency, and for the reconstitution of whole female germ cell development in vitro.	[Hayashi, Katsuhiko; Ogushi, Sugako; Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Saitou, Mitinori] Kyoto Univ, Ctr IPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Hayashi, Katsuhiko] Japan Sci & Technol Agcy CREST, Precursory Res Embryon Sci & Technol PRESTO, Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy JST,Sakyo Ku, Kyoto 6068501, Japan; [Ogushi, Sugako] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068302, Japan; [Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi] JST, CREST Exploratory Res Adv Technol ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Hayashi, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	khayashi@anat2.med.kyoto-u.ac.jp; saitou@anat2.med.kyoto-u.ac.jp		Ogushi, Sugako/0000-0001-8497-6972	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-PRESTO/CREST/ERATO; Takeda Science Foundation; Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research [24681039, 19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-PRESTO/CREST/ERATO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Silva and A. Smith for the MS2 female iPSCs, K. Okita and S. Yamanaka for the female iPSCs, and Y. Matsui for the GOF18-ESCs. We also thank S. Matoba and A. Ogura for their advice on ovary reconstitution, S. Aramaki and Y. Ishikura for assistance, and T. Mori for encouragement. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by JST-PRESTO/CREST/ERATO; by the Takeda Science Foundation; and by the the Academia for Repro-regenerative Medicine. The accession number for the microarray data presented in this study is GSE40716 [Gene Expression Omnibus (GEO) database].	Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; HASHIMOTO K, 1992, DEV GROWTH DIFFER, V34, P233; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; KAUFMAN MH, 1987, DEVELOPMENT, V101, P383; Matoba S, 2011, BIOL REPROD, V84, P631, DOI 10.1095/biolreprod.110.087122; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	13	476	510	7	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					971	975		10.1126/science.1226889	http://dx.doi.org/10.1126/science.1226889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23042295				2022-12-28	WOS:000311083600050
J	Diochot, S; Baron, A; Salinas, M; Douguet, D; Scarzello, S; Dabert-Gay, AS; Debayle, D; Friend, V; Alloui, A; Lazdunski, M; Lingueglia, E				Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Alloui, Abdelkrim; Lazdunski, Michel; Lingueglia, Eric			Black mamba venom peptides target acid-sensing ion channels to abolish pain	NATURE			English	Article							ACTIVATED CURRENTS; ASIC3; MECHANISMS; EVOLUTION; ALIGNMENT; TOXINS	Polypeptide toxins have played a central part in understanding physiological and physiopathological functions of ion channels(1,2). In the field of pain, they led to important advances in basic research(3-6) and even to clinical applications(7,8). Acid-sensing ion channels (ASICs) are generally considered principal players in the pain pathway(9), including in humans(10). A snake toxin activating peripheral ASICs in nociceptive neurons has been recently shown to evoke pain(11). Here we show that a new class of three-finger peptides from another snake, the black mamba, is able to abolish pain through inhibition of ASICs expressed either in central or peripheral neurons. These peptides, which we call mambalgins, are not toxic in mice but show a potent analgesic effect upon central and peripheral injection that can be as strong as morphine. This effect is, however, resistant to naloxone, and mambalgins cause much less tolerance than morphine and no respiratory distress. Pharmacological inhibition by mambalgins combined with the use of knockdown and knockout animals indicates that blockade of heteromeric channels made of ASIC1a and ASIC2a subunits in central neurons and of ASIC1b-containing channels in nociceptors is involved in the analgesic effect of mambalgins. These findings identify new potential therapeutic targets for pain and introduce natural peptides that block them to produce a potent analgesia.	[Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Lazdunski, Michel; Lingueglia, Eric] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, F-06560 Valbonne, France; [Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Lazdunski, Michel; Lingueglia, Eric] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Friend, Valerie; Lingueglia, Eric] LabEx Ion Channel Sci & Therapeut, F-06560 Valbonne, France; [Alloui, Abdelkrim] Univ Auvergne, Clermont Univ, NEURO DOL, F-63000 Clermont Ferrand, France; [Alloui, Abdelkrim] INSERM, U1107, F-63001 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Baron, A (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	baron@ipmc.cnrs.fr; lingueglia@ipmc.cnrs.fr	SALINAS, Miguel/N-6380-2016; Diochot, Sylvie/ABG-5495-2020; LINGUEGLIA, Eric/F-5509-2013; douguet, dominique/D-5644-2017; BARON, Anne/N-5691-2016	SALINAS, Miguel/0000-0002-7445-123X; LINGUEGLIA, Eric/0000-0003-3902-3405; BARON, Anne/0000-0002-8026-6380	Fondation pour la Recherche Medicale; Association Francaise contre les Myopathies; Agence Nationale de la Recherche; EMMAservice under European Union of the EC FP7 Capacities Specific Programme [227490]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); EMMAservice under European Union of the EC FP7 Capacities Specific Programme	We are grateful to M. P. Price and M. J. Welsh for their gift of the ASIC1a<SUP>-/-</SUP> mice, to A. Zimmer for providing the Penk1<SUP>-/-</SUP> mice, to H. Schweitz and L. Beress for their gift of pre-purified peptidic fractions of black mamba venom, to J. Noel for cultures of hippocampal neurons and comments, to E. Deval, P. Inquimbert, A. Delaunay and M. Christin for discussions, to C. Heurteaux and N. Blondeau for help with stereotaxic injections, to A. Lazzari for support with plethysmography, to V. Thieffin, N. Leroudier, S. Boulakirba, T. Lemaire, C. Karoutchi and G. Marrane for technical assistance, and to C. Chevance for secretarial assistance. We thank E. Bourinet, F. Rassendren and M. B. Emerit for providing the Cav3.2, P2X2 and 5-HT3A cDNAs, respectively. This work was supported by the Fondation pour la Recherche Medicale, the Association Francaise contre les Myopathies and the Agence Nationale de la Recherche. Part of this work has been supported by EMMAservice under European Union contract Grant Agreement number 227490 of the EC FP7 Capacities Specific Programme.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2008, J NEUROSCI, V28, P1498, DOI 10.1523/JNEUROSCI.4975-07.2008; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen TB, 2002, ANAL BIOCHEM, V311, P152, DOI 10.1016/S0003-2697(02)00404-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2011, J NEUROSCI, V31, P6059, DOI 10.1523/JNEUROSCI.5266-10.2011; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Douguet D, 2001, BIOINFORMATICS, V17, P752, DOI 10.1093/bioinformatics/17.8.752; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fitzjohn SM, 2001, NEUROPHARMACOLOGY, V41, P693, DOI 10.1016/S0028-3908(01)00128-9; Fromy B, 2012, NAT MED, V18, P1205, DOI 10.1038/nm.2844; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; Labesse G, 1998, BIOINFORMATICS, V14, P206, DOI 10.1093/bioinformatics/14.2.206; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; MALMBERG AB, 1995, PAIN, V60, P83, DOI 10.1016/0304-3959(94)00094-U; Mamet J, 2002, J NEUROSCI, V22, P10662; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; SCHWEITZ H, 1990, TOXICON, V28, P847, DOI 10.1016/S0041-0101(09)80007-X; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Vanegas H, 2000, PAIN, V85, P9, DOI 10.1016/S0304-3959(99)00241-9; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Zhou HY, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20732	43	276	288	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					552	+		10.1038/nature11494	http://dx.doi.org/10.1038/nature11494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23034652				2022-12-28	WOS:000310196200045
J	Hare, JD				Hare, J. Daniel			How Insect Herbivores Drive the Evolution of Plants	SCIENCE			English	Editorial Material									Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hare, JD (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	daniel.hare@ucr.edu	Hare, J. Daniel/F-9415-2015	Hare, J. Daniel/0000-0001-8424-4683				Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Barbehenn RV, 2006, J CHEM ECOL, V32, P2253, DOI 10.1007/s10886-006-9143-7; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Hamilton JG, 2001, ECOL LETT, V4, P86, DOI 10.1046/j.1461-0248.2001.00192.x; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Thompson J.N., 2005, INTERSPEC INTERACT; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	9	16	18	6	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					50	51		10.1126/science.1228893	http://dx.doi.org/10.1126/science.1228893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042873				2022-12-28	WOS:000309457400042
J	Vunda, A; Alcoba, G				Vunda, Aaron; Alcoba, Gabriel			Mydriasis in the Garden	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vunda, Aaron; Alcoba, Gabriel] Univ Hosp Geneva, Geneva, Switzerland	University of Geneva	Vunda, A (corresponding author), Univ Hosp Geneva, Geneva, Switzerland.		Alcoba, Gabriel/AAY-5264-2021; ALCOBA, Gabriel/AAQ-6918-2021	Alcoba, Gabriel/0000-0002-9423-1533; 					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1341	1341		10.1056/NEJMicm1208053	http://dx.doi.org/10.1056/NEJMicm1208053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034022				2022-12-28	WOS:000309406100010
J	Chiu, HY; Chiu, HC				Chiu, Hsien-Yi; Chiu, Hsien-Ching			A Florid, Tiny, Discrete Eruption on the Penis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENERALIZED LICHEN NITIDUS		[Chiu, Hsien-Ching] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chiu, HC (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, 7 Chung Shan S Rd, Taipei 100, Taiwan.	hcchiu1003@ntu.edu.tw		Chiu, Hsien-Yi/0000-0002-0493-9707; CHIU, HSIEN-CHING/0000-0002-1409-8470				Arizaga AT, 2002, CLIN EXP DERMATOL, V27, P115, DOI 10.1046/j.1365-2230.2002.00971.x; Dobbs Clifton R, 2004, J Drugs Dermatol, V3, P683; Farshi Susan, 2011, Dermatol Online J, V17, P11; Hernandez-Martin A, 2010, ARCH DERMATOL, V146, P1419, DOI 10.1001/archdermatol.2010.356-a; Kubota Y, 2002, BRIT J DERMATOL, V146, P1081, DOI 10.1046/j.1365-2133.2002.04700.x; Park JH, 2006, J AM ACAD DERMATOL, V54, P545, DOI 10.1016/j.jaad.2005.01.137; Scheler M, 2007, DERMATOLOGY, V215, P236, DOI 10.1159/000106582; Soroush V, 1999, CUTIS, V64, P135	8	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1264	1265		10.1001/2012.jama.11061	http://dx.doi.org/10.1001/2012.jama.11061			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011716				2022-12-28	WOS:000309103600030
J	Smith, R				Smith, Richard			Why a Macroeconomic Perspective Is Critical to the Prevention of Noncommunicable Disease	SCIENCE			English	Editorial Material							PANDEMIC INFLUENZA; HEALTH; EQUILIBRIUM; IMPACT; UK	Effective prevention of noncommunicable diseases will require changes in how we live, and thereby effect important economic changes across populations, sectors, and countries. What we do not know is which populations, sectors, or countries will be positively or negatively affected by such changes, nor by how much. Without this information we cannot know which policies will produce effects that are beneficial both for economies and for health.	Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Smith, R (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England.	richard.smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Beutels P, 2008, HEALTH ECON, V17, P1317, DOI 10.1002/hec.1339; Bloom DE, 2011, GLOBAL EC BURDEN NON; BLOUIN C, 2009, J GERONTOL B-PSYCHOL, V373, P502, DOI DOI 10.1016/S0140-6736(08)61777-8; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Lock K, 2010, LANCET, V376, P1699, DOI 10.1016/S0140-6736(10)61352-9; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Sachs JD, 2001, MACR HLTH INV HLTH E; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Smith R. D., 2011, INTRO HLTH EC, P21; Smith R. D., 2010, J PUBLIC HLTH BANGKO, V32, P2; Smith RD, 2011, SOC SCI MED, V73, P235, DOI 10.1016/j.socscimed.2011.05.025; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7	18	17	19	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1501	1503		10.1126/science.1222569	http://dx.doi.org/10.1126/science.1222569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997330	Green Published			2022-12-28	WOS:000308912900042
J	Fox, RJ; Miller, DH; Phillips, JT; Hutchinson, M; Havrdova, E; Kita, M; Yang, MH; Raghupathi, K; Novas, M; Sweetser, MT; Viglietta, V; Dawson, KT				Fox, Robert J.; Miller, David H.; Phillips, J. Theodore; Hutchinson, Michael; Havrdova, Eva; Kita, Mariko; Yang, Minhua; Raghupathi, Kartik; Novas, Mark; Sweetser, Marianne T.; Viglietta, Vissia; Dawson, Katherine T.		CONFIRM Study Investigators	Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIMETHYL FUMARATE; OXIDATIVE STRESS; DOUBLE-BLIND; RELAPSE RATE; DISABILITY; LESIONS; MULTICENTER; ACTIVATION; PATHWAY; ACETATE	BACKGROUND BG-12 (dimethyl fumarate) is in development as an oral treatment for relapsing-remitting multiple sclerosis, which is commonly treated with parenteral agents (interferon or glatiramer acetate). METHODS In this phase 3, randomized study, we investigated the efficacy and safety of oral BG-12, at a dose of 240 mg two or three times daily, as compared with placebo in patients with relapsing-remitting multiple sclerosis. An active agent, glatiramer acetate, was also included as a reference comparator. The primary end point was the annualized relapse rate over a period of 2 years. The study was not designed to test the superiority or noninferiority of BG-12 versus glatiramer acetate. RESULTS At 2 years, the annualized relapse rate was significantly lower with twice-daily BG-12 (0.22), thrice-daily BG-12 (0.20), and glatiramer acetate (0.29) than with placebo (0.40) (relative reductions: twice-daily BG-12, 44%, P<0.001; thrice-daily BG-12, 51%, P<0.001; glatiramer acetate, 29%, P = 0.01). Reductions in disability progression with twice-daily BG-12, thrice-daily BG-12, and glatiramer acetate versus placebo (21%, 24%, and 7%, respectively) were not significant. As compared with placebo, twice-daily BG-12, thrice-daily BG-12, and glatiramer acetate significantly reduced the numbers of new or enlarging T2-weighted hyperintense lesions (all P<0.001) and new T-1-weighted hypointense lesions (P<0.001, P<0.001, and P = 0.002, respectively). In post hoc comparisons of BG-12 versus glatiramer acetate, differences were not significant except for the annualized relapse rate (thrice-daily BG-12), new or enlarging T2-weighted hyperintense lesions (both BG-12 doses), and new T1-weighted hypointense lesions (thrice-daily BG-12) (nominal P<0.05 for each comparison). Adverse events occurring at a higher incidence with an active treatment than with placebo included flushing and gastrointestinal events (with BG-12) and injection-related events (with glatiramer acetate). There were no malignant neoplasms or opportunistic infections reported with BG-12. Lymphocyte counts decreased with BG-12. CONCLUSIONS In patients with relapsing-remitting multiple sclerosis, BG-12 (at both doses) and glatiramer acetate significantly reduced relapse rates and improved neuroradiologic outcomes relative to placebo.	[Fox, Robert J.] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44195 USA; [Miller, David H.] UCL, Inst Neurol, Nucl Magnet Resonance Res Unit, Dept Neuroinflammat, London, England; [Phillips, J. Theodore] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA; [Hutchinson, Michael] St Vincents Univ Hosp, Dublin 4, Ireland; [Havrdova, Eva] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Kita, Mariko] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Yang, Minhua; Raghupathi, Kartik; Novas, Mark; Sweetser, Marianne T.; Viglietta, Vissia; Dawson, Katherine T.] Biogen Idec Inc, Weston, MA USA	Cleveland Clinic Foundation; University of London; University College London; Baylor Scott & White Health; University College Dublin; Saint Vincent's University Hospital; Charles University Prague; Virginia Mason Medical Center; Biogen	Fox, RJ (corresponding author), Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, 9500 Euclid Ave,U-10, Cleveland, OH 44195 USA.	foxr@ccf.org	Sweeney, Brian J/D-2569-2013; Brassat, David/L-2173-2014; De Seze, Jerome/M-8316-2016; hutchinson, michael/H-3508-2019; Nehrych, Tetyana I/L-7555-2016; Groppa, Stanislav/AAM-5905-2020; Havrdova, Eva Kubala/P-4892-2017; Montalban, Xavier/J-5938-2016; Kremenchutzky, Marcelo/B-6413-2015; Macedo, Ana/L-9912-2018	De Seze, Jerome/0000-0002-7197-7578; Nehrych, Tetyana I/0000-0003-0170-511X; Groppa, Stanislav/0000-0002-2120-2408; Havrdova, Eva Kubala/0000-0002-9543-4359; Montalban, Xavier/0000-0002-0098-9918; Macedo, Ana/0000-0002-6978-8989; Selmaj, Krzysztof/0000-0003-1213-7218; antel, jack/0000-0002-5148-0636; Toomsoo, Toomas/0000-0002-8364-0438; Turcani, Peter/0000-0002-4868-6836; hutchinson, michael/0000-0002-8675-1723; Derfuss, Tobias/0000-0001-8656-4250	Avanir Pharmaceuticals; EMD Serono; Novartis; Questcor; GlaxoSmithKline; Genzyme; Sanofi; Teva; Roche; Bayer; Bayer HealthCare; Merck Serono; Biogen Idec	Avanir Pharmaceuticals; EMD Serono; Novartis(Novartis); Questcor; GlaxoSmithKline(GlaxoSmithKline); Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi; Teva(Teva Pharmaceutical Industries); Roche(Roche Holding); Bayer(Bayer AG); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Merck Serono(Merck & Company); Biogen Idec(Biogen)	Funded by Biogen Idec; CONFIRM ClinicalTrials.gov number, NCT00451451.; Dr. Fox reports receiving consulting fees from Avanir Pharmaceuticals, Biogen Idec, EMD Serono, Novartis, and Questcor. Dr. Miller reports receiving honoraria through his employer for serving on an advisory board for Biogen Idec, consulting fees and travel support from Biogen Idec, and grant support from Biogen Idec through his employer; honoraria through his employer for serving on an advisory board for Novartis, consulting fees from Novartis, and grant support from Novartis through his employer; honoraria through his employer for serving on an advisory board for GlaxoSmithKline, consulting fees and travel support from GlaxoSmithKline, and grant support from GlaxoSmithKline through his employer; honoraria through his employer for serving on an advisory board for Bayer Schering Pharma; and grant support from Genzyme through his employer. Dr. Phillips reports receiving consulting fees from Biogen Idec, Genzyme, Novartis, Sanofi, and Teva and grant support from Roche. Dr. Hutchinson reports receiving consulting fees and lecture fees from Biogen Idec and lecture fees from Bayer and Novartis. Dr. Havrdova reports receiving consulting and lecture fees from Bayer HealthCare, Merck Serono, Genzyme, Novartis, and Teva and grant support from Biogen Idec through her institution. Dr. Kita reports receiving consulting fees, lecture fees, and travel support from Biogen Idec. Ms. Yang, Mr. Raghupathi, and Drs. Novas, Sweetser, Viglietta, and Dawson report being employees of and holding stock in Biogen Idec. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2009, COP GLAT AC INJ SOL; [Anonymous], 2001, J CUTAN AESTHET SURG, V47, P45; Bista P, 2009, MULT SCLER, V15, pS132; Bista P, 2011, 5 JOINT TRIENN C EUR; Comi G, 2011, ANN NEUROL, V69, P75, DOI 10.1002/ana.22316; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 2009, LANCET, V373, P1340; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2012, MULT SCLER J, V18, P314, DOI 10.1177/1352458511421054; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lublin FD, 2001, ANN NEUROL, V49, P677, DOI 10.1002/ana.1025; MacManus DG, 2011, J NEUROL, V258, P449, DOI 10.1007/s00415-010-5777-z; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Papadopoulou A, 2010, EXPERT OPIN INV DRUG, V19, P1603, DOI 10.1517/13543784.2010.534778; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ryan S, 2009, NEUROLOGY, V72, pA379; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; World Medical Association, 2010, WMA DECL HELS ETH PR	25	914	946	1	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1087	1097		10.1056/NEJMoa1206328	http://dx.doi.org/10.1056/NEJMoa1206328			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AS	22992072	Green Published			2022-12-28	WOS:000308861800004
J	Glover, JD; Reganold, JP; Cox, CM				Glover, Jerry D.; Reganold, John P.; Cox, Cindy M.			Plant perennials to save Africa's soils	NATURE			English	Editorial Material							MANAGEMENT; SECURITY; FOOD		[Glover, Jerry D.] USAID Bur Food Secur, Washington, DC 20523 USA; [Reganold, John P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Cox, Cindy M.] Int Food Policy Res Inst, Washington, DC 20006 USA	United States Agency for International Development (USAID); Washington State University; CGIAR; International Food Policy Research Institute (IFPRI)	Glover, JD (corresponding author), USAID Bur Food Secur, Washington, DC 20523 USA.	jglover@usaid.gov						Adu-Gyamfi JJ, 2007, PLANT SOIL, V295, P127, DOI 10.1007/s11104-007-9270-0; Bationo A, 2007, AGR SYST, V94, P13, DOI 10.1016/j.agsy.2005.08.011; Betru S, 2010, AFR J AGR RES, V5, P2757; Committee on a Study of Technologies to Benefit Farmers in Africa and South Asia National Research Council, 2008, EM TECHN BEN FARM SU; Eswaran H, 1997, GEODERMA, V77, P1, DOI 10.1016/S0016-7061(97)00007-4; Garrity DP, 2010, FOOD SECUR, V2, P197, DOI 10.1007/s12571-010-0070-7; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Hassanali A, 2008, PHILOS T R SOC B, V363, P611, DOI 10.1098/rstb.2007.2173; Henao J., 2006, AGR PRODUCTION SOIL; Snapp SS, 2010, P NATL ACAD SCI USA, V107, P20840, DOI 10.1073/pnas.1007199107	10	64	67	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					359	361		10.1038/489359a	http://dx.doi.org/10.1038/489359a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AK	22996532	Bronze			2022-12-28	WOS:000308860900017
J	Watanabe, K; Kida, W				Watanabe, Kenta; Kida, Wataru			Battle's Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Watanabe, Kenta; Kida, Wataru] Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan		Watanabe, K (corresponding author), Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan.								0	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1135	1135		10.1056/NEJMicm1100820	http://dx.doi.org/10.1056/NEJMicm1100820			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AS	22992077				2022-12-28	WOS:000308861800009
J	Kahi, CJ; Imperiale, TF				Kahi, Charles J.; Imperiale, Thomas F.			Flexible sigmoidoscopy screening reduced colorectal cancer incidence and mortality in older adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kahi, Charles J.] Indiana Univ, Indianapolis, IN 46204 USA; Richard L Roudebush VA Med Ctr, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Kahi, CJ (corresponding author), Indiana Univ, Indianapolis, IN 46204 USA.			Imperiale, Thomas/0000-0001-7586-1073				Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2011, GASTROENTEROLOGY, V140, P65, DOI 10.1053/j.gastro.2010.09.006; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284	3	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6							JC3-3	10.7326/0003-4819-157-6-201209180-02003	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22986395				2022-12-28	WOS:000308912800002
J	Shamloul, R; Ghanem, H				Shamloul, Rany; Ghanem, Hussein			Erectile dysfunction	LANCET			English	Article							LIFE-STYLE CHANGES; PHOSPHODIESTERASE TYPE-5 INHIBITORS; ENDOTHELIAL PROGENITOR CELLS; URINARY-TRACT SYMPTOMS; TADALAFIL 5 MG; RISK-FACTORS; DOUBLE-BLIND; CARDIOVASCULAR RISK; SILDENAFIL CITRATE; PDE5 INHIBITORS	Erectile dysfunction is a common clinical entity that affects mainly men older than 40 years. In addition to the classical causes of erectile dysfunction, such as diabetes mellitus and hypertension, several common lifestyle factors, such as obesity, limited or an absence of physical exercise, and lower urinary tract symptoms, have been linked to the development of erectile dysfunction. Substantial steps have been taken in the study of the association between erectile dysfunction and cardiovascular disease. Erectile dysfunction is a strong predictor for coronary artery disease, and cardiovascular assessment of a non-cardiac patient presenting with erectile dysfunction is now recommended. Substantial advances have occurred in the understanding of the pathophysiology of erectile dysfunction that ultimately led to the development of successful oral therapies, namely the phosphodiesterase type 5 inhibitors. However, oral phosphodiesterase type 5 inhibitors have limitations, and present research is thus investigating cutting-edge therapeutic strategies including gene and cell-based technologies with the aim of discovering a cure for erectile dysfunction.	[Shamloul, Rany] Univ Ottawa, Dept Urol, Ottawa, ON, Canada; [Shamloul, Rany; Ghanem, Hussein] Cairo Univ, Dept Androl, Cairo, Egypt	University of Ottawa; Egyptian Knowledge Bank (EKB); Cairo University	Shamloul, R (corresponding author), Univ Ottowa, Dept Urol, Civ Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	ranyshamloul@gmail.com			Canadian Institutes of Health Research; Lilly Pharmaceuticals	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lilly Pharmaceuticals	RS is on a clinical research fellowship at the Ottawa Hospital Research Institute supported by Lilly Pharmaceuticals. HS declares that he has no conflicts of interest.; RS was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research.	Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; [Anonymous], 1993, Int J Impot Res, V5, P181; [Anonymous], 1999, INT J IMPOT RES, V11, P70; Aoyagi T, 1999, Bull Tokyo Dent Coll, V40, P215, DOI 10.2209/tdcpublication.40.215; Aversa A, 2008, INT J IMPOT RES, V20, P566, DOI 10.1038/ijir.2008.43; Aytac IA, 1999, BJU INT, V84, P50; Babaev A, 2012, J INVASIVE CARDIOL, V24, P236; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Baumhakel M, 2011, INT J CLIN PRACT, V65, P289, DOI 10.1111/j.1742-1241.2010.02563.x; Baumhakel M, 2006, EUR HEART J, V27, P2184, DOI 10.1093/eurheartj/ehl202; Behr-Roussel D, 2005, EUR UROL, V47, P87, DOI 10.1016/j.eururo.2004.09.005; Bejin A., 1999, ADROLOGIE, V9, P211; Bella AJ, 2007, EUR UROL, V52, P990, DOI 10.1016/j.eururo.2007.06.048; Bellinghieri G, 2008, J NEPHROL, V21, pS113; Bettocchi C, 2010, J SEX MED, V7, P304, DOI 10.1111/j.1743-6109.2009.01499.x; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1278, DOI 10.1152/ajpheart.00685.2006; Bocchio M, 2004, J UROLOGY, V171, P1601, DOI 10.1097/01.ju.0000116325.06572.85; Bohm M, 2010, CIRCULATION, V121, P1439, DOI 10.1161/CIRCULATIONAHA.109.864199; Brant WO, 2007, ENDOCRIN METAB CLIN, V36, P465, DOI 10.1016/j.ecl.2007.02.001; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Brioni JD, 2002, INT J IMPOT RES, V14, P8, DOI 10.1038/sj.ijir.3900801; Burchardt M, 2005, UROLOGY, V66, P665, DOI 10.1016/j.urology.2005.03.058; Burchardt M, 2000, J UROLOGY, V164, P1188, DOI 10.1016/S0022-5347(05)67138-8; Burnett AL, 2009, J ANDROL, V30, P391, DOI 10.2164/jandrol.108.006106; Carson C, 2006, MANAGEMENT ERECTILE; Carson CC, 2005, BJU INT, V96, P257, DOI 10.1111/j.1464-410X.2005.05614.x; Carson CC, 2002, UROLOGY, V60, P12, DOI 10.1016/S0090-4295(02)01687-4; Carson CC, 2007, UROL CLIN N AM, V34, P507, DOI 10.1016/j.ucl.2007.08.013; Cheng JYW, 2007, INT J OBESITY, V31, P1571, DOI 10.1038/sj.ijo.0803639; Chew KK, 2009, J SEX MED, V6, P1386, DOI 10.1111/j.1743-6109.2008.01115.x; Chitaley K, 2001, NAT MED, V7, P119, DOI 10.1038/83258; Chung Eric, 2011, Curr Urol Rep, V12, P432, DOI 10.1007/s11934-011-0216-y; Chung SD, 2011, J SEX MED, V8, P240, DOI 10.1111/j.1743-6109.2010.01973.x; Clark NG, 2007, DIABETES CARE, V30, P2868, DOI 10.2337/dc07-0816; Corona G, 2011, EUR J ENDOCRINOL, V165, P687, DOI 10.1530/EJE-11-0447; Dean RC, 2005, UROL CLIN N AM, V32, P379, DOI 10.1016/j.ucl.2005.08.007; Demir O, 2009, AGING MALE, V12, P29, DOI 10.1080/13685530902777425; Derby CA, 2000, UROLOGY, V56, P302, DOI 10.1016/S0090-4295(00)00614-2; Do C, 2009, DRUG SAFETY, V32, P591, DOI 10.2165/00002018-200932070-00005; Dong JY, 2011, J AM COLL CARDIOL, V58, P1378, DOI 10.1016/j.jacc.2011.06.024; Eardley I, 2010, J SEX MED, V7, P524, DOI 10.1111/j.1743-6109.2009.01627.x; Ekmekcioglu O, 2005, UROLOGY, V65, P347, DOI 10.1016/j.urology.2004.09.012; El Melegy NT, 2005, BJU INT, V96, P1079, DOI 10.1111/j.1464-410X.2005.05780.x; El-Sakka AI, 2007, J SEX MED, V4, P1691, DOI 10.1111/j.1743-6109.2006.00342.x; Esposito K, 2004, JAMA-J AM MED ASSOC, V291, P2978, DOI 10.1001/jama.291.24.2978; Esposito K, 2006, INT J IMPOT RES, V18, P405, DOI 10.1038/sj.ijir.3901447; Esposito K, 2006, INT J IMPOT RES, V18, P370, DOI 10.1038/sj.ijir.3901438; Esposito K, 2011, UROL CLIN N AM, V38, P293, DOI 10.1016/j.ucl.2011.04.006; Esposito K, 2009, J SEX MED, V6, P243, DOI 10.1111/j.1743-6109.2008.01030.x; Esposito K, 2009, J SEX MED, V6, P107, DOI 10.1111/j.1743-6109.2008.01042.x; Ferrini MG, 2007, BIOL REPROD, V76, P915, DOI 10.1095/biolreprod.106.059642; Fisher WA, 2004, J SEX MED, V1, P150, DOI 10.1111/j.1743-6109.2004.04023.x; Foresta C, 2005, INT J IMPOT RES, V17, P288, DOI 10.1038/sj.ijir.3901311; Gatti A, 2009, J ENDOCRINOL INVEST, V32, P542, DOI 10.1007/BF03346504; Ghanem H, 2008, J SEX MED, V5, P1582, DOI 10.1111/j.1743-6109.2007.00665.x; Glina S., 2006, STANDARD PRACTICE SE, P121; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Gruenwald I, 2009, EUR UROL, V55, P969, DOI 10.1016/j.eururo.2008.04.048; Guay A T, 1998, Endocr Pract, V4, P23; Guay AT, 2001, J ANDROL, V22, P793; Gupta BP, 2011, ARCH INTERN MED, V171, P1797, DOI 10.1001/archinternmed.2011.440; Hannan JL, 2007, J SEX MED, V4, P886, DOI 10.1111/j.1743-6109.2007.00517.x; Hannan JL, 2009, J SEX MED, V6, P254, DOI 10.1111/j.1743-6109.2008.01143.x; Hatzichristou D, 2010, J SEX MED, V7, P337, DOI 10.1111/j.1743-6109.2009.01619.x; Hatzimouratidis K, 2005, DRUGS, V65, P1621, DOI 10.2165/00003495-200565120-00003; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; HIRSHKOWITZ M, 1990, UROLOGY, V36, P232, DOI 10.1016/0090-4295(90)80262-L; Holden CA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-96; Horasanli K, 2008, ASIAN J ANDROL, V10, P28, DOI 10.1111/j.1745-7262.2008.00363.x; Huyghe E, 2009, J SEX MED, V6, P1395, DOI 10.1111/j.1743-6109.2008.01169.x; Inman BA, 2009, MAYO CLIN PROC, V84, P108, DOI 10.4065/84.2.108; Jackson Graham, 2007, Curr Urol Rep, V8, P463, DOI 10.1007/s11934-007-0049-x; Jain P, 2000, J UROLOGY, V164, P371, DOI 10.1016/S0022-5347(05)67363-6; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Kendirci M, 2006, CURR OPIN UROL, V16, P449, DOI 10.1097/01.mou.0000250286.60237.a6; King SH, 2005, UROLOGY, V66, pE15, DOI 10.1016/j.urology.2005.02.019; Konstantinos G, 2009, CURR PHARM DESIGN, V15, P3540, DOI 10.2174/138161209789206953; Koseoglu N, 2005, J UROLOGY, V174, P249, DOI 10.1097/01.ju.0000163259.33846.74; Kouvelas D, 2009, CURR PHARM DESIGN, V15, P3464, DOI 10.2174/138161209789206971; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Maio G, 2010, J SEX MED, V7, P2201, DOI 10.1111/j.1743-6109.2010.01783.x; MANNINO DM, 1994, AM J EPIDEMIOL, V140, P1003, DOI 10.1093/oxfordjournals.aje.a117189; Martin WJ, 2002, EUR J PHARMACOL, V454, P71, DOI 10.1016/S0014-2999(02)02479-2; Martin-Morales A, 2001, J UROLOGY, V166, P569, DOI 10.1016/S0022-5347(05)65986-1; Martin-Morales A, 2001, J UROLOGY, V166, P574; McGwin G, 2010, ARCH OTOLARYNGOL, V136, P488, DOI 10.1001/archoto.2010.51; McMahon CG, 2006, EUR UROL, V50, P215, DOI 10.1016/j.eururo.2006.03.018; Mehrotra N, 2007, INT J IMPOT RES, V19, P253, DOI 10.1038/sj.ijir.3901522; Melman A, 2006, HUM GENE THER, V17, P1165, DOI 10.1089/hum.2006.17.1165; MILLER NS, 1988, J SUBST ABUSE TREAT, V5, P171, DOI 10.1016/0740-5472(88)90006-2; Miner MM, 2011, J ANDROL, V32, P125, DOI 10.2164/jandrol.110.011338; Mittawae B, 2006, UROLOGY, V67, P575, DOI 10.1016/j.urology.2005.09.040; Montorsi F, 2010, J SEX MED, V7, P3572, DOI 10.1111/j.1743-6109.2010.02062.x; Montorsi P, 2003, EUR UROL, V44, P352, DOI 10.1016/S0302-2838(03)00307-5; Montorsi P, 2006, EUR UROL, V50, P721, DOI 10.1016/j.eururo.2006.07.015; Morganroth J, 2004, AM J CARDIOL, V93, P1378, DOI 10.1016/j.amjcard.2004.02.034; Mulhall JP, 2008, CURR OPIN UROL, V18, P613, DOI 10.1097/MOU.0b013e3283136462; Nehra A, 2012, MAYO CLIN PROC, V87, P766, DOI 10.1016/j.mayocp.2012.06.015; Nicolosi A, 2005, BJU INT, V95, P609, DOI 10.1111/j.1464-410X.2005.05348.x; Nicolosi A, 2003, UROLOGY, V61, P201, DOI 10.1016/S0090-4295(02)02102-7; Peled N, 2009, J RHEUMATOL, V36, P970, DOI 10.3899/jrheum.081088; Perimenis P, 2006, ASIAN J ANDROL, V8, P219, DOI 10.1111/j.1745-7262.2006.00095.x; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; Ponholzer A, 2005, EUR UROL, V47, P80, DOI 10.1016/j.eururo.2004.08.017; Ponholzer A, 2010, INT J IMPOT RES, V22, P25, DOI 10.1038/ijir.2009.40; Porst H, 2008, J SEX MED, V5, P2160, DOI 10.1111/j.1743-6109.2008.00935.x; Porst H, 2006, EUR UROL, V50, P351, DOI 10.1016/j.eururo.2006.02.052; Prieto D, 2008, INT J IMPOT RES, V20, P17, DOI 10.1038/sj.ijir.3901581; Quek KF, 2008, J SEX MED, V5, P70, DOI 10.1111/j.1743-6109.2006.00423.x; Rogers JH, 2010, CATHETER CARDIO INTE, V76, P882, DOI 10.1002/ccd.22646; Rosen R, 1999, INT J IMPOT RES, V11, P59, DOI 10.1038/sj.ijir.3900411; Rosen RC, 2009, BJU INT, V103, P42, DOI 10.1111/j.1464-410X.2009.08370.x; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 2005, UROL CLIN N AM, V32, P403, DOI 10.1016/j.ucl.2005.08.004; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Selph JP, 2011, UROL CLIN N AM, V38, P227, DOI 10.1016/j.ucl.2011.02.007; Serretti Alessandro, 2011, Int Clin Psychopharmacol, V26, P130, DOI 10.1097/YIC.0b013e328341e434; Setter SM, 2005, ANN PHARMACOTHER, V39, P1286, DOI 10.1345/aph.1E487; Shabsigh R, 2008, J UROLOGY, V179, pS97, DOI 10.1016/j.juro.2008.03.145; Shah J, 2002, BJU INT, V90, P433, DOI 10.1046/j.1464-410X.2002.02911.x; Shamloul R, 2005, J SEX MED, V2, P559, DOI 10.1111/j.1743-6109.2005.00071.x; Siddiqui MA, 2012, SPINE, V37, P797, DOI 10.1097/BRS.0b013e318232601c; Smith GE., 1974, PAPYRUS EBERS; Supuran CT, 2006, CURR PHARM DESIGN, V12, P3459, DOI 10.2174/138161206778343118; Thomas A, 2003, UROL CLIN N AM, V30, P123, DOI 10.1016/S0094-0143(02)00111-8; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Tomlinson JM, 2004, BMJ-BRIT MED J, V328, P1037, DOI 10.1136/bmj.38044.662176.EE; Tomsak R, 2005, INT J IMPOT RES, V17, P547, DOI 10.1038/sj.ijir.3901396; Traish AM, 2003, J ANDROL, V24, P381; Vardi Y, 2012, J UROLOGY, V187, P1769, DOI 10.1016/j.juro.2011.12.117; Vardi Y, 2009, EUR UROL, V55, P979, DOI 10.1016/j.eururo.2008.07.041; Venkateswarlu K, 2002, J UROLOGY, V168, P355, DOI 10.1016/S0022-5347(05)64920-8; VIRAG R, 1985, LANCET, V1, P181; WESPES E, 1993, J UROLOGY, V149, P1238, DOI 10.1016/S0022-5347(17)36358-9; Wessels H., 2006, MALE SEXUAL FUNCTION, P323; Williams G, 1998, BRIT J UROL, V81, P889; Wrishko R, 2009, J SEX MED, V6, P2039, DOI 10.1111/j.1743-6109.2009.01301.x; Xie DH, 2008, ASIAN J ANDROL, V10, P23, DOI 10.1111/j.1745-7262.2008.00372.x	140	535	571	5	92	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2013	381	9861					153	165		10.1016/S0140-6736(12)60520-0	http://dx.doi.org/10.1016/S0140-6736(12)60520-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23040455				2022-12-28	WOS:000313420900032
J	Duong, DL; Han, GH; Lee, SM; Gunes, F; Kim, ES; Kim, ST; Kim, H; Ta, QH; So, KP; Yoon, SJ; Chae, SJ; Jo, YW; Park, MH; Chae, SH; Lim, SC; Choi, JY; Lee, YH				Dinh Loc Duong; Han, Gang Hee; Lee, Seung Mi; Gunes, Fethullah; Kim, Eun Sung; Kim, Sung Tae; Kim, Heetae; Quang Huy Ta; So, Kang Pyo; Yoon, Seok Jun; Chae, Seung Jin; Jo, Young Woo; Park, Min Ho; Chae, Sang Hoon; Lim, Seong Chu; Choi, Jae Young; Lee, Young Hee			Probing graphene grain boundaries with optical microscopy	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; POLYCRYSTALLINE GRAPHENE; OZONE; FILMS	Grain boundaries in graphene are formed by the joining of islands during the initial growth stage, and these boundaries govern transport properties and related device performance(1,2). Although information on the atomic rearrangement at graphene grain boundaries can be obtained using transmission electron microscopy(3,4) and scanning tunnelling microscopy(2,5-8), large-scale information regarding the distribution of graphene grain boundaries is not easily accessible. Here we use optical microscopy to observe the grain boundaries of large-area graphene (grown on copper foil) directly, without transfer of the graphene. This imaging technique was realized by selectively oxidizing the underlying copper foil through graphene grain boundaries functionalized with O and OH radicals generated by ultraviolet irradiation under moisture-rich ambient conditions: selective diffusion of oxygen radicals through OH-functionalized defect sites was demonstrated by density functional calculations. The sheet resistance of large-area graphene decreased as the graphene grain sizes increased, but no strong correlation with the grain size of the copper was revealed, in contrast to a previous report(9). Furthermore, the influence of graphene grain boundaries on crack propagation (initialized by bending) and termination was clearly visualized using our technique. Our approach can be used as a simple protocol for evaluating the grain boundaries of other two-dimensional layered structures, such as boron nitride and exfoliated clays.	[Dinh Loc Duong; Chae, Seung Jin; Lee, Young Hee] Sungkyunkwan Univ, Sungkyunkwan Adv Inst Nanotechnol, Suwon 440746, South Korea; [Dinh Loc Duong; Han, Gang Hee; Gunes, Fethullah; Kim, Eun Sung; Kim, Sung Tae; Kim, Heetae; Quang Huy Ta; So, Kang Pyo; Yoon, Seok Jun; Chae, Seung Jin; Jo, Young Woo; Chae, Sang Hoon; Lim, Seong Chu; Choi, Jae Young; Lee, Young Hee] Sungkyunkwan Univ, Graphene Ctr, Dept Energy Sci, Phys Div BK21, Suwon 440746, South Korea; [Lee, Seung Mi] Korea Res Inst Stand & Sci, Ctr Nanocharacterizat, Taejon 305340, South Korea; [Park, Min Ho] Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon 440746, South Korea; [Choi, Jae Young] Samsung Adv Inst Technol SAIT, Graphene Ctr, Suwon 440600, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Korea Research Institute of Standards & Science (KRISS); Sungkyunkwan University (SKKU); Samsung	Lee, YH (corresponding author), Sungkyunkwan Univ, Sungkyunkwan Adv Inst Nanotechnol, Suwon 440746, South Korea.	leeyoung@skku.edu	Duong, Dinh Loc/AAX-5270-2020; Han, Gang Hee/P-7260-2014; Gunes, Fethullah/AGK-0538-2022; Chae, Sang Hoon/AAN-1534-2020; Lee, Young Hee/A-5424-2013; Lim, Seong Chu/A-6142-2013	Duong, Dinh Loc/0000-0002-4118-9589; Gunes, Fethullah/0000-0002-7553-3608; Ta, Huy/0000-0002-3219-5856; Chae, Sang Hoon/0000-0002-9612-5371	Star Faculty programme of the NRF of Korea [2010-0029653]; International Research and Development programme of the NRF of Korea [2011-00242]; WCU programme of the NRF of Korea [R31-2008-10029]; MEST	Star Faculty programme of the NRF of Korea; International Research and Development programme of the NRF of Korea; WCU programme of the NRF of Korea; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Star Faculty programme (2010-0029653), the International Research and Development programme (2011-00242) and the WCU programme (R31-2008-10029) of the NRF of Korea funded by MEST.	Blake P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768624; Chae SJ, 2009, ADV MATER, V21, P2328, DOI 10.1002/adma.200803016; Chen FY, 2002, WATER RES, V36, P4203, DOI 10.1016/S0043-1354(02)00140-9; Chen JH, 2008, NAT NANOTECHNOL, V3, P206, DOI 10.1038/nnano.2008.58; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Gao L, 2010, NANO LETT, V10, P3512, DOI 10.1021/nl1016706; Gunes F, 2011, NANO, V6, P409, DOI 10.1142/S1793292011002780; HALGREN TA, 1977, CHEM PHYS LETT, V49, P225, DOI 10.1016/0009-2614(77)80574-5; Han GH, 2011, NANO LETT, V11, P4144, DOI 10.1021/nl201980p; Huang MY, 2009, P NATL ACAD SCI USA, V106, P7304, DOI 10.1073/pnas.0811754106; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Jandhyala S, 2012, ACS NANO, V6, P2722, DOI 10.1021/nn300167t; Jeong CW, 2011, NANO LETT, V11, P5020, DOI 10.1021/nl203041n; Jin Z, 2011, CHEM MATER, V23, P3362, DOI 10.1021/cm201131v; Kim DW, 2012, NAT NANOTECHNOL, V7, P29, DOI [10.1038/nnano.2011.198, 10.1038/NNANO.2011.198]; Kim K, 2011, ACS NANO, V5, P2142, DOI 10.1021/nn1033423; Lee G, 2009, J PHYS CHEM C, V113, P14225, DOI 10.1021/jp904321n; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liu YY, 2010, NANO LETT, V10, P2178, DOI 10.1021/nl100988r; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rasool HI, 2011, J AM CHEM SOC, V133, P12536, DOI 10.1021/ja200245p; Rasool HI, 2011, NANO LETT, V11, P251, DOI 10.1021/nl1036403; Regan W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3337091; Tian JF, 2011, NANO LETT, V11, P3663, DOI 10.1021/nl201590f; Tkatchenko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073005; Wang JH, 2000, SEP PURIF TECHNOL, V19, P11, DOI 10.1016/S1383-5866(99)00078-7; Yazyev OV, 2010, NAT MATER, V9, P806, DOI [10.1038/nmat2830, 10.1038/NMAT2830]; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/NMAT3010, 10.1038/nmat3010]	30	307	309	8	594	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					235	+		10.1038/nature11562	http://dx.doi.org/10.1038/nature11562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23034653				2022-12-28	WOS:000309733300044
J	Sovacool, BK				Sovacool, Benjamin K.			Deploying Off-Grid Technology to Eradicate Energy Poverty	SCIENCE			English	Editorial Material									Vermont Law Sch, Inst Energy & Environm, S Royalton, VT 05068 USA		Sovacool, BK (corresponding author), Vermont Law Sch, Inst Energy & Environm, S Royalton, VT 05068 USA.	sovacool@vt.edu	Sovacool, Benjamin/Y-2392-2019	Sovacool, Benjamin/0000-0002-4794-9403				[Anonymous], 2009, ENERGY ACCESS SITUAT; [Anonymous], 2005, ENERGY SERVICES MILL; Bazilian M, 2010, ENERG POLICY, V38, P5409, DOI 10.1016/j.enpol.2010.06.007; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Enkvist P.-A., 2007, MCKINSEY Q, P35; Garud R, 2003, RES POLICY, V32, P277, DOI 10.1016/S0048-7333(02)00100-2; International Energy Agency, 2010, EN POV MAK MOD EN AC; Martinot E, 2002, ANNU REV ENERG ENV, V27, P309, DOI 10.1146/annurev.energy.27.122001.083444; Martinot E, 2001, ENERG POLICY, V29, P689, DOI 10.1016/S0301-4215(00)00151-8; Nieuwenhout FDJ, 2001, PROG PHOTOVOLTAICS, V9, P455, DOI 10.1002/pip.392; Ostojic D, 2011, ONE GOAL 2 PATHS ACH; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2010, GLOBAL ENVIRON CHANG, V20, P550, DOI 10.1016/j.gloenvcha.2010.07.004; Sovacool B.K., 2012, ENERGY ACCESS POVERT, V1st, DOI DOI 10.4324/9781315579535; Sovacool BK, 2012, ENERGY SUSTAIN DEV, V16, P272, DOI 10.1016/j.esd.2012.05.006; Sovacool BK, 2011, ENERGY SUSTAIN DEV, V15, P254, DOI 10.1016/j.esd.2011.06.005; Sovacool BK, 2011, ENERG POLICY, V39, P3832, DOI 10.1016/j.enpol.2011.04.014; Stern PC, 2010, ENVIRON SCI TECHNOL, V44, P4847, DOI 10.1021/es100896p; United Nations Foundation, 2012 INT YEAR SUST E; Vandenbergh MP, 2008, UCLA LAW REV, V55, P1701; Viray F. L., 2000, WORLD ENERGY ASSESSM, P61; World Health Organization, 2006, WHO HOUS EN DAT; Wustenhagen R, 2007, ENERG POLICY, V35, P2683, DOI 10.1016/j.enpol.2006.12.001	23	38	39	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					47	48		10.1126/science.1222307	http://dx.doi.org/10.1126/science.1222307			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015PC	23042871				2022-12-28	WOS:000309457400040
J	Zuiderent-Jerak, T; Forland, F; Macbeth, F				Zuiderent-Jerak, Teun; Forland, Frode; Macbeth, Fergus			Guidelines should reflect all knowledge, not just clinical trials	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zuiderent-Jerak, Teun] Erasmus Univ, Inst Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands; [Forland, Frode] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Macbeth, Fergus] Velindre NHS Trust, Cardiff, S Glam, Wales	Erasmus University Rotterdam	Zuiderent-Jerak, T (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Zuiderent-Jerak, Teun/E-4359-2013	Zuiderent-Jerak, Teun/0000-0003-3008-1297				Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Hutchison G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2685; National Institute for Health and Clinical Excellence (NICE), 2008, CG75 NICE; OCEBM Levels of Evidence Working Group, 2011, OXFORD LEVELS EVIDEN; Rawlins MD, 2008, DE TESTIMONIO EVIDEN; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; The AGREE Collaboration, 2001, APPR GUID RES EV AGR; Zuiderent-Jerak, 2007, SCI CULTURE, V16, P311, DOI DOI 10.1080/09505430701568719; Zuiderent-Jerak T, 2011, VARIATIE RICHTLIJNEN	10	36	37	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 5	2012	345								e6702	10.1136/bmj.e6702	http://dx.doi.org/10.1136/bmj.e6702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LO	23043093				2022-12-28	WOS:000309662300008
J	de Vries, BL; Acke, B; Blommaert, JADL; Waelkens, C; Waters, LBFM; Vandenbussche, B; Min, M; Olofsson, G; Dominik, C; Decin, L; Barlow, MJ; Brandeker, A; Di Francesco, J; Glauser, AM; Greaves, J; Harvey, PM; Holland, WS; Ivison, RJ; Liseau, R; Pantin, EE; Pilbratt, GL; Royer, P; Sibthorpe, B				de Vries, B. L.; Acke, B.; Blommaert, J. A. D. L.; Waelkens, C.; Waters, L. B. F. M.; Vandenbussche, B.; Min, M.; Olofsson, G.; Dominik, C.; Decin, L.; Barlow, M. J.; Brandeker, A.; Di Francesco, J.; Glauser, A. M.; Greaves, J.; Harvey, P. M.; Holland, W. S.; Ivison, R. J.; Liseau, R.; Pantin, E. E.; Pilbratt, G. L.; Royer, P.; Sibthorpe, B.			Comet-like mineralogy of olivine crystals in an extrasolar proto-Kuiper belt	NATURE			English	Article							BETA-PICTORIS; PROTOPLANETARY DISKS; DEBRIS DISKS; HD 100546; DUST; SILICATES; SPECTRA; SPECTROSCOPY; CHONDRITES; FORSTERITE	Some planetary systems harbour debris disks containing planetesimals such as asteroids and comets(1). Collisions between such bodies produce small dust particles(2), the spectral features of which reveal their composition and, hence, that of their parent bodies. A measurement of the composition of olivine crystals (Mg2-2xFe2xSiO4) has been done for the protoplanetary disk HD 100546 (refs 3, 4) and for olivine crystals in the warm inner parts of planetary systems. The latter compares well with the iron-rich olivine in asteroids(5,6) (x approximate to 0.29). In the cold outskirts of the beta Pictoris system, an analogue to the young Solar System, olivine crystals were detected(7) but their composition remained undetermined, leaving unknown how the composition of the bulk of Solar System cometary olivine grains compares with that of extrasolar comets(8,9). Here we report the detection of the 69-micrometre-wavelength band of olivine crystals in the spectrum of beta Pictoris. Because the disk is optically thin, we can associate the crystals with an extrasolar proto-Kuiper belt a distance of 15-45 astronomical units from the star (one astronomical unit is the Sun-Earth distance), determine their magnesium-rich composition (x = 0.01 +/- 0.001) and show that they make up 3.6 +/- 1.0 per cent of the total dust mass. These values are strikingly similar to those for the dust emitted by the most primitive comets in the Solar System(8-10), even though beta Pictoris is more massive and more luminous and has a different planetary system architecture.	[de Vries, B. L.; Acke, B.; Blommaert, J. A. D. L.; Waelkens, C.; Vandenbussche, B.; Decin, L.; Royer, P.] Katholieke Univ Leuven, Sterrekundig Inst, B-3001 Louvain, Belgium; [Waters, L. B. F. M.] SRON, NL-3584 CA Utrecht, Netherlands; [Waters, L. B. F. M.; Min, M.; Dominik, C.; Decin, L.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Olofsson, G.; Brandeker, A.] Stockholm Univ, AlbaNova Univ Ctr, Dept Astron, S-10691 Stockholm, Sweden; [Dominik, C.] Radboud Univ Nijmegen, Dept Astrophys IMAPP, NL-6500 GL Nijmegen, Netherlands; [Barlow, M. J.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Di Francesco, J.] Natl Res Council Canada, Victoria, BC V9E 2E7, Canada; [Glauser, A. M.] Swiss Fed Inst Technol, Inst Astron, CH-8093 Zurich, Switzerland; [Glauser, A. M.; Holland, W. S.; Ivison, R. J.; Sibthorpe, B.] Royal Observ Edinburgh, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Greaves, J.] SUPA, St Andrews KY16 9SS, Fife, Scotland; [Harvey, P. M.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Holland, W. S.] Univ Edinburgh, Inst Astron, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland; [Liseau, R.] Chalmers, Onsala Space Observ, S-43992 Onsala, Sweden; [Pantin, E. E.] Univ Paris Diderot, IRFU Serv Astrophys, CEA Saclay, Lab AIM,CEA,DSM,CNRS, F-91191 Gif Sur Yvette, France; [Pilbratt, G. L.] ESTEC SRE SA, ESA Res & Sci Support Dept, NL-2201 AZ Noordwijk, Netherlands	KU Leuven; University of Amsterdam; Stockholm University; Radboud University Nijmegen; University of London; University College London; National Research Council Canada; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Edinburgh; University of St Andrews; University of Texas System; University of Texas Austin; University of Edinburgh; Chalmers University of Technology; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; European Space Agency	de Vries, BL (corresponding author), Katholieke Univ Leuven, Sterrekundig Inst, Celestijnenlaan 200D, B-3001 Louvain, Belgium.	bldevries.science@gmail.com	Ivison, R. J./G-4450-2011; Barlow, Michael J/A-5638-2009	Ivison, R. J./0000-0001-5118-1313; Barlow, Michael J/0000-0002-3875-1171; Glauser, Adrian/0000-0001-9250-1547; Vandenbussche, Bart/0000-0002-1368-3109; Min, Michiel/0000-0001-5778-0376; Dominik, Carsten/0000-0002-3393-2459; Brandeker, Alexis/0000-0002-7201-7536; Decin, Leen/0000-0002-5342-8612	BMVIT (Austria); ESA-PRODEX (Belgium); CEA/CNES (France); DLR (Germany); ASI (Italy); CICT/MCT (Spain); STFC [ST/G001987/1, ST/J001511/1, ST/J001651/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001651/1, ST/J001511/1, ST/G001987/1] Funding Source: researchfish	BMVIT (Austria); ESA-PRODEX (Belgium); CEA/CNES (France)(French Atomic Energy CommissionCentre National D'etudes Spatiales); DLR (Germany)(Helmholtz AssociationGerman Aerospace Centre (DLR)); ASI (Italy)(Agenzia Spaziale Italiana (ASI)); CICT/MCT (Spain); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. PACS has been developed by a consortium of institutes led by MPE (Germany) and including UVIE (Austria); KUL, CSL and IMEC (Belgium); CEA and OAMP (France); MPIA (Germany); IFSI, OAP/AOT, OAA/CAISMI, LENS and SISSA (Italy); and IAC (Spain). This development has been supported by the funding agencies BMVIT (Austria), ESA-PRODEX (Belgium), CEA/CNES (France), DLR (Germany), ASI (Italy) and CICT/MCT (Spain). B.L.d.V. is an Aspirant Fellow of the Fund for Scientific Research, Flanders.	Abraham P, 2009, NATURE, V459, P224, DOI 10.1038/nature08004; Calvet N, 2005, ASTROPHYS J, V630, pL185, DOI 10.1086/491652; Chen CH, 2007, ASTROPHYS J, V666, P466, DOI 10.1086/519989; Davoisne C, 2006, ASTRON ASTROPHYS, V448, pL1, DOI 10.1051/0004-6361:200600002; des Etangs AL, 2001, NATURE, V412, P706, DOI 10.1038/35089006; Gail HP, 2004, ASTRON ASTROPHYS, V413, P571, DOI 10.1051/0004-6361:20031554; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Koike C, 2003, ASTRON ASTROPHYS, V399, P1101, DOI 10.1051/0004-6361:20021831; LAGAGE PO, 1994, NATURE, V369, P628, DOI 10.1038/369628a0; Lisse CM, 2007, ASTROPHYS J, V658, P584, DOI 10.1086/511001; Mulders GD, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116770; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nuth JA, 2006, ICARUS, V180, P243, DOI 10.1016/j.icarus.2005.09.003; Okamoto YK, 2004, NATURE, V431, P660, DOI 10.1038/nature02948; Olofsson J, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118735; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Reach WT, 2009, ICARUS, V203, P571, DOI 10.1016/j.icarus.2009.05.027; Sitko ML, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/3/80; Sturm B, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014674; Suto H, 2006, MON NOT R ASTRON SOC, V370, P1599, DOI 10.1111/j.1365-2966.2006.10594.x; Tanaka KK, 2010, ASTROPHYS J, V717, P586, DOI 10.1088/0004-637X/717/1/586; Vandenbussche B, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014626; Vinkovic D, 2009, NATURE, V459, P227, DOI 10.1038/nature08032; Wyatt MC, 2007, ASTROPHYS J, V663, P365, DOI 10.1086/518404; Zolensky M, 2008, METEORIT PLANET SCI, V43, P261, DOI 10.1111/j.1945-5100.2008.tb00621.x; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	30	40	40	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					74	76		10.1038/nature11469	http://dx.doi.org/10.1038/nature11469			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038467	Green Submitted			2022-12-28	WOS:000309446800034
J	Holt, R				Holt, Rush			Politicians should think like scientists	NATURE			English	Editorial Material									12th Congress Dist New Jersey, W Windsor, NJ 08550 USA		Holt, R (corresponding author), 12th Congress Dist New Jersey, W Windsor, NJ 08550 USA.	rush.holt@mail.house.gov							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					493	494		10.1038/489493a	http://dx.doi.org/10.1038/489493a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	011LT	23018947	Bronze			2022-12-28	WOS:000309167100022
J	Watts, D				Watts, David			Cure for the Common Cold	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EMPATHY		Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Watts, D (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							Chen D, 2007, J GEN INTERN MED, V22, P1434, DOI 10.1007/s11606-007-0298-x; Gonsalves B, 2004, PSYCHOL SCI, V15, P655, DOI 10.1111/j.0956-7976.2004.00736.x; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; ROGHMANN KJ, 1979, MED CARE, V17, P461, DOI 10.1097/00005650-197905000-00002; Woollett K, 2011, CURR BIOL, V21, P2109, DOI 10.1016/j.cub.2011.11.018	5	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1184	1185		10.1056/NEJMp1209265	http://dx.doi.org/10.1056/NEJMp1209265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JO	23013072				2022-12-28	WOS:000309161100004
J	Friedemann, C; Heneghan, C; Mahtani, K; Thompson, M; Perera, R; Ward, AM				Friedemann, Claire; Heneghan, Carl; Mahtani, Kamal; Thompson, Matthew; Perera, Rafael; Ward, Alison M.			Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEFT-VENTRICULAR MASS; AMBULATORY BLOOD-PRESSURE; CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY PROGRAM; INTIMA-MEDIA THICKNESS; MYOCARDIAL DEFORMATION PROPERTIES; OBESE CHILDREN; CHILDHOOD OBESITY; WAIST CIRCUMFERENCE; METABOLIC SYNDROME	Objectives To describe the association and its magnitude between body mass index category, sex, and cardiovascular disease risk parameters in school aged children in highly developed countries. Design Systematic review and meta-analysis. Quality of included studies assessed by an adapted version of the Cochrane Collaboration's risk of bias assessment tool. Results of included studies in meta-analysis were pooled and analysed by Review Manager version 5.1. Data sources Embase, PubMed, EBSCOHost's cumulative index to nursing and allied health literature, and the Web of Science databases for papers published between January 2000 and December 2011. Review methods Healthy children aged 5 to 15 in highly developed countries enrolled in studies done after 1990 and using prospective or retrospective cohort, cross sectional, case-control, or randomised clinical trial designs in school, outpatient, or community settings. Included studies had to report an objective measure of weight and at least one prespecified risk parameter for cardiovascular disease. Results We included 63 studies of 49 220 children. Studies reported a worsening of risk parameters for cardiovascular disease in overweight and obese participants. Compared with normal weight children, systolic blood pressure was higher by 4.54 mm Hg (99% confidence interval 2.44 to 6.64; n=12 169, eight studies) in overweight children, and by 7.49 mm Hg (3.36 to 11.62; n=8074, 15 studies) in obese children. We found similar associations between groups in diastolic and 24 h ambulatory systolic blood pressure. Obesity adversely affected concentrations of all blood lipids; total cholesterol and triglycerides were 0.15 mmol/L (0.04 to 0.25, n=5072) and 0.26 mmol/L (0.13 to 0.39, n=5138) higher in obese children, respectively. Fasting insulin and insulin resistance were significantly higher in obese participants but not in overweight participants. Obese children had a significant increase in left ventricular mass of 19.12 g (12.66 to 25.59, n=223), compared with normal weight children. Conclusion Having a body mass index outside the normal range significantly worsens risk parameters for cardiovascular disease in school aged children. This effect, already substantial in overweight children, increases in obesity and could be larger than previously thought. There is a need to establish whether acceptable parameter cut-off levels not considering weight are a valid measure of risk in modern children and whether methods used in their study and reporting should be standardised.	[Friedemann, Claire; Heneghan, Carl; Mahtani, Kamal; Thompson, Matthew; Perera, Rafael; Ward, Alison M.] Univ Oxford, Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford OX2 6GG, England	University of Oxford	Friedemann, C (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, New Radcliffe House, Oxford OX2 6GG, England.	claire.friedemann@phc.ox.ac.uk	Smith, Claire Friedemann/J-4491-2019	Smith, Claire Friedemann/0000-0001-9934-5882; Perera, Rafael/0000-0003-2418-2091	Medical Research Council; United States Preventive Services task force; National Institutes for Health Research School of Primary Care Research; National Institute for Health Research [CDF-2011-04-052, CL-2011-13-006] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States Preventive Services task force; National Institutes for Health Research School of Primary Care Research; National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; CF receives a stipend from the Medical Research Council; CH teaches workshops on evidence based medicine, does media work, writes for the Guardian newspaper, attends World Health Organization meetings, and has coauthored toolkit books on statistics and evidence based medicine; MT received grant funding in 2011-12 to Oregon Health Sciences University from the United States Preventive Services task force, to a lead the evidence review for the task force's review on screening for hypertension in children; AW attends WHO meetings; the University Department of Primary Care Health Sciences is part of the National Institutes for Health Research School of Primary Care Research, which provide financial support for senior staff who contributed to this paper; no other relationships or activities exist that could appear to have influenced the submitted work.	Aggoun Y, 2008, EUR HEART J, V29, P792, DOI 10.1093/eurheartj/ehm633; Alhassan S, 2008, ETHNIC DIS, V18, P421; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Andersen LB, 2003, PREV MED, V37, P363, DOI 10.1016/S0091-7435(03)00145-2; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Banach AM, 2010, EUR J PEDIATR, V169, P695, DOI 10.1007/s00431-009-1092-z; Barba G, 2006, NUTR METAB CARDIOVAS, V16, P239, DOI 10.1016/j.numecd.2006.02.005; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Borenstein M, 2009, INTRO META ANAL; Bouziotas C, 2004, ARCH DIS CHILD, V89, P41; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Calcaterra V, 2008, CLIN ENDOCRINOL, V68, P868, DOI 10.1111/j.1365-2265.2007.03115.x; Carrel AL, 2005, ARCH PEDIAT ADOL MED, V159, P963, DOI 10.1001/archpedi.159.10.963; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chen X, 2008, HYPERTENSION, V51, P642, DOI 10.1161/HYPERTENSIONAHA.107.102145; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Csabi G, 2000, EUR J PEDIATR, V159, P91, DOI 10.1007/PL00013812; Daniels SR, 2011, EXPERT PANEL INTEGRA; Dankner R, 2009, DIABETES CARE, V32, P1464, DOI 10.2337/dc09-0153; de Sousa G, 2009, KLIN PADIATR, V221, P237, DOI 10.1055/s-0028-1105927; Dekkers JC, 2003, PEDIATRICS, V111, P1387, DOI 10.1542/peds.111.6.1387; Department for Transport, 2012, NAT TRAV SURV 2010; Di Bonito P, 2008, NUTR METAB CARDIOVAS, V18, P613, DOI 10.1016/j.numecd.2007.09.002; Di Salvo G, 2008, J AM SOC ECHOCARDIOG, V21, P151, DOI 10.1016/j.echo.2007.05.028; Di Salvo G, 2006, EUR HEART J, V27, P2689, DOI 10.1093/eurheartj/ehl163; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Epstein LH, 1998, PEDIATRICS, V101, P554; Evans RK, 2009, INT J PEDIATR OBES, V4, P130, DOI 10.1080/17477160802314997; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Farpour-Lambert NJ, 2009, J AM COLL CARDIOL, V54, P2396, DOI 10.1016/j.jacc.2009.08.030; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Flouris AD, 2007, ARCH DIS CHILD, V92, P521, DOI 10.1136/adc.2006.099796; Freedman DS, 2008, INT J OBESITY, V32, P749, DOI 10.1038/sj.ijo.0803798; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Giannini C, 2009, EUR J ENDOCRINOL, V161, P73, DOI 10.1530/EJE-09-0042; Graf C, 2005, CARDIOL YOUNG, V15, P291, DOI 10.1017/S1047951105000594; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Hansen SE, 2005, PREV MED, V40, P740, DOI 10.1016/j.ypmed.2004.09.017; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Heneghan C, 2006, EVIDENCE BASED MED T; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; Hrafnkelsson H, 2009, SCAND J PRIM HEALTH, V27, P186, DOI 10.1080/02813430903155028; Iannuzzi A, 2004, METABOLISM, V53, P1243, DOI 10.1016/j.metabol.2004.03.023; Iannuzzi A, 2004, DIABETES CARE, V27, P2506, DOI 10.2337/diacare.27.10.2506; Jago R, 2006, PEDIATRICS, V117, P2065, DOI 10.1542/peds.2005-1716; Johnson ST, 2010, J PEDIATR-US, V156, P247, DOI 10.1016/j.jpeds.2009.08.010; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Kalarchian MA, 2009, PEDIATRICS, V124, P1060, DOI 10.1542/peds.2008-3727; Kelishadi R, 2009, PEDIATR CARDIOL, V30, P477, DOI 10.1007/s00246-009-9412-7; Kim C, 2010, DIABETES RES CLIN PR, V88, P307, DOI 10.1016/j.diabres.2010.02.005; Klasson-Heggebo L, 2006, BRIT J SPORT MED, V40, P25, DOI 10.1136/bjsm.2004.016113; Kovacs VA, 2009, ACTA PHYSIOL HUNG, V96, P337, DOI 10.1556/APhysiol.96.2009.3.7; Kriemler S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c785; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kuczmarski RJ, 2000, 314 NAT CTR HLTH STA; LAUER RM, 1992, PEDIATRICS, V89, P495; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lindquist P, 2002, J INTERN MED, V251, P484, DOI 10.1046/j.1365-2796.2002.00985.x; Lloyd LJ, 2010, INT J OBESITY, V34, P18, DOI 10.1038/ijo.2009.61; Lowry R, 2001, J SCHOOL HEALTH, V71, P145, DOI 10.1111/j.1746-1561.2001.tb01312.x; Maggio ABR, 2008, J PEDIATR-US, V152, P489, DOI 10.1016/j.jpeds.2007.10.042; McMurray RG, 2002, J ADOLESCENT HEALTH, V31, P125, DOI 10.1016/S1054-139X(02)00348-8; McPherson K, 2007, TACKLING OBESITIES F; Meyer AA, 2006, PEDIATRICS, V117, P1560, DOI 10.1542/peds.2005-2140; Mirzaei M, 2007, EUR J CARDIOV PREV R, V14, P624, DOI 10.1097/HJR.0b013e32828621c6; Morrison JA, 2012, METABOLISM, V61, P531, DOI 10.1016/j.metabol.2011.08.010; Morrison JA, 2009, METABOLISM, V58, P1277, DOI 10.1016/j.metabol.2009.04.009; National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, 2005, NIH PUBL; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Peralta-Huertas J, 2008, APPL PHYSIOL NUTR ME, V33, P1172, DOI 10.1139/H08-082; Platat C, 2006, DIABETOLOGIA, V49, P2078, DOI 10.1007/s00125-006-0320-6; Raman A, 2010, ACTA PAEDIATR, V99, P912, DOI 10.1111/j.1651-2227.2009.01639.x; Reed KE, 2008, PREV MED, V46, P525, DOI 10.1016/j.ypmed.2008.02.020; Reinehr T, 2010, CLIN NUTR, V29, P331, DOI 10.1016/j.clnu.2009.12.010; Resnicow K, 2005, OBES RES, V13, P1739, DOI 10.1038/oby.2005.212; Ribeiro JC, 2004, PREV MED, V39, P596, DOI 10.1016/j.ypmed.2004.02.023; Richey PA, 2008, J PEDIATR, V152, P343, DOI 10.1016/j.jpeds.2007.07.014; Roh EJ, 2007, J KOREAN MED SCI, V22, P192, DOI 10.3346/jkms.2007.22.2.192; Rosner B, 2009, HYPERTENSION, V54, P502, DOI 10.1161/HYPERTENSIONAHA.109.134049; Ruiz JR, 2007, PEDIATR RES, V61, P350, DOI 10.1203/pdr.0b013e318030d1bd; Sacher PM, 2010, OBESITY, V18, pS62, DOI 10.1038/oby.2009.433; Aguilar FS, 2010, J PEDIATR-US, V157, P36, DOI 10.1016/j.jpeds.2009.12.046; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Shalitin S, 2009, HORM RES, V72, P287, DOI 10.1159/000245931; Shaya FT, 2008, J SCHOOL HEALTH, V78, P189, DOI 10.1111/j.1746-1561.2008.00285.x; Simon C, 2008, INT J OBESITY, V32, P1489, DOI 10.1038/ijo.2008.99; Stabouli S, 2005, J PEDIATR-US, V147, P651, DOI 10.1016/j.jpeds.2005.06.008; Steene-Johannessen J, 2009, SCAND J CLIN LAB INV, V69, P380, DOI 10.1080/00365510802691771; Steinberger J, 2002, AM J CARDIOL, V90, P1177, DOI 10.1016/S0002-9149(02)02795-9; Suriano K, 2010, J PEDIATR-US, V157, P552, DOI 10.1016/j.jpeds.2010.04.042; Teixeira PJ, 2001, OBES RES, V9, P432, DOI 10.1038/oby.2001.57; Thomas NE, 2007, PEDIATR EXERC SCI, V19, P93, DOI 10.1123/pes.19.1.93; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; United Nations, 2010, HUM DEV REP 2010; Van Putte-Katier N, 2008, PEDIATR RES, V64, P205, DOI 10.1203/PDR.0b013e318176182b; Vizcaino VM, 2008, INT J OBESITY, V32, P12, DOI 10.1038/sj.ijo.0803738; Vizcaino VM, 2007, ACTA PAEDIATR, V96, P1338, DOI 10.1111/j.1651-2227.2007.00441.x; Watts K, 2008, J PAEDIATR CHILD H, V44, P709, DOI 10.1111/j.1440-1754.2008.01411.x; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; Woo KS, 2004, INT J OBESITY, V28, P852, DOI 10.1038/sj.ijo.0802539; Woo KS, 2004, CIRCULATION, V109, P1981, DOI 10.1161/01.CIR.0000126599.47470.BE; World Health Organization, 2011, OB OV FACTSH; Yoshinaga M, 2008, CIRC J, V72, P1594, DOI 10.1253/circj.CJ-08-0246	112	343	359	1	59	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2012	345								e4759	10.1136/bmj.e4759	http://dx.doi.org/10.1136/bmj.e4759			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014ON	23015032	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000309385500001
J	Zhang, W; Aida, T				Zhang, Wei; Aida, Takuzo			Thermally Responsive Pulsating Nanotubules	SCIENCE			English	Editorial Material									[Zhang, Wei; Aida, Takuzo] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Aida, Takuzo] Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	RIKEN; University of Tokyo	Zhang, W (corresponding author), RIKEN, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	zhangwei@riken.jp; aida@macro.t.u-tokyo.ac.jp	Aida, Takuzo/I-9117-2012					Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Hu JH, 2011, SOFT MATTER, V7, P11345, DOI 10.1039/c1sm06495a; Huang Z, 2012, SCIENCE, V337, P1521, DOI 10.1126/science.1224741; SAEKI S, 1976, POLYMER, V17, P685, DOI 10.1016/0032-3861(76)90208-1; Sicilia MC, 2005, J PHYS CHEM A, V109, P8341, DOI 10.1021/jp050530n; Unschuld Paul., 2010, MED CHINA HIST IDEAS; van Hest JCM, 2009, NATURE, V461, P45, DOI 10.1038/461045a; Yamaguchi T, 2003, J AM CHEM SOC, V125, P13934, DOI 10.1021/ja038178j	8	17	17	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1462	1463		10.1126/science.1228178	http://dx.doi.org/10.1126/science.1228178			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997314				2022-12-28	WOS:000308912900028
J	Hawrylycz, MJ; Lein, ES; Guillozet-Bongaarts, AL; Shen, EH; Ng, L; Miller, JA; van de Lagemaat, LN; Smith, KA; Ebbert, A; Riley, ZL; Abajian, C; Beckmann, CF; Bernard, A; Bertagnolli, D; Boe, AF; Cartagena, PM; Chakravarty, MM; Chapin, M; Chong, J; Dalley, RA; Daly, BD; Dang, C; Datta, S; Dee, N; Dolbeare, TA; Faber, V; Feng, D; Fowler, DR; Goldy, J; Gregor, BW; Haradon, Z; Haynor, DR; Hohmann, JG; Horvath, S; Howard, RE; Jeromin, A; Jochim, JM; Kinnunen, M; Lau, C; Lazarz, ET; Lee, C; Lemon, TA; Li, L; Li, Y; Morris, JA; Overly, CC; Parker, PD; Parry, SE; Reding, M; Royall, JJ; Schulkin, J; Sequeira, PA; Slaughterbeck, CR; Smith, SC; Sodt, AJ; Sunkin, SM; Swanson, BE; Vawter, MP; Williams, D; Wohnoutka, P; Zielke, HR; Geschwind, DH; Hof, PR; Smith, SM; Koch, C; Grant, SGN; Jones, AR				Hawrylycz, Michael J.; Lein, Ed S.; Guillozet-Bongaarts, Angela L.; Shen, Elaine H.; Ng, Lydia; Miller, Jeremy A.; van de lagemaat, Louie N.; Smith, Kimberly A.; Ebbert, Amanda; Riley, Zackery L.; Abajian, Chris; Beckmann, Christian F.; Bernard, Amy; Bertagnolli, Darren; Boe, Andrew F.; Cartagena, Preston M.; Chakravarty, M. Mallar; Chapin, Mike; Chong, Jimmy; Dalley, Rachel A.; Daly, Barry David; Dang, Chinh; Datta, Suvro; Dee, Nick; Dolbeare, Tim A.; Faber, Vance; Feng, David; Fowler, David R.; Goldy, Jeff; Gregor, Benjamin W.; Haradon, Zeb; Haynor, David R.; Hohmann, John G.; Horvath, Steve; Howard, Robert E.; Jeromin, Andreas; Jochim, Jayson M.; Kinnunen, Marty; Lau, Christopher; Lazarz, Evan T.; Lee, Changkyu; Lemon, Tracy A.; Li, Ling; Li, Yang; Morris, John A.; Overly, Caroline C.; Parker, Patrick D.; Parry, Sheana E.; Reding, Melissa; Royall, Joshua J.; Schulkin, Jay; Sequeira, Pedro Adolfo; Slaughterbeck, Clifford R.; Smith, Simon C.; Sodt, Andy J.; Sunkin, Susan M.; Swanson, Beryl E.; Vawter, Marquis P.; Williams, Derric; Wohnoutka, Paul; Zielke, H. Ronald; Geschwind, Daniel H.; Hof, Patrick R.; Smith, Stephen M.; Koch, Christof; Grant, Seth G. N.; Jones, Allan R.			An anatomically comprehensive atlas of the adult human brain transcriptome	NATURE			English	Article							LISTS	Neuroanatomically precise, genome-wide maps of transcript distributions are critical resources to complement genomic sequence data and to correlate functional and genetic brain architecture. Here we describe the generation and analysis of a transcriptional atlas of the adult human brain, comprising extensive histological analysis and comprehensive microarray profiling of similar to 900 neuroanatomically precise subdivisions in two individuals. Transcriptional regulation varies enormously by anatomical location, with different regions and their constituent cell types displaying robust molecular signatures that are highly conserved between individuals. Analysis of differential gene expression and gene co-expression relationships demonstrates that brain-wide variation strongly reflects the distributions of major cell classes such as neurons, oligodendrocytes, astrocytes and microglia. Local neighbourhood relationships between fine anatomical subdivisions are associated with discrete neuronal subtypes and genes involved with synaptic transmission. The neocortex displays a relatively homogeneous transcriptional pattern, but with distinct features associated selectively with primary sensorimotor cortices and with enriched frontal lobe expression. Notably, the spatial topography of the neocortex is strongly reflected in its molecular topography-the closer two cortical regions, the more similar their transcriptomes. This freely accessible online data resource forms a high-resolution transcriptional baseline for neurogenetic studies of normal and abnormal human brain function.	[Hawrylycz, Michael J.; Lein, Ed S.; Guillozet-Bongaarts, Angela L.; Shen, Elaine H.; Ng, Lydia; Miller, Jeremy A.; Smith, Kimberly A.; Ebbert, Amanda; Riley, Zackery L.; Abajian, Chris; Bernard, Amy; Bertagnolli, Darren; Boe, Andrew F.; Chakravarty, M. Mallar; Chapin, Mike; Chong, Jimmy; Dalley, Rachel A.; Dang, Chinh; Datta, Suvro; Dee, Nick; Dolbeare, Tim A.; Faber, Vance; Feng, David; Goldy, Jeff; Gregor, Benjamin W.; Haradon, Zeb; Hohmann, John G.; Howard, Robert E.; Jochim, Jayson M.; Kinnunen, Marty; Lau, Christopher; Lazarz, Evan T.; Lee, Changkyu; Lemon, Tracy A.; Li, Yang; Morris, John A.; Overly, Caroline C.; Parker, Patrick D.; Parry, Sheana E.; Reding, Melissa; Royall, Joshua J.; Slaughterbeck, Clifford R.; Sodt, Andy J.; Sunkin, Susan M.; Swanson, Beryl E.; Williams, Derric; Wohnoutka, Paul; Koch, Christof; Jones, Allan R.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [van de lagemaat, Louie N.; Grant, Seth G. N.] Univ Edinburgh, Genes Cognit Programme, Edinburgh EH16 4SB, Midlothian, Scotland; [Beckmann, Christian F.] Univ Twente, MIRA Inst, Nijmegen, Netherlands; [Beckmann, Christian F.] Radboud Univ Nijmegen, Donders Inst, NL-6525 ED Nijmegen, Netherlands; [Cartagena, Preston M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Chakravarty, M. Mallar] Ctr Addict & Mental Hlth Toronto, Kimel Family Translat Imaging Genet Lab, Toronto, ON M5S 2S1, Canada; [Daly, Barry David] Univ Maryland, Sch Med, Dept Diagnost Radiol, Med Ctr, Baltimore, MD 21201 USA; [Fowler, David R.] Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA; [Haynor, David R.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda Res Ctr, Los Angeles, CA 90095 USA; [Jeromin, Andreas] Banyan Biomarkers Inc, Alachua, FL 32615 USA; [Li, Ling] Off Chief Med Examiner, Baltimore, MD USA; [Li, Ling] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; [Schulkin, Jay] Georgetown Univ, Sch Med, Dept Neurosci, Washington, DC 20007 USA; [Sequeira, Pedro Adolfo; Vawter, Marquis P.] Univ Calif Irvine, Funct Genom Lab, Dept Psychiat & Human Behav, Sch Med, Irvine, CA 92697 USA; [Smith, Simon C.] Histion LLC, Everett, WA 98204 USA; [Zielke, H. Ronald] Univ Maryland, Eunice Kennedy Shriver NICHD Brain & Tissue Bank, Baltimore, MD 21201 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Smith, Stephen M.] Univ Oxford, FMRIB, Oxford OX3 9DU, England; [Koch, Christof] CALTECH, Pasadena, CA 91125 USA	Allen Institute for Brain Science; University of Edinburgh; Radboud University Nijmegen; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Banyan Biomarkers Inc.; University System of Maryland; University of Maryland Baltimore; Georgetown University; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford; California Institute of Technology	Hawrylycz, MJ (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	mikeh@alleninstitute.org	Sequeira, Adolfo/K-7278-2015; Beckmann, Christian F./E-6374-2012	Sequeira, Adolfo/0000-0003-3040-1190; Beckmann, Christian F./0000-0002-3373-3193; Feng, David/0000-0002-4920-8123; Koch, Christof/0000-0001-6482-8067; Smith, Stephen/0000-0001-8166-069X; Grant, Seth/0000-0001-8732-8735; Bernard, Amy/0000-0003-2540-1153; Dee, Nick/0000-0002-2831-9254; Parker, Patrick/0000-0001-5217-107X; Arnold, James/0000-0001-7011-591X	Department of Health and Human Services Health Resources and Services Administration Awards [1C76HF15069-01-00, 1 1C76HF19619-01-00]; MRCD; Wellcome Trust; European Union Seventh Framework Programme [241498 EUROSPIN, 242167 SynSys, 241995 GENCODYS]; MRC [G0802238, G0700399] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233, R01MH085801] Funding Source: NIH RePORTER; Medical Research Council [G0700399, G0802238] Funding Source: researchfish	Department of Health and Human Services Health Resources and Services Administration Awards; MRCD(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union Seventh Framework Programme(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank the Allen Institute founders, P. G. Allen and J. Allen, for their vision, encouragement, and support. We express our gratitude to past and present Allen Institute staff members R. Adams, K. Aiona, A. Alpisa, J. Arnold, C. Bennet, K. Brouner, S. Butler, E. Byrnes, S. Caldejon, J. Campiche, A. Carey, J. Chen, C. Copeland, C. Cuhaciyan, T. Desta, N. Dotson, S. Faber, T. Fliss, E. Fulfs, G. Gee, T. Gilbert, L. Gourley, G. Gu, J. Heilman, N. Ivanov, K. Keyser, A. Kriedberg, J. Laoenkue, F. Lee, S. Levine, L. Luong, N. Mastan, N. Mosqueda, E. Mott, N. Motz, D. Muzia, K. Ngo, A. Oldre, E. Olson, J. Parente, J. Phillips, L. Potekhina, T. Roberts, K. Roll, D. Rosen, M. Sarreal, S. Shapouri, N. Shapovalova, C. Simpson, D. Simpson, M. Smith, N. Stewart, K. Sweeney, A. Szafer, L. Velasquez, U. Wagley, W. Wakeman, C. White and B. Youngstrom for their technical assistance. We thank C. Long for mechanical engineering contract work. We thank R. Gullapalli, A. McMillan and R. Morales for post-mortem magnetic resonance imaging and radiology interpretation of MR data; J. Cottrell, M. Davis, R. Johnson, K. Moraniec, R. Vigorito, A. Weldon and the NICHD Brain and Tissue Bank for Developmental Disorders for tissue acquisition and processing; J. Davis for donor coordination; F. Mamdani, M. Martin, E. Moon, L. Morgan, B. Rollins and D. Walsh for tissue processing and psychological autopsy (DW); D. Patel for magnetic resonance imaging; and J. Sonnen for consultation on tissue microneuropathology. We also thank the External RNA Controls Consortium (ERCC), the US National Institute of Standards (NIST) and Technology, and M. Salit for access to ERCC transcripts during Phase V testing. We are grateful to Beckman Coulter Genomics (formerly Cogenics) and their staff P. Hurban, E. Lobenhofer, K. Phillips, A. Rouse and S. Beaver for microarray data generation and design of the custom Agilent array. We also wish to thank the Allen Human Brain Atlas Advisory Council members D. Geschwind, R. Gibbs, P. Hof, E. Jones, C. Koch, C. Saper, L. Swanson, A. Toga and D. Van Essen for their scientific guidance and dedication to the successful execution of this project. The project described was supported in part by Grant Numbers 1C76HF15069-01-00 and 1 1C76HF19619-01-00 from the Department of Health and Human Services Health Resources and Services Administration Awards and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services Health Resources and Services Administration Awards. S. G. N. G and L. V. L. were supported by the MRCD, Wellcome Trust and European Union Seventh Framework Programme under grants 241498 EUROSPIN, 242167 SynSys, and 241995 GENCODYS Projects.	Amaral D. G., 1990, HUMAN NERVOUS SYSTEM, P771; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bentivoglio M, 2005, HAND CHEM N, V21, P1; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; DeFelipe J., 1988, CAJAL CEREBRAL CORTE; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hawrylycz M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001065; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; HOF PR, 1995, J COMP NEUROL, V362, P109, DOI 10.1002/cne.903620107; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd Y. L., 2005, HDB CHEM NEUROANATOM, P525; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zilles K, 2002, EUR NEUROPSYCHOPHARM, V12, P587, DOI 10.1016/S0924-977X(02)00108-6	35	1401	1418	9	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					391	399		10.1038/nature11405	http://dx.doi.org/10.1038/nature11405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996553	Green Accepted			2022-12-28	WOS:000308860900037
J	Phillips, R; Hancock, B; Graham, J; Bromham, N; Jin, HJ; Berendse, S				Phillips, Robert; Hancock, Barry; Graham, John; Bromham, Nathan; Jin, Huajie; Berendse, Sabine			Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Graham, John; Bromham, Nathan; Jin, Huajie; Berendse, Sabine] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Phillips, Robert] Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; [Hancock, Barry] Univ Sheffield, Weston Pk Hosp, Sheffield S10 2SJ, S Yorkshire, England; [Graham, John] Taunton & Somerset NHS Fdn Trust, Taunton TA1 5DA, Somerset, England	Leeds General Infirmary; University of Leeds; University of Sheffield; Weston Park Hospital	Graham, J (corresponding author), Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales.	john.graham@nhs.net	; Jin, Huajie/J-1332-2014	Graham, John/0000-0003-3381-9787; Jin, Huajie/0000-0002-3872-3998; Bromham, Nathan/0000-0003-2165-4188	MRC [G0800472] Funding Source: UKRI; Medical Research Council [G0800472] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dommett R, 2009, EUR J CANCER, V45, P2843, DOI 10.1016/j.ejca.2009.06.003; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; National Cancer Action Team, 2011, MAN CANC SERV AC ONC; National Chemotherapy Advisory Group, 2010, CHEM SERV ENGL ENS Q; National Confidential Enquiry into Patient Outcome and Death, 2008, SYST ANT THER BETT W; National Institute of Health and Clinical Excellence, 2012, NEUTR SEPS PREV MAN	7	36	37	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 19	2012	345								e5368	10.1136/bmj.e5368	http://dx.doi.org/10.1136/bmj.e5368			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JI	22993392	Green Submitted			2022-12-28	WOS:000309160500001
J	Kirby, T				Kirby, Tony			Kerin O'Dea: improving the health of Indigenous Australians	LANCET			English	Biographical-Item												tony@tonykirby.com						ODEA K, PUBLICATION LIST	1	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					967	967		10.1016/S0140-6736(12)61525-6	http://dx.doi.org/10.1016/S0140-6736(12)61525-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22981105	Green Submitted			2022-12-28	WOS:000308746000015
J	Franchi, L; Nunez, G				Franchi, Luigi; Nunez, Gabriel			Orchestrating Inflammasomes	SCIENCE			English	Editorial Material							III SECRETION APPARATUS; INNATE IMMUNE RECEPTOR; NLRC4 INFLAMMASOME; HOST TARGET; ACTIVATION; FLAGELLIN; INTERLEUKIN-1-BETA; RECOGNITION; CASPASE-1; IPAF		[Franchi, Luigi] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Comprehens Canc Ctr, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Franchi, L (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK091191] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	13	51	52	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1299	1300		10.1126/science.1229010	http://dx.doi.org/10.1126/science.1229010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984056	Green Accepted			2022-12-28	WOS:000308705000026
J	Tischer, T; Hormanseder, E; Mayer, TU				Tischer, Thomas; Hoermanseder, Eva; Mayer, Thomas U.			The APC/C Inhibitor XErp1/Emi2 Is Essential for Xenopus Early Embryonic Divisions	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CYTOSTATIC FACTOR ARREST; MEIOTIC ARREST; CELL-CYCLE; GREATWALL KINASE; PHOSPHATASE 2A; LAEVIS EGGS; PHOSPHORYLATION; EMI2; MITOSIS	Mitotic divisions result from the oscillating activity of cyclin-dependent kinase 1 (Cdk1). Cdk1 activity is terminated by the anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase that targets cyclin B for destruction. In somatic divisions, the early mitotic inhibitor 1 (Emi1) and the spindle assembly checkpoint (SAC) regulate cell cycle progression by inhibiting the APC/C. Early embryonic divisions lack these APC/C-inhibitory components, which raises the question of how those cycles are controlled. We found that the APC/C-inhibitory activity of XErp1 (also known as Emi2) was essential for early divisions in Xenopus embryos. Loss of XErp1 resulted in untimely destruction of APC/C substrates and embryonic lethality. XErp1's APC/C-inhibitory function was negatively regulated by Cdk1 and positively by protein phosphatase 2A (PP2A). Thus, Cdk1 and PP2A operate at the core of early mitotic cell cycles by antagonistically controlling XErp1 activity, which results in oscillating APC/C activity.	[Mayer, Thomas U.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz	Mayer, TU (corresponding author), Univ Konstanz, Dept Biol, Univ Str 10, D-78457 Constance, Germany.	thomas.u.mayer@uni-konstanz.de		Tischer, Thomas/0000-0002-6845-2762; Mayer, Thomas/0000-0001-6954-2287; Hormanseder, Eva/0000-0003-0340-6340	Austrian Academy of Science; Collaborative Research Center 969 of the German Research Foundation (DFG)	Austrian Academy of Science; Collaborative Research Center 969 of the German Research Foundation (DFG)	We thank D. Bertinetti, A. Burkle, J. Gannon, T. Hunt, F. W. Herberg, T. Lorca, S. Mochida, and N. Sagata for reagents; the team of D. Schopper and G. Mende for excellent animal care; and the Mayer group and B. Novak for discussions. The authors declare no competing financial interests. Supported by the Doc-fForte program of the Austrian Academy of Science and by the Collaborative Research Center 969 of the German Research Foundation (DFG).	ASHBY CD, 1973, J BIOL CHEM, V248, P1255; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CLUTE P, 1992, DEV GROWTH DIFFER, V34, P27; Duncan T, 2004, CURR BIOL, V14, pR305, DOI 10.1016/j.cub.2004.03.050; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Hartley RS, 1996, DEV BIOL, V173, P408, DOI 10.1006/dbio.1996.0036; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Isoda M, 2011, DEV CELL, V21, P506, DOI 10.1016/j.devcel.2011.06.029; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; Liu JJ, 2006, J BIOL CHEM, V281, P34736, DOI 10.1074/jbc.M606607200; Maller JL, 2001, NOVART FDN SYMP, V237, P58, DOI 10.1002/0470846666.ch6; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022	22	33	33	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					520	524		10.1126/science.1228394	http://dx.doi.org/10.1126/science.1228394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23019610	Green Submitted			2022-12-28	WOS:000310195800056
J	Farago, M; Rosenbluh, C; Tevlin, M; Fraenkel, S; Schlesinger, S; Masika, H; Gouzman, M; Teng, G; Schatz, D; Rais, Y; Hanna, JH; Mildner, A; Jung, S; Mostoslavsky, G; Cedar, H; Bergman, Y				Farago, Marganit; Rosenbluh, Chaggai; Tevlin, Maya; Fraenkel, Shira; Schlesinger, Sharon; Masika, Hagit; Gouzman, Masha; Teng, Grace; Schatz, David; Rais, Yoach; Hanna, Jacob H.; Mildner, Alexander; Jung, Steffen; Mostoslavsky, Gustavo; Cedar, Howard; Bergman, Yehudit			Clonal allelic predetermination of immunoglobulin-kappa rearrangement	NATURE			English	Article							B-CELL DEVELOPMENT; ASYNCHRONOUS REPLICATION; IN-VITRO; MATURE B; GENES; EXPRESSION; TRANSCRIPTION; INACTIVATION; LYSINE-4; MICE	Although most genes are expressed biallelically, a number of key genomic sites-including immune and olfactory receptor regions-are controlled monoallelically in a stochastic manner, with some cells expressing the maternal allele and others the paternal allele in the target tissue(1,2). Very little is known about how this phenomenon is regulated and programmed during development. Here, using mouse immunoglobulin-kappa (Ig kappa) as a model system, we demonstrate that although individual haematopoietic stem cells are characterized by allelic plasticity, early lymphoid lineage cells become committed to the choice of a single allele, and this decision is then stably maintained in a clonal manner that predetermines monoallelic rearrangement in B cells. This is accompanied at the molecular level by underlying allelic changes in asynchronous replication timing patterns at the kappa locus. These experiments may serve to define a new concept of stem cell plasticity.	[Farago, Marganit; Rosenbluh, Chaggai; Tevlin, Maya; Fraenkel, Shira; Schlesinger, Sharon; Masika, Hagit; Gouzman, Masha; Cedar, Howard; Bergman, Yehudit] Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Teng, Grace; Schatz, David] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Schatz, David] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Rais, Yoach; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Mildner, Alexander; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Dept Med, Boston, MA 02118 USA	Hebrew University of Jerusalem; Yale University; Howard Hughes Medical Institute; Yale University; Weizmann Institute of Science; Weizmann Institute of Science; Boston University	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, POB 12272, IL-91120 Jerusalem, Israel.	cedar@mail.huji.ac.il; Yehudit.Bergman@huji.ac.il	mildner, alexander/AFK-2161-2022; Hanna, Jacob/K-1339-2012; Mildner, Alexander/ABG-6122-2020; mildner, alexander/GQA-3761-2022; mildner, alexander/AAF-9451-2022; Schatz, David/A-6748-2013; Jung, Steffen/K-1409-2012; Schlesinger, Sharon/A-5283-2016	mildner, alexander/0000-0002-2019-8427; Hanna, Jacob/0000-0003-2042-9974; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Schatz, David/0000-0002-5669-1176; Jung, Steffen/0000-0003-4290-5716; Schlesinger, Sharon/0000-0001-9549-2383; Mostoslavsky, Gustavo/0000-0002-0784-2169	Israel Academy of Sciences; National Institutes of Health; Israel Cancer Research Foundation; European Community	Israel Academy of Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Cancer Research Foundation; European Community(European Commission)	We thank M. Nussenzweig for providing the Ig kappa<SUP>m/h</SUP> mice, A. Waisman for providing the IiMOG-marked ES cells, A. G. Fisher and V. Azuara for guiding us through the replication timing analysis by S-phase fractionation assay, M. Inlay for coaching us on the purification and culturing of MPPs and CLPs, A. Wutz for providing some of the single-cell clones, Y. Smith for image analysis and L. Dempsey for sharing ideas. This work was supported by research grants from the Israel Academy of Sciences (H.C., Y.B.), National Institutes of Health (Y.B.), the Israel Cancer Research Foundation (H.C., Y.B.), the European Community 5th Framework Quality of Life Program (Y.B.), Lew Sanders (H.C.) and Norton Herrick (H.C.).	Alexander MK, 2007, J CELL BIOL, V179, P269, DOI 10.1083/jcb.200706053; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Fitzsimmons SP, 2007, J IMMUNOL, V179, P5264, DOI 10.4049/jimmunol.179.8.5264; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Goren A, 2003, NAT REV MOL CELL BIO, V4, P25, DOI 10.1038/nrm1008; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gribnau J, 2005, J CELL BIOL, V168, P365, DOI 10.1083/jcb.200405117; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Ikawa M, 1999, CURR TOP DEV BIOL, V44, P1; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Lande-Diner L, 2005, NAT REV GENET, V6, P648, DOI 10.1038/nrg1639; Lande-Diner L, 2009, MOL CELL, V34, P767, DOI 10.1016/j.molcel.2009.05.027; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Liu XD, 1999, MOL IMMUNOL, V36, P461, DOI 10.1016/S0161-5890(99)00065-6; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150	36	34	34	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					561	+		10.1038/nature11496	http://dx.doi.org/10.1038/nature11496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023124				2022-12-28	WOS:000310196200047
J	Yoshiba, S; Shiratori, H; Kuo, IY; Kawasumi, A; Shinohara, K; Nonaka, S; Asai, Y; Sasaki, G; Belo, JA; Sasaki, H; Nakai, J; Dworniczak, B; Ehrlich, BE; Pennekamp, P; Hamada, H				Yoshiba, Satoko; Shiratori, Hidetaka; Kuo, Ivana Y.; Kawasumi, Aiko; Shinohara, Kyosuke; Nonaka, Shigenori; Asai, Yasuko; Sasaki, Genta; Belo, Jose Antonio; Sasaki, Hiroshi; Nakai, Junichi; Dworniczak, Bernd; Ehrlich, Barbara E.; Pennekamp, Petra; Hamada, Hiroshi			Cilia at the Node of Mouse Embryos Sense Fluid Flow for Left-Right Determination via Pkd2	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; POLYCYSTIN-2; MICE; EXPRESSION; RELEASE; LACKING; KIF3A	Unidirectional fluid flow plays an essential role in the breaking of left-right (L-R) symmetry in mouse embryos, but it has remained unclear how the flow is sensed by the embryo. We report that the Ca2+ channel Polycystin-2 (Pkd2) is required specifically in the perinodal crown cells for sensing the nodal flow. Examination of mutant forms of Pkd2 shows that the ciliary localization of Pkd2 is essential for correct L-R patterning. Whereas Kif3a mutant embryos, which lack all cilia, failed to respond to an artificial flow, restoration of primary cilia in crown cells rescued the response to the flow. Our results thus suggest that nodal flow is sensed in a manner dependent on Pkd2 by the cilia of crown cells located at the edge of the node.	[Dworniczak, Bernd; Pennekamp, Petra] Univ Klinikum Munster, Inst Humangenet, D-48149 Munster, Germany; [Pennekamp, Petra] Univ Klinikum Muenster, Klin Kinder & Jugendmed, D-48149 Munster, Germany; [Yoshiba, Satoko; Shiratori, Hidetaka; Kawasumi, Aiko; Shinohara, Kyosuke; Asai, Yasuko; Sasaki, Genta; Hamada, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; [Yoshiba, Satoko; Shiratori, Hidetaka; Kawasumi, Aiko; Shinohara, Kyosuke; Asai, Yasuko; Sasaki, Genta; Hamada, Hiroshi] Japan Sci & Technol Corp JST, Japan Sci & Technol Agcy CREST, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; [Kuo, Ivana Y.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Nonaka, Shigenori] Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 4448585, Japan; [Belo, Jose Antonio] Univ Algarve, Regenerat Med Program, Dept Ciencias Biomed & Med, P-8005135 Faro, Portugal; [Belo, Jose Antonio] Univ Algarve, IBB Inst Biotechnol & Bioengn, P-8005135 Faro, Portugal; [Sasaki, Hiroshi] RIKEN Ctr Dev Biol, Lab Embryon Induct, Kobe, Hyogo 6500047, Japan; [Nakai, Junichi] Saitama Univ, Brain Sci Inst, Sakura Ku, Saitama 3388570, Japan	University of Munster; University of Munster; Osaka University; Japan Science & Technology Agency (JST); Yale University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Universidade do Algarve; Universidade do Algarve; RIKEN; Saitama University	Pennekamp, P (corresponding author), Univ Klinikum Munster, Inst Humangenet, Vesaliusweg 12-14, D-48149 Munster, Germany.	petra.pennekamp@uni-muenster.de; hamada@fbs.osaka-u.ac.jp	Shinohara, Kyosuke/AAU-2471-2020; Nakai, Junichi/GQZ-6415-2022; Belo, José A. A/F-4444-2012; Yoshiba, Satoko/AAD-1546-2019; Shinohara, Kyosuke/I-1470-2016; Hamada, Hiroshi/N-6374-2015; Sasaki, Hiroshi/AAY-5939-2020; Kawasumi, Aiko/D-1324-2017; Nonaka, Shigenori/I-2132-2013; /AAX-8408-2021	Shinohara, Kyosuke/0000-0002-6350-1684; Belo, José A. A/0000-0001-7384-0949; Hamada, Hiroshi/0000-0002-7196-5948; Sasaki, Hiroshi/0000-0001-8752-6846; Kawasumi, Aiko/0000-0002-8118-8548; Nonaka, Shigenori/0000-0002-8093-0325; /0000-0001-9657-9704; Yoshiba, Satoko/0000-0002-9415-3619; Kuo, Ivana/0000-0002-9867-2408	CREST of the Japan Science and Technology Corporation; NIH [P30 DK090744]; Human Frontier Science Program [ST00246/2003C]; Deutsche Forschungsgemeinschaft [PE 853/2]; Japan Society for the Promotion of Science; American Heart Association [R10682]; Grants-in-Aid for Scientific Research [24113004, 22770215] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087844, P30DK090744, P50DK057328] Funding Source: NIH RePORTER	CREST of the Japan Science and Technology Corporation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association(American Heart Association); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Cai for YCB9 antibodies to Pkd2; S. Somlo for very helpful comments on Pkd2 function; D. P. Norris for Pkd1l1-CC-GFP plasmid; and A. Fukumoto, Y. Ikawa, K. Miyama, K. Mochida, H. Nishimura, and S. Ohishi for technical assistance. This work was supported by a grant from CREST of the Japan Science and Technology Corporation to H. H., an NIH grant P30 DK090744 to B. E. E., and Human Frontier Science Program grant ST00246/2003C and the Deutsche Forschungsgemeinschaft grant PE 853/2 to P. P. S. Y. was supported by a fellowship from the Japan Society for the Promotion of Science for Japanese Junior Scientists. I. Y. K. was supported by the American Heart Association Postdoctoral Fellowship R10682.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Ermakov A, 2009, DEV DYNAM, V238, P581, DOI 10.1002/dvdy.21874; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hirokawa N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000802; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tanaka C, 2007, GENE DEV, V21, P3272, DOI 10.1101/gad.1623907; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494	27	198	208	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					226	231		10.1126/science.1222538	http://dx.doi.org/10.1126/science.1222538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22983710	Green Submitted, Green Accepted			2022-12-28	WOS:000309712300038
J	van Loenhout, MTJ; de Grunt, MV; Dekker, C				van Loenhout, M. T. J.; de Grunt, M. V.; Dekker, C.			Dynamics of DNA Supercoils	SCIENCE			English	Article							DOUBLE-STRANDED DNA; FLUCTUATIONS; RESOLVASE; MOLECULES; SYNAPSIS; FORCE	DNA in cells exhibits a supercoiled state in which the double helix is additionally twisted to form extended intertwined loops called plectonemes. Although supercoiling is vital to many cellular processes, its dynamics remain elusive. In this work, we directly visualize the dynamics of individual plectonemes. We observe that multiple plectonemes can be present and that their number depends on applied stretching force and ionic strength. Plectonemes moved along DNA by diffusion or, unexpectedly, by a fast hopping process that facilitated very rapid (<20 milliseconds) long-range plectoneme displacement by nucleating a new plectoneme at a distant position. These observations directly reveal the dynamics of plectonemes and identify a mode of movement that allows long-distance reorganization of the conformation of the genome on a millisecond time scale.	[van Loenhout, M. T. J.; de Grunt, M. V.; Dekker, C.] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	c.dekker@tudelft.nl		Dekker, Cees/0000-0001-6273-071X	European Research Council [247072]	European Research Council(European Research Council (ERC)European Commission)	We thank M. Emanuel and H. Schiessel for discussions on plectoneme energetics, I. De Vlaminck for discussions, D. van der Vlies for experimental assistance, S. Hage and B. Cross for DNA constructs, and J. van der Does for mechanical modifications to the magnetic tweezers. This work has been supported in part by the European Research Council research grant NanoforBio (no. 247072).	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Bao XR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265506; BOLES TC, 1990, J MOL BIOL, V213, P931, DOI 10.1016/S0022-2836(05)80272-4; Brutzer H, 2010, BIOPHYS J, V98, P1267, DOI 10.1016/j.bpj.2009.12.4292; De Vlaminck I, 2010, NUCLEIC ACIDS RES, V38, P4133, DOI 10.1093/nar/gkq067; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; LAUNDON CH, 1988, CELL, V52, P545, DOI 10.1016/0092-8674(88)90467-9; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MARKO JF, 1994, SCIENCE, V265, P506, DOI 10.1126/science.8036491; Marko JF, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011908; Neukirch S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.138104; Oram M, 1997, J MOL BIOL, V270, P396, DOI 10.1006/jmbi.1997.1109; PARKER CN, 1991, CELL, V66, P781, DOI 10.1016/0092-8674(91)90121-E; Roca J, 2011, CHROMOSOMA, V120, P323, DOI 10.1007/s00412-011-0324-y; STIGTER D, 1977, BIOPOLYMERS, V16, P1435, DOI 10.1002/bip.1977.360160705; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; VOLOGODSKII AV, 1992, J MOL BIOL, V227, P1224, DOI 10.1016/0022-2836(92)90533-P; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Zuccheri G, 1998, APPL PHYS A-MATER, V66, pS585, DOI 10.1007/s003390051206; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	23	133	134	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					94	97		10.1126/science.1225810	http://dx.doi.org/10.1126/science.1225810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22983709				2022-12-28	WOS:000309457400060
J	Kaptoge, S; Di Angelantonio, E; Pennells, L; Wood, AM; White, IR; Gao, P; Walker, M; Thompson, A; Sarwar, N; Caslake, M; Butterworth, AS; Amouyel, P; Assmann, G; Bakker, SJL; Barr, ELM; Barrett-Connor, E; Benjamin, EJ; Bjorkelund, C; Brenner, H; Brunner, E; Clarke, R; Cooper, JA; Cremer, P; Cushman, M; Dagenais, GR; D'Agostino, RB; Dankner, R; Davey-Smith, G; Deeg, D; Dekker, JM; Engstrom, G; Folsom, AR; Fowkes, FGR; Gallacher, J; Gaziano, JM; Giampaoli, S; Gillum, RF; Hofman, A; Howard, BV; Ingelsson, E; Iso, H; Jorgensen, T; Kiechl, S; Kitamura, A; Kiyohara, Y; Koenig, W; Kromhout, D; Kuller, LH; Lawlor, DA; Meade, TW; Nissinen, A; Nordestgaard, BG; Onat, A; Panagiotakos, DB; Psaty, BM; Rodriguez, B; Rosengren, A; Salomaa, V; Kauhanen, J; Salonen, JT; Shaffer, JA; Shea, S; Ford, I; Stehouwer, CDA; Strandberg, TE; Tipping, RW; Tosetto, A; Wassertheil-Smoller, S; Wennberg, P; Westendorp, RG; Whincup, PH; Wilhelmsen, L; Woodward, M; Lowe, GDO; Wareham, NJ; Khaw, KT; Sattar, N; Packard, CJ; Gudnason, V; Ridker, PM; Pepys, MB; Thompson, SG; Danesh, J				Kaptoge, Stephen; Di Angelantonio, Emanuele; Pennells, Lisa; Wood, Angela M.; White, Ian R.; Gao, Pei; Walker, Matthew; Thompson, Alexander; Sarwar, Nadeem; Caslake, Muriel; Butterworth, Adam S.; Amouyel, Philippe; Assmann, Gerd; Bakker, Stephan J. L.; Barr, Elizabeth L. M.; Barrett-Connor, Elizabeth; Benjamin, Emelia J.; Bjorkelund, Cecilia; Brenner, Hermann; Brunner, Eric; Clarke, Robert; Cooper, Jackie A.; Cremer, Peter; Cushman, Mary; Dagenais, Gilles R.; D'Agostino, Ralph B., Sr.; Dankner, Rachel; Davey-Smith, George; Deeg, Dorly; Dekker, Jacqueline M.; Engstrom, Gunnar; Folsom, Aaron R.; Fowkes, F. Gerry R.; Gallacher, John; Gaziano, J. Michael; Giampaoli, Simona; Gillum, Richard F.; Hofman, Albert; Howard, Barbara V.; Ingelsson, Erik; Iso, Hiroyasu; Jorgensen, Torben; Kiechl, Stefan; Kitamura, Akihiko; Kiyohara, Yutaka; Koenig, Wolfgang; Kromhout, Daan; Kuller, Lewis H.; Lawlor, Debbie A.; Meade, Tom W.; Nissinen, Aulikki; Nordestgaard, Borge G.; Onat, Altan; Panagiotakos, Demosthenes B.; Psaty, Bruce M.; Rodriguez, Beatriz; Rosengren, Annika; Salomaa, Veikko; Kauhanen, Jussi; Salonen, Jukka T.; Shaffer, Jonathan A.; Shea, Steven; Ford, Ian; Stehouwer, Coen D. A.; Strandberg, Timo E.; Tipping, Robert W.; Tosetto, Alberto; Wassertheil-Smoller, Sylvia; Wennberg, Patrik; Westendorp, Rudi G.; Whincup, Peter H.; Wilhelmsen, Lars; Woodward, Mark; Lowe, Gordon D. O.; Wareham, Nicholas J.; Khaw, Kay-Tee; Sattar, Naveed; Packard, Chris J.; Gudnason, Vilmundur; Ridker, Paul M.; Pepys, Mark B.; Thompson, Simon G.; Danesh, John		Emerging Risk Factors	C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; COST-EFFECTIVENESS; RISK PROFILE; GUIDELINES; INFLAMMATION; ASSOCIATION; CARE	Background There is debate about the value of assessing levels of C-reactive protein (CRP) and other biomarkers of inflammation for the prediction of first cardiovascular events. Methods We analyzed data from 52 prospective studies that included 246,669 participants without a history of cardiovascular disease to investigate the value of adding CRP or fibrinogen levels to conventional risk factors for the prediction of cardiovascular risk. We calculated measures of discrimination and reclassification during follow-up and modeled the clinical implications of initiation of statin therapy after the assessment of CRP or fibrinogen. Results The addition of information on high-density lipoprotein cholesterol to a prognostic model for cardiovascular disease that included age, sex, smoking status, blood pressure, history of diabetes, and total cholesterol level increased the C-index, a measure of risk discrimination, by 0.0050. The further addition to this model of information on CRP or fibrinogen increased the C-index by 0.0039 and 0.0027, respectively (P < 0.001), and yielded a net reclassification improvement of 1.52% and 0.83%, respectively, for the predicted 10-year risk categories of "low" (< 10%), " intermediate" (10% to < 20%), and "high" (>= 20%) (P < 0.02 for both comparisons). We estimated that among 100,000 adults 40 years of age or older, 15,025 persons would initially be classified as being at intermediate risk for a cardiovascular event if conventional risk factors alone were used to calculate risk. Assuming that statin therapy would be initiated in accordance with Adult Treatment Panel III guidelines (i.e., for persons with a predicted risk of >= 20% and for those with certain other risk factors, such as diabetes, irrespective of their 10-year predicted risk), additional targeted assessment of CRP or fibrinogen levels in the 13,199 remaining participants at intermediate risk could help prevent approximately 30 additional cardiovascular events over the course of 10 years. Conclusions In a study of people without known cardiovascular disease, we estimated that under current treatment guidelines, assessment of the CRP or fibrinogen level in people at intermediate risk for a cardiovascular event could help prevent one additional event over a period of 10 years for every 400 to 500 people screened. (Funded by the British Heart Foundation and others.)	[Kaptoge, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 8RN, England; [White, Ian R.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Caslake, Muriel; Ford, Ian; Lowe, Gordon D. O.; Sattar, Naveed; Packard, Chris J.] Univ Glasgow, Glasgow, Lanark, Scotland; [Amouyel, Philippe] Inst Pasteur, Lille, France; [Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Bakker, Stephan J. L.] Univ Groningen, Groningen, Netherlands; [Barrett-Connor, Elizabeth] Univ Calif San Diego, San Diego, CA 92103 USA; [Benjamin, Emelia J.; D'Agostino, Ralph B., Sr.] Boston Univ, Boston, MA 02215 USA; [Bjorkelund, Cecilia; Wilhelmsen, Lars] Univ Gothenburg, Gothenburg, Sweden; [Brenner, Hermann] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Brunner, Eric; Cooper, Jackie A.; Pepys, Mark B.] UCL, London, England; [Clarke, Robert] Univ Oxford, Oxford, England; [Cremer, Peter] Klinikum Univ Munchen LMU, Munich, Germany; [Cushman, Mary] Univ Vermont, Burlington, ON, Canada; [Dagenais, Gilles R.] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Dankner, Rachel] Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel; [Davey-Smith, George; Lawlor, Debbie A.] Univ Bristol, Bristol, Avon, England; [Deeg, Dorly; Dekker, Jacqueline M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Engstrom, Gunnar] Lund Univ, Lund, Sweden; [Folsom, Aaron R.] Univ Minnesota, Minneapolis, MN USA; [Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Gallacher, John] Cardiff Univ, Cardiff, S Glam, Wales; [Gaziano, J. Michael] Harvard Univ, Sch Med, Boston, MA USA; [Giampaoli, Simona] Ist Super Sanita, I-00161 Rome, Italy; [Gillum, Richard F.] Ctr Dis Control & Prevent, Hyattsville, MD USA; [Hofman, Albert] Erasmus MC, Rotterdam, Netherlands; [Howard, Barbara V.] Medstar Hlth Res Inst, Hyattsville, MD USA; [Ingelsson, Erik] Karolinska Inst, Stockholm, Sweden; [Iso, Hiroyasu] Osaka Univ, Osaka, Japan; [Jorgensen, Torben] Glostrup Univ Hosp, Glostrup, Denmark; [Jorgensen, Torben; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen, Denmark; [Kiechl, Stefan] Med Univ Innsbruck, Innsbruck, Austria; [Kitamura, Akihiko] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Kiyohara, Yutaka] Kyushu Univ, Fukuoka 812, Japan; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Ulm, Germany; [Kromhout, Daan] Wageningen Univ, Wageningen, Netherlands; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA USA; [Meade, Tom W.] London Sch Hyg & Trop Med, London WC1, England; [Nissinen, Aulikki] Natl Inst Hlth & Welf, Helsinki, Finland; [Onat, Altan] Istanbul Univ, Istanbul, Turkey; [Panagiotakos, Demosthenes B.] Harokopio Univ, Athens, Greece; [Psaty, Bruce M.] Univ Washington, Seattle, WA 98195 USA; [Rodriguez, Beatriz] Univ Hawaii, Honolulu, HI 96822 USA; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Kauhanen, Jussi] Univ Eastern Finland, Kuopio, Finland; [Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Salonen, Jukka T.] Metab Analyt Serv, Helsinki, Finland; [Shaffer, Jonathan A.; Shea, Steven] Columbia Univ, Med Ctr, New York, NY USA; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Strandberg, Timo E.] Univ Helsinki, Oulu, Finland; [Strandberg, Timo E.] Univ Oulu, Oulu, Finland; [Tipping, Robert W.] Merck Res Labs, Philadelphia, PA USA; [Tosetto, Alberto] San Bortolo Hosp, Vicenza, Italy; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, New York, NY USA; [Wennberg, Patrik] Umea Univ, Umea, Sweden; [Westendorp, Rudi G.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Whincup, Peter H.] St Georges Univ London, London, England; [Woodward, Mark] Univ Sydney, Sydney, NSW 2006, Australia; [Wareham, Nicholas J.] MRC Epidemiol Unit, Cambridge, England; [Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Kopavogur, Iceland; [Ridker, Paul M.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Cambridge; MRC Biostatistics Unit; University of Glasgow; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Groningen; University of Groningen; University of California System; University of California San Diego; Boston University; University of Gothenburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of London; University College London; University of Oxford; University of Munich; University of Bristol; Vrije Universiteit Amsterdam; Lund University; University of Minnesota System; University of Minnesota Twin Cities; University of Edinburgh; Cardiff University; Harvard University; Harvard Medical School; Istituto Superiore di Sanita (ISS); Centers for Disease Control & Prevention - USA; Erasmus University Rotterdam; Erasmus MC; MedStar Health Research Institute; Karolinska Institutet; Osaka University; University of Copenhagen; University of Copenhagen; Medical University of Innsbruck; Kyushu University; Ulm University; Wageningen University & Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; London School of Hygiene & Tropical Medicine; Finland National Institute for Health & Welfare; Istanbul University; Harokopio University Athens; University of Washington; University of Washington Seattle; University of Hawaii System; University of Gothenburg; University of Eastern Finland; Finland National Institute for Health & Welfare; Columbia University; Maastricht University; University of Helsinki; University of Oulu; Merck & Company; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Yeshiva University; Umea University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St Georges University London; University of Sydney; Icelandic Heart Association; University of Iceland; Harvard University; Brigham & Women's Hospital	Kaptoge, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Emerging Risk Factors Collaborat Coordinating Ctr, Worts Causeway, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	PALMIERI, LUIGI/O-1845-2017; Brunner, Eric/H-2114-2011; Woodward, Mark/L-6817-2017; Davey Smith, George/A-7407-2013; Brenner, Hermann/ABE-6383-2020; Khaw, Kay-Tee/AAZ-3209-2021; Gao, Pei/AAF-3065-2019; Meisinger, Christine/B-5358-2014; Tosetto, Alberto/AAB-9320-2022; Lamarche, Benoit/ABA-4785-2021; Panagiotakos, Demosthenes/M-9167-2019; Panagiotakos, Demosthenes/K-8294-2019; Kauhanen, Jussi/ABC-4064-2021; Gao, Pei/R-4794-2018; Gudnason, Vilmundur/K-6885-2015; Woodward, Mark/D-8492-2015; Gudnason, Vilmundur/AAE-7126-2019; Brenner, Hermann/B-4627-2017; Ford, Ian/ABE-6145-2020; Panagiotakos, Demosthenes/C-9776-2013; Kromhout, Daan/A-8566-2014; Shaffer, Jonathan A/B-2783-2013; Woo, Wai Lok/T-3662-2018; Dankner, Rachel/Q-5245-2019; Aspelund, Thor/C-5983-2008; Cushman, Mary/K-1157-2019; Jørgensen, Torben/Z-1335-2018; Tosetto, Alberto/AAM-3200-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; Stehouwer, Coen/AAB-3435-2021; Benn, Marianne/O-4164-2019; Schöttker, Ben/F-8183-2014; Stefanadis, Christodoulos/ABH-2232-2020; DiAngelantonio, Emanuele/ABE-6852-2020; Wood, Angela/GZA-5762-2022; Marmot, M G/Y-3920-2019; Bakker, Stephan J. L./J-4023-2015; donfrancesco, chiara/K-1460-2016; Benjamin, Emelia/E-7103-2011	PALMIERI, LUIGI/0000-0002-4298-2642; Brunner, Eric/0000-0002-0595-4474; Davey Smith, George/0000-0002-1407-8314; Brenner, Hermann/0000-0002-6129-1572; Gao, Pei/0000-0001-8649-1290; Lamarche, Benoit/0000-0002-4443-5378; Panagiotakos, Demosthenes/0000-0001-8583-153X; Gao, Pei/0000-0001-8649-1290; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Brenner, Hermann/0000-0002-6129-1572; Panagiotakos, Demosthenes/0000-0001-8583-153X; Woo, Wai Lok/0000-0002-8698-7605; Dankner, Rachel/0000-0001-6454-6000; Aspelund, Thor/0000-0002-7998-5433; Cushman, Mary/0000-0002-7871-6143; Tosetto, Alberto/0000-0002-0119-5204; Benn, Marianne/0000-0002-1701-595X; Schöttker, Ben/0000-0002-1217-4521; Stefanadis, Christodoulos/0000-0001-5974-6454; Wood, Angela/0000-0002-7937-304X; Marmot, M G/0000-0002-2431-6419; Bakker, Stephan J. L./0000-0003-3356-6791; Yamagishi, Kazumasa/0000-0003-3301-5519; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Rothenbacher, Dietrich/0000-0002-3563-2791; Alexander, Myriam/0000-0002-6848-9370; Ramachandran, Vasan/0000-0001-7357-5970; Lawlor, Debbie A/0000-0002-6793-2262; s, hema/0000-0002-3440-9475; Franco, Oscar/0000-0002-4606-4929; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Bremmer, Marijke/0000-0002-0415-1127; Butterworth, Adam/0000-0002-6915-9015; Whincup, Peter/0000-0002-5589-4107; Nordestgaard, Borge/0000-0002-1954-7220; Davidson, Karina/0000-0002-9162-477X; Nijpels, Giel/0000-0002-3679-9710; donfrancesco, chiara/0000-0002-8040-5571; Kirkland, Susan/0000-0002-8182-2369; Pennells, Lisa Anne/0000-0002-8594-3061; Lewington, Sarah/0000-0002-4496-4771; Koenig, Wolfgang/0000-0002-2064-9603; strandberg, timo/0000-0001-6299-925X; Jespersen, Jorgen/0000-0002-3059-2356; Stehouwer, Coen/0000-0001-8752-3223; Benjamin, Emelia/0000-0003-4076-2336; Woodward, Mark/0000-0001-9800-5296; Engstrom, Gunnar/0000-0002-8618-9152; Ballantyne, Christie/0000-0002-6432-1730; Amouyel, Philippe/0000-0001-9088-234X; Jorgensen, Torben/0000-0001-9453-2830; White, Ian/0000-0002-6718-7661; Di Angelantonio, Emanuele/0000-0001-8776-6719; Bladbjerg, Else Marie/0000-0003-0912-2437; Kivimaki, Mika/0000-0002-4699-5627; Haycock, Philip/0000-0001-5001-3350	British Heart Foundation; MRC [G0902037, G0701619, MC_U137686857, MC_U137686851, G0600705, G0701863, G7900510, MC_U105260558] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, PG/09/002/26056, RG/07/008/23674, RG/08/013/25942] Funding Source: researchfish; Medical Research Council [MC_U105260558, MC_U106179471, MC_U137686851, G0701619, G8802774, G7900510, G0600705, G19/35, MC_U137686857, G0902037, MC_U105260792, G0701863, G0100222, G1000143] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091099, K24HL084034, P01HL088117] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the British Heart Foundation and others.	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Blake GJ, 2003, AM J MED, V114, P485, DOI 10.1016/S0002-9343(03)00074-3; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper A, 2008, BRIT MED J, V336, P1246, DOI 10.1136/bmj.39554.624086.AD; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Godsland IF, 2011, QJM-INT J MED, V104, P387, DOI 10.1093/qjmed/hcq213; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Heart Protection Study, 2011, LANCET, V377, P469, DOI 10.1016/S0140-6736(10)62174-5; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; Lp-PLA2Studies Collaboration, 2010, J GERONTOL B-PSYCHOL, V375, P1536; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899; National Heart Lung and Blood Institute, DET EV TREATM HIGH B; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	30	747	767	2	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1310	1320		10.1056/NEJMoa1107477	http://dx.doi.org/10.1056/NEJMoa1107477			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034020	Green Published, Green Accepted			2022-12-28	WOS:000309406100007
J	Calarco, JP; Borges, F; Donoghue, MTA; Van Ex, F; Jullien, PE; Lopes, T; Gardner, R; Berger, F; Feijo, JA; Becker, JD; Martienssen, RA				Calarco, Joseph P.; Borges, Filipe; Donoghue, Mark T. A.; Van Ex, Frederic; Jullien, Pauline E.; Lopes, Telma; Gardner, Rui; Berger, Frederic; Feijo, Jose A.; Becker, Joerg D.; Martienssen, Robert A.			Reprogramming of DNA Methylation in Pollen Guides Epigenetic Inheritance via Small RNA	CELL			English	Article							TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; ARABIDOPSIS; PLANT; DEMETHYLATION; REVEALS; HETEROCHROMATIN; MAINTENANCE; INVOLVEMENT; ENDOSPERM	Epigenetic inheritance is more widespread in plants than in mammals, in part because mammals erase epigenetic information by germline reprogramming. We sequenced the methylome of three haploid cell types from developing pollen: the sperm cell, the vegetative cell, and their precursor, the postmeiotic microspore, and found that unlike in mammals the plant germline retains CG and CHG DNA methylation. However, CHH methylation is lost from retrotransposons in microspores and sperm cells and restored by de novo DNA methyltransferase guided by 24 nt small interfering RNA, both in the vegetative nucleus and in the embryo after fertilization. In the vegetative nucleus, CG methylation is lost from targets of DEMETER (DME), REPRESSOR OF SILENCING 1 (ROS1), and their homologs, which include imprinted loci and recurrent epialleles that accumulate corresponding small RNA and are premethylated in sperm. Thus genome reprogramming in pollen contributes to epigenetic inheritance, transposon silencing, and imprinting, guided by small RNA.	[Calarco, Joseph P.; Donoghue, Mark T. A.; Van Ex, Frederic; Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Borges, Filipe; Lopes, Telma; Gardner, Rui; Feijo, Jose A.; Becker, Joerg D.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Jullien, Pauline E.; Berger, Frederic] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1749016 Lisbon, Portugal	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Instituto Gulbenkian de Ciencia; National University of Singapore; Universidade de Lisboa	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Becker, Jorg/A-5930-2011; jullien, pauline emilie/AAN-6932-2021; Jullien, Pauline/B-7271-2009; Feijo, Jose A./ADM-0262-2022; Lopes, Telma/Q-9767-2016	Becker, Jorg/0000-0002-6845-6122; jullien, pauline emilie/0000-0003-1212-3246; Jullien, Pauline/0000-0003-1212-3246; Feijo, Jose A./0000-0002-1100-5478; Lopes, Telma/0000-0003-3816-4708; Berger, Frederic/0000-0002-3609-8260; Van Ex, Frederic/0000-0003-2481-0115; Borges, Filipe/0000-0002-7388-2118	NIH [R01 GM067014]; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/AGR-GPL/103778/2008, PTDC/BIA-BCM/103787/2008, PTDC/BIA-BCM/108044/2008, SFRH/BD/48761/2008]; Temasek Lifescience Laboratory; NSERC; Fred C. Gloeckner Foundation; Belgian American Educational Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER; Direct For Biological Sciences [1025830] Funding Source: National Science Foundation; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/108044/2008, PTDC/AGR-GPL/103778/2008, PTDC/BIA-BCM/103787/2008] Funding Source: FCT	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Temasek Lifescience Laboratory; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fred C. Gloeckner Foundation; Belgian American Educational Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Fundação para a Ciência e a Tecnologia	We thank Michael Regulski, Jude Kendall, Evan Ernst, Emily Hodges, and Antoine Molaro for advice with bisulfite sequencing and analysis; Vincent Colot, Arp Schnittger, and Daniel Bouyer for helpful discussions; and Shiran Pasternak for help with graphic presentation. This work was supported by NIH grant R01 GM067014 to R.A.M., grants PTDC/AGR-GPL/103778/2008 and PTDC/BIA-BCM/103787/2008 from Fundacao para a Ciencia e a Tecnologia (FCT) to J.D.B. and FCT grant PTDC/BIA-BCM/108044/2008 to J.A.F. F. Berger and P.E.J. were supported by Temasek Lifescience Laboratory. J.P.C. was supported by a graduate student fellowship from NSERC and by a grant from the Fred C. Gloeckner Foundation, F. Borges was supported by a FCT PhD fellowship SFRH/BD/48761/2008, and F.V.E. was funded by a Herbert Hoover postdoctoral fellowship from the Belgian American Educational Foundation.	Bartolomei Marisa S, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a002592; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Berger F, 2011, ANNU REV PLANT BIOL, V62, P461, DOI 10.1146/annurev-arplant-042110-103824; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grant-Downton R, 2009, MOL PLANT, V2, P500, DOI 10.1093/mp/ssp003; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2012, CURR BIOL, V22, P1825, DOI 10.1016/j.cub.2012.07.061; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lorkovic ZJ, 2012, CURR BIOL, V22, P933, DOI 10.1016/j.cub.2012.03.061; Lu J, 2012, P NATL ACAD SCI USA, V109, P5529, DOI 10.1073/pnas.1203094109; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; MARTIENSSEN R, 1990, GENE DEV, V4, P331, DOI 10.1101/gad.4.3.331; MARTIENSSEN R, 1994, GENETICS, V136, P1157; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MCCLINTOCK B, 1965, BROOKHAVEN SYM BIOL, P162; McKeown PC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-113; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Radford EJ, 2011, FEBS LETT, V585, P2059, DOI 10.1016/j.febslet.2011.05.063; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Salvaing J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038156; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schoft VK, 2011, P NATL ACAD SCI USA, V108, P8042, DOI 10.1073/pnas.1105117108; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teixeira FK, 2010, HEREDITY, V105, P14, DOI 10.1038/hdy.2010.52; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Vaillant I, 2006, EMBO REP, V7, P1273, DOI 10.1038/sj.embor.7400791; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Zhang P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096073	56	373	390	3	180	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					194	205		10.1016/j.cell.2012.09.001	http://dx.doi.org/10.1016/j.cell.2012.09.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23000270	Green Accepted, Bronze			2022-12-28	WOS:000309544200020
J	Wiig, JA; Hu, YL; Lee, CC; Ribbe, MW				Wiig, Jared A.; Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.			Radical SAM-Dependent Carbon Insertion into the Nitrogenase M-Cluster	SCIENCE			English	Article							IRON-MOLYBDENUM COFACTOR; FEMO-COFACTOR; PROTEIN; NIFEN; MECHANISM; PRECURSOR; ENZYMES; LIGAND; HYDROGENASE; SUPERFAMILY	The active site of nitrogenase, the M-cluster, is a metal-sulfur cluster containing a carbide at its core. Using radiolabeling experiments, we show that this carbide originates from the methyl group of S-adenosylmethionine (SAM) and that it is inserted into the M-cluster by the assembly protein NifB. Our SAM cleavage and deuterium substitution analyses suggest a similarity between the mechanism of carbon insertion by NifB and the proposed mechanism of RNA methylation by the radical SAM enzymes RlmN and Cfr, which involves methyl transfer from one SAM equivalent, followed by hydrogen atom abstraction from the methyl group by a 5'-deoxyadenosyl radical generated from a second SAM equivalent. This work is an initial step toward unraveling the importance of the interstitial carbide and providing insights into the nitrogenase mechanism.	[Wiig, Jared A.; Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			National Institutes of Health [GM 67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM 67626 (M.W.R.).	Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; DUKES GR, 1975, J AM CHEM SOC, V97, P528, DOI 10.1021/ja00836a011; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fay AW, 2011, ANGEW CHEM INT EDIT, V50, P7787, DOI 10.1002/anie.201102724; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; HANCOCK RD, 1989, CHEM REV, V89, P1875, DOI 10.1021/cr00098a011; Hartman F. C., 1989, J BIOL CHEM, V246, P11784; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; JOB RC, 1975, P NATL ACAD SCI USA, V72, P2478, DOI 10.1073/pnas.72.7.2478; Kaiser JT, 2011, SCIENCE, V331, P91, DOI 10.1126/science.1196954; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Pavlov M, 1998, J AM CHEM SOC, V120, P548, DOI 10.1021/ja971681+; Reed GH, 2004, CURR OPIN CHEM BIOL, V8, P477, DOI 10.1016/j.cbpa.2004.08.008; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; van der Kamp MW, 2010, J PHYS CHEM B, V114, P11303, DOI 10.1021/jp104069t; Wiig JA, 2011, P NATL ACAD SCI USA, V108, P8623, DOI 10.1073/pnas.1102773108; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Yang XZ, 2009, J AM CHEM SOC, V131, P10901, DOI 10.1021/ja902689n	27	179	181	7	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1672	1675		10.1126/science.1224603	http://dx.doi.org/10.1126/science.1224603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019652	Green Accepted			2022-12-28	WOS:000309215400050
J	Redelmeier, DA; Yarnell, CJ; Thiruchelvam, D; Tibshirani, RJ				Redelmeier, Donald A.; Yarnell, Christopher J.; Thiruchelvam, Deva; Tibshirani, Robert J.			Physicians' Warnings for Unfit Drivers and the Risk of Trauma from Road Crashes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CASE-CROSSOVER; OLDER DRIVERS; BIAS; ACCIDENTS; MILEAGE	BACKGROUND Physicians' warnings to patients who are potentially unfit to drive are a medical intervention intended to prevent trauma from motor vehicle crashes. We assessed the association between medical warnings and the risk of subsequent road crashes. METHODS We identified consecutive patients who received a medical warning in Ontario, Canada, between April 1, 2006, and December 31, 2009, from a physician who judged them to be potentially unfit to drive. We excluded patients who were younger than 18 years of age, who were not residents of Ontario, or who lacked valid health-card numbers under universal health insurance. We analyzed emergency department visits for road crashes during a baseline interval before the warning and a subsequent interval after the warning. RESULTS A total of 100,075 patients received a medical warning from a total of 6098 physicians. During the 3-year baseline interval, there were 1430 road crashes in which the patient was a driver and presented to the emergency department, as compared with 273 road crashes during the 1-year subsequent interval, representing a reduction of approximately 45% in the annual rate of crashes per 1000 patients after the warning (4.76 vs. 2.73, P<0.001). The lower rate was observed across patients with diverse characteristics. No significant change was observed in subsequent crashes in which patients were pedestrians or passengers. Medical warnings were associated with an increase in subsequent emergency department visits for depression and a decrease in return visits to the responsible physician. CONCLUSIONS Physicians' warnings to patients who are potentially unfit to drive may contribute to a decrease in subsequent trauma from road crashes, yet they may also exacerbate mood disorders and compromise the doctor-patient relationship. (Funded by the Canada Research Chairs program and others.)	[Redelmeier, Donald A.] Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON M4N 3M5, Canada; [Redelmeier, Donald A.; Yarnell, Christopher J.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Redelmeier, Donald A.; Yarnell, Christopher J.; Thiruchelvam, Deva] Sunnybrook Res Inst, Clin Epidemiol Program, Toronto, ON, Canada; [Redelmeier, Donald A.; Yarnell, Christopher J.; Thiruchelvam, Deva] Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada; [Redelmeier, Donald A.] Ctr Leading Injury Prevent Practice Educ & Res, Toronto, ON, Canada; [Tibshirani, Robert J.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Tibshirani, Robert J.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Stanford University; Stanford University	Redelmeier, DA (corresponding author), Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, G-151,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.			Yarnell, Christopher/0000-0001-5657-9398	Canada Research Chair in Medical Decision Sciences; Canadian Institutes of Health Research; Comprehensive Research Experience for Medical Students of the University of Toronto Faculty of Medicine; Canada Research Chairs program	Canada Research Chair in Medical Decision Sciences(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Comprehensive Research Experience for Medical Students of the University of Toronto Faculty of Medicine; Canada Research Chairs program(Canada Research Chairs)	Funded by the Canada Research Chairs program and others.; Supported by a Canada Research Chair in Medical Decision Sciences, the Canadian Institutes of Health Research, and the Comprehensive Research Experience for Medical Students of the University of Toronto Faculty of Medicine.	Annas GJ, 2008, NEW ENGL J MED, V359, P521, DOI 10.1056/NEJMhle0802548; [Anonymous], UNDERSTANDING DRIVER; [Anonymous], 2004, INT STAT CLASSIFICAT; [Anonymous], 2008, ONTARIO RAOD SAFETY; [Anonymous], 2011, SCHEDULE BENEFITS FE; [Anonymous], 2009, MED CONDITION REPORT; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Brison R, 1997, ONTARIO MED REV, V64, P17; Canadian Institute for Health Information, 2008, CIHI DAT QUAL STUD E, V2; Carr D. B., 2010, PHYS GUIDE ASSESSING, V2nd; Carr DB, 2010, JAMA-J AM MED ASSOC, V303, P1632, DOI 10.1001/jama.2010.481; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Council on Ethical and Judicial Affairs of the American Medical Association, 1999, IMP DRIV THEIR PHYS; CRANCER A, 1968, J AMER MED ASSOC, V205, P272, DOI 10.1001/jama.1968.03140310030006; Fain MJ, 2003, ARCH INTERN MED, V163, P2126, DOI 10.1001/archinte.163.18.2126; Foxman S, 2010, ONTARIO MED REV, V77, P42; Giachino AA, 1997, ONTARIO MED REV, V64, P23; Horswill MS, 2004, J APPL SOC PSYCHOL, V34, P177, DOI 10.1111/j.1559-1816.2004.tb02543.x; Iron K, 2008, LIVING DYING ONTARIO; Jang RW, 2007, J GEN INTERN MED, V22, P531, DOI 10.1007/s11606-006-0043-x; JANKE MK, 1991, ACCIDENT ANAL PREV, V23, P183, DOI 10.1016/0001-4575(91)90048-A; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Kerkstra P, 2004, PHILADELPHIA INQUIRE; Langford J, 2006, ACCIDENT ANAL PREV, V38, P574, DOI 10.1016/j.aap.2005.12.002; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Marshall SC, 2002, CAN MED ASSOC J, V167, P747; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Meuser TM, 2009, ACCIDENT ANAL PREV, V41, P246, DOI 10.1016/j.aap.2008.11.003; Nasvadi GC, 2009, GERONTOLOGIST, V49, P474, DOI 10.1093/geront/gnp039; Ontario Medical Association, 2006, ONTARIO MED REV, V73, P29; Redelmeier DA, 2003, LANCET, V361, P2177, DOI 10.1016/S0140-6736(03)13770-1; Redelmeier DA, 2012, CAN MED ASSOC J, V184, P1123, DOI 10.1503/cmaj.120521; Redelmeier DA, 2012, J CLIN EPIDEMIOL, V65, P467, DOI 10.1016/j.jclinepi.2011.09.007; Redelmeier Donald A, 2008, Open Med, V2, pe8; Schull MJ, 2010, DEV CONS EV BAS QUAL; Stutts J., 2009, DRIVER LICENSING POL; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324	37	99	101	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1228	1236		10.1056/NEJMsa1114310	http://dx.doi.org/10.1056/NEJMsa1114310			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JO	23013074				2022-12-28	WOS:000309161100009
J	Gallagher, TQ; Hill, C; Ojha, S; Ference, E; Keamy, DG; Williams, M; Hansen, M; Maurer, R; Collins, C; Setlur, J; Capra, GG; Brigger, MT; Hartnick, CJ				Gallagher, Thomas Q.; Hill, Courtney; Ojha, Shilpa; Ference, Elisabeth; Keamy, Donald G., Jr.; Williams, Michael; Hansen, Maynard; Maurer, Rie; Collins, Corey; Setlur, Jennifer; Capra, Gregory G.; Brigger, Matthew T.; Hartnick, Christopher J.			Perioperative Dexamethasone Administration and Risk of Bleeding Following Tonsillectomy in Children A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEMORRHAGE; ADENOTONSILLECTOMY; METAANALYSIS; ADENOIDECTOMY; COMPLICATIONS; MORBIDITY	Context Corticosteroids are commonly given to children undergoing tonsillectomy to reduce postoperative nausea and vomiting; however, they might increase the risk of perioperative and postoperative hemorrhage. Objective To determine the effect of dexamethasone on bleeding following tonsillectomy in children. Design, Setting, and Patients A multicenter, prospective, randomized, double-blind, placebo-controlled study at 2 tertiary medical centers of 314 children aged 3 to 18 years undergoing tonsillectomy without a history of bleeding disorder or recent corticosteroid medication use and conducted between July 15, 2010, and December 20, 2011, with 14-day follow-up. We tested the hypothesis that dexamethasone would not result in 5% more bleeding events than placebo using a noninferiority statistical design. Intervention A single perioperative dose of dexamethasone (0.5 mg/kg; maximum dose, 20 mg), with an equivalent volume of 0.9% saline administered to the placebo group. Main Outcome Measures Rate and severity of posttonsillectomy hemorrhage in the 14-day postoperative period using a bleeding severity scale (level I, self-reported or parent-reported postoperative bleeding; level II, required inpatient admission for postoperative bleeding; or level III, required reoperation to control postoperative bleeding). Results One hundred fifty-seven children (median [interquartile range] age, 6 [4-8] years) were randomized into each study group, with 17 patients (10.8%) in the dexamethasone group and 13 patients (8.2%) in the placebo group reporting bleeding events. In an intention-to-treat analysis, the rates of level I bleeding were 7.0% (n = 11) in the dexamethasone group and 4.5% (n = 7) in the placebo group (difference, 2.6%; upper limit 97.5% CI, 7.7%; P for noninferiority = .17); rates of level II bleeding were 1.9% (n = 3) and 3.2% (n = 5), respectively (difference, -1.3%; upper limit 97.5% CI, 2.2%; P for noninferiority < .001); and rates of level III bleeding were 1.9% (n = 3) and 0.6% (n = 1), respectively (difference, 1.3%; upper limit 97.5% CI, 3.8%; P for noninferiority = .002). Conclusions Perioperative dexamethasone administered during pediatric tonsillectomy was not associated with excessive, clinically significant level II or III bleeding events based on not having crossed the noninferior threshold of 5%. Increased subjective (level I) bleeding events caused by dexamethasone could not be excluded because the noninferiority threshold was crossed.	[Gallagher, Thomas Q.] USN, Dept Otolaryngol, Med Ctr Portsmouth, Portsmouth, VA USA; [Hill, Courtney] Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03766 USA; [Ojha, Shilpa; Keamy, Donald G., Jr.; Williams, Michael; Hansen, Maynard; Setlur, Jennifer; Hartnick, Christopher J.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Collins, Corey] Massachusetts Eye & Ear Infirm, Dept Anesthesiol, Boston, MA 02114 USA; [Ference, Elisabeth] Northwestern Univ, Dept Otolaryngol, Chicago, IL 60611 USA; [Maurer, Rie] Brigham & Womens Hosp, Boston, MA 02115 USA; [Capra, Gregory G.; Brigger, Matthew T.] USN, Dept Otolaryngol, San Diego Med Ctr, San Diego, CA 92152 USA	United States Department of Defense; United States Navy; Dartmouth College; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Northwestern University; Harvard University; Brigham & Women's Hospital; United States Department of Defense; United States Navy	Hartnick, CJ (corresponding author), Massachusetts Eye & Ear Infirm, Dept Pediat Otolaryngol, 243 Charles St, Boston, MA 02114 USA.	christopher_hartnick@meei.harvard.edu	Capra, Greg/AAC-6215-2019	Capra, Greg/0000-0002-4576-8190; Ference, Elisabeth/0000-0002-4177-6716	Gyrus ACMI; National Institutes of Health	Gyrus ACMI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hartnick reported receiving consultancy fees from Gyrus ACMI, receiving a grant from the National Institutes of Health to study voice disorders and voice therapy in children with vocal dysphonia, and receiving book royalties from Springer. No other authors reported any disclosures.	[Anonymous], 2006, AMB SURG US; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Blakley BW, 2009, OTOLARYNG HEAD NECK, V140, P288, DOI 10.1016/j.otohns.2008.12.005; Brigger MT, 2010, ARCH OTOLARYNGOL, V136, P766, DOI 10.1001/archoto.2010.133; CAPPER JWR, 1984, J LARYNGOL OTOL, V98, P363, DOI 10.1017/S0022215100146742; CARMODY D, 1982, J LARYNGOL OTOL, V96, P635, DOI 10.1017/S0022215100092926; Centers for Disease Control and Prevention, 1994, ADV DAT 283 AMB SURG; Collison P J, 2000, Ear Nose Throat J, V79, P640; Conley SF, 1999, ARCH OTOLARYNGOL, V125, P330, DOI 10.1001/archotol.125.3.330; Czarnetzki C, 2008, JAMA-J AM MED ASSOC, V300, P2621, DOI 10.1001/jama.2008.794; Derkay CS, 2006, OTOLARYNG HEAD NECK, V134, P114, DOI 10.1016/j.otohns.2005.10.039; Gallagher TQ, 2010, OTOLARYNG HEAD NECK, V142, P886, DOI 10.1016/j.otohns.2010.02.019; Goldman AC, 2000, OTOLARYNG HEAD NECK, V123, P682, DOI 10.1067/mhn.2000.111354; Gunter JB, 2009, JAMA-J AM MED ASSOC, V301, P1764, DOI 10.1001/jama.2009.575; HANDLER SD, 1986, LARYNGOSCOPE, V96, P1243; Kim MS, 2007, ANESTH ANALG, V104, P1052, DOI 10.1213/01.ane.0000263276.52287.3b; KRISTENSEN S, 1984, CLIN OTOLARYNGOL, V9, P347, DOI 10.1111/j.1365-2273.1984.tb01519.x; Macassey EA, 2007, ANZ J SURG, V77, P579, DOI 10.1111/j.1445-2197.2007.04154.x; PAPANGELOU L, 1972, LARYNGOSCOPE, V82, P297, DOI 10.1288/00005537-197202000-00016; Randall DA, 1998, OTOLARYNG HEAD NECK, V118, P61, DOI 10.1016/S0194-5998(98)70376-6; Ross AI, 2003, OTOLARYNG HEAD NECK, V128, P326, DOI 10.1067/mhn.2003.60; Shargorodsky J, 2012, LARYNGOSCOPE, V122, P1158, DOI 10.1002/lary.21881; Steward DL, 2001, LARYNGOSCOPE, V111, P1712, DOI 10.1097/00005537-200110000-00008; Steward DL, 2003, COCHRANE DB SYST REV; Windfuhr Jochen P, 2002, Ear Nose Throat J, V81, P626	25	50	52	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1221	1226		10.1001/2012.jama.11575	http://dx.doi.org/10.1001/2012.jama.11575			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011712	Bronze			2022-12-28	WOS:000309103600025
J	DeMuri, GP; Wald, ER				DeMuri, Gregory P.; Wald, Ellen R.			Acute Bacterial Sinusitis in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MAXILLARY SINUSITIS; ACUTE OTITIS-MEDIA; RESPIRATORY-TRACT INFECTIONS; PLACEBO-CONTROLLED TRIAL; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; IMAGING FINDINGS; SEROTYPE 19A; DOUBLE-BLIND; SUSCEPTIBILITIES	A 4-year-old girl who attends day care presents with rhinorrhea and a daytime cough that have been present for 12 days. She has not had fever, but her appetite is poor and her interest in activities is diminished. On physical examination, there is clear rhinorrhea present in the nasal passages. The remainder of the examination is unremarkable. Should she be treated with an antibiotic?	[DeMuri, Gregory P.; Wald, Ellen R.] Univ Wisconsin, Dept Pediat, Div Infect Dis, Sch Med & Publ Hlth, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	DeMuri, GP (corresponding author), Univ Wisconsin, Dept Pediat, Div Infect Dis, Sch Med & Publ Hlth, 600 Highland Ave,MC 4108, Madison, WI 53792 USA.	demuri@pediatrics.wisc.edu						Anand VK, 2004, ANN OTO RHINOL LARYN, V113, P3, DOI 10.1177/00034894041130S502; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Block SL, 2011, PEDIATR INFECT DIS J, V30, P203, DOI 10.1097/INF.0b013e3181faac7c; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Chen Chien-Fu, 2001, Journal of Microbiology Immunology and Infection, V34, P57; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Clinical practice guideline: management of sinusitis, 2002, PEDIATRICS, V109, P40; Clinical practice guideline: management of sinusitis, 2001, PEDIATRICS, V108, pA24; Critchley IA, 2008, ANTIMICROB AGENTS CH, V52, P2639, DOI 10.1128/AAC.00310-08; DEBOCK GH, 1994, J CLIN EPIDEMIOL, V47, P1343, DOI 10.1016/0895-4356(94)90078-7; DeMuri Gregory P, 2011, Pediatr Infect Dis J, V30, P701, DOI 10.1097/INF.0b013e31822855a0; DIAMENT MJ, 1987, J COMPUT ASSIST TOMO, V11, P426, DOI 10.1097/00004728-198705000-00011; EVANS FO, 1975, NEW ENGL J MED, V293, P735, DOI 10.1056/NEJM197510092931502; Garbutt J, 2004, PEDIATRICS, V114, P342, DOI 10.1542/peds.114.2.342; Garbutt JM, 2001, PEDIATRICS, V107, P619, DOI 10.1542/peds.107.4.619; GLASIER CM, 1986, AM J NEURORADIOL, V7, P861; Gordon KA, 2003, DIAGN MICR INFEC DIS, V46, P285, DOI 10.1016/S0732-8893(03)00087-7; Gunn VL, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e52; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; GWALTNEY JM, 1967, J AMER MED ASSOC, V202, P494, DOI 10.1001/jama.202.6.494; Harrison CJ, 2009, J ANTIMICROB CHEMOTH, V63, P511, DOI 10.1093/jac/dkn538; Jacobs MR, 2010, ANTIMICROB AGENTS CH, V54, P2716, DOI 10.1128/AAC.01797-09; Joloba ML, 2001, CLIN INFECT DIS, V33, P1489, DOI 10.1086/323027; Kassel JC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006821.pub2; KOVATCH AL, 1984, PEDIATRICS, V73, P306; Kristo A, 2005, ACTA PAEDIATR, V94, P1208, DOI [10.1080/08035250510028236, 10.1111/j.1651-2227.2005.tb02076.x]; Kristo A, 2003, ACTA PAEDIATR, V92, P34; Lindbaek M, 1996, Fam Med, V28, P183; Manning SC, 1996, INT J PEDIATR OTORHI, V37, P65, DOI 10.1016/0165-5876(96)01381-X; McCormick DP, 1996, CLIN PEDIATR, V35, P457, DOI 10.1177/000992289603500905; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; Mitra Andrew, 2011, Prim Health Care Res Dev, V12, P329, DOI 10.1017/S1463423611000193; Parsons DS, 1996, OTOLARYNG CLIN N AM, V29, P11; Ray NF, 1999, J ALLERGY CLIN IMMUN, V103, P408, DOI 10.1016/S0091-6749(99)70464-1; Revai K, 2007, PEDIATRICS, V119, pE1408, DOI 10.1542/peds.2006-2881; Shapiro DJ, 2011, PEDIATRICS, V127, P28, DOI 10.1542/peds.2010-1340; Tristram S, 2007, CLIN MICROBIOL REV, V20, P368, DOI 10.1128/CMR.00040-06; Ueda D, 1996, PEDIATR INFECT DIS J, V15, P576, DOI 10.1097/00006454-199607000-00003; Wald ER, 2009, PEDIATRICS, V124, P9, DOI 10.1542/peds.2008-2902; WALD ER, 1991, PEDIATRICS, V87, P129; WALD ER, 1984, J PEDIATR-US, V104, P297, DOI 10.1016/S0022-3476(84)81018-5; WALD ER, 1986, PEDIATRICS, V77, P795; Wald ER, 2001, PEDIATRICS, V108, P798; WALD ER, 1981, NEW ENGL J MED, V304, P749, DOI 10.1056/NEJM198103263041302; Zalmanovici A, 2007, COCHRANE DB SYST REV, V2	46	30	32	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1128	1134		10.1056/NEJMcp1106638	http://dx.doi.org/10.1056/NEJMcp1106638			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AS	22992076				2022-12-28	WOS:000308861800008
J	Dixon, JB; Schachter, LM; O'Brien, PE; Jones, K; Grima, M; Lambert, G; Brown, W; Bailey, M; Naughton, MT				Dixon, John B.; Schachter, Linda M.; O'Brien, Paul E.; Jones, Kay; Grima, Mariee; Lambert, Gavin; Brown, Wendy; Bailey, Michael; Naughton, Matthew T.			Surgical vs Conventional Therapy for Weight Loss Treatment of Obstructive Sleep Apnea A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBESE-PATIENTS; MANAGEMENT; IMPACT; BAND	Context Obstructive sleep apnea (OSA) is strongly related to obesity. Weight loss is recommended as part of the overall management plan for obese patients diagnosed with OSA. Objective To determine whether surgically induced weight loss is more effective than conventional weight loss therapy in the management of OSA. Design, Setting, and Patients A randomized controlled trial of 60 obese patients (body mass index: >35 and <55) with recently diagnosed (<6 months) OSA and an apnea-hypopnea index (AHI) of 20 events/hour or more. These patients had been prescribed continuous positive airway pressure (CPAP) therapy to manage OSA and were identified via accredited community sleep clinics. The trial was conducted between September 2006 and March 2009 by university-and teaching hospital-based clinical researchers in Melbourne, Australia. Patients with obesity hypoventilation syndrome, previous bariatric surgery, contraindications to bariatric surgery, or significant cardiopulmonary, neurological, vascular, gastrointestinal, or neoplastic disease were excluded. Interventions Patients were randomized to a conventional weight loss program that included regular consultations with a dietitian and physician, and the use of very low-calorie diets as necessary (n = 30) or to bariatric surgery (laparoscopic adjustable gastric banding; n = 30). Main Outcome Measures The primary outcome was baseline to 2-year change in AHI on diagnostic polysomnography scored by staff blinded to randomization. Secondary outcomes were changes in weight, CPAP adherence, and functional status. Results Patients lost a mean of 5.1 kg (95% CI, 0.8 to 9.3 kg) in the conventional weight loss program compared with 27.8 kg (95% CI, 20.9 to 34.7 kg) in the bariatric surgery group (P < .001). The AHI decreased by 14.0 events/hour (95% CI, 3.3 to 24.6 events/hour) in the conventional weight loss group and by 25.5 events/hour (95% CI, 14.2 to 36.7 events/hour) in the bariatric surgery group. The between-group difference was -11.5 events/hour (95% CI, -28.3 to 5.3 events/hour; P = .18). CPAP adherence did not differ between the groups. The bariatric surgery group had greater improvement in the Short Form 36 physical component summary score (mean, 9.3 [95% CI, 0.5 to 18.0]; P = .04). Conclusion Among a group of obese patients with OSA, the use of bariatric surgery compared with conventional weight loss therapy did not result in a statistically greater reduction in AHI despite major differences in weight loss.	[Dixon, John B.; Grima, Mariee; Lambert, Gavin] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Dixon, John B.; Jones, Kay] Monash Univ, Dept Gen Practice, Obes Res Unit, Melbourne, Vic 3004, Australia; [Schachter, Linda M.; O'Brien, Paul E.; Brown, Wendy] Monash Univ, Ctr Obes Res & Educ, Melbourne, Vic 3004, Australia; [Schachter, Linda M.; Lambert, Gavin; Naughton, Matthew T.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Brown, Wendy] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Bailey, Michael] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Naughton, Matthew T.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Monash University; Monash University; Monash University; Monash University; Monash University; Florey Institute of Neuroscience & Mental Health	Dixon, JB (corresponding author), Baker IDI Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia.	john.dixon@bakeridi.edu.au	Dixon, John B/A-5318-2011; Bailey, Michael J/A-4499-2012; Brown, Wendy Ann/H-7130-2014; Lambert, Gavin W/E-7384-2010; Lambert, Gavin/Q-4869-2017	Dixon, John B/0000-0001-5391-4082; Bailey, Michael J/0000-0002-5551-1401; Brown, Wendy Ann/0000-0002-0137-2688; Lambert, Gavin W/0000-0003-0315-645X; Lambert, Gavin/0000-0003-0315-645X	National Health and Medical Research Council; Allergan Inc; Applied Medical toward educational programs; Medtronic; Servier Australia; Abbott; Resmed; Respironics; National Health and Medical Research Council of Australia [436728]; Baker IDI Heart and Diabetes Institute	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Allergan Inc(AbbVieAllergan); Applied Medical toward educational programs; Medtronic(Medtronic); Servier Australia(Servier); Abbott(Abbott Laboratories); Resmed; Respironics; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Baker IDI Heart and Diabetes Institute	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Dixon reported being supported by a National Health and Medical Research Council Senior Research Fellowship; his laboratory receives competitive research grant funding from Allergan Inc; serving as a consultant for Allergan Inc, Bariatric Advantage, and Scientific Intake; being a member of the Optifast medical advisory board for Nestle Health Australia; serving on the speakers bureaus for Eli Lilly and iNova Pharmaceuticals; developing educational material for Novartis and iNova Pharmaceuticals; and receiving travel assistance from GI Dynamics for an educational meeting. Dr Schachter reported being the medical director of Sleep Services Australia, which uses continuous positive airway pressure machines and masks from Resmed Australia, Fisher and Paykel New Zealand, and Phillips Respironics United States. Dr O'Brien reported receiving compensation as the national medical director for the American Institute of Gastric Banding since 2007; receiving compensation as the author of The Lap-Band Solution: A Partnership for Weight Loss; serving as the emeritus director of the Centre for Obesity Research and Education (CORE), which receives a grant from Applied Medical toward educational programs; and receiving a grant from Allergan Inc for investigator-initiated research. Dr Lambert reported being supported by an National Health and Medical Research Council Senior Research Fellowship; his laboratory currently receives commercial research grant funding from Medtronic (formerly ARDIAN Inc), Servier Australia, Abbott (formerly Solvay), and Allergan Inc; serving as a consultant to Medtronic; and receiving honoraria or travel support for presentations from Pfizer, Wyeth Pharmaceuticals, Servier, and Medtronic. Dr Brown reported receiving an honorarium from Allergan Inc for attending a scientific advisory panel in London in 2009; serving as the director of CORE, which receives a grant from Allergan Inc for research support but the grant is not tied to any specified research projects and Allergan has no control of the protocol, analysis, and reporting of any studies; and that CORE receives a grant from Applied Medical toward educational programs. Dr Naughton reported being a recipient of competitive funding from Resmed and Respironics to assist in investigator-directed research; serving on the Australian Medical advisory boards of ResMed, Respironics, Covidian and Fisher, and Paykel; but that he and his family hold no stock or have any financial interest in any company related to sleep apnea or obesity. Drs Jones and Bailey and Ms Grima did not report any disclosures.; The study was funded by the National Health and Medical Research Council of Australia project grant 436728 awarded to Monash University and the Baker IDI Heart and Diabetes Institute. The continuous positive airway pressure (CPAP) pumps were provided for all study participants by ResMed Australia, Fisher and Paykel New Zealand, and Phillips Respironics United States. The laparoscopic adjustable gastric bands (Allergan Health) and the laparoscopic ports (Applied Medical) were provided without charge by the manufacturers. The Avenue Hospital subsidized the hospitalization costs for the surgical study participants.	[Anonymous], EFF NAS CONT POS AIR; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Chang CL, 2010, EUR RESPIR MONOGR, P302, DOI 10.1183/1025448x.00025409; Dempsey JA, 2002, CHEST, V122, P840, DOI 10.1378/chest.122.3.840; Dixon JB, 2005, INT J OBESITY, V29, P1048, DOI 10.1038/sj.ijo.0802960; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dixon JB, 2012, CIRCULATION, V126, P774, DOI 10.1161/CIRCULATIONAHA.111.040139; Favretti F, 2002, AM J SURG, V184, p38S, DOI 10.1016/S0002-9610(02)01178-9; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Greenburg DL, 2009, AM J MED, V122, P535, DOI 10.1016/j.amjmed.2008.10.037; GRUNSTEIN RR, 1995, SLEEP, V18, P635, DOI 10.1093/sleep/18.8.635; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Keating CL, 2009, DIABETES CARE, V32, P567, DOI 10.2337/dc08-1749; Kellett E, 1998, AUSTR GUIDE HLTH EAT; Khan A, 2009, MAYO CLIN PROC, V84, P795, DOI 10.1016/S0025-6196(11)60489-8; Mohsenin V, 2004, Minerva Med, V95, P291; Naughton MT, 2010, EUR RESPIR MONOGR, P396, DOI 10.1183/1025448x.00026209; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; O'Brien PE, 2005, OBES SURG, V15, P820, DOI 10.1381/0960892054222858; Patil SP, 2007, CHEST, V132, P325, DOI 10.1378/chest.07-0040; Pitsis AJ, 2002, AM J RESP CRIT CARE, V166, P860, DOI 10.1164/rccm.200204-342OC; Rosario Inell C, 2011, Minn Med, V94, P44; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Schwartz Alan R, 2008, Proc Am Thorac Soc, V5, P185, DOI 10.1513/pats.200708-137MG; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; Tuomilehto HPI, 2009, AM J RESP CRIT CARE, V179, P320, DOI 10.1164/rccm.200805-669OC; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Wright J, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001106; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	34	178	178	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1142	1149		10.1001/2012.jama.11580	http://dx.doi.org/10.1001/2012.jama.11580			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990273	Bronze			2022-12-28	WOS:000308861000030
J	Rodgers, GP; Collins, FS				Rodgers, Griffin P.; Collins, Francis S.			The Next Generation of Obesity Research No Time to Waste	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIFE-STYLE INTERVENTION; TRIAL; RISK		[Rodgers, Griffin P.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Rodgers, GP (corresponding author), NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	griffin.rodgers@nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Perkins E, 2012, J PEDIATR-US, V161, P31, DOI 10.1016/j.jpeds.2012.01.015; Spring B, 2012, ARCH INTERN MED, V172, P789, DOI 10.1001/archinternmed.2012.1044; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	7	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1095	1096		10.1001/2012.jama.11853	http://dx.doi.org/10.1001/2012.jama.11853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990265	Bronze, Green Published			2022-12-28	WOS:000308861000022
J	Talchai, C; Xuan, SH; Lin, HV; Sussel, L; Accili, D				Talchai, Chutima; Xuan, Shouhong; Lin, Hua V.; Sussel, Lori; Accili, Domenico			Pancreatic beta Cell Dedifferentiation as a Mechanism of Diabetic beta Cell Failure	CELL			English	Article							INSULIN-RECEPTOR; ALPHA-CELL; ISLET CELLS; STEM-CELLS; FOXO1; ENDOCRINE; DIFFERENTIATION; MICE; PROGENITORS; RESISTANCE	Diabetes is associated with beta cell failure. But it remains unclear whether the latter results from reduced beta cell number or function. FoxO1 integrates beta cell proliferation with adaptive beta cell function. We interrogated the contribution of these two processes to b cell dysfunction, using mice lacking FoxO1 in b cells. FoxO1 ablation caused hyperglycemia with reduced beta cell mass following physiologic stress, such as multiparity and aging. Surprisingly, lineage-tracing experiments demonstrated that loss of beta cell mass was due to beta cell dedifferentiation, not death. Dedifferentiated beta cells reverted to progenitor-like cells expressing Neurogenin3, Oct4, Nanog, and L-Myc. A subset of FoxO1-deficient beta cells adopted the alpha cell fate, resulting in hyperglucagonemia. Strikingly, we identify the same sequence of events as a feature of different models of murine diabetes. We propose that dedifferentiation trumps endocrine cell death in the natural history of beta cell failure and suggest that treatment of beta cell dysfunction should restore differentiation, rather than promoting beta cell replication.	[Talchai, Chutima; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA; [Xuan, Shouhong; Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Talchai, Chutima] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Bangkok 10330, Thailand; [Lin, Hua V.] Lilly China Res & Dev Ctr, Shanghai 201203, Peoples R China	Columbia University; Columbia University; Chulalongkorn University	Accili, D (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	da230@columbia.edu		Lin, Hua/0000-0001-5001-5567	Druckenmiller Fellowship of the New York Stem Cell Foundation; NIH [DK64819, DK58282, DK63608]; Brehm Coalition; Russell Berrie Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058282, R37DK058282, R01DK064819, R01DK057539, R01DK082590, P30DK063608] Funding Source: NIH RePORTER	Druckenmiller Fellowship of the New York Stem Cell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brehm Coalition; Russell Berrie Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Druckenmiller Fellowship of the New York Stem Cell Foundation to C.T., by NIH Grants DK64819, DK58282, and DK63608 (Columbia University Diabetes Research Center), the Brehm Coalition, and the Russell Berrie Foundation. We thank Drs. J.Y. Kim-Muller, T. Mastracci, H. Hua (Columbia University Medical Center), and S. Cinti (Universita Politecnica delle Marche) for advice and reagents and Q. Xu for excellent technical support. We thank members of the Accili laboratory for insightful discussion and critical reading of the manuscript.	Accili D, 2010, DIABETES OBES METAB, V12, P1, DOI 10.1111/j.1463-1326.2010.01296.x; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Elghazi L, 2009, GASTROENTEROLOGY, V136, P1091, DOI 10.1053/j.gastro.2008.11.043; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hur KY, 2010, DIABETES OBES METAB, V12, P20, DOI 10.1111/j.1463-1326.2010.01278.x; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi M, 2012, AM J PHYSIOL-ENDOC M, V302, pE603, DOI 10.1152/ajpendo.00469.2011; Lin HV, 2011, DIABETES, V60, P700, DOI 10.2337/db10-1056; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Movassat J, 1997, DIABETES, V46, P1445, DOI 10.2337/diabetes.46.9.1445; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rankin MM, 2010, ISLETS, V2, P345, DOI 10.4161/isl.2.6.13376; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Talchai C, 2009, DIABETES OBES METAB, V11, P38, DOI 10.1111/j.1463-1326.2009.01115.x; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Weinberg N, 2007, FORBES, V179, P56; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhao M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002666; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	57	904	948	14	150	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1223	1234		10.1016/j.cell.2012.07.029	http://dx.doi.org/10.1016/j.cell.2012.07.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980982	Bronze, Green Accepted			2022-12-28	WOS:000308928100015
J	Singer, T				Singer, Thea			NUTRITION The vitamin D complex	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; D DEFICIENCY; COPD											Banerjee A, 2012, CURR OPIN PHARMACOL, V12, P266, DOI 10.1016/j.coph.2012.01.014; Gold DR, 2012, ANN INTERN MED, V156, P156, DOI 10.7326/0003-4819-156-2-201201170-00013; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janssens W, 2011, VITAM HORM, V86, P379, DOI 10.1016/B978-0-12-386960-9.00017-4; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Persson LJ, 2012, AM J RESP CRIT CARE, V185, pA3889; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	9	6	6	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S10	S11		10.1038/489S10a	http://dx.doi.org/10.1038/489S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013708	Bronze			2022-12-28	WOS:000309167100006
